Citrus Sinensis ID: 002529

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-------820-------830-------840-------850-------860-------870-------880-------890-------900-------910--
Protein Sequence
MLKKEFISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVKVENPSGNWMQYRTRRDLPIDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLWSTVTVLDASRVYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDNFFLKVAARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRTREYPPVKVMQTAVVGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFADYSNAVVNIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIAAKTEWQDVMVLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILLVLFLCSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQKFSSSSSKGQSSRKTLLTSFLEIESPDLSNECLAPAAR
Secondary Structure (PSIPRED)
cccccEEEEcccccccccccccccEEEccccccccccEEEEccccccccccEEEEccccccccEEEEEEcccccEEEEEEEEEcccccccccccEEEEEEccEEEEEEEEEcccccEEEEEEEEcccccEEEEEEEcccccEEEEEEEcEEcccccccccccccccEEEEEEEEccccccccccccccccccEEEcccccccccccccccccEEEEccccccccccccccHHHHHHHcccccccEEEEEEcccccccEEEEEEEcccccccccccEEEEEEEcccccccccccccccccccccccccccccEEEcccEEEEEEEcccccccccHHHHHHHHHHHHHHccccccHHHHHHHHHHHccccccccccccccccccccccccccccccccEEEccccccccccccccccccccccEEEccccccccccccccccccccEEEccccccEEEcccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEEEHHHHHHHHHHHHHHHEEEEEEEccccccccccccccccccccccccccccccccccccccccEEEcHHHHHHHHHccccccccccccEEEEEEEccccEEEEEEcccccccHHHHHHHHHHHHHHccccccccEEEEEcccccEEEEEcccccccHHcccccccccccccHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccEEEccccccccccccccEEEEEEEcccccccHHHHHccccccccccccHHHHHHHHHHcccccccccccccccHHHHHHHHHHcccccccccccccccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccccEEEEEccccccccccccccEEEccccHcccccccEccccccccccccEEEEcccccccEEEEEEcccccEEEEEEEEEEcccccccccccEEEEEccccEEEEEEccccccEEEEEEEEcccccEEEEEEEccccccEEEEEEEcccccccccccccccEEEEEEEEEccccccccEEEccccccccEEccccccccccccccccccEEEEccccccccccccccHHHHHHccccccccccEEEEcccccccEEEEEEEHEHHccccccEEEEEEEEcccEccccccccccccccccEEEEcccccEEccccEEEEEEEEccccccccEEEEEEEEEEEcccccccHHHHHHHHHHHHHHccccccccccccccccccccEEEccccccEEEEEEEccccccccccHHHHHHHHHHEEEccccccccccccHHcccccEEEEcccccccccccHHHHccccccEEEEccccccccccHHHccccccccccccccccccccccccccEEEHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccEEcHHHHHHHHHHHHHHEccccccEEEEEEcccccEEEEEEEcccccccHHHHHHHHHHHHHHHHHHHHHHHEEccccccEEEEEEEcccccHHHHHccccccccccHHHHHHHHHHHHHHHHHHHccccccEccccccHHHEEEcccccEEEccccHHHHEccHHHHccccccccHHHccHHHHHHccccHHHHHHHHHHHHHHHHccccccccccccccccHHHHHHHHHHccccHHcEcccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHHHHHHccHccccccccccccccccccccccccccccccccccccccc
Coil and Loop (DISEMBL)
mlkkefisidcgstsnytdpstglawisdigimnngksvkvenpsgnwmqyrtrrdlpidnkkyCYNLITKERRRYLVRATFqygslgseasypkFQLYLDATLWSTVTVLDASRVYAKEMIirapsdsidvciccavtgspfistlelrplnlsmyatdfednFFLKVAARVNFGaltkdalrypddpydriwdsdldrrpnfvvgaasgtvrinttknietrtreyppvkvmQTAVVGTEGvlsyrlnledfpaNARAFAYFAEiqdlgpsetrkfkleqpyfadysNAVVNIAEnangsytlyepsymNVTLNFVLSFSFvktrdstlgpllNAIEISKYQKIAAKTEWQDVMVLEALRSIsdesertndrgdpcvpvpwewvtcstttppritkialsgknlkgeippelkNMEALTELwldgnfltgplpdmsrLIDLRIVHLenneltgslpsymgslpnlqelhiennsfvgeippalltgkvifkydnnpklhkESRRRMRFKLILGTSIGVLAILLVLFLCSLIVLRKLRRKISNQKSYEKADslrtstkpsntaysiargghfmdegvayfiplpeleeaTNNFCkkigkgsfgsvyygkmkdgKEVAVKIMADSCSHRTQQFVTEVALLSRihhrnlvpligyceeEHQRILVYEYMHngtlrdrlhgsvnqkplDWLTRLQIAHDAAKGLEYlhtgcnpgiihrdvkssnilldinmrakvsdfglsrqaeedlthissvargtvgyldpeyygnqqlteksdvYSFGVVLLELIsgkkpvsvedfGAELNIVHWARSMikkgdvisivdpvlignvkIESIWRIAEVAIQCVeqrgfsrpkMQEIVLAIQDSikiekggdqkfssssskgqssRKTLLTSFleiespdlsneclapaar
Flexible Loop (DISEMBL)
mlkkefisidcgstsnytdpstgLAWISDIGIMNNGKsvkvenpsgnwmqyrtrrdlpidnkKYCYNLITKERRRYLVRATFQygslgseasYPKFQLYLDATLWSTVTVLDASRVYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDNFFLKVAARVNFGaltkdalrypdDPYDriwdsdldrrpnfvvgaasgtvrinttknietrtreyppvkvmQTAVVGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFADYSNAVVNIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIAAKTEWQDVMVLEALRSisdesertndrgdpcvpvpwewvtcstttppritkialsgknlkgeipPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFkydnnpklhkesrRRMRFKLILGTSIGVLAILLVLFLCSLIVLRKLrrkisnqksyekadslrtstkpsntAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEqrgfsrpkmQEIVLAIQDSikiekggdqkfssssskgqssRKTLLTSfleiespdlsneclapaar
Low Complexity Region (SEG)
MLKKEFISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVKVENPSGNWMQYRTRRDLPIDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLWSTVTVLDASRVYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDNFFLKVAARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRTREYPPVKVMQTAVVGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFADYSNAVVNIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIAAKTEWQDVMVLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSigvlaillvlflcslivlRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEkggdqkfssssskgqssRKTLLTSFLEIESPDLSNECLAPAAR
Disordered region (IsUnstruct)
******ISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVKVENPSGNWMQYRTRRDLPIDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLWSTVTVLDASRVYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDNFFLKVAARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRTREYPPVKVMQTAVVGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFADYSNAVVNIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIAAKTEWQDVMVLEALR**************PCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILLVLFLCSLIVLRKLRR************************YSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI**********************************************
Disordered Region (DISOPRED)
*LKKEFISIDCGSTSNYTDPSTGLAWISDIGIMNNG***************RTRRDLPIDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLWSTVTVLDASRVYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDNFFLKVAARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRTREYPPVKVMQTAVVGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFADYSNAVVNIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIAAKTEWQDVMVLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIP*********************************TSIGVLAILLVLFLCSLIVLRKLRRK*************************************AYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAV***************TEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS***********************************************
Disordered Region (DISEMBL)
MLKKEFISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVKVENPSGNWMQYRTRRDLPIDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLWSTVTVLDASRVYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDNFFLKVAARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRTREYPPVKVMQTAVVGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFADYSNAVVNIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIAAKTEWQDVMVLEALRSISD*********DPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILLVLFLCSLIVLRKLRRKISN***************PSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE********************LLTSFLEIESPDLSNECLAPAAR
Disordered Region (DISPRO)
**KKEFISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVKVENPSGNWMQYRTRRDLPIDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLWSTVTVLDASRVYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDNFFLKVAARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRTREYPPVKVMQTAVVGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFADYSNAVVNIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIAAKTEWQDVMVLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKES*RRMRFKLILGTSIGVLAILLVLFLCSLIVLRKLRR************************************GVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG*****************************************
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MLKKEFISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVKVENPSGNWMQYRTRRDLPIDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLWSTVTVLDASRVYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDNFFLKVAARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRTREYPPVKVMQTAVVGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFADYSNAVVNIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIAAKTEWQDVMVLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILLVLFLCSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQKFSSSSSKGQSSRKTLLTSFLEIESPDLSNECLAPAAR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	912	2.2.26 [Sep-21-2011]
C0LGI2	929	Probable LRR receptor-lik	yes	no	0.989	0.970	0.731	0.0
Q8LKZ1	924	Nodulation receptor kinas	N/A	no	0.923	0.911	0.362	1e-131
Q9ZQQ7	886	Putative leucine-rich rep	no	no	0.903	0.930	0.349	1e-128
Q9ZQR3	868	Leucine-rich repeat recep	no	no	0.881	0.926	0.345	1e-128
Q8L4H4	925	Nodulation receptor kinas	N/A	no	0.929	0.916	0.349	1e-126
C0LGG4	890	Probable LRR receptor-lik	no	no	0.895	0.917	0.331	1e-126
O65924	881	Putative leucine-rich rep	no	no	0.872	0.903	0.334	1e-122
Q9FZB8	871	Probable LRR receptor-lik	no	no	0.860	0.901	0.332	1e-122
C0LGD6	852	Probable LRR receptor-lik	no	no	0.871	0.933	0.348	1e-121
Q9FZB1	872	Probable LRR receptor-lik	no	no	0.871	0.911	0.332	1e-121

>sp|C0LGI2|Y1677_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g67720 OS=Arabidopsis thaliana GN=At1g67720 PE=2 SV=1

 Score = 1353 bits (3501), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 666/911 (73%), Positives = 769/911 (84%), Gaps = 9/911 (0%)

Query: 5   EFISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVKVENPSGNWMQYRTRRDLPIDNKKY 64
           EF+SIDCG +SNYTDP TGL W+SD  I+  GK V + N + N MQYR RRD P DNKKY
Sbjct: 25  EFVSIDCGCSSNYTDPRTGLGWVSDSEIIKQGKPVTLANTNWNSMQYRRRRDFPTDNKKY 84

Query: 65  CYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLWSTVTVLDASRVYAKEMIIR 124
           CY L TKERRRY+VR TF YG LGSE +YPKFQLYLDAT W+TVT+ + SRVY +E+I+R
Sbjct: 85  CYRLSTKERRRYIVRTTFLYGGLGSEEAYPKFQLYLDATKWATVTIQEVSRVYVEELIVR 144

Query: 125 APSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDNFFLKVAARVNFGALTKDALR 184
           A S  +DVC+CCA+TGSPF+STLELRPLNLSMYATD+EDNFFLKVAARVNFGA   DALR
Sbjct: 145 ATSSYVDVCVCCAITGSPFMSTLELRPLNLSMYATDYEDNFFLKVAARVNFGAPNMDALR 204

Query: 185 YPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRTREYPPVKVMQTAVVGTEGV 244
           YPDDPYDRIW+SD+++RPN++VG A GT RINT+K I T TREYPP+KVMQTAVVGT+G+
Sbjct: 205 YPDDPYDRIWESDINKRPNYLVGVAPGTTRINTSKTINTLTREYPPMKVMQTAVVGTQGL 264

Query: 245 LSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFADYSNAVVNIAENANGSYT 304
           +SYRLNLEDFPANARA+AYFAEI++LG +ETRKFKL QPYF DYSNAVVNIAENANGSYT
Sbjct: 265 ISYRLNLEDFPANARAYAYFAEIEELGANETRKFKLVQPYFPDYSNAVVNIAENANGSYT 324

Query: 305 LYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIAAKTEWQDVMVLEALRSI 364
           LYEPSYMNVTL+FVL+FSF KT+DST GPLLNAIEISKY  I+ KT+  DV VL+A+RS+
Sbjct: 325 LYEPSYMNVTLDFVLTFSFGKTKDSTQGPLLNAIEISKYLPISVKTDRSDVSVLDAIRSM 384

Query: 365 SDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELW 424
           S +S+  ++ GDPC+PV W WV CS+T+PPR+TKIALS KNL+GEIPP +  MEALTELW
Sbjct: 385 SPDSDWASEGGDPCIPVLWSWVNCSSTSPPRVTKIALSRKNLRGEIPPGINYMEALTELW 444

Query: 425 LDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPA 484
           LD N LTG LPDMS+L++L+I+HLENN+L+GSLP Y+  LPNLQEL IENNSF G+IP A
Sbjct: 445 LDDNELTGTLPDMSKLVNLKIMHLENNQLSGSLPPYLAHLPNLQELSIENNSFKGKIPSA 504

Query: 485 LLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILLVLFLCSLIVLRKLRRKISN 544
           LL GKV+FKY+NNP+L  E++R+  F  ILG SI  +AILL+L   SL++L  LR+    
Sbjct: 505 LLKGKVLFKYNNNPELQNEAQRK-HFWQILGISIAAVAILLLLVGGSLVLLCALRK---- 559

Query: 545 QKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFG 604
            K  +K DS  T  K    AYS  RGGH +DEGVAYFI LP LEEAT+NF KK+G+GSFG
Sbjct: 560 TKRADKGDSTETKKK-GLVAYSAVRGGHLLDEGVAYFISLPVLEEATDNFSKKVGRGSFG 618

Query: 605 SVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 664
           SVYYG+MKDGKEVAVKI AD  SH  +QFVTEVALLSRIHHRNLVPLIGYCEE  +RILV
Sbjct: 619 SVYYGRMKDGKEVAVKITADPSSHLNRQFVTEVALLSRIHHRNLVPLIGYCEEADRRILV 678

Query: 665 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNIL 724
           YEYMHNG+L D LHGS + KPLDWLTRLQIA DAAKGLEYLHTGCNP IIHRDVKSSNIL
Sbjct: 679 YEYMHNGSLGDHLHGSSDYKPLDWLTRLQIAQDAAKGLEYLHTGCNPSIIHRDVKSSNIL 738

Query: 725 LDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLL 784
           LDINMRAKVSDFGLSRQ EEDLTH+SSVA+GTVGYLDPEYY +QQLTEKSDVYSFGVVL 
Sbjct: 739 LDINMRAKVSDFGLSRQTEEDLTHVSSVAKGTVGYLDPEYYASQQLTEKSDVYSFGVVLF 798

Query: 785 ELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQC 844
           EL+SGKKPVS EDFG ELNIVHWARS+I+KGDV  I+DP +  NVKIES+WR+AEVA QC
Sbjct: 799 ELLSGKKPVSAEDFGPELNIVHWARSLIRKGDVCGIIDPCIASNVKIESVWRVAEVANQC 858

Query: 845 VEQRGFSRPKMQEIVLAIQDSIKIEKGGDQKF---SSSSSKGQSSRKTLLTSFLEIESPD 901
           VEQRG +RP+MQE+++AIQD+I+IE+G +      SSSSSK QSSRKTLLTSFLE+ESPD
Sbjct: 859 VEQRGHNRPRMQEVIVAIQDAIRIERGNENGLKSSSSSSSKAQSSRKTLLTSFLELESPD 918

Query: 902 LSNECLAPAAR 912
           +S   LAPAAR
Sbjct: 919 ISRNSLAPAAR 929

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q8LKZ1|NORK_PEA Nodulation receptor kinase OS=Pisum sativum GN=NORK PE=1 SV=1

 Score =  469 bits (1207), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 329/907 (36%), Positives = 487/907 (53%), Gaps = 65/907 (7%)

Query: 6   FISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVKVENPSGNWMQYRTR---RDLPIDNK 62
           F SI C + SNYTDP T L + +D    ++  + + + P    + +R+    R   ID  
Sbjct: 34  FESIACCADSNYTDPKTNLNYTTDYRWYSDKSNCR-QIPE-ILLSHRSNINFRLFDIDEG 91

Query: 63  KYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLWSTVTVLDASRVYAKEM- 121
           K CYNL T + + YL+R TF + S+ +      F + + AT    VT   +SR+   E+ 
Sbjct: 92  KRCYNLPTIKDQVYLIRGTFPFDSVNT-----SFYVSIGATELGEVT---SSRLEDLEIE 143

Query: 122 -IIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDNFFLKVAARVNFGALTK 180
            + RAP D+ID C+      +PFIS LELRPL    Y  DF  N  LK+ +R N   + +
Sbjct: 144 GVFRAPKDNIDFCLLKEDV-NPFISQLELRPLP-EEYLHDFSTNV-LKLISRNNLCGI-E 199

Query: 181 DALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRTREYPPVKVMQTAVVG 240
           D +R+P D  DRIW +     P++ +      +  N + N+E   +  PP++V+QTA+  
Sbjct: 200 DDIRFPVDQNDRIWKAT--STPSYAL-----PLSFNVS-NVELNGKVTPPLQVLQTALTH 251

Query: 241 TEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFADYSNAVV-----NI 295
            E +    + LE          YF E+ D         K  Q  F  Y N+ +     ++
Sbjct: 252 PERLEFVHVGLETDDYEYSVLLYFLELND-------TLKAGQRVFDIYLNSEIKKEGFDV 304

Query: 296 AENANG-SYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIAAKTEWQD 354
            E  +  SYT+     +N++ N  L+ + VK   S  GPLLNA EI + +    +T+  D
Sbjct: 305 LEGGSKYSYTV-----LNISANGSLNITLVKASGSKFGPLLNAYEILQARPWIDETDQTD 359

Query: 355 VMVLEALRSISDESERTND-----RGDPCVPVPWEWVTCSTTTPPR-ITKIALSGKNLKG 408
           + V++ +R       + N+      GDPC+  PW+ V C  +     ITK+ LS  NLKG
Sbjct: 360 LEVIQKMRKELLLQNQDNEALESWSGDPCMLFPWKGVACDGSNGSSVITKLDLSSSNLKG 419

Query: 409 EIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQ 468
            IP  +  M  L  L L  N   G +P       L  V L  N+LTG LP  + SLP+L 
Sbjct: 420 TIPSSVTEMTKLQILNLSHNHFDGYIPSFPPSSLLISVDLSYNDLTGQLPESIISLPHLN 479

Query: 469 ELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRF-KLILGTSIGVLAILLVL 527
            L+   N  + +   A L   +I     N    + + ++ +F ++ +  +I   +IL+ L
Sbjct: 480 SLYFGCNQHMRDDDEAKLNSSLI-----NTDYGRCNAKKPKFGQVFMIGAITSGSILITL 534

Query: 528 FLCSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYF-IPLPE 586
            +  L   R   + I+ +    K   + T     N  +S+     F  + V+     L  
Sbjct: 535 AVVILFFCRYRHKSITLEGFGGKTYPMAT-----NIIFSLPSKDDFFIKSVSVKPFTLEY 589

Query: 587 LEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR 646
           +E AT  +   IG+G FGSVY G + DG+EVAVK+ + + +  T++F  E+ LLS I H 
Sbjct: 590 IELATEKYKTLIGEGGFGSVYRGTLDDGQEVAVKVRSATSTQGTREFDNELNLLSAIQHE 649

Query: 647 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGS-VNQKPLDWLTRLQIAHDAAKGLEYL 705
           NLVPL+GYC E  Q+ILVY +M NG+L DRL+G    +K LDW TRL IA  AA+GL YL
Sbjct: 650 NLVPLLGYCNEYDQQILVYPFMSNGSLLDRLYGEPAKRKILDWPTRLSIALGAARGLAYL 709

Query: 706 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTVGYLDPEY 764
           HT     +IHRDVKSSNILLD +M AKV+DFG S+ A +E  +++S   RGT GYLDPEY
Sbjct: 710 HTFPGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSYVSLEVRGTAGYLDPEY 769

Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 824
           Y  QQL+EKSDV+SFGVVLLE++SG++P++++    E ++V WA+  I+   V  IVDP 
Sbjct: 770 YKTQQLSEKSDVFSFGVVLLEIVSGREPLNIKRPRVEWSLVEWAKPYIRASKVDEIVDPG 829

Query: 825 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQKFSSSSSKGQ 884
           + G    E++WR+ EVA+QC+E     RP M +IV  ++D++ IE    +   S  S G 
Sbjct: 830 IKGGYHAEALWRVVEVALQCLEPYSTYRPCMVDIVRELEDALIIENNASEYMKSIDSLGG 889

Query: 885 SSRKTLL 891
           S+R +++
Sbjct: 890 SNRYSIV 896

Involved in the perception of symbiotic fungi and bacteria and required for the calcium spiking. Part of the perception/transduction system leading to nodulation or mycorrhizal infection.

Pisum sativum (taxid: 3888)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZQQ7|Y2144_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g14440 OS=Arabidopsis thaliana GN=At2g14440 PE=1 SV=1

 Score =  460 bits (1183), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 318/909 (34%), Positives = 482/909 (53%), Gaps = 85/909 (9%)

Query: 3   KKEFISIDCGSTSN---YTDPSTGLAWISDIGIMNNGKSVKVENPSG---NWMQYRTRRD 56
           ++ FIS+ CG  SN   Y +P T L +ISD+  +  GK+  ++N S        Y+  R 
Sbjct: 26  QQGFISLYCGLPSNESPYIEPLTNLTYISDVNFVRGGKTGNIKNNSDIDFTSRPYKVLRY 85

Query: 57  LPIDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLWSTVTV--LDAS 114
            P +  + CY+L  K+  +YL+R  F YG+     + P+F L+L   +W++V V  +D  
Sbjct: 86  FP-EGIRNCYSLSVKQGTKYLIRTLFFYGNYDGLNTSPRFDLFLGPNIWTSVDVQKVDGG 144

Query: 115 RVYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDNFFLKVAARVN 174
               +E+I     + +D+C+    T +P IS +ELRPL    Y         LK      
Sbjct: 145 DGVIEEIIHVTRCNILDICLVKTGTTTPMISAIELRPLRYDTYTARTGS---LKKILHFY 201

Query: 175 FGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRTREY-PPVKV 233
           F    K+ +RYP+D YDR+W          +  +     +INTT+N+   +  Y PP  V
Sbjct: 202 FTNSGKE-VRYPEDVYDRVW----------IPHSQPEWTQINTTRNVSGFSDGYNPPQDV 250

Query: 234 MQTAVVGTE--GVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKL--EQPYFADYS 289
           ++TA + T     L++    E       A+ YFAEIQ L  +ETR+FK+     Y+ DY 
Sbjct: 251 IKTASIPTNVSEPLTFTWMSESSDDETYAYLYFAEIQQLKANETRQFKILVNGVYYIDY- 309

Query: 290 NAVVNIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEI-SKYQKIAA 348
                       + TL  P+ +      V      KT  STL P +NAIEI S  Q   +
Sbjct: 310 ------IPRKFEAETLITPAALKCG-GGVCRVQLSKTPKSTLPPQMNAIEIFSVIQFPQS 362

Query: 349 KTEWQDVMVLEALRSISDESERTNDRGDPCVPVPWEW--VTCST---TTPPRITKIALSG 403
            T   +V+ ++ ++S    S R + +GDPCVP+ + W  V+C+    +TPPRI  + LS 
Sbjct: 363 DTNTDEVIAIKNIQSTYKVS-RISWQGDPCVPIQFSWMGVSCNVIDISTPPRIISLDLSS 421

Query: 404 KNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMG 462
             L G I P ++N+  L EL L  N LTG +P  +  L  LR + L NN LTG +P ++ 
Sbjct: 422 SGLTGVITPSIQNLTMLRELDLSNNNLTGVIPPSLQNLTMLRELDLSNNNLTGEVPEFLA 481

Query: 463 SLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNP--KLHKESRRRMRFKLILGTSIGV 520
           ++  L  +H+  N+  G +P AL         +NN   KL +   +   + + +  SI  
Sbjct: 482 TIKPLLVIHLRGNNLRGSVPQALQ------DRENNDGLKLLRGKHQPKSWLVAIVASISC 535

Query: 521 LAILLVLFLCSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAY 580
           +A+ +++ L  + + R  RRK S +K       +R S +  N  +  +            
Sbjct: 536 VAVTIIV-LVLIFIFR--RRKSSTRKV------IRPSLEMKNRRFKYS------------ 574

Query: 581 FIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALL 640
                E++E TNNF   +GKG FG VY+G + + ++VAVK+++ S +   ++F TEV LL
Sbjct: 575 -----EVKEMTNNFEVVLGKGGFGVVYHGFLNN-EQVAVKVLSQSSTQGYKEFKTEVELL 628

Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 700
            R+HH NLV L+GYC++ +   L+YE+M NG L++ L G      L+W  RL+IA ++A 
Sbjct: 629 LRVHHVNLVSLVGYCDKGNDLALIYEFMENGNLKEHLSGKRGGPVLNWPGRLKIAIESAL 688

Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGY 759
           G+EYLH GC P ++HRDVKS+NILL +   AK++DFGLSR       TH+S+   GT+GY
Sbjct: 689 GIEYLHIGCKPPMVHRDVKSTNILLGLRFEAKLADFGLSRSFLVGSQTHVSTNVAGTLGY 748

Query: 760 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 819
           LDPEYY    LTEKSDVYSFG+VLLE+I+G +PV +E    +  IV WA+SM+  GD+ S
Sbjct: 749 LDPEYYQKNWLTEKSDVYSFGIVLLEIITG-QPV-IEQSRDKSYIVEWAKSMLANGDIES 806

Query: 820 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI---EKGGDQKF 876
           I+D  L  +    S W+  E+A+ C+      RP M  +   + + ++I    K   Q  
Sbjct: 807 IMDRNLHQDYDTSSSWKALELAMLCINPSSTLRPNMTRVAHELNECLEIYNLTKRRSQDQ 866

Query: 877 SSSSSKGQS 885
           +SS S G +
Sbjct: 867 NSSKSSGHT 875

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZQR3|Y2451_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At2g14510 OS=Arabidopsis thaliana GN=At2g14510 PE=2 SV=1

 Score =  459 bits (1180), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 315/913 (34%), Positives = 484/913 (53%), Gaps = 109/913 (11%)

Query: 3   KKEFISIDCG--STSNYTDPSTGLAWISDIGIMNNGKSVKVENPSGN---WMQYRTRRDL 57
           ++ FIS+DCG  S  +Y +PS+ L +ISD+  +  GK+  ++N S     +  ++  R  
Sbjct: 26  QQGFISLDCGLPSKESYIEPSSNLTFISDVNFIRGGKTGNIQNNSRTNFIFKPFKVLRYF 85

Query: 58  PIDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLWSTVTVL--DASR 115
           P D  + CY+L  K+  +YL+R  F YG+     + P+F L+L   +W++V VL  D   
Sbjct: 86  P-DGIRNCYSLSVKQGTKYLIRTLFYYGNYDGLNTSPRFDLFLGPNIWTSVDVLIADVGD 144

Query: 116 VYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDNFFLKVAARVNF 175
              +E++    S+ +D+C+    T +P IS +ELRPL    Y         LK  A   F
Sbjct: 145 GVVEEIVHVTRSNILDICLVKTGTSTPMISAIELRPLRYDTYTARTGS---LKSMAHFYF 201

Query: 176 GALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRTREY-PPVKVM 234
              + +A+RYP+D YDR+W      +P +         +INTT+N+   +  Y PP  V+
Sbjct: 202 TN-SDEAIRYPEDVYDRVWMPY--SQPEWT--------QINTTRNVSGFSDGYNPPQGVI 250

Query: 235 QTAVVGTEGV--LSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFADYSNAV 292
           QTA + T G   L++  NLE       A+ +FAEIQ L  +ETR+FK+        +N V
Sbjct: 251 QTASIPTNGSEPLTFTWNLESSDDETYAYLFFAEIQQLKVNETREFKI-------LANGV 303

Query: 293 --VNIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEI-SKYQKIAAK 349
             ++       + TL  P+ +      V      KT  STL PL+NAIEI S  Q   + 
Sbjct: 304 DYIDYTPWKFEARTLSNPAPLKCE-GGVCRVQLSKTPKSTLPPLMNAIEIFSVIQFPQSD 362

Query: 350 TEWQDVMVLEALRSISDESERTNDRGDPCVPVPWEW--VTCST---TTPPRITKIALSGK 404
           T   +V+ ++ ++S    S R + +GDPCVP  + W  V+C+    +TPPRI  + LS  
Sbjct: 363 TNTDEVIAIKKIQSTYQLS-RISWQGDPCVPKQFSWMGVSCNVIDISTPPRIISLDLSLS 421

Query: 405 NLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSL 464
            L G I P ++N+  L EL                        L NN LTG +P ++ ++
Sbjct: 422 GLTGVISPSIQNLTMLREL-----------------------DLSNNNLTGEVPEFLATI 458

Query: 465 PNLQELHIENNSFVGEIPPALLT-----GKVIFKYDNNPKLHKESRRRMRFKLI-LGTSI 518
             L  +H+  N+  G +P AL       G  +F    +P + +  + + +  L+ +  SI
Sbjct: 459 KPLLVIHLRGNNLRGSVPQALQDREKNDGLKLFV---DPNITRRGKHQPKSWLVAIVASI 515

Query: 519 GVLAILLVLFLCSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGV 578
             +A+ +++ L  + + R  RRK S +K       +R S +  N  +  +          
Sbjct: 516 SCVAVTIIV-LVLIFIFR--RRKSSTRKV------IRPSLEMKNRRFKYS---------- 556

Query: 579 AYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVA 638
                  E++E TNNF   +GKG FG VY+G + + ++VAVK+++ S +   ++F TEV 
Sbjct: 557 -------EVKEMTNNFEVVLGKGGFGVVYHGFLNN-EQVAVKVLSQSSTQGYKEFKTEVE 608

Query: 639 LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDA 698
           LL R+HH NLV L+GYC+E     L+YE+M NG L++ L G      L+W +RL+IA ++
Sbjct: 609 LLLRVHHVNLVSLVGYCDEGIDLALIYEFMENGNLKEHLSGKRGGSVLNWSSRLKIAIES 668

Query: 699 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTV 757
           A G+EYLH GC P ++HRDVKS+NILL +   AK++DFGLSR        H+S+   GT+
Sbjct: 669 ALGIEYLHIGCQPPMVHRDVKSTNILLGLRFEAKLADFGLSRSFLVGSQAHVSTNVAGTL 728

Query: 758 GYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 817
           GYLDPEYY    LTEKSDVYSFG+VLLE I+G +PV +E    +  IV WA+SM+  GD+
Sbjct: 729 GYLDPEYYLKNWLTEKSDVYSFGIVLLESITG-QPV-IEQSRDKSYIVEWAKSMLANGDI 786

Query: 818 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQKFS 877
            SI+DP L  +    S W+  E+A+ C+      RP M  +   + + ++I        +
Sbjct: 787 ESIMDPNLHQDYDSSSSWKALELAMLCINPSSTQRPNMTRVAHELNECLEI-----YNLT 841

Query: 878 SSSSKGQSSRKTL 890
              S+ Q+S K+L
Sbjct: 842 KIRSQDQNSSKSL 854

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8L4H4|NORK_MEDTR Nodulation receptor kinase OS=Medicago truncatula GN=NORK PE=1 SV=2

 Score =  452 bits (1164), Expect = e-126,   Method: Compositional matrix adjust.
 Identities = 317/906 (34%), Positives = 472/906 (52%), Gaps = 58/906 (6%)

Query: 4   KEFISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVK-VENPSGNWMQYRTRRDLPIDNK 62
           K F SI C + SNYTDP T L + +D    ++ +S + +     +    +  R   I   
Sbjct: 32  KGFESIACCADSNYTDPKTTLTYTTDHIWFSDKRSCRQIPEILFSHRSNKNVRKFEIYEG 91

Query: 63  KYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLWSTVTVLDASRVYAKEM- 121
           K CYNL T + + YL+R  F + SL S      F + +  T    +  L +SR+   E+ 
Sbjct: 92  KRCYNLPTVKDQVYLIRGIFPFDSLNS-----SFYVSIGVT---ELGELRSSRLEDLEIE 143

Query: 122 -IIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDNFFLKVAARVNFGALTK 180
            + RA  D ID C+      +PFIS +ELRPL    Y   F  +  LK+ +R N G  T 
Sbjct: 144 GVFRATKDYIDFCLLKEDV-NPFISQIELRPLP-EEYLHGFGTSV-LKLISRNNLGD-TN 199

Query: 181 DALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRTREYPPVKVMQTAVVG 240
           D +R+PDD  DRIW     +R       ++  +  N + N++ +    PP++V+QTA+  
Sbjct: 200 DDIRFPDDQNDRIW-----KRKETSTPTSALPLSFNVS-NVDLKDSVTPPLQVLQTALTH 253

Query: 241 TEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFADYSNAVVN------ 294
            E +      LE        F +F E+     +  R F +       Y N  +       
Sbjct: 254 PERLEFVHDGLETDDYEYSVFLHFLELNGTVRAGQRVFDI-------YLNNEIKKEKFDV 306

Query: 295 IAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIAAKTEWQD 354
           +A  +  SYT      +N++ N  L+ + VK   S  GPLLNA EI + +    +T  +D
Sbjct: 307 LAGGSKNSYTA-----LNISANGSLNITLVKASGSEFGPLLNAYEILQARSWIEETNQKD 361

Query: 355 VMVLEALRSISDESERTND-----RGDPCVPVPWEWVTCSTTTPPRI-TKIALSGKNLKG 408
           + V++ +R       + N+      GDPC+  PW+ +TC  +T   I TK+ LS  NLKG
Sbjct: 362 LEVIQKMREELLLHNQENEALESWSGDPCMIFPWKGITCDDSTGSSIITKLDLSSNNLKG 421

Query: 409 EIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQ 468
            IP  +  M  L  L L  N      P       L  + L  N+L+G LP  + SLP+L+
Sbjct: 422 AIPSIVTKMTNLQILNLSHNQFDMLFPSFPPSSLLISLDLSYNDLSGWLPESIISLPHLK 481

Query: 469 ELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILLVLF 528
            L+   N  + +     L   +I     N    +   ++ +F  +          LL+  
Sbjct: 482 SLYFGCNPSMSDEDTTKLNSSLI-----NTDYGRCKAKKPKFGQVFVIGAITSGSLLITL 536

Query: 529 LCSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYF-IPLPEL 587
              ++   + R K    + + K   + T     N  +S+     F  + V+     L  +
Sbjct: 537 AVGILFFCRYRHKSITLEGFGKTYPMAT-----NIIFSLPSKDDFFIKSVSVKPFTLEYI 591

Query: 588 EEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRN 647
           E+AT  +   IG+G FGSVY G + DG+EVAVK+ + + +  T++F  E+ LLS I H N
Sbjct: 592 EQATEQYKTLIGEGGFGSVYRGTLDDGQEVAVKVRSSTSTQGTREFDNELNLLSAIQHEN 651

Query: 648 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQ-KPLDWLTRLQIAHDAAKGLEYLH 706
           LVPL+GYC E  Q+ILVY +M NG+L DRL+G  ++ K LDW TRL IA  AA+GL YLH
Sbjct: 652 LVPLLGYCNEYDQQILVYPFMSNGSLLDRLYGEASKRKILDWPTRLSIALGAARGLAYLH 711

Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTVGYLDPEYY 765
           T     +IHRDVKSSNILLD +M AKV+DFG S+ A +E  +++S   RGT GYLDPEYY
Sbjct: 712 TFPGRSVIHRDVKSSNILLDQSMCAKVADFGFSKYAPQEGDSYVSLEVRGTAGYLDPEYY 771

Query: 766 GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 825
             QQL+EKSDV+SFGVVLLE++SG++P++++    E ++V WA+  I+   V  IVDP +
Sbjct: 772 KTQQLSEKSDVFSFGVVLLEIVSGREPLNIKRPRIEWSLVEWAKPYIRASKVDEIVDPGI 831

Query: 826 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQKFSSSSSKGQS 885
            G    E++WR+ EVA+QC+E     RP M +IV  ++D++ IE    +   S  S G S
Sbjct: 832 KGGYHAEALWRVVEVALQCLEPYSTYRPCMVDIVRELEDALIIENNASEYMKSIDSLGGS 891

Query: 886 SRKTLL 891
           +R +++
Sbjct: 892 NRYSIV 897

Involved in the perception of symbiotic fungi and bacteria. Part of the perception/transduction system leading to nodulation or mycorrhizal infection.

Medicago truncatula (taxid: 3880)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGG4|Y1518_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51860 OS=Arabidopsis thaliana GN=At1g51860 PE=2 SV=2

 Score =  452 bits (1163), Expect = e-126,   Method: Compositional matrix adjust.
 Identities = 300/904 (33%), Positives = 479/904 (52%), Gaps = 87/904 (9%)

Query: 6   FISIDCG---STSNYTDPSTGLAWISDIGIMNNGKSVKVENPSGNWMQYRTR--RDLPID 60
           FIS+DCG     + YT+ ST + + SD+  +++G   K+ +      Q +    R  P+ 
Sbjct: 29  FISLDCGLVPKETTYTEKSTNITYKSDVDYIDSGLVGKINDAYKTQFQQQVWAVRSFPV- 87

Query: 61  NKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLWSTVTVLDASRVYAKE 120
            ++ CYN+      +YL+R TF YG+      +P F L++    WS+V +L  +     E
Sbjct: 88  GQRNCYNVNLTANNKYLIRGTFVYGNYDGLNQFPSFDLHIGPNKWSSVKILGVTNTSMHE 147

Query: 121 MIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDNFFLKVAARVNFGALTK 180
           +I   P DS++VC+      +PFIS+LE+RPLN   Y T       L + ARV F + + 
Sbjct: 148 IIHVVPQDSLEVCLVKTGPTTPFISSLEVRPLNNESYLTQSGS---LMLFARVYFPSSSS 204

Query: 181 DALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRTREYPPVKVMQTAVVG 240
             +RY +D +DR+W+S  D            TV I+T   I+T      P  VM+TA V 
Sbjct: 205 SFIRYDEDIHDRVWNSFTDDE----------TVWISTDLPIDTSNSYDMPQSVMKTAAVP 254

Query: 241 TEGVLSYRL--NLEDFPANARAFAYFAEIQDLGPSETRKFKLEQP----YFADYSNAVVN 294
                 + L   L++  A +  + +FAE+Q+L  +ETR+F +       +F+      ++
Sbjct: 255 KNASEPWLLWWTLDENTAQSYVYMHFAEVQNLTANETREFNITYNGGLRWFSYLRPPNLS 314

Query: 295 IAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIAA-KTEWQ 353
           I+       T++ P  ++ + N + +F+F  T +STL PLLNA+EI     I   +T   
Sbjct: 315 IS-------TIFNPRAVSSS-NGIFNFTFAMTGNSTLPPLLNALEIYTVVDILQLETNKD 366

Query: 354 DVMVLEALRSISDESERTNDRGDPCVP--VPWEWVTCS--TTTPPRITKIALSGKNLKGE 409
           +V  +  ++     S++ + +GDPC P    WE + CS   +   RI  + L+G  L G 
Sbjct: 367 EVSAMMNIKETYGLSKKISWQGDPCAPQLYRWEGLNCSYPDSEGSRIISLNLNGSELTGS 426

Query: 410 IPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQE 469
           I                         D+S+L  L ++ L NN+L+G +P++   + +L+ 
Sbjct: 427 I-----------------------TSDISKLTLLTVLDLSNNDLSGDIPTFFAEMKSLKL 463

Query: 470 LHIENNSFVG--EIPPAL---LTGK--VIFKYDNNPKLHKESRRRMRFKLILGTSIGVLA 522
           +++  N  +    IP +L   +  K   +   +N     K+  +++    I  +  GV A
Sbjct: 464 INLSGNPNLNLTAIPDSLQQRVNSKSLTLILGENLTLTPKKESKKVPMVAIAASVAGVFA 523

Query: 523 ILLVLFLCSLIVLRKLR-RKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYF 581
           +L++L +  +I  + ++  K            +++ T+ SN +  I R     +  + Y 
Sbjct: 524 LLVILAIFFVIKRKNVKAHKSPGPPPLVTPGIVKSETRSSNPSI-ITR-----ERKITY- 576

Query: 582 IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLS 641
              PE+ + TNNF + +GKG FG+VY+G + DG EVAVK+++ S +   ++F  EV LL 
Sbjct: 577 ---PEVLKMTNNFERVLGKGGFGTVYHGNL-DGAEVAVKMLSHSSAQGYKEFKAEVELLL 632

Query: 642 RIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 701
           R+HHR+LV L+GYC++     L+YEYM NG LR+ + G      L W  R+QIA +AA+G
Sbjct: 633 RVHHRHLVGLVGYCDDGDNLALIYEYMANGDLRENMSGKRGGNVLTWENRMQIAVEAAQG 692

Query: 702 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED-LTHISSVARGTVGYL 760
           LEYLH GC P ++HRDVK++NILL+    AK++DFGLSR    D   H+S+V  GT GYL
Sbjct: 693 LEYLHNGCRPPMVHRDVKTTNILLNERCGAKLADFGLSRSFPIDGECHVSTVVAGTPGYL 752

Query: 761 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 820
           DPEYY    L+EKSDVYSFGVVLLE+++  +PV ++      +I  W   M+ KGD+ SI
Sbjct: 753 DPEYYRTNWLSEKSDVYSFGVVLLEIVT-NQPV-IDKTRERPHINDWVGFMLTKGDIKSI 810

Query: 821 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE----KGGDQKF 876
           VDP L+G+      W+I E+A+ CV      RP M  +V+ + D + +E    +G ++ +
Sbjct: 811 VDPKLMGDYDTNGAWKIVELALACVNPSSNRRPTMAHVVMELNDCVALENARRQGSEEMY 870

Query: 877 SSSS 880
           S  S
Sbjct: 871 SMGS 874

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O65924|Y2921_ARATH Putative leucine-rich repeat receptor-like protein kinase At2g19210 OS=Arabidopsis thaliana GN=At2g19210 PE=3 SV=1

 Score =  440 bits (1131), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 305/911 (33%), Positives = 462/911 (50%), Gaps = 115/911 (12%)

Query: 6   FISIDCG--STSNYTDPSTGLAWISDIGIMNNGKSVKVE---NPSGNWMQYRTRRDLPID 60
           F+SIDCG    S+Y D +T + ++SD   + +G    ++     S    Q++  R  P  
Sbjct: 31  FVSIDCGIPEDSSYNDETTDIKYVSDAAFVESGTIHSIDPEFQTSSLEKQFQNVRSFPEG 90

Query: 61  NKKYCYNLITKERR--RYLVRATFQYGSLGSEASYPKFQLYLDATLWSTVTVLDASRVYA 118
           N+  CY++   + +  +YL+R  F YG+  +    P F LYL   +W +VT+ +A+ +  
Sbjct: 91  NRN-CYDVKPPQGKGFKYLIRTRFMYGNYDNLGKAPDFDLYLGFNIWDSVTIDNATTIVT 149

Query: 119 KEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDNFFLKVAARVNFGAL 178
           KE+I    SD + VC+     G+PF+S LE+R L  + Y T ++     K   R + G L
Sbjct: 150 KEIIHTLRSDHVHVCLVDKNRGTPFLSALEIRLLKSNTYETPYDSLILFK---RWDLGGL 206

Query: 179 TKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRTREYPPVKVMQTAV 238
               +RY DD +DRIW     R P + +  AS T+  N  +  +      P   VM TA 
Sbjct: 207 GALPVRYKDDVFDRIWIPL--RFPKYTIFNASLTIDSNNNEGFQ------PARFVMNTAT 258

Query: 239 VGTEGVLSYRLNLEDFPANARAFAY--FAEIQDLGPSETRKFKLEQPYFADYSNAVVNIA 296
              +       + E      + F Y  FAE+ +L  +ETR+FK+           ++N  
Sbjct: 259 SPEDLSQDIIFSWEPKDPTWKYFVYMHFAEVVELPSNETREFKV-----------LLNEK 307

Query: 297 ENANGSYTLYEPSYMNVTLNFV--------LSFSFVKTRDSTLGPLLNAIEISKYQK-IA 347
           E    S++   P Y+     FV        L F   +T  STL P++NAIE  +  + + 
Sbjct: 308 EINMSSFS---PRYLYTDTLFVQNPVSGPKLEFRLQQTPRSTLPPIINAIETYRVNEFLQ 364

Query: 348 AKTEWQDVMVLEALRSISDESERTNDRGDPCVPV--PWEWVTCS--TTTPPRITKIALSG 403
           + T+ QDV  +  +R  S    + +  GDPC PV  PW+ + CS      PRI  + LS 
Sbjct: 365 SPTDQQDVDAI--MRIKSKYGVKKSWLGDPCAPVKYPWKDINCSYVDNESPRIISVNLSS 422

Query: 404 KNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGS 463
             L GEI               D  F        S L  L I+ L NN LTG +P ++G+
Sbjct: 423 SGLTGEI---------------DAAF--------SNLTLLHILDLSNNSLTGKIPDFLGN 459

Query: 464 LPNLQELHIENNSFVGEIPPALLTGK----VIFKYDNNPKL---------HKESRRRMRF 510
           L NL EL++E N   G IP  LL       ++ + D NP L          +++++ +  
Sbjct: 460 LHNLTELNLEGNKLSGAIPVKLLERSNKKLILLRIDGNPDLCVSASCQISDEKTKKNVYI 519

Query: 511 KLILGTSIGVLAILLVLFLCSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARG 570
             ++ + +GVL ++L +   +L +L K R +        +A  L T+ +           
Sbjct: 520 IPLVASVVGVLGLVLAI---ALFLLYKKRHRRGGSGGV-RAGPLDTTKR----------- 564

Query: 571 GHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT 630
                     +    E+ + TNNF + +G+G FG VY+G + D  +VAVKI+++S +   
Sbjct: 565 ----------YYKYSEVVKVTNNFERVLGQGGFGKVYHGVLND-DQVAVKILSESSAQGY 613

Query: 631 QQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLT 690
           ++F  EV LL R+HH+NL  LIGYC E  +  L+YE+M NGTL D L G      L W  
Sbjct: 614 KEFRAEVELLLRVHHKNLTALIGYCHEGKKMALIYEFMANGTLGDYLSGE-KSYVLSWEE 672

Query: 691 RLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 750
           RLQI+ DAA+GLEYLH GC P I+ RDVK +NIL++  ++AK++DFGLSR    D  +  
Sbjct: 673 RLQISLDAAQGLEYLHNGCKPPIVQRDVKPANILINEKLQAKIADFGLSRSVALDGNNQD 732

Query: 751 SVA-RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE-LNIVHWA 808
           + A  GT+GYLDPEY+  Q+L+EKSD+YSFGVVLLE++SG+  ++     AE ++I    
Sbjct: 733 TTAVAGTIGYLDPEYHLTQKLSEKSDIYSFGVVLLEVVSGQPVIARSRTTAENIHITDRV 792

Query: 809 RSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 868
             M+  GD+  IVDP L       S W+I EVA+ C      +RP M  +V  +++S+  
Sbjct: 793 DLMLSTGDIRGIVDPKLGERFDAGSAWKITEVAMACASSSSKNRPTMSHVVAELKESVSR 852

Query: 869 EKGGDQKFSSS 879
            + G    +SS
Sbjct: 853 ARAGGGSGASS 863

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FZB8|Y5181_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51810 OS=Arabidopsis thaliana GN=At1g51810 PE=2 SV=1

 Score =  439 bits (1128), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 302/907 (33%), Positives = 474/907 (52%), Gaps = 122/907 (13%)

Query: 6   FISIDCGST---SNYTDPSTGLAWISDIGIMNNGKSVKV--ENPSGNWMQYRTRRDLPID 60
           FI++DCG +   S Y + STGL + SD G + +GK  K+  E  S      RT R  P D
Sbjct: 26  FINLDCGLSIQGSPYKESSTGLTYTSDDGFVQSGKIGKITKELESLYKKPERTLRYFP-D 84

Query: 61  NKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLWSTVTVLDASRVYAKE 120
             + C++L      +YL++ TF YG+       P F LY+   +W TV   +      KE
Sbjct: 85  GVRNCFSLNVTRGTKYLIKPTFLYGNYDGRNVIPDFDLYIGPNMWITVNTDNT----IKE 140

Query: 121 MIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDNFFLKVAARVNFGALTK 180
           ++  + S+++ VC+    T  P+I+TLELRPL   +Y  +      L    RV +  L K
Sbjct: 141 ILHVSKSNTLQVCLVKTGTSIPYINTLELRPLADDIYTNESGS---LNYLFRVYYSNL-K 196

Query: 181 DALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRTREYPPVKVMQTAVV- 239
             + YPDD +DRIW   L  +   ++   +  ++IN + + +       P +VM+TAV  
Sbjct: 197 GYIEYPDDVHDRIWKQILPYQDWQIL---TTNLQINVSNDYDL------PQRVMKTAVTP 247

Query: 240 --GTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFADYSNAVVNIAE 297
              +   + +  NLE   +    F +FAE+Q L  +ETR+F               N+  
Sbjct: 248 IKASTTTMEFPWNLEPPTSQFYLFLHFAELQSLQANETREF---------------NVVL 292

Query: 298 NANGSYTLYEPSYMNVTLNFVLS----------FSFVKTRDSTLGPLLNAIE---ISKYQ 344
           N N ++  Y P ++ +   +  +             VKT  STL PL+NA+E   +  + 
Sbjct: 293 NGNVTFKSYSPKFLEMQTVYSTAPKQCDGGKCLLQLVKTSRSTLPPLINAMEAYTVLDFP 352

Query: 345 KIAAKTEWQDVMVLEALRSISDESERTNDRGDPCVP--VPWEWVTCSTT---TPPRITKI 399
           +I  +T   +V+ ++ ++S    S +T  +GDPCVP    W+ + C+ +   TPP IT +
Sbjct: 353 QI--ETNVDEVIAIKNIQSTYGLS-KTTWQGDPCVPKKFLWDGLNCNNSDDSTPPIITSL 409

Query: 400 ALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPS 459
            LS   L G I   ++N+  L EL                        L NN L+G +P 
Sbjct: 410 NLSSSGLTGIIVLTIQNLANLQEL-----------------------DLSNNNLSGGVPE 446

Query: 460 YMGSLPNLQELHIENNSFVGEIPPALLTGKVI-FKYDNNPKLH----------KESRRRM 508
           ++  + +L  +++  N+  G +P  L+  K++    + NPKL+          +E  R++
Sbjct: 447 FLADMKSLLVINLSGNNLSGVVPQKLIEKKMLKLNIEGNPKLNCTVESCVNKDEEGGRQI 506

Query: 509 RFKLI-LGTSIGVLAILLVLFLCSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYS- 566
           +   I +  SIG +    V F  +L++   +R+   N  S ++A +  +   P+++  S 
Sbjct: 507 KSMTIPIVASIGSV----VAFTVALMIFCVVRK---NNPSNDEAPT--SCMLPADSRSSE 557

Query: 567 ---IARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMA 623
              + +   F            E+   TNNF K +GKG FG VYYG +   ++VAVK+++
Sbjct: 558 PTIVTKNKKFT---------YAEVLTMTNNFQKILGKGGFGIVYYGSVNGTEQVAVKMLS 608

Query: 624 DSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQ 683
            S +   +QF  EV LL R+HH+NLV L+GYCEE  +  L+YEYM NG L + + G    
Sbjct: 609 HSSAQGYKQFKAEVELLLRVHHKNLVGLVGYCEEGDKLALIYEYMANGDLDEHMSGKRGG 668

Query: 684 KPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 743
             L+W TRL+IA +AA+GLEYLH GC P ++HRDVK++NILL+ +   K++DFGLSR   
Sbjct: 669 SILNWGTRLKIALEAAQGLEYLHNGCKPLMVHRDVKTTNILLNEHFDTKLADFGLSRSFP 728

Query: 744 -EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL 802
            E  TH+S+V  GT+GYLDPEYY    LTEKSDVYSFGVVLL +I+  +PV ++    + 
Sbjct: 729 IEGETHVSTVVAGTIGYLDPEYYRTNWLTEKSDVYSFGVVLLVMIT-NQPV-IDQNREKR 786

Query: 803 NIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 862
           +I  W   M+ KGD+ SI DP L+G+    S+W+  E+A+ C+     +RP M ++V  +
Sbjct: 787 HIAEWVGGMLTKGDIKSITDPNLLGDYNSGSVWKAVELAMSCMNPSSMTRPTMSQVVFEL 846

Query: 863 QDSIKIE 869
           ++ +  E
Sbjct: 847 KECLASE 853

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGD6|Y1570_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g05700 OS=Arabidopsis thaliana GN=At1g05700 PE=2 SV=1

 Score =  437 bits (1123), Expect = e-121,   Method: Compositional matrix adjust.
 Identities = 309/887 (34%), Positives = 453/887 (51%), Gaps = 92/887 (10%)

Query: 6   FISIDCG--STSNYTDPSTGLAWISDIGIMNNGKSVKVENPSGNWMQYRTRRDLPIDNKK 63
           FISIDCG  S S+Y D +TG+ ++SD   +  G S  +  P     Q +  R  P +  +
Sbjct: 31  FISIDCGIPSGSSYKDDTTGINYVSDSSFVETGVSKSI--PFTAQRQLQNLRSFP-EGSR 87

Query: 64  YCYNLI--TKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLWSTVTVLDASRVYAKEM 121
            CY LI    + ++YL+RA+F YG+   E   P+F L+L   +W TV + + S + +KE+
Sbjct: 88  NCYTLIPIQGKGKKYLIRASFMYGNYDGENGSPEFDLFLGGNIWDTVLLSNGSSIVSKEV 147

Query: 122 IIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDNFFLKVAARVNFGALTKD 181
           +  + S++I VC+     G+PFISTLELR L       D   N  L  + R +  +L   
Sbjct: 148 VYLSQSENIFVCLGNKGKGTPFISTLELRFLGNDNTTYD-SPNGALFFSRRWDLRSLMGS 206

Query: 182 ALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVR-INTTKNIETRTREYPPVK-VMQTAVV 239
            +RY DD YDRIW   + R  NF      G  R INT+  + +    Y     VM TA+ 
Sbjct: 207 PVRYDDDVYDRIW---IPR--NF------GYCREINTSLPVTSDNNSYSLSSLVMSTAMT 255

Query: 240 GTEGVLSYRLNLEDFPANARAFAY--FAEIQDLG--PSETRKFKLEQPYFADYSNAVVNI 295
                    + LE+   N R F Y  FAE++DL   P++TR+F        D S   V +
Sbjct: 256 PINTTRPITMTLENSDPNVRYFVYMHFAEVEDLSLKPNQTREF--------DISINGVTV 307

Query: 296 AENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIAAK-TEWQD 354
           A   +  Y      ++N      ++FS V+T  STL P++NA+EI      +   T  +D
Sbjct: 308 AAGFSPKYLQTNTFFLNPESQSKIAFSLVRTPKSTLPPIVNALEIYVANSFSQSLTNQED 367

Query: 355 VMVLEALRSISDESERTNDRGDPCVP--VPWEWVTCS--TTTPPRITKIALSGKNLKGEI 410
              + +L++      + N  GDPC+P    WE + CS  + TPPRIT + LS   L G I
Sbjct: 368 GDAVTSLKT--SYKVKKNWHGDPCLPNDYIWEGLNCSYDSLTPPRITSLNLSSSGLTGHI 425

Query: 411 PPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQEL 470
                N+  + EL                        L NN LTG +P ++  L  L+ L
Sbjct: 426 SSSFSNLTMIQEL-----------------------DLSNNGLTGDIPEFLSKLKFLRVL 462

Query: 471 HIENNSFVGEIPPALL----TGKVIFKYDNNPKLHKE-SRRRMRFKLILGTSIGVLAILL 525
           ++ENN+  G +P  LL    TG    +   NP L  E S R+   K ++   +   A L 
Sbjct: 463 NLENNTLTGSVPSELLERSNTGSFSLRLGENPGLCTEISCRKSNSKKLVIPLVASFAALF 522

Query: 526 VLFLCSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLP 585
           +L L S +  R   R+    KS   A       K  N                       
Sbjct: 523 ILLLLSGVFWRIRNRR---NKSVNSAPQTSPMAKSEN----------------KLLFTFA 563

Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 645
           ++ + TNNF + +GKG FG+VY+G   D  +VAVK+++++ +   ++F +EV +L R+HH
Sbjct: 564 DVIKMTNNFGQVLGKGGFGTVYHG-FYDNLQVAVKLLSETSAQGFKEFRSEVEVLVRVHH 622

Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 705
            NL  LIGY  E  Q  L+YE+M NG + D L G   Q  L W  RLQIA DAA+GLEYL
Sbjct: 623 VNLTALIGYFHEGDQMGLIYEFMANGNMADHLAGKY-QHTLSWRQRLQIALDAAQGLEYL 681

Query: 706 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE-EDLTHISSVARGTVGYLDPEY 764
           H GC P I+HRDVK+SNILL+   RAK++DFGLSR    E  +H+S++  GT GYLDP  
Sbjct: 682 HCGCKPPIVHRDVKTSNILLNEKNRAKLADFGLSRSFHTESRSHVSTLVAGTPGYLDPLC 741

Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK-GDVISIVDP 823
           +    L EKSD+YSFGVVLLE+I+GK  +  E     +++  W  S+++   DV +++D 
Sbjct: 742 FETNGLNEKSDIYSFGVVLLEMITGKTVIK-ESQTKRVHVSDWVISILRSTNDVNNVIDS 800

Query: 824 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 870
            +  +  + S+W++ E+A+  V Q    RP M  IV  + + ++ E+
Sbjct: 801 KMAKDFDVNSVWKVVELALSSVSQNVSDRPNMPHIVRGLNECLQREE 847

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FZB1|Y5188_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51880 OS=Arabidopsis thaliana GN=At1g51880 PE=2 SV=1

 Score =  436 bits (1121), Expect = e-121,   Method: Compositional matrix adjust.
 Identities = 297/892 (33%), Positives = 462/892 (51%), Gaps = 97/892 (10%)

Query: 6   FISIDCG---STSNYTDPSTGLAWISDIGIMNNG--KSVKVENPSGNWMQYRTRRDLPID 60
           FIS+DCG     + YT+ +T + + SD   +++G    +  E  +    Q  T R  P +
Sbjct: 29  FISLDCGLVPKNATYTEKTTNITYKSDANYIDSGLVGRISAEYKAQLQQQTWTVRSFP-E 87

Query: 61  NKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLWSTVTVLDASRVYAKE 120
            ++ CYN     + RYL+RATF YG+       PKF +++  + W++V +         E
Sbjct: 88  GERNCYNFNLTAKSRYLIRATFTYGNYDGLRQVPKFDIHIGPSKWTSVKLDGVGNGAVLE 147

Query: 121 MIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDNFFLKVAARVNFGALTK 180
           MI     D + +C+     G PFIS+LELRPLN + Y T       L   ARV F A T 
Sbjct: 148 MIHVLTQDRLQICLVKTGKGIPFISSLELRPLNNNTYLTQSGS---LIGFARVFFSA-TP 203

Query: 181 DALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRTREYPPVKVMQTAVVG 240
             +RY +D +DR+W          V    +G   I+T   ++T      P  V +TA V 
Sbjct: 204 TFIRYDEDIHDRVW----------VRQFGNGLKSISTDLLVDTSNPYDVPQAVAKTACVP 253

Query: 241 TEGV--LSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFADYSNAVVNIAEN 298
           +     L +   L++  + +  + +FAEIQ L  ++ R+F           N   N  +N
Sbjct: 254 SNASQPLIFDWTLDNITSQSYVYMHFAEIQTLKDNDIREF-----------NITYNGGQN 302

Query: 299 ANGSYTLYEPSYMNVTLNF----------VLSFSFVKTRDSTLGPLLNAIEISK-YQKIA 347
               Y+   P    ++  F            S SF KT +STL PL+N +EI K    + 
Sbjct: 303 V---YSYLRPEKFEISTLFDSKPLSSPDGSFSLSFTKTGNSTLPPLINGLEIYKVLDLLE 359

Query: 348 AKTEWQDVMVLEALRSISDESERTNDRGDPCVPVPWEW--VTCS--TTTPPRITKIALSG 403
            +T+  +V  +  +++  D S++ + +GDPC P  ++W  + CS   +  PRI  + L+ 
Sbjct: 360 LETDQDEVSAMINIKATYDLSKKVSWQGDPCAPKSYQWEGLNCSYPNSDQPRIISLNLAE 419

Query: 404 KNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGS 463
             L G I PE+  +  L EL L  N L+G +P+     D++++ L N  L+G+L     +
Sbjct: 420 NKLTGTITPEISKLTQLIELDLSKNDLSGEIPEF--FADMKLLKLIN--LSGNL-GLNST 474

Query: 464 LPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAI 523
           +P+  +  +++ S +      L+  K + K        K   +++    I+ +  GV A+
Sbjct: 475 IPDSIQQRLDSKSLI------LILSKTVTK----TVTLKGKSKKVPMIPIVASVAGVFAL 524

Query: 524 LLVLFLCSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIP 583
           L++L +  ++     RRK  N +S  K  +    TK     Y                  
Sbjct: 525 LVILAIFFVV-----RRK--NGES-NKGTNPSIITKERRITY------------------ 558

Query: 584 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI 643
            PE+ + TNNF + +GKG FG+VY+G ++D  +VAVK+++ S +   ++F  EV LL R+
Sbjct: 559 -PEVLKMTNNFERVLGKGGFGTVYHGNLED-TQVAVKMLSHSSAQGYKEFKAEVELLLRV 616

Query: 644 HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 703
           HHRNLV L+GYC++     L+YEYM NG L++ + G      L W  R+QIA +AA+GLE
Sbjct: 617 HHRNLVGLVGYCDDGDNLALIYEYMANGDLKENMSGKRGGNVLTWENRMQIAVEAAQGLE 676

Query: 704 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED-LTHISSVARGTVGYLDP 762
           YLH GC P ++HRDVK++NILL+    AK++DFGLSR    D  +H+S+V  GT GYLDP
Sbjct: 677 YLHNGCTPPMVHRDVKTTNILLNERYGAKLADFGLSRSFPVDGESHVSTVVAGTPGYLDP 736

Query: 763 EYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 822
           EYY    L+EKSDVYSFGVVLLE+++  +PV+ +      +I  W  SM+ KGD+ SI+D
Sbjct: 737 EYYRTNWLSEKSDVYSFGVVLLEIVT-NQPVT-DKTRERTHINEWVGSMLTKGDIKSILD 794

Query: 823 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQ 874
           P L+G+      W+I E+A+ CV      RP M  +V  + + + +E    Q
Sbjct: 795 PKLMGDYDTNGAWKIVELALACVNPSSNRRPTMAHVVTELNECVALENARRQ 846

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	912
224107699	934	predicted protein [Populus trichocarpa]	0.993	0.970	0.798	0.0
224100089	932	predicted protein [Populus trichocarpa]	0.993	0.972	0.796	0.0
255547926	911	protein with unknown function [Ricinus c	0.969	0.970	0.783	0.0
225425928	930	PREDICTED: probable LRR receptor-like se	0.992	0.973	0.769	0.0
297738322	926	unnamed protein product [Vitis vinifera]	0.987	0.973	0.767	0.0
356567402	929	PREDICTED: probable LRR receptor-like se	0.991	0.973	0.753	0.0
449512995	956	PREDICTED: probable LRR receptor-like se	0.984	0.939	0.762	0.0
356538111	930	PREDICTED: probable LRR receptor-like se	0.991	0.972	0.748	0.0
449435025	923	PREDICTED: LOW QUALITY PROTEIN: probable	0.984	0.972	0.763	0.0
357463139	930	Leucine-rich repeat family protein / pro	0.991	0.972	0.738	0.0

>gi|224107699|ref|XP_002314568.1| predicted protein [Populus trichocarpa] gi|222863608|gb|EEF00739.1| predicted protein [Populus trichocarpa]

 Score = 1517 bits (3928), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 729/913 (79%), Positives = 811/913 (88%), Gaps = 7/913 (0%)

Query: 5   EFISIDCGSTSNYTDPSTGLAWISDIG-IMNNGKSVKVENPSGNWMQYRTRRDLPIDNKK 63
           EFISIDCG TSNYTDP TGLAW+SD G IMN GKS +VE P+GN MQYR RRD PID+KK
Sbjct: 24  EFISIDCGGTSNYTDPITGLAWVSDNGAIMNYGKSAEVEIPNGN-MQYRRRRDFPIDSKK 82

Query: 64  YCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLWSTVTVLDASRVYAKEMII 123
           YCY L TKERRRYLVRATFQYG LG+  +YPKF LYLDAT WSTV VLDASRVY KEMII
Sbjct: 83  YCYTLGTKERRRYLVRATFQYGILGNGDAYPKFDLYLDATKWSTVVVLDASRVYVKEMII 142

Query: 124 RAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDNFFLKVAARVNFGALTKDAL 183
           RAPS SIDVCICCA TGSPFISTLELRPLNLSMYATDFEDNFFL+VAARVNFGAL+KD +
Sbjct: 143 RAPSSSIDVCICCASTGSPFISTLELRPLNLSMYATDFEDNFFLEVAARVNFGALSKDVI 202

Query: 184 RYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRTREYPPVKVMQTAVVGTEG 243
           RYPDDPYDRIWDSDL++R N++VG A GTVRINT+K I+TRTREYPPVKVMQTAVVGT+G
Sbjct: 203 RYPDDPYDRIWDSDLEKRQNYLVGVAPGTVRINTSKYIDTRTREYPPVKVMQTAVVGTQG 262

Query: 244 VLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFADYSNAVVNIAENANGSY 303
           +LSYRLNL+DFPANARA+AYFAEI+DLG +ETRKFKL+QPYF DYSNAVVNIAENANGS+
Sbjct: 263 ILSYRLNLDDFPANARAYAYFAEIEDLGANETRKFKLQQPYFPDYSNAVVNIAENANGSH 322

Query: 304 TLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIAAKTEWQDVMVLEALRS 363
           TLYEPSYMNVTL+FVLSFSFVKTRDST GPLLNAIEISKY KI  +T+ QDV VL ALRS
Sbjct: 323 TLYEPSYMNVTLDFVLSFSFVKTRDSTQGPLLNAIEISKYLKIEPRTDSQDVTVLNALRS 382

Query: 364 ISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTEL 423
           +S ES  TN++GDPCVP  W+WV C++TTPPRITKIALSGKNLKGEIPPE+ NME LTEL
Sbjct: 383 LSAESAWTNEQGDPCVPAHWDWVNCTSTTPPRITKIALSGKNLKGEIPPEINNMETLTEL 442

Query: 424 WLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPP 483
           WLDGNFLTGP+P +S L++L+IVHLENN+L+G LP Y+GSLP+LQEL+I+NN F GEIP 
Sbjct: 443 WLDGNFLTGPIPSISNLVNLKIVHLENNKLSGQLPKYLGSLPDLQELYIQNNYFSGEIPS 502

Query: 484 ALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILLVLFLCSLIVLRKLRRKIS 543
            LLTGKVI  Y++NP LHKE+ ++   KLILG SIG+LA LLV+ + SL+ LR L+RK S
Sbjct: 503 GLLTGKVIINYEHNPGLHKEAGKKKHSKLILGVSIGILAALLVVLIGSLLFLRNLQRKTS 562

Query: 544 NQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSF 603
           +QK+  +  SLR S KPS TAYS++RG H MDEGV+Y+IPL E+EEAT NF KKIG+GSF
Sbjct: 563 HQKTAVQGSSLRVSAKPS-TAYSVSRGWHMMDEGVSYYIPLSEIEEATKNFSKKIGRGSF 621

Query: 604 GSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 663
           G+VYYG+MK+GKEVAVKIM DS +H TQQFVTEVALLSRIHHRNLVPLIGYCEEE+QRIL
Sbjct: 622 GTVYYGQMKEGKEVAVKIMGDSTTHMTQQFVTEVALLSRIHHRNLVPLIGYCEEENQRIL 681

Query: 664 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNI 723
           VYEYMHNGTLRD +HGSVNQK LDWL RLQIA D+AKGLEYLHTGCNP IIHRDVK+SNI
Sbjct: 682 VYEYMHNGTLRDHIHGSVNQKRLDWLARLQIAEDSAKGLEYLHTGCNPSIIHRDVKTSNI 741

Query: 724 LLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVL 783
           LLDINMRAKVSDFGLSRQAEEDLTH+SSVARGTVGYLDPEYY NQQLTEKSDVYSFGVVL
Sbjct: 742 LLDINMRAKVSDFGLSRQAEEDLTHVSSVARGTVGYLDPEYYANQQLTEKSDVYSFGVVL 801

Query: 784 LELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQ 843
           LEL+SGKKPVS EDFGAE+NIVHWAR++I+KGD +SIVDPVLIGNVKIESIWRIAEVAIQ
Sbjct: 802 LELLSGKKPVSTEDFGAEMNIVHWARALIRKGDAMSIVDPVLIGNVKIESIWRIAEVAIQ 861

Query: 844 CVEQRGFSRPKMQEIVLAIQDSIKIEKG--GDQKFSSSSSKGQSSRKTLLTSFLEIE--S 899
           CVEQR  SRP+MQEI+LAIQ++ KIEKG  G QK  S SSK QSSRKTLLTSFLEIE  S
Sbjct: 862 CVEQRAVSRPRMQEIILAIQEANKIEKGTYGSQKLPSGSSKAQSSRKTLLTSFLEIESQS 921

Query: 900 PDLSNECLAPAAR 912
           PDLSN CL PAAR
Sbjct: 922 PDLSNGCLVPAAR 934

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224100089|ref|XP_002311739.1| predicted protein [Populus trichocarpa] gi|222851559|gb|EEE89106.1| predicted protein [Populus trichocarpa]

 Score = 1492 bits (3863), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 726/911 (79%), Positives = 806/911 (88%), Gaps = 5/911 (0%)

Query: 5   EFISIDCGSTSNYTDPSTGLAWISDIG-IMNNGKSVKVENPSGNWMQYRTRRDLPIDNKK 63
           EFISIDCG TSNYTDP TGLAW+SD G IM  GKS + +  +GN  QY+ RRD PID+ K
Sbjct: 24  EFISIDCGGTSNYTDPRTGLAWVSDNGTIMKYGKSSEAQVSNGN-TQYQRRRDFPIDSNK 82

Query: 64  YCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLWSTVTVLDASRVYAKEMII 123
           YCY L TKERRRYLVRATFQYGS  +E +YPKF LYLD T WST+ VLDASRVY KEMII
Sbjct: 83  YCYTLGTKERRRYLVRATFQYGSSENEDAYPKFDLYLDTTKWSTMVVLDASRVYVKEMII 142

Query: 124 RAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDNFFLKVAARVNFGALTKDAL 183
           RAPS SIDVCICCA TGSPFISTLELRPLNLSMYATDFEDNFFL+VAARVNFGAL+KDA+
Sbjct: 143 RAPSSSIDVCICCATTGSPFISTLELRPLNLSMYATDFEDNFFLEVAARVNFGALSKDAI 202

Query: 184 RYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRTREYPPVKVMQTAVVGTEG 243
           RYPDDPYDRIW SDL++R N++VG A GTVRINT+K ++TRTREYPPVKVMQTAVVGTEG
Sbjct: 203 RYPDDPYDRIWGSDLEKRQNYLVGVAPGTVRINTSKYVDTRTREYPPVKVMQTAVVGTEG 262

Query: 244 VLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFADYSNAVVNIAENANGSY 303
           +LSYRLNLEDFPANARA+AYFAEI+DLG +ETRKFKL+QP+ +DYSNAVVNIAENANGSY
Sbjct: 263 ILSYRLNLEDFPANARAYAYFAEIEDLGANETRKFKLQQPFLSDYSNAVVNIAENANGSY 322

Query: 304 TLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIAAKTEWQDVMVLEALRS 363
           TLYEPSYMNV+L+FVLSFSF KTRDSTLGPLLNAIEISKY KI  KT+ +DV VL ALR 
Sbjct: 323 TLYEPSYMNVSLDFVLSFSFAKTRDSTLGPLLNAIEISKYLKIEPKTDSKDVTVLNALRF 382

Query: 364 ISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTEL 423
           +S ES   N++GDPCVP  WEWV CS+TTPPRITKIALSGKNLKGEIPPE+ NME LTEL
Sbjct: 383 LSAESAWANEQGDPCVPAHWEWVNCSSTTPPRITKIALSGKNLKGEIPPEINNMEQLTEL 442

Query: 424 WLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPP 483
           WLDGNFLTGP+P +S L++L+IVHLENN+L G LP Y+GSLP LQ L+I+NNSF GEIP 
Sbjct: 443 WLDGNFLTGPIPGISNLVNLKIVHLENNKLNGPLPKYLGSLPKLQALYIQNNSFSGEIPS 502

Query: 484 ALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILLVLFLCSLIVLRKLRRKIS 543
             LTGKVIF Y++NP LHKE+R++M  KLI+G SIG+LA LLV+ + SL+ LR L+RK S
Sbjct: 503 EFLTGKVIFNYEHNPGLHKEARKKMHLKLIVGISIGILAGLLVVVIGSLLFLRNLQRKTS 562

Query: 544 NQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSF 603
           ++KS  + +SLR STKPS TAYS+ARG H MDEGV+Y+IPLPELEEAT NF KKIG+GSF
Sbjct: 563 HKKSEVQGNSLRASTKPS-TAYSVARGWHMMDEGVSYYIPLPELEEATKNFSKKIGRGSF 621

Query: 604 GSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 663
           G+VYYG+MKDGKEVAVKIMADS +H T QFVTEVALLSRIHHRNLVPL+GYCEEEHQRIL
Sbjct: 622 GTVYYGQMKDGKEVAVKIMADSSTHLTLQFVTEVALLSRIHHRNLVPLLGYCEEEHQRIL 681

Query: 664 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNI 723
           VYEYMHNGTLRD +HG VNQK LDWL RLQIA DAAKGLEYLHTGCNP IIHRDVK+SNI
Sbjct: 682 VYEYMHNGTLRDHIHGPVNQKRLDWLARLQIAEDAAKGLEYLHTGCNPSIIHRDVKTSNI 741

Query: 724 LLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVL 783
           LLDINMRAKVSDFGLSRQAEEDLTH+SSVARGTVGYLDPEYY NQQLTEKSDVYSFGVVL
Sbjct: 742 LLDINMRAKVSDFGLSRQAEEDLTHVSSVARGTVGYLDPEYYANQQLTEKSDVYSFGVVL 801

Query: 784 LELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQ 843
           LEL+SGKKPVS EDFG+ELNIVHWARS+I+KGDV+SIVDPVLIGN KIESIWRIAEVAIQ
Sbjct: 802 LELVSGKKPVSTEDFGSELNIVHWARSLIRKGDVMSIVDPVLIGNAKIESIWRIAEVAIQ 861

Query: 844 CVEQRGFSRPKMQEIVLAIQDSIKIEKG--GDQKFSSSSSKGQSSRKTLLTSFLEIESPD 901
           CVEQR FSRP+M EI+LAIQ++ KIEKG  G QK  S+SSK QSSRKTLLTSFLEIESPD
Sbjct: 862 CVEQRAFSRPRMHEIILAIQEANKIEKGTDGSQKQQSASSKAQSSRKTLLTSFLEIESPD 921

Query: 902 LSNECLAPAAR 912
           LSN CL PAAR
Sbjct: 922 LSNGCLVPAAR 932

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255547926|ref|XP_002515020.1| protein with unknown function [Ricinus communis] gi|223546071|gb|EEF47574.1| protein with unknown function [Ricinus communis]

 Score = 1443 bits (3736), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 714/911 (78%), Positives = 788/911 (86%), Gaps = 27/911 (2%)

Query: 5   EFISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVKVENPSGNWMQYRTRRDLPIDNKKY 64
           EFISIDCGSTSNYTD  TGL WISD GIMN+GKSV+V+NP G W QY  RRD PID+KKY
Sbjct: 25  EFISIDCGSTSNYTDKRTGLEWISDNGIMNHGKSVEVKNPDGYWAQYGKRRDFPIDSKKY 84

Query: 65  CYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLWSTVTVLDASRVYAKEMIIR 124
           CYNL TKERRRYLVRATFQYGSL +E SYPKF LYLDAT WSTVTVL+ASR+Y KEMIIR
Sbjct: 85  CYNLGTKERRRYLVRATFQYGSLENEDSYPKFDLYLDATKWSTVTVLEASRIYVKEMIIR 144

Query: 125 APSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDNFFLKVAARVNFGALTKDALR 184
           APS SIDVCICCA TGSPFISTLELRPLNLSMYATD+ED FFLK+AARVNFGA  + ALR
Sbjct: 145 APSSSIDVCICCATTGSPFISTLELRPLNLSMYATDYEDRFFLKLAARVNFGAPDEFALR 204

Query: 185 YPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRTREYPPVKVMQTAVVGTEGV 244
           YPDDPYDRIWDSDL +R NF+VG A GTVRINT+KNI+ +TREYPPVKVMQTAVVGTEG+
Sbjct: 205 YPDDPYDRIWDSDLAKRQNFLVGVAPGTVRINTSKNIDIQTREYPPVKVMQTAVVGTEGL 264

Query: 245 LSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFADYSNAVVNIAENANGSYT 304
           LSYRLNLEDFPANARA+AYF+EI+DLG +ETRKFKL +PY +DYSNAVVNIAENANGSY 
Sbjct: 265 LSYRLNLEDFPANARAYAYFSEIEDLGSNETRKFKLMKPYISDYSNAVVNIAENANGSYR 324

Query: 305 LYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIAAKTEWQDVMVLEALRSI 364
           LYEPSYMNVTL+FVLSFSFVKTRDST GPL+NAIEISKY KI +KT+ QD  VL A RSI
Sbjct: 325 LYEPSYMNVTLDFVLSFSFVKTRDSTQGPLINAIEISKYLKIESKTDIQDANVLNAFRSI 384

Query: 365 SDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELW 424
           S  S  T + GDPCVP  WEWV CS+T+PPRITKIALSGKNLKGE+PPE+ NM  L+EL 
Sbjct: 385 SAGSYWTTEGGDPCVPAQWEWVNCSSTSPPRITKIALSGKNLKGEVPPEINNMVELSEL- 443

Query: 425 LDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPA 484
                                 HLENN+L+GSLP Y+GSLPNL+EL+I+NNSFVG++P A
Sbjct: 444 ----------------------HLENNKLSGSLPKYLGSLPNLRELYIQNNSFVGKVPAA 481

Query: 485 LLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILLVLFLCSLIVLRKLRRKISN 544
           LLTGKV   Y++NP LHKE  ++M FKL LG SIGVLAILLVL L +LI LR+L+RK S+
Sbjct: 482 LLTGKVNLNYEDNPGLHKEVAKKMHFKLTLGISIGVLAILLVLLLGTLIYLRRLQRKTSH 541

Query: 545 QKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFG 604
           QK+    +S+R STKPS TAYSI RG H MDEG +Y+I   ELEEAT NF KKIGKGSFG
Sbjct: 542 QKTDNPGNSMRASTKPS-TAYSITRGWHLMDEGGSYYISFAELEEATKNFFKKIGKGSFG 600

Query: 605 SVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 664
           SVYYG+MKDGKEVAVKIMADSCSH TQQFVTEVALLSRIHHRNLVPLIG+CEEEHQRILV
Sbjct: 601 SVYYGQMKDGKEVAVKIMADSCSHLTQQFVTEVALLSRIHHRNLVPLIGFCEEEHQRILV 660

Query: 665 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNIL 724
           YEYMHNGTLRD +HG  N+K LDWLTRLQIA DAAKGLEYLHTGC+P IIHRDVK+SNIL
Sbjct: 661 YEYMHNGTLRDHIHGIDNRKSLDWLTRLQIAEDAAKGLEYLHTGCSPSIIHRDVKTSNIL 720

Query: 725 LDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLL 784
           LDINMRAKVSDFGLSRQAE+DLTHISSVARGTVGYLDPEYY NQQLTEKSDVYSFGVVLL
Sbjct: 721 LDINMRAKVSDFGLSRQAEDDLTHISSVARGTVGYLDPEYYANQQLTEKSDVYSFGVVLL 780

Query: 785 ELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQC 844
           ELISGKKPVS EDFGAE+NIVHWAR++I+KGDV+SIVDPVLIGNVKIESIWR+AEVAIQC
Sbjct: 781 ELISGKKPVSTEDFGAEMNIVHWARALIRKGDVVSIVDPVLIGNVKIESIWRVAEVAIQC 840

Query: 845 VEQRGFSRPKMQEIVLAIQDSIKIEKG--GDQKFSSS-SSKGQSSRKTLLTSFLEIESPD 901
           V+QR  SRP+MQE++L+IQ++IKIEKG  G QK S+S SSK QSSRKTLLTSFLEIESPD
Sbjct: 841 VQQRAVSRPRMQEVILSIQEAIKIEKGTDGSQKLSNSGSSKAQSSRKTLLTSFLEIESPD 900

Query: 902 LSNECLAPAAR 912
           LSN CL PAAR
Sbjct: 901 LSNGCLVPAAR 911

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225425928|ref|XP_002267668.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Vitis vinifera]

 Score = 1432 bits (3706), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 700/910 (76%), Positives = 786/910 (86%), Gaps = 5/910 (0%)

Query: 5   EFISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVKVENPSGNWMQYRTRRDLPIDNKKY 64
           EFISIDCG TSNYTD  TGL WISD G ++ GKSV+VENP G W+QY+ RRD P ++K Y
Sbjct: 24  EFISIDCGGTSNYTDSRTGLQWISDTGAISYGKSVQVENPYGGWLQYQQRRDFPTESK-Y 82

Query: 65  CYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLWSTVTVLDASRVYAKEMIIR 124
           CY L T+ERRRYLVRATFQYGSL SE +YPKFQLYLDAT W+TVTVL+++RVY KEMIIR
Sbjct: 83  CYTLKTEERRRYLVRATFQYGSLESEGTYPKFQLYLDATKWATVTVLESARVYVKEMIIR 142

Query: 125 APSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDNFFLKVAARVNFGALTKDALR 184
           APS SIDVC+CCA TGSPFISTLELRPLNLSMYATDFED FFLKV+ARVNFGA ++D +R
Sbjct: 143 APSSSIDVCLCCATTGSPFISTLELRPLNLSMYATDFEDGFFLKVSARVNFGAPSEDPIR 202

Query: 185 YPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRTREYPPVKVMQTAVVGTEGV 244
           YPDDPYDRIW+SDL +R N++VG A GT R+NT+K I+ RTREYPPVKVMQTAVVGT G 
Sbjct: 203 YPDDPYDRIWESDLVKRQNYLVGVAPGTERVNTSKQIDVRTREYPPVKVMQTAVVGTRGR 262

Query: 245 LSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFADYSNAVVNIAENANGSYT 304
           LSYRLNLEDFPANARA+A+FAEI++LG +ETRKF++E+PY  DYSNAVVNIAENANGSY+
Sbjct: 263 LSYRLNLEDFPANARAYAFFAEIEELGVNETRKFRMERPYLPDYSNAVVNIAENANGSYS 322

Query: 305 LYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIAAKTEWQDVMVLEALRSI 364
           LYEPSYMNVT++FVLSFSFVKTRDST GPLL+AIEISKY +IA KT+  DV VL AL ++
Sbjct: 323 LYEPSYMNVTMDFVLSFSFVKTRDSTRGPLLSAIEISKYVQIAPKTDKGDVTVLNALCAM 382

Query: 365 SDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELW 424
           S ES  +N+  DPCVP  W WV CS TT PRITKI LSGKNL G IP ELKNME LTELW
Sbjct: 383 STESAWSNEGRDPCVPAHWSWVACSPTTTPRITKITLSGKNLNGVIPSELKNMEGLTELW 442

Query: 425 LDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPA 484
           LDGN+LTGP+PDMS LI L+IVHLENN LTG LPSY+GSLP+LQELH++NN   GEIPPA
Sbjct: 443 LDGNYLTGPIPDMSNLISLKIVHLENNRLTGPLPSYLGSLPSLQELHVQNNLLSGEIPPA 502

Query: 485 LLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILLVLFLCSLIVLRKLRRKISN 544
           LLTGKVIF Y+ N KLHKE+  +  FKLILG S+G+LA+LLVL + SL +L   RRK S 
Sbjct: 503 LLTGKVIFNYEGNSKLHKEA-HKTHFKLILGASVGLLALLLVLCIGSLFLLCNTRRKESQ 561

Query: 545 QKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFG 604
            KS +K  SLRTSTK S T+YSIARGG+ MDEGVA +I L +LEEAT NF K+IG+GSFG
Sbjct: 562 SKSNDKGSSLRTSTKAS-TSYSIARGGNLMDEGVACYISLSDLEEATKNFAKQIGRGSFG 620

Query: 605 SVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 664
            VYYGKM DGKE+AVKIMADS SH TQQFVTEVALLSRIHHRNLVPLIGYCE+EHQ +LV
Sbjct: 621 PVYYGKMPDGKEIAVKIMADSSSHGTQQFVTEVALLSRIHHRNLVPLIGYCEDEHQHLLV 680

Query: 665 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNIL 724
           YEYMHNGTLR+ +H S NQK LDWL RL +A DAAKGLEYLHTGCNP IIHRDVK+SNIL
Sbjct: 681 YEYMHNGTLRNHIHDSTNQKCLDWLGRLYVAEDAAKGLEYLHTGCNPSIIHRDVKTSNIL 740

Query: 725 LDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLL 784
           LDINMRAKVSDFGLSRQAEEDLTH+SSVARGTVGYLDPEYY NQQLTEKSDVYSFG+VLL
Sbjct: 741 LDINMRAKVSDFGLSRQAEEDLTHVSSVARGTVGYLDPEYYANQQLTEKSDVYSFGIVLL 800

Query: 785 ELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQC 844
           ELISG+KPVS ED+GAE NIVHWARS+I  GDVISIVDP L+GNVKIESIWRIAE+AI C
Sbjct: 801 ELISGRKPVSPEDYGAEWNIVHWARSLICNGDVISIVDPFLLGNVKIESIWRIAEIAILC 860

Query: 845 VEQRGFSRPKMQEIVLAIQDSIKIEKG--GDQKFSSSSSKGQSSRKTLLTSFLEIESPDL 902
           VEQ G SRPKMQEI+LAIQD+IKIE+G  GD K  S SSKGQSSRKTLLT+FL+IESPDL
Sbjct: 861 VEQHGTSRPKMQEIILAIQDAIKIERGNEGDHKACSGSSKGQSSRKTLLTNFLDIESPDL 920

Query: 903 SNECLAPAAR 912
           SN+CL P+AR
Sbjct: 921 SNDCLVPSAR 930

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297738322|emb|CBI27523.3| unnamed protein product [Vitis vinifera]

 Score = 1423 bits (3683), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 698/910 (76%), Positives = 784/910 (86%), Gaps = 9/910 (0%)

Query: 5   EFISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVKVENPSGNWMQYRTRRDLPIDNKKY 64
           EFISIDCG TSNYTD  TGL WISD G ++ GKSV+VENP G W+QY+ RRD P ++K Y
Sbjct: 24  EFISIDCGGTSNYTDSRTGLQWISDTGAISYGKSVQVENPYGGWLQYQQRRDFPTESK-Y 82

Query: 65  CYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLWSTVTVLDASRVYAKEMIIR 124
           CY L T+ERRRYLVRATFQYGSL SE +YPKFQLYLDAT W+TVTVL+++RVY KEMIIR
Sbjct: 83  CYTLKTEERRRYLVRATFQYGSLESEGTYPKFQLYLDATKWATVTVLESARVYVKEMIIR 142

Query: 125 APSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDNFFLKVAARVNFGALTKDALR 184
           APS SIDVC+CCA TGSPFISTLELRPLNLSMYATDFED FFLKV+ARVNFGA ++D +R
Sbjct: 143 APSSSIDVCLCCATTGSPFISTLELRPLNLSMYATDFEDGFFLKVSARVNFGAPSEDPIR 202

Query: 185 YPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRTREYPPVKVMQTAVVGTEGV 244
           YPDDPYDRIW+SDL +R N++VG A GT R+NT+K I+ RTREYPPVKVMQTAVVGT G 
Sbjct: 203 YPDDPYDRIWESDLVKRQNYLVGVAPGTERVNTSKQIDVRTREYPPVKVMQTAVVGTRGR 262

Query: 245 LSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFADYSNAVVNIAENANGSYT 304
           LSYRLNLEDFPANARA+A+FAEI++LG +ETRKF++E+PY  DYSNAVVNIAENANGSY+
Sbjct: 263 LSYRLNLEDFPANARAYAFFAEIEELGVNETRKFRMERPYLPDYSNAVVNIAENANGSYS 322

Query: 305 LYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIAAKTEWQDVMVLEALRSI 364
           LYEPSYMNVT++FVLSFSFVKTRDST GPLL+AIEISKY +IA KT+  DV VL AL ++
Sbjct: 323 LYEPSYMNVTMDFVLSFSFVKTRDSTRGPLLSAIEISKYVQIAPKTDKGDVTVLNALCAM 382

Query: 365 SDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELW 424
           S ES  +N+  DPCVP  W WV CS TT PRITKI LSGKNL G IP ELKNME LTELW
Sbjct: 383 STESAWSNEGRDPCVPAHWSWVACSPTTTPRITKITLSGKNLNGVIPSELKNMEGLTELW 442

Query: 425 LDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPA 484
           LDGN+LTGP+PDMS LI L+IVHLENN LTG LPSY+GSLP+LQELH++NN   GEIPPA
Sbjct: 443 LDGNYLTGPIPDMSNLISLKIVHLENNRLTGPLPSYLGSLPSLQELHVQNNLLSGEIPPA 502

Query: 485 LLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILLVLFLCSLIVLRKLRRKISN 544
           LLTGKVIF Y+ N KLHKE+  +  FKLILG S+G+LA+LLVL + SL +L   RRK   
Sbjct: 503 LLTGKVIFNYEGNSKLHKEA-HKTHFKLILGASVGLLALLLVLCIGSLFLLCNTRRK--- 558

Query: 545 QKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFG 604
            +S  K  SLRTSTK S T+YSIARGG+ MDEGVA +I L +LEEAT NF K+IG+GSFG
Sbjct: 559 -ESQSKRSSLRTSTKAS-TSYSIARGGNLMDEGVACYISLSDLEEATKNFAKQIGRGSFG 616

Query: 605 SVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 664
            VYYGKM DGKE+AVKIMADS SH TQQFVTEVALLSRIHHRNLVPLIGYCE+EHQ +LV
Sbjct: 617 PVYYGKMPDGKEIAVKIMADSSSHGTQQFVTEVALLSRIHHRNLVPLIGYCEDEHQHLLV 676

Query: 665 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNIL 724
           YEYMHNGTLR+ +H S NQK LDWL RL +A DAAKGLEYLHTGCNP IIHRDVK+SNIL
Sbjct: 677 YEYMHNGTLRNHIHDSTNQKCLDWLGRLYVAEDAAKGLEYLHTGCNPSIIHRDVKTSNIL 736

Query: 725 LDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLL 784
           LDINMRAKVSDFGLSRQAEEDLTH+SSVARGTVGYLDPEYY NQQLTEKSDVYSFG+VLL
Sbjct: 737 LDINMRAKVSDFGLSRQAEEDLTHVSSVARGTVGYLDPEYYANQQLTEKSDVYSFGIVLL 796

Query: 785 ELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQC 844
           ELISG+KPVS ED+GAE NIVHWARS+I  GDVISIVDP L+GNVKIESIWRIAE+AI C
Sbjct: 797 ELISGRKPVSPEDYGAEWNIVHWARSLICNGDVISIVDPFLLGNVKIESIWRIAEIAILC 856

Query: 845 VEQRGFSRPKMQEIVLAIQDSIKIEKG--GDQKFSSSSSKGQSSRKTLLTSFLEIESPDL 902
           VEQ G SRPKMQEI+LAIQD+IKIE+G  GD K  S SSKGQSSRKTLLT+FL+IESPDL
Sbjct: 857 VEQHGTSRPKMQEIILAIQDAIKIERGNEGDHKACSGSSKGQSSRKTLLTNFLDIESPDL 916

Query: 903 SNECLAPAAR 912
           SN+CL P+AR
Sbjct: 917 SNDCLVPSAR 926

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356567402|ref|XP_003551909.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Glycine max]

 Score = 1399 bits (3622), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 687/912 (75%), Positives = 778/912 (85%), Gaps = 8/912 (0%)

Query: 4   KEFISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVKVENPSGNWMQYRTRRDLPIDNKK 63
           +EFISIDCG T+NYTD STGLAWISD GIM +GK V+V+NPSGN +QY+ RR+ PID++K
Sbjct: 23  EEFISIDCGGTNNYTDKSTGLAWISDYGIMKHGKPVEVQNPSGNKVQYQRRREFPIDSRK 82

Query: 64  YCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLWSTVTVLDASRVYAKEMII 123
           YCY L T+ERRR+LVRATFQYGSL    +YP+FQLYLDAT W+TV++ DASR+Y KEMI 
Sbjct: 83  YCYTLGTEERRRHLVRATFQYGSLDDGDTYPQFQLYLDATKWATVSIYDASRIYVKEMIF 142

Query: 124 RAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDNFFLKVAARVNFGALTKDAL 183
           RAPS+SIDVC+CCA TGSPFISTLELRPLNLSMYATDFE +FFLKVAAR+NFGA ++D +
Sbjct: 143 RAPSNSIDVCMCCATTGSPFISTLELRPLNLSMYATDFEGSFFLKVAARINFGAPSEDVV 202

Query: 184 RYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRTREYPPVKVMQTAVVGTEG 243
           RYPDDPYDRIW+SDL +R N++VG A GT RINTTK IE  TREYPPVKVMQTAVVGT+G
Sbjct: 203 RYPDDPYDRIWESDLIKRQNYLVGVAPGTERINTTKKIEIETREYPPVKVMQTAVVGTKG 262

Query: 244 VLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFADYSNAVVNIAENANGSY 303
           +LSYRLNLEDFP NARA+AYFAEI+DL  +ETRKFKLEQPY ADYSNAVVNIAENANGSY
Sbjct: 263 ILSYRLNLEDFPGNARAYAYFAEIEDLPKNETRKFKLEQPYIADYSNAVVNIAENANGSY 322

Query: 304 TLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIAAKTEWQDVMVLEALRS 363
           TLYEPSYMNV+L FVLSFSFVKTRDST GPLLNA+EISKY  IA+KT+ QD   + A R 
Sbjct: 323 TLYEPSYMNVSLEFVLSFSFVKTRDSTQGPLLNAMEISKYVSIASKTDRQDSNFVNAFRF 382

Query: 364 ISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTEL 423
           +S ES   N+ GDPCVP PWEWV CSTTTPPRITKI LS +N+KGEIP EL NMEALTEL
Sbjct: 383 LSAESVLKNE-GDPCVPTPWEWVNCSTTTPPRITKINLSRRNMKGEIPRELNNMEALTEL 441

Query: 424 WLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPP 483
           WLDGN LTG LPDM  LI+L+IVHLENN+L+G LPSY+GSLP+LQ L I+NNSF G IP 
Sbjct: 442 WLDGNMLTGQLPDMRNLINLKIVHLENNKLSGPLPSYLGSLPSLQALFIQNNSFSGVIPS 501

Query: 484 ALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILLVLFLCSLIVLRKLRRKIS 543
            LL+GK+IF +D+NP+LHK +++   F+L+LG SIGVLAILL+LFL SL++L  LRRK S
Sbjct: 502 GLLSGKIIFNFDDNPELHKGNKK--HFQLMLGISIGVLAILLILFLTSLVLLLNLRRKTS 559

Query: 544 NQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSF 603
            QK  EK  S R+STKP  T YS  R G+ MDEG AY+I L EL+EATNNF K IGKGSF
Sbjct: 560 RQKCDEKGISGRSSTKPL-TGYSFGRNGNIMDEGTAYYITLSELKEATNNFSKNIGKGSF 618

Query: 604 GSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 663
           GSVYYGKMKDGKEVAVK M D  S+  QQFV EVALLSRIHHRNLVPLIGYCEEE+Q IL
Sbjct: 619 GSVYYGKMKDGKEVAVKTMTDPSSYGNQQFVNEVALLSRIHHRNLVPLIGYCEEEYQHIL 678

Query: 664 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNI 723
           VYEYMHNGTLR+ +H   +QK LDWL RL+IA DA+KGLEYLHTGCNP IIHRDVK+SNI
Sbjct: 679 VYEYMHNGTLREYIHECSSQKQLDWLARLRIAEDASKGLEYLHTGCNPSIIHRDVKTSNI 738

Query: 724 LLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVL 783
           LLDINMRAKVSDFGLSR AEEDLTHISSVARGTVGYLDPEYY NQQLTEKSDVYSFGVVL
Sbjct: 739 LLDINMRAKVSDFGLSRLAEEDLTHISSVARGTVGYLDPEYYANQQLTEKSDVYSFGVVL 798

Query: 784 LELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQ 843
           LELISGKKPVS ED+G E+NIVHWARS+I+KGDVISI+DP L+GNVK ES+WR+AE+AIQ
Sbjct: 799 LELISGKKPVSSEDYGPEMNIVHWARSLIRKGDVISIMDPSLVGNVKTESVWRVAEIAIQ 858

Query: 844 CVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQKF---SSSSSKGQSSRKTLLTSFLEIESP 900
           CVEQ G  RP+MQE++LAIQD+  IEKG + +    SS  SK QSSRKTLL SFLEIESP
Sbjct: 859 CVEQHGACRPRMQEVILAIQDASNIEKGSEIQLKLSSSGGSKPQSSRKTLLASFLEIESP 918

Query: 901 DLSNECLAPAAR 912
           DLSN CL P+AR
Sbjct: 919 DLSNSCL-PSAR 929

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449512995|ref|XP_004164199.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Cucumis sativus]

 Score = 1385 bits (3584), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 695/911 (76%), Positives = 776/911 (85%), Gaps = 13/911 (1%)

Query: 4   KEFISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVKVENPSGNWMQYRTRRDLPIDNKK 63
           KEFISIDCG T NYTDP TGLAWISD GIMN G S  VENP+GN MQY+TRRD PID+KK
Sbjct: 57  KEFISIDCGGTKNYTDPVTGLAWISDAGIMNAGGSSPVENPNGNLMQYQTRRDFPIDDKK 116

Query: 64  YCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLWSTVTVLDASRVYAKEMII 123
           YCY L T+ERRRYLVRATFQYGSL  E +YPKFQLYLDAT WSTVT+ DASRVY KEMII
Sbjct: 117 YCYTLKTEERRRYLVRATFQYGSLKDEETYPKFQLYLDATKWSTVTIFDASRVYVKEMII 176

Query: 124 RAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDNFFLKVAARVNFGALTKDAL 183
           RAPS+S DVCICCA TGSPFISTLELRP NLSMYATDFEDNFFL+VAARVNFGALTKDA+
Sbjct: 177 RAPSNSFDVCICCATTGSPFISTLELRPFNLSMYATDFEDNFFLEVAARVNFGALTKDAI 236

Query: 184 RYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRTREYPPVKVMQTAVVGTEG 243
           RYPDDPYDRIWDSDL++R N++VG A GT RI+T  NI   TREYPPVKVMQTAV+GT+G
Sbjct: 237 RYPDDPYDRIWDSDLEKRQNYLVGVAPGTERISTLNNINVMTREYPPVKVMQTAVLGTKG 296

Query: 244 VLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFADYSNAVVNIAENANGSY 303
           VLSYRLNL+DFPANARA+AYFAEI+DLG +ETRKFKLE+P   D SNAVVNIAENANG+Y
Sbjct: 297 VLSYRLNLDDFPANARAYAYFAEIEDLGWNETRKFKLEEPNIPDSSNAVVNIAENANGTY 356

Query: 304 TLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIAAKTEWQDVMVLEALRS 363
           TLYEPSYMNVTL+FVLSFSFVKTRDST GPLLNA+EIS+Y +IA KT+ +D  V    R+
Sbjct: 357 TLYEPSYMNVTLSFVLSFSFVKTRDSTRGPLLNALEISRYVEIAPKTDGRDEAVANIFRN 416

Query: 364 ISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTEL 423
           +S E+  +N  GDPCVP  WEWVTCS T PPRITKI LS KNLKGEIPPE+  M+ L EL
Sbjct: 417 VSAENVWSN-IGDPCVPTSWEWVTCSATQPPRITKIELSRKNLKGEIPPEINTMDGLVEL 475

Query: 424 WLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPP 483
           WLDGN L GPLPDMS LI+L+I+HLENN+LTG+LPSY+ SLPNLQEL+I+NN+F GEIP 
Sbjct: 476 WLDGNSLAGPLPDMSNLINLKILHLENNKLTGTLPSYLCSLPNLQELYIQNNTFSGEIPS 535

Query: 484 ALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILLVLFLCSLIVLRKLRRKIS 543
            LL  K+IFKYD N  LHK  R ++  KLILG S+GVL +L++L L SL++LRKLRRK +
Sbjct: 536 ELLAKKLIFKYDGNVGLHKTERYKVHSKLILGVSLGVLVLLVILLLGSLLLLRKLRRKTA 595

Query: 544 NQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSF 603
             +  +K  SL  STK S +AYSI +G    DEG+AY++ L ELEEATNNF KKIGKGSF
Sbjct: 596 PYQ--KKGGSLNISTKRS-SAYSIGKG----DEGMAYYLSLSELEEATNNFSKKIGKGSF 648

Query: 604 GSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 663
           GSV+YGKM DGKEVAVKIMA+S +H  QQF+TEVALLSRIHHRNLVPLIGYCEEEHQRIL
Sbjct: 649 GSVFYGKMIDGKEVAVKIMAESSTHGNQQFMTEVALLSRIHHRNLVPLIGYCEEEHQRIL 708

Query: 664 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNI 723
           VYEYMHNGTLRD L+GS  QK LDWL RL IA DAAKGLEYLHTGC+P IIHRDVK+SNI
Sbjct: 709 VYEYMHNGTLRDHLYGSTTQKHLDWLARLHIAEDAAKGLEYLHTGCSPSIIHRDVKTSNI 768

Query: 724 LLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVL 783
           LLDINMRAKVSDFGLSRQAEEDLTH+SSVARGTVGYLDPEYY  QQLTEKSDVYSFGVVL
Sbjct: 769 LLDINMRAKVSDFGLSRQAEEDLTHVSSVARGTVGYLDPEYYACQQLTEKSDVYSFGVVL 828

Query: 784 LELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQ 843
           LELISGKKPVS ED+G ELNIVHWARS++ KGDV SIVDP L G VKIES+WRIAEVAIQ
Sbjct: 829 LELISGKKPVSPEDYGNELNIVHWARSLVHKGDVTSIVDPFLEGKVKIESVWRIAEVAIQ 888

Query: 844 CVEQRGFSRPKMQEIVLAIQDSIKIEKG--GDQKFSSSSSKGQSSRKTLLTSFLEIESPD 901
           CV+Q G SRP+MQE++LAIQD+IKIE G  G+QK SS + K QSSRKTLLT+FLEIESPD
Sbjct: 889 CVQQHGVSRPRMQEVILAIQDAIKIEHGTEGNQKLSSENLKAQSSRKTLLTTFLEIESPD 948

Query: 902 LSNECLAPAAR 912
            S   L P+AR
Sbjct: 949 GS---LLPSAR 956

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356538111|ref|XP_003537548.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Glycine max]

 Score = 1381 bits (3575), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 683/913 (74%), Positives = 777/913 (85%), Gaps = 9/913 (0%)

Query: 4   KEFISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVKVENPSGNWMQYRTRRDLPIDNKK 63
           +EFISIDCG TSNYTD STGLAWISD GIM +GK V+V+NPSGN  QY+ RR+ PID++K
Sbjct: 23  EEFISIDCGGTSNYTDKSTGLAWISDSGIMKHGKPVEVQNPSGNKFQYQRRREFPIDSRK 82

Query: 64  YCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLWSTVTVLDASRVYAKEMII 123
           YCY L+T+ERRRYLVRATF+YG+L    +YP+FQLYLDAT W+TV++ DASR+YAKEMI 
Sbjct: 83  YCYTLVTEERRRYLVRATFKYGNLDDGDTYPQFQLYLDATKWATVSIYDASRIYAKEMIF 142

Query: 124 RAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDNFFLKVAARVNFGALTKDAL 183
           RAPS+SIDVC+CCA TGSPFISTLELRPLNLSMYATDFE +FFLKVAAR+NFGA ++D +
Sbjct: 143 RAPSNSIDVCMCCATTGSPFISTLELRPLNLSMYATDFEGSFFLKVAARINFGAPSEDVV 202

Query: 184 RYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRTREYPPVKVMQTAVVGTEG 243
           RYPDDPYDRIW+SDL +R N++VG A GT RINTTK IE  TRE PPVKVMQTAVVGT+G
Sbjct: 203 RYPDDPYDRIWESDLIKRQNYLVGVAPGTERINTTKKIEIETRENPPVKVMQTAVVGTKG 262

Query: 244 VLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFADYSNAVVNIAENANGSY 303
           +LSYRLNLEDFP NARA+AYFAEI+DL  +ETRKFKLEQPY ADYSNAVVNIAENANGSY
Sbjct: 263 ILSYRLNLEDFPGNARAYAYFAEIEDLPKNETRKFKLEQPYIADYSNAVVNIAENANGSY 322

Query: 304 TLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIAAKTEWQDVMVLEALRS 363
           TLYEPSYMNV+L FVLSFSFVKTRDST GPLLNA+EISKY  IA+KT+ QD   + A R 
Sbjct: 323 TLYEPSYMNVSLEFVLSFSFVKTRDSTQGPLLNAMEISKYMPIASKTDRQDSNFVNAFRF 382

Query: 364 ISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTEL 423
           +S ES   N+ GDPCVP PWEWV CSTTTPPRITKI LS +NLKGEIP +L NMEALTEL
Sbjct: 383 LSAESVLKNE-GDPCVPTPWEWVNCSTTTPPRITKINLSRRNLKGEIPGKLNNMEALTEL 441

Query: 424 WLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPP 483
           WLDGN LTG LPDMS LI+++I+HLENN+LTG LPSY+GSLP+LQ L I+NNSF G IP 
Sbjct: 442 WLDGNMLTGQLPDMSNLINVKIMHLENNKLTGPLPSYLGSLPSLQALFIQNNSFSGVIPS 501

Query: 484 ALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILLVLFLCSLIVLRKLRRKIS 543
            LL+GK+IF +D+NP+LHK +++   F+L+LG SIGVL ILL+LFL SL++L  LRRK S
Sbjct: 502 GLLSGKIIFNFDDNPELHKGNKK--HFQLMLGISIGVLVILLILFLTSLVLLLILRRKTS 559

Query: 544 NQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSF 603
            QK  EK  S R+STKP  T YS  R G+ MDEG AY+I L EL+EATNNF K IGKGSF
Sbjct: 560 QQKRDEKGVSGRSSTKPL-TGYSFGRDGNIMDEGTAYYITLSELKEATNNFSKNIGKGSF 618

Query: 604 GSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 663
           GSVYYGKMKDGKEVAVK M D  S+  QQFV EVALLSRIHHRNLVPLIGYCEEE+Q IL
Sbjct: 619 GSVYYGKMKDGKEVAVKTMTDPSSYGNQQFVNEVALLSRIHHRNLVPLIGYCEEEYQHIL 678

Query: 664 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNI 723
           VYEYMHNGTLR+ +H   +QK LDWL RL+IA DAAKGLEYLHTGCNP IIHRDVK+SNI
Sbjct: 679 VYEYMHNGTLREYIHECSSQKQLDWLARLRIAEDAAKGLEYLHTGCNPSIIHRDVKTSNI 738

Query: 724 LLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVL 783
           LLDINMRAKVSDFGLSR AEEDLTHISSVARGTVGYLDPEYY NQQLTEKSDVYSFGVVL
Sbjct: 739 LLDINMRAKVSDFGLSRLAEEDLTHISSVARGTVGYLDPEYYANQQLTEKSDVYSFGVVL 798

Query: 784 LELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQ 843
           LEL+SGKK VS ED+G E+NIVHWARS+I+KGDVISI+DP L+GN+K ES+WR+AE+A+Q
Sbjct: 799 LELLSGKKAVSSEDYGPEMNIVHWARSLIRKGDVISIMDPSLVGNLKTESVWRVAEIAMQ 858

Query: 844 CVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQKFSSSSSKG----QSSRKTLLTSFLEIES 899
           CVEQ G  RP+MQE++LAIQD+  IEKG + +   SSS G    QSSRKTLL SFLEIES
Sbjct: 859 CVEQHGACRPRMQEVILAIQDASNIEKGTESQLKLSSSGGNSKPQSSRKTLLASFLEIES 918

Query: 900 PDLSNECLAPAAR 912
           PDLSN CL P+AR
Sbjct: 919 PDLSNSCL-PSAR 930

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449435025|ref|XP_004135296.1| PREDICTED: LOW QUALITY PROTEIN: probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Cucumis sativus]

 Score = 1380 bits (3571), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 696/912 (76%), Positives = 776/912 (85%), Gaps = 14/912 (1%)

Query: 4   KEFISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVKVENPSGNWMQYRTRRDLPIDNKK 63
           KEFISIDCG T NYTDP TGLAWISD GIMN G S  VENP+GN MQY+TRRD PID+KK
Sbjct: 23  KEFISIDCGGTKNYTDPVTGLAWISDAGIMNAGGSSPVENPNGNLMQYQTRRDFPIDDKK 82

Query: 64  YCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLWSTVTVLDASRVYAKEMII 123
           YCY L T+ERRRYLVRATFQYGSL  E +YPKFQLYLDAT WSTVT+ DASRVY KEMII
Sbjct: 83  YCYTLKTEERRRYLVRATFQYGSLKDEETYPKFQLYLDATKWSTVTIFDASRVYVKEMII 142

Query: 124 RAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDNFFLKVAARVNFGALTKDAL 183
           RAPS+S DVCICCA TGSPFISTLELRP NLSMYATDFEDNFFL+VAARVNFGALTKDA+
Sbjct: 143 RAPSNSFDVCICCATTGSPFISTLELRPFNLSMYATDFEDNFFLEVAARVNFGALTKDAI 202

Query: 184 RYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRTREYPPVKVMQTAVVGTEG 243
           RYPDDPYDRIWDSDL++R N++VG A GT RI+T  NI   TREYPPVKVMQTAV+GT+G
Sbjct: 203 RYPDDPYDRIWDSDLEKRQNYLVGVAPGTERISTLNNINVMTREYPPVKVMQTAVLGTKG 262

Query: 244 VLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFADYSNAVVNIAENANGSY 303
           VLSYRLNL+DFPANARA+AYFAEI+DLG +ETRKFKLE+P   D SNAVVNIAENANG+Y
Sbjct: 263 VLSYRLNLDDFPANARAYAYFAEIEDLGWNETRKFKLEEPNIPDSSNAVVNIAENANGTY 322

Query: 304 TLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIAAKTEWQDVMVLEALRS 363
           TLYEPSYMNVTL+FVLSFSFVKTRDST GPLLNA+EIS+Y +IA KT+ +D  V    R+
Sbjct: 323 TLYEPSYMNVTLSFVLSFSFVKTRDSTRGPLLNALEISRYVEIAPKTDGRDEAVANIFRN 382

Query: 364 ISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTEL 423
           +S E+  TN  GDPCVP  WEWVTCS T PPRITKI LS KNLKGEIPPE+  M+ L EL
Sbjct: 383 VSAENVWTN-IGDPCVPTSWEWVTCSATQPPRITKIELSRKNLKGEIPPEINTMDGLVEL 441

Query: 424 WLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPP 483
           WLDGN L GPLPDMS LI+L+I+HLENN+LTG+LPSY+ SLPNLQEL+I+NN+F GEIP 
Sbjct: 442 WLDGNSLAGPLPDMSNLINLKILHLENNKLTGTLPSYLCSLPNLQELYIQNNTFSGEIPS 501

Query: 484 ALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILLVLFLCSLIVLRKLRRKIS 543
            LL  K+IFKYD N  LHK  R ++  KLILG S+GVL +L++L L SL++LRKLRRK +
Sbjct: 502 ELLAKKLIFKYDGNVGLHKTERYKVHSKLILGVSLGVLVLLVILLLGSLLLLRKLRRKTA 561

Query: 544 NQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSF 603
             +  +K  SL  STK S +AYSI +G    DEG+AY++ L ELEEATNNF KKIGKGSF
Sbjct: 562 PYQ--KKGGSLNISTKRS-SAYSIGKG----DEGMAYYLSLSELEEATNNFSKKIGKGSF 614

Query: 604 GSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 663
           GSV+YGKM DGKEVAVKIMA+S +H  QQF+TEVALLSRIHHRNLVPLIGYCEEEHQRIL
Sbjct: 615 GSVFYGKMIDGKEVAVKIMAESSTHGNQQFMTEVALLSRIHHRNLVPLIGYCEEEHQRIL 674

Query: 664 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG-IIHRDVKSSN 722
           VYEYMHNGTLRD L+GS  QK LDWL RL IA DAAKGLEYLHTGC+P  IIHRDVK+SN
Sbjct: 675 VYEYMHNGTLRDHLYGSTTQKHLDWLARLHIAEDAAKGLEYLHTGCSPSIIIHRDVKTSN 734

Query: 723 ILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVV 782
           ILLDINMRAKVSDFGLSRQAEEDLTH+SSVARGTVGYLDPEYY  QQLTEKSDVYSFGVV
Sbjct: 735 ILLDINMRAKVSDFGLSRQAEEDLTHVSSVARGTVGYLDPEYYACQQLTEKSDVYSFGVV 794

Query: 783 LLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAI 842
           LLELISGKKPVS ED+G ELNIVHWARS++ KGDV SIVDP L G VKIES+WRIAEVAI
Sbjct: 795 LLELISGKKPVSPEDYGNELNIVHWARSLVHKGDVTSIVDPFLEGKVKIESVWRIAEVAI 854

Query: 843 QCVEQRGFSRPKMQEIVLAIQDSIKIEKG--GDQKFSSSSSKGQSSRKTLLTSFLEIESP 900
           QCV+Q G SRP+MQE++LAIQD+IKIE G  G+QK SS + K QSSRKTLLT+FLEIESP
Sbjct: 855 QCVQQHGVSRPRMQEVILAIQDAIKIEHGTEGNQKLSSENLKAQSSRKTLLTTFLEIESP 914

Query: 901 DLSNECLAPAAR 912
           D S   L P+AR
Sbjct: 915 DGS---LLPSAR 923

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357463139|ref|XP_003601851.1| Leucine-rich repeat family protein / protein kinase family protein [Medicago truncatula] gi|355490899|gb|AES72102.1| Leucine-rich repeat family protein / protein kinase family protein [Medicago truncatula]

 Score = 1377 bits (3565), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 674/913 (73%), Positives = 772/913 (84%), Gaps = 9/913 (0%)

Query: 4   KEFISIDCGST-SNYTDPSTGLAWISDIGIMNNGKSVKVENPSGNWMQYRTRRDLPIDNK 62
           +EFISIDCG T SNYTD +TGL WISD  IM +G++V+V+NP+GN +QY+ RRD P D++
Sbjct: 23  QEFISIDCGGTRSNYTDTTTGLTWISDSEIMKHGETVEVKNPNGNKVQYQKRRDFPTDSR 82

Query: 63  KYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLWSTVTVLDASRVYAKEMI 122
           KYCY L  +ERRRYLVRATFQYGSL +  +YP+FQLYLDAT W+TV++ D SR+Y KEMI
Sbjct: 83  KYCYTLEAEERRRYLVRATFQYGSLQNGDTYPQFQLYLDATKWATVSIYDESRIYVKEMI 142

Query: 123 IRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDNFFLKVAARVNFGALTKDA 182
            RAPS+S+DVCICCA TGSPFIST+ELRPLNLSMYATDFED+FFLKVAAR+NFGA T DA
Sbjct: 143 FRAPSNSVDVCICCATTGSPFISTIELRPLNLSMYATDFEDDFFLKVAARINFGAPTGDA 202

Query: 183 LRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRTREYPPVKVMQTAVVGTE 242
           +RYP+DPYDRIW+SDL +R NF+VG A+GT RINTT+NI   TREYPPVKVMQ+AVVGT+
Sbjct: 203 VRYPEDPYDRIWESDLGKRQNFLVGVAAGTERINTTRNIAIETREYPPVKVMQSAVVGTK 262

Query: 243 GVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFADYSNAVVNIAENANGS 302
           G+LSYRLNLEDFP NARA+AY AEI+DL  +ETRKFKLEQP+ ADYSNAVVNIAENANGS
Sbjct: 263 GLLSYRLNLEDFPGNARAYAYLAEIEDLSQNETRKFKLEQPFIADYSNAVVNIAENANGS 322

Query: 303 YTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIAAKTEWQDVMVLEALR 362
           YTLYEPSYMNV+L FVLSFSF +T DST GPLLNA+EISKYQ+IA+KT  QD   + A  
Sbjct: 323 YTLYEPSYMNVSLEFVLSFSFKRTPDSTRGPLLNAMEISKYQEIASKTFKQDSNFVNAFS 382

Query: 363 SISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTE 422
           S+SDE    N+ GDPCVP PWEWV CST TP RIT I LSG+NL GEIP EL NMEALTE
Sbjct: 383 SLSDEIIPKNE-GDPCVPTPWEWVNCSTATPARITNINLSGRNLTGEIPRELNNMEALTE 441

Query: 423 LWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIP 482
           LWLD N LTG LPDMS LI+L+I+HLENN+LTG LP+Y+GSLP LQ L+I+NNSF G+IP
Sbjct: 442 LWLDRNLLTGQLPDMSNLINLKIMHLENNKLTGPLPTYLGSLPGLQALYIQNNSFTGDIP 501

Query: 483 PALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILLVLFLCSLIVLRKLRRKI 542
             LL+ K+ F YD+NP LHK S++   F L++G SIGVL IL+V+FL SL++LR LRRK 
Sbjct: 502 AGLLSTKITFIYDDNPGLHKRSKK--HFPLMIGISIGVLVILMVMFLASLVLLRYLRRKA 559

Query: 543 SNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGS 602
           S QKS E+A S RT TK   T YS  R G+ MDEG AY+I L +L+ ATNNF KKIGKGS
Sbjct: 560 SQQKSDERAISGRTGTK-HLTGYSFGRDGNLMDEGTAYYITLSDLKVATNNFSKKIGKGS 618

Query: 603 FGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 662
           FGSVYYGKMKDGKE+AVK M D  SH   QFVTEVALLSRIHHRNLVPLIGYCEEE+Q I
Sbjct: 619 FGSVYYGKMKDGKEIAVKTMTDPSSHGNHQFVTEVALLSRIHHRNLVPLIGYCEEEYQHI 678

Query: 663 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 722
           LVYEYMHNGTLRD +H   ++K LDWLTRL+IA DAAKGLEYLHTGCNP IIHRDVK+SN
Sbjct: 679 LVYEYMHNGTLRDHIHECSSEKRLDWLTRLRIAEDAAKGLEYLHTGCNPSIIHRDVKTSN 738

Query: 723 ILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVV 782
           ILLDINMRAKVSDFGLSR AEEDLTHISSVA+GTVGYLDPEYY NQQLTEKSDVYSFGVV
Sbjct: 739 ILLDINMRAKVSDFGLSRLAEEDLTHISSVAKGTVGYLDPEYYANQQLTEKSDVYSFGVV 798

Query: 783 LLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAI 842
           LLELI GKKPVS ED+G E+NIVHWARS+I+KGD+ISI+DP+LIGNVK ESIWR+AE+A+
Sbjct: 799 LLELICGKKPVSPEDYGPEMNIVHWARSLIRKGDIISIMDPLLIGNVKTESIWRVAEIAM 858

Query: 843 QCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQKFS---SSSSKGQSSRKTLLTSFLEIES 899
           QCVE  G SRP+MQE++LAIQD+ KIEKG + +     SSSS  QSSRKTLLTSFLEIES
Sbjct: 859 QCVEPHGASRPRMQEVILAIQDASKIEKGTESQLKVSSSSSSIPQSSRKTLLTSFLEIES 918

Query: 900 PDLSNECLAPAAR 912
           PDLSN CL P+AR
Sbjct: 919 PDLSNGCL-PSAR 930

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	912
TAIR|locus:2008565	929	AT1G67720 [Arabidopsis thalian	0.989	0.970	0.710	0.0
TAIR|locus:2057991	934	AT2G37050 [Arabidopsis thalian	0.933	0.911	0.483	4.5e-217
TAIR|locus:2824870	884	AT1G51805 [Arabidopsis thalian	0.473	0.488	0.380	7e-128
TAIR|locus:2126540	876	AT4G29990 [Arabidopsis thalian	0.466	0.485	0.397	2.7e-126
TAIR|locus:2055165	868	AT2G14510 [Arabidopsis thalian	0.307	0.322	0.464	8.1e-125
TAIR|locus:2055160	886	AT2G14440 [Arabidopsis thalian	0.307	0.316	0.461	3.5e-124
TAIR|locus:2028446	888	AT1G49100 [Arabidopsis thalian	0.309	0.317	0.491	2.2e-122
TAIR|locus:2078191	838	AT3G46420 [Arabidopsis thalian	0.305	0.332	0.471	1.1e-120
TAIR|locus:2195850	890	AT1G51860 [Arabidopsis thalian	0.312	0.320	0.477	9.5e-120
TAIR|locus:2017557	894	IOS1 "IMPAIRED OOMYCETE SUSCEP	0.480	0.489	0.357	9.7e-118

TAIR|locus:2008565 AT1G67720 [Arabidopsis thaliana (taxid:3702)]

 Score = 3395 (1200.2 bits), Expect = 0., P = 0.
 Identities = 647/911 (71%), Positives = 744/911 (81%)

Query:     5 EFISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVKVENPSGNWMQYRTRRDLPIDNKKY 64
             EF+SIDCG +SNYTDP TGL W+SD  I+  GK V + N + N MQYR RRD P DNKKY
Sbjct:    25 EFVSIDCGCSSNYTDPRTGLGWVSDSEIIKQGKPVTLANTNWNSMQYRRRRDFPTDNKKY 84

Query:    65 CYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLWSTVTVLDASRVYAKEMIIR 124
             CY L TKERRRY+VR TF YG LGSE +YPKFQLYLDAT W+TVT+ + SRVY +E+I+R
Sbjct:    85 CYRLSTKERRRYIVRTTFLYGGLGSEEAYPKFQLYLDATKWATVTIQEVSRVYVEELIVR 144

Query:   125 APSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDNFFLKVAARVNFGALTKDALR 184
             A S  +DVC+CCA+TGSPF+STLELRPLNLSMYATD+EDNFFLKVAARVNFGA   DALR
Sbjct:   145 ATSSYVDVCVCCAITGSPFMSTLELRPLNLSMYATDYEDNFFLKVAARVNFGAPNMDALR 204

Query:   185 YPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRTREYPPVKVMQTAVVGTEGV 244
             YPDDPYDRIW+SD+++RPN++VG A GT RINT+K I T TREYPP+KVMQTAVVGT+G+
Sbjct:   205 YPDDPYDRIWESDINKRPNYLVGVAPGTTRINTSKTINTLTREYPPMKVMQTAVVGTQGL 264

Query:   245 LSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFADYSNAVVNIAENANGSYT 304
             +SYRLNLEDFPANARA+AYFAEI++LG +ETRKFKL QPYF DYSNAVVNIAENANGSYT
Sbjct:   265 ISYRLNLEDFPANARAYAYFAEIEELGANETRKFKLVQPYFPDYSNAVVNIAENANGSYT 324

Query:   305 LYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIAAKTEWQDVMVLEALRSI 364
             LYEPSYMNVTL+FVL+FSF KT+DST GPLLNAIEISKY  I+ KT+  DV VL+A+RS+
Sbjct:   325 LYEPSYMNVTLDFVLTFSFGKTKDSTQGPLLNAIEISKYLPISVKTDRSDVSVLDAIRSM 384

Query:   365 SDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELW 424
             S +S+  ++ GDPC+PV W WV CS+T+PPR+TKIALS KNL+GEIPP +  MEALTELW
Sbjct:   385 SPDSDWASEGGDPCIPVLWSWVNCSSTSPPRVTKIALSRKNLRGEIPPGINYMEALTELW 444

Query:   425 LDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPA 484
             LD N LTG LPDMS+L++L+I+HLENN+L+GSLP Y+  LPNLQEL IENNSF G+IP A
Sbjct:   445 LDDNELTGTLPDMSKLVNLKIMHLENNQLSGSLPPYLAHLPNLQELSIENNSFKGKIPSA 504

Query:   485 LLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSXXXXXXXXXXXXXXXXXXRKLRRKISN 544
             LL GKV+FKY+NNP+L  E++R+  F  ILG S                    LR+    
Sbjct:   505 LLKGKVLFKYNNNPELQNEAQRK-HFWQILGISIAAVAILLLLVGGSLVLLCALRKT--- 560

Query:   545 QKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFG 604
              K  +K DS  T  K    AYS  RGGH +DEGVAYFI LP LEEAT+NF KK+G+GSFG
Sbjct:   561 -KRADKGDSTETKKK-GLVAYSAVRGGHLLDEGVAYFISLPVLEEATDNFSKKVGRGSFG 618

Query:   605 SVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 664
             SVYYG+MKDGKEVAVKI AD  SH  +QFVTEVALLSRIHHRNLVPLIGYCEE  +RILV
Sbjct:   619 SVYYGRMKDGKEVAVKITADPSSHLNRQFVTEVALLSRIHHRNLVPLIGYCEEADRRILV 678

Query:   665 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNIL 724
             YEYMHNG+L D LHGS + KPLDWLTRLQIA DAAKGLEYLHTGCNP IIHRDVKSSNIL
Sbjct:   679 YEYMHNGSLGDHLHGSSDYKPLDWLTRLQIAQDAAKGLEYLHTGCNPSIIHRDVKSSNIL 738

Query:   725 LDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLL 784
             LDINMRAKVSDFGLSRQ EEDLTH+SSVA+GTVGYLDPEYY +QQLTEKSDVYSFGVVL 
Sbjct:   739 LDINMRAKVSDFGLSRQTEEDLTHVSSVAKGTVGYLDPEYYASQQLTEKSDVYSFGVVLF 798

Query:   785 ELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQC 844
             EL+SGKKPVS EDFG ELNIVHWARS+I+KGDV  I+DP +  NVKIES+WR+AEVA QC
Sbjct:   799 ELLSGKKPVSAEDFGPELNIVHWARSLIRKGDVCGIIDPCIASNVKIESVWRVAEVANQC 858

Query:   845 VEQRGFSRPKMQEIVLAIQDSIKIEXXXXX---XXXXXXXXXXXXRKTLLTSFLEIESPD 901
             VEQRG +RP+MQE+++AIQD+I+IE                    RKTLLTSFLE+ESPD
Sbjct:   859 VEQRGHNRPRMQEVIVAIQDAIRIERGNENGLKSSSSSSSKAQSSRKTLLTSFLELESPD 918

Query:   902 LSNECLAPAAR 912
             +S   LAPAAR
Sbjct:   919 ISRNSLAPAAR 929

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007267 "cell-cell signaling" evidence=RCA

GO:0009616 "virus induced gene silencing" evidence=RCA

GO:0010267 "production of ta-siRNAs involved in RNA interference" evidence=RCA

GO:0035196 "production of miRNAs involved in gene silencing by miRNA" evidence=RCA

TAIR|locus:2057991 AT2G37050 [Arabidopsis thaliana (taxid:3702)]

 Score = 2097 (743.2 bits), Expect = 4.5e-217, P = 4.5e-217
 Identities = 421/870 (48%), Positives = 564/870 (64%)

Query:     6 FISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVKVENPSGNWMQYRTRRDLPIDNKKYC 65
             F+S+DCG    +TD   GL W  D  ++  G++  + + +    QY T R  P D++KYC
Sbjct:    28 FVSLDCGGAEPFTD-ELGLKWSPDNHLIY-GETANISSVNETRTQYTTLRHFPADSRKYC 85

Query:    66 YNLITKERRRYLVRATFQYGSL-GSEASYPKFQLYLDATLWSTVTVLDASRVYAKEMIIR 124
             Y L    R RYL+RATF YG+   S   YPKF + L AT W+T+ + +   +   E++  
Sbjct:    86 YTLNVTSRNRYLIRATFLYGNFDNSNNVYPKFDISLGATHWATIVISETYIIETAELVFL 145

Query:   125 APSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDF-EDNFFLKVAARVNFGALTKDAL 183
             A S ++ VC+  A TG PFISTLELR L+ SMY +   ED F+L VAAR+NFGA ++ ++
Sbjct:   146 ASSPTVSVCLSNATTGQPFISTLELRQLSGSMYGSMLSEDRFYLSVAARINFGAESEASV 205

Query:   184 RYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRTREYPPVKVMQTAVVGTEG 243
             RYPDDPYDRIW+SDL ++PN++V  A+GTVR++TT  IE+R  + PP KVMQTAVVGT G
Sbjct:   206 RYPDDPYDRIWESDLQKKPNYLVDVAAGTVRVSTTLPIESRVDDRPPQKVMQTAVVGTNG 265

Query:   244 VLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFADYSNAVVNIAENANGSY 303
              L+YR+NL+ FP    AF YFAEI+DL   E+RKF+L  P   +YS +VVNI EN    Y
Sbjct:   266 SLTYRMNLDGFPGFGWAFTYFAEIEDLAEDESRKFRLVLPEQPEYSKSVVNIKENTQRPY 325

Query:   304 TLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIAAKTEWQ-DVMVLEALR 362
              +Y P Y N+TL FVL+F F KT DS+ GP+LNA+EISKY +   K++   D  V+  + 
Sbjct:   326 RVYAPGYPNITLPFVLNFRFAKTADSSRGPILNAMEISKYLR---KSDGSVDATVMANVA 382

Query:   363 SISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTE 422
             S+   +E   + GDPC P PW WV C++   PR+  I LS  NL G IP +L  +  L E
Sbjct:   383 SLYSSTEWAQEGGDPCSPSPWSWVQCNSDPQPRVVAIKLSSMNLTGNIPSDLVKLTGLVE 442

Query:   423 LWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIP 482
             LWLDGN  TGP+PD SR  +L I+HLENN LTG +PS +  LPNL+EL+++NN   G IP
Sbjct:   443 LWLDGNSFTGPIPDFSRCPNLEIIHLENNRLTGKIPSSLTKLPNLKELYLQNNVLTGTIP 502

Query:   483 PALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSXXXXXXXXXXXXXXXXXXRKLRRKI 542
               L    VI  +  N  L K   +  +  +I+G S                  +  +   
Sbjct:   503 SDLAKD-VISNFSGNLNLEKSGDKGKKLGVIIGASVGAFVLLIATIISCIVMCKSKKNNK 561

Query:   543 SNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGS 602
               + S E  +      + S+T  S A G        A+   L E+EEAT  F K+IG G 
Sbjct:   562 LGKTSAELTNRPLPIQRVSSTL-SEAHGD------AAHCFTLYEIEEATKKFEKRIGSGG 614

Query:   603 FGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 662
             FG VYYGK ++GKE+AVK++A++     ++F  EV LLSRIHHRNLV  +GYC+EE + +
Sbjct:   615 FGIVYYGKTREGKEIAVKVLANNSYQGKREFANEVTLLSRIHHRNLVQFLGYCQEEGKNM 674

Query:   663 LVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSS 721
             LVYE+MHNGTL++ L+G V   + + W+ RL+IA DAA+G+EYLHTGC P IIHRD+K+S
Sbjct:   675 LVYEFMHNGTLKEHLYGVVPRDRRISWIKRLEIAEDAARGIEYLHTGCVPAIIHRDLKTS 734

Query:   722 NILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGV 781
             NILLD +MRAKVSDFGLS+ A +  +H+SS+ RGTVGYLDPEYY +QQLTEKSDVYSFGV
Sbjct:   735 NILLDKHMRAKVSDFGLSKFAVDGTSHVSSIVRGTVGYLDPEYYISQQLTEKSDVYSFGV 794

Query:   782 VLLELISGKKPVSVEDFGAEL-NIVHWARSMIKKGDVISIVDPVLI-GNVKIESIWRIAE 839
             +LLEL+SG++ +S E FG    NIV WA+  I  GD+  I+DP L   +  ++S+W+IAE
Sbjct:   795 ILLELMSGQEAISNESFGVNCRNIVQWAKMHIDNGDIRGIIDPALAEDDYSLQSMWKIAE 854

Query:   840 VAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 869
              A+ CV+  G  RP M E+   IQD+I+IE
Sbjct:   855 KALLCVKPHGNMRPSMSEVQKDIQDAIRIE 884

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009506 "plasmodesma" evidence=IDA

TAIR|locus:2824870 AT1G51805 [Arabidopsis thaliana (taxid:3702)]

 Score = 762 (273.3 bits), Expect = 7.0e-128, Sum P(2) = 7.0e-128
 Identities = 174/457 (38%), Positives = 258/457 (56%)

Query:   425 LDGNFLTGPL-PDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPP 483
             L  + LTG + P +  L  L I+ L NN LTG +P ++  L ++  + +  N+  G +P 
Sbjct:   410 LSASGLTGIIAPAIQNLTHLEILALSNNNLTGEVPEFLADLKSIMVIDLRGNNLSGPVPA 469

Query:   484 ALLTGK-VIFKYDNNPKL--------HKESRRRMRFKLILGTSXXXXXXXXXXXXXXXXX 534
             +LL  K ++   D+NP +        HK    +    + +  S                 
Sbjct:   470 SLLQKKGLMLHLDDNPHILCTTGSCMHKGEGEKKSIIVPVVASIVSLAVIIGALILFLVF 529

Query:   535 XRKLRRKISNQ-KSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNN 593
              +K   K+     SY +A   R S + S  A  + +   F    V            TNN
Sbjct:   530 RKKKASKVEGTLPSYMQASDGR-SPRSSEPAI-VTKNKRFTYSQVVIM---------TNN 578

Query:   594 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 653
             F + +GKG FG VY+G +   ++VAVKI++ S S   +QF  EV LL R+HH+NLV L+G
Sbjct:   579 FQRILGKGGFGIVYHGFVNGVEQVAVKILSHSSSQGYKQFKAEVELLLRVHHKNLVGLVG 638

Query:   654 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 713
             YC+E     L+YEYM NG L++ + G+ N+  L+W TRL+I  D+A+GLEYLH GC P +
Sbjct:   639 YCDEGENMALIYEYMANGDLKEHMSGTRNRFILNWETRLKIVIDSAQGLEYLHNGCKPLM 698

Query:   714 IHRDVKSSNILLDINMRAKVSDFGLSRQAE-EDLTHISSVARGTVGYLDPEYYGNQQLTE 772
             +HRDVK++NILL+ +  AK++DFGLSR       TH+S+V  GT GYLDPEYY   +LTE
Sbjct:   699 VHRDVKTTNILLNEHFEAKLADFGLSRSFPIGGETHVSTVVAGTPGYLDPEYYKTNRLTE 758

Query:   773 KSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE 832
             KSDVYSFG+VLLE+I+ + PV ++    +  I  W   M+ KGD+ISI+DP L G+    
Sbjct:   759 KSDVYSFGIVLLEMITNR-PV-IDQSREKPYISEWVGIMLTKGDIISIMDPSLNGDYDSG 816

Query:   833 SIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 869
             S+W+  E+A+ C+      RP M ++++A+ + +  E
Sbjct:   817 SVWKAVELAMSCLNPSSTRRPTMSQVLIALNECLVSE 853

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2126540 AT4G29990 [Arabidopsis thaliana (taxid:3702)]

 Score = 770 (276.1 bits), Expect = 2.7e-126, Sum P(2) = 2.7e-126
 Identities = 178/448 (39%), Positives = 251/448 (56%)

Query:   425 LDGNFLTGPL-PDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPP 483
             L  + LTG + P  + L  +  + L NN LTG +P ++ SLPNL EL++E N   G IP 
Sbjct:   416 LSSSGLTGQIDPAFANLTSINKLDLSNNSLTGKVPDFLASLPNLTELNLEGNKLTGSIPA 475

Query:   484 ALLT----GKVIFKYDNNPKLHKESRRRMRFKLILGTSXXXXXXXXXXXXXXXXXXRKLR 539
              LL     G +  ++  NP L +    +   K  +G                        
Sbjct:   476 KLLEKSKDGSLSLRFGGNPDLCQSPSCQTTTKKKIGYIVPVVASLAGLLIVLTALAL--- 532

Query:   540 RKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIG 599
               I + K   +  ++  S KP      +  G   +D    YFI   E+   TNNF + +G
Sbjct:   533 --IWHFKKRSRRGTI--SNKP----LGVNTGP--LDTAKRYFI-YSEVVNITNNFERVLG 581

Query:   600 KGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH 659
             KG FG VY+G + +G +VAVKI+++  +   ++F  EV LL R+HH NL  LIGYC E++
Sbjct:   582 KGGFGKVYHGFL-NGDQVAVKILSEESTQGYKEFRAEVELLMRVHHTNLTSLIGYCNEDN 640

Query:   660 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVK 719
                L+YEYM NG L D L G  +   L W  RLQI+ DAA+GLEYLH GC P I+HRDVK
Sbjct:   641 HMALIYEYMANGNLGDYLSGK-SSLILSWEERLQISLDAAQGLEYLHYGCKPPIVHRDVK 699

Query:   720 SSNILLDINMRAKVSDFGLSRQAE-EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYS 778
              +NILL+ N++AK++DFGLSR    E  + +S+V  GT+GYLDPEYY  +Q+ EKSDVYS
Sbjct:   700 PANILLNENLQAKIADFGLSRSFPVEGSSQVSTVVAGTIGYLDPEYYATRQMNEKSDVYS 759

Query:   779 FGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIA 838
             FGVVLLE+I+GK P         +++     SM+  GD+  IVD  L    ++ S W+I 
Sbjct:   760 FGVVLLEVITGK-PAIWHSRTESVHLSDQVGSMLANGDIKGIVDQRLGDRFEVGSAWKIT 818

Query:   839 EVAIQCVEQRGFSRPKMQEIVLAIQDSI 866
             E+A+ C  +    RP M ++V+ ++ SI
Sbjct:   819 ELALACASESSEQRPTMSQVVMELKQSI 846

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2055165 AT2G14510 [Arabidopsis thaliana (taxid:3702)]

 Score = 658 (236.7 bits), Expect = 8.1e-125, Sum P(2) = 8.1e-125
 Identities = 132/284 (46%), Positives = 187/284 (65%)

Query:   586 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 645
             E++E TNNF   +GKG FG VY+G + + ++VAVK+++ S +   ++F TEV LL R+HH
Sbjct:   557 EVKEMTNNFEVVLGKGGFGVVYHGFLNN-EQVAVKVLSQSSTQGYKEFKTEVELLLRVHH 615

Query:   646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 705
              NLV L+GYC+E     L+YE+M NG L++ L G      L+W +RL+IA ++A G+EYL
Sbjct:   616 VNLVSLVGYCDEGIDLALIYEFMENGNLKEHLSGKRGGSVLNWSSRLKIAIESALGIEYL 675

Query:   706 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYLDPEY 764
             H GC P ++HRDVKS+NILL +   AK++DFGLSR        H+S+   GT+GYLDPEY
Sbjct:   676 HIGCQPPMVHRDVKSTNILLGLRFEAKLADFGLSRSFLVGSQAHVSTNVAGTLGYLDPEY 735

Query:   765 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 824
             Y    LTEKSDVYSFG+VLLE I+G+ PV +E    +  IV WA+SM+  GD+ SI+DP 
Sbjct:   736 YLKNWLTEKSDVYSFGIVLLESITGQ-PV-IEQSRDKSYIVEWAKSMLANGDIESIMDPN 793

Query:   825 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 868
             L  +    S W+  E+A+ C+      RP M  +   + + ++I
Sbjct:   794 LHQDYDSSSSWKALELAMLCINPSSTQRPNMTRVAHELNECLEI 837

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2055160 AT2G14440 [Arabidopsis thaliana (taxid:3702)]

 Score = 654 (235.3 bits), Expect = 3.5e-124, Sum P(2) = 3.5e-124
 Identities = 131/284 (46%), Positives = 188/284 (66%)

Query:   586 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 645
             E++E TNNF   +GKG FG VY+G + + ++VAVK+++ S +   ++F TEV LL R+HH
Sbjct:   575 EVKEMTNNFEVVLGKGGFGVVYHGFLNN-EQVAVKVLSQSSTQGYKEFKTEVELLLRVHH 633

Query:   646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 705
              NLV L+GYC++ +   L+YE+M NG L++ L G      L+W  RL+IA ++A G+EYL
Sbjct:   634 VNLVSLVGYCDKGNDLALIYEFMENGNLKEHLSGKRGGPVLNWPGRLKIAIESALGIEYL 693

Query:   706 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYLDPEY 764
             H GC P ++HRDVKS+NILL +   AK++DFGLSR       TH+S+   GT+GYLDPEY
Sbjct:   694 HIGCKPPMVHRDVKSTNILLGLRFEAKLADFGLSRSFLVGSQTHVSTNVAGTLGYLDPEY 753

Query:   765 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 824
             Y    LTEKSDVYSFG+VLLE+I+G+ PV +E    +  IV WA+SM+  GD+ SI+D  
Sbjct:   754 YQKNWLTEKSDVYSFGIVLLEIITGQ-PV-IEQSRDKSYIVEWAKSMLANGDIESIMDRN 811

Query:   825 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 868
             L  +    S W+  E+A+ C+      RP M  +   + + ++I
Sbjct:   812 LHQDYDTSSSWKALELAMLCINPSSTLRPNMTRVAHELNECLEI 855

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2028446 AT1G49100 [Arabidopsis thaliana (taxid:3702)]

 Score = 720 (258.5 bits), Expect = 2.2e-122, Sum P(2) = 2.2e-122
 Identities = 140/285 (49%), Positives = 192/285 (67%)

Query:   586 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 645
             E+ E TNNF   +GKG FG VY+G +   ++VAVK+++ +  H  +QF  EV LL R+HH
Sbjct:   575 EVTEMTNNFRSVLGKGGFGMVYHGYVNGREQVAVKVLSHASKHGHKQFKAEVELLLRVHH 634

Query:   646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 705
             +NLV L+GYCE+  +  LVYEYM NG L++   G      L W TRLQIA +AA+GLEYL
Sbjct:   635 KNLVSLVGYCEKGKELALVYEYMANGDLKEFFSGKRGDDVLRWETRLQIAVEAAQGLEYL 694

Query:   706 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYLDPEY 764
             H GC P I+HRDVK++NILLD + +AK++DFGLSR    E  +H+S+V  GT+GYLDPEY
Sbjct:   695 HKGCRPPIVHRDVKTANILLDEHFQAKLADFGLSRSFLNEGESHVSTVVAGTIGYLDPEY 754

Query:   765 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 824
             Y    LTEKSDVYSFGVVLLE+I+ ++ +  E    + +I  W   MI KGD+  IVDP 
Sbjct:   755 YRTNWLTEKSDVYSFGVVLLEIITNQRVI--ERTREKPHIAEWVNLMITKGDIRKIVDPN 812

Query:   825 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 869
             L G+   +S+W+  E+A+ CV     +RP M ++V  + + + +E
Sbjct:   813 LKGDYHSDSVWKFVELAMTCVNDSSATRPTMTQVVTELTECVTLE 857

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2078191 AT3G46420 [Arabidopsis thaliana (taxid:3702)]

 Score = 688 (247.2 bits), Expect = 1.1e-120, Sum P(2) = 1.1e-120
 Identities = 133/282 (47%), Positives = 184/282 (65%)

Query:   589 EATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNL 648
             + TNNF + +G+G FG VY+G +   ++VAVK+++ S     ++F  EV LL R+HH NL
Sbjct:   528 DMTNNFQRALGEGGFGVVYHGYLNGSEQVAVKLLSQSSVQGYKEFKAEVELLLRVHHINL 587

Query:   649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
             V L+GYC++ +   LVYEYM NG L+  L G  N   L W TRLQIA DAA GLEYLH G
Sbjct:   588 VSLVGYCDDRNHLALVYEYMSNGDLKHHLSGRNNGFVLSWSTRLQIAVDAALGLEYLHIG 647

Query:   709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE-EDLTHISSVARGTVGYLDPEYYGN 767
             C P ++HRDVKS+NILL     AK++DFGLSR  +  D  HIS+V  GT GYLDPEYY  
Sbjct:   648 CRPSMVHRDVKSTNILLGEQFTAKMADFGLSRSFQIGDENHISTVVAGTPGYLDPEYYRT 707

Query:   768 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 827
              +L EKSD+YSFG+VLLE+I+ +   +++    + +I  W  S+I +GD+  I+DP L G
Sbjct:   708 SRLAEKSDIYSFGIVLLEMITSQH--AIDRTRVKHHITDWVVSLISRGDITRIIDPNLQG 765

Query:   828 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 869
             N    S+WR  E+A+ C       RP M ++V+ +++ +  E
Sbjct:   766 NYNSRSVWRALELAMSCANPTSEKRPNMSQVVIDLKECLATE 807

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2195850 AT1G51860 [Arabidopsis thaliana (taxid:3702)]

 Score = 693 (249.0 bits), Expect = 9.5e-120, Sum P(2) = 9.5e-120
 Identities = 138/289 (47%), Positives = 191/289 (66%)

Query:   582 IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLS 641
             I  PE+ + TNNF + +GKG FG+VY+G + DG EVAVK+++ S +   ++F  EV LL 
Sbjct:   574 ITYPEVLKMTNNFERVLGKGGFGTVYHGNL-DGAEVAVKMLSHSSAQGYKEFKAEVELLL 632

Query:   642 RIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 701
             R+HHR+LV L+GYC++     L+YEYM NG LR+ + G      L W  R+QIA +AA+G
Sbjct:   633 RVHHRHLVGLVGYCDDGDNLALIYEYMANGDLRENMSGKRGGNVLTWENRMQIAVEAAQG 692

Query:   702 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED-LTHISSVARGTVGYL 760
             LEYLH GC P ++HRDVK++NILL+    AK++DFGLSR    D   H+S+V  GT GYL
Sbjct:   693 LEYLHNGCRPPMVHRDVKTTNILLNERCGAKLADFGLSRSFPIDGECHVSTVVAGTPGYL 752

Query:   761 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 820
             DPEYY    L+EKSDVYSFGVVLLE+++ + PV ++      +I  W   M+ KGD+ SI
Sbjct:   753 DPEYYRTNWLSEKSDVYSFGVVLLEIVTNQ-PV-IDKTRERPHINDWVGFMLTKGDIKSI 810

Query:   821 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 869
             VDP L+G+      W+I E+A+ CV      RP M  +V+ + D + +E
Sbjct:   811 VDPKLMGDYDTNGAWKIVELALACVNPSSNRRPTMAHVVMELNDCVALE 859

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2017557 IOS1 "IMPAIRED OOMYCETE SUSCEPTIBILITY 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 715 (256.8 bits), Expect = 9.7e-118, Sum P(2) = 9.7e-118
 Identities = 166/464 (35%), Positives = 260/464 (56%)

Query:   420 LTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFV 478
             +  L L  + LTG + + +S L  L ++ L NN LTGS+P ++ ++  L+ +++  N   
Sbjct:   410 IISLDLSTSGLTGEILEFISDLTSLEVLDLSNNSLTGSVPEFLANMETLKLINLSGNELN 469

Query:   479 GEIPPALLT----GKVIFKYDNNPKLHKES-----RRRMRFKLI--LGTSXXXXXXXXXX 527
             G IP  LL     G +    + N  L   +     +++ +  +I  +  S          
Sbjct:   470 GSIPATLLDKERRGSITLSIEGNTGLCSSTSCATTKKKKKNTVIAPVAASLVSVFLIGAG 529

Query:   528 XXXXXXXXRKLRRKIS-NQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPE 586
                     RK R K+  N  S      L + +        IA+     +  + Y     +
Sbjct:   530 IVTFLILKRKKRTKLGLNPNSGTGTTPLHSRSHHGFEPPVIAK-----NRKLTYI----D 580

Query:   587 LEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR 646
             + + TNNF + +G+G FG VYYG + + + VAVK++ +S +   +QF  EV LL R+HH+
Sbjct:   581 VVKITNNFERVLGRGGFGVVYYGVLNN-EPVAVKMLTESTALGYKQFKAEVELLLRVHHK 639

Query:   647 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
             +L  L+GYCEE  +  L+YE+M NG L++ L G      L W  RL+IA ++A+GLEYLH
Sbjct:   640 DLTCLVGYCEEGDKMSLIYEFMANGDLKEHLSGKRGPSILTWEGRLRIAAESAQGLEYLH 699

Query:   707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPEYY 765
              GC P I+HRD+K++NILL+   +AK++DFGLSR       TH+S++  GT GYLDPEYY
Sbjct:   700 NGCKPQIVHRDIKTTNILLNEKFQAKLADFGLSRSFPLGTETHVSTIVAGTPGYLDPEYY 759

Query:   766 GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 825
                 LTEKSDV+SFGVVLLEL++ + PV ++    + +I  W   M+ +GD+ SIVDP L
Sbjct:   760 RTNWLTEKSDVFSFGVVLLELVTNQ-PV-IDMKREKSHIAEWVGLMLSRGDINSIVDPKL 817

Query:   826 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 869
              G+    +IW++ E A+ C+      RP M ++V+ +++ + +E
Sbjct:   818 QGDFDPNTIWKVVETAMTCLNPSSSRRPTMTQVVMDLKECLNME 861

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0050832 "defense response to fungus" evidence=IEP;IMP

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006569 "tryptophan catabolic process" evidence=RCA

GO:0006857 "oligopeptide transport" evidence=RCA

GO:0006865 "amino acid transport" evidence=RCA

GO:0009684 "indoleacetic acid biosynthetic process" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0015824 "proline transport" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
C0LGI2	Y1677_ARATH	2, ., 7, ., 1, 1, ., 1	0.7310	0.9890	0.9709	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: eugene3.00100504 hypothetical protein (934 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	912
pfam12819	335	pfam12819, Malectin_like, Carbohydrate-binding pro	6e-91
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	4e-53
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-52
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-52
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	6e-52
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	4e-48
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	7e-48
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-43
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	5e-41
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-39
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-35
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	7e-34
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	9e-34
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	9e-33
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-32
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	4e-32
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	4e-32
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	8e-32
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	4e-31
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-29
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-29
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-29
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	4e-29
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	4e-29
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	4e-29
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-28
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-28
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-28
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-28
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	7e-28
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-27
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-27
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	4e-27
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	5e-27
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-26
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-26
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-26
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	6e-26
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	8e-26
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-25
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-25
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-25
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	6e-25
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-24
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-24
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-24
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-24
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	4e-24
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	9e-24
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-23
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-23
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-23
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-23
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-23
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-23
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-23
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-23
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-23
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-23
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	4e-23
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	6e-23
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	6e-23
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	7e-23
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-22
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-22
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-22
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	3e-22
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-22
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	4e-22
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	5e-22
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	6e-22
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	8e-22
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	8e-22
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-21
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-21
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-21
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-21
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	3e-21
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-21
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-21
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	4e-21
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	5e-21
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	5e-21
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	9e-21
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	9e-21
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-20
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-20
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-20
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-20
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-20
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-20
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-20
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-20
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-20
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-20
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	6e-20
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	9e-20
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	9e-20
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-19
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-19
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-19
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-19
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-19
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-19
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-19
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	4e-19
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	4e-19
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	9e-19
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-18
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-18
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-18
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-18
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-18
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-18
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-18
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-18
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-18
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	5e-18
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	6e-18
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	7e-18
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-17
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-17
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-17
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	3e-17
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-17
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	3e-17
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	4e-17
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	4e-17
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	4e-17
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	4e-17
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	5e-17
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	5e-17
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	5e-17
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	5e-17
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	6e-17
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	7e-17
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	7e-17
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	8e-17
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	8e-17
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-16
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-16
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-16
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	4e-16
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	4e-16
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	4e-16
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	5e-16
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	6e-16
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	6e-16
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	7e-16
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-15
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-15
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-15
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-15
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-15
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-15
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-15
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-15
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	2e-15
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-15
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	4e-15
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	5e-15
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	7e-15
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	7e-15
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	9e-15
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-14
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-14
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-14
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-14
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-14
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-14
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-14
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-14
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-14
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-14
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	4e-14
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	4e-14
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	4e-14
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	4e-14
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	5e-14
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	6e-14
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	6e-14
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	7e-14
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	7e-14
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	7e-14
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	9e-14
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	9e-14
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-13
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-13
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-13
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-13
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-13
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-13
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-13
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-13
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-13
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-13
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	3e-13
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-13
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-13
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	4e-13
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	5e-13
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	6e-13
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	7e-13
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	7e-13
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	8e-13
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	8e-13
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	8e-13
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	9e-13
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	9e-13
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-12
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-12
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-12
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-12
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-12
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-12
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-12
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-12
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-12
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-12
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-12
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-12
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	4e-12
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	4e-12
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	9e-12
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	9e-12
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-11
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-11
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-11
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-11
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-11
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	2e-11
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-11
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-11
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-11
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-11
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-11
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-11
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-11
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-11
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-11
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-11
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	3e-11
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	3e-11
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	4e-11
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	4e-11
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	4e-11
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	6e-11
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	6e-11
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	6e-11
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	9e-11
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-10
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-10
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-10
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-10
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-10
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-10
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-10
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-10
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-10
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	3e-10
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-10
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-10
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	4e-10
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	4e-10
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	5e-10
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	5e-10
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	5e-10
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	8e-10
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	9e-10
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-09
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-09
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-09
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-09
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-09
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-09
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-09
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-09
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-09
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-09
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-09
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-09
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	4e-09
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	5e-09
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	5e-09
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-08
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-08
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-08
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-08
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-08
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	3e-08
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	3e-08
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	4e-08
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	6e-08
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	6e-08
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	7e-08
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	7e-08
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	8e-08
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	9e-08
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-07
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-07
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	2e-07
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-07
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-07
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	3e-07
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-07
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	6e-07
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-06
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	1e-06
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-06
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	1e-06
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-06
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-06
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	2e-06
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	4e-06
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	6e-06
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-05
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	1e-04
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	1e-04
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-04
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-04
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	3e-04
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	7e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.001
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	0.002
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	0.003

>gnl|CDD|221790 pfam12819, Malectin_like, Carbohydrate-binding protein of the ER

 Score =  291 bits (747), Expect = 6e-91
 Identities = 134/355 (37%), Positives = 185/355 (52%), Gaps = 40/355 (11%)

Query: 9   IDCGSTSN--YTDPSTGLAWISDIGIMNNGKSVKV-ENPSGNWM--QYRTRRDLPIDNKK 63
           IDCG  SN  YTDPSTG+ W+SD G ++ GKS  + +  S +++   Y+T R  P D K+
Sbjct: 1   IDCGLPSNESYTDPSTGITWVSDAGFIDTGKSGNISKENSSSFLSKPYKTLRSFP-DGKR 59

Query: 64  YCYNL--ITKERRRYLVRATFQYGS---LGSEASYPKFQLYLDATLWSTV-TVLDASRVY 117
            CY L     +  +YL+RATF YG+   L S +S P F LYL   LW+TV    D+    
Sbjct: 60  NCYTLPVTPGKGTKYLIRATFLYGNYDGLNSVSSPPSFDLYLGVNLWTTVNLSNDSGDSV 119

Query: 118 AKEMIIRAP-SDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDNFFLKVAARVNFG 176
            KE II    SD++ VC+    TG+PFIS LELRPL  S+Y +    +  LK+ AR+NFG
Sbjct: 120 VKEYIIHVTKSDTLSVCLVNTGTGTPFISALELRPLPDSLYPSSG-GSQALKLVARLNFG 178

Query: 177 ALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNI---ETRTREYPPVKV 233
             ++  +RYPDD YDRIW+             + G  +I+T+ ++          PP  V
Sbjct: 179 G-SEGTIRYPDDVYDRIWEPFFS---------SPGWSQISTSLSVDISSNNAPYIPPSAV 228

Query: 234 MQTAVVGTEGVLSYRL--NLEDFPANARAFAYFAEIQDLGPSETRKFKL---EQPYFADY 288
           +QTAV  T          +L D       + +FAEIQ L   ETR+F +    +  + D 
Sbjct: 229 LQTAVTPTNASAPLNFTWDLVDPNFEYYVYLHFAEIQSL---ETREFDIYINGKTVYGDV 285

Query: 289 SNAVVNIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKY 343
           S            +  LY    +NV+   +L+ S V T  STL PLLNA+EI K 
Sbjct: 286 S-----PKYLGTDTGALYLDFPVNVSGGGLLNISLVPTSGSTLPPLLNALEIFKV 335

Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. The domain is found on a number of plant receptor kinases. Length = 335

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  185 bits (473), Expect = 4e-53
 Identities = 73/207 (35%), Positives = 115/207 (55%), Gaps = 13/207 (6%)

Query: 594 FCKKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRN 647
             KK+G+G+FG VY G +K   E     VAVK + +  S   ++ F+ E +++ ++ H N
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62

Query: 648 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
           +V L+G C +     +V EYM  G L D L    + + L     LQ+A   AKG+EYL  
Sbjct: 63  IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLR--KHGEKLTLKDLLQMALQIAKGMEYLE- 119

Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV-ARGTVGYLDPEYYG 766
             +   +HRD+ + N L+  N+  K+SDFGLSR   ED  +      +  + ++ PE   
Sbjct: 120 --SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLK 177

Query: 767 NQQLTEKSDVYSFGVVLLELIS-GKKP 792
           + + T KSDV+SFGV+L E+ + G++P
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGEQP 204

Length = 258

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  182 bits (464), Expect = 1e-52
 Identities = 77/193 (39%), Positives = 113/193 (58%), Gaps = 10/193 (5%)

Query: 598 IGKGSFGSVYYGK-MKDGKEVAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 655
           +G+G FG+VY  +  K GK+VA+KI+  +  S   ++ + E+ +L +++H N+V L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 656 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 715
           E+E+   LV EY   G+L+D L    N+  L     L+I     +GLEYLH   + GIIH
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLK--ENEGKLSEDEILRILLQILEGLEYLH---SNGIIH 115

Query: 716 RDVKSSNILLD-INMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY-GNQQLTEK 773
           RD+K  NILLD  N + K++DFGLS+    D   +     GT  Y+ PE   G    +EK
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSD-KSLLKTIVGTPAYMAPEVLLGKGYYSEK 174

Query: 774 SDVYSFGVVLLEL 786
           SD++S GV+L EL
Sbjct: 175 SDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  183 bits (466), Expect = 3e-52
 Identities = 74/206 (35%), Positives = 113/206 (54%), Gaps = 11/206 (5%)

Query: 594 FCKKIGKGSFGSVYYGKMKDGK-----EVAVKIMADSCSHRTQQ-FVTEVALLSRIHHRN 647
             KK+G+G+FG VY G +K        EVAVK + +  S +  + F+ E  ++ ++ H N
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62

Query: 648 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
           +V L+G C EE   ++V EYM  G L D L  +   K L     L  A   A+G+EYL +
Sbjct: 63  IVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLES 121

Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 767
                 IHRD+ + N L+  N+  K+SDFGLSR   +D  +     +  + ++ PE    
Sbjct: 122 K---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKE 178

Query: 768 QQLTEKSDVYSFGVVLLELIS-GKKP 792
            + T KSDV+SFGV+L E+ + G++P
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEEP 204

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  182 bits (464), Expect = 6e-52
 Identities = 74/206 (35%), Positives = 113/206 (54%), Gaps = 12/206 (5%)

Query: 594 FCKKIGKGSFGSVYYGKMKDGK-----EVAVKIMADSCS-HRTQQFVTEVALLSRIHHRN 647
             KK+G+G+FG VY GK+K        EVAVK + +  S  + ++F+ E  ++ ++ H N
Sbjct: 3   LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62

Query: 648 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
           +V L+G C EE    +V EYM  G L   L    N+  L     L  A   A+G+EYL +
Sbjct: 63  VVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRK--NRPKLSLSDLLSFALQIARGMEYLES 120

Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 767
                 IHRD+ + N L+  N+  K+SDFGLSR   +D  +     +  + ++ PE    
Sbjct: 121 K---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKE 177

Query: 768 QQLTEKSDVYSFGVVLLELIS-GKKP 792
            + T KSDV+SFGV+L E+ + G++P
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFTLGEQP 203

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  171 bits (435), Expect = 4e-48
 Identities = 70/199 (35%), Positives = 105/199 (52%), Gaps = 10/199 (5%)

Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 653
           +K+G+GSFG VY  + K  GK VA+K++         ++ + E+ +L ++ H N+V L  
Sbjct: 5   EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64

Query: 654 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 713
             E+E +  LV EY   G L D L     +  L               LEYLH   + GI
Sbjct: 65  VFEDEDKLYLVMEYCEGGDLFDLLK---KRGRLSEDEARFYLRQILSALEYLH---SKGI 118

Query: 714 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 773
           +HRD+K  NILLD +   K++DFGL+RQ +      + V  GT  Y+ PE    +   + 
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFV--GTPEYMAPEVLLGKGYGKA 176

Query: 774 SDVYSFGVVLLELISGKKP 792
            D++S GV+L EL++GK P
Sbjct: 177 VDIWSLGVILYELLTGKPP 195

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  170 bits (434), Expect = 7e-48
 Identities = 75/210 (35%), Positives = 109/210 (51%), Gaps = 16/210 (7%)

Query: 596 KKIGKGSFGSVYYGKMKDGK----EVAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNLVP 650
           KK+G+G+FG VY GK+K       EVAVK + +  S   +  F+ E  ++ ++ H N+V 
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRL------HGSVNQKPLDWLTRLQIAHDAAKGLEY 704
           L+G C EE    LV EYM  G L D L        S  +  L     L  A   AKG+EY
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT-VGYLDPE 763
           L    +   +HRD+ + N L+  ++  K+SDFGLSR   +D  +         + ++ PE
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177

Query: 764 YYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
              +   T KSDV+SFGV+L E+ + G  P
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATP 207

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  158 bits (402), Expect = 2e-43
 Identities = 82/203 (40%), Positives = 112/203 (55%), Gaps = 15/203 (7%)

Query: 596 KKIGKGSFGSVYYGKMK-DGKEVAVKIM----ADSCSHRTQQFVTEVALLSRIHHRNLVP 650
           +K+G GSFG+VY  K K  GK VAVKI+      S   + Q    E+ +L R+ H N+V 
Sbjct: 5   RKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSK--KDQTARREIRILRRLSHPNIVR 62

Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 710
           LI   E++    LV EY   G L D L       PL      +IA    +GLEYLH   +
Sbjct: 63  LIDAFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLH---S 116

Query: 711 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYGNQQ 769
            GIIHRD+K  NILLD N   K++DFGL+++  +  + +++   GT  Y+ PE   G   
Sbjct: 117 NGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNG 175

Query: 770 LTEKSDVYSFGVVLLELISGKKP 792
              K DV+S GV+L EL++GK P
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPP 198

Length = 260

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  151 bits (383), Expect = 5e-41
 Identities = 65/205 (31%), Positives = 110/205 (53%), Gaps = 16/205 (7%)

Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVK-IMADSCSHRT-QQFVTEVALLSRIHHRNLVPLI 652
           + +G+GSFGSVY    KD G+ +AVK +     S    +    E+ +LS + H N+V   
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 653 G-YCEEEHQRILVY-EYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           G   +EE   + ++ EY+  G+L   L   G + +  +   TR QI      GL YLH  
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTR-QILE----GLAYLH-- 118

Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYLDPEYYGN 767
            + GI+HRD+K +NIL+D +   K++DFG +++  + +    +   RGT  ++ PE    
Sbjct: 119 -SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177

Query: 768 QQLTEKSDVYSFGVVLLELISGKKP 792
           ++    +D++S G  ++E+ +GK P
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKPP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  147 bits (373), Expect = 1e-39
 Identities = 74/201 (36%), Positives = 112/201 (55%), Gaps = 14/201 (6%)

Query: 596 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 654
           +KIGKG FG VY  + K  GKEVA+K++      + ++ + E+ +L +  H N+V   G 
Sbjct: 6   EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65

Query: 655 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGCNP 711
             ++ +  +V E+   G+L+D L  + NQ     LT  QIA    +  KGLEYLH   + 
Sbjct: 66  YLKKDELWIVMEFCSGGSLKDLLKST-NQT----LTESQIAYVCKELLKGLEYLH---SN 117

Query: 712 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 771
           GIIHRD+K++NILL  +   K+ DFGLS Q  +     + V  GT  ++ PE    +   
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV--GTPYWMAPEVINGKPYD 175

Query: 772 EKSDVYSFGVVLLELISGKKP 792
            K+D++S G+  +EL  GK P
Sbjct: 176 YKADIWSLGITAIELAEGKPP 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  144 bits (365), Expect = 3e-35
 Identities = 125/487 (25%), Positives = 210/487 (43%), Gaps = 45/487 (9%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNE 452
             + ++ LS   L GEIP EL + + L  L L  N L+G +P   S +  L  + L  N+
Sbjct: 499 SELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQ 558

Query: 453 LTGSLPSYMGSLPNLQELHIENNSFVGEIPP--ALL-------TGKVIFKYDNNPKLHKE 503
           L+G +P  +G++ +L +++I +N   G +P   A L        G +     +       
Sbjct: 559 LSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPP 618

Query: 504 SRRRMRFKLILGTSIGVLAILLVLFLCSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNT 563
            +R  +           L   LVL L +   +    R     K  E  D           
Sbjct: 619 CKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWEL------ 672

Query: 564 AYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGK-MKDGKEVAVKIM 622
                    F D  V+  I + ++  +       I +G  G+ Y GK +K+G +  VK +
Sbjct: 673 --------QFFDSKVSKSITINDILSSLKEE-NVISRGKKGASYKGKSIKNGMQFVVKEI 723

Query: 623 ADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVN 682
            D  S  +    +E+A + ++ H N+V LIG C  E    L++EY+    L + L     
Sbjct: 724 NDVNSIPS----SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN--- 776

Query: 683 QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 742
              L W  R +IA   AK L +LH  C+P ++  ++    I++D      +    L    
Sbjct: 777 ---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL 832

Query: 743 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL 802
             D     S A     Y+ PE    + +TEKSD+Y FG++L+EL++GK P   E FG   
Sbjct: 833 CTDTKCFISSA-----YVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAE-FGVHG 886

Query: 803 NIVHWARSMIKKGDVISIVDPVLIGNVKIES--IWRIAEVAIQCVEQRGFSRPKMQEIVL 860
           +IV WAR       +   +DP + G+V +    I  +  +A+ C      +RP   +++ 
Sbjct: 887 SIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLK 946

Query: 861 AIQDSIK 867
            ++ + +
Sbjct: 947 TLESASR 953

Length = 968

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  130 bits (330), Expect = 7e-34
 Identities = 75/216 (34%), Positives = 105/216 (48%), Gaps = 38/216 (17%)

Query: 596 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHR--TQQFVTEVALLSRIHHRNLVPLI 652
           K+IGKGSFG VY  + K DGK   +K +  S       +  + EV +L +++H N+   I
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI---I 62

Query: 653 GYCE--EEHQRIL-VYEYMHNGTLRDRLHGSVNQKP----------LDWLTRLQIAHDAA 699
            Y E  EE  ++  V EY   G L  ++     QK           LDW    Q+     
Sbjct: 63  KYYESFEEKGKLCIVMEYADGGDLSQKIK---KQKKEGKPFPEEQILDWFV--QLC---- 113

Query: 700 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG- 758
             L+YLH+     I+HRD+K  NI L  N   K+ DFG+S+     L+    +A+  VG 
Sbjct: 114 LALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKV----LSSTVDLAKTVVGT 166

Query: 759 --YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
             YL PE   N+    KSD++S G VL EL + K P
Sbjct: 167 PYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHP 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  130 bits (328), Expect = 9e-34
 Identities = 69/196 (35%), Positives = 110/196 (56%), Gaps = 11/196 (5%)

Query: 598 IGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE 657
           IGKG FG V  G  + G++VAVK + D  S   Q F+ E ++++ + H NLV L+G   +
Sbjct: 14  IGKGEFGDVMLGDYR-GQKVAVKCLKDD-STAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71

Query: 658 EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRD 717
            +   +V EYM  G+L D L  S  +  +    +L  A D  +G+EYL        +HRD
Sbjct: 72  GNPLYIVTEYMAKGSLVDYLR-SRGRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRD 127

Query: 718 VKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVY 777
           + + N+L+  ++ AKVSDFGL+++A +         +  V +  PE    ++ + KSDV+
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAKEASQGQD----SGKLPVKWTAPEALREKKFSTKSDVW 183

Query: 778 SFGVVLLELIS-GKKP 792
           SFG++L E+ S G+ P
Sbjct: 184 SFGILLWEIYSFGRVP 199

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score =  134 bits (340), Expect = 9e-33
 Identities = 140/566 (24%), Positives = 230/566 (40%), Gaps = 64/566 (11%)

Query: 7   ISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVKVENPSGNWMQYRTRRDLPI-DNKKYC 65
           + I CG+  N     T   W  D      G       PS      +T R  P+ D  + C
Sbjct: 26  MRISCGARVNVRTAPTNTLWYKDFA-YTGGIPANATRPSFIAPPLKTLRYFPLSDGPENC 84

Query: 66  YNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATL-------WSTVTVLDASRVYA 118
           YN+    +  Y VR  F   +  +  S P F + ++ T        WS+       +V+A
Sbjct: 85  YNINRVPKGHYSVRVFFGLVAEPNFDSEPLFDVSVEGTQISSLKSGWSS----HDEQVFA 140

Query: 119 KEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMY--ATDFEDNFFLKVAARVNFG 176
            E ++     S  +C      G P I ++E+  ++   Y     +     L+ A R++ G
Sbjct: 141 -EALVFLTDGSASICFHSTGHGDPAILSIEILQVDDKAYNFGPSWGQGVILRTAKRLSCG 199

Query: 177 A-LTKDALRYPDDPY--DRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRTREYPPVKV 233
           A  +K    Y  D +  DR W+        F  G+       N  K        YP   +
Sbjct: 200 AGKSKFDEDYSGDHWGGDRFWNRM----QTFGSGSDQAISTENVIKKASNAPNFYPE-SL 254

Query: 234 MQTAVVGTEGV--LSYRLNLEDFP-ANARAFAYFAEI-QDLGPSETRKFKL---EQPYFA 286
            Q+A+V T+    LSY ++++  P  N   + +FAEI   +     R F +       F 
Sbjct: 255 YQSALVSTDTQPDLSYTMDVD--PNRNYSVWLHFAEIDNSITAEGKRVFDVLINGDTAFK 312

Query: 287 DYSNAVVNIAENANGSYTLYEPSYMNVTLNF---VLSFSFVKTRDSTLGPLLNAIEISKY 343
           D     V+I + +   YT      +N T+      L+      + +    ++NAIE+  +
Sbjct: 313 D-----VDIVKMSGERYTAL---VLNKTVAVSGRTLTIVLQPKKGTH--AIINAIEV--F 360

Query: 344 QKIAA--KTEWQDVMVLEALRSISDESERTNDRGDPCVPV--PWEWVTC---STTTPPRI 396
           + I A  KT  ++V  L+ L+S      R    GDPCVP   PW    C   ST     I
Sbjct: 361 EIITAESKTLLEEVSALQTLKSSLGLPLRFGWNGDPCVPQQHPWSGADCQFDSTKGKWFI 420

Query: 397 TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTG 455
             + L  + L+G IP ++  +  L  + L GN + G +P  +  +  L ++ L  N   G
Sbjct: 421 DGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNG 480

Query: 456 SLPSYMGSLPNLQELHIENNSFVGEIPPAL---LTGKVIFKYDNNPKL-----HKESRRR 507
           S+P  +G L +L+ L++  NS  G +P AL   L  +  F + +N  L      +     
Sbjct: 481 SIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACGPH 540

Query: 508 MRFKLILGTSIGVLAILLVLFLCSLI 533
           +     +G + GV    L L +C++ 
Sbjct: 541 LSVGAKIGIAFGVSVAFLFLVICAMC 566

Length = 623

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  126 bits (320), Expect = 2e-32
 Identities = 72/208 (34%), Positives = 103/208 (49%), Gaps = 26/208 (12%)

Query: 596 KKIGKGSFGSVYYGKMK-DGKEVAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 653
           K +G+GS G VY  + K  GK  A+K I  D      +Q + E+  L       +V   G
Sbjct: 7   KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66

Query: 654 -YCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 710
            + +E    I V EYM  G+L D L   G + +  L ++ R QI      GL+YLHT  +
Sbjct: 67  AFYKEGEISI-VLEYMDGGSLADLLKKVGKIPEPVLAYIAR-QILK----GLDYLHTKRH 120

Query: 711 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGY-----LDPEY 764
             IIHRD+K SN+L++     K++DFG+S+  E  L    + V  GTV Y     +  E 
Sbjct: 121 --IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV--GTVTYMSPERIQGES 176

Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKP 792
           Y        +D++S G+ LLE   GK P
Sbjct: 177 YSY-----AADIWSLGLTLLECALGKFP 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  125 bits (315), Expect = 4e-32
 Identities = 71/201 (35%), Positives = 107/201 (53%), Gaps = 17/201 (8%)

Query: 596 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSC-----SHRTQQFVTEVALLSRIHHRNLVP 650
           +KIGKG+FG VY G +K   EVAVK    +C         ++F+ E  +L +  H N+V 
Sbjct: 1   EKIGKGNFGDVYKGVLKGNTEVAVK----TCRSTLPPDLKRKFLQEAEILKQYDHPNIVK 56

Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 710
           LIG C ++    +V E +  G+L   L    N+  +  L  LQ++ DAA G+EYL +   
Sbjct: 57  LIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKL--LQMSLDAAAGMEYLESKN- 113

Query: 711 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT--VGYLDPEYYGNQ 768
              IHRD+ + N L+  N   K+SDFG+SR+ EE   +  S       + +  PE     
Sbjct: 114 --CIHRDLAARNCLVGENNVLKISDFGMSRE-EEGGIYTVSDGLKQIPIKWTAPEALNYG 170

Query: 769 QLTEKSDVYSFGVVLLELISG 789
           + T +SDV+S+G++L E  S 
Sbjct: 171 RYTSESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  129 bits (323), Expect = 4e-32
 Identities = 75/218 (34%), Positives = 114/218 (52%), Gaps = 18/218 (8%)

Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRI-HHRNL 648
              +K+G+GSFG VY  +  D K VA+K++A   +S S   ++F+ E+ +L+ + H  N+
Sbjct: 3   RILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60

Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           V L  + ++E    LV EY+  G+L D L     + PL     L I       LEYLH+ 
Sbjct: 61  VKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK 120

Query: 709 CNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLTH-----ISSVARGTVGYLDP 762
              GIIHRD+K  NILLD +    K+ DFGL++   +  +      + S + GT GY+ P
Sbjct: 121 ---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177

Query: 763 EYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVED 797
           E          +  SD++S G+ L EL++G  P   E 
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215

Length = 384

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  125 bits (316), Expect = 8e-32
 Identities = 67/206 (32%), Positives = 105/206 (50%), Gaps = 17/206 (8%)

Query: 594 FCKKIGKGSFGSVYYGKM-----KDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHR 646
           F K++G+G FG V   +        G++VAVK +  S    HR+  F  E+ +L  + H 
Sbjct: 8   FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSD-FEREIEILRTLDHE 66

Query: 647 NLVPLIGYCEEEHQRI--LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 704
           N+V   G CE+   R   L+ EY+ +G+LRD L    +Q  ++    L  +    KG++Y
Sbjct: 67  NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ--INLKRLLLFSSQICKGMDY 124

Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT--VGYLDP 762
           L    +   IHRD+ + NIL++     K+SDFGL++   ED  +      G   + +  P
Sbjct: 125 LG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAP 181

Query: 763 EYYGNQQLTEKSDVYSFGVVLLELIS 788
           E     + +  SDV+SFGV L EL +
Sbjct: 182 ECLRTSKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  122 bits (309), Expect = 4e-31
 Identities = 61/202 (30%), Positives = 100/202 (49%), Gaps = 16/202 (7%)

Query: 597 KIGKGSFGSVYYG-KMKDGKEVAVK--IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 653
            IG+G+FG VY G  ++ G  VA+K   +        +  + E+ LL  + H N+V  IG
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66

Query: 654 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGCN 710
             E      ++ EY  NG+LR  +      K         +A   +   +GL YLH    
Sbjct: 67  SIETSDSLYIILEYAENGSLRQII------KKFGPFPESLVAVYVYQVLQGLAYLH---E 117

Query: 711 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 770
            G+IHRD+K++NIL   +   K++DFG++ +  +     +SV  GT  ++ PE       
Sbjct: 118 QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV-GTPYWMAPEVIEMSGA 176

Query: 771 TEKSDVYSFGVVLLELISGKKP 792
           +  SD++S G  ++EL++G  P
Sbjct: 177 STASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  119 bits (300), Expect = 1e-29
 Identities = 64/205 (31%), Positives = 104/205 (50%), Gaps = 16/205 (7%)

Query: 593 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 651
              +KIG+G+ G VY    +  GKEVA+K M        +  + E+ ++    H N+V  
Sbjct: 22  KNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINEILIMKDCKHPNIVDY 80

Query: 652 IG-YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHT 707
              Y   +    +V EYM  G+L D     + Q  +  +   QIA    +  +GLEYLH+
Sbjct: 81  YDSYLVGDEL-WVVMEYMDGGSLTD----IITQNFVR-MNEPQIAYVCREVLQGLEYLHS 134

Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 767
                +IHRD+KS NILL  +   K++DFG + Q  ++ +  +SV  GT  ++ PE    
Sbjct: 135 Q---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAPEVIKR 190

Query: 768 QQLTEKSDVYSFGVVLLELISGKKP 792
           +    K D++S G++ +E+  G+ P
Sbjct: 191 KDYGPKVDIWSLGIMCIEMAEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  118 bits (297), Expect = 1e-29
 Identities = 68/200 (34%), Positives = 108/200 (54%), Gaps = 7/200 (3%)

Query: 594 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 653
           F K++G G FG V+ GK +   +VA+K++ +  +     F+ E  ++ ++ H NLV L G
Sbjct: 8   FLKELGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYG 66

Query: 654 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 713
            C ++    +V EYM NG L + L     +   +WL  L +  D  + +EYL +      
Sbjct: 67  VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWL--LDMCSDVCEAMEYLESNG---F 121

Query: 714 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 773
           IHRD+ + N L+  +   KVSDFGL+R   +D    S   +  V +  PE +   + + K
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSK 181

Query: 774 SDVYSFGVVLLELIS-GKKP 792
           SDV+SFGV++ E+ S GK P
Sbjct: 182 SDVWSFGVLMWEVFSEGKMP 201

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  118 bits (297), Expect = 2e-29
 Identities = 72/225 (32%), Positives = 110/225 (48%), Gaps = 34/225 (15%)

Query: 594 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVT-EVALLSRI-HHRNL 648
           F K IG+GSF +V   K K   KE A+KI+        +  ++V  E  +L+R+  H  +
Sbjct: 5   FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGI 64

Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           + L    ++E     V EY  NG L    R +GS+++K     TR   A +    LEYLH
Sbjct: 65  IKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEK----CTRF-YAAEILLALEYLH 119

Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFG---------LSRQAEEDLTHISSVAR--- 754
              + GIIHRD+K  NILLD +M  K++DFG              + D T+I S      
Sbjct: 120 ---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176

Query: 755 -------GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
                  GT  Y+ PE    +   + SD+++ G ++ ++++GK P
Sbjct: 177 RRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score =  116 bits (293), Expect = 4e-29
 Identities = 71/201 (35%), Positives = 109/201 (54%), Gaps = 9/201 (4%)

Query: 594 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 653
           F K++G G FG V YGK +   +VA+K++ +  S    +F+ E  ++ ++ H  LV L G
Sbjct: 8   FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYG 66

Query: 654 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 713
            C ++    +V EYM NG L + L      K       L++  D  +G+ YL +      
Sbjct: 67  VCTKQRPIYIVTEYMSNGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLES---KQF 121

Query: 714 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV-ARGTVGYLDPEYYGNQQLTE 772
           IHRD+ + N L+D     KVSDFGLSR   +D  + SSV ++  V +  PE     + + 
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD-EYTSSVGSKFPVRWSPPEVLLYSKFSS 180

Query: 773 KSDVYSFGVVLLELIS-GKKP 792
           KSDV++FGV++ E+ S GK P
Sbjct: 181 KSDVWAFGVLMWEVYSLGKMP 201

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  116 bits (293), Expect = 4e-29
 Identities = 66/202 (32%), Positives = 103/202 (50%), Gaps = 6/202 (2%)

Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIH 644
           E+E        K+G G +G VY G  K     VAVK + +  +   ++F+ E A++  I 
Sbjct: 2   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIK 60

Query: 645 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 704
           H NLV L+G C  E    ++ E+M  G L D L    N++ ++ +  L +A   +  +EY
Sbjct: 61  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISSAMEY 119

Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
           L        IHRD+ + N L+  N   KV+DFGLSR    D     + A+  + +  PE 
Sbjct: 120 LEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 176

Query: 765 YGNQQLTEKSDVYSFGVVLLEL 786
               + + KSDV++FGV+L E+
Sbjct: 177 LAYNKFSIKSDVWAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  117 bits (294), Expect = 4e-29
 Identities = 65/199 (32%), Positives = 106/199 (53%), Gaps = 6/199 (3%)

Query: 595 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 654
            +K+G G FG V+ G  K+   VA+KI+      + Q F  EV  L R+ H++L+ L   
Sbjct: 11  ERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAV 70

Query: 655 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 714
           C       ++ E M  G+L   L  S   + L   + + +A   A+G+ YL        I
Sbjct: 71  CSVGEPVYIITELMEKGSLLAFL-RSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSI 126

Query: 715 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 774
           HRD+ + NIL+  ++  KV+DFGL+R  +ED+ ++SS  +    +  PE   +   + KS
Sbjct: 127 HRDLAARNILVGEDLVCKVADFGLARLIKEDV-YLSSDKKIPYKWTAPEAASHGTFSTKS 185

Query: 775 DVYSFGVVLLELIS-GKKP 792
           DV+SFG++L E+ + G+ P
Sbjct: 186 DVWSFGILLYEMFTYGQVP 204

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  115 bits (290), Expect = 1e-28
 Identities = 71/206 (34%), Positives = 107/206 (51%), Gaps = 15/206 (7%)

Query: 598 IGKGSFGSVYYGKMKD-GKEVAVKIM--ADSCSHRTQQFV-TEVALLSRIHHRNLVPLIG 653
           +GKGSFG V   + KD GK  A+K++        +  +   TE  +LSRI+H  +V L  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 654 YCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 711
             + E +  LV EY   G L   L   G  +++      R   A +    LEYLH   + 
Sbjct: 61  AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEE----RARFYAA-EIVLALEYLH---SL 112

Query: 712 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 771
           GII+RD+K  NILLD +   K++DFGL+++   + +  ++   GT  YL PE    +   
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLLGKGYG 171

Query: 772 EKSDVYSFGVVLLELISGKKPVSVED 797
           +  D +S GV+L E+++GK P   ED
Sbjct: 172 KAVDWWSLGVLLYEMLTGKPPFYAED 197

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  115 bits (289), Expect = 2e-28
 Identities = 70/218 (32%), Positives = 102/218 (46%), Gaps = 35/218 (16%)

Query: 596 KKIGKGSFGSVYYGKMK-DGKEVAVK-----IMADSCSHRTQQFVTEVALLSRIHHRNLV 649
           + IGKGSFG+V   + K DGK +  K      M        QQ V+EV +L  + H N+V
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT---EKEKQQLVSEVNILRELKHPNIV 62

Query: 650 PLIGYCEEEH----QRI-LVYEYMHNGTLRDRL-HGSVNQKPLD----WLTRLQIAHDAA 699
               Y +       Q + +V EY   G L   +      +K ++    W    Q+     
Sbjct: 63  ---RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLL--- 116

Query: 700 KGLEYLHTGCNPG--IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTV 757
             L   H   +PG  ++HRD+K +NI LD N   K+ DFGL++     L H SS A+  V
Sbjct: 117 -ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK----ILGHDSSFAKTYV 171

Query: 758 G---YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           G   Y+ PE   +    EKSD++S G ++ EL +   P
Sbjct: 172 GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  114 bits (287), Expect = 3e-28
 Identities = 69/201 (34%), Positives = 107/201 (53%), Gaps = 12/201 (5%)

Query: 596 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 655
           +K+G G FG V+ G      +VAVK +    +   + F+ E  ++ ++ H  LV L   C
Sbjct: 12  RKLGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVC 70

Query: 656 EEEHQRILVYEYMHNGTLRDRLH-GSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 714
            EE    +V EYM  G+L D L  G   +  L  L  + +A   A+G+ YL +      I
Sbjct: 71  SEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQL--VDMAAQIAEGMAYLES---RNYI 125

Query: 715 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE--YYGNQQLTE 772
           HRD+ + NIL+  N+  K++DFGL+R  E+D       A+  + +  PE   YG    T 
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGR--FTI 183

Query: 773 KSDVYSFGVVLLELIS-GKKP 792
           KSDV+SFG++L E+++ G+ P
Sbjct: 184 KSDVWSFGILLTEIVTYGRVP 204

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  114 bits (287), Expect = 3e-28
 Identities = 64/204 (31%), Positives = 110/204 (53%), Gaps = 12/204 (5%)

Query: 596 KKIGKGSFGSVYYGKM----KDGKEVAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNLVP 650
           K IG G FG V  G++    K   +VA+K +    S + +  F+TE +++ +  H N++ 
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69

Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 710
           L G   +    +++ EYM NG+L   L    N         + +    A G++YL     
Sbjct: 70  LEGVVTKSRPVMIITEYMENGSLDKFLR--ENDGKFTVGQLVGMLRGIASGMKYL---SE 124

Query: 711 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-DLTHISSVARGTVGYLDPEYYGNQQ 769
              +HRD+ + NIL++ N+  KVSDFGLSR+ E+ + T+ +   +  + +  PE    ++
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRK 184

Query: 770 LTEKSDVYSFGVVLLELIS-GKKP 792
            T  SDV+SFG+V+ E++S G++P
Sbjct: 185 FTSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  114 bits (286), Expect = 7e-28
 Identities = 70/219 (31%), Positives = 111/219 (50%), Gaps = 23/219 (10%)

Query: 594 FCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQ-FVTEVALLSRIHHR 646
             +++G+G+FG V+ G+    +       VAVK + ++ S+  ++ F  E  LL+   H 
Sbjct: 9   LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68

Query: 647 NLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHG------SVNQKPLDWLTR---LQIA 695
           N+V   G C E    I+V+EYM +G L    R HG           P+  LT    LQIA
Sbjct: 69  NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128

Query: 696 HDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVAR 754
              A G+ YL    +   +HRD+ + N L+  ++  K+ DFG+SR     D   +     
Sbjct: 129 VQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTM 185

Query: 755 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
             + ++ PE    ++ T +SDV+SFGVVL E+ + GK+P
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  111 bits (280), Expect = 2e-27
 Identities = 72/203 (35%), Positives = 115/203 (56%), Gaps = 23/203 (11%)

Query: 596 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 655
           + IG+G FG+V  G+   G++VAVK +   C    Q F+ E A+++++HH+NLV L+G  
Sbjct: 12  EIIGEGEFGAVLQGEYT-GQKVAVKNI--KCDVTAQAFLEETAVMTKLHHKNLVRLLGVI 68

Query: 656 EEEHQRI-LVYEYMHNGTL----RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 710
              H  + +V E M  G L    R R    V+   L     LQ + D A+G+EYL +   
Sbjct: 69  L--HNGLYIVMELMSKGNLVNFLRTRGRALVSVIQL-----LQFSLDVAEGMEYLES--- 118

Query: 711 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 770
             ++HRD+ + NIL+  +  AKVSDFGL+R     + +    ++  V +  PE   +++ 
Sbjct: 119 KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDN----SKLPVKWTAPEALKHKKF 174

Query: 771 TEKSDVYSFGVVLLELIS-GKKP 792
           + KSDV+S+GV+L E+ S G+ P
Sbjct: 175 SSKSDVWSYGVLLWEVFSYGRAP 197

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  111 bits (280), Expect = 2e-27
 Identities = 67/203 (33%), Positives = 109/203 (53%), Gaps = 13/203 (6%)

Query: 594 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 653
             ++IG G FG V+ G   + ++VA+K + +  +   + F+ E  ++ ++ H  LV L G
Sbjct: 8   LVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYG 66

Query: 654 YCEEEHQRILVYEYMHNGTLRDRLH---GSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 710
            C E     LV+E+M +G L D L    G  +Q+ L     L +  D  +G+ YL +   
Sbjct: 67  VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETL-----LGMCLDVCEGMAYLESSN- 120

Query: 711 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 770
             +IHRD+ + N L+  N   KVSDFG++R   +D    S+  +  V +  PE +   + 
Sbjct: 121 --VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKY 178

Query: 771 TEKSDVYSFGVVLLELIS-GKKP 792
           + KSDV+SFGV++ E+ S GK P
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGKTP 201

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score =  111 bits (278), Expect = 4e-27
 Identities = 81/270 (30%), Positives = 131/270 (48%), Gaps = 23/270 (8%)

Query: 594 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 653
           F K++G G FG V+ GK +   +VA+K + +  +   + F+ E  ++ ++ H  LV L G
Sbjct: 8   FMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYG 66

Query: 654 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 713
            C ++    +V E+M NG L + L     +   D L  L +  D  +G+EYL        
Sbjct: 67  VCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDML--LSMCQDVCEGMEYLERN---SF 121

Query: 714 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 773
           IHRD+ + N L+      KVSDFG++R   +D    SS A+  V +  PE +   + + K
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181

Query: 774 SDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE 832
           SDV+SFGV++ E+ + GK P   +   +   +V     MI +G    +  P L       
Sbjct: 182 SDVWSFGVLMWEVFTEGKMPFEKK---SNYEVV----EMISRGF--RLYRPKLASMT--- 229

Query: 833 SIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 862
               + EV   C  ++   RP   E++ AI
Sbjct: 230 ----VYEVMYSCWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  111 bits (279), Expect = 5e-27
 Identities = 75/233 (32%), Positives = 117/233 (50%), Gaps = 30/233 (12%)

Query: 582 IPLPELEEATNNFCKKIGKGSFGSVYYGK------MKDGKEVAVKIMADSCSHRTQQ-FV 634
           IPL  +      F +++G+G+FG VY G+            VA+K + ++   + QQ F 
Sbjct: 2   IPLSAVR-----FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFR 56

Query: 635 TEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL-----HGSVN------- 682
            E  L+S + H N+V L+G C +E    +++EY+ +G L + L     H  V        
Sbjct: 57  QEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDET 116

Query: 683 -QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 741
            +  LD    L IA   A G+EYL +      +HRD+ + N L+   +  K+SDFGLSR 
Sbjct: 117 VKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRD 173

Query: 742 A-EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
               D   + S +   V ++ PE     + T +SD++SFGVVL E+ S G +P
Sbjct: 174 IYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score =  109 bits (274), Expect = 1e-26
 Identities = 68/197 (34%), Positives = 109/197 (55%), Gaps = 13/197 (6%)

Query: 598 IGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE 657
           IGKG FG V  G  + G +VAVK + +  +   Q F+ E ++++++ H NLV L+G   E
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 70

Query: 658 EHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHR 716
           E   + +V EYM  G+L D L  S  +  L     L+ + D  + +EYL        +HR
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLR-SRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHR 126

Query: 717 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDV 776
           D+ + N+L+  +  AKVSDFGL+++A    +      +  V +  PE    ++ + KSDV
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKWTAPEALREKKFSTKSDV 182

Query: 777 YSFGVVLLELIS-GKKP 792
           +SFG++L E+ S G+ P
Sbjct: 183 WSFGILLWEIYSFGRVP 199

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  109 bits (274), Expect = 2e-26
 Identities = 63/207 (30%), Positives = 102/207 (49%), Gaps = 17/207 (8%)

Query: 596 KKIGKGSFGSVYYG-KMKDGKEVAVKIMA--DSCSHRTQQFVTEVALLSRIHHRNLVPLI 652
            KIG G+FG VY    +  G+ +AVK +   D+     ++   E+ +L  + H NLV   
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 653 GYCEEEHQRILVY-EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 711
           G  E   +++ ++ EY   GTL + L      + LD            +GL YLH+    
Sbjct: 66  G-VEVHREKVYIFMEYCSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHSH--- 118

Query: 712 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLDPEYYGNQ 768
           GI+HRD+K +NI LD N   K+ DFG + + + + T +    +   G   Y+ PE     
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178

Query: 769 QLTEK---SDVYSFGVVLLELISGKKP 792
           +       +D++S G V+LE+ +GK+P
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  108 bits (272), Expect = 3e-26
 Identities = 64/220 (29%), Positives = 119/220 (54%), Gaps = 25/220 (11%)

Query: 598 IGKGSFGSVYY------GKMKDGKEVAV-KIMADSCSHRTQQFV----TEVALLSRIHHR 646
           IGKG++G VY       G+M   K+V +   +A     R +  V    +E+  L  + H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 647 NLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGSVNQKPLDWLTRLQIAHDAAKGLEY 704
           N+V  +G+   E    +  EY+  G++    R +G   ++ + + T  Q+     +GL Y
Sbjct: 69  NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTE-QVL----EGLAY 123

Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA-RGTVGYLDPE 763
           LH   + GI+HRD+K+ N+L+D +   K+SDFG+S+++++   +  +++ +G+V ++ PE
Sbjct: 124 LH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180

Query: 764 YYGNQQ--LTEKSDVYSFGVVLLELISGKKPVS-VEDFGA 800
              +     + K D++S G V+LE+ +G++P S  E   A
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA 220

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  107 bits (269), Expect = 6e-26
 Identities = 75/218 (34%), Positives = 112/218 (51%), Gaps = 20/218 (9%)

Query: 598 IGKGSFGSVYYG-KMKDGKEVAVK-IMADSCSHRTQQFVT----EVALLSRIHHRNLVPL 651
           +G GSFGSVY G  + DG   AVK +         Q+ V     E+ALLS++ H N+V  
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 709
           +G   EE    +  E +  G+L   L  +GS  +  +   TR QI      GLEYLH   
Sbjct: 68  LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-QIL----LGLEYLH--- 119

Query: 710 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQ 769
           +   +HRD+K +NIL+D N   K++DFG+++Q  E  +   S  +G+  ++ PE    Q 
Sbjct: 120 DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVE-FSFAKSF-KGSPYWMAPEVIAQQG 177

Query: 770 L-TEKSDVYSFGVVLLELISGKKPVS-VEDFGAELNIV 805
                +D++S G  +LE+ +GK P S +E   A   I 
Sbjct: 178 GYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIG 215

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  107 bits (268), Expect = 8e-26
 Identities = 73/209 (34%), Positives = 109/209 (52%), Gaps = 23/209 (11%)

Query: 596 KKIGKGSFGSVYYG--KMKDGKE--VAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVP 650
           K++G G+FGSV  G   MK GKE  VAVK +         ++F+ E ++++++ H  +V 
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           LIG C+ E   +LV E    G L   L     +    L      ++AH  A G+ YL   
Sbjct: 61  LIGVCKGE-PLMLVMELAPLGPLLKYLKKRREIPVSDL-----KELAHQVAMGMAYLE-S 113

Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPE--Y 764
            +   +HRD+ + N+LL    +AK+SDFG+SR   A  D    ++  R  + +  PE   
Sbjct: 114 KH--FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECIN 171

Query: 765 YGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
           YG  + + KSDV+S+GV L E  S G KP
Sbjct: 172 YG--KFSSKSDVWSYGVTLWEAFSYGAKP 198

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score =  107 bits (268), Expect = 1e-25
 Identities = 71/216 (32%), Positives = 113/216 (52%), Gaps = 24/216 (11%)

Query: 596 KKIGKGSFGSVYYGKMK--DGK--EVAVKIM-ADSCSHR-TQQFVTEVALLSRIHHRNLV 649
           K +G+G FGSV  G++   DG   +VAVK M  D  ++   ++F++E A +    H N++
Sbjct: 5   KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64

Query: 650 PLIGYC--EEEHQRI----LVYEYMHNGTLRD-----RLHGSVNQKPLDWLTRLQIAHDA 698
            LIG C      Q+I    ++  +M +G L       RL G   + PL  L +  +  D 
Sbjct: 65  KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV--DI 122

Query: 699 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTV 757
           A G+EYL    N   IHRD+ + N +L  +M   V+DFGLS++    D      +A+  V
Sbjct: 123 ALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179

Query: 758 GYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
            ++  E   ++  T KSDV++FGV + E+ + G+ P
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  107 bits (268), Expect = 1e-25
 Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 19/213 (8%)

Query: 596 KKIGKGSFGSVYYGKMK---DGKEVAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVPL 651
            ++G G+ G V   K+     GK +AVK +  +      +Q + E+ +L + +   +V  
Sbjct: 7   GELGAGNSGVVS--KVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGF 64

Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 711
            G         +  EYM  G+L   L     + P   L ++ +A    KGL YLH     
Sbjct: 65  YGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVA--VLKGLTYLHE--KH 120

Query: 712 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDPEYYGNQ 768
            IIHRDVK SNIL++   + K+ DFG+S Q       ++S+A+   GT  Y+ PE     
Sbjct: 121 KIIHRDVKPSNILVNSRGQIKLCDFGVSGQL------VNSLAKTFVGTSSYMAPERIQGN 174

Query: 769 QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 801
             + KSD++S G+ L+EL +G+ P   E+   +
Sbjct: 175 DYSVKSDIWSLGLSLIELATGRFPYPPENDPPD 207

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score =  106 bits (267), Expect = 2e-25
 Identities = 70/219 (31%), Positives = 108/219 (49%), Gaps = 18/219 (8%)

Query: 585 PELEEATNNFCKKIGKGSFGSVYYGKM--KDGK----EVAVKIMADSCSHRTQQ-FVTEV 637
           PE+   +    + +G G+FG VY G    +DG     +VAVK + +SCS + +  F+ E 
Sbjct: 1   PEVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEA 60

Query: 638 ALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGS----VNQKPLDWLTRLQ 693
            ++S+ +H+N+V LIG   E   R ++ E M  G L+  L  +         L     L 
Sbjct: 61  LIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLF 120

Query: 694 IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQA-EEDLTHI 749
            A D AKG +YL        IHRD+ + N LL        AK++DFG++R          
Sbjct: 121 CARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRK 177

Query: 750 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
              A   + ++ PE + +   T K+DV+SFGV+L E+ S
Sbjct: 178 GGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  105 bits (264), Expect = 6e-25
 Identities = 71/210 (33%), Positives = 110/210 (52%), Gaps = 14/210 (6%)

Query: 588 EEATNNFCKKIGKGSFGSV---YYGKMKD--GKEVAVKIMADSCSHRTQQFVTEVALLSR 642
           EE    F +++GKG+FGSV    Y  ++D  G+ VAVK +  S +   + F  E+ +L  
Sbjct: 2   EERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKS 61

Query: 643 IHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 700
           + H N+V   G C    +R   LV EY+  G+LRD L    +++ LD    L  A    K
Sbjct: 62  LQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYL--QKHRERLDHRKLLLYASQICK 119

Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH--ISSVARGTVG 758
           G+EYL +      +HRD+ + NIL++   R K+ DFGL++   +D  +  +       + 
Sbjct: 120 GMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIF 176

Query: 759 YLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
           +  PE     + +  SDV+SFGVVL EL +
Sbjct: 177 WYAPESLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  104 bits (260), Expect = 1e-24
 Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 6/208 (2%)

Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 645
           E++  +    +K+G G FG V+ G   +   VAVK +    +   + F+ E  ++ ++ H
Sbjct: 2   EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRH 60

Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 705
             L+ L   C  E    +V E M  G+L + L G   +  L     + +A   A G+ YL
Sbjct: 61  PKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRA-LKLPQLIDMAAQVASGMAYL 119

Query: 706 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 765
                   IHRD+ + N+L+  N   KV+DFGL+R  +ED+      A+  + +  PE  
Sbjct: 120 EA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAA 176

Query: 766 GNQQLTEKSDVYSFGVVLLELIS-GKKP 792
              + + KSDV+SFG++L E+++ G+ P
Sbjct: 177 LYNRFSIKSDVWSFGILLTEIVTYGRMP 204

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  103 bits (258), Expect = 2e-24
 Identities = 72/213 (33%), Positives = 112/213 (52%), Gaps = 27/213 (12%)

Query: 598 IGKGSFGSVYYG-KMKDGKEVAVK------IMADSCSHRT---QQFVTEVALLSRIHHRN 647
           IG GSFGSVY G     G+ +AVK      + A S   +         E+ALL  + H N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 648 LVPLIG-YCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEY 704
           +V  +G   + +H  I + EY+  G++   L  +G+  +  +    R QI     KGL Y
Sbjct: 68  IVQYLGSSLDADHLNIFL-EYVPGGSVAALLNNYGAFEETLVRNFVR-QIL----KGLNY 121

Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA-----RGTVGY 759
           LH   N GIIHRD+K +NIL+D     K+SDFG+S++ E +     +       +G+V +
Sbjct: 122 LH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178

Query: 760 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           + PE       T K+D++S G +++E+++GK P
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  103 bits (257), Expect = 2e-24
 Identities = 70/209 (33%), Positives = 106/209 (50%), Gaps = 25/209 (11%)

Query: 596 KKIGKGSFGSVYYGKMKDG------KEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLV 649
           KKIG+GSFG +Y  K K        KE+ +  M       +++   EV LL+++ H N+V
Sbjct: 6   KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKK---EVILLAKMKHPNIV 62

Query: 650 PLIGYCEEEHQRILVYEYMHNGTLRDRL---HGSV--NQKPLDWLTRLQIAHDAAKGLEY 704
                 +E  +  +V EY   G L  R+    G +    + L W  ++ +      GL++
Sbjct: 63  TFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------GLKH 116

Query: 705 LHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 763
           +H   +  I+HRD+KS NI L  N M AK+ DFG++RQ   D   ++    GT  YL PE
Sbjct: 117 IH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN-DSMELAYTCVGTPYYLSPE 172

Query: 764 YYGNQQLTEKSDVYSFGVVLLELISGKKP 792
              N+    K+D++S G VL EL + K P
Sbjct: 173 ICQNRPYNNKTDIWSLGCVLYELCTLKHP 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score =  103 bits (258), Expect = 2e-24
 Identities = 78/272 (28%), Positives = 133/272 (48%), Gaps = 29/272 (10%)

Query: 596 KKIGKGSFGSVYYG--KMKDGKEVAVKIM---ADSCSHRTQQFVTEVALLSRIHHRNLVP 650
           K IG G FG V+ G  KM   KEVAV I          + Q F++E +++ +  H N++ 
Sbjct: 11  KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70

Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 710
           L G   +    +++ EYM NG L   L    +         + +    A G++YL    +
Sbjct: 71  LEGVVTKFKPAMIITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYL---SD 125

Query: 711 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED--LTHISSVARGTVGYLDPEYYGNQ 768
              +HRD+ + NIL++ N+  KVSDFGLSR  E+D   T+ +S  +  + +  PE    +
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR 185

Query: 769 QLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 827
           + T  SDV+SFG+V+ E++S G++P             +W  S     +V+  ++     
Sbjct: 186 KFTSASDVWSFGIVMWEVMSFGERP-------------YWDMS---NHEVMKAINDGFRL 229

Query: 828 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 859
              ++    + ++ +QC +Q    RP+  +IV
Sbjct: 230 PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIV 261

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  102 bits (257), Expect = 4e-24
 Identities = 62/209 (29%), Positives = 96/209 (45%), Gaps = 11/209 (5%)

Query: 593 NFCKKIGKGSFGSVYYGKMKDGKE-VAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVP 650
              + IG G+   VY        E VA+K +  + C     +   EV  +S+ +H N+V 
Sbjct: 4   ELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVK 63

Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 710
                    +  LV  Y+  G+L D +  S  +  LD      +  +  KGLEYLH+   
Sbjct: 64  YYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN-- 121

Query: 711 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDPEYYG 766
            G IHRD+K+ NILL  +   K++DFG+S    +     +   R    GT  ++ PE   
Sbjct: 122 -GQIHRDIKAGNILLGEDGSVKIADFGVSASLADG-GDRTRKVRKTFVGTPCWMAPEVME 179

Query: 767 NQQ-LTEKSDVYSFGVVLLELISGKKPVS 794
                  K+D++SFG+  +EL +G  P S
Sbjct: 180 QVHGYDFKADIWSFGITAIELATGAAPYS 208

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  101 bits (253), Expect = 9e-24
 Identities = 67/206 (32%), Positives = 99/206 (48%), Gaps = 15/206 (7%)

Query: 596 KKIGKGSFGSVYYGKMKD--GK--EVAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVP 650
           KK+G GSFG V  G+     GK   VAVK + +D  S     F+ E A++  + H NL+ 
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60

Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRL-QIAHDAAKGLEYLHTGC 709
           L G     H  ++V E    G+L DRL    +      ++ L   A   A G+ YL +  
Sbjct: 61  LYGVVLT-HPLMMVTELAPLGSLLDRLRK--DALGHFLISTLCDYAVQIANGMRYLES-- 115

Query: 710 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTV--GYLDPEYYGN 767
               IHRD+ + NILL  + + K+ DFGL R   ++  H        V   +  PE    
Sbjct: 116 -KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT 174

Query: 768 QQLTEKSDVYSFGVVLLELIS-GKKP 792
           +  +  SDV+ FGV L E+ + G++P
Sbjct: 175 RTFSHASDVWMFGVTLWEMFTYGEEP 200

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  102 bits (255), Expect = 1e-23
 Identities = 63/210 (30%), Positives = 100/210 (47%), Gaps = 29/210 (13%)

Query: 597 KIGKGSFGSVYYGKMKDGKEV-AVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 654
           ++G+G+ GSV   ++K+   + A+K I  D      +Q + E+ +        +V   G 
Sbjct: 8   RLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGA 67

Query: 655 CEEEHQRIL--VYEYMHNGTLRDRLHGSV-------NQKPLDWLTRLQIAHDAAKGLEYL 705
             +E    +    EY   G+L D ++  V        +K L      +IA    KGL YL
Sbjct: 68  FLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVL-----GKIAESVLKGLSYL 121

Query: 706 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDP 762
           H+     IIHRD+K SNILL    + K+ DFG+S +       ++S+A    GT  Y+ P
Sbjct: 122 HS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL------VNSLAGTFTGTSFYMAP 172

Query: 763 EYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           E    +  +  SDV+S G+ LLE+   + P
Sbjct: 173 ERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score =  101 bits (254), Expect = 1e-23
 Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 12/203 (5%)

Query: 596 KKIGKGSFGSVYYGKMKDGK----EVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVP 650
           + IG+G FG VY G     +     VAVK   +  S    ++F+ E  ++ +  H ++V 
Sbjct: 12  RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71

Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 710
           LIG   E    I V E    G LR  L   VN+  LD  + +  ++  +  L YL +   
Sbjct: 72  LIGVITENPVWI-VMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLES--- 125

Query: 711 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 770
              +HRD+ + N+L+      K+ DFGLSR  E++  + +S  +  + ++ PE    ++ 
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRF 185

Query: 771 TEKSDVYSFGVVLLELIS-GKKP 792
           T  SDV+ FGV + E++  G KP
Sbjct: 186 TSASDVWMFGVCMWEILMLGVKP 208

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score =  100 bits (251), Expect = 1e-23
 Identities = 64/198 (32%), Positives = 107/198 (54%), Gaps = 12/198 (6%)

Query: 596 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNLVPLIG 653
           ++IG+G+FG V+ G+++ D   VAVK   ++     + +F+ E  +L +  H N+V LIG
Sbjct: 1   ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60

Query: 654 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKP-LDWLTRLQIAHDAAKGLEYLHTGCNPG 712
            C ++    +V E +  G     L     + P L     +Q+  +AA G+EYL +     
Sbjct: 61  VCTQKQPIYIVMELVQGGDFLTFLR---TEGPRLKVKELIQMVENAAAGMEYLESKH--- 114

Query: 713 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS--VARGTVGYLDPEYYGNQQL 770
            IHRD+ + N L+      K+SDFG+SR+ EED  + S+  + +  V +  PE     + 
Sbjct: 115 CIHRDLAARNCLVTEKNVLKISDFGMSRE-EEDGVYASTGGMKQIPVKWTAPEALNYGRY 173

Query: 771 TEKSDVYSFGVVLLELIS 788
           + +SDV+SFG++L E  S
Sbjct: 174 SSESDVWSFGILLWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  100 bits (252), Expect = 1e-23
 Identities = 64/202 (31%), Positives = 107/202 (52%), Gaps = 15/202 (7%)

Query: 597 KIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 655
           K+G+GS+GSVY     + G+ VA+K++        Q+ + E+++L +     +V   G  
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVV--PVEEDLQEIIKEISILKQCDSPYIVKYYGSY 67

Query: 656 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGCNPG 712
            +     +V EY   G++ D +   +  K L   T  +IA   +   KGLEYLH   +  
Sbjct: 68  FKNTDLWIVMEYCGAGSVSDIM--KITNKTL---TEEEIAAILYQTLKGLEYLH---SNK 119

Query: 713 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 772
            IHRD+K+ NILL+   +AK++DFG+S Q  + +   ++V  GT  ++ PE         
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYNN 178

Query: 773 KSDVYSFGVVLLELISGKKPVS 794
           K+D++S G+  +E+  GK P S
Sbjct: 179 KADIWSLGITAIEMAEGKPPYS 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score =  100 bits (250), Expect = 1e-23
 Identities = 72/262 (27%), Positives = 128/262 (48%), Gaps = 21/262 (8%)

Query: 598 IGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNLVPLIGYCE 656
           +GKG+FG V+ G +KD   VAVK   +      + +F++E  +L +  H N+V LIG C 
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62

Query: 657 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHR 716
           +     +V E +  G     L    ++     L +  +  DAA G+ YL +      IHR
Sbjct: 63  QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFAL--DAAAGMAYLES---KNCIHR 117

Query: 717 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDV 776
           D+ + N L+  N   K+SDFG+SRQ ++ +   S + +  + +  PE     + + +SDV
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDV 177

Query: 777 YSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWR 836
           +S+G++L E  S    + V  +    N    AR  ++KG  +S            + +++
Sbjct: 178 WSYGILLWETFS----LGVCPYPGMTN--QQAREQVEKGYRMSCPQKC------PDDVYK 225

Query: 837 IAEVAIQCVEQRGFSRPKMQEI 858
           + +   +C + +  +RPK  E+
Sbjct: 226 VMQ---RCWDYKPENRPKFSEL 244

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score =  101 bits (252), Expect = 1e-23
 Identities = 77/275 (28%), Positives = 135/275 (49%), Gaps = 35/275 (12%)

Query: 596 KKIGKGSFGSVYYGKMK--DGKEVAVKIMADSCSHRTQQ---FVTEVALLSRIHHRNLVP 650
           K IG G FG V  G++K    +E+ V I      +  +Q   F++E +++ +  H N++ 
Sbjct: 10  KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIH 69

Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHT 707
           L G   +    ++V EYM NG+L   L     Q      T +Q+       A G++YL  
Sbjct: 70  LEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQ-----FTVIQLVGMLRGIASGMKYL-- 122

Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED--LTHISSVARGTVGYLDPEYY 765
             + G +HRD+ + NIL++ N+  KVSDFGLSR  E+D    + +   +  + +  PE  
Sbjct: 123 -SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 181

Query: 766 GNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 824
             ++ T  SDV+S+G+V+ E++S G++P             +W  S     DVI  ++  
Sbjct: 182 AYRKFTSASDVWSYGIVMWEVMSYGERP-------------YWEMS---NQDVIKAIEEG 225

Query: 825 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 859
                 ++    + ++ + C ++    RPK ++IV
Sbjct: 226 YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIV 260

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  100 bits (251), Expect = 2e-23
 Identities = 59/217 (27%), Positives = 107/217 (49%), Gaps = 14/217 (6%)

Query: 584 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHRTQQ-FVTEV 637
           L  L+E      K +G G+FG+VY G      E     VA+K++ +  S +  +  + E 
Sbjct: 1   LRILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEA 60

Query: 638 ALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHD 697
            +++ + H ++V L+G C    Q  L+ + M  G L D +    ++  +     L     
Sbjct: 61  YVMASVDHPHVVRLLGICLSS-QVQLITQLMPLGCLLDYVRN--HKDNIGSQYLLNWCVQ 117

Query: 698 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH-ISSVARGT 756
            AKG+ YL       ++HRD+ + N+L+      K++DFGL++  + D     +   +  
Sbjct: 118 IAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVP 174

Query: 757 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
           + ++  E   ++  T KSDV+S+GV + EL++ G KP
Sbjct: 175 IKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKP 211

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  100 bits (252), Expect = 2e-23
 Identities = 66/214 (30%), Positives = 104/214 (48%), Gaps = 38/214 (17%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQF-VT---EVALLSRIHHRNLVP 650
            +IG+G++G VY  +  K G+ VA+K +     +  + F +T   E+ LL ++ H N+V 
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKI--RMENEKEGFPITAIREIKLLQKLRHPNIVR 62

Query: 651 LIGYCEEEHQR--ILVYEYM-HNGTLRDRLHGSVNQKPLDWLTRLQI---AHDAAKGLEY 704
           L      + +    +V+EYM H+ T    L  S   K     T  QI        +GL+Y
Sbjct: 63  LKEIVTSKGKGSIYMVFEYMDHDLT---GLLDSPEVK----FTESQIKCYMKQLLEGLQY 115

Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARG-------TV 757
           LH   + GI+HRD+K SNIL++ +   K++DFGL+R         +            T+
Sbjct: 116 LH---SNGILHRDIKGSNILINNDGVLKLADFGLAR-------PYTKRNSADYTNRVITL 165

Query: 758 GYLDPE-YYGNQQLTEKSDVYSFGVVLLELISGK 790
            Y  PE   G  +   + D++S G +L EL  GK
Sbjct: 166 WYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  100 bits (250), Expect = 3e-23
 Identities = 64/209 (30%), Positives = 107/209 (51%), Gaps = 22/209 (10%)

Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVKIM-----ADSCSHRTQQFVTEVALLSRIHHRNLV 649
           K +G+G+FG VY     D G+E+AVK +     +            E+ LL  + H  +V
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67

Query: 650 PLIGYCEEEHQRILVY-EYMHNGTLRD--RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
              G C  + + + ++ EYM  G+++D  + +G++ +      TR QI      G+EYLH
Sbjct: 68  QYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTR-QILE----GVEYLH 121

Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE---DLTHISSVARGTVGYLDPE 763
           +     I+HRD+K +NIL D     K+ DFG S++ +      T + SV  GT  ++ PE
Sbjct: 122 SN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT-GTPYWMSPE 177

Query: 764 YYGNQQLTEKSDVYSFGVVLLELISGKKP 792
               +    K+DV+S G  ++E+++ K P
Sbjct: 178 VISGEGYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  100 bits (250), Expect = 3e-23
 Identities = 66/199 (33%), Positives = 98/199 (49%), Gaps = 12/199 (6%)

Query: 598 IGKGSFGSVYYGKMKDGKEV-AVKIMADS-C--SHRTQQFVTEVALLSRIHHRNLVPLIG 653
           IGKG+FG V   + +D K++ A+K M    C      +  + E  +L  ++H  LV L  
Sbjct: 8   IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWY 67

Query: 654 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 713
             ++E    LV + +  G LR   H S   K  +   +  I  +    LEYLH   + GI
Sbjct: 68  SFQDEENMYLVVDLLLGGDLR--YHLSQKVKFSEEQVKFWIC-EIVLALEYLH---SKGI 121

Query: 714 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 773
           IHRD+K  NILLD      ++DF ++ +   D T  +S + GT GY+ PE    Q  +  
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATKVTPD-TLTTSTS-GTPGYMAPEVLCRQGYSVA 179

Query: 774 SDVYSFGVVLLELISGKKP 792
            D +S GV   E + GK+P
Sbjct: 180 VDWWSLGVTAYECLRGKRP 198

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 99.5 bits (248), Expect = 4e-23
 Identities = 68/208 (32%), Positives = 105/208 (50%), Gaps = 10/208 (4%)

Query: 597 KIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRTQQ--FVTEVALLSRIHHRNLVPLIG 653
           KIGKGSFG V+    K  K V A+K +  S  +R ++   + E  +L+++    ++    
Sbjct: 7   KIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYE 66

Query: 654 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQK-PLDWLTRLQIAHDAAKGLEYLHTGCNPG 712
              ++ +  +V EY  NG L   L     +  P D + R  I      GL +LH+     
Sbjct: 67  SFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI--QILLGLAHLHSK---K 121

Query: 713 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 772
           I+HRD+KS N+ LD     K+ D G+++    D T+ ++   GT  YL PE   ++   E
Sbjct: 122 ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS-DNTNFANTIVGTPYYLSPELCEDKPYNE 180

Query: 773 KSDVYSFGVVLLELISGKKPVSVEDFGA 800
           KSDV++ GVVL E  +GK P    + GA
Sbjct: 181 KSDVWALGVVLYECCTGKHPFDANNQGA 208

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 99.1 bits (247), Expect = 6e-23
 Identities = 68/206 (33%), Positives = 105/206 (50%), Gaps = 18/206 (8%)

Query: 598 IGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT-----QQFVTEVALLSRIHHRNLVPLI 652
           IGKG FG VY+G + D     +     S +  T     +QF+ E  ++    H N++ L+
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 653 GYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR--LQIAHDAAKGLEYLHTGC 709
           G C   E   ++V  YM +G LR+ +    +   +  L    LQ+A    KG+EYL    
Sbjct: 63  GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVA----KGMEYL---A 115

Query: 710 NPGIIHRDVKSSNILLDINMRAKVSDFGLSR---QAEEDLTHISSVARGTVGYLDPEYYG 766
           +   +HRD+ + N +LD +   KV+DFGL+R     E    H  + A+  V ++  E   
Sbjct: 116 SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175

Query: 767 NQQLTEKSDVYSFGVVLLELISGKKP 792
            Q+ T KSDV+SFGV+L EL++   P
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMTRGAP 201

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 98.9 bits (247), Expect = 6e-23
 Identities = 64/211 (30%), Positives = 106/211 (50%), Gaps = 26/211 (12%)

Query: 596 KKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 654
           ++IG G++G VY  +    G+ VA+K++        +    E+++L    H N+V   G 
Sbjct: 9   QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68

Query: 655 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH---DAAKGLEYLHTGCNP 711
                +  +V EY   G+L+D     V + PL   + LQIA+   +  KGL YLH     
Sbjct: 69  YLRRDKLWIVMEYCGGGSLQDIYQ--VTRGPL---SELQIAYVCRETLKGLAYLH---ET 120

Query: 712 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR-----GTVGYLDPEYYG 766
           G IHRD+K +NILL  +   K++DFG+S Q    LT   ++A+     GT  ++ PE   
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVSAQ----LTA--TIAKRKSFIGTPYWMAPEVAA 174

Query: 767 NQQL---TEKSDVYSFGVVLLELISGKKPVS 794
            ++      K D+++ G+  +EL   + P+ 
Sbjct: 175 VERKGGYDGKCDIWALGITAIELAELQPPMF 205

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 99.8 bits (248), Expect = 7e-23
 Identities = 67/215 (31%), Positives = 107/215 (49%), Gaps = 21/215 (9%)

Query: 596 KKIGKGSFGSVYYGKM------KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLV 649
           +++G+G+FG V+  +       +D   VAVK + D+  +  + F  E  LL+ + H ++V
Sbjct: 11  RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIV 70

Query: 650 PLIGYCEEEHQRILVYEYMHNGTLRD--RLHGS-----VNQKPLDWLTR---LQIAHDAA 699
              G C E    I+V+EYM +G L    R HG              LT+   L IA   A
Sbjct: 71  KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130

Query: 700 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTVG 758
            G+ YL    +   +HRD+ + N L+  N+  K+ DFG+SR     D   +       + 
Sbjct: 131 AGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 187

Query: 759 YLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
           ++ PE    ++ T +SDV+S GVVL E+ + GK+P
Sbjct: 188 WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 98.1 bits (245), Expect = 1e-22
 Identities = 70/216 (32%), Positives = 102/216 (47%), Gaps = 24/216 (11%)

Query: 598 IGKGSFGSVYYGKMK-DGKEVAVKIM--AD-SCSHRTQQFVTEVALLSRIHHRNLVPLIG 653
           I KG++G V+  K K  G   A+K++  AD    ++  Q +TE  +LS+     +V L  
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 654 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 713
             + +    LV EY+  G L   L  +V     D   R+ IA +    LEYLH   + GI
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLLE-NVGSLDEDV-ARIYIA-EIVLALEYLH---SNGI 114

Query: 714 IHRDVKSSNILLDINMRAKVSDFGLSRQ--------AEEDLTHISSVARGTVGYLDPEYY 765
           IHRD+K  NIL+D N   K++DFGLS+           +D      +  GT  Y+ PE  
Sbjct: 115 IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV-GTPDYIAPEVI 173

Query: 766 GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 801
             Q  ++  D +S G +L E + G  P     F  E
Sbjct: 174 LGQGHSKTVDWWSLGCILYEFLVGIPP-----FHGE 204

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 98.8 bits (246), Expect = 1e-22
 Identities = 71/235 (30%), Positives = 107/235 (45%), Gaps = 47/235 (20%)

Query: 594 FCKKIGKGSFGSVYYGKM------KDGKEVAVKIMADSCSHRTQ-QFVTEVALLSRIHHR 646
           + + IG+G+FG V+  +       +    VAVK++ +  S   Q  F  E AL++   H 
Sbjct: 9   YVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHP 68

Query: 647 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRL------------HGSV-------NQKPLD 687
           N+V L+G C       L++EYM  G L + L            H +        N  PL 
Sbjct: 69  NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128

Query: 688 WLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ------ 741
              +L IA   A G+ YL        +HRD+ + N L+  NM  K++DFGLSR       
Sbjct: 129 CTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 185

Query: 742 ---AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
              +E D   I         ++ PE     + T +SDV+++GVVL E+ S G +P
Sbjct: 186 YKASENDAIPIR--------WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP 232

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 97.4 bits (242), Expect = 2e-22
 Identities = 65/209 (31%), Positives = 107/209 (51%), Gaps = 8/209 (3%)

Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 645
           E+   +    KK+G G FG V+ G   +  +VAVK +    +   Q F+ E  L+  + H
Sbjct: 2   EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQH 60

Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRL-QIAHDAAKGLEY 704
             LV L     +E    ++ EYM  G+L D L      K L  L +L   +   A+G+ Y
Sbjct: 61  DKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVL--LPKLIDFSAQIAEGMAY 118

Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
           +        IHRD++++N+L+  ++  K++DFGL+R  E++       A+  + +  PE 
Sbjct: 119 IE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 175

Query: 765 YGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
                 T KSDV+SFG++L E+++ GK P
Sbjct: 176 INFGSFTIKSDVWSFGILLYEIVTYGKIP 204

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 97.2 bits (242), Expect = 3e-22
 Identities = 65/208 (31%), Positives = 106/208 (50%), Gaps = 7/208 (3%)

Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 645
           E+   T    KK+G G FG V+ G      +VA+K +    S   + F+ E  L+ ++ H
Sbjct: 2   EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQG-SMSPEAFLAEANLMKQLQH 60

Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 705
             LV L     +E   I + EYM NG+L D L      K L     + +A   A+G+ ++
Sbjct: 61  PRLVRLYAVVTQEPIYI-ITEYMENGSLVDFLKTPEGIK-LTINKLIDMAAQIAEGMAFI 118

Query: 706 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 765
                   IHRD++++NIL+   +  K++DFGL+R  E++       A+  + +  PE  
Sbjct: 119 ER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 175

Query: 766 GNQQLTEKSDVYSFGVVLLELIS-GKKP 792
                T KSDV+SFG++L E+++ G+ P
Sbjct: 176 NYGTFTIKSDVWSFGILLTEIVTYGRIP 203

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 97.5 bits (243), Expect = 3e-22
 Identities = 57/209 (27%), Positives = 96/209 (45%), Gaps = 17/209 (8%)

Query: 598 IGKGSFGSVYYGKMK----DGKE--VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNLVP 650
           +G+G FG V+  K K    +G E  V VK +  +     Q  F  E+ +  ++ H+N+V 
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72

Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLHGS------VNQKPLDWLTRLQIAHDAAKGLEY 704
           L+G C E     ++ EY   G L+  L  +      +   PL    ++ +    A G+++
Sbjct: 73  LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132

Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
           L        +HRD+ + N L+      KVS   LS+       +    A   + +L PE 
Sbjct: 133 LSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEA 189

Query: 765 YGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
                 + KSDV+SFGV++ E+ + G+ P
Sbjct: 190 VQEDDFSTKSDVWSFGVLMWEVFTQGELP 218

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 97.0 bits (242), Expect = 4e-22
 Identities = 65/218 (29%), Positives = 100/218 (45%), Gaps = 33/218 (15%)

Query: 598 IGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIG-- 653
           IG+G++G VY  +  K G+ VA+KIM D      ++   E  +L +  +H N+    G  
Sbjct: 14  IGEGTYGKVYKARHKKTGQLVAIKIM-DIIEDEEEEIKEEYNILRKYSNHPNIATFYGAF 72

Query: 654 ----YCEEEHQRILVYEYMHNGTLRD---RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
                   + Q  LV E    G++ D    L     +   +W+    I  +  +GL YLH
Sbjct: 73  IKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIA--YILRETLRGLAYLH 130

Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR-----GTVGYLD 761
                 +IHRD+K  NILL  N   K+ DFG+S Q +      S++ R     GT  ++ 
Sbjct: 131 ---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLD------STLGRRNTFIGTPYWMA 181

Query: 762 PE-----YYGNQQLTEKSDVYSFGVVLLELISGKKPVS 794
           PE        +     +SDV+S G+  +EL  GK P+ 
Sbjct: 182 PEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLC 219

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 97.6 bits (243), Expect = 5e-22
 Identities = 68/204 (33%), Positives = 100/204 (49%), Gaps = 18/204 (8%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPL 651
           ++IG GSFG+VY+ + ++  + VA+K M+ S        Q  + EV  L ++ H N +  
Sbjct: 21  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80

Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 711
            G    EH   LV EY   G+  D L   V++KPL  +    I H A +GL YLH+    
Sbjct: 81  KGCYLREHTAWLVMEYCL-GSASDIL--EVHKKPLQEVEIAAICHGALQGLAYLHSHER- 136

Query: 712 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY---YGNQ 768
             IHRD+K+ NILL      K++DFG +       + +     GT  ++ PE        
Sbjct: 137 --IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVILAMDEG 189

Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
           Q   K DV+S G+  +EL   K P
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPP 213

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 97.0 bits (241), Expect = 6e-22
 Identities = 68/218 (31%), Positives = 108/218 (49%), Gaps = 24/218 (11%)

Query: 596 KKIGKGSFGSVYYGK------MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLV 649
           +++G+G+FG V+  +       KD   VAVK + D      + F  E  LL+ + H ++V
Sbjct: 11  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 70

Query: 650 PLIGYCEEEHQRILVYEYMHNGTLRD--RLHGS-----VNQKP------LDWLTRLQIAH 696
              G C +    I+V+EYM +G L    R HG      V+ +P      L     L IA 
Sbjct: 71  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130

Query: 697 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARG 755
             A G+ YL    +   +HRD+ + N L+  N+  K+ DFG+SR     D   +      
Sbjct: 131 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187

Query: 756 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
            + ++ PE    ++ T +SDV+SFGV+L E+ + GK+P
Sbjct: 188 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 96.2 bits (239), Expect = 8e-22
 Identities = 65/216 (30%), Positives = 105/216 (48%), Gaps = 23/216 (10%)

Query: 597 KIGKGSFGSVYYGKM------KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVP 650
           ++G+G+FG V+  +       +D   VAVK + ++     Q F  E  LL+ + H+++V 
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71

Query: 651 LIGYCEEEHQRILVYEYMHNGTLRD--RLHG----------SVNQKPLDWLTRLQIAHDA 698
             G C E    ++V+EYM +G L    R HG           V    L     L IA   
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 699 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTV 757
           A G+ YL    +   +HRD+ + N L+   +  K+ DFG+SR     D   +       +
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188

Query: 758 GYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
            ++ PE    ++ T +SD++SFGVVL E+ + GK+P
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 96.4 bits (240), Expect = 8e-22
 Identities = 63/205 (30%), Positives = 101/205 (49%), Gaps = 18/205 (8%)

Query: 593 NFCKKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 651
           NF  KIG+GS G V        G++VAVK M      R +    EV ++    H N+V +
Sbjct: 23  NF-VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEM 81

Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRL-HGSVNQKPLDWLTRLQIA---HDAAKGLEYLHT 707
                   +  +V E++  G L D + H  +N++        QIA       K L +LH 
Sbjct: 82  YSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE--------QIATVCLAVLKALSFLHA 133

Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 767
               G+IHRD+KS +ILL  + R K+SDFG   Q  +++    S+  GT  ++ PE    
Sbjct: 134 ---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPEVISR 189

Query: 768 QQLTEKSDVYSFGVVLLELISGKKP 792
                + D++S G++++E++ G+ P
Sbjct: 190 LPYGTEVDIWSLGIMVIEMVDGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 95.8 bits (238), Expect = 1e-21
 Identities = 67/229 (29%), Positives = 115/229 (50%), Gaps = 25/229 (10%)

Query: 586 ELEEATNNFCKKIGKGSFGSVYYGK-----MKDGKEVAVKIMAD-SCSHRTQQFVTEVAL 639
           EL  +   F +++G+ +FG +Y G      M   + VA+K + D +   +  +F  E +L
Sbjct: 1   ELPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASL 60

Query: 640 LSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL-----HGSVN---------QKP 685
           ++ +HH N+V L+G   +E    +++EY++ G L + L     H  V          +  
Sbjct: 61  MAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSS 120

Query: 686 LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EE 744
           LD    L IA   A G+EYL +      +H+D+ + NIL+   +  K+SD GLSR+    
Sbjct: 121 LDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSA 177

Query: 745 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
           D   +   +   + ++ PE     + +  SD++SFGVVL E+ S G +P
Sbjct: 178 DYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 95.4 bits (238), Expect = 1e-21
 Identities = 64/205 (31%), Positives = 95/205 (46%), Gaps = 16/205 (7%)

Query: 595 CKKIGKGSFGSVYYGKMKD-GKEVAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVPLI 652
            + IGKGSFG VY    K   + VA+K++  +      +    E+  LS+     +    
Sbjct: 6   LECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYY 65

Query: 653 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 712
           G   +  +  ++ EY   G+  D L        LD      I  +   GLEYLH     G
Sbjct: 66  GSFLKGSKLWIIMEYCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLH---EEG 118

Query: 713 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLDPEYYGNQQ 769
            IHRD+K++NILL      K++DFG+S Q    LT   S     VG   ++ PE      
Sbjct: 119 KIHRDIKAANILLSEEGDVKLADFGVSGQ----LTSTMSKRNTFVGTPFWMAPEVIKQSG 174

Query: 770 LTEKSDVYSFGVVLLELISGKKPVS 794
             EK+D++S G+  +EL  G+ P+S
Sbjct: 175 YDEKADIWSLGITAIELAKGEPPLS 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 94.9 bits (236), Expect = 2e-21
 Identities = 65/205 (31%), Positives = 114/205 (55%), Gaps = 15/205 (7%)

Query: 598 IGKGSFGSVYYGKMK-DGKE---VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNLVPLI 652
           IG G FG V  G++K  GK    VA+K +    + + ++ F++E +++ +  H N++ L 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 653 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 712
           G   +    +++ E+M NG L   L  +  Q  +  L  + +    A G++YL       
Sbjct: 72  GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL--VGMLRGIAAGMKYL---SEMN 126

Query: 713 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEE---DLTHISSVA-RGTVGYLDPEYYGNQ 768
            +HRD+ + NIL++ N+  KVSDFGLSR  E+   D T+ SS+  +  + +  PE    +
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR 186

Query: 769 QLTEKSDVYSFGVVLLELIS-GKKP 792
           + T  SDV+S+G+V+ E++S G++P
Sbjct: 187 KFTSASDVWSYGIVMWEVMSYGERP 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 95.9 bits (238), Expect = 2e-21
 Identities = 77/235 (32%), Positives = 115/235 (48%), Gaps = 19/235 (8%)

Query: 566 SIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGK-MKDGKEVAVKIMAD 624
           S +R G   D  +A      + E+   +  ++IG GSFG+VY+ + ++  + VA+K M+ 
Sbjct: 2   STSRAGSLKDPEIAELFFKEDPEKLFTDL-REIGHGSFGAVYFARDVRTNEVVAIKKMSY 60

Query: 625 SCSHRT---QQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSV 681
           S        Q  + EV  L RI H N +   G    EH   LV EY   G+  D L   V
Sbjct: 61  SGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLE--V 117

Query: 682 NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 741
           ++KPL  +    I H A +GL YLH+     +IHRD+K+ NILL    + K++DFG +  
Sbjct: 118 HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASI 174

Query: 742 AEEDLTHISSVARGTVGYLDPEY---YGNQQLTEKSDVYSFGVVLLELISGKKPV 793
           A    + +     GT  ++ PE        Q   K DV+S G+  +EL   K P+
Sbjct: 175 ASPANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 94.1 bits (234), Expect = 3e-21
 Identities = 66/223 (29%), Positives = 111/223 (49%), Gaps = 33/223 (14%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQ----FVTEVALLSRIHHRNLVP 650
           KK+GKGS+GSVY  K + D +  A+K +       +Q+     V E+ +L+ ++H N+  
Sbjct: 6   KKLGKGSYGSVYKVKRLSDNQFYALKEV--DLGSMSQKEREDAVNEIRILASVNHPNI-- 61

Query: 651 LIGYCE---EEHQRILVYEYMHNGTLRDRLHGSVNQKPL-----DWLTRLQIAHDAAKGL 702
            I Y E   + ++  +V EY   G L   +     ++ L      W   +Q+     +GL
Sbjct: 62  -ISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL----RGL 116

Query: 703 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL--THISSVARGTVGYL 760
           + LH      I+HRD+KS+NILL  N   K+ D G+S+  ++++  T I     GT  Y+
Sbjct: 117 QALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI-----GTPHYM 168

Query: 761 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN 803
            PE +  +  + KSD++S G +L E+ +   P        +L 
Sbjct: 169 APEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM-QDLR 210

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 94.7 bits (236), Expect = 3e-21
 Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 22/219 (10%)

Query: 597 KIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQ-----QFVTEVALLSRIHHRNLVP 650
           +IG+G+ G V+  K  + G+ VA+K +      R +     Q + E+  L    H  +V 
Sbjct: 7   RIGEGAHGIVFKAKDRETGETVALKKV---ALRRLEGGIPNQALREIKALQACQHPYVVK 63

Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI---AHDAAKGLEYLHT 707
           L+         +LV EYM    L + L     ++PL      Q+        KG+ Y+H 
Sbjct: 64  LLDVFPHGSGFVLVMEYM-PSDLSEVLRDE--ERPL---PEAQVKSYMRMLLKGVAYMH- 116

Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYG 766
               GI+HRD+K +N+L+  +   K++DFGL+R   E+   + S    T  Y  PE  YG
Sbjct: 117 --ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYG 174

Query: 767 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
            ++     D+++ G +  EL++G      E+   +L IV
Sbjct: 175 ARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIV 213

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 93.7 bits (233), Expect = 3e-21
 Identities = 55/199 (27%), Positives = 100/199 (50%), Gaps = 12/199 (6%)

Query: 598 IGKGSFGS-VYYGKMKDGKEVAVK-IMADSCSHRTQQFV-TEVALLSRIHHRNLVPLIGY 654
           +GKG+FG    Y + +D   V  K +     S + ++    E+ +LS + H N++    +
Sbjct: 8   LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67

Query: 655 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH--DAAKGLEYLHTGCNPG 712
             +++  ++  EY + GTL D++   V QK   +   + + +       + Y+H     G
Sbjct: 68  FMDDNTLLIEMEYANGGTLYDKI---VRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---G 121

Query: 713 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 772
           I+HRD+K+ NI L      K+ DFG+S+    + +   +V  GT  Y+ PE     +   
Sbjct: 122 ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELCQGVKYNF 180

Query: 773 KSDVYSFGVVLLELISGKK 791
           KSD+++ G VL EL++ K+
Sbjct: 181 KSDIWALGCVLYELLTLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 93.9 bits (233), Expect = 4e-21
 Identities = 65/198 (32%), Positives = 102/198 (51%), Gaps = 7/198 (3%)

Query: 596 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 655
           KK+G G FG V+ G      +VAVK +    +   + F+ E  ++ ++ H  LV L    
Sbjct: 12  KKLGNGQFGEVWMGTWNGNTKVAVKTLKPG-TMSPESFLEEAQIMKKLRHDKLVQLYAVV 70

Query: 656 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 715
            EE   I V EYM  G+L D L      + L     + +A   A G+ Y+        IH
Sbjct: 71  SEEPIYI-VTEYMSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIE---RMNYIH 125

Query: 716 RDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSD 775
           RD++S+NIL+   +  K++DFGL+R  E++       A+  + +  PE     + T KSD
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185

Query: 776 VYSFGVVLLELIS-GKKP 792
           V+SFG++L EL++ G+ P
Sbjct: 186 VWSFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 93.6 bits (232), Expect = 5e-21
 Identities = 64/197 (32%), Positives = 105/197 (53%), Gaps = 7/197 (3%)

Query: 597 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 656
           K+G+G FG V+ G      +VA+K +    +   + F+ E  ++ ++ H  LVPL     
Sbjct: 13  KLGQGCFGEVWMGTWNGTTKVAIKTLKPG-TMMPEAFLQEAQIMKKLRHDKLVPLYAVVS 71

Query: 657 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHR 716
           EE   I V E+M  G+L D L    + K L     + +A   A G+ Y+        IHR
Sbjct: 72  EEPIYI-VTEFMGKGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHR 126

Query: 717 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDV 776
           D++++NIL+  N+  K++DFGL+R  E++       A+  + +  PE     + T KSDV
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186

Query: 777 YSFGVVLLELIS-GKKP 792
           +SFG++L EL++ G+ P
Sbjct: 187 WSFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 93.2 bits (231), Expect = 5e-21
 Identities = 65/197 (32%), Positives = 103/197 (52%), Gaps = 7/197 (3%)

Query: 597 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 656
           K+G+G FG V+ G       VA+K +    +   + F+ E  ++ ++ H  LV L     
Sbjct: 13  KLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71

Query: 657 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHR 716
           EE   I V EYM  G+L D L G +  K L     + +A   A G+ Y+        +HR
Sbjct: 72  EEPIYI-VTEYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 126

Query: 717 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDV 776
           D++++NIL+  N+  KV+DFGL+R  E++       A+  + +  PE     + T KSDV
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186

Query: 777 YSFGVVLLELIS-GKKP 792
           +SFG++L EL + G+ P
Sbjct: 187 WSFGILLTELTTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 93.5 bits (232), Expect = 9e-21
 Identities = 75/224 (33%), Positives = 111/224 (49%), Gaps = 27/224 (12%)

Query: 585 PELEEATNNFCKKIGKGSFGSVYYGKM-KDG--KEVAVKIMADSCS---HRTQQFVTEVA 638
           P LE     F   IG+G+FG V   ++ KDG   + A+K M +  S   HR   F  E+ 
Sbjct: 2   PVLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR--DFAGELE 59

Query: 639 LLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGS----------VNQKPLD 687
           +L ++ HH N++ L+G CE      L  EY  +G L D L  S          +      
Sbjct: 60  VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 119

Query: 688 WLTRLQIAH---DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 744
            L+  Q+ H   D A+G++YL        IHRD+ + NIL+  N  AK++DFGLSR  E 
Sbjct: 120 TLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV 176

Query: 745 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
            +    ++ R  V ++  E       T  SDV+S+GV+L E++S
Sbjct: 177 YVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 93.6 bits (233), Expect = 9e-21
 Identities = 69/232 (29%), Positives = 113/232 (48%), Gaps = 33/232 (14%)

Query: 583 PLPELEEATNNFCKKIGKGSFGSVYYG------KMKDGKEVAVKIM-ADSCSHRTQQFVT 635
           P  EL        K +G+G+FG V            +   VAVK++  D+        V+
Sbjct: 5   PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVS 64

Query: 636 EVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGSVNQK-------- 684
           E+ ++  I  H+N++ L+G C +E    +V EY  +G LRD  R      +         
Sbjct: 65  EMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRP 124

Query: 685 PLDWLTR---LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 741
           P + LT+   +  A+  A+G+E+L +      IHRD+ + N+L+  +   K++DFGL+R 
Sbjct: 125 PEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKIADFGLAR- 180

Query: 742 AEEDLTHISSVARGTVGYLD-----PEYYGNQQLTEKSDVYSFGVVLLELIS 788
              D+ HI    + T G L      PE   ++  T +SDV+SFGV+L E+ +
Sbjct: 181 ---DIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 92.3 bits (229), Expect = 1e-20
 Identities = 60/213 (28%), Positives = 105/213 (49%), Gaps = 21/213 (9%)

Query: 598 IGKGSFGSVYYGKMKDGKEVAVKIMA------DSCSHRTQQFVTEVALLSRIHHRNLVPL 651
           +GKG++G+VY G    G+ +AVK +        +     ++   EV LL  + H N+V  
Sbjct: 8   LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67

Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 709
           +G C +++   +  E++  G++   L+  G + +      T+ QI      G+ YLH  C
Sbjct: 68  LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK-QIL----DGVAYLHNNC 122

Query: 710 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTH--ISSVARGTVGYLDPEY 764
              ++HRD+K +N++L  N   K+ DFG +R+        TH  +     GT  ++ PE 
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179

Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 797
                   KSD++S G  + E+ +GK P++  D
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPPLASMD 212

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 92.8 bits (230), Expect = 1e-20
 Identities = 68/211 (32%), Positives = 109/211 (51%), Gaps = 27/211 (12%)

Query: 598 IGKGSFGSVYYGKMK-DGKEV--AVKIMADSCSHRTQQ-FVTEVALLSRI-HHRNLVPLI 652
           IG+G+FG V    +K DG ++  A+K++ +  S    + F  E+ +L ++ HH N++ L+
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69

Query: 653 GYCEEEHQRILVYEYMHNGTLRD---------------RLHGSVNQKPLDWLTRLQIAHD 697
           G CE      +  EY   G L D               + HG+ +   L     LQ A D
Sbjct: 70  GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAST--LTSQQLLQFASD 127

Query: 698 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTV 757
            A G++YL        IHRD+ + N+L+  N+ +K++DFGLSR   E++    ++ R  V
Sbjct: 128 VATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRG--EEVYVKKTMGRLPV 182

Query: 758 GYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
            ++  E       T KSDV+SFGV+L E++S
Sbjct: 183 RWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 92.2 bits (229), Expect = 2e-20
 Identities = 68/276 (24%), Positives = 126/276 (45%), Gaps = 31/276 (11%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQ------FVTEVALLSRIHHRNL 648
           +++G G+F S Y  + +K G  +AVK +    +  ++Q         E+ L++R++H ++
Sbjct: 6   QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65

Query: 649 VPLIG-YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
           + ++G  CE+ H  + V E+M  G++   L              +       +GL YLH 
Sbjct: 66  IRMLGATCEDSHFNLFV-EWMAGGSVSHLLS---KYGAFKEAVIINYTEQLLRGLSYLH- 120

Query: 708 GCNPGIIHRDVKSSNILLD-INMRAKVSDFGLSRQAEEDLT---HISSVARGTVGYLDPE 763
                IIHRDVK +N+L+D    R +++DFG + +     T          GT+ ++ PE
Sbjct: 121 --ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178

Query: 764 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 823
               +Q     DV+S G V++E+ + K P + E     L ++    S      +   + P
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSP 238

Query: 824 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 859
            L             +V ++C+E +   RP  +E++
Sbjct: 239 GL------------RDVTLRCLELQPEDRPPSRELL 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 92.8 bits (230), Expect = 2e-20
 Identities = 60/197 (30%), Positives = 102/197 (51%), Gaps = 9/197 (4%)

Query: 597 KIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 655
           KIG+GS G V   + K  G++VAVK+M      R +    EV ++    H+N+V +    
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87

Query: 656 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 715
               +  ++ E++  G L D     V+Q  L+      +     + L YLH+    G+IH
Sbjct: 88  LVGEELWVLMEFLQGGALTD----IVSQTRLNEEQIATVCESVLQALCYLHS---QGVIH 140

Query: 716 RDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSD 775
           RD+KS +ILL ++ R K+SDFG   Q  +D+    S+  GT  ++ PE         + D
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRTPYGTEVD 199

Query: 776 VYSFGVVLLELISGKKP 792
           ++S G++++E++ G+ P
Sbjct: 200 IWSLGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 92.0 bits (228), Expect = 2e-20
 Identities = 64/213 (30%), Positives = 109/213 (51%), Gaps = 19/213 (8%)

Query: 596 KKIGKGSFGSVYYGKMKDGK---EVAVKIMADSCSHRTQ--QFVTEVALLSRIHHRNLVP 650
           K +G+G FGSV  G++       +VAVK M  +   R++   F++E   +    H N++ 
Sbjct: 5   KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64

Query: 651 LIGYCEEEHQR------ILVYEYMHNGTLRD-RLHGSVNQKPLDWLTRL--QIAHDAAKG 701
           LIG C +  +       +++  +M +G L    L+  +   P    T++  +   D A G
Sbjct: 65  LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124

Query: 702 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-DLTHISSVARGTVGYL 760
           +EYL +      IHRD+ + N +L+ NM   V+DFGLS++    D      +A+  V ++
Sbjct: 125 MEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWI 181

Query: 761 DPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
             E   ++  T KSDV+SFGV + E+ + G+ P
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 92.1 bits (228), Expect = 2e-20
 Identities = 66/211 (31%), Positives = 105/211 (49%), Gaps = 27/211 (12%)

Query: 598 IGKGSFGSVYYGKMK-DGKEV--AVKIMADSCSHRTQQ-FVTEVALLSRI-HHRNLVPLI 652
           IG+G+FG V   ++K DG  +  A+K M +  S    + F  E+ +L ++ HH N++ L+
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 653 GYCEEEHQRILVYEYMHNGTLRD---------------RLHGSVNQKPLDWLTRLQIAHD 697
           G CE      L  EY  +G L D                 + + +   L     L  A D
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST--LSSQQLLHFAAD 120

Query: 698 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTV 757
            A+G++YL        IHRD+ + NIL+  N  AK++DFGLSR   +++    ++ R  V
Sbjct: 121 VARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRG--QEVYVKKTMGRLPV 175

Query: 758 GYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
            ++  E       T  SDV+S+GV+L E++S
Sbjct: 176 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 92.8 bits (230), Expect = 2e-20
 Identities = 70/208 (33%), Positives = 105/208 (50%), Gaps = 24/208 (11%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPL 651
           ++IG GSFG+VY+ + +++ + VA+K M+ S    + + Q  + EV  L ++ H N +  
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80

Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 711
            G    EH   LV EY   G+  D L   V++KPL  +    + H A +GL YLH   + 
Sbjct: 81  RGCYLREHTAWLVMEYCL-GSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLH---SH 134

Query: 712 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLDPEY---Y 765
            +IHRDVK+ NILL      K+ DFG +         I + A   VG   ++ PE     
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSAS--------IMAPANXFVGTPYWMAPEVILAM 186

Query: 766 GNQQLTEKSDVYSFGVVLLELISGKKPV 793
              Q   K DV+S G+  +EL   K P+
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 92.8 bits (230), Expect = 2e-20
 Identities = 70/204 (34%), Positives = 104/204 (50%), Gaps = 18/204 (8%)

Query: 597 KIGKGSFGSVYYGKMKDGKE-VAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLI 652
           +IG GSFG+VY+       E VAVK M+ S    + + Q  + EV  L ++ H N +   
Sbjct: 28  EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87

Query: 653 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 712
           G   +EH   LV EY   G+  D L   V++KPL  +    I H A +GL YLH+     
Sbjct: 88  GCYLKEHTAWLVMEYCL-GSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHN--- 141

Query: 713 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY---YGNQQ 769
           +IHRD+K+ NILL    + K++DFG + ++    + +     GT  ++ PE        Q
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMDEGQ 196

Query: 770 LTEKSDVYSFGVVLLELISGKKPV 793
              K DV+S G+  +EL   K P+
Sbjct: 197 YDGKVDVWSLGITCIELAERKPPL 220

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 91.5 bits (227), Expect = 3e-20
 Identities = 66/214 (30%), Positives = 110/214 (51%), Gaps = 20/214 (9%)

Query: 596 KKIGKGSFGSVYYGKMK----DGKEVAVKIM-AD-SCSHRTQQFVTEVALLSRIHHRNLV 649
           + +GKG FGSV   ++K      ++VAVK++ AD   S   ++F+ E A +    H N++
Sbjct: 5   RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64

Query: 650 PLIGYC--EEEHQRI----LVYEYMHNGTLRDRLHGS-VNQKP--LDWLTRLQIAHDAAK 700
            LIG         R+    ++  +M +G L   L  S + ++P  L   T ++   D A 
Sbjct: 65  KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124

Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-DLTHISSVARGTVGY 759
           G+EYL    +   IHRD+ + N +L+ NM   V+DFGLS++    D       ++  V +
Sbjct: 125 GMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKW 181

Query: 760 LDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
           L  E   +   T  SDV++FGV + E+++ G+ P
Sbjct: 182 LALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 91.6 bits (227), Expect = 3e-20
 Identities = 63/198 (31%), Positives = 101/198 (51%), Gaps = 11/198 (5%)

Query: 597 KIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 655
           KIG+GS G V     K  GK+VAVK M      R +    EV ++   HH N+V +    
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88

Query: 656 EEEHQRILVYEYMHNGTLRDRL-HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 714
               +  +V E++  G L D + H  +N++ +       +     + L YLH   N G+I
Sbjct: 89  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----ATVCLSVLRALSYLH---NQGVI 140

Query: 715 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 774
           HRD+KS +ILL  + R K+SDFG   Q  +++    S+  GT  ++ PE         + 
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-GTPYWMAPEVISRLPYGTEV 199

Query: 775 DVYSFGVVLLELISGKKP 792
           D++S G++++E+I G+ P
Sbjct: 200 DIWSLGIMVIEMIDGEPP 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 91.4 bits (227), Expect = 6e-20
 Identities = 65/206 (31%), Positives = 105/206 (50%), Gaps = 17/206 (8%)

Query: 594 FCKKIGKGSFGSVY----YGKMKDGK--EVAVKIMADSCSHRT--QQFVTEVALLSRI-H 644
           F K +G G+FG V     YG  K     +VAVK M    +H +  +  ++E+ ++S + +
Sbjct: 39  FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVK-MLKPTAHSSEREALMSELKIMSHLGN 97

Query: 645 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 704
           H N+V L+G C      +++ EY   G L + L     +  L     L  ++  AKG+ +
Sbjct: 98  HENIVNLLGACTIGGPILVITEYCCYGDLLNFLR-RKRESFLTLEDLLSFSYQVAKGMAF 156

Query: 705 LHT-GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS-SVARGTVGYLDP 762
           L +  C    IHRD+ + N+LL      K+ DFGL+R    D  ++    AR  V ++ P
Sbjct: 157 LASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAP 212

Query: 763 EYYGNQQLTEKSDVYSFGVVLLELIS 788
           E   N   T +SDV+S+G++L E+ S
Sbjct: 213 ESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 90.2 bits (225), Expect = 9e-20
 Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 27/208 (12%)

Query: 595 CKKIGKGSFGSVYYGK-MKDGKEVAVKIMA---------DSCSHRTQQFVTEVALLSRIH 644
            +K+G+G++G VY  +  K G+ VA+K +           +        + E++LL  + 
Sbjct: 4   LEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTA-------LREISLLKELK 56

Query: 645 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 704
           H N+V L+     E +  LV+EY     L+  L       PL       I +   +GL Y
Sbjct: 57  HPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLD--KRPGPLSPNLIKSIMYQLLRGLAY 113

Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPE 763
            H+     I+HRD+K  NIL++ +   K++DFGL+R     L T+   V   T+ Y  PE
Sbjct: 114 CHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV--TLWYRAPE 168

Query: 764 -YYGNQQLTEKSDVYSFGVVLLELISGK 790
              G++  +   D++S G +  E+I+GK
Sbjct: 169 ILLGSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 90.1 bits (224), Expect = 9e-20
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 18/208 (8%)

Query: 596 KKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNL 648
           +++G+GSFG VY G  K          VA+K + ++ S R + +F+ E +++   +  ++
Sbjct: 12  RELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHV 71

Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHG----SVNQKPLDWLTR---LQIAHDAAKG 701
           V L+G        ++V E M  G L+  L      + N   L   T    +Q+A + A G
Sbjct: 72  VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131

Query: 702 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTVGYL 760
           + YL        +HRD+ + N ++  ++  K+ DFG++R   E D           V ++
Sbjct: 132 MAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188

Query: 761 DPEYYGNQQLTEKSDVYSFGVVLLELIS 788
            PE   +   T KSDV+SFGVVL E+ +
Sbjct: 189 APESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 89.7 bits (222), Expect = 1e-19
 Identities = 62/209 (29%), Positives = 108/209 (51%), Gaps = 9/209 (4%)

Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 645
           E+   +    KK+G G FG V+        +VAVK M    S   + F+ E  ++  + H
Sbjct: 2   EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQH 60

Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEY 704
             LV L     +E   I+  E+M  G+L D L     +++PL  L  +  +   A+G+ +
Sbjct: 61  DKLVKLHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPLPKL--IDFSAQIAEGMAF 117

Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
           +        IHRD++++NIL+  ++  K++DFGL+R  E++       A+  + +  PE 
Sbjct: 118 IE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 174

Query: 765 YGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
                 T KSDV+SFG++L+E+++ G+ P
Sbjct: 175 INFGSFTIKSDVWSFGILLMEIVTYGRIP 203

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 90.0 bits (223), Expect = 1e-19
 Identities = 67/209 (32%), Positives = 102/209 (48%), Gaps = 22/209 (10%)

Query: 594 FCKKI---GKGSFGSVY---YGKMKD--GKEVAVKIMADSCSHR-TQQFVTEVALLSRIH 644
           + KKI   G+G FG V    Y    D  G+ VAVK +   C  + T  +  E+ +L  ++
Sbjct: 5   YLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLY 64

Query: 645 HRNLVPLIGYCEEEHQRI--LVYEYMHNGTLRDRL-HGSVNQKPLDWLTRLQIAHDAAKG 701
           H N+V   G C E+  +   L+ EY+  G+LRD L    +N   L     L  A    +G
Sbjct: 65  HENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQL-----LLFAQQICEG 119

Query: 702 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE--DLTHISSVARGTVGY 759
           + YLH+      IHRD+ + N+LLD +   K+ DFGL++   E  +   +       V +
Sbjct: 120 MAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 176

Query: 760 LDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
              E     + +  SDV+SFGV L EL++
Sbjct: 177 YAVECLKENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 89.7 bits (223), Expect = 2e-19
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 21/204 (10%)

Query: 596 KKIGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHRTQQF----VTEVALLSRIHHRNLVP 650
            KIG+G++G VY  + K   E VA+K +       ++      + E+ LL  ++H N++ 
Sbjct: 5   GKIGEGTYGVVYKARDKLTGEIVAIKKI--KLRFESEGIPKTALREIKLLKELNHPNIIK 62

Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 710
           L+     +    LV+E+M    L   +     Q+ L         +   +GL + H+   
Sbjct: 63  LLDVFRHKGDLYLVFEFMDT-DLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCHSH-- 117

Query: 711 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED---LTHISSVARGTVGYLDPE-YYG 766
            GI+HRD+K  N+L++     K++DFGL+R         TH       T  Y  PE   G
Sbjct: 118 -GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV----TRWYRAPELLLG 172

Query: 767 NQQLTEKSDVYSFGVVLLELISGK 790
           ++  +   D++S G +  EL+S +
Sbjct: 173 DKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 88.3 bits (219), Expect = 2e-19
 Identities = 67/211 (31%), Positives = 92/211 (43%), Gaps = 26/211 (12%)

Query: 596 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR-----NLV 649
           K I KG+FGSVY  K +  G   A+K++  S      Q VT V     I         + 
Sbjct: 2   KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQ-VTNVKAERAIMMIQGESPYVA 60

Query: 650 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQK----PLDWLTRLQIAHDAAKGLEYL 705
            L    + +    LV EY++ G        S+ +     P DW    Q   +   G+E L
Sbjct: 61  KLYYSFQSKDYLYLVMEYLNGGDC-----ASLIKTLGGLPEDWAK--QYIAEVVLGVEDL 113

Query: 706 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 765
           H     GIIHRD+K  N+L+D     K++DFGLSR   E+   +     GT  YL PE  
Sbjct: 114 H---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV-----GTPDYLAPETI 165

Query: 766 GNQQLTEKSDVYSFGVVLLELISGKKPVSVE 796
                 + SD +S G V+ E + G  P   E
Sbjct: 166 LGVGDDKMSDWWSLGCVIFEFLFGYPPFHAE 196

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 88.9 bits (220), Expect = 2e-19
 Identities = 59/207 (28%), Positives = 104/207 (50%), Gaps = 18/207 (8%)

Query: 595 CKKIGKGSFGSVY----YGKMKDGKE--VAVKIMADSCSHRTQ-QFVTEVALLSRIHHRN 647
            +++G+GSFG VY     G +KD  E  VA+K + ++ S R + +F+ E +++   +  +
Sbjct: 11  SRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 70

Query: 648 LVPLIGYCEEEHQRILVYEYMHNG-------TLRDRLHGSVNQKPLDWLTRLQIAHDAAK 700
           +V L+G   +    +++ E M  G       +LR  +  +  Q P      +Q+A + A 
Sbjct: 71  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130

Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTVGY 759
           G+ YL+       +HRD+ + N ++  +   K+ DFG++R   E D           V +
Sbjct: 131 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187

Query: 760 LDPEYYGNQQLTEKSDVYSFGVVLLEL 786
           + PE   +   T  SDV+SFGVVL E+
Sbjct: 188 MSPESLKDGVFTTYSDVWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 89.3 bits (221), Expect = 2e-19
 Identities = 63/227 (27%), Positives = 112/227 (49%), Gaps = 33/227 (14%)

Query: 596 KKIGKGSFGSVYYGKMKDGK------EVAVKIMAD-SCSHRTQQFVTEVALLSRIHHRNL 648
           K +G+G FG V        K       VAVK++ + + S   +  ++E  LL +++H ++
Sbjct: 6   KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65

Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLH-------------GSVN--------QKPLD 687
           + L G C ++   +L+ EY   G+LR  L              G+ N        ++ L 
Sbjct: 66  IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125

Query: 688 WLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 747
               +  A   ++G++YL       ++HRD+ + N+L+    + K+SDFGLSR   E+ +
Sbjct: 126 MGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS 182

Query: 748 HIS-SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
           ++  S  R  V ++  E   +   T +SDV+SFGV+L E+++ G  P
Sbjct: 183 YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 229

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 89.3 bits (221), Expect = 3e-19
 Identities = 64/218 (29%), Positives = 113/218 (51%), Gaps = 29/218 (13%)

Query: 596 KKIGKGSFGSVY----YGKMKDGKE----VAVKIMADSCSHRT-QQFVTEVALLSRI-HH 645
           K +G+G FG V     YG  K   +    VAVK++ D+ + +     ++E+ L+  I  H
Sbjct: 18  KPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKH 77

Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG-------------SVNQKPLDWLTRL 692
           +N++ L+G C +E    ++ EY   G LR+ L                V ++ L +   +
Sbjct: 78  KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137

Query: 693 QIAHDAAKGLEYLHTG-CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-DLTHIS 750
             A+  A+G+EYL +  C    IHRD+ + N+L+  +   K++DFGL+R   + D    +
Sbjct: 138 SCAYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKT 193

Query: 751 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
           S  R  V ++ PE   ++  T +SDV+SFG+++ E+ +
Sbjct: 194 SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 88.9 bits (220), Expect = 4e-19
 Identities = 60/217 (27%), Positives = 107/217 (49%), Gaps = 27/217 (12%)

Query: 596 KKIGKGSFGSVYYG--------KMKDGKEVAVKIMADSCSHRT-QQFVTEVALLSRI-HH 645
           K +G+G FG V           K K+   VAVK++ D  + +     V+E+ ++  I  H
Sbjct: 21  KPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 80

Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGS-------------VNQKPLDWLTRL 692
           +N++ L+G C ++    ++ EY   G LR+ L                V  + + +   +
Sbjct: 81  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140

Query: 693 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-DLTHISS 751
              +  A+G+EYL    +   IHRD+ + N+L+  N   K++DFGL+R     D    ++
Sbjct: 141 SCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTT 197

Query: 752 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
             R  V ++ PE   ++  T +SDV+SFGV++ E+ +
Sbjct: 198 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 89.7 bits (223), Expect = 4e-19
 Identities = 66/254 (25%), Positives = 105/254 (41%), Gaps = 41/254 (16%)

Query: 592 NNFC--KKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRTQQ---FVTEVALLSRIHH 645
           ++F   K IG+G+FG V+  + KD  +V A+K++  S   +  Q      E  +L+    
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60

Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 705
             +V L    ++E    LV EYM  G L   L    +  P +   R  IA +    L+ +
Sbjct: 61  PWIVKLYYSFQDEEHLYLVMEYMPGGDLM-NLLIRKDVFPEET-ARFYIA-ELVLALDSV 117

Query: 706 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS-------------------------- 739
           H     G IHRD+K  NIL+D +   K++DFGL                           
Sbjct: 118 H---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVL 174

Query: 740 --RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 797
             R+  +     ++   GT  Y+ PE         + D +S GV+L E++ G  P   + 
Sbjct: 175 VRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234

Query: 798 -FGAELNIVHWARS 810
                  I++W  S
Sbjct: 235 LQETYNKIINWKES 248

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 87.0 bits (215), Expect = 9e-19
 Identities = 67/210 (31%), Positives = 110/210 (52%), Gaps = 22/210 (10%)

Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVK-IMADSCSHRTQQFVT----EVALLSRIHHRNLV 649
           K +G+G+FG VY     D G+E+AVK +  D  S  T + V     E+ LL  + H  +V
Sbjct: 8   KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67

Query: 650 PLIGYCEEEHQRIL--VYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYL 705
              G   +  +R L    E+M  G+++D+L  +G++ +      TR QI     +G+ YL
Sbjct: 68  QYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTR-QIL----EGVSYL 122

Query: 706 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE---DLTHISSVARGTVGYLDP 762
           H+     I+HRD+K +NIL D     K+ DFG S++ +      T + SV  GT  ++ P
Sbjct: 123 HSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT-GTPYWMSP 178

Query: 763 EYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           E    +    K+D++S G  ++E+++ K P
Sbjct: 179 EVISGEGYGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 87.1 bits (216), Expect = 1e-18
 Identities = 66/208 (31%), Positives = 107/208 (51%), Gaps = 21/208 (10%)

Query: 601 GSFGSVYYGKMKDGK-----EVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGY 654
           G+FG ++YG + D K     EV VK + D  S  +    + E  LL  + H+N++P++  
Sbjct: 17  GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76

Query: 655 CEEEHQRILV-YEYMHNGTLRDRL----HGSVNQKPLDWLTRLQIAHDA---AKGLEYLH 706
           C E+ +   V Y YM+ G L+  L     G  N      L+  Q+ H A   A G+ YLH
Sbjct: 77  CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQA--LSTQQLVHMAIQIACGMSYLH 134

Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYY 765
                G+IH+D+ + N ++D  ++ K++D  LSR       H +       V ++  E  
Sbjct: 135 ---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESL 191

Query: 766 GNQQLTEKSDVYSFGVVLLELIS-GKKP 792
            N++ +  SDV+SFGV+L EL++ G+ P
Sbjct: 192 VNKEYSSASDVWSFGVLLWELMTLGQTP 219

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 86.9 bits (215), Expect = 1e-18
 Identities = 56/198 (28%), Positives = 103/198 (52%), Gaps = 9/198 (4%)

Query: 596 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 654
           +KIG+G+ G+VY    +  G+EVA+K M      + +  + E+ ++    H N+V  +  
Sbjct: 25  EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDS 84

Query: 655 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 714
                +  +V EY+  G+L D     V +  +D      +  +  + LE+LH+     +I
Sbjct: 85  YLVGDELWVVMEYLAGGSLTD----VVTETCMDEGQIAAVCRECLQALEFLHSN---QVI 137

Query: 715 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 774
           HRD+KS NILL ++   K++DFG   Q   + +  S++  GT  ++ PE    +    K 
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196

Query: 775 DVYSFGVVLLELISGKKP 792
           D++S G++ +E++ G+ P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 87.0 bits (216), Expect = 1e-18
 Identities = 68/223 (30%), Positives = 107/223 (47%), Gaps = 30/223 (13%)

Query: 593 NFCKKIGKGSFGSVYYGKM--------KDGKE---------VAVKIM-ADSCSHRTQQFV 634
           NF +K+G+G FG V+  +         K   E         VAVK++  D+  +  + F+
Sbjct: 8   NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67

Query: 635 TEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSV--------NQKPL 686
            EV +LSR+   N+  L+G C  +    ++ EYM NG L   L   V        N K L
Sbjct: 68  KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127

Query: 687 DWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EED 745
            + T L +A   A G+ YL    +   +HRD+ + N L+  N   K++DFG+SR     D
Sbjct: 128 SFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSD 184

Query: 746 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
              +   A   + ++  E     + T KSDV++FGV L E+++
Sbjct: 185 YYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 86.6 bits (214), Expect = 2e-18
 Identities = 60/198 (30%), Positives = 98/198 (49%), Gaps = 11/198 (5%)

Query: 597 KIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 655
           KIG+GS G V    +K  GK VAVK M      R +    EV ++    H N+V +    
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86

Query: 656 EEEHQRILVYEYMHNGTLRDRL-HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 714
               +  +V E++  G L D + H  +N++ +       +     K L  LH     G+I
Sbjct: 87  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLKALSVLHA---QGVI 138

Query: 715 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 774
           HRD+KS +ILL  + R K+SDFG   Q  +++    S+  GT  ++ PE         + 
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPELISRLPYGPEV 197

Query: 775 DVYSFGVVLLELISGKKP 792
           D++S G++++E++ G+ P
Sbjct: 198 DIWSLGIMVIEMVDGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 85.8 bits (212), Expect = 2e-18
 Identities = 64/205 (31%), Positives = 103/205 (50%), Gaps = 15/205 (7%)

Query: 596 KKIGKGSFGSV---YYGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVP 650
            ++G G+FG+V    Y   K  K VAVKI+ +  +      + + E  ++ ++ +  +V 
Sbjct: 1   GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVR 60

Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 710
           +IG CE E   +LV E    G L   L  + +    + +T L   H  + G++YL     
Sbjct: 61  MIGICEAESW-MLVMELAELGPLNKFLQKNKHVTEKN-ITEL--VHQVSMGMKYLE---E 113

Query: 711 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT--VGYLDPEYYGNQ 768
              +HRD+ + N+LL     AK+SDFGLS+    D  +  +   G   V +  PE     
Sbjct: 114 TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYY 173

Query: 769 QLTEKSDVYSFGVVLLELIS-GKKP 792
           + + KSDV+SFGV++ E  S G+KP
Sbjct: 174 KFSSKSDVWSFGVLMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 85.8 bits (212), Expect = 2e-18
 Identities = 68/210 (32%), Positives = 109/210 (51%), Gaps = 22/210 (10%)

Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVK-IMADSCSHRTQQFVT----EVALLSRIHHRNLV 649
           K +G+G+FG VY     D G+E+AVK +  D  S  T + V     E+ LL  + H  +V
Sbjct: 8   KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67

Query: 650 PLIGYCEEEHQRIL--VYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYL 705
              G   +  ++ L    EYM  G+++D+L  +G++ +      TR QI     +G+ YL
Sbjct: 68  QYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTR-QIL----QGVSYL 122

Query: 706 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE---DLTHISSVARGTVGYLDP 762
           H+     I+HRD+K +NIL D     K+ DFG S++ +      T I SV  GT  ++ P
Sbjct: 123 HSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT-GTPYWMSP 178

Query: 763 EYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           E    +    K+DV+S    ++E+++ K P
Sbjct: 179 EVISGEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 86.1 bits (213), Expect = 2e-18
 Identities = 67/214 (31%), Positives = 105/214 (49%), Gaps = 22/214 (10%)

Query: 598 IGKGSFGSVYYGKMKD----GKE---VAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNLV 649
           +G G+FG VY G   D    G     VAVK +    + + + +F+ E  L+S  +H N+V
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 650 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQK---PLDWLTRL-QIAHDAAKGLEYL 705
            L+G C     + ++ E M  G L   L  +  ++   PL  L  L  I  D AKG  YL
Sbjct: 63  KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122

Query: 706 HTGCNPGIIHRDVKSSNILL-----DINMRAKVSDFGLSRQA-EEDLTHISSVARGTVGY 759
                   IHRD+ + N L+     D +   K+ DFGL+R   + D           V +
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW 179

Query: 760 LDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
           + PE   + + T +SDV+SFGV++ E+++ G++P
Sbjct: 180 MAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 85.5 bits (211), Expect = 3e-18
 Identities = 68/210 (32%), Positives = 110/210 (52%), Gaps = 22/210 (10%)

Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVK-IMADSCSHRTQQFVT----EVALLSRIHHRNLV 649
           K +G+G+FG VY     D G+E+A K +  D  S  T + V+    E+ LL  + H  +V
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67

Query: 650 PLIGYCEEEHQRILV--YEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYL 705
              G   +  ++ L    EYM  G+++D+L  +G++ +      TR QI     +G+ YL
Sbjct: 68  QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTR-QIL----EGMSYL 122

Query: 706 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE---DLTHISSVARGTVGYLDP 762
           H+     I+HRD+K +NIL D     K+ DFG S++ +      T I SV  GT  ++ P
Sbjct: 123 HSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVT-GTPYWMSP 178

Query: 763 EYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           E    +    K+DV+S G  ++E+++ K P
Sbjct: 179 EVISGEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 85.3 bits (211), Expect = 3e-18
 Identities = 67/206 (32%), Positives = 102/206 (49%), Gaps = 24/206 (11%)

Query: 596 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLI 652
           KKIG+GSFG     K K DGK+  +K +  S       ++   EVA+LS + H N+V   
Sbjct: 6   KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65

Query: 653 GYCEEEHQRILVYEYMHNGTLRDRLHGS-----VNQKPLDWLTRLQIAHDAAKGLEYLHT 707
              EE     +V +Y   G L  +++          + LDW  ++ +A      L+++H 
Sbjct: 66  ESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA------LKHVH- 118

Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDPEY 764
             +  I+HRD+KS NI L  +   K+ DFG++R     L     +AR   GT  YL PE 
Sbjct: 119 --DRKILHRDIKSQNIFLTKDGTIKLGDFGIARV----LNSTVELARTCIGTPYYLSPEI 172

Query: 765 YGNQQLTEKSDVYSFGVVLLELISGK 790
             N+    KSD+++ G VL E+ + K
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCTLK 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 84.9 bits (210), Expect = 5e-18
 Identities = 59/204 (28%), Positives = 104/204 (50%), Gaps = 18/204 (8%)

Query: 598 IGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 656
           +GKG++G VY  + +     +A+K + +  S   Q    E+AL S + HRN+V  +G   
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75

Query: 657 EEHQRILVYEYMHNGTLRDRLHG-----SVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 711
           E     +  E +  G+L   L         N++ + + T+ QI     +GL+YLH   + 
Sbjct: 76  ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK-QI----LEGLKYLH---DN 127

Query: 712 GIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY--YGNQ 768
            I+HRD+K  N+L++  +   K+SDFG S++    +   +    GT+ Y+ PE    G +
Sbjct: 128 QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL-AGINPCTETFTGTLQYMAPEVIDKGPR 186

Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
                +D++S G  ++E+ +GK P
Sbjct: 187 GYGAPADIWSLGCTIVEMATGKPP 210

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 84.1 bits (208), Expect = 6e-18
 Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 26/217 (11%)

Query: 596 KKIGKGSFGSVYYGKMK-DGKEVAVK-IMADSCSHRTQQFV-TEVALLSRIHHRNLVPLI 652
           + +G+G+FG V+  + K D K V +K I  +  +   +     E  +L  + H N+   I
Sbjct: 6   RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI---I 62

Query: 653 GYCE---EEHQRILVYEYMHNGTLRDRLHGSVN-----QKPLDWLTRLQIAHDAAKGLEY 704
            Y E   E+   ++V EY   GTL + +    N        L +  ++ +A      L +
Sbjct: 63  EYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA------LHH 116

Query: 705 LHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 763
           +HT     I+HRD+K+ NILLD + M  K+ DFG+S+         + V  GT  Y+ PE
Sbjct: 117 VHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVV--GTPCYISPE 171

Query: 764 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA 800
               +   +KSD+++ G VL EL S K+     +  A
Sbjct: 172 LCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 84.4 bits (209), Expect = 7e-18
 Identities = 58/206 (28%), Positives = 103/206 (50%), Gaps = 14/206 (6%)

Query: 598 IGKGSFGSVYYGK-MKDGKEVAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY- 654
           IG+G++G+VY GK +  G+ VA+KI+  D+          EVALLS++       +  Y 
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 655 -CEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 712
               +  R+ ++ EY   G++R  +       P+       I  +    L+Y+H     G
Sbjct: 69  GSYLKGPRLWIIMEYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKV---G 121

Query: 713 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY-GNQQLT 771
           +IHRD+K++NIL+      K+ DFG++    ++ +  S+   GT  ++ PE     +   
Sbjct: 122 VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGKYYD 180

Query: 772 EKSDVYSFGVVLLELISGKKPVSVED 797
            K+D++S G+ + E+ +G  P S  D
Sbjct: 181 TKADIWSLGITIYEMATGNPPYSDVD 206

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 88.4 bits (219), Expect = 1e-17
 Identities = 58/194 (29%), Positives = 92/194 (47%), Gaps = 21/194 (10%)

Query: 614 GKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL-VYEYMH 669
           G EVA+K++        H+  +F  E AL +R++H N+V L+   E     +  V+EY+ 
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62

Query: 670 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL---D 726
             TLR+ L        L      ++       L   H   N GI+HRD+K  NI++    
Sbjct: 63  GRTLREVL---AADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTG 116

Query: 727 INMRAKVSDFGLS-------RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSF 779
           +   AKV DFG+              LT  + V  GT  Y  PE    + +T  SD+Y++
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVL-GTPTYCAPEQLRGEPVTPNSDLYAW 175

Query: 780 GVVLLELISGKKPV 793
           G++ LE ++G++ V
Sbjct: 176 GLIFLECLTGQRVV 189

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 83.1 bits (205), Expect = 2e-17
 Identities = 60/210 (28%), Positives = 95/210 (45%), Gaps = 23/210 (10%)

Query: 593 NFCKKIGKGSFGS--VYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVP 650
           N  + +G+GSFG   +      D K    +I     S   +    E  LL+++ H N+V 
Sbjct: 3   NVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVA 62

Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRL---HGSV--NQKPLDWLTRLQIAHDAAKGLEYL 705
                E +    +V EY   G L  ++    G +      L W  ++ +      G++++
Sbjct: 63  FKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHI 116

Query: 706 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLDP 762
           H      ++HRD+KS NI L  N + K+ DFG +R     LT   + A   VG   Y+ P
Sbjct: 117 H---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARL----LTSPGAYACTYVGTPYYVPP 169

Query: 763 EYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           E + N     KSD++S G +L EL + K P
Sbjct: 170 EIWENMPYNNKSDIWSLGCILYELCTLKHP 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 83.7 bits (207), Expect = 3e-17
 Identities = 64/220 (29%), Positives = 114/220 (51%), Gaps = 13/220 (5%)

Query: 596 KKIGKGSFGSVYYGKMKDGKEV----AVKIMADSCSHRTQQFVT--EVALLSRIHHRNLV 649
           K +G+GSFG V+  +   G +     A+K++  +      +  T  E  +L+ ++H  +V
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61

Query: 650 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 709
            L    + E +  L+ +++  G L  RL   V     D   +  +A + A  L++LH+  
Sbjct: 62  KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED--VKFYLA-ELALALDHLHS-- 116

Query: 710 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQ 769
             GII+RD+K  NILLD     K++DFGLS+++ +      S   GTV Y+ PE    + 
Sbjct: 117 -LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMAPEVVNRRG 174

Query: 770 LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR 809
            T+ +D +SFGV++ E+++G  P   +D    + ++  A+
Sbjct: 175 HTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK 214

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 83.1 bits (205), Expect = 3e-17
 Identities = 69/235 (29%), Positives = 119/235 (50%), Gaps = 39/235 (16%)

Query: 596 KKIGKGSFGSVYYG------KMKDGK--EVAVKIM-ADSCSHRTQQFVTEVALLSRI-HH 645
           K +G+G FG V         K K  +  +VAVK++ +D+        ++E+ ++  I  H
Sbjct: 24  KPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 83

Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG----------SVNQKPLDWLTR---L 692
           +N++ L+G C ++    ++ EY   G LR+ L            +  Q P + L+    +
Sbjct: 84  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143

Query: 693 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV 752
             A+  A+G+EYL    +   IHRD+ + N+L+  +   K++DFGL+R    D+ HI   
Sbjct: 144 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYY 196

Query: 753 ARGTVG-----YLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP---VSVEDF 798
            + T G     ++ PE   ++  T +SDV+SFGV+L E+ + G  P   V VE+ 
Sbjct: 197 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 251

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 83.8 bits (208), Expect = 3e-17
 Identities = 70/210 (33%), Positives = 112/210 (53%), Gaps = 27/210 (12%)

Query: 596 KKIGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHRT--QQFVTEVALLSRI-HHRNLVPL 651
           +K+GKG++G V+    +  KE VA+K + D+  + T  Q+   E+  L  +  H N+V L
Sbjct: 13  QKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKL 72

Query: 652 IGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 709
           +   + E+ +   LV+EYM      D LH  +    L+ + +  I +   K L+Y+H+G 
Sbjct: 73  LNVIKAENDKDIYLVFEYMET----D-LHAVIRANILEDVHKRYIMYQLLKALKYIHSG- 126

Query: 710 NPGIIHRDVKSSNILLDINMRAKVSDFGLSR--------QAEEDLTHISSVARGTVGYLD 761
              +IHRD+K SNILL+ + R K++DFGL+R             LT    VA  T  Y  
Sbjct: 127 --NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDY--VA--TRWYRA 180

Query: 762 PE-YYGNQQLTEKSDVYSFGVVLLELISGK 790
           PE   G+ + T+  D++S G +L E++ GK
Sbjct: 181 PEILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 82.9 bits (205), Expect = 3e-17
 Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 16/204 (7%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 653
             +G G+ GSV   K +  G  +A K +   + S   +Q + E+ ++       +V   G
Sbjct: 11  SDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYG 70

Query: 654 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 713
               E+   +  E+M  G+L DR++      P++ L +  IA    +GL YL+      I
Sbjct: 71  AFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGK--IAVAVVEGLTYLYNVHR--I 125

Query: 714 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDPEYYGNQQL 770
           +HRD+K SNIL++   + K+ DFG+S +       I+S+A    GT  Y+ PE     + 
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGVSGEL------INSIADTFVGTSTYMSPERIQGGKY 179

Query: 771 TEKSDVYSFGVVLLELISGKKPVS 794
           T KSDV+S G+ ++EL  GK P +
Sbjct: 180 TVKSDVWSLGISIIELALGKFPFA 203

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 82.6 bits (205), Expect = 4e-17
 Identities = 60/218 (27%), Positives = 100/218 (45%), Gaps = 46/218 (21%)

Query: 596 KKIGKGSFGSVYYGKMK-DGKEVAVK-I------MADSCSHRTQQFVTEVALLSRIHHRN 647
           KK+G+G++  VY  + K  G+ VA+K I       A    + T   + E+ LL  + H N
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTA--LREIKLLQELKHPN 63

Query: 648 LVPLIG-YCEEEHQRI-LVYEYMHN---GTLRDRLHGSVNQKPLDWLTRLQIAHDAA--- 699
           ++ L+  +  +    I LV+E+M       ++D+               L  A   +   
Sbjct: 64  IIGLLDVFGHK--SNINLVFEFMETDLEKVIKDKS------------IVLTPADIKSYML 109

Query: 700 ---KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVA 753
              +GLEYLH   +  I+HRD+K +N+L+  +   K++DFGL+R        +TH   V 
Sbjct: 110 MTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTH--QVV 164

Query: 754 RGTVGYLDPE-YYGNQQLTEKSDVYSFGVVLLELISGK 790
             T  Y  PE  +G +      D++S G +  EL+   
Sbjct: 165 --TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 83.5 bits (206), Expect = 4e-17
 Identities = 67/235 (28%), Positives = 114/235 (48%), Gaps = 28/235 (11%)

Query: 583 PLPELEEATNNFCKKIGKGSFGSVYYG------KMKDGK--EVAVKIMADSCSHRT-QQF 633
           P  EL        K +G+G FG V         K K  K   VAVK++ D  + +     
Sbjct: 5   PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDL 64

Query: 634 VTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG------------- 679
           V+E+ ++  I  H+N++ L+G C ++    ++ EY   G LR+ L               
Sbjct: 65  VSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTC 124

Query: 680 SVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 739
            + ++ L +   +  A+  A+G+EYL    +   IHRD+ + N+L+  +   K++DFGL+
Sbjct: 125 KLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLA 181

Query: 740 RQAEE-DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
           R     D    ++  R  V ++ PE   ++  T +SDV+SFGV+L E+ + G  P
Sbjct: 182 RDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP 236

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 82.7 bits (204), Expect = 4e-17
 Identities = 60/230 (26%), Positives = 105/230 (45%), Gaps = 31/230 (13%)

Query: 594 FCKKIGKGSFGSVYYGKMKDGKE---------------VAVKIM-ADSCSHRTQQFVTEV 637
             +K+G+G FG V+  + +   E               VAVK++ AD        F+ E+
Sbjct: 9   LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68

Query: 638 ALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL---------RDRLHGSVNQKPLDW 688
            ++SR+ + N++ L+G C  +    ++ EYM NG L               + N   +  
Sbjct: 69  KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128

Query: 689 LTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLT 747
              L +A   A G++YL    +   +HRD+ + N L+  +   K++DFG+SR     D  
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY 185

Query: 748 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS--GKKPVSV 795
            I   A   + ++  E     + T  SDV++FGV L E+ +   ++P S+
Sbjct: 186 RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 82.4 bits (204), Expect = 4e-17
 Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 22/203 (10%)

Query: 597 KIGKGSFGSVYYGKMKD-GKEVAVKIMADSCS----HRTQQFVTEVALLSRIHHRNLVPL 651
            +G+G++G V   + K  G+ VA+K   +S       +T   + EV +L ++ H N+V L
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTA--LREVKVLRQLRHENIVNL 65

Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 711
                 + +  LV+EY+   TL + L  S    P D   R  I     + + Y H+    
Sbjct: 66  KEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPD-AVRSYI-WQLLQAIAYCHSH--- 119

Query: 712 GIIHRDVKSSNILLDINMRAKVSDFGLSRQ----AEEDLTHISSVARGTVGYLDPEYY-G 766
            IIHRD+K  NIL+  +   K+ DFG +R         LT    VA  T  Y  PE   G
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT--DYVA--TRWYRAPELLVG 175

Query: 767 NQQLTEKSDVYSFGVVLLELISG 789
           +    +  DV++ G ++ EL+ G
Sbjct: 176 DTNYGKPVDVWAIGCIMAELLDG 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 81.5 bits (201), Expect = 5e-17
 Identities = 58/203 (28%), Positives = 105/203 (51%), Gaps = 13/203 (6%)

Query: 597 KIGKGSFGSVYYG--KMKDGK-EVAVKIMADSCSHR-TQQFVTEVALLSRIHHRNLVPLI 652
           ++G G+FG V  G  KM+  + +VA+K++ +        + + E  ++ ++ +  +V +I
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 653 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 712
           G CE E   +LV E    G L   L G  ++  +  +  L   H  + G++YL       
Sbjct: 62  GVCEAE-ALMLVMEMASGGPLNKFLSGKKDEITVSNVVELM--HQVSMGMKYLE---GKN 115

Query: 713 IIHRDVKSSNILLDINMRAKVSDFGLSRQ--AEEDLTHISSVARGTVGYLDPEYYGNQQL 770
            +HRD+ + N+LL     AK+SDFGLS+   A++      S  +  + +  PE    ++ 
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKF 175

Query: 771 TEKSDVYSFGVVLLELIS-GKKP 792
           + +SDV+S+G+ + E  S G+KP
Sbjct: 176 SSRSDVWSYGITMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 81.7 bits (202), Expect = 5e-17
 Identities = 62/213 (29%), Positives = 95/213 (44%), Gaps = 19/213 (8%)

Query: 591 TNNFC--KKIGKGSFGSVYYGKMK-DGKEVA---VKIMADSCSHRTQQFVTEVALLSRIH 644
             NF   KKIGKG F  VY      DG+ VA   V+I     +   Q  + E+ LL ++ 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 645 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPL-----DWLTRLQIAHDAA 699
           H N++  +    E ++  +V E    G L   +     QK L      W   +Q+     
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC---- 116

Query: 700 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 759
             LE++H+     I+HRD+K +N+ +      K+ D GL R      T   S+  GT  Y
Sbjct: 117 SALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYY 172

Query: 760 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           + PE         KSD++S G +L E+ + + P
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 82.0 bits (202), Expect = 5e-17
 Identities = 62/202 (30%), Positives = 102/202 (50%), Gaps = 12/202 (5%)

Query: 596 KKIGKGSFGSVYYG-KMKDGKEVAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 653
           +KIGKGSFG V+ G   +  K VA+KI+  +      +    E+ +LS+     +    G
Sbjct: 10  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69

Query: 654 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 713
              ++ +  ++ EY+  G+  D L       PLD      I  +  KGL+YLH+      
Sbjct: 70  SYLKDTKLWIIMEYLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHS---EKK 122

Query: 714 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS-SVARGTVGYLDPEYYGNQQLTE 772
           IHRD+K++N+LL  +   K++DFG++ Q  +  T I  +   GT  ++ PE         
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIKQSAYDS 180

Query: 773 KSDVYSFGVVLLELISGKKPVS 794
           K+D++S G+  +EL  G+ P S
Sbjct: 181 KADIWSLGITAIELAKGEPPHS 202

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 82.5 bits (203), Expect = 5e-17
 Identities = 55/198 (27%), Positives = 103/198 (52%), Gaps = 9/198 (4%)

Query: 596 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 654
           +KIG+G+ G+VY    +  G+EVA++ M      + +  + E+ ++    + N+V  +  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 655 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 714
                +  +V EY+  G+L D     V +  +D      +  +  + LE+LH+     +I
Sbjct: 86  YLVGDELWVVMEYLAGGSLTD----VVTETCMDEGQIAAVCRECLQALEFLHSN---QVI 138

Query: 715 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 774
           HRD+KS NILL ++   K++DFG   Q   + +  S++  GT  ++ PE    +    K 
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 197

Query: 775 DVYSFGVVLLELISGKKP 792
           D++S G++ +E+I G+ P
Sbjct: 198 DIWSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 81.8 bits (202), Expect = 6e-17
 Identities = 54/199 (27%), Positives = 91/199 (45%), Gaps = 10/199 (5%)

Query: 598 IGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVPLIG 653
           +GKG FG V   ++K  GK  A K +      + +     + E  +L ++  R +V L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 654 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 713
             E +    LV   M+ G L+  ++ +V +        +  A     GLE+LH      I
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIY-NVGEPGFPEARAIFYAAQIICGLEHLH---QRRI 116

Query: 714 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 773
           ++RD+K  N+LLD +   ++SD GL+ + +           GT GY+ PE    +     
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA--GTPGYMAPEVLQGEVYDFS 174

Query: 774 SDVYSFGVVLLELISGKKP 792
            D ++ G  L E+I+G+ P
Sbjct: 175 VDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 82.1 bits (202), Expect = 7e-17
 Identities = 54/198 (27%), Positives = 103/198 (52%), Gaps = 9/198 (4%)

Query: 596 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 654
           +KIG+G+ G+VY    +  G+EVA+K M      + +  + E+ ++    + N+V  +  
Sbjct: 25  EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 84

Query: 655 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 714
                +  +V EY+  G+L D     V +  +D      +  +  + L++LH+     +I
Sbjct: 85  YLVGDELWVVMEYLAGGSLTD----VVTETCMDEGQIAAVCRECLQALDFLHSN---QVI 137

Query: 715 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 774
           HRD+KS NILL ++   K++DFG   Q   + +  S++  GT  ++ PE    +    K 
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196

Query: 775 DVYSFGVVLLELISGKKP 792
           D++S G++ +E++ G+ P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 81.1 bits (200), Expect = 7e-17
 Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 15/215 (6%)

Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMK-DGKE---VAVKIMADSCSHRTQQ-FVTEVALL 640
           EL+  +    + +G G FG +  G +K   K    VA+  +   CS + ++ F+ E   L
Sbjct: 1   ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTL 60

Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 700
            +  H N+V L G     +  ++V EYM NG L   L     Q  L     + +    A 
Sbjct: 61  GQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ--LVAGQLMGMLPGLAS 118

Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARG--TVG 758
           G++YL      G +H+ + +  +L++ ++  K+S F   R  E+    I +   G   V 
Sbjct: 119 GMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVL 173

Query: 759 YLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
           +  PE       +  SDV+SFG+V+ E++S G++P
Sbjct: 174 WAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 81.7 bits (201), Expect = 8e-17
 Identities = 52/198 (26%), Positives = 103/198 (52%), Gaps = 9/198 (4%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 654
           +KIG+G+ G+V+    +  G+EVA+K +      + +  + E+ ++  + + N+V  +  
Sbjct: 25  EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDS 84

Query: 655 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 714
                +  +V EY+  G+L D     V +  +D      +  +  + LE+LH      +I
Sbjct: 85  FLVGDELFVVMEYLAGGSLTD----VVTETCMDEAQIAAVCRECLQALEFLHAN---QVI 137

Query: 715 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 774
           HRD+KS N+LL ++   K++DFG   Q   + +  S++  GT  ++ PE    +    K 
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196

Query: 775 DVYSFGVVLLELISGKKP 792
           D++S G++ +E++ G+ P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 82.2 bits (204), Expect = 8e-17
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 32/213 (15%)

Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 652
           K IG G++G V     K  G++VA+K +++        ++ + E+ LL  + H N++ L+
Sbjct: 6   KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLL 65

Query: 653 -----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH---DAAKGLEY 704
                   E+ +   +V E M      D LH  V + P   LT   I +      +GL+Y
Sbjct: 66  DILRPPSPEDFNDVYIVTELMET----D-LH-KVIKSPQP-LTDDHIQYFLYQILRGLKY 118

Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
           LH+     +IHRD+K SNIL++ N   K+ DFGL+R  + D             Y+   +
Sbjct: 119 LHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE----KGFLTEYVVTRW 171

Query: 765 Y-------GNQQLTEKSDVYSFGVVLLELISGK 790
           Y        + + T+  D++S G +  EL++ K
Sbjct: 172 YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 81.5 bits (201), Expect = 1e-16
 Identities = 62/230 (26%), Positives = 105/230 (45%), Gaps = 38/230 (16%)

Query: 594 FCKKIGKGSFGSVYYGKMKDGKE-----------------VAVKIM-ADSCSHRTQQFVT 635
           F +K+G+G FG V+  ++ + ++                 VAVKI+  D+  +    F+ 
Sbjct: 9   FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68

Query: 636 EVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL------RDRLHGSVNQKPLD-- 687
           EV +LSR+   N++ L+G C +E    ++ EYM NG L              N       
Sbjct: 69  EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128

Query: 688 --------WLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 739
                   + + L +A   A G++YL +      +HRD+ + N L+  N+  K++DFG+S
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDLATRNCLVGENLTIKIADFGMS 185

Query: 740 RQAEE-DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
           R     D   I   A   + ++  E     + T  SDV++FGV L E++ 
Sbjct: 186 RNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 79.9 bits (197), Expect = 2e-16
 Identities = 59/206 (28%), Positives = 91/206 (44%), Gaps = 19/206 (9%)

Query: 596 KKIGKGSFGSVYYGKMKDGKEVA---VKIMADSCSHRTQ-QFVTEVALLSRIHHRNLVPL 651
            +IG G FG V  G+   G   A   VK +  S +   Q  F+ EV     ++H N++  
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60

Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRL---HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           +G C E    +LV E+   G L++ L    G V Q         ++A + A GL +LH  
Sbjct: 61  LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMA-QKDVLQRMACEVASGLLWLHQA 119

Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLS-RQAEEDLTHISSVARGTVGYLDPEYYGN 767
                IH D+   N  L  ++  K+ D+GL+  Q  ED           + +L PE    
Sbjct: 120 ---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEI 176

Query: 768 QQ-------LTEKSDVYSFGVVLLEL 786
           +         T+KS+++S GV + EL
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 80.0 bits (197), Expect = 3e-16
 Identities = 61/211 (28%), Positives = 104/211 (49%), Gaps = 18/211 (8%)

Query: 593 NFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCSHRTQ-QFVTEVALLSRIHH 645
              +++G+GSFG VY G  +D         VAVK + +S S R + +F+ E +++     
Sbjct: 9   TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC 68

Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG----SVNQ--KPLDWLTRL-QIAHDA 698
            ++V L+G   +    ++V E M +G L+  L      + N   +P   L  + Q+A + 
Sbjct: 69  HHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 128

Query: 699 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTV 757
           A G+ YL+       +HRD+ + N ++  +   K+ DFG++R   E D           V
Sbjct: 129 ADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185

Query: 758 GYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
            ++ PE   +   T  SD++SFGVVL E+ S
Sbjct: 186 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 79.6 bits (196), Expect = 4e-16
 Identities = 62/208 (29%), Positives = 106/208 (50%), Gaps = 18/208 (8%)

Query: 594 FCKKI---GKGSFGSV---YYGKMKD--GKEVAVK-IMADSCSHRTQQFVTEVALLSRIH 644
           F K+I   G+G FG V    Y    D  G++VAVK +  +S  +       E+ +L  ++
Sbjct: 5   FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY 64

Query: 645 HRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGL 702
           H N+V   G C E+      L+ E++ +G+L++ L  + N+  L    +L+ A    KG+
Sbjct: 65  HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLK--QQLKYAVQICKGM 122

Query: 703 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH--ISSVARGTVGYL 760
           +YL +      +HRD+ + N+L++   + K+ DFGL++  E D  +  +       V + 
Sbjct: 123 DYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY 179

Query: 761 DPEYYGNQQLTEKSDVYSFGVVLLELIS 788
            PE     +    SDV+SFGV L EL++
Sbjct: 180 APECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 79.4 bits (195), Expect = 4e-16
 Identities = 59/210 (28%), Positives = 105/210 (50%), Gaps = 21/210 (10%)

Query: 598 IGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYC 655
           +G G++G VY G+ +K G+  A+K+M D      ++   E+ +L +  HHRN+    G  
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72

Query: 656 EEEH------QRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTG 708
            +++      Q  LV E+   G++ D +  +  N    +W+    I  +  +GL +LH  
Sbjct: 73  IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA--YICREILRGLSHLH-- 128

Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
               +IHRD+K  N+LL  N   K+ DFG+S Q +  +   ++   GT  ++ PE     
Sbjct: 129 -QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACD 186

Query: 769 QLTE-----KSDVYSFGVVLLELISGKKPV 793
           +  +     KSD++S G+  +E+  G  P+
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEMAEGAPPL 216

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 79.3 bits (195), Expect = 4e-16
 Identities = 60/201 (29%), Positives = 99/201 (49%), Gaps = 10/201 (4%)

Query: 596 KKIGKGSFGSVYYGKMKDGKEV-AVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 653
           ++IGKGSFG VY G     KEV A+KI+  +      +    E+ +LS+     +    G
Sbjct: 10  ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69

Query: 654 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 713
              +  +  ++ EY+  G+  D L       PL+      I  +  KGL+YLH+      
Sbjct: 70  SYLKGTKLWIIMEYLGGGSALDLL----KPGPLEETYIATILREILKGLDYLHSERK--- 122

Query: 714 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 773
           IHRD+K++N+LL      K++DFG++ Q  +     ++   GT  ++ PE         K
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDFK 181

Query: 774 SDVYSFGVVLLELISGKKPVS 794
           +D++S G+  +EL  G+ P S
Sbjct: 182 ADIWSLGITAIELAKGEPPNS 202

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 79.3 bits (195), Expect = 5e-16
 Identities = 59/210 (28%), Positives = 103/210 (49%), Gaps = 21/210 (10%)

Query: 598 IGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGY- 654
           +G G++G VY G+ +K G+  A+K+M D      ++   E+ +L +  HHRN+    G  
Sbjct: 24  VGNGTYGQVYKGRHVKTGQLAAIKVM-DVTEDEEEEIKLEINMLKKYSHHRNIATYYGAF 82

Query: 655 -----CEEEHQRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTG 708
                   + Q  LV E+   G++ D +  +  N    DW+    I  +  +GL +LH  
Sbjct: 83  IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIA--YICREILRGLAHLHAH 140

Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
               +IHRD+K  N+LL  N   K+ DFG+S Q +  +   ++   GT  ++ PE     
Sbjct: 141 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACD 196

Query: 769 QLTE-----KSDVYSFGVVLLELISGKKPV 793
           +  +     +SD++S G+  +E+  G  P+
Sbjct: 197 ENPDATYDYRSDIWSLGITAIEMAEGAPPL 226

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 80.3 bits (198), Expect = 6e-16
 Identities = 63/228 (27%), Positives = 105/228 (46%), Gaps = 39/228 (17%)

Query: 583 PLPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIM----ADSCSHRTQQFVTEV 637
            L ELE        +IG G+ G+VY    +  G+  A+K++     D+     +Q   E+
Sbjct: 72  SLSELERV-----NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVR---RQICREI 123

Query: 638 ALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHD 697
            +L  ++H N+V      +   +  ++ E+M  G+L       +  +         +A  
Sbjct: 124 EILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGT---HIADEQ-------FLADV 173

Query: 698 AAK---GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSVA 753
           A +   G+ YLH      I+HRD+K SN+L++     K++DFG+SR   + +    SSV 
Sbjct: 174 ARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV- 229

Query: 754 RGTVGYLDPEYYGNQQLTE------KSDVYSFGVVLLELISGKKPVSV 795
            GT+ Y+ PE   N  L          D++S GV +LE   G+ P  V
Sbjct: 230 -GTIAYMSPERI-NTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV 275

Length = 353

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 79.0 bits (195), Expect = 6e-16
 Identities = 60/206 (29%), Positives = 98/206 (47%), Gaps = 22/206 (10%)

Query: 598 IGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI-GYC 655
           +G G+FG VY  + K+ G   A KI+        + F+ E+ +LS   H N+V L   Y 
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 656 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGCNPG 712
            E    IL+ E+   G L      S+  +    LT  QI        + L +LH   +  
Sbjct: 73  YENKLWILI-EFCDGGAL-----DSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHK 123

Query: 713 IIHRDVKSSNILLDINMRAKVSDFGLS-RQAEEDLTHISSVARGTVGYLDPEY-----YG 766
           +IHRD+K+ NILL ++   K++DFG+S +         + +  GT  ++ PE      + 
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI--GTPYWMAPEVVACETFK 181

Query: 767 NQQLTEKSDVYSFGVVLLELISGKKP 792
           +     K+D++S G+ L+EL   + P
Sbjct: 182 DNPYDYKADIWSLGITLIELAQMEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 78.8 bits (194), Expect = 7e-16
 Identities = 60/200 (30%), Positives = 102/200 (51%), Gaps = 21/200 (10%)

Query: 598 IGKGSFGSVYYG-KMKDGKEVAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 655
           +G G+ G+VY    +   + +AVK I  D      +Q ++E+ +L +     ++   G  
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 656 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 715
             E++  +  E+M  G+L   ++  +   P   L R+ +A    KGL YL +     I+H
Sbjct: 69  FVENRISICTEFMDGGSLD--VYRKI---PEHVLGRIAVA--VVKGLTYLWS---LKILH 118

Query: 716 RDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDPEYYGNQQLTE 772
           RDVK SN+L++   + K+ DFG+S Q       ++S+A+   GT  Y+ PE    +Q   
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVSTQL------VNSIAKTYVGTNAYMAPERISGEQYGI 172

Query: 773 KSDVYSFGVVLLELISGKKP 792
            SDV+S G+  +EL  G+ P
Sbjct: 173 HSDVWSLGISFMELALGRFP 192

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 78.5 bits (193), Expect = 1e-15
 Identities = 74/228 (32%), Positives = 113/228 (49%), Gaps = 22/228 (9%)

Query: 582 IPLPELEEATNNF--CKKIGKGSFGSVY-YGKMKDGKEVAVKIMADSCSHRTQQFVTEVA 638
           + L  L + T+ +   + IGKG++G VY     KDG   AVKI+ D  S   ++   E  
Sbjct: 12  LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKIL-DPISDVDEEIEAEYN 70

Query: 639 LLSRI-HHRNLVPLIG-YCEEEH----QRILVYEYMHNGTLRDRLHGSVNQ-KPLDWLTR 691
           +L  + +H N+V   G + + +     Q  LV E  + G++ + + G +   + LD    
Sbjct: 71  ILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMI 130

Query: 692 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHIS 750
             I + A  GL++LH   N  IIHRDVK +NILL      K+ DFG+S Q     L   +
Sbjct: 131 SYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNT 187

Query: 751 SVARGTVGYLDPEYYGNQQLTEKS-----DVYSFGVVLLELISGKKPV 793
           SV  GT  ++ PE    +Q  + S     DV+S G+  +EL  G  P+
Sbjct: 188 SV--GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 78.6 bits (193), Expect = 1e-15
 Identities = 64/218 (29%), Positives = 116/218 (53%), Gaps = 22/218 (10%)

Query: 587 LEEATNNFCKKIGKGSFGSVYYGK-MKDGKEV----AVKIMADSCSHRTQ-QFVTEVALL 640
           L+E      K +G G+FG+VY G  + +G+ V    A+KI+ ++   +   +F+ E  ++
Sbjct: 4   LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIM 63

Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVN----QKPLDWLTRLQIAH 696
           + + H +LV L+G C     + LV + M +G L D +H   +    Q  L+W  ++    
Sbjct: 64  ASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI---- 118

Query: 697 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS-VARG 755
             AKG+ YL       ++HRD+ + N+L+      K++DFGL+R  E D    ++   + 
Sbjct: 119 --AKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKM 173

Query: 756 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
            + ++  E    ++ T +SDV+S+GV + EL++ G KP
Sbjct: 174 PIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKP 211

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 78.3 bits (193), Expect = 1e-15
 Identities = 54/198 (27%), Positives = 104/198 (52%), Gaps = 8/198 (4%)

Query: 596 KKIGKGSFGSVYYGKMKDGKE-VAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 653
           +K+G+G++ +VY G+ +   E VA+K I  D+        + E++L+  + H N+V L  
Sbjct: 6   EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHD 65

Query: 654 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 713
               E++ +LV+EYM +  L+  +     +  LD  T     +   KG+ + H      +
Sbjct: 66  VIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RV 121

Query: 714 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYGNQQLTE 772
           +HRD+K  N+L++     K++DFGL+R     +   S+    T+ Y  P+   G++  + 
Sbjct: 122 LHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLLGSRTYST 180

Query: 773 KSDVYSFGVVLLELISGK 790
             D++S G ++ E+I+G+
Sbjct: 181 SIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 78.2 bits (193), Expect = 1e-15
 Identities = 58/198 (29%), Positives = 99/198 (50%), Gaps = 13/198 (6%)

Query: 597 KIGKGSFGSVYYGKMKD-GKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIG 653
            +G+GS+G V   K K+ G+ VA+K   +S       +  + E+ +L ++ H NLV LI 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 654 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 713
               + +  LV+E++ + T+ D L    N   LD     +      +G+E+ H   +  I
Sbjct: 68  VFRRKKRLYLVFEFVDH-TVLDDLEKYPNG--LDESRVRKYLFQILRGIEFCH---SHNI 121

Query: 714 IHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYLDPEYY-GNQQLT 771
           IHRD+K  NIL+  +   K+ DFG +R  A     +   VA  T  Y  PE   G+ +  
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVA--TRWYRAPELLVGDTKYG 179

Query: 772 EKSDVYSFGVVLLELISG 789
              D+++ G ++ E+++G
Sbjct: 180 RAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 76.9 bits (189), Expect = 2e-15
 Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 19/216 (8%)

Query: 594 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIM--ADSCSHRTQQFVTEVALLSRIHHRNLVP 650
           F + +GKGS+G V   + + DGK+  +K +   ++     +    E  LLS++ H N+V 
Sbjct: 4   FVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVA 63

Query: 651 LIGYCE-EEHQRILVYEYMHNGTLRDRLHGSVNQ-----KPLDWLTRLQIAHDAAKGLEY 704
                E E+    +V  +   G L  +L     +     + ++W  ++ +A      L+Y
Sbjct: 64  YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMA------LQY 117

Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
           LH      I+HRD+K+ N+ L      KV D G++R   E+   ++S   GT  Y+ PE 
Sbjct: 118 LH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIAR-VLENQCDMASTLIGTPYYMSPEL 173

Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA 800
           + N+    KSDV++ G  + E+ + K   + +D  +
Sbjct: 174 FSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 78.1 bits (193), Expect = 2e-15
 Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 32/208 (15%)

Query: 598 IGKGSFGSVYYGKMKDGKE-VAVKIMA---DSCSH--RTQQFVTEVALLSRIHHRNLVPL 651
           +G G++G V           VA+K ++    S  H  RT +   E+ LL  + H N++ L
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR---ELRLLKHMDHENVIGL 79

Query: 652 IG-YCEEEHQRIL--VYEYMHNGTLRDR-LHGSVNQKPL--DWLTRL--QIAHDAAKGLE 703
           +  +           VY   H   L    L+  V  + L  D +  L  QI     +GL+
Sbjct: 80  LDVFTPASSLEDFQDVYLVTH---LMGADLNNIVKCQKLSDDHIQFLVYQIL----RGLK 132

Query: 704 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 763
           Y+H+    GIIHRD+K SNI ++ +   K+ DFGL+R  ++++T    VA  T  Y  PE
Sbjct: 133 YIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMT--GYVA--TRWYRAPE 185

Query: 764 YYGN-QQLTEKSDVYSFGVVLLELISGK 790
              N     +  D++S G ++ EL++GK
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 77.9 bits (192), Expect = 2e-15
 Identities = 49/144 (34%), Positives = 74/144 (51%), Gaps = 15/144 (10%)

Query: 666 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL 725
           E+M  G+L D++     + P + L ++ IA    +GL YL       I+HRDVK SNIL+
Sbjct: 79  EHMDGGSL-DQVLKKAGRIPENILGKISIA--VLRGLTYLRE--KHKIMHRDVKPSNILV 133

Query: 726 DINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDPEYYGNQQLTEKSDVYSFGVV 782
           +     K+ DFG+S Q       I S+A    GT  Y+ PE       T +SD++S G+ 
Sbjct: 134 NSRGEIKLCDFGVSGQL------IDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLS 187

Query: 783 LLELISGKKPVSVEDFGAELNIVH 806
           L+E+  G+ P+   D   EL  + 
Sbjct: 188 LVEMAIGRYPIPPPD-AKELEAMF 210

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 77.0 bits (189), Expect = 2e-15
 Identities = 56/201 (27%), Positives = 98/201 (48%), Gaps = 10/201 (4%)

Query: 596 KKIGKGSFGSVYYG-KMKDGKEVAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 653
           ++IGKGSFG V+ G   +  + VA+KI+  +      +    E+ +LS+     +    G
Sbjct: 10  ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69

Query: 654 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 713
              +  +  ++ EY+  G+  D L       P D      +  +  KGL+YLH+      
Sbjct: 70  SYLKGTKLWIIMEYLGGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLHS---EKK 122

Query: 714 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 773
           IHRD+K++N+LL      K++DFG++ Q  +     ++   GT  ++ PE         K
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSAYDSK 181

Query: 774 SDVYSFGVVLLELISGKKPVS 794
           +D++S G+  +EL  G+ P S
Sbjct: 182 ADIWSLGITAIELAKGEPPNS 202

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 76.4 bits (188), Expect = 2e-15
 Identities = 59/220 (26%), Positives = 105/220 (47%), Gaps = 32/220 (14%)

Query: 598 IGKGSFGSVYYGKMKDGK--------EVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLV 649
           +G+G+F  ++ G  ++          EV +K++  S  + ++ F    +++S++ H++LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 650 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 709
              G C    + I+V EY+  G+L   L  + N   + W  +L++A   A  L +L    
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLE--- 117

Query: 710 NPGIIHRDVKSSNILLDINMRA--------KVSDFGLS--RQAEEDLTHISSVARGTVGY 759
           + G+ H +V + N+LL              K+SD G+S     +E L          + +
Sbjct: 118 DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLE-------RIPW 170

Query: 760 LDPEYYGN-QQLTEKSDVYSFGVVLLELISG-KKPVSVED 797
           + PE   N Q L+  +D +SFG  L E+ SG  KP+S  D
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD 210

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 76.8 bits (190), Expect = 3e-15
 Identities = 59/220 (26%), Positives = 96/220 (43%), Gaps = 53/220 (24%)

Query: 596 KKIGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHRTQQF--------VTEVALLSRI-HH 645
           K++G G+FGSVY  + K+  E VA+K M        ++F        + EV  L ++  H
Sbjct: 5   KQLGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMNLREVKSLRKLNEH 57

Query: 646 RNLVPLIGYCEEEHQRILVYEYMHN---GTLRDRLHGSVNQKPL------DWLTRLQIAH 696
            N+V L     E  +   V+EYM       ++DR       KP         +   QI  
Sbjct: 58  PNIVKLKEVFRENDELYFVFEYMEGNLYQLMKDR-----KGKPFSESVIRSII--YQIL- 109

Query: 697 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT 756
              +GL ++H     G  HRD+K  N+L+      K++DFGL+R+      +   V   T
Sbjct: 110 ---QGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYV--ST 161

Query: 757 VGYLDPE------YYGNQQLTEKSDVYSFGVVLLELISGK 790
             Y  PE       Y +  +    D+++ G ++ EL + +
Sbjct: 162 RWYRAPEILLRSTSY-SSPV----DIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 77.9 bits (192), Expect = 4e-15
 Identities = 66/216 (30%), Positives = 103/216 (47%), Gaps = 40/216 (18%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVKIMAD------SCSHRTQQFVTEVALLSRIHHRNL 648
           + IG G+FG V+     +DGK VA+K M +      SC    ++   E+ +L    H N+
Sbjct: 6   RPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSC----KRVFRELKMLCFFKHDNV 61

Query: 649 V--------PLIGYCEEEHQRILVYEYMHNGTLRDRLHGS-VNQKPLD----WLTRLQIA 695
           +        P I   EE +   +V E M +      LH   V+ +PL      +   QI 
Sbjct: 62  LSALDILQPPHIDPFEEIY---VVTELMQSD-----LHKIIVSPQPLSSDHVKVFLYQIL 113

Query: 696 HDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARG 755
               +GL+YLH+    GI+HRD+K  N+L++ N   K+ DFGL+R  E D +   +    
Sbjct: 114 ----RGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV 166

Query: 756 TVGYLDPE-YYGNQQLTEKSDVYSFGVVLLELISGK 790
           T  Y  PE   G++  T   D++S G +  EL+  +
Sbjct: 167 TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 76.0 bits (187), Expect = 5e-15
 Identities = 55/214 (25%), Positives = 102/214 (47%), Gaps = 28/214 (13%)

Query: 598 IGKGSFGSVYYGKMKDG-------KEVAVKIMADSCSHRTQ-----QFVTEVALL-SRIH 644
           +G G+FG VY  + K+        KE+ V   A     R +       V+EV ++  ++ 
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 645 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL------HGSVNQKPLDWLTRLQIAHDA 698
           H N+V       E  +  +V + +    L +             ++ + W   +Q+    
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERI-WNIFVQMV--- 123

Query: 699 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG 758
              L YLH      I+HRD+  +NI+L  + +  ++DFGL++Q + + + ++SV  GT+ 
Sbjct: 124 -LALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPE-SKLTSVV-GTIL 178

Query: 759 YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           Y  PE   N+   EK+DV++FG +L ++ + + P
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 75.9 bits (187), Expect = 7e-15
 Identities = 53/198 (26%), Positives = 89/198 (44%), Gaps = 21/198 (10%)

Query: 605 SVYYGKMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLIGY----CEE 657
           S+Y G   + KEV ++                  E+  L RI   N++ + G+     ++
Sbjct: 35  SIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93

Query: 658 EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN-PGIIHR 716
             +  L+ EY   G LR+ L     +K L + T+L +A D  KGL  L+   N P   ++
Sbjct: 94  LPRLSLILEYCTRGYLREVLD---KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP---YK 147

Query: 717 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN--QQLTEKS 774
           ++ S + L+  N + K+   GL    E+ L+         + Y   +   +   + T K 
Sbjct: 148 NLTSVSFLVTENYKLKIICHGL----EKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKD 203

Query: 775 DVYSFGVVLLELISGKKP 792
           D+YS GVVL E+ +GK P
Sbjct: 204 DIYSLGVVLWEIFTGKIP 221

Length = 283

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 75.5 bits (185), Expect = 7e-15
 Identities = 52/202 (25%), Positives = 96/202 (47%), Gaps = 11/202 (5%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 654
           ++IG G++G VY  + +  G+  A+K++             E+ ++    H N+V   G 
Sbjct: 15  QRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGS 74

Query: 655 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 714
                +  +  E+   G+L+D  H +    PL       ++ +  +GL YLH   + G +
Sbjct: 75  YLRRDKLWICMEFCGGGSLQDIYHVT---GPLSESQIAYVSRETLQGLYYLH---SKGKM 128

Query: 715 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQ---LT 771
           HRD+K +NILL  N   K++DFG+S Q    +    S   GT  ++ PE    ++     
Sbjct: 129 HRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAAVERKGGYN 187

Query: 772 EKSDVYSFGVVLLELISGKKPV 793
           +  D+++ G+  +EL   + P+
Sbjct: 188 QLCDIWAVGITAIELAELQPPM 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 75.4 bits (185), Expect = 9e-15
 Identities = 59/199 (29%), Positives = 98/199 (49%), Gaps = 10/199 (5%)

Query: 598 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQ---QFVTEVALLSRIHHRNLVPLIG 653
           +GKG FG V   +++  GK  A K +      + +     + E  +L +++ R +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67

Query: 654 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 713
             E +    LV   M+ G L+  ++  + +   +    +  A +   GLE LH      I
Sbjct: 68  AYETKDALCLVLTLMNGGDLKFHIY-HMGEAGFEEGRAVFYAAEICCGLEDLH---QERI 123

Query: 714 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 773
           ++RD+K  NILLD +   ++SD GL+    E  T    V  GTVGY+ PE   N++ T  
Sbjct: 124 VYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV--GTVGYMAPEVVKNERYTFS 181

Query: 774 SDVYSFGVVLLELISGKKP 792
            D ++ G +L E+I+G+ P
Sbjct: 182 PDWWALGCLLYEMIAGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 75.8 bits (187), Expect = 1e-14
 Identities = 63/217 (29%), Positives = 100/217 (46%), Gaps = 37/217 (17%)

Query: 597 KIGKGSFGSVYYGKMK---DGKEVAVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVP 650
            IG+G++G VY  K K   DGKE A+K         T   Q    E+ALL  + H N+V 
Sbjct: 7   CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66

Query: 651 LIGYCEEEHQRI--LVYEY----------MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDA 698
           L+    E   +   L+++Y           H    R  +  S+  K L W    QI +  
Sbjct: 67  LVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSM-VKSLLW----QILN-- 119

Query: 699 AKGLEYLHTGCNPGIIHRDVKSSNILL--DINMRA--KVSDFGLSRQAEEDLTHISSVAR 754
             G+ YLH+     ++HRD+K +NIL+  +   R   K+ D GL+R     L  ++ +  
Sbjct: 120 --GVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDP 174

Query: 755 G--TVGYLDPE-YYGNQQLTEKSDVYSFGVVLLELIS 788
              T+ Y  PE   G +  T+  D+++ G +  EL++
Sbjct: 175 VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 75.3 bits (185), Expect = 1e-14
 Identities = 55/200 (27%), Positives = 95/200 (47%), Gaps = 9/200 (4%)

Query: 598 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVPLIG 653
           +GKG FG V   +M+  GK  A K +      + + +   + E  +L+++H R +V L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 654 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKP-LDWLTRLQIAHDAAKGLEYLHTGCNPG 712
             + +    LV   M+ G LR  ++    + P                GLE+LH      
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRR 117

Query: 713 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 772
           II+RD+K  N+LLD +   ++SD GL+ + ++  +     A GT G++ PE    ++   
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA-GTPGFMAPELLQGEEYDF 176

Query: 773 KSDVYSFGVVLLELISGKKP 792
             D ++ GV L E+I+ + P
Sbjct: 177 SVDYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 75.9 bits (186), Expect = 1e-14
 Identities = 69/225 (30%), Positives = 107/225 (47%), Gaps = 26/225 (11%)

Query: 596 KKIGKGSFGSVYYGKMKDGKEV-AVKIMAD---SCSHRTQQFVTEVALLSRIHHRNLVPL 651
           K IG+G+FG V   K+K+  +V A+KI+          T  F  E  +L    ++ +  L
Sbjct: 7   KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTL 66

Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD----WLTRLQIAHDAAKGLEYLHT 707
               ++E+   LV +Y   G L   L    ++ P D    +L  + IA D+   L Y   
Sbjct: 67  HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY--- 123

Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY-- 765
                 +HRD+K  NIL+D+N   +++DFG   +  ED T  SSVA GT  Y+ PE    
Sbjct: 124 ------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 177

Query: 766 ---GNQQLTEKSDVYSFGVVLLELISGKKPVS----VEDFGAELN 803
              G  +   + D +S GV + E++ G+ P      VE +G  +N
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 222

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 74.6 bits (184), Expect = 1e-14
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 26/211 (12%)

Query: 598 IGKGSFGSVYYGKMK-DGKEVAVKIMA-DSCSHRTQQ--FVTEVALLSRIHHRNLVPLIG 653
           +G G FG V   K+K   +  A+K +         QQ    +E  +L   +H  +V L  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 654 YCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 711
             +++    ++ EY   G L   L   G  +    ++  R  IA       EYLH   N 
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRDRGLFD----EYTARFYIAC-VVLAFEYLH---NR 112

Query: 712 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR-----GTVGYLDPEYYG 766
           GII+RD+K  N+LLD N   K+ DFG +++       + S  +     GT  Y+ PE   
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAKK-------LKSGQKTWTFCGTPEYVAPEIIL 165

Query: 767 NQQLTEKSDVYSFGVVLLELISGKKPVSVED 797
           N+      D +S G++L EL++G+ P   +D
Sbjct: 166 NKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 75.1 bits (185), Expect = 2e-14
 Identities = 63/209 (30%), Positives = 98/209 (46%), Gaps = 28/209 (13%)

Query: 597 KIGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHR---TQQFVTEVALLSRIHHRNLVPLI 652
           ++G+G +G V+  K KD  E VA+K M  S   +    +  +TE  +L+      LV L+
Sbjct: 8   QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67

Query: 653 GYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLD------WLTRLQIAHDAAKGLEYL 705
            Y  ++ + + L  EY+  G  R  L    N   L       ++  +  A DA      L
Sbjct: 68  -YAFQDDEYLYLAMEYVPGGDFRTLL---NNLGVLSEDHARFYMAEMFEAVDA------L 117

Query: 706 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 765
           H     G IHRD+K  N L+D +   K++DFGLS+     +T+ +SV  G+  Y+ PE  
Sbjct: 118 H---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGI---VTYANSVV-GSPDYMAPEVL 170

Query: 766 GNQQLTEKSDVYSFGVVLLELISGKKPVS 794
             +      D +S G +L E + G  P S
Sbjct: 171 RGKGYDFTVDYWSLGCMLYEFLCGFPPFS 199

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 74.3 bits (182), Expect = 2e-14
 Identities = 58/229 (25%), Positives = 108/229 (47%), Gaps = 25/229 (10%)

Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKM------KDGKEVAVKIMADSCS-HRTQQFVTEVA 638
           E+  +T  F +++G+  FG VY G +      +  + VA+K + D       ++F  E  
Sbjct: 1   EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60

Query: 639 LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL-----HGSVNQKPLDWLTR-- 691
           + SR+ H N+V L+G   +E    +++ Y  +  L + L     H  V     D   +  
Sbjct: 61  MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120

Query: 692 ------LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EE 744
                 + I    A G+E+L +     ++H+D+ + N+L+   +  K+SD GL R+    
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAA 177

Query: 745 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
           D   +   +   + ++ PE     + +  SD++S+GVVL E+ S G +P
Sbjct: 178 DYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 73.8 bits (181), Expect = 2e-14
 Identities = 74/261 (28%), Positives = 114/261 (43%), Gaps = 65/261 (24%)

Query: 596 KKIGKGSFGSVYYGKMKDGKEVA---VKIM-----ADSCSHRTQQFVTEVALLSRIHHRN 647
           +++GKGSFG+VY   +KD K VA   +K++      +   + T Q   E  LLS++ H  
Sbjct: 6   QRLGKGSFGTVYL--VKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPA 63

Query: 648 LVP-------------LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI 694
           +V              +  YCE       + E  H G        S NQ   +W  +L +
Sbjct: 64  IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTL-----SENQV-CEWFIQLLL 117

Query: 695 AHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSV 752
                 G+ Y+H      I+HRD+K+ NI L  N+  K+ DFG+SR      DL   ++ 
Sbjct: 118 ------GVHYMHQ---RRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDL---ATT 164

Query: 753 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLEL-------------------ISGKKPV 793
             GT  Y+ PE   +Q    KSD++S G +L E+                   + G  P 
Sbjct: 165 FTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPS 224

Query: 794 SVEDFGAELNIVHWARSMIKK 814
             E +  +LN +   +SM+ K
Sbjct: 225 LPETYSRQLNSI--MQSMLNK 243

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 74.8 bits (184), Expect = 2e-14
 Identities = 64/211 (30%), Positives = 98/211 (46%), Gaps = 20/211 (9%)

Query: 596 KKIGKGSFGSVYYGKMKDGKEV-AVK------IMADSCSHRTQQFVTEVALLSRIHHRNL 648
           K +GKGSFG V   ++K   E  A+K      ++ D     T   V    L     H  L
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECT--MVERRVLALAWEHPFL 58

Query: 649 VPLIGYC--EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
             L  +C  + +     V EY++ G   D +    +    D       A +   GL++LH
Sbjct: 59  THL--FCTFQTKEHLFFVMEYLNGG---DLMFHIQSSGRFDEARARFYAAEIICGLQFLH 113

Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 766
                GII+RD+K  N+LLD +   K++DFG+ ++   +    +S   GT  Y+ PE   
Sbjct: 114 KK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKE-NMNGEGKASTFCGTPDYIAPEILK 169

Query: 767 NQQLTEKSDVYSFGVVLLELISGKKPVSVED 797
            Q+  E  D +SFGV+L E++ G+ P   ED
Sbjct: 170 GQKYNESVDWWSFGVLLYEMLIGQSPFHGED 200

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 74.3 bits (182), Expect = 2e-14
 Identities = 66/212 (31%), Positives = 104/212 (49%), Gaps = 22/212 (10%)

Query: 598 IGKGSFGSVY-YGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIG-Y 654
           IGKG++G V+     K+G + AVKI+ D      ++   E  +L  +  H N+V   G Y
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKIL-DPIHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84

Query: 655 CEEE----HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHT 707
            +++     Q  LV E  + G++ D + G + +   + +    IA   H+A  GL++LH 
Sbjct: 85  YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRG--ERMEEPIIAYILHEALMGLQHLH- 141

Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG- 766
                 IHRDVK +NILL      K+ DFG+S Q         + + GT  ++ PE    
Sbjct: 142 --VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQL-TSTRLRRNTSVGTPFWMAPEVIAC 198

Query: 767 NQQL----TEKSDVYSFGVVLLELISGKKPVS 794
            QQL      + DV+S G+  +EL  G  P++
Sbjct: 199 EQQLDSTYDARCDVWSLGITAIELGDGDPPLA 230

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 74.4 bits (183), Expect = 3e-14
 Identities = 62/228 (27%), Positives = 98/228 (42%), Gaps = 48/228 (21%)

Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA--------DSCSHRTQQFVTEVALLSRI 643
           NF   +GKGSFG V   + K   E+ A+KI+         D      ++ V  +AL  + 
Sbjct: 3   NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRV--LALPGKP 60

Query: 644 HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI--------- 694
               L  L    +   +   V EY++ G               D +  +Q          
Sbjct: 61  PF--LTQLHSCFQTMDRLYFVMEYVNGG---------------DLMYHIQQVGKFKEPHA 103

Query: 695 ---AHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA--EEDLTHI 749
              A + A GL +LH+    GII+RD+K  N++LD     K++DFG+ ++       T  
Sbjct: 104 VFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT 160

Query: 750 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 797
                GT  Y+ PE    Q   +  D ++FGV+L E+++G+ P   ED
Sbjct: 161 FC---GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED 205

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 74.5 bits (183), Expect = 4e-14
 Identities = 62/215 (28%), Positives = 102/215 (47%), Gaps = 31/215 (14%)

Query: 589 EATNNFC--KKIGKGSFGSVYYGK-MKDGKEVAVK-IMAD-SCSHRTQQFVTEVALLSRI 643
           E TN +   + +G G+FG V   +    G+ VA+K IM   S     ++   E+ LL  +
Sbjct: 7   EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL 66

Query: 644 HHRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGL 702
            H N++ L        + I  V E +  GT    LH  +  +PL+        +   +GL
Sbjct: 67  RHENIISLSDIFISPLEDIYFVTELL--GT---DLHRLLTSRPLEKQFIQYFLYQILRGL 121

Query: 703 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDP 762
           +Y+H+    G++HRD+K SNIL++ N   K+ DFGL+R  +  +T          GY+  
Sbjct: 122 KYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQMT----------GYVST 168

Query: 763 EYYGN-------QQLTEKSDVYSFGVVLLELISGK 790
            YY         Q+   + D++S G +  E++ GK
Sbjct: 169 RYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 73.5 bits (180), Expect = 4e-14
 Identities = 58/211 (27%), Positives = 109/211 (51%), Gaps = 22/211 (10%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKE----VAVKIMADSCSHRTQQFVTEVAL-LSRIHHRNLV 649
           K +G G FG+V+ G  + +G      VA+K + D    +T Q +T+  L +  + H  +V
Sbjct: 13  KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72

Query: 650 PLIGYCEEEHQRILVYEYMHNGTLRDRLH---GSVN-QKPLDWLTRLQIAHDAAKGLEYL 705
            L+G C     + LV +    G+L D +     S++ Q+ L+W  ++      AKG+ YL
Sbjct: 73  RLLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI------AKGMYYL 125

Query: 706 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTVGYLDPEY 764
                  ++HR++ + NILL  +   +++DFG++     +D  +  S  +  + ++  E 
Sbjct: 126 EEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALES 182

Query: 765 YGNQQLTEKSDVYSFGVVLLELIS-GKKPVS 794
               + T +SDV+S+GV + E++S G +P +
Sbjct: 183 ILFGRYTHQSDVWSYGVTVWEMMSYGAEPYA 213

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 73.6 bits (181), Expect = 4e-14
 Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 22/205 (10%)

Query: 596 KKIGKGSFGSVYYGKMKDGKE-VAVKIMA--DSCSHRTQQFV-TEVALLSRIHHRNLVPL 651
           K +G G+FG V+  + +  +   A+K+MA  +    + +Q V  E  +L  + H  ++ L
Sbjct: 7   KTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL 66

Query: 652 IGYCEEEHQRIL--VYEYMHNGTLRD--RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
             +  E  QR L  + EY+  G L    R  G  +       T L  A +    LEYLH+
Sbjct: 67  --FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNS-----TGLFYASEIVCALEYLHS 119

Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 767
                I++RD+K  NILLD     K++DFG +++  +    +     GT  YL PE   +
Sbjct: 120 ---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLC----GTPEYLAPEVIQS 172

Query: 768 QQLTEKSDVYSFGVVLLELISGKKP 792
           +   +  D ++ G+++ E++ G  P
Sbjct: 173 KGHNKAVDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 73.7 bits (181), Expect = 4e-14
 Identities = 67/217 (30%), Positives = 111/217 (51%), Gaps = 35/217 (16%)

Query: 598 IGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQF----VTEVALLSRIHHRNLVPL- 651
           IG+G++G VY  + KD G+ VA+K +     +  + F    + E+ +L +++HRN+V L 
Sbjct: 15  IGEGTYGQVYKARDKDTGELVALKKV--RLDNEKEGFPITAIREIKILRQLNHRNIVNLK 72

Query: 652 ---------IGYCEEEHQRILVYEYM-HN--GTLRDRLHGSVNQKPLDWLTRLQIAHDAA 699
                    + + +++    LV+EYM H+  G L   L          ++ +L       
Sbjct: 73  EIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQL------L 126

Query: 700 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTV 757
           +GL Y H       +HRD+K SNILL+   + K++DFGL+R   +EE   + + V   T+
Sbjct: 127 EGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI--TL 181

Query: 758 GYLDPE-YYGNQQLTEKSDVYSFGVVLLELISGKKPV 793
            Y  PE   G ++     DV+S G +L EL + KKP+
Sbjct: 182 WYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 73.3 bits (180), Expect = 5e-14
 Identities = 66/213 (30%), Positives = 106/213 (49%), Gaps = 25/213 (11%)

Query: 594 FCKKIGKGSFGSVYYGKMK-DGKEVAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPL 651
              ++GKG++GSVY    +  G  +A+K I  +    +  Q + E+ +L +     +V  
Sbjct: 5   VLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDF 64

Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLHG---SVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
            G    E    +  EYM  G+L D+L+    +    P D L R  I +   KGL++L   
Sbjct: 65  YGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRR--ITYAVVKGLKFLKEE 121

Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLDPEY- 764
            N  IIHRDVK +N+L++ N + K+ DFG+S          +S+A+  +G   Y+ PE  
Sbjct: 122 HN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV------ASLAKTNIGCQSYMAPERI 173

Query: 765 -----YGNQQLTEKSDVYSFGVVLLELISGKKP 792
                  N   T +SDV+S G+ +LE+  G+ P
Sbjct: 174 KSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 73.4 bits (180), Expect = 6e-14
 Identities = 58/222 (26%), Positives = 104/222 (46%), Gaps = 30/222 (13%)

Query: 594 FCKKIGKGSFGSVYYGK---MKDGKE--------------VAVKIM-ADSCSHRTQQFVT 635
           F +K+G+G FG V+  +   M+   +              VAVK++  D+  +    F+ 
Sbjct: 9   FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68

Query: 636 EVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL-----RDRLHGSV---NQKPLD 687
           E+ ++SR+   N++ L+  C       ++ EYM NG L     R     +    +   + 
Sbjct: 69  EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128

Query: 688 WLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-DL 746
           + T + +A   A G++YL +      +HRD+ + N L+  N   K++DFG+SR     D 
Sbjct: 129 YSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDY 185

Query: 747 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
             I   A   + ++  E     + T  SDV++FGV L E+++
Sbjct: 186 YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 73.0 bits (180), Expect = 6e-14
 Identities = 59/204 (28%), Positives = 99/204 (48%), Gaps = 14/204 (6%)

Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRTQQ---FVTEVALLSRIHHRNL 648
            F K +G GSFG V   + K   +  A+KI++ +   + +Q    + E  +L  I H  L
Sbjct: 4   EFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFL 63

Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           V L G  +++    LV EY+  G L   L     + P     R   A      LEYLH  
Sbjct: 64  VNLYGSFQDDSNLYLVMEYVPGGELFSHLR-KSGRFPEPV-ARFYAA-QVVLALEYLH-- 118

Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
            +  I++RD+K  N+LLD +   K++DFG +++ +     +     GT  YL PE   ++
Sbjct: 119 -SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC----GTPEYLAPEIILSK 173

Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
              +  D ++ G+++ E+++G  P
Sbjct: 174 GYGKAVDWWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 72.8 bits (179), Expect = 7e-14
 Identities = 61/201 (30%), Positives = 98/201 (48%), Gaps = 19/201 (9%)

Query: 597 KIGKGSFGSVYYGKMKD-GKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIG 653
           KIG+GS+G V+  + ++ G+ VA+K   +S       +  + E+ +L ++ H NLV LI 
Sbjct: 8   KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67

Query: 654 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT-GCNPG 712
               + +  LV+EY  + T+ + L    N + +      +I     + + + H   C   
Sbjct: 68  VFRRKRKLHLVFEYCDH-TVLNELEK--NPRGVPEHLIKKIIWQTLQAVNFCHKHNC--- 121

Query: 713 IIHRDVKSSNILLDINMRAKVSDFGLSR---QAEEDLTHISSVARGTVGYLDPEYY-GNQ 768
            IHRDVK  NIL+    + K+ DFG +R      +D T    VA  T  Y  PE   G+ 
Sbjct: 122 -IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYT--DYVA--TRWYRAPELLVGDT 176

Query: 769 QLTEKSDVYSFGVVLLELISG 789
           Q     DV++ G V  EL++G
Sbjct: 177 QYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 73.2 bits (180), Expect = 7e-14
 Identities = 67/208 (32%), Positives = 95/208 (45%), Gaps = 26/208 (12%)

Query: 598 IGKGSFGSVYYGKM---KDGKEVAVKIMADSCSHRTQQFV---TEVALLSRIHHR--NLV 649
           IG G+ G VY  KM   K G  +AVK M  + +    + +    +V L S   H    +V
Sbjct: 23  IGSGTCGQVY--KMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKS---HDCPYIV 77

Query: 650 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQK-PLDWLTRLQIAHDAAKGLEYLHTG 708
              GY   +    +  E M   T  D+L   +    P D L ++ +A    K L YL   
Sbjct: 78  KCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVA--IVKALHYLKE- 132

Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
              G+IHRDVK SNILLD +   K+ DFG+S +  +      S   G   Y+ PE     
Sbjct: 133 -KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSA--GCAAYMAPERIDPP 189

Query: 769 QLTEK----SDVYSFGVVLLELISGKKP 792
               K    +DV+S G+ L+EL +G+ P
Sbjct: 190 DPNPKYDIRADVWSLGISLVELATGQFP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 73.1 bits (180), Expect = 7e-14
 Identities = 64/229 (27%), Positives = 104/229 (45%), Gaps = 46/229 (20%)

Query: 593 NFCKKIGKGSFGSVYYG-KMKDGKEVAVK--IMADSCSHRTQQF-VT---EVALLSRIHH 645
               K+G+G+FG VY   ++K G+ VA+K  +M     +    F +T   E+ +L ++ H
Sbjct: 11  EILGKLGEGTFGEVYKARQIKTGRVVALKKILM----HNEKDGFPITALREIKILKKLKH 66

Query: 646 RNLVPLIGYCEEEHQRI--------LVYEYM-H--NGTLRD-RLHGSVNQ-KPLDWLTRL 692
            N+VPLI    E   +         +V  YM H  +G L +  +  + +Q K       L
Sbjct: 67  PNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIK----CYML 122

Query: 693 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED---LTHI 749
           Q+      G+ YLH   N  I+HRD+K++NIL+D     K++DFGL+R  +         
Sbjct: 123 QLLE----GINYLH--EN-HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGG 175

Query: 750 SSVARG-------TVGYLDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 790
                        T  Y  PE   G ++ T   D++  G V  E+ + +
Sbjct: 176 GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 75.3 bits (185), Expect = 9e-14
 Identities = 40/102 (39%), Positives = 61/102 (59%), Gaps = 6/102 (5%)

Query: 383 WEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD--MSRL 440
           W+ +TC+ ++  R+  I LSGKN+ G+I   +  +  +  + L  N L+GP+PD   +  
Sbjct: 60  WQGITCNNSS--RVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTS 117

Query: 441 IDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIP 482
             LR ++L NN  TGS+P   GS+PNL+ L + NN   GEIP
Sbjct: 118 SSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIP 157

Length = 968

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 73.2 bits (179), Expect = 9e-14
 Identities = 61/206 (29%), Positives = 97/206 (47%), Gaps = 11/206 (5%)

Query: 596 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPL 651
           K +GKG+FG V   + K  GK  A+KI+              +TE  +L    H  L  L
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60

Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 711
               + + +   V EY++ G L    H S  +   +  TR   A +    L+YLH+G   
Sbjct: 61  KYSFQTKDRLCFVMEYVNGGELF--FHLSRERVFSEDRTRFYGA-EIVSALDYLHSG--- 114

Query: 712 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 771
            I++RD+K  N++LD +   K++DFGL ++   D   + +   GT  YL PE   +    
Sbjct: 115 KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC-GTPEYLAPEVLEDNDYG 173

Query: 772 EKSDVYSFGVVLLELISGKKPVSVED 797
              D +  GVV+ E++ G+ P   +D
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPFYNQD 199

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 72.8 bits (179), Expect = 1e-13
 Identities = 64/220 (29%), Positives = 92/220 (41%), Gaps = 29/220 (13%)

Query: 594 FCKKIGKGSFG--SVYYGKMKD-GKEVAVKIMA-DSCSHRTQQFV-TEVALLSRIHHRNL 648
               IGK       V+  K K     VAVK +  DSCS    + +  E+    ++ H N+
Sbjct: 2   LLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNI 61

Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH---DAAKGLEYL 705
           +P +     + +  +V   M  G+  D L         + L  L IA    D    L+Y+
Sbjct: 62  LPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFP----EGLPELAIAFILKDVLNALDYI 117

Query: 706 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS--------RQAEEDLTHISSVARGTV 757
           H   + G IHR VK+S+ILL  + +  +S    S        RQ        SSV    +
Sbjct: 118 H---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK--NL 172

Query: 758 GYLDPEYYGNQQL---TEKSDVYSFGVVLLELISGKKPVS 794
            +L PE    Q L    EKSD+YS G+   EL +G  P  
Sbjct: 173 PWLSPEVL-QQNLQGYNEKSDIYSVGITACELANGHVPFK 211

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 72.6 bits (178), Expect = 1e-13
 Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 16/215 (7%)

Query: 598 IGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIG 653
           +GKGSFG V   ++K  G+  AVK++           +  +TE  +LS   +   +  + 
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 654 YCEEEHQRIL-VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 712
            C +   R+  V E+++ G L   +  S   +  D       A +    L +LH   + G
Sbjct: 63  CCFQTPDRLFFVMEFVNGGDLMFHIQKS---RRFDEARARFYAAEITSALMFLH---DKG 116

Query: 713 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 772
           II+RD+K  N+LLD     K++DFG+ ++   +    S+   GT  Y+ PE         
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC-GTPDYIAPEILQEMLYGP 175

Query: 773 KSDVYSFGVVLLELISGKKPVSVED----FGAELN 803
             D ++ GV+L E++ G  P   E+    F A LN
Sbjct: 176 SVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN 210

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 72.2 bits (177), Expect = 1e-13
 Identities = 61/201 (30%), Positives = 94/201 (46%), Gaps = 14/201 (6%)

Query: 598 IGKGSFGSV------YYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 651
           +GKG FG V        GKM   K++  K +           + E  +L +++ R +V L
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR--KGEAMALNEKQILEKVNSRFVVSL 65

Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 711
               E +    LV   M+ G L+  ++ ++     D    +  A +   GLE LH     
Sbjct: 66  AYAYETKDALCLVLTLMNGGDLKFHIY-NMGNPGFDEERAVFYAAEITCGLEDLHR---E 121

Query: 712 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 771
            I++RD+K  NILLD     ++SD GL+ +  E  T    V  GTVGY+ PE   N++ T
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV--GTVGYMAPEVVKNERYT 179

Query: 772 EKSDVYSFGVVLLELISGKKP 792
              D +  G ++ E+I GK P
Sbjct: 180 FSPDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 72.5 bits (178), Expect = 1e-13
 Identities = 63/213 (29%), Positives = 100/213 (46%), Gaps = 25/213 (11%)

Query: 596 KKIGKGSFGSVYYGKMK-DGKEVAVKIMA-------DSCSHRTQQFVTEVALLSRIHHRN 647
           K +GKG+FG V   + K  GK  A+KI+        D  +H     +TE  +L    H  
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHT----LTESRVLQNTRHPF 56

Query: 648 LVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           L  L  Y  + H R+  V EY + G L    H S  +   +   R   A +    L YLH
Sbjct: 57  LTAL-KYSFQTHDRLCFVMEYANGGELF--FHLSRERVFSEDRARFYGA-EIVSALGYLH 112

Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGYLDPEY 764
           +     +++RD+K  N++LD +   K++DFGL +   E ++  +++    GT  YL PE 
Sbjct: 113 SC---DVVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEV 166

Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 797
             +       D +  GVV+ E++ G+ P   +D
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 72.0 bits (177), Expect = 1e-13
 Identities = 62/213 (29%), Positives = 93/213 (43%), Gaps = 27/213 (12%)

Query: 595 CKKIGKGSFGSVYYGKM---KDGKEVAVK-IMADSCSHRTQQFVTEV-ALLSRIHHRNLV 649
             +IG+G+FG+V   KM     G  +AVK I +       ++ + ++  ++       +V
Sbjct: 9   LGEIGRGAFGTVN--KMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIV 66

Query: 650 PLIGYCEEEHQRILVYEYMHNG--TLRDRLHGSVNQK-PLDWLTRLQIAHDAAKGLEYLH 706
              G    E    +  E M          ++  +    P + L +  IA    K L YL 
Sbjct: 67  KFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGK--IAVATVKALNYLK 124

Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDP 762
                 IIHRDVK SNILLD N   K+ DFG+S Q  +      S+A+    G   Y+ P
Sbjct: 125 EELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD------SIAKTRDAGCRPYMAP 176

Query: 763 EY---YGNQQLTEKSDVYSFGVVLLELISGKKP 792
           E            +SDV+S G+ L E+ +GK P
Sbjct: 177 ERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 71.6 bits (175), Expect = 1e-13
 Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 17/205 (8%)

Query: 596 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 654
           +++G G++G VY    +  G+  AVKI+             E+ ++    H N+V   G 
Sbjct: 15  QRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGS 74

Query: 655 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH---DAAKGLEYLHTGCNP 711
                +  +  EY   G+L+D  H +    PL   + LQIA+   +  +GL YLH+    
Sbjct: 75  YLSREKLWICMEYCGGGSLQDIYHVT---GPL---SELQIAYVCRETLQGLAYLHS---K 125

Query: 712 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG---NQ 768
           G +HRD+K +NILL  N   K++DFG++ +    +    S   GT  ++ PE      N 
Sbjct: 126 GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPEVAAVEKNG 184

Query: 769 QLTEKSDVYSFGVVLLELISGKKPV 793
              +  D+++ G+  +EL   + P+
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPM 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 71.9 bits (177), Expect = 1e-13
 Identities = 56/203 (27%), Positives = 98/203 (48%), Gaps = 24/203 (11%)

Query: 598 IGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHR--TQQFVTEVALLSRI---HHRNLVPL 651
           IG+G++G+VY  + +  G+ VA+K +    S        + E+ALL ++    H N+V L
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66

Query: 652 IGYC-----EEEHQRILVYEYMHNGTLRDRLHG---SVNQKPLDWLTRLQIAHDAAKGLE 703
           +  C     + E +  LV+E++     +D L        +  L   T   +     +G++
Sbjct: 67  LDVCHGPRTDRELKLTLVFEHVD----QD-LATYLSKCPKPGLPPETIKDLMRQLLRGVD 121

Query: 704 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 763
           +LH+     I+HRD+K  NIL+  + + K++DFGL+R    ++   S V   T+ Y  PE
Sbjct: 122 FLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV--TLWYRAPE 176

Query: 764 YYGNQQLTEKSDVYSFGVVLLEL 786
                      D++S G +  EL
Sbjct: 177 VLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 72.0 bits (177), Expect = 2e-13
 Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 51/219 (23%)

Query: 597 KIGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHRTQQ--------FVTEVALLSRIHHRN 647
           +IG+G++G VY  +     E VA+K +      R            + E+ LL  + H N
Sbjct: 14  RIGEGTYGIVYRARDTTSGEIVALKKV------RMDNERDGIPISSLREITLLLNLRHPN 67

Query: 648 LVPL---------------IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRL 692
           +V L               + YCE++   +L           D +    ++  +  L  L
Sbjct: 68  IVELKEVVVGKHLDSIFLVMEYCEQDLASLL-----------DNMPTPFSESQVKCLM-L 115

Query: 693 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV 752
           Q+     +GL+YLH      IIHRD+K SN+LL      K++DFGL+R        ++  
Sbjct: 116 QLL----RGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPK 168

Query: 753 ARGTVGYLDPE-YYGNQQLTEKSDVYSFGVVLLELISGK 790
              T+ Y  PE   G    T   D+++ G +L EL++ K
Sbjct: 169 VV-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 72.3 bits (177), Expect = 2e-13
 Identities = 67/217 (30%), Positives = 95/217 (43%), Gaps = 13/217 (5%)

Query: 596 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQ----FVTEVALLSRIHHRNLVP 650
           K IGKGSFG V   K K DG   AVK++      + ++          LL  + H  LV 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 710
           L    +   +   V +Y++ G L    H    +  L+   R   A + A  + YLH+   
Sbjct: 61  LHYSFQTAEKLYFVLDYVNGGELF--FHLQRERCFLEPRARFYAA-EVASAIGYLHS--- 114

Query: 711 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 770
             II+RD+K  NILLD      ++DFGL ++  E     S+   GT  YL PE    +  
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC-GTPEYLAPEVLRKEPY 173

Query: 771 TEKSDVYSFGVVLLELISGKKPVSVEDFGAEL-NIVH 806
               D +  G VL E++ G  P    D      NI+H
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILH 210

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 71.6 bits (175), Expect = 2e-13
 Identities = 60/199 (30%), Positives = 104/199 (52%), Gaps = 14/199 (7%)

Query: 596 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNLVPLIG 653
           +K+G+GS+ +VY GK K +GK VA+K++       T    + E +LL  + H N+V L  
Sbjct: 11  EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHD 70

Query: 654 YCEEEHQRILVYEYMHNGTLR--DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 711
               +    LV+EY+H    +  D+  G ++ + +  L   Q+     +GL Y+H     
Sbjct: 71  IIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVK-LFLFQLL----RGLSYIH---QR 122

Query: 712 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYGNQQL 770
            I+HRD+K  N+L+      K++DFGL+R A+   +H  S    T+ Y  P+   G+ + 
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYRPPDVLLGSTEY 181

Query: 771 TEKSDVYSFGVVLLELISG 789
           +   D++  G + +E+I G
Sbjct: 182 STCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 70.7 bits (173), Expect = 3e-13
 Identities = 63/212 (29%), Positives = 101/212 (47%), Gaps = 18/212 (8%)

Query: 596 KKIGKGSFGSVYYGKMKDG---KEVAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNLVPL 651
           K+IG G FG V  G++  G    +V VK +  S S + Q +F+ E      + H NL+  
Sbjct: 1   KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60

Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPL--DWLTRLQIAHDAAKGLEYLHTGC 709
           +G C E    +LV E+   G L+  L      + +  D  T  ++A + A GL +LH   
Sbjct: 61  LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN- 119

Query: 710 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS-----VARGTVGYLDPEY 764
               IH D+   N LL  ++  K+ D+GLS    ++  +++        R     L  E 
Sbjct: 120 --NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177

Query: 765 YGNQQL---TEKSDVYSFGVVLLELIS-GKKP 792
           +GN  +   T++S+V+S GV + EL   G +P
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWELFELGSQP 209

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 71.3 bits (175), Expect = 3e-13
 Identities = 61/257 (23%), Positives = 98/257 (38%), Gaps = 68/257 (26%)

Query: 574 MDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVY-YGKMKDGKEVAVKIM------ADSC 626
                  +I               +G+G++G V        GK VA+K +       D  
Sbjct: 3   SFSISERYIQKG----------AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVT 52

Query: 627 SHRTQ------QFVT--EVALLSRIHHRNLVPLIG-YCEEEHQRILVYEYMHNGTLRDRL 677
             R         F T  E+ +++ I H N++ L+  Y E +    LV + M    L+   
Sbjct: 53  KDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFIN-LVMDIMA-SDLK--- 107

Query: 678 HGSVNQKPLDWLTRLQIAH------DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRA 731
                 K +D   RL  +           GL  LH       +HRD+  +NI ++     
Sbjct: 108 ------KVVDRKIRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGIC 158

Query: 732 KVSDFGLSR-----------------QAEEDLTHISSVARGTVGYLDPE-YYGNQQLTEK 773
           K++DFGL+R                 Q  E++T  S V   T+ Y  PE   G ++    
Sbjct: 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMT--SKVV--TLWYRAPELLMGAEKYHFA 214

Query: 774 SDVYSFGVVLLELISGK 790
            D++S G +  EL++GK
Sbjct: 215 VDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 71.6 bits (175), Expect = 3e-13
 Identities = 64/233 (27%), Positives = 109/233 (46%), Gaps = 42/233 (18%)

Query: 596 KKIGKGSFGSVYYGKMKDGKEV-AVKIM--------ADSCSHRTQQFVT---EVALLSRI 643
           K IG+G+FG V   KMK  + + A+KI+        A++   R ++ V    +   ++ +
Sbjct: 7   KVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTL 66

Query: 644 HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD----WLTRLQIAHDAA 699
           H+          ++E+   LV +Y   G L   L    ++ P D    ++  + +A  + 
Sbjct: 67  HYA--------FQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSI 118

Query: 700 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 759
             L Y         +HRD+K  N+LLD+N   +++DFG   +  +D T  SSVA GT  Y
Sbjct: 119 HQLHY---------VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDY 169

Query: 760 LDPEYY-----GNQQLTEKSDVYSFGVVLLELISGKKPVS----VEDFGAELN 803
           + PE       G  +   + D +S GV + E++ G+ P      VE +G  +N
Sbjct: 170 ISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 222

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 71.3 bits (175), Expect = 4e-13
 Identities = 68/231 (29%), Positives = 105/231 (45%), Gaps = 38/231 (16%)

Query: 596 KKIGKGSFGSVYYGKMKDGKEV-AVKIM---------ADSCSHRTQQFVTEVALLSRIHH 645
           K IG+G+FG V   KMK+  +V A+KI+           +C      F  E  +L     
Sbjct: 7   KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETAC------FREERDVLVNGDR 60

Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD----WLTRLQIAHDAAKG 701
           R +  L    ++E+   LV +Y   G L   L    ++ P D    +L  + +A D+   
Sbjct: 61  RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120

Query: 702 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 761
           L Y         +HRD+K  N+LLD N   +++DFG   +   D T  S+VA GT  Y+ 
Sbjct: 121 LGY---------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYIS 171

Query: 762 PEYY-----GNQQLTEKSDVYSFGVVLLELISGKKPV----SVEDFGAELN 803
           PE       G  +   + D +S GV + E++ G+ P      VE +G  +N
Sbjct: 172 PEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 222

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 70.1 bits (172), Expect = 5e-13
 Identities = 66/212 (31%), Positives = 106/212 (50%), Gaps = 31/212 (14%)

Query: 598 IGKGSFGSVYYGKMK---DGKEVAVKIMADSCSHRTQ-QFVTEVALLSR-IHHRNLVPLI 652
           +G+G++G V   KM+    G  +AVK +  + + + Q + + ++ +  R +     V   
Sbjct: 9   LGRGAYGVVD--KMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFY 66

Query: 653 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPL----DWLTRLQIAHDAAKGLEYLHTG 708
           G    E    +  E M   T  D+ +  V  K L    D L +  IA    K LEYLH+ 
Sbjct: 67  GALFREGDVWICMEVMD--TSLDKFYKKVYDKGLTIPEDILGK--IAVSIVKALEYLHSK 122

Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDPEY 764
            +  +IHRDVK SN+L++ N + K+ DFG+S         + SVA+    G   Y+ PE 
Sbjct: 123 LS--VIHRDVKPSNVLINRNGQVKLCDFGISGYL------VDSVAKTIDAGCKPYMAPER 174

Query: 765 Y---GNQQLTE-KSDVYSFGVVLLELISGKKP 792
                NQ+  + KSDV+S G+ ++EL +G+ P
Sbjct: 175 INPELNQKGYDVKSDVWSLGITMIELATGRFP 206

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 70.5 bits (173), Expect = 6e-13
 Identities = 59/218 (27%), Positives = 92/218 (42%), Gaps = 27/218 (12%)

Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA--------DSCSHRTQQFVTEVALLSRI 643
                +G+G FG V   + K   E+ A+K +         +  S   ++ + E A  +  
Sbjct: 2   RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETA--NSE 59

Query: 644 HHRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI-AHDAAKG 701
            H  LV L   C +    +  V EY   G L   +H  V  +P     R    A     G
Sbjct: 60  RHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP-----RAVFYAACVVLG 113

Query: 702 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGY 759
           L+YLH      I++RD+K  N+LLD     K++DFGL +   E +      +   GT  +
Sbjct: 114 LQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCK---EGMGFGDRTSTFCGTPEF 167

Query: 760 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 797
           L PE       T   D +  GV++ E++ G+ P   +D
Sbjct: 168 LAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD 205

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 70.4 bits (172), Expect = 7e-13
 Identities = 60/207 (28%), Positives = 95/207 (45%), Gaps = 12/207 (5%)

Query: 596 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVP 650
           K +GKGSFG V+  ++K   +  A+K +           +  + E  +LS    H  L  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 710
           L    + +     V EY++ G L    H     K  D       A +   GL++LH+   
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDLM--FHIQSCHK-FDLPRATFYAAEIICGLQFLHS--- 114

Query: 711 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 770
            GI++RD+K  NILLD +   K++DFG+ ++         +   GT  Y+ PE    Q+ 
Sbjct: 115 KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC-GTPDYIAPEILLGQKY 173

Query: 771 TEKSDVYSFGVVLLELISGKKPVSVED 797
               D +SFGV+L E++ G+ P    D
Sbjct: 174 NTSVDWWSFGVLLYEMLIGQSPFHGHD 200

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 69.6 bits (170), Expect = 7e-13
 Identities = 58/199 (29%), Positives = 94/199 (47%), Gaps = 10/199 (5%)

Query: 598 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQ---QFVTEVALLSRIHHRNLVPLIG 653
           +GKG FG V   +++  GK  A K +      + +     + E  +L +++ + +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67

Query: 654 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 713
             E +    LV   M+ G L+  ++   N    +    L  A +   GLE LH       
Sbjct: 68  AYETKDALCLVLTIMNGGDLKFHIYNMGNPG-FEEERALFYAAEILCGLEDLH---RENT 123

Query: 714 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 773
           ++RD+K  NILLD     ++SD GL+ +  E  +    V  GTVGY+ PE   NQ+ T  
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV--GTVGYMAPEVLNNQRYTLS 181

Query: 774 SDVYSFGVVLLELISGKKP 792
            D +  G ++ E+I G+ P
Sbjct: 182 PDYWGLGCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 71.0 bits (174), Expect = 8e-13
 Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 15/208 (7%)

Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQQ--FVTEVALLSRIHHRNL 648
           +  K IG+G+FG V   + K  K+V A+K+++      R+    F  E  +++  +   +
Sbjct: 46  DVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWI 105

Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           V L    +++    +V EYM  G L + +  S    P  W  R   A +    L+ +H  
Sbjct: 106 VQLHYAFQDDKYLYMVMEYMPGGDLVNLM--SNYDIPEKW-ARFYTA-EVVLALDAIH-- 159

Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
            + G IHRDVK  N+LLD +   K++DFG   + + +       A GT  Y+ PE   +Q
Sbjct: 160 -SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQ 218

Query: 769 ----QLTEKSDVYSFGVVLLELISGKKP 792
                   + D +S GV L E++ G  P
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 69.6 bits (170), Expect = 8e-13
 Identities = 63/231 (27%), Positives = 112/231 (48%), Gaps = 21/231 (9%)

Query: 596 KKIGKGSFGSVYYGKM----KDGKEVAVKIMADSC----SHRTQQFVTEVALLSRIHHRN 647
           K +G G++G V+  +       GK  A+K++  +     +  T+   TE  +L  I    
Sbjct: 6   KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 65

Query: 648 LVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI-AHDAAKGLEYL 705
            +  + Y  +   ++ L+ +Y++ G L   L      K       +QI + +    LE+L
Sbjct: 66  FLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKE----QEVQIYSGEIVLALEHL 121

Query: 706 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 765
           H     GII+RD+K  NILLD N    ++DFGLS++  ED    +    GT+ Y+ P+  
Sbjct: 122 H---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIV 178

Query: 766 --GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK 814
             G+    +  D +S GV++ EL++G  P +V+  G + +    +R ++K 
Sbjct: 179 RGGDGGHDKAVDWWSMGVLMYELLTGASPFTVD--GEKNSQAEISRRILKS 227

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 70.0 bits (171), Expect = 8e-13
 Identities = 62/225 (27%), Positives = 102/225 (45%), Gaps = 42/225 (18%)

Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMAD---------SCS---HRTQQFVTEVAL 639
           NF   +GKGSFG V   + K   E+ A+KI+            C+    R      +   
Sbjct: 3   NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPF 62

Query: 640 LSRIHHRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH-- 696
           L+++H          C +   R+  V EY++ G L  ++           + R +  H  
Sbjct: 63  LTQLHS---------CFQTMDRLYFVMEYVNGGDLMYQIQQ---------VGRFKEPHAV 104

Query: 697 ----DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV 752
               + A GL +LH+    GII+RD+K  N++LD     K++DFG+ ++   D     + 
Sbjct: 105 FYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTF 161

Query: 753 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 797
             GT  Y+ PE    Q   +  D ++FGV+L E+++G+ P   ED
Sbjct: 162 C-GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 205

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 70.0 bits (171), Expect = 9e-13
 Identities = 58/210 (27%), Positives = 112/210 (53%), Gaps = 24/210 (11%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKE----VAVKIMADSCSHRT-QQFVTEVALLSRIHHRNLV 649
           K +G G+FG+VY G  + +G++    VA+K + ++ S +  ++ + E  +++ + + ++ 
Sbjct: 13  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72

Query: 650 PLIGYCEEEHQRILVYEYMHNGTLRD--RLHGS--VNQKPLDWLTRLQIAHDAAKGLEYL 705
            L+G C     + L+ + M  G L D  R H     +Q  L+W  ++      AKG+ YL
Sbjct: 73  RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 125

Query: 706 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPE 763
                  ++HRD+ + N+L+      K++DFGL++   A+E   H     +  + ++  E
Sbjct: 126 E---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEG-GKVPIKWMALE 181

Query: 764 YYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
              ++  T +SDV+S+GV + EL++ G KP
Sbjct: 182 SILHRIYTHQSDVWSYGVTVWELMTFGSKP 211

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 69.4 bits (170), Expect = 9e-13
 Identities = 59/208 (28%), Positives = 106/208 (50%), Gaps = 20/208 (9%)

Query: 593 NFCK--KIGKGSFGSVYYGKMKD-GKEVAVK-IMADSCSHRT-QQFVTEVALLSRIHHRN 647
           NF K  KIG+G++G VY  + K  G+ VA+K I  D+ +       + E++LL  ++H N
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60

Query: 648 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEY 704
           +V L+     E++  LV+E++H       L   ++  PL  +    I        +GL +
Sbjct: 61  IVKLLDVIHTENKLYLVFEFLHQD-----LKKFMDASPLSGIPLPLIKSYLFQLLQGLAF 115

Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPE 763
            H+     ++HRD+K  N+L++     K++DFGL+R     + T+   V   T+ Y  PE
Sbjct: 116 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPE 170

Query: 764 -YYGNQQLTEKSDVYSFGVVLLELISGK 790
              G +  +   D++S G +  E+++ +
Sbjct: 171 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 69.8 bits (171), Expect = 1e-12
 Identities = 71/225 (31%), Positives = 99/225 (44%), Gaps = 29/225 (12%)

Query: 596 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVA----LLSRIHHRNLVP 650
           K IGKGSFG V   K K DGK  AVK++      + ++    +A    LL  + H  LV 
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 651 LIGYCEEEHQRILVYEYMHNGTL-----RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 705
           L    +   +   V +Y++ G L     R+R       +          A + A  L YL
Sbjct: 61  LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRAR--------FYAAEIASALGYL 112

Query: 706 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ--AEEDLTHISSVARGTVGYLDPE 763
           H+     II+RD+K  NILLD      ++DFGL ++       T   S   GT  YL PE
Sbjct: 113 HS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTT---STFCGTPEYLAPE 166

Query: 764 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL--NIVH 806
               Q      D +  G VL E++ G  P    D  AE+  NI++
Sbjct: 167 VLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT-AEMYDNILN 210

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 69.6 bits (170), Expect = 1e-12
 Identities = 71/220 (32%), Positives = 102/220 (46%), Gaps = 19/220 (8%)

Query: 596 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVT--EVALLSRIHHRNLVP 650
           K IGKGSFG V   K K DGK  AVK++      + + Q+ +      LL  + H  LV 
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 710
           L    +   +   V ++++ G L    H    +   +   R   A + A  L YLH+   
Sbjct: 61  LHYSFQTTEKLYFVLDFVNGGELF--FHLQRERSFPEPRARFYAA-EIASALGYLHS--- 114

Query: 711 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQ--AEEDLTHISSVARGTVGYLDPEYYGNQ 768
             I++RD+K  NILLD      ++DFGL ++  A+ D T   +   GT  YL PE    Q
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT---TTFCGTPEYLAPEVIRKQ 171

Query: 769 QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL--NIVH 806
                 D +  G VL E++ G  P    D  AE+  NI+H
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYGLPPFYCRDV-AEMYDNILH 210

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 68.9 bits (168), Expect = 1e-12
 Identities = 61/220 (27%), Positives = 103/220 (46%), Gaps = 25/220 (11%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVKI-----MADSCSHRTQQFVTEVALLSRIHHRNLV 649
           KKIG+G F  VY    + D K VA+K      M D+ +   Q  V E+ LL +++H N++
Sbjct: 8   KKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKAR--QDCVKEIDLLKQLNHPNVI 65

Query: 650 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD-----WLTRLQIAHDAAKGLEY 704
             +    E+++  +V E    G L   +     QK L      W   +Q+       +E+
Sbjct: 66  KYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLC----SAVEH 121

Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
           +H+     ++HRD+K +N+ +      K+ D GL R      T   S+  GT  Y+ PE 
Sbjct: 122 MHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 177

Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNI 804
                   KSD++S G +L E+ + + P     +G ++N+
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPF----YGDKMNL 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 69.0 bits (169), Expect = 1e-12
 Identities = 56/211 (26%), Positives = 105/211 (49%), Gaps = 19/211 (9%)

Query: 597 KIGKGSFGSVYYGKMKDGKE-VAVK-IMADSCSHRTQQF-VTEVALLSRIHHRNLVPLIG 653
           KIG+G++G+V+  K ++  E VA+K +  D          + E+ LL  + H+N+V L  
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66

Query: 654 YCEEEHQRILVYEYMHNGTLR--DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 711
               + +  LV+EY      +  D  +G ++ + +      Q+     KGL + H+    
Sbjct: 67  VLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFM-FQLL----KGLAFCHS---H 118

Query: 712 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYGNQQL 770
            ++HRD+K  N+L++ N   K++DFGL+R     +   S+    T+ Y  P+  +G +  
Sbjct: 119 NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLY 177

Query: 771 TEKSDVYSFGVVLLELISGKKPV----SVED 797
           +   D++S G +  EL +  +P+     V+D
Sbjct: 178 STSIDMWSAGCIFAELANAGRPLFPGNDVDD 208

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 59/218 (27%), Positives = 99/218 (45%), Gaps = 21/218 (9%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVK---IMADSCSHRTQQFVTEVALLSRIHHRNLVPL 651
           KKIG+G F  VY    + DG  VA+K   I     +      + E+ LL +++H N++  
Sbjct: 8   KKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 67

Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD-----WLTRLQIAHDAAKGLEYLH 706
                E+++  +V E    G L   +     QK L      W   +Q+       LE++H
Sbjct: 68  YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC----SALEHMH 123

Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 766
           +     ++HRD+K +N+ +      K+ D GL R      T   S+  GT  Y+ PE   
Sbjct: 124 S---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIH 179

Query: 767 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNI 804
                 KSD++S G +L E+ + + P     +G ++N+
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPF----YGDKMNL 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 68.9 bits (168), Expect = 2e-12
 Identities = 54/202 (26%), Positives = 103/202 (50%), Gaps = 12/202 (5%)

Query: 597 KIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 655
           ++G G+FG VY  K K+ G   A K++        + ++ E+ +L+  +H  +V L+G  
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 656 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 715
             + +  ++ E+   G + D +   +++     LT  QI     + LE L    +  IIH
Sbjct: 79  YWDGKLWIMIEFCPGGAV-DAIMLELDRG----LTEPQIQVICRQMLEALQYLHSMKIIH 133

Query: 716 RDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE--- 772
           RD+K+ N+LL ++   K++DFG+S +  + L    S   GT  ++ PE    + + +   
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-GTPYWMAPEVVMCETMKDTPY 192

Query: 773 --KSDVYSFGVVLLELISGKKP 792
             K+D++S G+ L+E+   + P
Sbjct: 193 DYKADIWSLGITLIEMAQIEPP 214

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 68.5 bits (168), Expect = 2e-12
 Identities = 58/213 (27%), Positives = 92/213 (43%), Gaps = 45/213 (21%)

Query: 597 KIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVT---EVALLSRI-HHRNLVPL 651
           KIG+G+F  V   +  K GK  A+K M        Q  V    E+  L R+  H N++ L
Sbjct: 6   KIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ--VNNLREIQALRRLSPHPNILRL 63

Query: 652 IGYC-EEEHQRI-LV--------YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 701
           I    + +  R+ LV        YE +     + R      ++   ++ +L       K 
Sbjct: 64  IEVLFDRKTGRLALVFELMDMNLYELI-----KGRKRPLPEKRVKSYMYQL------LKS 112

Query: 702 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 761
           L+++H     GI HRD+K  NIL+  +   K++DFG  R       +   ++  T  Y  
Sbjct: 113 LDHMHRN---GIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYIS--TRWYRA 166

Query: 762 PE------YYGNQQLTEKSDVYSFGVVLLELIS 788
           PE      YYG      K D+++ G V  E++S
Sbjct: 167 PECLLTDGYYG-----PKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 68.9 bits (168), Expect = 2e-12
 Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 21/211 (9%)

Query: 596 KKIGKGSFGSVYYGKMK-DGKEVAVKIM-------ADSCSHRTQQFVTEVALLSRIHHRN 647
           K +GKG+FG V   + K  G+  A+KI+        D  +H     VTE  +L    H  
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT----VTESRVLQNTRHPF 56

Query: 648 LVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           L  L  Y  + H R+  V EY + G L    H S  +   +   R   A +    LEYLH
Sbjct: 57  LTAL-KYAFQTHDRLCFVMEYANGGELF--FHLSRERVFTEERARFYGA-EIVSALEYLH 112

Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 766
           +     +++RD+K  N++LD +   K++DFGL ++   D   + +   GT  YL PE   
Sbjct: 113 S---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLE 168

Query: 767 NQQLTEKSDVYSFGVVLLELISGKKPVSVED 797
           +       D +  GVV+ E++ G+ P   +D
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 68.9 bits (168), Expect = 2e-12
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 30/216 (13%)

Query: 596 KKIGKGSFGSVYYGKMK-DGKEVAVKIMA-------DSCSHRTQQFVTEVALLSRIHHRN 647
           K +GKG+FG V   K K  G+  A+KI+        D  +H     +TE  +L    H  
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT----LTENRVLQNSRHPF 56

Query: 648 LVPLIGYCEEEHQRI-LVYEYMHNGTL-----RDRLHGSVNQKPLDWLTRLQIAHDAAKG 701
           L  L  Y  + H R+  V EY + G L     R+R+      +            +    
Sbjct: 57  LTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR--------FYGAEIVSA 107

Query: 702 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 761
           L+YLH+  N  +++RD+K  N++LD +   K++DFGL ++  +D   + +   GT  YL 
Sbjct: 108 LDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLA 164

Query: 762 PEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 797
           PE   +       D +  GVV+ E++ G+ P   +D
Sbjct: 165 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 200

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 68.1 bits (166), Expect = 2e-12
 Identities = 60/199 (30%), Positives = 94/199 (47%), Gaps = 10/199 (5%)

Query: 598 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQ---QFVTEVALLSRIHHRNLVPLIG 653
           +GKG FG V   +++  GK  A K +      + +     + E  +L +++ R +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67

Query: 654 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 713
             E +    LV   M+ G L+  ++   N    D    +  A +   GLE L       I
Sbjct: 68  AYETKDALCLVLTIMNGGDLKFHIYNMGNPG-FDEQRAIFYAAELCCGLEDLQ---RERI 123

Query: 714 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 773
           ++RD+K  NILLD     ++SD GL+ Q  E  T    V  GTVGY+ PE   N++ T  
Sbjct: 124 VYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV--GTVGYMAPEVINNEKYTFS 181

Query: 774 SDVYSFGVVLLELISGKKP 792
            D +  G ++ E+I G+ P
Sbjct: 182 PDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 67.7 bits (165), Expect = 3e-12
 Identities = 63/221 (28%), Positives = 116/221 (52%), Gaps = 28/221 (12%)

Query: 587 LEEATNNFCKKIGKGSFGSVYYGK-MKDGKE----VAVKIMADSCSHRT-QQFVTEVALL 640
           L+E      K +G G+FG+VY G  + DG+     VA+K++ ++ S +  ++ + E  ++
Sbjct: 4   LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVM 63

Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL-------RDRLHGSVNQKPLDWLTRLQ 693
           + +    +  L+G C     + LV + M  G L       +DR+ GS  Q  L+W  ++ 
Sbjct: 64  AGVGSPYVCRLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRI-GS--QDLLNWCVQI- 118

Query: 694 IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSV 752
                AKG+ YL       ++HRD+ + N+L+      K++DFGL+R  + D T   +  
Sbjct: 119 -----AKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADG 170

Query: 753 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
            +  + ++  E   +++ T +SDV+S+GV + EL++ G KP
Sbjct: 171 GKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKP 211

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 68.4 bits (167), Expect = 3e-12
 Identities = 81/324 (25%), Positives = 145/324 (44%), Gaps = 48/324 (14%)

Query: 596 KKIGKGSFGSVYYGKMK-DGKEVAVK-------IMAD--SCS---HRTQQFVTEVALLSR 642
           K +GKGSFG V   ++K  G+  AVK       ++ D   C+    R      E   L+ 
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 643 IHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGL 702
           ++         +  +EH    V E+++ G L   +    ++   D       A +   GL
Sbjct: 61  LY-------CTFQTKEHL-FFVMEFLNGGDLMFHIQ---DKGRFDLYRATFYAAEIVCGL 109

Query: 703 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDP 762
           ++LH+    GII+RD+K  N++LD +   K++DFG+ ++        S+   GT  Y+ P
Sbjct: 110 QFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-GTPDYIAP 165

Query: 763 EYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED----FGA-ELNIVHWARSMIKKG-D 816
           E     + T   D +SFGV+L E++ G+ P   +D    F +  ++  H+ R + K+  D
Sbjct: 166 EILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKD 225

Query: 817 VISIV---DPV----LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 869
           ++  +   DP     ++GN++    ++        +E+R    P  +  V +  D     
Sbjct: 226 ILEKLFERDPTRRLGVVGNIRGHPFFKTINWTA--LEKRELD-PPFKPKVKSPSDYSNF- 281

Query: 870 KGGDQKFSSSSSKGQSSRKTLLTS 893
              D++F S   +   S K L+ S
Sbjct: 282 ---DREFLSEKPRLSYSDKNLIDS 302

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 67.9 bits (166), Expect = 4e-12
 Identities = 65/217 (29%), Positives = 101/217 (46%), Gaps = 28/217 (12%)

Query: 596 KKIGKGSFGSVYYGKMKDGKE--VAVKIMADSCSHRTQ--QFVTEVALLSRIHHRNLVPL 651
           K I  G++G+VY  + K+ ++     KI   +   R Q  Q   E  +L+   +  +V +
Sbjct: 7   KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSM 66

Query: 652 IGYCEEEHQRIL--VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 709
             +C  E +R L  V EY+  G     L  ++   P+D + R+  A +    LEYLH   
Sbjct: 67  --FCSFETKRHLCMVMEYVEGGDCATLLK-NIGALPVD-MARMYFA-ETVLALEYLH--- 118

Query: 710 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT------HISSVAR--------G 755
           N GI+HRD+K  N+L+      K++DFGLS+     LT      HI    R        G
Sbjct: 119 NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCG 178

Query: 756 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           T  Y+ PE    Q   +  D ++ G++L E + G  P
Sbjct: 179 TPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 67.3 bits (165), Expect = 4e-12
 Identities = 61/212 (28%), Positives = 107/212 (50%), Gaps = 35/212 (16%)

Query: 597 KIGKGSFGSVYYGKMK-DGKEVAVK-IMAD-------SCSHRTQQFVTEVALLSRIHHRN 647
           KIG+G++G VY  + K  G+ VA+K I  +       S + R      E++LL  ++H N
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR------EISLLKELNHPN 59

Query: 648 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEY 704
           +V L+     E++  LV+E++        L   ++  PL  L    I    +   +G+ Y
Sbjct: 60  IVRLLDVVHSENKLYLVFEFLDLD-----LKKYMDSSPLTGLDPPLIKSYLYQLLQGIAY 114

Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL---THISSVARGTVGYLD 761
            H+     ++HRD+K  N+L+D     K++DFGL+R     +   TH   V   T+ Y  
Sbjct: 115 CHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH--EVV--TLWYRA 167

Query: 762 PE-YYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           PE   G++Q +   D++S G +  E+++ ++P
Sbjct: 168 PEILLGSRQYSTPVDIWSIGCIFAEMVN-RRP 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 67.0 bits (163), Expect = 9e-12
 Identities = 52/169 (30%), Positives = 84/169 (49%), Gaps = 14/169 (8%)

Query: 632 QFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR 691
           Q + E+ +L   +   +V   G    + +  +  E+M  G+L D++     + P + L +
Sbjct: 49  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKEAKRIPEEILGK 107

Query: 692 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 751
           + IA    +GL YL       I+HRDVK SNIL++     K+ DFG+S Q       I S
Sbjct: 108 VSIA--VLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL------IDS 157

Query: 752 VAR---GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 797
           +A    GT  Y+ PE       + +SD++S G+ L+EL  G+ P+   D
Sbjct: 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPD 206

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 67.2 bits (164), Expect = 9e-12
 Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 30/207 (14%)

Query: 598 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQ---FVTEVALLSRIHHRNLVPLIG 653
           +G GSFG V   K K  G+  A+K +      + +Q      E ++L  + H  +V ++ 
Sbjct: 26  LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85

Query: 654 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK--------GLEYL 705
             ++E++   + E++  G L   L     + P          +D AK          EYL
Sbjct: 86  SFQDENRVYFLLEFVVGGELFTHLR-KAGRFP----------NDVAKFYHAELVLAFEYL 134

Query: 706 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 765
           H   +  II+RD+K  N+LLD     KV+DFG +++  +    +     GT  YL PE  
Sbjct: 135 H---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLC----GTPEYLAPEVI 187

Query: 766 GNQQLTEKSDVYSFGVVLLELISGKKP 792
            ++   +  D ++ GV+L E I+G  P
Sbjct: 188 QSKGHGKAVDWWTMGVLLYEFIAGYPP 214

Length = 329

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 66.9 bits (163), Expect = 1e-11
 Identities = 58/214 (27%), Positives = 99/214 (46%), Gaps = 16/214 (7%)

Query: 591 TNNFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMADSC---SHRTQQFVTEVALLSRIHHR 646
             NF   +GKGSFG V   + K   E+ A+KI+           +  + E  +L+     
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60

Query: 647 NLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLE 703
             +  +  C +   R+  V EY++ G L   +   G   +        +  A + + GL 
Sbjct: 61  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEP-----QAVFYAAEISVGLF 115

Query: 704 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 763
           +LH     GII+RD+K  N++LD     K++DFG+ ++   D     +   GT  Y+ PE
Sbjct: 116 FLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFC-GTPDYIAPE 171

Query: 764 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 797
               Q   +  D +++GV+L E+++G+ P   ED
Sbjct: 172 IIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED 205

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 66.5 bits (162), Expect = 1e-11
 Identities = 65/214 (30%), Positives = 99/214 (46%), Gaps = 31/214 (14%)

Query: 597 KIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQ--------QFVTEVALLSRIH--- 644
           +IG G++G+VY  +    G  VA+K      S R Q          V EVALL R+    
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALK------SVRVQTNEDGLPLSTVREVALLKRLEAFD 60

Query: 645 HRNLVPLIGYC-----EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA 699
           H N+V L+  C     + E +  LV+E++ +  LR  L   V    L   T   +     
Sbjct: 61  HPNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLD-KVPPPGLPAETIKDLMRQFL 118

Query: 700 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 759
           +GL++LH  C   I+HRD+K  NIL+    + K++DFGL+R     +     V   T+ Y
Sbjct: 119 RGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV--TLWY 173

Query: 760 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPV 793
             PE           D++S G +  E+   +KP+
Sbjct: 174 RAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 66.2 bits (162), Expect = 1e-11
 Identities = 67/233 (28%), Positives = 104/233 (44%), Gaps = 25/233 (10%)

Query: 596 KKIGKGSFGSVYYGKMKDGKEV-AVK------IMADSCSHRTQQFVTEVALLSRIHHRNL 648
           K +GKGSFG V   ++K   E+ AVK      I+ D     T      +AL  +  H  L
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGK--HPFL 58

Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
             L    + + +   V EY++ G L   +         D       A +   GL++LH  
Sbjct: 59  TQLHSCFQTKDRLFFVMEYVNGGDLMFHIQ---RSGRFDEPRARFYAAEIVLGLQFLH-- 113

Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA--EEDLTHISSVARGTVGYLDPEYYG 766
              GII+RD+K  N+LLD     K++DFG+ ++       T   S   GT  Y+ PE   
Sbjct: 114 -ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT---STFCGTPDYIAPEILS 169

Query: 767 NQQLTEKSDVYSFGVVLLELISGKKPVSVED----FGAELNI-VHWARSMIKK 814
            Q      D ++ GV+L E+++G+ P   +D    F + L   V + R + K+
Sbjct: 170 YQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKE 222

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 53/202 (26%), Positives = 99/202 (49%), Gaps = 12/202 (5%)

Query: 597 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYC 655
           ++G G+FG VY  + K+   +A   + D+ S    + ++ E+ +L+   H N+V L+   
Sbjct: 12  ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 656 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 715
             E+   ++ E+   G + D +   + ++PL       +     + L YLH      IIH
Sbjct: 72  YYENNLWILIEFCAGGAV-DAVMLEL-ERPLTEPQIRVVCKQTLEALNYLH---ENKIIH 126

Query: 716 RDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY-----GNQQL 770
           RD+K+ NIL  ++   K++DFG+S +    +    S   GT  ++ PE        ++  
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDRPY 185

Query: 771 TEKSDVYSFGVVLLELISGKKP 792
             K+DV+S G+ L+E+   + P
Sbjct: 186 DYKADVWSLGITLIEMAQIEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 65.9 bits (161), Expect = 1e-11
 Identities = 58/205 (28%), Positives = 104/205 (50%), Gaps = 16/205 (7%)

Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVK-IMADSCSHRT-QQFVTEVALLSRIHHRNLVPLI 652
           +KIG+G++G VY G+ K  G+ VA+K I  +S         + E++LL  + H N+V L 
Sbjct: 6   EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQ 65

Query: 653 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 712
               +E +  L++E++ +  L+  L      + +D        +   +G+ + H+     
Sbjct: 66  DVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RR 121

Query: 713 IIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVGYLDPE-YYGNQ 768
           ++HRD+K  N+L+D     K++DFGL+R         TH   V   T+ Y  PE   G+ 
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTH--EVV--TLWYRAPEVLLGSP 177

Query: 769 QLTEKSDVYSFGVVLLELISGKKPV 793
           + +   D++S G +  E+ + KKP+
Sbjct: 178 RYSTPVDIWSIGTIFAEMAT-KKPL 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 65.2 bits (159), Expect = 2e-11
 Identities = 67/218 (30%), Positives = 108/218 (49%), Gaps = 33/218 (15%)

Query: 598 IGKGSFGSVYYGKMKD---------GKEVAVKI-MADSCSHRTQQFVTEVALLSRIHHRN 647
           +G+G+F ++Y G ++          G+EV+V + +  S    +  F    +L+S++ H++
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 648 LVPLIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           LV L G C  +E+  I+V EY+  G L   LH   N   L W   L +A   A  L YL 
Sbjct: 63  LVKLYGVCVRDEN--IMVEEYVKFGPLDVFLHREKNNVSLHWK--LDVAKQLASALHYLE 118

Query: 707 TGCNPGIIHRDVKSSNILL---DINMR----AKVSDFGLSRQAEEDLTHISSVARGTVGY 759
              +  ++H +V   NIL+    +N       K+SD G+       L+    V R  + +
Sbjct: 119 ---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITV---LSREERVER--IPW 170

Query: 760 LDPEYYGNQQ--LTEKSDVYSFGVVLLELIS-GKKPVS 794
           + PE   N Q  LT  +D +SFG  LLE+ S G++P+S
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLS 208

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 65.3 bits (159), Expect = 2e-11
 Identities = 64/208 (30%), Positives = 100/208 (48%), Gaps = 27/208 (12%)

Query: 598 IGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLV-----PL 651
           IG+G FG VY  +  D GK  A+K + D    + +Q  T +AL  RI   +LV     P 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCL-DKKRIKMKQGET-LALNERIM-LSLVSTGDCPF 58

Query: 652 I---GYCEEEHQRI-LVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYL 705
           I    Y      ++  + + M+ G L   L  HG  ++  + +      A +   GLE++
Sbjct: 59  IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFY-----AAEIILGLEHM 113

Query: 706 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 765
           H   N  +++RD+K +NILLD +   ++SD GL+    +   H S    GT GY+ PE  
Sbjct: 114 H---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVL 167

Query: 766 GNQQLTEKS-DVYSFGVVLLELISGKKP 792
                 + S D +S G +L +L+ G  P
Sbjct: 168 QKGVAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 66.2 bits (162), Expect = 2e-11
 Identities = 65/216 (30%), Positives = 106/216 (49%), Gaps = 36/216 (16%)

Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVT--EVALLSRIHHRNLVPLI 652
           K IG+G++G V   K  +  ++VA+K +A++  +R     T  E+ LL  + H N++ + 
Sbjct: 11  KPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIK 70

Query: 653 GYCEEEHQRI-----LVYEYMHNGTLRDRLHGSV--NQKPLD-----WLTRLQIAHDAAK 700
                 H+       +VYE M        LH  +  +Q   D     +L +L       +
Sbjct: 71  DIMPPPHREAFNDVYIVYELMDTD-----LHQIIRSSQTLSDDHCQYFLYQL------LR 119

Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS--VARGTVG 758
           GL+Y+H+     ++HRD+K SN+LL+ N   K+ DFGL+R   E    ++   V R    
Sbjct: 120 GLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTR---W 173

Query: 759 YLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPV 793
           Y  PE   N  + T   DV+S G +  EL+ G+KP+
Sbjct: 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 65.8 bits (161), Expect = 2e-11
 Identities = 64/213 (30%), Positives = 105/213 (49%), Gaps = 36/213 (16%)

Query: 597 KIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI- 652
            IG+G++G V     K  G +VA+K ++    H+T  Q+ + E+ +L R  H N++ ++ 
Sbjct: 12  YIGEGAYGMVCSATHKPTGVKVAIKKIS-PFEHQTFCQRTLREIKILRRFKHENIIGILD 70

Query: 653 ----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPL--DWLTRL--QIAHDAAKGLEY 704
                  E  +   +V E M        L+  +  + L  D +     QI     +GL+Y
Sbjct: 71  IIRPPSFESFNDVYIVQELMETD-----LYKLIKTQHLSNDHIQYFLYQIL----RGLKY 121

Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS------VARGTVG 758
           +H   N  ++HRD+K SN+LL+ N   K+ DFGL+R A  D  H  +      VA  T  
Sbjct: 122 IH-SAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIA--DPEHDHTGFLTEYVA--TRW 174

Query: 759 YLDPEYYGNQQLTEKS-DVYSFGVVLLELISGK 790
           Y  PE   N +   K+ D++S G +L E++S +
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 65.8 bits (160), Expect = 2e-11
 Identities = 52/169 (30%), Positives = 83/169 (49%), Gaps = 14/169 (8%)

Query: 632 QFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR 691
           Q + E+ +L   +   +V   G    + +  +  E+M  G+L D++     + P   L +
Sbjct: 49  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGK 107

Query: 692 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 751
           + IA    KGL YL       I+HRDVK SNIL++     K+ DFG+S Q       I S
Sbjct: 108 VSIA--VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL------IDS 157

Query: 752 VAR---GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 797
           +A    GT  Y+ PE       + +SD++S G+ L+E+  G+ P+   D
Sbjct: 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD 206

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 65.6 bits (160), Expect = 2e-11
 Identities = 65/244 (26%), Positives = 112/244 (45%), Gaps = 37/244 (15%)

Query: 596 KKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRTQQFVT----EVALLSRIHHRN 647
           K +GKG +G V+  +   G +     A+K++  +   R Q+       E  +L  + H  
Sbjct: 2   KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61

Query: 648 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGS---VNQKPLDWLTRLQIAHDAAKGLEY 704
           +V LI   +   +  L+ EY+  G L   L      +      +L+ + +A      LE+
Sbjct: 62  IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLA------LEH 115

Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA--EEDLTHISSVARGTVGYLDP 762
           LH     GII+RD+K  NILLD     K++DFGL +++  E  +TH      GT+ Y+ P
Sbjct: 116 LHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC---GTIEYMAP 169

Query: 763 EYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED--------FGAELNI----VHWARS 810
           E        +  D +S G ++ ++++G  P + E+           +LN+       AR 
Sbjct: 170 EILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARD 229

Query: 811 MIKK 814
           ++KK
Sbjct: 230 LLKK 233

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 65.2 bits (159), Expect = 2e-11
 Identities = 60/216 (27%), Positives = 105/216 (48%), Gaps = 23/216 (10%)

Query: 596 KKIGKGSFGSVYY----GKMKDGKEVAVKIMADSC---SHRTQQFV-TEVALLSRIHHRN 647
           + +G G++G V+     G    GK  A+K++  +      +T +   TE  +L  +    
Sbjct: 6   RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCP 65

Query: 648 -LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
            LV L    + + +  L+ +Y++ G L   L+   +    +   R+ IA +    L++LH
Sbjct: 66  FLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESE--VRVYIA-EIVLALDHLH 122

Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVGYLDPE 763
                GII+RD+K  NILLD      ++DFGLS++    EE+  +      GT+ Y+ PE
Sbjct: 123 ---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFC---GTIEYMAPE 176

Query: 764 YY--GNQQLTEKSDVYSFGVVLLELISGKKPVSVED 797
               G+    +  D +S GV+  EL++G  P +V+ 
Sbjct: 177 VIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDG 212

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 67.2 bits (164), Expect = 3e-11
 Identities = 34/81 (41%), Positives = 50/81 (61%), Gaps = 1/81 (1%)

Query: 406 LKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPSYMGSL 464
           L G IPP + +++ L  L L  N L+G +P++  +L +L I+HL +N  TG +P  + SL
Sbjct: 272 LSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSL 331

Query: 465 PNLQELHIENNSFVGEIPPAL 485
           P LQ L + +N F GEIP  L
Sbjct: 332 PRLQVLQLWSNKFSGEIPKNL 352

Length = 968

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 65.0 bits (158), Expect = 3e-11
 Identities = 52/201 (25%), Positives = 98/201 (48%), Gaps = 14/201 (6%)

Query: 598 IGKGSFGSV------YYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 651
           +GKG FG V        GKM   K++  K +      +    + E  +L +++   +V L
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMA--LLEKEILEKVNSPFIVNL 58

Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 711
               E +    LV   M+ G L+  ++ +V ++ L+    +  +     G+ +LH+    
Sbjct: 59  AYAFESKTHLCLVMSLMNGGDLKYHIY-NVGERGLEMERVIHYSAQITCGILHLHS---M 114

Query: 712 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 771
            I++RD+K  N+LLD     ++SD GL+ + ++  T I+  A GT GY+ PE    +  +
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT-ITQRA-GTNGYMAPEILKEEPYS 172

Query: 772 EKSDVYSFGVVLLELISGKKP 792
              D ++ G  + E+++G+ P
Sbjct: 173 YPVDWFAMGCSIYEMVAGRTP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 66.0 bits (161), Expect = 3e-11
 Identities = 41/111 (36%), Positives = 63/111 (56%), Gaps = 7/111 (6%)

Query: 685 PLDWLTRLQIAHDAAKGLEYLHT-GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 743
           PLD    L+ +   A+G+++L +  C    IHRDV + N+LL     AK+ DFGL+R   
Sbjct: 208 PLDLDDLLRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDIM 263

Query: 744 EDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
            D  + +   AR  V ++ PE   +   T +SDV+S+G++L E+ S GK P
Sbjct: 264 NDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 65.7 bits (160), Expect = 3e-11
 Identities = 58/210 (27%), Positives = 104/210 (49%), Gaps = 32/210 (15%)

Query: 596 KKIGKGSFGSVYYG-KMKDGKEVAVK-----IMADSCSHRTQQFVTEVALLSRIHHRNLV 649
           K++G G++G+V      + G +VA+K       ++  + R  +   E+ LL  + H N++
Sbjct: 21  KQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR---ELRLLKHMKHENVI 77

Query: 650 PLIGY------CEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKG 701
            L+         +  H   LV  +M  GT   +L  H  +++  + +L      +   KG
Sbjct: 78  GLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLV-----YQMLKG 130

Query: 702 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 761
           L+Y+H     GIIHRD+K  N+ ++ +   K+ DFGL+RQ + ++T        T  Y  
Sbjct: 131 LKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVV----TRWYRA 183

Query: 762 PEYYGN-QQLTEKSDVYSFGVVLLELISGK 790
           PE   N    T+  D++S G ++ E+++GK
Sbjct: 184 PEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 67.1 bits (163), Expect = 3e-11
 Identities = 68/237 (28%), Positives = 107/237 (45%), Gaps = 53/237 (22%)

Query: 596 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHR------TQQFVTEVALLSRIHHRNLV 649
           KKIG G FG V+  K K  +E        + S+R        Q V EV ++  + H+N+V
Sbjct: 19  KKIGNGRFGEVFLVKHKRTQEF---FCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIV 75

Query: 650 PLIG-YCEEEHQRI-LVYEYMHNGTLRD------RLHGSVNQKPLDWLTRLQIAHDAAKG 701
             I  +  + +Q++ ++ E+   G L        ++ G + +  +  +TR Q+ H     
Sbjct: 76  RYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITR-QLLH----A 130

Query: 702 LEYLHT---GCN-PGIIHRDVKSSNILLDINMR-----------------AKVSDFGLSR 740
           L Y H    G N   ++HRD+K  NI L   +R                 AK+ DFGLS+
Sbjct: 131 LAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK 190

Query: 741 QAEEDLTHISSVARGTVG---YLDPEY--YGNQQLTEKSDVYSFGVVLLELISGKKP 792
                   I S+A   VG   Y  PE   +  +   +KSD+++ G ++ EL SGK P
Sbjct: 191 N-----IGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242

Length = 1021

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 67.1 bits (164), Expect = 3e-11
 Identities = 59/233 (25%), Positives = 99/233 (42%), Gaps = 34/233 (14%)

Query: 596 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPL 651
           + IGKG  G VY        + VA+K + +  S      ++F+ E  + + + H  +VP+
Sbjct: 8   RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67

Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQ-----KPLDWLTR----LQIAHDAAKGL 702
              C +         Y+   TL+  L  SV Q     K L   T     L I H     +
Sbjct: 68  YSICSDGDPVYYTMPYIEGYTLKSLLK-SVWQKESLSKELAEKTSVGAFLSIFHKICATI 126

Query: 703 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG--LSRQAEEDLTHISSVAR------ 754
           EY+H+    G++HRD+K  NILL +     + D+G  + ++ EE+      V        
Sbjct: 127 EYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYS 183

Query: 755 ---------GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF 798
                    GT  Y+ PE       +E +D+Y+ GV+L ++++   P   +  
Sbjct: 184 SMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG 236

Length = 932

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 65.0 bits (159), Expect = 4e-11
 Identities = 58/232 (25%), Positives = 96/232 (41%), Gaps = 42/232 (18%)

Query: 596 KKIGKGSFGSVYYGKMKDGKEV-AVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPL 651
           K +GKG  G V+  ++K   ++ A+K++        ++ ++ +TE  +L+ + H  L  L
Sbjct: 7   KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66

Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK---GLEYLHTG 708
               + E    LV +Y   G     L   + ++P   L+       AA+    LEYLH  
Sbjct: 67  YASFQTETYLCLVMDYCPGG----ELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH-- 120

Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA----------------------EEDL 746
              GI++RD+K  NILL  +    +SDF LS+Q+                          
Sbjct: 121 -LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSE 179

Query: 747 THI-SSVAR-----GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           T       R     GT  Y+ PE           D ++ G++L E++ G  P
Sbjct: 180 TFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 64.9 bits (158), Expect = 4e-11
 Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 16/209 (7%)

Query: 596 KKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRTQQF---VTEVALLS-RIHHRNLVP 650
           K +GKGSFG V   ++K   EV A+K++      +       +TE  +L+    H  L  
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 710
           L    + + +   V EY++ G L  ++  S   +  D       A +    L +LH    
Sbjct: 61  LHCCFQTKDRLFFVMEYVNGGDLMFQIQRS---RKFDEPRSRFYAAEVTLALMFLHRH-- 115

Query: 711 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQ--AEEDLTHISSVARGTVGYLDPEYYGNQ 768
            G+I+RD+K  NILLD     K++DFG+ ++       T   +   GT  Y+ PE     
Sbjct: 116 -GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT---TTFCGTPDYIAPEILQEL 171

Query: 769 QLTEKSDVYSFGVVLLELISGKKPVSVED 797
           +     D ++ GV++ E+++G+ P   ++
Sbjct: 172 EYGPSVDWWALGVLMYEMMAGQPPFEADN 200

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 64.6 bits (158), Expect = 4e-11
 Identities = 56/207 (27%), Positives = 105/207 (50%), Gaps = 22/207 (10%)

Query: 597 KIGKGSFGSVYYGK-MKDGKEVAVK-IMADSCSHRTQQFVT---EVALLSRIHHRNLVPL 651
           +I +G++G VY  +  K G+ VA+K +  +    +    +T   E+ +L ++ H N+V +
Sbjct: 12  RIEEGTYGVVYRARDKKTGEIVALKKLKMEK--EKEGFPITSLREINILLKLQHPNIVTV 69

Query: 652 --IGYCEEEHQRILVYEYMHNG--TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
             +       +  +V EY+ +   +L + +     Q  +  L  LQ+      G+ +LH 
Sbjct: 70  KEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLM-LQLL----SGVAHLHD 124

Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYG 766
                I+HRD+K+SN+LL+     K+ DFGL+R+    L   + +   T+ Y  PE   G
Sbjct: 125 NW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-TLWYRAPELLLG 180

Query: 767 NQQLTEKSDVYSFGVVLLELISGKKPV 793
            ++ +   D++S G +  EL++ KKP+
Sbjct: 181 AKEYSTAIDMWSVGCIFAELLT-KKPL 206

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 65.0 bits (158), Expect = 6e-11
 Identities = 59/203 (29%), Positives = 97/203 (47%), Gaps = 20/203 (9%)

Query: 596 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 652
           K IG G+ G V        G  VAVK ++    ++T  ++   E+ LL  ++H+N++ L+
Sbjct: 27  KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 86

Query: 653 GY------CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
                    EE     LV E M +  L   +H  ++ + + +L    +      G+++LH
Sbjct: 87  NVFTPQKSLEEFQDVYLVMELM-DANLCQVIHMELDHERMSYLLYQMLC-----GIKHLH 140

Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 766
           +    GIIHRD+K SNI++  +   K+ DFGL+R A  +      V   T  Y  PE   
Sbjct: 141 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV--TRYYRAPEVIL 195

Query: 767 NQQLTEKSDVYSFGVVLLELISG 789
                E  D++S G ++ EL+ G
Sbjct: 196 GMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 63.9 bits (155), Expect = 6e-11
 Identities = 63/211 (29%), Positives = 100/211 (47%), Gaps = 33/211 (15%)

Query: 598 IGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI--GY 654
           IG+G FG VY  +  D GK  A+K + D    + +Q  T +AL  RI    ++ L+  G 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCL-DKKRIKMKQGET-LALNERI----MLSLVSTGD 55

Query: 655 C----------EEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGL 702
           C              +   + + M+ G L   L  HG  ++K + +      A +   GL
Sbjct: 56  CPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFY-----ATEIILGL 110

Query: 703 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDP 762
           E++H   N  +++RD+K +NILLD +   ++SD GL+    +   H S    GT GY+ P
Sbjct: 111 EHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAP 164

Query: 763 EYYGNQQLTEKS-DVYSFGVVLLELISGKKP 792
           E        + S D +S G +L +L+ G  P
Sbjct: 165 EVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 64.6 bits (157), Expect = 6e-11
 Identities = 69/268 (25%), Positives = 112/268 (41%), Gaps = 75/268 (27%)

Query: 596 KKIGKGSFGSVY------YGKMKDGKEVAVKIMADSCSHRTQQ-FVTEVALLSRI-HHRN 647
           K +G G+FG V         K      VAVK++ +  +    +  ++E+ +L  I +H N
Sbjct: 13  KVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLN 72

Query: 648 LVPLIGYCEEEHQRILV-YEYMHNGTL---------------------RDRLHGSVNQKP 685
           +V L+G C + +  ++V  E+   G L                     R R    V Q  
Sbjct: 73  VVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSR 132

Query: 686 LD--------------------------------WLTRLQI------AHDAAKGLEYLHT 707
           +D                                W + L +      +   A+G+E+L +
Sbjct: 133 VDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLAS 192

Query: 708 -GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSVARGTVGYLDPEYY 765
             C    IHRD+ + NILL  N   K+ DFGL+R   +D  ++    AR  + ++ PE  
Sbjct: 193 RKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESI 248

Query: 766 GNQQLTEKSDVYSFGVVLLELIS-GKKP 792
            ++  T +SDV+SFGV+L E+ S G  P
Sbjct: 249 FDKVYTTQSDVWSFGVLLWEIFSLGASP 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 64.3 bits (156), Expect = 9e-11
 Identities = 63/207 (30%), Positives = 107/207 (51%), Gaps = 30/207 (14%)

Query: 598 IGKGSFGSV---YYGKMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPL 651
           +G G++GSV   Y  +++  ++VAVK ++    S  H  + +  E+ LL  + H N++ L
Sbjct: 23  VGSGAYGSVCSAYDTRLR--QKVAVKKLSRPFQSLIHARRTY-RELRLLKHMKHENVIGL 79

Query: 652 IGY------CEEEHQRILVYEYMHNGTLRDRLHGSVN-QKPLDWLTRLQIAHDAAKGLEY 704
           +         E  ++  LV   M        L+  V  QK  D   +  I +   +GL+Y
Sbjct: 80  LDVFTPATSIENFNEVYLVTNLMGAD-----LNNIVKCQKLSDEHVQFLI-YQLLRGLKY 133

Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
           +H+    GIIHRD+K SN+ ++ +   ++ DFGL+RQA++++T    VA  T  Y  PE 
Sbjct: 134 IHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMT--GYVA--TRWYRAPEI 186

Query: 765 YGN-QQLTEKSDVYSFGVVLLELISGK 790
             N     +  D++S G ++ EL+ GK
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 63.5 bits (154), Expect = 1e-10
 Identities = 63/202 (31%), Positives = 91/202 (45%), Gaps = 12/202 (5%)

Query: 596 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEV-ALLSRIHHRNLVP 650
           K IGKGSFG V   + K + K  AVK++           +  ++E   LL  + H  LV 
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 710
           L    +   +   V +Y++ G L    H    +  L+   R   A + A  L YLH+   
Sbjct: 61  LHFSFQTADKLYFVLDYINGGELF--YHLQRERCFLEPRARFYAA-EIASALGYLHS--- 114

Query: 711 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 770
             I++RD+K  NILLD      ++DFGL ++  E     S+   GT  YL PE    Q  
Sbjct: 115 LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC-GTPEYLAPEVLHKQPY 173

Query: 771 TEKSDVYSFGVVLLELISGKKP 792
               D +  G VL E++ G  P
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 64.1 bits (156), Expect = 1e-10
 Identities = 65/223 (29%), Positives = 103/223 (46%), Gaps = 36/223 (16%)

Query: 598 IGKGSFGSVYYGK-MKDGKEVAVKI-----MADSCSHRTQQFVTEVALLSRIH------- 644
           +G G+ G+V   K + DG+  AVK+     M+++  +R Q    EV  L           
Sbjct: 40  LGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQ---AEVCCLLNCDFFSIVKC 96

Query: 645 HRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 703
           H +         E    I LV +Y + G LR  +             R    H+A  GL 
Sbjct: 97  HEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKT------NRTFREHEA--GLL 148

Query: 704 YL------HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--- 754
           ++      H   +  +IHRD+KS+NILL  N   K+ DFG S+     ++    V R   
Sbjct: 149 FIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVS--DDVGRTFC 206

Query: 755 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 797
           GT  Y+ PE +  +  ++K+D++S GV+L EL++ K+P   E+
Sbjct: 207 GTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN 249

Length = 496

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 62.7 bits (152), Expect = 2e-10
 Identities = 58/205 (28%), Positives = 100/205 (48%), Gaps = 24/205 (11%)

Query: 596 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVT-----EVALLSRIHHRNLV 649
           +K+G+GS+ +VY G  + +G+ VA+K++    S +T++ V      E +LL  + H N+V
Sbjct: 11  EKLGEGSYATVYKGISRINGQLVALKVI----SMKTEEGVPFTAIREASLLKGLKHANIV 66

Query: 650 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKP--LDWLTRLQIAHDAAKGLEYLHT 707
            L      +     V+EYMH       L   + Q P  L             +GL Y+H 
Sbjct: 67  LLHDIIHTKETLTFVFEYMHTD-----LAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH- 120

Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR-QAEEDLTHISSVARGTVGYLDPE-YY 765
                I+HRD+K  N+L+      K++DFGL+R ++    T+ S V   T+ Y  P+   
Sbjct: 121 --GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLL 176

Query: 766 GNQQLTEKSDVYSFGVVLLELISGK 790
           G    +   D++  G + +E++ G+
Sbjct: 177 GATDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 63.5 bits (154), Expect = 2e-10
 Identities = 58/203 (28%), Positives = 101/203 (49%), Gaps = 22/203 (10%)

Query: 598 IGKGSFGSVYYG-KMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLI- 652
           +G G++GSV      K G  VAVK ++    S  H  + +  E+ LL  + H N++ L+ 
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 83

Query: 653 ----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
                   EE   + +  ++    L + +     QK  D   +  I +   +GL+Y+H+ 
Sbjct: 84  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLI-YQILRGLKYIHSA 139

Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN- 767
               IIHRD+K SN+ ++ +   K+ DFGL+R  ++++T    VA  T  Y  PE   N 
Sbjct: 140 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVA--TRWYRAPEIMLNW 192

Query: 768 QQLTEKSDVYSFGVVLLELISGK 790
               +  D++S G ++ EL++G+
Sbjct: 193 MHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 63.4 bits (154), Expect = 2e-10
 Identities = 56/207 (27%), Positives = 102/207 (49%), Gaps = 27/207 (13%)

Query: 596 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRTQQFVT----EVALLSRIHHRNLVP 650
           K++G G++GSV      + G++VA+K +  S   +++ F      E+ LL  + H N++ 
Sbjct: 21  KQVGSGAYGSVCSAIDKRTGEKVAIKKL--SRPFQSEIFAKRAYRELTLLKHMQHENVIG 78

Query: 651 LIGY------CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 704
           L+         +E     LV  YM     +   H  +++  + +L      +    GL+Y
Sbjct: 79  LLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGH-PLSEDKVQYLV-----YQMLCGLKY 132

Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
           +H+    GIIHRD+K  N+ ++ +   K+ DFGL+R A+ ++T        T  Y  PE 
Sbjct: 133 IHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV----TRWYRAPEV 185

Query: 765 YGN-QQLTEKSDVYSFGVVLLELISGK 790
             N     +  D++S G ++ E+++GK
Sbjct: 186 ILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 62.7 bits (152), Expect = 2e-10
 Identities = 54/207 (26%), Positives = 98/207 (47%), Gaps = 20/207 (9%)

Query: 598 IGKGSFGSVYYGKMKDGKEV-AVKIMADSCSH--------RTQQFVTEVALLSRIHHRNL 648
           IG+GS+  V   ++K   ++ A+K++     H        +T++ V E A  +      L
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPF----L 58

Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           V L    +   +  LV EY++ G L    H    +K  +   R   A +    L +LH  
Sbjct: 59  VGLHSCFQTTSRLFLVIEYVNGGDLM--FHMQRQRKLPEEHARFYAA-EICIALNFLH-- 113

Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
              GII+RD+K  N+LLD +   K++D+G+ ++        S+   GT  Y+ PE    +
Sbjct: 114 -ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC-GTPNYIAPEILRGE 171

Query: 769 QLTEKSDVYSFGVVLLELISGKKPVSV 795
           +     D ++ GV++ E+++G+ P  +
Sbjct: 172 EYGFSVDWWALGVLMFEMMAGRSPFDI 198

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 63.1 bits (153), Expect = 2e-10
 Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 25/210 (11%)

Query: 596 KKIGKGSFGSVYYGKMKDGKEV-AVKIMAD-SCSHRTQQ--FVTEVALLSRIHHRNLVPL 651
           K IG+G+FG V   + K  ++V A+K+++      R+    F  E  +++  +   +V L
Sbjct: 49  KVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108

Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 711
               +++    +V EYM  G L + +  S    P  W  +   A +    L+ +H+    
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLVNLM--SNYDVPEKW-AKFYTA-EVVLALDAIHS---M 161

Query: 712 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-------- 763
           G+IHRDVK  N+LLD +   K++DFG   + +E        A GT  Y+ PE        
Sbjct: 162 GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGD 221

Query: 764 -YYGNQQLTEKSDVYSFGVVLLELISGKKP 792
            YYG +      D +S GV L E++ G  P
Sbjct: 222 GYYGRE-----CDWWSVGVFLFEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 62.6 bits (152), Expect = 2e-10
 Identities = 62/212 (29%), Positives = 98/212 (46%), Gaps = 23/212 (10%)

Query: 598 IGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRTQQF---VTEVALLSRIHHRN---LVP 650
           IGKG+FG VY  + KD + + A+K+++       ++    + E  +L R        +V 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    + +    LV +YM  G L   L   G  ++       +  IA +    LE+LH  
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDR----AKFYIA-ELVLALEHLHKY 115

Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ--AEEDLTHISSVARGTVGYLDPEYYG 766
               I++RD+K  NILLD      + DFGLS+    +   T+      GT  YL PE   
Sbjct: 116 ---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC---GTTEYLAPEVLL 169

Query: 767 NQQ-LTEKSDVYSFGVVLLELISGKKPVSVED 797
           +++  T+  D +S GV++ E+  G  P   ED
Sbjct: 170 DEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED 201

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 63.7 bits (155), Expect = 3e-10
 Identities = 36/100 (36%), Positives = 55/100 (55%), Gaps = 7/100 (7%)

Query: 393 PPRITKIA------LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRI 445
           P  +T +       L+   L G+IP EL  M++L  ++L  N L+G +P ++  L  L  
Sbjct: 181 PNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNH 240

Query: 446 VHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 485
           + L  N LTG +PS +G+L NLQ L +  N   G IPP++
Sbjct: 241 LDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSI 280

Length = 968

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 62.8 bits (153), Expect = 3e-10
 Identities = 68/272 (25%), Positives = 108/272 (39%), Gaps = 64/272 (23%)

Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFV---TEVALLSRIHHRNLVPL 651
           K IG+G+FG V   + KD G   A+K +  S     +Q      E  +L+   +  +V L
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKL 66

Query: 652 IGYC--EEEHQRILVYEYMHNG---TL---RDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 703
             Y   ++E+   L+ EY+  G   TL   +D              TR  IA +    ++
Sbjct: 67  --YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEE--------TRFYIA-ETILAID 115

Query: 704 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL--------SRQAEEDLTHISS---- 751
            +H     G IHRD+K  N+LLD     K+SDFGL          +    L+H       
Sbjct: 116 SIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFL 172

Query: 752 ----------------------VARGTVG---YLDPEYYGNQQLTEKSDVYSFGVVLLEL 786
                                 +A  TVG   Y+ PE +      ++ D +S GV++ E+
Sbjct: 173 DFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232

Query: 787 ISGKKP-VSVEDFGAELNIVHWARSMIKKGDV 817
           + G  P  S         I++W  ++    +V
Sbjct: 233 LVGYPPFCSDNPQETYRKIINWKETLQFPDEV 264

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 62.1 bits (151), Expect = 3e-10
 Identities = 59/232 (25%), Positives = 99/232 (42%), Gaps = 30/232 (12%)

Query: 598 IGKGSFGSVYYGKMKDGKEV-AVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIG 653
           +G+G FG V   + K   ++ A+K+M  S          F  E  +LS  +   +  L  
Sbjct: 9   VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQY 68

Query: 654 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD------WLTRLQIAHDAAKGLEYLHT 707
             +++    LV EY   G L   L  +  +   D      +L  L +A         +H+
Sbjct: 69  AFQDKDNLYLVMEYQPGGDLLSLL--NRYEDQFDEDMAQFYLAELVLA---------IHS 117

Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY--- 764
               G +HRD+K  N+L+D     K++DFG + +   +    S +  GT  Y+ PE    
Sbjct: 118 VHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTT 177

Query: 765 ---YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL--NIVHWARSM 811
               G      + D +S GV+  E+I G+ P   E   A+   NI+++ R +
Sbjct: 178 MNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH-EGTSAKTYNNIMNFQRFL 228

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 61.9 bits (150), Expect = 3e-10
 Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 19/208 (9%)

Query: 598 IGKGSFGSVYYGKMKDGKEV-AVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIG 653
           IGKGSFG V   + +D + + A+K +  +           + E  +L++++   +VPL  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 654 YCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 711
             +   +  LV  +++ G L   L   G  +        R   A +    LE LH     
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQREGRFDL----SRARFYTA-ELLCALENLHKF--- 112

Query: 712 GIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPEYYGNQQ 769
            +I+RD+K  NILLD      + DFGL +    ++D T+      GT  YL PE      
Sbjct: 113 NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC---GTPEYLAPELLLGHG 169

Query: 770 LTEKSDVYSFGVVLLELISGKKPVSVED 797
            T+  D ++ GV+L E+++G  P   E+
Sbjct: 170 YTKAVDWWTLGVLLYEMLTGLPPFYDEN 197

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 61.6 bits (149), Expect = 4e-10
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 24/204 (11%)

Query: 597 KIGKGSFGSVYYGKMK-DGKEVAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 654
           K+G+G++ +V+ G+ K     VA+K I  +         + EV+LL  + H N+V L   
Sbjct: 12  KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71

Query: 655 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA-------KGLEYLHT 707
              E    LV+EY+ +            ++ LD    L   H+         +GL Y H 
Sbjct: 72  IHTERCLTLVFEYLDSDL----------KQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH- 120

Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYG 766
                I+HRD+K  N+L++     K++DFGL+R A+   T   S    T+ Y  P+   G
Sbjct: 121 --KRKILHRDLKPQNLLINEKGELKLADFGLAR-AKSVPTKTYSNEVVTLWYRPPDVLLG 177

Query: 767 NQQLTEKSDVYSFGVVLLELISGK 790
           + + +   D++  G +L E+ +G+
Sbjct: 178 STEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 62.2 bits (151), Expect = 4e-10
 Identities = 38/97 (39%), Positives = 58/97 (59%), Gaps = 7/97 (7%)

Query: 699 AKGLEYLHT-GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSVARGT 756
           A+G+E+L +  C    IHRD+ + NILL  N   K+ DFGL+R   +D  ++    AR  
Sbjct: 183 ARGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238

Query: 757 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
           + ++ PE   ++  T +SDV+SFGV+L E+ S G  P
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 275

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 62.0 bits (151), Expect = 5e-10
 Identities = 65/212 (30%), Positives = 96/212 (45%), Gaps = 36/212 (16%)

Query: 596 KKIGKGSFGSV---YYGKMKDGKEVAVKIMADSCSHRTQQFVT-------EVALLSRIHH 645
           K IG G+ G V   Y      G+ VA+K ++     R  Q VT       E+ L+  ++H
Sbjct: 22  KPIGSGAQGIVCAAYD--TVTGQNVAIKKLS-----RPFQNVTHAKRAYRELVLMKLVNH 74

Query: 646 RNLVPLIGYCE-----EEHQRI-LVYEYM-HNGTLRDRLHGSVNQKPLDWLTRLQIAHDA 698
           +N++ L+         EE Q + LV E M  N      L   V Q  LD      + +  
Sbjct: 75  KNIIGLLNVFTPQKSLEEFQDVYLVMELMDAN------LC-QVIQMDLDHERMSYLLYQM 127

Query: 699 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG 758
             G+++LH   + GIIHRD+K SNI++  +   K+ DFGL+R A         V   T  
Sbjct: 128 LCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRY 182

Query: 759 YLDPEYYGNQQLTEKSDVYSFGVVLLELISGK 790
           Y  PE        E  D++S G ++ E+I G 
Sbjct: 183 YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 63.0 bits (153), Expect = 5e-10
 Identities = 49/162 (30%), Positives = 77/162 (47%), Gaps = 16/162 (9%)

Query: 585 PELEEATNNFCKKIGKGSFGSVYYG-KMKDGKEVAVKIMADS---CSHRTQQFVTEVALL 640
           P +EE      K I +G+FG VY G K  + K  AVK++  +     +   Q   E   L
Sbjct: 1   PSIEEFV--IVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDAL 58

Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDA 698
           +      +V L    +  +   LV EY+  G ++  LH  G  +++       ++   + 
Sbjct: 59  ALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEE-----MAVKYISEV 113

Query: 699 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 740
           A  L+YLH     GIIHRD+K  N+L+      K++DFGLS+
Sbjct: 114 ALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 62.7 bits (152), Expect = 5e-10
 Identities = 42/160 (26%), Positives = 83/160 (51%), Gaps = 5/160 (3%)

Query: 635 TEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQK-PLDWLTRLQ 693
           +E+  L+   H  +V      + + + +L+ EY   G L  ++   + +  P        
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGL 173

Query: 694 IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT-HISSV 752
           + +     L+ +H+     ++HRD+KS+NI L      K+ DFG S+Q  + ++  ++S 
Sbjct: 174 LFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS 230

Query: 753 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
             GT  YL PE +  ++ ++K+D++S GV+L EL++  +P
Sbjct: 231 FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270

Length = 478

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 61.3 bits (149), Expect = 8e-10
 Identities = 58/236 (24%), Positives = 103/236 (43%), Gaps = 45/236 (19%)

Query: 594 FCKKIGKGSFG---SVYYGKMKDGKEVAVKIMADSCSHR--TQQFVTEVALLSRIH-HRN 647
             K++G+G++G   S    +  + + VA+K + +  S +   ++ + E+ LL     H+N
Sbjct: 4   LIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKN 63

Query: 648 LVPLI--------GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH--- 696
           +  L          + E     + +YE +    L   +              L  AH   
Sbjct: 64  ITCLYDMDIVFPGNFNE-----LYLYEELMEADLHQIIRSGQ---------PLTDAHFQS 109

Query: 697 ---DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR----QAEEDLTHI 749
                  GL+Y+H+     ++HRD+K  N+L++ +   K+ DFGL+R       E+   +
Sbjct: 110 FIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM 166

Query: 750 SS-VARGTVGYLDPE-YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN 803
           +  VA  T  Y  PE     Q  T+  DV+S G +L EL+  K     +D+  +LN
Sbjct: 167 TEYVA--TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLN 220

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 61.4 bits (149), Expect = 9e-10
 Identities = 39/109 (35%), Positives = 58/109 (53%), Gaps = 5/109 (4%)

Query: 686 LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 745
           LD    L  ++  AKG+ +L    +   IHRD+ + NILL      K+ DFGL+R    D
Sbjct: 211 LDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267

Query: 746 LTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
             + +   AR  V ++ PE   N   T +SDV+S+G++L E+ S G  P
Sbjct: 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 60.8 bits (147), Expect = 1e-09
 Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 20/207 (9%)

Query: 598 IGKGSFGSVYYGKMKDGKEV-AVKIMADSCSH--------RTQQFVTEVALLSRIHHRNL 648
           IG+GS+  V   ++K  + + A+K++     +        +T++ V E A     +H  L
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA----SNHPFL 58

Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           V L    + E +   V EY++ G L    H    +K  +   R   A + +  L YLH  
Sbjct: 59  VGLHSCFQTESRLFFVIEYVNGGDLM--FHMQRQRKLPEEHARFYSA-EISLALNYLH-- 113

Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
              GII+RD+K  N+LLD     K++D+G+ ++        +S   GT  Y+ PE    +
Sbjct: 114 -ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDTTSTFCGTPNYIAPEILRGE 171

Query: 769 QLTEKSDVYSFGVVLLELISGKKPVSV 795
                 D ++ GV++ E+++G+ P  +
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPFDI 198

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 61.2 bits (148), Expect = 1e-09
 Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 25/210 (11%)

Query: 596 KKIGKGSFGSVYYGKMKDGKEV-AVKIMAD-SCSHRTQQ--FVTEVALLSRIHHRNLVPL 651
           K IG+G+FG V   + K  ++V A+K+++      R+    F  E  +++  +   +V L
Sbjct: 49  KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108

Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 711
               +++    +V EYM  G L + +  S    P  W  R   A +    L+ +H+    
Sbjct: 109 FYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKW-ARFYTA-EVVLALDAIHS---M 161

Query: 712 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-------- 763
           G IHRDVK  N+LLD +   K++DFG   +  ++       A GT  Y+ PE        
Sbjct: 162 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 221

Query: 764 -YYGNQQLTEKSDVYSFGVVLLELISGKKP 792
            YYG +      D +S GV L E++ G  P
Sbjct: 222 GYYGRE-----CDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 60.6 bits (147), Expect = 1e-09
 Identities = 64/210 (30%), Positives = 102/210 (48%), Gaps = 29/210 (13%)

Query: 598 IGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQ--QFVTEVALLSRIHHRNLVP---- 650
           IGKGS+G V        G++VA+K + D   H +   + + E+ LL  + H ++V     
Sbjct: 8   IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 67

Query: 651 LIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ---IAHDAAKGLEYLH 706
           ++     E + I +V+E M +      LH  +  K  D LT        +   + L+Y+H
Sbjct: 68  MLPPSRREFKDIYVVFELMESD-----LHQVI--KANDDLTPEHHQFFLYQLLRALKYIH 120

Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THI---SSVARGTVGYLDP 762
           T     + HRD+K  NIL + + + K+ DFGL+R A  D  T I     VA  T  Y  P
Sbjct: 121 TA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA--TRWYRAP 175

Query: 763 EYYGN--QQLTEKSDVYSFGVVLLELISGK 790
           E  G+   + T   D++S G +  E+++GK
Sbjct: 176 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 60.8 bits (147), Expect = 1e-09
 Identities = 39/97 (40%), Positives = 58/97 (59%), Gaps = 7/97 (7%)

Query: 699 AKGLEYLHT-GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSVARGT 756
           AKG+E+L +  C    IHRD+ + NILL  N   K+ DFGL+R   +D  ++    AR  
Sbjct: 189 AKGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244

Query: 757 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
           + ++ PE   ++  T +SDV+SFGV+L E+ S G  P
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 60.1 bits (145), Expect = 1e-09
 Identities = 53/211 (25%), Positives = 100/211 (47%), Gaps = 22/211 (10%)

Query: 597 KIGKGSFGSVYYGKMKDG---KEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL-- 651
           K+G+G++G VY  K KDG   KE A+K +  +    +     E+ALL  + H N++ L  
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQK 65

Query: 652 IGYCEEEHQRILVYEYMHNG---TLRDRLHGSVNQKPLDWLTRL--QIAHDAAKGLEYLH 706
           +     + +  L+++Y  +     ++       N+KP+     +   + +    G+ YLH
Sbjct: 66  VFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125

Query: 707 TGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAEEDLTHISSV--ARGTVGYL 760
                 ++HRD+K +NIL+        R K++D G +R     L  ++ +     T  Y 
Sbjct: 126 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182

Query: 761 DPE-YYGNQQLTEKSDVYSFGVVLLELISGK 790
            PE   G +  T+  D+++ G +  EL++ +
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 60.1 bits (145), Expect = 2e-09
 Identities = 53/204 (25%), Positives = 98/204 (48%), Gaps = 20/204 (9%)

Query: 596 KKIGKGSFGSV--YYGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPL 651
           K IG G+ G V   Y  + D + VA+K ++    ++T  ++   E+ L+  ++H+N++ L
Sbjct: 23  KPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 81

Query: 652 IGYCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           +         EE Q + +   + +  L   +   ++ + + +L    +      G+++LH
Sbjct: 82  LNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLH 136

Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 766
           +    GIIHRD+K SNI++  +   K+ DFGL+R A         V   T  Y  PE   
Sbjct: 137 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVIL 191

Query: 767 NQQLTEKSDVYSFGVVLLELISGK 790
                E  D++S G ++ E++  K
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 59.7 bits (145), Expect = 2e-09
 Identities = 60/241 (24%), Positives = 111/241 (46%), Gaps = 53/241 (21%)

Query: 597 KIGKGSFGSVYYGKMKDGKE-VAVK-IMADSCSHRTQQF----VTEVALLSRIHHRNLVP 650
           KIG+G+FG V+  + K  K+ VA+K ++ +   +  + F    + E+ +L  + H N+V 
Sbjct: 19  KIGQGTFGEVFKARHKKTKQIVALKKVLME---NEKEGFPITALREIKILQLLKHENVVN 75

Query: 651 LIGYCEEEHQR--------ILVYEYM-HNGTLRDRLHGSVNQKPLDW-LTRLQ-IAHDAA 699
           LI  C  +            LV+E+  H+      L G ++ K + + L+ ++ +     
Sbjct: 76  LIEICRTKATPYNRYKGSFYLVFEFCEHD------LAGLLSNKNVKFTLSEIKKVMKMLL 129

Query: 700 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR---QAEEDLTHISSVARGT 756
            GL Y+H      I+HRD+K++NIL+  +   K++DFGL+R    ++    +  +    T
Sbjct: 130 NGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVT 186

Query: 757 VGYLDPE-YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 815
           + Y  PE   G +      D++  G ++ E+                    W RS I +G
Sbjct: 187 LWYRPPELLLGERDYGPPIDMWGAGCIMAEM--------------------WTRSPIMQG 226

Query: 816 D 816
           +
Sbjct: 227 N 227

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 60.1 bits (145), Expect = 2e-09
 Identities = 53/204 (25%), Positives = 98/204 (48%), Gaps = 20/204 (9%)

Query: 596 KKIGKGSFGSV--YYGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPL 651
           K IG G+ G V   Y  + + + VA+K ++    ++T  ++   E+ L+  ++H+N++ L
Sbjct: 30  KPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88

Query: 652 IGYCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           +         EE Q + +   + +  L   +   ++ + + +L    +      G+++LH
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLH 143

Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 766
           +    GIIHRD+K SNI++  +   K+ DFGL+R A         V   T  Y  PE   
Sbjct: 144 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVIL 198

Query: 767 NQQLTEKSDVYSFGVVLLELISGK 790
                E  D++S G ++ E+I G 
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 59.6 bits (144), Expect = 2e-09
 Identities = 53/219 (24%), Positives = 99/219 (45%), Gaps = 32/219 (14%)

Query: 596 KKIGKGSFGSVYY----GKMKDGKEVAVKIMADSC---SHRTQQFV-TEVALLSRIHHRN 647
           K +G G++G V+          GK  A+K++  +      +T +   TE  +L  +    
Sbjct: 6   KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSP 65

Query: 648 LVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK------ 700
            +  + Y  +   ++ L+ +Y+  G +   L+            R   + D  +      
Sbjct: 66  FLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY-----------QRDNFSEDEVRFYSGEI 114

Query: 701 --GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG 758
              LE+LH     GI++RD+K  NILLD      ++DFGLS++   +    +    GT+ 
Sbjct: 115 ILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIE 171

Query: 759 YLDPEYYGNQQLTEKS-DVYSFGVVLLELISGKKPVSVE 796
           Y+ PE    +    K+ D +S G+++ EL++G  P ++E
Sbjct: 172 YMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE 210

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 59.8 bits (145), Expect = 2e-09
 Identities = 54/219 (24%), Positives = 96/219 (43%), Gaps = 37/219 (16%)

Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI-- 652
           + +G GS G V+     D  K VAVK +  +     +  + E+ ++ R+ H N+V +   
Sbjct: 11  RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEV 70

Query: 653 ----GYCEEEHQRIL--------VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 700
               G    E    L        V EYM        L   + Q PL         +   +
Sbjct: 71  LGPSGSDLTEDVGSLTELNSVYIVQEYMETD-----LANVLEQGPLSEEHARLFMYQLLR 125

Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEEDLTHISSVARGTVG- 758
           GL+Y+H+     ++HRD+K +N+ ++  ++  K+ DFGL+R  +   +H   ++ G V  
Sbjct: 126 GLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTK 182

Query: 759 -------YLDPEYYGNQQLTEKSDVYSFGVVLLELISGK 790
                   L P  Y     T+  D+++ G +  E+++GK
Sbjct: 183 WYRSPRLLLSPNNY-----TKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 59.1 bits (143), Expect = 3e-09
 Identities = 58/213 (27%), Positives = 102/213 (47%), Gaps = 37/213 (17%)

Query: 596 KKIGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHRTQQ--------FVTEVALLSRIHHR 646
           +KIG+G++G VY  + +   E +A+K +      R +Q         + E++LL  + H 
Sbjct: 8   EKIGEGTYGVVYKARDRVTNETIALKKI------RLEQEDEGVPSTAIREISLLKEMQHG 61

Query: 647 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA----HDAAKGL 702
           N+V L      E +  LV+EY     L   L   ++  P D+    ++     +   +G+
Sbjct: 62  NIVRLQDVVHSEKRLYLVFEY-----LDLDLKKHMDSSP-DFAKNPRLIKTYLYQILRGI 115

Query: 703 EYLHTGCNPGIIHRDVKSSNILLDINMRA-KVSDFGLSRQ---AEEDLTHISSVARGTVG 758
            Y H+     ++HRD+K  N+L+D    A K++DFGL+R         TH   V   T+ 
Sbjct: 116 AYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTH--EVV--TLW 168

Query: 759 YLDPE-YYGNQQLTEKSDVYSFGVVLLELISGK 790
           Y  PE   G++  +   D++S G +  E+++ K
Sbjct: 169 YRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 60.2 bits (146), Expect = 4e-09
 Identities = 35/85 (41%), Positives = 49/85 (57%), Gaps = 1/85 (1%)

Query: 399 IALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSL 457
           I L   NL GEIP E+  + +L  L L  N LTGP+P  +  L +L+ + L  N+L+G +
Sbjct: 217 IYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPI 276

Query: 458 PSYMGSLPNLQELHIENNSFVGEIP 482
           P  + SL  L  L + +NS  GEIP
Sbjct: 277 PPSIFSLQKLISLDLSDNSLSGEIP 301

Length = 968

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 58.9 bits (142), Expect = 4e-09
 Identities = 53/212 (25%), Positives = 101/212 (47%), Gaps = 24/212 (11%)

Query: 597 KIGKGSFGSVYYGKMKDG---KEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL-- 651
           K+G+G++G VY  K KDG   ++ A+K +  +    +     E+ALL  + H N++ L  
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQK 65

Query: 652 IGYCEEEHQRILVYEYMHNG---TLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYL 705
           +     + +  L+++Y  +     ++       N+KP+  L R  +    +    G+ YL
Sbjct: 66  VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQ-LPRGMVKSLLYQILDGIHYL 124

Query: 706 HTGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAEEDLTHISSV--ARGTVGY 759
           H      ++HRD+K +NIL+        R K++D G +R     L  ++ +     T  Y
Sbjct: 125 HANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181

Query: 760 LDPE-YYGNQQLTEKSDVYSFGVVLLELISGK 790
             PE   G +  T+  D+++ G +  EL++ +
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 58.5 bits (141), Expect = 5e-09
 Identities = 56/199 (28%), Positives = 96/199 (48%), Gaps = 14/199 (7%)

Query: 597 KIGKGSFGSVYYGKMKDGKE-VAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 654
           K+G+G++ +VY G+ K     VA+K I  +         + EV+LL  + H N+V L   
Sbjct: 13  KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 655 CEEEHQRILVYEYMHNGTLR--DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 712
              E    LV+EY+     +  D    S+N   +  L   Q+     +GL Y H      
Sbjct: 73  IHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVK-LFLFQLL----RGLNYCH---RRK 124

Query: 713 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYGNQQLT 771
           ++HRD+K  N+L++     K++DFGL+R A+   T   S    T+ Y  P+   G+   +
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYSNEVVTLWYRPPDILLGSTDYS 183

Query: 772 EKSDVYSFGVVLLELISGK 790
            + D++  G +  E+ +G+
Sbjct: 184 TQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 58.2 bits (141), Expect = 5e-09
 Identities = 53/209 (25%), Positives = 94/209 (44%), Gaps = 36/209 (17%)

Query: 597 KIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQ-------FVTEVALLSRIHHRNL 648
           K+G+GS+ +VY G+ K  G+ VA+K +      R +         + E +LL  + H N+
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEI------RLEHEEGAPFTAIREASLLKDLKHANI 65

Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA-------KG 701
           V L      +    LV+EY+      D       ++ +D        H+         +G
Sbjct: 66  VTLHDIIHTKKTLTLVFEYLD----TDL------KQYMDDCGGGLSMHNVRLFLFQLLRG 115

Query: 702 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 761
           L Y H      ++HRD+K  N+L+      K++DFGL+R A+   +   S    T+ Y  
Sbjct: 116 LAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLAR-AKSVPSKTYSNEVVTLWYRP 171

Query: 762 PE-YYGNQQLTEKSDVYSFGVVLLELISG 789
           P+   G+ + +   D++  G +  E+ +G
Sbjct: 172 PDVLLGSTEYSTSLDMWGVGCIFYEMATG 200

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 56.9 bits (137), Expect = 1e-08
 Identities = 55/201 (27%), Positives = 92/201 (45%), Gaps = 19/201 (9%)

Query: 598 IGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHRTQQFVT--EVALLSRIHHRNLVPLIGY 654
           +G+G++G V   + K+ KE VA+K   DS  +   +  T  E+ +L  +   N+V L   
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68

Query: 655 CEEEHQRILVYEYMHNGTLR---DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 711
                +  LV+EY+    L    +  +G   +K   ++ +L       K + + H     
Sbjct: 69  FRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQL------IKAIHWCHKN--- 119

Query: 712 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE--DLTHISSVARGTVGYLDPEYYGNQQ 769
            I+HRD+K  N+L+  N   K+ DFG +R   E  +  +   VA  T  Y  PE      
Sbjct: 120 DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVA--TRWYRSPELLLGAP 177

Query: 770 LTEKSDVYSFGVVLLELISGK 790
             +  D++S G +L EL  G+
Sbjct: 178 YGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 57.5 bits (139), Expect = 1e-08
 Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 24/206 (11%)

Query: 598 IGKGSFGSVYYGKMKDGKEV-AVKIMADSCSH--------RTQQFVTEVALLSRIHHRNL 648
           IG+GS+  V   ++K  + + A+K++     +        +T++ V E A     +H  L
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETA----SNHPFL 58

Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           V L    + E +   V E++  G L    H    +K  +   R   A + +  L +LH  
Sbjct: 59  VGLHSCFQTESRLFFVIEFVSGGDLM--FHMQRQRKLPEEHARFYSA-EISLALNFLHER 115

Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA--EEDLTHISSVARGTVGYLDPEYYG 766
              GII+RD+K  N+LLD     K++D+G+ ++     D T   S   GT  Y+ PE   
Sbjct: 116 ---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT---STFCGTPNYIAPEILR 169

Query: 767 NQQLTEKSDVYSFGVVLLELISGKKP 792
            +      D ++ GV++ E+++G+ P
Sbjct: 170 GEDYGFSVDWWALGVLMFEMMAGRSP 195

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 56.9 bits (137), Expect = 1e-08
 Identities = 54/200 (27%), Positives = 100/200 (50%), Gaps = 14/200 (7%)

Query: 596 KKIGKGSFGSVYYGKMKDGKE-VAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 653
           +K+G+G++ +V+ G+ K  +  VA+K I  +         + EV+LL  + H N+V L  
Sbjct: 12  EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71

Query: 654 YCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 711
               +    LV+EY+ +  L+  +   G++       +   QI     +GL Y H     
Sbjct: 72  IVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQIL----RGLAYCH---RR 123

Query: 712 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYGNQQL 770
            ++HRD+K  N+L++     K++DFGL+R A+   T   S    T+ Y  P+   G+ + 
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLAR-AKSVPTKTYSNEVVTLWYRPPDVLLGSSEY 182

Query: 771 TEKSDVYSFGVVLLELISGK 790
           + + D++  G +  E+ SG+
Sbjct: 183 STQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 56.9 bits (137), Expect = 2e-08
 Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 15/205 (7%)

Query: 593 NFCKKIGKGSFGSVYYGKMKDGK--EVAVKIMADSCSHRTQQ---FVTEVALLSRIHHRN 647
           NF + +G GSFG V     K+     VA+K    S   + +Q     +E  +L+ I+H  
Sbjct: 33  NFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPF 92

Query: 648 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
            V L G  ++E    LV E++  G     L  +  + P D       A       EYL +
Sbjct: 93  CVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRN-KRFPND--VGCFYAAQIVLIFEYLQS 149

Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 767
                I++RD+K  N+LLD +   K++DFG ++  +     +     GT  Y+ PE   N
Sbjct: 150 ---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLC----GTPEYIAPEILLN 202

Query: 768 QQLTEKSDVYSFGVVLLELISGKKP 792
               + +D ++ G+ + E++ G  P
Sbjct: 203 VGHGKAADWWTLGIFIYEILVGCPP 227

Length = 340

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 56.6 bits (137), Expect = 2e-08
 Identities = 53/216 (24%), Positives = 100/216 (46%), Gaps = 35/216 (16%)

Query: 597 KIGKGSFGSVYYG-KMKDGKEVAVKIMADS-----CSHRTQQFVTEVALLSRIHHRNLVP 650
            IG G++G V      + GK+VA+K +  +      + RT   + E+ +L    H N++ 
Sbjct: 12  NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRT---LRELKILRHFKHDNIIA 68

Query: 651 L--IGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRL---QIAHDAAKGLE 703
           +  I        +   +V + M +  L   +H   +Q   +   R    Q+     +GL+
Sbjct: 69  IRDILRPPGADFKDVYVVMDLMES-DLHHIIHS--DQPLTEEHIRYFLYQLL----RGLK 121

Query: 704 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA----EEDLTHISS-VARGTVG 758
           Y+H+     +IHRD+K SN+L++ +   ++ DFG++R       E    ++  VA  T  
Sbjct: 122 YIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA--TRW 176

Query: 759 YLDPE-YYGNQQLTEKSDVYSFGVVLLELISGKKPV 793
           Y  PE      + T   D++S G +  E++ G++ +
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 55.6 bits (134), Expect = 3e-08
 Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 17/213 (7%)

Query: 596 KKIGKGSFGSVYYGKMKDGKEVA---VKIMADSCSHRTQ-QFVTEVALLSRIHHRNLVPL 651
           ++IG G FG V   ++     VA   VK +  + S + Q +F+ +      + H N++  
Sbjct: 1   QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60

Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ-IAHDAAKGLEYLHTGCN 710
           +G C E    +LV+EY   G L+  L      +    L  LQ +A + A G+ ++H    
Sbjct: 61  LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---K 117

Query: 711 PGIIHRDVKSSNILLDINMRAKVSDFGLS-RQAEEDLTHISSVARGTVGYLDPEYYGNQQ 769
              +H D+   N  L  ++  KV D+G+   + +ED           + +L PE  G   
Sbjct: 118 HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFH 177

Query: 770 -------LTEKSDVYSFGVVLLELI-SGKKPVS 794
                   T+ S+V++ GV L EL  +  +P S
Sbjct: 178 GGLITAEQTKPSNVWALGVTLWELFENAAQPYS 210

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 57.0 bits (137), Expect = 3e-08
 Identities = 50/194 (25%), Positives = 85/194 (43%), Gaps = 24/194 (12%)

Query: 605 SVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLV--------PLIGYCE 656
           S   GK K  + +A ++ A S      Q   E+  L R++H N++            Y  
Sbjct: 184 STNQGKPKCERLIAKRVKAGS--RAAIQLENEILALGRLNHENILKIEEILRSEANTYMI 241

Query: 657 EEHQRILVYEYMHNGTL--RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 714
            +     +Y +M++     +DR        PL   TR  I       +EY+H   +  +I
Sbjct: 242 TQKYDFDLYSFMYDEAFDWKDR--------PLLKQTR-AIMKQLLCAVEYIH---DKKLI 289

Query: 715 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 774
           HRD+K  NI L+ + +  + DFG +   E++         GTV    PE        E +
Sbjct: 290 HRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEIT 349

Query: 775 DVYSFGVVLLELIS 788
           D++S G++LL+++S
Sbjct: 350 DIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 54.9 bits (133), Expect = 4e-08
 Identities = 41/145 (28%), Positives = 63/145 (43%), Gaps = 15/145 (10%)

Query: 662 ILVYEYMHNGTLRDRLHGSVNQKPLDW-LTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKS 720
           +L+ +Y+ +G L D L     +  L     +  I     + L  LH      IIH D+K 
Sbjct: 85  VLIMDYIKDGDLFDLLK---KEGKLSEAEVKK-IIRQLVEALNDLH---KHNIIHNDIKL 137

Query: 721 SNILLDINM-RAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSF 779
            N+L D    R  + D+GL +     +    S   GT+ Y  PE           D ++ 
Sbjct: 138 ENVLYDRAKDRIYLCDYGLCK-----IIGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAV 192

Query: 780 GVVLLELISGKKPVSVEDFGAELNI 804
           GV+  EL++GK P   ED   EL++
Sbjct: 193 GVLTYELLTGKHPF-KEDEDEELDL 216

Length = 267

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 56.4 bits (136), Expect = 6e-08
 Identities = 32/94 (34%), Positives = 51/94 (54%), Gaps = 1/94 (1%)

Query: 401 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPS 459
           LS  +L GEIP  +  ++ L  L L  N  TG +P  ++ L  L+++ L +N+ +G +P 
Sbjct: 291 LSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPK 350

Query: 460 YMGSLPNLQELHIENNSFVGEIPPALLTGKVIFK 493
            +G   NL  L +  N+  GEIP  L +   +FK
Sbjct: 351 NLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFK 384

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 56.4 bits (136), Expect = 6e-08
 Identities = 30/90 (33%), Positives = 51/90 (56%), Gaps = 1/90 (1%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNE 452
           P +  + LS   L GEIP ++ +  +L  L L GN L G +P  ++ L  L  + L +N+
Sbjct: 140 PNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQ 199

Query: 453 LTGSLPSYMGSLPNLQELHIENNSFVGEIP 482
           L G +P  +G + +L+ +++  N+  GEIP
Sbjct: 200 LVGQIPRELGQMKSLKWIYLGYNNLSGEIP 229

Length = 968

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 55.4 bits (133), Expect = 7e-08
 Identities = 54/200 (27%), Positives = 94/200 (47%), Gaps = 30/200 (15%)

Query: 671 GTLRDRLHGSVNQKP-LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM 729
            T RD L   +N+ P L ++  +  ++  A G+E+L    +   +HRD+ + N+L+    
Sbjct: 223 RTRRDTL---INESPALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGK 276

Query: 730 RAKVSDFGLSRQAEEDLTHISSVARGT----VGYLDPEYYGNQQLTEKSDVYSFGVVLLE 785
             K+ DFGL+R    D  +IS   +G+    + ++ PE   N   T  SDV+SFG++L E
Sbjct: 277 LVKICDFGLARDIMRDSNYIS---KGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWE 333

Query: 786 LIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQC 844
           + + G  P        EL +     + IK+G    +  P    +        I E+  +C
Sbjct: 334 IFTLGGTPYP------ELPMNEQFYNAIKRG--YRMAKPAHASD-------EIYEIMQKC 378

Query: 845 VEQRGFSRPKMQEIVLAIQD 864
            E++   RP   ++V  + D
Sbjct: 379 WEEKFEIRPDFSQLVHLVGD 398

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 54.8 bits (132), Expect = 7e-08
 Identities = 59/212 (27%), Positives = 102/212 (48%), Gaps = 28/212 (13%)

Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVKI----MADSCSHRTQQFVTEVALLSRIHHRN-LV 649
           +KIG+G++G VY  + K+ GK VA+K     M +     T   + E++LL  +     +V
Sbjct: 7   EKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTA--LREISLLQMLSESIYIV 64

Query: 650 PLIG--YCEEEHQRI---LVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGL 702
            L+   + EE++ +    LV+EY+ +  L+  +  +G    +PL   T     +   KG+
Sbjct: 65  RLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGV 123

Query: 703 EYLHTGCNPGIIHRDVKSSNILLD-INMRAKVSDFGLSRQAEEDL---THISSVARGTVG 758
            + H     G++HRD+K  N+L+D      K++D GL R     +   TH   V   T+ 
Sbjct: 124 AHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH-EIV---TLW 176

Query: 759 YLDPE-YYGNQQLTEKSDVYSFGVVLLELISG 789
           Y  PE   G+   +   D++S G +  E+   
Sbjct: 177 YRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 55.0 bits (132), Expect = 8e-08
 Identities = 36/108 (33%), Positives = 60/108 (55%), Gaps = 12/108 (11%)

Query: 686 LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 745
           L  L  L   +  A+G+E+L    +   +HRD+ + N+LL      K+ DFGL+R    D
Sbjct: 234 LTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLAR----D 286

Query: 746 LTHISS-VARGT----VGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
           + H S+ V++G+    V ++ PE   +   T  SDV+S+G++L E+ S
Sbjct: 287 IMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 54.1 bits (130), Expect = 9e-08
 Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 37/208 (17%)

Query: 613 DGKEVAVKIMADSCSHR--TQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 670
           +G+E+ V +     SHR     F    +L+S++ H +L  + G C    + I+V E++ +
Sbjct: 41  NGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEH 100

Query: 671 GTL-----RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL 725
           G L     +++        P+ W  ++ +A   A  L YL    +  ++H +V + NILL
Sbjct: 101 GPLDVCLRKEKGR-----VPVAW--KITVAQQLASALSYLE---DKNLVHGNVCAKNILL 150

Query: 726 DINMRA-------KVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYGNQQLTEKSDVY 777
                A       K+SD G+S  A   L+    V R  + ++ PE   G   L+  +D +
Sbjct: 151 ARLGLAEGTSPFIKLSDPGVSFTA---LSREERVER--IPWIAPECVPGGNSLSTAADKW 205

Query: 778 SFGVVLLEL-------ISGKKPVSVEDF 798
           SFG  LLE+       +  + P   E F
Sbjct: 206 SFGTTLLEICFDGEVPLKERTPSEKERF 233

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 54.5 bits (131), Expect = 1e-07
 Identities = 56/206 (27%), Positives = 87/206 (42%), Gaps = 39/206 (18%)

Query: 596 KKIGKGSFGSVYYGKMKDGKE--VAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL-- 651
           K +  GS G V+    K G+   V +KI     +      + E  LL  ++H +++ +  
Sbjct: 72  KTLTPGSEGRVFVAT-KPGQPDPVVLKIGQKGTT------LIEAMLLQNVNHPSVIRMKD 124

Query: 652 ------IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 705
                 I      H    +Y Y+   T R R        PL     L I     +GL YL
Sbjct: 125 TLVSGAITCMVLPHYSSDLYTYL---TKRSR--------PLPIDQALIIEKQILEGLRYL 173

Query: 706 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR---QAEEDLTHISSVARGTVGYLDP 762
           H      IIHRDVK+ NI ++   +  + D G ++    A   L     +A GTV    P
Sbjct: 174 HA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL----GLA-GTVETNAP 225

Query: 763 EYYGNQQLTEKSDVYSFGVVLLELIS 788
           E     +   K+D++S G+VL E+++
Sbjct: 226 EVLARDKYNSKADIWSAGIVLFEMLA 251

Length = 357

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 54.5 bits (131), Expect = 2e-07
 Identities = 30/92 (32%), Positives = 49/92 (53%), Gaps = 1/92 (1%)

Query: 395 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNEL 453
           R+  + LS     G +P +L ++  L +L L  N L+G +PD +S    L  + L +N+L
Sbjct: 476 RLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQL 535

Query: 454 TGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 485
           +G +P+    +P L +L +  N   GEIP  L
Sbjct: 536 SGQIPASFSEMPVLSQLDLSQNQLSGEIPKNL 567

Length = 968

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 53.4 bits (128), Expect = 2e-07
 Identities = 63/275 (22%), Positives = 107/275 (38%), Gaps = 42/275 (15%)

Query: 596 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL-IGY 654
           K IG G FG VY  +      +  + +A   +   +  V E  + + I+  + + L    
Sbjct: 18  KLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNI 77

Query: 655 CEEEHQRILVY---------EYMHNGTLRDRLHGSVNQ---------KPLDWLTRLQIAH 696
              +H  I  Y            +   L ++L  +  +         K L       I  
Sbjct: 78  HNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKL----IKNIMK 133

Query: 697 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS------ 750
           D    LEY+H     GI H D+K  NI++D N R  + D+G++        HI       
Sbjct: 134 DMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQK 190

Query: 751 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS 810
            + RGT+ Y   + +    +T + D+ S G  +L+       +  + FG   N++H A  
Sbjct: 191 DLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKW--AGIKLPWKGFGHNGNLIHAA-- 246

Query: 811 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCV 845
              K D I  +     G +KI++  +     I+CV
Sbjct: 247 ---KCDFIKRLHE---GKIKIKNANKFIYDFIECV 275

Length = 294

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 54.1 bits (130), Expect = 3e-07
 Identities = 30/87 (34%), Positives = 47/87 (54%), Gaps = 5/87 (5%)

Query: 401 LSGKNLKGEIPP-ELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLP 458
           LS  N  G IP   + N+E L    L  N L+G +P D+     L+++ L  N L G +P
Sbjct: 125 LSNNNFTGSIPRGSIPNLETLD---LSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIP 181

Query: 459 SYMGSLPNLQELHIENNSFVGEIPPAL 485
           + + +L +L+ L + +N  VG+IP  L
Sbjct: 182 NSLTNLTSLEFLTLASNQLVGQIPREL 208

Length = 968

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 53.1 bits (127), Expect = 3e-07
 Identities = 57/215 (26%), Positives = 100/215 (46%), Gaps = 32/215 (14%)

Query: 597 KIGKGSFGSVYYGKMKD----GKEVAVKIMADSCSHRTQQFVT--EVALLSRIH---HRN 647
           +IG+G++G V+  K +D    G+ VA+K +            T  EVA+L  +    H N
Sbjct: 8   EIGEGAYGKVF--KARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPN 65

Query: 648 LVPLIGYC-----EEEHQRILVYEYMHNG--TLRDRLH--GSVNQKPLDWLTRLQIAHDA 698
           +V L   C     + E +  LV+E++     T  D++   G   +   D + +L      
Sbjct: 66  VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL------ 119

Query: 699 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG 758
            +GL++LH+     ++HRD+K  NIL+  + + K++DFGL+R          +    T+ 
Sbjct: 120 LRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS--FQMALTSVVVTLW 174

Query: 759 YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPV 793
           Y  PE           D++S G +  E+   +KP+
Sbjct: 175 YRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 208

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 52.2 bits (125), Expect = 3e-07
 Identities = 50/178 (28%), Positives = 78/178 (43%), Gaps = 22/178 (12%)

Query: 647 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           N+V L  Y   E    LV ++   G L   +       P + + R   A +    L+ LH
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI-SKFLNIPEECVKRW--AAEMVVALDALH 102

Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE--DLTHISSVARGTVGYLDPEY 764
                GI+ RD+  +NILLD     +++ F    + E+  D   + ++      Y  PE 
Sbjct: 103 ---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YCAPEV 153

Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG----AELNIVHW----ARSMIKK 814
            G  + TE  D +S G +L EL++GK  V     G      LNI  W    ARS++++
Sbjct: 154 GGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVSEEARSLLQQ 211

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 53.7 bits (129), Expect = 4e-07
 Identities = 34/105 (32%), Positives = 50/105 (47%)

Query: 391 TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLEN 450
           T  P +  + +S  NL+G I     +M +L  L L  N   G LPD      L  + L  
Sbjct: 425 TKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSR 484

Query: 451 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYD 495
           N+ +G++P  +GSL  L +L +  N   GEIP  L + K +   D
Sbjct: 485 NQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLD 529

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 53.3 bits (128), Expect = 6e-07
 Identities = 34/87 (39%), Positives = 45/87 (51%), Gaps = 1/87 (1%)

Query: 396 ITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELT 454
           +T + LS  NL GEIP  L +   L +L L  N L G +P  +     LR V L++N  +
Sbjct: 358 LTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFS 417

Query: 455 GSLPSYMGSLPNLQELHIENNSFVGEI 481
           G LPS    LP +  L I NN+  G I
Sbjct: 418 GELPSEFTKLPLVYFLDISNNNLQGRI 444

Length = 968

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 51.8 bits (124), Expect = 1e-06
 Identities = 52/186 (27%), Positives = 81/186 (43%), Gaps = 23/186 (12%)

Query: 635 TEVALLSRIHHRNLVPLI-GYCEEEHQRILVYEYMHN-GTLRDRLHGSVNQKPLDWLTRL 692
            E+ +L  I HR ++ LI  Y  +    +++ +Y  +  T  DR        PL     +
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRS------GPLPLEQAI 188

Query: 693 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV 752
            I     + L YLH     GIIHRDVK+ NI LD    A + DFG + + +    H  + 
Sbjct: 189 TIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDA---HPDTP 242

Query: 753 A----RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV-HW 807
                 GT+    PE         K+D++S G+VL E+      +    FG ++      
Sbjct: 243 QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL----FGKQVKSSSSQ 298

Query: 808 ARSMIK 813
            RS+I+
Sbjct: 299 LRSIIR 304

Length = 392

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 50.7 bits (121), Expect = 1e-06
 Identities = 54/215 (25%), Positives = 95/215 (44%), Gaps = 41/215 (19%)

Query: 598 IGKGSFGSVYYGKMKD-----------GKEVAVKIMADSCSHR--TQQFVTEVALLSRIH 644
           +G+G+   +Y G +              KE+ V +     SHR  +  F    +++ ++ 
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 645 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 704
           H+++V L G C  + + I+V E++  G L   +H   +     W  + ++A   A  L Y
Sbjct: 63  HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASALSY 120

Query: 705 LHTGCNPGIIHRDVKSSNILL-------DINMRAKVSDFG-----LSRQAEEDLTHISSV 752
           L    +  ++H +V + NILL       +     K+SD G     LSRQ  E +  I  +
Sbjct: 121 LE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQ--ECVERIPWI 175

Query: 753 ARGTVGYLDPE-YYGNQQLTEKSDVYSFGVVLLEL 786
           A        PE    ++ L+  +D +SFG  L E+
Sbjct: 176 A--------PECVEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 52.0 bits (124), Expect = 1e-06
 Identities = 53/206 (25%), Positives = 91/206 (44%), Gaps = 26/206 (12%)

Query: 598 IGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 656
           IG GSFG VY     D  E VA+K +     ++ +    E+ ++  ++H N++ L  Y  
Sbjct: 74  IGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR----ELLIMKNLNHINIIFLKDYYY 129

Query: 657 EEHQRI--------LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
            E  +         +V E++     +   H + N   L        ++   + L Y+H+ 
Sbjct: 130 TECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK 189

Query: 709 CNPGIIHRDVKSSNILLDINMRA-KVSDFGLSRQ---AEEDLTHISSVARGTVGYLDPE- 763
               I HRD+K  N+L+D N    K+ DFG ++     +  +++I S       Y  PE 
Sbjct: 190 F---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF-----YRAPEL 241

Query: 764 YYGNQQLTEKSDVYSFGVVLLELISG 789
             G    T   D++S G ++ E+I G
Sbjct: 242 MLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 51.3 bits (123), Expect = 1e-06
 Identities = 42/166 (25%), Positives = 67/166 (40%), Gaps = 47/166 (28%)

Query: 689 LTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL---------- 738
           L R  IA +    +E +H     G IHRD+K  NIL+D +   K++DFGL          
Sbjct: 102 LARFYIA-ELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157

Query: 739 --------SRQ---------AEEDLTHISSVAR---------------GTVGYLDPEYYG 766
                    RQ         +E D   +  + R               GT  Y+ PE   
Sbjct: 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL 217

Query: 767 NQQLTEKSDVYSFGVVLLELISGKKPVSVED-FGAELNIVHWARSM 811
               T+  D +S GV+L E++ G+ P   +     +L +++W  ++
Sbjct: 218 RTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTL 263

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 51.2 bits (122), Expect = 1e-06
 Identities = 61/245 (24%), Positives = 96/245 (39%), Gaps = 56/245 (22%)

Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFV---TEVALLSRIHHRNLVPL 651
           K IG+G+FG V   + KD G   A+KI+  +     +Q      E  +L       +V +
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKM 66

Query: 652 IGYCEEEHQRILVYEYMHNGTL------RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 705
               +++    L+ E++  G +      +D L     Q    ++    +A DA   L   
Sbjct: 67  FYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQF---YIAETVLAIDAIHQL--- 120

Query: 706 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL--------------------------- 738
                 G IHRD+K  N+LLD     K+SDFGL                           
Sbjct: 121 ------GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174

Query: 739 ----SRQAEEDLTHISSVARGTVG---YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKK 791
                R+AE    +   +A  TVG   Y+ PE +      +  D +S GV++ E++ G  
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234

Query: 792 PVSVE 796
           P   E
Sbjct: 235 PFCSE 239

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 51.4 bits (123), Expect = 2e-06
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 13/99 (13%)

Query: 391 TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-------MSRLIDL 443
           T+ PR+  + L      GEIP  L     LT L L  N LTG +P+       + +LI  
Sbjct: 329 TSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLI-- 386

Query: 444 RIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIP 482
               L +N L G +P  +G+  +L+ + +++NSF GE+P
Sbjct: 387 ----LFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELP 421

Length = 968

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 50.7 bits (121), Expect = 2e-06
 Identities = 48/193 (24%), Positives = 91/193 (47%), Gaps = 22/193 (11%)

Query: 614 GKEVAVK-IMADSCSHRTQQFV-TEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 671
           G+ V V+ I  ++C++    F+  E+ +    +H N+VP       +++  +V  +M  G
Sbjct: 25  GEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYG 84

Query: 672 TLRDRLHGSVNQKPLDWLTRLQIAH---DAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN 728
           + +D +        +D ++ L IA+      K L+Y+H   + G +HR VK+S+IL+ ++
Sbjct: 85  SAKDLICTHF----MDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVD 137

Query: 729 ----MRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLDPEYYGN--QQLTEKSDVYSF 779
               +    S+  +    +  L  +    + +V    +L PE      Q    KSD+YS 
Sbjct: 138 GKVYLSGLRSNLSMINHGQR-LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSV 196

Query: 780 GVVLLELISGKKP 792
           G+   EL +G  P
Sbjct: 197 GITACELANGHVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 49.7 bits (118), Expect = 4e-06
 Identities = 59/239 (24%), Positives = 95/239 (39%), Gaps = 44/239 (18%)

Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQ---FVTEVALLSRIHHRNLVPL 651
           K IG+G+FG V   + KD G   A+KI+  +     +Q      E  +L       +V +
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKM 66

Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 711
               +++    L+ E++  G +   L         D LT  +     A+ +  + +    
Sbjct: 67  FYSFQDKLNLYLIMEFLPGGDMMTLLMKK------DTLTEEETQFYIAETVLAIDSIHQL 120

Query: 712 GIIHRDVKSSNILLDINMRAKVSDFGL-------------------------------SR 740
           G IHRD+K  N+LLD     K+SDFGL                                R
Sbjct: 121 GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180

Query: 741 QAEEDLTHISSVARGTVG---YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVE 796
           +AE    +   +A  TVG   Y+ PE +      +  D +S GV++ E++ G  P   E
Sbjct: 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 49.1 bits (117), Expect = 6e-06
 Identities = 63/258 (24%), Positives = 98/258 (37%), Gaps = 68/258 (26%)

Query: 596 KKIGKGSFGSV-YYGKMKDGKEVAVKIMADSCSHRTQQFV---TEVALLSRIHHRNLVPL 651
           K IGKG+FG V    K   GK  A+K +  S   +  Q      E  +L+      +V L
Sbjct: 7   KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66

Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDW------LTRLQIAHDAAKGLEYL 705
               ++     L+ E++  G L   L        + +      +TR  +A +    +E +
Sbjct: 67  YYSFQDAQYLYLIMEFLPGGDLMTML--------IKYDTFSEDVTRFYMA-ECVLAIEAV 117

Query: 706 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS---------------RQAEEDLTHIS 750
           H     G IHRD+K  NIL+D     K+SDFGLS                Q + +   I 
Sbjct: 118 H---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRID 174

Query: 751 S----------------------------VARGTVG---YLDPEYYGNQQLTEKSDVYSF 779
           +                            +A  TVG   Y+ PE +  Q   ++ D +S 
Sbjct: 175 NRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234

Query: 780 GVVLLELISGKKPVSVED 797
           G ++ E + G  P   E+
Sbjct: 235 GAIMFECLIGWPPFCSEN 252

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 49.1 bits (117), Expect = 1e-05
 Identities = 30/86 (34%), Positives = 47/86 (54%), Gaps = 1/86 (1%)

Query: 401 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPS 459
           L   N  G+IP  L ++  L  L L  N  +G +P ++ +  +L ++ L  N LTG +P 
Sbjct: 315 LFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPE 374

Query: 460 YMGSLPNLQELHIENNSFVGEIPPAL 485
            + S  NL +L + +NS  GEIP +L
Sbjct: 375 GLCSSGNLFKLILFSNSLEGEIPKSL 400

Length = 968

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 45.0 bits (106), Expect = 1e-04
 Identities = 57/212 (26%), Positives = 89/212 (41%), Gaps = 23/212 (10%)

Query: 597 KIGKG--SFGSVYYGK-MKDGKEVAVKIM-ADSCS-HRTQQFVTEVALLSRIHHRNLVPL 651
           +IG+G  +  SVY  +    G  V V+I   ++C+    +    EV L     H N++  
Sbjct: 5   EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTS 64

Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 711
                      ++  +M  G+    L     +   + L    I   A +GL YLH     
Sbjct: 65  WTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIG-NILFGALRGLNYLHQN--- 120

Query: 712 GIIHRDVKSSNILLDINMRAKVSDFGLSR--------QAEEDLTHISSVARGTVGYLDPE 763
           G IHR++K+S+IL  I+    VS  GLS         Q  + +      +   + +L PE
Sbjct: 121 GYIHRNIKASHIL--ISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPE 178

Query: 764 YYGNQQL---TEKSDVYSFGVVLLELISGKKP 792
               Q L     KSD+YS G+   EL +G+ P
Sbjct: 179 LL-RQDLYGYNVKSDIYSVGITACELATGRVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 44.6 bits (105), Expect = 1e-04
 Identities = 36/150 (24%), Positives = 61/150 (40%), Gaps = 53/150 (35%)

Query: 712 GIIHRDVKSSNILLDINMRAKVSDFGL--------------------------------- 738
           G IHRD+K  NIL+D++   K++DFGL                                 
Sbjct: 121 GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDV 180

Query: 739 ----------------SRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVV 782
                           ++Q +  L H S V  GT  Y+ PE    +  T+  D +S GV+
Sbjct: 181 SNCRCGDRLKTLEQRATKQHQRCLAH-SLV--GTPNYIAPEVLLRKGYTQLCDWWSVGVI 237

Query: 783 LLELISGKKP-VSVEDFGAELNIVHWARSM 811
           L E++ G+ P ++      +L +++W  ++
Sbjct: 238 LFEMLVGQPPFLAPTPTETQLKVINWENTL 267

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 44.2 bits (104), Expect = 2e-04
 Identities = 36/147 (24%), Positives = 58/147 (39%), Gaps = 47/147 (31%)

Query: 712 GIIHRDVKSSNILLDINMRAKVSDFGLS------------------RQAEEDLT------ 747
           G IHRD+K  NIL+D +   K++DFGL                   RQ   D +      
Sbjct: 121 GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDP 180

Query: 748 -------------------HISSVARGTVG---YLDPEYYGNQQLTEKSDVYSFGVVLLE 785
                              H   +A   VG   Y+ PE       T+  D +S GV+L E
Sbjct: 181 ANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 240

Query: 786 LISGKKP-VSVEDFGAELNIVHWARSM 811
           ++ G+ P ++      ++ +++W  S+
Sbjct: 241 MLVGQPPFLAQTPLETQMKVINWQTSL 267

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 44.2 bits (104), Expect = 2e-04
 Identities = 26/99 (26%), Positives = 43/99 (43%), Gaps = 3/99 (3%)

Query: 692 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 751
           L I     + ++YLH      IIHRD+K+ NI ++      + DFG +    +   +   
Sbjct: 185 LAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY 241

Query: 752 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGK 790
              GT+    PE           D++S G+VL E+ +  
Sbjct: 242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 41.6 bits (98), Expect = 3e-04
 Identities = 32/149 (21%), Positives = 54/149 (36%), Gaps = 17/149 (11%)

Query: 595 CKKIGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHRTQQFVTEVALLSRIHHRNL-VP-L 651
            K +  G    VY   +    E   +KI       +      EVA+L  +  + L VP +
Sbjct: 3   IKLLKGGLTNRVY--LLGTKDEDYVLKINPSR--EKGADREREVAILQLLARKGLPVPKV 58

Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 711
           +   E +    L+ E++   TL            +    +  IA   A+ L  LH     
Sbjct: 59  LASGESDGWSYLLMEWIEGETL----------DEVSEEEKEDIAEQLAELLAKLHQLPLL 108

Query: 712 GIIHRDVKSSNILLDINMRAKVSDFGLSR 740
            + H D+   NIL+D      + D+  + 
Sbjct: 109 VLCHGDLHPGNILVDDGKILGIIDWEYAG 137

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 42.6 bits (100), Expect = 7e-04
 Identities = 29/105 (27%), Positives = 48/105 (45%), Gaps = 8/105 (7%)

Query: 684 KPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 743
           +PL       +A      ++Y+H     GIIHRD+K+ N+L++      + DFG +  A 
Sbjct: 255 RPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFAR 311

Query: 744 EDLTHISSVARGTVGYLD---PEYYGNQQLTEKSDVYSFGVVLLE 785
              +  +    G  G +D   PE       T   D++S G+V+ E
Sbjct: 312 GSWS--TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 37.5 bits (88), Expect = 0.001
 Identities = 20/60 (33%), Positives = 30/60 (50%), Gaps = 3/60 (5%)

Query: 420 LTELWLDGNFLTGPLPDMS--RLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSF 477
           L  L L  N LT  +PD +   L +L+++ L  N LT   P     LP+L+ L +  N+ 
Sbjct: 2   LKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 41.0 bits (96), Expect = 0.002
 Identities = 28/89 (31%), Positives = 46/89 (51%), Gaps = 10/89 (11%)

Query: 594 FCKKIGKGSFGSVY------YGKMKDGKEVAVKIMADSCSHRTQQ--FVTEVALLSRI-H 644
           F K +G G+FG V        GK  +   VAVK M  + +H  ++   ++E+ +LS +  
Sbjct: 42  FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVK-MLKASAHTDEREALMSELKILSHLGQ 100

Query: 645 HRNLVPLIGYCEEEHQRILVYEYMHNGTL 673
           H+N+V L+G C      +++ EY   G L
Sbjct: 101 HKNIVNLLGACTHGGPVLVITEYCCYGDL 129

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 40.7 bits (95), Expect = 0.003
 Identities = 30/83 (36%), Positives = 46/83 (55%), Gaps = 2/83 (2%)

Query: 393 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 452
              +  + LSG N   ++PPE++ + AL EL L  N +   L  +S L +L  + L NN+
Sbjct: 185 LSNLNNLDLSG-NKISDLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNK 243

Query: 453 LTGSLPSYMGSLPNLQELHIENN 475
           L   LP  +G+L NL+ L + NN
Sbjct: 244 LE-DLPESIGNLSNLETLDLSNN 265

Length = 394

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	912
PLN03150	623	hypothetical protein; Provisional	100.0
PF12819	347	Malectin_like: Carbohydrate-binding protein of the	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.98
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.98
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.98
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.98
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.98
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.98
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.98
PHA03210	501	serine/threonine kinase US3; Provisional	99.98
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.98
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.98
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.98
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.98
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.98
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.98
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.98
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.98
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.98
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.98
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.98
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.98
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.98
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.98
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.98
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.98
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.98
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.98
PHA02882	294	putative serine/threonine kinase; Provisional	99.98
KOG0586	596	consensus Serine/threonine protein kinase [General	99.98
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.97
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.97
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.97
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.97
PLN00009	294	cyclin-dependent kinase A; Provisional	99.97
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.97
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.97
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.97
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.97
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.97
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.97
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.97
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.97
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.97
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.97
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.97
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.97
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.97
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.97
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.97
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.97
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.97
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.97
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.97
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.97
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.97
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.97
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.97
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.97
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.97
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.97
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.97
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.97
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.97
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.97
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.97
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.97
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.96
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.96
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.96
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.96
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.96
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.96
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.96
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.96
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.96
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.95
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.95
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.95
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.95
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.95
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.95
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.95
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.94
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.94
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.94
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.94
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.94
KOG1152	772	consensus Signal transduction serine/threonine kin	99.93
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.93
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.93
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.92
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.92
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.9
PLN00181	793	protein SPA1-RELATED; Provisional	99.89
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.89
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.87
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.86
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.85
PRK09188	365	serine/threonine protein kinase; Provisional	99.84
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.83
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.83
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.81
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.8
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.79
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.78
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.75
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.74
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.73
PRK12274	218	serine/threonine protein kinase; Provisional	99.73
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.72
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.69
PRK10345	210	hypothetical protein; Provisional	99.67
smart00090	237	RIO RIO-like kinase.	99.66
PRK14879	211	serine/threonine protein kinase; Provisional	99.63
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.62
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.61
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.6
PLN03150	623	hypothetical protein; Provisional	99.58
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.58
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.56
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.52
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.49
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.49
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.46
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.43
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.32
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.31
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.28
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.2
KOG1243	690	consensus Protein kinase [General function predict	99.18
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.16
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.14
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.13
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.06
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.0
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.98
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.9
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.89
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	98.88
KOG3087	229	consensus Serine/threonine protein kinase [General	98.85
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.78
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	98.77
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.73
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.68
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.62
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.61
KOG0472	565	consensus Leucine-rich repeat protein [Function un	98.59
COG4248	637	Uncharacterized protein with protein kinase and he	98.59
KOG0472	565	consensus Leucine-rich repeat protein [Function un	98.58
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.56
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	98.52
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.44
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.43
PRK09902	216	hypothetical protein; Provisional	98.43
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.43
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	98.39
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.37
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	98.34
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.24
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.24
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.22
PF11721	174	Malectin: Di-glucose binding within endoplasmic re	98.21
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	98.19
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	98.17
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	98.17
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.11
KOG4237	498	consensus Extracellular matrix protein slit, conta	98.11
KOG4237	498	consensus Extracellular matrix protein slit, conta	98.09
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	98.09
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	98.07
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	98.06
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.05
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	98.04
PF01636	239	APH: Phosphotransferase enzyme family This family	98.02
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	98.02
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.99
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.95
PLN03210	1153	Resistant to P. syringae 6; Provisional	97.92
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	97.89
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	97.82
PF12799	44	LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_	97.79
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.78
PF12799	44	LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_	97.75
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.73
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	97.72
PLN03210	1153	Resistant to P. syringae 6; Provisional	97.7
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	97.69
PLN02876	822	acyl-CoA dehydrogenase	97.65

>PLN03150 hypothetical protein; Provisional

Probab=100.00  E-value=7.7e-82  Score=753.44  Aligned_cols=521  Identities=24%  Similarity=0.407  Sum_probs=407.1

Q ss_pred             ccceEEeecCCCCCcccCCCCeEEecCCccccCCceeeecCCCCCccccceeecccC-CCCcceeeeeccCCceEEEEEE
Q 002529            3 KKEFISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVKVENPSGNWMQYRTRRDLPI-DNKKYCYNLITKERRRYLVRAT   81 (912)
Q Consensus         3 ~~~~~~idcg~~~~~~~~~~~~~~~~d~~~~~~g~~~~~~~~~~~~~~~~tlr~fp~-~~~~~cy~l~~~~~~~ylvr~~   81 (912)
                      +.++++||||++++++.+.+|++|++|..|+ .|....++.+....+++.|+|+||. .|++|||+||+++++|||||++
T Consensus        22 ~~~~~~I~CGs~~~~~~d~~~~~w~~D~~~~-~~~~~~~~~~~~~~~~~~t~R~F~~~~g~~~cY~~~~~~~g~ylVRl~  100 (623)
T PLN03150         22 EPFTMRISCGARVNVRTAPTNTLWYKDFAYT-GGIPANATRPSFIAPPLKTLRYFPLSDGPENCYNINRVPKGHYSVRVF  100 (623)
T ss_pred             CCccEEEeCCCCCCcccCCCCCEEcCCcccc-cCccccccCcccccchhhccccCCcccccccceEeeecCCCcEEEEEE
Confidence            5688999999998884336899999999985 4454444455556788999999996 5999999999999999999999


Q ss_pred             eeeCCCCCCCCCCcEEEEEcCceeEEEEec--CCccceEEEEEEEcCCCCcceeeeecCCCCceeeeeeeeccCCCCCcc
Q 002529           82 FQYGSLGSEASYPKFQLYLDATLWSTVTVL--DASRVYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYAT  159 (912)
Q Consensus        82 ~~yg~yd~~~~~p~fd~~~~~~~w~~v~~~--~~~~~~~~e~~~~~~~~~~~vcl~~~~~~~pfis~le~~~l~~~~y~~  159 (912)
                      |+|||||+++++|.|||++|||+|.+|...  ..+...++|+|+.+++++++|||+++++|+||||+||||||++++|..
T Consensus       101 F~~~~y~~~~~~~~Fdv~~~~~~~~tv~~~~~~~~~~v~~E~i~~~~~~~l~vcf~~~~~~~pFIs~iEv~~l~~~~y~~  180 (623)
T PLN03150        101 FGLVAEPNFDSEPLFDVSVEGTQISSLKSGWSSHDEQVFAEALVFLTDGSASICFHSTGHGDPAILSIEILQVDDKAYNF  180 (623)
T ss_pred             eecCCcCCCCCCCceEEEECcEEEEEEecCcccCCCcEEEEEEEEecCCcEEEEEecCCCCCCceeEEEEEEcCcccccc
Confidence            999999999999999999999999999753  234456789999999999999999999999999999999999999953


Q ss_pred             c--ccccceeEEEEeeccCCCCC-CcccCCCCCC--CCccccCCCCCCCcccccCCceeeecccccccC--CCCCCChhh
Q 002529          160 D--FEDNFFLKVAARVNFGALTK-DALRYPDDPY--DRIWDSDLDRRPNFVVGAASGTVRINTTKNIET--RTREYPPVK  232 (912)
Q Consensus       160 ~--~~~~~~~~~~~r~~~g~~~~-~~~ryp~D~~--dR~W~~~~~~~~~~~~~~~~~~~~i~~~~~i~~--~~~~~pP~~  232 (912)
                      .  .+.+.+|.++.|+|+|+.+. ..+|||||+|  ||+|.|+.+...       ..|..+++...|+.  ..++.+|+.
T Consensus       181 ~~~~~~~~~L~~~~R~n~G~~~~~~~~d~~~D~~~~dR~W~~d~~~~~-------~~~~~~st~~~I~~~~~~~~~~P~~  253 (623)
T PLN03150        181 GPSWGQGVILRTAKRLSCGAGKSKFDEDYSGDHWGGDRFWNRMQTFGS-------GSDQAISTENVIKKASNAPNFYPES  253 (623)
T ss_pred             cccccCceEEEEEEEEEecCcccccccCCCCCcccCccccCcCcccCC-------CcccccccccccccccCCCccChHH
Confidence            3  23466799999999998653 4699999999  999998754211       12334555555542  356778999


Q ss_pred             hhhcceecccc--eEEEeecCCCCCcCceEEEEeccccc-cCCCcceeEeeecCcccccCCceeeeeecCCCce-eeecc
Q 002529          233 VMQTAVVGTEG--VLSYRLNLEDFPANARAFAYFAEIQD-LGPSETRKFKLEQPYFADYSNAVVNIAENANGSY-TLYEP  308 (912)
Q Consensus       233 v~qtA~~~~~~--~~~~~~~~~~~~~~~~~~lyFae~~~-~~~~~~R~F~v~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  308 (912)
                      |||||.+..++  .+++.++. +.+..|+++|||||++. ....++|+|||+++.....+  .+++.....+.+ .++.-
T Consensus       254 VyqTA~~~~~~~~~lty~~~v-~~~~~Y~VrLhFaEi~~~~~~~~~R~F~V~ing~~~~~--~~di~~~~g~~~~~~~~~  330 (623)
T PLN03150        254 LYQSALVSTDTQPDLSYTMDV-DPNRNYSVWLHFAEIDNSITAEGKRVFDVLINGDTAFK--DVDIVKMSGERYTALVLN  330 (623)
T ss_pred             HhhhhccccCCCCceEEEeec-CCCCCEEEEEEEEeccCccCCCceEEEEEEECCEEeec--ccChhhhcCCcccceEEE
Confidence            99999877653  46666653 33467889999999984 56779999999766533222  233322221111 11110


Q ss_pred             ccceeeeeeEEEEEeeecCCCccccchhhhhheeeeeccccCCcchHHHHHHHHhhcCCCCCCCCCCCCCcCC--CCceE
Q 002529          309 SYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIAAKTEWQDVMVLEALRSISDESERTNDRGDPCVPV--PWEWV  386 (912)
Q Consensus       309 ~~~~~~~~~~~~~~l~~~~~s~l~P~in~~e~~~~~~~~~~t~~~d~~~l~~~~~~~~~~~~~~w~~dpC~~~--~w~~v  386 (912)
                      ...+++ .+.+++++.|+..+  +|+|||+|||++.+....|.+.|+.+|..+|+.+......+|++|||.|.  +|.|+
T Consensus       331 ~~v~~~-~g~l~isl~p~~~s--~pilNaiEI~~~~~~~~~t~~~~~~aL~~~k~~~~~~~~~~W~g~~C~p~~~~w~Gv  407 (623)
T PLN03150        331 KTVAVS-GRTLTIVLQPKKGT--HAIINAIEVFEIITAESKTLLEEVSALQTLKSSLGLPLRFGWNGDPCVPQQHPWSGA  407 (623)
T ss_pred             eEEeec-CCeEEEEEeeCCCC--cceeeeeeeeeccccccccCchHHHHHHHHHHhcCCcccCCCCCCCCCCcccccccc
Confidence            111222 36788999987655  79999999999999988999999999999998886544468999999875  79999


Q ss_pred             EEeCCC---CCcEEEEEcCCCCCcccCCcccccccccceeccccccCCCCCC-CcCCccccceeecccccccCCCCCcCC
Q 002529          387 TCSTTT---PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMG  462 (912)
Q Consensus       387 ~c~~~~---~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~  462 (912)
                      .|+...   ...|+.|+|++|+|.|.+|+.|++|++|+.|+|++|+|+|.+| .+++|++|+.|+|++|+|+|.+|++++
T Consensus       408 ~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~  487 (623)
T PLN03150        408 DCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLG  487 (623)
T ss_pred             eeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHh
Confidence            996432   1369999999999999999999999999999999999999998 599999999999999999999999999


Q ss_pred             CccccceeccccccCCCCCCccccC---CceeeeecCCCCCccc----ccc-cceeeeeeccchhhhHHHHHHHhhhhhe
Q 002529          463 SLPNLQELHIENNSFVGEIPPALLT---GKVIFKYDNNPKLHKE----SRR-RMRFKLILGTSIGVLAILLVLFLCSLIV  534 (912)
Q Consensus       463 ~l~~L~~L~l~~N~l~g~iP~~~~~---~~~~~~~~~Np~~c~~----~~~-~~~~~iii~~~i~~~~~ll~l~l~~~~~  534 (912)
                      +|++|+.|+|++|+|+|.+|..+..   ....+.+.+|+.+|+.    .|. +.....++++++++++++++++++.+++
T Consensus       488 ~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l~~C~~~~~~~~~i~~~~~~~~~~l~~~~~~~~~  567 (623)
T PLN03150        488 QLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACGPHLSVGAKIGIAFGVSVAFLFLVICAMCW  567 (623)
T ss_pred             cCCCCCEEECcCCcccccCChHHhhccccCceEEecCCccccCCCCCCCCcccCCCceEEEEEhHHHHHHHHHHHHHhhh
Confidence            9999999999999999999998765   3346788999999963    232 2233445555555554444444444333


Q ss_pred             eee
Q 002529          535 LRK  537 (912)
Q Consensus       535 ~~r  537 (912)
                      ++|
T Consensus       568 ~~~  570 (623)
T PLN03150        568 WKR  570 (623)
T ss_pred             eee
Confidence            333

>PF12819 Malectin_like: Carbohydrate-binding protein of the ER; InterPro: IPR024788 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan []

Probab=100.00  E-value=9.5e-63  Score=548.26  Aligned_cols=322  Identities=36%  Similarity=0.538  Sum_probs=256.3

Q ss_pred             eecCCCCC---cccCCCCeEEecCCccccCCceeeec-----CCCCCccccceeecccCCCCcceeeeecc--CCceEEE
Q 002529            9 IDCGSTSN---YTDPSTGLAWISDIGIMNNGKSVKVE-----NPSGNWMQYRTRRDLPIDNKKYCYNLITK--ERRRYLV   78 (912)
Q Consensus         9 idcg~~~~---~~~~~~~~~~~~d~~~~~~g~~~~~~-----~~~~~~~~~~tlr~fp~~~~~~cy~l~~~--~~~~ylv   78 (912)
                      ||||++.+   |+|+.||++|++|.+|+++|++++|+     ......+++.|+|+|| +|.||||+||+.  +|+||||
T Consensus         1 IdCG~~~~~s~y~D~~tg~~~~~D~~~~~~g~~~~i~~~~~~~~~~~~~~y~taR~F~-~g~r~cY~l~~~~~~~~~yli   79 (347)
T PF12819_consen    1 IDCGSSSNSSSYVDDSTGRTWVSDDDFIDTGKSGNISSQPDSSSSDSSPPYQTARIFP-EGSRNCYTLPVTPPGGGKYLI   79 (347)
T ss_pred             CcCCCCCCCcccccCCCCcEEeCCCCcccCCCccccccccCCcCCccccccceEEEcC-CCCccEEEeeccCCCCceEEE
Confidence            89997644   88999999999999999999999883     1234568899999999 777899999998  6779999


Q ss_pred             EEEeeeCCCCCCC-----CCCcEEEEEcCceeEEEEecCCc-cceEEE-EEEEcCCCCcceeeeecCCCC-ceeeeeeee
Q 002529           79 RATFQYGSLGSEA-----SYPKFQLYLDATLWSTVTVLDAS-RVYAKE-MIIRAPSDSIDVCICCAVTGS-PFISTLELR  150 (912)
Q Consensus        79 r~~~~yg~yd~~~-----~~p~fd~~~~~~~w~~v~~~~~~-~~~~~e-~~~~~~~~~~~vcl~~~~~~~-pfis~le~~  150 (912)
                      |+.|+||||||++     +||.|||++|++.|++|+..+.. ..+.+| +|+++++++++|||+++++|+ ||||+||||
T Consensus        80 Rl~F~~gnyd~~~fs~~~~~~~FdL~~~~n~~~tV~~~~~~~~~~~~E~ii~v~~~~~l~vclv~~~~g~~pFIsaiEl~  159 (347)
T PF12819_consen   80 RLHFYYGNYDGLNFSVSSSPPTFDLLLGFNFWSTVNLSNSPSSPVVKEFIINVTWSDTLSVCLVPTGSGTFPFISAIELR  159 (347)
T ss_pred             EEEeccccccccccccccCCcceEEEECCceeEEEEecCCCcceEEEEEEEEEcCCCcEEEEEEeCCCCCCCceeEEEEE
Confidence            9999999999874     47899999999999999987621 347789 566666899999999999999 999999999


Q ss_pred             ccCCCCCcc-cccccceeEEEEeeccCCCCCCcccCCCCCCCCccccCCCCCCCcccccCCceeeeccccccc---CCCC
Q 002529          151 PLNLSMYAT-DFEDNFFLKVAARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIE---TRTR  226 (912)
Q Consensus       151 ~l~~~~y~~-~~~~~~~~~~~~r~~~g~~~~~~~ryp~D~~dR~W~~~~~~~~~~~~~~~~~~~~i~~~~~i~---~~~~  226 (912)
                      ||++++|+. ....+.+|.++.|.|+|+.. ..+|||+|+|||+|+|+..         .+.|..++++.+|+   ...+
T Consensus       160 ~lp~~ly~~~~~~~s~~L~~~~R~n~G~~~-~~iryp~D~~dR~W~~~~~---------~~~~~~ist~~~i~~~~~~~~  229 (347)
T PF12819_consen  160 PLPDSLYPDTDANSSQALETVYRLNVGGSS-SFIRYPDDTYDRIWQPYSS---------SPGWSNISTTSNININSSNNP  229 (347)
T ss_pred             ECCccceeccccCCCceeEEEEeecCCCcc-cccCCCCCcceeecccccc---------CccccccccceeeecccCCcc
Confidence            999999952 23567889999999999854 3499999999999998621         23455667766665   2468


Q ss_pred             CCChhhhhhcceecccce--EEEeecCCCCCcCceEEEEeccccccC-CCcceeEeeecCcccccCCceeeeeecCCCce
Q 002529          227 EYPPVKVMQTAVVGTEGV--LSYRLNLEDFPANARAFAYFAEIQDLG-PSETRKFKLEQPYFADYSNAVVNIAENANGSY  303 (912)
Q Consensus       227 ~~pP~~v~qtA~~~~~~~--~~~~~~~~~~~~~~~~~lyFae~~~~~-~~~~R~F~v~~~~~~~~~~~~~~~~~~~~~~~  303 (912)
                      +.||.+|||||++..+.+  +.+.|...+...+||++|||||++.+. ..++|+|||.++.-..++ .+.+... .....
T Consensus       230 ~~~P~~V~~TA~~~~~~s~~~nltw~~~~~~~~y~v~lHFaEi~~~~~~~~~R~F~IyiN~~~~~~-~~~~~~~-~~~~~  307 (347)
T PF12819_consen  230 YDAPSAVYQTARTPSNSSDPLNLTWSFVDPGFSYYVRLHFAEIQSLSPNNNQREFDIYINGQTAYS-DVSPPYL-GADTV  307 (347)
T ss_pred             CcChHHHHHhhhcccccccceEEEeccCCCCccEEEEEEEeecccccCCCCeEEEEEEECCeEccC-ccCcccc-cCcce
Confidence            889999999999887665  888888855556889999999999975 444899999666544433 2222111 11122


Q ss_pred             eeeccccceeeeeeEEEEEeeecCCCccccchhhhhheee
Q 002529          304 TLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKY  343 (912)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~~~~s~l~P~in~~e~~~~  343 (912)
                      .+|......+...+.++++|.++..|+|||+|||+|||++
T Consensus       308 ~~~~d~~~~~~~~~~~~isL~~t~~S~lppiLNalEIy~v  347 (347)
T PF12819_consen  308 PYYSDYVVNVPDSGFLNISLGPTPDSTLPPILNALEIYKV  347 (347)
T ss_pred             EeecceEEEecCCCEEEEEEEeCCCCCcCceeEeeeeEeC
Confidence            3344444556566678899999999999999999999975

This entry represents a malectin-like domain found in a number of plant receptor kinases.

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.2e-50  Score=515.55  Aligned_cols=443  Identities=27%  Similarity=0.488  Sum_probs=308.9

Q ss_pred             CcEEEEEcCCCCCcccCCcccccccccceeccccccCCCCCC-CcCCccccceeecccccccCCCCCcCCCccccceecc
Q 002529          394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI  472 (912)
Q Consensus       394 ~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l  472 (912)
                      ++++.|+|++|++.|.+|..+.+|++|+.|+|++|.++|.+| .+.+|++|+.|+|++|+++|.+|..+.++++|+.|++
T Consensus       499 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l  578 (968)
T PLN00113        499 SELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNI  578 (968)
T ss_pred             hccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEec
Confidence            356677777777777777777777777777777777777777 4777777777777777777777777777777777777


Q ss_pred             ccccCCCCCCcccc-CCceeeeecCCCCCcccc-------ccc----ceeeeeeccchhhhHHHHHHHhhhhheeeeecc
Q 002529          473 ENNSFVGEIPPALL-TGKVIFKYDNNPKLHKES-------RRR----MRFKLILGTSIGVLAILLVLFLCSLIVLRKLRR  540 (912)
Q Consensus       473 ~~N~l~g~iP~~~~-~~~~~~~~~~Np~~c~~~-------~~~----~~~~iii~~~i~~~~~ll~l~l~~~~~~~r~r~  540 (912)
                      ++|+++|.+|..-. .......+.+|+.+|+..       |..    ....++++++++++++++++++ +++++++ ++
T Consensus       579 s~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~  656 (968)
T PLN00113        579 SHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAF-GFVFIRG-RN  656 (968)
T ss_pred             cCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccccceeeeehhHHHHHHHHHHHHHH-HHHHHHh-hh
Confidence            77777777775422 223344568899888532       211    1122233333332222222222 2222222 21


Q ss_pred             cccccccccccccccccCCCCCccceeccCCccccCCcccccChhHHHHHHHhhhcccCccccEEEEEEEec-CCCEEEE
Q 002529          541 KISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAV  619 (912)
Q Consensus       541 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAv  619 (912)
                      +.+. +..+....          .+..    .+........+.++++.. .+...+.||+|+||.||+|+.. +++.||+
T Consensus       657 ~~~~-~~~~~~~~----------~~~~----~~~~~~~~~~~~~~~~~~-~~~~~~~ig~G~~g~Vy~~~~~~~~~~vav  720 (968)
T PLN00113        657 NLEL-KRVENEDG----------TWEL----QFFDSKVSKSITINDILS-SLKEENVISRGKKGASYKGKSIKNGMQFVV  720 (968)
T ss_pred             cccc-cccccccc----------cccc----cccccccchhhhHHHHHh-hCCcccEEccCCCeeEEEEEECCCCcEEEE
Confidence            1111 10000000          0000    000001111223344432 2344678999999999999874 7899999


Q ss_pred             EEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 002529          620 KIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA  699 (912)
Q Consensus       620 K~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia  699 (912)
                      |+++.....    ..+|++.+++++||||++++++|.+.+..++||||+++|+|.++++      .++|.++.+++.|++
T Consensus       721 K~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~------~l~~~~~~~i~~~ia  790 (968)
T PLN00113        721 KEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR------NLSWERRRKIAIGIA  790 (968)
T ss_pred             EEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh------cCCHHHHHHHHHHHH
Confidence            998653221    2356889999999999999999999999999999999999999996      278999999999999


Q ss_pred             HHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccccccccccCCCcccCCCccCCCCCCchhHHHHH
Q 002529          700 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSF  779 (912)
Q Consensus       700 ~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSl  779 (912)
                      +||+|||..+..+|+||||||+||+++.++.+++. |+........     ....+++.|+|||++.+..++.++|||||
T Consensus       791 ~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~  864 (968)
T PLN00113        791 KALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCFISSAYVAPETRETKDITEKSDIYGF  864 (968)
T ss_pred             HHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----CCccccccccCcccccCCCCCcccchhhH
Confidence            99999996555899999999999999998888875 6554432211     12257899999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCC--CCHHHHHHHHHHHHhcccCCCCCCCCHHH
Q 002529          780 GVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN--VKIESIWRIAEVAIQCVEQRGFSRPKMQE  857 (912)
Q Consensus       780 Gvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~--~~~~~~~~l~~Li~~cL~~dP~~RPs~~e  857 (912)
                      ||++|||+||+.||. ...+....+.+|.+...........+|+.+...  ...++..++.+++.+||+.+|++||+|+|
T Consensus       865 Gvvl~el~tg~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~e  943 (968)
T PLN00113        865 GLILIELLTGKSPAD-AEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCAND  943 (968)
T ss_pred             HHHHHHHHhCCCCCC-cccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHH
Confidence            999999999999996 333344567777776665555666677766443  34566778999999999999999999999


Q ss_pred             HHHHHhhhhhhccC
Q 002529          858 IVLAIQDSIKIEKG  871 (912)
Q Consensus       858 vl~~L~~~~~~~~~  871 (912)
                      |++.|+++......
T Consensus       944 vl~~L~~~~~~~~~  957 (968)
T PLN00113        944 VLKTLESASRSSSS  957 (968)
T ss_pred             HHHHHHHhhccccc
Confidence            99999988765443

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-47  Score=428.01  Aligned_cols=288  Identities=49%  Similarity=0.840  Sum_probs=253.1

Q ss_pred             ccccChhHHHHHHHhhh--cccCccccEEEEEEEecCCCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEe
Q 002529          579 AYFIPLPELEEATNNFC--KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE  656 (912)
Q Consensus       579 ~~~~~~~~l~~~~~~~~--~~LG~G~fg~Vy~a~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~  656 (912)
                      ...+++.+|..+|.+|.  +.||+|+||.||+|.+.+++.||||++........++|.+|++++.+++|||+|+|+|||.
T Consensus        62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~  141 (361)
T KOG1187|consen   62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCL  141 (361)
T ss_pred             cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEe
Confidence            44577999999999996  7999999999999999999999999887644321456999999999999999999999999


Q ss_pred             cCC-eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEee
Q 002529          657 EEH-QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSD  735 (912)
Q Consensus       657 ~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~D  735 (912)
                      +.+ +.+||+|||++|+|.++|+..... .++|.++++|+.++|+||+|||+.+...|+|||||++|||+|+++++||+|
T Consensus       142 e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD  220 (361)
T KOG1187|consen  142 EGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD  220 (361)
T ss_pred             cCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence            988 599999999999999999975433 899999999999999999999998888999999999999999999999999


Q ss_pred             ccCcccccc-ccccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhcc
Q 002529          736 FGLSRQAEE-DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK  814 (912)
Q Consensus       736 FGla~~~~~-~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~  814 (912)
                      ||+|+.... ........ .||.+|+|||++..+..+.|+||||||++|+||+||+.+.+.........+.+|+...+.+
T Consensus       221 FGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~  299 (361)
T KOG1187|consen  221 FGLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE  299 (361)
T ss_pred             ccCcccCCccccceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence            999976654 22211111 6999999999999999999999999999999999999998754434556699999999999


Q ss_pred             CCcccccCcccc-CCCCH-HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhhhhh
Q 002529          815 GDVISIVDPVLI-GNVKI-ESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI  868 (912)
Q Consensus       815 ~~~~~~~d~~l~-~~~~~-~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~~~~  868 (912)
                      +.+.+++|+.+. +.++. +++..+.+++.+|++.+|.+||+|.||+++|+.+...
T Consensus       300 ~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~  355 (361)
T KOG1187|consen  300 GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL  355 (361)
T ss_pred             cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence            999999999987 66664 6888999999999999999999999999999665554

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-43  Score=371.69  Aligned_cols=252  Identities=27%  Similarity=0.387  Sum_probs=211.7

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCc-cchhhHHHHHHHHHHHhcCCCCccceeeEEecCC-eEEEEEEec
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS-CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH-QRILVYEYM  668 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~-~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~-~~~lV~E~~  668 (912)
                      .+..+.||+|..|+||+++++ +++.+|+|.+... .....+++.+|+++++..+||+||.++|.|..+. ...|+||||
T Consensus        81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM  160 (364)
T KOG0581|consen   81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM  160 (364)
T ss_pred             hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence            345678999999999999998 6889999999543 3455689999999999999999999999999988 599999999


Q ss_pred             CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccc
Q 002529          669 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH  748 (912)
Q Consensus       669 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  748 (912)
                      ++|+|.+++..   .+++++..+.+|+.++++||.|||+  .++||||||||+|||++..|++||||||.+....+.   
T Consensus       161 DgGSLd~~~k~---~g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---  232 (364)
T KOG0581|consen  161 DGGSLDDILKR---VGRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---  232 (364)
T ss_pred             CCCCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence            99999999984   4789999999999999999999996  399999999999999999999999999999887654   


Q ss_pred             ccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCC
Q 002529          749 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN  828 (912)
Q Consensus       749 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  828 (912)
                      ......||..|||||.+++..|+.++||||||++++|+.+|+.||... ......+.+.+...+.+ ..     |.+...
T Consensus       233 ~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~-~~~~~~~~~Ll~~Iv~~-pp-----P~lP~~  305 (364)
T KOG0581|consen  233 IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP-NPPYLDIFELLCAIVDE-PP-----PRLPEG  305 (364)
T ss_pred             hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc-CCCCCCHHHHHHHHhcC-CC-----CCCCcc
Confidence            455678999999999999999999999999999999999999999843 22223334433333321 11     222211


Q ss_pred             CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002529          829 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       829 ~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  861 (912)
                         ....++..++..||++||.+||+++|+++.
T Consensus       306 ---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  306 ---EFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             ---cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence               244579999999999999999999999864

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-41  Score=378.21  Aligned_cols=265  Identities=37%  Similarity=0.541  Sum_probs=216.3

Q ss_pred             HHHHHHHhhhcccCccccEEEEEEEecCCCEEEEEEccCccchh--hHHHHHHHHHHHhcCCCCccceeeEEecCC-eEE
Q 002529          586 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHR--TQQFVTEVALLSRIHHRNLVPLIGYCEEEH-QRI  662 (912)
Q Consensus       586 ~l~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~vAvK~l~~~~~~~--~~~~~~E~~il~~L~hpnIv~l~~~~~~~~-~~~  662 (912)
                      ++......+.+.||+|+||+||+|.++....||+|++.......  .+.|.+|+.+|.+++|||||+++|+|.+.. ..+
T Consensus        37 ~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~  116 (362)
T KOG0192|consen   37 EIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLC  116 (362)
T ss_pred             ecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceE
Confidence            33344445567799999999999999955559999998654322  568999999999999999999999999887 799


Q ss_pred             EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eeecCCCCCCccccCCC-cEEEeeccCcc
Q 002529          663 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG-IIHRDVKSSNILLDINM-RAKVSDFGLSR  740 (912)
Q Consensus       663 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~-ivH~DLkp~NILl~~~~-~vkL~DFGla~  740 (912)
                      +||||+++|+|.++++.. ....+++..+++|+.|||+||.|||+   .+ ||||||||+|||++.++ ++||+|||+++
T Consensus       117 iVtEy~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr  192 (362)
T KOG0192|consen  117 IVTEYMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSR  192 (362)
T ss_pred             EEEEeCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccce
Confidence            999999999999999864 46789999999999999999999998   67 99999999999999997 99999999998


Q ss_pred             ccccccccccccccCCCcccCCCccC--CCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcc
Q 002529          741 QAEEDLTHISSVARGTVGYLDPEYYG--NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI  818 (912)
Q Consensus       741 ~~~~~~~~~~~~~~gt~~y~APE~l~--~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  818 (912)
                      ....... ......||+.|||||++.  ...++.|+||||||+++|||+||+.||.....      .+.+......+.. 
T Consensus       193 ~~~~~~~-~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~~~~v~~~~~R-  264 (362)
T KOG0192|consen  193 EKVISKT-SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQVASAVVVGGLR-  264 (362)
T ss_pred             eeccccc-cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcCCC-
Confidence            7654322 122256999999999999  56999999999999999999999999984332      1212222222222 


Q ss_pred             cccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhhhhhcc
Q 002529          819 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK  870 (912)
Q Consensus       819 ~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~~~~~~  870 (912)
                              ...+......+..++.+||+.||++||++.|++..|+.+...-.
T Consensus       265 --------p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~  308 (362)
T KOG0192|consen  265 --------PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS  308 (362)
T ss_pred             --------CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence                    22222345588999999999999999999999999998876444

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-41  Score=362.92  Aligned_cols=199  Identities=33%  Similarity=0.558  Sum_probs=179.1

Q ss_pred             HHhhhcccCccccEEEEEEEec-CCCEEEEEEccCc--cchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEe
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY  667 (912)
Q Consensus       591 ~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  667 (912)
                      .|.+.++||+|+||+||+|+++ ++..||||.+...  .....+.+..|+.+|+.++|||||++++++..++..+|||||
T Consensus        11 ~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEy   90 (429)
T KOG0595|consen   11 DYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEY   90 (429)
T ss_pred             cceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEe
Confidence            3556678999999999999987 5899999999765  445567788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCC------CcEEEeeccCccc
Q 002529          668 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN------MRAKVSDFGLSRQ  741 (912)
Q Consensus       668 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~------~~vkL~DFGla~~  741 (912)
                      |.||+|.++++   ..+.+++..++.++.|||.||++||+   ++||||||||+||||+..      -.+||+|||+|+.
T Consensus        91 C~gGDLs~yi~---~~~~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~  164 (429)
T KOG0595|consen   91 CNGGDLSDYIR---RRGRLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF  164 (429)
T ss_pred             CCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence            99999999999   46689999999999999999999998   999999999999999764      4689999999998


Q ss_pred             cccccccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccC
Q 002529          742 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED  797 (912)
Q Consensus       742 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~  797 (912)
                      ....  ......+|++-|||||+++..+|+.|+|+||+|+++|+|++|+.||....
T Consensus       165 L~~~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t  218 (429)
T KOG0595|consen  165 LQPG--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET  218 (429)
T ss_pred             CCch--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence            8743  33455679999999999999999999999999999999999999998433

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.4e-42  Score=380.20  Aligned_cols=249  Identities=26%  Similarity=0.446  Sum_probs=211.7

Q ss_pred             HHHHHhhhcccCccccEEEEEEEe-cCCCEEEEEEccCc---cchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEE
Q 002529          588 EEATNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL  663 (912)
Q Consensus       588 ~~~~~~~~~~LG~G~fg~Vy~a~~-~~~~~vAvK~l~~~---~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~l  663 (912)
                      ...+|...+.||+|+|+.||.++. ..|+.||+|++.+.   .....+.+.+|+++.++|+|||||+++++|++.++.||
T Consensus        16 ~~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYi   95 (592)
T KOG0575|consen   16 RSKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYI   95 (592)
T ss_pred             CcceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEE
Confidence            346777889999999999999998 78999999999763   33456788999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccc
Q 002529          664 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE  743 (912)
Q Consensus       664 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~  743 (912)
                      |+|.|+.++|..+++   .++.+++.+++.+++||+.||.|||+   ++|+|||||..|+|++++.++||+|||+|....
T Consensus        96 vLELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le  169 (592)
T KOG0575|consen   96 VLELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLE  169 (592)
T ss_pred             EEEecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeec
Confidence            999999999999998   47889999999999999999999998   999999999999999999999999999999886


Q ss_pred             cccccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCc
Q 002529          744 EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP  823 (912)
Q Consensus       744 ~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  823 (912)
                      .+.. ...+.+|||.|+|||++.....+..+||||+||++|.||.|++||+.....+..       ..++..+.      
T Consensus       170 ~~~E-rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety-------~~Ik~~~Y------  235 (592)
T KOG0575|consen  170 YDGE-RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETY-------NKIKLNEY------  235 (592)
T ss_pred             Cccc-ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHH-------HHHHhcCc------
Confidence            5433 234567999999999999999999999999999999999999999833222211       11221111      


Q ss_pred             cccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          824 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       824 ~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                          ..+.....+..+||.++|+.+|.+|||+++|+.
T Consensus       236 ----~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  236 ----SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             ----ccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                011122336779999999999999999999985

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-42  Score=380.01  Aligned_cols=264  Identities=28%  Similarity=0.467  Sum_probs=225.1

Q ss_pred             hHHHHHHHhhhcccCccccEEEEEEEecCCCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEE
Q 002529          585 PELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV  664 (912)
Q Consensus       585 ~~l~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV  664 (912)
                      -++.....++.+.||+|.||.||+|.++....||+|.++.. .....+|.+|+++|++|+|+|||+++++|..++.++||
T Consensus       201 wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIV  279 (468)
T KOG0197|consen  201 WEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIV  279 (468)
T ss_pred             eeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEE
Confidence            35667778899999999999999999998889999999865 33457888999999999999999999999998899999


Q ss_pred             EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccc
Q 002529          665 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE  744 (912)
Q Consensus       665 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~  744 (912)
                      ||||+.|+|.++|+.. .+..+...+.+.++.|||+||+||++   +++|||||.++||||+++..+||+|||+|+...+
T Consensus       280 tE~m~~GsLl~yLr~~-~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d  355 (468)
T KOG0197|consen  280 TEYMPKGSLLDYLRTR-EGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIGD  355 (468)
T ss_pred             EEecccCcHHHHhhhc-CCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccCC
Confidence            9999999999999963 57789999999999999999999999   9999999999999999999999999999997666


Q ss_pred             ccccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhhhccCCcccccCc
Q 002529          745 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP  823 (912)
Q Consensus       745 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  823 (912)
                      +.........-+..|.|||.+....++.|||||||||+||||+| |+.|+......+   .    ...+..|        
T Consensus       356 ~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e---v----~~~le~G--------  420 (468)
T KOG0197|consen  356 DEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE---V----LELLERG--------  420 (468)
T ss_pred             CceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH---H----HHHHhcc--------
Confidence            65555554456789999999999999999999999999999999 999987433221   1    1122222        


Q ss_pred             cccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhhhhhc
Q 002529          824 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE  869 (912)
Q Consensus       824 ~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~~~~~  869 (912)
                       .+-..+..++..+.+|+..||+.+|++|||++.+...|+++....
T Consensus       421 -yRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~  465 (468)
T KOG0197|consen  421 -YRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST  465 (468)
T ss_pred             -CcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence             222334556778999999999999999999999999998876543

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.3e-42  Score=367.21  Aligned_cols=257  Identities=28%  Similarity=0.383  Sum_probs=208.1

Q ss_pred             hhHHHHHHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCccch-------hhHHHHHHHHHHHhcCCCCccceeeEE
Q 002529          584 LPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH-------RTQQFVTEVALLSRIHHRNLVPLIGYC  655 (912)
Q Consensus       584 ~~~l~~~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~-------~~~~~~~E~~il~~L~hpnIv~l~~~~  655 (912)
                      .++.....|.+.+.||+|+||.|-+|..+ +|+.||||++++....       ....+++|+++|++|+|||||+++++|
T Consensus       166 ~pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f  245 (475)
T KOG0615|consen  166 PPKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF  245 (475)
T ss_pred             ccchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee
Confidence            34445667778899999999999999755 7999999999763221       223467999999999999999999999


Q ss_pred             ecCCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCC---CcEE
Q 002529          656 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN---MRAK  732 (912)
Q Consensus       656 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~---~~vk  732 (912)
                      +..+..||||||++||.|.+.+-   ..+.+.+..-..+++|++.|+.|||+   .||+||||||+|||+..+   ..+|
T Consensus       246 ~~~ds~YmVlE~v~GGeLfd~vv---~nk~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llK  319 (475)
T KOG0615|consen  246 EVPDSSYMVLEYVEGGELFDKVV---ANKYLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLK  319 (475)
T ss_pred             ecCCceEEEEEEecCccHHHHHH---hccccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEE
Confidence            99999999999999999999998   46778888889999999999999999   999999999999999765   7799


Q ss_pred             EeeccCccccccccccccccccCCCcccCCCccCCCCC---CchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHH
Q 002529          733 VSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL---TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR  809 (912)
Q Consensus       733 L~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~---s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~  809 (912)
                      |+|||+|+..++  .......+||+.|.|||++.+...   ..+.|+||+||+||-+++|.+||.......  .    +.
T Consensus       320 ItDFGlAK~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--s----l~  391 (475)
T KOG0615|consen  320 ITDFGLAKVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--S----LK  391 (475)
T ss_pred             ecccchhhcccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--c----HH
Confidence            999999998763  233456779999999999976533   348899999999999999999998433221  1    22


Q ss_pred             hhhccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          810 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       810 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                      .++..|+....      .....+..++.+++|.+||..||++|||+.|+++
T Consensus       392 eQI~~G~y~f~------p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  392 EQILKGRYAFG------PLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             HHHhcCccccc------ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            23333433211      1122344568889999999999999999999985

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-42  Score=350.81  Aligned_cols=264  Identities=28%  Similarity=0.369  Sum_probs=216.9

Q ss_pred             HHHHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCc--cchhhHHHHHHHHHHHhcCCCCccceee-EEecCCe-EE
Q 002529          588 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIG-YCEEEHQ-RI  662 (912)
Q Consensus       588 ~~~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~L~hpnIv~l~~-~~~~~~~-~~  662 (912)
                      ..+.|++.++||+|.||+||++... +|..||.|.++-.  .....+++..|+.+|++|+|||||++++ -+.++.. ++
T Consensus        17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln   96 (375)
T KOG0591|consen   17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN   96 (375)
T ss_pred             cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence            4567888999999999999999754 8999999998743  2345567899999999999999999998 4444444 88


Q ss_pred             EEEEecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeeecCCCCCCccccCCCcEEEeeccCcc
Q 002529          663 LVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNP-GIIHRDVKSSNILLDINMRAKVSDFGLSR  740 (912)
Q Consensus       663 lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LHs~~~~-~ivH~DLkp~NILl~~~~~vkL~DFGla~  740 (912)
                      ||||+|.+|+|.++++..+ .++.+++..+++++.|++.||.++|+..++ -|+||||||.||+++.+|.+||+|||+++
T Consensus        97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r  176 (375)
T KOG0591|consen   97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR  176 (375)
T ss_pred             HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence            9999999999999998655 566799999999999999999999984423 38899999999999999999999999999


Q ss_pred             ccccccccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccc
Q 002529          741 QAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI  820 (912)
Q Consensus       741 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  820 (912)
                      .+...... ....+|||.||+||.+.+..|+.||||||+||++|||+.-++||.+.      ++.+ +...+.+++...+
T Consensus       177 ~l~s~~tf-A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~-L~~KI~qgd~~~~  248 (375)
T KOG0591|consen  177 FLSSKTTF-AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLS-LCKKIEQGDYPPL  248 (375)
T ss_pred             HhcchhHH-HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHH-HHHHHHcCCCCCC
Confidence            88765443 34567999999999999999999999999999999999999999844      3333 2334445544322


Q ss_pred             cCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhhhh
Q 002529          821 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK  867 (912)
Q Consensus       821 ~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~~~  867 (912)
                      .+        .....++.+||..|+..||+.||+.-.+++.++.-++
T Consensus       249 p~--------~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~l~  287 (375)
T KOG0591|consen  249 PD--------EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSELD  287 (375)
T ss_pred             cH--------HHhhhHHHHHHHHHccCCcccCCCcchHHHHHHHHhc
Confidence            22        3345589999999999999999998777777666554

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=9.8e-40  Score=377.23  Aligned_cols=267  Identities=31%  Similarity=0.488  Sum_probs=224.5

Q ss_pred             hHHHHHHHhhhcccCccccEEEEEEEec------CCCEEEEEEccCccch-hhHHHHHHHHHHHhcCCCCccceeeEEec
Q 002529          585 PELEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEE  657 (912)
Q Consensus       585 ~~l~~~~~~~~~~LG~G~fg~Vy~a~~~------~~~~vAvK~l~~~~~~-~~~~~~~E~~il~~L~hpnIv~l~~~~~~  657 (912)
                      .++.....++.+.||+|.||+||+|+..      +...||||.+++.... ...+|++|++++..++|||||+++|+|.+
T Consensus       481 ~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~  560 (774)
T KOG1026|consen  481 LEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE  560 (774)
T ss_pred             eEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence            4555666678899999999999999854      3567999999987666 67899999999999999999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHhccCC-------C----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCcccc
Q 002529          658 EHQRILVYEYMHNGTLRDRLHGSV-------N----QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD  726 (912)
Q Consensus       658 ~~~~~lV~E~~~~gsL~~~l~~~~-------~----~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~  726 (912)
                      ++.+++|+|||..|+|.++|+...       .    ..+++..+.+.|+.|||.||.||-+   +.+|||||..+|+||.
T Consensus       561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVg  637 (774)
T KOG1026|consen  561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVG  637 (774)
T ss_pred             CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---Ccccccchhhhhceec
Confidence            999999999999999999997543       1    2348899999999999999999998   9999999999999999


Q ss_pred             CCCcEEEeeccCccccccc-cccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhH
Q 002529          727 INMRAKVSDFGLSRQAEED-LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNI  804 (912)
Q Consensus       727 ~~~~vkL~DFGla~~~~~~-~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~  804 (912)
                      ++..|||+|||+++.+-.. ..+......-+.+|||||.+..++++.+||||||||+|||+++ |+.||.+....     
T Consensus       638 e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~-----  712 (774)
T KOG1026|consen  638 ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ-----  712 (774)
T ss_pred             cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH-----
Confidence            9999999999999885333 3333334445789999999999999999999999999999999 99999754432     


Q ss_pred             HHHHHhhhccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhhhhhcc
Q 002529          805 VHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK  870 (912)
Q Consensus       805 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~~~~~~  870 (912)
                        .+...+++|++..         .+..++.++.+|+..||+.+|++||+++||-..|+......+
T Consensus       713 --EVIe~i~~g~lL~---------~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~  767 (774)
T KOG1026|consen  713 --EVIECIRAGQLLS---------CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP  767 (774)
T ss_pred             --HHHHHHHcCCccc---------CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence              2334455555422         244566789999999999999999999999999998766443

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.6e-39  Score=331.17  Aligned_cols=263  Identities=21%  Similarity=0.279  Sum_probs=205.3

Q ss_pred             HHhhhcccCccccEEEEEEEec-CCCEEEEEEccCccch--hhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEe
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH--RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY  667 (912)
Q Consensus       591 ~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~--~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  667 (912)
                      .|+...++|+|+||.||+++++ +|+.||||++.....+  -.+-.++|+++|++|+|+|+|.++++|.....++||+||
T Consensus         3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~   82 (396)
T KOG0593|consen    3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY   82 (396)
T ss_pred             HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence            3566688999999999999988 5999999999765432  335578999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccc
Q 002529          668 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT  747 (912)
Q Consensus       668 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~  747 (912)
                      |+..-|.+. ..  ....++...+.+++.|+++|+.|+|+   ++++||||||+|||++.++.+||||||+|+...... 
T Consensus        83 ~dhTvL~eL-e~--~p~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg-  155 (396)
T KOG0593|consen   83 CDHTVLHEL-ER--YPNGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG-  155 (396)
T ss_pred             cchHHHHHH-Hh--ccCCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcCCc-
Confidence            987555444 33  45678999999999999999999998   999999999999999999999999999999876432 


Q ss_pred             cccccccCCCcccCCCccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHh--------hhccCCc-
Q 002529          748 HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS--------MIKKGDV-  817 (912)
Q Consensus       748 ~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~--------~~~~~~~-  817 (912)
                      ..-...+.|..|+|||.+.+ .+|+...||||+||++.||++|.+.|.+.+.-+..........        ......+ 
T Consensus       156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F  235 (396)
T KOG0593|consen  156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF  235 (396)
T ss_pred             chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence            22344568999999999877 7999999999999999999999999986665443332222211        1111111 


Q ss_pred             -----ccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          818 -----ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       818 -----~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                           .+.-++......-+....-+++++..||+.||.+|++.+|++.
T Consensus       236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence                 1111111111111223346889999999999999999999984

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-39  Score=340.01  Aligned_cols=242  Identities=28%  Similarity=0.375  Sum_probs=202.0

Q ss_pred             HHHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc---chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEE
Q 002529          589 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV  664 (912)
Q Consensus       589 ~~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV  664 (912)
                      ...+++.++||+|+||+|+.++.+ +++.+|+|++++..   ..+.+...+|..+|.+++||.||+++..|++.+.+|||
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            345667899999999999999876 58999999997643   23467788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccc
Q 002529          665 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE  744 (912)
Q Consensus       665 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~  744 (912)
                      +||+.||.|.-+|+   ..+.+++..+.-++..|+.||.|||+   ++||||||||+|||+|.+|+++|+|||+++....
T Consensus       104 ld~~~GGeLf~hL~---~eg~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~  177 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQ---REGRFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK  177 (357)
T ss_pred             EeccCCccHHHHHH---hcCCcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence            99999999999998   57789999999999999999999998   9999999999999999999999999999986543


Q ss_pred             ccccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCcc
Q 002529          745 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV  824 (912)
Q Consensus       745 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  824 (912)
                      ... .....+||+.|||||++.+..++.++|.||||+++|||++|.+||...+.      ..+.....+. +. .     
T Consensus       178 ~~~-~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~------~~~~~~I~~~-k~-~-----  243 (357)
T KOG0598|consen  178 DGD-ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV------KKMYDKILKG-KL-P-----  243 (357)
T ss_pred             CCC-ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH------HHHHHHHhcC-cC-C-----
Confidence            322 23446799999999999999999999999999999999999999984433      2222222222 10 0     


Q ss_pred             ccCCCCHHHHHHHHHHHHhcccCCCCCCC
Q 002529          825 LIGNVKIESIWRIAEVAIQCVEQRGFSRP  853 (912)
Q Consensus       825 l~~~~~~~~~~~l~~Li~~cL~~dP~~RP  853 (912)
                         ..+.-...+..+++.++|..||++|.
T Consensus       244 ---~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  244 ---LPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             ---CCCccCCHHHHHHHHHHhccCHHHhc
Confidence               00111223677899999999999995

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-39  Score=347.93  Aligned_cols=267  Identities=22%  Similarity=0.273  Sum_probs=211.0

Q ss_pred             HHHHHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCc-cchhhHHHHHHHHHHHhcC-CCCccceeeEEecCC-eEE
Q 002529          587 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS-CSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEH-QRI  662 (912)
Q Consensus       587 l~~~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~-~~~~~~~~~~E~~il~~L~-hpnIv~l~~~~~~~~-~~~  662 (912)
                      +...+|.+.++||.|.||.||+|+.+ +++.||||.+++. ...+...=++|++.|++|+ ||||+++.+++.+.+ .++
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~   86 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY   86 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence            34678999999999999999999866 6899999999764 2333444578999999998 999999999998877 999


Q ss_pred             EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccc
Q 002529          663 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA  742 (912)
Q Consensus       663 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~  742 (912)
                      +||||| ..+|.++++..  +..+++..+..|+.||++||+|+|+   +|+.|||+||+|||+.....+||+|||+|+.+
T Consensus        87 fVfE~M-d~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev  160 (538)
T KOG0661|consen   87 FVFEFM-DCNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREV  160 (538)
T ss_pred             eeHHhh-hhhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEeccccccccc
Confidence            999999 56999999865  7889999999999999999999998   99999999999999998999999999999987


Q ss_pred             ccccccccccccCCCcccCCCcc-CCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCccc--
Q 002529          743 EEDLTHISSVARGTVGYLDPEYY-GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS--  819 (912)
Q Consensus       743 ~~~~~~~~~~~~gt~~y~APE~l-~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~--  819 (912)
                      ......  ...+.|..|+|||++ +.+.|+.+.||||+|||++|+.+-++.|.+...-++..-+-.+..-..+....+  
T Consensus       161 ~SkpPY--TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~  238 (538)
T KOG0661|consen  161 RSKPPY--TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY  238 (538)
T ss_pred             ccCCCc--chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence            654333  345679999999986 667899999999999999999999999986554332221111111111111111  


Q ss_pred             ----ccCcccc-------CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002529          820 ----IVDPVLI-------GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       820 ----~~d~~l~-------~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  861 (912)
                          .+.-.+.       +..-.....+..+++.+||.+||.+||||+|.+++
T Consensus       239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence                1110110       01112355688999999999999999999999875

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-38  Score=341.32  Aligned_cols=258  Identities=28%  Similarity=0.404  Sum_probs=205.0

Q ss_pred             HHhhhcccCccccEEEEEEEecC-CCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEecCC--eEEEEEEe
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH--QRILVYEY  667 (912)
Q Consensus       591 ~~~~~~~LG~G~fg~Vy~a~~~~-~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~--~~~lV~E~  667 (912)
                      ++...+.||+|+||+||++...+ |+..|||.+........+.+.+|+.+|++++|||||+++|......  .+++.|||
T Consensus        18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy   97 (313)
T KOG0198|consen   18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY   97 (313)
T ss_pred             hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence            45567999999999999998774 8999999987653334677999999999999999999999854444  68899999


Q ss_pred             cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccC-CCcEEEeeccCcccccc--
Q 002529          668 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEE--  744 (912)
Q Consensus       668 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~-~~~vkL~DFGla~~~~~--  744 (912)
                      +++|+|.+++....  ..+++..+..++.||++||+|||+   ++|+|+||||+|||++. ++.+||+|||++.....  
T Consensus        98 ~~~GsL~~~~~~~g--~~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~  172 (313)
T KOG0198|consen   98 APGGSLSDLIKRYG--GKLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG  172 (313)
T ss_pred             cCCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence            99999999998642  279999999999999999999998   99999999999999999 79999999999987663  


Q ss_pred             ccccccccccCCCcccCCCccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCc
Q 002529          745 DLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP  823 (912)
Q Consensus       745 ~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  823 (912)
                      ..........||+.|||||++..+ ....++|||||||++.||+||+.||...     .....++-........     |
T Consensus       173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~-----P  242 (313)
T KOG0198|consen  173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSL-----P  242 (313)
T ss_pred             ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCC-----C
Confidence            222223346799999999999853 3446999999999999999999999842     1111212111211111     1


Q ss_pred             cccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhhhh
Q 002529          824 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK  867 (912)
Q Consensus       824 ~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~~~  867 (912)
                          ..+.....+..+++.+|++.+|++||||+|+++..--...
T Consensus       243 ----~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~  282 (313)
T KOG0198|consen  243 ----EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN  282 (313)
T ss_pred             ----CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence                2222334478899999999999999999999987554443

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-38  Score=347.93  Aligned_cols=249  Identities=27%  Similarity=0.379  Sum_probs=206.4

Q ss_pred             HHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCccc---hhhHHHHHHHHHHHhc-CCCCccceeeEEecCCeEEEE
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILV  664 (912)
Q Consensus       590 ~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~L-~hpnIv~l~~~~~~~~~~~lV  664 (912)
                      ..+.|++.||+|+|++|++|+.+ .++++|||++.+.--   ...+-+..|-.+|.+| .||.|++|+-.|+++..+|+|
T Consensus        73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv  152 (604)
T KOG0592|consen   73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV  152 (604)
T ss_pred             hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence            45678999999999999999866 699999999965322   2234577899999999 799999999999999999999


Q ss_pred             EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccc
Q 002529          665 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE  744 (912)
Q Consensus       665 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~  744 (912)
                      +||+++|+|.++|++   .+.+++...+.++.+|+.||+|||+   +|||||||||+|||+|.+|+++|+|||.|+.+..
T Consensus       153 Le~A~nGdll~~i~K---~Gsfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~  226 (604)
T KOG0592|consen  153 LEYAPNGDLLDLIKK---YGSFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKILSP  226 (604)
T ss_pred             EEecCCCcHHHHHHH---hCcchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence            999999999999994   5789999999999999999999998   9999999999999999999999999999988654


Q ss_pred             cccc----------cc--ccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhh
Q 002529          745 DLTH----------IS--SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI  812 (912)
Q Consensus       745 ~~~~----------~~--~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~  812 (912)
                      ....          ..  ...+||..|.+||++.....++.+|+|+|||+||+|+.|++||.+...   ..+.+.+   +
T Consensus       227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne---yliFqkI---~  300 (604)
T KOG0592|consen  227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE---YLIFQKI---Q  300 (604)
T ss_pred             hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH---HHHHHHH---H
Confidence            3221          11  346799999999999999999999999999999999999999983321   1111111   1


Q ss_pred             ccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002529          813 KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       813 ~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  861 (912)
                      .       ++-    .++...++.+.+|+.+.|..||.+|++++||.+.
T Consensus       301 ~-------l~y----~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  301 A-------LDY----EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             H-------hcc----cCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence            1       011    1222233578899999999999999999998764

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.1e-38  Score=341.26  Aligned_cols=269  Identities=23%  Similarity=0.269  Sum_probs=210.3

Q ss_pred             hHHHHHHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc--chhhHHHHHHHHHHHhcCCCCccceeeEEecC--C
Q 002529          585 PELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--H  659 (912)
Q Consensus       585 ~~l~~~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~--~  659 (912)
                      -......|+..++||+|.||.||+|+.. +|+.||+|+++-+.  .....-..+|+.+|++|.||||++|.+...+.  .
T Consensus       112 ~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~  191 (560)
T KOG0600|consen  112 GPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSG  191 (560)
T ss_pred             cccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCc
Confidence            3445667788899999999999999754 79999999987544  33345577999999999999999999998776  6


Q ss_pred             eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCc
Q 002529          660 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS  739 (912)
Q Consensus       660 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla  739 (912)
                      .+|||+|||+. +|.-++..  .+-.+++.++..+++||+.||+|||+   ++|+|||||.+|||||.+|.+||+|||+|
T Consensus       192 siYlVFeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLA  265 (560)
T KOG0600|consen  192 SIYLVFEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLA  265 (560)
T ss_pred             eEEEEEecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccce
Confidence            89999999976 77777763  35679999999999999999999998   99999999999999999999999999999


Q ss_pred             cccccccccccccccCCCcccCCCccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcc
Q 002529          740 RQAEEDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI  818 (912)
Q Consensus       740 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  818 (912)
                      +.+.......-...+-|..|+|||++.+. .|+.+.|+||.||||.||++|++.|.+....++.+.+-.+-....+..+.
T Consensus       266 r~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~  345 (560)
T KOG0600|consen  266 RFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP  345 (560)
T ss_pred             eeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc
Confidence            98766655444555679999999998764 89999999999999999999999998665544333322222222221111


Q ss_pred             cccC-c---ccc--CCCC-------HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          819 SIVD-P---VLI--GNVK-------IESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       819 ~~~d-~---~l~--~~~~-------~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                       ..+ |   .+.  ..+.       .......++|+..+|..||.+|.|+.++++
T Consensus       346 -~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  346 -VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             -cccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence             111 0   000  0111       112235679999999999999999999885

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-37  Score=334.74  Aligned_cols=261  Identities=25%  Similarity=0.330  Sum_probs=209.4

Q ss_pred             HHHHhhhcccCccccEEEEEEEec-CCCEEEEEEccC-ccchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEE
Q 002529          589 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMAD-SCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE  666 (912)
Q Consensus       589 ~~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~-~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E  666 (912)
                      ...|++.++||.|..++||+|+.. .++.||||++.- .+....+.+.+|+..|+.++||||++++..|..+..+++||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            456788899999999999999865 689999999964 344557899999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccc
Q 002529          667 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL  746 (912)
Q Consensus       667 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~  746 (912)
                      ||.+|++.++++... ...+++..+..|++++++||.|||+   +|.||||||+.||||+.+|.+||+|||.+..+.+..
T Consensus       105 fMa~GS~ldIik~~~-~~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G  180 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYY-PDGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG  180 (516)
T ss_pred             hhcCCcHHHHHHHHc-cccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence            999999999998764 4559999999999999999999998   999999999999999999999999999876654332


Q ss_pred             cc---ccccccCCCcccCCCccCC--CCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCccccc
Q 002529          747 TH---ISSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV  821 (912)
Q Consensus       747 ~~---~~~~~~gt~~y~APE~l~~--~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  821 (912)
                      ..   ......|++.|||||+++.  ..|+.|+||||||++..||.+|..||......  ..    +...++ +......
T Consensus       181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm--kv----Ll~tLq-n~pp~~~  253 (516)
T KOG0582|consen  181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM--KV----LLLTLQ-NDPPTLL  253 (516)
T ss_pred             ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH--HH----HHHHhc-CCCCCcc
Confidence            21   1144579999999999644  36889999999999999999999999843321  11    112222 2221111


Q ss_pred             CccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          822 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       822 d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                      -..+..+........+.+++..||+.||++|||++++++
T Consensus       254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            111111222233447899999999999999999999984

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.7e-37  Score=348.06  Aligned_cols=263  Identities=27%  Similarity=0.453  Sum_probs=206.7

Q ss_pred             HHHHHHhhhcccCccccEEEEEEEec------CCCEEEEEEccCccc-hhhHHHHHHHHHHHhc-CCCCccceeeEEecC
Q 002529          587 LEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE  658 (912)
Q Consensus       587 l~~~~~~~~~~LG~G~fg~Vy~a~~~------~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~L-~hpnIv~l~~~~~~~  658 (912)
                      +...+|++.++||+|+||.||+|.+.      +++.||+|+++.... .....+.+|+.+++++ +||||+++++++...
T Consensus         4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (338)
T cd05102           4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP   83 (338)
T ss_pred             cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence            34567888999999999999999742      356899999875432 3346789999999999 899999999988764


Q ss_pred             -CeEEEEEEecCCCCHHHHhccCCC-------------------------------------------------------
Q 002529          659 -HQRILVYEYMHNGTLRDRLHGSVN-------------------------------------------------------  682 (912)
Q Consensus       659 -~~~~lV~E~~~~gsL~~~l~~~~~-------------------------------------------------------  682 (912)
                       ...++||||+++|+|.+++.....                                                       
T Consensus        84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (338)
T cd05102          84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET  163 (338)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence             458899999999999999874311                                                       


Q ss_pred             ----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccccc-cccccCCC
Q 002529          683 ----QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSVARGTV  757 (912)
Q Consensus       683 ----~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~  757 (912)
                          ...+++..+..++.||++||+|||+   .+|+||||||+|||++.++.+||+|||+++......... .....++.
T Consensus       164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~  240 (338)
T cd05102         164 DDLWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL  240 (338)
T ss_pred             cccccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence                2357888999999999999999998   999999999999999999999999999998654322211 12234567


Q ss_pred             cccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCCCCHHHHHH
Q 002529          758 GYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWR  836 (912)
Q Consensus       758 ~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~  836 (912)
                      .|+|||++.+..++.++|||||||++|||++ |..||.......  ...    ..+..+....     .    +......
T Consensus       241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~~~----~~~~~~~~~~-----~----~~~~~~~  305 (338)
T cd05102         241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--EFC----QRLKDGTRMR-----A----PENATPE  305 (338)
T ss_pred             cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--HHH----HHHhcCCCCC-----C----CCCCCHH
Confidence            8999999999899999999999999999997 999997433211  111    1122221111     0    1122346


Q ss_pred             HHHHHHhcccCCCCCCCCHHHHHHHHhhhhh
Q 002529          837 IAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK  867 (912)
Q Consensus       837 l~~Li~~cL~~dP~~RPs~~evl~~L~~~~~  867 (912)
                      +.+++.+||+.||++|||+.||++.|++++.
T Consensus       306 l~~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         306 IYRIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            8899999999999999999999999998876

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-38  Score=347.91  Aligned_cols=248  Identities=27%  Similarity=0.416  Sum_probs=209.6

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEecCC
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN  670 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~  670 (912)
                      |.-.++||+|+.|.||.|... +++.||||++........+-+.+|+.+|+..+|+|||.+++.+...+.+++|||||+|
T Consensus       275 y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~g  354 (550)
T KOG0578|consen  275 YTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEG  354 (550)
T ss_pred             hcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCC
Confidence            344578999999999999754 6899999999877667778899999999999999999999999888999999999999


Q ss_pred             CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccccc
Q 002529          671 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS  750 (912)
Q Consensus       671 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~  750 (912)
                      |+|.|.+.    ...+++.++..|++++++||+|||.   ++|+|||||.+|||++.+|.+||+|||++..+...... .
T Consensus       355 gsLTDvVt----~~~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K-R  426 (550)
T KOG0578|consen  355 GSLTDVVT----KTRMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK-R  426 (550)
T ss_pred             Cchhhhhh----cccccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccccCc-c
Confidence            99999997    4459999999999999999999998   99999999999999999999999999999988776553 3


Q ss_pred             ccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCCCC
Q 002529          751 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK  830 (912)
Q Consensus       751 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  830 (912)
                      ....||+.|||||+.....|++|.||||||++++||+-|++||-.+..-      + +...+......++-.       +
T Consensus       427 ~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl------r-AlyLIa~ng~P~lk~-------~  492 (550)
T KOG0578|consen  427 STMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL------R-ALYLIATNGTPKLKN-------P  492 (550)
T ss_pred             ccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChH------H-HHHHHhhcCCCCcCC-------c
Confidence            4556999999999999999999999999999999999999999732221      1 111222222222222       2


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002529          831 IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       831 ~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  861 (912)
                      ......|.+++.+||+.|+++|++++|+|+.
T Consensus       493 ~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  493 EKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             cccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence            2233478899999999999999999999964

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=9.6e-38  Score=341.33  Aligned_cols=255  Identities=28%  Similarity=0.395  Sum_probs=214.8

Q ss_pred             HHhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc--chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEe
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY  667 (912)
Q Consensus       591 ~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  667 (912)
                      .|.+.+.||+|.||.||+|+.+ +.+.||+|.+.+..  ..+.+.+.+|+++++.++||||+.+++.|+...++++|+||
T Consensus         3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~   82 (808)
T KOG0597|consen    3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEY   82 (808)
T ss_pred             chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehh
Confidence            4566789999999999999877 58899999987643  33567799999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccc
Q 002529          668 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT  747 (912)
Q Consensus       668 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~  747 (912)
                      +.| +|..++.   ..+.++++.+..++.|++.||.|||+   .+|+|||+||+|||++.++.+|+||||+|+-.... +
T Consensus        83 a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-t  154 (808)
T KOG0597|consen   83 AVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-T  154 (808)
T ss_pred             hhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhcccC-c
Confidence            976 9999998   57889999999999999999999998   99999999999999999999999999999987653 3


Q ss_pred             cccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccC
Q 002529          748 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG  827 (912)
Q Consensus       748 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  827 (912)
                      .......|||-|||||++.+.+|+..+|+||+||++||+++|++||..      ..+.+.++....+..           
T Consensus       155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a------~si~~Lv~~I~~d~v-----------  217 (808)
T KOG0597|consen  155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA------RSITQLVKSILKDPV-----------  217 (808)
T ss_pred             eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH------HHHHHHHHHHhcCCC-----------
Confidence            444556799999999999999999999999999999999999999972      234444444433211           


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--Hhhhhhhcc
Q 002529          828 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDSIKIEK  870 (912)
Q Consensus       828 ~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~--L~~~~~~~~  870 (912)
                      ..+......+.+++...|++||.+|.+..+++..  .++.+.+.+
T Consensus       218 ~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~~~  262 (808)
T KOG0597|consen  218 KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINIAE  262 (808)
T ss_pred             CCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhhhc
Confidence            1122444578999999999999999999999864  444444333

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-37  Score=345.62  Aligned_cols=248  Identities=27%  Similarity=0.418  Sum_probs=205.0

Q ss_pred             HHHHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCc----cc-hhhHHHHHHHHHHHhcC-CCCccceeeEEecCCe
Q 002529          588 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS----CS-HRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQ  660 (912)
Q Consensus       588 ~~~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~----~~-~~~~~~~~E~~il~~L~-hpnIv~l~~~~~~~~~  660 (912)
                      ....|.+.+.||+|.||+|++|.+. +++.||+|++...    .. ...+.+.+|+.++++++ ||||+++++++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            3456778899999999999999766 6899999977653    11 23456778999999998 9999999999999999


Q ss_pred             EEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCC-CcEEEeeccCc
Q 002529          661 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLS  739 (912)
Q Consensus       661 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~-~~vkL~DFGla  739 (912)
                      .++||||+.||+|.+++.   ..+++.+.+...+++|++.|++|||+   ++|+||||||+|||++.+ +++||+|||++
T Consensus        95 ~~ivmEy~~gGdL~~~i~---~~g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG~s  168 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIV---NKGRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFGLS  168 (370)
T ss_pred             EEEEEEecCCccHHHHHH---HcCCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence            999999999999999998   46789999999999999999999999   999999999999999999 99999999999


Q ss_pred             cccccccccccccccCCCcccCCCccCCCC-CC-chhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCc
Q 002529          740 RQAEEDLTHISSVARGTVGYLDPEYYGNQQ-LT-EKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV  817 (912)
Q Consensus       740 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~s-~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  817 (912)
                      .... ..........|++.|+|||++.+.. |+ .++||||+||+||.|++|+.||+....      ...... +..+.+
T Consensus       169 ~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~------~~l~~k-i~~~~~  240 (370)
T KOG0583|consen  169 AISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV------PNLYRK-IRKGEF  240 (370)
T ss_pred             cccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH------HHHHHH-HhcCCc
Confidence            8874 2223345567999999999999877 75 799999999999999999999984221      111111 222221


Q ss_pred             ccccCccccCCCCHHH-HHHHHHHHHhcccCCCCCCCCHHHHH
Q 002529          818 ISIVDPVLIGNVKIES-IWRIAEVAIQCVEQRGFSRPKMQEIV  859 (912)
Q Consensus       818 ~~~~d~~l~~~~~~~~-~~~l~~Li~~cL~~dP~~RPs~~evl  859 (912)
                                .++... ..++..++.+||..+|.+|+++.|++
T Consensus       241 ----------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  241 ----------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             ----------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence                      011111 34788999999999999999999998

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=3.2e-37  Score=311.45  Aligned_cols=264  Identities=21%  Similarity=0.258  Sum_probs=208.8

Q ss_pred             HHhhhcccCccccEEEEEEEec-CCCEEEEEEccCccch--hhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEe
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH--RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY  667 (912)
Q Consensus       591 ~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~--~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  667 (912)
                      +|...++||+|.||.||+|++. +|+.||||+++-....  -.....+|++.|+.++|+||+.++++|.+.+...||+||
T Consensus         3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf   82 (318)
T KOG0659|consen    3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF   82 (318)
T ss_pred             hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence            5667789999999999999865 7999999999754222  235678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccc
Q 002529          668 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT  747 (912)
Q Consensus       668 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~  747 (912)
                      |+ .+|...++.  ....++..++..++.++++||+|||+   +.|+||||||.|+|++++|.+||+|||+|+.+.....
T Consensus        83 m~-tdLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~  156 (318)
T KOG0659|consen   83 MP-TDLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR  156 (318)
T ss_pred             cc-ccHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence            95 599999986  36789999999999999999999998   9999999999999999999999999999999876543


Q ss_pred             cccccccCCCcccCCCccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCccccc---C-
Q 002529          748 HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV---D-  822 (912)
Q Consensus       748 ~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~---d-  822 (912)
                      .... .+-|..|+|||.+.| ..|+...||||.||++.||+-|.+-|.+...-++....-.+..-.....+.++.   | 
T Consensus       157 ~~~~-~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY  235 (318)
T KOG0659|consen  157 IQTH-QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY  235 (318)
T ss_pred             cccc-ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence            3222 257899999998866 479999999999999999999998887655444333332222222222221111   1 


Q ss_pred             -------ccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002529          823 -------PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       823 -------~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  861 (912)
                             .......-.......++++.+|+..||.+|++++|++++
T Consensus       236 ~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  236 VKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             HHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence                   111111222344567999999999999999999999864

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-37  Score=340.84  Aligned_cols=273  Identities=26%  Similarity=0.422  Sum_probs=224.2

Q ss_pred             ccChhHHHHHHHhhhcccCccccEEEEEEEecCCCEEEEEEccCccch-hhHHHHHHHHHHHhcCCCCccceeeEEecCC
Q 002529          581 FIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEH  659 (912)
Q Consensus       581 ~~~~~~l~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~vAvK~l~~~~~~-~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~  659 (912)
                      .-++.|+......|+++||+|-||.|.++....+..||||+++..... ...+|.+|+++|.+|+||||++++|+|..++
T Consensus       529 ~~al~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De  608 (807)
T KOG1094|consen  529 GPALVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDD  608 (807)
T ss_pred             CcchhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC
Confidence            345678888888999999999999999999998899999999986544 4589999999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCc
Q 002529          660 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS  739 (912)
Q Consensus       660 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla  739 (912)
                      .+++|+|||++|+|.+++.+... ..+......+|+.||+.||+||.+   .++|||||.++|+|++.++++||+|||++
T Consensus       609 PicmI~EYmEnGDLnqFl~ahea-pt~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgms  684 (807)
T KOG1094|consen  609 PLCMITEYMENGDLNQFLSAHEL-PTAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMS  684 (807)
T ss_pred             chHHHHHHHhcCcHHHHHHhccC-cccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccc
Confidence            99999999999999999987632 224556677899999999999999   99999999999999999999999999999


Q ss_pred             cccccc-cccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh--CCCCCCccCccchhhHHHHHHhhhccCC
Q 002529          740 RQAEED-LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS--GKKPVSVEDFGAELNIVHWARSMIKKGD  816 (912)
Q Consensus       740 ~~~~~~-~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt--G~~Pf~~~~~~~~~~~~~~~~~~~~~~~  816 (912)
                      +..-.. ..+......-+.+|||||.+..++++.++|||+||+++||+++  ...||....   ..+.++........+.
T Consensus       685 R~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt---~e~vven~~~~~~~~~  761 (807)
T KOG1094|consen  685 RNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT---DEQVVENAGEFFRDQG  761 (807)
T ss_pred             cccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh---HHHHHHhhhhhcCCCC
Confidence            864332 2333334446789999999999999999999999999999865  788887322   2234444444443332


Q ss_pred             cccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhhh
Q 002529          817 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI  866 (912)
Q Consensus       817 ~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~~  866 (912)
                      ....+      ..+.-++..+.+++.+||..+-++||+++++...|++..
T Consensus       762 ~~~~l------~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~  805 (807)
T KOG1094|consen  762 RQVVL------SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA  805 (807)
T ss_pred             cceec------cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence            22221      123445678999999999999999999999999998754

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=372.72  Aligned_cols=269  Identities=31%  Similarity=0.488  Sum_probs=222.4

Q ss_pred             hhHHHHHHHhhhcccCccccEEEEEEEecC--CC----EEEEEEccCccc-hhhHHHHHHHHHHHhcCCCCccceeeEEe
Q 002529          584 LPELEEATNNFCKKIGKGSFGSVYYGKMKD--GK----EVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCE  656 (912)
Q Consensus       584 ~~~l~~~~~~~~~~LG~G~fg~Vy~a~~~~--~~----~vAvK~l~~~~~-~~~~~~~~E~~il~~L~hpnIv~l~~~~~  656 (912)
                      ++++......+.+.||+|.||.||.|...+  +.    .||+|.+++... ....+|.+|..+|++++|||||+++|++.
T Consensus       686 lp~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l  765 (1025)
T KOG1095|consen  686 LPEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCL  765 (1025)
T ss_pred             cccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeec
Confidence            566777778889999999999999998763  43    499999987544 45678999999999999999999999999


Q ss_pred             cCCeEEEEEEecCCCCHHHHhccCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEE
Q 002529          657 EEHQRILVYEYMHNGTLRDRLHGSV----NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK  732 (912)
Q Consensus       657 ~~~~~~lV~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vk  732 (912)
                      +....+|++|||++|+|..+|++.+    ....++..+++.++.|||+|+.||++   +++|||||..+|+||+....+|
T Consensus       766 ~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VK  842 (1025)
T KOG1095|consen  766 DSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVK  842 (1025)
T ss_pred             CCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEE
Confidence            9999999999999999999999764    35578999999999999999999998   9999999999999999999999


Q ss_pred             EeeccCccccccc-cccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHh
Q 002529          733 VSDFGLSRQAEED-LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARS  810 (912)
Q Consensus       733 L~DFGla~~~~~~-~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~  810 (912)
                      |+|||+|+.+... .........-+..|||||.++.+.++.|+|||||||++||++| |..||.....-      +.+..
T Consensus       843 IaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~------~v~~~  916 (1025)
T KOG1095|consen  843 IADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF------EVLLD  916 (1025)
T ss_pred             EcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH------HHHHH
Confidence            9999999954332 2222222234579999999999999999999999999999999 99999733221      11222


Q ss_pred             hhccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhhhhhccC
Q 002529          811 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG  871 (912)
Q Consensus       811 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~~~~~~~  871 (912)
                      ....+++          ..+..++..+.+|+..||+.+|++||++..|++.+..+......
T Consensus       917 ~~~ggRL----------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~  967 (1025)
T KOG1095|consen  917 VLEGGRL----------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALG  967 (1025)
T ss_pred             HHhCCcc----------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhcc
Confidence            2233311          23455667899999999999999999999999998887766554

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-37  Score=347.68  Aligned_cols=245  Identities=27%  Similarity=0.411  Sum_probs=207.0

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc---chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEe
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY  667 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  667 (912)
                      |++++.||.|+-|.|.+|++. +|+.+|||++.+..   ......+.+|+-+|+.+.||||+++++++++..++|+|.||
T Consensus        14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy   93 (786)
T KOG0588|consen   14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY   93 (786)
T ss_pred             eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence            567899999999999999876 79999999997652   22346789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccc
Q 002529          668 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT  747 (912)
Q Consensus       668 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~  747 (912)
                      +++|-|++++.   .++++++.+..+++.||+.|+.|+|.   .+|+|||+||+|+|+|..+++||+|||+|....++. 
T Consensus        94 v~gGELFdylv---~kG~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk-  166 (786)
T KOG0588|consen   94 VPGGELFDYLV---RKGPLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK-  166 (786)
T ss_pred             cCCchhHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccCCc-
Confidence            99999999998   57889999999999999999999998   999999999999999999999999999998754432 


Q ss_pred             cccccccCCCcccCCCccCCCCCC-chhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCcccc
Q 002529          748 HISSVARGTVGYLDPEYYGNQQLT-EKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI  826 (912)
Q Consensus       748 ~~~~~~~gt~~y~APE~l~~~~~s-~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  826 (912)
                       .-...+|.+.|.|||++.+.+|. .++||||+|||||.||||+.||++.      ++...+. .++.|.+         
T Consensus       167 -lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd------Nir~LLl-KV~~G~f---------  229 (786)
T KOG0588|consen  167 -LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD------NIRVLLL-KVQRGVF---------  229 (786)
T ss_pred             -cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc------cHHHHHH-HHHcCcc---------
Confidence             23456799999999999999884 7999999999999999999999821      2222221 2222322         


Q ss_pred             CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002529          827 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       827 ~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  861 (912)
                       +.+.....+..+|+.+||..||++|.|++||++.
T Consensus       230 -~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  230 -EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH  263 (786)
T ss_pred             -cCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence             1122333478899999999999999999999975

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-38  Score=340.71  Aligned_cols=252  Identities=30%  Similarity=0.493  Sum_probs=211.3

Q ss_pred             ccccChhHHHHHHHhhhcccCccccEEEEEEEecCCCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEecC
Q 002529          579 AYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE  658 (912)
Q Consensus       579 ~~~~~~~~l~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~  658 (912)
                      -+.+|+++|.+.     +-||.|+.|.||+|+++ ++.||||+++...       ..+++-|++|+||||+.+.|+|...
T Consensus       118 ~WeiPFe~IsEL-----eWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqs  184 (904)
T KOG4721|consen  118 LWEIPFEEISEL-----EWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQS  184 (904)
T ss_pred             hccCCHHHhhhh-----hhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCC
Confidence            355677777654     45999999999999998 7999999876432       2478889999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccC
Q 002529          659 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL  738 (912)
Q Consensus       659 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGl  738 (912)
                      ..+|||||||..|-|...|+   .+..+.......|..+||.|+.|||.   +.|||||||.=||||..+..+||+|||-
T Consensus       185 PcyCIiMEfCa~GqL~~VLk---a~~~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGT  258 (904)
T KOG4721|consen  185 PCYCIIMEFCAQGQLYEVLK---AGRPITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGT  258 (904)
T ss_pred             ceeEEeeeccccccHHHHHh---ccCccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccc
Confidence            99999999999999999999   57788899999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccccccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcc
Q 002529          739 SRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI  818 (912)
Q Consensus       739 a~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  818 (912)
                      ++...+..+.+  .++||..|||||+++..+.++|.|||||||+|||||||..||..-+...           +-.|   
T Consensus       259 S~e~~~~STkM--SFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA-----------IIwG---  322 (904)
T KOG4721|consen  259 SKELSDKSTKM--SFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA-----------IIWG---  322 (904)
T ss_pred             hHhhhhhhhhh--hhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe-----------eEEe---
Confidence            98876553333  3569999999999999999999999999999999999999998333211           0000   


Q ss_pred             cccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhhh
Q 002529          819 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI  866 (912)
Q Consensus       819 ~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~~  866 (912)
                       +=...+.-..+..+++.+.-|+++||+-.|..||++.+++..|+-..
T Consensus       323 -VGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~  369 (904)
T KOG4721|consen  323 -VGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS  369 (904)
T ss_pred             -ccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence             00112222345567778999999999999999999999999987543

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.8e-36  Score=327.92  Aligned_cols=258  Identities=22%  Similarity=0.400  Sum_probs=206.7

Q ss_pred             HHHHHHhhhcccCccccEEEEEEEec----CCCEEEEEEccCccc-hhhHHHHHHHHHHHhcCCCCccceeeEEecCCeE
Q 002529          587 LEEATNNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR  661 (912)
Q Consensus       587 l~~~~~~~~~~LG~G~fg~Vy~a~~~----~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~  661 (912)
                      +....+++.+.||+|+||.||+|.++    .+..||+|.++.... ...+.+.+|+.++++++||||+++++++..++..
T Consensus         2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   81 (266)
T cd05064           2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM   81 (266)
T ss_pred             CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence            34567788999999999999999764    356899999876533 3346788999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccc
Q 002529          662 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ  741 (912)
Q Consensus       662 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~  741 (912)
                      ++||||+++|+|.+++...  ...+++..++.++.|++.||+|||+   .+++||||||+||+++.++.++++|||.+..
T Consensus        82 ~lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~  156 (266)
T cd05064          82 MIVTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQE  156 (266)
T ss_pred             EEEEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCccccc
Confidence            9999999999999998743  3578999999999999999999998   9999999999999999999999999998765


Q ss_pred             cccccccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhhhccCCcccc
Q 002529          742 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISI  820 (912)
Q Consensus       742 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  820 (912)
                      .............++..|+|||.+.+..++.++|||||||++||+++ |+.||......   ...+.    +..+...  
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~---~~~~~----~~~~~~~--  227 (266)
T cd05064         157 DKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ---DVIKA----VEDGFRL--  227 (266)
T ss_pred             ccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHH----HHCCCCC--
Confidence            43222111122234678999999999999999999999999999775 99999743221   11121    1111110  


Q ss_pred             cCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhh
Q 002529          821 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS  865 (912)
Q Consensus       821 ~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~  865 (912)
                             ..+...+..+.+++.+||+.+|++||+++||++.|.++
T Consensus       228 -------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         228 -------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             -------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence                   01122345788999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-38  Score=355.33  Aligned_cols=267  Identities=26%  Similarity=0.437  Sum_probs=221.9

Q ss_pred             hHHHHHHHhhhcccCccccEEEEEEEecC----CCEEEEEEccCccc-hhhHHHHHHHHHHHhcCCCCccceeeEEecCC
Q 002529          585 PELEEATNNFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH  659 (912)
Q Consensus       585 ~~l~~~~~~~~~~LG~G~fg~Vy~a~~~~----~~~vAvK~l~~~~~-~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~  659 (912)
                      .||......+.++||.|.||.|++|+++-    ...||||.++.... ....+|+.|+.||.++.||||++|.|+.....
T Consensus       624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~  703 (996)
T KOG0196|consen  624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSK  703 (996)
T ss_pred             hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCc
Confidence            45555555567899999999999999872    35799999987544 35678999999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCc
Q 002529          660 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS  739 (912)
Q Consensus       660 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla  739 (912)
                      ...||+|||++|+|..+|+..  .+.+++.++..+++.||.|++||..   .++|||||..+|||++.+..+|++|||++
T Consensus       704 PvMIiTEyMENGsLDsFLR~~--DGqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILVNsnLvCKVsDFGLS  778 (996)
T KOG0196|consen  704 PVMIITEYMENGSLDSFLRQN--DGQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILVNSNLVCKVSDFGLS  778 (996)
T ss_pred             eeEEEhhhhhCCcHHHHHhhc--CCceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheeeccceEEEeccccce
Confidence            999999999999999999975  4669999999999999999999997   99999999999999999999999999999


Q ss_pred             ccccccccccccccc--CCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhhhccCC
Q 002529          740 RQAEEDLTHISSVAR--GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGD  816 (912)
Q Consensus       740 ~~~~~~~~~~~~~~~--gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~  816 (912)
                      +...++.........  -+.+|.|||.+....++.++||||+|++|||.++ |..||......+       +...+.   
T Consensus       779 Rvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd-------VIkaIe---  848 (996)
T KOG0196|consen  779 RVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-------VIKAIE---  848 (996)
T ss_pred             eecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH-------HHHHHH---
Confidence            987665422222221  2468999999999999999999999999999877 999987333211       111111   


Q ss_pred             cccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhhhhhccCC
Q 002529          817 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGG  872 (912)
Q Consensus       817 ~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~~~~~~~~  872 (912)
                            ...+-..+++++..|.+|++.||++|-.+||.+.||+..|++++.....-
T Consensus       849 ------~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SL  898 (996)
T KOG0196|consen  849 ------QGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSL  898 (996)
T ss_pred             ------hccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhh
Confidence                  12222335677789999999999999999999999999999998876653

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=3.8e-36  Score=331.82  Aligned_cols=265  Identities=26%  Similarity=0.401  Sum_probs=204.4

Q ss_pred             HHHHHhhhcccCccccEEEEEEEecC-----------------CCEEEEEEccCccc-hhhHHHHHHHHHHHhcCCCCcc
Q 002529          588 EEATNNFCKKIGKGSFGSVYYGKMKD-----------------GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLV  649 (912)
Q Consensus       588 ~~~~~~~~~~LG~G~fg~Vy~a~~~~-----------------~~~vAvK~l~~~~~-~~~~~~~~E~~il~~L~hpnIv  649 (912)
                      .+..|.+.++||+|+||.||+|.+++                 +..||+|.+..... .....+.+|++++++++||||+
T Consensus         3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv   82 (304)
T cd05096           3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNII   82 (304)
T ss_pred             chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCee
Confidence            35567788999999999999997542                 34699999876433 3456789999999999999999


Q ss_pred             ceeeEEecCCeEEEEEEecCCCCHHHHhccCC----------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 002529          650 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSV----------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI  713 (912)
Q Consensus       650 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~i  713 (912)
                      ++++++.+.+..++||||+++|+|.+++....                ....+++..+++++.||+.||+|||+   .+|
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i  159 (304)
T cd05096          83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNF  159 (304)
T ss_pred             EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCc
Confidence            99999999999999999999999999886421                11347888999999999999999998   999


Q ss_pred             eecCCCCCCccccCCCcEEEeeccCccccccccc-cccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh--CC
Q 002529          714 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS--GK  790 (912)
Q Consensus       714 vH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt--G~  790 (912)
                      +||||||+|||++.++.+||+|||++........ .......++..|+|||++.+..++.++||||||+++|||++  +.
T Consensus       160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~  239 (304)
T cd05096         160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE  239 (304)
T ss_pred             cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence            9999999999999999999999999876533221 12223345788999999988899999999999999999987  56


Q ss_pred             CCCCccCccchhhHHHHHHhhhccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhh
Q 002529          791 KPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD  864 (912)
Q Consensus       791 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~  864 (912)
                      .||.....   ......+.............      ..+...+..+.+++.+||+.+|++|||+.||.+.|++
T Consensus       240 ~p~~~~~~---~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         240 QPYGELTD---EQVIENAGEFFRDQGRQVYL------FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCCCcCCH---HHHHHHHHHHhhhccccccc------cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            77763322   12222222222111100000      0111233578999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-38  Score=335.50  Aligned_cols=247  Identities=26%  Similarity=0.376  Sum_probs=208.4

Q ss_pred             HHhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc-chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEec
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM  668 (912)
Q Consensus       591 ~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~  668 (912)
                      .|+-.++||+|.||.||+|... .++.||+|++.-.. .....++++|+.+|.+++++||.++++.+..+..++++||||
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~   93 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC   93 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence            3444589999999999999866 68999999986543 345678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccc
Q 002529          669 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH  748 (912)
Q Consensus       669 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  748 (912)
                      .||++.+.++   .+..+.+..+..|+++++.||.|||+   .+.+|||||+.|||+..+|.+||+|||.+.........
T Consensus        94 ~gGsv~~lL~---~~~~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r  167 (467)
T KOG0201|consen   94 GGGSVLDLLK---SGNILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR  167 (467)
T ss_pred             cCcchhhhhc---cCCCCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence            9999999998   45566888999999999999999998   99999999999999999999999999999887765544


Q ss_pred             ccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCC
Q 002529          749 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN  828 (912)
Q Consensus       749 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  828 (912)
                      . ...+||+.|||||++++..|+.|+||||||++.+||++|.+|+......                +..-++.....+.
T Consensus       168 r-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm----------------rvlflIpk~~PP~  230 (467)
T KOG0201|consen  168 R-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM----------------RVLFLIPKSAPPR  230 (467)
T ss_pred             c-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc----------------eEEEeccCCCCCc
Confidence            3 5677999999999999989999999999999999999999999743321                1122222222222


Q ss_pred             CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          829 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       829 ~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                      ........+.+++..||++||+.||+|+++++
T Consensus       231 L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  231 LDGDFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             cccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            22344457899999999999999999999985

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=4e-36  Score=328.52  Aligned_cols=246  Identities=24%  Similarity=0.358  Sum_probs=199.1

Q ss_pred             cccCccccEEEEEEEecCCCEEEEEEccCccchh---hHHHHHHHHHHHhcCCCCccceeeEEec----CCeEEEEEEec
Q 002529          596 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHR---TQQFVTEVALLSRIHHRNLVPLIGYCEE----EHQRILVYEYM  668 (912)
Q Consensus       596 ~~LG~G~fg~Vy~a~~~~~~~vAvK~l~~~~~~~---~~~~~~E~~il~~L~hpnIv~l~~~~~~----~~~~~lV~E~~  668 (912)
                      ..||+|++|.||+|.++ |+.||||.++......   .+.+.+|+.+|++++||||+++++++.+    ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIFN-NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEEC-CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            57999999999999984 8999999997643322   4678899999999999999999999876    34688999999


Q ss_pred             CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccc
Q 002529          669 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH  748 (912)
Q Consensus       669 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  748 (912)
                      ++|+|.+++..   ...+++...+.++.|++.||+|||+  ..+++||||||+||+++.++.+||+|||++.......  
T Consensus       105 ~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--  177 (283)
T PHA02988        105 TRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--  177 (283)
T ss_pred             CCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence            99999999984   4578899999999999999999997  2488999999999999999999999999987654321  


Q ss_pred             ccccccCCCcccCCCccCC--CCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCcccc
Q 002529          749 ISSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI  826 (912)
Q Consensus       749 ~~~~~~gt~~y~APE~l~~--~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  826 (912)
                        ....++..|+|||++.+  ..++.++|||||||++|||++|+.||......   .+   .......+...        
T Consensus       178 --~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~---~~---~~~i~~~~~~~--------  241 (283)
T PHA02988        178 --FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK---EI---YDLIINKNNSL--------  241 (283)
T ss_pred             --ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH---HH---HHHHHhcCCCC--------
Confidence              12347889999999976  68899999999999999999999999743221   11   11111111110        


Q ss_pred             CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhhh
Q 002529          827 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI  866 (912)
Q Consensus       827 ~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~~  866 (912)
                       ..+......+.+++.+||+.||++|||++|+++.|+...
T Consensus       242 -~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        242 -KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             -CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence             111123457899999999999999999999999998764

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2e-36  Score=344.33  Aligned_cols=260  Identities=28%  Similarity=0.430  Sum_probs=205.4

Q ss_pred             HHHHHhhhcccCccccEEEEEEEe------cCCCEEEEEEccCcc-chhhHHHHHHHHHHHhc-CCCCccceeeEEecCC
Q 002529          588 EEATNNFCKKIGKGSFGSVYYGKM------KDGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEH  659 (912)
Q Consensus       588 ~~~~~~~~~~LG~G~fg~Vy~a~~------~~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~L-~hpnIv~l~~~~~~~~  659 (912)
                      ....+++.++||+|+||.||+|++      +++..||||+++... ....+.+.+|+++++.+ +||||+++++++...+
T Consensus        33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~  112 (375)
T cd05104          33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG  112 (375)
T ss_pred             chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence            355678899999999999999974      235689999987543 33456788999999999 8999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHhccCC----------------------------------------------------------
Q 002529          660 QRILVYEYMHNGTLRDRLHGSV----------------------------------------------------------  681 (912)
Q Consensus       660 ~~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------  681 (912)
                      ..++||||+++|+|.++++...                                                          
T Consensus       113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (375)
T cd05104         113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG  192 (375)
T ss_pred             cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence            9999999999999999986421                                                          


Q ss_pred             --------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccc
Q 002529          682 --------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT  747 (912)
Q Consensus       682 --------------~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~  747 (912)
                                    ....+++..++.++.||++||+|||+   ++++||||||+|||++.++.+||+|||++........
T Consensus       193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  269 (375)
T cd05104         193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN  269 (375)
T ss_pred             eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence                          11257888999999999999999998   9999999999999999999999999999986543322


Q ss_pred             c-ccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhhhccCCcccccCccc
Q 002529          748 H-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL  825 (912)
Q Consensus       748 ~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  825 (912)
                      . ......++..|+|||++.+..++.++|||||||++|||++ |..||......  ....+.+    ..+....  .   
T Consensus       270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~--~~~~~~~----~~~~~~~--~---  338 (375)
T cd05104         270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD--SKFYKMI----KEGYRML--S---  338 (375)
T ss_pred             ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch--HHHHHHH----HhCccCC--C---
Confidence            1 1122334668999999999999999999999999999998 89998633221  1222221    1111100  0   


Q ss_pred             cCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhh
Q 002529          826 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS  865 (912)
Q Consensus       826 ~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~  865 (912)
                          +...+.++.+++.+||+.||++||+++||++.|++.
T Consensus       339 ----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         339 ----PECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             ----CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence                111234788999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2.6e-36  Score=325.13  Aligned_cols=257  Identities=26%  Similarity=0.448  Sum_probs=209.0

Q ss_pred             HHHHHhhhcccCccccEEEEEEEecCCCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEe
Q 002529          588 EEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY  667 (912)
Q Consensus       588 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  667 (912)
                      ....+++.++||+|++|.||+|..++++.||+|.+.... ...+.+.+|+.++++++|+||+++++.+...+..+++|||
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05072           4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY   82 (261)
T ss_pred             chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence            456677889999999999999998888999999986532 3356789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccc
Q 002529          668 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT  747 (912)
Q Consensus       668 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~  747 (912)
                      +++++|.++++.. ....+++..++.++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||++........
T Consensus        83 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05072          83 MAKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY  158 (261)
T ss_pred             CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence            9999999998754 34568889999999999999999998   9999999999999999999999999999987654332


Q ss_pred             cccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhhhccCCcccccCcccc
Q 002529          748 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI  826 (912)
Q Consensus       748 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  826 (912)
                      .......++..|+|||++.+..++.++|||||||++|+|++ |+.||......   .....+    ..+...    + . 
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~----~~~~~~----~-~-  225 (261)
T cd05072         159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS---DVMSAL----QRGYRM----P-R-  225 (261)
T ss_pred             eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH---HHHHHH----HcCCCC----C-C-
Confidence            22222335678999999988889999999999999999998 99999633221   112211    111110    0 0 


Q ss_pred             CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhh
Q 002529          827 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS  865 (912)
Q Consensus       827 ~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~  865 (912)
                         ....+..+.+++.+||+.+|++||+++++++.|++.
T Consensus       226 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         226 ---MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             ---CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence               111234688999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=7.5e-36  Score=333.86  Aligned_cols=263  Identities=22%  Similarity=0.315  Sum_probs=204.5

Q ss_pred             HHHHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCccc-hhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEE
Q 002529          588 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY  665 (912)
Q Consensus       588 ~~~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~  665 (912)
                      ....|++.+.||+|+||.||+++.+ ++..+|+|++..... .....+.+|++++++++||||+++++++..++..++||
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (331)
T cd06649           3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   82 (331)
T ss_pred             CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence            3456778899999999999999887 588899999875432 34467899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccc
Q 002529          666 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED  745 (912)
Q Consensus       666 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~  745 (912)
                      ||+++++|.+++..   ...+++..+..++.|++.||.|||+  ..+|+||||||+||+++.++.+||+|||++......
T Consensus        83 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  157 (331)
T cd06649          83 EHMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  157 (331)
T ss_pred             ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence            99999999999973   4568999999999999999999997  246999999999999999999999999998765432


Q ss_pred             cccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccC---Cc-----
Q 002529          746 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG---DV-----  817 (912)
Q Consensus       746 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~---~~-----  817 (912)
                      .   .....|++.|+|||++.+..++.++|||||||++|||++|+.||......+   +..........+   ..     
T Consensus       158 ~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  231 (331)
T cd06649         158 M---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE---LEAIFGRPVVDGEEGEPHSISP  231 (331)
T ss_pred             c---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhcccccccccCCccccCc
Confidence            2   223458999999999999999999999999999999999999997433211   111111000000   00     


Q ss_pred             ----------------------ccccCcc---ccCCC-CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002529          818 ----------------------ISIVDPV---LIGNV-KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       818 ----------------------~~~~d~~---l~~~~-~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  861 (912)
                                            .+..+..   ..... ......++.+++.+||+.||++|||++|+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         232 RPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             ccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                                  0000000   00000 01133478999999999999999999999875

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-37  Score=340.23  Aligned_cols=264  Identities=28%  Similarity=0.488  Sum_probs=209.6

Q ss_pred             HHHHHHHhhhcccCccccEEEEEEEecCCCEEEEEEccCcc--chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEE
Q 002529          586 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL  663 (912)
Q Consensus       586 ~l~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~l  663 (912)
                      ||......+.+.||+|.||+||+|.|.  ..||||+++...  .+..+.|++|+.++++-+|.||+-+.|+|..... .|
T Consensus       388 eIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AI  464 (678)
T KOG0193|consen  388 EIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AI  464 (678)
T ss_pred             ccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-ee
Confidence            333444457899999999999999997  359999997543  3456889999999999999999999999998877 99


Q ss_pred             EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccc
Q 002529          664 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE  743 (912)
Q Consensus       664 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~  743 (912)
                      |+.+|+|.+|..+++..  ...+...+.+.|++||++|+.|||.   ++|||+|||..|||+.+++.|||+|||++....
T Consensus       465 iTqwCeGsSLY~hlHv~--etkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~  539 (678)
T KOG0193|consen  465 ITQWCEGSSLYTHLHVQ--ETKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT  539 (678)
T ss_pred             eehhccCchhhhhccch--hhhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccceeeee
Confidence            99999999999999964  4678999999999999999999999   999999999999999999999999999986532


Q ss_pred             cc-cccccccccCCCcccCCCccCCC---CCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCccc
Q 002529          744 ED-LTHISSVARGTVGYLDPEYYGNQ---QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS  819 (912)
Q Consensus       744 ~~-~~~~~~~~~gt~~y~APE~l~~~---~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  819 (912)
                      .- ........-|...|||||+++..   +|++.+||||||+++|||++|..||.....+       .+.-++..|-.  
T Consensus       540 ~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d-------qIifmVGrG~l--  610 (678)
T KOG0193|consen  540 RWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD-------QIIFMVGRGYL--  610 (678)
T ss_pred             eeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh-------heEEEeccccc--
Confidence            21 11111223367889999998643   7899999999999999999999999822221       11111111111  


Q ss_pred             ccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhhhhhc
Q 002529          820 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE  869 (912)
Q Consensus       820 ~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~~~~~  869 (912)
                      ..|..   ......+.++.+|+..||..++++||.+.+|+..|++++...
T Consensus       611 ~pd~s---~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~  657 (678)
T KOG0193|consen  611 MPDLS---KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL  657 (678)
T ss_pred             Cccch---hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence            01110   122345668999999999999999999999999999988853

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-36  Score=350.64  Aligned_cols=265  Identities=22%  Similarity=0.273  Sum_probs=213.5

Q ss_pred             HHHhhhcccCccccEEEEEEEecCC-CEEEEEEccCccchhhHHHHHHHHHHHhcC-CCCccceeeEE-ec------CCe
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMKDG-KEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYC-EE------EHQ  660 (912)
Q Consensus       590 ~~~~~~~~LG~G~fg~Vy~a~~~~~-~~vAvK~l~~~~~~~~~~~~~E~~il~~L~-hpnIv~l~~~~-~~------~~~  660 (912)
                      .+.++.+.|.+|||+.||+|....+ ..||+|++-.......+.+.+|+++|++|+ |+|||.+++.. ..      .-+
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E  116 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE  116 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence            3445678999999999999998765 999999987666677889999999999997 99999999932 11      236


Q ss_pred             EEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcc
Q 002529          661 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR  740 (912)
Q Consensus       661 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~  740 (912)
                      .+|.||||+||.|-|++.... ...|++.++++|+.|+++|+++||. +..+|||||||.+||||+.+++.||||||.+.
T Consensus       117 vllLmEyC~gg~Lvd~mn~Rl-q~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSat  194 (738)
T KOG1989|consen  117 VLLLMEYCKGGSLVDFMNTRL-QTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSAT  194 (738)
T ss_pred             EEeehhhccCCcHHHHHHHHH-hccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence            789999999999999998664 3449999999999999999999997 45779999999999999999999999999987


Q ss_pred             ccccccccc--------cccccCCCcccCCCcc---CCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHH
Q 002529          741 QAEEDLTHI--------SSVARGTVGYLDPEYY---GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR  809 (912)
Q Consensus       741 ~~~~~~~~~--------~~~~~gt~~y~APE~l---~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~  809 (912)
                      ..-......        .-...-|+.|+|||.+   .+..+++|+|||+|||+||-|+....||+...            
T Consensus       195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg------------  262 (738)
T KOG1989|consen  195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG------------  262 (738)
T ss_pred             cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc------------
Confidence            643222110        1112368999999976   67789999999999999999999999998321            


Q ss_pred             hhhccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhhhhhccCCCCc
Q 002529          810 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQK  875 (912)
Q Consensus       810 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~~~~~~~~~~~  875 (912)
                             ...+++-...-.-.+.....|.+||+.||++||.+||++.+|+..+.++...+......
T Consensus       263 -------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~~  321 (738)
T KOG1989|consen  263 -------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPDI  321 (738)
T ss_pred             -------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCcccc
Confidence                   11222222211112456678999999999999999999999999999988877664433

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.2e-36  Score=323.59  Aligned_cols=258  Identities=26%  Similarity=0.471  Sum_probs=208.9

Q ss_pred             HHHHHHhhhcccCccccEEEEEEEecCCCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEE
Q 002529          587 LEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE  666 (912)
Q Consensus       587 l~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E  666 (912)
                      +...++++.+.||+|++|.||+|..++++.||+|.++... ...+++.+|++++++++||||+++++++...+..++|||
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (261)
T cd05068           3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE   81 (261)
T ss_pred             cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence            4456788899999999999999998888899999987543 335678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccc
Q 002529          667 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL  746 (912)
Q Consensus       667 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~  746 (912)
                      |+++++|.+++.... ...+++..+..++.|++.||.+||+   .+++||||||+||+++.++.++|+|||++.......
T Consensus        82 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05068          82 LMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI  157 (261)
T ss_pred             cccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence            999999999997542 4578999999999999999999998   999999999999999999999999999998765332


Q ss_pred             ccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhhhccCCcccccCccc
Q 002529          747 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL  825 (912)
Q Consensus       747 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  825 (912)
                      .........+..|+|||++.+..++.++||||||+++|||++ |+.||......   .....    +......       
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~----~~~~~~~-------  223 (261)
T cd05068         158 YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA---EVLQQ----VDQGYRM-------  223 (261)
T ss_pred             ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHH----HHcCCCC-------
Confidence            221111223457999999999899999999999999999999 99999733211   11111    1111100       


Q ss_pred             cCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhh
Q 002529          826 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS  865 (912)
Q Consensus       826 ~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~  865 (912)
                        ..+......+.+++.+|++.+|++||+++++++.|++.
T Consensus       224 --~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         224 --PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             --CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence              01112335789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=8.3e-36  Score=321.84  Aligned_cols=256  Identities=30%  Similarity=0.461  Sum_probs=207.2

Q ss_pred             HHHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEe
Q 002529          589 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY  667 (912)
Q Consensus       589 ~~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  667 (912)
                      ...+.+.++||+|++|.||+|..+ .++.||+|.+... ......+.+|++++++++|+||+++++++..++..+++|||
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (263)
T cd05052           5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   83 (263)
T ss_pred             hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence            445667889999999999999876 5889999998754 33456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccc
Q 002529          668 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT  747 (912)
Q Consensus       668 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~  747 (912)
                      +++++|.+++... ....+++..++.++.|+++||+|||+   .+++||||||+||++++++.+||+|||++........
T Consensus        84 ~~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~  159 (263)
T cd05052          84 MTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  159 (263)
T ss_pred             CCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence            9999999998753 24568999999999999999999998   9999999999999999999999999999887654322


Q ss_pred             cccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhhhccCCcccccCcccc
Q 002529          748 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI  826 (912)
Q Consensus       748 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  826 (912)
                      .......++..|+|||.+.+..++.++|||||||++|||++ |..||......   .....    +..+..         
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~---~~~~~----~~~~~~---------  223 (263)
T cd05052         160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYEL----LEKGYR---------  223 (263)
T ss_pred             eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH----HHCCCC---------
Confidence            22222234568999999998899999999999999999998 99998743321   11111    111100         


Q ss_pred             CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhh
Q 002529          827 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS  865 (912)
Q Consensus       827 ~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~  865 (912)
                      ...+...+..+.+++.+||+.+|++||++.|++++|+.+
T Consensus       224 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         224 MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            011122234788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=342.57  Aligned_cols=266  Identities=31%  Similarity=0.466  Sum_probs=214.0

Q ss_pred             HHHHHHHhhhcccCccccEEEEEEEecC--C--CE-EEEEEccC---ccchhhHHHHHHHHHHHhcCCCCccceeeEEec
Q 002529          586 ELEEATNNFCKKIGKGSFGSVYYGKMKD--G--KE-VAVKIMAD---SCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE  657 (912)
Q Consensus       586 ~l~~~~~~~~~~LG~G~fg~Vy~a~~~~--~--~~-vAvK~l~~---~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~  657 (912)
                      +|......+.++||+|+||.||+|+++.  +  .. ||+|..+.   .......++.+|+++|++++|||||+++|++..
T Consensus       153 el~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~  232 (474)
T KOG0194|consen  153 ELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL  232 (474)
T ss_pred             EEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC
Confidence            4445555567999999999999998763  2  23 89999885   234567889999999999999999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeecc
Q 002529          658 EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG  737 (912)
Q Consensus       658 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFG  737 (912)
                      +..+++|||+|.||+|.++|++.  ...++..++..++.+.|.||+|||+   ++++||||..+|+|++.++.+||+|||
T Consensus       233 ~~Pl~ivmEl~~gGsL~~~L~k~--~~~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFG  307 (474)
T KOG0194|consen  233 EEPLMLVMELCNGGSLDDYLKKN--KKSLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFG  307 (474)
T ss_pred             CCccEEEEEecCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCccc
Confidence            99999999999999999999964  3469999999999999999999999   999999999999999999999999999


Q ss_pred             CccccccccccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhhhccCC
Q 002529          738 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGD  816 (912)
Q Consensus       738 la~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~  816 (912)
                      +++....- ........-+..|+|||.+....++.++|||||||++||+++ |..||.+....   ....++   ..++.
T Consensus       308 Ls~~~~~~-~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~---~v~~kI---~~~~~  380 (474)
T KOG0194|consen  308 LSRAGSQY-VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY---EVKAKI---VKNGY  380 (474)
T ss_pred             cccCCcce-eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH---HHHHHH---HhcCc
Confidence            98765411 111111124679999999999999999999999999999999 88899743322   111211   12221


Q ss_pred             cccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhhhhhccCC
Q 002529          817 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGG  872 (912)
Q Consensus       817 ~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~~~~~~~~  872 (912)
                      ..         ..+...+..+..++.+|+..+|++||+|.++.+.|+.+.......
T Consensus       381 r~---------~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~  427 (474)
T KOG0194|consen  381 RM---------PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAF  427 (474)
T ss_pred             cC---------CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccccc
Confidence            11         112234457788888999999999999999999999988876653

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=6.5e-36  Score=321.82  Aligned_cols=256  Identities=27%  Similarity=0.432  Sum_probs=211.5

Q ss_pred             HHHHhhhcccCccccEEEEEEEecCCCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEec
Q 002529          589 EATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM  668 (912)
Q Consensus       589 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~  668 (912)
                      ...|.+.++||.|+||.||+|..++++.+++|.+..........+.+|+.+++.++|+||+++++++......++||||+
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   84 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM   84 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence            45688899999999999999999889999999998765555678899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccc
Q 002529          669 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH  748 (912)
Q Consensus       669 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  748 (912)
                      ++++|.+++... ....+++..+..++.||+.||+|||+   .+++|+||||+||+++.++.+||+|||.+.........
T Consensus        85 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~  160 (261)
T cd05148          85 EKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL  160 (261)
T ss_pred             ccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence            999999999854 34578999999999999999999998   99999999999999999999999999999776443222


Q ss_pred             ccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhhhccCCcccccCccccC
Q 002529          749 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG  827 (912)
Q Consensus       749 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  827 (912)
                      .. ...++..|+|||.+.+..++.++||||||+++|+|++ |+.||......   .......    .+..         .
T Consensus       161 ~~-~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~---~~~~~~~----~~~~---------~  223 (261)
T cd05148         161 SS-DKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH---EVYDQIT----AGYR---------M  223 (261)
T ss_pred             cc-CCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH---HHHHHHH----hCCc---------C
Confidence            11 2335678999999988899999999999999999998 89999743311   1111111    1100         0


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhh
Q 002529          828 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS  865 (912)
Q Consensus       828 ~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~  865 (912)
                      ..+...+..+.+++.+||+.+|++|||++++++.|+.+
T Consensus       224 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         224 PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence            11122334788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=3.7e-36  Score=328.77  Aligned_cols=264  Identities=19%  Similarity=0.205  Sum_probs=201.3

Q ss_pred             HHhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc--chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEe
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY  667 (912)
Q Consensus       591 ~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  667 (912)
                      .|++.+.||+|+||.||+|+++ +++.||+|+++...  ....+.+.+|++++++++||||+++++++..++..++||||
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY   81 (287)
T ss_pred             CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence            3667889999999999999987 58899999987542  22346688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccc
Q 002529          668 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT  747 (912)
Q Consensus       668 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~  747 (912)
                      ++++.+..+..   ....+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++........
T Consensus        82 ~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  155 (287)
T cd07848          82 VEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN  155 (287)
T ss_pred             CCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence            99887765543   24568999999999999999999998   9999999999999999999999999999987644332


Q ss_pred             cccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHH---------HhhhccCCcc
Q 002529          748 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWA---------RSMIKKGDVI  818 (912)
Q Consensus       748 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~---------~~~~~~~~~~  818 (912)
                      .......|++.|+|||++.+..++.++|||||||++|||++|+.||......+........         ..........
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07848         156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH  235 (287)
T ss_pred             ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence            2223345889999999999888999999999999999999999999754322111111110         0000000000


Q ss_pred             cccCccccC------CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          819 SIVDPVLIG------NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       819 ~~~d~~l~~------~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                      ....+....      .........+.+++.+||+.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            000000000      001112346899999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=3.6e-36  Score=335.28  Aligned_cols=241  Identities=24%  Similarity=0.351  Sum_probs=196.5

Q ss_pred             cccCccccEEEEEEEec-CCCEEEEEEccCcc---chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEecCCC
Q 002529          596 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG  671 (912)
Q Consensus       596 ~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~g  671 (912)
                      +.||+|+||.||+|+.+ +++.||+|+++...   ......+.+|++++++++||||+++++++..++..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999876 68999999987532   233456788999999999999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccccccc
Q 002529          672 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS  751 (912)
Q Consensus       672 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~  751 (912)
                      +|.+++.   ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++....... ...
T Consensus        81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~  153 (323)
T cd05571          81 ELFFHLS---RERVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA-TMK  153 (323)
T ss_pred             cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-ccc
Confidence            9999987   35678999999999999999999998   9999999999999999999999999999875322211 122


Q ss_pred             cccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCCCCH
Q 002529          752 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI  831 (912)
Q Consensus       752 ~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  831 (912)
                      ...|++.|+|||++.+..++.++|||||||++|||++|+.||...+..   ....    .+..+..      .    ++.
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~~----~~~~~~~------~----~p~  216 (323)
T cd05571         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFE----LILMEEI------R----FPR  216 (323)
T ss_pred             ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH---HHHH----HHHcCCC------C----CCC
Confidence            345899999999999999999999999999999999999999743221   1111    1111111      1    111


Q ss_pred             HHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 002529          832 ESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL  860 (912)
Q Consensus       832 ~~~~~l~~Li~~cL~~dP~~RP-----s~~evl~  860 (912)
                      .....+.+++.+||+.||++||     +++|+++
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            2234688999999999999999     7999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=5.5e-36  Score=327.59  Aligned_cols=250  Identities=24%  Similarity=0.306  Sum_probs=199.9

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc---chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEe
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY  667 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  667 (912)
                      |+..+.||+|+||.||+|... +++.||+|.+....   ......+.+|++++++++|+||+++++++.+++..++||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            456789999999999999875 78999999986432   12334678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccc
Q 002529          668 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT  747 (912)
Q Consensus       668 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~  747 (912)
                      +++|+|.+++... ....+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.++|+|||++........
T Consensus        82 ~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05631          82 MNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET  157 (285)
T ss_pred             cCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence            9999999887643 23468999999999999999999998   9999999999999999999999999999987543222


Q ss_pred             cccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccC
Q 002529          748 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG  827 (912)
Q Consensus       748 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  827 (912)
                        .....|+..|+|||++.+..++.++|||||||++|||++|+.||........   .+.+...+....          .
T Consensus       158 --~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~----------~  222 (285)
T cd05631         158 --VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK---REEVDRRVKEDQ----------E  222 (285)
T ss_pred             --ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh---HHHHHHHhhccc----------c
Confidence              1234589999999999999999999999999999999999999984432211   111111111110          0


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 002529          828 NVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVL  860 (912)
Q Consensus       828 ~~~~~~~~~l~~Li~~cL~~dP~~RPs-----~~evl~  860 (912)
                      .++......+.+|+.+||+.||++||+     ++|+++
T Consensus       223 ~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         223 EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            111222347889999999999999997     788876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=3.4e-36  Score=342.21  Aligned_cols=262  Identities=29%  Similarity=0.445  Sum_probs=206.1

Q ss_pred             HHHHHHhhhcccCccccEEEEEEEec------CCCEEEEEEccCcc-chhhHHHHHHHHHHHhc-CCCCccceeeEEecC
Q 002529          587 LEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE  658 (912)
Q Consensus       587 l~~~~~~~~~~LG~G~fg~Vy~a~~~------~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~L-~hpnIv~l~~~~~~~  658 (912)
                      +....+++.+.||+|+||.||+|.+.      +++.||+|+++... ......+.+|+++++.+ +|+||+++++++...
T Consensus        35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~  114 (374)
T cd05106          35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG  114 (374)
T ss_pred             ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence            44567888999999999999999743      24579999997543 33346788999999999 899999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHhccCC---------------------------------------------------------
Q 002529          659 HQRILVYEYMHNGTLRDRLHGSV---------------------------------------------------------  681 (912)
Q Consensus       659 ~~~~lV~E~~~~gsL~~~l~~~~---------------------------------------------------------  681 (912)
                      +..++||||+++|+|.++++...                                                         
T Consensus       115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (374)
T cd05106         115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS  194 (374)
T ss_pred             CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence            99999999999999999886421                                                         


Q ss_pred             ----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccc-cc
Q 002529          682 ----------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH-IS  750 (912)
Q Consensus       682 ----------~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~-~~  750 (912)
                                ...++++.++++++.||++||+|||+   ++++||||||+|||++.++.+||+|||++......... ..
T Consensus       195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~  271 (374)
T cd05106         195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK  271 (374)
T ss_pred             ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence                      11357888999999999999999998   99999999999999999999999999998765433221 11


Q ss_pred             ccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCCC
Q 002529          751 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV  829 (912)
Q Consensus       751 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  829 (912)
                      ....++..|+|||++.+..++.++|||||||++|||++ |+.||.......  ....    ....+..     ...    
T Consensus       272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~~~----~~~~~~~-----~~~----  336 (374)
T cd05106         272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KFYK----MVKRGYQ-----MSR----  336 (374)
T ss_pred             cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HHHH----HHHcccC-----ccC----
Confidence            22235668999999998899999999999999999997 999997332211  1111    1111110     000    


Q ss_pred             CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhhh
Q 002529          830 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI  866 (912)
Q Consensus       830 ~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~~  866 (912)
                      +...+..+.+++.+||+.+|++||++.||+++|++++
T Consensus       337 ~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         337 PDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            1111347889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.7e-35  Score=317.86  Aligned_cols=251  Identities=31%  Similarity=0.509  Sum_probs=203.2

Q ss_pred             HHHhhhcccCccccEEEEEEEecCCCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEecC
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH  669 (912)
Q Consensus       590 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~  669 (912)
                      ..+++.+.||+|+||.||+|.++++..+|+|.+.... ...+++.+|++++++++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            4566788999999999999999888899999886432 234678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccccc
Q 002529          670 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI  749 (912)
Q Consensus       670 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~  749 (912)
                      +|+|.++++..  ...+++..++.++.|++.||+|||+   ++++|+||||+||+++.++.+||+|||.+..........
T Consensus        83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05114          83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS  157 (256)
T ss_pred             CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence            99999998743  2468899999999999999999998   999999999999999999999999999987654332222


Q ss_pred             cccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCC
Q 002529          750 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN  828 (912)
Q Consensus       750 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  828 (912)
                      .....++..|+|||.+.+..++.++||||||+++|||++ |+.||.....   ......+    ..+..  ...+.    
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~---~~~~~~i----~~~~~--~~~~~----  224 (256)
T cd05114         158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN---YEVVEMI----SRGFR--LYRPK----  224 (256)
T ss_pred             cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHH----HCCCC--CCCCC----
Confidence            222235668999999988889999999999999999999 8999973322   1122221    11111  00111    


Q ss_pred             CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 002529          829 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI  862 (912)
Q Consensus       829 ~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  862 (912)
                         .....+.+++.+||+.+|++||+++|+++.|
T Consensus       225 ---~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         225 ---LASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             ---CCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence               1224688999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-36  Score=306.51  Aligned_cols=236  Identities=26%  Similarity=0.352  Sum_probs=198.9

Q ss_pred             HHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCccch---hhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEE
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH---RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY  665 (912)
Q Consensus       590 ~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~---~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~  665 (912)
                      ..+++.+.||.|+||+|.+++.+ +|..+|+|++.+..--   ..+...+|..+|+.+.||.++++.+.+.+.+..+|||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            34567889999999999999987 5889999999865433   3456778999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccc
Q 002529          666 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED  745 (912)
Q Consensus       666 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~  745 (912)
                      ||++||-|..+++   ..+++++...+-++.||+.||+|||+   .+|++|||||+|||+|.+|.+||+|||+|+.....
T Consensus       124 eyv~GGElFS~Lr---k~~rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r  197 (355)
T KOG0616|consen  124 EYVPGGELFSYLR---KSGRFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR  197 (355)
T ss_pred             eccCCccHHHHHH---hcCCCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence            9999999999999   46789999999999999999999999   99999999999999999999999999999987654


Q ss_pred             cccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccc
Q 002529          746 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL  825 (912)
Q Consensus       746 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  825 (912)
                          ....+|||.|+|||+++...+..++|-|||||++|||+.|.+||......   .+   . ..+-++++        
T Consensus       198 ----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~---~i---Y-~KI~~~~v--------  258 (355)
T KOG0616|consen  198 ----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI---QI---Y-EKILEGKV--------  258 (355)
T ss_pred             ----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH---HH---H-HHHHhCcc--------
Confidence                34567999999999999999999999999999999999999999733321   11   1 11112211        


Q ss_pred             cCCCCHHHHHHHHHHHHhcccCCCCCC
Q 002529          826 IGNVKIESIWRIAEVAIQCVEQRGFSR  852 (912)
Q Consensus       826 ~~~~~~~~~~~l~~Li~~cL~~dP~~R  852 (912)
                        .++......+.+|+.+.|+.|-.+|
T Consensus       259 --~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  259 --KFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             --cCCcccCHHHHHHHHHHHhhhhHhh
Confidence              1122223367899999999999998

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-36  Score=323.76  Aligned_cols=252  Identities=29%  Similarity=0.385  Sum_probs=197.3

Q ss_pred             HHHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCccch--------------hhHHHHHHHHHHHhcCCCCccceee
Q 002529          589 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH--------------RTQQFVTEVALLSRIHHRNLVPLIG  653 (912)
Q Consensus       589 ~~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~--------------~~~~~~~E~~il~~L~hpnIv~l~~  653 (912)
                      -..|++.+.||+|.||.|-+|+.. +++.||||++.+....              ..+...+|+.+|++++|||||+|++
T Consensus        96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE  175 (576)
T KOG0585|consen   96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE  175 (576)
T ss_pred             hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence            356778899999999999999876 6899999999653211              1247889999999999999999999


Q ss_pred             EEec--CCeEEEEEEecCCCCHHHHhccCCCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCc
Q 002529          654 YCEE--EHQRILVYEYMHNGTLRDRLHGSVNQKP-LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR  730 (912)
Q Consensus       654 ~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~-l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~  730 (912)
                      +..+  .+.+|||+|||..|.+...-    ..++ +++.+.++++++++.||+|||.   +||+||||||+|+||+++|+
T Consensus       176 vLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~g~  248 (576)
T KOG0585|consen  176 VLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSDGT  248 (576)
T ss_pred             eecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCCCc
Confidence            9976  46899999999988875433    2344 9999999999999999999999   99999999999999999999


Q ss_pred             EEEeeccCccccccc----cccccccccCCCcccCCCccCCC----CCCchhHHHHHHHHHHHHHhCCCCCCccCccchh
Q 002529          731 AKVSDFGLSRQAEED----LTHISSVARGTVGYLDPEYYGNQ----QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL  802 (912)
Q Consensus       731 vkL~DFGla~~~~~~----~~~~~~~~~gt~~y~APE~l~~~----~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~  802 (912)
                      +||+|||.+......    ....-....|||.|+|||...++    ..+.+.||||+||+||.|+.|+.||.+..     
T Consensus       249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~-----  323 (576)
T KOG0585|consen  249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF-----  323 (576)
T ss_pred             EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch-----
Confidence            999999998866221    11112236799999999988663    24578999999999999999999997221     


Q ss_pred             hHHHHHHhhhccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 002529          803 NIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI  862 (912)
Q Consensus       803 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  862 (912)
                       ..+.... +.+.        .+.-...++....+.+||.+||++||++|.+..+|....
T Consensus       324 -~~~l~~K-Ivn~--------pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp  373 (576)
T KOG0585|consen  324 -ELELFDK-IVND--------PLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP  373 (576)
T ss_pred             -HHHHHHH-HhcC--------cccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence             1221122 2111        111111123455889999999999999999999987553

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.5e-35  Score=329.95  Aligned_cols=202  Identities=26%  Similarity=0.393  Sum_probs=176.5

Q ss_pred             HHHHHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCccc-hhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEE
Q 002529          587 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV  664 (912)
Q Consensus       587 l~~~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV  664 (912)
                      +....|++.++||+|+||.||++.++ +++.+|+|++..... .....+.+|++++++++||||+++++++.+++..++|
T Consensus         2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (333)
T cd06650           2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   81 (333)
T ss_pred             cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence            45677889999999999999999887 688899998875422 3446789999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccc
Q 002529          665 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE  744 (912)
Q Consensus       665 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~  744 (912)
                      |||+++++|.+++..   ...+++..+..++.|++.||+|||+  ..+++|+||||+|||++.++.+||+|||++.....
T Consensus        82 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~  156 (333)
T cd06650          82 MEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (333)
T ss_pred             EecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence            999999999999973   4568899999999999999999997  25799999999999999999999999999876533


Q ss_pred             ccccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcc
Q 002529          745 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVE  796 (912)
Q Consensus       745 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~  796 (912)
                      ..   .....|+..|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus       157 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~  205 (333)
T cd06650         157 SM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP  205 (333)
T ss_pred             hc---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence            21   12345889999999999989999999999999999999999999743

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=8.9e-36  Score=326.45  Aligned_cols=263  Identities=22%  Similarity=0.283  Sum_probs=198.1

Q ss_pred             HHhhhcccCccccEEEEEEEec-CCCEEEEEEccCccc-hhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEec
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM  668 (912)
Q Consensus       591 ~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~  668 (912)
                      .|++.++||+|+||.||+|..+ +++.||+|+++.... .....+.+|++++++++||||+++++++..++..++||||+
T Consensus         6 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   85 (288)
T cd07871           6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL   85 (288)
T ss_pred             cceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCC
Confidence            3677899999999999999876 689999999864322 23456788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccc
Q 002529          669 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH  748 (912)
Q Consensus       669 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  748 (912)
                      + ++|.+++...  ...+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||++.........
T Consensus        86 ~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~  159 (288)
T cd07871          86 D-SDLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT  159 (288)
T ss_pred             C-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcc
Confidence            7 4899888642  3457899999999999999999998   99999999999999999999999999998764332211


Q ss_pred             ccccccCCCcccCCCccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhc---------cCCcc
Q 002529          749 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK---------KGDVI  818 (912)
Q Consensus       749 ~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~---------~~~~~  818 (912)
                       .....+++.|+|||++.+ ..++.++||||+||++|+|++|+.||......+.............         .....
T Consensus       160 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd07871         160 -YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR  238 (288)
T ss_pred             -ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence             223457899999998865 5689999999999999999999999975443222111110000000         00000


Q ss_pred             cccCccccCCC----CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          819 SIVDPVLIGNV----KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       819 ~~~d~~l~~~~----~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                      ....+......    ......++.+++.+||+.||.+|||++|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            11111100000    0112246789999999999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-36  Score=329.37  Aligned_cols=243  Identities=23%  Similarity=0.316  Sum_probs=199.1

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc---chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEe
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY  667 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  667 (912)
                      |++.+.||+|+||.||+|..+ +++.||+|++....   ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus         3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   82 (291)
T cd05612           3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEY   82 (291)
T ss_pred             ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeC
Confidence            567889999999999999877 68999999986432   12345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccc
Q 002529          668 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT  747 (912)
Q Consensus       668 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~  747 (912)
                      +++|+|.+++..   ...+++..+..++.|++.||+|||+   ++++||||||+|||++.++.+||+|||++....... 
T Consensus        83 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~-  155 (291)
T cd05612          83 VPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT-  155 (291)
T ss_pred             CCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc-
Confidence            999999999973   4578999999999999999999998   999999999999999999999999999988654321 


Q ss_pred             cccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccC
Q 002529          748 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG  827 (912)
Q Consensus       748 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  827 (912)
                         ....|++.|+|||++.+..++.++|||||||++|+|++|+.||......   ...   .... .+..          
T Consensus       156 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~---~~~---~~i~-~~~~----------  215 (291)
T cd05612         156 ---WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF---GIY---EKIL-AGKL----------  215 (291)
T ss_pred             ---ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHH---HHHH-hCCc----------
Confidence               2245899999999999988999999999999999999999999743221   111   1111 1111          


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHHH
Q 002529          828 NVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVLA  861 (912)
Q Consensus       828 ~~~~~~~~~l~~Li~~cL~~dP~~RPs-----~~evl~~  861 (912)
                      ..+......+.+++.+||+.||.+||+     ++|+++.
T Consensus       216 ~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         216 EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence            011112336889999999999999995     8887754

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-36  Score=335.43  Aligned_cols=251  Identities=23%  Similarity=0.317  Sum_probs=202.4

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc---chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEe
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY  667 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  667 (912)
                      |++.+.||+|+||.||+|+.. +++.||+|+++...   ......+.+|+++++.++||||+++++++...+..++||||
T Consensus         3 y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   82 (333)
T cd05600           3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEY   82 (333)
T ss_pred             cEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeC
Confidence            567789999999999999987 58999999987532   22345688899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccc
Q 002529          668 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT  747 (912)
Q Consensus       668 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~  747 (912)
                      +++|+|.+++.   ....+++..+..++.||+.||+|||+   .+|+||||||+||+++.++.+||+|||++.....   
T Consensus        83 ~~g~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---  153 (333)
T cd05600          83 VPGGDFRTLLN---NLGVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---  153 (333)
T ss_pred             CCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence            99999999997   34578999999999999999999998   9999999999999999999999999999986543   


Q ss_pred             cccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccC
Q 002529          748 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG  827 (912)
Q Consensus       748 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  827 (912)
                       ......|++.|+|||++.+..++.++|||||||++|||++|+.||......+..   ..+.............++    
T Consensus       154 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~~----  225 (333)
T cd05600         154 -YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETW---ENLKYWKETLQRPVYDDP----  225 (333)
T ss_pred             -ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHH---HHHHhccccccCCCCCcc----
Confidence             223345899999999999989999999999999999999999999743332111   111110000000000000    


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002529          828 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       828 ~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  861 (912)
                        .......+.+++.+||..+|.+||+++|+++.
T Consensus       226 --~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         226 --RFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             --ccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence              01223478899999999999999999999865

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.1e-36  Score=315.90  Aligned_cols=248  Identities=23%  Similarity=0.364  Sum_probs=211.7

Q ss_pred             HHHHHhhhcccCccccEEEEEEEe-cCCCEEEEEEccCccchh---hHHHHHHHHHHHhcCCCCccceeeEEecCCeEEE
Q 002529          588 EEATNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCSHR---TQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL  663 (912)
Q Consensus       588 ~~~~~~~~~~LG~G~fg~Vy~a~~-~~~~~vAvK~l~~~~~~~---~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~l  663 (912)
                      .+.+|+|.+.||+|.||.|-+|.. ..|+.||||.++++...+   .-.+.+|+++|..|+||||++++++|++.+...|
T Consensus        51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi  130 (668)
T KOG0611|consen   51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI  130 (668)
T ss_pred             hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence            467899999999999999999975 689999999998754433   3457899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccc
Q 002529          664 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE  743 (912)
Q Consensus       664 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~  743 (912)
                      ||||..+|.|.|++.   ..+.+++.+...+++||..|+.|+|.   ++++|||||.+|||+|.++++||+|||++..+.
T Consensus       131 vMEYaS~GeLYDYiS---er~~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~  204 (668)
T KOG0611|consen  131 VMEYASGGELYDYIS---ERGSLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYA  204 (668)
T ss_pred             EEEecCCccHHHHHH---HhccccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhc
Confidence            999999999999999   46789999999999999999999998   999999999999999999999999999998876


Q ss_pred             cccccccccccCCCcccCCCccCCCCC-CchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccC
Q 002529          744 EDLTHISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD  822 (912)
Q Consensus       744 ~~~~~~~~~~~gt~~y~APE~l~~~~~-s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  822 (912)
                      ..  .....++|++-|.+||++.+.+| ++..|-||||++||.|+.|..||++.+..   .    +-.++..|...+-  
T Consensus       205 ~~--kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk---~----lvrQIs~GaYrEP--  273 (668)
T KOG0611|consen  205 DK--KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK---R----LVRQISRGAYREP--  273 (668)
T ss_pred             cc--cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH---H----HHHHhhcccccCC--
Confidence            54  33456789999999999999888 47999999999999999999999865542   1    2223344433221  


Q ss_pred             ccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002529          823 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       823 ~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  861 (912)
                               +.+....-||++||..+|++|.|+.+|...
T Consensus       274 ---------~~PSdA~gLIRwmLmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  274 ---------ETPSDASGLIRWMLMVNPERRATIEDIASH  303 (668)
T ss_pred             ---------CCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence                     112245678999999999999999999754

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-36  Score=303.34  Aligned_cols=263  Identities=22%  Similarity=0.319  Sum_probs=209.2

Q ss_pred             HHHHHhhhcccCccccEEEEEEE-ecCCCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEecC-----CeE
Q 002529          588 EEATNNFCKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE-----HQR  661 (912)
Q Consensus       588 ~~~~~~~~~~LG~G~fg~Vy~a~-~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~-----~~~  661 (912)
                      -.++|++.+.||+|||+-||+++ ..+++.+|+|++.-...++.+..++|++..++++||||++++++...+     ...
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            45678889999999999999998 447899999999766667778899999999999999999999887443     358


Q ss_pred             EEEEEecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcc
Q 002529          662 ILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR  740 (912)
Q Consensus       662 ~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~  740 (912)
                      ||+++|...|+|.+.+.... .+..+++.+++.|+.+|++||++||+. ..+++||||||.|||+.+++.++|.|||.+.
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~  177 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSAT  177 (302)
T ss_pred             EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcc
Confidence            99999999999999998665 455899999999999999999999982 1349999999999999999999999999987


Q ss_pred             ccccccccc--------cccccCCCcccCCCccC---CCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHH
Q 002529          741 QAEEDLTHI--------SSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR  809 (912)
Q Consensus       741 ~~~~~~~~~--------~~~~~gt~~y~APE~l~---~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~  809 (912)
                      ...-.....        ......|..|+|||.+.   +...++++|||||||+||+|+.|..||+..-            
T Consensus       178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~------------  245 (302)
T KOG2345|consen  178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIY------------  245 (302)
T ss_pred             ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHh------------
Confidence            753221111        11223689999999874   4567899999999999999999999997211            


Q ss_pred             hhhccCCccc--ccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhhh
Q 002529          810 SMIKKGDVIS--IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI  866 (912)
Q Consensus       810 ~~~~~~~~~~--~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~~  866 (912)
                         ..|....  +....+.-.......+.+.+++..||+.||.+||++.|++..+++++
T Consensus       246 ---~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  246 ---QQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             ---hcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence               1122111  11111111111225568999999999999999999999999988764

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.4e-35  Score=322.72  Aligned_cols=258  Identities=28%  Similarity=0.472  Sum_probs=208.0

Q ss_pred             HHHHHhhhcccCccccEEEEEEEecC------CCEEEEEEccCccch-hhHHHHHHHHHHHhcCCCCccceeeEEecCCe
Q 002529          588 EEATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ  660 (912)
Q Consensus       588 ~~~~~~~~~~LG~G~fg~Vy~a~~~~------~~~vAvK~l~~~~~~-~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~  660 (912)
                      ...+|.+.+.||+|+||.||+|...+      ++.||+|.++..... ..+.+.+|++++++++|+||+++++++.....
T Consensus         3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   82 (280)
T cd05049           3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDP   82 (280)
T ss_pred             ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence            35678889999999999999998643      478999998765444 45789999999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHhccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCC
Q 002529          661 RILVYEYMHNGTLRDRLHGSV-----------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM  729 (912)
Q Consensus       661 ~~lV~E~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~  729 (912)
                      .++||||+++++|.+++....           ....+++..+..++.|++.||+|||+   ++++||||||+||+++.++
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~  159 (280)
T cd05049          83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDL  159 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCC
Confidence            999999999999999997532           23457889999999999999999998   8999999999999999999


Q ss_pred             cEEEeeccCccccccccc-cccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHH
Q 002529          730 RAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHW  807 (912)
Q Consensus       730 ~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~  807 (912)
                      .++|+|||++........ .......+++.|+|||++.+..++.++|||||||++|||++ |+.||......   .....
T Consensus       160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~---~~~~~  236 (280)
T cd05049         160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE---EVIEC  236 (280)
T ss_pred             eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHH
Confidence            999999999876432211 11223345778999999999999999999999999999998 99998633221   12221


Q ss_pred             HHhhhccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhh
Q 002529          808 ARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD  864 (912)
Q Consensus       808 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~  864 (912)
                      .    ..+.....         +......+.+++.+||+.+|++||+++||++.|++
T Consensus       237 ~----~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         237 I----TQGRLLQR---------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             H----HcCCcCCC---------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence            1    12211111         11223478899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=9.2e-36  Score=332.86  Aligned_cols=245  Identities=24%  Similarity=0.323  Sum_probs=200.7

Q ss_pred             HHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc---chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEE
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY  665 (912)
Q Consensus       590 ~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~  665 (912)
                      ..|++.+.||+|+||.||+|+++ +++.||+|+++...   ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            45778899999999999999987 58999999986532   123456889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccc
Q 002529          666 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED  745 (912)
Q Consensus       666 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~  745 (912)
                      ||+++|+|.+++..   ...+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||++......
T Consensus        98 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  171 (329)
T PTZ00263         98 EFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR  171 (329)
T ss_pred             cCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence            99999999999973   4578899999999999999999998   99999999999999999999999999999876433


Q ss_pred             cccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccc
Q 002529          746 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL  825 (912)
Q Consensus       746 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  825 (912)
                      .    ....|++.|+|||++.+..++.++|||||||++|||++|+.||......   ...    ..+..+...      +
T Consensus       172 ~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---~~~----~~i~~~~~~------~  234 (329)
T PTZ00263        172 T----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF---RIY----EKILAGRLK------F  234 (329)
T ss_pred             c----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH---HHH----HHHhcCCcC------C
Confidence            2    1245899999999999999999999999999999999999999733211   111    111122110      0


Q ss_pred             cCCCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHHH
Q 002529          826 IGNVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVLA  861 (912)
Q Consensus       826 ~~~~~~~~~~~l~~Li~~cL~~dP~~RPs-----~~evl~~  861 (912)
                          +......+.+++.+||+.||++||+     ++++++.
T Consensus       235 ----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        235 ----PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             ----CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence                1112236789999999999999997     6777743

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.6e-35  Score=328.35  Aligned_cols=241  Identities=24%  Similarity=0.359  Sum_probs=195.3

Q ss_pred             cccCccccEEEEEEEec-CCCEEEEEEccCcc---chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEecCCC
Q 002529          596 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG  671 (912)
Q Consensus       596 ~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~g  671 (912)
                      +.||+|+||.||+++.+ +|+.||+|+++...   ......+.+|+++++.++||||+++++.+...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999876 68999999987532   233456778999999999999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccccccc
Q 002529          672 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS  751 (912)
Q Consensus       672 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~  751 (912)
                      +|.+++..   ...+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||++........ ...
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~  153 (323)
T cd05595          81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMK  153 (323)
T ss_pred             cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-ccc
Confidence            99998873   4578999999999999999999998   9999999999999999999999999999875322211 122


Q ss_pred             cccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCCCCH
Q 002529          752 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI  831 (912)
Q Consensus       752 ~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  831 (912)
                      ...|++.|+|||++.+..++.++|||||||++|||++|+.||...+...   ..   ..... ...      .+    +.
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~---~~---~~~~~-~~~------~~----p~  216 (323)
T cd05595         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LF---ELILM-EEI------RF----PR  216 (323)
T ss_pred             cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH---HH---HHHhc-CCC------CC----CC
Confidence            3458999999999999999999999999999999999999997332211   11   11111 110      01    11


Q ss_pred             HHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 002529          832 ESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL  860 (912)
Q Consensus       832 ~~~~~l~~Li~~cL~~dP~~RP-----s~~evl~  860 (912)
                      .....+.+++.+||+.||++||     ++.++++
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            2234678999999999999998     8888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=3.6e-35  Score=326.04  Aligned_cols=261  Identities=24%  Similarity=0.419  Sum_probs=206.2

Q ss_pred             HHHHHHhhhcccCccccEEEEEEEec-CCC----EEEEEEccCcc-chhhHHHHHHHHHHHhcCCCCccceeeEEecCCe
Q 002529          587 LEEATNNFCKKIGKGSFGSVYYGKMK-DGK----EVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ  660 (912)
Q Consensus       587 l~~~~~~~~~~LG~G~fg~Vy~a~~~-~~~----~vAvK~l~~~~-~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~  660 (912)
                      +....|+..+.||+|+||.||+|.+. +++    .||+|+++... ....+.+.+|+.+++.++||||+++++++... .
T Consensus         4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~   82 (316)
T cd05108           4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T   82 (316)
T ss_pred             cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence            45567788899999999999999865 333    48999987543 34456788999999999999999999999765 5


Q ss_pred             EEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcc
Q 002529          661 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR  740 (912)
Q Consensus       661 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~  740 (912)
                      .++++||+++|+|.+++...  ...+++..++.++.||+.||+|||+   .+|+||||||+||+++.++.+||+|||+++
T Consensus        83 ~~~v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~  157 (316)
T cd05108          83 VQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAK  157 (316)
T ss_pred             ceeeeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccc
Confidence            67999999999999999853  3468899999999999999999998   999999999999999999999999999998


Q ss_pred             cccccccccc-ccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhhhccCCcc
Q 002529          741 QAEEDLTHIS-SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVI  818 (912)
Q Consensus       741 ~~~~~~~~~~-~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  818 (912)
                      .......... ....++..|+|||++.+..++.++||||||+++|||++ |+.||......   .+..    ....+...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~---~~~~----~~~~~~~~  230 (316)
T cd05108         158 LLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISS----ILEKGERL  230 (316)
T ss_pred             cccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHH----HHhCCCCC
Confidence            7654322211 12224668999999999999999999999999999998 99999743221   1111    11111110


Q ss_pred             cccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhhhhhc
Q 002529          819 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE  869 (912)
Q Consensus       819 ~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~~~~~  869 (912)
                      .         .+......+.+++.+||+.+|++||++.+++..|.++....
T Consensus       231 ~---------~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~  272 (316)
T cd05108         231 P---------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  272 (316)
T ss_pred             C---------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence            0         01112346889999999999999999999999999887644

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.5e-35  Score=318.81  Aligned_cols=252  Identities=30%  Similarity=0.481  Sum_probs=203.4

Q ss_pred             HHHhhhcccCccccEEEEEEEecCCCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEecC
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH  669 (912)
Q Consensus       590 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~  669 (912)
                      ..+.+.+.||+|+||.||+|.++++..+|+|.+.... .....+.+|+.++++++||||+++++++......++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            4567889999999999999998877789999987543 234678999999999999999999999998888999999999


Q ss_pred             CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccccc
Q 002529          670 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI  749 (912)
Q Consensus       670 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~  749 (912)
                      +++|.+++...  ...+++..++.++.||+.||+|||+   .+++|+||||+||+++.++.+||+|||.++.........
T Consensus        83 ~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05113          83 NGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS  157 (256)
T ss_pred             CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence            99999998753  3368999999999999999999998   999999999999999999999999999987654332222


Q ss_pred             cccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCC
Q 002529          750 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN  828 (912)
Q Consensus       750 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  828 (912)
                      .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||......   .....+    ..+....         
T Consensus       158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~----~~~~~~~---------  221 (256)
T cd05113         158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS---ETVEKV----SQGLRLY---------  221 (256)
T ss_pred             cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHHH----hcCCCCC---------
Confidence            222335678999999988889999999999999999998 99998633221   111111    1111100         


Q ss_pred             CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 002529          829 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ  863 (912)
Q Consensus       829 ~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  863 (912)
                      .+......+.+++.+||+.+|.+||++.+|++.|+
T Consensus       222 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         222 RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            00112347899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.7e-35  Score=317.08  Aligned_cols=255  Identities=27%  Similarity=0.468  Sum_probs=205.1

Q ss_pred             HHHHHhhhcccCccccEEEEEEEecCCCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEe
Q 002529          588 EEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY  667 (912)
Q Consensus       588 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  667 (912)
                      ....+++.++||+|++|.||+|..+++..+|+|.++.... ..+.+.+|+.++++++|+|++++++++.. ...+++|||
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~   81 (260)
T cd05070           4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEY   81 (260)
T ss_pred             chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEe
Confidence            4557888999999999999999988888999999875433 34678999999999999999999998854 567899999


Q ss_pred             cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccc
Q 002529          668 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT  747 (912)
Q Consensus       668 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~  747 (912)
                      +++++|.+++... ....+++.+++.++.|++.||+|||+   .+++|+||||+||++++++.++|+|||++........
T Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05070          82 MSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             cCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence            9999999999753 24568999999999999999999998   8999999999999999999999999999976544322


Q ss_pred             cccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhhhccCCcccccCcccc
Q 002529          748 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI  826 (912)
Q Consensus       748 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  826 (912)
                      .......++..|+|||.+.+..++.++||||||+++|+|++ |+.||.....   ....+..    ..+...        
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~----~~~~~~--------  222 (260)
T cd05070         158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN---REVLEQV----ERGYRM--------  222 (260)
T ss_pred             ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHH----HcCCCC--------
Confidence            22222235668999999988889999999999999999999 8999963321   1112211    111100        


Q ss_pred             CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhh
Q 002529          827 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD  864 (912)
Q Consensus       827 ~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~  864 (912)
                       ..+......+.+++.+||+.+|++|||+.++++.|++
T Consensus       223 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         223 -PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             -CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence             1112233478999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-35  Score=317.72  Aligned_cols=251  Identities=29%  Similarity=0.479  Sum_probs=202.4

Q ss_pred             HHHhhhcccCccccEEEEEEEecCCCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEecC
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH  669 (912)
Q Consensus       590 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~  669 (912)
                      ..+++.+.||+|+||.||+|.+++++.+|+|++..... ....+.+|++++++++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            45678899999999999999988888899999864322 33568889999999999999999999999999999999999


Q ss_pred             CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccccc
Q 002529          670 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI  749 (912)
Q Consensus       670 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~  749 (912)
                      +++|.+++...  ...+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+++.........
T Consensus        83 ~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~  157 (256)
T cd05059          83 NGCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS  157 (256)
T ss_pred             CCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence            99999999743  3468999999999999999999998   999999999999999999999999999987654332221


Q ss_pred             cccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCC
Q 002529          750 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN  828 (912)
Q Consensus       750 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  828 (912)
                      .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||......   .....+    ..+.     ..    .
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~----~~~~-----~~----~  221 (256)
T cd05059         158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS---EVVESV----SAGY-----RL----Y  221 (256)
T ss_pred             cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH---HHHHHH----HcCC-----cC----C
Confidence            122223457999999998899999999999999999999 89999743321   111111    1110     00    1


Q ss_pred             CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 002529          829 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI  862 (912)
Q Consensus       829 ~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  862 (912)
                      .+...+..+.+++.+||..+|++||++.|+++.|
T Consensus       222 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         222 RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            1112344789999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.7e-35  Score=330.53  Aligned_cols=242  Identities=25%  Similarity=0.355  Sum_probs=196.8

Q ss_pred             cccCccccEEEEEEEec-CCCEEEEEEccCcc---chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEecCCC
Q 002529          596 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG  671 (912)
Q Consensus       596 ~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~g  671 (912)
                      +.||+|+||.||++..+ +++.||+|++....   ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999876 68999999987532   234467788999999999999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccccccc
Q 002529          672 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS  751 (912)
Q Consensus       672 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~  751 (912)
                      +|.+++.   ....+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++....... ...
T Consensus        81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~  153 (328)
T cd05593          81 ELFFHLS---RERVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-TMK  153 (328)
T ss_pred             CHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc-ccc
Confidence            9999887   34578999999999999999999998   9999999999999999999999999999875432211 122


Q ss_pred             cccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCCCCH
Q 002529          752 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI  831 (912)
Q Consensus       752 ~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  831 (912)
                      ...|++.|+|||++.+..++.++|||||||++|+|++|+.||...+..      +...... .+..      .+    +.
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~------~~~~~~~-~~~~------~~----p~  216 (328)
T cd05593         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELIL-MEDI------KF----PR  216 (328)
T ss_pred             cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH------HHHHHhc-cCCc------cC----CC
Confidence            345899999999999989999999999999999999999999743221      1111111 1110      11    11


Q ss_pred             HHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 002529          832 ESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA  861 (912)
Q Consensus       832 ~~~~~l~~Li~~cL~~dP~~RP-----s~~evl~~  861 (912)
                      .....+.+++.+||+.||++||     +++|+++.
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            2234688999999999999997     89998864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=2.8e-35  Score=317.80  Aligned_cols=256  Identities=27%  Similarity=0.442  Sum_probs=205.5

Q ss_pred             HHHHhhhcccCccccEEEEEEEecCCCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEec
Q 002529          589 EATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM  668 (912)
Q Consensus       589 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~  668 (912)
                      ..+|++.++||+|+||.||+|++++...||+|+++.... ..+.+.+|++++++++||||+++++.+.. ...++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~   82 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   82 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence            456888999999999999999988777899999875322 34578899999999999999999998754 5579999999


Q ss_pred             CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccc
Q 002529          669 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH  748 (912)
Q Consensus       669 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  748 (912)
                      ++|+|.+++... ....+++..++.++.|+++||+|||+   .+++|+||||+||+++.++.++|+|||.+.........
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~  158 (262)
T cd05071          83 SKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  158 (262)
T ss_pred             CCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence            999999999753 24467899999999999999999998   99999999999999999999999999999766443322


Q ss_pred             ccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhhhccCCcccccCccccC
Q 002529          749 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG  827 (912)
Q Consensus       749 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  827 (912)
                      ......++..|+|||++.+..++.++||||||+++|+|++ |+.||......   ....    .+..+...         
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~---~~~~----~~~~~~~~---------  222 (262)
T cd05071         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLD----QVERGYRM---------  222 (262)
T ss_pred             cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH---HHHH----HHhcCCCC---------
Confidence            2223346678999999988899999999999999999999 88888633211   1111    11111100         


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhhh
Q 002529          828 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI  866 (912)
Q Consensus       828 ~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~~  866 (912)
                      ......+..+.+++.+|++.+|++||+++++++.|++..
T Consensus       223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~  261 (262)
T cd05071         223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  261 (262)
T ss_pred             CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence            111233457889999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.8e-35  Score=321.29  Aligned_cols=266  Identities=25%  Similarity=0.388  Sum_probs=202.6

Q ss_pred             hhhcccCccccEEEEEEEe-----cCCCEEEEEEccCccc-hhhHHHHHHHHHHHhcCCCCccceeeEEecC--CeEEEE
Q 002529          593 NFCKKIGKGSFGSVYYGKM-----KDGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRILV  664 (912)
Q Consensus       593 ~~~~~LG~G~fg~Vy~a~~-----~~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~--~~~~lV  664 (912)
                      .+.+.||+|+||+||++..     .+++.||+|.++.... .....+.+|++++++++||||+++++++...  ...++|
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI   86 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence            6789999999999988753     3578899999876433 3456788999999999999999999987653  467899


Q ss_pred             EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccc
Q 002529          665 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE  744 (912)
Q Consensus       665 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~  744 (912)
                      |||+++++|.+++..    ..+++..++.++.|++.||+|||+   ++++||||||+||+++.++.++|+|||++.....
T Consensus        87 ~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  159 (283)
T cd05080          87 MEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  159 (283)
T ss_pred             ecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence            999999999999873    358999999999999999999998   9999999999999999999999999999887644


Q ss_pred             cccc--ccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccC
Q 002529          745 DLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD  822 (912)
Q Consensus       745 ~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  822 (912)
                      ....  ......++..|+|||.+.+..++.++||||||+++|||++|..|+...... ..................+..+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd05080         160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK-FEEMIGPKQGQMTVVRLIELLE  238 (283)
T ss_pred             cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch-hhhhhcccccccchhhhhhhhh
Confidence            3221  111223566799999998888999999999999999999999998633211 1111110000000011111111


Q ss_pred             ccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhhh
Q 002529          823 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI  866 (912)
Q Consensus       823 ~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~~  866 (912)
                      .......+...+..+.+++.+||+.+|++||++++|++.|+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            11111122234458999999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.5e-35  Score=319.62  Aligned_cols=249  Identities=40%  Similarity=0.614  Sum_probs=195.0

Q ss_pred             hhcccCccccEEEEEEEec-----CCCEEEEEEccCccc-hhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEe
Q 002529          594 FCKKIGKGSFGSVYYGKMK-----DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY  667 (912)
Q Consensus       594 ~~~~LG~G~fg~Vy~a~~~-----~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  667 (912)
                      +.+.||.|.||.||+|.++     .+..|+||.++.... ...+.+.+|++.+++++||||++++|++...+..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            4578999999999999887     257899999976433 3468899999999999999999999999988889999999


Q ss_pred             cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccc-c
Q 002529          668 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED-L  746 (912)
Q Consensus       668 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~-~  746 (912)
                      +++|+|.+++... ....+++..+..|+.||++||+|||+   .+++|+||+++||++++++.+||+|||++...... .
T Consensus        83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred             ccccccccccccc-cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence            9999999999864 35679999999999999999999998   89999999999999999999999999999876322 1


Q ss_pred             ccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhhhccCCcccccCccc
Q 002529          747 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL  825 (912)
Q Consensus       747 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  825 (912)
                      ............|+|||.+.+..++.++||||||+++|||++ |+.||....   ...+...+    .++.....     
T Consensus       159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~---~~~~~~~~----~~~~~~~~-----  226 (259)
T PF07714_consen  159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD---NEEIIEKL----KQGQRLPI-----  226 (259)
T ss_dssp             EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC---HHHHHHHH----HTTEETTS-----
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccc----ccccccee-----
Confidence            122233346778999999988889999999999999999999 788886332   12222222    22211111     


Q ss_pred             cCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 002529          826 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI  862 (912)
Q Consensus       826 ~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  862 (912)
                          +...+..+.+++.+||+.+|++||+++|+++.|
T Consensus       227 ----~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  227 ----PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             ----BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ----ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                111234688999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.6e-35  Score=325.47  Aligned_cols=249  Identities=24%  Similarity=0.361  Sum_probs=202.9

Q ss_pred             HHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc---chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEE
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY  665 (912)
Q Consensus       590 ~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~  665 (912)
                      ..+++.+.||+|+||.||+|+-+ +|+.+|+|++++..   ....+.++.|-.+|....+|.||+++..|++.+.+||||
T Consensus       141 ~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiM  220 (550)
T KOG0605|consen  141 DDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIM  220 (550)
T ss_pred             ccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEE
Confidence            34556789999999999999866 69999999998753   334567888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccc-
Q 002529          666 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-  744 (912)
Q Consensus       666 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~-  744 (912)
                      ||++||++..+|.   ....|++.....++.+++.|++.+|+   .|+|||||||+|+|||..|++||+|||++.-... 
T Consensus       221 EylPGGD~mTLL~---~~~~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~  294 (550)
T KOG0605|consen  221 EYLPGGDMMTLLM---RKDTLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK  294 (550)
T ss_pred             EecCCccHHHHHH---hcCcCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccchhhhh
Confidence            9999999999998   57889999999999999999999998   9999999999999999999999999999854211 


Q ss_pred             --------------c--------ccc----c-------------------cccccCCCcccCCCccCCCCCCchhHHHHH
Q 002529          745 --------------D--------LTH----I-------------------SSVARGTVGYLDPEYYGNQQLTEKSDVYSF  779 (912)
Q Consensus       745 --------------~--------~~~----~-------------------~~~~~gt~~y~APE~l~~~~~s~ksDVwSl  779 (912)
                                    .        ...    .                   ....+|||.|+|||++.+..|+..+|.|||
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL  374 (550)
T KOG0605|consen  295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL  374 (550)
T ss_pred             hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence                          0        000    0                   011349999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCccCccch-hhHHHHHHhhhccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCC---H
Q 002529          780 GVVLLELISGKKPVSVEDFGAE-LNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK---M  855 (912)
Q Consensus       780 Gvil~eLltG~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs---~  855 (912)
                      |||+||||.|.+||...+..+. ..+..|-.......              ......+..+||.+||. ||++|--   +
T Consensus       375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~--------------~~~~s~eA~DLI~rll~-d~~~RLG~~G~  439 (550)
T KOG0605|consen  375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE--------------EVDLSDEAKDLITRLLC-DPENRLGSKGA  439 (550)
T ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC--------------cCcccHHHHHHHHHHhc-CHHHhcCcccH
Confidence            9999999999999986655432 34555543322111              01112467899999999 9999986   5


Q ss_pred             HHHH
Q 002529          856 QEIV  859 (912)
Q Consensus       856 ~evl  859 (912)
                      +||.
T Consensus       440 ~EIK  443 (550)
T KOG0605|consen  440 EEIK  443 (550)
T ss_pred             HHHh
Confidence            5544

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=3.7e-35  Score=316.03  Aligned_cols=257  Identities=26%  Similarity=0.442  Sum_probs=207.9

Q ss_pred             HHHHHHHhhhcccCccccEEEEEEEecCCCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEE
Q 002529          586 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY  665 (912)
Q Consensus       586 ~l~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~  665 (912)
                      ++...++++.++||+|+||.||+|..++++.||+|.+..... ...++.+|+.++++++|+||+++++++. .+..+++|
T Consensus         2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~   79 (260)
T cd05067           2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT   79 (260)
T ss_pred             ccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence            355778899999999999999999998899999999875432 3467889999999999999999999875 45689999


Q ss_pred             EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccc
Q 002529          666 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED  745 (912)
Q Consensus       666 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~  745 (912)
                      ||+++++|.+++... .+..+++.++..++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||++......
T Consensus        80 e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05067          80 EYMENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDN  155 (260)
T ss_pred             EcCCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence            999999999998754 34578999999999999999999998   99999999999999999999999999998776532


Q ss_pred             cccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhhhccCCcccccCcc
Q 002529          746 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV  824 (912)
Q Consensus       746 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  824 (912)
                      .........++..|+|||++.+..++.++||||||+++|||++ |+.||......   .....+.    .+...      
T Consensus       156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~----~~~~~------  222 (260)
T cd05067         156 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP---EVIQNLE----RGYRM------  222 (260)
T ss_pred             CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH---HHHHHHH----cCCCC------
Confidence            2222222335678999999998889999999999999999999 99999743321   1222111    11000      


Q ss_pred             ccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhh
Q 002529          825 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD  864 (912)
Q Consensus       825 l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~  864 (912)
                         ..+...+..+.+++.+||+.+|++||+++++++.|++
T Consensus       223 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         223 ---PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             ---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence               0111123478999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-35  Score=328.95  Aligned_cols=239  Identities=25%  Similarity=0.336  Sum_probs=193.7

Q ss_pred             cCccccEEEEEEEec-CCCEEEEEEccCcc---chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEecCCCCH
Q 002529          598 IGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL  673 (912)
Q Consensus       598 LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL  673 (912)
                      ||+|+||.||+|... +++.||+|+++...   ......+.+|+.++++++||||+++++++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999876 58899999986432   23446678899999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccccccccc
Q 002529          674 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA  753 (912)
Q Consensus       674 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~  753 (912)
                      .+++..   ...+++..+..++.||+.||+|||+   ++|+||||||+||+++.++.++|+|||++........ .....
T Consensus        81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~~  153 (312)
T cd05585          81 FHHLQR---EGRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-KTNTF  153 (312)
T ss_pred             HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-ccccc
Confidence            999973   4578999999999999999999998   9999999999999999999999999999876432221 22334


Q ss_pred             cCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCCCCHHH
Q 002529          754 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES  833 (912)
Q Consensus       754 ~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  833 (912)
                      .|++.|+|||++.+..++.++|||||||++|||++|+.||.....      .+........ ..          ..+...
T Consensus       154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~------~~~~~~~~~~-~~----------~~~~~~  216 (312)
T cd05585         154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV------NEMYRKILQE-PL----------RFPDGF  216 (312)
T ss_pred             cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH------HHHHHHHHcC-CC----------CCCCcC
Confidence            589999999999999999999999999999999999999974322      1112222211 10          111122


Q ss_pred             HHHHHHHHHhcccCCCCCCCC---HHHHHH
Q 002529          834 IWRIAEVAIQCVEQRGFSRPK---MQEIVL  860 (912)
Q Consensus       834 ~~~l~~Li~~cL~~dP~~RPs---~~evl~  860 (912)
                      ...+.+++.+||+.||++||+   +.|+++
T Consensus       217 ~~~~~~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         217 DRDAKDLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             CHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence            346889999999999999985   566654

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=4.9e-35  Score=319.03  Aligned_cols=256  Identities=30%  Similarity=0.526  Sum_probs=205.6

Q ss_pred             HHHhhhcccCccccEEEEEEEecC------CCEEEEEEccCccc-hhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEE
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI  662 (912)
Q Consensus       590 ~~~~~~~~LG~G~fg~Vy~a~~~~------~~~vAvK~l~~~~~-~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~  662 (912)
                      ..+++.+.||+|+||.||+|....      .+.|++|.++.... .....+.+|++++++++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            356778999999999999998653      25799999875433 33467899999999999999999999999989999


Q ss_pred             EEEEecCCCCHHHHhccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCC
Q 002529          663 LVYEYMHNGTLRDRLHGSVN-------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM  729 (912)
Q Consensus       663 lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~  729 (912)
                      ++|||+++++|.+++.....             ...+++..++.++.|++.||+|||+   .+++|+||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCC
Confidence            99999999999999975321             1568889999999999999999998   9999999999999999999


Q ss_pred             cEEEeeccCccccccccc-cccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHH
Q 002529          730 RAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHW  807 (912)
Q Consensus       730 ~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~  807 (912)
                      .++|+|||++........ .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+....   .+.+ 
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~---~~~~-  237 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ---EVIE-  237 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH-
Confidence            999999999876433221 12223346788999999988899999999999999999998 99999743321   1222 


Q ss_pred             HHhhhccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhh
Q 002529          808 ARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD  864 (912)
Q Consensus       808 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~  864 (912)
                         .+..+....         .+...+..+.+|+.+||+.+|++||+++||++.|+.
T Consensus       238 ---~i~~~~~~~---------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         238 ---MIRSRQLLP---------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             ---HHHcCCcCC---------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence               122221111         122334578999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=3.8e-35  Score=317.11  Aligned_cols=257  Identities=27%  Similarity=0.468  Sum_probs=206.3

Q ss_pred             HHHHhhhcccCccccEEEEEEEecC----CCEEEEEEccCccc-hhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEE
Q 002529          589 EATNNFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL  663 (912)
Q Consensus       589 ~~~~~~~~~LG~G~fg~Vy~a~~~~----~~~vAvK~l~~~~~-~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~l  663 (912)
                      ...+++.+.||+|+||.||+|.++.    ...||+|.++.... .....+.+|+.++++++||||+++++++...+..++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            3557778999999999999998753    45799999875433 345678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccc
Q 002529          664 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE  743 (912)
Q Consensus       664 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~  743 (912)
                      ||||+++++|.+++...  ...+++..++.++.|++.||+|||+   .+++|+||||+||++++++.++|+|||++....
T Consensus        83 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~  157 (266)
T cd05033          83 ITEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLE  157 (266)
T ss_pred             EEEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence            99999999999999753  3478999999999999999999998   999999999999999999999999999998764


Q ss_pred             cccc-cccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhhhccCCccccc
Q 002529          744 EDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV  821 (912)
Q Consensus       744 ~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  821 (912)
                      .... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.....   ....+.+    ..+....  
T Consensus       158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~----~~~~~~~--  228 (266)
T cd05033         158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN---QDVIKAV----EDGYRLP--  228 (266)
T ss_pred             ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH---HHHHHHH----HcCCCCC--
Confidence            2211 11122234678999999998899999999999999999998 9999863221   1122211    1111100  


Q ss_pred             CccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhhh
Q 002529          822 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI  866 (912)
Q Consensus       822 d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~~  866 (912)
                             .+...+..+.+++.+||+.+|++||+++||++.|++++
T Consensus       229 -------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~  266 (266)
T cd05033         229 -------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI  266 (266)
T ss_pred             -------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence                   01122347889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=3.6e-35  Score=321.44  Aligned_cols=262  Identities=27%  Similarity=0.461  Sum_probs=209.8

Q ss_pred             HHHHHhhhcccCccccEEEEEEEec------CCCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeE
Q 002529          588 EEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR  661 (912)
Q Consensus       588 ~~~~~~~~~~LG~G~fg~Vy~a~~~------~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~  661 (912)
                      .+..+.+.+.||+|+||.||++...      ++..+|+|.+..........+.+|++++++++||||+++++++...+..
T Consensus         3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (288)
T cd05093           3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL   82 (288)
T ss_pred             chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence            4556677899999999999999752      3456899998766555667899999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhccCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcE
Q 002529          662 ILVYEYMHNGTLRDRLHGSV----------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRA  731 (912)
Q Consensus       662 ~lV~E~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~v  731 (912)
                      ++||||+++++|.+++....          ....+++..++.++.|++.||+|||+   ++++||||||+||+++.++.+
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~  159 (288)
T cd05093          83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLV  159 (288)
T ss_pred             EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcE
Confidence            99999999999999987432          12358999999999999999999998   999999999999999999999


Q ss_pred             EEeeccCccccccccc-cccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHH
Q 002529          732 KVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWAR  809 (912)
Q Consensus       732 kL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~  809 (912)
                      +|+|||++........ .......++..|+|||++.+..++.++|||||||++|+|++ |..||......   ....   
T Consensus       160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~---~~~~---  233 (288)
T cd05093         160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN---EVIE---  233 (288)
T ss_pred             EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH---
Confidence            9999999876533221 11222335678999999998899999999999999999998 99998633221   1111   


Q ss_pred             hhhccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhhhhh
Q 002529          810 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI  868 (912)
Q Consensus       810 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~~~~  868 (912)
                       .+..+.....     ..    .....+.+++.+||+.+|.+|||++|+++.|+++...
T Consensus       234 -~i~~~~~~~~-----~~----~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         234 -CITQGRVLQR-----PR----TCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             -HHHcCCcCCC-----CC----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence             1222221111     11    1224689999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=5.4e-35  Score=329.93  Aligned_cols=248  Identities=23%  Similarity=0.378  Sum_probs=194.1

Q ss_pred             HHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCccc-hhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEe
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY  667 (912)
Q Consensus       590 ~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  667 (912)
                      ..+++.++||+|+||.||+|++. +++.||+|++..... .....+.+|+++++.++|+||+++++++...+..++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            34567789999999999999876 689999999865433 3346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccc
Q 002529          668 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT  747 (912)
Q Consensus       668 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~  747 (912)
                      +++++|.+.       ....+..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++........
T Consensus       154 ~~~~~L~~~-------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~  223 (353)
T PLN00034        154 MDGGSLEGT-------HIADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD  223 (353)
T ss_pred             CCCCccccc-------ccCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence            999998643       235677888999999999999998   9999999999999999999999999999987543322


Q ss_pred             cccccccCCCcccCCCccCC-----CCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccC
Q 002529          748 HISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD  822 (912)
Q Consensus       748 ~~~~~~~gt~~y~APE~l~~-----~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  822 (912)
                      . .....|+..|+|||++..     ...+.++|||||||++|||++|+.||......+....   ...... ...     
T Consensus       224 ~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~---~~~~~~-~~~-----  293 (353)
T PLN00034        224 P-CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASL---MCAICM-SQP-----  293 (353)
T ss_pred             c-ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHH---HHHHhc-cCC-----
Confidence            1 223458999999998743     2345689999999999999999999973222211111   111110 000     


Q ss_pred             ccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002529          823 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       823 ~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  861 (912)
                          ..........+.+++.+||+.||++||+++|+++.
T Consensus       294 ----~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        294 ----PEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             ----CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                01111233478899999999999999999999874

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=5e-35  Score=313.39  Aligned_cols=248  Identities=28%  Similarity=0.442  Sum_probs=197.9

Q ss_pred             cccCccccEEEEEEEec-CCCEEEEEEccCcc-chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEecCCCCH
Q 002529          596 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL  673 (912)
Q Consensus       596 ~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL  673 (912)
                      +.||+|+||.||+|..+ +++.||+|.+.... ......+.+|++++++++||||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            47999999999999876 68999999876543 33456789999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccccc-ccc
Q 002529          674 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSV  752 (912)
Q Consensus       674 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~-~~~  752 (912)
                      .+++...  ...+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++.......... ...
T Consensus        81 ~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  155 (252)
T cd05084          81 LTFLRTE--GPRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM  155 (252)
T ss_pred             HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence            9998742  4568899999999999999999998   999999999999999999999999999987644321111 111


Q ss_pred             ccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCCCCH
Q 002529          753 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI  831 (912)
Q Consensus       753 ~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  831 (912)
                      ...+..|+|||.+.+..++.++||||||+++|||++ |..||......   ....    .+.....         ...+.
T Consensus       156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~---~~~~----~~~~~~~---------~~~~~  219 (252)
T cd05084         156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ---QTRE----AIEQGVR---------LPCPE  219 (252)
T ss_pred             CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH---HHHH----HHHcCCC---------CCCcc
Confidence            123457999999999899999999999999999998 88888632211   1111    1111100         01111


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhh
Q 002529          832 ESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD  864 (912)
Q Consensus       832 ~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~  864 (912)
                      ..+..+.+++.+||+.+|++||++.||+++|++
T Consensus       220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~  252 (252)
T cd05084         220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS  252 (252)
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence            223478899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.6e-35  Score=326.36  Aligned_cols=241  Identities=26%  Similarity=0.375  Sum_probs=194.9

Q ss_pred             cccCccccEEEEEEEec----CCCEEEEEEccCcc----chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEe
Q 002529          596 KKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC----SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY  667 (912)
Q Consensus       596 ~~LG~G~fg~Vy~a~~~----~~~~vAvK~l~~~~----~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  667 (912)
                      +.||+|+||.||+++..    +++.||+|+++...    ......+.+|+++++.++||||+++++.+..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            68999999999999753    57899999987532    12335677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccc
Q 002529          668 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT  747 (912)
Q Consensus       668 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~  747 (912)
                      +++++|.+++..   ...+.+..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++........
T Consensus        82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (323)
T cd05584          82 LSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT  155 (323)
T ss_pred             CCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence            999999999873   4568888999999999999999998   9999999999999999999999999999875432221


Q ss_pred             cccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccC
Q 002529          748 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG  827 (912)
Q Consensus       748 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  827 (912)
                       ......|++.|+|||++.+..++.++|||||||++|||++|+.||......      ........ +..          
T Consensus       156 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~------~~~~~~~~-~~~----------  217 (323)
T cd05584         156 -VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK------KTIDKILK-GKL----------  217 (323)
T ss_pred             -cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH------HHHHHHHc-CCC----------
Confidence             122345899999999999888999999999999999999999999743321      11111111 111          


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 002529          828 NVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL  860 (912)
Q Consensus       828 ~~~~~~~~~l~~Li~~cL~~dP~~RP-----s~~evl~  860 (912)
                      ..+......+.+++.+||+.+|++||     +++++++
T Consensus       218 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         218 NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            01111234688999999999999999     8888876

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=3.6e-35  Score=335.71  Aligned_cols=262  Identities=24%  Similarity=0.401  Sum_probs=206.1

Q ss_pred             HHHHHhhhcccCccccEEEEEEEec------CCCEEEEEEccCccc-hhhHHHHHHHHHHHhcC-CCCccceeeEEecCC
Q 002529          588 EEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEH  659 (912)
Q Consensus       588 ~~~~~~~~~~LG~G~fg~Vy~a~~~------~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~L~-hpnIv~l~~~~~~~~  659 (912)
                      ....+.+.++||+|+||.||+|++.      .+..||||+++.... ...+.+.+|+++++++. ||||+++++++.+.+
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~  114 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG  114 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence            3556778899999999999999853      134799999975433 33467899999999996 999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHhccCC----------------------------------------------------------
Q 002529          660 QRILVYEYMHNGTLRDRLHGSV----------------------------------------------------------  681 (912)
Q Consensus       660 ~~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------  681 (912)
                      ..++||||+++|+|.+++....                                                          
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (400)
T cd05105         115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI  194 (400)
T ss_pred             ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence            9999999999999999886431                                                          


Q ss_pred             -----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCcccc
Q 002529          682 -----------------------------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD  726 (912)
Q Consensus       682 -----------------------------------~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~  726 (912)
                                                         ....+++..++.++.|+++||+|||+   .+++|+||||+|||++
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~  271 (400)
T cd05105         195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLA  271 (400)
T ss_pred             hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEe
Confidence                                               01347888899999999999999998   9999999999999999


Q ss_pred             CCCcEEEeeccCcccccccccc-ccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhH
Q 002529          727 INMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNI  804 (912)
Q Consensus       727 ~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~  804 (912)
                      .++.+||+|||++......... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.......  ..
T Consensus       272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~--~~  349 (400)
T cd05105         272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS--TF  349 (400)
T ss_pred             CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH--HH
Confidence            9999999999998865432221 1222346778999999998899999999999999999997 999987332211  11


Q ss_pred             HHHHHhhhccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhhhh
Q 002529          805 VHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK  867 (912)
Q Consensus       805 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~~~  867 (912)
                      ..    .+..+...         ..+......+.+++.+||+.+|++||++.+|.++|+++..
T Consensus       350 ~~----~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         350 YN----KIKSGYRM---------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             HH----HHhcCCCC---------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence            11    11111110         0112234578899999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5e-35  Score=334.06  Aligned_cols=260  Identities=18%  Similarity=0.193  Sum_probs=197.4

Q ss_pred             HHHHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEE
Q 002529          588 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE  666 (912)
Q Consensus       588 ~~~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E  666 (912)
                      ....|++.++||+|+||.||++... +++.||+|...      ...+.+|++++++++||||+++++++......++|+|
T Consensus        90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e  163 (391)
T PHA03212         90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP  163 (391)
T ss_pred             ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence            3456788899999999999999875 68899999753      2356789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccc
Q 002529          667 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL  746 (912)
Q Consensus       667 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~  746 (912)
                      ++. ++|.+++..   ...+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||++.......
T Consensus       164 ~~~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~  236 (391)
T PHA03212        164 RYK-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN  236 (391)
T ss_pred             cCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence            994 788888863   4568999999999999999999998   899999999999999999999999999997543322


Q ss_pred             ccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccc----hhhHHHHHHhhhccC--C----
Q 002529          747 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA----ELNIVHWARSMIKKG--D----  816 (912)
Q Consensus       747 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~----~~~~~~~~~~~~~~~--~----  816 (912)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.||.......    .......+.......  .    
T Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~  316 (391)
T PHA03212        237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID  316 (391)
T ss_pred             ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence            222334568999999999999999999999999999999999998875322110    000111110000000  0    


Q ss_pred             ----ccccc---------CccccCCC--CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          817 ----VISIV---------DPVLIGNV--KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       817 ----~~~~~---------d~~l~~~~--~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                          .....         .+......  ....+..+.+++.+||+.||++|||++|+++
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence                00000         00000000  0123457889999999999999999999985

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=5e-35  Score=320.84  Aligned_cols=261  Identities=27%  Similarity=0.453  Sum_probs=210.0

Q ss_pred             HHHHhhhcccCccccEEEEEEEec------CCCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEE
Q 002529          589 EATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI  662 (912)
Q Consensus       589 ~~~~~~~~~LG~G~fg~Vy~a~~~------~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~  662 (912)
                      ...+.+.+.||+|+||.||+|+..      ++..+++|.+........+.+.+|++++++++|+||+++++++......+
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (291)
T cd05094           4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI   83 (291)
T ss_pred             hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence            345667789999999999999753      35679999987665555678999999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCC
Q 002529          663 LVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM  729 (912)
Q Consensus       663 lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~  729 (912)
                      +||||+++++|.+++....             ....+++..++.++.||+.||+|||+   ++++||||||+||+++.++
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~  160 (291)
T cd05094          84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANL  160 (291)
T ss_pred             EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCC
Confidence            9999999999999997432             12458899999999999999999998   9999999999999999999


Q ss_pred             cEEEeeccCccccccccc-cccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHH
Q 002529          730 RAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHW  807 (912)
Q Consensus       730 ~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~  807 (912)
                      .++|+|||++........ .......++..|+|||++.+..++.++||||||+++|||++ |+.||......   ...+ 
T Consensus       161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~~-  236 (291)
T cd05094         161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT---EVIE-  236 (291)
T ss_pred             cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH-
Confidence            999999999876543221 12223446788999999999899999999999999999999 99998633221   1111 


Q ss_pred             HHhhhccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhhhhh
Q 002529          808 ARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI  868 (912)
Q Consensus       808 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~~~~  868 (912)
                         .+..+.....         ....+..+.+++.+||+.+|++||++++|+++|+++...
T Consensus       237 ---~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         237 ---CITQGRVLER---------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             ---HHhCCCCCCC---------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence               1222222111         111234788999999999999999999999999998663

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.2e-34  Score=313.16  Aligned_cols=259  Identities=23%  Similarity=0.319  Sum_probs=206.7

Q ss_pred             HHhhhcccCccccEEEEEEEec-CCCEEEEEEccCc---cchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEE
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE  666 (912)
Q Consensus       591 ~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~---~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E  666 (912)
                      .|++.+.||+|+||.||+|+.+ +++.||+|.++..   .......+.+|+++++.++||||+++++++...+..++++|
T Consensus         3 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   82 (267)
T cd08228           3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLE   82 (267)
T ss_pred             ceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEE
Confidence            4667889999999999999876 6899999987542   22334568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccc
Q 002529          667 YMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED  745 (912)
Q Consensus       667 ~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~  745 (912)
                      |+++++|.+++.... ....+++..++.++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||++......
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~  159 (267)
T cd08228          83 LADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             ecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence            999999998886432 24558899999999999999999998   99999999999999999999999999998876443


Q ss_pred             cccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccc
Q 002529          746 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL  825 (912)
Q Consensus       746 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  825 (912)
                      ... .....+++.|+|||.+.+..++.++|+||+|+++|||++|+.||.....    +....... +.......      
T Consensus       160 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~----~~~~~~~~-~~~~~~~~------  227 (267)
T cd08228         160 TTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLFSLCQK-IEQCDYPP------  227 (267)
T ss_pred             hHH-HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc----cHHHHHHH-HhcCCCCC------
Confidence            221 1223478899999999888899999999999999999999999963222    11111111 11111111      


Q ss_pred             cCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhhh
Q 002529          826 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI  866 (912)
Q Consensus       826 ~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~~  866 (912)
                        .........+.+++.+||+.+|++||++.||++.|+++.
T Consensus       228 --~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         228 --LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             --CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence              011223357889999999999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1e-35  Score=328.58  Aligned_cols=251  Identities=23%  Similarity=0.341  Sum_probs=211.8

Q ss_pred             HHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc--chhhHHHHHHHHHHHhcCCCCccceeeEEecCCe-EEEEE
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ-RILVY  665 (912)
Q Consensus       590 ~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~-~~lV~  665 (912)
                      +.|...+++|+|+||.+++++++ +++.+++|.+.-..  ....+...+|+.++++++|||||.+.+.+..++. .+|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            45778899999999999999887 57889999986432  2334567899999999999999999999998888 99999


Q ss_pred             EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccc
Q 002529          666 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED  745 (912)
Q Consensus       666 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~  745 (912)
                      +||+||+|.+.+.+.+ +.-++++.+..|+.|++.|+.|||+   ..|+|||||+.|||++.++.++|+|||+|+.....
T Consensus        84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            9999999999998763 6789999999999999999999998   99999999999999999999999999999998765


Q ss_pred             cccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccc
Q 002529          746 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL  825 (912)
Q Consensus       746 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  825 (912)
                      .. ......||+.|+.||++.+.+|..|+|||||||++|||++-+++|...+...   +   +....+. .    .+   
T Consensus       160 ~~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~---L---i~ki~~~-~----~~---  224 (426)
T KOG0589|consen  160 DS-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE---L---ILKINRG-L----YS---  224 (426)
T ss_pred             hh-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH---H---HHHHhhc-c----CC---
Confidence            42 3445679999999999999999999999999999999999999998544321   1   1111111 0    11   


Q ss_pred             cCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002529          826 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       826 ~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  861 (912)
                        ..+.....++..++..||+.+|+.||++.+++..
T Consensus       225 --Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  225 --PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             --CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence              2233445588999999999999999999999976

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-36  Score=327.87  Aligned_cols=262  Identities=29%  Similarity=0.440  Sum_probs=221.2

Q ss_pred             HHHHHHHhhhcccCccccEEEEEEEecC-CCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEE
Q 002529          586 ELEEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV  664 (912)
Q Consensus       586 ~l~~~~~~~~~~LG~G~fg~Vy~a~~~~-~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV  664 (912)
                      |+.+....+.++||-|-||.||.|.|+. .-.||||.++.+ .-..++|+.|..+|+.++|||+|+++|+|..+..+|||
T Consensus       263 EmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIi  341 (1157)
T KOG4278|consen  263 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYII  341 (1157)
T ss_pred             hccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEE
Confidence            4444555567999999999999999985 667999999865 44568999999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccc
Q 002529          665 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE  744 (912)
Q Consensus       665 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~  744 (912)
                      +|||..|+|.++|++. ++..++...++.++.||+.|++||..   +++|||||..+|+|+.++..+|++|||+++.+..
T Consensus       342 TEfM~yGNLLdYLRec-nr~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg  417 (1157)
T KOG4278|consen  342 TEFMCYGNLLDYLREC-NRSEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLMTG  417 (1157)
T ss_pred             EecccCccHHHHHHHh-chhhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhhcC
Confidence            9999999999999976 46677888889999999999999998   9999999999999999999999999999999866


Q ss_pred             ccccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhhhccCCcccccCc
Q 002529          745 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP  823 (912)
Q Consensus       745 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  823 (912)
                      +.........-+..|.|||-+....++.|+|||+|||+|||+.| |-.||.+.+.....       .         +++.
T Consensus       418 DTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY-------~---------LLEk  481 (1157)
T KOG4278|consen  418 DTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-------G---------LLEK  481 (1157)
T ss_pred             CceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHH-------H---------HHhc
Confidence            54443333345778999999999899999999999999999999 88999755443221       1         2222


Q ss_pred             cccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhhhhh
Q 002529          824 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI  868 (912)
Q Consensus       824 ~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~~~~  868 (912)
                      ..+-+.+..++.++.+|++.||+++|.+||++.|+-+.++.+...
T Consensus       482 gyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~  526 (1157)
T KOG4278|consen  482 GYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS  526 (1157)
T ss_pred             cccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence            333344556677999999999999999999999999999876654

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=9e-37  Score=303.76  Aligned_cols=253  Identities=24%  Similarity=0.324  Sum_probs=202.9

Q ss_pred             HHHHHHhhhcccCccccEEEEEEEec-CCCEEEEEEccC--ccchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEE
Q 002529          587 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMAD--SCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL  663 (912)
Q Consensus       587 l~~~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~--~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~l  663 (912)
                      +....|++.+.||+|.|+.||+..+. +|+.+|+|++.-  ....+.+++.+|+.+.+.|+||||+++.+.+.+....+|
T Consensus         8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl   87 (355)
T KOG0033|consen    8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL   87 (355)
T ss_pred             ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence            34566788899999999999999765 689999988743  233466889999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccC---CCcEEEeeccCcc
Q 002529          664 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSR  740 (912)
Q Consensus       664 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~---~~~vkL~DFGla~  740 (912)
                      |+|+|.|++|..-+-   .+...++..+-..++||+++|.|+|.   ++|||||+||+|+++.+   ..-+||+|||+|.
T Consensus        88 vFe~m~G~dl~~eIV---~R~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi  161 (355)
T KOG0033|consen   88 VFDLVTGGELFEDIV---AREFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAI  161 (355)
T ss_pred             EEecccchHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEE
Confidence            999999999965444   23567788888999999999999998   99999999999999953   3459999999999


Q ss_pred             ccccccccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccc
Q 002529          741 QAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI  820 (912)
Q Consensus       741 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  820 (912)
                      ....  ........|||+|||||+++..+++..+|||+.|++||-|+.|.+||.+++..   .+.+    .+..+...  
T Consensus       162 ~l~~--g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~---rlye----~I~~g~yd--  230 (355)
T KOG0033|consen  162 EVND--GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYE----QIKAGAYD--  230 (355)
T ss_pred             EeCC--ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH---HHHH----HHhccccC--
Confidence            8873  33344567999999999999999999999999999999999999999853322   1222    22222210  


Q ss_pred             cCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          821 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       821 ~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                      +++.    .-....+...+|+++||..||.+|.|+.|.|+
T Consensus       231 ~~~~----~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  231 YPSP----EWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             CCCc----ccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence            1111    11122236789999999999999999999873

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=9e-35  Score=320.84  Aligned_cols=262  Identities=22%  Similarity=0.277  Sum_probs=197.0

Q ss_pred             HHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCccc-hhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEe
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY  667 (912)
Q Consensus       590 ~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  667 (912)
                      ..|++.++||+|+||.||+|+.+ +++.||+|+++.... .....+.+|+.+++.++||||+++++++.++...++||||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (303)
T cd07869           5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY   84 (303)
T ss_pred             ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence            45677899999999999999987 689999999875432 2234677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccc
Q 002529          668 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT  747 (912)
Q Consensus       668 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~  747 (912)
                      +. ++|.+++...  ...+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++........
T Consensus        85 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  158 (303)
T cd07869          85 VH-TDLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH  158 (303)
T ss_pred             CC-cCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc
Confidence            95 6888877642  4568899999999999999999998   9999999999999999999999999999875432221


Q ss_pred             cccccccCCCcccCCCccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccC---Cccc----
Q 002529          748 HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG---DVIS----  819 (912)
Q Consensus       748 ~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~---~~~~----  819 (912)
                       ......+++.|+|||++.+ ..++.++||||+||++|+|++|+.||......  ....+.+.......   ....    
T Consensus       159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  235 (303)
T cd07869         159 -TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI--QDQLERIFLVLGTPNEDTWPGVHSL  235 (303)
T ss_pred             -cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHHhCCCChhhccchhhc
Confidence             1223457899999998865 46789999999999999999999999743221  11111111111000   0000    


Q ss_pred             -ccCc-cccCCCC---------HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          820 -IVDP-VLIGNVK---------IESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       820 -~~d~-~l~~~~~---------~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                       ..++ ......+         ......+.+++.+||+.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence             0000 0000000         001235779999999999999999999985

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-35  Score=324.70  Aligned_cols=266  Identities=29%  Similarity=0.440  Sum_probs=223.9

Q ss_pred             hHHHHHHHhhhcccCccccEEEEEEEecC---C--CEEEEEEccCcc-chhhHHHHHHHHHHHhcCCCCccceeeEEecC
Q 002529          585 PELEEATNNFCKKIGKGSFGSVYYGKMKD---G--KEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE  658 (912)
Q Consensus       585 ~~l~~~~~~~~~~LG~G~fg~Vy~a~~~~---~--~~vAvK~l~~~~-~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~  658 (912)
                      -+|.++...+.++||.|-||.||+|...+   |  -.||||..+.++ .+..+.|+.|..+|+++.||||++++|+|.+.
T Consensus       384 yel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~  463 (974)
T KOG4257|consen  384 YELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ  463 (974)
T ss_pred             ceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc
Confidence            46667777778999999999999997543   3  358999988754 45678899999999999999999999999875


Q ss_pred             CeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccC
Q 002529          659 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL  738 (912)
Q Consensus       659 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGl  738 (912)
                       ..++|||.++.|-|..+|+.  +...++......++.||+.||+|||+   ..+|||||..+|||+.+..-+||+|||+
T Consensus       464 -P~WivmEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGL  537 (974)
T KOG4257|consen  464 -PMWIVMELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGL  537 (974)
T ss_pred             -ceeEEEecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccch
Confidence             57999999999999999986  46779999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccccccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhhhccCCc
Q 002529          739 SRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDV  817 (912)
Q Consensus       739 a~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  817 (912)
                      ++...+..........-+..|||||-+.-.+++.++|||-|||++||++. |..||.+-...+                +
T Consensus       538 SR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD----------------V  601 (974)
T KOG4257|consen  538 SRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD----------------V  601 (974)
T ss_pred             hhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc----------------e
Confidence            99988776665555556789999999999999999999999999999887 999998543322                1


Q ss_pred             ccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhhhhhccCC
Q 002529          818 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGG  872 (912)
Q Consensus       818 ~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~~~~~~~~  872 (912)
                      .-.++..-+-..++.++..|..|+.+||..+|.+||++.|+...|.++...+...
T Consensus       602 I~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek~~  656 (974)
T KOG4257|consen  602 IGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEKIN  656 (974)
T ss_pred             EEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhhhh
Confidence            1122222222345566778999999999999999999999999999988865543

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.6e-35  Score=329.84  Aligned_cols=260  Identities=22%  Similarity=0.304  Sum_probs=195.1

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCc--cchhhHHHHHHHHHHHhcCCCCccceeeEEecC-----CeEEE
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE-----HQRIL  663 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~-----~~~~l  663 (912)
                      |++.++||+|+||.||+|..+ +++.||+|++...  .......+.+|++++++++||||+++++++...     ...++
T Consensus         2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l   81 (338)
T cd07859           2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV   81 (338)
T ss_pred             eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence            567889999999999999876 6899999998643  223345688999999999999999999987543     35799


Q ss_pred             EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccc
Q 002529          664 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE  743 (912)
Q Consensus       664 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~  743 (912)
                      ||||+. ++|.+++.   ....+++..+..++.||++||+|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus        82 v~e~~~-~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~  154 (338)
T cd07859          82 VFELME-SDLHQVIK---ANDDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAF  154 (338)
T ss_pred             EEecCC-CCHHHHHH---hcccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence            999995 68999887   34568999999999999999999998   999999999999999999999999999997643


Q ss_pred             cccc--cccccccCCCcccCCCccCC--CCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhh-------
Q 002529          744 EDLT--HISSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI-------  812 (912)
Q Consensus       744 ~~~~--~~~~~~~gt~~y~APE~l~~--~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~-------  812 (912)
                      ....  .......|++.|+|||++.+  ..++.++|||||||++|||++|+.||.........   ..+....       
T Consensus       155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~---~~~~~~~~~~~~~~  231 (338)
T cd07859         155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL---DLITDLLGTPSPET  231 (338)
T ss_pred             cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHH---HHHHHHhCCCCHHH
Confidence            2211  11223458999999999876  67899999999999999999999999744321111   1111100       


Q ss_pred             ----ccCCccccc---CccccCC---CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002529          813 ----KKGDVISIV---DPVLIGN---VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       813 ----~~~~~~~~~---d~~l~~~---~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  861 (912)
                          ........+   .+.....   ........+.+++.+||+.+|++||+++|+++.
T Consensus       232 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             HHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence                000000000   0000000   000122467899999999999999999999864

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=5.3e-35  Score=327.75  Aligned_cols=262  Identities=28%  Similarity=0.472  Sum_probs=205.7

Q ss_pred             HHHHHhhhcccCccccEEEEEEEec------CCCEEEEEEccCccc-hhhHHHHHHHHHHHhc-CCCCccceeeEEec-C
Q 002529          588 EEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEE-E  658 (912)
Q Consensus       588 ~~~~~~~~~~LG~G~fg~Vy~a~~~------~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~L-~hpnIv~l~~~~~~-~  658 (912)
                      ...+|++.+.||+|+||.||+|...      +++.||+|+++.... ...+.+.+|+++++++ +|+||+++++++.. +
T Consensus         5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~   84 (337)
T cd05054           5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG   84 (337)
T ss_pred             CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence            3457889999999999999999643      257899999875432 3345678899999999 79999999998864 4


Q ss_pred             CeEEEEEEecCCCCHHHHhccCCC--------------------------------------------------------
Q 002529          659 HQRILVYEYMHNGTLRDRLHGSVN--------------------------------------------------------  682 (912)
Q Consensus       659 ~~~~lV~E~~~~gsL~~~l~~~~~--------------------------------------------------------  682 (912)
                      ...++++||+++++|.+++.....                                                        
T Consensus        85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (337)
T cd05054          85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE  164 (337)
T ss_pred             CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence            578899999999999998864321                                                        


Q ss_pred             --CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccccc-cccccCCCcc
Q 002529          683 --QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSVARGTVGY  759 (912)
Q Consensus       683 --~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y  759 (912)
                        ...+++..+..++.||+.||+|||+   .+|+||||||+||+++.++.++|+|||++.......... .....++..|
T Consensus       165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y  241 (337)
T cd05054         165 LYKEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW  241 (337)
T ss_pred             HhhcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence              1368899999999999999999998   999999999999999999999999999998754332211 2223456789


Q ss_pred             cCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCCCCHHHHHHHH
Q 002529          760 LDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIA  838 (912)
Q Consensus       760 ~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~  838 (912)
                      +|||++.+..++.++|||||||++|||++ |..||......+  .+    ...+..+....         .+......+.
T Consensus       242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--~~----~~~~~~~~~~~---------~~~~~~~~~~  306 (337)
T cd05054         242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--EF----CRRLKEGTRMR---------APEYATPEIY  306 (337)
T ss_pred             cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--HH----HHHHhccCCCC---------CCccCCHHHH
Confidence            99999999999999999999999999998 999997432211  11    11122211110         0112234788


Q ss_pred             HHHHhcccCCCCCCCCHHHHHHHHhhhhh
Q 002529          839 EVAIQCVEQRGFSRPKMQEIVLAIQDSIK  867 (912)
Q Consensus       839 ~Li~~cL~~dP~~RPs~~evl~~L~~~~~  867 (912)
                      +++.+||+.+|++||++.||++.|+++++
T Consensus       307 ~l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         307 SIMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            99999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.5e-34  Score=311.56  Aligned_cols=255  Identities=27%  Similarity=0.435  Sum_probs=203.9

Q ss_pred             HHHHHhhhcccCccccEEEEEEEecCCCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEe
Q 002529          588 EEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY  667 (912)
Q Consensus       588 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  667 (912)
                      ...++++.++||+|++|.||+|..+.+..+|+|.+.... ...+.+.+|++++++++|+|++++++++.. +..+++|||
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~   81 (260)
T cd05069           4 PRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEF   81 (260)
T ss_pred             ChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEc
Confidence            345678889999999999999998877789999886543 234678899999999999999999998854 567899999


Q ss_pred             cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccc
Q 002529          668 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT  747 (912)
Q Consensus       668 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~  747 (912)
                      +++++|.+++... ....+++..+..++.|++.||+|||+   .+++|+||||+||++++++.++|+|||.+........
T Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05069          82 MGKGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             CCCCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence            9999999999753 34458899999999999999999998   8999999999999999999999999999976543322


Q ss_pred             cccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhhhccCCcccccCcccc
Q 002529          748 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI  826 (912)
Q Consensus       748 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  826 (912)
                      .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......   ...++.    ..+...        
T Consensus       158 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~----~~~~~~--------  222 (260)
T cd05069         158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR---EVLEQV----ERGYRM--------  222 (260)
T ss_pred             cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH----HcCCCC--------
Confidence            22222335678999999988899999999999999999999 99999743221   111111    111000        


Q ss_pred             CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhh
Q 002529          827 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD  864 (912)
Q Consensus       827 ~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~  864 (912)
                       ..+...+..+.+++.+||+.+|++||++++|++.|++
T Consensus       223 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         223 -PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             -CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence             0111234578899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.3e-35  Score=319.80  Aligned_cols=262  Identities=29%  Similarity=0.434  Sum_probs=202.3

Q ss_pred             HHHhhhcccCccccEEEEEEEec-----CCCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEec--CCeEE
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMK-----DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQRI  662 (912)
Q Consensus       590 ~~~~~~~~LG~G~fg~Vy~a~~~-----~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~--~~~~~  662 (912)
                      ..+++.+.||+|+||.||++..+     +++.||+|.++.......+.+.+|++++++++||||+++++++..  ....+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            45677899999999999999753     578999999887665666789999999999999999999998743  34688


Q ss_pred             EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccc
Q 002529          663 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA  742 (912)
Q Consensus       663 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~  742 (912)
                      +|+||+++++|.+++...  ...+++..++.++.|++.||+|||+   .+++||||||+||+++.++.++|+|||++...
T Consensus        84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            999999999999999743  3468999999999999999999998   99999999999999999999999999999876


Q ss_pred             ccccccc--cccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccch---------hhHHHHHHhh
Q 002529          743 EEDLTHI--SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE---------LNIVHWARSM  811 (912)
Q Consensus       743 ~~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~---------~~~~~~~~~~  811 (912)
                      .......  .....++..|+|||++.+..++.++||||||+++|||++|..|+........         ..........
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05081         159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL  238 (284)
T ss_pred             cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence            4332211  1112234569999999988999999999999999999998877642221100         0000001111


Q ss_pred             hccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhh
Q 002529          812 IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS  865 (912)
Q Consensus       812 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~  865 (912)
                      +..+.         ........+..+.+++.+||+.+|++|||++||++.|+.+
T Consensus       239 ~~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         239 LKNNG---------RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HhcCC---------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            11110         0011122334789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=4.1e-35  Score=327.95  Aligned_cols=251  Identities=24%  Similarity=0.322  Sum_probs=198.1

Q ss_pred             HhhhcccCccccEEEEEEEec----CCCEEEEEEccCcc----chhhHHHHHHHHHHHhc-CCCCccceeeEEecCCeEE
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC----SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRI  662 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~----~~~~vAvK~l~~~~----~~~~~~~~~E~~il~~L-~hpnIv~l~~~~~~~~~~~  662 (912)
                      |++.++||+|+||.||+++..    +++.||+|++....    ....+.+.+|+++++++ +|+||+++++++..++..+
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (332)
T cd05614           2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH   81 (332)
T ss_pred             ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence            567889999999999999753    57899999986432    22345678899999999 4999999999999999999


Q ss_pred             EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccc
Q 002529          663 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA  742 (912)
Q Consensus       663 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~  742 (912)
                      +||||+++|+|.+++.   ....+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||++...
T Consensus        82 lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~  155 (332)
T cd05614          82 LILDYVSGGEMFTHLY---QRDNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (332)
T ss_pred             EEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence            9999999999999987   34678999999999999999999998   99999999999999999999999999999865


Q ss_pred             ccccccccccccCCCcccCCCccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCccccc
Q 002529          743 EEDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV  821 (912)
Q Consensus       743 ~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  821 (912)
                      ............||+.|+|||++.+. .++.++|||||||++|||++|+.||.........  ..........       
T Consensus       156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--~~~~~~~~~~-------  226 (332)
T cd05614         156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ--SEVSRRILKC-------  226 (332)
T ss_pred             cccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH--HHHHHHHhcC-------
Confidence            43333223345689999999998765 4788999999999999999999999743322111  1111111111       


Q ss_pred             CccccCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 002529          822 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA  861 (912)
Q Consensus       822 d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP-----s~~evl~~  861 (912)
                      ++.+.    ......+.+++.+||+.||++||     +++++++.
T Consensus       227 ~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         227 DPPFP----SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             CCCCC----CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence            11111    12234678999999999999999     77787753

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2.2e-34  Score=307.88  Aligned_cols=247  Identities=29%  Similarity=0.463  Sum_probs=200.0

Q ss_pred             cccCccccEEEEEEEecCCCEEEEEEccCccc-hhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEecCCCCHH
Q 002529          596 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLR  674 (912)
Q Consensus       596 ~~LG~G~fg~Vy~a~~~~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~  674 (912)
                      +.||+|+||.||+|...+++.+|+|.++.... .....+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            47999999999999988899999999876543 23456889999999999999999999999999999999999999999


Q ss_pred             HHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccccccccc
Q 002529          675 DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR  754 (912)
Q Consensus       675 ~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~  754 (912)
                      +++...  ...+++..++.++.|++.+|.|||+   ++++|+||||+||+++.++.++|+|||++...............
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (250)
T cd05085          81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ  155 (250)
T ss_pred             HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence            998743  3468899999999999999999998   99999999999999999999999999998764433222222223


Q ss_pred             CCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCCCCHHH
Q 002529          755 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES  833 (912)
Q Consensus       755 gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  833 (912)
                      ++..|+|||++.+..++.++||||||+++|++++ |..||......   ....    .+..+...         ..+...
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~---~~~~----~~~~~~~~---------~~~~~~  219 (250)
T cd05085         156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ---QARE----QVEKGYRM---------SCPQKC  219 (250)
T ss_pred             CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH---HHHH----HHHcCCCC---------CCCCCC
Confidence            4568999999998899999999999999999998 99999733221   1111    11111110         111123


Q ss_pred             HHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 002529          834 IWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ  863 (912)
Q Consensus       834 ~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  863 (912)
                      +..+.+++.+|++.+|++||++.|+++.|.
T Consensus       220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         220 PDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            457899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=3.6e-35  Score=329.46  Aligned_cols=248  Identities=24%  Similarity=0.290  Sum_probs=201.3

Q ss_pred             HHHHHHhhhcccCccccEEEEEEEecC--CCEEEEEEccCcc---chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeE
Q 002529          587 LEEATNNFCKKIGKGSFGSVYYGKMKD--GKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR  661 (912)
Q Consensus       587 l~~~~~~~~~~LG~G~fg~Vy~a~~~~--~~~vAvK~l~~~~---~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~  661 (912)
                      +....|++.+.||+|+||.||+|.++.  +..||+|++....   ......+.+|+++++.++||||+++++++.+++..
T Consensus        27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~  106 (340)
T PTZ00426         27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYL  106 (340)
T ss_pred             CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEE
Confidence            344567888999999999999998653  3689999986432   22345688899999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccc
Q 002529          662 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ  741 (912)
Q Consensus       662 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~  741 (912)
                      ++||||+++|+|.+++..   ...+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++..
T Consensus       107 ~lv~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~  180 (340)
T PTZ00426        107 YLVLEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKV  180 (340)
T ss_pred             EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCee
Confidence            999999999999999973   4578999999999999999999998   9999999999999999999999999999986


Q ss_pred             cccccccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCccccc
Q 002529          742 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV  821 (912)
Q Consensus       742 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  821 (912)
                      .....    ....||+.|+|||++.+..++.++|||||||++|||++|+.||......   ...+    .+..+..    
T Consensus       181 ~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~---~~~~----~i~~~~~----  245 (340)
T PTZ00426        181 VDTRT----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL---LIYQ----KILEGII----  245 (340)
T ss_pred             cCCCc----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH---HHHH----HHhcCCC----
Confidence            54321    2345899999999999888999999999999999999999999743221   1111    1111111    


Q ss_pred             CccccCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 002529          822 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA  861 (912)
Q Consensus       822 d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP-----s~~evl~~  861 (912)
                            ..+......+.+++.+||+.+|++|+     +++|+++.
T Consensus       246 ------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        246 ------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             ------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence                  01111223678999999999999995     89988764

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=7.6e-35  Score=341.47  Aligned_cols=250  Identities=20%  Similarity=0.313  Sum_probs=202.4

Q ss_pred             HhhhcccCccccEEEEEEEec-C-CCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEecC
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-D-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH  669 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~-~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~  669 (912)
                      |.+.+.||+|++|.||+|... + ++.||+|.+..........+.+|+.+++.++||||+++++++..++..++||||++
T Consensus        69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~  148 (478)
T PTZ00267         69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS  148 (478)
T ss_pred             EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence            677899999999999999765 3 67888888765544555677889999999999999999999999999999999999


Q ss_pred             CCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccc-
Q 002529          670 NGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT-  747 (912)
Q Consensus       670 ~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~-  747 (912)
                      +|+|.+++.... ....+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++....... 
T Consensus       149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~  225 (478)
T PTZ00267        149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL  225 (478)
T ss_pred             CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence            999999886432 34578999999999999999999998   9999999999999999999999999999987644322 


Q ss_pred             cccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccC
Q 002529          748 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG  827 (912)
Q Consensus       748 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  827 (912)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||......      +.+..... +....        
T Consensus       226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~------~~~~~~~~-~~~~~--------  290 (478)
T PTZ00267        226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR------EIMQQVLY-GKYDP--------  290 (478)
T ss_pred             ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHh-CCCCC--------
Confidence            1233445899999999999999999999999999999999999999743221      11111111 11110        


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          828 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       828 ~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                       .+......+.+++.+||+.+|++||++++++.
T Consensus       291 -~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        291 -FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             -CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence             11122346889999999999999999999874

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=6e-35  Score=326.27  Aligned_cols=248  Identities=22%  Similarity=0.349  Sum_probs=196.9

Q ss_pred             cccCccccEEEEEEEec-CCCEEEEEEccCcc---chhhHHHHHHHHHHHhc-CCCCccceeeEEecCCeEEEEEEecCC
Q 002529          596 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN  670 (912)
Q Consensus       596 ~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~L-~hpnIv~l~~~~~~~~~~~lV~E~~~~  670 (912)
                      +.||+|+||.||+|+.+ +++.||+|+++...   ....+.+.+|..+++++ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999876 58899999997532   22345678899999998 699999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccccc
Q 002529          671 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS  750 (912)
Q Consensus       671 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~  750 (912)
                      |+|.+++.   ....+++..++.++.||+.||+|||+   ++++||||||+||+++.++.+||+|||+++....... ..
T Consensus        81 g~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~-~~  153 (329)
T cd05588          81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD-TT  153 (329)
T ss_pred             CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCCC-cc
Confidence            99999887   34679999999999999999999998   9999999999999999999999999999875322111 12


Q ss_pred             ccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccc--hhhHHHHHHhhhccCCcccccCccccCC
Q 002529          751 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA--ELNIVHWARSMIKKGDVISIVDPVLIGN  828 (912)
Q Consensus       751 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~l~~~  828 (912)
                      ....|++.|+|||++.+..++.++|||||||++|+|++|+.||.......  .....++....+.....      .    
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~----  223 (329)
T cd05588         154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI------R----  223 (329)
T ss_pred             ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC------C----
Confidence            23468999999999999999999999999999999999999997332221  11222222222222211      0    


Q ss_pred             CCHHHHHHHHHHHHhcccCCCCCCCC------HHHHHH
Q 002529          829 VKIESIWRIAEVAIQCVEQRGFSRPK------MQEIVL  860 (912)
Q Consensus       829 ~~~~~~~~l~~Li~~cL~~dP~~RPs------~~evl~  860 (912)
                      .+......+.+++.+||+.||.+||+      ++|+++
T Consensus       224 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         224 IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence            11122346889999999999999997      667764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=6.1e-35  Score=317.55  Aligned_cols=258  Identities=25%  Similarity=0.434  Sum_probs=203.3

Q ss_pred             HHHHHhhhcccCccccEEEEEEEec------CCCEEEEEEccCccc-hhhHHHHHHHHHHHhcCCCCccceeeEEecCCe
Q 002529          588 EEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ  660 (912)
Q Consensus       588 ~~~~~~~~~~LG~G~fg~Vy~a~~~------~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~  660 (912)
                      ....|++.+.||+|+||.||+|.++      .++.||+|.+..... ....++.+|+.+++.++||||+++++++..+..
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4566888999999999999999764      256799999865332 334568899999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHhccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEE
Q 002529          661 RILVYEYMHNGTLRDRLHGSVN-------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKV  733 (912)
Q Consensus       661 ~~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL  733 (912)
                      .++||||+++++|.+++.....       ...+++..++.++.|++.||+|||+   .+++|+||||+||++++++.++|
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEE
Confidence            9999999999999999875321       2346788899999999999999998   89999999999999999999999


Q ss_pred             eeccCcccccccccc-ccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhh
Q 002529          734 SDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSM  811 (912)
Q Consensus       734 ~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~  811 (912)
                      +|||++......... ......++..|+|||++.+..++.++|||||||++|||++ |..||......   ....    .
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~---~~~~----~  233 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE---QVLR----F  233 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH----H
Confidence            999998765432221 1112235678999999998899999999999999999999 78898633221   1111    1


Q ss_pred             hccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhh
Q 002529          812 IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD  864 (912)
Q Consensus       812 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~  864 (912)
                      +..+.....         +...+..+.+++.+||+.+|++||++.|+++.|++
T Consensus       234 ~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         234 VMEGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             HHcCCcCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            111111111         11223478899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=4.9e-35  Score=320.36  Aligned_cols=260  Identities=21%  Similarity=0.272  Sum_probs=194.1

Q ss_pred             HHhhhcccCccccEEEEEEEec--CCCEEEEEEccCccc--hhhHHHHHHHHHHHhc---CCCCccceeeEEe-----cC
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMK--DGKEVAVKIMADSCS--HRTQQFVTEVALLSRI---HHRNLVPLIGYCE-----EE  658 (912)
Q Consensus       591 ~~~~~~~LG~G~fg~Vy~a~~~--~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~L---~hpnIv~l~~~~~-----~~  658 (912)
                      .|++.+.||+|+||.||+|+..  +++.||+|+++....  .....+.+|+.+++.+   +||||+++++++.     ..
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            4677899999999999999874  468899999864322  2234566788777766   5999999999885     34


Q ss_pred             CeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccC
Q 002529          659 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL  738 (912)
Q Consensus       659 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGl  738 (912)
                      ...++||||+. ++|.+++... ....+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+
T Consensus        82 ~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T cd07862          82 TKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGL  156 (290)
T ss_pred             CcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence            56899999996 6899988754 34568999999999999999999998   9999999999999999999999999999


Q ss_pred             ccccccccccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhc---cC
Q 002529          739 SRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK---KG  815 (912)
Q Consensus       739 a~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~---~~  815 (912)
                      +......  .......|++.|+|||++.+..++.++|||||||++|||++|++||......+   ....+.....   ..
T Consensus       157 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~---~~~~i~~~~~~~~~~  231 (290)
T cd07862         157 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLPGEE  231 (290)
T ss_pred             eEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH---HHHHHHHHhCCCChh
Confidence            9765433  12233458999999999988899999999999999999999999998443221   1111111110   00


Q ss_pred             Cccc-------ccCcccc---CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          816 DVIS-------IVDPVLI---GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       816 ~~~~-------~~d~~l~---~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                      ....       .+.+...   ..........+.+++.+||+.+|++|||+.|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            0000       0000000   0000122346789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-34  Score=311.53  Aligned_cols=257  Identities=28%  Similarity=0.467  Sum_probs=208.3

Q ss_pred             HHHHHHhhhcccCccccEEEEEEEecCCCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEE
Q 002529          587 LEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE  666 (912)
Q Consensus       587 l~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E  666 (912)
                      +....+++.++||+|++|.||+|..++++.||+|.+.... ...+.+.+|+.++++++|+||+++++++......++|||
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   81 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE   81 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence            4456778889999999999999998888899999987543 334678999999999999999999999999889999999


Q ss_pred             ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccc
Q 002529          667 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL  746 (912)
Q Consensus       667 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~  746 (912)
                      |+++++|.+++... ....+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||.+.......
T Consensus        82 ~~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (261)
T cd05034          82 YMSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE  157 (261)
T ss_pred             ccCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence            99999999999754 24568999999999999999999998   899999999999999999999999999988765432


Q ss_pred             ccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhhhccCCcccccCccc
Q 002529          747 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL  825 (912)
Q Consensus       747 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  825 (912)
                      .........+..|+|||.+.+..++.++||||+|+++|+|++ |+.||......   ...+......   ..        
T Consensus       158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~~~~~~~---~~--------  223 (261)
T cd05034         158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR---EVLEQVERGY---RM--------  223 (261)
T ss_pred             hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHcCC---CC--------
Confidence            222222234568999999998889999999999999999998 99999633211   1111111100   00        


Q ss_pred             cCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhh
Q 002529          826 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD  864 (912)
Q Consensus       826 ~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~  864 (912)
                        ..+...+..+.+++.+||+.+|++||+++|+++.|++
T Consensus       224 --~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         224 --PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             --CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence              0011123478899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=7.8e-35  Score=317.75  Aligned_cols=256  Identities=26%  Similarity=0.469  Sum_probs=202.8

Q ss_pred             HHHhhhcccCccccEEEEEEEe-----cCCCEEEEEEccCccc-hhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEE
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKM-----KDGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL  663 (912)
Q Consensus       590 ~~~~~~~~LG~G~fg~Vy~a~~-----~~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~l  663 (912)
                      ..+++.++||+|+||.||+|..     .+++.|++|.+..... .....+.+|++++++++||||+++++++..+...++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4567789999999999999985     2467899999875332 334678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhccCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCC
Q 002529          664 VYEYMHNGTLRDRLHGSV--------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM  729 (912)
Q Consensus       664 V~E~~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~  729 (912)
                      ||||+++++|.+++....              ....+++.++..++.|++.||+|||+   ++++|+||||+||+++.++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCC
Confidence            999999999999985321              12357889999999999999999998   8999999999999999999


Q ss_pred             cEEEeeccCcccccccc-ccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHH
Q 002529          730 RAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHW  807 (912)
Q Consensus       730 ~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~  807 (912)
                      .+||+|||++....... ........++..|+|||++.+..++.++||||||+++|||++ |..||.....   ..+.+.
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~---~~~~~~  238 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN---QEVIEM  238 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH
Confidence            99999999997653322 112222335678999999988889999999999999999998 9999863321   112221


Q ss_pred             HHhhhccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhh
Q 002529          808 ARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD  864 (912)
Q Consensus       808 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~  864 (912)
                      +    .......         .+......+.+++.+||+.+|++||++.+|++.|+.
T Consensus       239 ~----~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         239 V----RKRQLLP---------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             H----HcCCcCC---------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            1    1111111         111223478899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2.3e-34  Score=310.76  Aligned_cols=259  Identities=22%  Similarity=0.326  Sum_probs=207.4

Q ss_pred             HHhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc---chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEE
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE  666 (912)
Q Consensus       591 ~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E  666 (912)
                      .|++.+.||+|++|.||+|..+ +++.++||.+....   ......+.+|+++++.++||||+++++++..++..+++||
T Consensus         3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   82 (267)
T cd08229           3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE   82 (267)
T ss_pred             hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence            4677899999999999999865 78999999876432   2334678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccc
Q 002529          667 YMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED  745 (912)
Q Consensus       667 ~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~  745 (912)
                      |+++++|.+++.... ....+++..++.++.||+.||+|||+   .+++|+||||+||+++.++.++|+|||++......
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd08229          83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence            999999999886432 34568999999999999999999998   99999999999999999999999999998765433


Q ss_pred             cccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccc
Q 002529          746 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL  825 (912)
Q Consensus       746 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  825 (912)
                      ... .....++..|+|||++.+..++.++||||||+++|+|++|..||......    .....+.. ....     .+..
T Consensus       160 ~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~-~~~~-----~~~~  228 (267)
T cd08229         160 TTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKI-EQCD-----YPPL  228 (267)
T ss_pred             Ccc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHhhhh-hcCC-----CCCC
Confidence            221 12235788999999998888999999999999999999999999633221    11111111 1111     0111


Q ss_pred             cCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhhh
Q 002529          826 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI  866 (912)
Q Consensus       826 ~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~~  866 (912)
                         ........+.+++.+||+.+|++|||+.+|++.++++.
T Consensus       229 ---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         229 ---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             ---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence               11123457889999999999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=3.2e-35  Score=327.95  Aligned_cols=243  Identities=24%  Similarity=0.352  Sum_probs=195.6

Q ss_pred             cccCccccEEEEEEEec-CCCEEEEEEccCcc---chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEecCCC
Q 002529          596 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG  671 (912)
Q Consensus       596 ~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~g  671 (912)
                      +.||+|+||.||++..+ +++.||+|+++...   ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999875 68999999987532   223456778999999999999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccccccc
Q 002529          672 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS  751 (912)
Q Consensus       672 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~  751 (912)
                      +|.+++.   ....+++..+..++.||+.||+|||+  ..+|+||||||+|||++.++.+||+|||++......... ..
T Consensus        81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~-~~  154 (325)
T cd05594          81 ELFFHLS---RERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT-MK  154 (325)
T ss_pred             cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc-cc
Confidence            9999887   34578999999999999999999996  269999999999999999999999999998754322211 22


Q ss_pred             cccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCCCCH
Q 002529          752 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI  831 (912)
Q Consensus       752 ~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  831 (912)
                      ...|++.|+|||++.+..++.++|||||||++|+|++|+.||......   ....   . +.....      .+    +.
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~---~~~~---~-i~~~~~------~~----p~  217 (325)
T cd05594         155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFE---L-ILMEEI------RF----PR  217 (325)
T ss_pred             cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH---HHHH---H-HhcCCC------CC----CC
Confidence            345899999999999989999999999999999999999999743321   1111   1 111110      01    11


Q ss_pred             HHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 002529          832 ESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA  861 (912)
Q Consensus       832 ~~~~~l~~Li~~cL~~dP~~RP-----s~~evl~~  861 (912)
                      .....+.+++.+||+.||++|+     +++++++.
T Consensus       218 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         218 TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            1234688999999999999996     89999854

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=7e-35  Score=302.50  Aligned_cols=265  Identities=20%  Similarity=0.206  Sum_probs=204.3

Q ss_pred             HHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCccchh--hHHHHHHHHHHHhcCCCCccceeeEEec--CCeEEEE
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHR--TQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQRILV  664 (912)
Q Consensus       590 ~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~~--~~~~~~E~~il~~L~hpnIv~l~~~~~~--~~~~~lV  664 (912)
                      ..|+...+|++|.||.||+|+++ +++.||+|+++......  .-.-++|+.+|.+++|||||.+-.+...  -+..|||
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            34566789999999999999987 68999999997543221  1235789999999999999999998754  4579999


Q ss_pred             EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccc
Q 002529          665 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE  744 (912)
Q Consensus       665 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~  744 (912)
                      ||||+. +|...++..  ..++...++..+..|+++|++|||.   ..|+|||||++|+|++..|.+||+|||+|+.++.
T Consensus       156 Me~~Eh-DLksl~d~m--~q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs  229 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETM--KQPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYGS  229 (419)
T ss_pred             HHHHHh-hHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhcC
Confidence            999965 898888853  4689999999999999999999998   9999999999999999999999999999999987


Q ss_pred             ccccccccccCCCcccCCCccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCc
Q 002529          745 DLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP  823 (912)
Q Consensus       745 ~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  823 (912)
                      ..... ...+-|..|+|||.+.+. .|+.+.|+||+|||+.||+++++-|.+....++.+.+-.......+..+..+...
T Consensus       230 p~k~~-T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~l  308 (419)
T KOG0663|consen  230 PLKPY-TPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSEL  308 (419)
T ss_pred             CcccC-cceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcccc
Confidence            64433 334578999999988764 7899999999999999999999999866554433322222222222211111111


Q ss_pred             c--------------ccCCCCHH-HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002529          824 V--------------LIGNVKIE-SIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       824 ~--------------l~~~~~~~-~~~~l~~Li~~cL~~dP~~RPs~~evl~~  861 (912)
                      .              +++.+... ..+.-.+|+..+|..||.+|.|++|.|+.
T Consensus       309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence            1              11111111 22456789999999999999999998863

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=6.9e-35  Score=325.04  Aligned_cols=244  Identities=23%  Similarity=0.339  Sum_probs=193.5

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc---chhhHHHHHHHHHH---HhcCCCCccceeeEEecCCeEEEE
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALL---SRIHHRNLVPLIGYCEEEHQRILV  664 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il---~~L~hpnIv~l~~~~~~~~~~~lV  664 (912)
                      |++.+.||+|+||.||+|..+ +++.||+|+++...   ....+.+.+|.+++   +.++||||+++++++...+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            356789999999999999876 68999999987532   22335566676665   456799999999999999999999


Q ss_pred             EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccc
Q 002529          665 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE  744 (912)
Q Consensus       665 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~  744 (912)
                      |||+++++|...+.    ...+++..++.++.||+.||+|||+   .+++||||||+||+++.++.+||+|||++.....
T Consensus        81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05589          81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG  153 (324)
T ss_pred             EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence            99999999998886    3468999999999999999999998   9999999999999999999999999999875332


Q ss_pred             ccccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCcc
Q 002529          745 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV  824 (912)
Q Consensus       745 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  824 (912)
                      ... ......|++.|+|||++.+..++.++|||||||++|||++|+.||......   ..   ...... +..      .
T Consensus       154 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~---~~---~~~i~~-~~~------~  219 (324)
T cd05589         154 FGD-RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE---EV---FDSIVN-DEV------R  219 (324)
T ss_pred             CCC-cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH---HH---HHHHHh-CCC------C
Confidence            211 123355899999999999999999999999999999999999999743321   11   111111 111      0


Q ss_pred             ccCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 002529          825 LIGNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL  860 (912)
Q Consensus       825 l~~~~~~~~~~~l~~Li~~cL~~dP~~RP-----s~~evl~  860 (912)
                          .+......+.+++.+||+.||.+||     +++++++
T Consensus       220 ----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         220 ----YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             ----CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence                1111234678999999999999999     5677665

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=8.6e-35  Score=323.15  Aligned_cols=240  Identities=27%  Similarity=0.405  Sum_probs=190.8

Q ss_pred             cccCccccEEEEEEEec-CCCEEEEEEccCcc---chhhHHHHHHHHHHHhc-CCCCccceeeEEecCCeEEEEEEecCC
Q 002529          596 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN  670 (912)
Q Consensus       596 ~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~L-~hpnIv~l~~~~~~~~~~~lV~E~~~~  670 (912)
                      +.||+|+||.||+|+.+ +++.||+|+++...   ....+.+..|..++..+ +||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999876 57899999987532   22334556677777654 799999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccccc
Q 002529          671 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS  750 (912)
Q Consensus       671 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~  750 (912)
                      |+|.+++..   ...+++..+..++.||+.||+|||+   .+|+||||||+||+++.++.+||+|||++....... ...
T Consensus        81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~  153 (316)
T cd05592          81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKA  153 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccc
Confidence            999999873   4578999999999999999999998   999999999999999999999999999987643322 222


Q ss_pred             ccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCCCC
Q 002529          751 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK  830 (912)
Q Consensus       751 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  830 (912)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||......   ....   .... ..      +    ..+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~---~~~~---~i~~-~~------~----~~~  216 (316)
T cd05592         154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED---ELFD---SILN-DR------P----HFP  216 (316)
T ss_pred             ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH---HHHH---HHHc-CC------C----CCC
Confidence            3345899999999999989999999999999999999999999743321   1111   1111 10      0    111


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHH-HHH
Q 002529          831 IESIWRIAEVAIQCVEQRGFSRPKMQ-EIV  859 (912)
Q Consensus       831 ~~~~~~l~~Li~~cL~~dP~~RPs~~-evl  859 (912)
                      ......+.+++.+||+.+|++||++. +++
T Consensus       217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         217 RWISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            12234678999999999999999875 454

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-35  Score=330.69  Aligned_cols=243  Identities=24%  Similarity=0.366  Sum_probs=202.7

Q ss_pred             HHHHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc---chhhHHHHHHHHHHHhc-CCCCccceeeEEecCCeEE
Q 002529          588 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRI  662 (912)
Q Consensus       588 ~~~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~L-~hpnIv~l~~~~~~~~~~~  662 (912)
                      ....+++.++||+|.||+|+++..+ +++.+|||++++..   .++.+..+.|.+++... +||.+++++..|+..++++
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~  445 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF  445 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence            3345667899999999999999988 58899999998754   34556788899998888 4999999999999999999


Q ss_pred             EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccc
Q 002529          663 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA  742 (912)
Q Consensus       663 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~  742 (912)
                      +||||+.||++..+.+    ...+++..+.-++..++.||+|||+   ++|||||||.+|||+|.+|.+||+|||+++..
T Consensus       446 fvmey~~Ggdm~~~~~----~~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~  518 (694)
T KOG0694|consen  446 FVMEYVAGGDLMHHIH----TDVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKEG  518 (694)
T ss_pred             EEEEecCCCcEEEEEe----cccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEeccccccccc
Confidence            9999999999554443    5679999999999999999999998   99999999999999999999999999999874


Q ss_pred             ccccccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccC
Q 002529          743 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD  822 (912)
Q Consensus       743 ~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  822 (912)
                      -.. .....+.+|||.|||||++.+..|+.+.|-|||||+||||+.|..||.+.+.++..      ...+..       |
T Consensus       519 m~~-g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~F------dsI~~d-------~  584 (694)
T KOG0694|consen  519 MGQ-GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVF------DSIVND-------E  584 (694)
T ss_pred             CCC-CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHH------HHHhcC-------C
Confidence            322 22456778999999999999999999999999999999999999999855443211      111111       1


Q ss_pred             ccccCCCCHHHHHHHHHHHHhcccCCCCCCCCH
Q 002529          823 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKM  855 (912)
Q Consensus       823 ~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~  855 (912)
                          ..++.....+.+++++++|..+|++|--+
T Consensus       585 ----~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  585 ----VRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             ----CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence                12344455688899999999999999966

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=2e-34  Score=314.37  Aligned_cols=257  Identities=23%  Similarity=0.412  Sum_probs=203.9

Q ss_pred             HHHHhhhcccCccccEEEEEEEecC------CCEEEEEEccCccch-hhHHHHHHHHHHHhcCCCCccceeeEEecCCeE
Q 002529          589 EATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR  661 (912)
Q Consensus       589 ~~~~~~~~~LG~G~fg~Vy~a~~~~------~~~vAvK~l~~~~~~-~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~  661 (912)
                      -..+++.++||+|+||.||+|...+      ++.||+|+++..... ..+.+.+|+.++..++||||+++++++......
T Consensus         4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~   83 (283)
T cd05091           4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL   83 (283)
T ss_pred             HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence            4567889999999999999998642      578999999755433 346688999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCC
Q 002529          662 ILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN  728 (912)
Q Consensus       662 ~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~  728 (912)
                      ++++||+.+++|.+++....             ....+++..++.++.|++.||+|||+   ++++||||||+||+++++
T Consensus        84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~  160 (283)
T cd05091          84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDK  160 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCC
Confidence            99999999999999985321             12358888999999999999999998   999999999999999999


Q ss_pred             CcEEEeeccCccccccccc-cccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHH
Q 002529          729 MRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVH  806 (912)
Q Consensus       729 ~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~  806 (912)
                      +.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.....   ..+.+
T Consensus       161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~~  237 (283)
T cd05091         161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDVIE  237 (283)
T ss_pred             CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHH
Confidence            9999999999876533221 11223345778999999988889999999999999999998 8888863322   11222


Q ss_pred             HHHhhhccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhh
Q 002529          807 WARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD  864 (912)
Q Consensus       807 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~  864 (912)
                      .    +..+....         .+...+..+.+++.+||+.+|++||+++||++.|+.
T Consensus       238 ~----i~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         238 M----IRNRQVLP---------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             H----HHcCCcCC---------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            1    21221111         112234468899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-34  Score=310.13  Aligned_cols=251  Identities=30%  Similarity=0.510  Sum_probs=205.8

Q ss_pred             HHHHhhhcccCccccEEEEEEEecCCCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEec
Q 002529          589 EATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM  668 (912)
Q Consensus       589 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~  668 (912)
                      ...+++.+.||.|++|.||+|... ++.||+|.++.... ..+++.+|+.++++++|+||+++++++.+....++||||+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            345678899999999999999876 88999999976544 5678899999999999999999999999899999999999


Q ss_pred             CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccc
Q 002529          669 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH  748 (912)
Q Consensus       669 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  748 (912)
                      ++++|.+++... ....+++..++.++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||.+........ 
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-  157 (256)
T cd05039          83 AKGSLVDYLRSR-GRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-  157 (256)
T ss_pred             CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence            999999999753 23468999999999999999999998   9999999999999999999999999999987643222 


Q ss_pred             ccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhhhccCCcccccCccccC
Q 002529          749 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG  827 (912)
Q Consensus       749 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  827 (912)
                         ....+..|+|||++.+..++.++||||||+++|+|++ |..||......   .+...+    ..+...         
T Consensus       158 ---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~----~~~~~~---------  218 (256)
T cd05039         158 ---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPHV----EKGYRM---------  218 (256)
T ss_pred             ---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHH----hcCCCC---------
Confidence               2224568999999988889999999999999999997 99999733221   111111    111110         


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhh
Q 002529          828 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS  865 (912)
Q Consensus       828 ~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~  865 (912)
                      ..+...+..+.+++.+||+.+|++||+++|++++|+++
T Consensus       219 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         219 EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence            11112235788999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=8.5e-35  Score=323.80  Aligned_cols=236  Identities=25%  Similarity=0.379  Sum_probs=190.7

Q ss_pred             cccCccccEEEEEEEec-CCCEEEEEEccCcc---chhhHHHHHHHHHHHhc-CCCCccceeeEEecCCeEEEEEEecCC
Q 002529          596 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN  670 (912)
Q Consensus       596 ~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~L-~hpnIv~l~~~~~~~~~~~lV~E~~~~  670 (912)
                      +.||+|+||.||+|+.+ +++.||+|+++...   ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999876 58899999987532   23345677888888877 699999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccccc
Q 002529          671 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS  750 (912)
Q Consensus       671 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~  750 (912)
                      |+|.+++..   ...+++..+..++.|++.||+|||+   ++++||||||+|||++.++.+||+|||++........ ..
T Consensus        81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-~~  153 (320)
T cd05590          81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-TT  153 (320)
T ss_pred             chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-cc
Confidence            999998873   4578999999999999999999998   9999999999999999999999999999875422211 12


Q ss_pred             ccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCCCC
Q 002529          751 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK  830 (912)
Q Consensus       751 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  830 (912)
                      ....|++.|+|||++.+..++.++|||||||++|||++|+.||......   ..   ..... .+..          ..+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~---~~---~~~i~-~~~~----------~~~  216 (320)
T cd05590         154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED---DL---FEAIL-NDEV----------VYP  216 (320)
T ss_pred             cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---HH---HHHHh-cCCC----------CCC
Confidence            2345899999999999999999999999999999999999999743321   11   11111 1111          011


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCH
Q 002529          831 IESIWRIAEVAIQCVEQRGFSRPKM  855 (912)
Q Consensus       831 ~~~~~~l~~Li~~cL~~dP~~RPs~  855 (912)
                      ......+.+++.+||+.||++||++
T Consensus       217 ~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         217 TWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             CCCCHHHHHHHHHHcccCHHHCCCC
Confidence            1123468899999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.2e-34  Score=323.90  Aligned_cols=248  Identities=23%  Similarity=0.354  Sum_probs=195.5

Q ss_pred             cccCccccEEEEEEEec-CCCEEEEEEccCcc---chhhHHHHHHHHHHHhc-CCCCccceeeEEecCCeEEEEEEecCC
Q 002529          596 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN  670 (912)
Q Consensus       596 ~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~L-~hpnIv~l~~~~~~~~~~~lV~E~~~~  670 (912)
                      +.||+|+||.||+|..+ +++.||+|+++...   ......+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999876 57899999987532   23345677899988877 799999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccccc
Q 002529          671 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS  750 (912)
Q Consensus       671 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~  750 (912)
                      |+|.+++..   ...+++..+..++.||+.||+|||+   ++|+||||||+||+++.++.+||+|||++........ ..
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~~  153 (329)
T cd05618          81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TT  153 (329)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-cc
Confidence            999988873   4678999999999999999999998   9999999999999999999999999999875322211 12


Q ss_pred             ccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcc--chhhHHHHHHhhhccCCcccccCccccCC
Q 002529          751 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG--AELNIVHWARSMIKKGDVISIVDPVLIGN  828 (912)
Q Consensus       751 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  828 (912)
                      ....|++.|+|||++.+..++.++|||||||++|||++|+.||......  .......+....+.....          .
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~----------~  223 (329)
T cd05618         154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----------R  223 (329)
T ss_pred             ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC----------C
Confidence            2345899999999999999999999999999999999999999632211  111222222222222211          1


Q ss_pred             CCHHHHHHHHHHHHhcccCCCCCCCC------HHHHHH
Q 002529          829 VKIESIWRIAEVAIQCVEQRGFSRPK------MQEIVL  860 (912)
Q Consensus       829 ~~~~~~~~l~~Li~~cL~~dP~~RPs------~~evl~  860 (912)
                      .+......+.+++.+||+.||++||+      +.++++
T Consensus       224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05618         224 IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  261 (329)
T ss_pred             CCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence            11222346789999999999999998      456654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.2e-34  Score=313.17  Aligned_cols=256  Identities=23%  Similarity=0.378  Sum_probs=202.9

Q ss_pred             HHHHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEE
Q 002529          588 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE  666 (912)
Q Consensus       588 ~~~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E  666 (912)
                      ....|++.+.||+|+||.||+|+.. +++.||+|++..........+.+|+.++++++||||+++++.+..++..++|||
T Consensus         7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e   86 (267)
T cd06646           7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME   86 (267)
T ss_pred             chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence            4567888999999999999999875 688999999876544555678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccc
Q 002529          667 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL  746 (912)
Q Consensus       667 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~  746 (912)
                      |+++++|.++++.   ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.++|+|||++.......
T Consensus        87 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06646          87 YCGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI  160 (267)
T ss_pred             CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence            9999999999873   4578999999999999999999998   999999999999999999999999999998654322


Q ss_pred             ccccccccCCCcccCCCccC---CCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCc
Q 002529          747 THISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP  823 (912)
Q Consensus       747 ~~~~~~~~gt~~y~APE~l~---~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  823 (912)
                      .. .....++..|+|||.+.   ...++.++||||+||++|||++|+.||........  ..     .+.....   ..+
T Consensus       161 ~~-~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~--~~-----~~~~~~~---~~~  229 (267)
T cd06646         161 AK-RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--LF-----LMSKSNF---QPP  229 (267)
T ss_pred             cc-cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh--he-----eeecCCC---CCC
Confidence            11 12235788999999874   44578899999999999999999999863221110  00     0000000   001


Q ss_pred             cccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 002529          824 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI  862 (912)
Q Consensus       824 ~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  862 (912)
                      ....  .......+.+++.+||+.+|++||+++++++.|
T Consensus       230 ~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         230 KLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             CCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            1110  112234788999999999999999999998743

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-35  Score=331.89  Aligned_cols=251  Identities=24%  Similarity=0.335  Sum_probs=202.3

Q ss_pred             HHhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc---chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEE
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE  666 (912)
Q Consensus       591 ~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E  666 (912)
                      +|++.+.||+|+||+||+|+.. +++.||+|+++...   ......+.+|++++..++||||+++++++.+++..++|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (350)
T cd05573           2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME   81 (350)
T ss_pred             CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence            3567889999999999999877 68999999987532   2344678889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccc
Q 002529          667 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL  746 (912)
Q Consensus       667 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~  746 (912)
                      |+++++|.+++..   ...+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||++.......
T Consensus        82 ~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~  155 (350)
T cd05573          82 YMPGGDLMNLLIR---KDVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK  155 (350)
T ss_pred             CCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence            9999999999984   3678999999999999999999998   999999999999999999999999999998754432


Q ss_pred             ----------------------------ccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCc
Q 002529          747 ----------------------------THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF  798 (912)
Q Consensus       747 ----------------------------~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~  798 (912)
                                                  ........||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~  235 (350)
T cd05573         156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL  235 (350)
T ss_pred             cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence                                        1122334589999999999999999999999999999999999999974332


Q ss_pred             cchhhHHHHHHhhhccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCC-HHHHHHH
Q 002529          799 GAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK-MQEIVLA  861 (912)
Q Consensus       799 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs-~~evl~~  861 (912)
                      ..      ............. + +.     .......+.+++.+||+ +|.+||+ ++|+++.
T Consensus       236 ~~------~~~~i~~~~~~~~-~-p~-----~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         236 QE------TYNKIINWKESLR-F-PP-----DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             HH------HHHHHhccCCccc-C-CC-----CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            11      1111111000000 0 00     00123478899999997 9999999 9999874

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.2e-34  Score=312.19  Aligned_cols=256  Identities=25%  Similarity=0.438  Sum_probs=206.6

Q ss_pred             HHHHHHhhhcccCccccEEEEEEEecCCCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEE
Q 002529          587 LEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE  666 (912)
Q Consensus       587 l~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E  666 (912)
                      +..+++++.++||+|+||.||+|...++..+++|.++.. ....+.+.+|++++++++|+||+++++++.. ...+++||
T Consensus         3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e   80 (260)
T cd05073           3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE   80 (260)
T ss_pred             ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence            445677889999999999999999888888999988754 2345678899999999999999999999887 77899999


Q ss_pred             ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccc
Q 002529          667 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL  746 (912)
Q Consensus       667 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~  746 (912)
                      |+++++|.+++... ....+++..++.++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||.+.......
T Consensus        81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  156 (260)
T cd05073          81 FMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE  156 (260)
T ss_pred             eCCCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence            99999999999754 34568889999999999999999998   899999999999999999999999999987654332


Q ss_pred             ccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhhhccCCcccccCccc
Q 002529          747 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL  825 (912)
Q Consensus       747 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  825 (912)
                      ........++..|+|||++....++.++|+||||+++|++++ |+.||......   ......    ..+....      
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~----~~~~~~~------  223 (260)
T cd05073         157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRAL----ERGYRMP------  223 (260)
T ss_pred             cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH---HHHHHH----hCCCCCC------
Confidence            222222335678999999998889999999999999999999 99999743221   122211    1111110      


Q ss_pred             cCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhh
Q 002529          826 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD  864 (912)
Q Consensus       826 ~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~  864 (912)
                         .....+..+.+++.+|++.+|++||++.++++.|+.
T Consensus       224 ---~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         224 ---RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             ---CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence               111223478899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=3.1e-34  Score=316.58  Aligned_cols=267  Identities=24%  Similarity=0.453  Sum_probs=211.6

Q ss_pred             HHHHHHHhhhcccCccccEEEEEEEec--------CCCEEEEEEccCcc-chhhHHHHHHHHHHHhc-CCCCccceeeEE
Q 002529          586 ELEEATNNFCKKIGKGSFGSVYYGKMK--------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYC  655 (912)
Q Consensus       586 ~l~~~~~~~~~~LG~G~fg~Vy~a~~~--------~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~L-~hpnIv~l~~~~  655 (912)
                      ++....+.+.+.||+|+||.||+|++.        ++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++
T Consensus        11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   90 (304)
T cd05101          11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC   90 (304)
T ss_pred             cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence            455677788899999999999999742        24579999987543 34456789999999999 799999999999


Q ss_pred             ecCCeEEEEEEecCCCCHHHHhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 002529          656 EEEHQRILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN  722 (912)
Q Consensus       656 ~~~~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~N  722 (912)
                      ......++||||+++|+|.+++....             ....+++..++.++.||++||+|||+   ++++||||||+|
T Consensus        91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~N  167 (304)
T cd05101          91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARN  167 (304)
T ss_pred             ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccce
Confidence            99999999999999999999997532             12457888999999999999999998   999999999999


Q ss_pred             ccccCCCcEEEeeccCcccccccccc-ccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccc
Q 002529          723 ILLDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGA  800 (912)
Q Consensus       723 ILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~  800 (912)
                      |+++.++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|+|++ |..||...... 
T Consensus       168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-  246 (304)
T cd05101         168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE-  246 (304)
T ss_pred             EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH-
Confidence            99999999999999999876432221 1122335678999999988889999999999999999998 78888633221 


Q ss_pred             hhhHHHHHHhhhccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhhhhhccC
Q 002529          801 ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG  871 (912)
Q Consensus       801 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~~~~~~~  871 (912)
                        .+..    .+..+....         .+......+.+++.+||+.+|++||++.|+++.|++++.....
T Consensus       247 --~~~~----~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~~  302 (304)
T cd05101         247 --ELFK----LLKEGHRMD---------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTTN  302 (304)
T ss_pred             --HHHH----HHHcCCcCC---------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhhc
Confidence              1111    122211111         1112345788999999999999999999999999998876543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=3.1e-34  Score=312.42  Aligned_cols=248  Identities=21%  Similarity=0.305  Sum_probs=195.0

Q ss_pred             cCccccEEEEEEEec-CCCEEEEEEccCccc---hhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEecCCCCH
Q 002529          598 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL  673 (912)
Q Consensus       598 LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL  673 (912)
                      ||+|+||.||+++.+ +|+.||+|.+.....   .....+..|++++++++||||+++++.+..+...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            799999999999876 589999999864221   2234556799999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccccccccc
Q 002529          674 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA  753 (912)
Q Consensus       674 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~  753 (912)
                      .+++... ....+++..+..++.|++.||+|||+   .+++||||||+||+++.++.++|+|||++........  ....
T Consensus        81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~  154 (277)
T cd05607          81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQR  154 (277)
T ss_pred             HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce--eecc
Confidence            9888643 34468899999999999999999998   9999999999999999999999999999877644322  1234


Q ss_pred             cCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCCCCHHH
Q 002529          754 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES  833 (912)
Q Consensus       754 ~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  833 (912)
                      .|+..|+|||++.+..++.++||||+||++|||++|+.||......  ....+....... .... ..    .    ...
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~-~~~~-~~----~----~~~  222 (277)
T cd05607         155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK--VAKEELKRRTLE-DEVK-FE----H----QNF  222 (277)
T ss_pred             CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch--hhHHHHHHHhhc-cccc-cc----c----ccC
Confidence            5889999999999888999999999999999999999999743221  111111111111 1110 00    0    112


Q ss_pred             HHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 002529          834 IWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ  863 (912)
Q Consensus       834 ~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  863 (912)
                      ..++.+++.+||+.||++||+++|+++.+.
T Consensus       223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~~~  252 (277)
T cd05607         223 TEESKDICRLFLAKKPEDRLGSREKNDDPR  252 (277)
T ss_pred             CHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence            336889999999999999999988764433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2.1e-34  Score=309.71  Aligned_cols=247  Identities=28%  Similarity=0.453  Sum_probs=196.7

Q ss_pred             cccCccccEEEEEEEec---CCCEEEEEEccCccc--hhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEecCC
Q 002529          596 KKIGKGSFGSVYYGKMK---DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN  670 (912)
Q Consensus       596 ~~LG~G~fg~Vy~a~~~---~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~  670 (912)
                      ++||+|+||.||+|.++   +++.+|+|+++....  ...+.+.+|+.+++.++||||+++++++.. +..++||||+++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~   79 (257)
T cd05116           1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAEL   79 (257)
T ss_pred             CcCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCC
Confidence            36899999999999753   578899999865432  235678899999999999999999998864 467899999999


Q ss_pred             CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccccc-
Q 002529          671 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-  749 (912)
Q Consensus       671 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~-  749 (912)
                      ++|.+++..   ...+++..+..++.|++.||+|||+   ++++||||||+||+++.++.+||+|||++.......... 
T Consensus        80 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~  153 (257)
T cd05116          80 GPLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK  153 (257)
T ss_pred             CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence            999999973   4568999999999999999999998   999999999999999999999999999998764432211 


Q ss_pred             -cccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhhhccCCcccccCccccC
Q 002529          750 -SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG  827 (912)
Q Consensus       750 -~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  827 (912)
                       .....++..|+|||.+....++.++|||||||++|||++ |+.||......   ...+    .+..+....        
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~----~i~~~~~~~--------  218 (257)
T cd05116         154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN---EVTQ----MIESGERME--------  218 (257)
T ss_pred             ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHHCCCCCC--------
Confidence             112224578999999988889999999999999999998 99999733221   1112    122222111        


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhh
Q 002529          828 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS  865 (912)
Q Consensus       828 ~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~  865 (912)
                       .+.....++.+++.+||+.+|++||++.+|.+.|++.
T Consensus       219 -~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         219 -CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             -CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence             1112334788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=8.8e-35  Score=318.84  Aligned_cols=262  Identities=27%  Similarity=0.455  Sum_probs=207.9

Q ss_pred             HHHHHHHhhhcccCccccEEEEEEEecC------CCEEEEEEccCcc-chhhHHHHHHHHHHHhc-CCCCccceeeEEec
Q 002529          586 ELEEATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEE  657 (912)
Q Consensus       586 ~l~~~~~~~~~~LG~G~fg~Vy~a~~~~------~~~vAvK~l~~~~-~~~~~~~~~E~~il~~L-~hpnIv~l~~~~~~  657 (912)
                      ++....+++.+.||+|+||.||++....      ...+|+|.+.... ......+.+|+++++++ +|+||+++++++..
T Consensus         8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   87 (293)
T cd05053           8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ   87 (293)
T ss_pred             ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence            3445567778999999999999998652      3679999987542 23446688999999999 79999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHhccC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCcc
Q 002529          658 EHQRILVYEYMHNGTLRDRLHGS-------------VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNIL  724 (912)
Q Consensus       658 ~~~~~lV~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NIL  724 (912)
                      ++..+++|||+++|+|.++++..             .....+++..++.++.|++.||+|||+   .+++||||||+||+
T Consensus        88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil  164 (293)
T cd05053          88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVL  164 (293)
T ss_pred             CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEE
Confidence            99999999999999999998642             134568999999999999999999998   99999999999999


Q ss_pred             ccCCCcEEEeeccCcccccccccc-ccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchh
Q 002529          725 LDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAEL  802 (912)
Q Consensus       725 l~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~  802 (912)
                      ++.++.+||+|||++......... ......++..|+|||++.+..++.++|||||||++|||++ |..||.......  
T Consensus       165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--  242 (293)
T cd05053         165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--  242 (293)
T ss_pred             EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH--
Confidence            999999999999999875433211 1122234678999999988899999999999999999997 999986332211  


Q ss_pred             hHHHHHHhhhccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhhh
Q 002529          803 NIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI  866 (912)
Q Consensus       803 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~~  866 (912)
                       ..+    .+..+...         ..+......+.+++.+||+.+|++|||++|+++.|++++
T Consensus       243 -~~~----~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         243 -LFK----LLKEGYRM---------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             -HHH----HHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence             111    11111110         111223347889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1e-34  Score=323.27  Aligned_cols=242  Identities=24%  Similarity=0.375  Sum_probs=194.4

Q ss_pred             cccCccccEEEEEEEec-CCCEEEEEEccCcc---chhhHHHHHHHHHHHhc-CCCCccceeeEEecCCeEEEEEEecCC
Q 002529          596 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN  670 (912)
Q Consensus       596 ~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~L-~hpnIv~l~~~~~~~~~~~lV~E~~~~  670 (912)
                      +.||+|+||.||+|+.+ +++.||+|+++...   ......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999876 57899999987532   23345677888998876 799999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccccc
Q 002529          671 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS  750 (912)
Q Consensus       671 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~  750 (912)
                      |+|.+.+..   ...+++..+..++.||+.||+|||+   ++|+||||||+||+++.++.+||+|||++........ ..
T Consensus        81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~  153 (321)
T cd05591          81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TT  153 (321)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCCc-cc
Confidence            999998873   4578999999999999999999998   9999999999999999999999999999875432221 12


Q ss_pred             ccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCCCC
Q 002529          751 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK  830 (912)
Q Consensus       751 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  830 (912)
                      ....|++.|+|||++.+..++.++|||||||++|||++|+.||......   ..   ...... +..   .       .+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~---~~---~~~i~~-~~~---~-------~p  216 (321)
T cd05591         154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED---DL---FESILH-DDV---L-------YP  216 (321)
T ss_pred             cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH---HH---HHHHHc-CCC---C-------CC
Confidence            2345899999999999989999999999999999999999999743321   11   111111 111   0       01


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCC-------CHHHHHHH
Q 002529          831 IESIWRIAEVAIQCVEQRGFSRP-------KMQEIVLA  861 (912)
Q Consensus       831 ~~~~~~l~~Li~~cL~~dP~~RP-------s~~evl~~  861 (912)
                      ......+.+++.+||+.+|++||       +++++++.
T Consensus       217 ~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         217 VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            11224688999999999999999       78888754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.2e-34  Score=329.14  Aligned_cols=255  Identities=23%  Similarity=0.337  Sum_probs=201.9

Q ss_pred             HHHHHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc---chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEE
Q 002529          587 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI  662 (912)
Q Consensus       587 l~~~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~  662 (912)
                      +....|++.+.||+|+||.||+|+.+ +++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+++..+
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~  119 (370)
T cd05596          40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY  119 (370)
T ss_pred             CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            34567788899999999999999876 58899999986432   223355778999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccc
Q 002529          663 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA  742 (912)
Q Consensus       663 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~  742 (912)
                      +||||+++|+|.+++..    ..+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||++...
T Consensus       120 lv~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~  192 (370)
T cd05596         120 MVMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM  192 (370)
T ss_pred             EEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence            99999999999999863    357888899999999999999998   99999999999999999999999999999876


Q ss_pred             ccccccccccccCCCcccCCCccCCC----CCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcc
Q 002529          743 EEDLTHISSVARGTVGYLDPEYYGNQ----QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI  818 (912)
Q Consensus       743 ~~~~~~~~~~~~gt~~y~APE~l~~~----~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  818 (912)
                      ............|++.|+|||++.+.    .++.++|||||||++|||++|+.||......      .............
T Consensus       193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~~~~~~  266 (370)
T cd05596         193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMDHKNSL  266 (370)
T ss_pred             cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH------HHHHHHHcCCCcC
Confidence            44332223345689999999998653    4788999999999999999999999743321      1111111111110


Q ss_pred             cccCccccCCCCHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 002529          819 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFS--RPKMQEIVLA  861 (912)
Q Consensus       819 ~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~--RPs~~evl~~  861 (912)
                      ...+       .......+.+++.+||+.+|.+  ||+++|+++.
T Consensus       267 ~~~~-------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         267 TFPD-------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             CCCC-------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            1000       0112347889999999999988  9999999764

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.1e-34  Score=320.38  Aligned_cols=264  Identities=30%  Similarity=0.504  Sum_probs=206.3

Q ss_pred             HHHHHHHhhhcccCccccEEEEEEEec-CCC--EEEEEEccCcc-chhhHHHHHHHHHHHhc-CCCCccceeeEEecCCe
Q 002529          586 ELEEATNNFCKKIGKGSFGSVYYGKMK-DGK--EVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQ  660 (912)
Q Consensus       586 ~l~~~~~~~~~~LG~G~fg~Vy~a~~~-~~~--~vAvK~l~~~~-~~~~~~~~~E~~il~~L-~hpnIv~l~~~~~~~~~  660 (912)
                      .+.-..+++.+.||+|+||.||+|.++ ++.  .+++|.++... ......+.+|++++.++ +||||+++++++..++.
T Consensus         3 ~~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~   82 (303)
T cd05088           3 VLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY   82 (303)
T ss_pred             ccchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence            345566788899999999999999875 344  45777766432 33456788999999999 89999999999999999


Q ss_pred             EEEEEEecCCCCHHHHhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccC
Q 002529          661 RILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI  727 (912)
Q Consensus       661 ~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~  727 (912)
                      .++||||+++++|.++++...             ....+++.+++.++.|++.||+|||+   ++++||||||+|||++.
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~  159 (303)
T cd05088          83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGE  159 (303)
T ss_pred             ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecC
Confidence            999999999999999997532             12368899999999999999999998   99999999999999999


Q ss_pred             CCcEEEeeccCccccccccccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHH
Q 002529          728 NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVH  806 (912)
Q Consensus       728 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~  806 (912)
                      ++.+||+|||++........  .....++..|+|||++.+..++.++|||||||++|||+| |..||......   ....
T Consensus       160 ~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~  234 (303)
T cd05088         160 NYVAKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYE  234 (303)
T ss_pred             CCcEEeCccccCcccchhhh--cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH---HHHH
Confidence            99999999999864321111  111224567999999988889999999999999999998 99999633221   1111


Q ss_pred             HHHhhhccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhhhhhcc
Q 002529          807 WARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK  870 (912)
Q Consensus       807 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~~~~~~  870 (912)
                      .    ...+...         ..+......+.+++.+||+.+|++||+++++++.|++++..+.
T Consensus       235 ~----~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~  285 (303)
T cd05088         235 K----LPQGYRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  285 (303)
T ss_pred             H----HhcCCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence            1    1111000         0111123468899999999999999999999999998877664

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2.9e-34  Score=317.39  Aligned_cols=266  Identities=24%  Similarity=0.441  Sum_probs=209.4

Q ss_pred             HHHHHHHhhhcccCccccEEEEEEEec--------CCCEEEEEEccCcc-chhhHHHHHHHHHHHhc-CCCCccceeeEE
Q 002529          586 ELEEATNNFCKKIGKGSFGSVYYGKMK--------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYC  655 (912)
Q Consensus       586 ~l~~~~~~~~~~LG~G~fg~Vy~a~~~--------~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~L-~hpnIv~l~~~~  655 (912)
                      ++....|.+.+.||+|+||.||+|...        +...+|+|.++... ......+.+|+++++++ +||||+++++++
T Consensus        14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (307)
T cd05098          14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC   93 (307)
T ss_pred             eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            344567888999999999999999753        23579999987543 33456788899999999 799999999999


Q ss_pred             ecCCeEEEEEEecCCCCHHHHhccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 002529          656 EEEHQRILVYEYMHNGTLRDRLHGSVN-------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN  722 (912)
Q Consensus       656 ~~~~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~N  722 (912)
                      ...+..++||||+++|+|.+++.....             ...+++.+++.++.|++.||+|||+   .+++||||||+|
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~N  170 (307)
T cd05098          94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARN  170 (307)
T ss_pred             ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHh
Confidence            999999999999999999999975421             2358899999999999999999998   999999999999


Q ss_pred             ccccCCCcEEEeeccCccccccccccc-cccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccc
Q 002529          723 ILLDINMRAKVSDFGLSRQAEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGA  800 (912)
Q Consensus       723 ILl~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~  800 (912)
                      |+++.++.++|+|||.+.......... .....++..|+|||++.+..++.++|||||||++|||++ |+.||...... 
T Consensus       171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~-  249 (307)
T cd05098         171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-  249 (307)
T ss_pred             eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH-
Confidence            999999999999999987654321111 111224568999999998889999999999999999998 88888632211 


Q ss_pred             hhhHHHHHHhhhccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhhhhhcc
Q 002529          801 ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK  870 (912)
Q Consensus       801 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~~~~~~  870 (912)
                        ....    .+..+...+         .+......+.+++.+||+.+|++||++.||++.|++++....
T Consensus       250 --~~~~----~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~  304 (307)
T cd05098         250 --ELFK----LLKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS  304 (307)
T ss_pred             --HHHH----HHHcCCCCC---------CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence              1111    122221111         111223478899999999999999999999999999887643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=3.1e-34  Score=312.90  Aligned_cols=246  Identities=23%  Similarity=0.307  Sum_probs=195.3

Q ss_pred             cCccccEEEEEEEec-CCCEEEEEEccCccc---hhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEecCCCCH
Q 002529          598 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL  673 (912)
Q Consensus       598 LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL  673 (912)
                      ||+|+||+||++..+ +++.||+|.+.....   ...+.+..|+++++.++|+||+++.+++..+...++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            799999999999876 688999999864322   2235677899999999999999999999999999999999999999


Q ss_pred             HHHhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccccccc
Q 002529          674 RDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV  752 (912)
Q Consensus       674 ~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~  752 (912)
                      .+.+.... ....+++..++.++.||+.||+|||+   .+|+||||||+||+++.++.++|+|||++......... ...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~  156 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKG  156 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-ccc
Confidence            98875322 34578999999999999999999998   99999999999999999999999999998765443222 223


Q ss_pred             ccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCCCCHH
Q 002529          753 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE  832 (912)
Q Consensus       753 ~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  832 (912)
                      ..|++.|+|||++.+..++.++|||||||++|||++|+.||........  ......... ....          ..+..
T Consensus       157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~-~~~~----------~~~~~  223 (280)
T cd05608         157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRIL-NDSV----------TYPDK  223 (280)
T ss_pred             cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--HHHHHHhhc-ccCC----------CCccc
Confidence            4589999999999999999999999999999999999999974322111  111111111 1100          11122


Q ss_pred             HHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 002529          833 SIWRIAEVAIQCVEQRGFSRP-----KMQEIVL  860 (912)
Q Consensus       833 ~~~~l~~Li~~cL~~dP~~RP-----s~~evl~  860 (912)
                      ....+.+++.+||+.||++||     +++|+++
T Consensus       224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            344788999999999999999     6777775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-34  Score=314.73  Aligned_cols=266  Identities=23%  Similarity=0.375  Sum_probs=203.1

Q ss_pred             HHHHHHhhhcccCccccEEEEEEEecC---------------CCEEEEEEccCccc-hhhHHHHHHHHHHHhcCCCCccc
Q 002529          587 LEEATNNFCKKIGKGSFGSVYYGKMKD---------------GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVP  650 (912)
Q Consensus       587 l~~~~~~~~~~LG~G~fg~Vy~a~~~~---------------~~~vAvK~l~~~~~-~~~~~~~~E~~il~~L~hpnIv~  650 (912)
                      +....|++.++||+|+||.||++...+               ...||+|.++.... .....+.+|++++++++|+||++
T Consensus         2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~   81 (295)
T cd05097           2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIR   81 (295)
T ss_pred             CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCe
Confidence            345678889999999999999997642               23589999876432 34467899999999999999999


Q ss_pred             eeeEEecCCeEEEEEEecCCCCHHHHhccCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 002529          651 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSV---------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSS  721 (912)
Q Consensus       651 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~---------~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~  721 (912)
                      +++++...+..++||||+++++|.+++....         ....+++..++.++.|++.||+|||+   .+++|+||||+
T Consensus        82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~  158 (295)
T cd05097          82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATR  158 (295)
T ss_pred             EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChh
Confidence            9999999999999999999999999986421         11246888999999999999999998   99999999999


Q ss_pred             CccccCCCcEEEeeccCccccccccc-cccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh--CCCCCCccCc
Q 002529          722 NILLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS--GKKPVSVEDF  798 (912)
Q Consensus       722 NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt--G~~Pf~~~~~  798 (912)
                      ||+++.++.+||+|||++........ .......++..|+|||++.+..++.++|||||||++|+|++  +..||.....
T Consensus       159 Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~  238 (295)
T cd05097         159 NCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD  238 (295)
T ss_pred             hEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence            99999999999999999876433221 11122335678999999988889999999999999999998  6677763322


Q ss_pred             cchhhHHHHHHhhhccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhh
Q 002529          799 GAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD  864 (912)
Q Consensus       799 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~  864 (912)
                      .   ...................      ..+...+..+.+++.+||+.+|++||++++|++.|++
T Consensus       239 ~---~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         239 E---QVIENTGEFFRNQGRQIYL------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             H---HHHHHHHHhhhhccccccC------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence            1   1111111111111000000      0111123479999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.1e-35  Score=314.50  Aligned_cols=257  Identities=24%  Similarity=0.303  Sum_probs=195.9

Q ss_pred             hcccCccccEEEEEEEec-CCCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEecCC-----eEEEEEEec
Q 002529          595 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH-----QRILVYEYM  668 (912)
Q Consensus       595 ~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~-----~~~lV~E~~  668 (912)
                      .+++|.|+||.||+|... +++.||||+.-.+..    --.+|+++|+.+.|||||+++-+|....     ...+|||||
T Consensus        29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym  104 (364)
T KOG0658|consen   29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM  104 (364)
T ss_pred             eEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence            588999999999999876 479999999865432    2246999999999999999999885432     335899999


Q ss_pred             CCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCC-CcEEEeeccCcccccccc
Q 002529          669 HNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDL  746 (912)
Q Consensus       669 ~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~-~~vkL~DFGla~~~~~~~  746 (912)
                      + .+|.+.++... .+..++...++-+..||++||+|||+   .+|+||||||.|+|+|.+ |.+||||||.|+....+.
T Consensus       105 P-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e  180 (364)
T KOG0658|consen  105 P-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE  180 (364)
T ss_pred             h-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcceeeccCC
Confidence            7 48888887432 45678888999999999999999998   999999999999999965 999999999999876655


Q ss_pred             ccccccccCCCcccCCCccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcc-------
Q 002529          747 THISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI-------  818 (912)
Q Consensus       747 ~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-------  818 (912)
                      ...+  ...+..|+|||.+.+. .|+.+.||||.||++.||+-|++-|.+.+..+.....-.+-......++.       
T Consensus       181 pniS--YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~  258 (364)
T KOG0658|consen  181 PNIS--YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYT  258 (364)
T ss_pred             Ccee--EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccc
Confidence            4433  4468899999988764 89999999999999999999999998755443322222221111111111       


Q ss_pred             cccCccccCC-----CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002529          819 SIVDPVLIGN-----VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       819 ~~~d~~l~~~-----~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  861 (912)
                      +...+.+...     .......+..+++.++|+.+|.+|.++.|++..
T Consensus       259 ~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h  306 (364)
T KOG0658|consen  259 EFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH  306 (364)
T ss_pred             cccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence            1111111111     222344578899999999999999999999853

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-35  Score=311.15  Aligned_cols=266  Identities=23%  Similarity=0.340  Sum_probs=203.6

Q ss_pred             hcccCccccEEEEEEEec-CCCEEEEEEccC--ccchhhHHHHHHHHHHHhcCCCCccceeeEEec-----CCeEEEEEE
Q 002529          595 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMAD--SCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE-----EHQRILVYE  666 (912)
Q Consensus       595 ~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~--~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~-----~~~~~lV~E  666 (912)
                      .+.||+|+||.|+.|..+ +|+.||+|++..  ......+...+|+++|+.++|+||+.+.+++..     -+..|+|+|
T Consensus        27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e  106 (359)
T KOG0660|consen   27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE  106 (359)
T ss_pred             cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence            588999999999999876 689999999873  334456778899999999999999999998855     457899999


Q ss_pred             ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccc
Q 002529          667 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL  746 (912)
Q Consensus       667 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~  746 (912)
                      +| +.+|.+.++   .+..++...+.-++.||++||+|+|+   .+|+||||||+|++++.+..+||+|||+|+......
T Consensus       107 lM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~  179 (359)
T KOG0660|consen  107 LM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFF  179 (359)
T ss_pred             HH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccccceeeccccC
Confidence            99 679999998   45669999999999999999999999   999999999999999999999999999999875431


Q ss_pred             -ccccccccCCCcccCCCccC-CCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccc----
Q 002529          747 -THISSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI----  820 (912)
Q Consensus       747 -~~~~~~~~gt~~y~APE~l~-~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~----  820 (912)
                       ...-+....|..|+|||++. ...|+.+.||||.|||+.||++|++-|.+.+.-....+...+.....+..+..+    
T Consensus       180 ~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~  259 (359)
T KOG0660|consen  180 EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEK  259 (359)
T ss_pred             cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHH
Confidence             11223456799999999874 568999999999999999999999999866554333332222111111111000    


Q ss_pred             ----cC---ccccCC---CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--Hhhhhh
Q 002529          821 ----VD---PVLIGN---VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDSIK  867 (912)
Q Consensus       821 ----~d---~~l~~~---~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~--L~~~~~  867 (912)
                          +.   ..-+..   .-+......++|+.+||..||.+|+|++|.++.  |...-+
T Consensus       260 ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hd  318 (359)
T KOG0660|consen  260 ARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHD  318 (359)
T ss_pred             HHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcC
Confidence                00   000000   001222367899999999999999999999864  444433

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.3e-35  Score=293.07  Aligned_cols=248  Identities=26%  Similarity=0.406  Sum_probs=206.6

Q ss_pred             HHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc---chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEE
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY  665 (912)
Q Consensus       590 ~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~  665 (912)
                      ..+++++.||+|-||.||+|+.+ ++-.||+|++.+..   ..-..++.+|+++-..|+||||++++++|.+....||++
T Consensus        22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil  101 (281)
T KOG0580|consen   22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL  101 (281)
T ss_pred             hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence            34567899999999999999876 57789999986542   223468999999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccc
Q 002529          666 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED  745 (912)
Q Consensus       666 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~  745 (912)
                      ||..+|.|...|... ....+++.....++.|+|.||.|+|.   ++|+||||||+|+|++..+.+||+|||-+..... 
T Consensus       102 Eya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~-  176 (281)
T KOG0580|consen  102 EYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-  176 (281)
T ss_pred             EecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecCC-
Confidence            999999999999865 35678899999999999999999998   9999999999999999999999999999876542 


Q ss_pred             cccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccc
Q 002529          746 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL  825 (912)
Q Consensus       746 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  825 (912)
                        ......+||..|.+||...+...+...|+|++|++.||++.|.+||.....++  ...+     +..   .++.+|  
T Consensus       177 --~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e--tYkr-----I~k---~~~~~p--  242 (281)
T KOG0580|consen  177 --NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE--TYKR-----IRK---VDLKFP--  242 (281)
T ss_pred             --CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH--HHHH-----HHH---ccccCC--
Confidence              23345679999999999999999999999999999999999999998444221  1111     111   111122  


Q ss_pred             cCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002529          826 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       826 ~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  861 (912)
                           ........++|.+|+..+|.+|.+..|+++.
T Consensus       243 -----~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  243 -----STISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             -----cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence                 2233467899999999999999999999864

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=5.5e-34  Score=307.50  Aligned_cols=259  Identities=24%  Similarity=0.345  Sum_probs=208.2

Q ss_pred             HHhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc---chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEE
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE  666 (912)
Q Consensus       591 ~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E  666 (912)
                      .|++.+.||+|++|.||+|... +++.||+|.++...   ....+.+.+|++++++++|+||+++++.+...+..++|||
T Consensus         3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   82 (267)
T cd08224           3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLE   82 (267)
T ss_pred             ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEe
Confidence            4667899999999999999987 79999999886422   2235678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccc
Q 002529          667 YMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED  745 (912)
Q Consensus       667 ~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~  745 (912)
                      |+++++|.+++.... ....+++..++.++.|++.||+|||+   .+++||||+|+||+++.++.++|+|||++......
T Consensus        83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~  159 (267)
T cd08224          83 LADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             cCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence            999999999986532 34568999999999999999999998   99999999999999999999999999998765433


Q ss_pred             cccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccc
Q 002529          746 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL  825 (912)
Q Consensus       746 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  825 (912)
                      ... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||.....    +..+.... +..+.....     
T Consensus       160 ~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~-~~~~~~~~~-----  228 (267)
T cd08224         160 TTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKK-IEKCDYPPL-----  228 (267)
T ss_pred             Ccc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHHHHhh-hhcCCCCCC-----
Confidence            221 1223478899999999888899999999999999999999999963321    11111111 111111111     


Q ss_pred             cCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhhh
Q 002529          826 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI  866 (912)
Q Consensus       826 ~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~~  866 (912)
                         ........+.+++.+||..+|++||++.+|+++|+++.
T Consensus       229 ---~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         229 ---PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             ---ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence               01133447889999999999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2e-34  Score=317.18  Aligned_cols=259  Identities=30%  Similarity=0.494  Sum_probs=203.2

Q ss_pred             HHhhhcccCccccEEEEEEEecC-C--CEEEEEEccCcc-chhhHHHHHHHHHHHhc-CCCCccceeeEEecCCeEEEEE
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMKD-G--KEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVY  665 (912)
Q Consensus       591 ~~~~~~~LG~G~fg~Vy~a~~~~-~--~~vAvK~l~~~~-~~~~~~~~~E~~il~~L-~hpnIv~l~~~~~~~~~~~lV~  665 (912)
                      .|++.+.||+|+||.||+|..++ +  ..+++|.++... ....+.+.+|++++.++ +||||+++++++...+..++++
T Consensus         3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~   82 (297)
T cd05089           3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAI   82 (297)
T ss_pred             cceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEE
Confidence            45678899999999999998763 3  347888887532 33456788999999999 7999999999999999999999


Q ss_pred             EecCCCCHHHHhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEE
Q 002529          666 EYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK  732 (912)
Q Consensus       666 E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vk  732 (912)
                      ||+++++|.+++....             ....+++..++.++.|++.||+|||+   ++++||||||+||+++.++.+|
T Consensus        83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~k  159 (297)
T cd05089          83 EYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASK  159 (297)
T ss_pred             EecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeEE
Confidence            9999999999997532             12358899999999999999999998   9999999999999999999999


Q ss_pred             EeeccCccccccccccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhh
Q 002529          733 VSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSM  811 (912)
Q Consensus       733 L~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~  811 (912)
                      |+|||++.........  .....+..|+|||++.+..++.++|||||||++|||++ |..||.......   ...   . 
T Consensus       160 l~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~---~~~---~-  230 (297)
T cd05089         160 IADFGLSRGEEVYVKK--TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE---LYE---K-  230 (297)
T ss_pred             ECCcCCCccccceecc--CCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH---H-
Confidence            9999998643221111  11123457999999988889999999999999999997 999997433211   111   1 


Q ss_pred             hccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhhhhhcc
Q 002529          812 IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK  870 (912)
Q Consensus       812 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~~~~~~  870 (912)
                      +..+..     .    ..+......+.+++.+||+.+|.+||+++++++.|++++....
T Consensus       231 ~~~~~~-----~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~  280 (297)
T cd05089         231 LPQGYR-----M----EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK  280 (297)
T ss_pred             HhcCCC-----C----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence            111100     0    1111223478899999999999999999999999998887553

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=3.8e-34  Score=309.99  Aligned_cols=261  Identities=25%  Similarity=0.420  Sum_probs=207.2

Q ss_pred             HHHHHHhhhcccCccccEEEEEEEecC----CCEEEEEEccCcc-chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeE
Q 002529          587 LEEATNNFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR  661 (912)
Q Consensus       587 l~~~~~~~~~~LG~G~fg~Vy~a~~~~----~~~vAvK~l~~~~-~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~  661 (912)
                      +...++.+.++||+|+||.||+|.+.+    ...|++|...... ....+.+.+|+.++++++||||+++++++.+. ..
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~   81 (270)
T cd05056           3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN-PV   81 (270)
T ss_pred             echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-Cc
Confidence            345567788999999999999998653    2468999887654 34456789999999999999999999998764 57


Q ss_pred             EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccc
Q 002529          662 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ  741 (912)
Q Consensus       662 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~  741 (912)
                      ++||||+++++|.+++...  ...+++..++.++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||++..
T Consensus        82 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~  156 (270)
T cd05056          82 WIVMELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRY  156 (270)
T ss_pred             EEEEEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeee
Confidence            8999999999999999753  3468999999999999999999998   9999999999999999999999999999876


Q ss_pred             cccccccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhhhccCCcccc
Q 002529          742 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISI  820 (912)
Q Consensus       742 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  820 (912)
                      .............++..|+|||.+....++.++||||||+++||+++ |..||......   .....    +..+.... 
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~~----~~~~~~~~-  228 (270)
T cd05056         157 LEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN---DVIGR----IENGERLP-  228 (270)
T ss_pred             cccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHH----HHcCCcCC-
Confidence            54433222222334568999999988889999999999999999986 99999743321   11111    11111111 


Q ss_pred             cCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhhhhhc
Q 002529          821 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE  869 (912)
Q Consensus       821 ~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~~~~~  869 (912)
                              .+...+..+.+++.+|+..+|++|||+.|+++.|+++...+
T Consensus       229 --------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~  269 (270)
T cd05056         229 --------MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE  269 (270)
T ss_pred             --------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence                    11122347889999999999999999999999999977654

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=2.2e-34  Score=315.40  Aligned_cols=257  Identities=26%  Similarity=0.430  Sum_probs=204.1

Q ss_pred             HhhhcccCccccEEEEEEEec------CCCEEEEEEccCccc-hhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEE
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV  664 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~------~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV  664 (912)
                      +++.+.||+|+||.||+|...      ....+++|.+..... ....++.+|+.+++.++||||+++++.+..++..+++
T Consensus         2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (290)
T cd05045           2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLI   81 (290)
T ss_pred             ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEE
Confidence            456789999999999999754      235789998875433 3456788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhccCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCc
Q 002529          665 YEYMHNGTLRDRLHGSV---------------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNI  723 (912)
Q Consensus       665 ~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NI  723 (912)
                      +||+.+++|.+++....                     ....+++..++.++.|++.||+|||+   .+++||||||+||
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~ni  158 (290)
T cd05045          82 VEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNV  158 (290)
T ss_pred             EEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhheE
Confidence            99999999999986432                     12357899999999999999999998   9999999999999


Q ss_pred             cccCCCcEEEeeccCccccccccccc-cccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccch
Q 002529          724 LLDINMRAKVSDFGLSRQAEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAE  801 (912)
Q Consensus       724 Ll~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~  801 (912)
                      ++++++.+||+|||++.......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||.....   
T Consensus       159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---  235 (290)
T cd05045         159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP---  235 (290)
T ss_pred             EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH---
Confidence            99999999999999987653322211 122235678999999988889999999999999999998 9999964322   


Q ss_pred             hhHHHHHHhhhccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhhhh
Q 002529          802 LNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK  867 (912)
Q Consensus       802 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~~~  867 (912)
                      ..+.+...    .+..         ...+......+.+++.+||+.+|++||+++|+++.|+++..
T Consensus       236 ~~~~~~~~----~~~~---------~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         236 ERLFNLLK----TGYR---------MERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             HHHHHHHh----CCCC---------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence            12222221    1110         01111223478899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.4e-34  Score=322.64  Aligned_cols=240  Identities=25%  Similarity=0.345  Sum_probs=192.1

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc---chhhHHHHHHHHHHHhcCC-CCccceeeEEecCCeEEEEEE
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHH-RNLVPLIGYCEEEHQRILVYE  666 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~L~h-pnIv~l~~~~~~~~~~~lV~E  666 (912)
                      |++.+.||+|+||.||+|+.+ +++.||+|+++...   ....+.+..|.+++..++| ++|+++++++...+..++|||
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (324)
T cd05587           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME   81 (324)
T ss_pred             ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence            466789999999999999876 57899999987532   2344567889999999976 568889999999999999999


Q ss_pred             ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccc
Q 002529          667 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL  746 (912)
Q Consensus       667 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~  746 (912)
                      |+++|+|.+++..   ...+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||++.......
T Consensus        82 ~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05587          82 YVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG  155 (324)
T ss_pred             CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence            9999999999873   4568899999999999999999998   999999999999999999999999999987532211


Q ss_pred             ccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCcccc
Q 002529          747 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI  826 (912)
Q Consensus       747 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  826 (912)
                      . ......|++.|+|||++.+..++.++||||+||++|||++|+.||......   .....+   . ....         
T Consensus       156 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~~~i---~-~~~~---------  218 (324)
T cd05587         156 K-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---ELFQSI---M-EHNV---------  218 (324)
T ss_pred             C-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHH---H-cCCC---------
Confidence            1 122345899999999999999999999999999999999999999743321   111111   1 1110         


Q ss_pred             CCCCHHHHHHHHHHHHhcccCCCCCCCCH
Q 002529          827 GNVKIESIWRIAEVAIQCVEQRGFSRPKM  855 (912)
Q Consensus       827 ~~~~~~~~~~l~~Li~~cL~~dP~~RPs~  855 (912)
                       ..+......+.+++.+||+.+|.+|++.
T Consensus       219 -~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         219 -SYPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             -CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence             1111123467899999999999999976

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.5e-34  Score=321.30  Aligned_cols=240  Identities=26%  Similarity=0.379  Sum_probs=191.8

Q ss_pred             cccCccccEEEEEEEec-CCCEEEEEEccCcc---chhhHHHHHHHHHHHhc-CCCCccceeeEEecCCeEEEEEEecCC
Q 002529          596 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN  670 (912)
Q Consensus       596 ~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~L-~hpnIv~l~~~~~~~~~~~lV~E~~~~  670 (912)
                      +.||+|+||.||+|+.+ +++.||+|+++...   ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            47999999999999887 58899999987532   22345567788888765 899999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccccc
Q 002529          671 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS  750 (912)
Q Consensus       671 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~  750 (912)
                      |+|.+++..   ...+++..+..++.|++.||+|||+   ++|+||||||+||+++.++.++|+|||++....... ...
T Consensus        81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~  153 (316)
T cd05620          81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRA  153 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cce
Confidence            999999873   4578999999999999999999998   999999999999999999999999999987532211 112


Q ss_pred             ccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCCCC
Q 002529          751 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK  830 (912)
Q Consensus       751 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  830 (912)
                      ....|++.|+|||++.+..++.++|||||||++|||++|+.||...+..   ...+.    +..+.      +.+    +
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~---~~~~~----~~~~~------~~~----~  216 (316)
T cd05620         154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED---ELFES----IRVDT------PHY----P  216 (316)
T ss_pred             eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHH----HHhCC------CCC----C
Confidence            3345899999999999999999999999999999999999999743321   11111    11110      111    1


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHH-HHH
Q 002529          831 IESIWRIAEVAIQCVEQRGFSRPKMQ-EIV  859 (912)
Q Consensus       831 ~~~~~~l~~Li~~cL~~dP~~RPs~~-evl  859 (912)
                      .....++.+++.+||+.||++||++. +++
T Consensus       217 ~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         217 RWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            11234678999999999999999985 555

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.5e-35  Score=329.62  Aligned_cols=250  Identities=23%  Similarity=0.326  Sum_probs=197.7

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc---chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEe
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY  667 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  667 (912)
                      |++.+.||+|+||.||+|+.+ +++.||||++....   ......+.+|+++++.++||||+++++++.+++..++||||
T Consensus         3 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~   82 (364)
T cd05599           3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEY   82 (364)
T ss_pred             ceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECC
Confidence            556789999999999999886 58999999987532   23345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccc
Q 002529          668 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT  747 (912)
Q Consensus       668 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~  747 (912)
                      +++|+|.+++..   ...+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.++|+|||++........
T Consensus        83 ~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  156 (364)
T cd05599          83 LPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR  156 (364)
T ss_pred             CCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence            999999999873   4578999999999999999999998   9999999999999999999999999999875432110


Q ss_pred             c-------------------------------------ccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCC
Q 002529          748 H-------------------------------------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGK  790 (912)
Q Consensus       748 ~-------------------------------------~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~  790 (912)
                      .                                     ......||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~  236 (364)
T cd05599         157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY  236 (364)
T ss_pred             ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence            0                                     011235899999999999989999999999999999999999


Q ss_pred             CCCCccCccchhhHHHHHHhhhccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCC---HHHHHHH
Q 002529          791 KPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK---MQEIVLA  861 (912)
Q Consensus       791 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs---~~evl~~  861 (912)
                      .||......      +................       .......+.+++.+|+. +|.+|++   ++|+++.
T Consensus       237 ~Pf~~~~~~------~~~~~i~~~~~~~~~~~-------~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h  296 (364)
T cd05599         237 PPFCSDNPQ------ETYRKIINWKETLQFPD-------EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH  296 (364)
T ss_pred             CCCCCCCHH------HHHHHHHcCCCccCCCC-------CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence            999743321      11111111110000000       00122367789999996 8999998   8888763

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=2e-34  Score=313.90  Aligned_cols=262  Identities=26%  Similarity=0.440  Sum_probs=208.8

Q ss_pred             HHHHHHhhhcccCccccEEEEEEEecC-----CCEEEEEEccCcc-chhhHHHHHHHHHHHhcCCCCccceeeEEec-CC
Q 002529          587 LEEATNNFCKKIGKGSFGSVYYGKMKD-----GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE-EH  659 (912)
Q Consensus       587 l~~~~~~~~~~LG~G~fg~Vy~a~~~~-----~~~vAvK~l~~~~-~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~-~~  659 (912)
                      +...+|.+.+.||+|+||.||+|.+.+     +..|++|++.... ......+.+|+.++++++|+||+++++++.. +.
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   82 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE   82 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            345677788999999999999999875     7889999987543 3345678899999999999999999998765 56


Q ss_pred             eEEEEEEecCCCCHHHHhccCCCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEe
Q 002529          660 QRILVYEYMHNGTLRDRLHGSVNQ-----KPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVS  734 (912)
Q Consensus       660 ~~~lV~E~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~  734 (912)
                      ..++++||+++++|.+++......     ..+++..++.++.|++.||+|||+   .+++|+||||+||++++++.+||+
T Consensus        83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~  159 (280)
T cd05043          83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKIT  159 (280)
T ss_pred             CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEEC
Confidence            788999999999999998754322     568999999999999999999998   999999999999999999999999


Q ss_pred             eccCcccccccccc-ccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhhh
Q 002529          735 DFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMI  812 (912)
Q Consensus       735 DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~  812 (912)
                      |||+++........ ......++..|+|||++.+..++.++||||||+++||+++ |+.||.....   ..+..+..   
T Consensus       160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~---  233 (280)
T cd05043         160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---FEMAAYLK---  233 (280)
T ss_pred             CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---HHHHHHHH---
Confidence            99999865332221 1122335678999999988889999999999999999999 9999973321   12222221   


Q ss_pred             ccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhhhh
Q 002529          813 KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK  867 (912)
Q Consensus       813 ~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~~~  867 (912)
                       .+...         ......+..+.+++.+||+.+|++|||+.|+++.|+++..
T Consensus       234 -~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         234 -DGYRL---------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             -cCCCC---------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence             11100         0011123478899999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2.1e-34  Score=320.07  Aligned_cols=241  Identities=25%  Similarity=0.389  Sum_probs=191.9

Q ss_pred             cccCccccEEEEEEEec-CCCEEEEEEccCcc---chhhHHHHHHHHHHHhc-CCCCccceeeEEecCCeEEEEEEecCC
Q 002529          596 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN  670 (912)
Q Consensus       596 ~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~L-~hpnIv~l~~~~~~~~~~~lV~E~~~~  670 (912)
                      +.||+|+||.||+|..+ +++.||+|+++...   .........|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999876 57899999987542   22334566788888764 899999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccccc
Q 002529          671 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS  750 (912)
Q Consensus       671 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~  750 (912)
                      |+|.+++..   ...+++.++..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++........ ..
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~  153 (316)
T cd05619          81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KT  153 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-ce
Confidence            999999873   4568899999999999999999998   9999999999999999999999999999875322111 12


Q ss_pred             ccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCCCC
Q 002529          751 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK  830 (912)
Q Consensus       751 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  830 (912)
                      ....|++.|+|||++.+..++.++||||+||++|||++|+.||......   ...+.+    ....      +..    +
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~~~~i----~~~~------~~~----~  216 (316)
T cd05619         154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE---ELFQSI----RMDN------PCY----P  216 (316)
T ss_pred             eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH---HHHHHH----HhCC------CCC----C
Confidence            2345899999999999989999999999999999999999999743321   111111    1111      111    1


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHH-HHHH
Q 002529          831 IESIWRIAEVAIQCVEQRGFSRPKMQ-EIVL  860 (912)
Q Consensus       831 ~~~~~~l~~Li~~cL~~dP~~RPs~~-evl~  860 (912)
                      ......+.+++.+||+.+|++||++. ++++
T Consensus       217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         217 RWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             ccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            11223678999999999999999997 5543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2.4e-34  Score=317.49  Aligned_cols=260  Identities=28%  Similarity=0.440  Sum_probs=206.5

Q ss_pred             HHHHHHhhhcccCccccEEEEEEEec------CCCEEEEEEccCcc-chhhHHHHHHHHHHHhc-CCCCccceeeEEecC
Q 002529          587 LEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE  658 (912)
Q Consensus       587 l~~~~~~~~~~LG~G~fg~Vy~a~~~------~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~L-~hpnIv~l~~~~~~~  658 (912)
                      +...++.+.+.||+|+||.||+|...      .+..||+|+++... ....+.+.+|+++++++ +||||+++++++...
T Consensus        32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  111 (302)
T cd05055          32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG  111 (302)
T ss_pred             ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence            44566788999999999999999752      34579999987543 33446788999999999 799999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccC
Q 002529          659 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL  738 (912)
Q Consensus       659 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGl  738 (912)
                      +..++||||+++|+|.++++... ...+++.++..++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||+
T Consensus       112 ~~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~  187 (302)
T cd05055         112 GPILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGL  187 (302)
T ss_pred             CceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCcc
Confidence            99999999999999999997432 3348999999999999999999998   8999999999999999999999999999


Q ss_pred             cccccccccc-ccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhhhccCC
Q 002529          739 SRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGD  816 (912)
Q Consensus       739 a~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~  816 (912)
                      +......... ......++..|+|||.+.+..++.++||||+||++|||++ |+.||.......  ....    .+..+.
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~--~~~~----~~~~~~  261 (302)
T cd05055         188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS--KFYK----LIKEGY  261 (302)
T ss_pred             cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH--HHHH----HHHcCC
Confidence            8865433221 1122335678999999998899999999999999999998 999987433211  1111    111111


Q ss_pred             cccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhh
Q 002529          817 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS  865 (912)
Q Consensus       817 ~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~  865 (912)
                      ..         ..+......+.+++.+||+.+|++||++.|+++.|+++
T Consensus       262 ~~---------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         262 RM---------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             cC---------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            10         00111234788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.3e-35  Score=326.69  Aligned_cols=238  Identities=25%  Similarity=0.360  Sum_probs=192.5

Q ss_pred             cccCccccEEEEEEEe----cCCCEEEEEEccCccc--hhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEecC
Q 002529          596 KKIGKGSFGSVYYGKM----KDGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH  669 (912)
Q Consensus       596 ~~LG~G~fg~Vy~a~~----~~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~  669 (912)
                      +.||+|+||.||+++.    .+++.||+|+++....  .....+.+|++++++++||||+++++++.+++..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            6799999999999975    2578999999875322  233457789999999999999999999999999999999999


Q ss_pred             CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccccc
Q 002529          670 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI  749 (912)
Q Consensus       670 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~  749 (912)
                      +|+|.+++..   ...+++..++.++.||+.||+|||+   .+|+||||||+||+++.++.+||+|||++......... 
T Consensus        82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~-  154 (318)
T cd05582          82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK-  154 (318)
T ss_pred             CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc-
Confidence            9999999873   4578999999999999999999998   99999999999999999999999999998765433221 


Q ss_pred             cccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCCC
Q 002529          750 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV  829 (912)
Q Consensus       750 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  829 (912)
                      .....|++.|+|||++.+..++.++|||||||++|||++|+.||......   ..   ...... ...          ..
T Consensus       155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~---~~---~~~i~~-~~~----------~~  217 (318)
T cd05582         155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK---ET---MTMILK-AKL----------GM  217 (318)
T ss_pred             eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH---HH---HHHHHc-CCC----------CC
Confidence            22345899999999999888999999999999999999999999743221   11   111111 110          01


Q ss_pred             CHHHHHHHHHHHHhcccCCCCCCCCHHH
Q 002529          830 KIESIWRIAEVAIQCVEQRGFSRPKMQE  857 (912)
Q Consensus       830 ~~~~~~~l~~Li~~cL~~dP~~RPs~~e  857 (912)
                      +......+.+++.+||+.||++||++.+
T Consensus       218 p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         218 PQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            1112346789999999999999999554

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=3e-34  Score=310.85  Aligned_cols=253  Identities=26%  Similarity=0.443  Sum_probs=198.3

Q ss_pred             hhcccCccccEEEEEEEecCC-C--EEEEEEccCcc--chhhHHHHHHHHHHHhcCCCCccceeeEEecC------CeEE
Q 002529          594 FCKKIGKGSFGSVYYGKMKDG-K--EVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQRI  662 (912)
Q Consensus       594 ~~~~LG~G~fg~Vy~a~~~~~-~--~vAvK~l~~~~--~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~------~~~~  662 (912)
                      +.++||+|+||.||+|.+.+. +  .+|+|.++...  ....+.+.+|+++++.++|+||+++++++...      ...+
T Consensus         3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   82 (272)
T cd05075           3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV   82 (272)
T ss_pred             cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence            568999999999999987643 2  68999886532  33456788999999999999999999987432      2468


Q ss_pred             EEEEecCCCCHHHHhccCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCc
Q 002529          663 LVYEYMHNGTLRDRLHGSV---NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS  739 (912)
Q Consensus       663 lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla  739 (912)
                      ++|||+++|+|.+++....   ....+++..+..++.|++.||+|||+   ++|+||||||+||+++.++.++|+|||++
T Consensus        83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  159 (272)
T cd05075          83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLS  159 (272)
T ss_pred             EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCCcc
Confidence            9999999999998874322   23458999999999999999999998   99999999999999999999999999999


Q ss_pred             ccccccccc-ccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhhhccCCc
Q 002529          740 RQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDV  817 (912)
Q Consensus       740 ~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  817 (912)
                      ......... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||.....   ..+.+    .+..+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~----~~~~~~~  232 (272)
T cd05075         160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN---SEIYD----YLRQGNR  232 (272)
T ss_pred             cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHH----HHHcCCC
Confidence            876433221 1122235678999999999999999999999999999999 8899974322   11111    2222221


Q ss_pred             ccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhh
Q 002529          818 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS  865 (912)
Q Consensus       818 ~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~  865 (912)
                      ..         ........+.+++.+||+.+|++|||+.||++.|+++
T Consensus       233 ~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         233 LK---------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            11         0112234688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2.3e-34  Score=329.03  Aligned_cols=263  Identities=26%  Similarity=0.437  Sum_probs=206.6

Q ss_pred             HHHHHHHhhhcccCccccEEEEEEEec------CCCEEEEEEccCccc-hhhHHHHHHHHHHHhcC-CCCccceeeEEec
Q 002529          586 ELEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIH-HRNLVPLIGYCEE  657 (912)
Q Consensus       586 ~l~~~~~~~~~~LG~G~fg~Vy~a~~~------~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~L~-hpnIv~l~~~~~~  657 (912)
                      ++....+.+.++||+|+||.||+|+++      .++.||+|+++.... ...+.+.+|+++|.++. ||||+++++++..
T Consensus        33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~  112 (401)
T cd05107          33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK  112 (401)
T ss_pred             eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence            445556777899999999999999864      246899999975432 23457889999999997 9999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHhccCC--------------------------------------------------------
Q 002529          658 EHQRILVYEYMHNGTLRDRLHGSV--------------------------------------------------------  681 (912)
Q Consensus       658 ~~~~~lV~E~~~~gsL~~~l~~~~--------------------------------------------------------  681 (912)
                      .+..++||||+++|+|.++++...                                                        
T Consensus       113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (401)
T cd05107         113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM  192 (401)
T ss_pred             CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence            999999999999999999997532                                                        


Q ss_pred             ---------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 002529          682 ---------------------------------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN  722 (912)
Q Consensus       682 ---------------------------------------~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~N  722 (912)
                                                             ....+++..++.++.||+.||+|||+   .+++||||||+|
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~N  269 (401)
T cd05107         193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARN  269 (401)
T ss_pred             hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcce
Confidence                                                   11246778889999999999999998   999999999999


Q ss_pred             ccccCCCcEEEeeccCccccccccc-cccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccc
Q 002529          723 ILLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGA  800 (912)
Q Consensus       723 ILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~  800 (912)
                      ||++.++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||......+
T Consensus       270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~  349 (401)
T cd05107         270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE  349 (401)
T ss_pred             EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence            9999999999999999986533221 11122346788999999998889999999999999999998 899986332211


Q ss_pred             hhhHHHHHHhhhccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhhh
Q 002529          801 ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI  866 (912)
Q Consensus       801 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~~  866 (912)
                        ..    ...+..+...         ..+......+.+++.+||+.+|++||+++||++.|++++
T Consensus       350 --~~----~~~~~~~~~~---------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         350 --QF----YNAIKRGYRM---------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             --HH----HHHHHcCCCC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence              11    1111111110         011122347889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.7e-34  Score=321.01  Aligned_cols=241  Identities=27%  Similarity=0.373  Sum_probs=194.5

Q ss_pred             cccCccccEEEEEEEec-CCCEEEEEEccCcc---chhhHHHHHHHHHHHhc-CCCCccceeeEEecCCeEEEEEEecCC
Q 002529          596 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN  670 (912)
Q Consensus       596 ~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~L-~hpnIv~l~~~~~~~~~~~lV~E~~~~  670 (912)
                      +.||+|+||.||+|.++ +++.||+|+++...   ......+.+|.++++.+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999877 57899999987532   23345677899999888 699999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccccc
Q 002529          671 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS  750 (912)
Q Consensus       671 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~  750 (912)
                      |+|.+++..   ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++........ ..
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~  153 (318)
T cd05570          81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TT  153 (318)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-cc
Confidence            999998873   4579999999999999999999998   9999999999999999999999999999875322211 12


Q ss_pred             ccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCCCC
Q 002529          751 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK  830 (912)
Q Consensus       751 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  830 (912)
                      ....|++.|+|||++.+..++.++|||||||++|+|++|+.||......   ....   . +.....          ..+
T Consensus       154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~---~~~~---~-i~~~~~----------~~~  216 (318)
T cd05570         154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED---ELFQ---S-ILEDEV----------RYP  216 (318)
T ss_pred             cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH---HHHH---H-HHcCCC----------CCC
Confidence            2345899999999999999999999999999999999999999743321   1111   1 111111          011


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCH-----HHHHH
Q 002529          831 IESIWRIAEVAIQCVEQRGFSRPKM-----QEIVL  860 (912)
Q Consensus       831 ~~~~~~l~~Li~~cL~~dP~~RPs~-----~evl~  860 (912)
                      ......+.+++.+||+.||.+||++     .++++
T Consensus       217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            1223478899999999999999999     77765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-34  Score=312.47  Aligned_cols=268  Identities=26%  Similarity=0.389  Sum_probs=204.3

Q ss_pred             HhhhcccCccccEEEEEEEecCCCEEEEEEccCccchhhHHHHHHHHHHHhc--CCCCccceeeEEecCC----eEEEEE
Q 002529          592 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI--HHRNLVPLIGYCEEEH----QRILVY  665 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L--~hpnIv~l~~~~~~~~----~~~lV~  665 (912)
                      .++.+.||+|+||.||+|.++ ++.||||++..   ...+.|+.|-++++..  +|+||++++++-....    .++||+
T Consensus       212 l~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt  287 (534)
T KOG3653|consen  212 LQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT  287 (534)
T ss_pred             hhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence            346789999999999999998 59999999873   4567788888887754  7999999999876555    889999


Q ss_pred             EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCeeecCCCCCCccccCCCcEEEeeccCc
Q 002529          666 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC------NPGIIHRDVKSSNILLDINMRAKVSDFGLS  739 (912)
Q Consensus       666 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~------~~~ivH~DLkp~NILl~~~~~vkL~DFGla  739 (912)
                      ||.+.|+|.++|.    ...++|....+|+..+++||+|||+..      +.+|+|||||.+|||+.+|+.+.|+|||+|
T Consensus       288 ~fh~kGsL~dyL~----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA  363 (534)
T KOG3653|consen  288 EFHPKGSLCDYLK----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA  363 (534)
T ss_pred             eeccCCcHHHHHH----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence            9999999999998    567999999999999999999999743      568999999999999999999999999999


Q ss_pred             cccccccccc-cccccCCCcccCCCccCCC-CCC-----chhHHHHHHHHHHHHHhCCCCCCc-cCcc----------ch
Q 002529          740 RQAEEDLTHI-SSVARGTVGYLDPEYYGNQ-QLT-----EKSDVYSFGVVLLELISGKKPVSV-EDFG----------AE  801 (912)
Q Consensus       740 ~~~~~~~~~~-~~~~~gt~~y~APE~l~~~-~~s-----~ksDVwSlGvil~eLltG~~Pf~~-~~~~----------~~  801 (912)
                      ..+....... .-..+||.+|||||++.+. .+.     .+.||||+|.+||||++...-+.. ....          ..
T Consensus       364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h  443 (534)
T KOG3653|consen  364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH  443 (534)
T ss_pred             EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC
Confidence            8876443221 2235699999999999764 222     478999999999999986544431 1111          11


Q ss_pred             hhHHHHHHhhhccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhhhhhccC
Q 002529          802 LNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG  871 (912)
Q Consensus       802 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~~~~~~~  871 (912)
                      ..+.+.-.-.+++.....+.+.-.    ....+..+.+.+..||+.||+.|.|+.=|-+.+.++....+.
T Consensus       444 Pt~e~mq~~VV~kK~RP~~p~~W~----~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~  509 (534)
T KOG3653|consen  444 PTLEEMQELVVRKKQRPKIPDAWR----KHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED  509 (534)
T ss_pred             CCHHHHHHHHHhhccCCCChhhhh----cCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence            111111111111111111111111    113455788999999999999999999999999999888776

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.8e-34  Score=314.53  Aligned_cols=257  Identities=26%  Similarity=0.421  Sum_probs=204.0

Q ss_pred             HHHHhhhcccCccccEEEEEEEec------CCCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEE
Q 002529          589 EATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI  662 (912)
Q Consensus       589 ~~~~~~~~~LG~G~fg~Vy~a~~~------~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~  662 (912)
                      ...+.+.++||+|+||.||++...      ++..+++|.+..........+.+|+++++.++|+||+++++++.+....+
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL   83 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence            345567899999999999999642      35689999987766666678999999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhccCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCc
Q 002529          663 LVYEYMHNGTLRDRLHGSVN------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR  730 (912)
Q Consensus       663 lV~E~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~  730 (912)
                      ++|||+++++|.+++.....            ...+++..++.++.|++.||+|||+   .+++||||||+||++++++.
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~  160 (280)
T cd05092          84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLV  160 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCC
Confidence            99999999999999875321            1358899999999999999999998   99999999999999999999


Q ss_pred             EEEeeccCccccccccc-cccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHH
Q 002529          731 AKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWA  808 (912)
Q Consensus       731 vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~  808 (912)
                      +||+|||++........ .......+++.|+|||.+.+..++.++|||||||++|||++ |++||......   ....  
T Consensus       161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~--  235 (280)
T cd05092         161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT---EAIE--  235 (280)
T ss_pred             EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH---HHHH--
Confidence            99999999876533221 11222335678999999998899999999999999999998 99998632221   1111  


Q ss_pred             HhhhccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhh
Q 002529          809 RSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD  864 (912)
Q Consensus       809 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~  864 (912)
                       .. ..+....         .+...+..+.+++.+||+.+|++||+++||++.|+.
T Consensus       236 -~~-~~~~~~~---------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         236 -CI-TQGRELE---------RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             -HH-HcCccCC---------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence             11 1111100         011123468899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-34  Score=314.97  Aligned_cols=251  Identities=25%  Similarity=0.304  Sum_probs=200.6

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCccc---hhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEe
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY  667 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  667 (912)
                      |+..++||+|+||+||++... +++.||+|++.....   .....+.+|+.++++++||||+++++.+..++..++||||
T Consensus         2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05605           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence            566789999999999999875 689999999865322   2234577899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccc
Q 002529          668 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT  747 (912)
Q Consensus       668 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~  747 (912)
                      +++|+|.+++... ....+++..+..++.|++.||+|||+   .+++||||||+||++++++.++|+|||++........
T Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05605          82 MNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET  157 (285)
T ss_pred             cCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence            9999999888643 24568999999999999999999998   8999999999999999999999999999876543222


Q ss_pred             cccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccC
Q 002529          748 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG  827 (912)
Q Consensus       748 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  827 (912)
                      .  ....|+..|+|||++.+..++.++||||+||++|||++|+.||.......   ..+.+...+....          .
T Consensus       158 ~--~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~----------~  222 (285)
T cd05605         158 I--RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV---KREEVERRVKEDQ----------E  222 (285)
T ss_pred             c--ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh---HHHHHHHHhhhcc----------c
Confidence            1  22358899999999998899999999999999999999999997433211   1111111111111          1


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 002529          828 NVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA  861 (912)
Q Consensus       828 ~~~~~~~~~l~~Li~~cL~~dP~~RP-----s~~evl~~  861 (912)
                      .++......+.+++.+||+.||++||     +++++++.
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         223 EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            11222344788999999999999999     88888653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2.2e-34  Score=313.33  Aligned_cols=257  Identities=29%  Similarity=0.466  Sum_probs=201.7

Q ss_pred             HHHHhhhcccCccccEEEEEEEecC------CCEEEEEEccCccc-hhhHHHHHHHHHHHhcCCCCccceeeEEecCCeE
Q 002529          589 EATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR  661 (912)
Q Consensus       589 ~~~~~~~~~LG~G~fg~Vy~a~~~~------~~~vAvK~l~~~~~-~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~  661 (912)
                      ...+.+.+.||+|++|.||+|.+.+      +..|++|.+..... .....+.+|+.++++++|+||+++++++.+.+..
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            4556778999999999999998763      56789998865433 3345688999999999999999999999988899


Q ss_pred             EEEEEecCCCCHHHHhccCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCC---cEEEe
Q 002529          662 ILVYEYMHNGTLRDRLHGSV----NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM---RAKVS  734 (912)
Q Consensus       662 ~lV~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~---~vkL~  734 (912)
                      ++||||+++++|.+++....    ....+++..++.++.||+.||+|||+   ++++|+||||+||+++.++   .+||+
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEec
Confidence            99999999999999987543    12358999999999999999999998   8999999999999998654   59999


Q ss_pred             eccCcccccccccc-ccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhhh
Q 002529          735 DFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMI  812 (912)
Q Consensus       735 DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~  812 (912)
                      |||+++........ .......+..|+|||++.+..++.++|||||||++|||++ |..||......   .....   ..
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~---~~~~~---~~  235 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ---EVMEF---VT  235 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH---HH
Confidence            99999875332111 1112223568999999998899999999999999999997 99999743322   11111   11


Q ss_pred             ccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhh
Q 002529          813 KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD  864 (912)
Q Consensus       813 ~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~  864 (912)
                      .....          ..+...+..+.+++.+||+.+|++||++.+|++.|++
T Consensus       236 ~~~~~----------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~  277 (277)
T cd05036         236 GGGRL----------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY  277 (277)
T ss_pred             cCCcC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence            11110          1112223478899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.5e-34  Score=329.82  Aligned_cols=251  Identities=21%  Similarity=0.316  Sum_probs=194.7

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc---chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEe
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY  667 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  667 (912)
                      |++.+.||+|+||+||+|+.. +++.||+|++....   ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus         3 f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~   82 (381)
T cd05626           3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY   82 (381)
T ss_pred             ceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEec
Confidence            456789999999999999876 68899999986532   23346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccc
Q 002529          668 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT  747 (912)
Q Consensus       668 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~  747 (912)
                      +++|+|.+++..   ...+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++........
T Consensus        83 ~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~  156 (381)
T cd05626          83 IPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN  156 (381)
T ss_pred             CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence            999999999873   4568899999999999999999998   9999999999999999999999999998754311000


Q ss_pred             ----------------------------------------------cccccccCCCcccCCCccCCCCCCchhHHHHHHH
Q 002529          748 ----------------------------------------------HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGV  781 (912)
Q Consensus       748 ----------------------------------------------~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGv  781 (912)
                                                                    .......||+.|+|||++.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~  236 (381)
T cd05626         157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV  236 (381)
T ss_pred             cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence                                                          0011245899999999999888999999999999


Q ss_pred             HHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCCCCHHHHHHHHHHHHh--cccCCCCCCCCHHHHH
Q 002529          782 VLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQ--CVEQRGFSRPKMQEIV  859 (912)
Q Consensus       782 il~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~--cL~~dP~~RPs~~evl  859 (912)
                      ++|||++|+.||........   .   ...+........ .+      ......++.+++.+  |+..+|..||+++|++
T Consensus       237 il~elltG~~Pf~~~~~~~~---~---~~i~~~~~~~~~-~~------~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l  303 (381)
T cd05626         237 ILFEMLVGQPPFLAPTPTET---Q---LKVINWENTLHI-PP------QVKLSPEAVDLITKLCCSAEERLGRNGADDIK  303 (381)
T ss_pred             HHHHHHhCCCCCcCCCHHHH---H---HHHHccccccCC-CC------CCCCCHHHHHHHHHHccCcccccCCCCHHHHh
Confidence            99999999999974332111   1   111111000000 00      00112356778877  5566677799999998


Q ss_pred             HH
Q 002529          860 LA  861 (912)
Q Consensus       860 ~~  861 (912)
                      +.
T Consensus       304 ~h  305 (381)
T cd05626         304 AH  305 (381)
T ss_pred             cC
Confidence            64

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.7e-34  Score=310.66  Aligned_cols=257  Identities=29%  Similarity=0.499  Sum_probs=203.9

Q ss_pred             HHHHhhhcccCccccEEEEEEEecC-C---CEEEEEEccCcc-chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEE
Q 002529          589 EATNNFCKKIGKGSFGSVYYGKMKD-G---KEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL  663 (912)
Q Consensus       589 ~~~~~~~~~LG~G~fg~Vy~a~~~~-~---~~vAvK~l~~~~-~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~l  663 (912)
                      ...++..+.||+|+||.||+|..+. +   ..+++|.++... ....+.+.+|++++++++|+||+++++++...+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            3455668899999999999998762 3   379999987543 3345678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccc
Q 002529          664 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE  743 (912)
Q Consensus       664 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~  743 (912)
                      ||||+++++|.+++...  ...+++.++..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++....
T Consensus        84 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  158 (268)
T cd05063          84 ITEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLE  158 (268)
T ss_pred             EEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceecc
Confidence            99999999999998742  3568999999999999999999998   899999999999999999999999999987654


Q ss_pred             ccccccc--ccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhhhccCCcccc
Q 002529          744 EDLTHIS--SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISI  820 (912)
Q Consensus       744 ~~~~~~~--~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  820 (912)
                      .......  .....+..|+|||++.+..++.++|||||||++|||++ |+.||.....   .....   . +..+...  
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~---~~~~~---~-i~~~~~~--  229 (268)
T cd05063         159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN---HEVMK---A-INDGFRL--  229 (268)
T ss_pred             cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH---HHHHH---H-HhcCCCC--
Confidence            3222111  11123457999999988889999999999999999997 9999963322   11111   1 1111100  


Q ss_pred             cCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhhh
Q 002529          821 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI  866 (912)
Q Consensus       821 ~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~~  866 (912)
                        +     ........+.+++.+||+.+|++||++.+|++.|++++
T Consensus       230 --~-----~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~  268 (268)
T cd05063         230 --P-----APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL  268 (268)
T ss_pred             --C-----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence              0     01122347889999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.9e-34  Score=315.01  Aligned_cols=262  Identities=23%  Similarity=0.409  Sum_probs=203.8

Q ss_pred             HHHHhhhcccCccccEEEEEEEec-----CCCEEEEEEccCcc-chhhHHHHHHHHHHHhcCCCCccceeeEEecC--Ce
Q 002529          589 EATNNFCKKIGKGSFGSVYYGKMK-----DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQ  660 (912)
Q Consensus       589 ~~~~~~~~~LG~G~fg~Vy~a~~~-----~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~--~~  660 (912)
                      ...+++.+.||+|+||.||+++.+     +++.||+|.++... ......+.+|++++++++||||+++++++...  ..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (284)
T cd05079           3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   82 (284)
T ss_pred             hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence            456778899999999999999742     47889999987543 33346789999999999999999999998765  56


Q ss_pred             EEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcc
Q 002529          661 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR  740 (912)
Q Consensus       661 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~  740 (912)
                      .++||||+++++|.+++...  ...+++..+..++.|++.||+|||+   ++++||||||+||+++.++.++|+|||++.
T Consensus        83 ~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~  157 (284)
T cd05079          83 IKLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTK  157 (284)
T ss_pred             eEEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCcccc
Confidence            88999999999999998643  3468999999999999999999998   999999999999999999999999999998


Q ss_pred             cccccccc--ccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcc---------chhhHHHHHH
Q 002529          741 QAEEDLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG---------AELNIVHWAR  809 (912)
Q Consensus       741 ~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~---------~~~~~~~~~~  809 (912)
                      ........  ......++..|+|||++.+..++.++||||||+++|||++++.|.......         ........+ 
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  236 (284)
T cd05079         158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV-  236 (284)
T ss_pred             ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH-
Confidence            76433221  112334667899999998888999999999999999999987765321100         000111111 


Q ss_pred             hhhccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhh
Q 002529          810 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS  865 (912)
Q Consensus       810 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~  865 (912)
                      ..+..+....         .....+..+.+++.+||+.+|++||+++++++.|+++
T Consensus       237 ~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         237 RVLEEGKRLP---------RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHHHcCccCC---------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            1111111111         1112345789999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.2e-34  Score=321.43  Aligned_cols=243  Identities=22%  Similarity=0.337  Sum_probs=193.6

Q ss_pred             cccCccccEEEEEEEec-CCCEEEEEEccCcc---chhhHHHHHHHHHHHhc-CCCCccceeeEEecCCeEEEEEEecCC
Q 002529          596 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN  670 (912)
Q Consensus       596 ~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~L-~hpnIv~l~~~~~~~~~~~lV~E~~~~  670 (912)
                      +.||+|+||.||+|..+ +++.||+|+++...   ....+.+.+|..++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999876 57899999997542   22345678899999888 699999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccccc
Q 002529          671 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS  750 (912)
Q Consensus       671 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~  750 (912)
                      |+|.+++..   ...+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||++........ ..
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~  153 (327)
T cd05617          81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-TT  153 (327)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-ce
Confidence            999998873   4579999999999999999999998   9999999999999999999999999999875322111 12


Q ss_pred             ccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCCCC
Q 002529          751 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK  830 (912)
Q Consensus       751 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  830 (912)
                      ....|++.|+|||++.+..++.++|||||||++|||++|+.||............++....+.....      .    .+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~------~----~p  223 (327)
T cd05617         154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI------R----IP  223 (327)
T ss_pred             ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC------C----CC
Confidence            2345899999999999999999999999999999999999999743332222222222222222111      0    11


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCH
Q 002529          831 IESIWRIAEVAIQCVEQRGFSRPKM  855 (912)
Q Consensus       831 ~~~~~~l~~Li~~cL~~dP~~RPs~  855 (912)
                      ......+.+++.+||+.||++|+++
T Consensus       224 ~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         224 RFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             CCCCHHHHHHHHHHhccCHHHcCCC
Confidence            1122367899999999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-34  Score=310.69  Aligned_cols=254  Identities=27%  Similarity=0.440  Sum_probs=200.5

Q ss_pred             hhhcccCccccEEEEEEEecC----CCEEEEEEccCcc--chhhHHHHHHHHHHHhcCCCCccceeeEEecCCe------
Q 002529          593 NFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ------  660 (912)
Q Consensus       593 ~~~~~LG~G~fg~Vy~a~~~~----~~~vAvK~l~~~~--~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~------  660 (912)
                      .+.+.||+|+||.||+|.+..    +..||+|+++...  ......+.+|++.++.++||||+++++++.....      
T Consensus         2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   81 (273)
T cd05035           2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK   81 (273)
T ss_pred             ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence            467899999999999998752    3679999987532  2334678999999999999999999998866544      


Q ss_pred             EEEEEEecCCCCHHHHhccCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeecc
Q 002529          661 RILVYEYMHNGTLRDRLHGSV---NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG  737 (912)
Q Consensus       661 ~~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFG  737 (912)
                      .++++||+++|+|.+++....   ....+++..++.++.|++.||+|||+   .+++||||||+||++++++.+||+|||
T Consensus        82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg  158 (273)
T cd05035          82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFG  158 (273)
T ss_pred             cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCcc
Confidence            789999999999999886432   23468999999999999999999998   899999999999999999999999999


Q ss_pred             Cccccccccccc-cccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhhhccC
Q 002529          738 LSRQAEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKG  815 (912)
Q Consensus       738 la~~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~  815 (912)
                      +++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.....   ....+..    ..+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~---~~~~~~~----~~~  231 (273)
T cd05035         159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN---HEIYDYL----RHG  231 (273)
T ss_pred             ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH----HcC
Confidence            988754332211 112234678999999988899999999999999999999 8899863321   1122211    111


Q ss_pred             CcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhh
Q 002529          816 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS  865 (912)
Q Consensus       816 ~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~  865 (912)
                      ....         .+......+.+++.+||+.||++||++.|+++.|+++
T Consensus       232 ~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         232 NRLK---------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             CCCC---------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            1111         1122344789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=5.3e-35  Score=330.05  Aligned_cols=272  Identities=22%  Similarity=0.260  Sum_probs=210.0

Q ss_pred             cccChhHHHHHHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCccchhhHHHHHHHHHHHhcC-C-----CCcccee
Q 002529          580 YFIPLPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-H-----RNLVPLI  652 (912)
Q Consensus       580 ~~~~~~~l~~~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~-h-----pnIv~l~  652 (912)
                      +.+-..|....+|++.+.||+|.||.|-+|... +++.||||++++. ....++-..|+.+|..|+ |     -|+|+++
T Consensus       176 Y~~v~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~  254 (586)
T KOG0667|consen  176 YQLVVNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRML  254 (586)
T ss_pred             eeEEecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEee
Confidence            333344444458888999999999999999765 6999999999865 334567778999999996 4     4799999


Q ss_pred             eEEecCCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCC--Cc
Q 002529          653 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN--MR  730 (912)
Q Consensus       653 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~--~~  730 (912)
                      ++|...++.|||+|.+ ..+|.++++.+ .-..++...++.++.||+.||.+||+   .+|||+||||+||||.+.  ..
T Consensus       255 d~F~fr~HlciVfELL-~~NLYellK~n-~f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~  329 (586)
T KOG0667|consen  255 DYFYFRNHLCIVFELL-STNLYELLKNN-KFRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSR  329 (586)
T ss_pred             eccccccceeeeehhh-hhhHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCc
Confidence            9999999999999999 67999999976 45569999999999999999999998   999999999999999653  36


Q ss_pred             EEEeeccCccccccccccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHh
Q 002529          731 AKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS  810 (912)
Q Consensus       731 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~  810 (912)
                      +||+|||.|+.......    ....+..|+|||++.+.+|+.+.||||||||+.||++|.+.|.+....+.......+..
T Consensus       330 vKVIDFGSSc~~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG  405 (586)
T KOG0667|consen  330 IKVIDFGSSCFESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLG  405 (586)
T ss_pred             eeEEecccccccCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhC
Confidence            99999999987654322    45678899999999999999999999999999999999988876554333222221111


Q ss_pred             hhc-----cC-CcccccCc--------------------------------cccC--------CCCHHHHHHHHHHHHhc
Q 002529          811 MIK-----KG-DVISIVDP--------------------------------VLIG--------NVKIESIWRIAEVAIQC  844 (912)
Q Consensus       811 ~~~-----~~-~~~~~~d~--------------------------------~l~~--------~~~~~~~~~l~~Li~~c  844 (912)
                      ...     .+ +....++.                                ....        .........+++++++|
T Consensus       406 ~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~  485 (586)
T KOG0667|consen  406 LPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRC  485 (586)
T ss_pred             CCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHH
Confidence            110     00 00000000                                0000        00113345789999999


Q ss_pred             ccCCCCCCCCHHHHHHH
Q 002529          845 VEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       845 L~~dP~~RPs~~evl~~  861 (912)
                      |++||.+|+|+.|+++.
T Consensus       486 L~~dP~~R~tp~qal~H  502 (586)
T KOG0667|consen  486 LEWDPAERITPAQALNH  502 (586)
T ss_pred             hccCchhcCCHHHHhcC
Confidence            99999999999999864

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.7e-34  Score=310.69  Aligned_cols=257  Identities=27%  Similarity=0.483  Sum_probs=204.9

Q ss_pred             HHHHhhhcccCccccEEEEEEEec----CCCEEEEEEccCcc-chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEE
Q 002529          589 EATNNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL  663 (912)
Q Consensus       589 ~~~~~~~~~LG~G~fg~Vy~a~~~----~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~l  663 (912)
                      ..++++.+.||+|+||.||+|.+.    .+..+|+|.++... ....+.+.+|+.++++++||||+++++++..++..++
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI   82 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            356778899999999999999864    23479999987543 2345678999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccc
Q 002529          664 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE  743 (912)
Q Consensus       664 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~  743 (912)
                      ||||+++++|.+++...  ...+++.+++.++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||++....
T Consensus        83 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd05066          83 VTEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  157 (267)
T ss_pred             EEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence            99999999999999743  3568999999999999999999998   999999999999999999999999999998765


Q ss_pred             cccccccc--cccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhhhccCCcccc
Q 002529          744 EDLTHISS--VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISI  820 (912)
Q Consensus       744 ~~~~~~~~--~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  820 (912)
                      ........  ...++..|+|||.+.+..++.++|+||||+++||+++ |+.||......   .....+.    .+..   
T Consensus       158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~---~~~~~~~----~~~~---  227 (267)
T cd05066         158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ---DVIKAIE----EGYR---  227 (267)
T ss_pred             cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH---HHHHHHh----CCCc---
Confidence            43322111  1123467999999998889999999999999999886 99999733221   1222111    1110   


Q ss_pred             cCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhhh
Q 002529          821 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI  866 (912)
Q Consensus       821 ~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~~  866 (912)
                        .    ......+..+.+++.+|++.+|++||++.++++.|++++
T Consensus       228 --~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~  267 (267)
T cd05066         228 --L----PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI  267 (267)
T ss_pred             --C----CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhhC
Confidence              0    001122346889999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=2.9e-34  Score=326.39  Aligned_cols=259  Identities=24%  Similarity=0.337  Sum_probs=197.1

Q ss_pred             hhhcccCccccEEEEEEEec-CCCEEEEEEccCcc--chhhHHHHHHHHHHHhcCCCCccceeeEEecCC-----eEEEE
Q 002529          593 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH-----QRILV  664 (912)
Q Consensus       593 ~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~-----~~~lV  664 (912)
                      ++.++||+|+||.||+|... +++.||+|++....  ....+.+.+|+++++.++||||+++++++...+     ..++|
T Consensus         3 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv   82 (372)
T cd07853           3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVV   82 (372)
T ss_pred             cccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEE
Confidence            45789999999999999875 68999999986532  234467889999999999999999999998766     78999


Q ss_pred             EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccc
Q 002529          665 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE  744 (912)
Q Consensus       665 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~  744 (912)
                      +||+. ++|.+.+.   ....+++..+..++.||+.||+|||+   .+++||||||+|||++.++.+||+|||++.....
T Consensus        83 ~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~  155 (372)
T cd07853          83 TELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP  155 (372)
T ss_pred             eeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence            99996 67888776   35679999999999999999999998   9999999999999999999999999999986543


Q ss_pred             ccccccccccCCCcccCCCccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCccc----
Q 002529          745 DLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS----  819 (912)
Q Consensus       745 ~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~----  819 (912)
                      ..........+++.|+|||++.+. .++.++||||+||++|||++|+.||.........   ..+..........+    
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~i~~~~g~~~~~~~~~~  232 (372)
T cd07853         156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQL---DLITDLLGTPSLEAMRSA  232 (372)
T ss_pred             CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHH---HHHHHHcCCCCHHHHHHh
Confidence            322222334578899999998764 5789999999999999999999999754432111   11111100000000    


Q ss_pred             -------cc----C-cccc--CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002529          820 -------IV----D-PVLI--GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       820 -------~~----d-~~l~--~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  861 (912)
                             +.    . +...  ..........+.+++.+||+.||++|||++|+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence                   00    0 0000  00111123478899999999999999999999864

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.2e-34  Score=318.62  Aligned_cols=264  Identities=21%  Similarity=0.288  Sum_probs=197.8

Q ss_pred             HHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCccc-hhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEe
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY  667 (912)
Q Consensus       590 ~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  667 (912)
                      .+|.+.++||+|+||.||+|+.+ +++.||+|.++.... .....+.+|++++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            34667899999999999999876 578899999864332 2334677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccc
Q 002529          668 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT  747 (912)
Q Consensus       668 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~  747 (912)
                      +++ +|.+++...  +..+++..+..++.||+.||+|||+   ++|+||||||+||+++.++.+||+|||++........
T Consensus        86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  159 (309)
T cd07872          86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK  159 (309)
T ss_pred             CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence            974 888887643  4568899999999999999999998   9999999999999999999999999999876433222


Q ss_pred             cccccccCCCcccCCCccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccc------
Q 002529          748 HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI------  820 (912)
Q Consensus       748 ~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------  820 (912)
                      . .....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||......+...................+      
T Consensus       160 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
T cd07872         160 T-YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF  238 (309)
T ss_pred             c-cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence            1 122347889999998865 46889999999999999999999999754433221111111000000000000      


Q ss_pred             cCccccC-------CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          821 VDPVLIG-------NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       821 ~d~~l~~-------~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                      .+.....       .........+.+++.+||+.||++|||++|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            0000000       000112346789999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.8e-34  Score=309.84  Aligned_cols=252  Identities=33%  Similarity=0.543  Sum_probs=200.1

Q ss_pred             HhhhcccCccccEEEEEEEecC-CCEEEEEEccCccchhh--HHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEec
Q 002529          592 NNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM  668 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~~-~~~vAvK~l~~~~~~~~--~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~  668 (912)
                      |++.+.||+|+||+||+++... ++.+|+|++........  ....+|+.++++++||||+++++++.+....++|||++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            4577899999999999999874 67899999987644332  23456999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccc
Q 002529          669 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH  748 (912)
Q Consensus       669 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  748 (912)
                      ++++|.+++.   ....+++..++.++.|+++||++||+   .+++|+||||+||+++.++.++|+|||.+...... ..
T Consensus        81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~-~~  153 (260)
T PF00069_consen   81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN-NE  153 (260)
T ss_dssp             TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEESTST-TS
T ss_pred             cccccccccc---cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc-cc
Confidence            9999999998   35678999999999999999999999   99999999999999999999999999998764221 22


Q ss_pred             ccccccCCCcccCCCccC-CCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccC
Q 002529          749 ISSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG  827 (912)
Q Consensus       749 ~~~~~~gt~~y~APE~l~-~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  827 (912)
                      ......++..|+|||++. +...+.++||||+|+++|+|++|..||............   ....... ...   . .  
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~---~~~~~~~-~~~---~-~--  223 (260)
T PF00069_consen  154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEII---EKILKRP-LPS---S-S--  223 (260)
T ss_dssp             EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHH---HHHHHTH-HHH---H-T--
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhh---hhccccc-ccc---c-c--
Confidence            233455889999999998 889999999999999999999999999844211111111   1111100 000   0 0  


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          828 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       828 ~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                      .........+.+++.+||+.||++||++.|+++
T Consensus       224 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  224 QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000011258999999999999999999999985

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=8.5e-35  Score=325.10  Aligned_cols=250  Identities=21%  Similarity=0.269  Sum_probs=200.4

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCccc---hhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEe
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY  667 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  667 (912)
                      |++.+.||+|+||.||++..+ +++.||+|+++....   .....+.+|+.+++.++|+||+++++++.+.+..++||||
T Consensus         3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~   82 (330)
T cd05601           3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEY   82 (330)
T ss_pred             ceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECC
Confidence            567889999999999999876 689999999875422   2345688899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccc
Q 002529          668 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT  747 (912)
Q Consensus       668 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~  747 (912)
                      +++|+|.+++...  ...+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++........
T Consensus        83 ~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  157 (330)
T cd05601          83 QPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM  157 (330)
T ss_pred             CCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence            9999999999743  3578999999999999999999998   9999999999999999999999999999987654433


Q ss_pred             cccccccCCCcccCCCccC------CCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCccccc
Q 002529          748 HISSVARGTVGYLDPEYYG------NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV  821 (912)
Q Consensus       748 ~~~~~~~gt~~y~APE~l~------~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  821 (912)
                      .......|++.|+|||++.      ...++.++|||||||++|||++|+.||......      ................
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~~i~~~~~~~~~~  231 (330)
T cd05601         158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA------KTYNNIMNFQRFLKFP  231 (330)
T ss_pred             eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH------HHHHHHHcCCCccCCC
Confidence            3333446899999999986      456788999999999999999999999743221      1111111111111110


Q ss_pred             CccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          822 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       822 d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                      +       .......+.+++.+||+ +|++||+++++++
T Consensus       232 ~-------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         232 E-------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             C-------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            0       01123468899999998 9999999999985

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.6e-34  Score=325.60  Aligned_cols=251  Identities=22%  Similarity=0.349  Sum_probs=193.9

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc---chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEe
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY  667 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  667 (912)
                      |++.+.||+|+||+||+|..+ +++.||+|+++...   ......+.+|+.++.+++|+||+++++.+.+....++||||
T Consensus         3 y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~   82 (363)
T cd05628           3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEF   82 (363)
T ss_pred             ceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcC
Confidence            556789999999999999876 58999999987532   22345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccc
Q 002529          668 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT  747 (912)
Q Consensus       668 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~  747 (912)
                      +++|+|.+++..   ...+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+++.......
T Consensus        83 ~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~  156 (363)
T cd05628          83 LPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR  156 (363)
T ss_pred             CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence            999999999973   5679999999999999999999998   9999999999999999999999999999875432110


Q ss_pred             ----------------------------------cccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 002529          748 ----------------------------------HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPV  793 (912)
Q Consensus       748 ----------------------------------~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf  793 (912)
                                                        .......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf  236 (363)
T cd05628         157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (363)
T ss_pred             ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence                                              0011246899999999999999999999999999999999999999


Q ss_pred             CccCccchhhHHHHHHhhhccCCcccccCccccCCCCHHHHHHHHHHHHhccc--CCCCCCCCHHHHHHH
Q 002529          794 SVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVE--QRGFSRPKMQEIVLA  861 (912)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~--~dP~~RPs~~evl~~  861 (912)
                      ......+   .   ........... .+.+..      .....+.+++.+|+.  .++..||+++||++.
T Consensus       237 ~~~~~~~---~---~~~i~~~~~~~-~~p~~~------~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         237 CSETPQE---T---YKKVMNWKETL-IFPPEV------PISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CCCCHHH---H---HHHHHcCcCcc-cCCCcC------CCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            7433211   1   11111100000 011100      112356677776543  234457899999875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.4e-34  Score=305.16  Aligned_cols=250  Identities=24%  Similarity=0.356  Sum_probs=199.9

Q ss_pred             HHhhhcccCccccEEEEEEEec-CCCEEEEEEccCccc-----hhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEE
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-----HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV  664 (912)
Q Consensus       591 ~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~-----~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV  664 (912)
                      .|+..+.||+|++|.||+|... +++.||+|.+.....     ...+.+.+|++++++++||||+++++++.+++..++|
T Consensus         3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   82 (263)
T cd06625           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIF   82 (263)
T ss_pred             cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEE
Confidence            3566789999999999999875 689999999864321     1235688899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccc
Q 002529          665 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE  744 (912)
Q Consensus       665 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~  744 (912)
                      +||+++++|.+.+..   ...+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||++.....
T Consensus        83 ~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~  156 (263)
T cd06625          83 MEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT  156 (263)
T ss_pred             EEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence            999999999999873   4568899999999999999999998   9999999999999999999999999999876543


Q ss_pred             cccccc--ccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccC
Q 002529          745 DLTHIS--SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD  822 (912)
Q Consensus       745 ~~~~~~--~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  822 (912)
                      ......  ....++..|+|||++.+..++.++||||||+++|||++|+.||......   ..   ..........     
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~---~~~~~~~~~~-----  225 (263)
T cd06625         157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM---AA---IFKIATQPTN-----  225 (263)
T ss_pred             cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH---HH---HHHHhccCCC-----
Confidence            221111  2334778999999999988999999999999999999999999732211   11   1111111110     


Q ss_pred             ccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002529          823 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       823 ~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  861 (912)
                          ...+......+.+++.+||+.+|.+||++.|+++.
T Consensus       226 ----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         226 ----PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             ----CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence                11122233478899999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-34  Score=311.04  Aligned_cols=259  Identities=25%  Similarity=0.443  Sum_probs=206.6

Q ss_pred             HHHHHHhhhcccCccccEEEEEEEecC------CCEEEEEEccCcc-chhhHHHHHHHHHHHhcCCCCccceeeEEecCC
Q 002529          587 LEEATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH  659 (912)
Q Consensus       587 l~~~~~~~~~~LG~G~fg~Vy~a~~~~------~~~vAvK~l~~~~-~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~  659 (912)
                      +....+++.+.||+|+||.||+|..+.      ++.||+|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   82 (277)
T cd05032           3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ   82 (277)
T ss_pred             cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence            455677788999999999999998753      4689999987543 234467889999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHhccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEE
Q 002529          660 QRILVYEYMHNGTLRDRLHGSV-------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK  732 (912)
Q Consensus       660 ~~~lV~E~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vk  732 (912)
                      ..++||||+++++|.+++....       ....+++..++.++.|++.||+|||+   .+++|+||||+||+++.++.+|
T Consensus        83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~k  159 (277)
T cd05032          83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVK  159 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEE
Confidence            9999999999999999987532       12347888999999999999999998   9999999999999999999999


Q ss_pred             EeeccCccccccccc-cccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHh
Q 002529          733 VSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARS  810 (912)
Q Consensus       733 L~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~  810 (912)
                      |+|||+++....... .......++..|+|||.+.+..++.++|||||||++||+++ |+.||......   ......  
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~~~~--  234 (277)
T cd05032         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE---EVLKFV--  234 (277)
T ss_pred             ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH---HHHHHH--
Confidence            999999876543321 12223346788999999988889999999999999999998 99998633221   122211  


Q ss_pred             hhccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhh
Q 002529          811 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD  864 (912)
Q Consensus       811 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~  864 (912)
                        ..+.....         +......+.+++.+||+.+|++|||+.|+++.|++
T Consensus       235 --~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         235 --IDGGHLDL---------PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             --hcCCCCCC---------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence              11111111         11124578899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=3.4e-34  Score=313.80  Aligned_cols=262  Identities=26%  Similarity=0.441  Sum_probs=205.1

Q ss_pred             HHHHHHhhhcccCccccEEEEEEEecC------CCEEEEEEccCccc-hhhHHHHHHHHHHHhcCCCCccceeeEEecCC
Q 002529          587 LEEATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH  659 (912)
Q Consensus       587 l~~~~~~~~~~LG~G~fg~Vy~a~~~~------~~~vAvK~l~~~~~-~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~  659 (912)
                      +...+|++.++||+|+||.||+|..++      +..||+|.+..... .....+.+|+.+++.++||||+++++++.+..
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ   82 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            345678889999999999999997542      45799998865432 23456788999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHhccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEE
Q 002529          660 QRILVYEYMHNGTLRDRLHGSV-------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK  732 (912)
Q Consensus       660 ~~~lV~E~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vk  732 (912)
                      ..++||||+++|+|.+++....       ....+++..+..++.|++.||+|||+   ++++||||||+||+++.++.++
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEE
Confidence            9999999999999999997532       12345677889999999999999998   9999999999999999999999


Q ss_pred             EeeccCcccccccccc-ccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHh
Q 002529          733 VSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARS  810 (912)
Q Consensus       733 L~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~  810 (912)
                      |+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||......   ....   .
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~---~~~~---~  233 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE---QVLK---F  233 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH---H
Confidence            9999998764332211 1112234678999999998899999999999999999998 78898633221   1111   1


Q ss_pred             hhccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhhhh
Q 002529          811 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK  867 (912)
Q Consensus       811 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~~~  867 (912)
                       +..+.....         +......+.+++.+||+.+|++||++.|+++.|++.+.
T Consensus       234 -~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  280 (288)
T cd05061         234 -VMDGGYLDQ---------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH  280 (288)
T ss_pred             -HHcCCCCCC---------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC
Confidence             111111110         11123478999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=3.9e-34  Score=306.67  Aligned_cols=249  Identities=27%  Similarity=0.399  Sum_probs=203.1

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCc--cchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEec
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM  668 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~  668 (912)
                      |.+.+.||+|++|.||+|..+ +++.|++|.+...  .......+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd08529           2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA   81 (256)
T ss_pred             ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence            456789999999999999876 6899999998643  2345577889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccc
Q 002529          669 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH  748 (912)
Q Consensus       669 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  748 (912)
                      ++++|.+++... ....+++..++.++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++.........
T Consensus        82 ~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~  157 (256)
T cd08529          82 ENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF  157 (256)
T ss_pred             CCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence            999999999854 24678999999999999999999998   99999999999999999999999999998876543222


Q ss_pred             ccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCC
Q 002529          749 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN  828 (912)
Q Consensus       749 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  828 (912)
                       .....+++.|+|||++.+..++.++|+||||+++++|++|+.||.....   .....   . ...+....         
T Consensus       158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~---~-~~~~~~~~---------  220 (256)
T cd08529         158 -ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ---GALIL---K-IIRGVFPP---------  220 (256)
T ss_pred             -hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---HHHHH---H-HHcCCCCC---------
Confidence             2233578899999999998899999999999999999999999974331   11111   1 11111111         


Q ss_pred             CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002529          829 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       829 ~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  861 (912)
                      .+......+.+++.+||+.+|++||++.|+++.
T Consensus       221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         221 VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             CccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            111233478999999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=4.9e-34  Score=313.26  Aligned_cols=264  Identities=29%  Similarity=0.445  Sum_probs=205.3

Q ss_pred             HHHHhhhcccCccccEEEEEEEecC-----------------CCEEEEEEccCccc-hhhHHHHHHHHHHHhcCCCCccc
Q 002529          589 EATNNFCKKIGKGSFGSVYYGKMKD-----------------GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVP  650 (912)
Q Consensus       589 ~~~~~~~~~LG~G~fg~Vy~a~~~~-----------------~~~vAvK~l~~~~~-~~~~~~~~E~~il~~L~hpnIv~  650 (912)
                      ...|++.++||+|+||.||+|...+                 +..||+|.+..... ...+.+.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            4567788999999999999997653                 24689999875433 34567889999999999999999


Q ss_pred             eeeEEecCCeEEEEEEecCCCCHHHHhccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 002529          651 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSV--------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN  722 (912)
Q Consensus       651 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~N  722 (912)
                      +++++..++..++++|++++++|.+++....        ....+++..++.++.|++.||+|||+   .+++|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhc
Confidence            9999999999999999999999999987532        12368999999999999999999998   999999999999


Q ss_pred             ccccCCCcEEEeeccCccccccccc-cccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh--CCCCCCccCcc
Q 002529          723 ILLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS--GKKPVSVEDFG  799 (912)
Q Consensus       723 ILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt--G~~Pf~~~~~~  799 (912)
                      |+++.++.++|+|||++........ .......++..|+|||++.+..++.++|||||||++|||++  +..||..... 
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~-  239 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD-  239 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence            9999999999999999876433221 12223345778999999988889999999999999999998  7778763221 


Q ss_pred             chhhHHHHHHhhhccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhh
Q 002529          800 AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD  864 (912)
Q Consensus       800 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~  864 (912)
                        ....................+      .+...+..+.+++.+||+.+|++||++.||++.|++
T Consensus       240 --~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         240 --QQVIENAGHFFRDDGRQIYLP------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             --HHHHHHHHhccccccccccCC------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence              112222222111111111111      111223478999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.5e-34  Score=322.14  Aligned_cols=237  Identities=29%  Similarity=0.386  Sum_probs=188.7

Q ss_pred             cccCccccEEEEEEEec-CCCEEEEEEccCcc---chhhHHHHHHHH-HHHhcCCCCccceeeEEecCCeEEEEEEecCC
Q 002529          596 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVA-LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN  670 (912)
Q Consensus       596 ~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~-il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~  670 (912)
                      +.||+|+||+||+|..+ +++.||+|++....   ......+.+|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999986 68999999986532   122344555554 56788999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccccc
Q 002529          671 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS  750 (912)
Q Consensus       671 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~  750 (912)
                      |+|.+++..   ...+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||++........ ..
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~  153 (323)
T cd05575          81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK-TT  153 (323)
T ss_pred             CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC-cc
Confidence            999999873   5678999999999999999999998   9999999999999999999999999999875322211 12


Q ss_pred             ccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCCCC
Q 002529          751 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK  830 (912)
Q Consensus       751 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  830 (912)
                      ....|++.|+|||++.+..++.++|||||||++|||++|+.||...+..      +....... +..      .+..   
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~------~~~~~i~~-~~~------~~~~---  217 (323)
T cd05575         154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA------EMYDNILN-KPL------RLKP---  217 (323)
T ss_pred             ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH------HHHHHHHc-CCC------CCCC---
Confidence            2345899999999999999999999999999999999999999743221      11111111 110      1111   


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHH
Q 002529          831 IESIWRIAEVAIQCVEQRGFSRPKMQ  856 (912)
Q Consensus       831 ~~~~~~l~~Li~~cL~~dP~~RPs~~  856 (912)
                       .....+.+++.+||+.+|++||++.
T Consensus       218 -~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         218 -NISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             -CCCHHHHHHHHHHhhcCHHhCCCCC
Confidence             1234688999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.4e-34  Score=303.07  Aligned_cols=268  Identities=21%  Similarity=0.273  Sum_probs=203.4

Q ss_pred             HHHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCccch--hhHHHHHHHHHHHhcCCCC-ccceeeEEecCC-----
Q 002529          589 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH--RTQQFVTEVALLSRIHHRN-LVPLIGYCEEEH-----  659 (912)
Q Consensus       589 ~~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~--~~~~~~~E~~il~~L~hpn-Iv~l~~~~~~~~-----  659 (912)
                      ...|...++||+|.||+||+|+.+ +|+.||+|+++-....  ......+|+.+|+.|+|+| |+++++++...+     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            445666788999999999999876 6899999998754331  2345689999999999999 999999998877     


Q ss_pred             -eEEEEEEecCCCCHHHHhccCCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeecc
Q 002529          660 -QRILVYEYMHNGTLRDRLHGSVNQ-KPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG  737 (912)
Q Consensus       660 -~~~lV~E~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFG  737 (912)
                       ..++|+||+ .-+|.+++...... ..++...++.++.||++||+|||+   ++|+||||||+|||++++|.+||+|||
T Consensus        90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccc
Confidence             789999999 56999999865321 467778999999999999999999   999999999999999999999999999


Q ss_pred             CccccccccccccccccCCCcccCCCccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCC
Q 002529          738 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD  816 (912)
Q Consensus       738 la~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  816 (912)
                      +|+...-.... ....++|..|+|||++.+. .|+...||||+||++.||++++.-|.+....+.....-.+.....+..
T Consensus       166 lAra~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~  244 (323)
T KOG0594|consen  166 LARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD  244 (323)
T ss_pred             hHHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence            99976543332 2334589999999998776 899999999999999999999999985544222111111111111111


Q ss_pred             ccccc---Cc--cccCCC-----CH---HHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002529          817 VISIV---DP--VLIGNV-----KI---ESIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       817 ~~~~~---d~--~l~~~~-----~~---~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  861 (912)
                      +....   +-  ......     ..   .......+++.+||+.+|.+|.|++.++++
T Consensus       245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            11111   10  000000     00   111367899999999999999999999875

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=7.9e-34  Score=309.48  Aligned_cols=257  Identities=25%  Similarity=0.384  Sum_probs=201.1

Q ss_pred             HHHHhhhcccCccccEEEEEEEec-CCC----EEEEEEccCccc-hhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEE
Q 002529          589 EATNNFCKKIGKGSFGSVYYGKMK-DGK----EVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI  662 (912)
Q Consensus       589 ~~~~~~~~~LG~G~fg~Vy~a~~~-~~~----~vAvK~l~~~~~-~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~  662 (912)
                      ...+++.+.||+|+||.||+|.+. +++    .+++|.+..... ....++..|+..++++.||||+++++++.. ...+
T Consensus         6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~   84 (279)
T cd05111           6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQ   84 (279)
T ss_pred             HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccE
Confidence            345667899999999999999875 344    478888754322 234567788889999999999999998864 4578


Q ss_pred             EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccc
Q 002529          663 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA  742 (912)
Q Consensus       663 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~  742 (912)
                      +++||+++|+|.+++...  ...+++..++.++.||+.||+|||+   ++++|+||||+||+++.++.+||+|||+++..
T Consensus        85 ~i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~  159 (279)
T cd05111          85 LVTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLL  159 (279)
T ss_pred             EEEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceec
Confidence            899999999999999743  4568999999999999999999998   99999999999999999999999999999765


Q ss_pred             ccccc-cccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhhhccCCcccc
Q 002529          743 EEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISI  820 (912)
Q Consensus       743 ~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  820 (912)
                      ..... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||.......   ..    ..+..+.... 
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~~----~~~~~~~~~~-  231 (279)
T cd05111         160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE---VP----DLLEKGERLA-  231 (279)
T ss_pred             cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HH----HHHHCCCcCC-
Confidence            43222 11223446778999999998899999999999999999998 999997432211   11    1122222111 


Q ss_pred             cCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhhhh
Q 002529          821 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK  867 (912)
Q Consensus       821 ~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~~~  867 (912)
                       .+.       .....+.+++.+||..+|++||++.|+++.|+.+..
T Consensus       232 -~~~-------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         232 -QPQ-------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             -CCC-------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence             111       112357889999999999999999999999988664

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=5.4e-34  Score=306.95  Aligned_cols=247  Identities=25%  Similarity=0.454  Sum_probs=195.9

Q ss_pred             ccCccccEEEEEEEec---CCCEEEEEEccCccc-hhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEecCCCC
Q 002529          597 KIGKGSFGSVYYGKMK---DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGT  672 (912)
Q Consensus       597 ~LG~G~fg~Vy~a~~~---~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~gs  672 (912)
                      .||+|+||.||+|.+.   .+..||+|++..... ...+.+.+|+.++++++||||+++++++.. ...++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence            4899999999999764   355799999876533 334678899999999999999999998864 46899999999999


Q ss_pred             HHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccccc--
Q 002529          673 LRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS--  750 (912)
Q Consensus       673 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~--  750 (912)
                      |.+++...  ...+++..++.++.|++.||+|||+   ++++||||||+||+++.++.+||+|||++...........  
T Consensus        81 L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  155 (257)
T cd05115          81 LNKFLSGK--KDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR  155 (257)
T ss_pred             HHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence            99998742  4578999999999999999999998   8999999999999999999999999999876543322111  


Q ss_pred             ccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCCC
Q 002529          751 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV  829 (912)
Q Consensus       751 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  829 (912)
                      ....++..|+|||.+.+..++.++||||||+++||+++ |+.||......   ....    .+..+...         ..
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~----~~~~~~~~---------~~  219 (257)
T cd05115         156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP---EVMS----FIEQGKRL---------DC  219 (257)
T ss_pred             CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH---HHHH----HHHCCCCC---------CC
Confidence            11223568999999988889999999999999999996 99999733221   1111    11111111         11


Q ss_pred             CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhh
Q 002529          830 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS  865 (912)
Q Consensus       830 ~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~  865 (912)
                      +.....++.+++.+||+.+|++||++.+|.+.|+..
T Consensus       220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            122345788999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.5e-34  Score=328.12  Aligned_cols=253  Identities=23%  Similarity=0.339  Sum_probs=198.5

Q ss_pred             HHHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc---chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEE
Q 002529          589 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV  664 (912)
Q Consensus       589 ~~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV  664 (912)
                      ...|++.+.||+|+||.||+++.+ +++.+|+|++....   ......+.+|+.+++.++||||+++++++.+++..++|
T Consensus        42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv  121 (370)
T cd05621          42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV  121 (370)
T ss_pred             HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence            456778899999999999999987 58899999986421   22345678899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccc
Q 002529          665 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE  744 (912)
Q Consensus       665 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~  744 (912)
                      |||+++|+|.+++..    ..+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||++.....
T Consensus       122 ~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~  194 (370)
T cd05621         122 MEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE  194 (370)
T ss_pred             EcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence            999999999999863    357889999999999999999998   9999999999999999999999999999987644


Q ss_pred             ccccccccccCCCcccCCCccCCC----CCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccc
Q 002529          745 DLTHISSVARGTVGYLDPEYYGNQ----QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI  820 (912)
Q Consensus       745 ~~~~~~~~~~gt~~y~APE~l~~~----~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  820 (912)
                      ..........||+.|+|||++.+.    .++.++||||+||++|||++|+.||......      ...............
T Consensus       195 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~------~~~~~i~~~~~~~~~  268 (370)
T cd05621         195 TGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV------GTYSKIMDHKNSLNF  268 (370)
T ss_pred             CCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCcccCC
Confidence            332223345689999999998654    3788999999999999999999999743321      111111111111110


Q ss_pred             cCccccCCCCHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 002529          821 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFS--RPKMQEIVLA  861 (912)
Q Consensus       821 ~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~--RPs~~evl~~  861 (912)
                      .+       .......+.+++.+||+.++.+  |++++|+++.
T Consensus       269 p~-------~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         269 PE-------DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             CC-------cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            00       1112346778899999865543  8899999875

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=3.6e-34  Score=307.27  Aligned_cols=251  Identities=30%  Similarity=0.522  Sum_probs=202.2

Q ss_pred             HHhhhcccCccccEEEEEEEecCCCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEecCC
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN  670 (912)
Q Consensus       591 ~~~~~~~LG~G~fg~Vy~a~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~  670 (912)
                      .+++.+.||+|+||.||+|.+.+++.+|+|.++.... ....+.+|++++++++|||++++++++......++|+||+++
T Consensus         5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   83 (256)
T cd05112           5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH   83 (256)
T ss_pred             HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence            4567899999999999999988788999999875422 345788999999999999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccccc
Q 002529          671 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS  750 (912)
Q Consensus       671 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~  750 (912)
                      ++|.+++...  ...+++..++.++.|++.||++||+   .+++|+||||+||+++.++.++|+|||++...........
T Consensus        84 ~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~  158 (256)
T cd05112          84 GCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS  158 (256)
T ss_pred             CcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence            9999998743  3467899999999999999999998   8999999999999999999999999999876543322212


Q ss_pred             ccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCCC
Q 002529          751 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV  829 (912)
Q Consensus       751 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  829 (912)
                      ....++..|+|||.+.+..++.++||||||+++|||++ |+.||......   ...+.    +..+.  ....+..    
T Consensus       159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~~~----~~~~~--~~~~~~~----  225 (256)
T cd05112         159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS---EVVET----INAGF--RLYKPRL----  225 (256)
T ss_pred             CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH---HHHHH----HhCCC--CCCCCCC----
Confidence            22234678999999998899999999999999999998 99999733221   11111    11111  0111111    


Q ss_pred             CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 002529          830 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ  863 (912)
Q Consensus       830 ~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  863 (912)
                         ....+.+++.+||+.+|++||++.|+++.|.
T Consensus       226 ---~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         226 ---ASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             ---CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence               2347889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.2e-33  Score=307.89  Aligned_cols=248  Identities=25%  Similarity=0.361  Sum_probs=196.3

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc-chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEecC
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH  669 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~  669 (912)
                      +++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++.+...+..++||||++
T Consensus         3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   82 (279)
T cd06619           3 IQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMD   82 (279)
T ss_pred             chheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCC
Confidence            466789999999999999865 68899999986542 3344678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccccc
Q 002529          670 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI  749 (912)
Q Consensus       670 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~  749 (912)
                      +++|..+.       .+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||++.......   
T Consensus        83 ~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~---  149 (279)
T cd06619          83 GGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI---  149 (279)
T ss_pred             CCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---
Confidence            99996542       36788899999999999999998   999999999999999999999999999987654322   


Q ss_pred             cccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchh-hHHHHHHhhhccCCcccccCccccCC
Q 002529          750 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL-NIVHWARSMIKKGDVISIVDPVLIGN  828 (912)
Q Consensus       750 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~~~  828 (912)
                      .....++..|+|||++.+..++.++||||||+++|+|++|+.||......... ........... ...     +.+.  
T Consensus       150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~-----~~~~--  221 (279)
T cd06619         150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVD-EDP-----PVLP--  221 (279)
T ss_pred             ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhc-cCC-----CCCC--
Confidence            22345889999999999889999999999999999999999999743221111 11111111111 110     1110  


Q ss_pred             CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002529          829 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       829 ~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  861 (912)
                       .......+.+++.+||+.+|++||+++|+++.
T Consensus       222 -~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         222 -VGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             -CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence             11122368899999999999999999999864

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.2e-34  Score=305.97  Aligned_cols=248  Identities=29%  Similarity=0.452  Sum_probs=198.0

Q ss_pred             cccCccccEEEEEEEecC----CCEEEEEEccCccc-hhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEecCC
Q 002529          596 KKIGKGSFGSVYYGKMKD----GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN  670 (912)
Q Consensus       596 ~~LG~G~fg~Vy~a~~~~----~~~vAvK~l~~~~~-~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~  670 (912)
                      ++||+|+||.||+|.+..    +..+|+|.+..... ...+++.+|+++++++.|+||+++++++.. +..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence            579999999999997542    26899999876543 345678999999999999999999998764 467999999999


Q ss_pred             CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccccc
Q 002529          671 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS  750 (912)
Q Consensus       671 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~  750 (912)
                      ++|.+++..   ...+++..++.++.|++.||+|||.   .+++|+||||+||+++.++.+||+|||++...........
T Consensus        80 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~  153 (257)
T cd05060          80 GPLLKYLKK---RREIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR  153 (257)
T ss_pred             CcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence            999999984   3478999999999999999999998   8999999999999999999999999999987644332211


Q ss_pred             c--cccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhhhccCCcccccCccccC
Q 002529          751 S--VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG  827 (912)
Q Consensus       751 ~--~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  827 (912)
                      .  ...++..|+|||.+.+..++.++||||||+++|+|++ |+.||.....   ......+    ..+....        
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~~----~~~~~~~--------  218 (257)
T cd05060         154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAML----ESGERLP--------  218 (257)
T ss_pred             cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHH----HcCCcCC--------
Confidence            1  1123467999999998899999999999999999998 9999973322   1222222    1111111        


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhhh
Q 002529          828 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI  866 (912)
Q Consensus       828 ~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~~  866 (912)
                       .+...+..+.+++.+||+.+|++||++.+|++.|+++.
T Consensus       219 -~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         219 -RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             -CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence             11122347889999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=9.7e-34  Score=306.11  Aligned_cols=253  Identities=23%  Similarity=0.363  Sum_probs=201.5

Q ss_pred             HHHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEe
Q 002529          589 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY  667 (912)
Q Consensus       589 ~~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  667 (912)
                      ...|++.+.||+|+||.||+|... +++.||+|.++.........+.+|+.+++.++||||+++++.+...+..++||||
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~   87 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF   87 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence            457888999999999999999875 6889999998765555556788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccc
Q 002529          668 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT  747 (912)
Q Consensus       668 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~  747 (912)
                      +++++|.+++..   ...+++.+++.++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||++........
T Consensus        88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd06645          88 CGGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA  161 (267)
T ss_pred             cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence            999999999873   4578999999999999999999998   8999999999999999999999999999876543222


Q ss_pred             cccccccCCCcccCCCccC---CCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCcc
Q 002529          748 HISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV  824 (912)
Q Consensus       748 ~~~~~~~gt~~y~APE~l~---~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  824 (912)
                      . .....|+..|+|||++.   ...++.++|||||||++|+|++|+.||.......  .....    .. ...   ..+.
T Consensus       162 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~--~~~~~----~~-~~~---~~~~  230 (267)
T cd06645         162 K-RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR--ALFLM----TK-SNF---QPPK  230 (267)
T ss_pred             c-cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh--hHHhh----hc-cCC---CCCc
Confidence            1 22345889999999874   4568899999999999999999999986322111  11110    00 000   0011


Q ss_pred             ccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          825 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       825 l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                      ...  .......+.+++.+||+.+|++||++++|++
T Consensus       231 ~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         231 LKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             ccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            110  0012236789999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=3.5e-34  Score=310.07  Aligned_cols=256  Identities=26%  Similarity=0.470  Sum_probs=203.4

Q ss_pred             HHHhhhcccCccccEEEEEEEecC-C---CEEEEEEccCcc-chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEE
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMKD-G---KEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV  664 (912)
Q Consensus       590 ~~~~~~~~LG~G~fg~Vy~a~~~~-~---~~vAvK~l~~~~-~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV  664 (912)
                      ..+++.+.||+|+||.||+|.++. +   ..||+|.++... ......+..|+.++++++||||+++++++.++...++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            456778999999999999998763 3   369999987542 33456899999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccc
Q 002529          665 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE  744 (912)
Q Consensus       665 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~  744 (912)
                      |||+++++|.+++...  ...+++.+++.++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||++.....
T Consensus        84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          84 TEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             EecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCcccccccc
Confidence            9999999999998753  4568999999999999999999998   9999999999999999999999999999876543


Q ss_pred             ccccc--ccccc--CCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhhhccCCccc
Q 002529          745 DLTHI--SSVAR--GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVIS  819 (912)
Q Consensus       745 ~~~~~--~~~~~--gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  819 (912)
                      .....  .....  .+..|+|||++.+..++.++|||||||++||+++ |..||.....   .....++..   ....  
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~---~~~~~~i~~---~~~~--  230 (269)
T cd05065         159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN---QDVINAIEQ---DYRL--  230 (269)
T ss_pred             CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH---HHHHHHHHc---CCcC--
Confidence            22111  11111  2357999999999999999999999999999886 9999963322   122222211   0000  


Q ss_pred             ccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhhh
Q 002529          820 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI  866 (912)
Q Consensus       820 ~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~~  866 (912)
                              ..+...+..+.+++.+||+.+|++||++++|+..|++++
T Consensus       231 --------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~  269 (269)
T cd05065         231 --------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI  269 (269)
T ss_pred             --------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence                    001122346889999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=9.7e-34  Score=311.42  Aligned_cols=264  Identities=24%  Similarity=0.401  Sum_probs=202.9

Q ss_pred             HHHHhhhcccCccccEEEEEEEec-----------------CCCEEEEEEccCcc-chhhHHHHHHHHHHHhcCCCCccc
Q 002529          589 EATNNFCKKIGKGSFGSVYYGKMK-----------------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVP  650 (912)
Q Consensus       589 ~~~~~~~~~LG~G~fg~Vy~a~~~-----------------~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~L~hpnIv~  650 (912)
                      ...|++.++||+|+||.||++...                 +...||+|+++... ......+.+|+++++.++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            456788899999999999998643                 23468999987543 334567899999999999999999


Q ss_pred             eeeEEecCCeEEEEEEecCCCCHHHHhccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 002529          651 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSV--------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN  722 (912)
Q Consensus       651 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~N  722 (912)
                      +++++..++..++||||+++++|.+++....        ....+++..+..++.|++.||+|||+   .+++|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~N  160 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhe
Confidence            9999999999999999999999999987532        12347788999999999999999998   899999999999


Q ss_pred             ccccCCCcEEEeeccCcccccccccc-ccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh--CCCCCCccCcc
Q 002529          723 ILLDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS--GKKPVSVEDFG  799 (912)
Q Consensus       723 ILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt--G~~Pf~~~~~~  799 (912)
                      |+++.++.++|+|||++......... ......++..|+|||...+..++.++|||||||++|||++  |..||......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE  240 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence            99999999999999998765332211 1122234678999999888889999999999999999998  77888633322


Q ss_pred             chhhHHHHHHhhhccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhh
Q 002529          800 AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD  864 (912)
Q Consensus       800 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~  864 (912)
                      .   .................. +     .+...+..+.+++.+||+.+|++||++.||++.|++
T Consensus       241 ~---~~~~~~~~~~~~~~~~~~-~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         241 Q---VIENTGEFFRDQGRQVYL-P-----KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             H---HHHHHHHHHhhccccccC-C-----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            1   111111111111100000 0     011223578899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=3e-34  Score=319.82  Aligned_cols=240  Identities=25%  Similarity=0.347  Sum_probs=192.3

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc---chhhHHHHHHHHHHHhc-CCCCccceeeEEecCCeEEEEEE
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYE  666 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~L-~hpnIv~l~~~~~~~~~~~lV~E  666 (912)
                      |++.+.||+|+||.||+|..+ +++.||+|+++...   ......+..|..++..+ +|++|+++++++...+..++|||
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (323)
T cd05616           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME   81 (323)
T ss_pred             ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence            456789999999999999877 57899999987532   22334567788888877 58999999999999999999999


Q ss_pred             ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccc
Q 002529          667 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL  746 (912)
Q Consensus       667 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~  746 (912)
                      |+++|+|.+.+..   ...+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++.......
T Consensus        82 ~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~  155 (323)
T cd05616          82 YVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG  155 (323)
T ss_pred             CCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence            9999999998873   4568999999999999999999998   999999999999999999999999999987543221


Q ss_pred             ccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCcccc
Q 002529          747 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI  826 (912)
Q Consensus       747 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  826 (912)
                      . ......|++.|+|||++.+..++.++|||||||++|||++|+.||......   ...+.+   . ....         
T Consensus       156 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---~~~~~i---~-~~~~---------  218 (323)
T cd05616         156 V-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELFQSI---M-EHNV---------  218 (323)
T ss_pred             C-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH---HHHHHH---H-hCCC---------
Confidence            1 122345899999999999999999999999999999999999999743321   111111   1 1111         


Q ss_pred             CCCCHHHHHHHHHHHHhcccCCCCCCCCH
Q 002529          827 GNVKIESIWRIAEVAIQCVEQRGFSRPKM  855 (912)
Q Consensus       827 ~~~~~~~~~~l~~Li~~cL~~dP~~RPs~  855 (912)
                       ..+.....++.+++.+||+.+|++|++.
T Consensus       219 -~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         219 -AYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             -CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence             0111223478899999999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.2e-33  Score=316.41  Aligned_cols=267  Identities=25%  Similarity=0.455  Sum_probs=210.4

Q ss_pred             hHHHHHHHhhhcccCccccEEEEEEEecC--------CCEEEEEEccCcc-chhhHHHHHHHHHHHhc-CCCCccceeeE
Q 002529          585 PELEEATNNFCKKIGKGSFGSVYYGKMKD--------GKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGY  654 (912)
Q Consensus       585 ~~l~~~~~~~~~~LG~G~fg~Vy~a~~~~--------~~~vAvK~l~~~~-~~~~~~~~~E~~il~~L-~hpnIv~l~~~  654 (912)
                      -++...+|++.+.||+|+||.||+|....        +..||+|.++... ....+.+.+|+++++++ +||||++++++
T Consensus         7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~   86 (334)
T cd05100           7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGA   86 (334)
T ss_pred             cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence            35667788999999999999999997531        2368999887543 33456889999999999 79999999999


Q ss_pred             EecCCeEEEEEEecCCCCHHHHhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 002529          655 CEEEHQRILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSS  721 (912)
Q Consensus       655 ~~~~~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~  721 (912)
                      +..++..++++||+++|+|.+++....             ....+++.+++.++.|++.||+|||+   ++++||||||+
T Consensus        87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~  163 (334)
T cd05100          87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAAR  163 (334)
T ss_pred             EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccc
Confidence            999999999999999999999987532             23357889999999999999999998   99999999999


Q ss_pred             CccccCCCcEEEeeccCccccccccccc-cccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcc
Q 002529          722 NILLDINMRAKVSDFGLSRQAEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFG  799 (912)
Q Consensus       722 NILl~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~  799 (912)
                      ||+++.++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||......
T Consensus       164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~  243 (334)
T cd05100         164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE  243 (334)
T ss_pred             eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence            9999999999999999987654322111 111224567999999999999999999999999999998 88888643221


Q ss_pred             chhhHHHHHHhhhccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhhhhhcc
Q 002529          800 AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK  870 (912)
Q Consensus       800 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~~~~~~  870 (912)
                         ....    .+..+....         .+......+.+++.+||+.+|++||++.|+++.|+++.....
T Consensus       244 ---~~~~----~~~~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~  298 (334)
T cd05100         244 ---ELFK----LLKEGHRMD---------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS  298 (334)
T ss_pred             ---HHHH----HHHcCCCCC---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence               1111    111111111         111223478899999999999999999999999999885443

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=9.2e-34  Score=314.50  Aligned_cols=265  Identities=25%  Similarity=0.448  Sum_probs=208.2

Q ss_pred             HHHHHHhhhcccCccccEEEEEEEec--------CCCEEEEEEccCcc-chhhHHHHHHHHHHHhc-CCCCccceeeEEe
Q 002529          587 LEEATNNFCKKIGKGSFGSVYYGKMK--------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCE  656 (912)
Q Consensus       587 l~~~~~~~~~~LG~G~fg~Vy~a~~~--------~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~L-~hpnIv~l~~~~~  656 (912)
                      +...++.+.++||+|+||.||+|+..        ....+|+|.++... ......+.+|+++++++ +||||+++++++.
T Consensus         9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (314)
T cd05099           9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT   88 (314)
T ss_pred             ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence            34566778899999999999999752        24579999987543 33456788999999999 6999999999999


Q ss_pred             cCCeEEEEEEecCCCCHHHHhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCc
Q 002529          657 EEHQRILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNI  723 (912)
Q Consensus       657 ~~~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NI  723 (912)
                      .....+++|||+++|+|.+++....             ....+++.++..++.|++.||+|||+   ++++||||||+||
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Ni  165 (314)
T cd05099          89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNV  165 (314)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeE
Confidence            9899999999999999999997532             12458899999999999999999998   9999999999999


Q ss_pred             cccCCCcEEEeeccCcccccccccc-ccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccch
Q 002529          724 LLDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAE  801 (912)
Q Consensus       724 Ll~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~  801 (912)
                      +++.++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |..||......  
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--  243 (314)
T cd05099         166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE--  243 (314)
T ss_pred             EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH--
Confidence            9999999999999999865432211 1111224467999999998899999999999999999999 89998633221  


Q ss_pred             hhHHHHHHhhhccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhhhhhcc
Q 002529          802 LNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK  870 (912)
Q Consensus       802 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~~~~~~  870 (912)
                       ....    .+..+....         .+......+.+++.+||+.+|++||++.|+++.|+++.....
T Consensus       244 -~~~~----~~~~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~  298 (314)
T cd05099         244 -ELFK----LLREGHRMD---------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVS  298 (314)
T ss_pred             -HHHH----HHHcCCCCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhc
Confidence             1111    111111111         111223478899999999999999999999999998876543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2e-34  Score=321.47  Aligned_cols=243  Identities=26%  Similarity=0.362  Sum_probs=190.1

Q ss_pred             cccCccccEEEEEEEec-CCCEEEEEEccCccc---hhhHHHHHHH-HHHHhcCCCCccceeeEEecCCeEEEEEEecCC
Q 002529          596 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEV-ALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN  670 (912)
Q Consensus       596 ~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~-~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~  670 (912)
                      +.||+|+||+||+|+.+ +++.||+|++.....   .....+..|. .+++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999877 578899999865321   2223444444 456788999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccccc
Q 002529          671 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS  750 (912)
Q Consensus       671 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~  750 (912)
                      ++|.+++..   ...+.+..+..++.||++||+|||+   .+|+||||||+|||++.++.+||+|||++........ ..
T Consensus        81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~~  153 (325)
T cd05602          81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-TT  153 (325)
T ss_pred             CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-Cc
Confidence            999999973   4568888899999999999999998   9999999999999999999999999999875432211 12


Q ss_pred             ccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCCCC
Q 002529          751 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK  830 (912)
Q Consensus       751 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  830 (912)
                      ....|++.|+|||++.+..++.++|||||||++|+|++|+.||......   ..   ...... ...      .    ..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~---~~~i~~-~~~------~----~~  216 (325)
T cd05602         154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---EM---YDNILN-KPL------Q----LK  216 (325)
T ss_pred             ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH---HH---HHHHHh-CCc------C----CC
Confidence            3345899999999999999999999999999999999999999743221   11   111111 110      0    11


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 002529          831 IESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI  862 (912)
Q Consensus       831 ~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  862 (912)
                      ......+.+++.+||+.+|.+||++.+.+..+
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i  248 (325)
T cd05602         217 PNITNSARHLLEGLLQKDRTKRLGAKDDFMEI  248 (325)
T ss_pred             CCCCHHHHHHHHHHcccCHHHCCCCCCCHHHH
Confidence            12234688999999999999999987544433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=7.5e-34  Score=304.60  Aligned_cols=249  Identities=34%  Similarity=0.544  Sum_probs=203.5

Q ss_pred             cccCccccEEEEEEEecC----CCEEEEEEccCccchh-hHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEecCC
Q 002529          596 KKIGKGSFGSVYYGKMKD----GKEVAVKIMADSCSHR-TQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN  670 (912)
Q Consensus       596 ~~LG~G~fg~Vy~a~~~~----~~~vAvK~l~~~~~~~-~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~  670 (912)
                      +.||+|+||.||+|....    +..|++|.++...... .+.+.+|+++++.++|+||+++++++......++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            479999999999998764    7889999997654433 67889999999999999999999999999999999999999


Q ss_pred             CCHHHHhccCCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccc
Q 002529          671 GTLRDRLHGSVN------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE  744 (912)
Q Consensus       671 gsL~~~l~~~~~------~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~  744 (912)
                      ++|.+++.....      ...+++..++.++.|++.||+|||+   ++++|+||||+||+++.++.++|+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence            999999985421      3779999999999999999999998   9999999999999999999999999999987654


Q ss_pred             ccc-cccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhhhccCCcccccC
Q 002529          745 DLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD  822 (912)
Q Consensus       745 ~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  822 (912)
                      ... .......++..|+|||.+.+..++.++||||+|+++|+|++ |..||.....   ....+.+.    .+...    
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~----~~~~~----  226 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN---EEVLEYLR----KGYRL----  226 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHH----cCCCC----
Confidence            321 11223446889999999988889999999999999999999 6999974422   11222111    11110    


Q ss_pred             ccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 002529          823 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ  863 (912)
Q Consensus       823 ~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  863 (912)
                           ..+......+.+++.+||+.+|++||++.|+++.|+
T Consensus       227 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         227 -----PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             -----CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                 111122457889999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.7e-34  Score=322.08  Aligned_cols=241  Identities=28%  Similarity=0.392  Sum_probs=190.3

Q ss_pred             cccCccccEEEEEEEec-CCCEEEEEEccCcc---chhhHHHHHHHH-HHHhcCCCCccceeeEEecCCeEEEEEEecCC
Q 002529          596 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVA-LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN  670 (912)
Q Consensus       596 ~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~-il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~  670 (912)
                      +.||+|+||.||+|+.+ +|+.||+|++....   ......+..|.. +++.++||||+++++.+..++..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999876 68999999986532   123344555555 46778999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccccc
Q 002529          671 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS  750 (912)
Q Consensus       671 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~  750 (912)
                      |+|.+++.   ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++........ ..
T Consensus        81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~  153 (325)
T cd05604          81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-TT  153 (325)
T ss_pred             CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-Cc
Confidence            99999887   35678999999999999999999998   9999999999999999999999999999875322211 12


Q ss_pred             ccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCCCC
Q 002529          751 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK  830 (912)
Q Consensus       751 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  830 (912)
                      ....|++.|+|||++.+..++.++|||||||++|||++|+.||...+..      +....... +..      .+..   
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~------~~~~~~~~-~~~------~~~~---  217 (325)
T cd05604         154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA------EMYDNILH-KPL------VLRP---  217 (325)
T ss_pred             ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH------HHHHHHHc-CCc------cCCC---
Confidence            2345899999999999999999999999999999999999999743321      11111111 110      0111   


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          831 IESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       831 ~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                       .....+.+++.+||+.+|++||++++.++
T Consensus       218 -~~~~~~~~ll~~ll~~~p~~R~~~~~~~~  246 (325)
T cd05604         218 -GASLTAWSILEELLEKDRQRRLGAKEDFL  246 (325)
T ss_pred             -CCCHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence             12346789999999999999998864433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-34  Score=319.03  Aligned_cols=252  Identities=27%  Similarity=0.385  Sum_probs=210.4

Q ss_pred             HHHHHhhhcccCccccEEEEEEEecC-CCEEEEEEccCccch---hhHHHHHHHHHHHhcC-CCCccceeeEEecCCeEE
Q 002529          588 EEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSH---RTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRI  662 (912)
Q Consensus       588 ~~~~~~~~~~LG~G~fg~Vy~a~~~~-~~~vAvK~l~~~~~~---~~~~~~~E~~il~~L~-hpnIv~l~~~~~~~~~~~  662 (912)
                      ....|++.+.||+|.||.||+++.+. |+.+|+|.+.+....   ....+.+|+++|+++. ||||+.+.+++++....+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            45567788999999999999999885 999999999765432   3468999999999998 999999999999999999


Q ss_pred             EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccC----CCcEEEeeccC
Q 002529          663 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI----NMRAKVSDFGL  738 (912)
Q Consensus       663 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~----~~~vkL~DFGl  738 (912)
                      +|||++.||.|.+.+...    .+++.....++.|++.+++|||+   .||+||||||+|+|+..    ++.+|++|||+
T Consensus       113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl  185 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGL  185 (382)
T ss_pred             EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence            999999999999999854    39999999999999999999998   99999999999999953    35799999999


Q ss_pred             ccccccccccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcc
Q 002529          739 SRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI  818 (912)
Q Consensus       739 a~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  818 (912)
                      +.....  .......+||+.|+|||++....++..+||||+|+++|.|++|..||.+........       .+..++. 
T Consensus       186 a~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------~i~~~~~-  255 (382)
T KOG0032|consen  186 AKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------AILRGDF-  255 (382)
T ss_pred             ceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------HHHcCCC-
Confidence            998776  333455679999999999999999999999999999999999999998554322111       2222222 


Q ss_pred             cccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002529          819 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       819 ~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  861 (912)
                      +     +....-......+.+++.+|+..||.+|+|+.++++.
T Consensus       256 ~-----f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  256 D-----FTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             C-----CCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence            1     1111122334578899999999999999999999983

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.3e-34  Score=329.62  Aligned_cols=250  Identities=22%  Similarity=0.284  Sum_probs=195.0

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc---chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEe
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY  667 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  667 (912)
                      |++.+.||+|+||.||+|+.+ +++.||+|++....   ......+.+|++++++++||||+++++.+.+++..++||||
T Consensus         3 y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~   82 (376)
T cd05598           3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY   82 (376)
T ss_pred             ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeC
Confidence            567789999999999999876 58999999986432   12345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccc-
Q 002529          668 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-  746 (912)
Q Consensus       668 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~-  746 (912)
                      +++|+|.+++..   ...+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++..+.... 
T Consensus        83 ~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~  156 (376)
T cd05598          83 IPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (376)
T ss_pred             CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence            999999999973   4568899999999999999999998   999999999999999999999999999975321000 


Q ss_pred             -----------------------------------------ccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHH
Q 002529          747 -----------------------------------------THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLE  785 (912)
Q Consensus       747 -----------------------------------------~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~e  785 (912)
                                                               ........||+.|+|||++.+..++.++|||||||++||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye  236 (376)
T cd05598         157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE  236 (376)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence                                                     000112358999999999999999999999999999999


Q ss_pred             HHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCC---CHHHHHHH
Q 002529          786 LISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP---KMQEIVLA  861 (912)
Q Consensus       786 LltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP---s~~evl~~  861 (912)
                      |++|+.||......+.      .............  +.     .......+.+++.+|+ .+|.+|+   ++.|+++.
T Consensus       237 ll~G~~Pf~~~~~~~~------~~~i~~~~~~~~~--~~-----~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         237 MLVGQPPFLADTPAET------QLKVINWETTLHI--PS-----QAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             hhhCCCCCCCCCHHHH------HHHHhccCccccC--CC-----CCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            9999999974432211      1111110000000  00     0112235677888876 5999999   89999865

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.2e-34  Score=303.21  Aligned_cols=248  Identities=32%  Similarity=0.472  Sum_probs=199.9

Q ss_pred             cccCccccEEEEEEEecCCCEEEEEEccCccch-hhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEecCCCCHH
Q 002529          596 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLR  674 (912)
Q Consensus       596 ~~LG~G~fg~Vy~a~~~~~~~vAvK~l~~~~~~-~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~  674 (912)
                      ++||+|++|.||++..++++.|++|.+...... ....+.+|++++++++|+||+++++++.+....++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            479999999999999877999999998765433 4567899999999999999999999999999999999999999999


Q ss_pred             HHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccccc-ccc
Q 002529          675 DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS-SVA  753 (912)
Q Consensus       675 ~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~-~~~  753 (912)
                      +++...  ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.++|+|||++........... ...
T Consensus        81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence            998743  3468899999999999999999998   8999999999999999999999999999876543221111 112


Q ss_pred             cCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCCCCHH
Q 002529          754 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE  832 (912)
Q Consensus       754 ~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  832 (912)
                      ..+..|+|||.+.+..++.++|+||||+++|||++ |..||......   .....    +..+..         ...+..
T Consensus       156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~---~~~~~----~~~~~~---------~~~~~~  219 (251)
T cd05041         156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ---QTRER----IESGYR---------MPAPQL  219 (251)
T ss_pred             cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH---HHHHH----HhcCCC---------CCCCcc
Confidence            23567999999988899999999999999999999 88888633221   11111    111100         001112


Q ss_pred             HHHHHHHHHHhcccCCCCCCCCHHHHHHHHhh
Q 002529          833 SIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD  864 (912)
Q Consensus       833 ~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~  864 (912)
                      .+..+.+++.+||+.+|.+||++.||++.|+.
T Consensus       220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~  251 (251)
T cd05041         220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQI  251 (251)
T ss_pred             CCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence            23478899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=6.5e-34  Score=309.83  Aligned_cols=261  Identities=25%  Similarity=0.413  Sum_probs=204.6

Q ss_pred             HHHHHHhhhcccCccccEEEEEEEec-CCC----EEEEEEccCcc-chhhHHHHHHHHHHHhcCCCCccceeeEEecCCe
Q 002529          587 LEEATNNFCKKIGKGSFGSVYYGKMK-DGK----EVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ  660 (912)
Q Consensus       587 l~~~~~~~~~~LG~G~fg~Vy~a~~~-~~~----~vAvK~l~~~~-~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~  660 (912)
                      +....+++.++||+|+||+||+|++. +++    .||+|+++... ......+.+|+.+++.++||||+++++++... .
T Consensus         4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~   82 (279)
T cd05109           4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-T   82 (279)
T ss_pred             cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-C
Confidence            34456677899999999999999864 444    48999987543 33456788999999999999999999999764 4


Q ss_pred             EEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcc
Q 002529          661 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR  740 (912)
Q Consensus       661 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~  740 (912)
                      .++++||+++|+|.++++..  ...+++..++.++.|++.||+|||+   ++++||||||+||++++++.+||+|||+++
T Consensus        83 ~~l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~  157 (279)
T cd05109          83 VQLVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLAR  157 (279)
T ss_pred             cEEEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCcee
Confidence            67999999999999999743  4568999999999999999999998   999999999999999999999999999998


Q ss_pred             ccccccccc-cccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhhhccCCcc
Q 002529          741 QAEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVI  818 (912)
Q Consensus       741 ~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  818 (912)
                      ......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.....   ..+..++    ..+...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~----~~~~~~  230 (279)
T cd05109         158 LLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA---REIPDLL----EKGERL  230 (279)
T ss_pred             ecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHH----HCCCcC
Confidence            764322211 111234678999999988899999999999999999998 9999873322   1122222    111111


Q ss_pred             cccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhhhhhc
Q 002529          819 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE  869 (912)
Q Consensus       819 ~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~~~~~  869 (912)
                      .         .+......+.+++.+||+.||++||++.|+++.|+++....
T Consensus       231 ~---------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         231 P---------QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             C---------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence            1         01122347889999999999999999999999998775543

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1e-33  Score=311.42  Aligned_cols=249  Identities=24%  Similarity=0.376  Sum_probs=202.2

Q ss_pred             HHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEec
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM  668 (912)
Q Consensus       590 ~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~  668 (912)
                      .+|++.+.||+|++|.||+|... +++.|++|.+..........+.+|+.+++.++|+||+++++.+..+...++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            46677889999999999999865 68999999987655555677889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccc
Q 002529          669 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH  748 (912)
Q Consensus       669 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  748 (912)
                      ++++|.+++..    ..+++.++..++.|++.||+|||+   .+++||||||+||+++.++.++|+|||++.........
T Consensus       100 ~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~  172 (296)
T cd06654         100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  172 (296)
T ss_pred             CCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhccccccc
Confidence            99999999863    457899999999999999999998   99999999999999999999999999998765432211


Q ss_pred             ccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCC
Q 002529          749 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN  828 (912)
Q Consensus       749 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  828 (912)
                       .....+++.|+|||.+.+..++.++|||||||++|+|++|+.||.......  .+..    ....+. ...       .
T Consensus       173 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~--~~~~----~~~~~~-~~~-------~  237 (296)
T cd06654         173 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--ALYL----IATNGT-PEL-------Q  237 (296)
T ss_pred             -cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH--hHHH----HhcCCC-CCC-------C
Confidence             123357889999999988888999999999999999999999997332211  1111    111110 000       0


Q ss_pred             CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          829 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       829 ~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                      .+......+.+++.+||..+|++||+++|+++
T Consensus       238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             CccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence            11223346889999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.2e-33  Score=317.60  Aligned_cols=264  Identities=27%  Similarity=0.450  Sum_probs=204.3

Q ss_pred             HHHHHHhhhcccCccccEEEEEEEe------cCCCEEEEEEccCccc-hhhHHHHHHHHHHHhc-CCCCccceeeEEec-
Q 002529          587 LEEATNNFCKKIGKGSFGSVYYGKM------KDGKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEE-  657 (912)
Q Consensus       587 l~~~~~~~~~~LG~G~fg~Vy~a~~------~~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~L-~hpnIv~l~~~~~~-  657 (912)
                      +...+|++.+.||+|+||.||+|.+      .+++.||||+++.... .....+.+|+.++.++ +||||+++++++.. 
T Consensus         4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (343)
T cd05103           4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP   83 (343)
T ss_pred             cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence            3456788999999999999999974      2478899999975432 3346788999999999 68999999998865 


Q ss_pred             CCeEEEEEEecCCCCHHHHhccCCC-------------------------------------------------------
Q 002529          658 EHQRILVYEYMHNGTLRDRLHGSVN-------------------------------------------------------  682 (912)
Q Consensus       658 ~~~~~lV~E~~~~gsL~~~l~~~~~-------------------------------------------------------  682 (912)
                      +...+++|||+++|+|.+++.....                                                       
T Consensus        84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (343)
T cd05103          84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE  163 (343)
T ss_pred             CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence            4567899999999999999864210                                                       


Q ss_pred             ---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccc-cccc
Q 002529          683 ---------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH-ISSV  752 (912)
Q Consensus       683 ---------~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~  752 (912)
                               ...+++..+..++.||++||+|||+   ++|+||||||+||+++.++.+||+|||++......... ....
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  240 (343)
T cd05103         164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD  240 (343)
T ss_pred             hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence                     1246788889999999999999998   99999999999999999999999999998765332211 1122


Q ss_pred             ccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCCCCH
Q 002529          753 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI  831 (912)
Q Consensus       753 ~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  831 (912)
                      ..++..|+|||.+.+..++.++||||||+++|+|++ |..||.......  ...    ..+..+.....  +       .
T Consensus       241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~----~~~~~~~~~~~--~-------~  305 (343)
T cd05103         241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFC----RRLKEGTRMRA--P-------D  305 (343)
T ss_pred             CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--HHH----HHHhccCCCCC--C-------C
Confidence            335678999999988899999999999999999997 999986432211  111    11112211110  0       0


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhhhhh
Q 002529          832 ESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI  868 (912)
Q Consensus       832 ~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~~~~  868 (912)
                      .....+.+++.+||+.+|++||++.||++.|+.+++.
T Consensus       306 ~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~  342 (343)
T cd05103         306 YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  342 (343)
T ss_pred             CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            1123688999999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=3e-33  Score=305.11  Aligned_cols=251  Identities=22%  Similarity=0.360  Sum_probs=199.9

Q ss_pred             HHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEec
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM  668 (912)
Q Consensus       590 ~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~  668 (912)
                      +-|++.+.||+|+||.||+|... ++..+++|.+..........+.+|+++++.++||||+++++++..++..++|+||+
T Consensus         5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~   84 (282)
T cd06643           5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   84 (282)
T ss_pred             HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence            33677899999999999999887 47788999987655555677889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccc
Q 002529          669 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH  748 (912)
Q Consensus       669 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  748 (912)
                      ++++|..++..  ....+++..+..++.|+++||+|||+   .+++||||||+||+++.++.++|+|||++........ 
T Consensus        85 ~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-  158 (282)
T cd06643          85 AGGAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-  158 (282)
T ss_pred             CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEcccccccccccccc-
Confidence            99999988764  24578999999999999999999998   9999999999999999999999999999876533222 


Q ss_pred             ccccccCCCcccCCCccC-----CCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCc
Q 002529          749 ISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP  823 (912)
Q Consensus       749 ~~~~~~gt~~y~APE~l~-----~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  823 (912)
                      ......++..|+|||++.     +..++.++|||||||++|+|++|+.||......  .....    ... ........ 
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~----~~~-~~~~~~~~-  230 (282)
T cd06643         159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM--RVLLK----IAK-SEPPTLAQ-  230 (282)
T ss_pred             ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH--HHHHH----Hhh-cCCCCCCC-
Confidence            122345788999999974     445778999999999999999999999733211  11111    111 11101111 


Q ss_pred             cccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          824 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       824 ~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                            +......+.+++.+||+.+|.+||++.++++
T Consensus       231 ------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         231 ------PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             ------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                  1112347889999999999999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2.1e-33  Score=301.57  Aligned_cols=248  Identities=29%  Similarity=0.432  Sum_probs=199.8

Q ss_pred             cccCccccEEEEEEEecC--C--CEEEEEEccCccc-hhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEecCC
Q 002529          596 KKIGKGSFGSVYYGKMKD--G--KEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN  670 (912)
Q Consensus       596 ~~LG~G~fg~Vy~a~~~~--~--~~vAvK~l~~~~~-~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~  670 (912)
                      +.||+|++|.||+|.+.+  +  ..||+|.+..... ...+.+.+|++++++++||||+++++.+.. ...++|+||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            478999999999998753  3  3699999987655 556789999999999999999999999988 889999999999


Q ss_pred             CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccc--
Q 002529          671 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH--  748 (912)
Q Consensus       671 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~--  748 (912)
                      ++|.+++..... ..+++..++.++.|++.||+|||+   ++++|+||||+||+++.++.+||+|||++.........  
T Consensus        80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            999999985422 578999999999999999999998   99999999999999999999999999999876442221  


Q ss_pred             ccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhhhccCCcccccCccccC
Q 002529          749 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG  827 (912)
Q Consensus       749 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  827 (912)
                      ......++..|+|||++.+..++.++|||||||++|||++ |+.||......   ......   ........        
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~---~~~~~~~~--------  221 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS---QILKKI---DKEGERLE--------  221 (257)
T ss_pred             cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH---HhcCCcCC--------
Confidence            1112346778999999998899999999999999999999 99999633221   111111   11111100        


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 002529          828 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ  863 (912)
Q Consensus       828 ~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  863 (912)
                       .+...+..+.+++.+||+.+|++||++.|+++.|.
T Consensus       222 -~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         222 -RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             -CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence             11122347889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=5.3e-34  Score=306.30  Aligned_cols=250  Identities=30%  Similarity=0.496  Sum_probs=200.5

Q ss_pred             HHHHhhhcccCccccEEEEEEEecCCCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEE-ecCCeEEEEEEe
Q 002529          589 EATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC-EEEHQRILVYEY  667 (912)
Q Consensus       589 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~-~~~~~~~lV~E~  667 (912)
                      ...+++.+.||+|+||.||++..+ ++.|++|.++...  ..+.+.+|+.++++++|+|++++++++ ..++..++++||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   81 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence            346677899999999999999876 7889999986532  345788999999999999999999975 455678999999


Q ss_pred             cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccc
Q 002529          668 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT  747 (912)
Q Consensus       668 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~  747 (912)
                      +++++|.++++.. ....+++..++.++.|++.||+|||+   ++++||||||+||+++.++.+||+|||++....... 
T Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-  156 (256)
T cd05082          82 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-  156 (256)
T ss_pred             CCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence            9999999998753 23458899999999999999999998   999999999999999999999999999987643322 


Q ss_pred             cccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhhhccCCcccccCcccc
Q 002529          748 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI  826 (912)
Q Consensus       748 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  826 (912)
                         ....++..|+|||++.+..++.++|||||||++|||++ |+.||.....   ......+    ..+....       
T Consensus       157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~---~~~~~~~----~~~~~~~-------  219 (256)
T cd05082         157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRV----EKGYKMD-------  219 (256)
T ss_pred             ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH----hcCCCCC-------
Confidence               12234568999999998899999999999999999997 9999863322   1111111    1111111       


Q ss_pred             CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhh
Q 002529          827 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS  865 (912)
Q Consensus       827 ~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~  865 (912)
                        .....+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus       220 --~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         220 --APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             --CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence              1112234788999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=4.9e-34  Score=335.11  Aligned_cols=253  Identities=23%  Similarity=0.328  Sum_probs=201.7

Q ss_pred             HHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc--chhhHHHHHHHHHHHhcCCCCccceeeEEecCC-------
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH-------  659 (912)
Q Consensus       590 ~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~-------  659 (912)
                      .+|.+.+.||+|+||+||+|+.. +++.||||++....  ......+.+|+.++..++|+||+++++.+....       
T Consensus        32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~  111 (496)
T PTZ00283         32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV  111 (496)
T ss_pred             CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence            46778899999999999999865 68999999986432  334566888999999999999999988764322       


Q ss_pred             -eEEEEEEecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeecc
Q 002529          660 -QRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG  737 (912)
Q Consensus       660 -~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFG  737 (912)
                       ..++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||
T Consensus       112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vkL~DFG  188 (496)
T PTZ00283        112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKLGDFG  188 (496)
T ss_pred             eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEEEEecc
Confidence             3679999999999999987532 34578999999999999999999998   999999999999999999999999999


Q ss_pred             Cccccccccc-cccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCC
Q 002529          738 LSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD  816 (912)
Q Consensus       738 la~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  816 (912)
                      +++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....      .+.+..... +.
T Consensus       189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~------~~~~~~~~~-~~  261 (496)
T PTZ00283        189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM------EEVMHKTLA-GR  261 (496)
T ss_pred             cCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHhc-CC
Confidence            9986543221 122345689999999999999999999999999999999999999974322      112222111 11


Q ss_pred             cccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002529          817 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       817 ~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  861 (912)
                      ...         .+......+.+++.+||+.+|.+||++.++++.
T Consensus       262 ~~~---------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        262 YDP---------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             CCC---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            110         112223478899999999999999999999863

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.3e-34  Score=292.23  Aligned_cols=256  Identities=26%  Similarity=0.346  Sum_probs=204.6

Q ss_pred             hhcccCccccEEEEEEEec-CCCEEEEEEccCccc----h----hhHHHHHHHHHHHhc-CCCCccceeeEEecCCeEEE
Q 002529          594 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS----H----RTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRIL  663 (912)
Q Consensus       594 ~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~----~----~~~~~~~E~~il~~L-~hpnIv~l~~~~~~~~~~~l  663 (912)
                      -.+.||+|..+.|.+..++ +|+++|+|++.....    .    -.+.-.+|+.+|+++ .||+|+++.++++.+...++
T Consensus        21 pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~Fl  100 (411)
T KOG0599|consen   21 PKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFL  100 (411)
T ss_pred             hHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhh
Confidence            3678999999999998776 688999999853211    1    123456799999999 59999999999999999999


Q ss_pred             EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccc
Q 002529          664 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE  743 (912)
Q Consensus       664 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~  743 (912)
                      |+|.|+.|.|.|+|.   ..-.++++...+|++|+.+|++|||.   ++||||||||+|||++++.++||+|||+++.+.
T Consensus       101 VFdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFGFa~~l~  174 (411)
T KOG0599|consen  101 VFDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFGFACQLE  174 (411)
T ss_pred             hhhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEeccceeeccC
Confidence            999999999999998   46789999999999999999999998   999999999999999999999999999999887


Q ss_pred             cccccccccccCCCcccCCCccC------CCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCc
Q 002529          744 EDLTHISSVARGTVGYLDPEYYG------NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV  817 (912)
Q Consensus       744 ~~~~~~~~~~~gt~~y~APE~l~------~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  817 (912)
                      .+..  -...+|||+|+|||.+.      ...|+...|+|++|+++|.|+.|.+||....       .-.+..++.+|..
T Consensus       175 ~Gek--LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk-------QmlMLR~ImeGky  245 (411)
T KOG0599|consen  175 PGEK--LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK-------QMLMLRMIMEGKY  245 (411)
T ss_pred             Cchh--HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH-------HHHHHHHHHhccc
Confidence            6533  34467999999999874      3467889999999999999999999997221       1223334444443


Q ss_pred             ccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--Hhhhhhhcc
Q 002529          818 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDSIKIEK  870 (912)
Q Consensus       818 ~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~--L~~~~~~~~  870 (912)
                      .--      ...-.+......+||.+||+.||.+|.|++|+++.  +..+...+.
T Consensus       246 qF~------speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~~  294 (411)
T KOG0599|consen  246 QFR------SPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQA  294 (411)
T ss_pred             ccC------CcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhcc
Confidence            111      11112333468899999999999999999999864  444444333

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-34  Score=328.03  Aligned_cols=250  Identities=25%  Similarity=0.326  Sum_probs=195.0

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc---chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEe
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY  667 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  667 (912)
                      |++.++||+|+||.||++..+ +++.||+|++....   ....+.+.+|++++++++||||+++++++.+....++||||
T Consensus         3 y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~   82 (377)
T cd05629           3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEF   82 (377)
T ss_pred             ceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeC
Confidence            556789999999999999876 68999999986432   22345688899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccc
Q 002529          668 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT  747 (912)
Q Consensus       668 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~  747 (912)
                      +++|+|.+++..   ...+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......
T Consensus        83 ~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~  156 (377)
T cd05629          83 LPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD  156 (377)
T ss_pred             CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence            999999999973   4678899999999999999999998   9999999999999999999999999999864321000


Q ss_pred             ------------c----------------------------------ccccccCCCcccCCCccCCCCCCchhHHHHHHH
Q 002529          748 ------------H----------------------------------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGV  781 (912)
Q Consensus       748 ------------~----------------------------------~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGv  781 (912)
                                  .                                  ......||+.|+|||++.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv  236 (377)
T cd05629         157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA  236 (377)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence                        0                                  001235899999999999989999999999999


Q ss_pred             HHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCC---CCHHHH
Q 002529          782 VLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSR---PKMQEI  858 (912)
Q Consensus       782 il~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~R---Ps~~ev  858 (912)
                      ++|||++|+.||......+   .   ..............+.       ......+.+++.+||+ +|.+|   +++.|+
T Consensus       237 il~elltG~~Pf~~~~~~~---~---~~~i~~~~~~~~~p~~-------~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~  302 (377)
T cd05629         237 IMFECLIGWPPFCSENSHE---T---YRKIINWRETLYFPDD-------IHLSVEAEDLIRRLIT-NAENRLGRGGAHEI  302 (377)
T ss_pred             hhhhhhcCCCCCCCCCHHH---H---HHHHHccCCccCCCCC-------CCCCHHHHHHHHHHhc-CHhhcCCCCCHHHH
Confidence            9999999999997433211   1   1111111110010000       0122367899999997 66665   599998


Q ss_pred             HHH
Q 002529          859 VLA  861 (912)
Q Consensus       859 l~~  861 (912)
                      ++.
T Consensus       303 l~h  305 (377)
T cd05629         303 KSH  305 (377)
T ss_pred             hcC
Confidence            874

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.4e-34  Score=328.24  Aligned_cols=249  Identities=22%  Similarity=0.270  Sum_probs=192.9

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc---chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEe
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY  667 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  667 (912)
                      |++.++||+|+||.||+|+.. +++.||+|++....   ......+.+|++++++++||||+++++.+.+++..++||||
T Consensus         3 f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~   82 (382)
T cd05625           3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY   82 (382)
T ss_pred             cEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeC
Confidence            456789999999999999876 68899999987532   22345788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccc-
Q 002529          668 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-  746 (912)
Q Consensus       668 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~-  746 (912)
                      +++|+|.+++..   ...+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++....... 
T Consensus        83 ~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~  156 (382)
T cd05625          83 IPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (382)
T ss_pred             CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence            999999999873   4568899999999999999999998   999999999999999999999999999975321000 


Q ss_pred             ---------------------------------------------ccccccccCCCcccCCCccCCCCCCchhHHHHHHH
Q 002529          747 ---------------------------------------------THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGV  781 (912)
Q Consensus       747 ---------------------------------------------~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGv  781 (912)
                                                                   ........||+.|+|||++.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv  236 (382)
T cd05625         157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV  236 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence                                                         00011235899999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCC---HHHH
Q 002529          782 VLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK---MQEI  858 (912)
Q Consensus       782 il~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs---~~ev  858 (912)
                      ++|||++|+.||........      .............  +.     .......+.+++.+|+ .+|++|++   ++|+
T Consensus       237 il~elltG~~Pf~~~~~~~~------~~~i~~~~~~~~~--p~-----~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei  302 (382)
T cd05625         237 ILYEMLVGQPPFLAQTPLET------QMKVINWQTSLHI--PP-----QAKLSPEASDLIIKLC-RGPEDRLGKNGADEI  302 (382)
T ss_pred             HHHHHHhCCCCCCCCCHHHH------HHHHHccCCCcCC--CC-----cccCCHHHHHHHHHHc-cCHhHcCCCCCHHHH
Confidence            99999999999974332111      1111111000000  00     0111235667777776 49999997   8887


Q ss_pred             HH
Q 002529          859 VL  860 (912)
Q Consensus       859 l~  860 (912)
                      ++
T Consensus       303 ~~  304 (382)
T cd05625         303 KA  304 (382)
T ss_pred             hc
Confidence            75

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-33  Score=306.75  Aligned_cols=250  Identities=30%  Similarity=0.522  Sum_probs=196.7

Q ss_pred             cccCccccEEEEEEEecC-CC--EEEEEEccCcc-chhhHHHHHHHHHHHhc-CCCCccceeeEEecCCeEEEEEEecCC
Q 002529          596 KKIGKGSFGSVYYGKMKD-GK--EVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN  670 (912)
Q Consensus       596 ~~LG~G~fg~Vy~a~~~~-~~--~vAvK~l~~~~-~~~~~~~~~E~~il~~L-~hpnIv~l~~~~~~~~~~~lV~E~~~~  670 (912)
                      +.||+|+||.||+|.+++ +.  .+++|.++... ......+.+|+++++++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            468999999999998864 43  47888887533 34456788999999999 799999999999999999999999999


Q ss_pred             CCHHHHhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeecc
Q 002529          671 GTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG  737 (912)
Q Consensus       671 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFG  737 (912)
                      |+|.+++....             ....+++..++.++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCC
Confidence            99999987532             12357899999999999999999998   999999999999999999999999999


Q ss_pred             CccccccccccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhhhccCC
Q 002529          738 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGD  816 (912)
Q Consensus       738 la~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~  816 (912)
                      ++........  ......+..|+|||++....++.++||||||+++|||++ |..||......   ...+   . +..+.
T Consensus       158 l~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~---~-~~~~~  228 (270)
T cd05047         158 LSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYE---K-LPQGY  228 (270)
T ss_pred             Cccccchhhh--ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH---HHHH---H-HhCCC
Confidence            9864321111  111223567999999988889999999999999999997 99999643221   1111   1 11111


Q ss_pred             cccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhhh
Q 002529          817 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI  866 (912)
Q Consensus       817 ~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~~  866 (912)
                      ..+         .+......+.+++.+|++.+|.+||++.|+++.|++++
T Consensus       229 ~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         229 RLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             CCC---------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            100         11112346889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.8e-34  Score=310.84  Aligned_cols=262  Identities=27%  Similarity=0.453  Sum_probs=205.9

Q ss_pred             HHHhhhcccCccccEEEEEEEec-----CCCEEEEEEccCccch-hhHHHHHHHHHHHhcCCCCccceeeEEec--CCeE
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMK-----DGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQR  661 (912)
Q Consensus       590 ~~~~~~~~LG~G~fg~Vy~a~~~-----~~~~vAvK~l~~~~~~-~~~~~~~E~~il~~L~hpnIv~l~~~~~~--~~~~  661 (912)
                      ..+++.+.||+|+||.||+|.+.     +++.+|+|.++..... ....+.+|+++++.++|+||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            45667899999999999999864     3688999999765443 46789999999999999999999999877  5678


Q ss_pred             EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccc
Q 002529          662 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ  741 (912)
Q Consensus       662 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~  741 (912)
                      +++|||+++++|.+++...  ...+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||.+..
T Consensus        84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            9999999999999999753  3368999999999999999999998   9999999999999999999999999999987


Q ss_pred             ccccccc--ccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchh--------hHHHHHHhh
Q 002529          742 AEEDLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL--------NIVHWARSM  811 (912)
Q Consensus       742 ~~~~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~--------~~~~~~~~~  811 (912)
                      .......  ......++..|+|||.+.+..++.++||||||++++||++|+.|+.........        .........
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05038         159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL  238 (284)
T ss_pred             cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence            6532221  111223456799999998889999999999999999999999998633221100        001111111


Q ss_pred             hccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhh
Q 002529          812 IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS  865 (912)
Q Consensus       812 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~  865 (912)
                      +..+..         ...+...+..+.+++.+||+.+|++||++.||+++|+++
T Consensus       239 ~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         239 LKEGER---------LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHcCCc---------CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            111110         011122335789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=3.8e-33  Score=306.03  Aligned_cols=251  Identities=22%  Similarity=0.349  Sum_probs=201.0

Q ss_pred             HHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEec
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM  668 (912)
Q Consensus       590 ~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~  668 (912)
                      ..|++.++||+|+||.||+|+.. +++.+++|.+........+.+.+|+++++.++||||+++++.+..++..++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            56888999999999999999886 48999999997665566678899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccc
Q 002529          669 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH  748 (912)
Q Consensus       669 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  748 (912)
                      ++++|..++...  ...+++..+..++.|++.+|+|||+   .+++||||||+||+++.++.++|+|||++.........
T Consensus        92 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~  166 (292)
T cd06644          92 PGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR  166 (292)
T ss_pred             CCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceeccccccc
Confidence            999998887642  3568999999999999999999998   99999999999999999999999999988754332211


Q ss_pred             ccccccCCCcccCCCccC-----CCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCc
Q 002529          749 ISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP  823 (912)
Q Consensus       749 ~~~~~~gt~~y~APE~l~-----~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  823 (912)
                       .....++..|+|||++.     ...++.++|||||||++|||++|+.||......      ........ .......  
T Consensus       167 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~~~~~-~~~~~~~--  236 (292)
T cd06644         167 -RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIAK-SEPPTLS--  236 (292)
T ss_pred             -cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH------HHHHHHhc-CCCccCC--
Confidence             12334788999999884     345678999999999999999999999733211      11111111 1111110  


Q ss_pred             cccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          824 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       824 ~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                           .+......+.+++.+||+.+|++||+++|+++
T Consensus       237 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         237 -----QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             -----CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                 01122346889999999999999999999975

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.4e-33  Score=306.87  Aligned_cols=249  Identities=27%  Similarity=0.401  Sum_probs=202.1

Q ss_pred             HHHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc-chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEE
Q 002529          589 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE  666 (912)
Q Consensus       589 ~~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E  666 (912)
                      .+.|...+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|++++++++||||+++++.+..+...++|+|
T Consensus         3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06642           3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME   82 (277)
T ss_pred             HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence            356777889999999999999876 57889999987433 3345678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccc
Q 002529          667 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL  746 (912)
Q Consensus       667 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~  746 (912)
                      |+++++|.+++.    ...+++..+..++.|+++||.|||+   .+++|+||+|+||++++++.++|+|||++.......
T Consensus        83 ~~~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06642          83 YLGGGSALDLLK----PGPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             ccCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence            999999999886    3468899999999999999999998   999999999999999999999999999987654332


Q ss_pred             ccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCcccc
Q 002529          747 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI  826 (912)
Q Consensus       747 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  826 (912)
                      . ......++..|+|||++.+..++.++||||||+++|||++|+.|+......   ....    .+..+.     .+.  
T Consensus       156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~---~~~~----~~~~~~-----~~~--  220 (277)
T cd06642         156 I-KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM---RVLF----LIPKNS-----PPT--  220 (277)
T ss_pred             h-hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh---hHHh----hhhcCC-----CCC--
Confidence            1 122234788999999999988999999999999999999999998632211   1111    111111     111  


Q ss_pred             CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002529          827 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       827 ~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  861 (912)
                        ........+.+++.+||+.+|++||++.|+++.
T Consensus       221 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         221 --LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             --CCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence              112234578899999999999999999999973

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.7e-33  Score=307.54  Aligned_cols=258  Identities=25%  Similarity=0.371  Sum_probs=207.0

Q ss_pred             HHHHHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc-chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEE
Q 002529          587 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV  664 (912)
Q Consensus       587 l~~~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV  664 (912)
                      |....|++.+.||+|+||+||++... +++.||+|++.... ....+.+.+|+++++.++||||+++++++......++|
T Consensus         2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   81 (284)
T cd06620           2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC   81 (284)
T ss_pred             ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence            44567889999999999999999876 58899999876532 33456789999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccc
Q 002529          665 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE  744 (912)
Q Consensus       665 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~  744 (912)
                      |||+++++|.+++..   .+.+++..+..++.+++.||.|||+  ..+++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~  156 (284)
T cd06620          82 MEFMDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN  156 (284)
T ss_pred             EecCCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence            999999999999873   4568999999999999999999996  26899999999999999999999999999865432


Q ss_pred             ccccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcc-----chhhHHHHHHhhhccCCccc
Q 002529          745 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG-----AELNIVHWARSMIKKGDVIS  819 (912)
Q Consensus       745 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~  819 (912)
                      ...   ....++..|+|||++.+..++.++|||||||++|+|++|+.||......     ....+..+....+....   
T Consensus       157 ~~~---~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  230 (284)
T cd06620         157 SIA---DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP---  230 (284)
T ss_pred             hcc---CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC---
Confidence            211   2345789999999998888999999999999999999999999744331     11112222222222110   


Q ss_pred             ccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002529          820 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       820 ~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  861 (912)
                         +.+.   ....+..+.+++.+||+.||++||+++|++++
T Consensus       231 ---~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~  266 (284)
T cd06620         231 ---PRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAM  266 (284)
T ss_pred             ---CCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence               1110   11133478899999999999999999999976

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.2e-33  Score=303.17  Aligned_cols=249  Identities=25%  Similarity=0.369  Sum_probs=201.6

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCc-cchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEecC
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS-CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH  669 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~-~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~  669 (912)
                      |++.++||+|+||.||++... +++.+|+|.++.. .....+.+.+|+.+++.++|+||+++++.+..++..+++|||++
T Consensus         2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   81 (255)
T cd08219           2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCD   81 (255)
T ss_pred             ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCC
Confidence            456789999999999999876 6889999998643 23345678889999999999999999999999999999999999


Q ss_pred             CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccccc
Q 002529          670 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI  749 (912)
Q Consensus       670 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~  749 (912)
                      +++|.+++... ....+++..++.++.|++.||+|||+   ++++|+||||+||++++++.++|+|||.+........ .
T Consensus        82 ~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~  156 (255)
T cd08219          82 GGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-Y  156 (255)
T ss_pred             CCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeeccccc-c
Confidence            99999988643 34568899999999999999999998   9999999999999999999999999999876543222 1


Q ss_pred             cccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCCC
Q 002529          750 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV  829 (912)
Q Consensus       750 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  829 (912)
                      .....+++.|+|||++.+..++.++|+||||+++|+|++|+.||......      ..... +..+.....         
T Consensus       157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~------~~~~~-~~~~~~~~~---------  220 (255)
T cd08219         157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK------NLILK-VCQGSYKPL---------  220 (255)
T ss_pred             cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH------HHHHH-HhcCCCCCC---------
Confidence            22345788999999999888999999999999999999999999733221      11111 111211111         


Q ss_pred             CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002529          830 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       830 ~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  861 (912)
                      +......+.+++.+||+.+|++||++.|++..
T Consensus       221 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         221 PSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            11223468899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=9.7e-34  Score=312.21  Aligned_cols=261  Identities=23%  Similarity=0.330  Sum_probs=197.8

Q ss_pred             HHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc-chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEe
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY  667 (912)
Q Consensus       590 ~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  667 (912)
                      ..|.+.++||+|+||.||+|..+ +++.||+|.++... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            34667899999999999999876 58899999986432 22335677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccc
Q 002529          668 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT  747 (912)
Q Consensus       668 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~  747 (912)
                      ++ ++|.+++...  ...+++..+..++.|+++||+|||+   .+++|+||||+||+++.++.++|+|||++........
T Consensus        86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  159 (301)
T cd07873          86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  159 (301)
T ss_pred             cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence            96 5898888743  4568899999999999999999998   9999999999999999999999999999876433221


Q ss_pred             cccccccCCCcccCCCccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhc---cCCcccccC-
Q 002529          748 HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK---KGDVISIVD-  822 (912)
Q Consensus       748 ~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~d-  822 (912)
                      . .....+++.|+|||++.+ ..++.++|||||||++|||++|+.||...+..+.   ...+.....   ......+.+ 
T Consensus       160 ~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  235 (301)
T cd07873         160 T-YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ---LHFIFRILGTPTEETWPGILSN  235 (301)
T ss_pred             c-ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCChhhchhhhcc
Confidence            1 122346889999998765 4578899999999999999999999974433211   111111110   000000000 


Q ss_pred             --------ccccC----CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          823 --------PVLIG----NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       823 --------~~l~~----~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                              +....    .........+.+++.+||+.||.+|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                    00000    001122346789999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=7.5e-34  Score=322.58  Aligned_cols=255  Identities=23%  Similarity=0.323  Sum_probs=199.5

Q ss_pred             HHHHHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc---chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEE
Q 002529          587 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI  662 (912)
Q Consensus       587 l~~~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~  662 (912)
                      +....|++.+.||+|+||.||+++.+ +++.+|+|++....   ......+.+|+.+++.++||||+++++.+.++...+
T Consensus        40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~  119 (371)
T cd05622          40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY  119 (371)
T ss_pred             cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence            34567888999999999999999887 58899999986422   223355788999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccc
Q 002529          663 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA  742 (912)
Q Consensus       663 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~  742 (912)
                      +||||+++|+|.+++..    ..+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||++...
T Consensus       120 lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~  192 (371)
T cd05622         120 MVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM  192 (371)
T ss_pred             EEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCCceeEc
Confidence            99999999999999863    357888999999999999999998   99999999999999999999999999999876


Q ss_pred             ccccccccccccCCCcccCCCccCCC----CCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcc
Q 002529          743 EEDLTHISSVARGTVGYLDPEYYGNQ----QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI  818 (912)
Q Consensus       743 ~~~~~~~~~~~~gt~~y~APE~l~~~----~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  818 (912)
                      ............||+.|+|||++.+.    .++.++|||||||++|||++|+.||......      .............
T Consensus       193 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~~~~~~  266 (371)
T cd05622         193 NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMNHKNSL  266 (371)
T ss_pred             CcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH------HHHHHHHcCCCcc
Confidence            54333233345689999999998653    3788999999999999999999999743321      1111111111111


Q ss_pred             cccCccccCCCCHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 002529          819 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFS--RPKMQEIVLA  861 (912)
Q Consensus       819 ~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~--RPs~~evl~~  861 (912)
                      ...+       .......+.+++.+||..++.+  |++++|+++.
T Consensus       267 ~~~~-------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         267 TFPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             cCCC-------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence            1111       0122346789999999844433  7899998875

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=4e-34  Score=318.43  Aligned_cols=237  Identities=27%  Similarity=0.378  Sum_probs=188.0

Q ss_pred             cccCccccEEEEEEEec-CCCEEEEEEccCccc---hhhHHHHHHHH-HHHhcCCCCccceeeEEecCCeEEEEEEecCC
Q 002529          596 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVA-LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN  670 (912)
Q Consensus       596 ~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~~-il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~  670 (912)
                      +.||+|+||.||+|+.+ +++.||+|++.....   .....+.+|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999886 588999999865321   22334555554 67888999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccccc
Q 002529          671 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS  750 (912)
Q Consensus       671 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~  750 (912)
                      ++|.+.+.   ....+++..+..++.||+.||+|||+   .+|+||||||+||+++.++.+||+|||++........ ..
T Consensus        81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~  153 (321)
T cd05603          81 GELFFHLQ---RERCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE-TT  153 (321)
T ss_pred             CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC-cc
Confidence            99998887   34678899999999999999999998   9999999999999999999999999999875322211 12


Q ss_pred             ccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCCCC
Q 002529          751 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK  830 (912)
Q Consensus       751 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  830 (912)
                      ....|++.|+|||++.+..++.++|||||||++|||++|+.||...+..      +....... ...          ..+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~-~~~----------~~~  216 (321)
T cd05603         154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS------QMYDNILH-KPL----------QLP  216 (321)
T ss_pred             ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH------HHHHHHhc-CCC----------CCC
Confidence            3345899999999999989999999999999999999999999743221      11111111 110          111


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHH
Q 002529          831 IESIWRIAEVAIQCVEQRGFSRPKMQ  856 (912)
Q Consensus       831 ~~~~~~l~~Li~~cL~~dP~~RPs~~  856 (912)
                      ......+.+++.+||+.+|.+||++.
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         217 GGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            12234688999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=4.8e-34  Score=331.06  Aligned_cols=259  Identities=21%  Similarity=0.254  Sum_probs=191.6

Q ss_pred             HHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEecC--------Ce
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--------HQ  660 (912)
Q Consensus       590 ~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~--------~~  660 (912)
                      ..|++.++||+|+||.||+|... +++.||||++....    ....+|+.+++.++||||+++++++...        ..
T Consensus        66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  141 (440)
T PTZ00036         66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF  141 (440)
T ss_pred             CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence            45778899999999999999875 68899999885432    2345799999999999999999876432        24


Q ss_pred             EEEEEEecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCC-cEEEeeccC
Q 002529          661 RILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGL  738 (912)
Q Consensus       661 ~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~-~vkL~DFGl  738 (912)
                      .++||||+++ +|.+++.... ....+++..++.++.||+.||+|||+   ++|+||||||+|||++.++ .+||+|||+
T Consensus       142 l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DFGl  217 (440)
T PTZ00036        142 LNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGS  217 (440)
T ss_pred             EEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeecccc
Confidence            6799999974 7776665322 45678999999999999999999998   9999999999999998654 699999999


Q ss_pred             ccccccccccccccccCCCcccCCCccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccC--
Q 002529          739 SRQAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG--  815 (912)
Q Consensus       739 a~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--  815 (912)
                      ++........  ....|++.|+|||++.+ ..++.++|||||||++|||++|.+||.+....+  .+...+. .+...  
T Consensus       218 a~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~--~~~~i~~-~~~~p~~  292 (440)
T PTZ00036        218 AKNLLAGQRS--VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD--QLVRIIQ-VLGTPTE  292 (440)
T ss_pred             chhccCCCCc--ccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHH-HhCCCCH
Confidence            9876433221  23457899999998865 468999999999999999999999997543321  1111111 00000  


Q ss_pred             --------Cccc-----ccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002529          816 --------DVIS-----IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       816 --------~~~~-----~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  861 (912)
                              ....     .....+...++.....++.+|+.+||+.||.+|||+.|+++.
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence                    0000     000011111112233578899999999999999999999843

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=5.5e-34  Score=317.71  Aligned_cols=240  Identities=25%  Similarity=0.359  Sum_probs=192.3

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc---chhhHHHHHHHHHHHhcC-CCCccceeeEEecCCeEEEEEE
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYE  666 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~L~-hpnIv~l~~~~~~~~~~~lV~E  666 (912)
                      +++.+.||+|+||.||+|..+ +++.||+|++....   ....+.+..|..+++.+. |++|+++++++.+.+..++|||
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (323)
T cd05615           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME   81 (323)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence            456789999999999999876 68999999987532   223456778889988885 5788899999999999999999


Q ss_pred             ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccc
Q 002529          667 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL  746 (912)
Q Consensus       667 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~  746 (912)
                      |+++|+|.+++..   ...+++.+++.++.||+.||+|||+   ++++||||||+|||++.++.+||+|||++.......
T Consensus        82 y~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~  155 (323)
T cd05615          82 YVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG  155 (323)
T ss_pred             CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence            9999999999873   4579999999999999999999998   999999999999999999999999999987543221


Q ss_pred             ccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCcccc
Q 002529          747 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI  826 (912)
Q Consensus       747 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  826 (912)
                      . ......|++.|+|||++.+..++.++||||+||++|||++|+.||......   ...+   .... ...         
T Consensus       156 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~~---~i~~-~~~---------  218 (323)
T cd05615         156 V-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED---ELFQ---SIME-HNV---------  218 (323)
T ss_pred             c-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH---HHHH---HHHh-CCC---------
Confidence            1 122345899999999999989999999999999999999999999743221   1111   1111 111         


Q ss_pred             CCCCHHHHHHHHHHHHhcccCCCCCCCCH
Q 002529          827 GNVKIESIWRIAEVAIQCVEQRGFSRPKM  855 (912)
Q Consensus       827 ~~~~~~~~~~l~~Li~~cL~~dP~~RPs~  855 (912)
                       ..+......+.+++.+||+.+|.+|++.
T Consensus       219 -~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         219 -SYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             -CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence             0111223467899999999999999975

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.4e-33  Score=308.69  Aligned_cols=257  Identities=29%  Similarity=0.461  Sum_probs=203.6

Q ss_pred             HHHHhhhcccCccccEEEEEEEec------CCCEEEEEEccCccc-hhhHHHHHHHHHHHhcCCCCccceeeEEecCCeE
Q 002529          589 EATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR  661 (912)
Q Consensus       589 ~~~~~~~~~LG~G~fg~Vy~a~~~------~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~  661 (912)
                      ...+++.+.||+|+||.||+|...      +++.||+|++..... .....+.+|+.++++++||||+++++++.++...
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            455777899999999999999864      467899999875433 3456788999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhccCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 002529          662 ILVYEYMHNGTLRDRLHGSV-------------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN  722 (912)
Q Consensus       662 ~lV~E~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~N  722 (912)
                      ++|+||+++++|.+++....                   ....+++..++.++.|++.||+|||+   .+++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhh
Confidence            99999999999999997421                   12357888999999999999999998   999999999999


Q ss_pred             ccccCCCcEEEeeccCccccccccc-cccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccc
Q 002529          723 ILLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGA  800 (912)
Q Consensus       723 ILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~  800 (912)
                      |+++.++.++|+|||++........ ........+..|+|||.+.+..++.++|||||||++|||++ |..||...... 
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~-  239 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE-  239 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence            9999999999999999876432211 11122234667999999988899999999999999999998 88888633221 


Q ss_pred             hhhHHHHHHhhhccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhh
Q 002529          801 ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD  864 (912)
Q Consensus       801 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~  864 (912)
                           +... .+..+.....         +...+..+.+++.+||+.+|++||++.|+++.|++
T Consensus       240 -----~~~~-~~~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         240 -----EVIY-YVRDGNVLSC---------PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             -----HHHH-HHhcCCCCCC---------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence                 1111 1222222111         11223478899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.2e-33  Score=303.19  Aligned_cols=240  Identities=23%  Similarity=0.403  Sum_probs=190.2

Q ss_pred             cccCccccEEEEEEEecC-------------CCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEE
Q 002529          596 KKIGKGSFGSVYYGKMKD-------------GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI  662 (912)
Q Consensus       596 ~~LG~G~fg~Vy~a~~~~-------------~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~  662 (912)
                      +.||+|+||.||+|++..             ...|++|.+..........+.+|+.+++.++||||+++++++..+...+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999998542             2358999887655555567888999999999999999999999988999


Q ss_pred             EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCc-------EEEee
Q 002529          663 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR-------AKVSD  735 (912)
Q Consensus       663 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~-------vkL~D  735 (912)
                      +||||+++++|..++...  ...+++..++.++.||++||+|||+   ++++||||||+|||++.++.       ++++|
T Consensus        81 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             EEEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            999999999999888642  4568999999999999999999998   99999999999999986654       89999


Q ss_pred             ccCccccccccccccccccCCCcccCCCccC-CCCCCchhHHHHHHHHHHHHH-hCCCCCCccCccchhhHHHHHHhhhc
Q 002529          736 FGLSRQAEEDLTHISSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELI-SGKKPVSVEDFGAELNIVHWARSMIK  813 (912)
Q Consensus       736 FGla~~~~~~~~~~~~~~~gt~~y~APE~l~-~~~~s~ksDVwSlGvil~eLl-tG~~Pf~~~~~~~~~~~~~~~~~~~~  813 (912)
                      ||++......     ....++..|+|||++. +..++.++|||||||++|||+ +|..|+......+..       ... 
T Consensus       156 ~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-------~~~-  222 (262)
T cd05077         156 PGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-------RFY-  222 (262)
T ss_pred             CCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-------HHH-
Confidence            9998764322     1234678899999886 567899999999999999998 588888633221110       000 


Q ss_pred             cCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 002529          814 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ  863 (912)
Q Consensus       814 ~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  863 (912)
                      .+.. ..         .......+.+++.+||+.||.+||++++|++.|+
T Consensus       223 ~~~~-~~---------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         223 EGQC-ML---------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             hcCc-cC---------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            1110 00         0112346889999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2.5e-33  Score=310.16  Aligned_cols=259  Identities=22%  Similarity=0.319  Sum_probs=200.2

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCccc-hhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEecC
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH  669 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~  669 (912)
                      |++.++||+|+||.||++.+. +++.+|+|.++.... ....++.+|++++++++||||+++++++..++..++||||++
T Consensus         3 ~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~   82 (308)
T cd06615           3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMD   82 (308)
T ss_pred             ceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccC
Confidence            566789999999999999876 578899998865432 334668899999999999999999999999999999999999


Q ss_pred             CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccccc
Q 002529          670 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI  749 (912)
Q Consensus       670 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~  749 (912)
                      +++|.++++.   ...+++..+..++.|+++||+|||+  ..+++|+||||+||+++.++.++|+|||++.......   
T Consensus        83 ~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---  154 (308)
T cd06615          83 GGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---  154 (308)
T ss_pred             CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCcccccccc---
Confidence            9999999974   4668999999999999999999997  2589999999999999999999999999987653321   


Q ss_pred             cccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcc-----------
Q 002529          750 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI-----------  818 (912)
Q Consensus       750 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-----------  818 (912)
                      .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+..   ................           
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (308)
T cd06615         155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK---ELEAMFGRPVSEGEAKESHRPVSGHPP  231 (308)
T ss_pred             cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh---hHHHhhcCccccccccCCcccccCCCC
Confidence            22345788999999998888999999999999999999999999643321   1111111110000000           


Q ss_pred             ---------cccCccc---cCCCC-HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002529          819 ---------SIVDPVL---IGNVK-IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       819 ---------~~~d~~l---~~~~~-~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  861 (912)
                               +..+...   ....+ ......+.+++.+||+.+|++||+++||++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                     0000000   00000 0123468899999999999999999999875

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=8.5e-34  Score=310.08  Aligned_cols=259  Identities=25%  Similarity=0.315  Sum_probs=192.9

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCccch--hhHHHHHHHHHHHhc---CCCCccceeeEEec-----CCe
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH--RTQQFVTEVALLSRI---HHRNLVPLIGYCEE-----EHQ  660 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~--~~~~~~~E~~il~~L---~hpnIv~l~~~~~~-----~~~  660 (912)
                      |++.+.||+|+||+||+|..+ +++.||+|.++.....  ....+.+|+++++.+   +||||+++++++..     ...
T Consensus         2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~   81 (288)
T cd07863           2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK   81 (288)
T ss_pred             ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence            566789999999999999876 6889999998653221  223556777777766   69999999998754     345


Q ss_pred             EEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcc
Q 002529          661 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR  740 (912)
Q Consensus       661 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~  740 (912)
                      .++|||++. ++|.+++... ....+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++.
T Consensus        82 ~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          82 VTLVFEHVD-QDLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             EEEEEcccc-cCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCccc
Confidence            789999997 5898888753 24568999999999999999999998   999999999999999999999999999998


Q ss_pred             ccccccccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhc---cCCc
Q 002529          741 QAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK---KGDV  817 (912)
Q Consensus       741 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~---~~~~  817 (912)
                      .......  .....++..|+|||++.+..++.++||||+||++|+|++|++||........  +.. +.....   ....
T Consensus       157 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~--~~~-~~~~~~~~~~~~~  231 (288)
T cd07863         157 IYSCQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ--LGK-IFDLIGLPPEDDW  231 (288)
T ss_pred             cccCccc--CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH--HHH-HHHHhCCCChhhC
Confidence            6543221  1234578899999999988999999999999999999999999974332211  111 111100   0000


Q ss_pred             cc-------ccCcccc---CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          818 IS-------IVDPVLI---GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       818 ~~-------~~d~~l~---~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                      ..       ...+...   ..........+.+++.+||+.||++|||+.|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            00       0000000   0011123346789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.9e-33  Score=305.26  Aligned_cols=257  Identities=25%  Similarity=0.404  Sum_probs=203.2

Q ss_pred             HHHhhhcccCccccEEEEEEEec------CCCEEEEEEccCccch-hhHHHHHHHHHHHhcCCCCccceeeEEecCCeEE
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI  662 (912)
Q Consensus       590 ~~~~~~~~LG~G~fg~Vy~a~~~------~~~~vAvK~l~~~~~~-~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~  662 (912)
                      ..++..+.||+|+||.||+|+.+      +.+.|++|.+...... ..+.+.+|++++++++|+||+++++++.+....+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            45667789999999999999865      2467999988654433 4567899999999999999999999999989999


Q ss_pred             EEEEecCCCCHHHHhccCCCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeec
Q 002529          663 LVYEYMHNGTLRDRLHGSVNQ------KPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDF  736 (912)
Q Consensus       663 lV~E~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DF  736 (912)
                      +||||+++|+|.+++......      ..+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.++++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEccc
Confidence            999999999999999754322      268999999999999999999998   89999999999999999999999999


Q ss_pred             cCccccccccccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhhhccC
Q 002529          737 GLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKG  815 (912)
Q Consensus       737 Gla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~  815 (912)
                      |++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||.....   .......    ..+
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~---~~~~~~~----~~~  234 (275)
T cd05046         162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD---EEVLNRL----QAG  234 (275)
T ss_pred             ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch---HHHHHHH----HcC
Confidence            9987543322222222345678999999988888999999999999999998 8889863221   1111111    111


Q ss_pred             CcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhh
Q 002529          816 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD  864 (912)
Q Consensus       816 ~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~  864 (912)
                      .....        .....+..+.+++.+||+.+|++||++.|+++.|.+
T Consensus       235 ~~~~~--------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         235 KLELP--------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             CcCCC--------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence            11100        011223478899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.5e-33  Score=311.21  Aligned_cols=196  Identities=24%  Similarity=0.383  Sum_probs=160.8

Q ss_pred             hcccCccccEEEEEEEec---CCCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEec--CCeEEEEEEecC
Q 002529          595 CKKIGKGSFGSVYYGKMK---DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQRILVYEYMH  669 (912)
Q Consensus       595 ~~~LG~G~fg~Vy~a~~~---~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~--~~~~~lV~E~~~  669 (912)
                      .++||+|+||+||+|+.+   +++.||+|.+....  ....+.+|++++++++||||+++++++..  +...++++||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            468999999999999865   46789999986532  23457789999999999999999998854  456889999985


Q ss_pred             CCCHHHHhccCC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccc----cCCCcEEEeeccCc
Q 002529          670 NGTLRDRLHGSV------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLS  739 (912)
Q Consensus       670 ~gsL~~~l~~~~------~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl----~~~~~vkL~DFGla  739 (912)
                       ++|.+++....      ....+++..+..++.||+.||+|||+   .+|+||||||+|||+    +.++.+||+|||++
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence             58888775321      22358899999999999999999998   999999999999999    45678999999999


Q ss_pred             ccccccccc--ccccccCCCcccCCCccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCcc
Q 002529          740 RQAEEDLTH--ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVE  796 (912)
Q Consensus       740 ~~~~~~~~~--~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~eLltG~~Pf~~~  796 (912)
                      .........  ......+|+.|+|||++.+ ..++.++||||+||++|||++|++||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            876443221  1223468999999999876 46899999999999999999999999743

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.4e-33  Score=308.70  Aligned_cols=250  Identities=25%  Similarity=0.308  Sum_probs=198.5

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCccc---hhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEe
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY  667 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  667 (912)
                      |+..+.||+|+||.||++... +++.||+|.+.....   .....+.+|+.++++++|++|+++++.+.+.+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            455688999999999999876 689999999864321   2234577899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccc
Q 002529          668 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT  747 (912)
Q Consensus       668 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~  747 (912)
                      +++++|.+++... ....+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++........
T Consensus        82 ~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05630          82 MNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT  157 (285)
T ss_pred             cCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence            9999999988643 23468999999999999999999998   9999999999999999999999999999876543222


Q ss_pred             cccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccC
Q 002529          748 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG  827 (912)
Q Consensus       748 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  827 (912)
                      .  ....|+..|+|||++.+..++.++||||+|+++|+|++|+.||............   ........      ..   
T Consensus       158 ~--~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~---~~~~~~~~------~~---  223 (285)
T cd05630         158 I--KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV---ERLVKEVQ------EE---  223 (285)
T ss_pred             c--cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHH---Hhhhhhhh------hh---
Confidence            1  2235899999999999999999999999999999999999999743321111111   11111000      00   


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 002529          828 NVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVL  860 (912)
Q Consensus       828 ~~~~~~~~~l~~Li~~cL~~dP~~RPs-----~~evl~  860 (912)
                       ........+.+++.+||+.||++|||     ++|+++
T Consensus       224 -~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         224 -YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             -cCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence             11112236789999999999999999     888886

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.3e-33  Score=308.07  Aligned_cols=262  Identities=21%  Similarity=0.263  Sum_probs=196.8

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCccc--hhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEec
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM  668 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~  668 (912)
                      |++.+.||+|++|.||+|..+ +++.||+|.++....  .....+.+|+.++++++||||+++++++.++...++||||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (285)
T cd07861           2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL   81 (285)
T ss_pred             ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecC
Confidence            456789999999999999876 689999999864322  23356888999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccc
Q 002529          669 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH  748 (912)
Q Consensus       669 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  748 (912)
                      + ++|.+++.....+..+++..++.++.||++||+|||+   .+++|+||||+||+++.++.++|+|||++........ 
T Consensus        82 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-  156 (285)
T cd07861          82 S-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR-  156 (285)
T ss_pred             C-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc-
Confidence            7 6898888755445678999999999999999999998   9999999999999999999999999999876533221 


Q ss_pred             ccccccCCCcccCCCccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhc--cC---------C
Q 002529          749 ISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK--KG---------D  816 (912)
Q Consensus       749 ~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~--~~---------~  816 (912)
                      ......+++.|+|||++.+. .++.++|||||||++|+|++|+.||........  ..........  ..         .
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
T cd07861         157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ--LFRIFRILGTPTEDVWPGVTSLPD  234 (285)
T ss_pred             cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCChhhhhcchhhHH
Confidence            11223468899999988654 578999999999999999999999974332111  1110000000  00         0


Q ss_pred             cccccCccccC---CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          817 VISIVDPVLIG---NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       817 ~~~~~d~~l~~---~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                      .....+.....   ........++.+++.+||+.||++|||++||++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            00000000000   000112346789999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.2e-34  Score=317.43  Aligned_cols=254  Identities=25%  Similarity=0.315  Sum_probs=196.3

Q ss_pred             HHhhhcccCccccEEEEEEEec-CCCEEEEEEccCc---cchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEE
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE  666 (912)
Q Consensus       591 ~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~---~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E  666 (912)
                      .|++.+.||+|+||.||+++.+ +++.||+|++...   .....+.+.+|+.+++.++|+||+++++++.+++..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (331)
T cd05597           2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD   81 (331)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence            3567899999999999999876 5899999998642   12234568889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccc
Q 002529          667 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL  746 (912)
Q Consensus       667 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~  746 (912)
                      |+++|+|.+++...  ...+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||++.......
T Consensus        82 ~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (331)
T cd05597          82 YYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG  156 (331)
T ss_pred             cCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence            99999999999742  4568999999999999999999998   999999999999999999999999999987654433


Q ss_pred             ccccccccCCCcccCCCccCC-----CCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCccccc
Q 002529          747 THISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV  821 (912)
Q Consensus       747 ~~~~~~~~gt~~y~APE~l~~-----~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  821 (912)
                      ........|++.|+|||++..     ..++.++|||||||++|||++|+.||......      +.............+ 
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~------~~~~~i~~~~~~~~~-  229 (331)
T cd05597         157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHKEHFQF-  229 (331)
T ss_pred             CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH------HHHHHHHcCCCcccC-
Confidence            322333458999999999863     45788999999999999999999999743221      111111111111111 


Q ss_pred             CccccCCCCHHHHHHHHHHHHhcccCCC--CCCCCHHHHHHH
Q 002529          822 DPVLIGNVKIESIWRIAEVAIQCVEQRG--FSRPKMQEIVLA  861 (912)
Q Consensus       822 d~~l~~~~~~~~~~~l~~Li~~cL~~dP--~~RPs~~evl~~  861 (912)
                      .+.     .......+.+++.+||..++  ..||+++++++.
T Consensus       230 ~~~-----~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         230 PPD-----VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             CCc-----cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            000     01123467788888775533  347899999876

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.5e-33  Score=322.59  Aligned_cols=264  Identities=22%  Similarity=0.249  Sum_probs=201.3

Q ss_pred             HHHHHHHhhhcccCccccEEEEEEEec---CCCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEE
Q 002529          586 ELEEATNNFCKKIGKGSFGSVYYGKMK---DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI  662 (912)
Q Consensus       586 ~l~~~~~~~~~~LG~G~fg~Vy~a~~~---~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~  662 (912)
                      .+....|++.+.||+|+||.||++...   .++.||+|.+...     ....+|++++++++||||+++++++......+
T Consensus        88 ~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~  162 (392)
T PHA03207         88 SVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVC  162 (392)
T ss_pred             hhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence            344556888999999999999999754   3578999987643     34568999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccc
Q 002529          663 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA  742 (912)
Q Consensus       663 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~  742 (912)
                      +|||++. ++|.+++.   ....+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.++|+|||++...
T Consensus       163 lv~e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~  235 (392)
T PHA03207        163 MVMPKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKL  235 (392)
T ss_pred             EEehhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence            9999995 68888885   35679999999999999999999998   99999999999999999999999999999765


Q ss_pred             cccccc-ccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcc--c
Q 002529          743 EEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI--S  819 (912)
Q Consensus       743 ~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~  819 (912)
                      ...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+............+...+......  .
T Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~  315 (392)
T PHA03207        236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ  315 (392)
T ss_pred             CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence            443221 2223568999999999999999999999999999999999999997544322111111111111100000  0


Q ss_pred             -----------ccCccccCCCC-------HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002529          820 -----------IVDPVLIGNVK-------IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       820 -----------~~d~~l~~~~~-------~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  861 (912)
                                 ......+..+.       ......+.++|.+||+.+|++||++.|++..
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence                       00000000000       0112467889999999999999999999864

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=4.6e-33  Score=302.90  Aligned_cols=248  Identities=26%  Similarity=0.394  Sum_probs=203.3

Q ss_pred             HHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc-chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEe
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY  667 (912)
Q Consensus       590 ~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  667 (912)
                      ..|+..++||.|+||.||+|..+ +++.||+|.+.... ......+.+|+++++++.||||+++++++.++...++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            45667789999999999999876 58899999987543 34456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccc
Q 002529          668 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT  747 (912)
Q Consensus       668 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~  747 (912)
                      +++++|.+++..    ..+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||++........
T Consensus        84 ~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06640          84 LGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence            999999999863    458899999999999999999998   9999999999999999999999999999876543322


Q ss_pred             cccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccC
Q 002529          748 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG  827 (912)
Q Consensus       748 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  827 (912)
                      . .....++..|+|||++.+..++.++|+||||+++|||++|+.||.......   ...    .+..+.         ..
T Consensus       157 ~-~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~----~~~~~~---------~~  219 (277)
T cd06640         157 K-RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR---VLF----LIPKNN---------PP  219 (277)
T ss_pred             c-cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh---Hhh----hhhcCC---------CC
Confidence            1 222347889999999988889999999999999999999999997332211   110    111111         11


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002529          828 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       828 ~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  861 (912)
                      ......+..+.+++.+||+.+|++||+++++++.
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            2233455678999999999999999999999765

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-33  Score=304.06  Aligned_cols=252  Identities=23%  Similarity=0.354  Sum_probs=202.5

Q ss_pred             HHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEec
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM  668 (912)
Q Consensus       590 ~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~  668 (912)
                      ..|++.++||.|++|.||+|.++ +++.+|+|.+........+.+.+|++++++++||||+++++.+..+...++||||+
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC   84 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence            45888999999999999999876 68999999987665556678899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccc
Q 002529          669 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH  748 (912)
Q Consensus       669 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  748 (912)
                      ++++|.+++...  ...+++..++.++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||++.........
T Consensus        85 ~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~  159 (280)
T cd06611          85 DGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK  159 (280)
T ss_pred             CCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhcccccc
Confidence            999999998743  4568999999999999999999998   99999999999999999999999999988765432221


Q ss_pred             ccccccCCCcccCCCccC-----CCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCc
Q 002529          749 ISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP  823 (912)
Q Consensus       749 ~~~~~~gt~~y~APE~l~-----~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  823 (912)
                       .....+++.|+|||.+.     ...++.++||||||+++|+|++|+.||......      +..... ..+......  
T Consensus       160 -~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~------~~~~~~-~~~~~~~~~--  229 (280)
T cd06611         160 -RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM------RVLLKI-LKSEPPTLD--  229 (280)
T ss_pred             -cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH------HHHHHH-hcCCCCCcC--
Confidence             22334788999999874     345678999999999999999999999743211      111111 111111110  


Q ss_pred             cccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002529          824 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       824 ~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  861 (912)
                           .+......+.+++.+||+.+|.+||++.++++.
T Consensus       230 -----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         230 -----QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             -----CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence                 011223468899999999999999999999763

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.5e-33  Score=305.06  Aligned_cols=252  Identities=26%  Similarity=0.399  Sum_probs=201.0

Q ss_pred             HHhhhcccCccccEEEEEEEec-CCCEEEEEEccCc-cchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEec
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS-CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM  668 (912)
Q Consensus       591 ~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~-~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~  668 (912)
                      .|++.+.||+|+||.||++..+ +++.||+|.++.. .......+.+|++++++++|+||+++++.+...+..++||||+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM   81 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence            4678899999999999999887 6899999988653 2334467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccc
Q 002529          669 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH  748 (912)
Q Consensus       669 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  748 (912)
                      ++++|.+++........+++..+..++.|++.||.|||+  ..+++|+||||+||+++.++.++|+|||++........ 
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-  158 (286)
T cd06622          82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA-  158 (286)
T ss_pred             CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc-
Confidence            999999998754334578999999999999999999996  26999999999999999999999999999876533222 


Q ss_pred             ccccccCCCcccCCCccCCC------CCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccC
Q 002529          749 ISSVARGTVGYLDPEYYGNQ------QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD  822 (912)
Q Consensus       749 ~~~~~~gt~~y~APE~l~~~------~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  822 (912)
                        ....++..|+|||.+.+.      .++.++|||||||++|+|++|+.||.......   ......... .+...    
T Consensus       159 --~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~-~~~~~----  228 (286)
T cd06622         159 --KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN---IFAQLSAIV-DGDPP----  228 (286)
T ss_pred             --ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh---HHHHHHHHh-hcCCC----
Confidence              223478899999998554      34789999999999999999999997432211   111111111 11111    


Q ss_pred             ccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          823 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       823 ~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                           ..+......+.+++.+||+.+|++||+++++++
T Consensus       229 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         229 -----TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             -----CCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence                 112223457889999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.5e-33  Score=304.86  Aligned_cols=239  Identities=24%  Similarity=0.380  Sum_probs=188.0

Q ss_pred             ccCccccEEEEEEEecC-------------------------CCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccce
Q 002529          597 KIGKGSFGSVYYGKMKD-------------------------GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL  651 (912)
Q Consensus       597 ~LG~G~fg~Vy~a~~~~-------------------------~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l  651 (912)
                      +||+|+||.||+|.+..                         ...|++|++..........+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999997521                         13589999876544445678889999999999999999


Q ss_pred             eeEEecCCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCC--
Q 002529          652 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM--  729 (912)
Q Consensus       652 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~--  729 (912)
                      ++++..+...++||||+++|+|..++...  ...+++..+..++.||++||+|||+   ++|+||||||+||+++..+  
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCcc
Confidence            99999999999999999999999998742  4568899999999999999999998   9999999999999997543  


Q ss_pred             -----cEEEeeccCccccccccccccccccCCCcccCCCccCC-CCCCchhHHHHHHHHHHHHH-hCCCCCCccCccchh
Q 002529          730 -----RAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELI-SGKKPVSVEDFGAEL  802 (912)
Q Consensus       730 -----~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~eLl-tG~~Pf~~~~~~~~~  802 (912)
                           .++++|||.+.......     ...++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||........ 
T Consensus       157 ~~~~~~~kl~d~g~~~~~~~~~-----~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-  230 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTALSRE-----ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK-  230 (274)
T ss_pred             cCccceeeecCCcccccccccc-----ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH-
Confidence                 38999999876542221     1246788999998865 56899999999999999985 69999974332211 


Q ss_pred             hHHHHHHhhhccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 002529          803 NIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ  863 (912)
Q Consensus       803 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  863 (912)
                        ......   ...        ..    ......+.+++.+||+.+|++||++++|++.|.
T Consensus       231 --~~~~~~---~~~--------~~----~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         231 --ERFYEK---KHR--------LP----EPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             --HHHHHh---ccC--------CC----CCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence              111110   000        00    011236889999999999999999999998773

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.5e-33  Score=300.87  Aligned_cols=238  Identities=26%  Similarity=0.435  Sum_probs=190.2

Q ss_pred             cccCccccEEEEEEEecCCC-----------EEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEE
Q 002529          596 KKIGKGSFGSVYYGKMKDGK-----------EVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV  664 (912)
Q Consensus       596 ~~LG~G~fg~Vy~a~~~~~~-----------~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV  664 (912)
                      +.||+|+||.||+|.+.+..           .+++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            47999999999999987433           5788887654333 6788899999999999999999999988 778999


Q ss_pred             EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCC-------cEEEeecc
Q 002529          665 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-------RAKVSDFG  737 (912)
Q Consensus       665 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~-------~vkL~DFG  737 (912)
                      |||+++|+|.+++...  ...+++..+..++.||+.||+|||+   ++++|+||||+||+++.++       .+||+|||
T Consensus        79 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          79 EEYVKFGPLDVFLHRE--KNNVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             EEcCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence            9999999999999853  2378999999999999999999998   9999999999999999887       79999999


Q ss_pred             CccccccccccccccccCCCcccCCCccCCC--CCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhhhcc
Q 002529          738 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQ--QLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKK  814 (912)
Q Consensus       738 la~~~~~~~~~~~~~~~gt~~y~APE~l~~~--~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~  814 (912)
                      ++......     ....++..|+|||++.+.  .++.++||||||+++|+|++ |..||.......   ...+..   . 
T Consensus       154 ~a~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~---~~~~~~---~-  221 (259)
T cd05037         154 IPITVLSR-----EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE---KERFYQ---D-  221 (259)
T ss_pred             cccccccc-----cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh---HHHHHh---c-
Confidence            98865431     123366789999999876  78999999999999999999 577776332111   111111   0 


Q ss_pred             CCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 002529          815 GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ  863 (912)
Q Consensus       815 ~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  863 (912)
                      ....           +......+.+++.+||..+|.+||++.||++.|+
T Consensus       222 ~~~~-----------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         222 QHRL-----------PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             CCCC-----------CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            0000           0001157889999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-33  Score=301.61  Aligned_cols=253  Identities=26%  Similarity=0.407  Sum_probs=204.1

Q ss_pred             HHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEec
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM  668 (912)
Q Consensus       590 ~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~  668 (912)
                      ..|++.+.||.|++|.||+|... +++.+++|.+........+.+.+|++++++++||||+++++++......+++|||+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            35667889999999999999876 57889999997665556678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccc
Q 002529          669 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH  748 (912)
Q Consensus       669 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  748 (912)
                      ++++|.+++...  ...+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||.+.........
T Consensus        83 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~  157 (262)
T cd06613          83 GGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK  157 (262)
T ss_pred             CCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhhhc
Confidence            999999998742  3578999999999999999999998   99999999999999999999999999998765432211


Q ss_pred             ccccccCCCcccCCCccCCC---CCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccc
Q 002529          749 ISSVARGTVGYLDPEYYGNQ---QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL  825 (912)
Q Consensus       749 ~~~~~~gt~~y~APE~l~~~---~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  825 (912)
                       .....++..|+|||.+.+.   .++.++||||||+++|+|++|+.||.......  ....     ......   ..+.+
T Consensus       158 -~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~--~~~~-----~~~~~~---~~~~~  226 (262)
T cd06613         158 -RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR--ALFL-----ISKSNF---PPPKL  226 (262)
T ss_pred             -cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-----HHhccC---CCccc
Confidence             2234578899999998776   88899999999999999999999997433211  1111     111100   00011


Q ss_pred             cCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          826 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       826 ~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                        .........+.+++.+||+.+|.+||++++|+.
T Consensus       227 --~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         227 --KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             --cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence              112234457899999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=2.8e-33  Score=308.17  Aligned_cols=249  Identities=24%  Similarity=0.373  Sum_probs=202.8

Q ss_pred             HHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEec
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM  668 (912)
Q Consensus       590 ~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~  668 (912)
                      ..|.+.+.||+|++|.||+|... +++.||+|.+........+.+.+|+.+++.++|+||+++++++..++..++||||+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   98 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   98 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence            66778899999999999999865 69999999987655555577889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccc
Q 002529          669 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH  748 (912)
Q Consensus       669 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  748 (912)
                      ++++|.+++..    ..+++.++..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++.........
T Consensus        99 ~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~  171 (297)
T cd06656          99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  171 (297)
T ss_pred             CCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC
Confidence            99999999863    457899999999999999999998   99999999999999999999999999998765433221


Q ss_pred             ccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCC
Q 002529          749 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN  828 (912)
Q Consensus       749 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  828 (912)
                       .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||.........      ......+ ....       .
T Consensus       172 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~------~~~~~~~-~~~~-------~  236 (297)
T cd06656         172 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------YLIATNG-TPEL-------Q  236 (297)
T ss_pred             -cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe------eeeccCC-CCCC-------C
Confidence             22335788999999999888999999999999999999999999743321110      0000000 0000       0


Q ss_pred             CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          829 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       829 ~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                      .+......+.+++.+||+.+|++||+++++++
T Consensus       237 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         237 NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            11222346789999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=3e-33  Score=299.78  Aligned_cols=249  Identities=28%  Similarity=0.413  Sum_probs=202.8

Q ss_pred             HHHhhhcccCccccEEEEEEEecC-CCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEec
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM  668 (912)
Q Consensus       590 ~~~~~~~~LG~G~fg~Vy~a~~~~-~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~  668 (912)
                      +.|++.++||+|++|.||+|.+++ ++.+++|.+.....  ..++.+|++++++++|+||+++++.+..+...++++||+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~   80 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC   80 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence            457778999999999999999875 78999999875432  678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccc
Q 002529          669 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH  748 (912)
Q Consensus       669 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  748 (912)
                      ++++|.+++...  ...+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||++........ 
T Consensus        81 ~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-  154 (256)
T cd06612          81 GAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-  154 (256)
T ss_pred             CCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence            999999998642  4678999999999999999999998   8999999999999999999999999999887654322 


Q ss_pred             ccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCC
Q 002529          749 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN  828 (912)
Q Consensus       749 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  828 (912)
                      ......++..|+|||++.+..++.++||||||+++|+|++|+.||........  . .   . ......     +.+  .
T Consensus       155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~--~-~---~-~~~~~~-----~~~--~  220 (256)
T cd06612         155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA--I-F---M-IPNKPP-----PTL--S  220 (256)
T ss_pred             ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh--h-h---h-hccCCC-----CCC--C
Confidence            12233478899999999988999999999999999999999999973322110  0 0   0 000000     000  0


Q ss_pred             CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          829 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       829 ~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                      .+......+.+++.+||+.+|++||+++||++
T Consensus       221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            11222347889999999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=6.6e-33  Score=300.24  Aligned_cols=253  Identities=27%  Similarity=0.398  Sum_probs=192.3

Q ss_pred             cccCccccEEEEEEEecC---CCEEEEEEccCccc-hhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEecCCC
Q 002529          596 KKIGKGSFGSVYYGKMKD---GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG  671 (912)
Q Consensus       596 ~~LG~G~fg~Vy~a~~~~---~~~vAvK~l~~~~~-~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~g  671 (912)
                      +.||+|+||.||+|.+.+   +..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            469999999999998653   45799998875433 33457889999999999999999999999988999999999999


Q ss_pred             CHHHHhccCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccccc
Q 002529          672 TLRDRLHGSV--NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI  749 (912)
Q Consensus       672 sL~~~l~~~~--~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~  749 (912)
                      +|.+++....  .....++..+..++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||++..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            9999997532  22356777888999999999999998   999999999999999999999999999987543322111


Q ss_pred             -cccccCCCcccCCCccCCC-------CCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhhhccCCcccc
Q 002529          750 -SSVARGTVGYLDPEYYGNQ-------QLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISI  820 (912)
Q Consensus       750 -~~~~~gt~~y~APE~l~~~-------~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  820 (912)
                       .....++..|+|||++.+.       .++.++||||||+++|||++ |+.||......+   ....   ... +.....
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~~~---~~~-~~~~~~  230 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ---VLTY---TVR-EQQLKL  230 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH---HHHH---Hhh-cccCCC
Confidence             1223467889999998642       35789999999999999996 999997332211   1111   111 111112


Q ss_pred             cCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 002529          821 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ  863 (912)
Q Consensus       821 ~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  863 (912)
                      .++.+..    .....+.+++.+|+ .+|++|||++||++.|+
T Consensus       231 ~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         231 PKPRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            2222211    12235778999998 58999999999998875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-34  Score=319.75  Aligned_cols=244  Identities=27%  Similarity=0.441  Sum_probs=204.2

Q ss_pred             ccCccccEEEEEEEecC-CCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEecCCCCHHH
Q 002529          597 KIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD  675 (912)
Q Consensus       597 ~LG~G~fg~Vy~a~~~~-~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~  675 (912)
                      +||+|.||+||.|++.+ ...+|||.+....+...+.+.+|+.+.++|+|.|||+++|.+.++++.-+.||.++||+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            69999999999998774 56799999988777777889999999999999999999999999999999999999999999


Q ss_pred             HhccCCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCcccc-CCCcEEEeeccCcccccccccccccc
Q 002529          676 RLHGSVNQKPL--DWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-INMRAKVSDFGLSRQAEEDLTHISSV  752 (912)
Q Consensus       676 ~l~~~~~~~~l--~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~-~~~~vkL~DFGla~~~~~~~~~~~~~  752 (912)
                      .|+..  -+++  .+.++-.+.+||++||.|||+   ..|||||||-+|||++ -.|.+||+|||-++.... .......
T Consensus       662 LLrsk--WGPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~TET  735 (1226)
T KOG4279|consen  662 LLRSK--WGPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCTET  735 (1226)
T ss_pred             HHHhc--cCCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhcc-CCccccc
Confidence            99864  3455  788889999999999999998   9999999999999996 579999999999987643 3334455


Q ss_pred             ccCCCcccCCCccCCC--CCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCCCC
Q 002529          753 ARGTVGYLDPEYYGNQ--QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK  830 (912)
Q Consensus       753 ~~gt~~y~APE~l~~~--~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  830 (912)
                      ..||..|||||++..+  .|+.++|||||||++.||.||++||.........        +.+-|-.      ...+..+
T Consensus       736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA--------MFkVGmy------KvHP~iP  801 (1226)
T KOG4279|consen  736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA--------MFKVGMY------KVHPPIP  801 (1226)
T ss_pred             cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh--------hhhhcce------ecCCCCc
Confidence            6799999999999765  5889999999999999999999999732221110        0111111      1233556


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          831 IESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       831 ~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                      .+...+...+|.+|+.++|.+||+++++++
T Consensus       802 eelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             HHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            677778999999999999999999999986

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.6e-33  Score=302.60  Aligned_cols=247  Identities=28%  Similarity=0.420  Sum_probs=198.2

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCccch---------hhHHHHHHHHHHHhcCCCCccceeeEEecCCeE
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH---------RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR  661 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~---------~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~  661 (912)
                      |.+.+.||+|++|.||+|... +++.+|+|.+......         ..+.+.+|++++++++||||+++++++...+..
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL   81 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence            456789999999999999875 5889999988643221         125688899999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccc
Q 002529          662 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ  741 (912)
Q Consensus       662 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~  741 (912)
                      ++|+||+++++|.+++..   ...+++..+..++.|++.||+|||+   .+++||||+|+||+++.++.++|+|||.++.
T Consensus        82 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~~  155 (267)
T cd06628          82 NIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKK  155 (267)
T ss_pred             EEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence            999999999999999973   4568899999999999999999998   8999999999999999999999999999887


Q ss_pred             ccccccc-----ccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCC
Q 002529          742 AEEDLTH-----ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD  816 (912)
Q Consensus       742 ~~~~~~~-----~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  816 (912)
                      .......     ......++..|+|||.+.+..++.++||||||+++|+|++|+.||......   ..   +.... .. 
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~---~~~~~-~~-  227 (267)
T cd06628         156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL---QA---IFKIG-EN-  227 (267)
T ss_pred             cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH---HH---HHHHh-cc-
Confidence            6532111     111234788999999999888999999999999999999999999733211   11   11110 00 


Q ss_pred             cccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          817 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       817 ~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                          ..+    ..+......+.+++.+||+.+|.+||++.|+++
T Consensus       228 ----~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         228 ----ASP----EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             ----CCC----cCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence                111    111223457889999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2.1e-33  Score=307.14  Aligned_cols=250  Identities=23%  Similarity=0.285  Sum_probs=197.9

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCccc---hhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEe
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY  667 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  667 (912)
                      |+..+.||+|+||+||+|.+. +++.||+|.+.....   .....+.+|++++++++|+||+++.+.+..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            345688999999999999876 688999999865322   2234578899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccc
Q 002529          668 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT  747 (912)
Q Consensus       668 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~  747 (912)
                      +++++|.+++... ....+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.++|+|||++........
T Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05632          82 MNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES  157 (285)
T ss_pred             ccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence            9999999888643 24469999999999999999999998   9999999999999999999999999999876533221


Q ss_pred             cccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccC
Q 002529          748 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG  827 (912)
Q Consensus       748 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  827 (912)
                        .....|+..|+|||++.+..++.++|+||||+++|+|++|+.||........   .+.+.........          
T Consensus       158 --~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~---~~~~~~~~~~~~~----------  222 (285)
T cd05632         158 --IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK---REEVDRRVLETEE----------  222 (285)
T ss_pred             --ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhhhcccc----------
Confidence              1234589999999999988999999999999999999999999974322111   1111111111110          


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 002529          828 NVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVL  860 (912)
Q Consensus       828 ~~~~~~~~~l~~Li~~cL~~dP~~RPs-----~~evl~  860 (912)
                      .+.......+.+++.+||+.+|++||+     +.++++
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         223 VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence            011122336789999999999999999     667665

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-33  Score=306.08  Aligned_cols=246  Identities=22%  Similarity=0.341  Sum_probs=207.7

Q ss_pred             HHhhhcccCccccEEEEEEEec-CCCEEEEEEccCccch--hhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEe
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH--RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY  667 (912)
Q Consensus       591 ~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~--~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  667 (912)
                      -|.+.+.||+|.|+.|-+|++- +|+.||||++.+..-+  ...++.+|++.|+.++|||||+++++...+..+|||+|.
T Consensus        19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL   98 (864)
T KOG4717|consen   19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL   98 (864)
T ss_pred             eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence            3556689999999999999875 7999999999765433  456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccc-cCCCcEEEeeccCcccccccc
Q 002529          668 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL-DINMRAKVSDFGLSRQAEEDL  746 (912)
Q Consensus       668 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl-~~~~~vkL~DFGla~~~~~~~  746 (912)
                      -.+|+|.|+|-+.  ...+.+....+++.||+.|+.|+|+   ..+|||||||+||.+ ..-|-+||.|||++..+....
T Consensus        99 GD~GDl~DyImKH--e~Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~  173 (864)
T KOG4717|consen   99 GDGGDLFDYIMKH--EEGLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK  173 (864)
T ss_pred             cCCchHHHHHHhh--hccccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence            9999999999864  5679999999999999999999998   999999999999866 567899999999998876543


Q ss_pred             ccccccccCCCcccCCCccCCCCCC-chhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccc
Q 002529          747 THISSVARGTVGYLDPEYYGNQQLT-EKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL  825 (912)
Q Consensus       747 ~~~~~~~~gt~~y~APE~l~~~~~s-~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  825 (912)
                      .  -...+|+..|-|||++.+..|. ++.||||||||||.|++|++||+.....+...               -++|-. 
T Consensus       174 k--L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLT---------------mImDCK-  235 (864)
T KOG4717|consen  174 K--LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLT---------------MIMDCK-  235 (864)
T ss_pred             h--hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhh---------------hhhccc-
Confidence            3  2345699999999999998886 68999999999999999999998544433221               122221 


Q ss_pred             cCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          826 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       826 ~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                       -..+.....++.+||..||..||.+|.+.+||..
T Consensus       236 -YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  236 -YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             -ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence             2345566778999999999999999999998863

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=3.4e-33  Score=311.76  Aligned_cols=256  Identities=21%  Similarity=0.299  Sum_probs=193.9

Q ss_pred             hhcccCcc--ccEEEEEEEec-CCCEEEEEEccCcc--chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEec
Q 002529          594 FCKKIGKG--SFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM  668 (912)
Q Consensus       594 ~~~~LG~G--~fg~Vy~a~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~  668 (912)
                      +.++||+|  +|++||++..+ +|+.||+|++....  ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            56789999  78999999876 68999999987542  233456788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccc
Q 002529          669 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH  748 (912)
Q Consensus       669 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  748 (912)
                      ++|+|.+++... ....+++..++.++.|++.||+|||+   .+|+||||||+||+++.++.++++||+...........
T Consensus        82 ~~~~l~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~  157 (327)
T cd08227          82 AYGSAKDLICTH-FMDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR  157 (327)
T ss_pred             CCCcHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence            999999998643 23458999999999999999999998   99999999999999999999999999865443211110


Q ss_pred             ------ccccccCCCcccCCCccCC--CCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccc
Q 002529          749 ------ISSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI  820 (912)
Q Consensus       749 ------~~~~~~gt~~y~APE~l~~--~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  820 (912)
                            ......++..|+|||++.+  ..++.++|||||||++|||++|+.||.......  .......     +.....
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~-----~~~~~~  230 (327)
T cd08227         158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKLN-----GTVPCL  230 (327)
T ss_pred             ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH--HHHHHhc-----CCcccc
Confidence                  1112246678999999876  468899999999999999999999997332211  1111110     000000


Q ss_pred             cC-------------------ccc-----------------cCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          821 VD-------------------PVL-----------------IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       821 ~d-------------------~~l-----------------~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                      .+                   ...                 ...........+.+++.+||+.||++|||++|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         231 LDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             ccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence            00                   000                 00011123347889999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2.8e-33  Score=301.42  Aligned_cols=251  Identities=30%  Similarity=0.464  Sum_probs=193.7

Q ss_pred             cccCccccEEEEEEEecC----CCEEEEEEccCc-cchhhHHHHHHHHHHHhcCCCCccceeeEEe-cCCeEEEEEEecC
Q 002529          596 KKIGKGSFGSVYYGKMKD----GKEVAVKIMADS-CSHRTQQFVTEVALLSRIHHRNLVPLIGYCE-EEHQRILVYEYMH  669 (912)
Q Consensus       596 ~~LG~G~fg~Vy~a~~~~----~~~vAvK~l~~~-~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~-~~~~~~lV~E~~~  669 (912)
                      +.||+|+||.||+|.+.+    +..||+|.+... .....+.+.+|+.+++.++||||+++++++. .+...++++||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            468999999999998642    457999988643 2334567889999999999999999999775 4556889999999


Q ss_pred             CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccc-
Q 002529          670 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH-  748 (912)
Q Consensus       670 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~-  748 (912)
                      +++|.+++...  ...+++..+..++.|+++||+|||+   .+++||||||+||+++.++.+||+|||++......... 
T Consensus        81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~  155 (262)
T cd05058          81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS  155 (262)
T ss_pred             CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence            99999999743  3446778889999999999999998   89999999999999999999999999998764332110 


Q ss_pred             --ccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhC-CCCCCccCccchhhHHHHHHhhhccCCcccccCccc
Q 002529          749 --ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISG-KKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL  825 (912)
Q Consensus       749 --~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  825 (912)
                        ......++..|+|||.+.+..++.++|||||||++|||++| .+||....   .......+    ..+....     .
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~---~~~~~~~~----~~~~~~~-----~  223 (262)
T cd05058         156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD---SFDITVYL----LQGRRLL-----Q  223 (262)
T ss_pred             ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHH----hcCCCCC-----C
Confidence              11122356789999999888999999999999999999995 55564221   11222211    1111100     0


Q ss_pred             cCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhhhh
Q 002529          826 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK  867 (912)
Q Consensus       826 ~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~~~  867 (912)
                          +...+..+.+++.+||+.+|++||++.||++.|+++..
T Consensus       224 ----~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         224 ----PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             ----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence                11123468899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=5.2e-33  Score=300.04  Aligned_cols=249  Identities=25%  Similarity=0.412  Sum_probs=198.6

Q ss_pred             HhhhcccCccccEEEEEEEecCCCEEEEEEccCccc------hhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEE
Q 002529          592 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY  665 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~~~~~vAvK~l~~~~~------~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~  665 (912)
                      |.+.+.||+|+||.||+|...+++.+|+|.+.....      .....+.+|++++++++|+||+++++++.+.+..++++
T Consensus         2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   81 (265)
T cd06631           2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM   81 (265)
T ss_pred             ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence            456789999999999999988899999998864321      22356889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccc
Q 002529          666 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED  745 (912)
Q Consensus       666 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~  745 (912)
                      ||+++++|.+++..   ...+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||++......
T Consensus        82 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  155 (265)
T cd06631          82 EFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV  155 (265)
T ss_pred             ecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence            99999999999973   3568899999999999999999998   89999999999999999999999999998764221


Q ss_pred             c-----ccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccc
Q 002529          746 L-----THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI  820 (912)
Q Consensus       746 ~-----~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  820 (912)
                      .     ........++..|+|||++.+..++.++||||||+++|+|++|+.||...+...  ....   .....+..   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--~~~~---~~~~~~~~---  227 (265)
T cd06631         156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA--AMFY---IGAHRGLM---  227 (265)
T ss_pred             cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH--HHHH---hhhccCCC---
Confidence            1     111223457889999999999889999999999999999999999997332111  1100   00000111   


Q ss_pred             cCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          821 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       821 ~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                        +.+    +......+.+++.+||+.+|++||++.|+++
T Consensus       228 --~~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         228 --PRL----PDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             --CCC----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence              111    1123346889999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=3.2e-33  Score=337.19  Aligned_cols=262  Identities=23%  Similarity=0.360  Sum_probs=204.0

Q ss_pred             HHhhhcccCccccEEEEEEEec-CCCEEEEEEccCccc---hhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEE
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE  666 (912)
Q Consensus       591 ~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E  666 (912)
                      +|++.++||+|+||.||+|... +++.||+|++.....   ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         3 rYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVME   82 (932)
T PRK13184          3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMP   82 (932)
T ss_pred             CeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEE
Confidence            4667899999999999999876 589999999875322   234678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccC
Q 002529          667 YMHNGTLRDRLHGSV--------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL  738 (912)
Q Consensus       667 ~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGl  738 (912)
                      |++||+|.+++....        ....+++..++.++.||++||+|||+   ++|+||||||+||+++.++.++|+|||+
T Consensus        83 Y~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFGL  159 (932)
T PRK13184         83 YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGA  159 (932)
T ss_pred             cCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecCc
Confidence            999999999886421        12345677889999999999999998   9999999999999999999999999999


Q ss_pred             ccccccccc-----------------cccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccch
Q 002529          739 SRQAEEDLT-----------------HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE  801 (912)
Q Consensus       739 a~~~~~~~~-----------------~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~  801 (912)
                      +........                 .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... 
T Consensus       160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k-  238 (932)
T PRK13184        160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK-  238 (932)
T ss_pred             ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh-
Confidence            976521100                 01112458999999999999999999999999999999999999997422111 


Q ss_pred             hhHHHHHHhhhccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCC-CHHHHHHHHhhhhhhc
Q 002529          802 LNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP-KMQEIVLAIQDSIKIE  869 (912)
Q Consensus       802 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP-s~~evl~~L~~~~~~~  869 (912)
                        ...  ......  .... .+      ....+..+.+++.+||+.||++|| +++++++.|+..+...
T Consensus       239 --i~~--~~~i~~--P~~~-~p------~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~  294 (932)
T PRK13184        239 --ISY--RDVILS--PIEV-AP------YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGS  294 (932)
T ss_pred             --hhh--hhhccC--hhhc-cc------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcC
Confidence              000  000000  0000 00      012234688999999999999996 6788888888876643

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=4.2e-33  Score=306.64  Aligned_cols=249  Identities=22%  Similarity=0.374  Sum_probs=201.8

Q ss_pred             HHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEec
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM  668 (912)
Q Consensus       590 ~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~  668 (912)
                      .+|++.+.||.|++|.||+|... +++.|++|.+........+.+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            34667789999999999999864 68999999987655555677889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccc
Q 002529          669 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH  748 (912)
Q Consensus       669 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  748 (912)
                      ++++|.+++.    ...+++.++..++.|++.||+|||+   .+++||||||+||+++.++.++|+|||++.........
T Consensus        99 ~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~  171 (296)
T cd06655          99 AGGSLTDVVT----ETCMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK  171 (296)
T ss_pred             CCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence            9999999886    3458999999999999999999998   99999999999999999999999999998765433221


Q ss_pred             ccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCC
Q 002529          749 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN  828 (912)
Q Consensus       749 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  828 (912)
                       .....++..|+|||.+.+..++.++|||||||++|+|++|+.||........  .    ..... .......       
T Consensus       172 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~--~----~~~~~-~~~~~~~-------  236 (296)
T cd06655         172 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--L----YLIAT-NGTPELQ-------  236 (296)
T ss_pred             -CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--H----HHHHh-cCCcccC-------
Confidence             2233578899999999988899999999999999999999999974332111  1    11111 1110000       


Q ss_pred             CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          829 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       829 ~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                      .+......+.+++.+||..+|++||++.++++
T Consensus       237 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         237 NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             CcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            11122346889999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=3e-33  Score=302.93  Aligned_cols=251  Identities=24%  Similarity=0.409  Sum_probs=196.7

Q ss_pred             HHHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCccchhhHHHHHHHHHHHhc-CCCCccceeeEEec------CCe
Q 002529          589 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEE------EHQ  660 (912)
Q Consensus       589 ~~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L-~hpnIv~l~~~~~~------~~~  660 (912)
                      ...|++.+.||+|+||.||+|... +++.||+|++.... .....+.+|+.+++++ +|+||+++++++..      ...
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (272)
T cd06637           5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ   83 (272)
T ss_pred             hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence            345677889999999999999876 58899999986543 3346788999999998 69999999999864      246


Q ss_pred             EEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcc
Q 002529          661 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR  740 (912)
Q Consensus       661 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~  740 (912)
                      .+++|||+++++|.+++... ....+++..+..++.|++.||+|||+   ++++|+||||+||++++++.++|+|||++.
T Consensus        84 ~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~~~  159 (272)
T cd06637          84 LWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSA  159 (272)
T ss_pred             EEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence            88999999999999998753 24568899999999999999999998   899999999999999999999999999987


Q ss_pred             ccccccccccccccCCCcccCCCccC-----CCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccC
Q 002529          741 QAEEDLTHISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG  815 (912)
Q Consensus       741 ~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  815 (912)
                      ....... ......|+..|+|||++.     +..++.++|||||||++|||++|+.||........   ..    .....
T Consensus       160 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~---~~----~~~~~  231 (272)
T cd06637         160 QLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA---LF----LIPRN  231 (272)
T ss_pred             ecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH---HH----HHhcC
Confidence            6543222 123345888999999985     34678899999999999999999999963221110   00    00111


Q ss_pred             CcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          816 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       816 ~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                      ......        .......+.+++.+||..+|.+||+++|+++
T Consensus       232 ~~~~~~--------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         232 PAPRLK--------SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             CCCCCC--------CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            111111        1122346889999999999999999999975

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-33  Score=302.89  Aligned_cols=247  Identities=29%  Similarity=0.409  Sum_probs=201.8

Q ss_pred             HHhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc-chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEec
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM  668 (912)
Q Consensus       591 ~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~  668 (912)
                      +|++.+.||.|++|.||+|... +++.||+|.+.... ......+.+|+++++.++|+||+++++++.++...++|+||+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC   81 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence            4677899999999999999876 68899999986543 334567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccc
Q 002529          669 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH  748 (912)
Q Consensus       669 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  748 (912)
                      ++++|.+++..    ..+++..++.++.|++.||.|||+   .+++|+||+|+||++++++.++|+|||++.........
T Consensus        82 ~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~  154 (274)
T cd06609          82 GGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK  154 (274)
T ss_pred             CCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeecccccc
Confidence            99999999873    378999999999999999999998   99999999999999999999999999999876543222


Q ss_pred             ccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCC
Q 002529          749 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN  828 (912)
Q Consensus       749 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  828 (912)
                       .....++..|+|||++.+..++.++||||||+++|+|++|+.||.......   ..    ..+..+....     +...
T Consensus       155 -~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~---~~----~~~~~~~~~~-----~~~~  221 (274)
T cd06609         155 -RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR---VL----FLIPKNNPPS-----LEGN  221 (274)
T ss_pred             -cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH---HH----HHhhhcCCCC-----Cccc
Confidence             223357889999999998889999999999999999999999997332111   11    1111111111     1111


Q ss_pred             CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          829 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       829 ~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                         .....+.+++.+||..+|++||+++++++
T Consensus       222 ---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         222 ---KFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             ---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence               02346889999999999999999999976

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-34  Score=318.54  Aligned_cols=257  Identities=25%  Similarity=0.394  Sum_probs=210.3

Q ss_pred             ccccChhHHHHHHHhhhcccCccccEEEEEEEecC--CC--EEEEEEccCccch-hhHHHHHHHHHHHhcCCCCccceee
Q 002529          579 AYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKD--GK--EVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIG  653 (912)
Q Consensus       579 ~~~~~~~~l~~~~~~~~~~LG~G~fg~Vy~a~~~~--~~--~vAvK~l~~~~~~-~~~~~~~E~~il~~L~hpnIv~l~~  653 (912)
                      ...|+.++|     .+.|+||+|.||.|++|.|+.  |+  .||||.++..... ...+|++|+.+|.+|+|+|+++|+|
T Consensus       104 kclIpee~i-----~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyG  178 (1039)
T KOG0199|consen  104 KCLIPEEQI-----KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYG  178 (1039)
T ss_pred             ceeccHHHH-----HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEee
Confidence            344554444     467899999999999999873  44  5899999876554 6688999999999999999999999


Q ss_pred             EEecCCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEE
Q 002529          654 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKV  733 (912)
Q Consensus       654 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL  733 (912)
                      +..+ ....||+|.++.|+|.+.|++. ....+....+..++.|||.||+||.+   +++|||||..+|+|+-....+||
T Consensus       179 vVl~-qp~mMV~ELaplGSLldrLrka-~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI  253 (1039)
T KOG0199|consen  179 VVLD-QPAMMVFELAPLGSLLDRLRKA-KKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKI  253 (1039)
T ss_pred             eecc-chhhHHhhhcccchHHHHHhhc-cccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeee
Confidence            9987 6788999999999999999973 56678888999999999999999999   99999999999999999999999


Q ss_pred             eeccCcccccccccc--ccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHh
Q 002529          734 SDFGLSRQAEEDLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARS  810 (912)
Q Consensus       734 ~DFGla~~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~  810 (912)
                      +|||+.+-++.....  +.....-...|+|||.++...++.++|||+|||++|||+| |+.||.+....   .+.+    
T Consensus       254 ~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~---qIL~----  326 (1039)
T KOG0199|consen  254 CDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI---QILK----  326 (1039)
T ss_pred             ecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH---HHHH----
Confidence            999999887654332  2223334668999999999999999999999999999999 89999744321   1111    


Q ss_pred             hhccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002529          811 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       811 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  861 (912)
                               .+|..-+-..+..+.+.+.+++.+||..+|++|||+..|.+.
T Consensus       327 ---------~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~  368 (1039)
T KOG0199|consen  327 ---------NIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED  368 (1039)
T ss_pred             ---------hccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence                     122111112345677899999999999999999999999743

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=4.6e-33  Score=301.19  Aligned_cols=246  Identities=25%  Similarity=0.387  Sum_probs=195.0

Q ss_pred             hcccCccccEEEEEEEec-CCCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEecCCCCH
Q 002529          595 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL  673 (912)
Q Consensus       595 ~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL  673 (912)
                      ...||+|+||.||+|.+. +++.|++|.+........+.+.+|++++++++|+||+++++++..++..++|+||+++++|
T Consensus        13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L   92 (268)
T cd06624          13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSL   92 (268)
T ss_pred             eEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCH
Confidence            357999999999999866 5788999998766556667899999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccC-CCcEEEeeccCcccccccccccc
Q 002529          674 RDRLHGSVNQKPL--DWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEEDLTHIS  750 (912)
Q Consensus       674 ~~~l~~~~~~~~l--~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~-~~~vkL~DFGla~~~~~~~~~~~  750 (912)
                      .+++....  ..+  ++..+..++.||+.||+|||+   .+|+||||||+||+++. ++.++|+|||.+........ ..
T Consensus        93 ~~~l~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~-~~  166 (268)
T cd06624          93 SALLRSKW--GPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-CT  166 (268)
T ss_pred             HHHHHHhc--ccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC-cc
Confidence            99997532  334  788889999999999999998   99999999999999976 67899999999876543222 12


Q ss_pred             ccccCCCcccCCCccCCC--CCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCC
Q 002529          751 SVARGTVGYLDPEYYGNQ--QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN  828 (912)
Q Consensus       751 ~~~~gt~~y~APE~l~~~--~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  828 (912)
                      ....+++.|+|||++.+.  .++.++||||||+++|+|++|+.||.......   ...+......           ....
T Consensus       167 ~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~---~~~~~~~~~~-----------~~~~  232 (268)
T cd06624         167 ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ---AAMFKVGMFK-----------IHPE  232 (268)
T ss_pred             ccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh---hhHhhhhhhc-----------cCCC
Confidence            223478899999998654  37889999999999999999999997322111   1111000000           0011


Q ss_pred             CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          829 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       829 ~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                      .+......+.+++.+||+.+|++||++.|+++
T Consensus       233 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         233 IPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             CCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            12223347889999999999999999999986

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=3e-33  Score=316.49  Aligned_cols=262  Identities=23%  Similarity=0.285  Sum_probs=195.4

Q ss_pred             HHHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc--chhhHHHHHHHHHHHhcCCCCccceeeEEecCC------
Q 002529          589 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------  659 (912)
Q Consensus       589 ~~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~------  659 (912)
                      ...|++.+.||+|+||.||++... +++.||+|++....  ......+.+|+.+++.++||||+++++++....      
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            456778899999999999999875 58999999986432  234467789999999999999999999986443      


Q ss_pred             eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCc
Q 002529          660 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS  739 (912)
Q Consensus       660 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla  739 (912)
                      ..++||||+++ +|.+.+.     ..+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||++
T Consensus       100 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a  170 (359)
T cd07876         100 DVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA  170 (359)
T ss_pred             eeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCCc
Confidence            57999999965 6666664     247888999999999999999998   99999999999999999999999999999


Q ss_pred             cccccccccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhh------------H---
Q 002529          740 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN------------I---  804 (912)
Q Consensus       740 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~------------~---  804 (912)
                      .......  ......+++.|+|||++.+..++.++|||||||++|+|++|+.||...+......            .   
T Consensus       171 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (359)
T cd07876         171 RTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNR  248 (359)
T ss_pred             cccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHH
Confidence            7643321  1223457899999999999999999999999999999999999998543211100            0   


Q ss_pred             -HHHHHhhhccC-C-----cccccCcccc---CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002529          805 -VHWARSMIKKG-D-----VISIVDPVLI---GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       805 -~~~~~~~~~~~-~-----~~~~~d~~l~---~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  861 (912)
                       ...+....... .     ..+.......   ..........+.+++.+||+.||++|||++|+++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence             00000000000 0     0000000000   00011123468899999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.6e-33  Score=315.01  Aligned_cols=253  Identities=23%  Similarity=0.296  Sum_probs=196.5

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc---chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEe
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY  667 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  667 (912)
                      |++.+.||+|+||.||+++.+ +++.||+|++....   ......+.+|..++..++|+||+++++++.+++..++||||
T Consensus         3 y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey   82 (331)
T cd05624           3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDY   82 (331)
T ss_pred             ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence            567889999999999999876 57889999986422   22345578899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccc
Q 002529          668 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT  747 (912)
Q Consensus       668 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~  747 (912)
                      +++|+|.+++...  ...+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||++........
T Consensus        83 ~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  157 (331)
T cd05624          83 YVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT  157 (331)
T ss_pred             CCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence            9999999999742  4568899999999999999999998   9999999999999999999999999999977654333


Q ss_pred             cccccccCCCcccCCCccCC-----CCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccC
Q 002529          748 HISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD  822 (912)
Q Consensus       748 ~~~~~~~gt~~y~APE~l~~-----~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  822 (912)
                      .......|++.|+|||++.+     ..++.++|||||||++|||++|+.||......      +............. +.
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------~~~~~i~~~~~~~~-~p  230 (331)
T cd05624         158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHEERFQ-FP  230 (331)
T ss_pred             eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH------HHHHHHHcCCCccc-CC
Confidence            32333568999999999865     46788999999999999999999999743221      11111111111000 01


Q ss_pred             ccccCCCCHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 002529          823 PVLIGNVKIESIWRIAEVAIQCVEQRGFS--RPKMQEIVLA  861 (912)
Q Consensus       823 ~~l~~~~~~~~~~~l~~Li~~cL~~dP~~--RPs~~evl~~  861 (912)
                      +..     ......+.+++.+||...+++  |++++++++.
T Consensus       231 ~~~-----~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         231 SHI-----TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             Ccc-----ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            110     112346888999999876544  4688888754

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2.9e-33  Score=299.78  Aligned_cols=250  Identities=33%  Similarity=0.556  Sum_probs=201.5

Q ss_pred             hhhcccCccccEEEEEEEecC-----CCEEEEEEccCccch-hhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEE
Q 002529          593 NFCKKIGKGSFGSVYYGKMKD-----GKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE  666 (912)
Q Consensus       593 ~~~~~LG~G~fg~Vy~a~~~~-----~~~vAvK~l~~~~~~-~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E  666 (912)
                      ++.+.||.|+||.||++...+     +..||+|.++..... ..+.+.+|+++++.++|+||+++++++.+.+..+++||
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e   81 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME   81 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence            356899999999999998764     488999999765443 56789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccc
Q 002529          667 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL  746 (912)
Q Consensus       667 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~  746 (912)
                      ++++++|.+++.... ...+++..+..++.|++.||++||+   .+++|+||||+||+++.++.++|+|||++.......
T Consensus        82 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       82 YMEGGDLLDYLRKNR-PKELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             ccCCCCHHHHHHhhh-hccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence            999999999997532 2228999999999999999999998   899999999999999999999999999998765542


Q ss_pred             ccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhhhccCCcccccCccc
Q 002529          747 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL  825 (912)
Q Consensus       747 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  825 (912)
                      ........++..|+|||.+.+..++.++||||+|+++++|++ |..||.....   ....+.+    ..+.....     
T Consensus       158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~---~~~~~~~----~~~~~~~~-----  225 (258)
T smart00219      158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN---EEVLEYL----KKGYRLPK-----  225 (258)
T ss_pred             ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH----hcCCCCCC-----
Confidence            222222336789999999988889999999999999999998 7888863221   1122211    11111110     


Q ss_pred             cCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 002529          826 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI  862 (912)
Q Consensus       826 ~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  862 (912)
                          .......+.+++.+||..+|++|||+.|+++.|
T Consensus       226 ----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      226 ----PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             ----CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                111344788999999999999999999999864

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2.2e-33  Score=303.46  Aligned_cols=250  Identities=28%  Similarity=0.452  Sum_probs=197.5

Q ss_pred             cccCccccEEEEEEEecC-------CCEEEEEEccCcc-chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEe
Q 002529          596 KKIGKGSFGSVYYGKMKD-------GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY  667 (912)
Q Consensus       596 ~~LG~G~fg~Vy~a~~~~-------~~~vAvK~l~~~~-~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  667 (912)
                      +.||+|+||.||+|+.++       ++.+++|.+.... ......+.+|+++++.++||||+++++++......++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            468999999999998753       2579999886543 23456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCC-----cEEEeeccC
Q 002529          668 MHNGTLRDRLHGSV----NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-----RAKVSDFGL  738 (912)
Q Consensus       668 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~-----~vkL~DFGl  738 (912)
                      +++++|.+++....    ....+++.+++.++.|++.||+|||+   .+++|+||||+||+++.++     .++|+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            99999999997532    22457889999999999999999998   8999999999999999877     899999999


Q ss_pred             ccccccccc-cccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhhhccCC
Q 002529          739 SRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGD  816 (912)
Q Consensus       739 a~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~  816 (912)
                      +........ .......++..|+|||++.+..++.++||||||+++|||++ |+.||.....   ......+    ..+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~---~~~~~~~----~~~~  230 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN---QEVLQHV----TAGG  230 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH---HHHHHHH----hcCC
Confidence            876533211 11122235678999999999999999999999999999998 9999963221   1111111    1111


Q ss_pred             cccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhh
Q 002529          817 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD  864 (912)
Q Consensus       817 ~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~  864 (912)
                      ..         ..+...+..+.+++.+||+.+|++||++++|++.|++
T Consensus       231 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         231 RL---------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             cc---------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            10         1112234578899999999999999999999999874

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1e-32  Score=298.66  Aligned_cols=253  Identities=25%  Similarity=0.379  Sum_probs=189.9

Q ss_pred             cccCccccEEEEEEEecC---CCEEEEEEccCccc-hhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEecCCC
Q 002529          596 KKIGKGSFGSVYYGKMKD---GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG  671 (912)
Q Consensus       596 ~~LG~G~fg~Vy~a~~~~---~~~vAvK~l~~~~~-~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~g  671 (912)
                      ++||+|+||.||+|...+   ...+++|.+..... .....+.+|+++++.++|+||+++++.+.+....++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            469999999999997653   45788888764432 33467889999999999999999999999999999999999999


Q ss_pred             CHHHHhccCCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccc-c
Q 002529          672 TLRDRLHGSVN--QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT-H  748 (912)
Q Consensus       672 sL~~~l~~~~~--~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~-~  748 (912)
                      +|.+++.....  ....++..+..++.||+.||+|||+   ++|+||||||+||+++.++.+||+|||++........ .
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            99999975432  2345678889999999999999998   9999999999999999999999999999865432211 1


Q ss_pred             ccccccCCCcccCCCccC-------CCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhhhccCCcccc
Q 002529          749 ISSVARGTVGYLDPEYYG-------NQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISI  820 (912)
Q Consensus       749 ~~~~~~gt~~y~APE~l~-------~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  820 (912)
                      ......++..|+|||++.       ...++.++|||||||++|||++ |..||......   ..   ....+..+ ....
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~---~~~~~~~~-~~~~  230 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE---QV---LKQVVREQ-DIKL  230 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH---HH---HHHHhhcc-CccC
Confidence            112233567899999864       3456889999999999999999 78888632211   11   11112211 1112


Q ss_pred             cCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 002529          821 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ  863 (912)
Q Consensus       821 ~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  863 (912)
                      .++.+.    ......+.+++..|+ .||++||+++||++.|.
T Consensus       231 ~~~~~~----~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         231 PKPQLD----LKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCCccc----ccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            222221    122345677888888 59999999999998873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.1e-33  Score=296.76  Aligned_cols=258  Identities=24%  Similarity=0.278  Sum_probs=208.4

Q ss_pred             hhHHHHHHHhhhcccCccccEEEEEEEecC-CCEEEEEEccCccch---hhHHHHHHHHHHHhcCCCCccceeeEEecCC
Q 002529          584 LPELEEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSH---RTQQFVTEVALLSRIHHRNLVPLIGYCEEEH  659 (912)
Q Consensus       584 ~~~l~~~~~~~~~~LG~G~fg~Vy~a~~~~-~~~vAvK~l~~~~~~---~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~  659 (912)
                      ...|.-...++.+.||+|.-|+||++++++ +..+|+|++.+..-.   ...+.+.|-+||+.+.||.++.|+..|+.++
T Consensus        71 ~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~  150 (459)
T KOG0610|consen   71 DGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDK  150 (459)
T ss_pred             CCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccc
Confidence            345555667788999999999999999884 589999999765433   3355677999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCc
Q 002529          660 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS  739 (912)
Q Consensus       660 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla  739 (912)
                      ..|+|||||+||+|....+++ .++.+++..++-++..++-||+|||-   .|||+|||||+||||.++|++.|+||.++
T Consensus       151 ~~cl~meyCpGGdL~~LrqkQ-p~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS  226 (459)
T KOG0610|consen  151 YSCLVMEYCPGGDLHSLRQKQ-PGKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLS  226 (459)
T ss_pred             eeEEEEecCCCccHHHHHhhC-CCCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeecccc
Confidence            999999999999999888765 67889999999999999999999998   99999999999999999999999999887


Q ss_pred             cccccc--------------------------------c-c----------------------cccccccCCCcccCCCc
Q 002529          740 RQAEED--------------------------------L-T----------------------HISSVARGTVGYLDPEY  764 (912)
Q Consensus       740 ~~~~~~--------------------------------~-~----------------------~~~~~~~gt~~y~APE~  764 (912)
                      ......                                . .                      ..+...+||-.|+|||+
T Consensus       227 ~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEv  306 (459)
T KOG0610|consen  227 LRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEV  306 (459)
T ss_pred             ccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccccee
Confidence            542110                                0 0                      00112358999999999


Q ss_pred             cCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCCCCHHHHHHHHHHHHhc
Q 002529          765 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQC  844 (912)
Q Consensus       765 l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~c  844 (912)
                      +.+...+.+.|-|+|||++|||+.|+.||.+....+  .+...+.+.+           .+.  ..+.....+.+||++.
T Consensus       307 I~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~--Tl~NIv~~~l-----------~Fp--~~~~vs~~akDLIr~L  371 (459)
T KOG0610|consen  307 IRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE--TLRNIVGQPL-----------KFP--EEPEVSSAAKDLIRKL  371 (459)
T ss_pred             eecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchh--hHHHHhcCCC-----------cCC--CCCcchhHHHHHHHHH
Confidence            999999999999999999999999999998655432  2222221111           111  1123445789999999


Q ss_pred             ccCCCCCCCC----HHHHHH
Q 002529          845 VEQRGFSRPK----MQEIVL  860 (912)
Q Consensus       845 L~~dP~~RPs----~~evl~  860 (912)
                      |.+||++|..    +.||-+
T Consensus       372 LvKdP~kRlg~~rGA~eIK~  391 (459)
T KOG0610|consen  372 LVKDPSKRLGSKRGAAEIKR  391 (459)
T ss_pred             hccChhhhhccccchHHhhc
Confidence            9999999998    777764

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-32  Score=300.07  Aligned_cols=259  Identities=26%  Similarity=0.431  Sum_probs=205.7

Q ss_pred             HHHHHHhhhcccCccccEEEEEEEecC-CC----EEEEEEccCccc-hhhHHHHHHHHHHHhcCCCCccceeeEEecCCe
Q 002529          587 LEEATNNFCKKIGKGSFGSVYYGKMKD-GK----EVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ  660 (912)
Q Consensus       587 l~~~~~~~~~~LG~G~fg~Vy~a~~~~-~~----~vAvK~l~~~~~-~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~  660 (912)
                      +....+++.+.||+|+||.||+|.+++ ++    .+|+|.+..... .....+.+|+.++++++||||+++++++.. ..
T Consensus         4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~   82 (279)
T cd05057           4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQ   82 (279)
T ss_pred             cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cc
Confidence            345667788999999999999998753 33    589998875543 345678899999999999999999999987 78


Q ss_pred             EEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcc
Q 002529          661 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR  740 (912)
Q Consensus       661 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~  740 (912)
                      .++|+||+++|+|.+++...  ...+++..++.++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||.++
T Consensus        83 ~~~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~  157 (279)
T cd05057          83 VQLITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAK  157 (279)
T ss_pred             eEEEEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccc
Confidence            89999999999999999753  3458999999999999999999998   999999999999999999999999999998


Q ss_pred             cccccccccc-ccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhhhccCCcc
Q 002529          741 QAEEDLTHIS-SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVI  818 (912)
Q Consensus       741 ~~~~~~~~~~-~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  818 (912)
                      .......... ....++..|+|||.+....++.++|+||||+++||+++ |+.||......   .+.+.    +..+...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~----~~~~~~~  230 (279)
T cd05057         158 LLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV---EIPDL----LEKGERL  230 (279)
T ss_pred             cccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH---HHHHH----HhCCCCC
Confidence            7653322111 11223568999999988889999999999999999998 99999743221   12221    1111110


Q ss_pred             cccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhhhh
Q 002529          819 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK  867 (912)
Q Consensus       819 ~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~~~  867 (912)
                      .         .+......+.+++.+||..+|.+||++.++++.|+++..
T Consensus       231 ~---------~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         231 P---------QPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             C---------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            0         011122368899999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.1e-33  Score=301.01  Aligned_cols=240  Identities=25%  Similarity=0.442  Sum_probs=189.9

Q ss_pred             cccCccccEEEEEEEecC--------CCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEe
Q 002529          596 KKIGKGSFGSVYYGKMKD--------GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY  667 (912)
Q Consensus       596 ~~LG~G~fg~Vy~a~~~~--------~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  667 (912)
                      +.||+|+||.||+|..+.        ...|++|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            479999999999998642        235888887655445557788999999999999999999999998899999999


Q ss_pred             cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCc--------EEEeeccCc
Q 002529          668 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR--------AKVSDFGLS  739 (912)
Q Consensus       668 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~--------vkL~DFGla  739 (912)
                      +++|+|.++++..  +..+++..++.++.||+.||+|||+   ++|+||||||+||+++.++.        ++++|||.+
T Consensus        81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEecccccc
Confidence            9999999999753  3468899999999999999999998   99999999999999987665        699999988


Q ss_pred             cccccccccccccccCCCcccCCCccCC-CCCCchhHHHHHHHHHHHHHhCC-CCCCccCccchhhHHHHHHhhhccCCc
Q 002529          740 RQAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGK-KPVSVEDFGAELNIVHWARSMIKKGDV  817 (912)
Q Consensus       740 ~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~eLltG~-~Pf~~~~~~~~~~~~~~~~~~~~~~~~  817 (912)
                      ......     ....++..|+|||++.+ ..++.++||||||+++|||++|. .|+.......   ......   ...  
T Consensus       156 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~---~~~~~~---~~~--  222 (258)
T cd05078         156 ITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK---KLQFYE---DRH--  222 (258)
T ss_pred             cccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH---HHHHHH---ccc--
Confidence            654322     12346788999999976 45789999999999999999985 5554222111   111000   000  


Q ss_pred             ccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 002529          818 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ  863 (912)
Q Consensus       818 ~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  863 (912)
                                ..+.....++.+++.+||+.+|++|||++++++.|+
T Consensus       223 ----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         223 ----------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             ----------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                      111112246889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.9e-33  Score=314.44  Aligned_cols=192  Identities=24%  Similarity=0.336  Sum_probs=163.9

Q ss_pred             HHHHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEE
Q 002529          588 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE  666 (912)
Q Consensus       588 ~~~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E  666 (912)
                      ....|++.+.||+|+||.||+|..+ +++.||+|+....      ....|+.++++++||||+++++++......++|+|
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  137 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP  137 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence            3445788899999999999999876 5788999975432      23569999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccc
Q 002529          667 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL  746 (912)
Q Consensus       667 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~  746 (912)
                      ++. ++|.+++..  ....+++..++.|+.||+.||+|||+   ++|+||||||+|||++.++.+||+|||++.......
T Consensus       138 ~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  211 (357)
T PHA03209        138 HYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP  211 (357)
T ss_pred             ccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccCc
Confidence            994 688888864  34678999999999999999999998   999999999999999999999999999987533221


Q ss_pred             ccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 002529          747 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPV  793 (912)
Q Consensus       747 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf  793 (912)
                      .  .....||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus       212 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        212 A--FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             c--cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            1  12345899999999999999999999999999999999865554

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-33  Score=298.79  Aligned_cols=267  Identities=25%  Similarity=0.376  Sum_probs=204.4

Q ss_pred             HhhhcccCccccEEEEEEEecCCCEEEEEEccCccchhhHHHHHHHHHHHhc--CCCCccceeeEEecC----CeEEEEE
Q 002529          592 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI--HHRNLVPLIGYCEEE----HQRILVY  665 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L--~hpnIv~l~~~~~~~----~~~~lV~  665 (912)
                      ..+.+.||+|.||.||+|.|+ |+.||||++..   .+.+.+.+|.++++.+  +|+||+.+++.-..+    .+++||+
T Consensus       213 I~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvT  288 (513)
T KOG2052|consen  213 IVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVT  288 (513)
T ss_pred             eEEEEEecCccccceeecccc-CCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEee
Confidence            345889999999999999999 99999999974   3456788999998865  999999999876433    3689999


Q ss_pred             EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCCeeecCCCCCCccccCCCcEEEeeccCcc
Q 002529          666 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT-----GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR  740 (912)
Q Consensus       666 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs-----~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~  740 (912)
                      +|.+.|||.|+|.    ...++....++++..+|.||+|||.     +.+..|.|||||.+|||+..++.+.|+|+|+|.
T Consensus       289 dYHe~GSL~DyL~----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv  364 (513)
T KOG2052|consen  289 DYHEHGSLYDYLN----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  364 (513)
T ss_pred             ecccCCcHHHHHh----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeE
Confidence            9999999999997    4689999999999999999999995     235789999999999999999999999999998


Q ss_pred             ccccccc---cccccccCCCcccCCCccCCCC----C--CchhHHHHHHHHHHHHHhC----------CCCCCccCccch
Q 002529          741 QAEEDLT---HISSVARGTVGYLDPEYYGNQQ----L--TEKSDVYSFGVVLLELISG----------KKPVSVEDFGAE  801 (912)
Q Consensus       741 ~~~~~~~---~~~~~~~gt~~y~APE~l~~~~----~--s~ksDVwSlGvil~eLltG----------~~Pf~~~~~~~~  801 (912)
                      .......   -......||.+|||||++...-    +  -..+||||||+++||++-.          +.||.+-.. .+
T Consensus       365 ~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp-~D  443 (513)
T KOG2052|consen  365 RHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP-SD  443 (513)
T ss_pred             EecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC-CC
Confidence            8655432   2334567999999999986531    1  2469999999999999752          466652221 11


Q ss_pred             hhHHHHHHhhhccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhhhhhccC
Q 002529          802 LNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG  871 (912)
Q Consensus       802 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~~~~~~~  871 (912)
                      .++.+ ++..+--.+....++.+   -.+.+.+..+.++++.||..+|..|-|+--+.+.|.++...+++
T Consensus       444 Ps~ee-MrkVVCv~~~RP~ipnr---W~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~~ek  509 (513)
T KOG2052|consen  444 PSFEE-MRKVVCVQKLRPNIPNR---WKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNSDEK  509 (513)
T ss_pred             CCHHH-HhcceeecccCCCCCcc---cccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcChhh
Confidence            12211 11111111111111111   12356778899999999999999999999999999988765443

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3.4e-33  Score=315.47  Aligned_cols=262  Identities=22%  Similarity=0.295  Sum_probs=196.4

Q ss_pred             HHHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc--chhhHHHHHHHHHHHhcCCCCccceeeEEecC------C
Q 002529          589 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------H  659 (912)
Q Consensus       589 ~~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~------~  659 (912)
                      ..+|++.+.||+|+||.||++... .++.||+|++....  ......+.+|+.+++.++||||+++++++...      .
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   95 (355)
T cd07874          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ   95 (355)
T ss_pred             hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence            356778899999999999999875 58899999987532  23346678899999999999999999988543      3


Q ss_pred             eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCc
Q 002529          660 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS  739 (912)
Q Consensus       660 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla  739 (912)
                      ..++||||+++ +|.+.+.     ..+++..+..++.|+++||+|||+   ++|+||||||+|||++.++.+||+|||++
T Consensus        96 ~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~~  166 (355)
T cd07874          96 DVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_pred             eeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCccc
Confidence            57999999964 6777665     247888999999999999999998   99999999999999999999999999999


Q ss_pred             cccccccccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhh-HHH------------
Q 002529          740 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN-IVH------------  806 (912)
Q Consensus       740 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~-~~~------------  806 (912)
                      +.......  .....+++.|+|||++.+..++.++|||||||++|+|++|+.||.......... ...            
T Consensus       167 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (355)
T cd07874         167 RTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  244 (355)
T ss_pred             ccCCCccc--cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            86543221  223458999999999999899999999999999999999999997543221110 000            


Q ss_pred             ---HHHhhhccC-CcccccCcc-----cc---CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002529          807 ---WARSMIKKG-DVISIVDPV-----LI---GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       807 ---~~~~~~~~~-~~~~~~d~~-----l~---~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  861 (912)
                         .+....... .......+.     +.   ..........+.+++.+||+.||++|||+.|+++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             hcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence               000000000 000000000     00   00111223467899999999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=4.8e-33  Score=303.48  Aligned_cols=260  Identities=23%  Similarity=0.293  Sum_probs=200.8

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc--chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEec
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM  668 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~  668 (912)
                      |++.+.||+|++|.||+|... +++.||+|++....  ......+.+|+.++++++||||+++++++..+...++|+||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   81 (286)
T cd07832           2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM   81 (286)
T ss_pred             ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence            567789999999999999876 68999999987543  233567899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccc
Q 002529          669 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH  748 (912)
Q Consensus       669 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  748 (912)
                       +++|.+++...  ...+++.+++.++.||++||+|||+   .+++|+||||+||+++.++.++|+|||++.........
T Consensus        82 -~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~  155 (286)
T cd07832          82 -PSDLSEVLRDE--ERPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR  155 (286)
T ss_pred             -CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence             99999998743  3668999999999999999999998   99999999999999999999999999998876543322


Q ss_pred             ccccccCCCcccCCCccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCC-----------
Q 002529          749 ISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD-----------  816 (912)
Q Consensus       749 ~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~-----------  816 (912)
                      ......++..|+|||.+.+. .++.++||||+|++++||++|.+||.......   .............           
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07832         156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE---QLAIVFRTLGTPNEETWPGLTSLP  232 (286)
T ss_pred             ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH---HHHHHHHHcCCCChHHHhhccCcc
Confidence            22334578899999998654 46899999999999999999988886433211   1111111111000           


Q ss_pred             -cccccCcccc----CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          817 -VISIVDPVLI----GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       817 -~~~~~d~~l~----~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                       ...+..+...    .....+....+.+++.+||+.+|++||+++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence             0000000000    0001123368899999999999999999999986

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=8.4e-33  Score=296.69  Aligned_cols=248  Identities=26%  Similarity=0.405  Sum_probs=199.2

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc--chhhHHHHHHHHHHHhcCCCCccceeeEEec-CCeEEEEEEe
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE-EHQRILVYEY  667 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~-~~~~~lV~E~  667 (912)
                      |++.+.||+|++|.||++..+ +++.||+|.+....  ....+.+.+|++++++++|+|++++++.+.. +...+++|||
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (257)
T cd08223           2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF   81 (257)
T ss_pred             ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence            567899999999999999876 57899999986432  2344678899999999999999999998764 4467899999


Q ss_pred             cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccc
Q 002529          668 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT  747 (912)
Q Consensus       668 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~  747 (912)
                      +++++|.+++... ....+++.+++.++.|++.||++||+   .+++|+||||+||+++.++.++|+|||++........
T Consensus        82 ~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~  157 (257)
T cd08223          82 CEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD  157 (257)
T ss_pred             cCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence            9999999999753 24568999999999999999999998   9999999999999999999999999999876543222


Q ss_pred             cccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccC
Q 002529          748 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG  827 (912)
Q Consensus       748 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  827 (912)
                       ......+++.|+|||++.+..++.++||||||+++++|++|+.||...+..      ....... .+...         
T Consensus       158 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~------~~~~~~~-~~~~~---------  220 (257)
T cd08223         158 -MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN------SLVYRII-EGKLP---------  220 (257)
T ss_pred             -ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHH-hcCCC---------
Confidence             222345788999999999999999999999999999999999999733221      1111111 11111         


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          828 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       828 ~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                      ..+......+.+++.+|++.+|++||++.|+++
T Consensus       221 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         221 PMPKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             CCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            111223347889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.7e-33  Score=321.01  Aligned_cols=259  Identities=21%  Similarity=0.246  Sum_probs=194.1

Q ss_pred             HHhhhcccCccccEEEEEEEec-CCCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEecC
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH  669 (912)
Q Consensus       591 ~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~  669 (912)
                      .|.+.+.||+|+||.||+|.+. .++.||||...      ...+.+|+++|++++|+||+++++++..++..++|||++ 
T Consensus       170 gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-  242 (461)
T PHA03211        170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY-  242 (461)
T ss_pred             CeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-
Confidence            4566789999999999999887 47889999643      234578999999999999999999999999999999999 


Q ss_pred             CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccc-c
Q 002529          670 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT-H  748 (912)
Q Consensus       670 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~-~  748 (912)
                      .++|.+++...  ...+++..++.|+.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++....... .
T Consensus       243 ~~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~  317 (461)
T PHA03211        243 RSDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP  317 (461)
T ss_pred             CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence            47888888642  3479999999999999999999998   9999999999999999999999999999986543221 1


Q ss_pred             ccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcc-c----hhhHHHHHHhhhc-cCCcccccC
Q 002529          749 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG-A----ELNIVHWARSMIK-KGDVISIVD  822 (912)
Q Consensus       749 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~-~----~~~~~~~~~~~~~-~~~~~~~~d  822 (912)
                      ......||..|+|||++.+..++.++|||||||++|||++|..|+...... .    ...+.+.+..... .........
T Consensus       318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~  397 (461)
T PHA03211        318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAG  397 (461)
T ss_pred             cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcc
Confidence            122345899999999999999999999999999999999988765422211 1    1112221111100 000000000


Q ss_pred             cc------------ccCCCC-------HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002529          823 PV------------LIGNVK-------IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       823 ~~------------l~~~~~-------~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  861 (912)
                      ..            ......       ......+.+|+.+||+.||++|||+.|+++.
T Consensus       398 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        398 SRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             hHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            00            000000       0112367899999999999999999999874

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=6.8e-33  Score=299.35  Aligned_cols=251  Identities=24%  Similarity=0.407  Sum_probs=199.5

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCccc------hhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEE
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV  664 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~------~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV  664 (912)
                      |+..+.||+|++|.||+|... +++.||+|.+.....      ...+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus         2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v   81 (268)
T cd06630           2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLF   81 (268)
T ss_pred             ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEE
Confidence            445688999999999999864 689999999864321      1346788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCC-cEEEeeccCccccc
Q 002529          665 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAE  743 (912)
Q Consensus       665 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~-~vkL~DFGla~~~~  743 (912)
                      +||+++++|.+++..   ...+++..++.++.|++.||+|||+   ++++|+||+|+||+++.++ .++|+|||.+....
T Consensus        82 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~  155 (268)
T cd06630          82 VEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA  155 (268)
T ss_pred             EeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence            999999999999973   4578899999999999999999998   9999999999999998775 59999999987764


Q ss_pred             ccccc---ccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccc
Q 002529          744 EDLTH---ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI  820 (912)
Q Consensus       744 ~~~~~---~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  820 (912)
                      .....   ......++..|+|||.+.+..++.++||||+|+++++|++|+.||..........   ..........    
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~---~~~~~~~~~~----  228 (268)
T cd06630         156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLA---LIFKIASATT----  228 (268)
T ss_pred             cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHH---HHHHHhccCC----
Confidence            43211   1123357889999999988889999999999999999999999997433221111   1111111000    


Q ss_pred             cCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          821 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       821 ~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                           ....+......+.+++.+||+.+|.+||++.|+++
T Consensus       229 -----~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         229 -----APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             -----CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence                 11222233457889999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.3e-33  Score=313.97  Aligned_cols=253  Identities=24%  Similarity=0.304  Sum_probs=195.8

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc---chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEe
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY  667 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  667 (912)
                      |++.++||+|+||.||+++.+ +++.+|+|++.+..   ......+.+|+.++..++|++|+++++.+.+.+..++||||
T Consensus         3 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey   82 (332)
T cd05623           3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDY   82 (332)
T ss_pred             ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEec
Confidence            567789999999999999887 47889999986422   22334578899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccc
Q 002529          668 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT  747 (912)
Q Consensus       668 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~  747 (912)
                      +++|+|.+++...  ...+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||++........
T Consensus        83 ~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~  157 (332)
T cd05623          83 YVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT  157 (332)
T ss_pred             cCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence            9999999999742  4568999999999999999999998   9999999999999999999999999999876543333


Q ss_pred             cccccccCCCcccCCCccC-----CCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccC
Q 002529          748 HISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD  822 (912)
Q Consensus       748 ~~~~~~~gt~~y~APE~l~-----~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  822 (912)
                      .......||+.|+|||++.     ...++.++|||||||++|||++|+.||......      +.............. .
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~------~~~~~i~~~~~~~~~-p  230 (332)
T cd05623         158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHKERFQF-P  230 (332)
T ss_pred             ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH------HHHHHHhCCCccccC-C
Confidence            3333456899999999986     346788999999999999999999999743221      111222111110000 0


Q ss_pred             ccccCCCCHHHHHHHHHHHHhcccCCCC--CCCCHHHHHHH
Q 002529          823 PVLIGNVKIESIWRIAEVAIQCVEQRGF--SRPKMQEIVLA  861 (912)
Q Consensus       823 ~~l~~~~~~~~~~~l~~Li~~cL~~dP~--~RPs~~evl~~  861 (912)
                      .     ........+.+++.+|+..++.  .|++++|+++.
T Consensus       231 ~-----~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         231 A-----QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             C-----ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            0     0111234677888898865444  37899999866

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=3.4e-33  Score=299.68  Aligned_cols=247  Identities=30%  Similarity=0.489  Sum_probs=198.6

Q ss_pred             HHHhhhcccCccccEEEEEEEecCCCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEecC
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH  669 (912)
Q Consensus       590 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~  669 (912)
                      ..|++.+.||+|+||.||++.. +++.||+|.++...  ....+.+|+.++++++|||++++++++..+ ..+++|||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            4577889999999999999975 57889999986532  346788999999999999999999998765 4799999999


Q ss_pred             CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccccc
Q 002529          670 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI  749 (912)
Q Consensus       670 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~  749 (912)
                      +++|.+++... ....+++..++.++.|++.||+|||+   .+++||||||+||+++.++.++|+|||++........  
T Consensus        82 ~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~--  155 (254)
T cd05083          82 KGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD--  155 (254)
T ss_pred             CCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccCC--
Confidence            99999999754 34468899999999999999999998   9999999999999999999999999999876433211  


Q ss_pred             cccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCC
Q 002529          750 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN  828 (912)
Q Consensus       750 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  828 (912)
                        ....+..|+|||.+.+..++.++|+||||+++|||++ |+.||......   ...+    .+..+....         
T Consensus       156 --~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~~----~~~~~~~~~---------  217 (254)
T cd05083         156 --NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK---EVKE----CVEKGYRME---------  217 (254)
T ss_pred             --CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH---HHHH----HHhCCCCCC---------
Confidence              1224568999999988899999999999999999998 99999743321   1111    111111111         


Q ss_pred             CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhh
Q 002529          829 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD  864 (912)
Q Consensus       829 ~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~  864 (912)
                      .....+..+.+++.+||+.+|++||+++++++.|++
T Consensus       218 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            111223478899999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=8.3e-33  Score=296.48  Aligned_cols=246  Identities=28%  Similarity=0.386  Sum_probs=198.5

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc-----chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEE
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-----SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY  665 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~-----~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~  665 (912)
                      |+..+.||+|++|.||+|..+ +++.|++|.+....     ....+.+.+|+++++.++|+||+++++++..+...++++
T Consensus         2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   81 (258)
T cd06632           2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL   81 (258)
T ss_pred             ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence            455688999999999999887 78999999986432     224467889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccc
Q 002529          666 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED  745 (912)
Q Consensus       666 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~  745 (912)
                      ||+++++|.+++..   ...+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.+||+|||++......
T Consensus        82 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~  155 (258)
T cd06632          82 ELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF  155 (258)
T ss_pred             EecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence            99999999999973   4568899999999999999999998   99999999999999999999999999998765433


Q ss_pred             cccccccccCCCcccCCCccCCCC-CCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCcc
Q 002529          746 LTHISSVARGTVGYLDPEYYGNQQ-LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV  824 (912)
Q Consensus       746 ~~~~~~~~~gt~~y~APE~l~~~~-~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  824 (912)
                      .  ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||.....  .    .............      
T Consensus       156 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~--~----~~~~~~~~~~~~~------  221 (258)
T cd06632         156 S--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG--V----AAVFKIGRSKELP------  221 (258)
T ss_pred             c--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH--H----HHHHHHHhcccCC------
Confidence            2  122345788999999987766 89999999999999999999999973321  1    1111111101111      


Q ss_pred             ccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          825 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       825 l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                         ..+......+.+++.+||+.+|++||++.++++
T Consensus       222 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         222 ---PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             ---CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence               111122346889999999999999999999985

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1e-33  Score=320.36  Aligned_cols=250  Identities=22%  Similarity=0.342  Sum_probs=194.8

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc---chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEe
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY  667 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  667 (912)
                      |++.+.||+|+||.||++..+ +++.||+|+++...   ......+.+|+.++.+++||||+++++.+.+.+..++||||
T Consensus         3 f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~   82 (360)
T cd05627           3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEF   82 (360)
T ss_pred             ceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence            456789999999999999876 58999999986432   22345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccc
Q 002529          668 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT  747 (912)
Q Consensus       668 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~  747 (912)
                      +++|+|.+++.   ....+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.++|+|||++........
T Consensus        83 ~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~  156 (360)
T cd05627          83 LPGGDMMTLLM---KKDTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR  156 (360)
T ss_pred             CCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence            99999999997   35678999999999999999999998   9999999999999999999999999999875432110


Q ss_pred             ----------------------------------cccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 002529          748 ----------------------------------HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPV  793 (912)
Q Consensus       748 ----------------------------------~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf  793 (912)
                                                        .......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf  236 (360)
T cd05627         157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (360)
T ss_pred             cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence                                              0011245899999999999999999999999999999999999999


Q ss_pred             CccCccchhhHHHHHHhhhccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCC---HHHHHHH
Q 002529          794 SVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK---MQEIVLA  861 (912)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs---~~evl~~  861 (912)
                      .......      ............. +.+.      ......+.+++.+|+. +|.+|++   +.|+++.
T Consensus       237 ~~~~~~~------~~~~i~~~~~~~~-~p~~------~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h  293 (360)
T cd05627         237 CSETPQE------TYRKVMNWKETLV-FPPE------VPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH  293 (360)
T ss_pred             CCCCHHH------HHHHHHcCCCcee-cCCC------CCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence            7433211      1111111110000 1110      0122367788888774 9999995   5666643

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=4.9e-33  Score=303.42  Aligned_cols=263  Identities=23%  Similarity=0.287  Sum_probs=199.0

Q ss_pred             HHhhhcccCccccEEEEEEEec-CCCEEEEEEccCccc--hhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEe
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY  667 (912)
Q Consensus       591 ~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  667 (912)
                      .|++.+.||+|++|.||+|..+ +++.||+|++.....  ...+.+.+|++++++++|+||+++++++......++||||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~   81 (286)
T cd07847           2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY   81 (286)
T ss_pred             ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence            3667789999999999999887 589999999864322  2335678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccc
Q 002529          668 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT  747 (912)
Q Consensus       668 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~  747 (912)
                      ++++.|..++.   ....+++..++.++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||++........
T Consensus        82 ~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07847          82 CDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD  155 (286)
T ss_pred             cCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence            99988888775   34568999999999999999999998   9999999999999999999999999999987644322


Q ss_pred             cccccccCCCcccCCCccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhh-HHHHHHhhhc-------cCCc-
Q 002529          748 HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN-IVHWARSMIK-------KGDV-  817 (912)
Q Consensus       748 ~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~-~~~~~~~~~~-------~~~~-  817 (912)
                      . .....++..|+|||++.+ ..++.++||||||+++|+|++|+.||......+... ..........       .... 
T Consensus       156 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07847         156 D-YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF  234 (286)
T ss_pred             c-ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence            1 122346789999999865 567899999999999999999999997443321111 1110000000       0000 


Q ss_pred             ccccCccccCCCC-----HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          818 ISIVDPVLIGNVK-----IESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       818 ~~~~d~~l~~~~~-----~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                      .....+......+     ......+.+++.+||+.+|++||++.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            0000010000000     112357889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=3.2e-33  Score=327.31  Aligned_cols=261  Identities=19%  Similarity=0.270  Sum_probs=190.8

Q ss_pred             HHHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCccchhhHHHHHHHHHHHhcCC------CCccceeeEEecC-Ce
Q 002529          589 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH------RNLVPLIGYCEEE-HQ  660 (912)
Q Consensus       589 ~~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~h------pnIv~l~~~~~~~-~~  660 (912)
                      ...|++.++||+|+||+||+|.+. .++.||||+++... ...+....|+++++.++|      .+++++++++..+ .+
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~  206 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGH  206 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCce
Confidence            356778899999999999999876 57889999986432 223455678888777754      4588888888654 57


Q ss_pred             EEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCC-----------
Q 002529          661 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-----------  729 (912)
Q Consensus       661 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~-----------  729 (912)
                      .++|||++ +++|.+++..   ...+++..+..|+.||+.||+|||+  ..+|+||||||+|||++.++           
T Consensus       207 ~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~  280 (467)
T PTZ00284        207 MCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVTNRAL  280 (467)
T ss_pred             EEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCccccccccccc
Confidence            88999988 7889888873   4679999999999999999999996  25999999999999998665           


Q ss_pred             -----cEEEeeccCccccccccccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhH
Q 002529          730 -----RAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNI  804 (912)
Q Consensus       730 -----~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~  804 (912)
                           .+||+|||.+......    .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....
T Consensus       281 ~~~~~~vkl~DfG~~~~~~~~----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~  356 (467)
T PTZ00284        281 PPDPCRVRICDLGGCCDERHS----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL  356 (467)
T ss_pred             CCCCceEEECCCCccccCccc----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence                 4999999987643222    2335689999999999999999999999999999999999999975443222111


Q ss_pred             HHHHHhhhc------------------cCCcccccCccc-----cC--CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 002529          805 VHWARSMIK------------------KGDVISIVDPVL-----IG--NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV  859 (912)
Q Consensus       805 ~~~~~~~~~------------------~~~~~~~~d~~l-----~~--~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl  859 (912)
                      .......+.                  .+......++..     ..  .........+.+||.+||+.||++|||++|++
T Consensus       357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L  436 (467)
T PTZ00284        357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT  436 (467)
T ss_pred             HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence            111100000                  000000000000     00  00001124578999999999999999999998


Q ss_pred             H
Q 002529          860 L  860 (912)
Q Consensus       860 ~  860 (912)
                      +
T Consensus       437 ~  437 (467)
T PTZ00284        437 T  437 (467)
T ss_pred             c
Confidence            6

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=8.3e-33  Score=296.73  Aligned_cols=249  Identities=22%  Similarity=0.362  Sum_probs=202.9

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCc--cchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEec
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM  668 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~  668 (912)
                      |++.+.||.|+||.||.++.. +++.+++|.+...  .....+.+.+|++++++++|+||+++++++.+.+..+++|||+
T Consensus         2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~   81 (256)
T cd08221           2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA   81 (256)
T ss_pred             ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence            567899999999999999865 5889999987643  2344567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccc
Q 002529          669 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH  748 (912)
Q Consensus       669 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  748 (912)
                      ++++|.+++.... ...+++.++..++.|++.||+|||+   .+++|+||+|+||+++.++.+||+|||++........ 
T Consensus        82 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-  156 (256)
T cd08221          82 NGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-  156 (256)
T ss_pred             CCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence            9999999997542 4568999999999999999999998   8999999999999999999999999999877644332 


Q ss_pred             ccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCC
Q 002529          749 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN  828 (912)
Q Consensus       749 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  828 (912)
                      ......+++.|+|||.+.+..++.++||||||+++|||++|+.||.....      .+...... .+.....        
T Consensus       157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~~-~~~~~~~--------  221 (256)
T cd08221         157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP------LNLVVKIV-QGNYTPV--------  221 (256)
T ss_pred             cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHH-cCCCCCC--------
Confidence            22334578999999999888889999999999999999999999973221      11121111 1111111        


Q ss_pred             CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002529          829 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       829 ~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  861 (912)
                       .......+.+++.+||+.+|.+||+++|+++.
T Consensus       222 -~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         222 -VSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             -ccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence             11223478899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-33  Score=303.87  Aligned_cols=264  Identities=21%  Similarity=0.258  Sum_probs=201.1

Q ss_pred             HHhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc--chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEe
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY  667 (912)
Q Consensus       591 ~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  667 (912)
                      +|++.+.||+|++|.||+|.++ +++.|++|.++...  ......+.+|++++++++|+||+++++++..++..++||||
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   81 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY   81 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence            4667889999999999999887 58899999986532  22346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccc
Q 002529          668 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT  747 (912)
Q Consensus       668 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~  747 (912)
                      ++++.+..+..   ....+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.+||+|||++........
T Consensus        82 ~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~  155 (288)
T cd07833          82 VERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA  155 (288)
T ss_pred             CCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence            99877766654   34568999999999999999999998   8999999999999999999999999999887655433


Q ss_pred             cccccccCCCcccCCCccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhh---------ccCCc
Q 002529          748 HISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI---------KKGDV  817 (912)
Q Consensus       748 ~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~---------~~~~~  817 (912)
                      .......++..|+|||++.+. .++.++||||||+++|+|++|+.||......+............         .....
T Consensus       156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07833         156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF  235 (288)
T ss_pred             ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence            223334578899999999887 88999999999999999999999997433221110000000000         00000


Q ss_pred             -----ccccCcc-ccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          818 -----ISIVDPV-LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       818 -----~~~~d~~-l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                           ....++. ....++.....++.+++++||..+|++||+++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence                 0000000 000111122567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=6.8e-33  Score=335.44  Aligned_cols=257  Identities=23%  Similarity=0.348  Sum_probs=198.0

Q ss_pred             HHHHHHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCc--cchhhHHHHHHHHHHHhcCCCCccceeeEEec--CCe
Q 002529          586 ELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQ  660 (912)
Q Consensus       586 ~l~~~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~--~~~  660 (912)
                      +.....|++.++||+|+||+||+|.+. +++.||+|++...  .......+..|+.++++|+||||++++++|..  ...
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~   88 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK   88 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence            444457888999999999999999876 5778999988643  22345678899999999999999999998854  457


Q ss_pred             EEEEEEecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcC----CCCeeecCCCCCCccccC--------
Q 002529          661 RILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGC----NPGIIHRDVKSSNILLDI--------  727 (912)
Q Consensus       661 ~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LHs~~----~~~ivH~DLkp~NILl~~--------  727 (912)
                      .+|||||+++|+|.++|.... ....+++..++.|+.||+.||+|||+..    ..+|+||||||+||||+.        
T Consensus        89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i  168 (1021)
T PTZ00266         89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI  168 (1021)
T ss_pred             EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence            899999999999999987532 2357999999999999999999999721    135999999999999964        


Q ss_pred             ---------CCcEEEeeccCccccccccccccccccCCCcccCCCccCC--CCCCchhHHHHHHHHHHHHHhCCCCCCcc
Q 002529          728 ---------NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVE  796 (912)
Q Consensus       728 ---------~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~s~ksDVwSlGvil~eLltG~~Pf~~~  796 (912)
                               .+.+||+|||++.......  ......||+.|+|||++.+  ..++.++|||||||++|||++|+.||...
T Consensus       169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~  246 (1021)
T PTZ00266        169 TAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA  246 (1021)
T ss_pred             cccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence                     2348999999998654322  1233468999999999854  45889999999999999999999999732


Q ss_pred             CccchhhHHHHHHhhhccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          797 DFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       797 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                      ..     ....+. .+..+..     ..+ .    .....+.+||.+||+.+|.+||++.|+++
T Consensus       247 ~~-----~~qli~-~lk~~p~-----lpi-~----~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        247 NN-----FSQLIS-ELKRGPD-----LPI-K----GKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             Cc-----HHHHHH-HHhcCCC-----CCc-C----CCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            21     111111 1111110     000 0    11346889999999999999999999984

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=5.1e-33  Score=315.14  Aligned_cols=262  Identities=23%  Similarity=0.290  Sum_probs=196.1

Q ss_pred             HHHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc--chhhHHHHHHHHHHHhcCCCCccceeeEEecC------C
Q 002529          589 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------H  659 (912)
Q Consensus       589 ~~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~------~  659 (912)
                      ..+|++.+.||+|+||.||+|... .++.||||++....  ......+.+|+.+++.++||||+++++++...      .
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            356778899999999999999876 58899999987532  23446678899999999999999999987543      3


Q ss_pred             eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCc
Q 002529          660 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS  739 (912)
Q Consensus       660 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla  739 (912)
                      ..++||||++ ++|.+.+.     ..+++..+..++.|++.||+|||+   ++|+||||||+||+++.++.+||+|||++
T Consensus       103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a  173 (364)
T cd07875         103 DVYIVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA  173 (364)
T ss_pred             eEEEEEeCCC-CCHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence            5799999996 47777765     247888999999999999999998   99999999999999999999999999999


Q ss_pred             cccccccccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHH-H--------H---
Q 002529          740 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV-H--------W---  807 (912)
Q Consensus       740 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~-~--------~---  807 (912)
                      +......  ......++..|+|||++.+..++.++|||||||++|+|++|+.||...+..+..... .        +   
T Consensus       174 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (364)
T cd07875         174 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK  251 (364)
T ss_pred             cccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence            8654322  122345899999999999999999999999999999999999999754332111000 0        0   


Q ss_pred             ----HHhhhccCC-c-----ccccCccc---cCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002529          808 ----ARSMIKKGD-V-----ISIVDPVL---IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       808 ----~~~~~~~~~-~-----~~~~d~~l---~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  861 (912)
                          +........ .     ........   ...........+.+++.+||+.||.+|||++|+++.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             hhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                000000000 0     00000000   000011123468899999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.6e-32  Score=297.01  Aligned_cols=254  Identities=22%  Similarity=0.369  Sum_probs=200.4

Q ss_pred             HhhhcccCccccEEEEEEEecC--CCEEEEEEccCcc----------chhhHHHHHHHHHHHh-cCCCCccceeeEEecC
Q 002529          592 NNFCKKIGKGSFGSVYYGKMKD--GKEVAVKIMADSC----------SHRTQQFVTEVALLSR-IHHRNLVPLIGYCEEE  658 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~~--~~~vAvK~l~~~~----------~~~~~~~~~E~~il~~-L~hpnIv~l~~~~~~~  658 (912)
                      |.+.+.||+|+||.||+|.++.  ++.+|+|.+....          ......+.+|+.++.+ ++||||+++++++..+
T Consensus         2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   81 (269)
T cd08528           2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN   81 (269)
T ss_pred             chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence            5567899999999999999875  6889999875321          1233456778888865 6899999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeecc
Q 002529          659 HQRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG  737 (912)
Q Consensus       659 ~~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFG  737 (912)
                      +..+++|||+++++|.+++.... ....+++..++.++.|++.||.|||+  ..+++|+||+|+||+++.++.++|+|||
T Consensus        82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~dfg  159 (269)
T cd08528          82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFG  159 (269)
T ss_pred             CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEeccc
Confidence            99999999999999999875422 34568999999999999999999995  2689999999999999999999999999


Q ss_pred             CccccccccccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCc
Q 002529          738 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV  817 (912)
Q Consensus       738 la~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  817 (912)
                      .+.......  ......++..|+|||.+.+..++.++||||||+++|+|++|+.||......   ...   ... ..+..
T Consensus       160 ~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~---~~~---~~~-~~~~~  230 (269)
T cd08528         160 LAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML---SLA---TKI-VEAVY  230 (269)
T ss_pred             ceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH---HHH---HHH-hhccC
Confidence            998754432  223345788999999999888999999999999999999999999732211   111   111 11111


Q ss_pred             ccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhh
Q 002529          818 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD  864 (912)
Q Consensus       818 ~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~  864 (912)
                      ....        .......+.+++.+||+.||++||++.|+..++++
T Consensus       231 ~~~~--------~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~  269 (269)
T cd08528         231 EPLP--------EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD  269 (269)
T ss_pred             CcCC--------cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence            1110        01123478899999999999999999999998864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.8e-32  Score=296.85  Aligned_cols=253  Identities=24%  Similarity=0.367  Sum_probs=189.9

Q ss_pred             cccCccccEEEEEEEecCC---CEEEEEEccCcc-chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEecCCC
Q 002529          596 KKIGKGSFGSVYYGKMKDG---KEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG  671 (912)
Q Consensus       596 ~~LG~G~fg~Vy~a~~~~~---~~vAvK~l~~~~-~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~g  671 (912)
                      +.||+|+||.||+|...++   ..+++|.++... ....+.+.+|+.+++.++||||+++++.+......++||||+++|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            3699999999999976543   346677665433 234568899999999999999999999999999999999999999


Q ss_pred             CHHHHhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccc-cccc
Q 002529          672 TLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED-LTHI  749 (912)
Q Consensus       672 sL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~-~~~~  749 (912)
                      +|.++++... .....++..+..++.||++||+|||+   .+++|+||||+|||++.++.++|+|||++...... ....
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            9999997542 23456777888999999999999998   99999999999999999999999999987643211 1111


Q ss_pred             cccccCCCcccCCCccCC-------CCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhhhccCCccccc
Q 002529          750 SSVARGTVGYLDPEYYGN-------QQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV  821 (912)
Q Consensus       750 ~~~~~gt~~y~APE~l~~-------~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  821 (912)
                      .....++..|+|||++..       ..++.++||||||+++|||++ |..||.....      .+.....+.. ......
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~------~~~~~~~~~~-~~~~~~  230 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD------REVLNHVIKD-QQVKLF  230 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHhh-cccccC
Confidence            223457889999998753       245789999999999999997 5678753221      1111112221 222233


Q ss_pred             CccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 002529          822 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ  863 (912)
Q Consensus       822 d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  863 (912)
                      ++.+...    ....+.+++..|+ .+|++||+++||++.|.
T Consensus       231 ~~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         231 KPQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CCccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            3333222    2246778999999 67999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-34  Score=295.67  Aligned_cols=248  Identities=25%  Similarity=0.380  Sum_probs=209.3

Q ss_pred             HHHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEe
Q 002529          589 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY  667 (912)
Q Consensus       589 ~~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  667 (912)
                      +.-+.+.++||+|+||.||+|.++ .|+.+|+|.+.-  ..+.+++.+|+.++++++.|+||+++|.+.....+++||||
T Consensus        32 EEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY  109 (502)
T KOG0574|consen   32 EEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY  109 (502)
T ss_pred             HHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence            344567899999999999999887 599999998754  34567889999999999999999999998888899999999


Q ss_pred             cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccc
Q 002529          668 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT  747 (912)
Q Consensus       668 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~  747 (912)
                      |..|++.|+++..  ++++++.++..+++..++||+|||.   ..-+|||||..|||++.+|.+||+|||.|-...+...
T Consensus       110 CGAGSiSDI~R~R--~K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA  184 (502)
T KOG0574|consen  110 CGAGSISDIMRAR--RKPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA  184 (502)
T ss_pred             cCCCcHHHHHHHh--cCCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhhHH
Confidence            9999999999863  6889999999999999999999998   8889999999999999999999999999988766544


Q ss_pred             cccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccC
Q 002529          748 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG  827 (912)
Q Consensus       748 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  827 (912)
                      .. ....||+.|||||+++.-.|..++||||||++..||..|++||......                +..-++.....+
T Consensus       185 KR-NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM----------------RAIFMIPT~PPP  247 (502)
T KOG0574|consen  185 KR-NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM----------------RAIFMIPTKPPP  247 (502)
T ss_pred             hh-CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc----------------ceeEeccCCCCC
Confidence            43 3457999999999999999999999999999999999999999732211                000111111111


Q ss_pred             --CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          828 --NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       828 --~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                        ..+.....++-++++.||-+.|++|-|+-++++
T Consensus       248 TF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  248 TFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             CCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence              234556678999999999999999999998875

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=9.8e-33  Score=306.15  Aligned_cols=196  Identities=26%  Similarity=0.388  Sum_probs=159.9

Q ss_pred             hcccCccccEEEEEEEec---CCCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEe--cCCeEEEEEEecC
Q 002529          595 CKKIGKGSFGSVYYGKMK---DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE--EEHQRILVYEYMH  669 (912)
Q Consensus       595 ~~~LG~G~fg~Vy~a~~~---~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~--~~~~~~lV~E~~~  669 (912)
                      ..+||+|+||.||+|+.+   +++.||+|.+....  ....+.+|++++++++||||+++++++.  .+...++|+||++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            368999999999999875   35789999886532  2345778999999999999999999884  3567899999986


Q ss_pred             CCCHHHHhccCC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccc----cCCCcEEEeeccCc
Q 002529          670 NGTLRDRLHGSV------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLS  739 (912)
Q Consensus       670 ~gsL~~~l~~~~------~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl----~~~~~vkL~DFGla  739 (912)
                       ++|.+++....      ....+++..+..++.||+.||+|||+   .+++||||||+||++    +.++.+||+|||++
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence             57877764321      23358899999999999999999998   999999999999999    45678999999999


Q ss_pred             ccccccccc--ccccccCCCcccCCCccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCcc
Q 002529          740 RQAEEDLTH--ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVE  796 (912)
Q Consensus       740 ~~~~~~~~~--~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~eLltG~~Pf~~~  796 (912)
                      +........  ......+++.|+|||++.+ ..++.++|||||||++|||+||++||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            876443221  1223457899999999876 45799999999999999999999999743

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-33  Score=315.34  Aligned_cols=240  Identities=27%  Similarity=0.315  Sum_probs=186.7

Q ss_pred             cCccccEEEEEEEec-CCCEEEEEEccCccc---hhhHHHHHHHHHHHhc---CCCCccceeeEEecCCeEEEEEEecCC
Q 002529          598 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRI---HHRNLVPLIGYCEEEHQRILVYEYMHN  670 (912)
Q Consensus       598 LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~L---~hpnIv~l~~~~~~~~~~~lV~E~~~~  670 (912)
                      ||+|+||+||+|+.+ +++.||+|++.....   ........|..++..+   +||||+++++.+.+....++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999876 589999999864321   1223455677777665   699999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccccc
Q 002529          671 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS  750 (912)
Q Consensus       671 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~  750 (912)
                      |+|.+++.   ....+++..+..++.||++||+|||+   ++|+||||||+|||++.++.++|+|||++........ ..
T Consensus        81 g~L~~~l~---~~~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~  153 (330)
T cd05586          81 GELFWHLQ---KEGRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TT  153 (330)
T ss_pred             ChHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-Cc
Confidence            99999987   35678999999999999999999998   9999999999999999999999999999875432221 12


Q ss_pred             ccccCCCcccCCCccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCCC
Q 002529          751 SVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV  829 (912)
Q Consensus       751 ~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  829 (912)
                      ....|++.|+|||++.+. .++.++|||||||++|+|++|+.||......      +.. ..+..+.. .     +... 
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~------~~~-~~i~~~~~-~-----~~~~-  219 (330)
T cd05586         154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ------QMY-RNIAFGKV-R-----FPKN-  219 (330)
T ss_pred             cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH------HHH-HHHHcCCC-C-----CCCc-
Confidence            234589999999998654 4789999999999999999999999743221      111 11111111 0     0000 


Q ss_pred             CHHHHHHHHHHHHhcccCCCCCCC----CHHHHHH
Q 002529          830 KIESIWRIAEVAIQCVEQRGFSRP----KMQEIVL  860 (912)
Q Consensus       830 ~~~~~~~l~~Li~~cL~~dP~~RP----s~~evl~  860 (912)
                        .....+.+++.+||+.+|++||    ++.|+++
T Consensus       220 --~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         220 --VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             --cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence              1123678999999999999998    5666654

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.2e-32  Score=303.13  Aligned_cols=246  Identities=26%  Similarity=0.397  Sum_probs=198.4

Q ss_pred             hhcccCccccEEEEEEEec-CCCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEecCCCC
Q 002529          594 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGT  672 (912)
Q Consensus       594 ~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~gs  672 (912)
                      ....||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++|+||+++++
T Consensus        25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~  104 (297)
T cd06659          25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA  104 (297)
T ss_pred             hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence            3457999999999999875 689999999865444455678899999999999999999999999999999999999999


Q ss_pred             HHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccccccc
Q 002529          673 LRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV  752 (912)
Q Consensus       673 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~  752 (912)
                      |.+++.    ...+++..++.++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||++......... ...
T Consensus       105 L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~-~~~  176 (297)
T cd06659         105 LTDIVS----QTRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-RKS  176 (297)
T ss_pred             HHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhccccccc-ccc
Confidence            999875    3468899999999999999999998   89999999999999999999999999998765433221 223


Q ss_pred             ccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCCCCHH
Q 002529          753 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE  832 (912)
Q Consensus       753 ~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  832 (912)
                      ..++..|+|||++.+..++.++|||||||++|||++|+.||.......   ....+.    ......     .  .....
T Consensus       177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---~~~~~~----~~~~~~-----~--~~~~~  242 (297)
T cd06659         177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ---AMKRLR----DSPPPK-----L--KNAHK  242 (297)
T ss_pred             eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHh----ccCCCC-----c--cccCC
Confidence            457899999999998889999999999999999999999997332211   111111    110000     0  00111


Q ss_pred             HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002529          833 SIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       833 ~~~~l~~Li~~cL~~dP~~RPs~~evl~~  861 (912)
                      ....+.+++.+||+.+|++||+++|+++.
T Consensus       243 ~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         243 ISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             CCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            23368899999999999999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.6e-33  Score=313.72  Aligned_cols=255  Identities=22%  Similarity=0.322  Sum_probs=193.7

Q ss_pred             HHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCccc--hhhHHHHHHHHHHHhcCCCCccceeeEEecC------Ce
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQ  660 (912)
Q Consensus       590 ~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~------~~  660 (912)
                      .+|.+.+.||+|+||.||+|... +++.||+|++.....  .....+.+|++++++++||||+++++++...      ..
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07878          15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE   94 (343)
T ss_pred             hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence            56778899999999999999865 688999999865322  2345677899999999999999999987543      35


Q ss_pred             EEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcc
Q 002529          661 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR  740 (912)
Q Consensus       661 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~  740 (912)
                      .++++|++ +++|.+++.    ...+++..+..++.||+.||+|||+   ++|+||||||+||+++.++.+||+|||++.
T Consensus        95 ~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~  166 (343)
T cd07878          95 VYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLAR  166 (343)
T ss_pred             EEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCccce
Confidence            68999988 789988875    3468999999999999999999998   999999999999999999999999999998


Q ss_pred             ccccccccccccccCCCcccCCCccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhcc-----
Q 002529          741 QAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK-----  814 (912)
Q Consensus       741 ~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~-----  814 (912)
                      ......    ....|++.|+|||++.+ ..++.++|||||||++|+|++|+.||........  +.. +......     
T Consensus       167 ~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~-~~~~~~~~~~~~  239 (343)
T cd07878         167 QADDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ--LKR-IMEVVGTPSPEV  239 (343)
T ss_pred             ecCCCc----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH--HHH-HHHHhCCCCHHH
Confidence            754322    23458899999999876 5788999999999999999999999974332111  111 1100000     


Q ss_pred             ------CCcccccCccccCCCCH--------HHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002529          815 ------GDVISIVDPVLIGNVKI--------ESIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       815 ------~~~~~~~d~~l~~~~~~--------~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  861 (912)
                            ......+. .+. ..+.        .....+.+++.+||+.||++|||++|+++.
T Consensus       240 ~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         240 LKKISSEHARKYIQ-SLP-HMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             HHhcchhhHHHHhh-ccc-cccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                  00000000 000 0000        112257799999999999999999999964

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1e-32  Score=304.55  Aligned_cols=261  Identities=27%  Similarity=0.447  Sum_probs=203.2

Q ss_pred             HHHHHhhhcccCccccEEEEEEEec-CCC----EEEEEEccCccc-hhhHHHHHHHHHHHhcCCCCccceeeEEecCCeE
Q 002529          588 EEATNNFCKKIGKGSFGSVYYGKMK-DGK----EVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR  661 (912)
Q Consensus       588 ~~~~~~~~~~LG~G~fg~Vy~a~~~-~~~----~vAvK~l~~~~~-~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~  661 (912)
                      ....++..+.||+|+||.||+|.+. +++    .||+|.+..... .....+.+|+.+++.++||||+++++++... ..
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~   83 (303)
T cd05110           5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI   83 (303)
T ss_pred             chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence            3455566789999999999999865 343    578998875433 2334688999999999999999999998754 46


Q ss_pred             EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccc
Q 002529          662 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ  741 (912)
Q Consensus       662 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~  741 (912)
                      ++++||+++|+|.+++...  ...+++..++.++.|++.||+|||+   ++++|+||||+||+++.++.+||+|||++..
T Consensus        84 ~~v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~  158 (303)
T cd05110          84 QLVTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARL  158 (303)
T ss_pred             eeeehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEcccccccc
Confidence            7999999999999998742  3468899999999999999999998   9999999999999999999999999999987


Q ss_pred             ccccccc-ccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhhhccCCccc
Q 002529          742 AEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVIS  819 (912)
Q Consensus       742 ~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  819 (912)
                      ....... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.....   ....+++    ..+....
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~---~~~~~~~----~~~~~~~  231 (303)
T cd05110         159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT---REIPDLL----EKGERLP  231 (303)
T ss_pred             ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH----HCCCCCC
Confidence            5432221 1112335678999999998899999999999999999997 9999964322   1122222    1111110


Q ss_pred             ccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhhhhhcc
Q 002529          820 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK  870 (912)
Q Consensus       820 ~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~~~~~~  870 (912)
                        .       +......+.+++.+||..+|++||+++|+++.|+++...+.
T Consensus       232 --~-------~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~  273 (303)
T cd05110         232 --Q-------PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQ  273 (303)
T ss_pred             --C-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchh
Confidence              0       11123468899999999999999999999999998765443

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=5.4e-33  Score=298.17  Aligned_cols=248  Identities=27%  Similarity=0.395  Sum_probs=201.3

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCc--cchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEec
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM  668 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~  668 (912)
                      |++.+.||+|+||.||++... +++.||+|.+...  .......+.+|++++++++||||+++++++...+..++|+||+
T Consensus         2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd08218           2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC   81 (256)
T ss_pred             ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence            566789999999999999876 6899999998643  2234467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccc
Q 002529          669 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH  748 (912)
Q Consensus       669 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  748 (912)
                      ++++|.+++... ....+++..++.++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||++.........
T Consensus        82 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~  157 (256)
T cd08218          82 EGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL  157 (256)
T ss_pred             CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence            999999998743 23467899999999999999999998   99999999999999999999999999998765443221


Q ss_pred             ccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCC
Q 002529          749 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN  828 (912)
Q Consensus       749 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  828 (912)
                       .....+++.|+|||++.+...+.++|+|||||++++|++|+.||.....      .+.+..... +....         
T Consensus       158 -~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~~~-~~~~~---------  220 (256)
T cd08218         158 -ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM------KNLVLKIIR-GSYPP---------  220 (256)
T ss_pred             -hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH------HHHHHHHhc-CCCCC---------
Confidence             2234478899999999988899999999999999999999999973221      111212111 11111         


Q ss_pred             CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          829 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       829 ~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                      .+......+.+++.+||+.+|.+||++.||++
T Consensus       221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         221 VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             CcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            11122347889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=3.8e-33  Score=304.48  Aligned_cols=263  Identities=23%  Similarity=0.327  Sum_probs=198.2

Q ss_pred             HHhhhcccCccccEEEEEEEec-CCCEEEEEEccCccc--hhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEe
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY  667 (912)
Q Consensus       591 ~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  667 (912)
                      +|++.++||+|+||.||+|.++ +++.||+|++.....  ...+.+.+|+++++.++||||+++++++..++..++|+||
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   81 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF   81 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence            4567799999999999999986 589999999865322  2345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccc
Q 002529          668 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT  747 (912)
Q Consensus       668 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~  747 (912)
                      +++++|.++...   ...+++..++.++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||++........
T Consensus        82 ~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07846          82 VDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE  155 (286)
T ss_pred             CCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc
Confidence            999999887662   3458999999999999999999998   8999999999999999999999999999876544322


Q ss_pred             cccccccCCCcccCCCccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCccchh-hHHHHHHhh-------hccCCcc
Q 002529          748 HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL-NIVHWARSM-------IKKGDVI  818 (912)
Q Consensus       748 ~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~-~~~~~~~~~-------~~~~~~~  818 (912)
                      . .....++..|+|||++.+ ..++.++||||||+++|||++|++||......+.. .+.......       .......
T Consensus       156 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07846         156 V-YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF  234 (286)
T ss_pred             c-cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh
Confidence            1 223447889999998865 45788999999999999999999999743321110 011100000       0000000


Q ss_pred             -cccCccccC-----CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          819 -SIVDPVLIG-----NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       819 -~~~d~~l~~-----~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                       ....+....     .........+.+++.+||+.+|++||+++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence             000000000     001123457899999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.4e-32  Score=300.17  Aligned_cols=253  Identities=26%  Similarity=0.371  Sum_probs=196.0

Q ss_pred             HHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCccchhhHHHHHHHHHHHhc-CCCCccceeeEEe-----cCCeEE
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCE-----EEHQRI  662 (912)
Q Consensus       590 ~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L-~hpnIv~l~~~~~-----~~~~~~  662 (912)
                      .+|++.+.||+|+||.||+|..+ +++.+|+|++.... .....+.+|+.+++++ +||||+++++++.     .++..+
T Consensus        18 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~   96 (286)
T cd06638          18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLW   96 (286)
T ss_pred             cceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEE
Confidence            45667899999999999999876 57899999876432 2345678899999999 6999999999873     445789


Q ss_pred             EEEEecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccc
Q 002529          663 LVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ  741 (912)
Q Consensus       663 lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~  741 (912)
                      +||||+++++|.+++.... ....+++..+..++.|+++||.|||+   .+++||||||+||+++.++.++|+|||++..
T Consensus        97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~  173 (286)
T cd06638          97 LVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQ  173 (286)
T ss_pred             EEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCEEEccCCceee
Confidence            9999999999999876432 34568899999999999999999998   9999999999999999999999999999876


Q ss_pred             cccccccccccccCCCcccCCCccCC-----CCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCC
Q 002529          742 AEEDLTHISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD  816 (912)
Q Consensus       742 ~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  816 (912)
                      ...... ......|++.|+|||++..     ..++.++||||+||++|||++|+.||.......  .+    ... ....
T Consensus       174 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~--~~----~~~-~~~~  245 (286)
T cd06638         174 LTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR--AL----FKI-PRNP  245 (286)
T ss_pred             cccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH--HH----hhc-cccC
Confidence            543221 1223458899999998753     457889999999999999999999997332111  11    111 1111


Q ss_pred             cccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002529          817 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       817 ~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  861 (912)
                      .....++       ......+.+++.+||+.+|++||+++||++.
T Consensus       246 ~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         246 PPTLHQP-------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             CCcccCC-------CCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            1111111       1112368899999999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.4e-32  Score=301.95  Aligned_cols=245  Identities=27%  Similarity=0.389  Sum_probs=198.2

Q ss_pred             hcccCccccEEEEEEEec-CCCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEecCCCCH
Q 002529          595 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL  673 (912)
Q Consensus       595 ~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL  673 (912)
                      ...||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++|+||+++++.+..++..++||||+++++|
T Consensus        27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L  106 (292)
T cd06658          27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL  106 (292)
T ss_pred             hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence            467999999999999875 6889999998765555567789999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccccccccc
Q 002529          674 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA  753 (912)
Q Consensus       674 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~  753 (912)
                      .+++.    ...+++.+++.++.||+.||+|||+   ++++||||||+||+++.++.++|+|||++......... ....
T Consensus       107 ~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~-~~~~  178 (292)
T cd06658         107 TDIVT----HTRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK-RKSL  178 (292)
T ss_pred             HHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc-Ccee
Confidence            99885    3458899999999999999999998   89999999999999999999999999998765432221 1224


Q ss_pred             cCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCCCCHHH
Q 002529          754 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES  833 (912)
Q Consensus       754 ~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  833 (912)
                      .++..|+|||.+.+..++.++||||||+++|||++|+.||......   .....+...         +.+.+..  ....
T Consensus       179 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---~~~~~~~~~---------~~~~~~~--~~~~  244 (292)
T cd06658         179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL---QAMRRIRDN---------LPPRVKD--SHKV  244 (292)
T ss_pred             ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhc---------CCCcccc--cccc
Confidence            5788999999998888999999999999999999999999733221   111111110         1111111  1112


Q ss_pred             HHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002529          834 IWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       834 ~~~l~~Li~~cL~~dP~~RPs~~evl~~  861 (912)
                      ...+.+++.+||..+|++|||++|+++.
T Consensus       245 ~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         245 SSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            3367899999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=5.6e-33  Score=302.99  Aligned_cols=260  Identities=22%  Similarity=0.293  Sum_probs=194.9

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCccc--hhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEec
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM  668 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~  668 (912)
                      |++.+.||+|+||.||+|... +|+.||+|.++....  .....+.+|++++++++||||+++++++.+....++|+||+
T Consensus         2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (284)
T cd07839           2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC   81 (284)
T ss_pred             ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence            566789999999999999886 689999999864322  22356778999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccc
Q 002529          669 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH  748 (912)
Q Consensus       669 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  748 (912)
                      + ++|.+++...  ...+++..++.++.||++||+|||+   .+++||||||+||+++.++.++|+|||++.........
T Consensus        82 ~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~  155 (284)
T cd07839          82 D-QDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC  155 (284)
T ss_pred             C-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC
Confidence            6 5788877642  4568999999999999999999998   99999999999999999999999999998765433221


Q ss_pred             ccccccCCCcccCCCccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCC------ccccc
Q 002529          749 ISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD------VISIV  821 (912)
Q Consensus       749 ~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~------~~~~~  821 (912)
                       .....++..|+|||++.+. .++.++|||||||++|+|++|+.|+...... . ...+..........      .....
T Consensus       156 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07839         156 -YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-D-DQLKRIFRLLGTPTEESWPGVSKLP  232 (284)
T ss_pred             -cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH-H-HHHHHHHHHhCCCChHHhHHhhhcc
Confidence             1223468899999988664 4689999999999999999999986522211 1 11111111110000      00000


Q ss_pred             Cc----cccC-----CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          822 DP----VLIG-----NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       822 d~----~l~~-----~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                      +.    ....     .........+.+++.+||+.||.+|||++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            00    0000     011123357789999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.1e-32  Score=297.81  Aligned_cols=249  Identities=28%  Similarity=0.424  Sum_probs=201.4

Q ss_pred             HHHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc-chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEE
Q 002529          589 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE  666 (912)
Q Consensus       589 ~~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E  666 (912)
                      .+.|++.++||+|+||.||+|..+ +++.||+|.+.... ....+.+.+|+.++++++||||+++++++..+...++|||
T Consensus         3 ~~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   82 (277)
T cd06641           3 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME   82 (277)
T ss_pred             HHhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence            345677889999999999999875 68899999876432 2344678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccc
Q 002529          667 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL  746 (912)
Q Consensus       667 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~  746 (912)
                      |+++++|.+++.    ...+++..+..++.|++.||++||+   .+++|+||+|+||+++.++.++|+|||++.......
T Consensus        83 ~~~~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06641          83 YLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             eCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence            999999999986    3468899999999999999999998   999999999999999999999999999987654322


Q ss_pred             ccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCcccc
Q 002529          747 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI  826 (912)
Q Consensus       747 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  826 (912)
                      . ......++..|+|||.+.+..++.++|+|||||++|+|++|..||.....   .....   . +..+..     +.  
T Consensus       156 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---~~~~~---~-~~~~~~-----~~--  220 (277)
T cd06641         156 I-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP---MKVLF---L-IPKNNP-----PT--  220 (277)
T ss_pred             h-hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch---HHHHH---H-HhcCCC-----CC--
Confidence            1 12223578899999999888889999999999999999999999973221   11111   1 111111     11  


Q ss_pred             CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002529          827 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       827 ~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  861 (912)
                        ........+.+++.+||+.+|.+||++.++++.
T Consensus       221 --~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         221 --LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             --CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence              111233468899999999999999999999984

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1e-32  Score=296.52  Aligned_cols=253  Identities=27%  Similarity=0.394  Sum_probs=201.5

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCc--cchhhHHHHHHHHHHHhcCCCCccceeeEEec--CCeEEEEEE
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQRILVYE  666 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~--~~~~~lV~E  666 (912)
                      |++.+.||.|+||.||+|... +++.||+|.+...  .....+.+.+|++++++++||||+++++++..  +...+++||
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e   81 (265)
T cd08217           2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME   81 (265)
T ss_pred             ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence            556789999999999999865 6889999998643  23345678899999999999999999997753  456789999


Q ss_pred             ecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeeecCCCCCCccccCCCcEEEeeccCccccc
Q 002529          667 YMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGC--NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE  743 (912)
Q Consensus       667 ~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LHs~~--~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~  743 (912)
                      |+++++|.+++.... ....+++..++.++.||+.||+|||..+  ..+++|+||+|+||+++.++.+||+|||++....
T Consensus        82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~  161 (265)
T cd08217          82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG  161 (265)
T ss_pred             hccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccccc
Confidence            999999999987532 3467899999999999999999999211  2899999999999999999999999999998765


Q ss_pred             cccccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCc
Q 002529          744 EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP  823 (912)
Q Consensus       744 ~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  823 (912)
                      ..... .....+++.|+|||.+.+..++.++|+||||+++++|++|+.||.....   ....+    .+..+...     
T Consensus       162 ~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~----~~~~~~~~-----  228 (265)
T cd08217         162 HDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ---LQLAS----KIKEGKFR-----  228 (265)
T ss_pred             CCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH---HHHHH----HHhcCCCC-----
Confidence            43321 2233578999999999988899999999999999999999999974331   11111    12222111     


Q ss_pred             cccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002529          824 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       824 ~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  861 (912)
                          ..+......+.+++.+||+.+|++||+++||++.
T Consensus       229 ----~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         229 ----RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             ----CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                1122334578999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.8e-33  Score=306.28  Aligned_cols=250  Identities=26%  Similarity=0.332  Sum_probs=199.1

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCccch---hhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEe
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH---RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY  667 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~---~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  667 (912)
                      |++.+.||+|++|.||+|... +++.||+|.+......   ..+.+.+|+++++.++|+||+++++.+.++...++||||
T Consensus         3 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   82 (316)
T cd05574           3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDY   82 (316)
T ss_pred             eEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEe
Confidence            556789999999999999877 4899999998754322   446788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccc
Q 002529          668 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT  747 (912)
Q Consensus       668 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~  747 (912)
                      +.+++|.+++... ....+++..++.++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||++........
T Consensus        83 ~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~  158 (316)
T cd05574          83 CPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP  158 (316)
T ss_pred             cCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence            9999999998743 34678999999999999999999998   9999999999999999999999999998875432211


Q ss_pred             c----------------------------ccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcc
Q 002529          748 H----------------------------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG  799 (912)
Q Consensus       748 ~----------------------------~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~  799 (912)
                      .                            ......|+..|+|||++.+..++.++||||||+++|+|++|+.||......
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~  238 (316)
T cd05574         159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD  238 (316)
T ss_pred             ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence            0                            111235788999999999888999999999999999999999999743321


Q ss_pred             chhhHHHHHHhhhccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCC----HHHHHH
Q 002529          800 AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK----MQEIVL  860 (912)
Q Consensus       800 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs----~~evl~  860 (912)
                      .  .+.    ..... ..      ...  ........+.+++.+||+.+|++||+    ++|+++
T Consensus       239 ~--~~~----~~~~~-~~------~~~--~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         239 E--TFS----NILKK-EV------TFP--GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             H--HHH----HHhcC-Cc------cCC--CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            1  111    11111 00      000  01113457899999999999999999    666655

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.8e-32  Score=295.48  Aligned_cols=255  Identities=25%  Similarity=0.365  Sum_probs=203.5

Q ss_pred             HHhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc-chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEec
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM  668 (912)
Q Consensus       591 ~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~  668 (912)
                      .|++.+.||.|++|+||+|... ++..+++|++.... ....+.+.+|+++++.++|+||+++++.+...+..++|+|++
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   81 (267)
T cd06610           2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYL   81 (267)
T ss_pred             cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEecc
Confidence            3667899999999999999865 68899999986432 335678899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccc
Q 002529          669 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH  748 (912)
Q Consensus       669 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  748 (912)
                      ++++|.++++.......+++..+..++.|++.||++||+   .+++|+||+|+||++++++.++|+|||++.........
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~  158 (267)
T cd06610          82 SGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR  158 (267)
T ss_pred             CCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence            999999999754333578999999999999999999998   99999999999999999999999999998775543222


Q ss_pred             ---ccccccCCCcccCCCccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCcc
Q 002529          749 ---ISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV  824 (912)
Q Consensus       749 ---~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  824 (912)
                         ......++..|+|||++... .++.++|+||||+++|+|++|+.||......  .....    .....      .+.
T Consensus       159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--~~~~~----~~~~~------~~~  226 (267)
T cd06610         159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM--KVLML----TLQND------PPS  226 (267)
T ss_pred             cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh--hhHHH----HhcCC------CCC
Confidence               22334578899999998776 7899999999999999999999999733221  11111    11111      011


Q ss_pred             ccCCC-CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          825 LIGNV-KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       825 l~~~~-~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                      +.... .......+.+++.+||+.+|++||+++|+++
T Consensus       227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         227 LETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             cCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            11100 1123457889999999999999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2.4e-32  Score=294.21  Aligned_cols=250  Identities=29%  Similarity=0.431  Sum_probs=200.3

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCccc--hhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEec
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM  668 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~  668 (912)
                      |+..+.||+|++|.||+|... +++.|++|.++....  ...+.+.+|++++++++|+||+++++.+...+..++|+||+
T Consensus         2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (264)
T cd06626           2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC   81 (264)
T ss_pred             ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence            556789999999999999875 689999999876543  35678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccc
Q 002529          669 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH  748 (912)
Q Consensus       669 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  748 (912)
                      ++++|.+++..   +..+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.+||+|||++.........
T Consensus        82 ~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~  155 (264)
T cd06626          82 SGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT  155 (264)
T ss_pred             CCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence            99999999973   4568899999999999999999998   99999999999999999999999999998876543322


Q ss_pred             ccc---cccCCCcccCCCccCCCC---CCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccC
Q 002529          749 ISS---VARGTVGYLDPEYYGNQQ---LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD  822 (912)
Q Consensus       749 ~~~---~~~gt~~y~APE~l~~~~---~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  822 (912)
                      ...   ...++..|+|||++.+..   .+.++||||||++++++++|+.||......  .......    ..+.     .
T Consensus       156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~--~~~~~~~----~~~~-----~  224 (264)
T cd06626         156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE--FQIMFHV----GAGH-----K  224 (264)
T ss_pred             ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch--HHHHHHH----hcCC-----C
Confidence            211   245788999999998766   889999999999999999999999733211  1111111    1111     0


Q ss_pred             ccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          823 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       823 ~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                      +.+..  .......+.+++.+||+.+|.+||++.|++.
T Consensus       225 ~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         225 PPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             CCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            11110  0112346789999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.8e-32  Score=295.47  Aligned_cols=253  Identities=28%  Similarity=0.374  Sum_probs=203.6

Q ss_pred             HHhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc-chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEec
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM  668 (912)
Q Consensus       591 ~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~  668 (912)
                      .+++.+.||+|++|.||++.++ +++.+++|.+.... .....++.+|++++++++||||+++++.+..+...++++||+
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM   81 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence            3567789999999999999887 68999999987653 344567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccc
Q 002529          669 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH  748 (912)
Q Consensus       669 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  748 (912)
                      ++++|.+++...  ...+++..+..++.|++.||+|||+  ..+++|+||||+||+++.++.++|+|||.+.........
T Consensus        82 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~  157 (265)
T cd06605          82 DGGSLDKILKEV--QGRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK  157 (265)
T ss_pred             CCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh
Confidence            999999999753  2678999999999999999999996  379999999999999999999999999998765432221


Q ss_pred             ccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCC
Q 002529          749 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN  828 (912)
Q Consensus       749 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  828 (912)
                         ...++..|+|||.+.+..++.++||||||+++|+|++|+.||...... .....+.+....... .     +.+.. 
T Consensus       158 ---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~-~-----~~~~~-  226 (265)
T cd06605         158 ---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP-PDGIFELLQYIVNEP-P-----PRLPS-  226 (265)
T ss_pred             ---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc-cccHHHHHHHHhcCC-C-----CCCCh-
Confidence               145788999999999989999999999999999999999999733211 112222222222111 1     01100 


Q ss_pred             CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          829 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       829 ~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                        ......+.++|.+||..+|++||++.|++.
T Consensus       227 --~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         227 --GKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             --hhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence              113446889999999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.4e-32  Score=297.14  Aligned_cols=247  Identities=25%  Similarity=0.383  Sum_probs=192.4

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc-----chhhHHHHHHHHHHHhcCCCCccceeeEEec--CCeEEE
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-----SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQRIL  663 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~-----~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~--~~~~~l  663 (912)
                      |+..+.||+|+||.||+|... +++.|++|.+....     ......+.+|+.++++++||||+++++++.+  ....++
T Consensus         4 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   83 (266)
T cd06651           4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTI   83 (266)
T ss_pred             ccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEE
Confidence            456789999999999999875 58999999875321     1234568889999999999999999998865  357789


Q ss_pred             EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccc
Q 002529          664 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE  743 (912)
Q Consensus       664 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~  743 (912)
                      ++||+++++|.+++..   ...+++..++.++.|++.||+|||+   .+++||||+|+||+++.++.++|+|||++....
T Consensus        84 ~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~  157 (266)
T cd06651          84 FMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ  157 (266)
T ss_pred             EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence            9999999999999973   4568899999999999999999998   999999999999999999999999999987653


Q ss_pred             cccc--cccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCccccc
Q 002529          744 EDLT--HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV  821 (912)
Q Consensus       744 ~~~~--~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  821 (912)
                      ....  .......++..|+|||++.+..++.++||||+||++|||++|+.||......      ...........     
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~------~~~~~~~~~~~-----  226 (266)
T cd06651         158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM------AAIFKIATQPT-----  226 (266)
T ss_pred             cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH------HHHHHHhcCCC-----
Confidence            2111  1112234788999999999888999999999999999999999999733211      11111111111     


Q ss_pred             CccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          822 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       822 d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                      .+    ..+......+.+++ +||..+|++||+++||++
T Consensus       227 ~~----~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         227 NP----QLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             CC----CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            11    11222233566666 688899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.5e-32  Score=301.99  Aligned_cols=259  Identities=20%  Similarity=0.236  Sum_probs=197.6

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCccch-----hhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEE
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH-----RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY  665 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~-----~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~  665 (912)
                      |++.+.||+|++|.||+|..+ +++.|++|.++.....     ....+..|++++++++|+||+++++++.+.+..++||
T Consensus         2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   81 (298)
T cd07841           2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF   81 (298)
T ss_pred             ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence            456788999999999999876 6899999998754322     2345678999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccc
Q 002529          666 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED  745 (912)
Q Consensus       666 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~  745 (912)
                      ||+ +++|.+++...  ...+++..++.++.||++||+|||+   ++++|+||+|+||+++.++.++|+|||++......
T Consensus        82 e~~-~~~L~~~i~~~--~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~  155 (298)
T cd07841          82 EFM-ETDLEKVIKDK--SIVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP  155 (298)
T ss_pred             ccc-CCCHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence            999 99999999743  2379999999999999999999998   99999999999999999999999999999876543


Q ss_pred             cccccccccCCCcccCCCccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccC---------
Q 002529          746 LTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG---------  815 (912)
Q Consensus       746 ~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~---------  815 (912)
                      ... .....+++.|+|||.+.+ ..++.++|||||||++|||++|.+||......+.  + ..........         
T Consensus       156 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~--~-~~~~~~~~~~~~~~~~~~~  231 (298)
T cd07841         156 NRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ--L-GKIFEALGTPTEENWPGVT  231 (298)
T ss_pred             Ccc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH--H-HHHHHHcCCCchhhhhhcc
Confidence            222 122346788999998854 4678999999999999999999888864332111  1 1111110000         


Q ss_pred             CcccccCccccCC-----CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          816 DVISIVDPVLIGN-----VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       816 ~~~~~~d~~l~~~-----~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                      .............     ........+.+++.+||+.+|++|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            0000000000000     11223457889999999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-33  Score=320.39  Aligned_cols=257  Identities=25%  Similarity=0.393  Sum_probs=210.7

Q ss_pred             HHHhhhcccCccccEEEEEEEec-CC----CEEEEEEccCcc-chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEE
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMK-DG----KEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL  663 (912)
Q Consensus       590 ~~~~~~~~LG~G~fg~Vy~a~~~-~~----~~vAvK~l~~~~-~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~l  663 (912)
                      ...+-.++||+|+||+||+|.+- +|    -+||+|++.... .....++++|+-+|.+|.|||+++++++|.... ..|
T Consensus       696 telkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql  774 (1177)
T KOG1025|consen  696 TELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL  774 (1177)
T ss_pred             hhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence            33445689999999999999764 33    468999987643 345678999999999999999999999998776 789


Q ss_pred             EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccc
Q 002529          664 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE  743 (912)
Q Consensus       664 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~  743 (912)
                      |++|++.|+|.|+++..  +..+-.+..+.|..|||+||.|||.   ++++||||..+|||+.+-..+|+.|||+++...
T Consensus       775 vtq~mP~G~LlDyvr~h--r~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~  849 (1177)
T KOG1025|consen  775 VTQLMPLGCLLDYVREH--RDNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLA  849 (1177)
T ss_pred             HHHhcccchHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence            99999999999999974  5678889999999999999999998   999999999999999999999999999999876


Q ss_pred             cccccccc-cccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhhhccCCccccc
Q 002529          744 EDLTHISS-VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV  821 (912)
Q Consensus       744 ~~~~~~~~-~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  821 (912)
                      .+...... ...-.+.|||=|.+....++.++|||||||++||++| |..|+++....+.       ...++.+..    
T Consensus       850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI-------~dlle~geR----  918 (1177)
T KOG1025|consen  850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI-------PDLLEKGER----  918 (1177)
T ss_pred             cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh-------hHHHhcccc----
Confidence            55443322 2224568999999999999999999999999999999 9999985544332       223333322    


Q ss_pred             CccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhhhhh
Q 002529          822 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI  868 (912)
Q Consensus       822 d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~~~~  868 (912)
                           -..++-...++..++.+||..|+..||+++|+...+.+....
T Consensus       919 -----LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard  960 (1177)
T KOG1025|consen  919 -----LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD  960 (1177)
T ss_pred             -----CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence                 122344556788999999999999999999999888876553

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-32  Score=300.86  Aligned_cols=262  Identities=22%  Similarity=0.320  Sum_probs=195.4

Q ss_pred             HHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCccch-hhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEe
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY  667 (912)
Q Consensus       590 ~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~-~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  667 (912)
                      ..|++.+.||+|++|.||+|..+ +++.||+|.+...... ....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            34667789999999999999876 6899999998653322 234567899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccc
Q 002529          668 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT  747 (912)
Q Consensus       668 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~  747 (912)
                      +. ++|.+++...  ...+++..++.++.|+++||+|||+   .+++|+||||+||+++.++.+||+|||++........
T Consensus        85 ~~-~~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  158 (291)
T cd07844          85 LD-TDLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK  158 (291)
T ss_pred             CC-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence            97 4999988743  3478899999999999999999998   9999999999999999999999999999875432211


Q ss_pred             cccccccCCCcccCCCccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhcc---CCcccc---
Q 002529          748 HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK---GDVISI---  820 (912)
Q Consensus       748 ~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~---  820 (912)
                      . .....++..|+|||++.+ ..++.++||||+|+++|+|++|+.||.......  ............   ......   
T Consensus       159 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  235 (291)
T cd07844         159 T-YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE--DQLHKIFRVLGTPTEETWPGVSSN  235 (291)
T ss_pred             c-ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHhcCCCChhhhhhhhhc
Confidence            1 112236788999998865 467899999999999999999999997433111  111111111000   000000   


Q ss_pred             ---c--------CccccCCC-CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          821 ---V--------DPVLIGNV-KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       821 ---~--------d~~l~~~~-~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                         .        ...+.... .......+.+++.+||+.+|++||++.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence               0        00000000 0111246789999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2.9e-32  Score=292.18  Aligned_cols=247  Identities=26%  Similarity=0.384  Sum_probs=199.4

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCc--cchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEec
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM  668 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~  668 (912)
                      |++.+.||+|++|.||++... +++.+|+|.+...  .......+.+|++++++++||||+++++.+..++..++||||+
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd08220           2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA   81 (256)
T ss_pred             ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence            566789999999999999875 6889999998643  2334567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCC-CcEEEeeccCccccccccc
Q 002529          669 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLT  747 (912)
Q Consensus       669 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~-~~vkL~DFGla~~~~~~~~  747 (912)
                      ++++|.+++... ....+++..++.++.|++++|+|||+   ++++|+||+|+||+++.+ +.++|+|||.+........
T Consensus        82 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (256)
T cd08220          82 PGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK  157 (256)
T ss_pred             CCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence            999999999753 24568999999999999999999998   999999999999999854 4689999999987654322


Q ss_pred             cccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccC
Q 002529          748 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG  827 (912)
Q Consensus       748 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  827 (912)
                        .....++..|+|||.+.+..++.++||||||+++|+|++|+.||......   ..   ...... +....+       
T Consensus       158 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~---~~---~~~~~~-~~~~~~-------  221 (256)
T cd08220         158 --AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP---AL---VLKIMS-GTFAPI-------  221 (256)
T ss_pred             --ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH---HH---HHHHHh-cCCCCC-------
Confidence              12245788999999999888999999999999999999999999743321   11   111111 111111       


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          828 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       828 ~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                        +......+.+++.+||+.+|++|||+.|+++
T Consensus       222 --~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         222 --SDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             --CCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence              1112347889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.7e-32  Score=301.31  Aligned_cols=253  Identities=24%  Similarity=0.290  Sum_probs=198.5

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCccc---hhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEe
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY  667 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  667 (912)
                      |++.+.||+|+||.||++... .++.|++|.+.....   .....+.+|+++++.++||||+++++.+..++..++||||
T Consensus         3 y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   82 (305)
T cd05609           3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEY   82 (305)
T ss_pred             ceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEec
Confidence            556789999999999999877 578999999875432   2345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccc
Q 002529          668 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT  747 (912)
Q Consensus       668 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~  747 (912)
                      +++++|.+++..   ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.++|+|||+++.......
T Consensus        83 ~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~  156 (305)
T cd05609          83 VEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT  156 (305)
T ss_pred             CCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence            999999999973   4568999999999999999999998   9999999999999999999999999998864211000


Q ss_pred             --------------cccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhc
Q 002529          748 --------------HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK  813 (912)
Q Consensus       748 --------------~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~  813 (912)
                                    .......++..|+|||.+.+..++.++|+||||+++|||++|+.||.+....      +.......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~------~~~~~~~~  230 (305)
T cd05609         157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE------ELFGQVIS  230 (305)
T ss_pred             ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHh
Confidence                          0111234678899999998888999999999999999999999999743221      11111111


Q ss_pred             cCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhh
Q 002529          814 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD  864 (912)
Q Consensus       814 ~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~  864 (912)
                       +...   .+...    ......+.+++.+||+.+|++||++.++.+.|+.
T Consensus       231 -~~~~---~~~~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         231 -DDIE---WPEGD----EALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             -cccC---CCCcc----ccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence             1110   01100    1123468899999999999999997767666665

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-33  Score=308.59  Aligned_cols=244  Identities=31%  Similarity=0.434  Sum_probs=200.3

Q ss_pred             HHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCccc---hhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEE
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY  665 (912)
Q Consensus       590 ~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~  665 (912)
                      ..+.=.+.||.|+||.||.|+.. +.+.||||++.-...   +.-.++..|+..|++++|||++.+-|++..+...+|||
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM  105 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM  105 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence            33444678999999999999865 678999999865332   34467899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccc
Q 002529          666 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED  745 (912)
Q Consensus       666 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~  745 (912)
                      ||| -|+-.|++.-  ..+++-+.++..|+.+.+.||+|||+   ++.||||||..|||+++.|.|||+|||.|......
T Consensus       106 EYC-lGSAsDlleV--hkKplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA  179 (948)
T KOG0577|consen  106 EYC-LGSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA  179 (948)
T ss_pred             HHH-hccHHHHHHH--HhccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCch
Confidence            999 5788888764  36789999999999999999999999   99999999999999999999999999999875443


Q ss_pred             cccccccccCCCcccCCCcc---CCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccC
Q 002529          746 LTHISSVARGTVGYLDPEYY---GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD  822 (912)
Q Consensus       746 ~~~~~~~~~gt~~y~APE~l---~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  822 (912)
                           ..++|||.|||||++   ..++|+-+.||||||++..||.-.++|.......  ..+     ..+.....     
T Consensus       180 -----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM--SAL-----YHIAQNes-----  242 (948)
T KOG0577|consen  180 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SAL-----YHIAQNES-----  242 (948)
T ss_pred             -----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH--HHH-----HHHHhcCC-----
Confidence                 346799999999986   4679999999999999999999999997622211  111     11111111     


Q ss_pred             ccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 002529          823 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV  859 (912)
Q Consensus       823 ~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl  859 (912)
                      |.+.   ..+....+.+++..||++-|.+|||.++++
T Consensus       243 PtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll  276 (948)
T KOG0577|consen  243 PTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELL  276 (948)
T ss_pred             CCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHh
Confidence            2221   345667899999999999999999999887

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=3e-32  Score=298.68  Aligned_cols=242  Identities=26%  Similarity=0.375  Sum_probs=198.6

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc---chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEe
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY  667 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  667 (912)
                      |++.+.||+|++|.||++... +++.||+|++....   ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus         3 y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (290)
T cd05580           3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEY   82 (290)
T ss_pred             eEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEec
Confidence            567789999999999999876 58999999986532   23346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccc
Q 002529          668 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT  747 (912)
Q Consensus       668 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~  747 (912)
                      +++++|.+++..   ...+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.+||+|||++......  
T Consensus        83 ~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--  154 (290)
T cd05580          83 VPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--  154 (290)
T ss_pred             CCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence            999999999974   4678999999999999999999998   99999999999999999999999999998876543  


Q ss_pred             cccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccC
Q 002529          748 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG  827 (912)
Q Consensus       748 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  827 (912)
                        .....+++.|+|||.+.+...+.++||||||+++|+|++|+.||......   ...+   . +..+..      .+  
T Consensus       155 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~---~-~~~~~~------~~--  217 (290)
T cd05580         155 --TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI---QIYE---K-ILEGKV------RF--  217 (290)
T ss_pred             --CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---HHHH---H-HhcCCc------cC--
Confidence              22345788999999998888899999999999999999999999743311   1111   1 111111      11  


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 002529          828 NVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL  860 (912)
Q Consensus       828 ~~~~~~~~~l~~Li~~cL~~dP~~RP-----s~~evl~  860 (912)
                        +......+.+++.+||+.+|.+|+     +++|+++
T Consensus       218 --~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         218 --PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             --CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence              111234788999999999999999     7777763

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.7e-32  Score=294.56  Aligned_cols=252  Identities=25%  Similarity=0.404  Sum_probs=196.1

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCccc----------hhhHHHHHHHHHHHhcCCCCccceeeEEecCCe
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS----------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ  660 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~----------~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~  660 (912)
                      |...+.||+|++|.||+|... +++.||+|.++....          ...+.+.+|+.++++++|||++++++++...+.
T Consensus         3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   82 (272)
T cd06629           3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEY   82 (272)
T ss_pred             eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCc
Confidence            345688999999999999865 689999998753211          112457889999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcc
Q 002529          661 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR  740 (912)
Q Consensus       661 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~  740 (912)
                      .++||||+++++|.++++.   ...+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||++.
T Consensus        83 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~~  156 (272)
T cd06629          83 LSIFLEYVPGGSIGSCLRT---YGRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISK  156 (272)
T ss_pred             eEEEEecCCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeeccccc
Confidence            9999999999999999974   3578999999999999999999998   899999999999999999999999999987


Q ss_pred             cccccccc-ccccccCCCcccCCCccCCCC--CCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCc
Q 002529          741 QAEEDLTH-ISSVARGTVGYLDPEYYGNQQ--LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV  817 (912)
Q Consensus       741 ~~~~~~~~-~~~~~~gt~~y~APE~l~~~~--~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  817 (912)
                      ........ ......++..|+|||.+....  ++.++|+||||+++|++++|..||......      .......... .
T Consensus       157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~-~  229 (272)
T cd06629         157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI------AAMFKLGNKR-S  229 (272)
T ss_pred             cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH------HHHHHhhccc-c
Confidence            65432211 122334788999999987654  789999999999999999999999622211      1111111111 1


Q ss_pred             ccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          818 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       818 ~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                      ...++..    ........+.+++.+||..+|++||+++||++
T Consensus       230 ~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         230 APPIPPD----VSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             CCcCCcc----ccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            1111111    11123457889999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2.4e-32  Score=297.88  Aligned_cols=251  Identities=25%  Similarity=0.419  Sum_probs=195.9

Q ss_pred             HHHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCccchhhHHHHHHHHHHHhc-CCCCccceeeEEec------CCe
Q 002529          589 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEE------EHQ  660 (912)
Q Consensus       589 ~~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L-~hpnIv~l~~~~~~------~~~  660 (912)
                      ...|++.+.||+|+||.||+|... +++.+|+|++.... .....+..|+.+++++ +|+||+++++++..      ...
T Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   93 (282)
T cd06636          15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQ   93 (282)
T ss_pred             hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCE
Confidence            356778899999999999999875 58899999986442 3346688899999998 69999999999843      457


Q ss_pred             EEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcc
Q 002529          661 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR  740 (912)
Q Consensus       661 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~  740 (912)
                      .+++|||+++|+|.+++... ....+++..++.++.||+.||+|||+   .+++|+||+|+||+++.++.++|+|||++.
T Consensus        94 ~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~l~dfg~~~  169 (282)
T cd06636          94 LWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSA  169 (282)
T ss_pred             EEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence            89999999999999998754 24568888899999999999999998   999999999999999999999999999987


Q ss_pred             ccccccccccccccCCCcccCCCccC-----CCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccC
Q 002529          741 QAEEDLTHISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG  815 (912)
Q Consensus       741 ~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  815 (912)
                      ........ .....|+..|+|||.+.     ...++.++|||||||++|||++|+.||........  .    .. ....
T Consensus       170 ~~~~~~~~-~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~--~----~~-~~~~  241 (282)
T cd06636         170 QLDRTVGR-RNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA--L----FL-IPRN  241 (282)
T ss_pred             hhhccccC-CCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh--h----hh-HhhC
Confidence            65432211 22345788999999875     34678899999999999999999999963321111  0    00 0000


Q ss_pred             CcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          816 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       816 ~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                      ..     +..   ........+.+++.+||+.+|.+||++.|+++
T Consensus       242 ~~-----~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         242 PP-----PKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             CC-----CCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            00     000   01123347899999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.7e-32  Score=294.69  Aligned_cols=247  Identities=23%  Similarity=0.330  Sum_probs=193.7

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc-----chhhHHHHHHHHHHHhcCCCCccceeeEEecC--CeEEE
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-----SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRIL  663 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~-----~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~--~~~~l  663 (912)
                      |++.+.||+|+||.||+|... +++.||+|.+....     ....+.+.+|++++++++||||+++++++.+.  ...++
T Consensus         4 ~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (265)
T cd06652           4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSI   83 (265)
T ss_pred             ceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEE
Confidence            456789999999999999876 58999999875321     12345788899999999999999999988663  46789


Q ss_pred             EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccc
Q 002529          664 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE  743 (912)
Q Consensus       664 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~  743 (912)
                      +|||+++++|.+++..   ...+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||++....
T Consensus        84 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~  157 (265)
T cd06652          84 FMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ  157 (265)
T ss_pred             EEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence            9999999999999873   3568889999999999999999998   999999999999999999999999999987653


Q ss_pred             ccccc--ccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCccccc
Q 002529          744 EDLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV  821 (912)
Q Consensus       744 ~~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  821 (912)
                      .....  ......++..|+|||.+.+..++.++||||||+++|+|++|+.||......  ...    ........     
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~~~----~~~~~~~~-----  226 (265)
T cd06652         158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM--AAI----FKIATQPT-----  226 (265)
T ss_pred             cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH--HHH----HHHhcCCC-----
Confidence            22111  112234788999999998888999999999999999999999999733211  111    11111100     


Q ss_pred             CccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          822 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       822 d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                          ....+......+.+++.+|+. +|++||+++||++
T Consensus       227 ----~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         227 ----NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             ----CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence                111223344578889999995 8999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=5.8e-32  Score=293.08  Aligned_cols=254  Identities=28%  Similarity=0.426  Sum_probs=197.5

Q ss_pred             hhhcccCccccEEEEEEEec----CCCEEEEEEccCcc--chhhHHHHHHHHHHHhcCCCCccceeeEEecCC------e
Q 002529          593 NFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------Q  660 (912)
Q Consensus       593 ~~~~~LG~G~fg~Vy~a~~~----~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~------~  660 (912)
                      .+.+.||+|+||.||+|.++    +++.||+|++....  ....+++.+|++++++++||||+++++++....      .
T Consensus         2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   81 (273)
T cd05074           2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI   81 (273)
T ss_pred             cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccc
Confidence            45688999999999999864    36889999987542  334567889999999999999999999885532      2


Q ss_pred             EEEEEEecCCCCHHHHhccCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeecc
Q 002529          661 RILVYEYMHNGTLRDRLHGSV---NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG  737 (912)
Q Consensus       661 ~~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFG  737 (912)
                      .++++||+++|+|.+++....   ....+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||
T Consensus        82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg  158 (273)
T cd05074          82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFG  158 (273)
T ss_pred             eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECccc
Confidence            478899999999998875322   22357889999999999999999998   899999999999999999999999999


Q ss_pred             Ccccccccccc-ccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhhhccC
Q 002529          738 LSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKG  815 (912)
Q Consensus       738 la~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~  815 (912)
                      .++........ ......+++.|++||.+.+..++.++|||||||++|||++ |+.||.....   ..+..+..    .+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~~~~~----~~  231 (273)
T cd05074         159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYNYLI----KG  231 (273)
T ss_pred             ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHHHHHH----cC
Confidence            98865432211 1122235678999999988889999999999999999999 8899863322   12222111    11


Q ss_pred             CcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhh
Q 002529          816 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS  865 (912)
Q Consensus       816 ~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~  865 (912)
                      ....         .+......+.+++.+||+.+|++||++.|+++.|+++
T Consensus       232 ~~~~---------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         232 NRLK---------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             CcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            1100         0112234789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.6e-32  Score=295.49  Aligned_cols=256  Identities=25%  Similarity=0.324  Sum_probs=200.0

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCccc-hhhHHHHHHHHHHHhcCCCCccceeeEEec--CCeEEEEEEe
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQRILVYEY  667 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~L~hpnIv~l~~~~~~--~~~~~lV~E~  667 (912)
                      +++.++||.|++|.||++..+ +++.+|+|.+..... .....+.+|++++++++||||+++++++..  ....++||||
T Consensus         3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~   82 (287)
T cd06621           3 IVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEY   82 (287)
T ss_pred             eEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEe
Confidence            455789999999999999986 588999999875432 345678999999999999999999998854  3478999999


Q ss_pred             cCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccc
Q 002529          668 MHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL  746 (912)
Q Consensus       668 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~  746 (912)
                      +++++|.+++.... ....+++..+..++.||+.||+|||+   .+++|+||+|+||+++.++.++|+|||++.......
T Consensus        83 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  159 (287)
T cd06621          83 CEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL  159 (287)
T ss_pred             cCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence            99999998876432 34568899999999999999999998   999999999999999999999999999987654322


Q ss_pred             ccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcc--chhhHHHHHHhhhccCCcccccCcc
Q 002529          747 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG--AELNIVHWARSMIKKGDVISIVDPV  824 (912)
Q Consensus       747 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~d~~  824 (912)
                      .   ....++..|+|||.+.+..++.++||||||+++|+|++|+.||......  .......+...    ...... ...
T Consensus       160 ~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~-~~~  231 (287)
T cd06621         160 A---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN----MPNPEL-KDE  231 (287)
T ss_pred             c---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc----CCchhh-ccC
Confidence            1   1234678999999999889999999999999999999999999844321  11122222111    111111 100


Q ss_pred             ccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          825 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       825 l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                      .  .........+.+++.+||+.+|++|||+.|+++
T Consensus       232 ~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         232 P--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             C--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            0  001123457889999999999999999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=6.7e-32  Score=290.49  Aligned_cols=251  Identities=29%  Similarity=0.392  Sum_probs=205.0

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCccc-hhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEecC
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH  669 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~  669 (912)
                      +++.+.||+|++|.||+|..+ +++.|++|++..... .....+.+|++.+.+++|+||+++++++......++|+||++
T Consensus         3 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (264)
T cd06623           3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMD   82 (264)
T ss_pred             ceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecC
Confidence            556789999999999999887 499999999876543 446789999999999999999999999999999999999999


Q ss_pred             CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccccc
Q 002529          670 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI  749 (912)
Q Consensus       670 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~  749 (912)
                      +++|.+++..   ...+++..++.++.|+++||+|||+  ..+++|+||+|+||+++.++.++|+|||.+..........
T Consensus        83 ~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lh~--~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~  157 (264)
T cd06623          83 GGSLADLLKK---VGKIPEPVLAYIARQILKGLDYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC  157 (264)
T ss_pred             CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhc--cCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcc
Confidence            9999999973   3678999999999999999999995  2899999999999999999999999999988764433221


Q ss_pred             cccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCCC
Q 002529          750 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV  829 (912)
Q Consensus       750 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  829 (912)
                       ....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...............   .. ....     .    .
T Consensus       158 -~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~---~~-~~~~-----~----~  223 (264)
T cd06623         158 -NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI---CD-GPPP-----S----L  223 (264)
T ss_pred             -cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHH---hc-CCCC-----C----C
Confidence             2334788999999999989999999999999999999999999744321222222221   11 1111     1    1


Q ss_pred             CHH-HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002529          830 KIE-SIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       830 ~~~-~~~~l~~Li~~cL~~dP~~RPs~~evl~~  861 (912)
                      +.. .+..+.+++.+||+.+|++||++.|+++.
T Consensus       224 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         224 PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            111 33578999999999999999999999873

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=8.8e-32  Score=294.36  Aligned_cols=245  Identities=25%  Similarity=0.377  Sum_probs=198.4

Q ss_pred             hhcccCccccEEEEEEEec-CCCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEecCCCC
Q 002529          594 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGT  672 (912)
Q Consensus       594 ~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~gs  672 (912)
                      ..+.||+|++|.||++... +++.+++|++........+.+.+|+.+++.++||||+++++++...+..++++||+++++
T Consensus        23 ~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~  102 (285)
T cd06648          23 NFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGA  102 (285)
T ss_pred             cceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCC
Confidence            3579999999999999865 688999999865544455678899999999999999999999999999999999999999


Q ss_pred             HHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccccccc
Q 002529          673 LRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV  752 (912)
Q Consensus       673 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~  752 (912)
                      |.+++..    ..+++..+..++.|++.||+|||+   ++++||||+|+||+++.++.++|+|||.+......... ...
T Consensus       103 L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~-~~~  174 (285)
T cd06648         103 LTDIVTH----TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR-RKS  174 (285)
T ss_pred             HHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc-ccc
Confidence            9999873    468899999999999999999998   99999999999999999999999999988765432221 223


Q ss_pred             ccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCCCCHH
Q 002529          753 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE  832 (912)
Q Consensus       753 ~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  832 (912)
                      ..|+..|+|||.+.+..++.++||||||+++|+|++|+.||.....      ....... .....     +...  ....
T Consensus       175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~------~~~~~~~-~~~~~-----~~~~--~~~~  240 (285)
T cd06648         175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP------LQAMKRI-RDNLP-----PKLK--NLHK  240 (285)
T ss_pred             ccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH------HHHHHHH-HhcCC-----CCCc--cccc
Confidence            4578899999999888899999999999999999999999963221      1111111 11111     0110  0111


Q ss_pred             HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          833 SIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       833 ~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                      ....+.+++.+||+.+|++||++.++++
T Consensus       241 ~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         241 VSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             CCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            2347899999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2.7e-32  Score=297.57  Aligned_cols=260  Identities=20%  Similarity=0.285  Sum_probs=195.3

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCccc--hhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEec
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM  668 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~  668 (912)
                      |+..+.||.|++|.||+|+.+ +++.||+|.+.....  .....+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (284)
T cd07860           2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL   81 (284)
T ss_pred             ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeecc
Confidence            456789999999999999876 689999998864322  22356889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccc
Q 002529          669 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH  748 (912)
Q Consensus       669 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  748 (912)
                      . ++|.+++... ....+++..++.++.|++.||+|||+   .+++|+||+|+||+++.++.+||+|||++.........
T Consensus        82 ~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~  156 (284)
T cd07860          82 H-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT  156 (284)
T ss_pred             c-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence            5 6898888754 34578999999999999999999998   99999999999999999999999999998765432221


Q ss_pred             ccccccCCCcccCCCccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccC------------
Q 002529          749 ISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG------------  815 (912)
Q Consensus       749 ~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~------------  815 (912)
                       .....++..|+|||++.+. .++.++||||||+++|||+||+.||.......  ...+.....-...            
T Consensus       157 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07860         157 -YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDEVVWPGVTSLPD  233 (284)
T ss_pred             -cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhhhhHHHH
Confidence             1223467889999988664 46889999999999999999999997433211  1111111000000            


Q ss_pred             ---CcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          816 ---DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       816 ---~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                         .........+. .........+.+++.+||+.||++||+++|+++
T Consensus       234 ~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         234 YKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence               00000000000 000112236789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.3e-33  Score=312.32  Aligned_cols=244  Identities=27%  Similarity=0.450  Sum_probs=194.8

Q ss_pred             hhcccCccccEEEEEEEec-CCCEEEEEEcc--C--ccchhhHHHHHHHHHHHhcCCCCccceeeEEecCCe--EEEEEE
Q 002529          594 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMA--D--SCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ--RILVYE  666 (912)
Q Consensus       594 ~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~--~--~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~--~~lV~E  666 (912)
                      |.++||+|+|-+||+|.+. +|.+||=-.++  +  ......+.|..|+.+|+.|+||||+++++.+.+...  .-+|+|
T Consensus        44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE  123 (632)
T KOG0584|consen   44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE  123 (632)
T ss_pred             hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence            5678999999999999876 47777632221  1  223345789999999999999999999999876554  678999


Q ss_pred             ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccC-CCcEEEeeccCccccccc
Q 002529          667 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEED  745 (912)
Q Consensus       667 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~-~~~vkL~DFGla~~~~~~  745 (912)
                      .+..|+|..+++   ..+.++.+.+..|++||++||.|||+. +.+|+|||||.+||||+. -|.|||+|+|+|......
T Consensus       124 L~TSGtLr~Y~k---k~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s  199 (632)
T KOG0584|consen  124 LFTSGTLREYRK---KHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS  199 (632)
T ss_pred             cccCCcHHHHHH---HhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence            999999999998   457788999999999999999999985 689999999999999974 589999999999886543


Q ss_pred             cccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccc
Q 002529          746 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL  825 (912)
Q Consensus       746 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  825 (912)
                      ..   ....|||.|||||.+. ..|.+..||||||++++||+|+..||.....  ...+...+..-++...+..+-||  
T Consensus       200 ~a---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n--~AQIYKKV~SGiKP~sl~kV~dP--  271 (632)
T KOG0584|consen  200 HA---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN--PAQIYKKVTSGIKPAALSKVKDP--  271 (632)
T ss_pred             cc---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC--HHHHHHHHHcCCCHHHhhccCCH--
Confidence            32   2367999999999987 6899999999999999999999999983222  12222222222222223333333  


Q ss_pred             cCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          826 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       826 ~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                                ++.++|.+||.. .++|||+.|+|+
T Consensus       272 ----------evr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  272 ----------EVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             ----------HHHHHHHHHhcC-chhccCHHHHhh
Confidence                      678999999999 999999999986

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=5.4e-32  Score=296.87  Aligned_cols=261  Identities=20%  Similarity=0.233  Sum_probs=197.7

Q ss_pred             HHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCccch--hhHHHHHHHHHHHhcCCCCccceeeEEecC--CeEEEE
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH--RTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRILV  664 (912)
Q Consensus       590 ~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~--~~~~~~~E~~il~~L~hpnIv~l~~~~~~~--~~~~lV  664 (912)
                      ..|++.+.||+|++|.||+|..+ +++.+++|.++.....  ....+.+|++++++++||||+++++++...  ...++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            35778899999999999999987 5889999998643222  234567899999999999999999998777  889999


Q ss_pred             EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccc
Q 002529          665 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE  744 (912)
Q Consensus       665 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~  744 (912)
                      +||++ ++|.+.+...  ...+++..++.++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||++.....
T Consensus        85 ~e~~~-~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          85 MEYVE-HDLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGS  158 (293)
T ss_pred             ehhcC-cCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence            99997 5999888743  3468999999999999999999998   8999999999999999999999999999887654


Q ss_pred             ccccccccccCCCcccCCCccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhc----------
Q 002529          745 DLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK----------  813 (912)
Q Consensus       745 ~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~----------  813 (912)
                      .... .....+++.|+|||.+.+. .++.++|+||+|+++|+|++|+.||.........   ..+.....          
T Consensus       159 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~---~~~~~~~~~~~~~~~~~~  234 (293)
T cd07843         159 PLKP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQL---NKIFKLLGTPTEKIWPGF  234 (293)
T ss_pred             Cccc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCCchHHHHHh
Confidence            3221 1223468899999988654 4689999999999999999999999744322111   11100000          


Q ss_pred             -------cCCcccccCccccCCCCHH-HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          814 -------KGDVISIVDPVLIGNVKIE-SIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       814 -------~~~~~~~~d~~l~~~~~~~-~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                             ...........+...++.. ....+.+++.+||+.+|++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         235 SELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             hccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence                   0000000001111111111 2456889999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-32  Score=294.42  Aligned_cols=246  Identities=27%  Similarity=0.420  Sum_probs=197.9

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCc-cchhhHHHHHHHHHHHhcC---CCCccceeeEEecCCeEEEEEE
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS-CSHRTQQFVTEVALLSRIH---HRNLVPLIGYCEEEHQRILVYE  666 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~-~~~~~~~~~~E~~il~~L~---hpnIv~l~~~~~~~~~~~lV~E  666 (912)
                      |++.+.||+|+||.||+|.+. +++.||+|.+... ......++.+|+.++++++   |||++++++++..+...++|||
T Consensus         3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e   82 (277)
T cd06917           3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIME   82 (277)
T ss_pred             hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEe
Confidence            556789999999999999875 6899999998654 2334567889999999997   9999999999999999999999


Q ss_pred             ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccc
Q 002529          667 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL  746 (912)
Q Consensus       667 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~  746 (912)
                      |+++++|.++++.    ..+++..++.++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++.......
T Consensus        83 ~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06917          83 YAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS  155 (277)
T ss_pred             cCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence            9999999999863    368999999999999999999998   999999999999999999999999999988765433


Q ss_pred             ccccccccCCCcccCCCccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccc
Q 002529          747 THISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL  825 (912)
Q Consensus       747 ~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  825 (912)
                      .. .....|+..|+|||.+.++ .++.++||||||+++|+|++|+.||......      .... .+....     .+.+
T Consensus       156 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~------~~~~-~~~~~~-----~~~~  222 (277)
T cd06917         156 SK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF------RAMM-LIPKSK-----PPRL  222 (277)
T ss_pred             cc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh------hhhh-ccccCC-----CCCC
Confidence            22 2234588899999988654 5688999999999999999999999733221      1110 111111     1111


Q ss_pred             cCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          826 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       826 ~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                      ...   .....+.+++.+||+.+|++||++.|+++
T Consensus       223 ~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         223 EDN---GYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             Ccc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            111   13347889999999999999999999976

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=4.7e-32  Score=295.52  Aligned_cols=262  Identities=22%  Similarity=0.308  Sum_probs=198.1

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCccc-hhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEecC
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH  669 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~  669 (912)
                      |++.++||.|++|.||+|+.+ +++.||+|.++.... .....+.+|++++++++|+||+++++++.+.+..++||||++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   81 (284)
T cd07836           2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD   81 (284)
T ss_pred             ceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC
Confidence            456789999999999999986 588999999875432 234567789999999999999999999999999999999997


Q ss_pred             CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccccc
Q 002529          670 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI  749 (912)
Q Consensus       670 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~  749 (912)
                      + +|.+++........+++..+..++.|++.||+|||+   .+++||||||+||++++++.++|+|||++......... 
T Consensus        82 ~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~-  156 (284)
T cd07836          82 K-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT-  156 (284)
T ss_pred             c-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc-
Confidence            4 898888754344578999999999999999999998   89999999999999999999999999998765432211 


Q ss_pred             cccccCCCcccCCCccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhh--hccCCcccccC-ccc
Q 002529          750 SSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM--IKKGDVISIVD-PVL  825 (912)
Q Consensus       750 ~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~d-~~l  825 (912)
                      .....++..|++||++.+. .++.++||||||+++|+|++|+.||...+..+...  ......  ........+.+ +.+
T Consensus       157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07836         157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLL--KIFRIMGTPTESTWPGISQLPEY  234 (284)
T ss_pred             cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHH--HHHHHhCCCChhhHHHHhcCchh
Confidence            1223467889999988654 56889999999999999999999997544322111  100000  00000000000 000


Q ss_pred             c-----------CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          826 I-----------GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       826 ~-----------~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                      .           ..........+.+++.+||+.+|.+||+++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0           0011122457889999999999999999999985

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-32  Score=295.65  Aligned_cols=260  Identities=23%  Similarity=0.269  Sum_probs=197.8

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc--chhhHHHHHHHHHHHhcCCCCccceeeEEecC--CeEEEEEE
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRILVYE  666 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~--~~~~lV~E  666 (912)
                      |++.++||+|++|.||+|... +++.+|+|.+....  ......+.+|++++++++|+|++++++++...  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            346789999999999999877 48899999997653  23345688999999999999999999999887  88999999


Q ss_pred             ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccc
Q 002529          667 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL  746 (912)
Q Consensus       667 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~  746 (912)
                      |++ ++|.+++...  ...+++..++.++.||++||+|||+   .+++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~-~~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~  154 (287)
T cd07840          81 YMD-HDLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRN  154 (287)
T ss_pred             ccc-ccHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence            997 4888888642  2578999999999999999999998   899999999999999999999999999998765443


Q ss_pred             ccccccccCCCcccCCCccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhc---cCCcccccC
Q 002529          747 THISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK---KGDVISIVD  822 (912)
Q Consensus       747 ~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~d  822 (912)
                      ........++..|+|||.+.+ ..++.++||||||+++|||++|+.||........   ...+.....   ........+
T Consensus       155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  231 (287)
T cd07840         155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ---LEKIFELCGSPTDENWPGVSK  231 (287)
T ss_pred             cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCchhhcccccc
Confidence            222223346788999997754 4678999999999999999999999974442211   111111110   000000000


Q ss_pred             --------------ccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          823 --------------PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       823 --------------~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                                    ..+...........+.+++.+||+.+|++||+++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                          00000001112457899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-32  Score=293.18  Aligned_cols=252  Identities=28%  Similarity=0.413  Sum_probs=198.4

Q ss_pred             HHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCccchhhHHHHHHHHHHHhc-CCCCccceeeEEecCC------eE
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEH------QR  661 (912)
Q Consensus       590 ~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L-~hpnIv~l~~~~~~~~------~~  661 (912)
                      .+|++.+.||+|++|.||+|..+ +++.+++|++..... ..+.+.+|+.+++++ +|+||+++++++....      ..
T Consensus         6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~   84 (275)
T cd06608           6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQL   84 (275)
T ss_pred             hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEE
Confidence            56778899999999999999986 578999999875433 346789999999999 6999999999986543      58


Q ss_pred             EEEEEecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcc
Q 002529          662 ILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR  740 (912)
Q Consensus       662 ~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~  740 (912)
                      ++||||+++++|.+++.... .+..+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||++.
T Consensus        85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~  161 (275)
T cd06608          85 WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSA  161 (275)
T ss_pred             EEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCccce
Confidence            99999999999999887532 24678999999999999999999998   999999999999999999999999999987


Q ss_pred             ccccccccccccccCCCcccCCCccCC-----CCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccC
Q 002529          741 QAEEDLTHISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG  815 (912)
Q Consensus       741 ~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  815 (912)
                      ........ .....++..|+|||++..     ..++.++||||||+++|+|++|+.||.....  .....+    .. .+
T Consensus       162 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~----~~-~~  233 (275)
T cd06608         162 QLDSTLGR-RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP--MRALFK----IP-RN  233 (275)
T ss_pred             ecccchhh-hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch--HHHHHH----hh-cc
Confidence            65433222 223457889999998753     3467899999999999999999999973221  111111    11 11


Q ss_pred             CcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          816 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       816 ~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                      ....     +  ..+......+.+++.+||..||++|||+.|+++
T Consensus       234 ~~~~-----~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         234 PPPT-----L--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             CCCC-----C--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            1111     1  111223457889999999999999999999986

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-32  Score=300.78  Aligned_cols=264  Identities=21%  Similarity=0.272  Sum_probs=195.8

Q ss_pred             HhhhcccCccccEEEEEEEecC---CCEEEEEEccCcc---chhhHHHHHHHHHHHhcCCCCccceeeEEecC--CeEEE
Q 002529          592 NNFCKKIGKGSFGSVYYGKMKD---GKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRIL  663 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~~---~~~vAvK~l~~~~---~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~--~~~~l  663 (912)
                      |++.++||+|++|.||+|..+.   ++.||+|.+....   ......+.+|+.++++++||||+++++++.+.  ...++
T Consensus         2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   81 (316)
T cd07842           2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL   81 (316)
T ss_pred             ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence            5567889999999999998764   7899999997633   33346678899999999999999999999887  88999


Q ss_pred             EEEecCCCCHHHHhccCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccC----CCcEEEeecc
Q 002529          664 VYEYMHNGTLRDRLHGSV--NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI----NMRAKVSDFG  737 (912)
Q Consensus       664 V~E~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~----~~~vkL~DFG  737 (912)
                      ||||+++ +|.+.+....  ....+++..++.++.|++.||+|||+   .+++||||||+||+++.    ++.+||+|||
T Consensus        82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg  157 (316)
T cd07842          82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLG  157 (316)
T ss_pred             EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence            9999964 6777665332  22378999999999999999999998   99999999999999998    8999999999


Q ss_pred             Cccccccccc--cccccccCCCcccCCCccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCccch-------hhHHHH
Q 002529          738 LSRQAEEDLT--HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE-------LNIVHW  807 (912)
Q Consensus       738 la~~~~~~~~--~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~-------~~~~~~  807 (912)
                      ++........  .......++..|+|||++.+ ..++.++||||||+++++|++|+.||........       ..+...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
T cd07842         158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI  237 (316)
T ss_pred             cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence            9887544322  11223457889999998766 4578999999999999999999999975443220       011111


Q ss_pred             HHhhhcc------------CCcccccCccccCCCC---------H--HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          808 ARSMIKK------------GDVISIVDPVLIGNVK---------I--ESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       808 ~~~~~~~------------~~~~~~~d~~l~~~~~---------~--~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                      +. .+..            .......+......++         .  .....+.+++.+||+.+|++|||+.|+++
T Consensus       238 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         238 FE-VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HH-HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            10 0000            0000000000000000         0  22346889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-32  Score=300.27  Aligned_cols=254  Identities=24%  Similarity=0.328  Sum_probs=200.7

Q ss_pred             HHHHHHhhhcccCccccEEEEEEEecCCCEEEEEEccCc--cchhhHHHHHHHHHHHhcC-CCCccceeeEEecCCeEEE
Q 002529          587 LEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADS--CSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRIL  663 (912)
Q Consensus       587 l~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~L~-hpnIv~l~~~~~~~~~~~l  663 (912)
                      +....|++.++||+||.+.||++...+.+.+|+|++...  .......+.+|+..|.+|+ |.+|+++++|-..++.+||
T Consensus       358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm  437 (677)
T KOG0596|consen  358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM  437 (677)
T ss_pred             ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence            345567888999999999999999998899999887543  2344577999999999996 9999999999999999999


Q ss_pred             EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccc
Q 002529          664 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE  743 (912)
Q Consensus       664 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~  743 (912)
                      |||+- ..+|..+|++.  ...++.-.++.+..|++.|+.+.|+   +||||.||||.|+|+- .|.+||+|||.|..+.
T Consensus       438 vmE~G-d~DL~kiL~k~--~~~~~~~~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~  510 (677)
T KOG0596|consen  438 VMECG-DIDLNKILKKK--KSIDPDWFLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQ  510 (677)
T ss_pred             Eeecc-cccHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEE-eeeEEeeeechhcccC
Confidence            99976 57999999864  2223323778899999999999998   9999999999999985 6899999999999887


Q ss_pred             cccccc-cccccCCCcccCCCccCCC-----------CCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhh
Q 002529          744 EDLTHI-SSVARGTVGYLDPEYYGNQ-----------QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM  811 (912)
Q Consensus       744 ~~~~~~-~~~~~gt~~y~APE~l~~~-----------~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~  811 (912)
                      .+.+.. ....+||+.||+||.+...           ..+.++||||||||||+|+.|+.||.     ...+....+.  
T Consensus       511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~-----~~~n~~aKl~--  583 (677)
T KOG0596|consen  511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFG-----QIINQIAKLH--  583 (677)
T ss_pred             ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchH-----HHHHHHHHHH--
Confidence            665443 3446799999999988432           25679999999999999999999997     2222222222  


Q ss_pred             hccCCcccccCccccCCCC-HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002529          812 IKKGDVISIVDPVLIGNVK-IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       812 ~~~~~~~~~~d~~l~~~~~-~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  861 (912)
                             .+.||.-.-+++ ....++++++++.||..||.+||++.|+|+.
T Consensus       584 -------aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  584 -------AITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             -------hhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence                   233332211111 1122349999999999999999999999863

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=5.5e-32  Score=297.29  Aligned_cols=250  Identities=25%  Similarity=0.386  Sum_probs=201.8

Q ss_pred             HHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEec
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM  668 (912)
Q Consensus       590 ~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~  668 (912)
                      .+|.+.+.||+|+||.||++... +++.|++|.+........+.+.+|+.++++++||||+++++.+...+..++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            56778899999999999999865 68899999986554445577889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccc
Q 002529          669 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH  748 (912)
Q Consensus       669 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  748 (912)
                      ++++|.+++..    ..+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||++.........
T Consensus        99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~  171 (293)
T cd06647          99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  171 (293)
T ss_pred             CCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence            99999999873    357889999999999999999998   99999999999999999999999999988765433222


Q ss_pred             ccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCC
Q 002529          749 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN  828 (912)
Q Consensus       749 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  828 (912)
                       .....+++.|+|||.+.+..++.++||||||+++|++++|+.||........      .......+.      +..  .
T Consensus       172 -~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~------~~~~~~~~~------~~~--~  236 (293)
T cd06647         172 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------LYLIATNGT------PEL--Q  236 (293)
T ss_pred             -cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh------eeehhcCCC------CCC--C
Confidence             2223578899999999888889999999999999999999999974322111      000000000      000  0


Q ss_pred             CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002529          829 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       829 ~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  861 (912)
                      ........+.+++.+||+.+|++||++.+++..
T Consensus       237 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         237 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            111223468899999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-33  Score=306.65  Aligned_cols=252  Identities=21%  Similarity=0.342  Sum_probs=206.0

Q ss_pred             HHHHhhhcccCccccEEEEEEEecC-CCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEe
Q 002529          589 EATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY  667 (912)
Q Consensus       589 ~~~~~~~~~LG~G~fg~Vy~a~~~~-~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  667 (912)
                      ..-++++..||.|+||.||+|..++ +-..|.|++.........++.-|++||..+.||+||++++.|..++.+++..||
T Consensus        31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF  110 (1187)
T KOG0579|consen   31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF  110 (1187)
T ss_pred             HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence            3456788899999999999998875 344567877766677788999999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccc
Q 002529          668 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT  747 (912)
Q Consensus       668 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~  747 (912)
                      |.||-+..++-.  -+..+.+.++.-+++|++.||.|||+   .+|||||||..|||++-+|.++|+|||.+........
T Consensus       111 C~GGAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~q  185 (1187)
T KOG0579|consen  111 CGGGAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQ  185 (1187)
T ss_pred             cCCchHhHHHHH--hccccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchhHHh
Confidence            999999888765  36789999999999999999999998   9999999999999999999999999998865433222


Q ss_pred             cccccccCCCcccCCCcc-----CCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccC
Q 002529          748 HISSVARGTVGYLDPEYY-----GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD  822 (912)
Q Consensus       748 ~~~~~~~gt~~y~APE~l-----~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  822 (912)
                       ....+.|||.|||||+.     ...+|+.++||||||++|.||..+.+|-+.-      +....+. .+.......++.
T Consensus       186 -kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel------npMRVll-KiaKSePPTLlq  257 (1187)
T KOG0579|consen  186 -KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL------NPMRVLL-KIAKSEPPTLLQ  257 (1187)
T ss_pred             -hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc------chHHHHH-HHhhcCCCcccC
Confidence             23456799999999986     4568999999999999999999999997621      1112111 122222222222


Q ss_pred             ccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          823 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       823 ~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                             +......+.+++.+||.+||..||++.++++
T Consensus       258 -------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  258 -------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             -------cchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence                   2345567899999999999999999999884

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.1e-31  Score=285.61  Aligned_cols=248  Identities=29%  Similarity=0.490  Sum_probs=202.9

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEecCC
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN  670 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~  670 (912)
                      |...+.||+|++|.||++..+ +++.+++|++..........+.+|++++++++|+||+++++++......++++||+++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~   81 (253)
T cd05122           2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG   81 (253)
T ss_pred             ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence            445688999999999999986 6889999999776555667899999999999999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccccc
Q 002529          671 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS  750 (912)
Q Consensus       671 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~  750 (912)
                      ++|.+++...  ...+++..+..++.|++.||++||+   .+++||||+|+||+++.++.++|+|||.+........  .
T Consensus        82 ~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~  154 (253)
T cd05122          82 GSLKDLLKST--NQTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--R  154 (253)
T ss_pred             CcHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc--c
Confidence            9999998753  2578999999999999999999998   9999999999999999999999999999887654332  2


Q ss_pred             ccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCCCC
Q 002529          751 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK  830 (912)
Q Consensus       751 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  830 (912)
                      ....++..|+|||.+.+...+.++||||||+++++|++|+.||...+...   ...   .... .........       
T Consensus       155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~---~~~~-~~~~~~~~~-------  220 (253)
T cd05122         155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK---ALF---KIAT-NGPPGLRNP-------  220 (253)
T ss_pred             cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH---HHH---HHHh-cCCCCcCcc-------
Confidence            23457889999999988889999999999999999999999997332211   111   1111 111111111       


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          831 IESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       831 ~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                      ......+.+++.+||+.+|++|||+.|+++
T Consensus       221 ~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         221 EKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             cccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            111347889999999999999999999985

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.9e-32  Score=294.38  Aligned_cols=246  Identities=25%  Similarity=0.326  Sum_probs=200.3

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc---chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEe
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY  667 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  667 (912)
                      |++.+.||.|+||.||+|..+ +++.||+|.+....   ....+.+.+|++++++++||||+++++.+.++...++|+||
T Consensus         2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   81 (258)
T cd05578           2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL   81 (258)
T ss_pred             ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence            566789999999999999887 58999999986532   23457789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccc
Q 002529          668 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT  747 (912)
Q Consensus       668 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~  747 (912)
                      +++++|.+++..   ...+++..+..++.|+++||.|||+   .+++|+||+|+||++++++.++|+|||.+........
T Consensus        82 ~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~  155 (258)
T cd05578          82 LLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL  155 (258)
T ss_pred             CCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc
Confidence            999999999973   3578999999999999999999998   8999999999999999999999999999877544321


Q ss_pred             cccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccC
Q 002529          748 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG  827 (912)
Q Consensus       748 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  827 (912)
                        .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||........    ..........          ..
T Consensus       156 --~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~~----------~~  219 (258)
T cd05578         156 --TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR----DQIRAKQETA----------DV  219 (258)
T ss_pred             --ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHH----HHHHHHhccc----------cc
Confidence              2234478899999999888899999999999999999999999984433211    1111111110          01


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCCCH--HHHH
Q 002529          828 NVKIESIWRIAEVAIQCVEQRGFSRPKM--QEIV  859 (912)
Q Consensus       828 ~~~~~~~~~l~~Li~~cL~~dP~~RPs~--~evl  859 (912)
                      ..+...+..+.+++.+||+.+|.+||++  +|++
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         220 LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             cCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            1112233578899999999999999999  6654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=8.2e-32  Score=295.17  Aligned_cols=252  Identities=27%  Similarity=0.373  Sum_probs=196.0

Q ss_pred             HHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCccchhhHHHHHHHHHHHhc-CCCCccceeeEEecC-----CeEE
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE-----HQRI  662 (912)
Q Consensus       590 ~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L-~hpnIv~l~~~~~~~-----~~~~  662 (912)
                      ..|.+.+.||+|+||.||+|..+ +++.+|+|++.... .....+.+|+.+++++ +|||++++++++...     ...+
T Consensus        22 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~  100 (291)
T cd06639          22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLW  100 (291)
T ss_pred             CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeE
Confidence            34566789999999999999875 68899999986532 2345678899999999 799999999998653     3689


Q ss_pred             EEEEecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccc
Q 002529          663 LVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ  741 (912)
Q Consensus       663 lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~  741 (912)
                      +|+||+++++|.++++... ....+++..++.++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++..
T Consensus       101 lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~kl~dfg~~~~  177 (291)
T cd06639         101 LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ  177 (291)
T ss_pred             EEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEeecccchh
Confidence            9999999999999886432 34578999999999999999999998   9999999999999999999999999999876


Q ss_pred             cccccccccccccCCCcccCCCccCCC-----CCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCC
Q 002529          742 AEEDLTHISSVARGTVGYLDPEYYGNQ-----QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD  816 (912)
Q Consensus       742 ~~~~~~~~~~~~~gt~~y~APE~l~~~-----~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  816 (912)
                      ....... .....++..|+|||.+...     .++.++|||||||++|||++|+.||......  ..+..     +..+.
T Consensus       178 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~--~~~~~-----~~~~~  249 (291)
T cd06639         178 LTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV--KTLFK-----IPRNP  249 (291)
T ss_pred             ccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH--HHHHH-----HhcCC
Confidence            5432211 1234578899999998543     3678999999999999999999999733211  11111     11111


Q ss_pred             cccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          817 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       817 ~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                      ...+.+       +......+.+++.+||+.+|++||++.|+++
T Consensus       250 ~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         250 PPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             CCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            111111       1122346889999999999999999999986

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.2e-31  Score=288.97  Aligned_cols=242  Identities=24%  Similarity=0.327  Sum_probs=195.9

Q ss_pred             cCccccEEEEEEEec-CCCEEEEEEccCccc---hhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEecCCCCH
Q 002529          598 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL  673 (912)
Q Consensus       598 LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL  673 (912)
                      ||.|++|.||+|+.. +++.+|+|++.....   ...+.+.+|++++++++||||+++++.+.++...++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            799999999999986 489999999865322   3446789999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccccccccc
Q 002529          674 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA  753 (912)
Q Consensus       674 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~  753 (912)
                      .+++..   ...+++..+..++.||+.||+|||+   .+++|+||+|+||+++.++.++|+|||++.......  .....
T Consensus        81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~  152 (262)
T cd05572          81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTF  152 (262)
T ss_pred             HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccc
Confidence            999974   4568999999999999999999998   999999999999999999999999999998765432  12223


Q ss_pred             cCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCCCCHHH
Q 002529          754 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES  833 (912)
Q Consensus       754 ~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  833 (912)
                      .++..|+|||.+.+..++.++|+||+|+++|+|++|+.||......    ..+..........         ....+...
T Consensus       153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~---------~~~~~~~~  219 (262)
T cd05572         153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED----PMEIYNDILKGNG---------KLEFPNYI  219 (262)
T ss_pred             cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC----HHHHHHHHhccCC---------CCCCCccc
Confidence            5788999999998888999999999999999999999999744321    1111111111000         01112222


Q ss_pred             HHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 002529          834 IWRIAEVAIQCVEQRGFSRPK-----MQEIVL  860 (912)
Q Consensus       834 ~~~l~~Li~~cL~~dP~~RPs-----~~evl~  860 (912)
                      ...+.+++.+||+.+|++||+     ++|+++
T Consensus       220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            457899999999999999999     677665

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.98  E-value=7.1e-32  Score=293.96  Aligned_cols=249  Identities=22%  Similarity=0.349  Sum_probs=191.9

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc-chhhHHHHHHHHH-HHhcCCCCccceeeEEecCCeEEEEEEec
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVAL-LSRIHHRNLVPLIGYCEEEHQRILVYEYM  668 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~-~~~~~~~~~E~~i-l~~L~hpnIv~l~~~~~~~~~~~lV~E~~  668 (912)
                      +++.+.||+|+||.||+|..+ +|+.||+|+++... ......+..|+.. ++.++||||+++++++..++..+++|||+
T Consensus         3 ~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~   82 (283)
T cd06617           3 LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVM   82 (283)
T ss_pred             ceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhh
Confidence            556789999999999999886 68999999987543 2334456666665 56668999999999999999999999999


Q ss_pred             CCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeeecCCCCCCccccCCCcEEEeeccCcccccccc
Q 002529          669 HNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNP-GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL  746 (912)
Q Consensus       669 ~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LHs~~~~-~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~  746 (912)
                      + |+|.+++.... ....+++..++.++.|++.||+|||+   + +++||||||+||+++.++.+||+|||++.......
T Consensus        83 ~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (283)
T cd06617          83 D-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV  158 (283)
T ss_pred             c-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence            6 68888776432 34578999999999999999999998   5 99999999999999999999999999988654322


Q ss_pred             ccccccccCCCcccCCCccCC----CCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccC
Q 002529          747 THISSVARGTVGYLDPEYYGN----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD  822 (912)
Q Consensus       747 ~~~~~~~~gt~~y~APE~l~~----~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  822 (912)
                      .  .....++..|+|||.+.+    ..++.++|+|||||++|+|++|+.||...... ...    ....... .......
T Consensus       159 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~----~~~~~~~-~~~~~~~  230 (283)
T cd06617         159 A--KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-FQQ----LKQVVEE-PSPQLPA  230 (283)
T ss_pred             c--cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-HHH----HHHHHhc-CCCCCCc
Confidence            1  122347889999998865    45688999999999999999999999632211 111    1111111 1111100


Q ss_pred             ccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          823 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       823 ~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                              ......+.+++.+||..+|++||+++++++
T Consensus       231 --------~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         231 --------EKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             --------cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                    112346889999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.98  E-value=1.1e-32  Score=311.45  Aligned_cols=271  Identities=27%  Similarity=0.415  Sum_probs=208.3

Q ss_pred             hhcccCccccEEEEEEEec-CCCEEEEEEccCcc-chhhHHHHHHHHHHHhcCCCCccceeeEEecCC------eEEEEE
Q 002529          594 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------QRILVY  665 (912)
Q Consensus       594 ~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~------~~~lV~  665 (912)
                      ..+.||+|+||.||+|+++ .|+.||||.++... ....+...+|+++|++|+|+|||+++++-++..      ...+||
T Consensus        17 ~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvm   96 (732)
T KOG4250|consen   17 MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVM   96 (732)
T ss_pred             ehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEE
Confidence            4588999999999999965 79999999998643 234567889999999999999999999865543      568999


Q ss_pred             EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCcccc--CCCc--EEEeeccCccc
Q 002529          666 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD--INMR--AKVSDFGLSRQ  741 (912)
Q Consensus       666 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~--~~~~--vkL~DFGla~~  741 (912)
                      |||.+|+|...+..-.+...+++.+++.++.+++.||.|||+   ++|+||||||.||++-  .+|+  .||+|||.|+.
T Consensus        97 EyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are  173 (732)
T KOG4250|consen   97 EYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE  173 (732)
T ss_pred             eecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence            999999999999988888899999999999999999999998   9999999999999983  3343  89999999999


Q ss_pred             cccccccccccccCCCcccCCCccC-CCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccc
Q 002529          742 AEEDLTHISSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI  820 (912)
Q Consensus       742 ~~~~~~~~~~~~~gt~~y~APE~l~-~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  820 (912)
                      .+++.  ......||..|++||.+. ...++...|.|||||++|+++||..||.............|....-+.......
T Consensus       174 l~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~  251 (732)
T KOG4250|consen  174 LDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIG  251 (732)
T ss_pred             CCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEe
Confidence            87765  334467999999999998 588999999999999999999999999743332211111221111111111111


Q ss_pred             cCcccc------------CCCCHHHHHHHHHHHHhcccCCCCCCC--CHHHHHHHHhhhhhhc
Q 002529          821 VDPVLI------------GNVKIESIWRIAEVAIQCVEQRGFSRP--KMQEIVLAIQDSIKIE  869 (912)
Q Consensus       821 ~d~~l~------------~~~~~~~~~~l~~Li~~cL~~dP~~RP--s~~evl~~L~~~~~~~  869 (912)
                      ..+...            -.........+-..+..+|..+|++|.  ...+....+.+++...
T Consensus       252 ~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~  314 (732)
T KOG4250|consen  252 AQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLK  314 (732)
T ss_pred             eecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhh
Confidence            111111            112233444677888899999999999  7666666666666543

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.98  E-value=5.7e-32  Score=295.79  Aligned_cols=255  Identities=27%  Similarity=0.354  Sum_probs=195.1

Q ss_pred             HHhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc-chhhHHHHHHHHHHHhcC-CCCccceeeEEecCCeEEEEEEe
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEY  667 (912)
Q Consensus       591 ~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~L~-hpnIv~l~~~~~~~~~~~lV~E~  667 (912)
                      .+.+.+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++.++. |+||+++++++..+...+++||+
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            3445688999999999999876 58999999986432 234567889999999996 99999999999988899999999


Q ss_pred             cCCCCHHHHhccC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccc
Q 002529          668 MHNGTLRDRLHGS--VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED  745 (912)
Q Consensus       668 ~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~  745 (912)
                      +. +++.++....  .....+++..+..++.|++.||+|||+  ..+++||||||+||+++.++.++|+|||++......
T Consensus        85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  161 (288)
T cd06616          85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS  161 (288)
T ss_pred             cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence            85 4555433211  124678999999999999999999997  359999999999999999999999999998765432


Q ss_pred             cccccccccCCCcccCCCccCCC---CCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccC
Q 002529          746 LTHISSVARGTVGYLDPEYYGNQ---QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD  822 (912)
Q Consensus       746 ~~~~~~~~~gt~~y~APE~l~~~---~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  822 (912)
                      ...  ....++..|+|||.+.+.   .++.++|||||||++|+|++|+.||....     ...+.+...... ..     
T Consensus       162 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~~-~~-----  228 (288)
T cd06616         162 IAK--TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVKG-DP-----  228 (288)
T ss_pred             Ccc--ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcCC-CC-----
Confidence            221  223478899999998776   68899999999999999999999997322     111212211111 11     


Q ss_pred             ccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002529          823 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       823 ~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  861 (912)
                      +.+...........+.+++.+||+.+|++||+++||++.
T Consensus       229 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         229 PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            111111112344578999999999999999999999863

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.98  E-value=6.9e-32  Score=294.22  Aligned_cols=260  Identities=22%  Similarity=0.292  Sum_probs=195.5

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCccc--hhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEec
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM  668 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~  668 (912)
                      |++.+.||.|++|.||+|..+ +|+.||+|++.....  .....+.+|++++++++|||++++++++.+++..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            345789999999999999876 699999999864322  22356788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccc
Q 002529          669 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH  748 (912)
Q Consensus       669 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  748 (912)
                      + ++|.+++.... ...+++..++.++.|+++||+|||+   ++++||||+|+||+++.++.++|+|||++.........
T Consensus        81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~  155 (283)
T cd07835          81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT  155 (283)
T ss_pred             C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence            5 68999887432 2468999999999999999999998   89999999999999999999999999998765432211


Q ss_pred             ccccccCCCcccCCCccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccC-----------C
Q 002529          749 ISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG-----------D  816 (912)
Q Consensus       749 ~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~-----------~  816 (912)
                       .....++..|+|||++.+. .++.++||||||+++|+|++|+.||.......  .............           .
T Consensus       156 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07835         156 -YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID--QLFRIFRTLGTPDEDVWPGVTSLPD  232 (283)
T ss_pred             -cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChHHhhhhhhchh
Confidence             1122467889999987654 57899999999999999999999997433211  1111111000000           0


Q ss_pred             ----cccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          817 ----VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       817 ----~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                          ......... ..........+.+++.+||+.+|++||+++|+++
T Consensus       233 ~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         233 YKPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                000000000 0011122347889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.98  E-value=9.9e-32  Score=295.86  Aligned_cols=265  Identities=23%  Similarity=0.268  Sum_probs=197.8

Q ss_pred             HHHHHHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCccc--hhhHHHHHHHHHHHhcCCCCccceeeEEecCC---
Q 002529          586 ELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH---  659 (912)
Q Consensus       586 ~l~~~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~---  659 (912)
                      +.....|++.+.||+|+||.||+|..+ +++.||+|+++....  .....+.+|++++++++||||+++++++.+..   
T Consensus         3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~   82 (302)
T cd07864           3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL   82 (302)
T ss_pred             hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence            344567888999999999999999987 588999999865322  23356778999999999999999999886654   


Q ss_pred             -------eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEE
Q 002529          660 -------QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK  732 (912)
Q Consensus       660 -------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vk  732 (912)
                             ..++|+||+++ ++.+.+...  ...+++..++.++.|++.||+|||+   .+|+|+||||+||++++++.+|
T Consensus        83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~k  156 (302)
T cd07864          83 DFKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIK  156 (302)
T ss_pred             hccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEE
Confidence                   78999999975 777776642  4468999999999999999999998   8999999999999999999999


Q ss_pred             EeeccCccccccccccccccccCCCcccCCCccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhh
Q 002529          733 VSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM  811 (912)
Q Consensus       733 L~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~  811 (912)
                      |+|||.+...............++..|+|||.+.+ ..++.++|||||||++|||++|++||.......   ....+...
T Consensus       157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~---~~~~~~~~  233 (302)
T cd07864         157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA---QLELISRL  233 (302)
T ss_pred             eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHH
Confidence            99999988764433222222335778999998764 457889999999999999999999997432211   11111111


Q ss_pred             hccC---CcccccC--------c------cccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          812 IKKG---DVISIVD--------P------VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       812 ~~~~---~~~~~~d--------~------~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                      ....   ....+..        +      ..... ....+..+.+++.+||+.+|.+||+++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             hCCCChhhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1110   0000000        0      00000 0012357899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.98  E-value=6.8e-32  Score=289.43  Aligned_cols=248  Identities=28%  Similarity=0.434  Sum_probs=199.5

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc--chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEec
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM  668 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~  668 (912)
                      |.+.+.||+|+||.||+|..+ +++.+|+|.+....  ....+.+.+|++++++++|+||+++++.+......++|+||+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   81 (257)
T cd08225           2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC   81 (257)
T ss_pred             ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecC
Confidence            456789999999999999887 58899999986431  234467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCC-cEEEeeccCccccccccc
Q 002529          669 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEEDLT  747 (912)
Q Consensus       669 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~-~vkL~DFGla~~~~~~~~  747 (912)
                      ++++|.+++... ....+++..+..++.|+++||+|||+   .+++|+||||+||++++++ .++|+|||.+........
T Consensus        82 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (257)
T cd08225          82 DGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME  157 (257)
T ss_pred             CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence            999999998753 23467999999999999999999998   9999999999999998875 479999999877654322


Q ss_pred             cccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccC
Q 002529          748 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG  827 (912)
Q Consensus       748 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  827 (912)
                       ......|++.|+|||++.+..++.++|+||||+++++|++|+.||.....      .+....... +....        
T Consensus       158 -~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~-~~~~~--------  221 (257)
T cd08225         158 -LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL------HQLVLKICQ-GYFAP--------  221 (257)
T ss_pred             -cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHhc-ccCCC--------
Confidence             22234578899999999888899999999999999999999999973321      222222221 11111        


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          828 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       828 ~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                       ........+.+++.+||+.+|++|||+.|+++
T Consensus       222 -~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         222 -ISPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             -CCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence             11122347889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.98  E-value=1.5e-31  Score=292.25  Aligned_cols=250  Identities=25%  Similarity=0.389  Sum_probs=201.8

Q ss_pred             HHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEec
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM  668 (912)
Q Consensus       590 ~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~  668 (912)
                      ..|++.+.||+|++|.||+|.++ +++.|++|++..... ....+.+|++++++++|+||+++++.+......++++||+
T Consensus        19 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   97 (286)
T cd06614          19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYM   97 (286)
T ss_pred             ccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEecc
Confidence            34666789999999999999987 689999999876544 4567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccc
Q 002529          669 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH  748 (912)
Q Consensus       669 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  748 (912)
                      ++++|.+++...  ...+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||++........ 
T Consensus        98 ~~~~L~~~l~~~--~~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-  171 (286)
T cd06614          98 DGGSLTDIITQN--FVRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-  171 (286)
T ss_pred             CCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-
Confidence            999999999853  1379999999999999999999998   9999999999999999999999999998876543221 


Q ss_pred             ccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCC
Q 002529          749 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN  828 (912)
Q Consensus       749 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  828 (912)
                      ......++..|+|||.+.+..++.++||||||+++|+|++|+.||.......  ...    .... .......+      
T Consensus       172 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~--~~~----~~~~-~~~~~~~~------  238 (286)
T cd06614         172 KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR--ALF----LITT-KGIPPLKN------  238 (286)
T ss_pred             hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH--HHH----HHHh-cCCCCCcc------
Confidence            1122346789999999988889999999999999999999999997332211  111    1111 11111100      


Q ss_pred             CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          829 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       829 ~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                       .......+.+++.+||+.+|.+||++.++++
T Consensus       239 -~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         239 -PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             -hhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence             1112347889999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.98  E-value=4e-32  Score=319.79  Aligned_cols=269  Identities=19%  Similarity=0.241  Sum_probs=189.8

Q ss_pred             HHHHHhhhcccCccccEEEEEEEecC--CCEEEEE------------------EccCccchhhHHHHHHHHHHHhcCCCC
Q 002529          588 EEATNNFCKKIGKGSFGSVYYGKMKD--GKEVAVK------------------IMADSCSHRTQQFVTEVALLSRIHHRN  647 (912)
Q Consensus       588 ~~~~~~~~~~LG~G~fg~Vy~a~~~~--~~~vAvK------------------~l~~~~~~~~~~~~~E~~il~~L~hpn  647 (912)
                      ....|++.++||+|+||+||++.++.  +...+.|                  .+. ........+.+|+++|++++|||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence            34678889999999999999987642  2222222                  111 11223456889999999999999


Q ss_pred             ccceeeEEecCCeEEEEEEecCCCCHHHHhccCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccc
Q 002529          648 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSV--NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL  725 (912)
Q Consensus       648 Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl  725 (912)
                      |+++++++...+..++|+|++. ++|.+++....  .........+..++.||+.||+|||+   ++|+||||||+|||+
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl  300 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFL  300 (501)
T ss_pred             cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEE
Confidence            9999999999999999999984 57777765322  12233456778899999999999998   999999999999999


Q ss_pred             cCCCcEEEeeccCccccccccccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcc-chhhH
Q 002529          726 DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG-AELNI  804 (912)
Q Consensus       726 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~-~~~~~  804 (912)
                      +.++.+||+|||++..+............|+..|+|||++.+..++.++|||||||++|||++|..++...... ....+
T Consensus       301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~  380 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL  380 (501)
T ss_pred             CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence            99999999999999876554333333456899999999999999999999999999999999987644322221 11222


Q ss_pred             HHHHHhhhc-cCCc-------ccccCccccC----CCC-----HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002529          805 VHWARSMIK-KGDV-------ISIVDPVLIG----NVK-----IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       805 ~~~~~~~~~-~~~~-------~~~~d~~l~~----~~~-----~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  861 (912)
                      .+.+..... ...+       .+.++.....    ..+     ......+.+++.+||+.||++|||+.|+++.
T Consensus       381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            221111000 0000       0000000000    000     0112356788999999999999999999863

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.98  E-value=1.4e-31  Score=298.92  Aligned_cols=266  Identities=20%  Similarity=0.256  Sum_probs=195.5

Q ss_pred             cccCcc--ccEEEEEEEec-CCCEEEEEEccCcc--chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEecCC
Q 002529          596 KKIGKG--SFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN  670 (912)
Q Consensus       596 ~~LG~G--~fg~Vy~a~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~  670 (912)
                      +.||+|  +||+||+|.+. +++.||+|++....  ....+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            456666  99999999875 69999999986432  23346788999999999999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccccc-
Q 002529          671 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-  749 (912)
Q Consensus       671 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~-  749 (912)
                      ++|.+++.... ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.++++||+.+.......... 
T Consensus        84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~  159 (328)
T cd08226          84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK  159 (328)
T ss_pred             CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence            99999987542 3458899999999999999999998   899999999999999999999999997553321111100 


Q ss_pred             -----cccccCCCcccCCCccCCC--CCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhh----------
Q 002529          750 -----SSVARGTVGYLDPEYYGNQ--QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI----------  812 (912)
Q Consensus       750 -----~~~~~gt~~y~APE~l~~~--~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~----------  812 (912)
                           .....++..|+|||++.+.  .++.++|||||||++|+|++|+.||......  ...........          
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  237 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT--QMLLQKLKGPPYSPLDITTFP  237 (328)
T ss_pred             ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH--HHHHHHhcCCCCCCccccccc
Confidence                 0112245679999998763  4789999999999999999999999743221  11111110000          


Q ss_pred             ----------------------ccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--Hhhhhh
Q 002529          813 ----------------------KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDSIK  867 (912)
Q Consensus       813 ----------------------~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~--L~~~~~  867 (912)
                                            ..+......+..+...........+.+++.+||+.||++|||++|+++.  ++.+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~  316 (328)
T cd08226         238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE  316 (328)
T ss_pred             hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence                                  0000001111111111223455688999999999999999999999743  444444

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.98  E-value=7.8e-32  Score=295.66  Aligned_cols=261  Identities=21%  Similarity=0.271  Sum_probs=193.1

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCccc--hhhHHHHHHHHHHHhcC-CCCccceeeEEecCCe-----EE
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQ-----RI  662 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~L~-hpnIv~l~~~~~~~~~-----~~  662 (912)
                      |++.+.||+|+||.||+|... +++.||+|.++....  .....+.+|+.+++.++ ||||+++++++...+.     .+
T Consensus         3 y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~   82 (295)
T cd07837           3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLY   82 (295)
T ss_pred             ceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEE
Confidence            566789999999999999876 689999998765322  23356888999999995 6999999999877665     89


Q ss_pred             EEEEecCCCCHHHHhccCCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccC-CCcEEEeeccCc
Q 002529          663 LVYEYMHNGTLRDRLHGSVN--QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLS  739 (912)
Q Consensus       663 lV~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~-~~~vkL~DFGla  739 (912)
                      +||||+++ +|.+++.....  ...+++..++.++.||++||+|||+   ++++||||+|+||+++. ++.+||+|||++
T Consensus        83 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg~~  158 (295)
T cd07837          83 LVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLG  158 (295)
T ss_pred             EEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecccc
Confidence            99999975 89888865431  3568999999999999999999998   99999999999999998 889999999998


Q ss_pred             cccccccccccccccCCCcccCCCccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCC--
Q 002529          740 RQAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD--  816 (912)
Q Consensus       740 ~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~--  816 (912)
                      ......... .....+++.|+|||++.+ ..++.++||||||+++|+|++|..||.......  ...... ..+....  
T Consensus       159 ~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~--~~~~~~-~~~~~~~~~  234 (295)
T cd07837         159 RAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ--QLLHIF-KLLGTPTEQ  234 (295)
T ss_pred             eecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHH-HHhCCCChh
Confidence            765332111 112246788999998765 467899999999999999999999997433211  111111 1110000  


Q ss_pred             -cccc---cC----cccc----CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          817 -VISI---VD----PVLI----GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       817 -~~~~---~d----~~l~----~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                       ....   .+    +...    ..........+.++|.+||+.+|++||+++|++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence             0000   00    0000    0001123457889999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.98  E-value=1.8e-31  Score=292.45  Aligned_cols=261  Identities=21%  Similarity=0.299  Sum_probs=193.3

Q ss_pred             HHhhhcccCccccEEEEEEEec-CCCEEEEEEccCccch-hhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEec
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM  668 (912)
Q Consensus       591 ~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~-~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~  668 (912)
                      .|.+.+.||+|+||.||+|... +++.||+|++...... ....+.+|+++++.++|+||+++.+++..+...++|+||+
T Consensus         6 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~   85 (291)
T cd07870           6 SYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYM   85 (291)
T ss_pred             eeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEecc
Confidence            4566789999999999999875 6899999998654322 2346778999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccc
Q 002529          669 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH  748 (912)
Q Consensus       669 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  748 (912)
                      . ++|.+.+...  ...+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||++.........
T Consensus        86 ~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  159 (291)
T cd07870          86 H-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT  159 (291)
T ss_pred             c-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC
Confidence            5 6777776532  3457888899999999999999998   89999999999999999999999999998764332211


Q ss_pred             ccccccCCCcccCCCccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhcc---C------Ccc
Q 002529          749 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK---G------DVI  818 (912)
Q Consensus       749 ~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~---~------~~~  818 (912)
                       .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||....... ..+.+ .......   .      ...
T Consensus       160 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~  236 (291)
T cd07870         160 -YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF-EQLEK-IWTVLGVPTEDTWPGVSKLP  236 (291)
T ss_pred             -CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH-HHHHH-HHHHcCCCChhhhhhhhhcc
Confidence             122346889999999865 357889999999999999999999997433211 11111 1110000   0      000


Q ss_pred             cccCccc----cCCC-----CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          819 SIVDPVL----IGNV-----KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       819 ~~~d~~l----~~~~-----~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                      .......    ....     .......+.+++.+|++.||++|||++|++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            0000000    0000     0011346789999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.98  E-value=9e-32  Score=297.68  Aligned_cols=261  Identities=23%  Similarity=0.245  Sum_probs=194.3

Q ss_pred             HHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCccch--hhHHHHHHHHHHHhcCCCCccceeeEEecC--CeEEEE
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH--RTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRILV  664 (912)
Q Consensus       590 ~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~--~~~~~~~E~~il~~L~hpnIv~l~~~~~~~--~~~~lV  664 (912)
                      ..|++.+.||+|+||.||+|..+ +++.||+|.++.....  ....+.+|+.++++++|+||+++++++...  +..++|
T Consensus         7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (309)
T cd07845           7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLV   86 (309)
T ss_pred             cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEE
Confidence            34667889999999999999876 5899999998643222  223566899999999999999999998654  568999


Q ss_pred             EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccc
Q 002529          665 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE  744 (912)
Q Consensus       665 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~  744 (912)
                      |||+. ++|.+++...  ...+++..++.++.|+++||+|||+   .+++||||||+||+++.++.+||+|||++.....
T Consensus        87 ~e~~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~  160 (309)
T cd07845          87 MEYCE-QDLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL  160 (309)
T ss_pred             EecCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence            99996 5888888743  3568999999999999999999998   9999999999999999999999999999987654


Q ss_pred             ccccccccccCCCcccCCCccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhcc--CCcc-cc
Q 002529          745 DLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK--GDVI-SI  820 (912)
Q Consensus       745 ~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~-~~  820 (912)
                      .... .....++..|+|||.+.+ ..++.++||||+||++|||++|+.||...+....   ...+......  .... ..
T Consensus       161 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~~  236 (309)
T cd07845         161 PAKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ---LDLIIQLLGTPNESIWPGF  236 (309)
T ss_pred             ccCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCChhhchhh
Confidence            3211 122235778999999865 4678999999999999999999999974332211   1111111110  0000 00


Q ss_pred             cC-----c-cccCC-C------CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          821 VD-----P-VLIGN-V------KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       821 ~d-----~-~l~~~-~------~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                      .+     . .+... .      .......+.+++.+||+.||++|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            00     0 00000 0      0112346789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.98  E-value=1.3e-31  Score=291.56  Aligned_cols=257  Identities=23%  Similarity=0.258  Sum_probs=193.2

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc-chhhHHHHHHHHHHHhcC-CCCccceeeEEecC--CeEEEEEE
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEE--HQRILVYE  666 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~L~-hpnIv~l~~~~~~~--~~~~lV~E  666 (912)
                      |++.++||+|+||.||+|..+ +++.||+|+++... ........+|+.+++++. |+||+++++++.++  +..++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            356789999999999999876 68999999987542 222234457899999885 99999999999887  88999999


Q ss_pred             ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccc
Q 002529          667 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL  746 (912)
Q Consensus       667 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~  746 (912)
                      |++ ++|.+.+...  ...+++..++.++.|++.||+|||+   .+++||||+|+||+++. +.+||+|||++.......
T Consensus        81 ~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~  153 (282)
T cd07831          81 LMD-MNLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP  153 (282)
T ss_pred             cCC-ccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence            996 5888887642  3578999999999999999999998   99999999999999999 999999999998764332


Q ss_pred             ccccccccCCCcccCCCccC-CCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhc-----------c
Q 002529          747 THISSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK-----------K  814 (912)
Q Consensus       747 ~~~~~~~~gt~~y~APE~l~-~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~-----------~  814 (912)
                      ..  ....++..|+|||++. +..++.++|||||||++|||++|+.||...+..+   ...+......           .
T Consensus       154 ~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  228 (282)
T cd07831         154 PY--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVLKKFRK  228 (282)
T ss_pred             Cc--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHHHhhcc
Confidence            21  2234788999999764 4567889999999999999999999997443221   1111111110           0


Q ss_pred             CCcccccCccccC----CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          815 GDVISIVDPVLIG----NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       815 ~~~~~~~d~~l~~----~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                      ........+...+    .........+.+++.+||+.+|++||+++|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            0000000000000    001123568999999999999999999999986

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.98  E-value=2.7e-31  Score=283.85  Aligned_cols=249  Identities=27%  Similarity=0.404  Sum_probs=202.9

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCccc--hhhHHHHHHHHHHHhcCCCCccceeeEEecC--CeEEEEEE
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRILVYE  666 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~--~~~~lV~E  666 (912)
                      |...+.||+|++|.||+|... +++.|++|++.....  ...+.+.+|++++++++|+||+++++.+...  ...++++|
T Consensus         2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   81 (260)
T cd06606           2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLE   81 (260)
T ss_pred             ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEE
Confidence            345688999999999999987 689999999875542  4467889999999999999999999999888  88999999


Q ss_pred             ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccc
Q 002529          667 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL  746 (912)
Q Consensus       667 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~  746 (912)
                      ++++++|.+++..   ...+++..++.++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||.+.......
T Consensus        82 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  155 (260)
T cd06606          82 YVSGGSLSSLLKK---FGKLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE  155 (260)
T ss_pred             ecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence            9999999999984   3489999999999999999999998   999999999999999999999999999988765543


Q ss_pred             cc-ccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccc
Q 002529          747 TH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL  825 (912)
Q Consensus       747 ~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  825 (912)
                      .. ......++..|+|||.+.+...+.++||||||+++++|++|..||....     +..............        
T Consensus       156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~--------  222 (260)
T cd06606         156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-----NPMAALYKIGSSGEP--------  222 (260)
T ss_pred             ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHhccccCCC--------
Confidence            21 1223457889999999988889999999999999999999999997433     111111111111111        


Q ss_pred             cCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          826 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       826 ~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                       ...+......+.+++.+|++.+|++||++.|+++
T Consensus       223 -~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         223 -PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             -cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence             1122223457899999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.98  E-value=7.9e-32  Score=289.66  Aligned_cols=245  Identities=28%  Similarity=0.384  Sum_probs=195.6

Q ss_pred             cCccccEEEEEEEec-CCCEEEEEEccCccc---hhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEecCCCCH
Q 002529          598 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL  673 (912)
Q Consensus       598 LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL  673 (912)
                      ||.|+||.||++... +++.+++|.+.....   .....+.+|++++++++||||+++++.+..+...++++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999987 489999999875433   3456788999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccc------
Q 002529          674 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT------  747 (912)
Q Consensus       674 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~------  747 (912)
                      .+++..   ...+++..+..++.|+++||+|||+   .+++|+||+|+||+++.++.++|+|||++........      
T Consensus        81 ~~~l~~---~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  154 (265)
T cd05579          81 ASLLEN---VGSLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD  154 (265)
T ss_pred             HHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence            999974   3478999999999999999999998   9999999999999999999999999999876433211      


Q ss_pred             -cccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCcccc
Q 002529          748 -HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI  826 (912)
Q Consensus       748 -~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  826 (912)
                       .......++..|+|||.+.+...+.++||||||+++|+|++|+.||......   ....   ... .+....   +   
T Consensus       155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---~~~~---~~~-~~~~~~---~---  221 (265)
T cd05579         155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE---EIFQ---NIL-NGKIEW---P---  221 (265)
T ss_pred             cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH---HHHH---HHh-cCCcCC---C---
Confidence             1122334778999999998888899999999999999999999999743321   1111   111 111100   0   


Q ss_pred             CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 002529          827 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ  863 (912)
Q Consensus       827 ~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  863 (912)
                      .  .......+.+++.+||+.+|++|||+.++.+.|+
T Consensus       222 ~--~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         222 E--DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             c--cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence            0  0001347889999999999999999966665554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.98  E-value=2e-31  Score=290.08  Aligned_cols=244  Identities=23%  Similarity=0.290  Sum_probs=192.1

Q ss_pred             cCccccEEEEEEEec-CCCEEEEEEccCcc---chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEecCCCCH
Q 002529          598 IGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL  673 (912)
Q Consensus       598 LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL  673 (912)
                      ||+|+||+||++..+ +++.||+|.+....   ......+.+|++++++++||||+++++.+...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            699999999999866 68999999986432   22344567899999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccccccccc
Q 002529          674 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA  753 (912)
Q Consensus       674 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~  753 (912)
                      .+++... ....+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||.+........  ....
T Consensus        81 ~~~l~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~  154 (277)
T cd05577          81 KYHIYNV-GEPGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGR  154 (277)
T ss_pred             HHHHHHc-CcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc--cccc
Confidence            9998754 23468999999999999999999998   9999999999999999999999999999876543211  2233


Q ss_pred             cCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCCCCHHH
Q 002529          754 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES  833 (912)
Q Consensus       754 ~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  833 (912)
                      .++..|+|||.+.+..++.++||||||+++|+|++|+.||.........   ..+.......      .    ...+...
T Consensus       155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~------~----~~~~~~~  221 (277)
T cd05577         155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK---EELKRRTLEM------A----VEYPDKF  221 (277)
T ss_pred             cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH---HHHHhccccc------c----ccCCccC
Confidence            4778999999998888999999999999999999999999743321111   1111111100      0    0111122


Q ss_pred             HHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 002529          834 IWRIAEVAIQCVEQRGFSRP-----KMQEIVL  860 (912)
Q Consensus       834 ~~~l~~Li~~cL~~dP~~RP-----s~~evl~  860 (912)
                      ...+.+++.+||+.+|++||     ++.++++
T Consensus       222 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         222 SPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             CHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            34788999999999999999     6666653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.98  E-value=3.2e-31  Score=291.13  Aligned_cols=244  Identities=26%  Similarity=0.375  Sum_probs=197.0

Q ss_pred             hcccCccccEEEEEEEec-CCCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEecCCCCH
Q 002529          595 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL  673 (912)
Q Consensus       595 ~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL  673 (912)
                      ..+||+|+||.||++..+ +++.||+|.+..........+.+|+.+++.++|+||+++++.+...+..++||||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            478999999999999875 6899999998655445567789999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccccccccc
Q 002529          674 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA  753 (912)
Q Consensus       674 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~  753 (912)
                      .+++.    ...+++..+..++.|++.||+|||+   .+++||||+|+||+++.++.++|+|||++......... ....
T Consensus       105 ~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~-~~~~  176 (292)
T cd06657         105 TDIVT----HTRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RKSL  176 (292)
T ss_pred             HHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceeccccccc-cccc
Confidence            99875    3457899999999999999999998   89999999999999999999999999988765432221 2234


Q ss_pred             cCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCCCCHHH
Q 002529          754 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES  833 (912)
Q Consensus       754 ~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  833 (912)
                      .++..|+|||.+.+..++.++|+||+|+++|+|++|+.||......   ...........         +.+..  ....
T Consensus       177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~---~~~~~~~~~~~---------~~~~~--~~~~  242 (292)
T cd06657         177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKMIRDNLP---------PKLKN--LHKV  242 (292)
T ss_pred             ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhhCC---------cccCC--cccC
Confidence            5788999999998888899999999999999999999999743221   11111111110         01100  0112


Q ss_pred             HHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          834 IWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       834 ~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                      ...+.+++.+||+.+|.+||++.++++
T Consensus       243 ~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         243 SPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             CHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            236789999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.98  E-value=2.7e-31  Score=293.67  Aligned_cols=246  Identities=30%  Similarity=0.425  Sum_probs=195.9

Q ss_pred             HHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc---chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEE
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY  665 (912)
Q Consensus       590 ~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~  665 (912)
                      ..|++.+.||+|+||.||+|... +++.||+|.+....   ....+.+.+|+++++.++||||+++++++.+++..++|+
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            45778899999999999999876 68999999886432   233456889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccc
Q 002529          666 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED  745 (912)
Q Consensus       666 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~  745 (912)
                      ||+. |++.+.+...  ...+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++......
T Consensus        95 e~~~-g~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~  168 (307)
T cd06607          95 EYCL-GSASDILEVH--KKPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA  168 (307)
T ss_pred             HhhC-CCHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence            9996 6777776532  3468999999999999999999998   99999999999999999999999999998765332


Q ss_pred             cccccccccCCCcccCCCccC---CCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccC
Q 002529          746 LTHISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD  822 (912)
Q Consensus       746 ~~~~~~~~~gt~~y~APE~l~---~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  822 (912)
                           ....++..|+|||++.   ...++.++||||||+++|||++|+.||.......   .   ... +.....     
T Consensus       169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~---~---~~~-~~~~~~-----  231 (307)
T cd06607         169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---A---LYH-IAQNDS-----  231 (307)
T ss_pred             -----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH---H---HHH-HhcCCC-----
Confidence                 1234788999999874   4568889999999999999999999997332211   1   111 111111     


Q ss_pred             ccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002529          823 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       823 ~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  861 (912)
                      +.+   ........+.+++.+||+.+|++||++.+|++.
T Consensus       232 ~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         232 PTL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             CCC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            000   112234578999999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.98  E-value=1.5e-31  Score=301.92  Aligned_cols=262  Identities=23%  Similarity=0.294  Sum_probs=196.7

Q ss_pred             HHHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCc--cchhhHHHHHHHHHHHhcCCCCccceeeEEecC------C
Q 002529          589 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------H  659 (912)
Q Consensus       589 ~~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~------~  659 (912)
                      ...|+..+.||+|+||.||+|... +++.||+|.+...  .......+.+|+.++++++||||+++++++...      .
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   94 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ   94 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence            456777899999999999999876 6899999998643  223345677899999999999999999988543      3


Q ss_pred             eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCc
Q 002529          660 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS  739 (912)
Q Consensus       660 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla  739 (912)
                      ..++||||+. ++|.+.+..     .+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++
T Consensus        95 ~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~  165 (353)
T cd07850          95 DVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA  165 (353)
T ss_pred             cEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCccc
Confidence            5799999995 588888762     28889999999999999999998   89999999999999999999999999999


Q ss_pred             cccccccccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhh-HH-----------HH
Q 002529          740 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN-IV-----------HW  807 (912)
Q Consensus       740 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~-~~-----------~~  807 (912)
                      ........  .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+...... +.           ..
T Consensus       166 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (353)
T cd07850         166 RTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR  243 (353)
T ss_pred             eeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            87544322  223347889999999999999999999999999999999999997443211100 00           00


Q ss_pred             ----HHhhhccCC------cccccCccc----cCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002529          808 ----ARSMIKKGD------VISIVDPVL----IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       808 ----~~~~~~~~~------~~~~~d~~l----~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  861 (912)
                          .........      +........    ...........+.+++.+||+.||++|||++|+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                000000000      000110000    000011234568899999999999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=3.1e-31  Score=283.34  Aligned_cols=246  Identities=26%  Similarity=0.416  Sum_probs=201.6

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCccc--hhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEec
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM  668 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~  668 (912)
                      |++.+.||+|++|.||++... +++.|++|.+.....  .....+.+|++++++++|+|++++++++.+++..++++|++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (254)
T cd06627           2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA   81 (254)
T ss_pred             ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence            556789999999999999876 578999999976543  45578899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccc
Q 002529          669 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH  748 (912)
Q Consensus       669 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  748 (912)
                      ++++|.+++..   ...+++..+..++.|++.||.+||+   .+++||||+|+||+++.++.++|+|||.+.........
T Consensus        82 ~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  155 (254)
T cd06627          82 ENGSLRQIIKK---FGPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD  155 (254)
T ss_pred             CCCcHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence            99999999874   3678999999999999999999998   99999999999999999999999999999876543332


Q ss_pred             ccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCC
Q 002529          749 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN  828 (912)
Q Consensus       749 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  828 (912)
                       .....++..|+|||.+.+..++.++||||+|+++|+|++|+.||.....  ....    ..... ....         .
T Consensus       156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~--~~~~----~~~~~-~~~~---------~  218 (254)
T cd06627         156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP--MAAL----FRIVQ-DDHP---------P  218 (254)
T ss_pred             -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH--HHHH----HHHhc-cCCC---------C
Confidence             2234578899999999888889999999999999999999999973321  1111    11111 1110         1


Q ss_pred             CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          829 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       829 ~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                      .+......+.+++.+||..+|++||++.|++.
T Consensus       219 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         219 LPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            11122347889999999999999999999974

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.98  E-value=1.2e-31  Score=286.75  Aligned_cols=249  Identities=30%  Similarity=0.461  Sum_probs=203.8

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCccc--hhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEec
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM  668 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~  668 (912)
                      |++.+.||.|++|.||++... +++.+++|++.....  .....+.+|+++++.++|+|++++++.+..+...++|+|++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~   81 (258)
T cd08215           2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYA   81 (258)
T ss_pred             ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEec
Confidence            456788999999999999876 689999999875433  45567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccc
Q 002529          669 HNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT  747 (912)
Q Consensus       669 ~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~  747 (912)
                      ++++|.+++.... ....+++..+..++.|++.||++||+   .+++|+||+|+||+++.++.++|+|||.+....... 
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-  157 (258)
T cd08215          82 DGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-  157 (258)
T ss_pred             CCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCc-
Confidence            9999999998542 24779999999999999999999998   899999999999999999999999999988765443 


Q ss_pred             cccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccC
Q 002529          748 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG  827 (912)
Q Consensus       748 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  827 (912)
                      .......+++.|+|||.+.+..++.++|+||+|+++++|++|+.||.....      .+....... ....         
T Consensus       158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~-~~~~---------  221 (258)
T cd08215         158 DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL------LELALKILK-GQYP---------  221 (258)
T ss_pred             ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH------HHHHHHHhc-CCCC---------
Confidence            122334578899999999888899999999999999999999999973321      111111111 1111         


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          828 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       828 ~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                      ..+......+.+++.+||..+|++||++.|+++
T Consensus       222 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         222 PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            111123347889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.98  E-value=1.3e-31  Score=295.85  Aligned_cols=264  Identities=20%  Similarity=0.239  Sum_probs=193.3

Q ss_pred             HHhhhcccCccccEEEEEEEec-CCCEEEEEEccCccc--hhhHHHHHHHHHHHhcCCCCccceeeEEecCC--------
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH--------  659 (912)
Q Consensus       591 ~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~--------  659 (912)
                      .|++.++||+|+||.||+|..+ +++.||+|.+.....  .....+.+|++++++++||||+++++++....        
T Consensus        13 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   92 (310)
T cd07865          13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKG   92 (310)
T ss_pred             heEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCc
Confidence            4777899999999999999876 689999998864322  22345678999999999999999999986543        


Q ss_pred             eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCc
Q 002529          660 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS  739 (912)
Q Consensus       660 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla  739 (912)
                      ..++||||+. ++|.+.+...  ...+++.+++.++.||+.||+|||+   ++++|+||||+||+++.++.+||+|||++
T Consensus        93 ~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~  166 (310)
T cd07865          93 SFYLVFEFCE-HDLAGLLSNK--NVKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGLA  166 (310)
T ss_pred             eEEEEEcCCC-cCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence            4599999996 5888877642  3468999999999999999999998   89999999999999999999999999998


Q ss_pred             ccccccccc---ccccccCCCcccCCCccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccC
Q 002529          740 RQAEEDLTH---ISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG  815 (912)
Q Consensus       740 ~~~~~~~~~---~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  815 (912)
                      .........   ......++..|+|||.+.+. .++.++||||||+++|||++|+.||..............+.......
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (310)
T cd07865         167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE  246 (310)
T ss_pred             ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            765432211   11223467889999988664 46889999999999999999999997543322222222111111110


Q ss_pred             Ccccc-----cCc-cccCCCC---------HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          816 DVISI-----VDP-VLIGNVK---------IESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       816 ~~~~~-----~d~-~l~~~~~---------~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                      .....     .+. .......         ......+.+++.+||+.||++|||++|+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            00000     000 0000000         001235679999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.98  E-value=4.9e-32  Score=303.67  Aligned_cols=266  Identities=23%  Similarity=0.324  Sum_probs=197.1

Q ss_pred             HHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc-chhhHHHHHHHHHHHhcCCCCccceeeEEecC-----CeEE
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE-----HQRI  662 (912)
Q Consensus       590 ~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~-----~~~~  662 (912)
                      ..|++.++||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++...     ...+
T Consensus         5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   84 (336)
T cd07849           5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY   84 (336)
T ss_pred             cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence            35677899999999999999875 68999999986432 23345678899999999999999999987543     3579


Q ss_pred             EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccc
Q 002529          663 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA  742 (912)
Q Consensus       663 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~  742 (912)
                      +|+||+. ++|.+.+.    ...+++..+..++.|+++||+|||+   .+++||||||+||+++.++.+||+|||++...
T Consensus        85 lv~e~~~-~~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~  156 (336)
T cd07849          85 IVQELME-TDLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIA  156 (336)
T ss_pred             EEehhcc-cCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccceeec
Confidence            9999996 58888775    3568999999999999999999998   99999999999999999999999999998765


Q ss_pred             cccccc--ccccccCCCcccCCCccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCC---
Q 002529          743 EEDLTH--ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD---  816 (912)
Q Consensus       743 ~~~~~~--~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~---  816 (912)
                      ......  ......++..|+|||.+.+ ..++.++||||+||++|+|++|+.||...+...   ....+...+....   
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~~~~~~~~~~~~  233 (336)
T cd07849         157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLILGVLGTPSQED  233 (336)
T ss_pred             cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCCHHH
Confidence            432221  1122457889999998654 568899999999999999999999997433211   1111111111100   


Q ss_pred             cccccCcc-------c--cCCCC-----HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--Hhhhh
Q 002529          817 VISIVDPV-------L--IGNVK-----IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDSI  866 (912)
Q Consensus       817 ~~~~~d~~-------l--~~~~~-----~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~--L~~~~  866 (912)
                      ...+.+..       .  ....+     ......+.+++.+||+.+|++||++.|+++.  ++...
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~  299 (336)
T cd07849         234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH  299 (336)
T ss_pred             HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence            00000000       0  00000     1123468899999999999999999999876  55443

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.98  E-value=1.2e-31  Score=287.17  Aligned_cols=247  Identities=25%  Similarity=0.380  Sum_probs=202.1

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc--chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEec
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM  668 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~  668 (912)
                      |++.++||+|++|.||+++.+ +++.+++|.+....  ......+.+|++++++++|+||+++++++......++|+||+
T Consensus         2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (256)
T cd08530           2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA   81 (256)
T ss_pred             ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhc
Confidence            456789999999999999866 68899999986532  234467788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccc
Q 002529          669 HNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT  747 (912)
Q Consensus       669 ~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~  747 (912)
                      ++++|.+++.... ....+++..++.++.|++.||+|||+   .+++|+||+|+||+++.++.+||+|||++....... 
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~-  157 (256)
T cd08530          82 PFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM-  157 (256)
T ss_pred             CCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccCC-
Confidence            9999999887532 24578999999999999999999998   999999999999999999999999999998765542 


Q ss_pred             cccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccC
Q 002529          748 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG  827 (912)
Q Consensus       748 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  827 (912)
                        .....++..|+|||.+.+..++.++|+||+|+++|+|++|+.||...+..   .+..    .+..+...         
T Consensus       158 --~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~~----~~~~~~~~---------  219 (256)
T cd08530         158 --AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ---DLRY----KVQRGKYP---------  219 (256)
T ss_pred             --cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH----HHhcCCCC---------
Confidence              22244788999999999989999999999999999999999999743321   1111    11111111         


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          828 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       828 ~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                      ..+......+.+++.+||+.+|++||++.|+++
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         220 PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            112234457899999999999999999999986

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.98  E-value=2.3e-31  Score=290.29  Aligned_cols=242  Identities=23%  Similarity=0.287  Sum_probs=187.1

Q ss_pred             ccCccccEEEEEEEec-CCCEEEEEEccCccc---hhhHHHHHHHHHHHh---cCCCCccceeeEEecCCeEEEEEEecC
Q 002529          597 KIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSR---IHHRNLVPLIGYCEEEHQRILVYEYMH  669 (912)
Q Consensus       597 ~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~---L~hpnIv~l~~~~~~~~~~~lV~E~~~  669 (912)
                      .||+|+||.||++... +++.+|+|.+.....   .....+.+|..+++.   .+||||+.+++.+..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999875 589999998865321   122334445444443   369999999999999999999999999


Q ss_pred             CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccccc
Q 002529          670 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI  749 (912)
Q Consensus       670 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~  749 (912)
                      +++|.+++..   ...+++..+..++.|++.||+|||+   .+++|+||||+||++++++.++|+|||++........  
T Consensus        81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~--  152 (279)
T cd05633          81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--  152 (279)
T ss_pred             CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc--
Confidence            9999998873   4579999999999999999999998   9999999999999999999999999999876543221  


Q ss_pred             cccccCCCcccCCCccC-CCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCC
Q 002529          750 SSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN  828 (912)
Q Consensus       750 ~~~~~gt~~y~APE~l~-~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  828 (912)
                       ....|+..|+|||.+. +..++.++||||+||++|+|++|+.||..........+..    ....      ...    .
T Consensus       153 -~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~----~~~~------~~~----~  217 (279)
T cd05633         153 -HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR----MTLT------VNV----E  217 (279)
T ss_pred             -cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHH----Hhhc------CCc----C
Confidence             2235899999999886 4568899999999999999999999997433222111111    1100      011    1


Q ss_pred             CCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 002529          829 VKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA  861 (912)
Q Consensus       829 ~~~~~~~~l~~Li~~cL~~dP~~RP-----s~~evl~~  861 (912)
                      .+......+.+++.+||+.||++||     +++|+++.
T Consensus       218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            1222334788999999999999999     59988764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.98  E-value=1.2e-31  Score=291.94  Aligned_cols=258  Identities=21%  Similarity=0.271  Sum_probs=198.8

Q ss_pred             hhhcccCccccEEEEEEEec-CCCEEEEEEccCccch--hhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEecC
Q 002529          593 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH--RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH  669 (912)
Q Consensus       593 ~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~--~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~  669 (912)
                      ++.+.||+|++|.||+|... +++.+++|.+......  ....+.+|++++++++|+||+++++++..+...++|+||++
T Consensus         2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (283)
T cd05118           2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD   81 (283)
T ss_pred             ccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccC
Confidence            45688999999999999876 6899999998754332  45678889999999999999999999999999999999997


Q ss_pred             CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccccc
Q 002529          670 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI  749 (912)
Q Consensus       670 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~  749 (912)
                      + +|.+++...  ...+++..+..++.|+++||+|||+   .+++|+||||+||+++.++.++|+|||.+........ .
T Consensus        82 ~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~-~  154 (283)
T cd05118          82 T-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR-P  154 (283)
T ss_pred             C-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-c
Confidence            5 888888743  3578999999999999999999998   9999999999999999999999999999877654431 1


Q ss_pred             cccccCCCcccCCCccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccC---CcccccC---
Q 002529          750 SSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG---DVISIVD---  822 (912)
Q Consensus       750 ~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~~d---  822 (912)
                      .....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||......+.   .......+...   ......+   
T Consensus       155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd05118         155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ---LFKIFRTLGTPDPEVWPKFTSLAR  231 (283)
T ss_pred             ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCchHhcccchhhhh
Confidence            2223477889999998776 789999999999999999999999974332111   11111111100   0000000   


Q ss_pred             ---cccc-------CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          823 ---PVLI-------GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       823 ---~~l~-------~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                         ....       .........++.+++.+||+.+|.+||++.|++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence               0000       0111234568899999999999999999999985

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.98  E-value=1.5e-31  Score=294.08  Aligned_cols=261  Identities=19%  Similarity=0.237  Sum_probs=187.6

Q ss_pred             hhHHHHHHHhhhcccCccccEEEEEEEecC----CCEEEEEEccCccchhh-----------HHHHHHHHHHHhcCCCCc
Q 002529          584 LPELEEATNNFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSCSHRT-----------QQFVTEVALLSRIHHRNL  648 (912)
Q Consensus       584 ~~~l~~~~~~~~~~LG~G~fg~Vy~a~~~~----~~~vAvK~l~~~~~~~~-----------~~~~~E~~il~~L~hpnI  648 (912)
                      +.++....|++.++||+|+||.||+|.+.+    +..+|+|+.........           .....+...+..+.|+++
T Consensus         6 ~~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i   85 (294)
T PHA02882          6 LIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGI   85 (294)
T ss_pred             eeccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCC
Confidence            455666778899999999999999998764    35567775432211100           112233444556689999


Q ss_pred             cceeeEEecCC----eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCcc
Q 002529          649 VPLIGYCEEEH----QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNIL  724 (912)
Q Consensus       649 v~l~~~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NIL  724 (912)
                      +++++.+....    ..++++|++. .++.+.+..   ....++..+..++.|++.||+|||+   .+++||||||+|||
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nil  158 (294)
T PHA02882         86 PKYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIM  158 (294)
T ss_pred             CcEEEeeeEecCCceEEEEEEehhc-cCHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEE
Confidence            99998765433    3467888773 467666653   2345788889999999999999998   89999999999999


Q ss_pred             ccCCCcEEEeeccCcccccccccc------ccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCc
Q 002529          725 LDINMRAKVSDFGLSRQAEEDLTH------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF  798 (912)
Q Consensus       725 l~~~~~vkL~DFGla~~~~~~~~~------~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~  798 (912)
                      ++.++.++|+|||+++........      ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       159 l~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~  238 (294)
T PHA02882        159 VDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGH  238 (294)
T ss_pred             EcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcccc
Confidence            999999999999999875432111      11223589999999999999999999999999999999999999985432


Q ss_pred             cch-hhH--HHHHHhhhccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 002529          799 GAE-LNI--VHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ  863 (912)
Q Consensus       799 ~~~-~~~--~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  863 (912)
                      ... ...  .++.. .+..+...           ....+..+.+++..|++.+|++||+++++++.|+
T Consensus       239 ~~~~~~~~~~~~~~-~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        239 NGNLIHAAKCDFIK-RLHEGKIK-----------IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             chHHHHHhHHHHHH-Hhhhhhhc-----------cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            211 110  11111 11111110           0112357889999999999999999999998763

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.98  E-value=3.6e-32  Score=303.97  Aligned_cols=245  Identities=28%  Similarity=0.416  Sum_probs=205.7

Q ss_pred             HHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCccch--hhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEE
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH--RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE  666 (912)
Q Consensus       590 ~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~--~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E  666 (912)
                      .-|.+.+.||+|.|+.|.+|++. ++..||+|.+.+....  ....+.+|+++|+.|+|||||+++.+...+..+|+|||
T Consensus        56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~e  135 (596)
T KOG0586|consen   56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVME  135 (596)
T ss_pred             cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEE
Confidence            34556789999999999999876 6999999999875433  33558899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccc
Q 002529          667 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL  746 (912)
Q Consensus       667 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~  746 (912)
                      |+.+|.+.+++.   +.....+.....++.|+.+|++|||+   +.|+|||||++||||+.+.++||+|||++..+..  
T Consensus       136 ya~~ge~~~yl~---~~gr~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~--  207 (596)
T KOG0586|consen  136 YASGGELFDYLV---KHGRMKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFDY--  207 (596)
T ss_pred             eccCchhHHHHH---hcccchhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeecc--
Confidence            999999999998   45677778899999999999999998   9999999999999999999999999999998764  


Q ss_pred             ccccccccCCCcccCCCccCCCCC-CchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccc
Q 002529          747 THISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL  825 (912)
Q Consensus       747 ~~~~~~~~gt~~y~APE~l~~~~~-s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  825 (912)
                      ........|++.|.|||++.+..+ ++++|+||+|+++|-|+.|..||++....                   ++-++.+
T Consensus       208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk-------------------~Lr~rvl  268 (596)
T KOG0586|consen  208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK-------------------ELRPRVL  268 (596)
T ss_pred             cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc-------------------cccchhe
Confidence            334556779999999999988766 57999999999999999999999844332                   1112222


Q ss_pred             cCCCC--HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002529          826 IGNVK--IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       826 ~~~~~--~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  861 (912)
                      .+.+.  .....++.++++++|..+|.+|++++++.+.
T Consensus       269 ~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  269 RGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             eeeecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence            22221  1222367899999999999999999999754

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.97  E-value=3.7e-31  Score=294.12  Aligned_cols=250  Identities=31%  Similarity=0.423  Sum_probs=197.3

Q ss_pred             HHHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc---chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEE
Q 002529          589 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV  664 (912)
Q Consensus       589 ~~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV  664 (912)
                      +..+...+.||+|+||.||+|... +++.||+|.+....   ......+.+|++++++++|||++++++++.++...++|
T Consensus        24 ~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  103 (317)
T cd06635          24 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLV  103 (317)
T ss_pred             hhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEE
Confidence            344677889999999999999875 68899999986432   23345788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccc
Q 002529          665 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE  744 (912)
Q Consensus       665 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~  744 (912)
                      |||+. |+|.+.+..  ....+++.++..++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||++.....
T Consensus       104 ~e~~~-g~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~  177 (317)
T cd06635         104 MEYCL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASP  177 (317)
T ss_pred             EeCCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence            99996 578777753  24568999999999999999999998   9999999999999999999999999998875433


Q ss_pred             ccccccccccCCCcccCCCccC---CCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCccccc
Q 002529          745 DLTHISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV  821 (912)
Q Consensus       745 ~~~~~~~~~~gt~~y~APE~l~---~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  821 (912)
                      .     ....++..|+|||++.   ...++.++|||||||++|||++|+.||......  .....    ....+.. .  
T Consensus       178 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~----~~~~~~~-~--  243 (317)
T cd06635         178 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYH----IAQNESP-T--  243 (317)
T ss_pred             c-----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH--HHHHH----HHhccCC-C--
Confidence            2     2234788999999873   457889999999999999999999998733211  11111    1111110 0  


Q ss_pred             CccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhh
Q 002529          822 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD  864 (912)
Q Consensus       822 d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~  864 (912)
                            .........+.+++.+||+.+|.+||++.++++.+-.
T Consensus       244 ------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~  280 (317)
T cd06635         244 ------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV  280 (317)
T ss_pred             ------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence                  0111233468899999999999999999999976443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=3.9e-31  Score=284.60  Aligned_cols=244  Identities=27%  Similarity=0.315  Sum_probs=189.0

Q ss_pred             cccCccccEEEEEEEec-CCCEEEEEEccCccc---hhhHHHHHHHHHH-HhcCCCCccceeeEEecCCeEEEEEEecCC
Q 002529          596 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALL-SRIHHRNLVPLIGYCEEEHQRILVYEYMHN  670 (912)
Q Consensus       596 ~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~~il-~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~  670 (912)
                      +.||+|++|.||+|... +++.||+|.+.....   .....+..|..++ ...+|+|++++++++..++..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            57999999999999875 589999999865322   1223344555544 345899999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccccc
Q 002529          671 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS  750 (912)
Q Consensus       671 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~  750 (912)
                      ++|.+++..   ...+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||++.....     .
T Consensus        82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~  150 (260)
T cd05611          82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----N  150 (260)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc-----c
Confidence            999999973   4568999999999999999999998   8999999999999999999999999998876433     1


Q ss_pred             ccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCCCC
Q 002529          751 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK  830 (912)
Q Consensus       751 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  830 (912)
                      ....++..|+|||.+.+..++.++||||||+++|+|++|..||.......   ...   . +..+...  ...    ...
T Consensus       151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~---~-~~~~~~~--~~~----~~~  217 (260)
T cd05611         151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA---VFD---N-ILSRRIN--WPE----EVK  217 (260)
T ss_pred             ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH---HHH---H-HHhcccC--CCC----ccc
Confidence            23347889999999988888999999999999999999999997433211   111   1 1111110  000    011


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 002529          831 IESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ  863 (912)
Q Consensus       831 ~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  863 (912)
                      ......+.+++.+||+.+|++||++.++.+.|.
T Consensus       218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~  250 (260)
T cd05611         218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS  250 (260)
T ss_pred             ccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence            122347889999999999999998876655443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.97  E-value=6.7e-32  Score=302.30  Aligned_cols=265  Identities=20%  Similarity=0.309  Sum_probs=196.9

Q ss_pred             HHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc--chhhHHHHHHHHHHHhcCCCCccceeeEEec----CCeEE
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE----EHQRI  662 (912)
Q Consensus       590 ~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~----~~~~~  662 (912)
                      ..|++.+.||+|++|.||+|..+ +++.||+|++....  ......+.+|+.++++++||||+++++++..    ....+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            45667789999999999999876 68999999987532  2334667889999999999999999998753    35689


Q ss_pred             EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccc
Q 002529          663 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA  742 (912)
Q Consensus       663 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~  742 (912)
                      +|+||+. ++|.+++..   ...+++..+..++.||+.||+|||+   .+++||||||+||+++.++.+||+|||++...
T Consensus        85 lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~  157 (334)
T cd07855          85 VVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGL  157 (334)
T ss_pred             EEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence            9999995 689998873   4569999999999999999999998   99999999999999999999999999998765


Q ss_pred             cccccc---ccccccCCCcccCCCccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHh--------
Q 002529          743 EEDLTH---ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS--------  810 (912)
Q Consensus       743 ~~~~~~---~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~--------  810 (912)
                      ......   ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+.............        
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~  237 (334)
T cd07855         158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN  237 (334)
T ss_pred             cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence            432211   1123357889999998765 4688999999999999999999999974432211110000000        


Q ss_pred             hhccCCcccccCcc-ccCCC-----CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002529          811 MIKKGDVISIVDPV-LIGNV-----KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       811 ~~~~~~~~~~~d~~-l~~~~-----~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  861 (912)
                      ...........+.. .....     .......+.+++.+||+.+|++||+++++++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            00000000000000 00000     11234578999999999999999999998873

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.97  E-value=5.4e-31  Score=285.38  Aligned_cols=241  Identities=23%  Similarity=0.313  Sum_probs=186.7

Q ss_pred             HHhhhccc--CccccEEEEEEEec-CCCEEEEEEccCccchhhHHHHHHHHHHHhc-CCCCccceeeEEecCCeEEEEEE
Q 002529          591 TNNFCKKI--GKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYE  666 (912)
Q Consensus       591 ~~~~~~~L--G~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L-~hpnIv~l~~~~~~~~~~~lV~E  666 (912)
                      .+++.+.+  |+|+||.||++..+ +++.+|+|.+.......     .|+.....+ +||||+++++.+...+..++|||
T Consensus        15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e   89 (267)
T PHA03390         15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMD   89 (267)
T ss_pred             hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEE
Confidence            34455554  99999999999876 68889999986432211     122222223 69999999999999999999999


Q ss_pred             ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCC-cEEEeeccCccccccc
Q 002529          667 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEED  745 (912)
Q Consensus       667 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~-~vkL~DFGla~~~~~~  745 (912)
                      |+++++|.+++..   ...+++.+++.++.|+++||+|||+   .+++||||||+||+++.++ .++|+|||++......
T Consensus        90 ~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~  163 (267)
T PHA03390         90 YIKDGDLFDLLKK---EGKLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP  163 (267)
T ss_pred             cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC
Confidence            9999999999974   3489999999999999999999998   8999999999999999888 9999999998765432


Q ss_pred             cccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccc
Q 002529          746 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL  825 (912)
Q Consensus       746 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  825 (912)
                      .     ...++..|+|||++.+..++.++||||+|+++|+|++|+.||.... ........+.... . ... .      
T Consensus       164 ~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~-~-~~~-~------  228 (267)
T PHA03390        164 S-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE-DEELDLESLLKRQ-Q-KKL-P------  228 (267)
T ss_pred             c-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC-cchhhHHHHHHhh-c-ccC-C------
Confidence            1     2347889999999999899999999999999999999999997332 2222222222211 1 000 0      


Q ss_pred             cCCCCHHHHHHHHHHHHhcccCCCCCCCC-HHHHHH
Q 002529          826 IGNVKIESIWRIAEVAIQCVEQRGFSRPK-MQEIVL  860 (912)
Q Consensus       826 ~~~~~~~~~~~l~~Li~~cL~~dP~~RPs-~~evl~  860 (912)
                         ........+.+++.+||+.+|.+||+ ++|+++
T Consensus       229 ---~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        229 ---FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             ---cccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence               01123347889999999999999996 688874

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.97  E-value=1.9e-31  Score=292.78  Aligned_cols=261  Identities=20%  Similarity=0.274  Sum_probs=193.6

Q ss_pred             HHhhhcccCccccEEEEEEEec-CCCEEEEEEccCccc--hhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEe
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY  667 (912)
Q Consensus       591 ~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  667 (912)
                      .|++.+.||+|++|.||+|..+ +++.||+|.+.....  ...+.+.+|++++++++||||+++++++..+...++||||
T Consensus         3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (294)
T PLN00009          3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEY   82 (294)
T ss_pred             ceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEec
Confidence            3566789999999999999876 689999999864322  2335688899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccC-CCcEEEeeccCcccccccc
Q 002529          668 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEEDL  746 (912)
Q Consensus       668 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~-~~~vkL~DFGla~~~~~~~  746 (912)
                      ++ ++|.+++... ....+++..+..++.||+.||+|||+   ++++|+||+|+||+++. ++.+||+|||++.......
T Consensus        83 ~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         83 LD-LDLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             cc-ccHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            95 5888877643 23346788889999999999999998   89999999999999985 5679999999997654322


Q ss_pred             ccccccccCCCcccCCCccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccC--Cc------
Q 002529          747 THISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG--DV------  817 (912)
Q Consensus       747 ~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~------  817 (912)
                      .. .....+++.|+|||++.+ ..++.++||||+|+++|+|++|+.||......+.  +.+ ........  ..      
T Consensus       158 ~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~  233 (294)
T PLN00009        158 RT-FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE--LFK-IFRILGTPNEETWPGVTS  233 (294)
T ss_pred             cc-cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-HHHHhCCCChhhcccccc
Confidence            11 122346789999998865 4678999999999999999999999974332111  111 10000000  00      


Q ss_pred             -ccccC--ccccC----CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          818 -ISIVD--PVLIG----NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       818 -~~~~d--~~l~~----~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                       .....  +....    .........+.+++.+||+.+|++||++.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence             00000  00000    001122346889999999999999999999986

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.97  E-value=2.7e-31  Score=290.59  Aligned_cols=255  Identities=22%  Similarity=0.306  Sum_probs=199.7

Q ss_pred             HhhhcccCccccEEEEEEEec----CCCEEEEEEccCccc----hhhHHHHHHHHHHHhc-CCCCccceeeEEecCCeEE
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSCS----HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRI  662 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~----~~~~vAvK~l~~~~~----~~~~~~~~E~~il~~L-~hpnIv~l~~~~~~~~~~~  662 (912)
                      |++.+.||+|++|.||++...    +++.||+|.++....    .....+.+|++++.++ +||||+++++.+..+...+
T Consensus         2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~   81 (288)
T cd05583           2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH   81 (288)
T ss_pred             ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence            456789999999999999753    578899999864321    2335678899999999 5999999999999999999


Q ss_pred             EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccc
Q 002529          663 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA  742 (912)
Q Consensus       663 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~  742 (912)
                      +||||+++++|.+++..   ...+++..+..++.|++++|+|||+   .+++||||+|+||+++.++.++|+|||++...
T Consensus        82 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~  155 (288)
T cd05583          82 LILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (288)
T ss_pred             EEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence            99999999999999873   4568899999999999999999998   99999999999999999999999999998765


Q ss_pred             ccccccccccccCCCcccCCCccCCCC--CCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccc
Q 002529          743 EEDLTHISSVARGTVGYLDPEYYGNQQ--LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI  820 (912)
Q Consensus       743 ~~~~~~~~~~~~gt~~y~APE~l~~~~--~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  820 (912)
                      ............++..|+|||.+.+..  .+.++||||||+++|+|++|..||.......  ...+..+......     
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~-----  228 (288)
T cd05583         156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISRRILKSK-----  228 (288)
T ss_pred             ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHHHHHccC-----
Confidence            443322222345788999999987654  7889999999999999999999996322111  1111111111110     


Q ss_pred             cCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhh
Q 002529          821 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS  865 (912)
Q Consensus       821 ~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~  865 (912)
                        +..    +......+.+++.+||+.+|++|||++++.+.|+..
T Consensus       229 --~~~----~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~  267 (288)
T cd05583         229 --PPF----PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP  267 (288)
T ss_pred             --CCC----CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence              111    111224678999999999999999999888777653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.97  E-value=4e-31  Score=296.33  Aligned_cols=266  Identities=25%  Similarity=0.320  Sum_probs=196.8

Q ss_pred             HHHHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCc--cchhhHHHHHHHHHHHhc-CCCCccceeeEEecC--CeE
Q 002529          588 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE--HQR  661 (912)
Q Consensus       588 ~~~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~L-~hpnIv~l~~~~~~~--~~~  661 (912)
                      ....|++.+.||+|+||.||+|... +++.+|+|++...  .......+.+|+.+++++ +||||+++++++...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            3567888999999999999999876 5889999988542  223345677899999999 999999999988643  468


Q ss_pred             EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccc
Q 002529          662 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ  741 (912)
Q Consensus       662 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~  741 (912)
                      ++||||++ ++|.+++..    ..+++..+..++.||+.||+|||+   .+++|+||||+||+++.++.+||+|||++..
T Consensus        85 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~  156 (337)
T cd07852          85 YLVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARS  156 (337)
T ss_pred             EEEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence            99999996 599988873    278889999999999999999998   9999999999999999999999999999886


Q ss_pred             cccccc----cccccccCCCcccCCCccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhh-----
Q 002529          742 AEEDLT----HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM-----  811 (912)
Q Consensus       742 ~~~~~~----~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~-----  811 (912)
                      ......    .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||..................     
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
T cd07852         157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED  236 (337)
T ss_pred             cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            543321    12223457889999998754 56788999999999999999999999743322111000000000     


Q ss_pred             ---hccCCcccccCcccc------CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002529          812 ---IKKGDVISIVDPVLI------GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       812 ---~~~~~~~~~~d~~l~------~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  861 (912)
                         +.......+++....      ..........+.+++.+||+.+|++|||+.++++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence               000000000100000      00001134578999999999999999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.97  E-value=9.9e-32  Score=300.09  Aligned_cols=266  Identities=23%  Similarity=0.318  Sum_probs=203.0

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc--chhhHHHHHHHHHHHhcCCCCccceeeEEecCC-----eEEE
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH-----QRIL  663 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~-----~~~l  663 (912)
                      |++.+.||.|++|.||+|... +++.||+|++....  ....+.+.+|+.+++.++|+||+++++++....     ..++
T Consensus         2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l   81 (330)
T cd07834           2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI   81 (330)
T ss_pred             ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence            567789999999999999976 48999999987643  344567889999999999999999999987765     7899


Q ss_pred             EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccc
Q 002529          664 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE  743 (912)
Q Consensus       664 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~  743 (912)
                      +|||++ ++|.+++..   ...+++..++.++.||+.||+|||+   .+++||||||+||+++.++.++|+|||++....
T Consensus        82 v~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~  154 (330)
T cd07834          82 VTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVD  154 (330)
T ss_pred             Eecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence            999997 589888873   4489999999999999999999998   999999999999999999999999999998765


Q ss_pred             cccc--cccccccCCCcccCCCccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhcc------
Q 002529          744 EDLT--HISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK------  814 (912)
Q Consensus       744 ~~~~--~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~------  814 (912)
                      ....  .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||......+..   ..+......      
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~  231 (330)
T cd07834         155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQL---NLIVEVLGTPSEEDL  231 (330)
T ss_pred             ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHH---HHHHHhcCCCChhHh
Confidence            4321  112233478899999999887 8899999999999999999999999744322111   111111000      


Q ss_pred             -----CCcccccCc-ccc-----CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--Hhhhhh
Q 002529          815 -----GDVISIVDP-VLI-----GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDSIK  867 (912)
Q Consensus       815 -----~~~~~~~d~-~l~-----~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~--L~~~~~  867 (912)
                           ......+.. ...     ..........+.+++.+||+.+|++||+++++++.  +++...
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~  297 (330)
T cd07834         232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD  297 (330)
T ss_pred             hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence                 000000000 000     00011134578899999999999999999999974  555444

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.97  E-value=7.7e-31  Score=290.71  Aligned_cols=261  Identities=21%  Similarity=0.239  Sum_probs=192.9

Q ss_pred             hhcccCccccEEEEEEEecCCCEEEEEEccCc--cchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEecCCC
Q 002529          594 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG  671 (912)
Q Consensus       594 ~~~~LG~G~fg~Vy~a~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~g  671 (912)
                      +.+.+|.|+++.|+++.. +++.||+|++...  .....+.+.+|++++++++|+||+++++++.+.+..+++|||++++
T Consensus         6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~   84 (314)
T cd08216           6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG   84 (314)
T ss_pred             hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence            445566666666666555 5899999998754  3345578999999999999999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccc----
Q 002529          672 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT----  747 (912)
Q Consensus       672 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~----  747 (912)
                      +|.+++... ....+++..+..++.|+++||+|||+   ++|+||||||+||+++.++.++|+|||.+........    
T Consensus        85 ~l~~~l~~~-~~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~  160 (314)
T cd08216          85 SCEDLLKTH-FPEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV  160 (314)
T ss_pred             CHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence            999999854 23468899999999999999999998   9999999999999999999999999998865432111    


Q ss_pred             --cccccccCCCcccCCCccCC--CCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhc----cCC---
Q 002529          748 --HISSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK----KGD---  816 (912)
Q Consensus       748 --~~~~~~~gt~~y~APE~l~~--~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~----~~~---  816 (912)
                        .......++..|+|||++.+  ..++.++|||||||++|||++|+.||......  ....+.......    ...   
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  238 (314)
T cd08216         161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT--QMLLEKVRGTVPCLLDKSTYPL  238 (314)
T ss_pred             cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhccCccccccCchhh
Confidence              11122346778999999866  35788999999999999999999999743221  111111111000    000   


Q ss_pred             ----ccc----ccCcccc----CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002529          817 ----VIS----IVDPVLI----GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       817 ----~~~----~~d~~l~----~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  861 (912)
                          ...    ..++...    ..........+.+++.+||+.+|++|||++|+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence                000    0000000    01122334578899999999999999999999863

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.97  E-value=1.1e-31  Score=301.12  Aligned_cols=266  Identities=23%  Similarity=0.318  Sum_probs=197.6

Q ss_pred             HHhhhcccCccccEEEEEEEec-CCCEEEEEEccCc--cchhhHHHHHHHHHHHhcCCCCccceeeEEecC-----CeEE
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE-----HQRI  662 (912)
Q Consensus       591 ~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~-----~~~~  662 (912)
                      .|.+.+.||+|+||+||+|... +++.||+|.++..  .......+.+|+.+++.++|+||+++++++...     ...+
T Consensus         6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~   85 (337)
T cd07858           6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVY   85 (337)
T ss_pred             ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEE
Confidence            4666789999999999999875 6899999998653  223345677899999999999999999987644     3579


Q ss_pred             EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccc
Q 002529          663 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA  742 (912)
Q Consensus       663 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~  742 (912)
                      +|+||+. ++|.+++.   ....+++..+..++.|++.||.|||+   ++++|+||||+||+++.++.+||+|||++...
T Consensus        86 lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~  158 (337)
T cd07858          86 IVYELMD-TDLHQIIR---SSQTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTT  158 (337)
T ss_pred             EEEeCCC-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence            9999995 78988887   34679999999999999999999998   99999999999999999999999999999875


Q ss_pred             ccccccccccccCCCcccCCCccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhh--------hc
Q 002529          743 EEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM--------IK  813 (912)
Q Consensus       743 ~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~--------~~  813 (912)
                      ..... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+..........+...        +.
T Consensus       159 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
T cd07858         159 SEKGD-FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIR  237 (337)
T ss_pred             CCCcc-cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcC
Confidence            43321 1223347889999998764 46889999999999999999999999744321111110000000        00


Q ss_pred             cCCccccc-------CccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--Hhhh
Q 002529          814 KGDVISIV-------DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDS  865 (912)
Q Consensus       814 ~~~~~~~~-------d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~--L~~~  865 (912)
                      .......+       ++... .........+.+++.+||+.+|++|||++|+++.  ++.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         238 NEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             chhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence            00000000       00000 0011234568899999999999999999999976  5543

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=3.4e-31  Score=285.96  Aligned_cols=248  Identities=23%  Similarity=0.329  Sum_probs=194.9

Q ss_pred             HHhhhcccCccccEEEEEEEec-CCCEEEEEEccCc-----cchhhHHHHHHHHHHHhcCCCCccceeeEEecC--CeEE
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS-----CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRI  662 (912)
Q Consensus       591 ~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~-----~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~--~~~~  662 (912)
                      .|++.+.||+|+||.||+|... +++.||+|.+...     .......+.+|++++++++|+||+++++++.+.  ...+
T Consensus         3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (264)
T cd06653           3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS   82 (264)
T ss_pred             ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence            3567899999999999999875 5899999987432     123346788999999999999999999998653  4678


Q ss_pred             EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccc
Q 002529          663 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA  742 (912)
Q Consensus       663 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~  742 (912)
                      +++||+++++|.+++..   ...+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||++...
T Consensus        83 ~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  156 (264)
T cd06653          83 IFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRI  156 (264)
T ss_pred             EEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence            99999999999999873   3558899999999999999999998   99999999999999999999999999998765


Q ss_pred             ccccc--cccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccc
Q 002529          743 EEDLT--HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI  820 (912)
Q Consensus       743 ~~~~~--~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  820 (912)
                      .....  .......++..|+|||++.+..++.++|+|||||++|+|++|+.||......      ..+........    
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~----  226 (264)
T cd06653         157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM------AAIFKIATQPT----  226 (264)
T ss_pred             ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH------HHHHHHHcCCC----
Confidence            32111  1112234788999999999888999999999999999999999999732211      11111111110    


Q ss_pred             cCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          821 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       821 ~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                           ....+......+.+++.+||+ +|.+||++.+++.
T Consensus       227 -----~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         227 -----KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             -----CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence                 111222334578899999999 4799999998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1e-31  Score=276.66  Aligned_cols=254  Identities=24%  Similarity=0.359  Sum_probs=200.0

Q ss_pred             hcccCccccEEEEEEE-ecCCCEEEEEEccCccchhhHHHHHHHHHHHhcC-CCCccceeeEEecCCeEEEEEEecCCCC
Q 002529          595 CKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMHNGT  672 (912)
Q Consensus       595 ~~~LG~G~fg~Vy~a~-~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~-hpnIv~l~~~~~~~~~~~lV~E~~~~gs  672 (912)
                      .+.||+|+++.|--+. +.+|.++|||++.+........+.+|++++.+.+ |+||++++++|+++...|||||.|.||+
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp  162 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP  162 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence            5789999999999885 5689999999999888888889999999999996 9999999999999999999999999999


Q ss_pred             HHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCc---EEEeeccCccccccc--cc
Q 002529          673 LRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR---AKVSDFGLSRQAEED--LT  747 (912)
Q Consensus       673 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~---vkL~DFGla~~~~~~--~~  747 (912)
                      |..+|+   .+.-+++.+..++.++|+.||.+||.   +||.||||||+|||......   +|||||.+...+...  ..
T Consensus       163 lLshI~---~~~~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s  236 (463)
T KOG0607|consen  163 LLSHIQ---KRKHFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS  236 (463)
T ss_pred             HHHHHH---HhhhccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence            999998   46789999999999999999999998   99999999999999975443   899999887653221  11


Q ss_pred             c----ccccccCCCcccCCCcc-----CCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcc-------chh-hHHHHHHh
Q 002529          748 H----ISSVARGTVGYLDPEYY-----GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG-------AEL-NIVHWARS  810 (912)
Q Consensus       748 ~----~~~~~~gt~~y~APE~l-----~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~-------~~~-~~~~~~~~  810 (912)
                      .    .-....|+..|||||+.     +...|+.++|.||||+|||-|+.|.+||.+....       +.- .=.+.+-.
T Consensus       237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFe  316 (463)
T KOG0607|consen  237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFE  316 (463)
T ss_pred             CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHH
Confidence            1    11234588899999976     2346889999999999999999999999854322       110 11111222


Q ss_pred             hhccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          811 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       811 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                      .+++|.. ++-|..     -.....+..+++...|..++.+|-++.++++
T Consensus       317 sIQEGkY-eFPdkd-----WahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  317 SIQEGKY-EFPDKD-----WAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             HHhccCC-cCChhh-----hHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            3333332 111110     0123346678899999999999999999987

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.97  E-value=7.5e-32  Score=272.62  Aligned_cols=249  Identities=24%  Similarity=0.399  Sum_probs=196.4

Q ss_pred             hhhcccCccccEEEEEEEec-CCCEEEEEEccCc-cchhhHHHHHHHHHHHhcC-CCCccceeeEEecCCeEEEEEEecC
Q 002529          593 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS-CSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMH  669 (912)
Q Consensus       593 ~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~-~~~~~~~~~~E~~il~~L~-hpnIv~l~~~~~~~~~~~lV~E~~~  669 (912)
                      ++...||.|..|.|++++.+ .|..+|||.+... ..+..+.++..++++..-+ +|+||+.+|+|..+...++.||.|.
T Consensus        95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs  174 (391)
T KOG0983|consen   95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS  174 (391)
T ss_pred             hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence            45678999999999999987 5899999999764 3445577888888876665 8999999999999999999999883


Q ss_pred             CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccccc
Q 002529          670 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI  749 (912)
Q Consensus       670 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~  749 (912)
                       .-+...++.  -.+++++.-+-++...++.||.||.+  +++|+|||+||+|||+|+.|++||||||.+-..-+...+ 
T Consensus       175 -~C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh-  248 (391)
T KOG0983|consen  175 -TCAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH-  248 (391)
T ss_pred             -HHHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccccc-
Confidence             344444443  35678999999999999999999998  699999999999999999999999999999887655443 


Q ss_pred             cccccCCCcccCCCccC---CCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCcccc
Q 002529          750 SSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI  826 (912)
Q Consensus       750 ~~~~~gt~~y~APE~l~---~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  826 (912)
                       ...+|-+.|||||.+.   ...|+.++||||||++++||.||+.||.+...+-     +.+...+.+.      .|.+.
T Consensus       249 -trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF-----e~ltkvln~e------PP~L~  316 (391)
T KOG0983|consen  249 -TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF-----EVLTKVLNEE------PPLLP  316 (391)
T ss_pred             -ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH-----HHHHHHHhcC------CCCCC
Confidence             3455899999999985   3478889999999999999999999998544321     1111222211      12222


Q ss_pred             CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002529          827 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       827 ~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  861 (912)
                      +..  .....+.+++..||++|+.+||...++++.
T Consensus       317 ~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  317 GHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             ccc--CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence            211  133478899999999999999999998863

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.97  E-value=4.4e-31  Score=295.69  Aligned_cols=256  Identities=20%  Similarity=0.207  Sum_probs=193.0

Q ss_pred             hhcccCccccEEEEEEEec-CCCEEEEEEccCccchh--------------hHHHHHHHHHHHhcCCCCccceeeEEecC
Q 002529          594 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHR--------------TQQFVTEVALLSRIHHRNLVPLIGYCEEE  658 (912)
Q Consensus       594 ~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~~--------------~~~~~~E~~il~~L~hpnIv~l~~~~~~~  658 (912)
                      +.+.||+|+||+||+|..+ +++.||+|.++......              ...+.+|++++++++|+||+++++++..+
T Consensus        13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   92 (335)
T PTZ00024         13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG   92 (335)
T ss_pred             hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence            3577999999999999876 68999999986432211              12477899999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccC
Q 002529          659 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL  738 (912)
Q Consensus       659 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGl  738 (912)
                      +..++||||+. |+|.+++.   ....+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||+
T Consensus        93 ~~~~lv~e~~~-~~l~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~dfg~  165 (335)
T PTZ00024         93 DFINLVMDIMA-SDLKKVVD---RKIRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGL  165 (335)
T ss_pred             CcEEEEEeccc-cCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEECCccc
Confidence            99999999996 68999887   34568999999999999999999998   9999999999999999999999999999


Q ss_pred             cccccccc-------------ccccccccCCCcccCCCccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhH
Q 002529          739 SRQAEEDL-------------THISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNI  804 (912)
Q Consensus       739 a~~~~~~~-------------~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~  804 (912)
                      +.......             ........++..|+|||.+.+. .++.++|||||||++|+|++|+.||......+   .
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~---~  242 (335)
T PTZ00024        166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID---Q  242 (335)
T ss_pred             eeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---H
Confidence            87654111             0111122357789999998764 46899999999999999999999997443221   1


Q ss_pred             HHHHHhhhccCC---ccccc------------CccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          805 VHWARSMIKKGD---VISIV------------DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       805 ~~~~~~~~~~~~---~~~~~------------d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                      ...+........   .....            .+... .........+.+++.+||+.+|++||+++|++.
T Consensus       243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        243 LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            111111111100   00000            00000 000112346889999999999999999999985

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.97  E-value=6.8e-31  Score=287.75  Aligned_cols=250  Identities=26%  Similarity=0.351  Sum_probs=195.7

Q ss_pred             HhhhcccCccccEEEEEEEec----CCCEEEEEEccCcc----chhhHHHHHHHHHHHhc-CCCCccceeeEEecCCeEE
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC----SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRI  662 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~----~~~~vAvK~l~~~~----~~~~~~~~~E~~il~~L-~hpnIv~l~~~~~~~~~~~  662 (912)
                      |++.+.||+|+||.||+|...    +|+.||+|+++...    ....+.+.+|+++++++ +|+||+++++.+..+...+
T Consensus         2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (290)
T cd05613           2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH   81 (290)
T ss_pred             ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence            456789999999999999863    68999999987532    22346678899999999 5999999999999999999


Q ss_pred             EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccc
Q 002529          663 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA  742 (912)
Q Consensus       663 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~  742 (912)
                      +|+||+++++|.+++..   ...+++..+..++.|+++||+|||+   .+++||||+|+||+++.++.++|+|||++...
T Consensus        82 lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  155 (290)
T cd05613          82 LILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  155 (290)
T ss_pred             EEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence            99999999999999973   4568899999999999999999998   99999999999999999999999999998775


Q ss_pred             ccccccccccccCCCcccCCCccCCC--CCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccc
Q 002529          743 EEDLTHISSVARGTVGYLDPEYYGNQ--QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI  820 (912)
Q Consensus       743 ~~~~~~~~~~~~gt~~y~APE~l~~~--~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  820 (912)
                      ............|+..|+|||.+.+.  .++.++||||||+++|+|++|+.||......  ...............    
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~~----  229 (290)
T cd05613         156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--NSQAEISRRILKSEP----  229 (290)
T ss_pred             ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--ccHHHHHHHhhccCC----
Confidence            44322222234578899999998653  4678999999999999999999999632221  111222222111110    


Q ss_pred             cCccccCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 002529          821 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL  860 (912)
Q Consensus       821 ~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP-----s~~evl~  860 (912)
                             ..+......+.+++.+||+.+|++||     ++++++.
T Consensus       230 -------~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         230 -------PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             -------CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence                   01112234678999999999999997     7777765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.97  E-value=5.3e-31  Score=287.35  Aligned_cols=259  Identities=22%  Similarity=0.273  Sum_probs=194.3

Q ss_pred             hhhcccCccccEEEEEEEec-CCCEEEEEEccCccc--hhhHHHHHHHHHHHhc---CCCCccceeeEEecCCe-----E
Q 002529          593 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRI---HHRNLVPLIGYCEEEHQ-----R  661 (912)
Q Consensus       593 ~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~L---~hpnIv~l~~~~~~~~~-----~  661 (912)
                      ++.+.||+|+||.||+|+.+ +++.||+|+++....  .....+.+|+.+++++   +|+||+++++++...+.     .
T Consensus         2 ~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~   81 (287)
T cd07838           2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKL   81 (287)
T ss_pred             eEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCcee
Confidence            45788999999999999987 489999999874322  2234566788877766   59999999999987766     8


Q ss_pred             EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccc
Q 002529          662 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ  741 (912)
Q Consensus       662 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~  741 (912)
                      +++||++. ++|.+++... ....+++..++.++.|+++||+|||+   .+++|+||+|+||+++.++.++|+|||++..
T Consensus        82 ~l~~e~~~-~~l~~~l~~~-~~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          82 TLVFEHVD-QDLATYLSKC-PKPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             EEEehhcc-cCHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCccee
Confidence            99999996 5898888743 23468999999999999999999998   8999999999999999999999999999877


Q ss_pred             cccccccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcc---
Q 002529          742 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI---  818 (912)
Q Consensus       742 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~---  818 (912)
                      .......  ....++..|+|||++.+..++.++|+|||||++|+|++|++||......+  ................   
T Consensus       157 ~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07838         157 YSFEMAL--TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD--QLDKIFDVIGLPSEEEWPR  232 (287)
T ss_pred             ccCCccc--ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH--HHHHHHHHcCCCChHhcCC
Confidence            6443221  12336788999999999899999999999999999999999997433221  1111111110000000   


Q ss_pred             ------cccCcccc---CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          819 ------SIVDPVLI---GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       819 ------~~~d~~l~---~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                            ........   ..........+.+++.+||+.||.+||+++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence                  00000000   0111233457789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.97  E-value=4.1e-31  Score=286.98  Aligned_cols=246  Identities=27%  Similarity=0.401  Sum_probs=199.3

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc---chhhHHHHHHHHHHHhcC-CCCccceeeEEecCCeEEEEEE
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYE  666 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~L~-hpnIv~l~~~~~~~~~~~lV~E  666 (912)
                      |.+.+.||+|++|.||+|..+ +++.|++|++....   ....+.+.+|++++++++ ||||+++++++..++..++|||
T Consensus         3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   82 (280)
T cd05581           3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLE   82 (280)
T ss_pred             ceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEc
Confidence            566789999999999999876 68999999986532   233467888999999998 9999999999999999999999


Q ss_pred             ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccc
Q 002529          667 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL  746 (912)
Q Consensus       667 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~  746 (912)
                      ++++++|.+++..   ...+++..++.++.|++.||++||+   .+++|+||+|+||+++.++.++|+|||++.......
T Consensus        83 ~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~  156 (280)
T cd05581          83 YAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS  156 (280)
T ss_pred             CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence            9999999999984   4579999999999999999999998   999999999999999999999999999988754432


Q ss_pred             c-------------------cccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHH
Q 002529          747 T-------------------HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHW  807 (912)
Q Consensus       747 ~-------------------~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~  807 (912)
                      .                   .......++..|+|||.+.+..++.++||||||++++++++|+.||.....   ....+ 
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~-  232 (280)
T cd05581         157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE---YLTFQ-  232 (280)
T ss_pred             ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH---HHHHH-
Confidence            1                   112233478899999999888899999999999999999999999974331   11111 


Q ss_pred             HHhhhccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCH----HHHHH
Q 002529          808 ARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKM----QEIVL  860 (912)
Q Consensus       808 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~----~evl~  860 (912)
                        ..... .          ...+......+.+++.+||+.+|.+||++    +|+++
T Consensus       233 --~~~~~-~----------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         233 --KILKL-E----------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             --HHHhc-C----------CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence              11110 0          01111223478899999999999999999    77654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=7.1e-31  Score=286.07  Aligned_cols=262  Identities=23%  Similarity=0.323  Sum_probs=195.7

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCccc-hhhHHHHHHHHHHHhcC-CCCccceeeEEecCCeEEEEEEec
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYM  668 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~L~-hpnIv~l~~~~~~~~~~~lV~E~~  668 (912)
                      |++.+.||+|++|+||+|... +++.|++|.+..... .......+|+..+++++ |+||+++++++..++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            346789999999999999986 478999999865422 23334567999999998 999999999999999999999999


Q ss_pred             CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccc
Q 002529          669 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH  748 (912)
Q Consensus       669 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  748 (912)
                       +|+|.+.+.... ...+++..++.++.|++.+|+|||+   .+++|+||+|+||+++.++.++|+|||.+.........
T Consensus        81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~  155 (283)
T cd07830          81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY  155 (283)
T ss_pred             -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCc
Confidence             889999887532 3578999999999999999999998   99999999999999999999999999998765443221


Q ss_pred             ccccccCCCcccCCCccC-CCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhh-HHH---------HHHhhhccCCc
Q 002529          749 ISSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN-IVH---------WARSMIKKGDV  817 (912)
Q Consensus       749 ~~~~~~gt~~y~APE~l~-~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~-~~~---------~~~~~~~~~~~  817 (912)
                        ....++..|+|||++. ...++.++|+||||++++||++|+.||......+... ...         |..........
T Consensus       156 --~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07830         156 --TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL  233 (283)
T ss_pred             --CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence              2234788999999874 4567899999999999999999999996443221110 000         00000000000


Q ss_pred             ccccCccc---cCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          818 ISIVDPVL---IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       818 ~~~~d~~l---~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                      ...+....   ...........+.+++.+||+.+|++||+++|++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            00000000   00000111357889999999999999999999975

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.97  E-value=9.7e-31  Score=287.59  Aligned_cols=252  Identities=25%  Similarity=0.375  Sum_probs=193.5

Q ss_pred             HHHhhhcccCccccEEEEEEEecC-CCEEEEEEccCcc-chhhHHHHHHHHHHHhcC-CCCccceeeEEecCCeEEEEEE
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSC-SHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYE  666 (912)
Q Consensus       590 ~~~~~~~~LG~G~fg~Vy~a~~~~-~~~vAvK~l~~~~-~~~~~~~~~E~~il~~L~-hpnIv~l~~~~~~~~~~~lV~E  666 (912)
                      ..+++.+.||+|++|.||+|.+++ ++.||||.++... ......+.+|+.++.+.. ||||+++++++.+....+++||
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   94 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME   94 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence            446778999999999999999875 8999999987543 233455677887777775 9999999999999999999999


Q ss_pred             ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccc
Q 002529          667 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL  746 (912)
Q Consensus       667 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~  746 (912)
                      |+. ++|.+.+...  ...+++..+..++.|++.||+|||+  ..+++||||+|+||++++++.++|+|||++.......
T Consensus        95 ~~~-~~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~  169 (296)
T cd06618          95 LMS-TCLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK  169 (296)
T ss_pred             ccC-cCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence            985 5777766542  3478999999999999999999996  2599999999999999999999999999987654332


Q ss_pred             ccccccccCCCcccCCCccCCCC----CCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccC
Q 002529          747 THISSVARGTVGYLDPEYYGNQQ----LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD  822 (912)
Q Consensus       747 ~~~~~~~~gt~~y~APE~l~~~~----~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  822 (912)
                      ..  ....++..|+|||.+.+..    ++.++||||||+++|+|++|+.||......     .+......... ......
T Consensus       170 ~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~-~~~~~~  241 (296)
T cd06618         170 AK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLTKILQEE-PPSLPP  241 (296)
T ss_pred             cc--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHHHHhcCC-CCCCCC
Confidence            22  2234678999999987553    788999999999999999999999732111     11111111111 000000


Q ss_pred             ccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002529          823 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       823 ~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  861 (912)
                             .......+.+++.+||+.+|++||+++++++.
T Consensus       242 -------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         242 -------NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             -------CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                   00123478999999999999999999999864

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.97  E-value=1.3e-30  Score=284.21  Aligned_cols=241  Identities=23%  Similarity=0.279  Sum_probs=186.5

Q ss_pred             ccCccccEEEEEEEec-CCCEEEEEEccCccc---hhhHHHHHHHH---HHHhcCCCCccceeeEEecCCeEEEEEEecC
Q 002529          597 KIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVA---LLSRIHHRNLVPLIGYCEEEHQRILVYEYMH  669 (912)
Q Consensus       597 ~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~~---il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~  669 (912)
                      .||+|+||.||+|... +++.||+|.+.....   .....+..|..   .++...||+|+++++++...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999875 588999999865321   11222334443   3444579999999999999999999999999


Q ss_pred             CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccccc
Q 002529          670 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI  749 (912)
Q Consensus       670 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~  749 (912)
                      +++|.+++.   ....+++..++.++.|++.||+|||+   .+++||||||+||+++.++.++|+|||++........  
T Consensus        81 g~~L~~~l~---~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~--  152 (278)
T cd05606          81 GGDLHYHLS---QHGVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--  152 (278)
T ss_pred             CCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC--
Confidence            999999887   34579999999999999999999998   9999999999999999999999999999876543221  


Q ss_pred             cccccCCCcccCCCccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCC
Q 002529          750 SSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN  828 (912)
Q Consensus       750 ~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  828 (912)
                       ....|+..|+|||.+.+. .++.++||||+|+++|+|++|+.||.............    ....      ....+.  
T Consensus       153 -~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~----~~~~------~~~~~~--  219 (278)
T cd05606         153 -HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR----MTLT------MAVELP--  219 (278)
T ss_pred             -cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHH----Hhhc------cCCCCC--
Confidence             223588999999998754 68899999999999999999999997442221111111    1100      011111  


Q ss_pred             CCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 002529          829 VKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL  860 (912)
Q Consensus       829 ~~~~~~~~l~~Li~~cL~~dP~~RP-----s~~evl~  860 (912)
                        ......+.+++.+||..+|.+||     ++.|+++
T Consensus       220 --~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         220 --DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             --CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence              11234788999999999999999     9999975

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.97  E-value=2.1e-30  Score=286.78  Aligned_cols=249  Identities=29%  Similarity=0.417  Sum_probs=196.0

Q ss_pred             HHHHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCc---cchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEE
Q 002529          588 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL  663 (912)
Q Consensus       588 ~~~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~---~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~l  663 (912)
                      ...+|...+.||+|++|.||+|... +++.+++|.+...   ......++.+|+++++.++|+|++++++++......++
T Consensus        13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   92 (308)
T cd06634          13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL   92 (308)
T ss_pred             cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence            4556777889999999999999876 5788999988642   22334568889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccc
Q 002529          664 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE  743 (912)
Q Consensus       664 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~  743 (912)
                      |+||+. |+|.+.+...  ...+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||++....
T Consensus        93 v~e~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  166 (308)
T cd06634          93 VMEYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA  166 (308)
T ss_pred             EEEccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeec
Confidence            999996 6887777532  4568899999999999999999998   999999999999999999999999999987654


Q ss_pred             cccccccccccCCCcccCCCccC---CCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccc
Q 002529          744 EDLTHISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI  820 (912)
Q Consensus       744 ~~~~~~~~~~~gt~~y~APE~l~---~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  820 (912)
                      ..     ....++..|+|||.+.   ...++.++|||||||++|+|++|+.||.......  ....    .. .+.....
T Consensus       167 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~----~~-~~~~~~~  234 (308)
T cd06634         167 PA-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALYH----IA-QNESPAL  234 (308)
T ss_pred             Cc-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH--HHHH----Hh-hcCCCCc
Confidence            32     1234788999999874   3567889999999999999999999986322111  0111    11 1111110


Q ss_pred             cCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 002529          821 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI  862 (912)
Q Consensus       821 ~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  862 (912)
                              ........+.+++.+||+.+|++||+++++++..
T Consensus       235 --------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~  268 (308)
T cd06634         235 --------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (308)
T ss_pred             --------CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence                    0112334688999999999999999999998653

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.97  E-value=8.5e-32  Score=275.61  Aligned_cols=246  Identities=24%  Similarity=0.334  Sum_probs=194.8

Q ss_pred             hcccCccccEEEEEEEec-CCCEEEEEEccCccchhhHHHHHHHHHHHhc-CCCCccceeeEEec----CCeEEEEEEec
Q 002529          595 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEE----EHQRILVYEYM  668 (912)
Q Consensus       595 ~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L-~hpnIv~l~~~~~~----~~~~~lV~E~~  668 (912)
                      .++||-|-.|.|-...++ +++.+|+|++...     ....+|+++.-.. .|||||++++++.+    ...+.+|||.|
T Consensus        67 ~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~m  141 (400)
T KOG0604|consen   67 WQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECM  141 (400)
T ss_pred             hhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecc
Confidence            378999999999999877 6899999998754     3445788775555 59999999998854    45678999999


Q ss_pred             CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccC---CCcEEEeeccCccccccc
Q 002529          669 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQAEED  745 (912)
Q Consensus       669 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~---~~~vkL~DFGla~~~~~~  745 (912)
                      +||.|...++.. ....+++.++..|++||..|+.|||+   .+|.||||||+|+|...   +..+||+|||+|+.....
T Consensus       142 eGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~  217 (400)
T KOG0604|consen  142 EGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEP  217 (400)
T ss_pred             cchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEecccccccccCCC
Confidence            999999999865 46679999999999999999999998   99999999999999964   556999999999986643


Q ss_pred             cccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccc
Q 002529          746 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL  825 (912)
Q Consensus       746 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  825 (912)
                      ..-  ...+-|+.|.|||++....|+..+|+||+||++|-|++|.+||-...-   ..+.--++..+..|... +-++  
T Consensus       218 ~~L--~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg---~aispgMk~rI~~gqy~-FP~p--  289 (400)
T KOG0604|consen  218 GDL--MTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG---LAISPGMKRRIRTGQYE-FPEP--  289 (400)
T ss_pred             ccc--cCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC---ccCChhHHhHhhccCcc-CCCh--
Confidence            332  234479999999999999999999999999999999999999962211   22222233444433321 1111  


Q ss_pred             cCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          826 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       826 ~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                         --....+...++|+.+|..+|.+|.|+.|++.
T Consensus       290 ---EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  290 ---EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             ---hHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence               11234457789999999999999999999875

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-32  Score=325.11  Aligned_cols=245  Identities=28%  Similarity=0.388  Sum_probs=197.1

Q ss_pred             hcccCccccEEEEEEEe-cCCCEEEEEEccCccc--hhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEecCCC
Q 002529          595 CKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG  671 (912)
Q Consensus       595 ~~~LG~G~fg~Vy~a~~-~~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~g  671 (912)
                      ..+||.|.||.||-|.. ++|+-.|+|-++-...  ...+.+.+|..++..|+|||+|+++|+-.+.+..+|.||||++|
T Consensus      1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred             ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence            45799999999999975 4689999998865433  33467889999999999999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccc---
Q 002529          672 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH---  748 (912)
Q Consensus       672 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~---  748 (912)
                      +|.+.++   .+...++.....+..|++.|++|||+   +|||||||||.||+++.+|.+|++|||.|..+......   
T Consensus      1320 sLa~ll~---~gri~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~ 1393 (1509)
T KOG4645|consen 1320 SLASLLE---HGRIEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPG 1393 (1509)
T ss_pred             cHHHHHH---hcchhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEecCchhcCCH
Confidence            9999998   34556677777789999999999998   99999999999999999999999999999987655322   


Q ss_pred             ccccccCCCcccCCCccCCC---CCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccc
Q 002529          749 ISSVARGTVGYLDPEYYGNQ---QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL  825 (912)
Q Consensus       749 ~~~~~~gt~~y~APE~l~~~---~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  825 (912)
                      .-....||+.|||||++.+.   ....++||||+||++.||+||+.||...+  .+..+...    +..|...       
T Consensus      1394 el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d--ne~aIMy~----V~~gh~P------- 1460 (1509)
T KOG4645|consen 1394 ELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELD--NEWAIMYH----VAAGHKP------- 1460 (1509)
T ss_pred             HHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhcc--chhHHHhH----HhccCCC-------
Confidence            22345699999999999664   34568999999999999999999997332  22222222    2223222       


Q ss_pred             cCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          826 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       826 ~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                        .++.....+-.+++.+||+.||++|.++.|+++
T Consensus      1461 --q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1461 --QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred             --CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence              222233345678999999999999999988765

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.97  E-value=4.6e-31  Score=291.46  Aligned_cols=265  Identities=22%  Similarity=0.267  Sum_probs=192.1

Q ss_pred             HHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCccch--hhHHHHHHHHHHHhcCCCCccceeeEEecC--------
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH--RTQQFVTEVALLSRIHHRNLVPLIGYCEEE--------  658 (912)
Q Consensus       590 ~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~--~~~~~~~E~~il~~L~hpnIv~l~~~~~~~--------  658 (912)
                      ..|++.++||+|++|.||+|..+ +++.+|+|++......  ....+.+|++++++++||||+++++++...        
T Consensus         8 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   87 (311)
T cd07866           8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKR   87 (311)
T ss_pred             ccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccC
Confidence            45677899999999999999876 5899999998643222  234567899999999999999999987443        


Q ss_pred             CeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccC
Q 002529          659 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL  738 (912)
Q Consensus       659 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGl  738 (912)
                      ...++|+||+. ++|.+.+..  ....+++..+..++.|+++||+|||+   .+++|+||||+||++++++.++|+|||+
T Consensus        88 ~~~~lv~~~~~-~~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~  161 (311)
T cd07866          88 GSVYMVTPYMD-HDLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGL  161 (311)
T ss_pred             ceEEEEEecCC-cCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcCcc
Confidence            34699999996 467776653  24579999999999999999999998   9999999999999999999999999999


Q ss_pred             ccccccccccc----------cccccCCCcccCCCccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHH
Q 002529          739 SRQAEEDLTHI----------SSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHW  807 (912)
Q Consensus       739 a~~~~~~~~~~----------~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~  807 (912)
                      +..........          .....+++.|+|||.+.+ ..++.++|||||||++|||++|++||..............
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~  241 (311)
T cd07866         162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK  241 (311)
T ss_pred             chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            87654322111          112346788999998765 4578999999999999999999999974433221111110


Q ss_pred             HHhhhccC------CcccccCccccCCCC-------HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          808 ARSMIKKG------DVISIVDPVLIGNVK-------IESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       808 ~~~~~~~~------~~~~~~d~~l~~~~~-------~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                      ........      ......+.......+       ......+.+++.+||+.+|++|||+.|++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            00000000      000000000000000       111246889999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.97  E-value=6.3e-30  Score=283.74  Aligned_cols=244  Identities=30%  Similarity=0.426  Sum_probs=192.3

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCccc---hhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEe
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY  667 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  667 (912)
                      +...++||+|+||+||+|+.. +++.|++|++.....   .....+.+|+++++.++|||++++++++.+....++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            445678999999999999875 688999999864322   2345688899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccc
Q 002529          668 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT  747 (912)
Q Consensus       668 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~  747 (912)
                      +. +++.+.+..  ....+++.+++.++.||+.||+|||+   .+++|+||+|+||+++.++.++|+|||++......  
T Consensus       103 ~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~--  174 (313)
T cd06633         103 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA--  174 (313)
T ss_pred             CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCCC--
Confidence            95 678777763  24568999999999999999999998   89999999999999999999999999988653221  


Q ss_pred             cccccccCCCcccCCCccC---CCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCcc
Q 002529          748 HISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV  824 (912)
Q Consensus       748 ~~~~~~~gt~~y~APE~l~---~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  824 (912)
                         ....++..|+|||++.   ...++.++||||||+++|+|++|..||.......   ..   ...... ......   
T Consensus       175 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~---~~---~~~~~~-~~~~~~---  241 (313)
T cd06633         175 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---AL---YHIAQN-DSPTLQ---  241 (313)
T ss_pred             ---CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH---HH---HHHHhc-CCCCCC---
Confidence               2345788999999974   4568889999999999999999999987332211   11   111111 111111   


Q ss_pred             ccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002529          825 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       825 l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  861 (912)
                           .......+.+++.+||+.+|.+||++.++++.
T Consensus       242 -----~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         242 -----SNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             -----ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 11122368899999999999999999999853

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.97  E-value=3.6e-30  Score=274.85  Aligned_cols=236  Identities=30%  Similarity=0.396  Sum_probs=192.4

Q ss_pred             cCccccEEEEEEEec-CCCEEEEEEccCccc---hhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEecCCCCH
Q 002529          598 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL  673 (912)
Q Consensus       598 LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL  673 (912)
                      ||+|++|.||++... +++.+++|.+.....   .....+.+|++++++++|+||+++++.+..+...++|||++++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            799999999999876 589999999875432   2445788999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccccccccc
Q 002529          674 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA  753 (912)
Q Consensus       674 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~  753 (912)
                      .+++..   ...+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++........ .....
T Consensus        81 ~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~  153 (250)
T cd05123          81 FSHLSK---EGRFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTNTF  153 (250)
T ss_pred             HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCCC-cccCC
Confidence            999974   3468999999999999999999998   9999999999999999999999999999877544321 12334


Q ss_pred             cCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCCCCHHH
Q 002529          754 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES  833 (912)
Q Consensus       754 ~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  833 (912)
                      .++..|+|||...+...+.++|+||||+++|+|++|+.||...+.   .....   .... ...          ..+...
T Consensus       154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~---~~~~-~~~----------~~~~~~  216 (250)
T cd05123         154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYE---KILK-DPL----------RFPEFL  216 (250)
T ss_pred             cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHH---HHhc-CCC----------CCCCCC
Confidence            578899999999888889999999999999999999999974332   11111   1111 100          111112


Q ss_pred             HHHHHHHHHhcccCCCCCCCCHHH
Q 002529          834 IWRIAEVAIQCVEQRGFSRPKMQE  857 (912)
Q Consensus       834 ~~~l~~Li~~cL~~dP~~RPs~~e  857 (912)
                      ...+.+++.+||..+|++||++++
T Consensus       217 ~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         217 SPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CHHHHHHHHHHhcCCHhhCCCccc
Confidence            347889999999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=1.3e-30  Score=283.47  Aligned_cols=258  Identities=24%  Similarity=0.302  Sum_probs=197.0

Q ss_pred             hhhcccCccccEEEEEEEec-CCCEEEEEEccCcc--chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEecC
Q 002529          593 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH  669 (912)
Q Consensus       593 ~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~  669 (912)
                      ++.+.||+|++|.||+|+.. +++.||+|++....  ....+.+.+|++++++++|+|++++++++.+.+..++|+||++
T Consensus         2 ~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (282)
T cd07829           2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD   81 (282)
T ss_pred             eeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC
Confidence            45678999999999999887 48999999987643  2234667889999999999999999999999999999999997


Q ss_pred             CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccccc
Q 002529          670 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI  749 (912)
Q Consensus       670 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~  749 (912)
                       ++|.+++...  ...+++..++.++.|++.||++||+   .+++||||+|+||++++++.++|+|||.+......... 
T Consensus        82 -~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~-  154 (282)
T cd07829          82 -MDLKKYLDKR--PGPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT-  154 (282)
T ss_pred             -cCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCccc-
Confidence             5999999843  2578999999999999999999998   89999999999999999999999999998776443221 


Q ss_pred             cccccCCCcccCCCccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccC---------Cc--
Q 002529          750 SSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG---------DV--  817 (912)
Q Consensus       750 ~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~---------~~--  817 (912)
                      .....++..|+|||.+.+. .++.++||||||+++|||++|+.||........   ...+.......         ..  
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
T cd07829         155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ---LFKIFQILGTPTEESWPGVTKLPD  231 (282)
T ss_pred             cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH---HHHHHHHhCCCcHHHHHhhccccc
Confidence            1223356789999998766 788999999999999999999999974432211   11111110000         00  


Q ss_pred             -ccccCccccC---CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          818 -ISIVDPVLIG---NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       818 -~~~~d~~l~~---~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                       ..........   .........+.+++.+||+.+|++||++.+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         232 YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             ccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence             0000000000   000112457899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.97  E-value=1.3e-30  Score=280.66  Aligned_cols=248  Identities=26%  Similarity=0.370  Sum_probs=193.9

Q ss_pred             HhhhcccCccccEEEEEEEecC-CCEEEEEEccCcc-----chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEE
Q 002529          592 NNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSC-----SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY  665 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~~-~~~vAvK~l~~~~-----~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~  665 (912)
                      |.+.++||+|+||.||++.... +..+++|+++...     .....++.+|+.++++++||||+++++++.+....++|+
T Consensus         2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (260)
T cd08222           2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT   81 (260)
T ss_pred             ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence            5677899999999999998763 4556666654321     223345678999999999999999999999889999999


Q ss_pred             EecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccc
Q 002529          666 EYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE  744 (912)
Q Consensus       666 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~  744 (912)
                      ||+++++|.+.+.... ....+++..++.++.|+++||.|||+   .+++|+||+|+||+++. +.++|+|||.+.....
T Consensus        82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~  157 (260)
T cd08222          82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG  157 (260)
T ss_pred             EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecCC
Confidence            9999999999886432 34678999999999999999999998   99999999999999975 5699999999876543


Q ss_pred             ccccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCcc
Q 002529          745 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV  824 (912)
Q Consensus       745 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  824 (912)
                      ... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||.....      ........ .+..     + 
T Consensus       158 ~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~~~~~-~~~~-----~-  223 (260)
T cd08222         158 SCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF------LSVVLRIV-EGPT-----P-  223 (260)
T ss_pred             Ccc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHH-cCCC-----C-
Confidence            322 12234478899999999888889999999999999999999999963221      11111111 1111     1 


Q ss_pred             ccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          825 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       825 l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                         ..+......+.+++.+||+.+|++||++.|+++
T Consensus       224 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         224 ---SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             ---CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence               112233457889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.97  E-value=5.5e-31  Score=295.95  Aligned_cols=261  Identities=21%  Similarity=0.284  Sum_probs=191.6

Q ss_pred             HHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEecC----------
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE----------  658 (912)
Q Consensus       590 ~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~----------  658 (912)
                      .+|++.+.||.|+||.||+|... +++.||+|.+........+.+.+|++++++++||||+++++++...          
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            45667899999999999999876 5899999998765555567788999999999999999999876543          


Q ss_pred             ----CeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCcccc-CCCcEEE
Q 002529          659 ----HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-INMRAKV  733 (912)
Q Consensus       659 ----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~-~~~~vkL  733 (912)
                          ...++|+||++ ++|.+++.    ...+++..++.++.||++||+|||+   .+++||||||+||+++ .++.++|
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~kl  156 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKI  156 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEEE
Confidence                35789999996 58988875    3468899999999999999999998   9999999999999997 4567899


Q ss_pred             eeccCccccccccccc--cccccCCCcccCCCccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHh
Q 002529          734 SDFGLSRQAEEDLTHI--SSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS  810 (912)
Q Consensus       734 ~DFGla~~~~~~~~~~--~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~  810 (912)
                      +|||.+..........  .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||........  .......
T Consensus       157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~--~~~~~~~  234 (342)
T cd07854         157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ--MQLILES  234 (342)
T ss_pred             CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHh
Confidence            9999987653322111  122346889999997654 5678899999999999999999999974332111  0000000


Q ss_pred             hhc--c---CCcccccCc-----cccCCC-----CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          811 MIK--K---GDVISIVDP-----VLIGNV-----KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       811 ~~~--~---~~~~~~~d~-----~l~~~~-----~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                      ...  .   .........     ......     ......++.+++.+||+.||++||++.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            000  0   000000000     000000     0112346889999999999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=9.3e-31  Score=313.20  Aligned_cols=264  Identities=26%  Similarity=0.421  Sum_probs=212.3

Q ss_pred             HHHHHHHhhhcccCccccEEEEEEEecC--------CCEEEEEEccCccc-hhhHHHHHHHHHHHhc-CCCCccceeeEE
Q 002529          586 ELEEATNNFCKKIGKGSFGSVYYGKMKD--------GKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYC  655 (912)
Q Consensus       586 ~l~~~~~~~~~~LG~G~fg~Vy~a~~~~--------~~~vAvK~l~~~~~-~~~~~~~~E~~il~~L-~hpnIv~l~~~~  655 (912)
                      |+......+.+.||+|.||.|++|..+.        ...||||.++.... .+.+.+..|+++|+.+ +|+||+.++|+|
T Consensus       292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~  371 (609)
T KOG0200|consen  292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC  371 (609)
T ss_pred             eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence            4444555677799999999999997541        45799999986533 4567899999999999 599999999999


Q ss_pred             ecCCeEEEEEEecCCCCHHHHhccCC-----CC--------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 002529          656 EEEHQRILVYEYMHNGTLRDRLHGSV-----NQ--------KPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN  722 (912)
Q Consensus       656 ~~~~~~~lV~E~~~~gsL~~~l~~~~-----~~--------~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~N  722 (912)
                      ...+..++|+||+..|+|.++++..+     ..        ..++..+++.++.|||.|++||++   .+++||||..+|
T Consensus       372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRN  448 (609)
T KOG0200|consen  372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARN  448 (609)
T ss_pred             ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhh
Confidence            99999999999999999999998654     01        248899999999999999999998   999999999999


Q ss_pred             ccccCCCcEEEeeccCcccccccccccccccc--CCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcc
Q 002529          723 ILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFG  799 (912)
Q Consensus       723 ILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~--gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~  799 (912)
                      ||+..+..+||+|||+|+..............  -+..|||||.+....++.++||||||++|||++| |..||.+... 
T Consensus       449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~-  527 (609)
T KOG0200|consen  449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP-  527 (609)
T ss_pred             EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc-
Confidence            99999999999999999975544333222222  2456999999999999999999999999999999 8999974211 


Q ss_pred             chhhHHHHHHhhhccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhhhh
Q 002529          800 AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK  867 (912)
Q Consensus       800 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~~~  867 (912)
                       ...+.+    .++.|...+         .+..+..++.++++.||+.+|++||++.|+.+.++..+.
T Consensus       528 -~~~l~~----~l~~G~r~~---------~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~  581 (609)
T KOG0200|consen  528 -TEELLE----FLKEGNRME---------QPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ  581 (609)
T ss_pred             -HHHHHH----HHhcCCCCC---------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence             122222    333443222         233345578899999999999999999999999999644

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=7.6e-31  Score=276.58  Aligned_cols=261  Identities=25%  Similarity=0.381  Sum_probs=210.0

Q ss_pred             HHHHHHHhhhcccCccccEEEEEEEecC------CCEEEEEEccCccch-hhHHHHHHHHHHHhcCCCCccceeeEEec-
Q 002529          586 ELEEATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEE-  657 (912)
Q Consensus       586 ~l~~~~~~~~~~LG~G~fg~Vy~a~~~~------~~~vAvK~l~~~~~~-~~~~~~~E~~il~~L~hpnIv~l~~~~~~-  657 (912)
                      .+.+.+.++...+-+|.||.||+|.|.+      .+.|.+|.++...+. ....++.|.-.+..+.|||+.++.+++.+ 
T Consensus       280 ~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~  359 (563)
T KOG1024|consen  280 TVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIED  359 (563)
T ss_pred             hhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeec
Confidence            3455555567789999999999997653      456788888765443 45678899999999999999999998754 


Q ss_pred             CCeEEEEEEecCCCCHHHHhc-----cCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEE
Q 002529          658 EHQRILVYEYMHNGTLRDRLH-----GSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK  732 (912)
Q Consensus       658 ~~~~~lV~E~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vk  732 (912)
                      ....++++.++.-|+|..++.     +....+.++..++..++.|++.|++|||+   +++||.||..+|++|++..++|
T Consensus       360 ~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~LqVk  436 (563)
T KOG1024|consen  360 YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQLQVK  436 (563)
T ss_pred             cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhheeEE
Confidence            556788999999999999998     33355678888999999999999999998   9999999999999999999999


Q ss_pred             EeeccCcccccc-ccccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHh
Q 002529          733 VSDFGLSRQAEE-DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARS  810 (912)
Q Consensus       733 L~DFGla~~~~~-~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~  810 (912)
                      |+|=.+++..-. +..........+..||+||.+....++.++||||||++||||+| |+.|+...+.-+       +..
T Consensus       437 ltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE-------m~~  509 (563)
T KOG1024|consen  437 LTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE-------MEH  509 (563)
T ss_pred             eccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH-------HHH
Confidence            999999987543 33334444456789999999999999999999999999999999 999997433322       222


Q ss_pred             hhccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhh
Q 002529          811 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS  865 (912)
Q Consensus       811 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~  865 (912)
                      .++.|..       +  ..+.+++++|..++.-||...|++||+.+|++.-|.+.
T Consensus       510 ylkdGyR-------l--aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF  555 (563)
T KOG1024|consen  510 YLKDGYR-------L--AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF  555 (563)
T ss_pred             HHhccce-------e--cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence            2222211       1  22456778999999999999999999999999988764

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.97  E-value=2e-30  Score=290.09  Aligned_cols=259  Identities=21%  Similarity=0.279  Sum_probs=190.1

Q ss_pred             HhhhcccCccccEEEEEEEec-C--CCEEEEEEccCcc--chhhHHHHHHHHHHHhc-CCCCccceeeEEec----CCeE
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-D--GKEVAVKIMADSC--SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEE----EHQR  661 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~--~~~vAvK~l~~~~--~~~~~~~~~E~~il~~L-~hpnIv~l~~~~~~----~~~~  661 (912)
                      |++.+.||+|+||.||++... .  ++.||+|.+....  ......+.+|+++++++ +||||+++++.+..    ....
T Consensus         2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~   81 (332)
T cd07857           2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL   81 (332)
T ss_pred             ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence            456789999999999999876 3  7789999986432  22345678899999999 59999999987533    2457


Q ss_pred             EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccc
Q 002529          662 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ  741 (912)
Q Consensus       662 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~  741 (912)
                      ++++|++. ++|.+.+.   ....+++..++.++.||+.||+|||+   .+++||||||+||+++.++.++|+|||++..
T Consensus        82 ~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a~~  154 (332)
T cd07857          82 YLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARG  154 (332)
T ss_pred             EEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence            88889885 68998886   35678999999999999999999998   9999999999999999999999999999986


Q ss_pred             ccccccc---ccccccCCCcccCCCccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhc----
Q 002529          742 AEEDLTH---ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK----  813 (912)
Q Consensus       742 ~~~~~~~---~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~----  813 (912)
                      .......   ......|+..|+|||++.+ ..++.++||||+|+++|+|++|+.||...+...   ....+.....    
T Consensus       155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~  231 (332)
T cd07857         155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD---QLNQILQVLGTPDE  231 (332)
T ss_pred             cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH---HHHHHHHHhCCCCH
Confidence            5432211   1122357889999998765 568899999999999999999999997433211   1110000000    


Q ss_pred             -------cCCcccc---cCc---cccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          814 -------KGDVISI---VDP---VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       814 -------~~~~~~~---~d~---~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                             .......   ...   .............+.+++.+||+.+|++|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                   0000000   000   0000000112347889999999999999999999874

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.8e-31  Score=286.30  Aligned_cols=243  Identities=24%  Similarity=0.289  Sum_probs=198.8

Q ss_pred             hhhcccCccccEEEEEEEec-CCCEEEEEEccCcc---chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEec
Q 002529          593 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM  668 (912)
Q Consensus       593 ~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~  668 (912)
                      +.-++||+|+||.||-.+.+ +|+.+|.|.+.+..   .......++|-.+|.+++.+.||.+--.|+..+.+|+|+..|
T Consensus       188 ~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlM  267 (591)
T KOG0986|consen  188 RVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLM  267 (591)
T ss_pred             eeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEee
Confidence            34578999999999999766 69999999885432   233455778999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccc
Q 002529          669 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH  748 (912)
Q Consensus       669 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  748 (912)
                      .||+|.-+|... ....+++..++-++.+|+.||++||+   .+||.||+||+|||+|+.|+++|+|+|+|..+.+....
T Consensus       268 NGGDLkfHiyn~-g~~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~  343 (591)
T KOG0986|consen  268 NGGDLKFHIYNH-GNPGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPI  343 (591)
T ss_pred             cCCceeEEeecc-CCCCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecCCCCcc
Confidence            999998888744 45689999999999999999999998   99999999999999999999999999999998776554


Q ss_pred             ccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCC
Q 002529          749 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN  828 (912)
Q Consensus       749 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  828 (912)
                      ..  .+||.+|||||+++++.|+...|-|||||++|||+.|+.||........   .+.+.+.+.+.          ...
T Consensus       344 ~~--rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk---~eEvdrr~~~~----------~~e  408 (591)
T KOG0986|consen  344 RG--RVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK---REEVDRRTLED----------PEE  408 (591)
T ss_pred             cc--ccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh---HHHHHHHHhcc----------hhh
Confidence            33  3699999999999999999999999999999999999999973322111   11111111111          113


Q ss_pred             CCHHHHHHHHHHHHhcccCCCCCCCC
Q 002529          829 VKIESIWRIAEVAIQCVEQRGFSRPK  854 (912)
Q Consensus       829 ~~~~~~~~l~~Li~~cL~~dP~~RPs  854 (912)
                      ++....++...+.+..|+.||++|--
T Consensus       409 y~~kFS~eakslc~~LL~Kdp~~RLG  434 (591)
T KOG0986|consen  409 YSDKFSEEAKSLCEGLLTKDPEKRLG  434 (591)
T ss_pred             cccccCHHHHHHHHHHHccCHHHhcc
Confidence            34444557888889999999999864

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.97  E-value=5.5e-30  Score=286.14  Aligned_cols=259  Identities=22%  Similarity=0.321  Sum_probs=193.8

Q ss_pred             HHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc--chhhHHHHHHHHHHHhcCCCCccceeeEEec-CCeEEEEE
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE-EHQRILVY  665 (912)
Q Consensus       590 ~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~-~~~~~lV~  665 (912)
                      ..|++.+.||.|+||.||+|..+ +++.||+|++....  ....+.+.+|++++++++||||+++.+++.. ....++++
T Consensus        10 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~   89 (328)
T cd07856          10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVT   89 (328)
T ss_pred             cceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEe
Confidence            45667899999999999999866 78999999875432  2234677889999999999999999998865 56789999


Q ss_pred             EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccc
Q 002529          666 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED  745 (912)
Q Consensus       666 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~  745 (912)
                      ||+ +++|.++++    ...+++..+..++.|+++||+|||+   .+++|+||+|+||+++.++.++|+|||.+......
T Consensus        90 e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~  161 (328)
T cd07856          90 ELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ  161 (328)
T ss_pred             ehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccccccccCCC
Confidence            998 578988886    3457888889999999999999998   99999999999999999999999999998754332


Q ss_pred             cccccccccCCCcccCCCccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhh-HHHH--------HHhhhccC
Q 002529          746 LTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN-IVHW--------ARSMIKKG  815 (912)
Q Consensus       746 ~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~-~~~~--------~~~~~~~~  815 (912)
                      .    ....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.......... +.+.        ..... .+
T Consensus       162 ~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  236 (328)
T cd07856         162 M----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC-SE  236 (328)
T ss_pred             c----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc-ch
Confidence            1    22346788999998765 578999999999999999999999997443211110 0000        00000 00


Q ss_pred             CcccccCc-cccCCCC-----HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002529          816 DVISIVDP-VLIGNVK-----IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       816 ~~~~~~d~-~l~~~~~-----~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  861 (912)
                      ...+++.. ......+     ......+.+++.+||+.+|++||+++|++..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         237 NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             hhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00000000 0000111     1123578899999999999999999999764

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.97  E-value=5e-30  Score=288.32  Aligned_cols=263  Identities=23%  Similarity=0.328  Sum_probs=195.4

Q ss_pred             HHHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc--chhhHHHHHHHHHHHhcCCCCccceeeEEecCC------
Q 002529          589 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------  659 (912)
Q Consensus       589 ~~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~------  659 (912)
                      ..+|.+.+.||+|+||.||+|... +++.||+|++....  ......+.+|++++++++||||+++++++..+.      
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07880          14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH   93 (343)
T ss_pred             ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence            345667889999999999999865 68999999986432  223456889999999999999999999986543      


Q ss_pred             eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCc
Q 002529          660 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS  739 (912)
Q Consensus       660 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla  739 (912)
                      ..++|||++ +++|.+++.    ...+++..++.++.|+++||+|||+   .+|+||||||+||+++.++.++|+|||++
T Consensus        94 ~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg~~  165 (343)
T cd07880          94 DFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLA  165 (343)
T ss_pred             eEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccc
Confidence            458999999 789988876    3468999999999999999999998   99999999999999999999999999998


Q ss_pred             cccccccccccccccCCCcccCCCccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHH---------
Q 002529          740 RQAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR---------  809 (912)
Q Consensus       740 ~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~---------  809 (912)
                      .......    ....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||.......  .......         
T Consensus       166 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~  239 (343)
T cd07880         166 RQTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD--QLMEIMKVTGTPSKEF  239 (343)
T ss_pred             cccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCCHHH
Confidence            8654322    22346889999998865 468899999999999999999999997433211  1111000         


Q ss_pred             -hhhccCCcccccC--cccc----CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--HHhhh
Q 002529          810 -SMIKKGDVISIVD--PVLI----GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL--AIQDS  865 (912)
Q Consensus       810 -~~~~~~~~~~~~d--~~l~----~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~--~L~~~  865 (912)
                       ..+..........  +...    ..........+.+++.+||+.||++|||+.++++  .++..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~  304 (343)
T cd07880         240 VQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF  304 (343)
T ss_pred             HHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence             0000000000000  0000    0001122336889999999999999999999984  34444

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.97  E-value=6.5e-31  Score=270.10  Aligned_cols=268  Identities=21%  Similarity=0.273  Sum_probs=198.5

Q ss_pred             HHHhhhcccCccccEEEEEEEecC-----CCEEEEEEccCccc--hhhHHHHHHHHHHHhcCCCCccceeeEEec-CCeE
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMKD-----GKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEE-EHQR  661 (912)
Q Consensus       590 ~~~~~~~~LG~G~fg~Vy~a~~~~-----~~~vAvK~l~~~~~--~~~~~~~~E~~il~~L~hpnIv~l~~~~~~-~~~~  661 (912)
                      ..|+.+.+||+|.||.||+|..++     .+.+|+|.++....  .-.....+|+.+++.++||||+.+..++.. +...
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            356778999999999999996442     34799999976422  222456789999999999999999998866 7889


Q ss_pred             EEEEEecCCCCHHHHhccCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCC----CcEEEee
Q 002529          662 ILVYEYMHNGTLRDRLHGSV--NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN----MRAKVSD  735 (912)
Q Consensus       662 ~lV~E~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~----~~vkL~D  735 (912)
                      ++++||.+. +|.++++-.+  ..+.++...+..|+.||+.|+.|||+   .=|+||||||.|||+..+    |.+||+|
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEeec
Confidence            999999975 8888886543  34679999999999999999999999   779999999999999877    8999999


Q ss_pred             ccCccccccccccc--cccccCCCcccCCCccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCccCccchh------hHHH
Q 002529          736 FGLSRQAEEDLTHI--SSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL------NIVH  806 (912)
Q Consensus       736 FGla~~~~~~~~~~--~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~------~~~~  806 (912)
                      ||+++.+.+.....  ....+-|..|+|||.+.+. .|+++.||||.|||+.||+|-++-|.+.......      +-.+
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~  259 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD  259 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence            99999987655433  3345578999999998775 7899999999999999999999988755433111      1111


Q ss_pred             HHHhhhc---cCCcccccC-c-------ccc-CCCCH----H-------HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002529          807 WARSMIK---KGDVISIVD-P-------VLI-GNVKI----E-------SIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       807 ~~~~~~~---~~~~~~~~d-~-------~l~-~~~~~----~-------~~~~l~~Li~~cL~~dP~~RPs~~evl~~  861 (912)
                      .+-..+.   ..+...+.. |       .++ ..+..    .       ....-.+|+.++|+.||.+|.|+++.++.
T Consensus       260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh  337 (438)
T KOG0666|consen  260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH  337 (438)
T ss_pred             HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence            1111111   111111100 0       000 00000    0       00126789999999999999999998864

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.97  E-value=2e-30  Score=291.39  Aligned_cols=265  Identities=23%  Similarity=0.325  Sum_probs=193.4

Q ss_pred             HHhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc--chhhHHHHHHHHHHHhcCCCCccceeeEEecC------CeE
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQR  661 (912)
Q Consensus       591 ~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~------~~~  661 (912)
                      .|.+.+.||+|+||.||+|... +++.||+|++....  ......+.+|++++++++||||+++++++...      ...
T Consensus        16 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   95 (342)
T cd07879          16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDF   95 (342)
T ss_pred             ceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceE
Confidence            4555789999999999999875 68999999986532  22235678999999999999999999998654      346


Q ss_pred             EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccc
Q 002529          662 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ  741 (912)
Q Consensus       662 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~  741 (912)
                      ++|+||+. .+|.+++.     ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++.++|+|||++..
T Consensus        96 ~lv~e~~~-~~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~  166 (342)
T cd07879          96 YLVMPYMQ-TDLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARH  166 (342)
T ss_pred             EEEecccc-cCHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence            89999995 47776643     358899999999999999999998   8999999999999999999999999999876


Q ss_pred             cccccccccccccCCCcccCCCccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHH--------hhh
Q 002529          742 AEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR--------SMI  812 (912)
Q Consensus       742 ~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~--------~~~  812 (912)
                      .....    ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||................        ..+
T Consensus       167 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (342)
T cd07879         167 ADAEM----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKL  242 (342)
T ss_pred             CCCCC----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence            53321    22346788999999866 468899999999999999999999997433211110000000        000


Q ss_pred             ccCCccccc---CccccCCC---CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--Hhhhhhh
Q 002529          813 KKGDVISIV---DPVLIGNV---KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDSIKI  868 (912)
Q Consensus       813 ~~~~~~~~~---d~~l~~~~---~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~--L~~~~~~  868 (912)
                      .........   ........   .......+.+++.+||+.||++||+++|++..  +++....
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~  306 (342)
T cd07879         243 EDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA  306 (342)
T ss_pred             cccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence            000000000   00000000   01123467899999999999999999999954  7766553

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.97  E-value=1.8e-30  Score=306.88  Aligned_cols=245  Identities=27%  Similarity=0.403  Sum_probs=184.6

Q ss_pred             hcccCccccEEEEEEEec-CCCEEEEEEccCcc-chhhHHHHHHHHHHHhcCCCCccceeeEE-----------------
Q 002529          595 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYC-----------------  655 (912)
Q Consensus       595 ~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~L~hpnIv~l~~~~-----------------  655 (912)
                      .+.||+||||.||+++.+ ||+.+|||++.-.. ......+.+|+..|.+|+|||||+++..+                 
T Consensus       484 L~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~  563 (1351)
T KOG1035|consen  484 LELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDS  563 (1351)
T ss_pred             HHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccch
Confidence            578999999999999988 89999999987543 23346788999999999999999986210                 


Q ss_pred             -------------------------------------------e------------------c-----------------
Q 002529          656 -------------------------------------------E------------------E-----------------  657 (912)
Q Consensus       656 -------------------------------------------~------------------~-----------------  657 (912)
                                                                 .                  +                 
T Consensus       564 ~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d  643 (1351)
T KOG1035|consen  564 ESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILD  643 (1351)
T ss_pred             hhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccC
Confidence                                                       0                  0                 


Q ss_pred             ----------------C--------CeEEEEEEecCCCCHHHHhccCCCCCCC-CHHHHHHHHHHHHHHHHHHHhcCCCC
Q 002529          658 ----------------E--------HQRILVYEYMHNGTLRDRLHGSVNQKPL-DWLTRLQIAHDAAKGLEYLHTGCNPG  712 (912)
Q Consensus       658 ----------------~--------~~~~lV~E~~~~gsL~~~l~~~~~~~~l-~~~~~~~i~~qia~aL~~LHs~~~~~  712 (912)
                                      +        ..+||-||||+...|.++++.+.   .. .....++++++|++||+|+|+   .|
T Consensus       644 ~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~---~~~~~d~~wrLFreIlEGLaYIH~---~g  717 (1351)
T KOG1035|consen  644 DTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNH---FNSQRDEAWRLFREILEGLAYIHD---QG  717 (1351)
T ss_pred             cchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcc---cchhhHHHHHHHHHHHHHHHHHHh---Cc
Confidence                            0        12578899999989999888532   22 466789999999999999998   99


Q ss_pred             eeecCCCCCCccccCCCcEEEeeccCccccc------c-----------ccccccccccCCCcccCCCccCCC---CCCc
Q 002529          713 IIHRDVKSSNILLDINMRAKVSDFGLSRQAE------E-----------DLTHISSVARGTVGYLDPEYYGNQ---QLTE  772 (912)
Q Consensus       713 ivH~DLkp~NILl~~~~~vkL~DFGla~~~~------~-----------~~~~~~~~~~gt~~y~APE~l~~~---~~s~  772 (912)
                      +|||||||.|||++++..|||+|||+|....      +           ......+..+||.-|+|||++.+.   .|+.
T Consensus       718 iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~  797 (1351)
T KOG1035|consen  718 IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNS  797 (1351)
T ss_pred             eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccc
Confidence            9999999999999999999999999998721      0           000112335699999999999765   4999


Q ss_pred             hhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCC
Q 002529          773 KSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSR  852 (912)
Q Consensus       773 ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~R  852 (912)
                      |+|+||||+|++||+   .||. ..+ +.    ..+...++.+.+..-      ..+..+....=..+|++|+++||.+|
T Consensus       798 KiDmYSLGIVlFEM~---yPF~-TsM-ER----a~iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~hdP~kR  862 (1351)
T KOG1035|consen  798 KIDMYSLGIVLFEML---YPFG-TSM-ER----ASILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLLSHDPSKR  862 (1351)
T ss_pred             hhhhHHHHHHHHHHh---ccCC-chH-HH----HHHHHhcccCCCCCC------cccccccchHHHHHHHHHhcCCCccC
Confidence            999999999999998   4564 111 11    112223334443332      11222233355689999999999999


Q ss_pred             CCHHHHHH
Q 002529          853 PKMQEIVL  860 (912)
Q Consensus       853 Ps~~evl~  860 (912)
                      |||.|+|+
T Consensus       863 PtA~eLL~  870 (1351)
T KOG1035|consen  863 PTATELLN  870 (1351)
T ss_pred             CCHHHHhh
Confidence            99999984

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=3.3e-31  Score=287.19  Aligned_cols=243  Identities=26%  Similarity=0.402  Sum_probs=197.1

Q ss_pred             hcccCccccEEEEEEEec-CCCEEEEEEccCc--cchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEecCCC
Q 002529          595 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG  671 (912)
Q Consensus       595 ~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~g  671 (912)
                      .+.||.|-||+||-|+++ +|+.||||++.+.  ......++.+|+.+|++++||.||.+...|+..+..++|||.+ .|
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence            688999999999999876 7999999999753  3345578999999999999999999999999999999999999 56


Q ss_pred             CHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCC---CcEEEeeccCcccccccccc
Q 002529          672 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN---MRAKVSDFGLSRQAEEDLTH  748 (912)
Q Consensus       672 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~---~~vkL~DFGla~~~~~~~~~  748 (912)
                      ++.+++... ..+++++..-.-++.||+.||+|||.   ++|+|+||||+|||+.+.   -++||||||+|+.+++..- 
T Consensus       648 DMLEMILSs-EkgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF-  722 (888)
T KOG4236|consen  648 DMLEMILSS-EKGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF-  722 (888)
T ss_pred             hHHHHHHHh-hcccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhhh-
Confidence            666666544 46789999989999999999999998   999999999999999643   5799999999999877533 


Q ss_pred             ccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCC
Q 002529          749 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN  828 (912)
Q Consensus       749 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  828 (912)
                       .....||+.|+|||++++..|...-|+||.|+++|.-++|..||....     ++-+    ++++..+  +..+...  
T Consensus       723 -RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE-----dInd----QIQNAaF--MyPp~PW--  788 (888)
T KOG4236|consen  723 -RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE-----DIND----QIQNAAF--MYPPNPW--  788 (888)
T ss_pred             -hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc-----chhH----Hhhcccc--ccCCCch--
Confidence             344679999999999999999999999999999999999999998221     2222    1221111  1111111  


Q ss_pred             CCHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 002529          829 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIV  859 (912)
Q Consensus       829 ~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl  859 (912)
                        .+.....+++|...|+..-++|-+.+.-+
T Consensus       789 --~eis~~AidlIn~LLqVkm~kRysvdk~l  817 (888)
T KOG4236|consen  789 --SEISPEAIDLINNLLQVKMRKRYSVDKSL  817 (888)
T ss_pred             --hhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence              22233567899999999999999988765

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.97  E-value=2.7e-30  Score=290.65  Aligned_cols=258  Identities=22%  Similarity=0.305  Sum_probs=190.9

Q ss_pred             HHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc--chhhHHHHHHHHHHHhcCCCCccceeeEEecC------Ce
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQ  660 (912)
Q Consensus       590 ~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~------~~  660 (912)
                      .+|.+.+.||+|+||.||+|... +++.||+|++....  ....+.+.+|++++++++||||+++++++...      ..
T Consensus        17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (345)
T cd07877          17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND   96 (345)
T ss_pred             CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccccc
Confidence            34556789999999999999864 68999999987532  22345678899999999999999999988543      34


Q ss_pred             EEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcc
Q 002529          661 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR  740 (912)
Q Consensus       661 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~  740 (912)
                      .+++++++ +++|.+++.    ...+++..+..++.|+++||+|||+   .+++||||||+||+++.++.+||+|||++.
T Consensus        97 ~~lv~~~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~dfg~~~  168 (345)
T cd07877          97 VYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR  168 (345)
T ss_pred             EEEEehhc-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCCEEEecccccc
Confidence            67888876 789988876    3458999999999999999999998   999999999999999999999999999987


Q ss_pred             ccccccccccccccCCCcccCCCccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhh--------
Q 002529          741 QAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM--------  811 (912)
Q Consensus       741 ~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~--------  811 (912)
                      .....    .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.......  .+.......        
T Consensus       169 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~  242 (345)
T cd07877         169 HTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID--QLKLILRLVGTPGAELL  242 (345)
T ss_pred             ccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHHH
Confidence            65332    123357889999998866 567889999999999999999999996433211  111100000        


Q ss_pred             --hccCCc---ccccCcccc---CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002529          812 --IKKGDV---ISIVDPVLI---GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       812 --~~~~~~---~~~~d~~l~---~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  861 (912)
                        +.....   ...++....   ..........+.+++.+||+.+|.+||++.|+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         243 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             hhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence              000000   000000000   00000123467899999999999999999999864

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-30  Score=269.31  Aligned_cols=247  Identities=24%  Similarity=0.337  Sum_probs=200.5

Q ss_pred             HHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCccc---hhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEE
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY  665 (912)
Q Consensus       590 ~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~  665 (912)
                      ..+.|.++||+|.||.|.+++-+ .++.+|+|++++...   .....-+.|-++|+..+||.+..+--.|+..+++|+||
T Consensus       168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM  247 (516)
T KOG0690|consen  168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM  247 (516)
T ss_pred             chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence            34567899999999999999877 699999999987543   33445667999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccc
Q 002529          666 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED  745 (912)
Q Consensus       666 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~  745 (912)
                      ||..||.|.-+|.   ....+++....-+-..|+.||.|||+   ++||.||||.+|.|+|.+|++||+|||+++.--..
T Consensus       248 eyanGGeLf~HLs---rer~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~  321 (516)
T KOG0690|consen  248 EYANGGELFFHLS---RERVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY  321 (516)
T ss_pred             EEccCceEeeehh---hhhcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhcccc
Confidence            9999999998887   35678888888899999999999999   99999999999999999999999999999874322


Q ss_pred             cccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccc
Q 002529          746 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL  825 (912)
Q Consensus       746 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  825 (912)
                      .. .....+|||.|+|||++....|..+.|-|.+|+++|||++|+.||...+...-..++-     ..+-+         
T Consensus       322 g~-t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl-----~ed~k---------  386 (516)
T KOG0690|consen  322 GD-TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL-----MEDLK---------  386 (516)
T ss_pred             cc-eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH-----hhhcc---------
Confidence            22 2345679999999999999999999999999999999999999998444322111110     01111         


Q ss_pred             cCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 002529          826 IGNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL  860 (912)
Q Consensus       826 ~~~~~~~~~~~l~~Li~~cL~~dP~~RP-----s~~evl~  860 (912)
                         ++.....+...|+...|.+||.+|.     .++||.+
T Consensus       387 ---FPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~  423 (516)
T KOG0690|consen  387 ---FPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR  423 (516)
T ss_pred             ---CCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence               1112223567888999999999997     4566654

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2e-30  Score=291.52  Aligned_cols=239  Identities=25%  Similarity=0.356  Sum_probs=195.1

Q ss_pred             HHHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCccchhhHHHHHHHHHHHhc-CCCCccceeeEEecCCeEEEEEE
Q 002529          589 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYE  666 (912)
Q Consensus       589 ~~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L-~hpnIv~l~~~~~~~~~~~lV~E  666 (912)
                      ...|++...+|.|+|+.|-.+.+. +++..++|++.+.    ..+-.+|+.++... +||||+++.+.+.++.+.++|||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            356777888999999999999876 6889999998765    23345677776666 69999999999999999999999


Q ss_pred             ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccc-cCCCcEEEeeccCccccccc
Q 002529          667 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL-DINMRAKVSDFGLSRQAEED  745 (912)
Q Consensus       667 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl-~~~~~vkL~DFGla~~~~~~  745 (912)
                      .+.++-+.+.+...   .... .++..|+.+|+.|+.|||+   +|++||||||+|||+ ++.++++|+|||.++.....
T Consensus       397 ~l~g~ell~ri~~~---~~~~-~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~  469 (612)
T KOG0603|consen  397 LLDGGELLRRIRSK---PEFC-SEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS  469 (612)
T ss_pred             hccccHHHHHHHhc---chhH-HHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence            99999888888732   2233 6777899999999999998   999999999999999 58999999999999887655


Q ss_pred             cccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccc
Q 002529          746 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL  825 (912)
Q Consensus       746 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  825 (912)
                          ....+-|..|.|||++....+++++|+||||++||+|++|+.||.....+      ..+...+..+...       
T Consensus       470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------~ei~~~i~~~~~s-------  532 (612)
T KOG0603|consen  470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------IEIHTRIQMPKFS-------  532 (612)
T ss_pred             ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch------HHHHHhhcCCccc-------
Confidence                12234578999999999999999999999999999999999999854443      1222333333322       


Q ss_pred             cCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          826 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       826 ~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                           ........+|+.+||+.||.+||+|.|+..
T Consensus       533 -----~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  533 -----ECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             -----cccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence                 233447789999999999999999999875

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.9e-30  Score=291.76  Aligned_cols=255  Identities=21%  Similarity=0.304  Sum_probs=193.2

Q ss_pred             HHhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc--chhhHHHHHHHHHHHhcCCCCccceeeEEecCCe------E
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ------R  661 (912)
Q Consensus       591 ~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~------~  661 (912)
                      .|++.+.||+|++|.||+|... +++.||+|++....  ......+.+|+.++++++||||+++++++...+.      .
T Consensus        16 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   95 (343)
T cd07851          16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDV   95 (343)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccE
Confidence            4667789999999999999886 58899999986532  2234567789999999999999999998766554      8


Q ss_pred             EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccc
Q 002529          662 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ  741 (912)
Q Consensus       662 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~  741 (912)
                      ++|+||+ +++|.+++..    ..+++..+..++.|+++||+|||+   .+++||||||+||+++.++.++|+|||++..
T Consensus        96 ~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~  167 (343)
T cd07851          96 YLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARH  167 (343)
T ss_pred             EEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEcccccccc
Confidence            9999998 6799998873    568999999999999999999998   9999999999999999999999999999887


Q ss_pred             cccccccccccccCCCcccCCCccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhcc------
Q 002529          742 AEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK------  814 (912)
Q Consensus       742 ~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~------  814 (912)
                      ....    .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.......   ...........      
T Consensus       168 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~---~~~~i~~~~~~~~~~~~  240 (343)
T cd07851         168 TDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID---QLKRIMNLVGTPDEELL  240 (343)
T ss_pred             cccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHhcCCCCHHHH
Confidence            5433    122347888999998765 467899999999999999999999997433211   11111110000      


Q ss_pred             -----CCcccccCc---cccCCC---CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          815 -----GDVISIVDP---VLIGNV---KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       815 -----~~~~~~~d~---~l~~~~---~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                           ......+..   .....+   .......+.+++.+||+.+|++|||+.||++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             hhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence                 000000000   000000   0012457889999999999999999999986

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-31  Score=270.43  Aligned_cols=252  Identities=25%  Similarity=0.349  Sum_probs=195.5

Q ss_pred             hcccCccccEEEEEEEec-CCCEEEEEEccCccc-hhhHHHHHHHHHHHhc-CCCCccceeeEEecCCeEEEEEEecCCC
Q 002529          595 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHNG  671 (912)
Q Consensus       595 ~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~L-~hpnIv~l~~~~~~~~~~~lV~E~~~~g  671 (912)
                      ...||.|+||+|++..++ .|+..|||+++.... .+..+++.|.+...+- ++||||+++|.+..++..++.||.| ..
T Consensus        69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~  147 (361)
T KOG1006|consen   69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DI  147 (361)
T ss_pred             HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hh
Confidence            367999999999999887 699999999986544 4567788888875554 6999999999999999999999999 45


Q ss_pred             CHHHHhccC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccccc
Q 002529          672 TLRDRLHGS--VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI  749 (912)
Q Consensus       672 sL~~~l~~~--~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~  749 (912)
                      ||..+-+..  .....+++.-+-.|....+.||.||.+  ...|+|||+||+|||++..|.+||||||.+-...+...  
T Consensus       148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiA--  223 (361)
T KOG1006|consen  148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIA--  223 (361)
T ss_pred             hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHHHHH--
Confidence            665433211  145678888888999999999999998  58999999999999999999999999999877655432  


Q ss_pred             cccccCCCcccCCCccCCC--CCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccC
Q 002529          750 SSVARGTVGYLDPEYYGNQ--QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG  827 (912)
Q Consensus       750 ~~~~~gt~~y~APE~l~~~--~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  827 (912)
                      ....+|-..|||||.+...  .|..+|||||||++|||+.||+.|+..-+     +..+.+.... .|+...+..+.   
T Consensus       224 kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~-----svfeql~~Vv-~gdpp~l~~~~---  294 (361)
T KOG1006|consen  224 KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD-----SVFEQLCQVV-IGDPPILLFDK---  294 (361)
T ss_pred             hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH-----HHHHHHHHHH-cCCCCeecCcc---
Confidence            2334588899999998543  47889999999999999999999997322     2223232222 23332222111   


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002529          828 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       828 ~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  861 (912)
                       -..+....+.++|..||.+|-.+||...+++++
T Consensus       295 -~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  295 -ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             -cccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence             112344578999999999999999999998764

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.97  E-value=6.1e-31  Score=278.53  Aligned_cols=267  Identities=21%  Similarity=0.271  Sum_probs=205.3

Q ss_pred             hhHHHHHHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCccchhhHHHHHHHHHHHhcC-C-CC----ccceeeEEe
Q 002529          584 LPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-H-RN----LVPLIGYCE  656 (912)
Q Consensus       584 ~~~l~~~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~-h-pn----Iv~l~~~~~  656 (912)
                      ..+....+|.+...+|+|.||.|-..... .+..||||+++.-. ...+..+-|+++|+++. + |+    ++++.++|+
T Consensus        83 ~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd  161 (415)
T KOG0671|consen   83 VGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFD  161 (415)
T ss_pred             eccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh
Confidence            45667889999999999999999999765 47899999997543 33355567999999994 2 33    788888999


Q ss_pred             cCCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccC---------
Q 002529          657 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---------  727 (912)
Q Consensus       657 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~---------  727 (912)
                      -.++.|+|+|.+ |.|+.+++..+ +..+++...+..++.|+++++++||+   .+++|.||||+|||+-+         
T Consensus       162 yrghiCivfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~~~  236 (415)
T KOG0671|consen  162 YRGHICIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTYNP  236 (415)
T ss_pred             ccCceEEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEecc
Confidence            999999999998 77999999965 56788999999999999999999998   99999999999999921         


Q ss_pred             -----------CCcEEEeeccCccccccccccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCcc
Q 002529          728 -----------NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVE  796 (912)
Q Consensus       728 -----------~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~  796 (912)
                                 +..++++|||.|....+..    ...+.|..|+|||++.+-.++.++||||+||||+|+.||...|+..
T Consensus       237 k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtH  312 (415)
T KOG0671|consen  237 KKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTH  312 (415)
T ss_pred             CCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccC
Confidence                       2358999999998765443    3455799999999999999999999999999999999999999855


Q ss_pred             CccchhhHHHHHHhhhc--------------cCCc-----------ccccCcc--cc--CCCCHHHHHHHHHHHHhcccC
Q 002529          797 DFGAELNIVHWARSMIK--------------KGDV-----------ISIVDPV--LI--GNVKIESIWRIAEVAIQCVEQ  847 (912)
Q Consensus       797 ~~~~~~~~~~~~~~~~~--------------~~~~-----------~~~~d~~--l~--~~~~~~~~~~l~~Li~~cL~~  847 (912)
                      +..+.....+.+.+.+.              .+.+           ....++.  +.  -.....+..+|++|+++||..
T Consensus       313 en~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~f  392 (415)
T KOG0671|consen  313 ENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEF  392 (415)
T ss_pred             CcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHcc
Confidence            53222222221111110              0100           0000000  00  011234556899999999999


Q ss_pred             CCCCCCCHHHHHH
Q 002529          848 RGFSRPKMQEIVL  860 (912)
Q Consensus       848 dP~~RPs~~evl~  860 (912)
                      ||.+|+|+.|+++
T Consensus       393 DP~~RiTl~EAL~  405 (415)
T KOG0671|consen  393 DPARRITLREALS  405 (415)
T ss_pred             CccccccHHHHhc
Confidence            9999999999985

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.96  E-value=1.1e-29  Score=270.05  Aligned_cols=220  Identities=22%  Similarity=0.210  Sum_probs=176.0

Q ss_pred             cccEEEEEEEec-CCCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEecCCCCHHHHhcc
Q 002529          601 GSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG  679 (912)
Q Consensus       601 G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  679 (912)
                      |.+|.||++..+ +++.+|+|.++...     .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            899999999876 68999999987542     233455555566799999999999999999999999999999999874


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccccccccccCCCcc
Q 002529          680 SVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY  759 (912)
Q Consensus       680 ~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y  759 (912)
                         ...+++..+..++.|+++||+|||+   .+++||||||+||+++.++.++++|||.+.......    ....++..|
T Consensus        79 ---~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~y  148 (237)
T cd05576          79 ---FLNIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENMY  148 (237)
T ss_pred             ---hcCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCccc
Confidence               3468999999999999999999998   999999999999999999999999999876554321    123356789


Q ss_pred             cCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCCCCHHHHHHHHH
Q 002529          760 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAE  839 (912)
Q Consensus       760 ~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~  839 (912)
                      +|||.+.+..++.++||||+|+++|||++|+.|+.......            ...     ...    ..+......+.+
T Consensus       149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~~~-----~~~----~~~~~~~~~~~~  207 (237)
T cd05576         149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------NTH-----TTL----NIPEWVSEEARS  207 (237)
T ss_pred             cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------ccc-----ccc----CCcccCCHHHHH
Confidence            99999988888999999999999999999998875221100            000     000    011122346889


Q ss_pred             HHHhcccCCCCCCCCHH
Q 002529          840 VAIQCVEQRGFSRPKMQ  856 (912)
Q Consensus       840 Li~~cL~~dP~~RPs~~  856 (912)
                      ++.+||+.||++||++.
T Consensus       208 li~~~l~~dp~~R~~~~  224 (237)
T cd05576         208 LLQQLLQFNPTERLGAG  224 (237)
T ss_pred             HHHHHccCCHHHhcCCC
Confidence            99999999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.96  E-value=8.7e-30  Score=242.90  Aligned_cols=261  Identities=20%  Similarity=0.272  Sum_probs=202.3

Q ss_pred             hhhcccCccccEEEEEEEec-CCCEEEEEEccCccch--hhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEecC
Q 002529          593 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH--RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH  669 (912)
Q Consensus       593 ~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~--~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~  669 (912)
                      .-.++||+|.||+|++|+.+ +++.||+|.++-+..+  -.....+|+-+|+.++|.|||+++++...+...-+|+||| 
T Consensus         5 dkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c-   83 (292)
T KOG0662|consen    5 DKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC-   83 (292)
T ss_pred             HHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh-
Confidence            34589999999999999866 5889999998754322  2356789999999999999999999999999999999999 


Q ss_pred             CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccccc
Q 002529          670 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI  749 (912)
Q Consensus       670 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~  749 (912)
                      ..+|..+...  -++.++.+.+..++.|+++||.++|+   +++.|||+||.|.||+.+|++||+|||+++-++-.....
T Consensus        84 dqdlkkyfds--lng~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgipvrcy  158 (292)
T KOG0662|consen   84 DQDLKKYFDS--LNGDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCY  158 (292)
T ss_pred             hHHHHHHHHh--cCCcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCceEee
Confidence            4688888775  35778999999999999999999999   999999999999999999999999999999876554333


Q ss_pred             cccccCCCcccCCCccCCC-CCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhhhccCCcccc---cCcc
Q 002529          750 SSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISI---VDPV  824 (912)
Q Consensus       750 ~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---~d~~  824 (912)
                      + ...-|..|++|.++.+. -|+...|+||.||++.|+.. |++.|.+.+..+...-.-|......+.....+   .|-.
T Consensus       159 s-aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk  237 (292)
T KOG0662|consen  159 S-AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK  237 (292)
T ss_pred             e-ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence            2 23468899999998775 57889999999999999987 67667765555444444444444444333322   2211


Q ss_pred             ccCCCCH---------HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          825 LIGNVKI---------ESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       825 l~~~~~~---------~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                      ..+.++.         .....=.+++++.|.-+|.+|.++++.++
T Consensus       238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            1112221         11113367888999999999999998875

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.96  E-value=3.3e-29  Score=304.22  Aligned_cols=144  Identities=32%  Similarity=0.459  Sum_probs=129.1

Q ss_pred             HHhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc---chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEE
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE  666 (912)
Q Consensus       591 ~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E  666 (912)
                      .|.+.++||+|+||.||+|.+. +++.||||+++...   ......+.+|+.+++.++||||+++++++......++|||
T Consensus         5 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmE   84 (669)
T cd05610           5 EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVME   84 (669)
T ss_pred             CEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEe
Confidence            3567899999999999999887 68999999987532   2234678889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcc
Q 002529          667 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR  740 (912)
Q Consensus       667 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~  740 (912)
                      |+.+++|.+++..   ...+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++
T Consensus        85 y~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          85 YLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             CCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999973   4568899999999999999999998   899999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.8e-30  Score=303.02  Aligned_cols=254  Identities=26%  Similarity=0.319  Sum_probs=207.5

Q ss_pred             HHHHHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCc---cchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEE
Q 002529          587 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI  662 (912)
Q Consensus       587 l~~~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~---~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~  662 (912)
                      +....|++.++||+|+||.|.+++++ +++.||+|++.+.   ......-|..|-.+|..-..+=|++++-.|+++.++|
T Consensus        72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LY  151 (1317)
T KOG0612|consen   72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLY  151 (1317)
T ss_pred             CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceE
Confidence            45667888999999999999999987 5889999999873   2345567889999998888899999999999999999


Q ss_pred             EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccc
Q 002529          663 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA  742 (912)
Q Consensus       663 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~  742 (912)
                      +|||||+||+|...+.+.   ..+++..++.++..|+.||.-||+   .|+|||||||+|||||..|++||+|||.+..+
T Consensus       152 lVMdY~pGGDlltLlSk~---~~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLADFGsClkm  225 (1317)
T KOG0612|consen  152 LVMDYMPGGDLLTLLSKF---DRLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLADFGSCLKM  225 (1317)
T ss_pred             EEEecccCchHHHHHhhc---CCChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeeccchhHHhc
Confidence            999999999999999843   479999999999999999999998   99999999999999999999999999999988


Q ss_pred             ccccccccccccCCCcccCCCccC----C-CCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCc
Q 002529          743 EEDLTHISSVARGTVGYLDPEYYG----N-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV  817 (912)
Q Consensus       743 ~~~~~~~~~~~~gt~~y~APE~l~----~-~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  817 (912)
                      ..+....+...+|||.|++||+++    + +.|++.+|-||+||++|||+.|..||.....      ++-..........
T Consensus       226 ~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl------veTY~KIm~hk~~  299 (1317)
T KOG0612|consen  226 DADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL------VETYGKIMNHKES  299 (1317)
T ss_pred             CCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH------HHHHHHHhchhhh
Confidence            877777788889999999999984    3 5789999999999999999999999973332      2222222221111


Q ss_pred             ccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCC---HHHHHH
Q 002529          818 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK---MQEIVL  860 (912)
Q Consensus       818 ~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs---~~evl~  860 (912)
                      ..+.+.       ........+||.+.+. +|+.|-.   ++++..
T Consensus       300 l~FP~~-------~~VSeeakdLI~~ll~-~~e~RLgrngiedik~  337 (1317)
T KOG0612|consen  300 LSFPDE-------TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN  337 (1317)
T ss_pred             cCCCcc-------cccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence            111110       1233466778877665 5788887   877764

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=2.4e-29  Score=289.38  Aligned_cols=251  Identities=24%  Similarity=0.368  Sum_probs=204.5

Q ss_pred             HHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCccchhhHHHHHHHHHHHhc-CCCCccceeeEEe-----cCCeEE
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCE-----EEHQRI  662 (912)
Q Consensus       590 ~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L-~hpnIv~l~~~~~-----~~~~~~  662 (912)
                      .+.+|.+.||.|.+|.||+++.. +++.+|+|++.... +..++++.|.++|+.+ .|||++.++|++.     .++.++
T Consensus        19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLW   97 (953)
T KOG0587|consen   19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLW   97 (953)
T ss_pred             CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEE
Confidence            34567899999999999999865 68899999987653 3447788899999988 5999999999884     367899


Q ss_pred             EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccc
Q 002529          663 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA  742 (912)
Q Consensus       663 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~  742 (912)
                      ||||||.+|+..|+++... +..+.|..+..|++.++.||.|||.   ..++|||||-.|||++.++.+||+|||.+...
T Consensus        98 LVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLvDFGvSaQl  173 (953)
T KOG0587|consen   98 LVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  173 (953)
T ss_pred             EEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEeeeeeeeee
Confidence            9999999999999999775 8899999999999999999999998   99999999999999999999999999999887


Q ss_pred             ccccccccccccCCCcccCCCccCC-----CCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCc
Q 002529          743 EEDLTHISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV  817 (912)
Q Consensus       743 ~~~~~~~~~~~~gt~~y~APE~l~~-----~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  817 (912)
                      ...... .....||+.|||||++..     ..|+..+|+||||++..||.-|.+|+.+...      ..-+-...+    
T Consensus       174 dsT~gr-RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP------mraLF~IpR----  242 (953)
T KOG0587|consen  174 DSTVGR-RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP------MRALFLIPR----  242 (953)
T ss_pred             eccccc-ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch------hhhhccCCC----
Confidence            654332 345679999999999843     3567799999999999999999999872221      111111111    


Q ss_pred             ccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          818 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       818 ~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                          .|...-..+.....++.++|..||.+|.++||++.++++
T Consensus       243 ----NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  243 ----NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             ----CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence                111222234566779999999999999999999998874

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.96  E-value=2.3e-28  Score=258.03  Aligned_cols=238  Identities=32%  Similarity=0.450  Sum_probs=192.9

Q ss_pred             ccEEEEEEEec-CCCEEEEEEccCccchh-hHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEecCCCCHHHHhcc
Q 002529          602 SFGSVYYGKMK-DGKEVAVKIMADSCSHR-TQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG  679 (912)
Q Consensus       602 ~fg~Vy~a~~~-~~~~vAvK~l~~~~~~~-~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  679 (912)
                      +||.||+|... +++.+++|++....... .+.+.+|++.+++++|+||+++++++......++++|++++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999987 48999999997654444 67899999999999999999999999999999999999999999999874


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccccccccccCCCcc
Q 002529          680 SVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY  759 (912)
Q Consensus       680 ~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y  759 (912)
                      .   ..+++..++.++.++++++++||+   .+++|+||+|+||+++.++.++|+|||.+.......  ......++..|
T Consensus        81 ~---~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~  152 (244)
T smart00220       81 R---GRLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEY  152 (244)
T ss_pred             c---cCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCC
Confidence            2   338899999999999999999998   899999999999999999999999999998765432  22234578899


Q ss_pred             cCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCCCCHHHHHHHHH
Q 002529          760 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAE  839 (912)
Q Consensus       760 ~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~  839 (912)
                      ++||.+.+..++.++||||||+++++|++|..||....  ......+...    .+..... ..      .......+.+
T Consensus       153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~--~~~~~~~~~~----~~~~~~~-~~------~~~~~~~~~~  219 (244)
T smart00220      153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD--QLLELFKKIG----KPKPPFP-PP------EWKISPEAKD  219 (244)
T ss_pred             CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--cHHHHHHHHh----ccCCCCc-cc------cccCCHHHHH
Confidence            99999988888999999999999999999999997321  1112222211    1111000 00      0002347889


Q ss_pred             HHHhcccCCCCCCCCHHHHHH
Q 002529          840 VAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       840 Li~~cL~~dP~~RPs~~evl~  860 (912)
                      ++.+|+..+|++||++.++++
T Consensus       220 ~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      220 LIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHccCCchhccCHHHHhh
Confidence            999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=3.4e-30  Score=257.75  Aligned_cols=265  Identities=21%  Similarity=0.318  Sum_probs=194.7

Q ss_pred             HHHhhhcccCccccEEEEEEEec-CCCEEEEEEccC--ccchhhHHHHHHHHHHHhcCCCCccceeeEEec--------C
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMAD--SCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--------E  658 (912)
Q Consensus       590 ~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~--~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~--------~  658 (912)
                      ..|+-..+||+|.||.||+|+.+ +++.||+|++--  ..........+|+++|..|+|+|++.+++.|..        .
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            34555678999999999999876 578889887532  112223456789999999999999999988743        2


Q ss_pred             CeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccC
Q 002529          659 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL  738 (912)
Q Consensus       659 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGl  738 (912)
                      ..+++|+.+|+. +|.-.|..  ....++..++.+++.++..||.|+|+   ..|+|||+|+.|+||+.+|.+||+|||+
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGl  170 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGL  170 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeecccc
Confidence            358999999965 78888764  24678999999999999999999998   8999999999999999999999999999


Q ss_pred             ccccccccccc---cccccCCCcccCCCccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhcc
Q 002529          739 SRQAEEDLTHI---SSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK  814 (912)
Q Consensus       739 a~~~~~~~~~~---~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~  814 (912)
                      ++.+.......   .....-|..|++||.+.+ ..++++.|||+.||++.||+|+.+-+++........+...+-..+..
T Consensus       171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk  250 (376)
T KOG0669|consen  171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK  250 (376)
T ss_pred             ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence            97654322211   123345889999998765 57999999999999999999999999855544333333333222222


Q ss_pred             CCcccc--------c--CccccCCCC--HHHH------HHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          815 GDVISI--------V--DPVLIGNVK--IESI------WRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       815 ~~~~~~--------~--d~~l~~~~~--~~~~------~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                      ..+...        +  +|...+.+.  .+..      ....+|+.++|..||.+|+++++++.
T Consensus       251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln  314 (376)
T KOG0669|consen  251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN  314 (376)
T ss_pred             ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence            111111        1  111111111  1111      15678999999999999999999874

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.7e-29  Score=267.27  Aligned_cols=245  Identities=25%  Similarity=0.329  Sum_probs=198.4

Q ss_pred             hHHHHHHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCccch---hhHHHHHHHHHHHhc-CCCCccceeeEEecCC
Q 002529          585 PELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH---RTQQFVTEVALLSRI-HHRNLVPLIGYCEEEH  659 (912)
Q Consensus       585 ~~l~~~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~---~~~~~~~E~~il~~L-~hpnIv~l~~~~~~~~  659 (912)
                      +.+....++|..+||+|+||.|-+|..+ +.+.+|||+++++...   +.+--+.|-++|... +-|.+++++..|+.-+
T Consensus       344 d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmD  423 (683)
T KOG0696|consen  344 DRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD  423 (683)
T ss_pred             cceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhh
Confidence            4566777899999999999999999877 4678999999876432   223334577777665 4689999999999999


Q ss_pred             eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCc
Q 002529          660 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS  739 (912)
Q Consensus       660 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla  739 (912)
                      ++|+||||+.||+|--+++   +-+.+.+..+.-++..||-||-+||+   +||+.||||.+||+++.+|++||+|||++
T Consensus       424 RLyFVMEyvnGGDLMyhiQ---Q~GkFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmc  497 (683)
T KOG0696|consen  424 RLYFVMEYVNGGDLMYHIQ---QVGKFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMC  497 (683)
T ss_pred             heeeEEEEecCchhhhHHH---HhcccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeecccc
Confidence            9999999999999998888   45678888889999999999999998   99999999999999999999999999999


Q ss_pred             cccccccccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCccc
Q 002529          740 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS  819 (912)
Q Consensus       740 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  819 (912)
                      +.---.. .......|||.|+|||++...+|+.+.|-||+|++||||+.|++||++++..+-   .+    .+.      
T Consensus       498 KEni~~~-~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el---F~----aI~------  563 (683)
T KOG0696|consen  498 KENIFDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL---FQ----AIM------  563 (683)
T ss_pred             cccccCC-cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH---HH----HHH------
Confidence            8632221 223456799999999999999999999999999999999999999986654321   11    111      


Q ss_pred             ccCccccCCCCHHHHHHHHHHHHhcccCCCCCCC
Q 002529          820 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP  853 (912)
Q Consensus       820 ~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP  853 (912)
                        +..  -.++.....+...+....|.+.|.+|.
T Consensus       564 --ehn--vsyPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  564 --EHN--VSYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             --Hcc--CcCcccccHHHHHHHHHHhhcCCcccc
Confidence              111  123444455777888899999999986

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.96  E-value=3e-28  Score=288.96  Aligned_cols=259  Identities=20%  Similarity=0.251  Sum_probs=167.9

Q ss_pred             HHHhhhcccCccccEEEEEEEec-C----CCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeE------EecC
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMK-D----GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY------CEEE  658 (912)
Q Consensus       590 ~~~~~~~~LG~G~fg~Vy~a~~~-~----~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~------~~~~  658 (912)
                      ..|++.++||+|+||.||+|++. +    ++.||+|++......  +....|  .++...+.++..++..      ...+
T Consensus       132 ~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~  207 (566)
T PLN03225        132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSKKE  207 (566)
T ss_pred             CCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccccC
Confidence            45667899999999999999876 4    689999987643211  111111  1122222222222221      2456


Q ss_pred             CeEEEEEEecCCCCHHHHhccCCC-----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 002529          659 HQRILVYEYMHNGTLRDRLHGSVN-----------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSS  721 (912)
Q Consensus       659 ~~~~lV~E~~~~gsL~~~l~~~~~-----------------~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~  721 (912)
                      ...++|+||+.+++|.+++.....                 ........+..++.||+.||+|||+   ++|+||||||+
T Consensus       208 ~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLKP~  284 (566)
T PLN03225        208 DEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVKPQ  284 (566)
T ss_pred             CceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCCHH
Confidence            678999999999999998874310                 0111234466899999999999998   99999999999


Q ss_pred             CccccC-CCcEEEeeccCccccccccccccccccCCCcccCCCccCCC----------------------CCCchhHHHH
Q 002529          722 NILLDI-NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ----------------------QLTEKSDVYS  778 (912)
Q Consensus       722 NILl~~-~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~----------------------~~s~ksDVwS  778 (912)
                      |||++. ++.+||+|||+++..............+++.|+|||.+...                      .+..++||||
T Consensus       285 NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS  364 (566)
T PLN03225        285 NIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS  364 (566)
T ss_pred             HEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence            999985 57999999999987654444444456689999999965322                      2344679999


Q ss_pred             HHHHHHHHHhCCCCCCccCcc-------chhhHHHHHHhhhccCCcccccCccccCCC--CHHHHHHHHHHHHhcccCCC
Q 002529          779 FGVVLLELISGKKPVSVEDFG-------AELNIVHWARSMIKKGDVISIVDPVLIGNV--KIESIWRIAEVAIQCVEQRG  849 (912)
Q Consensus       779 lGvil~eLltG~~Pf~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~--~~~~~~~l~~Li~~cL~~dP  849 (912)
                      |||++|||+++..++......       .......|.......      ..+.+...+  .........+|+.+||+.||
T Consensus       365 lGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP  438 (566)
T PLN03225        365 AGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELLKSMMRFKG  438 (566)
T ss_pred             HHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence            999999999987765411000       000111111110000      000000000  00011245589999999999


Q ss_pred             CCCCCHHHHHHH
Q 002529          850 FSRPKMQEIVLA  861 (912)
Q Consensus       850 ~~RPs~~evl~~  861 (912)
                      ++|||++|+++.
T Consensus       439 ~kR~ta~e~L~H  450 (566)
T PLN03225        439 RQRISAKAALAH  450 (566)
T ss_pred             ccCCCHHHHhCC
Confidence            999999999864

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.7e-29  Score=273.71  Aligned_cols=241  Identities=22%  Similarity=0.296  Sum_probs=200.1

Q ss_pred             HHhhhcccCccccEEEEEEEecCCC-EEEEEEccCcc---chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEE
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMKDGK-EVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE  666 (912)
Q Consensus       591 ~~~~~~~LG~G~fg~Vy~a~~~~~~-~vAvK~l~~~~---~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E  666 (912)
                      ..+.+..||-|+||.|=++..+..+ .+|+|++++..   ....+.+..|-++|...+.|.||+++..|.++...|+.||
T Consensus       421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE  500 (732)
T KOG0614|consen  421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME  500 (732)
T ss_pred             hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence            3345678999999999999887544 48999987643   3345667889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccc
Q 002529          667 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL  746 (912)
Q Consensus       667 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~  746 (912)
                      -|-||.|..+|+   .++.++.....-++..+++|++|||+   ++||.|||||+|.+++.+|-+||.|||+|+.+....
T Consensus       501 aClGGElWTiLr---dRg~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~  574 (732)
T KOG0614|consen  501 ACLGGELWTILR---DRGSFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR  574 (732)
T ss_pred             hhcCchhhhhhh---hcCCcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence            999999999998   57889999999999999999999999   999999999999999999999999999999987654


Q ss_pred             ccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCcccc
Q 002529          747 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI  826 (912)
Q Consensus       747 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  826 (912)
                      .  ....+||+.|.|||++.+...+.+.|.||||+++|||++|.+||.+.+.....++.-.-...+              
T Consensus       575 K--TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i--------------  638 (732)
T KOG0614|consen  575 K--TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI--------------  638 (732)
T ss_pred             c--eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh--------------
Confidence            3  345789999999999999999999999999999999999999999666543333322111111              


Q ss_pred             CCCCHHHHHHHHHHHHhcccCCCCCCCC
Q 002529          827 GNVKIESIWRIAEVAIQCVEQRGFSRPK  854 (912)
Q Consensus       827 ~~~~~~~~~~l~~Li~~cL~~dP~~RPs  854 (912)
                       .++........+++++.+..+|.+|.-
T Consensus       639 -~~Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  639 -EFPRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             -hcccccchhHHHHHHHHHhcCcHhhhc
Confidence             112222335678999999999999975

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.6e-28  Score=261.77  Aligned_cols=262  Identities=24%  Similarity=0.345  Sum_probs=199.6

Q ss_pred             hhHHHHHHHhhhcccCccccEEEEEEEe-cCCCEEEEEEccCcc--c-h----hhHHHHHHHHHHHhcCCCCccceeeEE
Q 002529          584 LPELEEATNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSC--S-H----RTQQFVTEVALLSRIHHRNLVPLIGYC  655 (912)
Q Consensus       584 ~~~l~~~~~~~~~~LG~G~fg~Vy~a~~-~~~~~vAvK~l~~~~--~-~----~~~~~~~E~~il~~L~hpnIv~l~~~~  655 (912)
                      -..+...+|-+.+.||+|+|+.||+|.+ ...+.||+|+-.-..  . +    ..+...+|.++.+.|.||.||+++++|
T Consensus       457 DHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyf  536 (775)
T KOG1151|consen  457 DHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYF  536 (775)
T ss_pred             cCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeee
Confidence            4456778888899999999999999964 468899999853211  1 1    124567899999999999999999998


Q ss_pred             e-cCCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCcccc---CCCcE
Q 002529          656 E-EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD---INMRA  731 (912)
Q Consensus       656 ~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~---~~~~v  731 (912)
                      . +.+.+|-|+|||+|.+|.-+|+   ..+.+++++...|+.||+.||.||.+. ..+|||-||||.|||+-   .-|.+
T Consensus       537 slDtdsFCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeI  612 (775)
T KOG1151|consen  537 SLDTDSFCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEI  612 (775)
T ss_pred             eeccccceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCccccee
Confidence            5 5567899999999999999998   567899999999999999999999985 47999999999999995   35789


Q ss_pred             EEeeccCccccccccc------cccccccCCCcccCCCccC----CCCCCchhHHHHHHHHHHHHHhCCCCCCccCccch
Q 002529          732 KVSDFGLSRQAEEDLT------HISSVARGTVGYLDPEYYG----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE  801 (912)
Q Consensus       732 kL~DFGla~~~~~~~~------~~~~~~~gt~~y~APE~l~----~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~  801 (912)
                      ||+|||+++.+.++..      ......+||..|++||++-    ....+.|.||||+|||+|+++.|+.||.....  .
T Consensus       613 KITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs--Q  690 (775)
T KOG1151|consen  613 KITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS--Q  690 (775)
T ss_pred             EeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh--H
Confidence            9999999998765432      2234567999999999873    23678899999999999999999999973221  1


Q ss_pred             hhHHHHHHhhhccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          802 LNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       802 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                      ..+.+       ...+...-+-.+..  .+....+...+|++||+..-++|....++..
T Consensus       691 QdILq-------eNTIlkAtEVqFP~--KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  691 QDILQ-------ENTILKATEVQFPP--KPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             HHHHh-------hhchhcceeccCCC--CCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence            12221       11111111111110  1112235678999999999999988777653

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.95  E-value=2e-27  Score=275.26  Aligned_cols=258  Identities=22%  Similarity=0.303  Sum_probs=177.5

Q ss_pred             HHHhhhcccCccccEEEEEEEe-----------------cCCCEEEEEEccCccchhhHH--------------HHHHHH
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKM-----------------KDGKEVAVKIMADSCSHRTQQ--------------FVTEVA  638 (912)
Q Consensus       590 ~~~~~~~~LG~G~fg~Vy~a~~-----------------~~~~~vAvK~l~~~~~~~~~~--------------~~~E~~  638 (912)
                      ..|++.++||+|+||+||+|.+                 ..++.||||++........++              ...|+.
T Consensus       145 d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~  224 (507)
T PLN03224        145 DDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAY  224 (507)
T ss_pred             cCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHH
Confidence            3466789999999999999964                 235689999986543322222              334677


Q ss_pred             HHHhcCCCCc-----cceeeEEec--------CCeEEEEEEecCCCCHHHHhccCC---------------------CCC
Q 002529          639 LLSRIHHRNL-----VPLIGYCEE--------EHQRILVYEYMHNGTLRDRLHGSV---------------------NQK  684 (912)
Q Consensus       639 il~~L~hpnI-----v~l~~~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~---------------------~~~  684 (912)
                      ++.+++|.++     ++++++|..        .+..+|||||+++++|.++++...                     ...
T Consensus       225 ~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~  304 (507)
T PLN03224        225 MCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQD  304 (507)
T ss_pred             HHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccc
Confidence            7777766554     677777643        356899999999999999987421                     112


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccccccccccCCCcccCCCc
Q 002529          685 PLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY  764 (912)
Q Consensus       685 ~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~  764 (912)
                      .+++..++.++.|++.+|+|||+   .+|+||||||+||+++.++.+||+|||++...............+++.|+|||.
T Consensus       305 ~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~  381 (507)
T PLN03224        305 KRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEE  381 (507)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhh
Confidence            34677888999999999999998   899999999999999999999999999997654332221222235789999998


Q ss_pred             cCCCCC----------------------CchhHHHHHHHHHHHHHhCCC-CCCccCccc------hhhHHHHHHhhhccC
Q 002529          765 YGNQQL----------------------TEKSDVYSFGVVLLELISGKK-PVSVEDFGA------ELNIVHWARSMIKKG  815 (912)
Q Consensus       765 l~~~~~----------------------s~ksDVwSlGvil~eLltG~~-Pf~~~~~~~------~~~~~~~~~~~~~~~  815 (912)
                      +.....                      ..+.||||+||++++|++|.. |+.....-.      ......|..  ....
T Consensus       382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~--~~~~  459 (507)
T PLN03224        382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM--YKGQ  459 (507)
T ss_pred             hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh--hccc
Confidence            754321                      124699999999999999875 664221110      001111111  1111


Q ss_pred             CcccccCccccCCCCHHHHHHHHHHHHhcccCCC---CCCCCHHHHHH
Q 002529          816 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRG---FSRPKMQEIVL  860 (912)
Q Consensus       816 ~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP---~~RPs~~evl~  860 (912)
                      ..    +-..    .........+++.+||..+|   .+|+|++|+++
T Consensus       460 ~~----~~~~----~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        460 KY----DFSL----LDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             CC----Cccc----ccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            10    0000    11123467899999999766   68999999985

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.95  E-value=8.1e-29  Score=269.13  Aligned_cols=276  Identities=21%  Similarity=0.253  Sum_probs=217.9

Q ss_pred             CcccccChhHHHHHHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCccchhhHHHHHHHHHHHhcC------CCCcc
Q 002529          577 GVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH------HRNLV  649 (912)
Q Consensus       577 ~~~~~~~~~~l~~~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~------hpnIv  649 (912)
                      .-.|.+.+.|+...+|++....|+|-|++|.+|... .|..||||++.+... ..+.=+.|+++|++|.      .-|++
T Consensus       419 EGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hcl  497 (752)
T KOG0670|consen  419 EGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCL  497 (752)
T ss_pred             cceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHH
Confidence            345677899999999999999999999999999866 478999999986532 2344567999999995      35899


Q ss_pred             ceeeEEecCCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCC-
Q 002529          650 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-  728 (912)
Q Consensus       650 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~-  728 (912)
                      +++..|...+++|||+|-+ ..+|.+.|++......|....+..++.|+.-||.+|..   .+|+|.||||+|||+++. 
T Consensus       498 rl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLVNE~k  573 (752)
T KOG0670|consen  498 RLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILVNESK  573 (752)
T ss_pred             HHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEeccCc
Confidence            9999999999999999988 67999999988777789999999999999999999998   899999999999999865 


Q ss_pred             CcEEEeeccCccccccccccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHH
Q 002529          729 MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWA  808 (912)
Q Consensus       729 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~  808 (912)
                      ..+||||||.|....+....   ++.-+..|.|||++.+.+|+...|+||.||+||||.||+..|.+........+...+
T Consensus       574 ~iLKLCDfGSA~~~~eneit---PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~  650 (752)
T KOG0670|consen  574 NILKLCDFGSASFASENEIT---PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMEL  650 (752)
T ss_pred             ceeeeccCcccccccccccc---HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHh
Confidence            45899999999887654332   223456799999999999999999999999999999999999866554333333222


Q ss_pred             Hhh-----hccCCccc-ccC--------------------------c------cccC--CCC---HHHHHHHHHHHHhcc
Q 002529          809 RSM-----IKKGDVIS-IVD--------------------------P------VLIG--NVK---IESIWRIAEVAIQCV  845 (912)
Q Consensus       809 ~~~-----~~~~~~~~-~~d--------------------------~------~l~~--~~~---~~~~~~l~~Li~~cL  845 (912)
                      +..     ++.+.+.+ -+|                          |      .+.+  .++   ......|.+|+.+||
T Consensus       651 KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml  730 (752)
T KOG0670|consen  651 KGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKML  730 (752)
T ss_pred             cCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHh
Confidence            221     22222111 011                          1      0111  122   334557899999999


Q ss_pred             cCCCCCCCCHHHHHH
Q 002529          846 EQRGFSRPKMQEIVL  860 (912)
Q Consensus       846 ~~dP~~RPs~~evl~  860 (912)
                      ..||++|.|..+.|+
T Consensus       731 ~LdP~KRit~nqAL~  745 (752)
T KOG0670|consen  731 ILDPEKRITVNQALK  745 (752)
T ss_pred             ccChhhcCCHHHHhc
Confidence            999999999999875

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.7e-27  Score=258.25  Aligned_cols=141  Identities=26%  Similarity=0.424  Sum_probs=119.6

Q ss_pred             cccChhHHHH-HHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCccchhhHHHHHHHHHHHhcC-----C---CCcc
Q 002529          580 YFIPLPELEE-ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-----H---RNLV  649 (912)
Q Consensus       580 ~~~~~~~l~~-~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~-----h---pnIv  649 (912)
                      ..+.+.+... .+|-+.++||.|.|++||++.+. +.+.||+|+.+.. ....+....|+++|++++     |   .+||
T Consensus        67 HpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV  145 (590)
T KOG1290|consen   67 HPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVV  145 (590)
T ss_pred             ceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceee
Confidence            3444566666 88989999999999999999765 5788999998754 344566788999999994     2   4699


Q ss_pred             ceeeEEec----CCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccc
Q 002529          650 PLIGYCEE----EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL  725 (912)
Q Consensus       650 ~l~~~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl  725 (912)
                      +|++.|..    +.+.|||+|++ |-+|..+|... ..+.++...+.+|++||+.||.|||..  .+|||.||||+|||+
T Consensus       146 ~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s-~YrGlpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  146 QLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYS-NYRGLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPENVLL  221 (590)
T ss_pred             eeeccceecCCCCcEEEEEehhh-hhHHHHHHHHh-CCCCCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcceeee
Confidence            99999954    56999999999 77898988865 577899999999999999999999994  799999999999999

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.95  E-value=3.3e-28  Score=237.49  Aligned_cols=199  Identities=25%  Similarity=0.381  Sum_probs=166.9

Q ss_pred             HHhhhcccCccccEEEEEEEec-CCCEEEEEEccCcc-chhhHHHHHHHHHHHhc-CCCCccceeeEEecCCeEEEEEEe
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEY  667 (912)
Q Consensus       591 ~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~L-~hpnIv~l~~~~~~~~~~~lV~E~  667 (912)
                      ...-.+.||+|++|.|-+.++. +|+..|+|.++... ....+++++|+.+..+. .+|.+|.++|........++.||.
T Consensus        47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~  126 (282)
T KOG0984|consen   47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMEL  126 (282)
T ss_pred             hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHH
Confidence            3344678999999999998876 79999999997653 34556788898887655 699999999999889999999999


Q ss_pred             cCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccc
Q 002529          668 MHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL  746 (912)
Q Consensus       668 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~  746 (912)
                      | ..||..+-++.. .+..+++.-+-+|+..+.+||.|||+  ...++|||+||+|||++.+|++|+||||.+-...+..
T Consensus       127 M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi  203 (282)
T KOG0984|consen  127 M-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI  203 (282)
T ss_pred             h-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhhh
Confidence            9 457766544322 57789999999999999999999999  5899999999999999999999999999998766543


Q ss_pred             ccccccccCCCcccCCCccCC----CCCCchhHHHHHHHHHHHHHhCCCCCC
Q 002529          747 THISSVARGTVGYLDPEYYGN----QQLTEKSDVYSFGVVLLELISGKKPVS  794 (912)
Q Consensus       747 ~~~~~~~~gt~~y~APE~l~~----~~~s~ksDVwSlGvil~eLltG~~Pf~  794 (912)
                      ..  +...|...|||||.+..    ..|+.++||||||+++.||.+++.||.
T Consensus       204 Ak--t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~  253 (282)
T KOG0984|consen  204 AK--TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYE  253 (282)
T ss_pred             HH--HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccc
Confidence            32  22347889999998743    478899999999999999999999997

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.95  E-value=2.9e-28  Score=279.26  Aligned_cols=241  Identities=26%  Similarity=0.425  Sum_probs=185.3

Q ss_pred             hcccCccccE-EEEEEEecCCCEEEEEEccCccchhhHHHHHHHHHHHhc-CCCCccceeeEEecCCeEEEEEEecCCCC
Q 002529          595 CKKIGKGSFG-SVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHNGT  672 (912)
Q Consensus       595 ~~~LG~G~fg-~Vy~a~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L-~hpnIv~l~~~~~~~~~~~lV~E~~~~gs  672 (912)
                      .+.+|.|+.| .||+|... |+.||||++-..   ..+-..+|+..|+.- .|||||++++.-.+++..||+.|.| ..+
T Consensus       514 ~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~s  588 (903)
T KOG1027|consen  514 KEILGYGSNGTVVFRGVYE-GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACS  588 (903)
T ss_pred             HHHcccCCCCcEEEEEeeC-CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhh
Confidence            4678999987 56999987 889999988643   334567899999888 5999999999999999999999999 569


Q ss_pred             HHHHhccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccC---C--CcEEEeeccCcccccccc
Q 002529          673 LRDRLHGS-VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---N--MRAKVSDFGLSRQAEEDL  746 (912)
Q Consensus       673 L~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~---~--~~vkL~DFGla~~~~~~~  746 (912)
                      |.+++... ...........+.++.|+++||+|||+   .+||||||||.||||+.   +  ..++|+|||+++....+.
T Consensus       589 L~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~  665 (903)
T KOG1027|consen  589 LQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK  665 (903)
T ss_pred             HHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence            99999863 111112224557789999999999999   99999999999999965   2  569999999999976654


Q ss_pred             cccc--ccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhC-CCCCCccCccchhhHHHHHHhhhccCCcccccCc
Q 002529          747 THIS--SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISG-KKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP  823 (912)
Q Consensus       747 ~~~~--~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  823 (912)
                      ...+  ....||-+|+|||++....-+.+.||||+||++|..++| .+||.. ....+.++..       ...-...+.+
T Consensus       666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd-~~~R~~NIl~-------~~~~L~~L~~  737 (903)
T KOG1027|consen  666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGD-SLERQANILT-------GNYTLVHLEP  737 (903)
T ss_pred             chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCc-hHHhhhhhhc-------Cccceeeecc
Confidence            4332  345699999999999998888899999999999998885 999972 2111111111       1100011111


Q ss_pred             cccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 002529          824 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV  859 (912)
Q Consensus       824 ~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl  859 (912)
                            ..++  +..+||.+|+.++|..||++.+|+
T Consensus       738 ------~~d~--eA~dLI~~ml~~dP~~RPsa~~VL  765 (903)
T KOG1027|consen  738 ------LPDC--EAKDLISRMLNPDPQLRPSATDVL  765 (903)
T ss_pred             ------CchH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence                  0111  677999999999999999999997

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.6e-27  Score=246.51  Aligned_cols=245  Identities=22%  Similarity=0.350  Sum_probs=196.5

Q ss_pred             HhhhcccCccccEEEEEEEec-CCCEEEEEEccCc---cchhhHHHHHHHHHHHhc-CCCCccceeeEEecCCeEEEEEE
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYE  666 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~---~~~~~~~~~~E~~il~~L-~hpnIv~l~~~~~~~~~~~lV~E  666 (912)
                      +.+.++||+|+|+.|-+++++ +.+.+|+|++++.   ..++.+-.+.|-.+..+. +||.+|-+..+|+.+.++++|.|
T Consensus       252 f~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvie  331 (593)
T KOG0695|consen  252 FDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIE  331 (593)
T ss_pred             ceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEE
Confidence            456789999999999999987 5788999999764   233445567788888777 69999999999999999999999


Q ss_pred             ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccc
Q 002529          667 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL  746 (912)
Q Consensus       667 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~  746 (912)
                      |++||+|--+++   .+..++++...-+...|..||.|||+   +||+.||||.+|+|+|..|++||+|+|+++.--...
T Consensus       332 yv~ggdlmfhmq---rqrklpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~l~~g  405 (593)
T KOG0695|consen  332 YVNGGDLMFHMQ---RQRKLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG  405 (593)
T ss_pred             EecCcceeeehh---hhhcCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcCCCCC
Confidence            999999977776   46789999999999999999999999   999999999999999999999999999998743332


Q ss_pred             ccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcc-chhhHHHHHHhhhccCCcccccCccc
Q 002529          747 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG-AELNIVHWARSMIKKGDVISIVDPVL  825 (912)
Q Consensus       747 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~d~~l  825 (912)
                      . .....+|||.|.|||++++..|....|-|+||++++||+.|+.||+.-... .+.+-.+++-+.+.+..+.       
T Consensus       406 d-~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir-------  477 (593)
T KOG0695|consen  406 D-TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR-------  477 (593)
T ss_pred             c-ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc-------
Confidence            2 345677999999999999999999999999999999999999999844433 2333334444433332221       


Q ss_pred             cCCCCHHHHHHHHHHHHhcccCCCCCCC
Q 002529          826 IGNVKIESIWRIAEVAIQCVEQRGFSRP  853 (912)
Q Consensus       826 ~~~~~~~~~~~l~~Li~~cL~~dP~~RP  853 (912)
                         .+.....+...+++.-|.+||.+|.
T Consensus       478 ---iprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  478 ---IPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             ---ccceeehhhHHHHHHhhcCCcHHhc
Confidence               1111122455778888999999886

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.4e-28  Score=248.34  Aligned_cols=261  Identities=22%  Similarity=0.278  Sum_probs=193.4

Q ss_pred             hcccCccccEEEEEEEec-CCCEEEEEEccCc--cchhhHHHHHHHHHHHhcCCCCccceeeEEecC-----CeEEEEEE
Q 002529          595 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE-----HQRILVYE  666 (912)
Q Consensus       595 ~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~-----~~~~lV~E  666 (912)
                      .+-||.|+||.||.+++. +|+.||+|++.+.  .-...+.+.+|+++|.-++|.|++..+++.+..     ++.|+++|
T Consensus        58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE  137 (449)
T KOG0664|consen   58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE  137 (449)
T ss_pred             CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence            477999999999999875 7999999998653  223457788999999999999999999876543     24677888


Q ss_pred             ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccc
Q 002529          667 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL  746 (912)
Q Consensus       667 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~  746 (912)
                      .| ..+|..++-   ....++...+.-++.||++||+|||+   .+|.||||||.|.|++++..+||||||+++..+.+.
T Consensus       138 Lm-QSDLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~  210 (449)
T KOG0664|consen  138 LM-QSDLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD  210 (449)
T ss_pred             HH-Hhhhhheec---cCCCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccccchhh
Confidence            87 457777665   56788999999999999999999999   999999999999999999999999999999865544


Q ss_pred             ccccccccCCCcccCCCccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHH---------hhhccCC
Q 002529          747 THISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR---------SMIKKGD  816 (912)
Q Consensus       747 ~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~---------~~~~~~~  816 (912)
                      ........-|..|+|||++++. .|+.+.||||.||++.||+..+..|+........++...+.         ... +|.
T Consensus       211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~AC-EGA  289 (449)
T KOG0664|consen  211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYAC-EGA  289 (449)
T ss_pred             hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHh-hhh
Confidence            3333334468899999998775 78999999999999999999999998554433222221110         000 011


Q ss_pred             cccccC-----ccccCCC----CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 002529          817 VISIVD-----PVLIGNV----KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ  863 (912)
Q Consensus       817 ~~~~~d-----~~l~~~~----~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  863 (912)
                      ..-++.     |.+.--+    +...-.+-+.+..+++..||.+|.+..+.+..+.
T Consensus       290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~  345 (449)
T KOG0664|consen  290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY  345 (449)
T ss_pred             HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence            000111     0000000    1112224567888999999999999999887543

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.94  E-value=1e-26  Score=229.97  Aligned_cols=257  Identities=19%  Similarity=0.306  Sum_probs=194.3

Q ss_pred             HHHHhhhcccCccccEEEEEEEe-cCCCEEEEEEccCccchhhHHHHHHHHHHHhcC-CCCccceeeEEecC--CeEEEE
Q 002529          589 EATNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEE--HQRILV  664 (912)
Q Consensus       589 ~~~~~~~~~LG~G~fg~Vy~a~~-~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~-hpnIv~l~~~~~~~--~~~~lV  664 (912)
                      ...|++.+++|+|.++.|+.|.. .+++.++||++++-   ..+.+.+|+.+|+.|. ||||++++++..+.  ....||
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            46788999999999999999974 57889999999853   4578899999999997 99999999998664  456799


Q ss_pred             EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCC-CcEEEeeccCccccc
Q 002529          665 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAE  743 (912)
Q Consensus       665 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~-~~vkL~DFGla~~~~  743 (912)
                      +||+.+.+....-      ..++...+...+.+++.||.|+|+   .||.|||+||.|++||.. ..++|+|+|+|..+.
T Consensus       114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH  184 (338)
T KOG0668|consen  114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  184 (338)
T ss_pred             hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhhcC
Confidence            9999988877654      357888899999999999999999   999999999999999854 569999999998876


Q ss_pred             cccccccccccCCCcccCCCccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhh--------hc-
Q 002529          744 EDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM--------IK-  813 (912)
Q Consensus       744 ~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~--------~~-  813 (912)
                      ......  ....+..|--||.+-. ..++..-|+|||||++..|+..+.||. ...++..+++..++-.        +. 
T Consensus       185 p~~eYn--VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFF-hG~dN~DQLVkIakVLGt~el~~Yl~K  261 (338)
T KOG0668|consen  185 PGKEYN--VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF-HGHDNYDQLVKIAKVLGTDELYAYLNK  261 (338)
T ss_pred             CCceee--eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCccc-CCCCCHHHHHHHHHHhChHHHHHHHHH
Confidence            554432  2345778899998754 467889999999999999999999986 2233333333322211        00 


Q ss_pred             -----cCCcccccCccccCC--------CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          814 -----KGDVISIVDPVLIGN--------VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       814 -----~~~~~~~~d~~l~~~--------~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                           ......++....+..        ...-...+.++++.+.|..|-++|+|++|.+.
T Consensus       262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  262 YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence                 011111111111100        00001236789999999999999999999875

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.94  E-value=9.5e-26  Score=231.80  Aligned_cols=210  Identities=38%  Similarity=0.618  Sum_probs=183.1

Q ss_pred             cCccccEEEEEEEecC-CCEEEEEEccCccch-hhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEecCCCCHHH
Q 002529          598 IGKGSFGSVYYGKMKD-GKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD  675 (912)
Q Consensus       598 LG~G~fg~Vy~a~~~~-~~~vAvK~l~~~~~~-~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~  675 (912)
                      ||+|.+|.||++...+ ++.+++|++...... ..+.+.+|++.++.++|++|+++++++......++++|++++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999875 899999998765332 34678999999999999999999999999899999999999999999


Q ss_pred             HhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccC-CCcEEEeeccCcccccccccccccccc
Q 002529          676 RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEEDLTHISSVAR  754 (912)
Q Consensus       676 ~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~-~~~vkL~DFGla~~~~~~~~~~~~~~~  754 (912)
                      ++...  ...+++..+..++.+++++|++||+   .+++|+||+|.||+++. ++.++|+|||.+........ ......
T Consensus        81 ~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~  154 (215)
T cd00180          81 LLKEN--EGKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIV  154 (215)
T ss_pred             HHHhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhccc
Confidence            98742  1468899999999999999999998   89999999999999998 89999999999887644321 122234


Q ss_pred             CCCcccCCCccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCCCCHHH
Q 002529          755 GTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES  833 (912)
Q Consensus       755 gt~~y~APE~l~~~-~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  833 (912)
                      +...|++||.+... ..+.++|+|++|+++++|                                               
T Consensus       155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------------------  187 (215)
T cd00180         155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------------------  187 (215)
T ss_pred             CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------
Confidence            67899999999887 888999999999999999                                               


Q ss_pred             HHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002529          834 IWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       834 ~~~l~~Li~~cL~~dP~~RPs~~evl~~  861 (912)
                       ..+.+++.+|++.+|++||++.++++.
T Consensus       188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 -PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             -HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence             267899999999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=1e-26  Score=257.27  Aligned_cols=200  Identities=25%  Similarity=0.376  Sum_probs=169.4

Q ss_pred             hcccCccccEEEEEEEe-cCCCEEEEEEccCccc---hhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEecCC
Q 002529          595 CKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN  670 (912)
Q Consensus       595 ~~~LG~G~fg~Vy~a~~-~~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~  670 (912)
                      ++.||-|+||.|.+++- ++...+|+|.+++...   .....++.|-+||.....+=||+|+-.|++.+.+|+||+|++|
T Consensus       634 ik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPG  713 (1034)
T KOG0608|consen  634 IKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPG  713 (1034)
T ss_pred             EeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCC
Confidence            45699999999999964 4567899999976432   3345678899999999999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccc------
Q 002529          671 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE------  744 (912)
Q Consensus       671 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~------  744 (912)
                      |++-.+|-   ..+.+.+...+.++..+..|+++.|.   .|+|||||||+|||||.+|++||+|||++.-+.-      
T Consensus       714 GDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskY  787 (1034)
T KOG0608|consen  714 GDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY  787 (1034)
T ss_pred             ccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeeccccccceecccccc
Confidence            99999887   35678888888899999999999998   9999999999999999999999999999854310      


Q ss_pred             --cccc---------------------------------ccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhC
Q 002529          745 --DLTH---------------------------------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISG  789 (912)
Q Consensus       745 --~~~~---------------------------------~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG  789 (912)
                        ...+                                 .....+||+.|+|||++....++..+|-||.|||||||+.|
T Consensus       788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g  867 (1034)
T KOG0608|consen  788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVG  867 (1034)
T ss_pred             ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhC
Confidence              0000                                 00113499999999999999999999999999999999999


Q ss_pred             CCCCCccCccc
Q 002529          790 KKPVSVEDFGA  800 (912)
Q Consensus       790 ~~Pf~~~~~~~  800 (912)
                      ++||......+
T Consensus       868 ~~pf~~~tp~~  878 (1034)
T KOG0608|consen  868 QPPFLADTPGE  878 (1034)
T ss_pred             CCCccCCCCCc
Confidence            99998665553

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.93  E-value=1.3e-26  Score=255.08  Aligned_cols=194  Identities=25%  Similarity=0.428  Sum_probs=167.5

Q ss_pred             HhhhcccCccccEEEEEEEecC-CCEEEEEEccCccch--------hhHHHHHHHHHHHhcC---CCCccceeeEEecCC
Q 002529          592 NNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSH--------RTQQFVTEVALLSRIH---HRNLVPLIGYCEEEH  659 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~~-~~~vAvK~l~~~~~~--------~~~~~~~E~~il~~L~---hpnIv~l~~~~~~~~  659 (912)
                      |...+.+|.|+||.|++|.++. ...|+||.+.+..--        ..-.+-.|++||..|+   |+||++++++|++++
T Consensus       563 yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd  642 (772)
T KOG1152|consen  563 YTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDD  642 (772)
T ss_pred             ceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCC
Confidence            4557899999999999999884 678999998653211        1123456999999997   999999999999999


Q ss_pred             eEEEEEEec-CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccC
Q 002529          660 QRILVYEYM-HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL  738 (912)
Q Consensus       660 ~~~lV~E~~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGl  738 (912)
                      .+||+||-. ++.+|.+++.   .+..+++.+...|++|++.|+++||+   .+|||||||-+||.++.+|-+||+|||.
T Consensus       643 ~yyl~te~hg~gIDLFd~IE---~kp~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klidfgs  716 (772)
T KOG1152|consen  643 YYYLETEVHGEGIDLFDFIE---FKPRMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLIDFGS  716 (772)
T ss_pred             eeEEEecCCCCCcchhhhhh---ccCccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEeeccc
Confidence            999999965 6779999998   57889999999999999999999998   9999999999999999999999999999


Q ss_pred             ccccccccccccccccCCCcccCCCccCCCCC-CchhHHHHHHHHHHHHHhCCCCCC
Q 002529          739 SRQAEEDLTHISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVS  794 (912)
Q Consensus       739 a~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-s~ksDVwSlGvil~eLltG~~Pf~  794 (912)
                      +.......   ....+||..|.|||++.+..| +..-|||++|++||.++....||-
T Consensus       717 aa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  717 AAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             hhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            98765432   345679999999999999877 567899999999999999998885

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.6e-25  Score=226.72  Aligned_cols=252  Identities=19%  Similarity=0.345  Sum_probs=189.6

Q ss_pred             HHHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCccchhhHHHHHHHHHHHhc-CCCCccceeeE-EecCCeEEEEE
Q 002529          589 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGY-CEEEHQRILVY  665 (912)
Q Consensus       589 ~~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L-~hpnIv~l~~~-~~~~~~~~lV~  665 (912)
                      ...|.+.+.||+|.||.+-+++++ ..+.+++|.+... ....++|.+|..---.| .|.||+.-+++ |+..+.+.+++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            456788899999999999999988 4778999988754 34467888888765556 48999988774 67778888999


Q ss_pred             EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccc-c-CCCcEEEeeccCccccc
Q 002529          666 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL-D-INMRAKVSDFGLSRQAE  743 (912)
Q Consensus       666 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl-~-~~~~vkL~DFGla~~~~  743 (912)
                      ||++.|+|..-+.    ...+.+....+++.|++.||.|+|+   +++||||||.+|||| + +..++||||||..+..+
T Consensus       102 E~aP~gdL~snv~----~~GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g  174 (378)
T KOG1345|consen  102 EFAPRGDLRSNVE----AAGIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG  174 (378)
T ss_pred             ccCccchhhhhcC----cccccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccC
Confidence            9999999998876    3567888889999999999999998   999999999999999 2 34579999999988654


Q ss_pred             cccccccccccCCCcccCCCccCC-----CCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccC-Cc
Q 002529          744 EDLTHISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG-DV  817 (912)
Q Consensus       744 ~~~~~~~~~~~gt~~y~APE~l~~-----~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~-~~  817 (912)
                      ..-...    ..+..|.+||....     ....+.+|||.||+++|.++||+.||+ ..........+|.+-.-+.. ..
T Consensus       175 ~tV~~~----~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQ-ka~~~d~~Y~~~~~w~~rk~~~~  249 (378)
T KOG1345|consen  175 TTVKYL----EYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQ-KASIMDKPYWEWEQWLKRKNPAL  249 (378)
T ss_pred             ceehhh----hhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcch-hhhccCchHHHHHHHhcccCccC
Confidence            432221    13557899997633     245678999999999999999999998 33334444455443322211 11


Q ss_pred             ccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 002529          818 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI  862 (912)
Q Consensus       818 ~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  862 (912)
                      .+.+.+         ....+.++.++-|.++|++|--..++.++-
T Consensus       250 P~~F~~---------fs~~a~r~Fkk~lt~~~~drcki~~~kk~r  285 (378)
T KOG1345|consen  250 PKKFNP---------FSEKALRLFKKSLTPRFKDRCKIWTAKKMR  285 (378)
T ss_pred             chhhcc---------cCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence            111111         123677888899999999996666655543

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.93  E-value=8.3e-25  Score=228.79  Aligned_cols=196  Identities=37%  Similarity=0.618  Sum_probs=171.5

Q ss_pred             hhhcccCccccEEEEEEEecC-CCEEEEEEccCccch-hhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEecCC
Q 002529          593 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN  670 (912)
Q Consensus       593 ~~~~~LG~G~fg~Vy~a~~~~-~~~vAvK~l~~~~~~-~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~  670 (912)
                      .+.+.||.|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+++++|+|++++++++......++++|++++
T Consensus         2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~   81 (225)
T smart00221        2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEG   81 (225)
T ss_pred             ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCC
Confidence            456889999999999999875 899999999866554 567889999999999999999999999998999999999999


Q ss_pred             CCHHHHhccCCCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccccc
Q 002529          671 GTLRDRLHGSVNQKP-LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI  749 (912)
Q Consensus       671 gsL~~~l~~~~~~~~-l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~  749 (912)
                      ++|.+++...   .. +++..+..++.+++.+|.+||+   .+++|+||+|+||+++.++.++|+|||.+..........
T Consensus        82 ~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~  155 (225)
T smart00221       82 GDLFDYLRKK---GGKLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL  155 (225)
T ss_pred             CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence            9999999843   23 8899999999999999999998   899999999999999999999999999988765442111


Q ss_pred             cccccCCCcccCCCcc-CCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 002529          750 SSVARGTVGYLDPEYY-GNQQLTEKSDVYSFGVVLLELISGKKPVS  794 (912)
Q Consensus       750 ~~~~~gt~~y~APE~l-~~~~~s~ksDVwSlGvil~eLltG~~Pf~  794 (912)
                      .....++..|++||.+ ....++.++|+|+||+++++|++|+.||.
T Consensus       156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~  201 (225)
T smart00221      156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS  201 (225)
T ss_pred             ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence            2234467889999998 66778889999999999999999999996

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.92  E-value=1.6e-26  Score=258.41  Aligned_cols=252  Identities=24%  Similarity=0.378  Sum_probs=205.3

Q ss_pred             HHHhhhcccCccccEEEEEEEec-CCCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEec
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM  668 (912)
Q Consensus       590 ~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~  668 (912)
                      ..|++..++|.|.+|.||+|+.+ .++..|+|+++-....+..-+++|+-+++..+||||+.+++.+...+..+++||||
T Consensus        15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEyc   94 (829)
T KOG0576|consen   15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYC   94 (829)
T ss_pred             cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEec
Confidence            45677899999999999999876 68999999998777777888899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccc
Q 002529          669 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH  748 (912)
Q Consensus       669 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  748 (912)
                      .+|+|.+.-+   ...++++.++...++..++||+|||+   .+-+|||||-.||++++.|.+|++|||.+..+.....+
T Consensus        95 gggslQdiy~---~TgplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~K  168 (829)
T KOG0576|consen   95 GGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAK  168 (829)
T ss_pred             CCCcccceee---ecccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhhhhhh
Confidence            9999999887   46789999999999999999999998   89999999999999999999999999999887655443


Q ss_pred             ccccccCCCcccCCCcc---CCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccc
Q 002529          749 ISSVARGTVGYLDPEYY---GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL  825 (912)
Q Consensus       749 ~~~~~~gt~~y~APE~l---~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  825 (912)
                      . ....||+.|||||+.   +.+.|..++|||++|+...|+-.-++|.....  ....+     .+...    ...++.-
T Consensus       169 r-ksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh--pmr~l-----~LmTk----S~~qpp~  236 (829)
T KOG0576|consen  169 R-KSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH--PMRAL-----FLMTK----SGFQPPT  236 (829)
T ss_pred             h-hcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccc--hHHHH-----HHhhc----cCCCCCc
Confidence            3 345699999999975   55678999999999999999988887754111  11111     11111    1111111


Q ss_pred             cCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          826 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       826 ~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                      . +-.......+.++++.||.++|++||+++.+++
T Consensus       237 l-kDk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  237 L-KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             c-cCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            1 112233447889999999999999999988763

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.92  E-value=9.8e-26  Score=233.96  Aligned_cols=250  Identities=24%  Similarity=0.317  Sum_probs=189.4

Q ss_pred             hcccCccccEEEEEEEec-CCCEEEEEEccCc--cchhhHHHHHHHHHHHhcCCCCccceeeEEecC------CeEEEEE
Q 002529          595 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQRILVY  665 (912)
Q Consensus       595 ~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~------~~~~lV~  665 (912)
                      .+.+|.|.- .|..|.+. .+++||+|++...  .....+...+|..++..++|+||++++.+|.-.      ...|+||
T Consensus        22 L~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~  100 (369)
T KOG0665|consen   22 LKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVM  100 (369)
T ss_pred             ecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHH
Confidence            456788887 56555443 5889999987543  222345677899999999999999999998543      3578999


Q ss_pred             EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccc
Q 002529          666 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED  745 (912)
Q Consensus       666 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~  745 (912)
                      |+| ..+|.+.+.     -.++.+++..|+.|++.|++|||+   .+|+||||||+||++..+..+||.|||+|+.....
T Consensus       101 e~m-~~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~  171 (369)
T KOG0665|consen  101 ELM-DANLCQVIL-----MELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD  171 (369)
T ss_pred             Hhh-hhHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhhcccCcc
Confidence            999 568888876     347788999999999999999999   99999999999999999999999999999876544


Q ss_pred             cccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCC---------
Q 002529          746 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD---------  816 (912)
Q Consensus       746 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~---------  816 (912)
                        ...+....+..|.|||++.+..+.+..||||+||++.||++|+.-|.+.+.-     .+|.+..-..|.         
T Consensus       172 --~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~i-----dQ~~ki~~~lgtpd~~F~~qL  244 (369)
T KOG0665|consen  172 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHI-----DQWNKIIEQLGTPDPSFMKQL  244 (369)
T ss_pred             --cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHH-----HHHHHHHHHhcCCCHHHHHHh
Confidence              3445667889999999998888999999999999999999999999754432     222221111110         


Q ss_pred             ------------------ccccc-CccccC--CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002529          817 ------------------VISIV-DPVLIG--NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       817 ------------------~~~~~-d~~l~~--~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  861 (912)
                                        +.+.+ |.....  +.+.-......+++.+||..+|++|.+++++|+.
T Consensus       245 ~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  245 QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             hHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence                              00111 000110  1111233467899999999999999999999874

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.90  E-value=5.4e-24  Score=229.09  Aligned_cols=259  Identities=25%  Similarity=0.332  Sum_probs=191.7

Q ss_pred             HHHhhhcccCccccEEEEEEEec----CCCEEEEEEccCccchhhHHHHHHHHHHHhcC-CCCccceeeEEecCCeEEEE
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILV  664 (912)
Q Consensus       590 ~~~~~~~~LG~G~fg~Vy~a~~~----~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~-hpnIv~l~~~~~~~~~~~lV  664 (912)
                      ..|...++||+|.|++||++.+.    ..+.||+|.+....  ....+.+|+++|..+. +.||+++.+++..++..++|
T Consensus        36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~iv  113 (418)
T KOG1167|consen   36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIV  113 (418)
T ss_pred             hhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEE
Confidence            34556889999999999999754    36789999986543  3356889999999995 99999999999999999999


Q ss_pred             EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccC-CCcEEEeeccCccccc
Q 002529          665 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAE  743 (912)
Q Consensus       665 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~-~~~vkL~DFGla~~~~  743 (912)
                      +||++.....++...      ++...+..+++.++.||+++|+   .|||||||||+|+|.+. .+.-.|+|||+|...+
T Consensus       114 lp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d  184 (418)
T KOG1167|consen  114 LPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYD  184 (418)
T ss_pred             ecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhHHHHH
Confidence            999999999888763      5688899999999999999998   99999999999999974 5678999999997211


Q ss_pred             ccc-------------c------------------------------cccccccCCCcccCCCccCCC-CCCchhHHHHH
Q 002529          744 EDL-------------T------------------------------HISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSF  779 (912)
Q Consensus       744 ~~~-------------~------------------------------~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSl  779 (912)
                      ...             .                              ......+||++|+|||++... .-+.+.||||.
T Consensus       185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~  264 (418)
T KOG1167|consen  185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSA  264 (418)
T ss_pred             hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeec
Confidence            000             0                              001123599999999998654 56789999999


Q ss_pred             HHHHHHHHhCCCCCCccCccchhhHHHHHH---------hhhccCC--ccc------c---------cC-ccccC-----
Q 002529          780 GVVLLELISGKKPVSVEDFGAELNIVHWAR---------SMIKKGD--VIS------I---------VD-PVLIG-----  827 (912)
Q Consensus       780 Gvil~eLltG~~Pf~~~~~~~~~~~~~~~~---------~~~~~~~--~~~------~---------~d-~~l~~-----  827 (912)
                      |+|++.+++++.||.....+ ...+.+.+.         .....|.  +.+      +         ++ ..+..     
T Consensus       265 GVI~Lslls~~~PFf~a~dd-~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n  343 (418)
T KOG1167|consen  265 GVILLSLLSRRYPFFKAKDD-ADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPN  343 (418)
T ss_pred             cceeehhhccccccccCccc-cchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccc
Confidence            99999999999999744332 122222211         0111122  111      0         00 00000     


Q ss_pred             ----CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          828 ----NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       828 ----~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                          ......+..+++++.+|++.||.+|.|++|.|+
T Consensus       344 ~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  344 TEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             eeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence                001112236789999999999999999999985

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.89  E-value=8.5e-24  Score=262.89  Aligned_cols=195  Identities=19%  Similarity=0.261  Sum_probs=138.6

Q ss_pred             hcCC-CCccceeeEE-------ecCCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 002529          642 RIHH-RNLVPLIGYC-------EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI  713 (912)
Q Consensus       642 ~L~h-pnIv~l~~~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~i  713 (912)
                      .++| +||+++++.|       .+...+++++|++ +++|.+++..  ....+++.+++.++.||++||+|||+   ++|
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~---~gI  101 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--PDRSVDAFECFHVFRQIVEIVNAAHS---QGI  101 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--ccccccHHHHHHHHHHHHHHHHHHHh---CCe
Confidence            4455 6888888877       2234567788887 6799999974  24569999999999999999999998   999


Q ss_pred             eecCCCCCCccccCCC-------------------cEEEeeccCcccccccc--------c-------cccccccCCCcc
Q 002529          714 IHRDVKSSNILLDINM-------------------RAKVSDFGLSRQAEEDL--------T-------HISSVARGTVGY  759 (912)
Q Consensus       714 vH~DLkp~NILl~~~~-------------------~vkL~DFGla~~~~~~~--------~-------~~~~~~~gt~~y  759 (912)
                      +||||||+||||+..+                   .+|++|||+++......        .       .......||+.|
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  181 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY  181 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence            9999999999996544                   45566666654321100        0       000113478889


Q ss_pred             cCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCCCCHHHHHHHHH
Q 002529          760 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAE  839 (912)
Q Consensus       760 ~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~  839 (912)
                      +|||++.+..++.++|||||||+||||++|..|+....    .........         .+.+..     ........+
T Consensus       182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~----~~~~~~~~~---------~~~~~~-----~~~~~~~~~  243 (793)
T PLN00181        182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS----RTMSSLRHR---------VLPPQI-----LLNWPKEAS  243 (793)
T ss_pred             EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH----HHHHHHHHh---------hcChhh-----hhcCHHHHH
Confidence            99999999999999999999999999999988875211    001111000         011110     011224568


Q ss_pred             HHHhcccCCCCCCCCHHHHHH
Q 002529          840 VAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       840 Li~~cL~~dP~~RPs~~evl~  860 (912)
                      ++.+||+++|.+||+|.|+++
T Consensus       244 ~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        244 FCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHHHhCCCChhhCcChHHHhh
Confidence            889999999999999999975

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.89  E-value=1e-22  Score=205.87  Aligned_cols=170  Identities=22%  Similarity=0.198  Sum_probs=127.5

Q ss_pred             CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccccccccc
Q 002529          671 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS  750 (912)
Q Consensus       671 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~  750 (912)
                      |+|.++++..  +..+++.+++.|+.|+++||+|||+   .+      ||+||+++.++.+|+  ||++.......    
T Consensus         1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----   63 (176)
T smart00750        1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ----   63 (176)
T ss_pred             CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecccc----
Confidence            6899999742  4569999999999999999999998   55      999999999999999  99987654422    


Q ss_pred             ccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCCCC
Q 002529          751 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK  830 (912)
Q Consensus       751 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  830 (912)
                        ..|++.|+|||++.+..++.++|||||||++|||++|+.||...... ...+........ ...      +... ...
T Consensus        64 --~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~-~~~~~~~~~~~~-~~~------~~~~-~~~  132 (176)
T smart00750       64 --SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL-SAILEILLNGMP-ADD------PRDR-SNL  132 (176)
T ss_pred             --CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh-cHHHHHHHHHhc-cCC------cccc-ccH
Confidence              24789999999999999999999999999999999999999633211 111111111111 100      0000 011


Q ss_pred             HHHH--HHHHHHHHhcccCCCCCCCCHHHHHHHHhhhhhh
Q 002529          831 IESI--WRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI  868 (912)
Q Consensus       831 ~~~~--~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~~~~  868 (912)
                      ....  ..+.+++.+||+.+|++||++.|+++.+......
T Consensus       133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~  172 (176)
T smart00750      133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE  172 (176)
T ss_pred             HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence            1122  2589999999999999999999999988766543

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.87  E-value=4e-21  Score=213.88  Aligned_cols=262  Identities=24%  Similarity=0.300  Sum_probs=198.8

Q ss_pred             HHhhhcccCccccEEEEEEEecCC--CEEEEEEccCccchhhHHHHHHHHHHHhcCC----CCccceeeEE-ecCCeEEE
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMKDG--KEVAVKIMADSCSHRTQQFVTEVALLSRIHH----RNLVPLIGYC-EEEHQRIL  663 (912)
Q Consensus       591 ~~~~~~~LG~G~fg~Vy~a~~~~~--~~vAvK~l~~~~~~~~~~~~~E~~il~~L~h----pnIv~l~~~~-~~~~~~~l  663 (912)
                      .|.+.++||+|+||.||++.....  +.+|+|............+..|..++..+..    .++..+++.. ..+...++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            677889999999999999987653  5889998765433333378889999999863    6899999998 57778899


Q ss_pred             EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCC-----CcEEEeeccC
Q 002529          664 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-----MRAKVSDFGL  738 (912)
Q Consensus       664 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~-----~~vkL~DFGl  738 (912)
                      ||+.+ |.+|.++..... .+.++..+.+.|+.|++.+|++||+   .|++||||||.|+++...     ..+.|.|||+
T Consensus        99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl  173 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL  173 (322)
T ss_pred             EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence            99988 899999876543 5789999999999999999999998   999999999999999754     4699999999


Q ss_pred             cc--cccccc----ccc---cccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHH
Q 002529          739 SR--QAEEDL----THI---SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR  809 (912)
Q Consensus       739 a~--~~~~~~----~~~---~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~  809 (912)
                      ++  ......    ...   .....||..|++++...+...+.+.|+||++.++.|++.|..||.............   
T Consensus       174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~---  250 (322)
T KOG1164|consen  174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE---  250 (322)
T ss_pred             CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH---
Confidence            98  321111    111   233559999999999999999999999999999999999999997444332211111   


Q ss_pred             hhhccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhhhhhc
Q 002529          810 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE  869 (912)
Q Consensus       810 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~~~~~  869 (912)
                      .......    ...  .....   +..+.++...+-..+...+|....+...|++.....
T Consensus       251 ~~~~~~~----~~~--~~~~~---~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~  301 (322)
T KOG1164|consen  251 KDPRKLL----TDR--FGDLK---PEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE  301 (322)
T ss_pred             HHhhhhc----ccc--ccCCC---hHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence            1111100    010  11112   224555555555689999999999999998887765

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.86  E-value=6.3e-21  Score=198.68  Aligned_cols=263  Identities=19%  Similarity=0.247  Sum_probs=203.1

Q ss_pred             HHHhhhcccCccccEEEEEEEe-cCCCEEEEEEccCccchhhHHHHHHHHHHHhcC-CCCccceeeEEecCCeEEEEEEe
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEY  667 (912)
Q Consensus       590 ~~~~~~~~LG~G~fg~Vy~a~~-~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~-hpnIv~l~~~~~~~~~~~lV~E~  667 (912)
                      -.|+++++||+|.||.++.|+. -+++.||||.-..  ..+..++..|.+.++.|. .++|..++-|...+.+..||+|.
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr--kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL  105 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR--KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL  105 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccc--cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence            3467789999999999999974 4799999997543  334578889999999995 79999999999999999999999


Q ss_pred             cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCC-----CcEEEeeccCcccc
Q 002529          668 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-----MRAKVSDFGLSRQA  742 (912)
Q Consensus       668 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~-----~~vkL~DFGla~~~  742 (912)
                      + |.+|.|...-  .+..++.++++.++.|++.-++++|+   +.+|.|||||+|+||...     ..+.++|||+|+.+
T Consensus       106 L-GPSLEDLFD~--CgR~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y  179 (449)
T KOG1165|consen  106 L-GPSLEDLFDL--CGRRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY  179 (449)
T ss_pred             h-CcCHHHHHHH--hcCcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence            8 8899998874  57889999999999999999999998   999999999999999643     34899999999998


Q ss_pred             cccccccc------ccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCC
Q 002529          743 EEDLTHIS------SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD  816 (912)
Q Consensus       743 ~~~~~~~~------~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  816 (912)
                      .+..+...      ....||.+||+-....+...+.+.|+-|||-++...|-|..||++-..+....-.+.+...-+...
T Consensus       180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~  259 (449)
T KOG1165|consen  180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTP  259 (449)
T ss_pred             cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCC
Confidence            76655433      223599999999999999999999999999999999999999997666543333332222222222


Q ss_pred             cccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhhhhhc
Q 002529          817 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE  869 (912)
Q Consensus       817 ~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~~~~~  869 (912)
                      +.++.     ..+    +.++..-+.-.-..+-.+-|..+-+...+.++++..
T Consensus       260 i~~Lc-----~g~----P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~  303 (449)
T KOG1165|consen  260 IEVLC-----EGF----PEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRL  303 (449)
T ss_pred             HHHHH-----hcC----HHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhc
Confidence            22211     112    223444444444556678888888877777766543

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.85  E-value=2.7e-22  Score=203.05  Aligned_cols=253  Identities=22%  Similarity=0.357  Sum_probs=192.8

Q ss_pred             HHHHHhhhcccCccccEEEEEEEecCCCEEEEEEccCc--cchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEE
Q 002529          588 EEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY  665 (912)
Q Consensus       588 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~  665 (912)
                      .-...++.-+|.+...|..|+|+|. |..+++|++.-.  .....++|..|.-.|+-+.||||+.+++.|....+..++.
T Consensus       188 d~~~lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~is  266 (448)
T KOG0195|consen  188 DVSSLNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIIS  266 (448)
T ss_pred             chhhhhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEee
Confidence            3345567788999999999999998 555666776532  2233467999999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEe--eccCccccc
Q 002529          666 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVS--DFGLSRQAE  743 (912)
Q Consensus       666 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~--DFGla~~~~  743 (912)
                      .||+.|+|...+++. ..-..+..+..+++.++++|++|||+. +.-|..--|+.+.+++|++..++|.  |--++..  
T Consensus       267 q~mp~gslynvlhe~-t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfq--  342 (448)
T KOG0195|consen  267 QYMPFGSLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ--  342 (448)
T ss_pred             eeccchHHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeee--
Confidence            999999999999965 345677888999999999999999983 2334445689999999999887774  3222221  


Q ss_pred             cccccccccccCCCcccCCCccCCCCCC---chhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccc
Q 002529          744 EDLTHISSVARGTVGYLDPEYYGNQQLT---EKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI  820 (912)
Q Consensus       744 ~~~~~~~~~~~gt~~y~APE~l~~~~~s---~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  820 (912)
                            .....-.+.||+||.++..+-+   .++|+|||++++|||.|...||..-...+-       ...+.-      
T Consensus       343 ------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec-------gmkial------  403 (448)
T KOG0195|consen  343 ------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC-------GMKIAL------  403 (448)
T ss_pred             ------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh-------hhhhhh------
Confidence                  1122347899999999876543   589999999999999999999984333211       111111      


Q ss_pred             cCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhhh
Q 002529          821 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI  866 (912)
Q Consensus       821 ~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~~  866 (912)
                        ..++...++.....+.+|+.-|+..||.+||.+..|+-.|+++.
T Consensus       404 --eglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  404 --EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             --ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence              12233344445557889999999999999999999999998764

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.84  E-value=1e-20  Score=210.85  Aligned_cols=164  Identities=19%  Similarity=0.151  Sum_probs=126.4

Q ss_pred             HHHHhhhcccCccccEEEEEEEec--CCCEEEEEEccCc-----cchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeE
Q 002529          589 EATNNFCKKIGKGSFGSVYYGKMK--DGKEVAVKIMADS-----CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR  661 (912)
Q Consensus       589 ~~~~~~~~~LG~G~fg~Vy~a~~~--~~~~vAvK~l~~~-----~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~  661 (912)
                      ...|.+.+.||+|+||+||+|.++  +++.||||++...     .......+.+|+++|++++|+|+++.+..   .+..
T Consensus        17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~   93 (365)
T PRK09188         17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKD   93 (365)
T ss_pred             cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCc
Confidence            345777899999999999999875  4777899986532     12234568999999999999999863322   2457


Q ss_pred             EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCC-CCCCccccCCCcEEEeeccCcc
Q 002529          662 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDV-KSSNILLDINMRAKVSDFGLSR  740 (912)
Q Consensus       662 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DL-kp~NILl~~~~~vkL~DFGla~  740 (912)
                      ++||||++|++|... ..   ..      ...++.|++++|+|||+   ++|+|||| ||+|||++.++++||+|||+|+
T Consensus        94 ~LVmE~~~G~~L~~~-~~---~~------~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~  160 (365)
T PRK09188         94 GLVRGWTEGVPLHLA-RP---HG------DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQLAS  160 (365)
T ss_pred             EEEEEccCCCCHHHh-Cc---cc------hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECccce
Confidence            999999999999732 11   11      14678999999999998   99999999 9999999999999999999998


Q ss_pred             cccccccccc-------ccccCCCcccCCCccCCC
Q 002529          741 QAEEDLTHIS-------SVARGTVGYLDPEYYGNQ  768 (912)
Q Consensus       741 ~~~~~~~~~~-------~~~~gt~~y~APE~l~~~  768 (912)
                      ..........       ....+++.|+|||.+...
T Consensus       161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             ecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            7654321111       234578889999998543

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.83  E-value=2.9e-19  Score=195.48  Aligned_cols=260  Identities=29%  Similarity=0.432  Sum_probs=197.6

Q ss_pred             HhhhcccCccccEEEEEEEecCCCEEEEEEccCccch---hhHHHHHHHHHHHhcCCC-CccceeeEEecCCeEEEEEEe
Q 002529          592 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH---RTQQFVTEVALLSRIHHR-NLVPLIGYCEEEHQRILVYEY  667 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~~~~~vAvK~l~~~~~~---~~~~~~~E~~il~~L~hp-nIv~l~~~~~~~~~~~lV~E~  667 (912)
                      |++.+.||.|+||.||++...  ..+++|.+......   ....+.+|+.+++.+.|+ +++++.+.+......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            445688999999999999887  88999998764332   367899999999999988 799999999887778999999


Q ss_pred             cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCC-cEEEeeccCcccccccc
Q 002529          668 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEEDL  746 (912)
Q Consensus       668 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~-~vkL~DFGla~~~~~~~  746 (912)
                      +.++++.+++........+.......++.|++.+++|+|+   .+++|||+||+||+++..+ .++++|||.+.......
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            9999999777632111378899999999999999999998   8999999999999999888 79999999998654433


Q ss_pred             cc-----ccccccCCCcccCCCccCC---CCCCchhHHHHHHHHHHHHHhCCCCCCccCcc-chhhHHHHHHhhhccCCc
Q 002529          747 TH-----ISSVARGTVGYLDPEYYGN---QQLTEKSDVYSFGVVLLELISGKKPVSVEDFG-AELNIVHWARSMIKKGDV  817 (912)
Q Consensus       747 ~~-----~~~~~~gt~~y~APE~l~~---~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~  817 (912)
                      ..     ......|+..|+|||.+.+   .......|+|++|++++++++|..||...... ........+....    .
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~----~  232 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP----T  232 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcC----C
Confidence            22     2345668999999999987   57889999999999999999999997643321 0111111111111    1


Q ss_pred             ccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002529          818 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       818 ~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  861 (912)
                      . .................+.+++.+|+..+|..|.++.+....
T Consensus       233 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         233 P-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             c-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            0 000000000001223467899999999999999999987764

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.83  E-value=3.4e-20  Score=185.48  Aligned_cols=263  Identities=21%  Similarity=0.287  Sum_probs=195.6

Q ss_pred             HHHHHHHhhhcccCccccEEEEEEEe-cCCCEEEEEEccCccchhhHHHHHHHHHHHhcCC-CCccceeeEEecCCeEEE
Q 002529          586 ELEEATNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH-RNLVPLIGYCEEEHQRIL  663 (912)
Q Consensus       586 ~l~~~~~~~~~~LG~G~fg~Vy~a~~-~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~h-pnIv~l~~~~~~~~~~~l  663 (912)
                      .+....|+++++||.|+||.+|+|.. .+|++||||+-+..  ....++..|.++.+.|++ ..|..+.-+..+...-.+
T Consensus        11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvl   88 (341)
T KOG1163|consen   11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVL   88 (341)
T ss_pred             heeccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhcccccccee
Confidence            45566788899999999999999974 57999999986543  334678889999999975 678888888888889999


Q ss_pred             EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccC---CCcEEEeeccCcc
Q 002529          664 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSR  740 (912)
Q Consensus       664 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~---~~~vkL~DFGla~  740 (912)
                      ||+.+ |.+|.+.+.-  ....++..+++-++-|++.-++|+|.   ++++||||||+|+|+.-   ..++.|+|||+|+
T Consensus        89 VMdLL-GPsLEdLfnf--C~R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK  162 (341)
T KOG1163|consen   89 VMDLL-GPSLEDLFNF--CSRRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK  162 (341)
T ss_pred             eeecc-CccHHHHHHH--HhhhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchh
Confidence            99998 8899998764  45678999999999999999999998   99999999999999964   3569999999999


Q ss_pred             ccccccccc------cccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhcc
Q 002529          741 QAEEDLTHI------SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK  814 (912)
Q Consensus       741 ~~~~~~~~~------~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~  814 (912)
                      .+.+..+..      .....||.+|.+-....+...+.+.|+-|+|.+|..+.-|..||++.......+..+.+.+.   
T Consensus       163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~Ek---  239 (341)
T KOG1163|consen  163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEK---  239 (341)
T ss_pred             hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHh---
Confidence            875543322      23345899999988888878889999999999999999999999966554333332222221   


Q ss_pred             CCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhh
Q 002529          815 GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS  865 (912)
Q Consensus       815 ~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~  865 (912)
                       .....+. .+...++.    ++.-.+.-|-..--++-|...-+.+.+.-+
T Consensus       240 -K~s~~ie-~LC~G~P~----EF~myl~Y~R~L~F~E~Pdy~ylrqlFriL  284 (341)
T KOG1163|consen  240 -KMSTPIE-VLCKGFPA----EFAMYLNYCRGLGFEEKPDYMYLRQLFRIL  284 (341)
T ss_pred             -hcCCCHH-HHhCCCcH----HHHHHHHHHhhcCCCCCCcHHHHHHHHHHH
Confidence             1111111 12222222    344555556565666666655555444433

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.81  E-value=1.3e-20  Score=223.23  Aligned_cols=251  Identities=22%  Similarity=0.269  Sum_probs=184.9

Q ss_pred             hcccCccccEEEEEEEec-CCCEEEEEEcc----Cccch--hhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEe
Q 002529          595 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMA----DSCSH--RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY  667 (912)
Q Consensus       595 ~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~----~~~~~--~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  667 (912)
                      .+.+|.|.+|.|+.+... ..+..+.|.++    .....  ....+..|+-+-..++|+|++..+..+.+.....-+|||
T Consensus       323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~  402 (601)
T KOG0590|consen  323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEY  402 (601)
T ss_pred             cceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhc
Confidence            578999999988777543 34444444332    21111  112256677777888999998888877766666666999


Q ss_pred             cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccc
Q 002529          668 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT  747 (912)
Q Consensus       668 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~  747 (912)
                      |++ +|..++..   ...+...++..+++|++.|++|||+   .|+.|||+|++|+++..+|.+||+|||.+....-...
T Consensus       403 ~~~-Dlf~~~~~---~~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e  475 (601)
T KOG0590|consen  403 CPY-DLFSLVMS---NGKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE  475 (601)
T ss_pred             ccH-HHHHHHhc---ccccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence            999 99999873   3578888999999999999999998   9999999999999999999999999999877544332


Q ss_pred             ---cccccccCCCcccCCCccCCCCCCc-hhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCc
Q 002529          748 ---HISSVARGTVGYLDPEYYGNQQLTE-KSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP  823 (912)
Q Consensus       748 ---~~~~~~~gt~~y~APE~l~~~~~s~-ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  823 (912)
                         .......|+..|+|||++.+..|.+ ..||||.|+++..|.+|+.||......+...     ......++......+
T Consensus       476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-----~~~~~~~~~~~~~~~  550 (601)
T KOG0590|consen  476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-----KTNNYSDQRNIFEGP  550 (601)
T ss_pred             hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-----hhhccccccccccCh
Confidence               4556677999999999999988875 6899999999999999999998554432211     000000000000000


Q ss_pred             cccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          824 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       824 ~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                         .......+.....++.+||+++|.+|.|+++|++
T Consensus       551 ---~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  551 ---NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             ---HHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence               0111233456789999999999999999999985

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.80  E-value=1.7e-20  Score=220.43  Aligned_cols=248  Identities=21%  Similarity=0.299  Sum_probs=180.3

Q ss_pred             HHhhhcccCccccEEEEEEEecCCCEEEEEEccCcc-chhhHHHHHHHHH--HHhcCCCCccceeeEEecCCeEEEEEEe
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC-SHRTQQFVTEVAL--LSRIHHRNLVPLIGYCEEEHQRILVYEY  667 (912)
Q Consensus       591 ~~~~~~~LG~G~fg~Vy~a~~~~~~~vAvK~l~~~~-~~~~~~~~~E~~i--l~~L~hpnIv~l~~~~~~~~~~~lV~E~  667 (912)
                      .+.+.+.||.+.|=+|.+|++++|. |+||++-+.. ....+.+.++++-  ...++|||++++......+...|||-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            3456789999999999999999888 8899986543 3334444443333  4455899999998888778888888888


Q ss_pred             cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccc--ccc
Q 002529          668 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA--EED  745 (912)
Q Consensus       668 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~--~~~  745 (912)
                      .. -+|.|.+.   .+..+...+.+.|+.|++.||..+|.   .||+|||||.+||||++-.-+.|+||..-+..  .++
T Consensus       103 vk-hnLyDRlS---TRPFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD  175 (1431)
T KOG1240|consen  103 VK-HNLYDRLS---TRPFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED  175 (1431)
T ss_pred             Hh-hhhhhhhc---cchHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence            85 48999988   56778888999999999999999998   99999999999999999888999999865442  221


Q ss_pred             c----ccccccccCCCcccCCCccCC----------C-CCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHH
Q 002529          746 L----THISSVARGTVGYLDPEYYGN----------Q-QLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWAR  809 (912)
Q Consensus       746 ~----~~~~~~~~gt~~y~APE~l~~----------~-~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~  809 (912)
                      .    .........-..|+|||.+-.          . ..+++.||||+||++.||++ |++||.         +.+...
T Consensus       176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~---------LSQL~a  246 (1431)
T KOG1240|consen  176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT---------LSQLLA  246 (1431)
T ss_pred             CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc---------HHHHHh
Confidence            1    112222234457999997632          1 26789999999999999998 788886         122111


Q ss_pred             hhhccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 002529          810 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI  862 (912)
Q Consensus       810 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  862 (912)
                      ..-.+....+   ..+. ..+   ...+.+++..|++.||++|-++++.|+.-
T Consensus       247 Yr~~~~~~~e---~~Le-~Ie---d~~~Rnlil~Mi~rdPs~RlSAedyL~~y  292 (1431)
T KOG1240|consen  247 YRSGNADDPE---QLLE-KIE---DVSLRNLILSMIQRDPSKRLSAEDYLQKY  292 (1431)
T ss_pred             HhccCccCHH---HHHH-hCc---CccHHHHHHHHHccCchhccCHHHHHHhh
Confidence            1111000000   0000 000   01577999999999999999999999873

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.79  E-value=1.7e-19  Score=187.31  Aligned_cols=175  Identities=15%  Similarity=0.187  Sum_probs=137.2

Q ss_pred             hhHHHHHHHhhhcccCccccEEEEEEEecCCCEEEEEEccCccchhhH---------HHHHHHHHHHhcCCCCccceeeE
Q 002529          584 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQ---------QFVTEVALLSRIHHRNLVPLIGY  654 (912)
Q Consensus       584 ~~~l~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~vAvK~l~~~~~~~~~---------~~~~E~~il~~L~hpnIv~l~~~  654 (912)
                      .+++...+|+..+.||.|+||.||++.. +++.+|+|++++.......         .+.+|++.+.++.|++|..+.++
T Consensus        25 ~~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~  103 (232)
T PRK10359         25 FDDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDF  103 (232)
T ss_pred             HHHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEe
Confidence            5677888899999999999999999766 5778999999764333222         26789999999999999999988


Q ss_pred             EecC--------CeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCcccc
Q 002529          655 CEEE--------HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD  726 (912)
Q Consensus       655 ~~~~--------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~  726 (912)
                      +...        ...+|+|||++|.+|.++..       ++.    ....+++.+|..||+   .|++|||+||+||+++
T Consensus       104 ~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~  169 (232)
T PRK10359        104 YLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVS  169 (232)
T ss_pred             eeecccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEe
Confidence            6532        35789999999999988742       222    245699999999998   9999999999999999


Q ss_pred             CCCcEEEeeccCccccccccccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHH
Q 002529          727 INMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELI  787 (912)
Q Consensus       727 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLl  787 (912)
                      .++ ++|+|||......+....             ..+.....+..++|+|+||+++..+.
T Consensus       170 ~~g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        170 KNG-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CCC-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence            888 999999988765322111             01333445667999999999987654

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.78  E-value=6e-19  Score=180.80  Aligned_cols=140  Identities=18%  Similarity=0.188  Sum_probs=110.0

Q ss_pred             hcccCccccEEEEEEEecCCCEEEEEEccCccch--h-------h-----------------HHHHHHHHHHHhcCCCCc
Q 002529          595 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH--R-------T-----------------QQFVTEVALLSRIHHRNL  648 (912)
Q Consensus       595 ~~~LG~G~fg~Vy~a~~~~~~~vAvK~l~~~~~~--~-------~-----------------~~~~~E~~il~~L~hpnI  648 (912)
                      .+.||+|++|.||+|...+|+.||||+++.....  .       .                 ....+|++++.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4689999999999999888999999999754211  0       0                 122459999999988877


Q ss_pred             cceeeEEecCCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeeecCCCCCCccccC
Q 002529          649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL-HTGCNPGIIHRDVKSSNILLDI  727 (912)
Q Consensus       649 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~L-Hs~~~~~ivH~DLkp~NILl~~  727 (912)
                      .....+...  ..+|||||++++++.....   ....++...+..++.|++.+|++| |+   .+|+||||||+||+++ 
T Consensus        82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli~-  152 (190)
T cd05147          82 PCPEPILLK--SHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLYH-  152 (190)
T ss_pred             CCCcEEEec--CCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEE-
Confidence            544333222  2389999999887765432   235688999999999999999999 67   8999999999999998 


Q ss_pred             CCcEEEeeccCccccc
Q 002529          728 NMRAKVSDFGLSRQAE  743 (912)
Q Consensus       728 ~~~vkL~DFGla~~~~  743 (912)
                      ++.++|+|||+|....
T Consensus       153 ~~~v~LiDFG~a~~~~  168 (190)
T cd05147         153 DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             CCcEEEEEccccccCC
Confidence            5789999999997653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.75  E-value=6.1e-18  Score=180.93  Aligned_cols=229  Identities=21%  Similarity=0.312  Sum_probs=148.0

Q ss_pred             hcccCccccEEEEEEEec-CCCEEEEEEccCcc---chhhHHHHHHHHHHHhcC----------CCCccceeeEEe----
Q 002529          595 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIH----------HRNLVPLIGYCE----  656 (912)
Q Consensus       595 ~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~L~----------hpnIv~l~~~~~----  656 (912)
                      .+.||.|+++.||.+++. +++++|+|++.-..   ....+++++|.-....+.          |-.++-.++...    
T Consensus        17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~   96 (288)
T PF14531_consen   17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK   96 (288)
T ss_dssp             EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred             ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence            578999999999999987 58999999985332   224456666665554432          212222222221    


Q ss_pred             -----c---CC-----eEEEEEEecCCCCHHHHhccCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC
Q 002529          657 -----E---EH-----QRILVYEYMHNGTLRDRLHGSV----NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVK  719 (912)
Q Consensus       657 -----~---~~-----~~~lV~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLk  719 (912)
                           .   ..     ..+++|+.+ .++|.+++....    ....+....++.+..|+++.+++||+   .|++|+||+
T Consensus        97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVHgdi~  172 (288)
T PF14531_consen   97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVHGDIK  172 (288)
T ss_dssp             -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEEST-S
T ss_pred             CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEecccc
Confidence                 1   11     236788877 578888765311    12234455667788999999999999   999999999


Q ss_pred             CCCccccCCCcEEEeeccCccccccccccccccccCCCcccCCCccCC--------CCCCchhHHHHHHHHHHHHHhCCC
Q 002529          720 SSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN--------QQLTEKSDVYSFGVVLLELISGKK  791 (912)
Q Consensus       720 p~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~--------~~~s~ksDVwSlGvil~eLltG~~  791 (912)
                      |+|++++.+|.++|+||+.....+.....    ...+..|.+||....        ..++.+.|.|+||+++|.|++|..
T Consensus       173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l  248 (288)
T PF14531_consen  173 PENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL  248 (288)
T ss_dssp             GGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred             eeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence            99999999999999999987765543332    224578999997633        357889999999999999999999


Q ss_pred             CCCccCccchhhHHHHHHhhhccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCC
Q 002529          792 PVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSR  852 (912)
Q Consensus       792 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~R  852 (912)
                      ||...........                   .+ .... +.++.+..||..+|+.+|++|
T Consensus       249 Pf~~~~~~~~~~~-------------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  249 PFGLSSPEADPEW-------------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             STCCCGGGSTSGG-------------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCccccccc-------------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence            9984433211110                   11 1223 566789999999999999988

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.74  E-value=1.3e-17  Score=171.16  Aligned_cols=142  Identities=20%  Similarity=0.229  Sum_probs=112.0

Q ss_pred             hcccCccccEEEEEEEecCCCEEEEEEccCccchh--------------------------hHHHHHHHHHHHhcCCCCc
Q 002529          595 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHR--------------------------TQQFVTEVALLSRIHHRNL  648 (912)
Q Consensus       595 ~~~LG~G~fg~Vy~a~~~~~~~vAvK~l~~~~~~~--------------------------~~~~~~E~~il~~L~hpnI  648 (912)
                      .+.||+|++|.||+|...+|+.||||+++......                          ...+.+|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            46899999999999998889999999987542110                          1123578999999999987


Q ss_pred             cceeeEEecCCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCC
Q 002529          649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN  728 (912)
Q Consensus       649 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~  728 (912)
                      .....+....  .+|||||++++++.....   ....++......++.|++.++.+||+  ..||+||||||+||+++ +
T Consensus        82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~-~  153 (190)
T cd05145          82 PVPEPILLKK--NVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH-D  153 (190)
T ss_pred             CCceEEEecC--CEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE-C
Confidence            5544443332  489999999885543322   23457788899999999999999997  37999999999999998 8


Q ss_pred             CcEEEeeccCcccccc
Q 002529          729 MRAKVSDFGLSRQAEE  744 (912)
Q Consensus       729 ~~vkL~DFGla~~~~~  744 (912)
                      +.++|+|||++.....
T Consensus       154 ~~~~liDFG~a~~~~~  169 (190)
T cd05145         154 GKPYIIDVSQAVELDH  169 (190)
T ss_pred             CCEEEEEcccceecCC
Confidence            9999999999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.73  E-value=1e-17  Score=189.83  Aligned_cols=219  Identities=28%  Similarity=0.414  Sum_probs=164.9

Q ss_pred             HHhcCCCCccceeeEEecCCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC
Q 002529          640 LSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVK  719 (912)
Q Consensus       640 l~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLk  719 (912)
                      |+.+.|.|+.+++|.+.++...++|.+||..|+|.|.+..  ....+++.-...++++|+.||+|||.  ..-.+|+.++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~--s~i~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHN--SPIGYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhc--Ccceeeeeec
Confidence            3567899999999999999999999999999999999985  35678999999999999999999998  2333999999


Q ss_pred             CCCccccCCCcEEEeeccCcccccccc-ccccccccCCCcccCCCccCCC-------CCCchhHHHHHHHHHHHHHhCCC
Q 002529          720 SSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPEYYGNQ-------QLTEKSDVYSFGVVLLELISGKK  791 (912)
Q Consensus       720 p~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~APE~l~~~-------~~s~ksDVwSlGvil~eLltG~~  791 (912)
                      ..|++++....+||+|||+........ ........-..-|.|||.+...       ..+.+.||||||++++|+++.+.
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~  156 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG  156 (484)
T ss_pred             cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence            999999999999999999987764211 0111111234579999998763       24678999999999999999999


Q ss_pred             CCCccCccch-hhHHHHHHhhhccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhhhhhc
Q 002529          792 PVSVEDFGAE-LNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE  869 (912)
Q Consensus       792 Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~~~~~  869 (912)
                      ||........ ..+...++.   .+  ...+-|.+....  +....+..++.+||..+|++||++++|-..++.+....
T Consensus       157 ~~~~~~~~~~~~eii~~~~~---~~--~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~  228 (484)
T KOG1023|consen  157 PFDLRNLVEDPDEIILRVKK---GG--SNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG  228 (484)
T ss_pred             ccccccccCChHHHHHHHHh---cC--CCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence            9985433322 233333322   01  111111111110  33337899999999999999999999999888776643

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.73  E-value=3.5e-17  Score=166.58  Aligned_cols=184  Identities=15%  Similarity=0.136  Sum_probs=139.9

Q ss_pred             hcccCccccEEEEEEEecCCCEEEEEEccCccchh----hHHHHHHHHHHHhcC-CCCccceeeEEecCCeEEEEEEecC
Q 002529          595 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHR----TQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMH  669 (912)
Q Consensus       595 ~~~LG~G~fg~Vy~a~~~~~~~vAvK~l~~~~~~~----~~~~~~E~~il~~L~-hpnIv~l~~~~~~~~~~~lV~E~~~  669 (912)
                      ...|++|+||+||.+.. .+.+++.+.+.......    ...+.+|+++|++|+ |+++++++++    +..+++|||+.
T Consensus         7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~   81 (218)
T PRK12274          7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA   81 (218)
T ss_pred             ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence            47899999999998876 57888888776543311    235789999999995 5889999886    34699999999


Q ss_pred             CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCC-CCCCccccCCCcEEEeeccCcccccccccc
Q 002529          670 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDV-KSSNILLDINMRAKVSDFGLSRQAEEDLTH  748 (912)
Q Consensus       670 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DL-kp~NILl~~~~~vkL~DFGla~~~~~~~~~  748 (912)
                      |.+|.+.+..          ....++.|++++|+++|+   .||+|||| ||.|||++.++.++|+|||++.........
T Consensus        82 G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~  148 (218)
T PRK12274         82 GAAMYQRPPR----------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW  148 (218)
T ss_pred             CccHHhhhhh----------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence            9998754321          113578899999999998   99999999 799999999999999999999865433210


Q ss_pred             ----c--------cccccCCCcccCCCccCCC-CCC-chhHHHHHHHHHHHHHhCCCCCCcc
Q 002529          749 ----I--------SSVARGTVGYLDPEYYGNQ-QLT-EKSDVYSFGVVLLELISGKKPVSVE  796 (912)
Q Consensus       749 ----~--------~~~~~gt~~y~APE~l~~~-~~s-~ksDVwSlGvil~eLltG~~Pf~~~  796 (912)
                          .        ......++.|++|+...-. ..+ ...+-++.|+-+|.++|+..+...+
T Consensus       149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence                0        1112257778888754221 233 5778899999999999999987633

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.72  E-value=2.9e-17  Score=198.10  Aligned_cols=253  Identities=21%  Similarity=0.226  Sum_probs=182.7

Q ss_pred             HHHHHHhhhcccCccccEEEEEEEecCCCEEEEEEccCccchhhHHHHHHHHHHHhcC---CCCccceeeEEecCCeEEE
Q 002529          587 LEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH---HRNLVPLIGYCEEEHQRIL  663 (912)
Q Consensus       587 l~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~---hpnIv~l~~~~~~~~~~~l  663 (912)
                      +....+.+.+.||+|+||+||+|...+|+.||+|+-+..+..+.   ---.+++.+|+   -+.|..+...+.-.+..+|
T Consensus       695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEf---YI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l  771 (974)
T KOG1166|consen  695 VGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEF---YICLQVMERLKPQMLPSIMHISSAHVFQNASVL  771 (974)
T ss_pred             ecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceee---eehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence            34445566789999999999999998899999999877654431   11122333333   2445555555556677899


Q ss_pred             EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCcccc-------CCCcEEEeec
Q 002529          664 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-------INMRAKVSDF  736 (912)
Q Consensus       664 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~-------~~~~vkL~DF  736 (912)
                      |+||.+.|+|.+++.   ..+.+++.-++.++.|+++.+++||.   .+||||||||+|+||.       ....++|+||
T Consensus       772 v~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf  845 (974)
T KOG1166|consen  772 VSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYLIDF  845 (974)
T ss_pred             eeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEEEec
Confidence            999999999999998   56789999999999999999999998   9999999999999994       2345999999


Q ss_pred             cCcccccccc-ccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccC
Q 002529          737 GLSRQAEEDL-THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG  815 (912)
Q Consensus       737 Gla~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  815 (912)
                      |.+..+.--. .......++|-.+-.+|...|..++.++|.|.++.+++.||.|+.--                  ..+|
T Consensus       846 G~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q------------------~~~g  907 (974)
T KOG1166|consen  846 GRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME------------------VKNG  907 (974)
T ss_pred             ccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH------------------hcCC
Confidence            9886542211 11233456888999999999999999999999999999999997431                  1111


Q ss_pred             CcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhhhhhcc
Q 002529          816 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK  870 (912)
Q Consensus       816 ~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~~~~~~~  870 (912)
                      .. ..++..++.....+   ..-+++.++|..+-..=|...++...+++.+....
T Consensus       908 ~~-~~~~~~~~Ry~~~~---~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~~  958 (974)
T KOG1166|consen  908 SS-WMVKTNFPRYWKRD---MWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEHF  958 (974)
T ss_pred             cc-eeccccchhhhhHH---HHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHHH
Confidence            11 11111111111122   23355556666776777888888888888776543

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.69  E-value=5.5e-18  Score=191.64  Aligned_cols=225  Identities=26%  Similarity=0.344  Sum_probs=178.4

Q ss_pred             ccCccccEEEEEEE----ecCCCEEEEEEccCccch--hhHHHHHHHHHHHhcC-CCCccceeeEEecCCeEEEEEEecC
Q 002529          597 KIGKGSFGSVYYGK----MKDGKEVAVKIMADSCSH--RTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMH  669 (912)
Q Consensus       597 ~LG~G~fg~Vy~a~----~~~~~~vAvK~l~~~~~~--~~~~~~~E~~il~~L~-hpnIv~l~~~~~~~~~~~lV~E~~~  669 (912)
                      .+|+|.||.|++++    .+.+..+|+|++++....  .......|..++..++ ||.++++.-.++.+...++++++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            37999999999874    345788999988764321  1124456888888887 9999999999999999999999999


Q ss_pred             CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccccc
Q 002529          670 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI  749 (912)
Q Consensus       670 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~  749 (912)
                      +|.|...+.   ....+.+.........++-+++++|+   .+++|+|+|++||+++.+|++++.|||+++..-+.... 
T Consensus        81 gg~lft~l~---~~~~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-  153 (612)
T KOG0603|consen   81 GGDLFTRLS---KEVMFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-  153 (612)
T ss_pred             cchhhhccc---cCCchHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence            999998887   45667788888889999999999998   99999999999999999999999999999875433222 


Q ss_pred             cccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCCC
Q 002529          750 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV  829 (912)
Q Consensus       750 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  829 (912)
                          +||..|||||++.  ....+.|-||||++++||+||..||..          +.++..++.           .-..
T Consensus       154 ----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----------~~~~~Il~~-----------~~~~  206 (612)
T KOG0603|consen  154 ----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----------DTMKRILKA-----------ELEM  206 (612)
T ss_pred             ----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----------HHHHHHhhh-----------ccCC
Confidence                6899999999998  457789999999999999999999983          112222211           0122


Q ss_pred             CHHHHHHHHHHHHhcccCCCCCCCCH
Q 002529          830 KIESIWRIAEVAIQCVEQRGFSRPKM  855 (912)
Q Consensus       830 ~~~~~~~l~~Li~~cL~~dP~~RPs~  855 (912)
                      +.+......+++..++..+|..|--.
T Consensus       207 p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  207 PRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             chhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            33344466678888888888888755

>PRK10345 hypothetical protein; Provisional

Probab=99.67  E-value=4.1e-16  Score=161.58  Aligned_cols=134  Identities=16%  Similarity=0.166  Sum_probs=104.8

Q ss_pred             hcccCccccEEEEEEEecCCCEEEEEEccCccchhhHHHHHHHHHHHhc-----CCCCccceeeEEecCC---e-EEEEE
Q 002529          595 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-----HHRNLVPLIGYCEEEH---Q-RILVY  665 (912)
Q Consensus       595 ~~~LG~G~fg~Vy~a~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L-----~hpnIv~l~~~~~~~~---~-~~lV~  665 (912)
                      .+.||+|+||.||.  +.+....+||++........+.+.+|+.+++.+     .||||++++|++.++.   . ..+|+
T Consensus         7 ~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~   84 (210)
T PRK10345          7 QSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA   84 (210)
T ss_pred             cceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence            36899999999996  443333368888654444567899999999999     5799999999998864   3 33789


Q ss_pred             Ee--cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeeecCCCCCCccccC----CCcEEEeeccC
Q 002529          666 EY--MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGL-EYLHTGCNPGIIHRDVKSSNILLDI----NMRAKVSDFGL  738 (912)
Q Consensus       666 E~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL-~~LHs~~~~~ivH~DLkp~NILl~~----~~~vkL~DFGl  738 (912)
                      ||  +.+++|.+++..    ..+++.  ..++.|++.++ +|||+   ++|+||||||+|||++.    +.+++|+||+.
T Consensus        85 e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G  155 (210)
T PRK10345         85 DFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCDNIG  155 (210)
T ss_pred             cCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence            99  557999999973    235554  35678888777 99998   99999999999999973    34799999543


Q ss_pred             c
Q 002529          739 S  739 (912)
Q Consensus       739 a  739 (912)
                      +
T Consensus       156 ~  156 (210)
T PRK10345        156 E  156 (210)
T ss_pred             C
Confidence            3

>smart00090 RIO RIO-like kinase

Probab=99.66  E-value=5.9e-16  Score=164.15  Aligned_cols=141  Identities=21%  Similarity=0.241  Sum_probs=110.5

Q ss_pred             HhhhcccCccccEEEEEEE--ecCCCEEEEEEccCccch------------------------hhHHHHHHHHHHHhcCC
Q 002529          592 NNFCKKIGKGSFGSVYYGK--MKDGKEVAVKIMADSCSH------------------------RTQQFVTEVALLSRIHH  645 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~--~~~~~~vAvK~l~~~~~~------------------------~~~~~~~E~~il~~L~h  645 (912)
                      |.+.+.||+|++|.||+|.  ..+|+.||+|+++.....                        ....+.+|++++.++.+
T Consensus        30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~  109 (237)
T smart00090       30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE  109 (237)
T ss_pred             HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence            5678899999999999998  458999999998743210                        01235689999999975


Q ss_pred             C--CccceeeEEecCCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eeecCCCCCC
Q 002529          646 R--NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG-IIHRDVKSSN  722 (912)
Q Consensus       646 p--nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~-ivH~DLkp~N  722 (912)
                      .  .+.++++.    ...++||||+++.+|.....   ....+...+...++.|++.+|++||+   .+ ++||||||+|
T Consensus       110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp~N  179 (237)
T smart00090      110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSEYN  179 (237)
T ss_pred             cCCCCCeeeEe----cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCChhh
Confidence            3  34444443    23489999999988876543   23445666778999999999999998   88 9999999999


Q ss_pred             ccccCCCcEEEeeccCccccc
Q 002529          723 ILLDINMRAKVSDFGLSRQAE  743 (912)
Q Consensus       723 ILl~~~~~vkL~DFGla~~~~  743 (912)
                      |+++ ++.++|+|||.+....
T Consensus       180 Ili~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      180 ILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             EEEE-CCCEEEEEChhhhccC
Confidence            9999 8899999999987543

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.63  E-value=2.7e-15  Score=156.53  Aligned_cols=134  Identities=25%  Similarity=0.407  Sum_probs=113.2

Q ss_pred             cccCccccEEEEEEEecCCCEEEEEEccCccc--------hhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEe
Q 002529          596 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS--------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY  667 (912)
Q Consensus       596 ~~LG~G~fg~Vy~a~~~~~~~vAvK~l~~~~~--------~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  667 (912)
                      +.||+|++|.||+|.+ .+..+++|+......        .....+.+|++++..++|+++.....++......+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999988 577899998654221        1124577899999999999988877777777788999999


Q ss_pred             cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccc
Q 002529          668 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ  741 (912)
Q Consensus       668 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~  741 (912)
                      ++|++|.+.+...   .   . .+..++.+++.+|.+||+   .+++|+|++|+||+++ ++.++|+|||.+..
T Consensus        81 ~~G~~L~~~~~~~---~---~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN---G---M-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc---c---H-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999998632   1   1 778999999999999998   9999999999999999 78999999998764

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.62  E-value=2e-15  Score=160.93  Aligned_cols=197  Identities=20%  Similarity=0.224  Sum_probs=137.1

Q ss_pred             CCCCccceeeEEec---------------------------CCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHH
Q 002529          644 HHRNLVPLIGYCEE---------------------------EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH  696 (912)
Q Consensus       644 ~hpnIv~l~~~~~~---------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~  696 (912)
                      +|||||++.++|.+                           ...+|+||..++ .+|.+++-.    ...+.....-++.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~----~~~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT----RHRSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc----CCCchHHHHHHHH
Confidence            49999999887632                           346789999884 589888873    3456667778999


Q ss_pred             HHHHHHHHHHhcCCCCeeecCCCCCCcccc--CCC--cEEEeeccCcccccccc---cc--ccccccCCCcccCCCccCC
Q 002529          697 DAAKGLEYLHTGCNPGIIHRDVKSSNILLD--INM--RAKVSDFGLSRQAEEDL---TH--ISSVARGTVGYLDPEYYGN  767 (912)
Q Consensus       697 qia~aL~~LHs~~~~~ivH~DLkp~NILl~--~~~--~vkL~DFGla~~~~~~~---~~--~~~~~~gt~~y~APE~l~~  767 (912)
                      |+++|..|||+   +||.|||+|.+|||+.  +|+  .+.|+|||++---....   ..  ..-...|.-.-||||+...
T Consensus       349 QlLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta  425 (598)
T KOG4158|consen  349 QLLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA  425 (598)
T ss_pred             HHHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence            99999999998   9999999999999994  333  47889999874322211   11  1112236778899999754


Q ss_pred             CC------CCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCCCCHHHHHHHHHHH
Q 002529          768 QQ------LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVA  841 (912)
Q Consensus       768 ~~------~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li  841 (912)
                      .+      .-.|+|.|+.|.+.||+++...||-..... ..+...     .++..+     |.    .+...+..+.+++
T Consensus       426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem-~L~~r~-----Yqe~qL-----Pa----lp~~vpp~~rqlV  490 (598)
T KOG4158|consen  426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM-LLDTRT-----YQESQL-----PA----LPSRVPPVARQLV  490 (598)
T ss_pred             CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh-eechhh-----hhhhhC-----CC----CcccCChHHHHHH
Confidence            32      125899999999999999999999742111 000000     111111     11    1223344678999


Q ss_pred             HhcccCCCCCCCCHHHHHHHHh
Q 002529          842 IQCVEQRGFSRPKMQEIVLAIQ  863 (912)
Q Consensus       842 ~~cL~~dP~~RPs~~evl~~L~  863 (912)
                      ...|+.||.+|++..-....|.
T Consensus       491 ~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  491 FDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             HHHhcCCccccCCccHHHhHHH
Confidence            9999999999999876665554

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.61  E-value=3.8e-15  Score=153.91  Aligned_cols=131  Identities=24%  Similarity=0.426  Sum_probs=106.8

Q ss_pred             ccCccccEEEEEEEecCCCEEEEEEccCccc--------hhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEec
Q 002529          597 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCS--------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM  668 (912)
Q Consensus       597 ~LG~G~fg~Vy~a~~~~~~~vAvK~l~~~~~--------~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~  668 (912)
                      .||+|++|.||+|.+. ++.|++|.......        .....+.+|++++..++|+++.....++......++||||+
T Consensus         1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            4899999999999864 78899998653211        12356778999999999887665555555666779999999


Q ss_pred             CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccc
Q 002529          669 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA  742 (912)
Q Consensus       669 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~  742 (912)
                      +|++|.+.+...   ..       .++.+++.+|.+||+   .+++|||++|+||+++ ++.++++|||++...
T Consensus        80 ~g~~l~~~~~~~---~~-------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        80 EGKPLKDVIEEG---ND-------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CCccHHHHHhhc---HH-------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            999999987632   11       789999999999998   9999999999999999 899999999988753

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.60  E-value=5.4e-15  Score=152.84  Aligned_cols=137  Identities=20%  Similarity=0.236  Sum_probs=109.0

Q ss_pred             HhhhcccCccccEEEEEEEecCCCEEEEEEccCccch----------------------hhHHHHHHHHHHHhcCCC--C
Q 002529          592 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH----------------------RTQQFVTEVALLSRIHHR--N  647 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~~~~~vAvK~l~~~~~~----------------------~~~~~~~E~~il~~L~hp--n  647 (912)
                      +.+.+.||+|+||.||++..++|+.||||++......                      ......+|+.++..+.|+  .
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   96 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP   96 (198)
T ss_pred             hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence            6678999999999999999888999999986542210                      112356789999999877  4


Q ss_pred             ccceeeEEecCCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccC
Q 002529          648 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI  727 (912)
Q Consensus       648 Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~  727 (912)
                      +++.++.    ...++||||+++++|.+....         .....++.+++.++.++|+   .+++||||||+||+++.
T Consensus        97 v~~~~~~----~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p~Nill~~  160 (198)
T cd05144          97 VPKPIDW----NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYK---HGIIHGDLSEFNILVDD  160 (198)
T ss_pred             CCceeec----CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHH---CCCCcCCCCcccEEEcC
Confidence            4555442    345899999999998765431         2356788999999999998   99999999999999999


Q ss_pred             CCcEEEeeccCcccccc
Q 002529          728 NMRAKVSDFGLSRQAEE  744 (912)
Q Consensus       728 ~~~vkL~DFGla~~~~~  744 (912)
                      ++.++|+|||++.....
T Consensus       161 ~~~~~liDfg~~~~~~~  177 (198)
T cd05144         161 DEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             CCcEEEEECCccccCCC
Confidence            99999999999865543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PLN03150 hypothetical protein; Provisional

Probab=99.58  E-value=5.4e-14  Score=169.32  Aligned_cols=129  Identities=26%  Similarity=0.489  Sum_probs=100.4

Q ss_pred             CcEEEEEcCCCCCcccCCcccccccccceeccccccCCCCCCC-cCCccccceeecccccccCCCCCcCCCc-cccceec
Q 002529          394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSL-PNLQELH  471 (912)
Q Consensus       394 ~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~iP~~l~~l-~~L~~L~  471 (912)
                      ++|+.|+|++|+|.|.+|+.+++|++|+.|+|++|+|+|.+|+ +++|++|+.|+|++|+|+|.+|..++.+ .++..++
T Consensus       442 ~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~  521 (623)
T PLN03150        442 RHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFN  521 (623)
T ss_pred             CCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEE
Confidence            5799999999999999999999999999999999999999995 9999999999999999999999999874 5778899


Q ss_pred             cccccCCCCCCccccCCceeeeecCCCCCcccc-cccceeeeeeccchhhhHHHHHHHhhhhheeee
Q 002529          472 IENNSFVGEIPPALLTGKVIFKYDNNPKLHKES-RRRMRFKLILGTSIGVLAILLVLFLCSLIVLRK  537 (912)
Q Consensus       472 l~~N~l~g~iP~~~~~~~~~~~~~~Np~~c~~~-~~~~~~~iii~~~i~~~~~ll~l~l~~~~~~~r  537 (912)
                      +.+|...+.+|. +             ..|... ....+..++++++++++++++.++ +++..+++
T Consensus       522 ~~~N~~lc~~p~-l-------------~~C~~~~~~~~~i~~~~~~~~~~l~~~~~~~-~~~~~r~~  573 (623)
T PLN03150        522 FTDNAGLCGIPG-L-------------RACGPHLSVGAKIGIAFGVSVAFLFLVICAM-CWWKRRQN  573 (623)
T ss_pred             ecCCccccCCCC-C-------------CCCcccCCCceEEEEEhHHHHHHHHHHHHHh-hheeehhh
Confidence            999986545553 1             113222 223456677777766555555444 44444443

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.58  E-value=5.6e-16  Score=172.39  Aligned_cols=174  Identities=26%  Similarity=0.368  Sum_probs=132.4

Q ss_pred             eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCc
Q 002529          660 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS  739 (912)
Q Consensus       660 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla  739 (912)
                      ..++.|++|+..+|.+++.........++...+.++.|++.|++|      ++.+|+|+||.||+...+.++||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence            578999999999999999877677788899999999999999999      58999999999999999999999999998


Q ss_pred             ccccccc-----ccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHhhhc
Q 002529          740 RQAEEDL-----THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIK  813 (912)
Q Consensus       740 ~~~~~~~-----~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~  813 (912)
                      .......     ........||..||+||.+.+.+|+.|+||||||++|+|++. =..++.          ..-...-++
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e----------r~~t~~d~r  473 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE----------RIATLTDIR  473 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH----------HHHhhhhhh
Confidence            7765443     122344569999999999999999999999999999999986 222221          000111122


Q ss_pred             cCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHH
Q 002529          814 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEI  858 (912)
Q Consensus       814 ~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~ev  858 (912)
                      .+.+    ++....+++     +=..++.+++.+.|.+||++.++
T Consensus       474 ~g~i----p~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  474 DGII----PPEFLQDYP-----EEYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             cCCC----ChHHhhcCc-----HHHHHHHHhcCCCcccCchHHHH
Confidence            2222    222222233     22478889999999999954443

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.56  E-value=1.5e-14  Score=172.04  Aligned_cols=134  Identities=24%  Similarity=0.353  Sum_probs=108.9

Q ss_pred             hhcccCccccEEEEEEEecCCCEEEEEEccCc-cc------hhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEE
Q 002529          594 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADS-CS------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE  666 (912)
Q Consensus       594 ~~~~LG~G~fg~Vy~a~~~~~~~vAvK~l~~~-~~------~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E  666 (912)
                      ..+.||+|+||.||+|.+.+...++.+...+. ..      ...+.+.+|+++++.++|++++....++......++|||
T Consensus       337 ~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E  416 (535)
T PRK09605        337 PDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVME  416 (535)
T ss_pred             ccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEE
Confidence            46889999999999998875443332222211 11      123568899999999999999988887777777899999


Q ss_pred             ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccc
Q 002529          667 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA  742 (912)
Q Consensus       667 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~  742 (912)
                      |+++++|.+++.           ....++.|++++|.+||+   .+++||||||+||++ .++.++|+|||+++..
T Consensus       417 ~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        417 YIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             ecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            999999999875           346789999999999998   999999999999999 5789999999998753

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.52  E-value=9.4e-15  Score=172.86  Aligned_cols=206  Identities=26%  Similarity=0.348  Sum_probs=140.3

Q ss_pred             HhhhcccCccccEEEEEEEecC-CCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEecCC
Q 002529          592 NNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN  670 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~~-~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~  670 (912)
                      ++.++.|..|++|.||.+++++ .+++|+|+=++.      .+.+-  ++.....|.+|                     
T Consensus        85 f~~IklisngAygavylvrh~~trqrfa~kiNkq~------lilRn--ilt~a~npfvv---------------------  135 (1205)
T KOG0606|consen   85 FNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN------LILRN--ILTFAGNPFVV---------------------  135 (1205)
T ss_pred             cceeEeeccCCCCceeeeeccccccchhhcccccc------hhhhc--cccccCCccee---------------------
Confidence            3446899999999999999884 678888543221      11110  22222333333                     


Q ss_pred             CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccc---
Q 002529          671 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT---  747 (912)
Q Consensus       671 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~---  747 (912)
                      |+-...++   .-+.++...        +.+++|||+   .+|+|||+||+|.+|+.-|++|+.|||+++.......   
T Consensus       136 gDc~tllk---~~g~lPvdm--------vla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl  201 (1205)
T KOG0606|consen  136 GDCATLLK---NIGPLPVDM--------VLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNL  201 (1205)
T ss_pred             chhhhhcc---cCCCCcchh--------hHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhccchh
Confidence            33344444   233444332        789999998   9999999999999999999999999998876321111   


Q ss_pred             -----------cccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccC-
Q 002529          748 -----------HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG-  815 (912)
Q Consensus       748 -----------~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~-  815 (912)
                                 ......+||+.|+|||++....|....|-|++|+|+||.+.|+.||.++...+-      +...+... 
T Consensus       202 ~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel------fg~visd~i  275 (1205)
T KOG0606|consen  202 KEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL------FGQVISDDI  275 (1205)
T ss_pred             hhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH------Hhhhhhhhc
Confidence                       112334699999999999999999999999999999999999999985544321      11111110 


Q ss_pred             CcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCH
Q 002529          816 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKM  855 (912)
Q Consensus       816 ~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~  855 (912)
                      .+.+- |        .....+..+++.+.|+.+|..|--.
T Consensus       276 ~wpE~-d--------ea~p~Ea~dli~~LL~qnp~~Rlgt  306 (1205)
T KOG0606|consen  276 EWPEE-D--------EALPPEAQDLIEQLLRQNPLCRLGT  306 (1205)
T ss_pred             ccccc-C--------cCCCHHHHHHHHHHHHhChHhhccc
Confidence            11111 2        2223367889999999999999743

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.49  E-value=1.8e-13  Score=133.34  Aligned_cols=134  Identities=22%  Similarity=0.207  Sum_probs=113.6

Q ss_pred             hcccCccccEEEEEEEecCCCEEEEEEccCccchhhHHHHHHHHHHHhcCC--CCccceeeEEecCCeEEEEEEecCCCC
Q 002529          595 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH--RNLVPLIGYCEEEHQRILVYEYMHNGT  672 (912)
Q Consensus       595 ~~~LG~G~fg~Vy~a~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~h--pnIv~l~~~~~~~~~~~lV~E~~~~gs  672 (912)
                      .+.||+|.++.||++...+ +.+++|.......  ...+.+|+.+++.++|  .++++++.+....+..++++||++++.
T Consensus         3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~   79 (155)
T cd05120           3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET   79 (155)
T ss_pred             ceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence            4679999999999999875 7899999865433  4678899999999976  589999999888888999999998876


Q ss_pred             HHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccc
Q 002529          673 LRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ  741 (912)
Q Consensus       673 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~  741 (912)
                      +...          +......++.+++++|++||.....+++|+|++|+||+++..+.+++.|||.+..
T Consensus        80 ~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          80 LDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             cccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            6432          4566778899999999999984335799999999999999889999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.49  E-value=1.6e-13  Score=140.30  Aligned_cols=137  Identities=22%  Similarity=0.299  Sum_probs=99.4

Q ss_pred             hcccCccccEEEEEEEecCCCEEEEEEccCccch--hhHH----------------------HHHHHHHHHhcCCC--Cc
Q 002529          595 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH--RTQQ----------------------FVTEVALLSRIHHR--NL  648 (912)
Q Consensus       595 ~~~LG~G~fg~Vy~a~~~~~~~vAvK~l~~~~~~--~~~~----------------------~~~E~~il~~L~hp--nI  648 (912)
                      .+.||+|+||+||+|...+++.||||+++.....  ....                      ...|.+.+.++.+.  .+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            4689999999999999888999999998653221  1111                      13566666666543  34


Q ss_pred             cceeeEEecCCeEEEEEEecCCCCHHHH-hccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccC
Q 002529          649 VPLIGYCEEEHQRILVYEYMHNGTLRDR-LHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI  727 (912)
Q Consensus       649 v~l~~~~~~~~~~~lV~E~~~~gsL~~~-l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~  727 (912)
                      .+.++.    ...++||||++++.+... +...    ... .....++.+++.++.++|+  ..+++|+||||+||+++ 
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~----~~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili~-  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV----RLL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILVD-  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhh----hhc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEEE-
Confidence            445443    235899999998543211 1110    011 5678899999999999996  48999999999999999 


Q ss_pred             CCcEEEeeccCccccc
Q 002529          728 NMRAKVSDFGLSRQAE  743 (912)
Q Consensus       728 ~~~vkL~DFGla~~~~  743 (912)
                      ++.++|+|||.+....
T Consensus       150 ~~~~~liDfg~a~~~~  165 (187)
T cd05119         150 DGKVYIIDVPQAVEID  165 (187)
T ss_pred             CCcEEEEECccccccc
Confidence            8999999999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.46  E-value=5.3e-13  Score=141.84  Aligned_cols=135  Identities=19%  Similarity=0.246  Sum_probs=105.5

Q ss_pred             hcccC-ccccEEEEEEEecCCCEEEEEEccCcc-------------chhhHHHHHHHHHHHhcCCCCc--cceeeEEecC
Q 002529          595 CKKIG-KGSFGSVYYGKMKDGKEVAVKIMADSC-------------SHRTQQFVTEVALLSRIHHRNL--VPLIGYCEEE  658 (912)
Q Consensus       595 ~~~LG-~G~fg~Vy~a~~~~~~~vAvK~l~~~~-------------~~~~~~~~~E~~il~~L~hpnI--v~l~~~~~~~  658 (912)
                      ...|| .|+.|+||.+... +..++||.+....             ......+.+|++++.+|+|++|  ++.+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            35687 8999999999886 7788998875311             1223567889999999998775  6777765432


Q ss_pred             C----eEEEEEEecCC-CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEE
Q 002529          659 H----QRILVYEYMHN-GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKV  733 (912)
Q Consensus       659 ~----~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL  733 (912)
                      .    ..++|||+++| .+|.+++..    ..++..    .+.+|+.+|.+||+   .||+|+||||+|||++.++.++|
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~L  183 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFWL  183 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEEE
Confidence            2    23599999997 699988863    234443    35789999999998   99999999999999998889999


Q ss_pred             eeccCccc
Q 002529          734 SDFGLSRQ  741 (912)
Q Consensus       734 ~DFGla~~  741 (912)
                      +|||.+..
T Consensus       184 IDfg~~~~  191 (239)
T PRK01723        184 IDFDRGEL  191 (239)
T ss_pred             EECCCccc
Confidence            99998865

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.43  E-value=1.2e-14  Score=172.57  Aligned_cols=252  Identities=22%  Similarity=0.301  Sum_probs=186.7

Q ss_pred             HhhhcccCccccEEEEEEEecC--CCEEEEEEccCcc--chhhHHHHHHHHHHHhcC-CCCccceeeEEecCCeEEEEEE
Q 002529          592 NNFCKKIGKGSFGSVYYGKMKD--GKEVAVKIMADSC--SHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYE  666 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~~--~~~vAvK~l~~~~--~~~~~~~~~E~~il~~L~-hpnIv~l~~~~~~~~~~~lV~E  666 (912)
                      |++.+.||+|.|+.|-......  ...+|+|.+....  .........|..+-+.+. |+|++.+++...+.+..+++++
T Consensus        22 ~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~  101 (601)
T KOG0590|consen   22 YKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLS  101 (601)
T ss_pred             ccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccC
Confidence            4456779999999998887643  4456667665432  223344555777777776 9999999999999999999999


Q ss_pred             ecCCCCHHHHh-ccCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeeecCCCCCCccccCCC-cEEEeeccCccccc
Q 002529          667 YMHNGTLRDRL-HGSVNQKPLDWLTRLQIAHDAAKGLEYLH-TGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAE  743 (912)
Q Consensus       667 ~~~~gsL~~~l-~~~~~~~~l~~~~~~~i~~qia~aL~~LH-s~~~~~ivH~DLkp~NILl~~~~-~vkL~DFGla~~~~  743 (912)
                      +..++++.+.+ ...  ....+....-.++.|+..++.|+| .   .++.|+||||+|.+++..+ ..+++|||+|..+.
T Consensus       102 ~s~g~~~f~~i~~~~--~~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~  176 (601)
T KOG0590|consen  102 YSDGGSLFSKISHPD--STGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATAYR  176 (601)
T ss_pred             cccccccccccccCC--ccCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence            99999999888 421  225566667788999999999999 6   9999999999999999999 99999999998876


Q ss_pred             c--ccccccccccC-CCcccCCCccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCccc
Q 002529          744 E--DLTHISSVARG-TVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS  819 (912)
Q Consensus       744 ~--~~~~~~~~~~g-t~~y~APE~l~~~-~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  819 (912)
                      .  +.........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+....... .....|.....   ....
T Consensus       177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-~~~~~~~~~~~---~~~~  252 (601)
T KOG0590|consen  177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-GRYSSWKSNKG---RFTQ  252 (601)
T ss_pred             ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-ccceeeccccc---cccc
Confidence            5  33333344567 9999999998874 55678999999999999999999998443322 22222222110   0000


Q ss_pred             ccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          820 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       820 ~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                              ...........+++.+++..+|..|.+.+++..
T Consensus       253 --------~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  253 --------LPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             --------CccccCChhhhhcccccccCCchhccccccccc
Confidence                    001111225668888999999999999988753

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.32  E-value=3.2e-12  Score=134.06  Aligned_cols=203  Identities=26%  Similarity=0.371  Sum_probs=143.6

Q ss_pred             HHHHHhcCCCCccceeeEEecC-----CeEEEEEEecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 002529          637 VALLSRIHHRNLVPLIGYCEEE-----HQRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCN  710 (912)
Q Consensus       637 ~~il~~L~hpnIv~l~~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LHs~~~  710 (912)
                      ...|-++-|.|||+++.|+.+.     .+..++.|||..|+|.++|++.. .+..+......+|+.||+.||.|||+ |+
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~  196 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CD  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cC
Confidence            3345556799999999988553     35789999999999999998755 66778899999999999999999998 78


Q ss_pred             CCeeecCCCCCCccccCCCcEEEeeccCcccc---ccccccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHH
Q 002529          711 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQA---EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELI  787 (912)
Q Consensus       711 ~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~---~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLl  787 (912)
                      ..|+|+++..+-|++..+|-+|+.--......   ............+-++|.|||.=.....+.++|||+||....||.
T Consensus       197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence            99999999999999999998887522111110   001111122234678999999877778888999999999999998


Q ss_pred             hCCCCCC-ccCcc-chhhHHHHHHhhhccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002529          788 SGKKPVS-VEDFG-AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       788 tG~~Pf~-~~~~~-~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  861 (912)
                      .+..--. ..... .+.++..-         +...-+. +           =..++.+|++..|..||+|.+++..
T Consensus       277 ilEiq~tnseS~~~~ee~ia~~---------i~~len~-l-----------qr~~i~kcl~~eP~~rp~ar~llfH  331 (458)
T KOG1266|consen  277 ILEIQSTNSESKVEVEENIANV---------IIGLENG-L-----------QRGSITKCLEGEPNGRPDARLLLFH  331 (458)
T ss_pred             HheeccCCCcceeehhhhhhhh---------eeeccCc-c-----------ccCcCcccccCCCCCCcchhhhhcC
Confidence            8764422 11111 11111110         0000111 1           1257789999999999999998743

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.31  E-value=6.8e-12  Score=144.79  Aligned_cols=141  Identities=24%  Similarity=0.301  Sum_probs=100.9

Q ss_pred             cccCccccEEEEEEEecCCCEEEEEEccCccchhh----------------------------------------HHHHH
Q 002529          596 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT----------------------------------------QQFVT  635 (912)
Q Consensus       596 ~~LG~G~fg~Vy~a~~~~~~~vAvK~l~~~~~~~~----------------------------------------~~~~~  635 (912)
                      +.||.|++|.||+|++++|+.||||+.++......                                        -++.+
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            46999999999999999999999999865421110                                        02445


Q ss_pred             HHHHHHhcC----CCCccceeeEE-ecCCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHH-HHHHHHhcC
Q 002529          636 EVALLSRIH----HRNLVPLIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK-GLEYLHTGC  709 (912)
Q Consensus       636 E~~il~~L~----hpnIv~l~~~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~-aL~~LHs~~  709 (912)
                      |.+.+.+++    |.+-+.+-.++ ......+|||||++|++|.+......  ...   ....++.+++. .+..+|.  
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~--~~~---~~~~ia~~~~~~~l~ql~~--  275 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE--AGL---DRKALAENLARSFLNQVLR--  275 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh--cCC---CHHHHHHHHHHHHHHHHHh--
Confidence            666666653    22223322233 22445799999999999988765321  112   23456666666 4788897  


Q ss_pred             CCCeeecCCCCCCccccCCCcEEEeeccCcccccc
Q 002529          710 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE  744 (912)
Q Consensus       710 ~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~  744 (912)
                       .|++|+|+||.||+++.+++++++|||++.....
T Consensus       276 -~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       276 -DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             -CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence             9999999999999999999999999999987654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.28  E-value=8.6e-12  Score=159.64  Aligned_cols=147  Identities=28%  Similarity=0.521  Sum_probs=102.5

Q ss_pred             ccCCcchHHHHHHHHhhcCCC--CCCCCCC-CCCcCCCCceEEEeCCCCCcEEEEEcCCCCCcccCCcccccccccceec
Q 002529          348 AKTEWQDVMVLEALRSISDES--ERTNDRG-DPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELW  424 (912)
Q Consensus       348 ~~t~~~d~~~l~~~~~~~~~~--~~~~w~~-dpC~~~~w~~v~c~~~~~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~  424 (912)
                      ..+.++|..+|.++|+.+.++  ...+|+. +.|+  .|.|+.|+..  .+|+.|+|++|+++|.+|+.|..|++|+.|+
T Consensus        24 ~~~~~~~~~~l~~~~~~~~~~~~~~~~w~~~~~~c--~w~gv~c~~~--~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~   99 (968)
T PLN00113         24 SMLHAEELELLLSFKSSINDPLKYLSNWNSSADVC--LWQGITCNNS--SRVVSIDLSGKNISGKISSAIFRLPYIQTIN   99 (968)
T ss_pred             cCCCHHHHHHHHHHHHhCCCCcccCCCCCCCCCCC--cCcceecCCC--CcEEEEEecCCCccccCChHHhCCCCCCEEE
Confidence            345778999999999888543  3457853 3443  6999999753  4899999999999888888888888888888


Q ss_pred             cccccCCCCCCC--cCCccccceeeccccccc----------------------CCCCCcCCCccccceeccccccCCCC
Q 002529          425 LDGNFLTGPLPD--MSRLIDLRIVHLENNELT----------------------GSLPSYMGSLPNLQELHIENNSFVGE  480 (912)
Q Consensus       425 L~~N~l~~~~p~--~~~l~~L~~L~L~~N~l~----------------------g~iP~~l~~l~~L~~L~l~~N~l~g~  480 (912)
                      |++|+++|.+|.  +.++++|+.|+|++|+++                      |.+|..++++++|+.|+|++|.+.+.
T Consensus       100 Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~  179 (968)
T PLN00113        100 LSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGK  179 (968)
T ss_pred             CCCCccCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCccccc
Confidence            888888877773  335566666655555555                      45555566666666666666666666


Q ss_pred             CCccccC--CceeeeecCCC
Q 002529          481 IPPALLT--GKVIFKYDNNP  498 (912)
Q Consensus       481 iP~~~~~--~~~~~~~~~Np  498 (912)
                      +|..+.+  .+..+.+++|.
T Consensus       180 ~p~~~~~l~~L~~L~L~~n~  199 (968)
T PLN00113        180 IPNSLTNLTSLEFLTLASNQ  199 (968)
T ss_pred             CChhhhhCcCCCeeeccCCC
Confidence            6665543  34455555554

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.20  E-value=2e-11  Score=139.12  Aligned_cols=254  Identities=23%  Similarity=0.245  Sum_probs=185.8

Q ss_pred             hhHHHHHHHhhhcccCc--cccEEEEEEEe--c-CCCEEEEEEccCccc--hhhHHHHHHHHHHHhcC-CCCccceeeEE
Q 002529          584 LPELEEATNNFCKKIGK--GSFGSVYYGKM--K-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIH-HRNLVPLIGYC  655 (912)
Q Consensus       584 ~~~l~~~~~~~~~~LG~--G~fg~Vy~a~~--~-~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~L~-hpnIv~l~~~~  655 (912)
                      ..+..+.+..+.+.+|.  |.+|.||.+..  . ++..+|+|.-+....  .....=.+|+...+.++ |++.++....+
T Consensus       108 ~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~  187 (524)
T KOG0601|consen  108 FDSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW  187 (524)
T ss_pred             ccchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc
Confidence            45666777778899999  99999999987  3 688899998443222  22233345777767774 99999988899


Q ss_pred             ecCCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCeeecCCCCCCccccCC-Cc
Q 002529          656 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK----GLEYLHTGCNPGIIHRDVKSSNILLDIN-MR  730 (912)
Q Consensus       656 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~----aL~~LHs~~~~~ivH~DLkp~NILl~~~-~~  730 (912)
                      ...+..++-+|.+ +.+|.++.+..  ...++...++..+.+...    ||.++|+   .+++|-|+||.||++..+ ..
T Consensus       188 e~~~~lfiqtE~~-~~sl~~~~~~~--~~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s  261 (524)
T KOG0601|consen  188 EGSGILFIQTELC-GESLQSYCHTP--CNFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTS  261 (524)
T ss_pred             ccCCcceeeeccc-cchhHHhhhcc--cccCCchhhhhHHhhhhhcccccccccCC---Ccccccccchhheecccccce
Confidence            9999999999998 57888887742  334777888888888888    9999998   999999999999999988 88


Q ss_pred             EEEeeccCcccccccccc----ccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHH
Q 002529          731 AKVSDFGLSRQAEEDLTH----ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVH  806 (912)
Q Consensus       731 vkL~DFGla~~~~~~~~~----~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~  806 (912)
                      .+++|||+...+.+....    ......|...|++||..++ .++.++|+|++|.+..+..++..+........      
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~------  334 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSS------  334 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCC------
Confidence            999999998887654311    1122257789999998866 56889999999999999998877665221110      


Q ss_pred             HHHhhhccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002529          807 WARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       807 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  860 (912)
                      |.  .++.+-   +-+     ++-......+...+..|++.+|..|++.+++..
T Consensus       335 W~--~~r~~~---ip~-----e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  335 WS--QLRQGY---IPL-----EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             cc--cccccc---Cch-----hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            00  011100   000     111111124556899999999999999888764

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.18  E-value=1.7e-10  Score=132.38  Aligned_cols=166  Identities=20%  Similarity=0.226  Sum_probs=127.7

Q ss_pred             cCCCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHH
Q 002529          612 KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR  691 (912)
Q Consensus       612 ~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~  691 (912)
                      .++.+|.|...+...........+-++.|+.++||||+++++.++.++..|||+|.+.  .|..++..      +....+
T Consensus        35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~v  106 (690)
T KOG1243|consen   35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEEV  106 (690)
T ss_pred             ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHHH
Confidence            3688888888776555445667788999999999999999999999999999999883  67777763      235667


Q ss_pred             HHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccccccccccCCCcccCCCccCCCCCC
Q 002529          692 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT  771 (912)
Q Consensus       692 ~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s  771 (912)
                      .-.+.||+.||.|||.  +.+++|++|....|+++..|..||++|.++........ ......---.|..|+.+....  
T Consensus       107 ~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~--  181 (690)
T KOG1243|consen  107 CLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE--  181 (690)
T ss_pred             HHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc--
Confidence            7789999999999997  58999999999999999999999999988765432211 011111122466666543322  


Q ss_pred             chhHHHHHHHHHHHHHhCC
Q 002529          772 EKSDVYSFGVVLLELISGK  790 (912)
Q Consensus       772 ~ksDVwSlGvil~eLltG~  790 (912)
                      -..|.|-|||+++|++.|.
T Consensus       182 ~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  182 WSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             cchhhhhHHHHHHHHhCcc
Confidence            4579999999999999993

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.16  E-value=1.4e-10  Score=116.37  Aligned_cols=127  Identities=18%  Similarity=0.197  Sum_probs=96.3

Q ss_pred             cccCccccEEEEEEEecCCCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCc-cceeeEEecCCeEEEEEEecCCCCHH
Q 002529          596 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNL-VPLIGYCEEEHQRILVYEYMHNGTLR  674 (912)
Q Consensus       596 ~~LG~G~fg~Vy~a~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnI-v~l~~~~~~~~~~~lV~E~~~~gsL~  674 (912)
                      +.|+.|.++.||+++.. ++.+++|+...... ....+.+|+++++.+.+.++ .+++.+..  ...++|||+++|.++.
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~   79 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELL   79 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCccc
Confidence            57899999999999876 78899998765432 23456789999999875554 45555443  3357999999998775


Q ss_pred             HHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-----eeecCCCCCCccccCCCcEEEeeccCccc
Q 002529          675 DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG-----IIHRDVKSSNILLDINMRAKVSDFGLSRQ  741 (912)
Q Consensus       675 ~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~-----ivH~DLkp~NILl~~~~~vkL~DFGla~~  741 (912)
                      +. .          .....++.+++++|+.||+   .+     ++|||++|.||+++ ++.++++||+.+..
T Consensus        80 ~~-~----------~~~~~~~~~l~~~l~~LH~---~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          80 TE-D----------FSDPENLEKIAKLLKKLHS---SPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cc-c----------ccCHHHHHHHHHHHHHHhC---CCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            42 0          1113457899999999998   55     59999999999999 67899999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.14  E-value=2.7e-12  Score=122.98  Aligned_cols=167  Identities=25%  Similarity=0.418  Sum_probs=133.3

Q ss_pred             EEeeecCCCccccchhhhhheeeeeccc---cCCcchHHHHHHHHhhcCCCCCCCCCCCCCcCCCCceEEEeCCCCCcEE
Q 002529          321 FSFVKTRDSTLGPLLNAIEISKYQKIAA---KTEWQDVMVLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRIT  397 (912)
Q Consensus       321 ~~l~~~~~s~l~P~in~~e~~~~~~~~~---~t~~~d~~~l~~~~~~~~~~~~~~w~~dpC~~~~w~~v~c~~~~~~~l~  397 (912)
                      +++..+.-+.+||-|..+..++++.+..   ...+..+..|..++..-....+.+-  -|      .|.    +..+.+.
T Consensus        38 LtLSHNKl~~vppnia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~~--lp------rgf----gs~p~le  105 (264)
T KOG0617|consen   38 LTLSHNKLTVVPPNIAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLNI--LP------RGF----GSFPALE  105 (264)
T ss_pred             hhcccCceeecCCcHHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhhhc--Cc------ccc----CCCchhh
Confidence            3455677788999999998888888764   3566677777777654321111111  11      121    2346899


Q ss_pred             EEEcCCCCCcc-cCCcccccccccceeccccccCCCCCCCcCCccccceeecccccccCCCCCcCCCccccceecccccc
Q 002529          398 KIALSGKNLKG-EIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNS  476 (912)
Q Consensus       398 ~L~L~~n~l~g-~ip~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~  476 (912)
                      .|||+.|+|.. .+|..|+.++.|+-|+|+.|.|.-.+|++++|++|+.|.|..|.|- ++|.+++.|+.|++|++.+|+
T Consensus       106 vldltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnr  184 (264)
T KOG0617|consen  106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNR  184 (264)
T ss_pred             hhhccccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccce
Confidence            99999999975 5899999999999999999999999999999999999999999999 999999999999999999999


Q ss_pred             CCCCCCccccC-----CceeeeecCCCCCc
Q 002529          477 FVGEIPPALLT-----GKVIFKYDNNPKLH  501 (912)
Q Consensus       477 l~g~iP~~~~~-----~~~~~~~~~Np~~c  501 (912)
                      ++ .+|++++.     ....+.+..|||..
T Consensus       185 l~-vlppel~~l~l~~~k~v~r~E~NPwv~  213 (264)
T KOG0617|consen  185 LT-VLPPELANLDLVGNKQVMRMEENPWVN  213 (264)
T ss_pred             ee-ecChhhhhhhhhhhHHHHhhhhCCCCC
Confidence            99 99998876     34456778899873

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.13  E-value=7.5e-11  Score=137.74  Aligned_cols=139  Identities=20%  Similarity=0.267  Sum_probs=92.3

Q ss_pred             cccCccccEEEEEEEecC-CCEEEEEEccCccchh----------------------------------hH------HHH
Q 002529          596 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHR----------------------------------TQ------QFV  634 (912)
Q Consensus       596 ~~LG~G~fg~Vy~a~~~~-~~~vAvK~l~~~~~~~----------------------------------~~------~~~  634 (912)
                      +.||.|++|.||+|++++ |+.||||+.++.....                                  .+      ++.
T Consensus       125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~  204 (537)
T PRK04750        125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM  204 (537)
T ss_pred             hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence            579999999999999987 9999999997542110                                  11      234


Q ss_pred             HHHHHHHhcC----CCCccceeeEEec-CCeEEEEEEecCCCCHHHHhccCCCC---CCCCHHHHHHHHHHHHHHHHHHH
Q 002529          635 TEVALLSRIH----HRNLVPLIGYCEE-EHQRILVYEYMHNGTLRDRLHGSVNQ---KPLDWLTRLQIAHDAAKGLEYLH  706 (912)
Q Consensus       635 ~E~~il~~L~----hpnIv~l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~---~~l~~~~~~~i~~qia~aL~~LH  706 (912)
                      +|+..+.+++    +...+.+-.++.+ ....+|||||++|+.+.+...-...+   ..+....+..++.|+       +
T Consensus       205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f  277 (537)
T PRK04750        205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------F  277 (537)
T ss_pred             HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------H
Confidence            4555555553    3333333333322 45678999999999998742211011   122223333333333       3


Q ss_pred             hcCCCCeeecCCCCCCccccCCC----cEEEeeccCcccccc
Q 002529          707 TGCNPGIIHRDVKSSNILLDINM----RAKVSDFGLSRQAEE  744 (912)
Q Consensus       707 s~~~~~ivH~DLkp~NILl~~~~----~vkL~DFGla~~~~~  744 (912)
                      .   .|++|+|+||.||+++.++    +++++|||++.....
T Consensus       278 ~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        278 R---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             h---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            3   7999999999999999887    999999999887654

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.06  E-value=1.1e-09  Score=111.79  Aligned_cols=137  Identities=15%  Similarity=0.181  Sum_probs=100.6

Q ss_pred             cccCccccEEEEEEEecC-------CCEEEEEEccCccc----------------------hhhHHH----HHHHHHHHh
Q 002529          596 KKIGKGSFGSVYYGKMKD-------GKEVAVKIMADSCS----------------------HRTQQF----VTEVALLSR  642 (912)
Q Consensus       596 ~~LG~G~fg~Vy~a~~~~-------~~~vAvK~l~~~~~----------------------~~~~~~----~~E~~il~~  642 (912)
                      ..||.|--+.||.|...+       +..+|||+.+....                      ...+.+    ++|++.|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            578999999999997553       47999999742100                      011223    379999999


Q ss_pred             cCC--CCccceeeEEecCCeEEEEEEecCCCCHHH-HhccCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeeecCC
Q 002529          643 IHH--RNLVPLIGYCEEEHQRILVYEYMHNGTLRD-RLHGSVNQKPLDWLTRLQIAHDAAKGLEYL-HTGCNPGIIHRDV  718 (912)
Q Consensus       643 L~h--pnIv~l~~~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~qia~aL~~L-Hs~~~~~ivH~DL  718 (912)
                      +..  -++.+++++    ...+|||||+.+..+.. .++    ...++..+...+..+++.+|..| |+   .+++||||
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk----d~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHGDL  151 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK----DAKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHADL  151 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh----ccccCHHHHHHHHHHHHHHHHHHHHh---CCeecCCC
Confidence            963  466677764    45689999997654422 222    22345566778889999999999 77   89999999


Q ss_pred             CCCCccccCCCcEEEeeccCcccccc
Q 002529          719 KSSNILLDINMRAKVSDFGLSRQAEE  744 (912)
Q Consensus       719 kp~NILl~~~~~vkL~DFGla~~~~~  744 (912)
                      ++.||+++ ++.++|+|||.+....+
T Consensus       152 s~~NIL~~-~~~v~iIDF~qav~~~h  176 (197)
T cd05146         152 SEYNMLWH-DGKVWFIDVSQSVEPTH  176 (197)
T ss_pred             CHHHEEEE-CCcEEEEECCCceeCCC
Confidence            99999997 57899999998876543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.00  E-value=6e-11  Score=113.82  Aligned_cols=84  Identities=31%  Similarity=0.481  Sum_probs=81.1

Q ss_pred             CCcEEEEEcCCCCCcccCCcccccccccceeccccccCCCCCCCcCCccccceeecccccccCCCCCcCCCccccceecc
Q 002529          393 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI  472 (912)
Q Consensus       393 ~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l  472 (912)
                      ..+++.|-||+|+|+ .+|+.|++|.+|+.|+|++|+++..+++++.|++|+.|+++-|+|. .+|..||.++.|+.|||
T Consensus        32 ~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldl  109 (264)
T KOG0617|consen   32 MSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDL  109 (264)
T ss_pred             hhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhc
Confidence            347899999999999 9999999999999999999999999999999999999999999999 99999999999999999


Q ss_pred             ccccCC
Q 002529          473 ENNSFV  478 (912)
Q Consensus       473 ~~N~l~  478 (912)
                      ..|+++
T Consensus       110 tynnl~  115 (264)
T KOG0617|consen  110 TYNNLN  115 (264)
T ss_pred             cccccc
Confidence            999997

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.98  E-value=3.8e-09  Score=110.57  Aligned_cols=142  Identities=21%  Similarity=0.317  Sum_probs=111.3

Q ss_pred             cccCccccEEEEEEEecCCCEEEEEEccCccc-hhhHHHHHHHHHHHhcCC--CCccceeeEEecCC---eEEEEEEecC
Q 002529          596 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHH--RNLVPLIGYCEEEH---QRILVYEYMH  669 (912)
Q Consensus       596 ~~LG~G~fg~Vy~a~~~~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~L~h--pnIv~l~~~~~~~~---~~~lV~E~~~  669 (912)
                      +.|+.|..+.||++...+|+.+++|+...... .....+.+|+++++.+++  ..+.+++.+.....   ..++|||+++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            56899999999999987778999999765332 134678899999999975  44677888776542   5689999999


Q ss_pred             CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 002529          670 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC----------------------------------------  709 (912)
Q Consensus       670 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~----------------------------------------  709 (912)
                      |.++.+.+.    ...++..+...++.+++++|..||+..                                        
T Consensus        84 G~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          84 GRVLRDRLL----RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             CEecCCCCC----CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            988876543    134677778888889999999998521                                        


Q ss_pred             -------------CCCeeecCCCCCCccccC--CCcEEEeeccCccc
Q 002529          710 -------------NPGIIHRDVKSSNILLDI--NMRAKVSDFGLSRQ  741 (912)
Q Consensus       710 -------------~~~ivH~DLkp~NILl~~--~~~vkL~DFGla~~  741 (912)
                                   ...++|+|+++.||+++.  ++.+.|+||+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                         256799999999999998  56789999998764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.90  E-value=9.6e-10  Score=125.47  Aligned_cols=242  Identities=22%  Similarity=0.229  Sum_probs=172.7

Q ss_pred             hhhcccCccccEEEEEEEec--CCCEEEEEEccCccchhhHH--HHHHHHHHHhc-CCCCccceeeEEecCCeEEEEEEe
Q 002529          593 NFCKKIGKGSFGSVYYGKMK--DGKEVAVKIMADSCSHRTQQ--FVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEY  667 (912)
Q Consensus       593 ~~~~~LG~G~fg~Vy~a~~~--~~~~vAvK~l~~~~~~~~~~--~~~E~~il~~L-~hpnIv~l~~~~~~~~~~~lV~E~  667 (912)
                      .++..||.|.|+.|+....+  ++..+++|.+.+.......+  -..|+.+...+ .|.+++.....+....+.++=.||
T Consensus       268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~  347 (524)
T KOG0601|consen  268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEF  347 (524)
T ss_pred             ceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhh
Confidence            34678999999999988644  57889999887643332222  24577777666 488999988877777778899999


Q ss_pred             cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCC-CcEEEeeccCcccccccc
Q 002529          668 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDL  746 (912)
Q Consensus       668 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~-~~vkL~DFGla~~~~~~~  746 (912)
                      |+++++...+.   ....+++..++++..|++.++.++|+   +.++|+|+||+||++..+ +..++.|||......-..
T Consensus       348 ~~~~s~~l~~~---~~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~  421 (524)
T KOG0601|consen  348 CEGGSSSLRSV---TSQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS  421 (524)
T ss_pred             hcCcchhhhhH---HHHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhccccccccccceec
Confidence            99999877663   34567788889999999999999998   999999999999999875 788999999886422111


Q ss_pred             ccccccccCCCccc--CCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHhhhccCCcccccCcc
Q 002529          747 THISSVARGTVGYL--DPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV  824 (912)
Q Consensus       747 ~~~~~~~~gt~~y~--APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  824 (912)
                          .......++.  +|+......+..+.|+++||..+.+.+++..--..        ..+|.  .+..+..     +.
T Consensus       422 ----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~--------~~~~~--~i~~~~~-----p~  482 (524)
T KOG0601|consen  422 ----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES--------GVQSL--TIRSGDT-----PN  482 (524)
T ss_pred             ----ccccccccccccchhhccccccccccccccccccccccccCcccCcc--------cccce--eeecccc-----cC
Confidence                1111223333  55666677888999999999999999998754331        01110  0111111     11


Q ss_pred             ccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhh
Q 002529          825 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD  864 (912)
Q Consensus       825 l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~  864 (912)
                      +    +.. ...+..+...++.+++..||.+.++..+.+.
T Consensus       483 ~----~~~-~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~  517 (524)
T KOG0601|consen  483 L----PGL-KLQLQVLLKVMINPDRKRRPSAVELSLHSEF  517 (524)
T ss_pred             C----Cch-HHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence            1    111 1467788889999999999999988765543

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.89  E-value=1.6e-08  Score=99.87  Aligned_cols=131  Identities=24%  Similarity=0.367  Sum_probs=100.5

Q ss_pred             cccCccccEEEEEEEecCCCEEEEEEccCc-cc-------hhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEe
Q 002529          596 KKIGKGSFGSVYYGKMKDGKEVAVKIMADS-CS-------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY  667 (912)
Q Consensus       596 ~~LG~G~fg~Vy~a~~~~~~~vAvK~l~~~-~~-------~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  667 (912)
                      ..+++|+-+.+|.+.+. |..+++|.-.+. -.       -....-.+|+.++.+++--.|....=+..+.....|+|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            46789999999999876 444666654221 11       1224466799999999766666555566667778899999


Q ss_pred             cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccc
Q 002529          668 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ  741 (912)
Q Consensus       668 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~  741 (912)
                      ++|..|.+.+...          ...++..+-.-+.-||.   .+|+||||.++||++..+. +.++|||++..
T Consensus        81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc----------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999999988742          24567778888889998   9999999999999997544 99999999874

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=98.88  E-value=2.3e-10  Score=128.23  Aligned_cols=177  Identities=22%  Similarity=0.296  Sum_probs=142.1

Q ss_pred             eeeeEEEEEeeecCCCccccchhhhhheeeeeccccCCcchHHHHHHHHhhcCCCCCCCCCCCCCcCCCCceEEEeCCCC
Q 002529          314 TLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIAAKTEWQDVMVLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTP  393 (912)
Q Consensus       314 ~~~~~~~~~l~~~~~s~l~P~in~~e~~~~~~~~~~t~~~d~~~l~~~~~~~~~~~~~~w~~dpC~~~~w~~v~c~~~~~  393 (912)
                      +...++.++-+....+.+||-|..+.++.-+.++...++.-..+|-.+......    |-+++--     .-.+.....-
T Consensus       197 tsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp~vPecly~l~~LrrL----NLS~N~i-----teL~~~~~~W  267 (1255)
T KOG0444|consen  197 TSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLPIVPECLYKLRNLRRL----NLSGNKI-----TELNMTEGEW  267 (1255)
T ss_pred             hhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCCcchHHHhhhhhhhee----ccCcCce-----eeeeccHHHH
Confidence            334456666677778899999999999999999999998888888887765543    2222111     0011111112


Q ss_pred             CcEEEEEcCCCCCcccCCcccccccccceeccccccCC--CCCCCcCCccccceeecccccccCCCCCcCCCccccceec
Q 002529          394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLT--GPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH  471 (912)
Q Consensus       394 ~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~L~~N~l~--~~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~  471 (912)
                      .+|.+|+||+|+|+ .+|..+.+|+.|+.|++.+|+|+  |++..|+.|.+|+++.+++|+|. .+|+++..|..|+.|.
T Consensus       268 ~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~  345 (1255)
T KOG0444|consen  268 ENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLK  345 (1255)
T ss_pred             hhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhc
Confidence            47999999999999 99999999999999999999985  55557999999999999999999 9999999999999999


Q ss_pred             cccccCCCCCCccc--cCCceeeeecCCCCCcc
Q 002529          472 IENNSFVGEIPPAL--LTGKVIFKYDNNPKLHK  502 (912)
Q Consensus       472 l~~N~l~g~iP~~~--~~~~~~~~~~~Np~~c~  502 (912)
                      |++|+|- .+|+.+  ...+..+.+..||.+--
T Consensus       346 L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVM  377 (1255)
T KOG0444|consen  346 LDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVM  377 (1255)
T ss_pred             cccccee-echhhhhhcCCcceeeccCCcCccC
Confidence            9999999 999976  34777888899998753

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.85  E-value=2.3e-08  Score=98.15  Aligned_cols=143  Identities=20%  Similarity=0.243  Sum_probs=105.8

Q ss_pred             hcccCccccEEEEEEEecCCCEEEEEEc-cCcc-------chhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEE
Q 002529          595 CKKIGKGSFGSVYYGKMKDGKEVAVKIM-ADSC-------SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE  666 (912)
Q Consensus       595 ~~~LG~G~fg~Vy~a~~~~~~~vAvK~l-~~~~-------~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E  666 (912)
                      ...|-+|+-+.|+++.+. |+..+||.- .+.-       .-..+..++|++.|.+++--.|.-..-++.+...-.|+||
T Consensus        12 l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME   90 (229)
T KOG3087|consen   12 LELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME   90 (229)
T ss_pred             ceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence            467889999999999987 676666653 2211       1123567889999999875565555555666666789999


Q ss_pred             ecCC-CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCc---EEEeeccCcccc
Q 002529          667 YMHN-GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR---AKVSDFGLSRQA  742 (912)
Q Consensus       667 ~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~---vkL~DFGla~~~  742 (912)
                      |++| .++.+++.... ...........++.+|-+.+.-||.   .+++||||..+||++..++.   +.++|||++...
T Consensus        91 ~~~g~~~vk~~i~~~~-~~~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen   91 FIDGASTVKDFILSTM-EDESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             eccchhHHHHHHHHHc-cCcccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            9976 47888887653 2233333447889999999999998   99999999999999975543   589999998653

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.78  E-value=2.1e-07  Score=104.16  Aligned_cols=169  Identities=21%  Similarity=0.305  Sum_probs=130.0

Q ss_pred             cEEEEEEEec-CCCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccceeeEEe----cCCeEEEEEEecCC-CCHHHH
Q 002529          603 FGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE----EEHQRILVYEYMHN-GTLRDR  676 (912)
Q Consensus       603 fg~Vy~a~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~----~~~~~~lV~E~~~~-gsL~~~  676 (912)
                      -.+.|++..+ ||..|++|+++............-+++++++.|+|||++.+++.    .+..+++|++|+++ ++|.+.
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            3578999766 89999999996544333334445688999999999999999886    34578899999986 577665


Q ss_pred             hccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccccc
Q 002529          677 LHGSV------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE  744 (912)
Q Consensus       677 l~~~~------------~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~  744 (912)
                      -....            .+...++..+|.++.|+..||.++|+   .|+.-+-|.+++|+++.+.+++|+..|.......
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            43211            34457889999999999999999999   8999999999999999988999988887655443


Q ss_pred             ccccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCC
Q 002529          745 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP  792 (912)
Q Consensus       745 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~P  792 (912)
                      +..               |-+.+   ..+-|.=.||.+++.|.||..-
T Consensus       446 d~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  446 DPT---------------EPLES---QQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCC---------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence            320               11111   2467999999999999999644

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=98.77  E-value=1.3e-09  Score=122.36  Aligned_cols=84  Identities=30%  Similarity=0.366  Sum_probs=60.2

Q ss_pred             CCcEEEEEcCCCCCcccCCcccccccccceeccccccCCCCCCC-cCCccccceeecccccccCCCCCcCCCccccceec
Q 002529          393 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH  471 (912)
Q Consensus       393 ~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~  471 (912)
                      ...|+.||||+|+|. ..|..+-+-+++-.|+||+|+|..++.+ |-+|+.|-.||||+|+|. .+|+.+-.|..||.|.
T Consensus       102 l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~  179 (1255)
T KOG0444|consen  102 LKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLK  179 (1255)
T ss_pred             cccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhh
Confidence            345677777777777 7777777777777777777777766554 567777777777777777 7777777777777777


Q ss_pred             cccccCC
Q 002529          472 IENNSFV  478 (912)
Q Consensus       472 l~~N~l~  478 (912)
                      |++|.|.
T Consensus       180 Ls~NPL~  186 (1255)
T KOG0444|consen  180 LSNNPLN  186 (1255)
T ss_pred             cCCChhh
Confidence            7777653

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.73  E-value=6.3e-08  Score=98.56  Aligned_cols=126  Identities=25%  Similarity=0.318  Sum_probs=83.8

Q ss_pred             EEEEEEecCCCEEEEEEccCccch--------------------------hhHHHHHHHHHHHhcCCC--CccceeeEEe
Q 002529          605 SVYYGKMKDGKEVAVKIMADSCSH--------------------------RTQQFVTEVALLSRIHHR--NLVPLIGYCE  656 (912)
Q Consensus       605 ~Vy~a~~~~~~~vAvK~l~~~~~~--------------------------~~~~~~~E~~il~~L~hp--nIv~l~~~~~  656 (912)
                      .||.|...+|..+|||+.+.....                          ......+|.+.|.++..-  ++.+++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            389999989999999997431100                          112366899999999755  566776553 


Q ss_pred             cCCeEEEEEEecC--CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCCeeecCCCCCCccccCCCcEEE
Q 002529          657 EEHQRILVYEYMH--NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY-LHTGCNPGIIHRDVKSSNILLDINMRAKV  733 (912)
Q Consensus       657 ~~~~~~lV~E~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~-LHs~~~~~ivH~DLkp~NILl~~~~~vkL  733 (912)
                         ..+|||||++  |..+......     .++......++.+++..+.. +|.   .|++||||++.||+++++ .+.+
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~-----~~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~~i  147 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDV-----DLSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KVYI  147 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHC-----GGGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CEEE
T ss_pred             ---CCEEEEEecCCCccchhhHHhc-----cccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eEEE
Confidence               3479999998  6555443331     11234556778888886665 566   999999999999999877 9999


Q ss_pred             eeccCccccc
Q 002529          734 SDFGLSRQAE  743 (912)
Q Consensus       734 ~DFGla~~~~  743 (912)
                      +|||.+....
T Consensus       148 IDf~qav~~~  157 (188)
T PF01163_consen  148 IDFGQAVDSS  157 (188)
T ss_dssp             --GTTEEETT
T ss_pred             EecCcceecC
Confidence            9999887654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.68  E-value=2.6e-07  Score=99.62  Aligned_cols=140  Identities=16%  Similarity=0.161  Sum_probs=100.4

Q ss_pred             ccCccccEEEEEEEecCCCEEEEEEccCccch-----------hhHHHHHHHHHHHhcCCCC--ccceeeEEec-----C
Q 002529          597 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH-----------RTQQFVTEVALLSRIHHRN--LVPLIGYCEE-----E  658 (912)
Q Consensus       597 ~LG~G~fg~Vy~a~~~~~~~vAvK~l~~~~~~-----------~~~~~~~E~~il~~L~hpn--Iv~l~~~~~~-----~  658 (912)
                      .+-.-....|.+..+. |+.+.||........           ....+.+|...+.+|...+  +++++++...     .
T Consensus        29 ~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~  107 (268)
T PRK15123         29 VFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT  107 (268)
T ss_pred             EEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence            3333334456677664 788999976433211           1114778999999885433  3455556543     2


Q ss_pred             CeEEEEEEecCCC-CHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccC-------CCc
Q 002529          659 HQRILVYEYMHNG-TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-------NMR  730 (912)
Q Consensus       659 ~~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~-------~~~  730 (912)
                      ...++|+|++++. +|.+++.... ....+......++.+++..+..||.   .||+|+|++++|||++.       +..
T Consensus       108 ~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~~~  183 (268)
T PRK15123        108 RTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREEDLK  183 (268)
T ss_pred             ceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCCCce
Confidence            3578999999886 8999885321 2345566778899999999999998   99999999999999975       467


Q ss_pred             EEEeeccCccc
Q 002529          731 AKVSDFGLSRQ  741 (912)
Q Consensus       731 vkL~DFGla~~  741 (912)
                      +.|+||+.+..
T Consensus       184 ~~LIDl~r~~~  194 (268)
T PRK15123        184 LSVIDLHRAQI  194 (268)
T ss_pred             EEEEECCcccc
Confidence            99999997753

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.62  E-value=1.3e-08  Score=121.70  Aligned_cols=243  Identities=20%  Similarity=0.218  Sum_probs=160.8

Q ss_pred             hhcccCccccEEEEEEEec-CCCEEEEEEccCc---cchhhHHHHHHHHHHHhcCCCCccceeeEEecCCeEEEEEEecC
Q 002529          594 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH  669 (912)
Q Consensus       594 ~~~~LG~G~fg~Vy~a~~~-~~~~vAvK~l~~~---~~~~~~~~~~E~~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~  669 (912)
                      +.+-+-+|.++.+..+.-. .|...+.|+....   ...+.+....+-.++-..++|-++...--+.-....+|+++|+.
T Consensus       808 i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~  887 (1205)
T KOG0606|consen  808 ITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLN  887 (1205)
T ss_pred             ecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhc
Confidence            3457888999988877533 2333334333221   11112223333333333345666655555555667899999999


Q ss_pred             CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccc----
Q 002529          670 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED----  745 (912)
Q Consensus       670 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~----  745 (912)
                      +++|...++.   ....+.......+..+..++++||+   ..+.|+|++|.|.+...++..++.||+........    
T Consensus       888 ~~~~~Skl~~---~~~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~  961 (1205)
T KOG0606|consen  888 GGDLPSKLHN---SGCLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTT  961 (1205)
T ss_pred             cCCchhhhhc---CCCcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCccccccccccccCcC
Confidence            9999999884   3456666666777888999999997   66999999999999999999999999733221100    


Q ss_pred             -c-------------------------ccccccccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcc
Q 002529          746 -L-------------------------THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG  799 (912)
Q Consensus       746 -~-------------------------~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~~~~~~  799 (912)
                       .                         ........+|+.|.+||.+.+......+|.|+.|++++|.++|.+||......
T Consensus       962 ~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq 1041 (1205)
T KOG0606|consen  962 DLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQ 1041 (1205)
T ss_pred             CcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchh
Confidence             0                         00122345899999999999999999999999999999999999999843332


Q ss_pred             chhhHHHHHHhhhccCCcccccCccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHH
Q 002529          800 AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQ  856 (912)
Q Consensus       800 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~  856 (912)
                      ..      ... +..+...-       ...+........+++.+.+..+|.+|-.|.
T Consensus      1042 ~~------f~n-i~~~~~~~-------p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1042 QI------FEN-ILNRDIPW-------PEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             hh------hhc-cccCCCCC-------CCCccccChhhhhhhhhhhccCchhccCcc
Confidence            11      111 11111100       111222233566778888899999998877

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.61  E-value=3e-07  Score=96.14  Aligned_cols=136  Identities=23%  Similarity=0.221  Sum_probs=100.3

Q ss_pred             HhhhcccCccccEEEEEEEecCCCEEEEEEccCccc----------------------hhhHHHHHHHHHHHhcCCC--C
Q 002529          592 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS----------------------HRTQQFVTEVALLSRIHHR--N  647 (912)
Q Consensus       592 ~~~~~~LG~G~fg~Vy~a~~~~~~~vAvK~l~~~~~----------------------~~~~~~~~E~~il~~L~hp--n  647 (912)
                      +.++..||-|--+.||.|....|.++|||.=+....                      ......++|.++|.+|...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            346789999999999999999999999997432100                      0123467899999999744  6


Q ss_pred             ccceeeEEecCCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccC
Q 002529          648 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI  727 (912)
Q Consensus       648 Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~  727 (912)
                      |.+.++    .+..++|||+++|-.|...        +++......++..|++-+..+-.   .|+||||+++-||++++
T Consensus       173 VP~P~~----~nRHaVvMe~ieG~eL~~~--------r~~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~~  237 (304)
T COG0478         173 VPKPIA----WNRHAVVMEYIEGVELYRL--------RLDVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVTE  237 (304)
T ss_pred             CCCccc----cccceeeeehcccceeecc--------cCcccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEec
Confidence            777765    3566899999988665432        12333444555566665555555   89999999999999999


Q ss_pred             CCcEEEeeccCcccc
Q 002529          728 NMRAKVSDFGLSRQA  742 (912)
Q Consensus       728 ~~~vkL~DFGla~~~  742 (912)
                      +|.+.++||--+...
T Consensus       238 dg~~~vIDwPQ~v~~  252 (304)
T COG0478         238 DGDIVVIDWPQAVPI  252 (304)
T ss_pred             CCCEEEEeCcccccC
Confidence            999999999766543

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=98.59  E-value=4.5e-09  Score=113.27  Aligned_cols=103  Identities=21%  Similarity=0.334  Sum_probs=86.3

Q ss_pred             CcEEEEEcCCCCCcccCCcccccccccceeccccccCCCCCCCc-CCccccceeecccccccCCCCCcCCCccccceecc
Q 002529          394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI  472 (912)
Q Consensus       394 ~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~L~~N~l~~~~p~~-~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l  472 (912)
                      .++.-|+|.+|+|. .+| +|..++.|.+|+++.|+|+-.+.+. .+|.+|.+|||..|+|. +.|+++.-|++|..||+
T Consensus       206 ~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDl  282 (565)
T KOG0472|consen  206 ESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDL  282 (565)
T ss_pred             hhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcc
Confidence            46777788888888 777 7888888888888888887776664 48999999999999999 99999999999999999


Q ss_pred             ccccCCCCCCccccC-CceeeeecCCCCC
Q 002529          473 ENNSFVGEIPPALLT-GKVIFKYDNNPKL  500 (912)
Q Consensus       473 ~~N~l~g~iP~~~~~-~~~~~~~~~Np~~  500 (912)
                      |+|.++ .+|.++++ .+..+.+.|||..
T Consensus       283 SNN~is-~Lp~sLgnlhL~~L~leGNPlr  310 (565)
T KOG0472|consen  283 SNNDIS-SLPYSLGNLHLKFLALEGNPLR  310 (565)
T ss_pred             cCCccc-cCCcccccceeeehhhcCCchH
Confidence            999999 89988887 4556677888853

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.59  E-value=1.7e-06  Score=94.67  Aligned_cols=264  Identities=16%  Similarity=0.138  Sum_probs=160.7

Q ss_pred             hcccCccccEEEEEEEecCCCEEEEEEccCccchhhHHHHHHHHHHHhc-CCCCccceeeE------Ee-cCCeEEEEEE
Q 002529          595 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGY------CE-EEHQRILVYE  666 (912)
Q Consensus       595 ~~~LG~G~fg~Vy~a~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L-~hpnIv~l~~~------~~-~~~~~~lV~E  666 (912)
                      ++.||+|+-+.+|-.--  -...+.|+.+........+.   +..|... .||-+-.-+.+      .. .+....+.|.
T Consensus        16 gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP   90 (637)
T COG4248          16 GRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP   90 (637)
T ss_pred             CccccCCccceeeecch--hhchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence            57899999999986521  12234566665433322222   2233333 35543321111      11 1223667888


Q ss_pred             ecCCC-CHHHHhccC---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCcccc
Q 002529          667 YMHNG-TLRDRLHGS---VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA  742 (912)
Q Consensus       667 ~~~~g-sL~~~l~~~---~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~  742 (912)
                      .+.+. .+.++....   +.-....|.-.++.++.++.+.+.||.   .|.+-||++++|+|+.+++.+.|.|-..-...
T Consensus        91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~  167 (637)
T COG4248          91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN  167 (637)
T ss_pred             cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEcccceeec
Confidence            87664 233333221   133457799999999999999999998   99999999999999999999999986543333


Q ss_pred             ccccccccccccCCCcccCCCccC-----CCCCCchhHHHHHHHHHHHHHhC-CCCCCccCccc-hhhHHHHHHhhhccC
Q 002529          743 EEDLTHISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISG-KKPVSVEDFGA-ELNIVHWARSMIKKG  815 (912)
Q Consensus       743 ~~~~~~~~~~~~gt~~y~APE~l~-----~~~~s~ksDVwSlGvil~eLltG-~~Pf~~~~~~~-~~~~~~~~~~~~~~~  815 (912)
                      ..+..  .....|...|.+||.-.     +..-+...|.|.||+++++++.| ++||.+..... ..+..+   ..+..+
T Consensus       168 ~ng~~--~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E---~~Ia~g  242 (637)
T COG4248         168 ANGTL--HLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE---TDIAHG  242 (637)
T ss_pred             cCCce--EecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch---hhhhcc
Confidence            22222  23345889999999743     34556789999999999999886 99998544321 111100   011112


Q ss_pred             CcccccCcccc-----CCCC-HHHHHHHHHHHHhcccC--CCCCCCCHHHHHHHHhhhhhhccC
Q 002529          816 DVISIVDPVLI-----GNVK-IESIWRIAEVAIQCVEQ--RGFSRPKMQEIVLAIQDSIKIEKG  871 (912)
Q Consensus       816 ~~~~~~d~~l~-----~~~~-~~~~~~l~~Li~~cL~~--dP~~RPs~~evl~~L~~~~~~~~~  871 (912)
                      .+...-+....     ...+ .-.+..+.-+..+|+..  ++.-|||++..+..|..+.+...+
T Consensus       243 ~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~  306 (637)
T COG4248         243 RFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKK  306 (637)
T ss_pred             eeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhh
Confidence            22111111100     0111 11123566777788865  367899999999988877666554

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=98.58  E-value=1.5e-08  Score=109.30  Aligned_cols=136  Identities=21%  Similarity=0.228  Sum_probs=101.1

Q ss_pred             CCcchHHHHHHHHhhcC-CCCCCCCCCCCCcCCCCceEEEeCCCCCcEEEEEcCCCCCcccCCcccccccccceeccccc
Q 002529          350 TEWQDVMVLEALRSISD-ESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGN  428 (912)
Q Consensus       350 t~~~d~~~l~~~~~~~~-~~~~~~w~~dpC~~~~w~~v~c~~~~~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~L~~N  428 (912)
                      +.+.+...|..+...+. .....+|-+-            .-+..++++.|+|++|-|. .+|.+++.|..|+.|+||+|
T Consensus       402 elPk~L~~lkelvT~l~lsnn~isfv~~------------~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~N  468 (565)
T KOG0472|consen  402 ELPKRLVELKELVTDLVLSNNKISFVPL------------ELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFN  468 (565)
T ss_pred             hhhhhhHHHHHHHHHHHhhcCccccchH------------HHHhhhcceeeecccchhh-hcchhhhhhhhhheeccccc
Confidence            55666666666665443 2445566542            1123468999999999998 99999999999999999999


Q ss_pred             cCCCCCCCcCCccccceeecccccccCCCCCc-CCCccccceeccccccCCCCCCccccC--CceeeeecCCCCC
Q 002529          429 FLTGPLPDMSRLIDLRIVHLENNELTGSLPSY-MGSLPNLQELHIENNSFVGEIPPALLT--GKVIFKYDNNPKL  500 (912)
Q Consensus       429 ~l~~~~p~~~~l~~L~~L~L~~N~l~g~iP~~-l~~l~~L~~L~l~~N~l~g~iP~~~~~--~~~~~~~~~Np~~  500 (912)
                      +|...+.-+-.+..|+.+-.++|++. .+|.+ +++|.+|+.|||.+|.+. .||+.+++  ....+.++|||..
T Consensus       469 rFr~lP~~~y~lq~lEtllas~nqi~-~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  469 RFRMLPECLYELQTLETLLASNNQIG-SVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR  541 (565)
T ss_pred             ccccchHHHhhHHHHHHHHhcccccc-ccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence            88776555666777777777778887 55544 888888888888888888 88888776  5677788888765

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.56  E-value=2.8e-08  Score=81.80  Aligned_cols=59  Identities=39%  Similarity=0.515  Sum_probs=37.9

Q ss_pred             ccceeccccccCCCCCC-CcCCccccceeecccccccCCCCCcCCCccccceeccccccC
Q 002529          419 ALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSF  477 (912)
Q Consensus       419 ~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l  477 (912)
                      +|+.|+|++|+|+..++ .|.++++|+.|+|++|+++...|..|.++++|++|++++|+|
T Consensus         2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            56666666666666655 356666666666666666644445666666677777666654

...

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=98.52  E-value=4.3e-08  Score=98.24  Aligned_cols=102  Identities=27%  Similarity=0.450  Sum_probs=39.6

Q ss_pred             CcEEEEEcCCCCCcccCCcccc-cccccceeccccccCCCCCCCcCCccccceeecccccccCCCCCcC-CCccccceec
Q 002529          394 PRITKIALSGKNLKGEIPPELK-NMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELH  471 (912)
Q Consensus       394 ~~l~~L~L~~n~l~g~ip~~i~-~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~iP~~l-~~l~~L~~L~  471 (912)
                      .++++|+|.+|.|+ .|. .++ .|++|+.|+|++|.|+.. +.+..|++|+.|+|++|+++ .+++.+ ..+++|+.|+
T Consensus        19 ~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~~l-~~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~   94 (175)
T PF14580_consen   19 VKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQITKL-EGLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELY   94 (175)
T ss_dssp             -------------------S--TT-TT--EEE-TTS--S---TT----TT--EEE--SS----S-CHHHHHH-TT--EEE
T ss_pred             cccccccccccccc-ccc-chhhhhcCCCEEECCCCCCccc-cCccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEE
Confidence            36899999999998 564 576 589999999999999974 57888999999999999999 776655 4689999999


Q ss_pred             cccccCCCCCCc--cc--cCCceeeeecCCCCC
Q 002529          472 IENNSFVGEIPP--AL--LTGKVIFKYDNNPKL  500 (912)
Q Consensus       472 l~~N~l~g~iP~--~~--~~~~~~~~~~~Np~~  500 (912)
                      |++|++. .+-+  .+  +..+..+.+.+||..
T Consensus        95 L~~N~I~-~l~~l~~L~~l~~L~~L~L~~NPv~  126 (175)
T PF14580_consen   95 LSNNKIS-DLNELEPLSSLPKLRVLSLEGNPVC  126 (175)
T ss_dssp             -TTS----SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred             CcCCcCC-ChHHhHHHHcCCCcceeeccCCccc
Confidence            9999997 4433  11  235677889999963

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.44  E-value=4.3e-08  Score=113.50  Aligned_cols=150  Identities=18%  Similarity=0.261  Sum_probs=105.1

Q ss_pred             HHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccccc--------cccccCCCcccCCCccC
Q 002529          695 AHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI--------SSVARGTVGYLDPEYYG  766 (912)
Q Consensus       695 ~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~--------~~~~~gt~~y~APE~l~  766 (912)
                      +.+++.||.|+|.  ..++||++|.|++|.++.++..||+.|+++..........        .....-...|.|||++.
T Consensus       105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            3455599999998  6899999999999999999999999999876654321111        11112456799999999


Q ss_pred             CCCCCchhHHHHHHHHHHHHH-hCCCCCCccCccchhhHHHHHHhhhccCCcccccCccccCCCCHHHHHHHHHHHHhcc
Q 002529          767 NQQLTEKSDVYSFGVVLLELI-SGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCV  845 (912)
Q Consensus       767 ~~~~s~ksDVwSlGvil~eLl-tG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cL  845 (912)
                      +...+.++|+||+|+++|.+. .|+.-+.............             ..+..-...+..+.+.++.+=+.+++
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~-------------~~~~~~~~~~s~~~p~el~~~l~k~l  249 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSR-------------NLLNAGAFGYSNNLPSELRESLKKLL  249 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhh-------------cccccccccccccCcHHHHHHHHHHh
Confidence            988899999999999999999 4555554222211111111             01111111223445567888899999


Q ss_pred             cCCCCCCCCHHHHH
Q 002529          846 EQRGFSRPKMQEIV  859 (912)
Q Consensus       846 ~~dP~~RPs~~evl  859 (912)
                      ..++..||++.++.
T Consensus       250 ~~~~~~rp~~~~l~  263 (700)
T KOG2137|consen  250 NGDSAVRPTLDLLL  263 (700)
T ss_pred             cCCcccCcchhhhh
Confidence            99999999887765

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.43  E-value=5e-07  Score=105.26  Aligned_cols=141  Identities=23%  Similarity=0.299  Sum_probs=93.7

Q ss_pred             cccCccccEEEEEEEecCCCEEEEEEccCccchhh----------------------------------------HHHHH
Q 002529          596 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT----------------------------------------QQFVT  635 (912)
Q Consensus       596 ~~LG~G~fg~Vy~a~~~~~~~vAvK~l~~~~~~~~----------------------------------------~~~~~  635 (912)
                      +-|+.++-|.||+|++++|+.||||+.++......                                        -++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            56889999999999999999999999865322111                                        01344


Q ss_pred             HHHHHHhcC-----CCCccceeeEE-ecCCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHH-HHHHHhc
Q 002529          636 EVALLSRIH-----HRNLVPLIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG-LEYLHTG  708 (912)
Q Consensus       636 E~~il~~L~-----hpnIv~l~~~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~a-L~~LHs~  708 (912)
                      |...+.+++     .+++ ++=.++ +-.+...|+|||++|..+.+...-.  ....+.+.+   +..++++ +..+-. 
T Consensus       211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~--~~g~d~k~i---a~~~~~~f~~q~~~-  283 (517)
T COG0661         211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALK--SAGIDRKEL---AELLVRAFLRQLLR-  283 (517)
T ss_pred             HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHH--hcCCCHHHH---HHHHHHHHHHHHHh-
Confidence            555555553     2222 222222 2245678999999999888874321  233443333   3333332 222222 


Q ss_pred             CCCCeeecCCCCCCccccCCCcEEEeeccCccccccc
Q 002529          709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED  745 (912)
Q Consensus       709 ~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~  745 (912)
                        .|++|.|.+|.||+++.+|++.+.|||+.....+.
T Consensus       284 --dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         284 --DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             --cCccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence              79999999999999999999999999998776543

>PRK09902 hypothetical protein; Provisional

Probab=98.43  E-value=2.9e-06  Score=87.04  Aligned_cols=137  Identities=20%  Similarity=0.225  Sum_probs=103.2

Q ss_pred             CccccEEEEEEEecCCCEEEEEEccCcc------chhhHHHHHHHHHHHhcCC--CCccceeeEEe-c----CCeEEEEE
Q 002529          599 GKGSFGSVYYGKMKDGKEVAVKIMADSC------SHRTQQFVTEVALLSRIHH--RNLVPLIGYCE-E----EHQRILVY  665 (912)
Q Consensus       599 G~G~fg~Vy~a~~~~~~~vAvK~l~~~~------~~~~~~~~~E~~il~~L~h--pnIv~l~~~~~-~----~~~~~lV~  665 (912)
                      |+||.+.|++.... |+.+-+|.-....      ......|.+|+..|++|..  -.+.+++ ++. .    ....+||+
T Consensus        27 ~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         27 RRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT  104 (216)
T ss_pred             CCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence            56899999998877 4468888765211      2345779999999999953  2255555 332 1    22467999


Q ss_pred             EecCC-CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCc--EEEeeccCccc
Q 002529          666 EYMHN-GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR--AKVSDFGLSRQ  741 (912)
Q Consensus       666 E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~--vkL~DFGla~~  741 (912)
                      |.+.+ .+|.+++... .-.+.+......++.++++.++-||.   .|+.|+|+.++||+++.++.  ++++||.-++.
T Consensus       105 e~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        105 EDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            98854 6898888643 23356777788999999999999998   99999999999999986666  99999986654

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.43  E-value=1.3e-07  Score=77.93  Aligned_cols=60  Identities=35%  Similarity=0.482  Sum_probs=54.1

Q ss_pred             CcEEEEEcCCCCCcccCCcccccccccceeccccccCCCCCC-CcCCccccceeecccccc
Q 002529          394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNEL  453 (912)
Q Consensus       394 ~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l  453 (912)
                      ++|+.|+|++|+|+..-+..|.++++|++|+|++|.|+...| .|.+|++|+.|+|++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            478999999999995544678999999999999999999888 589999999999999986

...

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=98.39  E-value=8.6e-08  Score=113.29  Aligned_cols=104  Identities=29%  Similarity=0.425  Sum_probs=93.4

Q ss_pred             CcEEEEEcCCCCCcccCCc-ccccccccceeccccccCCCCCCCcCCccccceeecccccccCCCCCcCCCccccceecc
Q 002529          394 PRITKIALSGKNLKGEIPP-ELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI  472 (912)
Q Consensus       394 ~~l~~L~L~~n~l~g~ip~-~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l  472 (912)
                      .+|+.|+|++|.|. ++|. .+.+|..|++|+||+|+|+.++-++.++..|++|...+|+|. ..| ++.+++.|+.+||
T Consensus       383 ~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDl  459 (1081)
T KOG0618|consen  383 KHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLTTLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDL  459 (1081)
T ss_pred             cceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhhhhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEec
Confidence            58999999999998 7775 589999999999999999999888999999999999999999 899 8999999999999


Q ss_pred             ccccCC-CCCCcccc-CCceeeeecCCCCC
Q 002529          473 ENNSFV-GEIPPALL-TGKVIFKYDNNPKL  500 (912)
Q Consensus       473 ~~N~l~-g~iP~~~~-~~~~~~~~~~Np~~  500 (912)
                      +.|+|+ +.+|..+- ..++.+.++||+++
T Consensus       460 S~N~L~~~~l~~~~p~p~LkyLdlSGN~~l  489 (1081)
T KOG0618|consen  460 SCNNLSEVTLPEALPSPNLKYLDLSGNTRL  489 (1081)
T ss_pred             ccchhhhhhhhhhCCCcccceeeccCCccc
Confidence            999997 45666665 57788999999865

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.37  E-value=2.8e-06  Score=88.38  Aligned_cols=106  Identities=27%  Similarity=0.305  Sum_probs=84.2

Q ss_pred             hHHHHHHHHHHHhcCCC--CccceeeEEecC----CeEEEEEEecCC-CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHH
Q 002529          630 TQQFVTEVALLSRIHHR--NLVPLIGYCEEE----HQRILVYEYMHN-GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGL  702 (912)
Q Consensus       630 ~~~~~~E~~il~~L~hp--nIv~l~~~~~~~----~~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL  702 (912)
                      .....+|...+..|...  .+++.+++....    ...++|+|++++ .+|.+++...   ...+......++.++++.+
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~---~~~~~~~~~~ll~~l~~~i  131 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW---EQLDPSQRRELLRALARLI  131 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh---cccchhhHHHHHHHHHHHH
Confidence            34577899988888533  356666666542    245899999987 4899998742   2266677788999999999


Q ss_pred             HHHHhcCCCCeeecCCCCCCccccCCC---cEEEeeccCccc
Q 002529          703 EYLHTGCNPGIIHRDVKSSNILLDINM---RAKVSDFGLSRQ  741 (912)
Q Consensus       703 ~~LHs~~~~~ivH~DLkp~NILl~~~~---~vkL~DFGla~~  741 (912)
                      +-||.   .||+|+|++++|||++.+.   .+.++||+-+..
T Consensus       132 ~~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  132 AKLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            99998   9999999999999998876   899999997765

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=98.34  E-value=6.1e-08  Score=108.96  Aligned_cols=107  Identities=20%  Similarity=0.290  Sum_probs=86.9

Q ss_pred             CcEEEEEcCCCCCcccCCcccccccccceeccccccCCCCCC-CcCCccccceeecccccccCCCCC---cCCCccccce
Q 002529          394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPS---YMGSLPNLQE  469 (912)
Q Consensus       394 ~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~g~iP~---~l~~l~~L~~  469 (912)
                      ++|.+|+|++|+|+.--+.+|..|+.|+.|+|++|+++.+-. .|..|++|+.|||++|.|++.|-+   .+..|++|+.
T Consensus       317 qkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~Lrk  396 (873)
T KOG4194|consen  317 QKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRK  396 (873)
T ss_pred             ccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhh
Confidence            478889999999985556678888899999999998887766 588899999999999999988865   4667899999


Q ss_pred             eccccccCCCCCCccccC---CceeeeecCCCCCc
Q 002529          470 LHIENNSFVGEIPPALLT---GKVIFKYDNNPKLH  501 (912)
Q Consensus       470 L~l~~N~l~g~iP~~~~~---~~~~~~~~~Np~~c  501 (912)
                      |.|.+|++. .||...+.   ++..+.+.+|+...
T Consensus       397 L~l~gNqlk-~I~krAfsgl~~LE~LdL~~NaiaS  430 (873)
T KOG4194|consen  397 LRLTGNQLK-SIPKRAFSGLEALEHLDLGDNAIAS  430 (873)
T ss_pred             eeecCceee-ecchhhhccCcccceecCCCCccee
Confidence            999999998 88876655   45667778887553

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.24  E-value=1.3e-05  Score=84.56  Aligned_cols=133  Identities=15%  Similarity=0.119  Sum_probs=87.0

Q ss_pred             cccCccccEEEEEEEecCCCEEEEEEccCccchhhHHHHHHHHHHHhcCCCC--ccceeeEEecCCeEEEEEEecCCCC-
Q 002529          596 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRN--LVPLIGYCEEEHQRILVYEYMHNGT-  672 (912)
Q Consensus       596 ~~LG~G~fg~Vy~a~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpn--Iv~l~~~~~~~~~~~lV~E~~~~gs-  672 (912)
                      ..||+|..+.||+.   .+..+++|......  ......+|.++++.+..-.  +.+.+++....+...+|||+++|.. 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            57899999999984   25568889876533  3355788999999996433  5778888888888889999998863 


Q ss_pred             HHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------cCCCC
Q 002529          673 LRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT----------------------------------------GCNPG  712 (912)
Q Consensus       673 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs----------------------------------------~~~~~  712 (912)
                      +...+.       .+......++.++++.+.-||+                                        .....
T Consensus        82 ~~~~~~-------~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~  154 (226)
T TIGR02172        82 FSRIIS-------DNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTST  154 (226)
T ss_pred             hhhhhc-------CCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCc
Confidence            211111       0001111111112222221221                                        01346


Q ss_pred             eeecCCCCCCccccCCCcEEEeeccCccc
Q 002529          713 IIHRDVKSSNILLDINMRAKVSDFGLSRQ  741 (912)
Q Consensus       713 ivH~DLkp~NILl~~~~~vkL~DFGla~~  741 (912)
                      ++|+|+.|.||++++++ +.++||+.+..
T Consensus       155 ~~HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       155 CLHGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             eEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            78999999999999877 99999997753

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.24  E-value=9.3e-06  Score=84.43  Aligned_cols=138  Identities=25%  Similarity=0.325  Sum_probs=98.4

Q ss_pred             cccCccccEEEEEEEecCCCEEEEEEccCccchhh-------------------H-----HHHHHHHHHHhcC--CCCcc
Q 002529          596 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT-------------------Q-----QFVTEVALLSRIH--HRNLV  649 (912)
Q Consensus       596 ~~LG~G~fg~Vy~a~~~~~~~vAvK~l~~~~~~~~-------------------~-----~~~~E~~il~~L~--hpnIv  649 (912)
                      ..|..|--+.||+|...++..+|+|+++.......                   +     -..+|+..|+++.  +=.+.
T Consensus        54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP  133 (268)
T COG1718          54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP  133 (268)
T ss_pred             eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence            35788889999999988899999999864322111                   1     1346888888884  44556


Q ss_pred             ceeeEEecCCeEEEEEEecCCCCH-HHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCC
Q 002529          650 PLIGYCEEEHQRILVYEYMHNGTL-RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN  728 (912)
Q Consensus       650 ~l~~~~~~~~~~~lV~E~~~~gsL-~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~  728 (912)
                      +.+++..    ..|||||+..... .-.|    ...++...+...+..++++.+.-|-.  ..++||+||+.-|||+. +
T Consensus       134 ~Pi~~~~----nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~--~a~LVHgDLSEyNiL~~-~  202 (268)
T COG1718         134 EPIAFRN----NVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYK--EAGLVHGDLSEYNILVH-D  202 (268)
T ss_pred             CceeecC----CeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHH--hcCcccccchhhheEEE-C
Confidence            6666553    3799999954311 1111    12233333567778888888888875  47999999999999999 8


Q ss_pred             CcEEEeeccCcccccc
Q 002529          729 MRAKVSDFGLSRQAEE  744 (912)
Q Consensus       729 ~~vkL~DFGla~~~~~  744 (912)
                      +.+.++|+|-|....+
T Consensus       203 ~~p~iID~~QaV~~~h  218 (268)
T COG1718         203 GEPYIIDVSQAVTIDH  218 (268)
T ss_pred             CeEEEEECccccccCC
Confidence            8999999998876554

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.22  E-value=7.2e-06  Score=84.43  Aligned_cols=142  Identities=15%  Similarity=0.173  Sum_probs=92.5

Q ss_pred             hhHHHHHHHhhhcccCccccEEEEEEEecCCCEEEEEEccCccchhhHH---------HHHHHHHHHhcCC---CCccce
Q 002529          584 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQ---------FVTEVALLSRIHH---RNLVPL  651 (912)
Q Consensus       584 ~~~l~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~vAvK~l~~~~~~~~~~---------~~~E~~il~~L~h---pnIv~l  651 (912)
                      .+++....++..+.+-......|.+...+ |+.+++|..+.......+.         ..+++..+.+++.   .....+
T Consensus        25 ~~~i~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~  103 (229)
T PF06176_consen   25 GEKILDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADP  103 (229)
T ss_pred             HHHHHhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccc
Confidence            34555556666677777666666666655 7899999887643332222         2344454555532   222232


Q ss_pred             eeEE-----ecCCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCcccc
Q 002529          652 IGYC-----EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD  726 (912)
Q Consensus       652 ~~~~-----~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~  726 (912)
                      +.+.     .-....+++|||++|..|.+...       +++    .++..+++++..||+   .|++|||.+|.|++++
T Consensus       104 yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~  169 (229)
T PF06176_consen  104 YLAAEKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVS  169 (229)
T ss_pred             eeeeeeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEE
Confidence            2222     22334568999999988876543       222    245677888999998   9999999999999998


Q ss_pred             CCCcEEEeeccCccc
Q 002529          727 INMRAKVSDFGLSRQ  741 (912)
Q Consensus       727 ~~~~vkL~DFGla~~  741 (912)
                      . +.++++||+..+.
T Consensus       170 ~-~~i~iID~~~k~~  183 (229)
T PF06176_consen  170 N-NGIRIIDTQGKRM  183 (229)
T ss_pred             C-CcEEEEECccccc
Confidence            5 4599999986543

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan

Probab=98.21  E-value=4.5e-06  Score=84.21  Aligned_cols=135  Identities=20%  Similarity=0.396  Sum_probs=74.0

Q ss_pred             EEeecCCCCCcccCCCCeEEecCCccccCCcee--e-------ecCC-----CCCccccceeecccCCCCcceeeeeccC
Q 002529            7 ISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSV--K-------VENP-----SGNWMQYRTRRDLPIDNKKYCYNLITKE   72 (912)
Q Consensus         7 ~~idcg~~~~~~~~~~~~~~~~d~~~~~~g~~~--~-------~~~~-----~~~~~~~~tlr~fp~~~~~~cy~l~~~~   72 (912)
                      +.|+||+... +| ..|+.|.+|..|..++..-  .       ....     ....+.+.|-|+=|   ...-|.+|+.+
T Consensus         3 ~~IN~Gg~~~-~~-~~g~~w~~D~~~~~g~~~y~~~~~~~~~~~~~~~~i~~t~d~~Lyqt~R~g~---~~f~Y~ip~~~   77 (174)
T PF11721_consen    3 LRINAGGPAY-TD-SSGIVWEADQYYTGGSWGYYVSSDNNGSTSSTNSSIPGTTDDPLYQTERYGP---SSFSYDIPVVP   77 (174)
T ss_dssp             EEEEETSSSE-EE-TTTEEE-SSSSSTTSS-----------SSTTS--TTS-HHHHHTTT-----S---SSEEEEEE--S
T ss_pred             EEEECCCCcc-cC-CCCCEEcCCCCCCCCCcccccccccccccccccccccCCCchhhhHhhcCCC---CceEEEEecCC
Confidence            5799998777 55 8899999999996555510  0       0000     11123466778744   35799999999


Q ss_pred             CceEEEEEEe---eeCCCCCCCCCC---cEEEEEcCce-eEEEEecC---Ccc-ceEEEE-EEEcCCCCcceeeee----
Q 002529           73 RRRYLVRATF---QYGSLGSEASYP---KFQLYLDATL-WSTVTVLD---ASR-VYAKEM-IIRAPSDSIDVCICC----  136 (912)
Q Consensus        73 ~~~ylvr~~~---~yg~yd~~~~~p---~fd~~~~~~~-w~~v~~~~---~~~-~~~~e~-~~~~~~~~~~vcl~~----  136 (912)
                      .+.|-||..|   +++. ++..+.|   +||+.++|+. ...+++..   ... ....+. -+.+.+..+.++|..    
T Consensus        78 ~G~Y~V~L~FaE~~~~~-~~~~~~~G~RvFdV~v~g~~vl~~~Di~~~~G~~~~~~~~~~~~v~v~dg~L~i~f~~~~~~  156 (174)
T PF11721_consen   78 NGTYTVRLHFAELYFGA-SGGASGPGQRVFDVYVNGETVLKNFDIYAEAGGFNKAAVRRFFNVTVTDGTLNIQFVWAGKG  156 (174)
T ss_dssp             -EEEEEEEEEE-SSS---------SSSS-EEEEETTEEEEEEE-HHHHHSSSS---EEEEEEEEEETTEEETTEEEE--S
T ss_pred             CcEEEEEEEeccccccc-cccccCCCceEEEEEecceEEEeccCHHHHcCCCceEEEEEEEEEEEeCCcEEEEEEecCCC
Confidence            9999999999   3443 4444444   7999999954 33333311   111 233333 233477889999986    


Q ss_pred             -------cCCCCceeeee
Q 002529          137 -------AVTGSPFISTL  147 (912)
Q Consensus       137 -------~~~~~pfis~l  147 (912)
                             ...|.|.||+|
T Consensus       157 ~~~i~~~~~~~~p~IsaI  174 (174)
T PF11721_consen  157 TLCIPFIGSYGNPLISAI  174 (174)
T ss_dssp             EEEEEEESSSSSSSEEEE
T ss_pred             cEEeeccccCCCcEEeeC
Confidence                   44567888886

It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A.

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=98.19  E-value=6.7e-07  Score=89.70  Aligned_cols=82  Identities=24%  Similarity=0.392  Sum_probs=42.5

Q ss_pred             CcEEEEEcCCCCCcccCCcccccccccceeccccccCCCCCCCc-CCccccceeecccccccCCCC--CcCCCcccccee
Q 002529          394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLP--SYMGSLPNLQEL  470 (912)
Q Consensus       394 ~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~L~~N~l~~~~p~~-~~l~~L~~L~L~~N~l~g~iP--~~l~~l~~L~~L  470 (912)
                      .+++.|+|++|+|+ .++ .+..|+.|+.|+|++|+|+...+.+ ..+++|+.|+|++|++. .+-  ..+..|++|+.|
T Consensus        42 ~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~L~~N~I~-~l~~l~~L~~l~~L~~L  118 (175)
T PF14580_consen   42 DKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELYLSNNKIS-DLNELEPLSSLPKLRVL  118 (175)
T ss_dssp             TT--EEE-TTS--S---T-T----TT--EEE--SS---S-CHHHHHH-TT--EEE-TTS----SCCCCGGGGG-TT--EE
T ss_pred             cCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCCccccchHHhCCcCCEEECcCCcCC-ChHHhHHHHcCCCccee
Confidence            47999999999999 665 5888999999999999999876655 46899999999999998 443  357789999999


Q ss_pred             ccccccCC
Q 002529          471 HIENNSFV  478 (912)
Q Consensus       471 ~l~~N~l~  478 (912)
                      +|.+|.++
T Consensus       119 ~L~~NPv~  126 (175)
T PF14580_consen  119 SLEGNPVC  126 (175)
T ss_dssp             E-TT-GGG
T ss_pred             eccCCccc
Confidence            99999998

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=98.17  E-value=2e-06  Score=105.01  Aligned_cols=96  Identities=24%  Similarity=0.357  Sum_probs=69.6

Q ss_pred             CcEEEEEcCCCCCcccCCcccccccccceeccccccCCCCCCCcCCccccceeecccccccCCCCCcCCCccccceeccc
Q 002529          394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE  473 (912)
Q Consensus       394 ~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~  473 (912)
                      +.++.|+|++|+|+ .+|..+.  ++|+.|+|++|+|+..+..+.  .+|+.|+|++|+++ .+|..+.  .+|+.|+|+
T Consensus       199 ~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~LtsLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls  270 (754)
T PRK15370        199 EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLTSIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLF  270 (754)
T ss_pred             cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccccCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECc
Confidence            46888888888888 6777665  478888888888886544443  36777788888777 7777664  467777777


Q ss_pred             cccCCCCCCccccCCceeeeecCCC
Q 002529          474 NNSFVGEIPPALLTGKVIFKYDNNP  498 (912)
Q Consensus       474 ~N~l~g~iP~~~~~~~~~~~~~~Np  498 (912)
                      +|+|+ .+|..+..++..+.+++|.
T Consensus       271 ~N~L~-~LP~~l~~sL~~L~Ls~N~  294 (754)
T PRK15370        271 HNKIS-CLPENLPEELRYLSVYDNS  294 (754)
T ss_pred             CCccC-ccccccCCCCcEEECCCCc
Confidence            77777 6777666666666666663

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=98.17  E-value=2.8e-06  Score=95.93  Aligned_cols=122  Identities=21%  Similarity=0.314  Sum_probs=84.2

Q ss_pred             cchHHHHHHHHhhcCCCCCCCCCCCCCcCCCCceEEEeCCCCCcEEEEEcCCCCCcccCCcccccccccceeccccccCC
Q 002529          352 WQDVMVLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLT  431 (912)
Q Consensus       352 ~~d~~~l~~~~~~~~~~~~~~w~~dpC~~~~w~~v~c~~~~~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~L~~N~l~  431 (912)
                      .++..++.+++..-...+...--..||.|..           .+++.|+|++|.|+..--..|.+|.+|..|.|+.|+++
T Consensus       142 se~L~~l~alrslDLSrN~is~i~~~sfp~~-----------~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrit  210 (873)
T KOG4194|consen  142 SEELSALPALRSLDLSRNLISEIPKPSFPAK-----------VNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRIT  210 (873)
T ss_pred             HHHHHhHhhhhhhhhhhchhhcccCCCCCCC-----------CCceEEeeccccccccccccccccchheeeecccCccc
Confidence            3455566665543332233344456676522           46888888888888555567888888888888888888


Q ss_pred             CCCC-CcCCccccceeecccccccCCC-CCcCCCccccceeccccccCCCCCCcccc
Q 002529          432 GPLP-DMSRLIDLRIVHLENNELTGSL-PSYMGSLPNLQELHIENNSFVGEIPPALL  486 (912)
Q Consensus       432 ~~~p-~~~~l~~L~~L~L~~N~l~g~i-P~~l~~l~~L~~L~l~~N~l~g~iP~~~~  486 (912)
                      ..++ .|.+|++|+.|+|..|++. .+ =-.|..|++|+.|.|..|.++ .+-++.+
T Consensus       211 tLp~r~Fk~L~~L~~LdLnrN~ir-ive~ltFqgL~Sl~nlklqrN~I~-kL~DG~F  265 (873)
T KOG4194|consen  211 TLPQRSFKRLPKLESLDLNRNRIR-IVEGLTFQGLPSLQNLKLQRNDIS-KLDDGAF  265 (873)
T ss_pred             ccCHHHhhhcchhhhhhcccccee-eehhhhhcCchhhhhhhhhhcCcc-cccCcce
Confidence            8877 5777888888888888887 33 345677777777777777776 6655543

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.11  E-value=3.1e-07  Score=85.78  Aligned_cols=106  Identities=25%  Similarity=0.318  Sum_probs=88.5

Q ss_pred             CCcEEEEEcCCCCCcccCCcccccc-cccceeccccccCCCCCCCcCCccccceeecccccccCCCCCcCCCccccceec
Q 002529          393 PPRITKIALSGKNLKGEIPPELKNM-EALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH  471 (912)
Q Consensus       393 ~~~l~~L~L~~n~l~g~ip~~i~~L-~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~  471 (912)
                      ..+++.++|++|++. ..|+.|... +.++.|+|++|.|+..+-++..++.|+.|++++|.|. ..|.-+..|.+|..|+
T Consensus        52 ~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neisdvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Ld  129 (177)
T KOG4579|consen   52 GYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEISDVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLD  129 (177)
T ss_pred             CceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhhhchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhc
Confidence            357999999999999 788877654 6999999999999999889999999999999999999 8899898899999999


Q ss_pred             cccccCCCCCCccccCC--ceeeeecCCCCCc
Q 002529          472 IENNSFVGEIPPALLTG--KVIFKYDNNPKLH  501 (912)
Q Consensus       472 l~~N~l~g~iP~~~~~~--~~~~~~~~Np~~c  501 (912)
                      ..+|.+. .||-.++..  .....+.+||+-.
T Consensus       130 s~~na~~-eid~dl~~s~~~al~~lgnepl~~  160 (177)
T KOG4579|consen  130 SPENARA-EIDVDLFYSSLPALIKLGNEPLGD  160 (177)
T ss_pred             CCCCccc-cCcHHHhccccHHHHHhcCCcccc
Confidence            9999998 898776542  2223345556543

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=98.11  E-value=5.8e-07  Score=97.31  Aligned_cols=103  Identities=28%  Similarity=0.383  Sum_probs=79.1

Q ss_pred             CCCCCcCCCCceEEEeCC----------CCCcEEEEEcCCCCCcccCC-cccccccccceeccccccCCCCCC-CcCCcc
Q 002529          374 RGDPCVPVPWEWVTCSTT----------TPPRITKIALSGKNLKGEIP-PELKNMEALTELWLDGNFLTGPLP-DMSRLI  441 (912)
Q Consensus       374 ~~dpC~~~~w~~v~c~~~----------~~~~l~~L~L~~n~l~g~ip-~~i~~L~~L~~L~L~~N~l~~~~p-~~~~l~  441 (912)
                      ...||.+..-+|..++|+          -|+..++|.|..|+|+ .|| ..|+.|++|+.||||+|+|+.+-| .|.+|+
T Consensus        37 CP~pC~Cs~~~g~~VdCr~~GL~eVP~~LP~~tveirLdqN~I~-~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~  115 (498)
T KOG4237|consen   37 CPAPCTCSDVEGGIVDCRGKGLTEVPANLPPETVEIRLDQNQIS-SIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLA  115 (498)
T ss_pred             CCCCcccCCCCCceEEccCCCcccCcccCCCcceEEEeccCCcc-cCChhhccchhhhceecccccchhhcChHhhhhhH
Confidence            346787655456555553          2567899999999999 555 568999999999999999999988 588888


Q ss_pred             ccceeec-ccccccCCCCC-cCCCccccceeccccccCC
Q 002529          442 DLRIVHL-ENNELTGSLPS-YMGSLPNLQELHIENNSFV  478 (912)
Q Consensus       442 ~L~~L~L-~~N~l~g~iP~-~l~~l~~L~~L~l~~N~l~  478 (912)
                      +|..|-| ++|+|+ .+|. .|++|.+|+-|.+.-|++.
T Consensus       116 ~l~~Lvlyg~NkI~-~l~k~~F~gL~slqrLllNan~i~  153 (498)
T KOG4237|consen  116 SLLSLVLYGNNKIT-DLPKGAFGGLSSLQRLLLNANHIN  153 (498)
T ss_pred             hhhHHHhhcCCchh-hhhhhHhhhHHHHHHHhcChhhhc
Confidence            8765544 558899 7775 6788888877777777766

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=98.09  E-value=8.3e-07  Score=96.11  Aligned_cols=113  Identities=22%  Similarity=0.313  Sum_probs=91.5

Q ss_pred             EEeCCCCCcEEEEEcCCCCCcccCCcccccccccceeccccccCCCCCC-CcCCccccceeecccccccCCCCCcCCCcc
Q 002529          387 TCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLP  465 (912)
Q Consensus       387 ~c~~~~~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~  465 (912)
                      .|.|++.. =...+.++-+|+ .+|..+-  ..-..|+|..|+|+.++| .|+.+++|+.||||+|+|+-.-|+.|..|+
T Consensus        40 pC~Cs~~~-g~~VdCr~~GL~-eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~  115 (498)
T KOG4237|consen   40 PCTCSDVE-GGIVDCRGKGLT-EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLA  115 (498)
T ss_pred             CcccCCCC-CceEEccCCCcc-cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhH
Confidence            57776533 467789999999 8886543  367789999999999999 599999999999999999988899999999


Q ss_pred             ccceecccc-ccCCCCCCccccCCceee-eecCCCCCcccc
Q 002529          466 NLQELHIEN-NSFVGEIPPALLTGKVIF-KYDNNPKLHKES  504 (912)
Q Consensus       466 ~L~~L~l~~-N~l~g~iP~~~~~~~~~~-~~~~Np~~c~~~  504 (912)
                      +|..|-+-+ |+|+ .+|...+.++..+ .+..|++.|.+.
T Consensus       116 ~l~~Lvlyg~NkI~-~l~k~~F~gL~slqrLllNan~i~Ci  155 (498)
T KOG4237|consen  116 SLLSLVLYGNNKIT-DLPKGAFGGLSSLQRLLLNANHINCI  155 (498)
T ss_pred             hhhHHHhhcCCchh-hhhhhHhhhHHHHHHHhcChhhhcch
Confidence            998876666 9999 9999988865443 346788777543

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=98.09  E-value=3.4e-06  Score=102.58  Aligned_cols=97  Identities=25%  Similarity=0.369  Sum_probs=58.7

Q ss_pred             cEEEEEcCCCCCcccCCccccc-----------------ccccceeccccccCCCCCCCcCCccccceeecccccccCCC
Q 002529          395 RITKIALSGKNLKGEIPPELKN-----------------MEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSL  457 (912)
Q Consensus       395 ~l~~L~L~~n~l~g~ip~~i~~-----------------L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~i  457 (912)
                      +|+.|+|++|+|+ .+|....+                 +++|+.|+|++|+|++.++.   .++|+.|+|++|+|+ .+
T Consensus       343 ~Lq~LdLS~N~Ls-~LP~lp~~L~~L~Ls~N~L~~LP~l~~~L~~LdLs~N~Lt~LP~l---~s~L~~LdLS~N~Ls-sI  417 (788)
T PRK15387        343 GLQELSVSDNQLA-SLPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNRLTSLPVL---PSELKELMVSGNRLT-SL  417 (788)
T ss_pred             ccceEecCCCccC-CCCCCCcccceehhhccccccCcccccccceEEecCCcccCCCCc---ccCCCEEEccCCcCC-CC
Confidence            5666777777666 34432211                 13455666666666653322   245667777777776 46


Q ss_pred             CCcCCCccccceeccccccCCCCCCccccC--CceeeeecCCCCC
Q 002529          458 PSYMGSLPNLQELHIENNSFVGEIPPALLT--GKVIFKYDNNPKL  500 (912)
Q Consensus       458 P~~l~~l~~L~~L~l~~N~l~g~iP~~~~~--~~~~~~~~~Np~~  500 (912)
                      |...   .+|+.|+|++|+|+ .||..++.  .+..+.+++|+..
T Consensus       418 P~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls  458 (788)
T PRK15387        418 PMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS  458 (788)
T ss_pred             Ccch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCC
Confidence            6532   45677778888877 77776654  4556777888754

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=98.07  E-value=7.8e-07  Score=100.32  Aligned_cols=102  Identities=23%  Similarity=0.342  Sum_probs=87.5

Q ss_pred             EEEEEcCCCCCcccCCcccccccccceeccccccCCCCCCCcCCccccceeecccccccCCCCCcCCCccccceeccccc
Q 002529          396 ITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN  475 (912)
Q Consensus       396 l~~L~L~~n~l~g~ip~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N  475 (912)
                      |..|-+++|+|+ .+|+.|+.+..|..||.+.|++...++.++.|.+|+.|.+..|++. .+|.+++.| .|..||+|+|
T Consensus       145 Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScN  221 (722)
T KOG0532|consen  145 LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQSLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCN  221 (722)
T ss_pred             ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhhhchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccC
Confidence            788889999998 8999999888999999999999998889999999999999999988 888888855 4888999999


Q ss_pred             cCCCCCCccccC--CceeeeecCCCCCc
Q 002529          476 SFVGEIPPALLT--GKVIFKYDNNPKLH  501 (912)
Q Consensus       476 ~l~g~iP~~~~~--~~~~~~~~~Np~~c  501 (912)
                      +++ .||-.+..  .+..+.+.+||...
T Consensus       222 kis-~iPv~fr~m~~Lq~l~LenNPLqS  248 (722)
T KOG0532|consen  222 KIS-YLPVDFRKMRHLQVLQLENNPLQS  248 (722)
T ss_pred             cee-ecchhhhhhhhheeeeeccCCCCC
Confidence            998 88888765  56778888888653

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=98.06  E-value=1.8e-06  Score=104.90  Aligned_cols=84  Identities=27%  Similarity=0.376  Sum_probs=72.9

Q ss_pred             CcEEEEEcCCCCCcccCCcccccccccceeccccccCCCCCCCcCCccccceeecccccccCCCCCcCCCccccceeccc
Q 002529          394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE  473 (912)
Q Consensus       394 ~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~  473 (912)
                      ..|..|+|++|.|+ .+|..+   ++|+.|+|++|+|++. |.+  ..+|+.|+|++|+|+ .+|.+++++++|+.|+|+
T Consensus       382 ~~L~~LdLs~N~Lt-~LP~l~---s~L~~LdLS~N~LssI-P~l--~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs  453 (788)
T PRK15387        382 SGLKELIVSGNRLT-SLPVLP---SELKELMVSGNRLTSL-PML--PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLE  453 (788)
T ss_pred             cccceEEecCCccc-CCCCcc---cCCCEEEccCCcCCCC-Ccc--hhhhhhhhhccCccc-ccChHHhhccCCCeEECC
Confidence            46899999999999 577543   6799999999999974 543  357889999999999 899999999999999999


Q ss_pred             cccCCCCCCccc
Q 002529          474 NNSFVGEIPPAL  485 (912)
Q Consensus       474 ~N~l~g~iP~~~  485 (912)
                      +|+|+|.+|..+
T Consensus       454 ~N~Ls~~~~~~L  465 (788)
T PRK15387        454 GNPLSERTLQAL  465 (788)
T ss_pred             CCCCCchHHHHH
Confidence            999999988876

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.05  E-value=4e-07  Score=104.84  Aligned_cols=163  Identities=20%  Similarity=0.216  Sum_probs=112.6

Q ss_pred             hhhhhheeeeeccccCCcchHHHHHHHHhhcCCCC-----------CCCCCCCCCcCCCCce---EEEeCCC--------
Q 002529          335 LNAIEISKYQKIAAKTEWQDVMVLEALRSISDESE-----------RTNDRGDPCVPVPWEW---VTCSTTT--------  392 (912)
Q Consensus       335 in~~e~~~~~~~~~~t~~~d~~~l~~~~~~~~~~~-----------~~~w~~dpC~~~~w~~---v~c~~~~--------  392 (912)
                      |--|-.+.++.+.+..... +..|..+++.+....           ...-.||-|...+|.-   ..|+|..        
T Consensus       105 ifpF~sLr~LElrg~~L~~-~~GL~~lr~qLe~LIC~~Sl~Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~~mD~SL  183 (1096)
T KOG1859|consen  105 IFPFRSLRVLELRGCDLST-AKGLQELRHQLEKLICHNSLDALRHVFASCGGDISNSPVWNKLATASFSYNRLVLMDESL  183 (1096)
T ss_pred             eccccceeeEEecCcchhh-hhhhHHHHHhhhhhhhhccHHHHHHHHHHhccccccchhhhhHhhhhcchhhHHhHHHHH
Confidence            4445555555555543333 444444443332111           1133468887777754   5666642        


Q ss_pred             --CCcEEEEEcCCCCCcccCCcccccccccceeccccccCCCCCC-CcCCccccceeecccccccCCCCCcCCCccccce
Q 002529          393 --PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQE  469 (912)
Q Consensus       393 --~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~  469 (912)
                        .+.++.|||++|+++ ..- .|..|+.|++|||+.|.|.-.+- ....+. |+.|.|+||-++ ++- .+.+|++|+.
T Consensus       184 qll~ale~LnLshNk~~-~v~-~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrnN~l~-tL~-gie~LksL~~  258 (1096)
T KOG1859|consen  184 QLLPALESLNLSHNKFT-KVD-NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRNNALT-TLR-GIENLKSLYG  258 (1096)
T ss_pred             HHHHHhhhhccchhhhh-hhH-HHHhcccccccccccchhccccccchhhhh-heeeeecccHHH-hhh-hHHhhhhhhc
Confidence              467899999999998 333 88899999999999999987654 455555 999999999998 443 4789999999


Q ss_pred             eccccccCCCC---CCccccCCceeeeecCCCCCccc
Q 002529          470 LHIENNSFVGE---IPPALLTGKVIFKYDNNPKLHKE  503 (912)
Q Consensus       470 L~l~~N~l~g~---iP~~~~~~~~~~~~~~Np~~c~~  503 (912)
                      |||+.|-|++.   .|-+....+..+.+.|||..|..
T Consensus       259 LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p  295 (1096)
T KOG1859|consen  259 LDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP  295 (1096)
T ss_pred             cchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence            99999998743   23333345667888999988853

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=98.04  E-value=8.2e-07  Score=105.25  Aligned_cols=100  Identities=27%  Similarity=0.431  Sum_probs=90.1

Q ss_pred             cEEEEEcCCCCCcccCCcccccccccceeccccccCCCCCCCcCCccccceeecccccccCCCCCcCCCccccceecccc
Q 002529          395 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN  474 (912)
Q Consensus       395 ~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~  474 (912)
                      +|.+|||++|.++ ..|..|..+.+|+.|+++.|.+...+-+.+++++|++|+|.+|++. .+|.++..+++|+.|+++.
T Consensus        46 ~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~  123 (1081)
T KOG0618|consen   46 KLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIRSVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSF  123 (1081)
T ss_pred             eeEEeeccccccc-cCCchhhhHHHHhhcccchhhHhhCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccch
Confidence            4999999999998 9999999999999999999999999988999999999999999999 9999999999999999999


Q ss_pred             ccCCCCCCccccC--CceeeeecCC
Q 002529          475 NSFVGEIPPALLT--GKVIFKYDNN  497 (912)
Q Consensus       475 N~l~g~iP~~~~~--~~~~~~~~~N  497 (912)
                      |+|. .+|..+..  ....+.+++|
T Consensus       124 N~f~-~~Pl~i~~lt~~~~~~~s~N  147 (1081)
T KOG0618|consen  124 NHFG-PIPLVIEVLTAEEELAASNN  147 (1081)
T ss_pred             hccC-CCchhHHhhhHHHHHhhhcc
Confidence            9998 99987644  2334445566

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.02  E-value=3.3e-05  Score=81.19  Aligned_cols=143  Identities=20%  Similarity=0.258  Sum_probs=86.0

Q ss_pred             cccCccccEEEEEEEecCCCEEEEEEccCccchhhHHHHHHHHHHHhcCCC--CccceeeEEe---cCCeEEEEEEecCC
Q 002529          596 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR--NLVPLIGYCE---EEHQRILVYEYMHN  670 (912)
Q Consensus       596 ~~LG~G~fg~Vy~a~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hp--nIv~l~~~~~---~~~~~~lV~E~~~~  670 (912)
                      +.|+.|..+.||+....+ +.+++|.....  .....+.+|..+++.+...  .+.+++....   .....+++|++++|
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g   79 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG   79 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence            578899999999999987 69999987654  4557788999999988533  3566776442   23356899999999


Q ss_pred             CCHHH----------------Hh---ccC-CCCCCCCHHH---------HHHH------------HHHHHH-HHHHHHh-
Q 002529          671 GTLRD----------------RL---HGS-VNQKPLDWLT---------RLQI------------AHDAAK-GLEYLHT-  707 (912)
Q Consensus       671 gsL~~----------------~l---~~~-~~~~~l~~~~---------~~~i------------~~qia~-aL~~LHs-  707 (912)
                      ..+..                .+   +.. .....+....         ....            ...+.+ .++.+++ 
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (239)
T PF01636_consen   80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL  159 (239)
T ss_dssp             EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence            87776                11   111 0111111100         0000            111222 2333332 


Q ss_pred             ---cCCCCeeecCCCCCCcccc-CCCcEEEeeccCccc
Q 002529          708 ---GCNPGIIHRDVKSSNILLD-INMRAKVSDFGLSRQ  741 (912)
Q Consensus       708 ---~~~~~ivH~DLkp~NILl~-~~~~vkL~DFGla~~  741 (912)
                         .....++|+|+.|.||+++ +++.+-|+||+.+..
T Consensus       160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             hccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence               1246799999999999999 666678999987653

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=98.02  E-value=5e-06  Score=101.55  Aligned_cols=96  Identities=20%  Similarity=0.335  Sum_probs=74.5

Q ss_pred             cEEEEEcCCCCCcccCCcccccccccceeccccccCCCCCCCcCCccccceeecccccccCCCCCcCCCccccceecccc
Q 002529          395 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN  474 (912)
Q Consensus       395 ~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~  474 (912)
                      .|+.|+|++|+|+ .+|..+.  ++|+.|+|++|+|++.++.+.  ++|+.|+|++|+|+ .+|..+.  ++|+.|++++
T Consensus       263 ~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~LP~~lp--~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~  334 (754)
T PRK15370        263 ALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRTLPAHLP--SGITHLNVQSNSLT-ALPETLP--PGLKTLEAGE  334 (754)
T ss_pred             CCCEEECcCCccC-ccccccC--CCCcEEECCCCccccCcccch--hhHHHHHhcCCccc-cCCcccc--ccceeccccC
Confidence            6888888888888 6777664  478888888888887655443  46888888888888 5776553  6888999999


Q ss_pred             ccCCCCCCccccCCceeeeecCCCC
Q 002529          475 NSFVGEIPPALLTGKVIFKYDNNPK  499 (912)
Q Consensus       475 N~l~g~iP~~~~~~~~~~~~~~Np~  499 (912)
                      |.|+ .+|..+...+..+.+++|..
T Consensus       335 N~Lt-~LP~~l~~sL~~L~Ls~N~L  358 (754)
T PRK15370        335 NALT-SLPASLPPELQVLDVSKNQI  358 (754)
T ss_pred             Cccc-cCChhhcCcccEEECCCCCC
Confidence            9988 68887777777788888753

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.99  E-value=2.5e-05  Score=90.81  Aligned_cols=141  Identities=19%  Similarity=0.237  Sum_probs=91.5

Q ss_pred             cccCccccEEEEEEEecCCCEEEEEEccCccchhh-------------------------------------HHHHHHHH
Q 002529          596 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT-------------------------------------QQFVTEVA  638 (912)
Q Consensus       596 ~~LG~G~fg~Vy~a~~~~~~~vAvK~l~~~~~~~~-------------------------------------~~~~~E~~  638 (912)
                      +-||.-+.|.||+|++++|+.||||+-++......                                     -+|.+|.+
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            56999999999999999999999999765322110                                     01445555


Q ss_pred             HHHhc----CCCC------ccceeeEEecCCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 002529          639 LLSRI----HHRN------LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG  708 (912)
Q Consensus       639 il~~L----~hpn------Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~  708 (912)
                      ...+.    +|-+      |.+++-  .-.....|+||||+|..+.|.-.-  ....++...+..   .+.++...  ..
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i--~~~gi~~~~i~~---~l~~~~~~--qI  317 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAI--DKRGISPHDILN---KLVEAYLE--QI  317 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHH--HHcCCCHHHHHH---HHHHHHHH--HH
Confidence            44444    3444      233322  223467899999999877654221  233455554433   33333222  11


Q ss_pred             CCCCeeecCCCCCCccccC----CCcEEEeeccCccccccc
Q 002529          709 CNPGIIHRDVKSSNILLDI----NMRAKVSDFGLSRQAEED  745 (912)
Q Consensus       709 ~~~~ivH~DLkp~NILl~~----~~~vkL~DFGla~~~~~~  745 (912)
                      ...|++|+|-+|.||+++.    ++++.+.|||+...+...
T Consensus       318 f~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~  358 (538)
T KOG1235|consen  318 FKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK  358 (538)
T ss_pred             HhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence            1268999999999999983    678999999998876543

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.95  E-value=7.2e-05  Score=79.90  Aligned_cols=140  Identities=19%  Similarity=0.177  Sum_probs=86.5

Q ss_pred             ccCcccc-EEEEEEEecCCCEEEEEEccCccchhhHHHHHHHHHHHhcC-CCCccceeeEEecCCeEEEEEEecCCCCHH
Q 002529          597 KIGKGSF-GSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMHNGTLR  674 (912)
Q Consensus       597 ~LG~G~f-g~Vy~a~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~-hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~  674 (912)
                      .|..|.. ..||+.... +..+++|+.....   ...+.+|+++++.+. +--+.+++++....+..++|||+++|.+|.
T Consensus         5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   80 (244)
T cd05150           5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA   80 (244)
T ss_pred             ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence            3444555 789999765 4788999876442   345778999998884 444667888777766789999999998776


Q ss_pred             HHh-------------------ccCCC-CCCCCHH--HHHHHHH--------------------HHHHHHHHHHh----c
Q 002529          675 DRL-------------------HGSVN-QKPLDWL--TRLQIAH--------------------DAAKGLEYLHT----G  708 (912)
Q Consensus       675 ~~l-------------------~~~~~-~~~l~~~--~~~~i~~--------------------qia~aL~~LHs----~  708 (912)
                      ...                   +.... ..++...  .......                    .+...++.|-.    .
T Consensus        81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  160 (244)
T cd05150          81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE  160 (244)
T ss_pred             HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence            432                   11100 0011100  0000000                    01111222211    0


Q ss_pred             CCCCeeecCCCCCCccccCCCcEEEeeccCcc
Q 002529          709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSR  740 (912)
Q Consensus       709 ~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~  740 (912)
                      ....++|+|+.|.||+++++..+.|+||+.+.
T Consensus       161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            12568999999999999987778899999765

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PLN03210 Resistant to P

Probab=97.92  E-value=1.5e-05  Score=103.52  Aligned_cols=106  Identities=18%  Similarity=0.312  Sum_probs=89.3

Q ss_pred             CCcEEEEEcCCCCCcccCCcccccccccceeccccccCCCCCCCcCCccccceeecccccccCCCCCcCCCccccceecc
Q 002529          393 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI  472 (912)
Q Consensus       393 ~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l  472 (912)
                      +.+|+.|+|++|+|. .++..+..|++|+.|+|++|...+.+|+++.+++|+.|+|++|.....+|.++++|++|+.|+|
T Consensus       610 ~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L  688 (1153)
T PLN03210        610 PENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPDLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDM  688 (1153)
T ss_pred             ccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCccccCCcccEEEecCCCCccccchhhhccCCCCEEeC
Confidence            357999999999998 8899999999999999999887788899999999999999998876799999999999999999


Q ss_pred             ccccCCCCCCcccc-CCceeeeecCCCC
Q 002529          473 ENNSFVGEIPPALL-TGKVIFKYDNNPK  499 (912)
Q Consensus       473 ~~N~l~g~iP~~~~-~~~~~~~~~~Np~  499 (912)
                      ++|...+.+|..+. ..+..+.+++|..
T Consensus       689 ~~c~~L~~Lp~~i~l~sL~~L~Lsgc~~  716 (1153)
T PLN03210        689 SRCENLEILPTGINLKSLYRLNLSGCSR  716 (1153)
T ss_pred             CCCCCcCccCCcCCCCCCCEEeCCCCCC
Confidence            99765558888652 3455666666643

syringae 6; Provisional

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=97.89  E-value=1.6e-06  Score=97.81  Aligned_cols=103  Identities=26%  Similarity=0.414  Sum_probs=93.9

Q ss_pred             CCcEEEEEcCCCCCcccCCcccccccccceeccccccCCCCCCCcCCccccceeecccccccCCCCCcCCCccccceecc
Q 002529          393 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI  472 (912)
Q Consensus       393 ~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l  472 (912)
                      ...++.|||+.|+|+ .+|..+..|+ |+.|-+++|+++..+++++.+..|..||.+.|++. .+|..++.|.+|+.|++
T Consensus       120 L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~v  196 (722)
T KOG0532|consen  120 LEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLTSLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNV  196 (722)
T ss_pred             hhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccccCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHH
Confidence            347899999999999 9999999886 89999999999999999999999999999999999 99999999999999999


Q ss_pred             ccccCCCCCCccccC-CceeeeecCCCC
Q 002529          473 ENNSFVGEIPPALLT-GKVIFKYDNNPK  499 (912)
Q Consensus       473 ~~N~l~g~iP~~~~~-~~~~~~~~~Np~  499 (912)
                      ..|++. .+|++++. .+..+.|+.|.-
T Consensus       197 rRn~l~-~lp~El~~LpLi~lDfScNki  223 (722)
T KOG0532|consen  197 RRNHLE-DLPEELCSLPLIRLDFSCNKI  223 (722)
T ss_pred             hhhhhh-hCCHHHhCCceeeeecccCce
Confidence            999999 99999885 456777888864

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=97.82  E-value=7.8e-06  Score=93.92  Aligned_cols=102  Identities=28%  Similarity=0.506  Sum_probs=89.7

Q ss_pred             CcEEEEEcCCCCCcccCCccccccc-ccceeccccccCCCCCCCcCCccccceeecccccccCCCCCcCCCccccceecc
Q 002529          394 PRITKIALSGKNLKGEIPPELKNME-ALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI  472 (912)
Q Consensus       394 ~~l~~L~L~~n~l~g~ip~~i~~L~-~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l  472 (912)
                      ..++.|++.+|+++ .||+.++.++ +|+.|++++|++...+..++.++.|+.|++++|+++ .+|...+.+++|+.|++
T Consensus       116 ~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~l  193 (394)
T COG4886         116 TNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDL  193 (394)
T ss_pred             cceeEEecCCcccc-cCccccccchhhcccccccccchhhhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheec
Confidence            46899999999999 9999999995 999999999999998888999999999999999999 89988888999999999


Q ss_pred             ccccCCCCCCcc--ccCCceeeeecCCC
Q 002529          473 ENNSFVGEIPPA--LLTGKVIFKYDNNP  498 (912)
Q Consensus       473 ~~N~l~g~iP~~--~~~~~~~~~~~~Np  498 (912)
                      ++|+++ .+|..  ....+..+.+++|+
T Consensus       194 s~N~i~-~l~~~~~~~~~L~~l~~~~N~  220 (394)
T COG4886         194 SGNKIS-DLPPEIELLSALEELDLSNNS  220 (394)
T ss_pred             cCCccc-cCchhhhhhhhhhhhhhcCCc
Confidence            999999 89986  44456777777775

>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B

Probab=97.79  E-value=8.3e-06  Score=62.14  Aligned_cols=36  Identities=36%  Similarity=0.506  Sum_probs=17.4

Q ss_pred             ccceeccccccCCCCCCCcCCccccceeeccccccc
Q 002529          419 ALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELT  454 (912)
Q Consensus       419 ~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~  454 (912)
                      +|++|+|++|+|+..+|.+++|++|+.|+|++|+++
T Consensus         2 ~L~~L~l~~N~i~~l~~~l~~l~~L~~L~l~~N~i~   37 (44)
T PF12799_consen    2 NLEELDLSNNQITDLPPELSNLPNLETLNLSNNPIS   37 (44)
T ss_dssp             T-SEEEETSSS-SSHGGHGTTCTTSSEEEETSSCCS
T ss_pred             cceEEEccCCCCcccCchHhCCCCCCEEEecCCCCC
Confidence            455555555555543333555555555555555544

...

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.78  E-value=5e-06  Score=95.49  Aligned_cols=184  Identities=20%  Similarity=0.237  Sum_probs=134.3

Q ss_pred             hhcccCccccEEEEEEEecCCCEEEEEEccCccchhhHHHHHHHHHHHhcCCCC-ccceeeEEecCCeEEEEEEecCCC-
Q 002529          594 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRN-LVPLIGYCEEEHQRILVYEYMHNG-  671 (912)
Q Consensus       594 ~~~~LG~G~fg~Vy~a~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpn-Iv~l~~~~~~~~~~~lV~E~~~~g-  671 (912)
                      +-+.+++|+++.+++.+-.-.+....+.+...     ....-++++|.+++||| .+..++-++.+...+++++++.++ 
T Consensus       246 ~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~r  320 (829)
T KOG0576|consen  246 FFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGR  320 (829)
T ss_pred             HHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCc
Confidence            44667889999999887553444445555432     33455889999999999 777777777788889999999776 


Q ss_pred             CHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCccccCCCcEEEeeccCccccccccccccc
Q 002529          672 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS  751 (912)
Q Consensus       672 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~  751 (912)
                      +-..-..  .....+...+...+.+.-+++|++||+   ..=+|+|    ||+.. ++..+..||+....+....  ...
T Consensus       321 s~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s-~~~~~~~~~~v~~~L~~~~--~~~  388 (829)
T KOG0576|consen  321 SSALEMT--VSEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGS-EEEVKLLDFAVPPQLTRTM--KPR  388 (829)
T ss_pred             cccccCC--hhhHhhhhhhhhhhhhhhccccccccc---ccccCcc----ccccc-ccccccccccCCcccCccc--ccc
Confidence            2211111  122334445556677788899999997   4457888    77765 4789999999887766544  234


Q ss_pred             cccCCCcccCCCccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 002529          752 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVS  794 (912)
Q Consensus       752 ~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~eLltG~~Pf~  794 (912)
                      ...+++.++|||+.....+..+-|+|++|.-..++.-|-+|-.
T Consensus       389 t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  389 TAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             cCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence            4568999999999999999999999999988778877777654

>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B

Probab=97.75  E-value=9.8e-06  Score=61.76  Aligned_cols=37  Identities=38%  Similarity=0.666  Sum_probs=23.9

Q ss_pred             cccceeecccccccCCCCCcCCCccccceeccccccCC
Q 002529          441 IDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFV  478 (912)
Q Consensus       441 ~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~  478 (912)
                      ++|+.|+|++|+|+ .+|..|++|++|+.|++++|+++
T Consensus         1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~   37 (44)
T PF12799_consen    1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS   37 (44)
T ss_dssp             TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred             CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence            35667777777777 56666677777777777777666

...

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.73  E-value=0.00023  Score=70.29  Aligned_cols=129  Identities=22%  Similarity=0.294  Sum_probs=90.1

Q ss_pred             hhhcccCccccEEEEEEEecCCCEEEEEEccCccchhhHHHHHHHHHHHhcCCCCccc-eeeEEecCCeEEEEEEecCCC
Q 002529          593 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVP-LIGYCEEEHQRILVYEYMHNG  671 (912)
Q Consensus       593 ~~~~~LG~G~fg~Vy~a~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~L~hpnIv~-l~~~~~~~~~~~lV~E~~~~g  671 (912)
                      +..+.|++|.+|.||++.+. |..+|+|+-+.+  .....++.|+++|..++-.++.+ ++.+..+    .+.|||+.|-
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~   97 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGR   97 (201)
T ss_pred             hhhhhhhcccccEEEEeecc-CceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCc
Confidence            44678999999999999998 568899886543  34577899999999998666544 4443332    3559999988


Q ss_pred             CHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC-CCCccccCCCcEEEeeccCccc
Q 002529          672 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVK-SSNILLDINMRAKVSDFGLSRQ  741 (912)
Q Consensus       672 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LHs~~~~~ivH~DLk-p~NILl~~~~~vkL~DFGla~~  741 (912)
                      .|.+.-...      +..++    ..+++.---|..   .||-|+.|+ |...++-.++.+.|+||..|+.
T Consensus        98 ~L~~~~~~~------~rk~l----~~vlE~a~~LD~---~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          98 PLGKLEIGG------DRKHL----LRVLEKAYKLDR---LGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             chhhhhhcc------cHHHH----HHHHHHHHHHHH---hccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            887765421      22333    344454334554   899999997 4444444455999999998874

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=97.72  E-value=6.9e-06  Score=85.92  Aligned_cols=84  Identities=24%  Similarity=0.309  Sum_probs=61.0

Q ss_pred             CCCcEEEEEcCCCCCcccCCcccccccccceeccccccCCCCCCCcCCccccceeecccccccCCCCCcCCCccccceec
Q 002529          392 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH  471 (912)
Q Consensus       392 ~~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~  471 (912)
                      +-..+++||||+|.|+ .|.+++.-++.++.|+||+|.|...-. +..|.+|+.||||+|.|+ .+-.+-..|-+.+.|.
T Consensus       282 TWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v~n-La~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~  358 (490)
T KOG1259|consen  282 TWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTVQN-LAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLK  358 (490)
T ss_pred             hHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeeehh-hhhcccceEeecccchhH-hhhhhHhhhcCEeeee
Confidence            3346788888888888 788888888888888888888875433 777888888888888887 5555444555555666


Q ss_pred             cccccCC
Q 002529          472 IENNSFV  478 (912)
Q Consensus       472 l~~N~l~  478 (912)
                      |++|.+.
T Consensus       359 La~N~iE  365 (490)
T KOG1259|consen  359 LAQNKIE  365 (490)
T ss_pred             hhhhhHh
Confidence            6666554

>PLN03210 Resistant to P

Probab=97.70  E-value=4.5e-05  Score=99.13  Aligned_cols=102  Identities=19%  Similarity=0.285  Sum_probs=71.4

Q ss_pred             CCcEEEEEcCCCCCcccCCcccccccccceeccccccCCCCCCCcCCccccceeecccccccCCCCCcCCCccccceecc
Q 002529          393 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI  472 (912)
Q Consensus       393 ~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l  472 (912)
                      +++|+.|+|++|...+.+|.++++|++|+.|+|++|..-+.+|...++++|+.|+|++|.....+|..   ..+|+.|+|
T Consensus       777 ~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~L  853 (1153)
T PLN03210        777 SPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGINLESLESLDLSGCSRLRTFPDI---STNISDLNL  853 (1153)
T ss_pred             cccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCCCccccCEEECCCCCcccccccc---ccccCEeEC
Confidence            35799999999988889999999999999999999866556665446777777777776544455543   245666677


Q ss_pred             ccccCCCCCCccccC--CceeeeecCCC
Q 002529          473 ENNSFVGEIPPALLT--GKVIFKYDNNP  498 (912)
Q Consensus       473 ~~N~l~g~iP~~~~~--~~~~~~~~~Np  498 (912)
                      ++|.++ .+|.++..  .+..+.+.+++
T Consensus       854 s~n~i~-~iP~si~~l~~L~~L~L~~C~  880 (1153)
T PLN03210        854 SRTGIE-EVPWWIEKFSNLSFLDMNGCN  880 (1153)
T ss_pred             CCCCCc-cChHHHhcCCCCCEEECCCCC
Confidence            777766 66665433  34444444433

syringae 6; Provisional

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=97.69  E-value=1e-05  Score=84.77  Aligned_cols=82  Identities=23%  Similarity=0.382  Sum_probs=50.3

Q ss_pred             CCcEEEEEcCCCCCcccCCcccccccccceeccccccCCCCCCCcCCccccceeecccccccCCCCCcCCCccccceecc
Q 002529          393 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI  472 (912)
Q Consensus       393 ~~~l~~L~L~~n~l~g~ip~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l  472 (912)
                      .|.++.|+||+|+|. .+.. +..|.+|+.||||+|.|+..-----.|-+.+.|.|+.|.+. .+ +.++.|=+|..||+
T Consensus       306 ~Pkir~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls~~~Gwh~KLGNIKtL~La~N~iE-~L-SGL~KLYSLvnLDl  381 (490)
T KOG1259|consen  306 APKLRRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLAECVGWHLKLGNIKTLKLAQNKIE-TL-SGLRKLYSLVNLDL  381 (490)
T ss_pred             ccceeEEecccccee-eehh-hhhcccceEeecccchhHhhhhhHhhhcCEeeeehhhhhHh-hh-hhhHhhhhheeccc
Confidence            578999999999998 5554 88899999999999999865332222333344444444433 11 12333334444444


Q ss_pred             ccccCC
Q 002529          473 ENNSFV  478 (912)
Q Consensus       473 ~~N~l~  478 (912)
                      ++|++.
T Consensus       382 ~~N~Ie  387 (490)
T KOG1259|consen  382 SSNQIE  387 (490)
T ss_pred             cccchh
Confidence            444443

>PLN02876 acyl-CoA dehydrogenase

Probab=97.65  E-value=0.00039  Score=87.34  Aligned_cols=78  Identities=13%  Similarity=0.299  Sum_probs=57.8

Q ss_pred             hcccCccccEEEEEEEecCC---CEEEEEEccCcc-chhhHHHHHHHHHHHhcC-CCCc--cceeeEEecC---CeEEEE
Q 002529          595 CKKIGKGSFGSVYYGKMKDG---KEVAVKIMADSC-SHRTQQFVTEVALLSRIH-HRNL--VPLIGYCEEE---HQRILV  664 (912)
Q Consensus       595 ~~~LG~G~fg~Vy~a~~~~~---~~vAvK~l~~~~-~~~~~~~~~E~~il~~L~-hpnI--v~l~~~~~~~---~~~~lV  664 (912)
                      .+.++.|.+..+|+....++   ..+++|+..... ......+.+|+++|+.+. |.++  .+++.+|.+.   +..++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            46789999999999887654   467888764322 123357889999999995 6664  7888887664   467899


Q ss_pred             EEecCCCC
Q 002529          665 YEYMHNGT  672 (912)
Q Consensus       665 ~E~~~~gs  672 (912)
                      |||++|..
T Consensus       123 ME~v~G~~  130 (822)
T PLN02876        123 MEYLEGRI  130 (822)
T ss_pred             EEecCCcc
Confidence            99998764

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	912
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		3e-59
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-58
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		5e-56
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-55
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-37
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		8e-37
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-36
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		5e-35
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-34
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-34
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-25
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		9e-25
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-24
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-24
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-24
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		3e-24
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-24
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		4e-24
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		8e-24
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-23
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-23
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-23
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-23
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-23
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		8e-23
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		9e-23
4h58_A	275	Braf In Complex With Compound 3 Length = 275		9e-23
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		9e-23
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		9e-23
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-22
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-22
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-22
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-22
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-22
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-22
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-22
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-22
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-22
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-22
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-22
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-22
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-22
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-22
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-22
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-22
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-22
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-22
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-22
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-22
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-22
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-22
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-22
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-22
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-22
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-22
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-22
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-22
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-22
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-22
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-22
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-22
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-22
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-22
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-22
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-22
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-22
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-22
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-22
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-22
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		6e-22
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		6e-22
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		6e-22
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		8e-22
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		8e-22
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		8e-22
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		8e-22
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		8e-22
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-22
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		9e-22
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		9e-22
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-21
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-21
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-21
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-21
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-21
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-21
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-21
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-21
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-21
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-21
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-21
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-21
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-21
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-21
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-21
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-21
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-21
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-21
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		3e-21
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		5e-21
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		6e-21
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-21
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		8e-21
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-21
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		8e-21
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		9e-21
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		9e-21
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-21
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		9e-21
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		9e-21
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-20
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-20
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-20
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-20
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-20
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-20
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-20
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-20
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-20
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-20
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-20
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-20
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-20
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-20
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-20
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-20
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-20
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		3e-20
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-20
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-20
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		3e-20
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-20
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-20
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		4e-20
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		4e-20
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		4e-20
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		4e-20
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		4e-20
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		4e-20
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		4e-20
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		4e-20
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		5e-20
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		6e-20
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		6e-20
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		6e-20
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		7e-20
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		7e-20
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		7e-20
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		7e-20
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		7e-20
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		8e-20
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		8e-20
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		8e-20
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		8e-20
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		9e-20
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		9e-20
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		9e-20
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-19
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-19
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-19
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-19
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-19
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-19
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-19
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-19
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-19
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-19
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-19
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-19
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-19
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-19
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		3e-19
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		4e-19
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		5e-19
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-19
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		6e-19
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		7e-19
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		7e-19
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		7e-19
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		7e-19
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		7e-19
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		7e-19
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		8e-19
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		8e-19
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		9e-19
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		9e-19
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		9e-19
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-18
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-18
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-18
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-18
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-18
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-18
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-18
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-18
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-18
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-18
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-18
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-18
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-18
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-18
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-18
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		3e-18
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-18
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-18
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		4e-18
1fvr_A	327	Tie2 Kinase Domain Length = 327		5e-18
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		5e-18
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		5e-18
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		5e-18
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-18
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		8e-18
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-17
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-17
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-17
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-17
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-17
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-17
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-17
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-17
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-17
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-17
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-17
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		3e-17
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-17
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		4e-17
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		5e-17
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		5e-17
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		6e-17
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		6e-17
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		7e-17
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		7e-17
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		7e-17
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		7e-17
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		7e-17
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		7e-17
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		7e-17
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		8e-17
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-17
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		9e-17
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		9e-17
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		9e-17
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		9e-17
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-16
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-16
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-16
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-16
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-16
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-16
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-16
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-16
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-16
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-16
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-16
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-16
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-16
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-16
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-16
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-16
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-16
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-16
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-16
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-16
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-16
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-16
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-16
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-16
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-16
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-16
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-16
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-16
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-16
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-16
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-16
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-16
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-16
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-16
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-16
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-16
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-16
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-16
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-16
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-16
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-16
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-16
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-16
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-16
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-16
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-16
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-16
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-16
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-16
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-16
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-16
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-16
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-16
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-16
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-16
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-16
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		3e-16
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-16
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-16
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-16
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-16
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-16
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		4e-16
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		4e-16
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		4e-16
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		4e-16
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		4e-16
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		4e-16
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-16
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		5e-16
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-16
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-16
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		5e-16
3g51_A	325	Structural Diversity Of The Active Conformation Of		5e-16
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		6e-16
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		6e-16
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		6e-16
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-16
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		7e-16
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		7e-16
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		8e-16
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		8e-16
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		8e-16
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		8e-16
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		8e-16
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-15
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-15
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-15
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-15
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-15
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-15
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-15
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-15
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-15
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-15
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-15
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-15
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-15
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-15
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		3e-15
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-15
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		3e-15
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-15
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-15
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		3e-15
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		3e-15
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		3e-15
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		3e-15
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		3e-15
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		3e-15
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-15
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-15
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		3e-15
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		4e-15
3a7f_A	303	Human Mst3 Kinase Length = 303		4e-15
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		4e-15
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		4e-15
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-15
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		4e-15
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-15
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		4e-15
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-15
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		5e-15
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-15
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-15
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		5e-15
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		5e-15
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		5e-15
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		5e-15
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		5e-15
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		6e-15
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		6e-15
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		6e-15
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		6e-15
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		6e-15
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		6e-15
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		6e-15
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		6e-15
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		7e-15
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		7e-15
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		7e-15
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		7e-15
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		7e-15
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		7e-15
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		7e-15
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		7e-15
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		7e-15
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		8e-15
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		8e-15
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		8e-15
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		8e-15
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		8e-15
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		8e-15
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		8e-15
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		8e-15
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		8e-15
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		8e-15
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		9e-15
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-14
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-14
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-14
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-14
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-14
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-14
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-14
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-14
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-14
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-14
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-14
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-14
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-14
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-14
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-14
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-14
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-14
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-14
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-14
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-14
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-14
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-14
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-14
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-14
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-14
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-14
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		3e-14
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-14
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-14
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-14
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		3e-14
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-14
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-14
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-14
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-14
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-14
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-14
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		3e-14
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-14
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-14
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		3e-14
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-14
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-14
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		4e-14
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		4e-14
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		4e-14
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-14
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-14
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		4e-14
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		4e-14
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		4e-14
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		5e-14
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		5e-14
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		5e-14
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		5e-14
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		6e-14
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		6e-14
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		8e-14
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		8e-14
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		9e-14
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-13
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-13
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-13
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		1e-13
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-13
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-13
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-13
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-13
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-13
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-13
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-13
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-13
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-13
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-13
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-13
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-13
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-13
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-13
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-13
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-13
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-13
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		3e-13
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		3e-13
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		4e-13
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-13
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		5e-13
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		5e-13
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		5e-13
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		5e-13
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		5e-13
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		5e-13
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		6e-13
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		6e-13
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		6e-13
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		6e-13
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		7e-13
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		7e-13
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		7e-13
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		8e-13
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		8e-13
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		8e-13
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		8e-13
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		8e-13
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		8e-13
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		8e-13
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		8e-13
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		8e-13
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		8e-13
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		9e-13
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		9e-13
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		9e-13
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		9e-13
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		9e-13
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		9e-13
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		9e-13
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		9e-13
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		9e-13
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		9e-13
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		9e-13
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		9e-13
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		9e-13
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-12
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-12
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-12
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-12
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-12
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-12
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-12
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-12
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-12
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-12
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-12
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-12
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-12
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-12
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-12
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-12
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-12
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-12
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-12
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-12
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-12
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-12
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-12
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-12
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-12
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-12
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-12
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-12
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-12
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		3e-12
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-12
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-12
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		3e-12
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-12
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-12
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		4e-12
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-12
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		4e-12
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		4e-12
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-12
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		4e-12
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-12
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		4e-12
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		4e-12
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		4e-12
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		4e-12
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		4e-12
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-12
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		4e-12
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		4e-12
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		4e-12
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		4e-12
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		4e-12
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		4e-12
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		4e-12
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-12
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		4e-12
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		4e-12
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		5e-12
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		5e-12
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		5e-12
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		5e-12
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-12
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		5e-12
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		5e-12
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		5e-12
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-12
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-12
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		6e-12
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		6e-12
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		6e-12
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-12
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		6e-12
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		6e-12
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		6e-12
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		6e-12
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		6e-12
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		7e-12
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		7e-12
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		7e-12
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		7e-12
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		7e-12
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		7e-12
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		8e-12
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		9e-12
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-11
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-11
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-11
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-11
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-11
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-11
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-11
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-11
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-11
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-11
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-11
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-11
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-11
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-11
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-11
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-11
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-11
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-11
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-11
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-11
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-11
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-11
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		3e-11
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-11
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-11
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-11
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-11
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-11
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-11
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-11
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-11
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		3e-11
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		3e-11
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		3e-11
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		3e-11
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		3e-11
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-11
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-11
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		3e-11
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		3e-11
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		3e-11
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		4e-11
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		4e-11
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		4e-11
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		4e-11
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		4e-11
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		4e-11
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		5e-11
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		5e-11
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		5e-11
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		6e-11
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		6e-11
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-11
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		6e-11
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		7e-11
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-11
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		8e-11
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		8e-11
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		8e-11
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		9e-11
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		9e-11
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		9e-11
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		9e-11
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		9e-11
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-10
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-10
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-10
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-10
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-10
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-10
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-10
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-10
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-10
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-10
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-10
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-10
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-10
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-10
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-10
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-10
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-10
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-10
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-10
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-10
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-10
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-10
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-10
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-10
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-10
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-10
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-10
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-10
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-10
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-10
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-10
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-10
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-10
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-10
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-10
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-10
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-10
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-10
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-10
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-10
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-10
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-10
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-10
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-10
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-10
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-10
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-10
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-10
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-10
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-10
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-10
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-10
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-10
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-10
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-10
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-10
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-10
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-10
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-10
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-10
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-10
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-10
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-10
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-10
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-10
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-10
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-10
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-10
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-10
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-10
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-10
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-10
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-10
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-10
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-10
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-10
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		3e-10
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		3e-10
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-10
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		3e-10
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		3e-10
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		3e-10
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		3e-10
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		3e-10
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		3e-10
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		3e-10
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		3e-10
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-10
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-10
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-10
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-10
3kk8_A	284	Camkii Substrate Complex A Length = 284		4e-10
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		4e-10
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		4e-10
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-10
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		4e-10
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		4e-10
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-10
3kk9_A	282	Camkii Substrate Complex B Length = 282		4e-10
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		4e-10
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		4e-10
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		4e-10
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-10
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		5e-10
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		5e-10
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		5e-10
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-10
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-10
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		5e-10
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		5e-10
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		6e-10
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		6e-10
4exu_A	371	Mapk13, Inactive Form Length = 371		6e-10
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		7e-10
3soa_A	444	Full-Length Human Camkii Length = 444		7e-10
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		7e-10
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-10
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		7e-10
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		7e-10
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		8e-10
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		8e-10
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		8e-10
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		8e-10
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		9e-10
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		9e-10
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		9e-10
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		9e-10
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		9e-10
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		9e-10
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-09
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-09
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-09
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-09
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-09
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-09
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-09
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-09
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		1e-09
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-09
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-09
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-09
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-09
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-09
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-09
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-09
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-09
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-09
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-09
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-09
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-09
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-09
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-09
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-09
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-09
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-09
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-09
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-09
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-09
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-09
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-09
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		3e-09
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-09
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-09
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-09
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		3e-09
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		4e-09
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		4e-09
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-09
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-09
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		4e-09
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-09
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-09
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		4e-09
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		4e-09
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		4e-09
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		4e-09
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		5e-09
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		5e-09
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		5e-09
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		5e-09
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		5e-09
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		5e-09
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		5e-09
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		5e-09
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		5e-09
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		5e-09
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		6e-09
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		6e-09
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		6e-09
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		6e-09
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		7e-09
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		7e-09
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		7e-09
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		8e-09
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		8e-09
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		8e-09
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		8e-09
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		8e-09
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		8e-09
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		8e-09
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		8e-09
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		8e-09
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		8e-09
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-08
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-08
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-08
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-08
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		1e-08
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		1e-08
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-08
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-08
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		1e-08
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-08
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		2e-08
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-08
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-08
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-08
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-08
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-08
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-08
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-08
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		3e-08
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-08
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		3e-08
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		3e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		3e-08
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		3e-08
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		4e-08
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		4e-08
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		4e-08
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		5e-08
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		5e-08
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		5e-08
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		5e-08
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		5e-08
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		6e-08
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		6e-08
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		6e-08
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		6e-08
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		6e-08
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		7e-08
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		7e-08
4ae6_A	343	Structure And Function Of The Human Sperm-specific		7e-08
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		7e-08
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		7e-08
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		7e-08
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		7e-08
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		8e-08
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		8e-08
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		8e-08
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		8e-08
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		8e-08
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		8e-08
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		8e-08
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-08
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-08
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		9e-08
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		9e-08
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		9e-08
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		9e-08
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		9e-08
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-07
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		1e-07
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-07
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		1e-07
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-07
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-07
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-07
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-07
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-07
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-07
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-07
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-07
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-07
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-07
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-07
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-07
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-07
3gni_B	389	Structure Of Strad And Mo25 Length = 389		2e-07
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-07
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-07
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		2e-07
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		3e-07
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		3e-07
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		3e-07
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-07
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		4e-07
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		4e-07
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		4e-07
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		4e-07
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		4e-07
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		5e-07
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		5e-07
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		6e-07
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		6e-07
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		7e-07
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		9e-07
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		9e-07
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-06
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-06
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-06
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-06
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		1e-06
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		1e-06
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		3e-06
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-06
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		3e-06
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-06
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		3e-06
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		4e-06
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		5e-06
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		5e-06
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		7e-06
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		7e-06
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		7e-06
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		8e-06
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		8e-06
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		8e-06
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-06
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		8e-06
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		8e-06
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-06
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		8e-06
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-06
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		9e-06
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		9e-06
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		9e-06
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		9e-06

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  226 bits (577), Expect = 3e-59,   Method: Compositional matrix adjust.
 Identities = 127/296 (42%), Positives = 187/296 (63%), Gaps = 9/296 (3%)
Query: 579 AYFIPLPELEEATNNFCKK--IGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTE 636
           +Y +PL +LEEATNNF  K  IG G FG VY G ++DG +VA+K      S   ++F TE
Sbjct: 26  SYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETE 85
Query: 637 VALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGS-VNQKPLDWLTRLQIA 695
           +  LS   H +LV LIG+C+E ++ IL+Y+YM NG L+  L+GS +    + W  RL+I 
Sbjct: 86  IETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEIC 145
Query: 696 HDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-DLTHISSVAR 754
             AA+GL YLHT     IIHRDVKS NILLD N   K++DFG+S++  E D TH+  V +
Sbjct: 146 IGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVK 202
Query: 755 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL-NIVHWARSMIK 813
           GT+GY+DPEY+   +LTEKSDVYSFGVVL E++  +  + V+    E+ N+  WA     
Sbjct: 203 GTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAI-VQSLPREMVNLAEWAVESHN 261
Query: 814 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 869
            G +  IVDP L   ++ ES+ +  + A++C+      RP M +++  ++ +++++
Sbjct: 262 NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  224 bits (570), Expect = 2e-58,   Method: Compositional matrix adjust.
 Identities = 126/296 (42%), Positives = 186/296 (62%), Gaps = 9/296 (3%)
Query: 579 AYFIPLPELEEATNNFCKK--IGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTE 636
           +Y +PL +LEEATNNF  K  IG G FG VY G ++DG +VA+K      S   ++F TE
Sbjct: 26  SYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETE 85
Query: 637 VALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGS-VNQKPLDWLTRLQIA 695
           +  LS   H +LV LIG+C+E ++ IL+Y+YM NG L+  L+GS +    + W  RL+I 
Sbjct: 86  IETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEIC 145
Query: 696 HDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-DLTHISSVAR 754
             AA+GL YLHT     IIHRDVKS NILLD N   K++DFG+S++  E   TH+  V +
Sbjct: 146 IGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVK 202
Query: 755 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL-NIVHWARSMIK 813
           GT+GY+DPEY+   +LTEKSDVYSFGVVL E++  +  + V+    E+ N+  WA     
Sbjct: 203 GTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAI-VQSLPREMVNLAEWAVESHN 261
Query: 814 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 869
            G +  IVDP L   ++ ES+ +  + A++C+      RP M +++  ++ +++++
Sbjct: 262 NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  216 bits (549), Expect = 5e-56,   Method: Compositional matrix adjust.
 Identities = 116/289 (40%), Positives = 178/289 (61%), Gaps = 12/289 (4%)
Query: 584 LPELEEATNNFCKK--IGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQ-QFVTEVALL 640
           L EL+ A++NF  K  +G+G FG VY G++ DG  VAVK + +      + QF TEV ++
Sbjct: 30  LRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTEVEMI 89
Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGT----LRDRLHGSVNQKPLDWLTRLQIAH 696
           S   HRNL+ L G+C    +R+LVY YM NG+    LR+R     +Q PLDW  R +IA 
Sbjct: 90  SMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRER---PESQPPLDWPKRQRIAL 146
Query: 697 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT 756
            +A+GL YLH  C+P IIHRDVK++NILLD    A V DFGL++  +    H+    RGT
Sbjct: 147 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGT 206
Query: 757 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG--AELNIVHWARSMIKK 814
           +G++ PEY    + +EK+DV+ +GV+LLELI+G++   +       ++ ++ W + ++K+
Sbjct: 207 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 266
Query: 815 GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 863
             + ++VD  L GN K E + ++ +VA+ C +     RPKM E+V  ++
Sbjct: 267 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 315

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  214 bits (546), Expect = 1e-55,   Method: Compositional matrix adjust.
 Identities = 118/292 (40%), Positives = 179/292 (61%), Gaps = 18/292 (6%)
Query: 584 LPELEEATNNFCKK--IGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQ----QFVTEV 637
           L EL+ A++NF  K  +G+G FG VY G++ DG  VAVK + +    RTQ    QF TEV
Sbjct: 22  LRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEE---RTQGGELQFQTEV 78
Query: 638 ALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGT----LRDRLHGSVNQKPLDWLTRLQ 693
            ++S   HRNL+ L G+C    +R+LVY YM NG+    LR+R     +Q PLDW  R +
Sbjct: 79  EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRER---PESQPPLDWPKRQR 135
Query: 694 IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 753
           IA  +A+GL YLH  C+P IIHRDVK++NILLD    A V DFGL++  +    H+    
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAV 195
Query: 754 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG--AELNIVHWARSM 811
           RG +G++ PEY    + +EK+DV+ +GV+LLELI+G++   +       ++ ++ W + +
Sbjct: 196 RGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255
Query: 812 IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 863
           +K+  + ++VD  L GN K E + ++ +VA+ C +     RPKM E+V  ++
Sbjct: 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  154 bits (389), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 106/292 (36%), Positives = 157/292 (53%), Gaps = 20/292 (6%)
Query: 586 ELEEATNNF--------CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT----QQF 633
           EL+  TNNF          K+G+G FG VY G + +   VAVK +A      T    QQF
Sbjct: 19  ELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEELKQQF 77
Query: 634 VTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ 693
             E+ ++++  H NLV L+G+  +     LVY YM NG+L DRL       PL W  R +
Sbjct: 78  DQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCK 137
Query: 694 IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-DLTHISSV 752
           IA  AA G+ +LH   +   IHRD+KS+NILLD    AK+SDFGL+R +E+   T + S 
Sbjct: 138 IAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSR 194
Query: 753 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI 812
             GT  Y+ PE     ++T KSD+YSFGVVLLE+I+G  P   E    +L +        
Sbjct: 195 IVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITG-LPAVDEHREPQLLLDIKEEIED 252
Query: 813 KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 864
           ++  +   +D  +  +    S+  +  VA QC+ ++   RP ++++   +Q+
Sbjct: 253 EEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  152 bits (384), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 105/292 (35%), Positives = 156/292 (53%), Gaps = 20/292 (6%)
Query: 586 ELEEATNNF--------CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT----QQF 633
           EL+  TNNF          K+G+G FG VY G + +   VAVK +A      T    QQF
Sbjct: 19  ELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEELKQQF 77
Query: 634 VTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ 693
             E+ ++++  H NLV L+G+  +     LVY YM NG+L DRL       PL W  R +
Sbjct: 78  DQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCK 137
Query: 694 IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-DLTHISSV 752
           IA  AA G+ +LH   +   IHRD+KS+NILLD    AK+SDFGL+R +E+   T +   
Sbjct: 138 IAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXR 194
Query: 753 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI 812
             GT  Y+ PE     ++T KSD+YSFGVVLLE+I+G  P   E    +L +        
Sbjct: 195 IVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITG-LPAVDEHREPQLLLDIKEEIED 252
Query: 813 KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 864
           ++  +   +D  +  +    S+  +  VA QC+ ++   RP ++++   +Q+
Sbjct: 253 EEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  152 bits (383), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 106/293 (36%), Positives = 154/293 (52%), Gaps = 22/293 (7%)
Query: 586 ELEEATNNF--------CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT----QQF 633
           EL+  TNNF          K+G+G FG VY G + +   VAVK +A      T    QQF
Sbjct: 13  ELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEELKQQF 71
Query: 634 VTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ 693
             E+ ++++  H NLV L+G+  +     LVY YM NG+L DRL       PL W  R +
Sbjct: 72  DQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCK 131
Query: 694 IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 753
           IA  AA G+ +LH   +   IHRD+KS+NILLD    AK+SDFGL+R A E         
Sbjct: 132 IAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLAR-ASEKFAQXVMXX 187
Query: 754 R--GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM 811
           R  GT  Y+ PE     ++T KSD+YSFGVVLLE+I+G  P   E    +L +       
Sbjct: 188 RIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITG-LPAVDEHREPQLLLDIKEEIE 245
Query: 812 IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 864
            ++  +   +D  +  +    S+  +  VA QC+ ++   RP ++++   +Q+
Sbjct: 246 DEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 297

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  146 bits (368), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 85/202 (42%), Positives = 120/202 (59%), Gaps = 5/202 (2%)
Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH--RTQQFVTEVALLSRIHHRNLVP 650
           N  +KIG GSFG+V+  +   G +VAVKI+ +   H  R  +F+ EVA++ R+ H N+V 
Sbjct: 40  NIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVL 98
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 710
            +G   +     +V EY+  G+L   LH S  ++ LD   RL +A+D AKG+ YLH   N
Sbjct: 99  FMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-N 157
Query: 711 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 770
           P I+HRD+KS N+L+D     KV DFGLSR         S  A GT  ++ PE   ++  
Sbjct: 158 PPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFL-XSKXAAGTPEWMAPEVLRDEPS 216
Query: 771 TEKSDVYSFGVVLLELISGKKP 792
            EKSDVYSFGV+L EL + ++P
Sbjct: 217 NEKSDVYSFGVILWELATLQQP 238

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  144 bits (364), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 84/202 (41%), Positives = 120/202 (59%), Gaps = 5/202 (2%)
Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH--RTQQFVTEVALLSRIHHRNLVP 650
           N  +KIG GSFG+V+  +   G +VAVKI+ +   H  R  +F+ EVA++ R+ H N+V 
Sbjct: 40  NIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVL 98
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 710
            +G   +     +V EY+  G+L   LH S  ++ LD   RL +A+D AKG+ YLH   N
Sbjct: 99  FMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-N 157
Query: 711 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 770
           P I+HR++KS N+L+D     KV DFGLSR          S A GT  ++ PE   ++  
Sbjct: 158 PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA-GTPEWMAPEVLRDEPS 216
Query: 771 TEKSDVYSFGVVLLELISGKKP 792
            EKSDVYSFGV+L EL + ++P
Sbjct: 217 NEKSDVYSFGVILWELATLQQP 238

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  144 bits (363), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 105/293 (35%), Positives = 149/293 (50%), Gaps = 22/293 (7%)
Query: 586 ELEEATNNF--------CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT----QQF 633
           EL+  TNNF          K G+G FG VY G + +   VAVK +A      T    QQF
Sbjct: 10  ELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEELKQQF 68
Query: 634 VTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ 693
             E+ + ++  H NLV L+G+  +     LVY Y  NG+L DRL       PL W  R +
Sbjct: 69  DQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCK 128
Query: 694 IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 753
           IA  AA G+ +LH   +   IHRD+KS+NILLD    AK+SDFGL+R A E        +
Sbjct: 129 IAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLAR-ASEKFAQXVXXS 184
Query: 754 R--GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM 811
           R  GT  Y  PE     ++T KSD+YSFGVVLLE+I+G  P   E    +L +       
Sbjct: 185 RIVGTTAYXAPEAL-RGEITPKSDIYSFGVVLLEIITG-LPAVDEHREPQLLLDIKEEIE 242
Query: 812 IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 864
            ++  +   +D     +    S+     VA QC+ ++   RP ++++   +Q+
Sbjct: 243 DEEKTIEDYIDKK-XNDADSTSVEAXYSVASQCLHEKKNKRPDIKKVQQLLQE 294

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  114 bits (285), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 80/231 (34%), Positives = 126/231 (54%), Gaps = 24/231 (10%)
Query: 584 LPELEEATNNFCKKIGKGSFGSVYYGKM-KDGKEVAVK--IMADS-----CSHRTQQFVT 635
           LP L +    + K+IGKG FG V+ G++ KD   VA+K  I+ DS        + Q+F  
Sbjct: 13  LPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQR 72
Query: 636 EVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA 695
           EV ++S ++H N+V L G      +  +V E++  G L  RL    +  P+ W  +L++ 
Sbjct: 73  EVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLM 128
Query: 696 HDAAKGLEYLHTGCNPGIIHRDVKSSNILL-----DINMRAKVSDFGLSRQAEEDLTHIS 750
            D A G+EY+    NP I+HRD++S NI L     +  + AKV+DFGLS+Q+     H  
Sbjct: 129 LDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS----VHSV 183
Query: 751 SVARGTVGYLDPEYYGNQQ--LTEKSDVYSFGVVLLELISGKKPVSVEDFG 799
           S   G   ++ PE  G ++   TEK+D YSF ++L  +++G+ P     +G
Sbjct: 184 SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG 234

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score =  112 bits (280), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 79/231 (34%), Positives = 125/231 (54%), Gaps = 24/231 (10%)
Query: 584 LPELEEATNNFCKKIGKGSFGSVYYGKM-KDGKEVAVK--IMADS-----CSHRTQQFVT 635
           LP L +    + K+IGKG FG V+ G++ KD   VA+K  I+ DS        + Q+F  
Sbjct: 13  LPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQR 72
Query: 636 EVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA 695
           EV ++S ++H N+V L G      +  +V E++  G L  RL    +  P+ W  +L++ 
Sbjct: 73  EVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLM 128
Query: 696 HDAAKGLEYLHTGCNPGIIHRDVKSSNILL-----DINMRAKVSDFGLSRQAEEDLTHIS 750
            D A G+EY+    NP I+HRD++S NI L     +  + AKV+DFG S+Q+     H  
Sbjct: 129 LDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQS----VHSV 183
Query: 751 SVARGTVGYLDPEYYGNQQ--LTEKSDVYSFGVVLLELISGKKPVSVEDFG 799
           S   G   ++ PE  G ++   TEK+D YSF ++L  +++G+ P     +G
Sbjct: 184 SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG 234

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  112 bits (279), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 79/231 (34%), Positives = 125/231 (54%), Gaps = 24/231 (10%)
Query: 584 LPELEEATNNFCKKIGKGSFGSVYYGKM-KDGKEVAVK--IMADS-----CSHRTQQFVT 635
           LP L +    + K+IGKG FG V+ G++ KD   VA+K  I+ DS        + Q+F  
Sbjct: 13  LPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQR 72
Query: 636 EVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA 695
           EV ++S ++H N+V L G      +  +V E++  G L  RL    +  P+ W  +L++ 
Sbjct: 73  EVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLM 128
Query: 696 HDAAKGLEYLHTGCNPGIIHRDVKSSNILL-----DINMRAKVSDFGLSRQAEEDLTHIS 750
            D A G+EY+    NP I+HRD++S NI L     +  + AKV+DF LS+Q+     H  
Sbjct: 129 LDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQS----VHSV 183
Query: 751 SVARGTVGYLDPEYYGNQQ--LTEKSDVYSFGVVLLELISGKKPVSVEDFG 799
           S   G   ++ PE  G ++   TEK+D YSF ++L  +++G+ P     +G
Sbjct: 184 SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG 234

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score =  110 bits (276), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 107/201 (53%), Gaps = 7/201 (3%)
Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 652
            F ++IG G FG V+ G   +  +VA+K + +  +   + F+ E  ++ ++ H  LV L 
Sbjct: 8   TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLY 66
Query: 653 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 712
           G C E+    LV+E+M +G L D L         +  T L +  D  +G+ YL   C   
Sbjct: 67  GVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE--TLLGMCLDVCEGMAYLEEAC--- 121
Query: 713 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 772
           +IHRD+ + N L+  N   KVSDFG++R   +D    S+  +  V +  PE +   + + 
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 181
Query: 773 KSDVYSFGVVLLELIS-GKKP 792
           KSDV+SFGV++ E+ S GK P
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIP 202

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score =  110 bits (276), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 68/201 (33%), Positives = 106/201 (52%), Gaps = 7/201 (3%)
Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 652
            F ++IG G FG V+ G   +  +VA+K + +  S     F+ E  ++ ++ H  LV L 
Sbjct: 30  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIKEG-SMSEDDFIEEAEVMMKLSHPKLVQLY 88
Query: 653 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 712
           G C E+    LV+E+M +G L D L         +  T L +  D  +G+ YL   C   
Sbjct: 89  GVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE--TLLGMCLDVCEGMAYLEEAC--- 143
Query: 713 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 772
           +IHRD+ + N L+  N   KVSDFG++R   +D    S+  +  V +  PE +   + + 
Sbjct: 144 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 203
Query: 773 KSDVYSFGVVLLELIS-GKKP 792
           KSDV+SFGV++ E+ S GK P
Sbjct: 204 KSDVWSFGVLMWEVFSEGKIP 224

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score =  110 bits (276), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 107/201 (53%), Gaps = 7/201 (3%)
Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 652
            F ++IG G FG V+ G   +  +VA+K + +  +   + F+ E  ++ ++ H  LV L 
Sbjct: 10  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLY 68
Query: 653 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 712
           G C E+    LV+E+M +G L D L         +  T L +  D  +G+ YL   C   
Sbjct: 69  GVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE--TLLGMCLDVCEGMAYLEEAC--- 123
Query: 713 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 772
           +IHRD+ + N L+  N   KVSDFG++R   +D    S+  +  V +  PE +   + + 
Sbjct: 124 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 183
Query: 773 KSDVYSFGVVLLELIS-GKKP 792
           KSDV+SFGV++ E+ S GK P
Sbjct: 184 KSDVWSFGVLMWEVFSEGKIP 204

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score =  110 bits (276), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 107/201 (53%), Gaps = 7/201 (3%)
Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 652
            F ++IG G FG V+ G   +  +VA+K + +  +   + F+ E  ++ ++ H  LV L 
Sbjct: 13  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLY 71
Query: 653 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 712
           G C E+    LV+E+M +G L D L         +  T L +  D  +G+ YL   C   
Sbjct: 72  GVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE--TLLGMCLDVCEGMAYLEEAC--- 126
Query: 713 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 772
           +IHRD+ + N L+  N   KVSDFG++R   +D    S+  +  V +  PE +   + + 
Sbjct: 127 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 186
Query: 773 KSDVYSFGVVLLELIS-GKKP 792
           KSDV+SFGV++ E+ S GK P
Sbjct: 187 KSDVWSFGVLMWEVFSEGKIP 207

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score =  110 bits (275), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 77/223 (34%), Positives = 116/223 (52%), Gaps = 30/223 (13%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIM--ADSCSHRTQQFVTEVALLSRI 643
           E+E +      +IG GSFG+VY GK     +VAVKI+   D    + Q F  EVA+L + 
Sbjct: 32  EIEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKT 89
Query: 644 HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 703
            H N++  +GY  +++  I V ++    +L   LH  V +        + IA   A+G++
Sbjct: 90  RHVNILLFMGYMTKDNLAI-VTQWCEGSSLYKHLH--VQETKFQMFQLIDIARQTAQGMD 146
Query: 704 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL---------SRQAEEDLTHISSVAR 754
           YLH      IIHRD+KS+NI L   +  K+ DFGL         S+Q E+          
Sbjct: 147 YLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQ--------PT 195
Query: 755 GTVGYLDPE---YYGNQQLTEKSDVYSFGVVLLELISGKKPVS 794
           G+V ++ PE      N   + +SDVYS+G+VL EL++G+ P S
Sbjct: 196 GSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYS 238

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score =  109 bits (272), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 85/268 (31%), Positives = 140/268 (52%), Gaps = 34/268 (12%)
Query: 598 IGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE 657
           +G+G+FG V   K +  K+VA+K + +S S R + F+ E+  LSR++H N+V L G C  
Sbjct: 17  VGRGAFGVVCKAKWR-AKDVAIKQI-ESESER-KAFIVELRQLSRVNHPNIVKLYGACL- 72
Query: 658 EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR---LQIAHDAAKGLEYLHTGCNPGII 714
            +   LV EY   G+L + LHG+   +PL + T    +      ++G+ YLH+     +I
Sbjct: 73  -NPVCLVMEYAEGGSLYNVLHGA---EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 128
Query: 715 HRDVKSSNILLDINMRA-KVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 773
           HRD+K  N+LL       K+ DFG +   +  +T+     +G+  ++ PE +     +EK
Sbjct: 129 HRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTN----NKGSAAWMAPEVFEGSNYSEK 184
Query: 774 SDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV--KI 831
            DV+S+G++L E+I+ +KP   ++ G     + WA        V +   P LI N+   I
Sbjct: 185 CDVFSWGIILWEVITRRKP--FDEIGGPAFRIMWA--------VHNGTRPPLIKNLPKPI 234
Query: 832 ESIWRIAEVAIQCVEQRGFSRPKMQEIV 859
           ES+        +C  +    RP M+EIV
Sbjct: 235 ESL------MTRCWSKDPSQRPSMEEIV 256

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score =  108 bits (271), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 106/201 (52%), Gaps = 7/201 (3%)
Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 652
            F ++IG G FG V+ G   +  +VA+K + +  +   + F+ E  ++ ++ H  LV L 
Sbjct: 11  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLY 69
Query: 653 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 712
           G C E+    LV E+M +G L D L         +  T L +  D  +G+ YL   C   
Sbjct: 70  GVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAE--TLLGMCLDVCEGMAYLEEAC--- 124
Query: 713 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 772
           +IHRD+ + N L+  N   KVSDFG++R   +D    S+  +  V +  PE +   + + 
Sbjct: 125 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 184
Query: 773 KSDVYSFGVVLLELIS-GKKP 792
           KSDV+SFGV++ E+ S GK P
Sbjct: 185 KSDVWSFGVLMWEVFSEGKIP 205

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score =  108 bits (271), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 85/268 (31%), Positives = 140/268 (52%), Gaps = 34/268 (12%)
Query: 598 IGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE 657
           +G+G+FG V   K +  K+VA+K + +S S R + F+ E+  LSR++H N+V L G C  
Sbjct: 16  VGRGAFGVVCKAKWR-AKDVAIKQI-ESESER-KAFIVELRQLSRVNHPNIVKLYGACL- 71
Query: 658 EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR---LQIAHDAAKGLEYLHTGCNPGII 714
            +   LV EY   G+L + LHG+   +PL + T    +      ++G+ YLH+     +I
Sbjct: 72  -NPVCLVMEYAEGGSLYNVLHGA---EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 715 HRDVKSSNILLDINMRA-KVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 773
           HRD+K  N+LL       K+ DFG +   +  +T+     +G+  ++ PE +     +EK
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTN----NKGSAAWMAPEVFEGSNYSEK 183
Query: 774 SDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV--KI 831
            DV+S+G++L E+I+ +KP   ++ G     + WA        V +   P LI N+   I
Sbjct: 184 CDVFSWGIILWEVITRRKP--FDEIGGPAFRIMWA--------VHNGTRPPLIKNLPKPI 233
Query: 832 ESIWRIAEVAIQCVEQRGFSRPKMQEIV 859
           ES+        +C  +    RP M+EIV
Sbjct: 234 ESL------MTRCWSKDPSQRPSMEEIV 255

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score =  108 bits (269), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 81/281 (28%), Positives = 135/281 (48%), Gaps = 30/281 (10%)
Query: 596 KKIGKGSFGSVYYGKMKDG---KEVAVKIMADSCSHRTQQ---FVTEVALLSRIHHRNLV 649
           K IG G FG VY G +K     KEV V I      +  +Q   F+ E  ++ +  H N++
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109
Query: 650 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 709
            L G   +    +++ EYM NG L   L     +     L  + +    A G++YL    
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLREKDGE--FSVLQLVGMLRGIAAGMKYL---A 164
Query: 710 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED--LTHISSVARGTVGYLDPEYYGN 767
           N   +HRD+ + NIL++ N+  KVSDFGLSR  E+D   T+ +S  +  + +  PE    
Sbjct: 165 NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY 224
Query: 768 QQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 826
           ++ T  SDV+SFG+V+ E+++ G++P             +W  S     +V+  ++    
Sbjct: 225 RKFTSASDVWSFGIVMWEVMTYGERP-------------YWELS---NHEVMKAINDGFR 268
Query: 827 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 867
               ++    I ++ +QC +Q    RPK  +IV  +   I+
Sbjct: 269 LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score =  107 bits (267), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 106/201 (52%), Gaps = 7/201 (3%)
Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 652
            F ++IG G FG V+ G   +  +VA+K + +  +   + F+ E  ++ ++ H  LV L 
Sbjct: 10  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLY 68
Query: 653 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 712
           G C E+    LV+E+M +G L D L         +  T L +  D  +G+ YL       
Sbjct: 69  GVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE--TLLGMCLDVCEGMAYLE---EAS 123
Query: 713 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 772
           +IHRD+ + N L+  N   KVSDFG++R   +D    S+  +  V +  PE +   + + 
Sbjct: 124 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 183
Query: 773 KSDVYSFGVVLLELIS-GKKP 792
           KSDV+SFGV++ E+ S GK P
Sbjct: 184 KSDVWSFGVLMWEVFSEGKIP 204

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score =  106 bits (264), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 143/290 (49%), Gaps = 29/290 (10%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMK--DGKEVAVKIMADSCSHRTQQ---FVTEVALL 640
           EL+    +  K +G G FG V  G++K    KE++V I      +  +Q   F+ E +++
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 700
            +  H N++ L G   +    ++V EYM NG+L   L     Q  +  +  + +    A 
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIAS 158
Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED--LTHISSVARGTVG 758
           G++YL    + G +HRD+ + NIL++ N+  KVSDFGLSR  E+D    + +   +  + 
Sbjct: 159 GMKYL---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 759 YLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDV 817
           +  PE    ++ T  SDV+S+G+VL E++S G++P             +W  S     DV
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP-------------YWEMS---NQDV 259
Query: 818 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 867
           I  VD        ++    + ++ + C ++   +RPK ++IV  +   I+
Sbjct: 260 IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score =  105 bits (263), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 117/215 (54%), Gaps = 14/215 (6%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRI 643
           E+ +      ++IG GSFG+VY GK     +VAVK++  +     + Q F  EV +L + 
Sbjct: 4   EIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61
Query: 644 HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 703
            H N++  +GY  +  Q  +V ++    +L   LH  + +   + +  + IA   A+G++
Sbjct: 62  RHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMD 118
Query: 704 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL-SRQAEEDLTHISSVARGTVGYLDP 762
           YLH      IIHRD+KS+NI L  ++  K+ DFGL + ++    +H      G++ ++ P
Sbjct: 119 YLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 175
Query: 763 EYYGNQQ---LTEKSDVYSFGVVLLELISGKKPVS 794
           E    Q     + +SDVY+FG+VL EL++G+ P S
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 210

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score =  105 bits (263), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 143/285 (50%), Gaps = 25/285 (8%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRI 643
           E+ +      ++IG GSFG+VY GK     +VAVK++  +     + Q F  EV +L + 
Sbjct: 8   EIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 65
Query: 644 HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 703
            H N++  +GY  +  Q  +V ++    +L   LH S  +  +  L  + IA   A+G++
Sbjct: 66  RHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHASETKFEMKKL--IDIARQTARGMD 122
Query: 704 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR-QAEEDLTHISSVARGTVGYLDP 762
           YLH      IIHRD+KS+NI L  +   K+ DFGL+  ++    +H      G++ ++ P
Sbjct: 123 YLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 179
Query: 763 EYYGNQQ---LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 819
           E    Q     + +SDVY+FG+VL EL++G+ P S       +N       M+ +G    
Sbjct: 180 EVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS------NINNRDQIIEMVGRGS--- 230
Query: 820 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 864
            + P L   V+     R+  +  +C++++   RP    I+  I++
Sbjct: 231 -LSPDL-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEE 273

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score =  105 bits (263), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 117/215 (54%), Gaps = 14/215 (6%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRI 643
           E+ +      ++IG GSFG+VY GK     +VAVK++  +     + Q F  EV +L + 
Sbjct: 4   EIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61
Query: 644 HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 703
            H N++  +GY  +  Q  +V ++    +L   LH  + +   + +  + IA   A+G++
Sbjct: 62  RHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMD 118
Query: 704 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR-QAEEDLTHISSVARGTVGYLDP 762
           YLH      IIHRD+KS+NI L  ++  K+ DFGL+  ++    +H      G++ ++ P
Sbjct: 119 YLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175
Query: 763 EYYGNQQ---LTEKSDVYSFGVVLLELISGKKPVS 794
           E    Q     + +SDVY+FG+VL EL++G+ P S
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 210

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score =  105 bits (263), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 143/290 (49%), Gaps = 29/290 (10%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMK--DGKEVAVKIMADSCSHRTQQ---FVTEVALL 640
           EL+    +  K +G G FG V  G++K    KE++V I      +  +Q   F+ E +++
Sbjct: 12  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 71
Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 700
            +  H N++ L G   +    ++V EYM NG+L   L     Q  +  +  + +    A 
Sbjct: 72  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIAS 129
Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED--LTHISSVARGTVG 758
           G++YL    + G +HRD+ + NIL++ N+  KVSDFGLSR  E+D    + +   +  + 
Sbjct: 130 GMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 186
Query: 759 YLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDV 817
           +  PE    ++ T  SDV+S+G+VL E++S G++P             +W  S     DV
Sbjct: 187 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP-------------YWEMS---NQDV 230
Query: 818 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 867
           I  VD        ++    + ++ + C ++   +RPK ++IV  +   I+
Sbjct: 231 IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 280

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score =  105 bits (263), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 143/290 (49%), Gaps = 29/290 (10%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMK--DGKEVAVKIMADSCSHRTQQ---FVTEVALL 640
           EL+    +  K +G G FG V  G++K    KE++V I      +  +Q   F+ E +++
Sbjct: 29  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 88
Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 700
            +  H N++ L G   +    ++V EYM NG+L   L     Q  +  +  + +    A 
Sbjct: 89  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIAS 146
Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED--LTHISSVARGTVG 758
           G++YL    + G +HRD+ + NIL++ N+  KVSDFGLSR  E+D    + +   +  + 
Sbjct: 147 GMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 203
Query: 759 YLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDV 817
           +  PE    ++ T  SDV+S+G+VL E++S G++P             +W  S     DV
Sbjct: 204 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP-------------YWEMS---NQDV 247
Query: 818 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 867
           I  VD        ++    + ++ + C ++   +RPK ++IV  +   I+
Sbjct: 248 IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 297

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score =  105 bits (263), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 77/236 (32%), Positives = 116/236 (49%), Gaps = 20/236 (8%)
Query: 562 NTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSV---YYGKMKD--GKE 616
           N  +  A G  F D     F      EE    F +++GKG+FGSV    Y  ++D  G+ 
Sbjct: 19  NLYFQGAMGSAFEDRDPTQF------EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEV 72
Query: 617 VAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLR 674
           VAVK +  S     + F  E+ +L  + H N+V   G C    +R   L+ EY+  G+LR
Sbjct: 73  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 132
Query: 675 DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVS 734
           D L    +++ +D +  LQ      KG+EYL T      IHRD+ + NIL++   R K+ 
Sbjct: 133 DYLQK--HKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIG 187
Query: 735 DFGLSRQAEED--LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
           DFGL++   +D     +       + +  PE     + +  SDV+SFGVVL EL +
Sbjct: 188 DFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score =  105 bits (263), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 117/215 (54%), Gaps = 14/215 (6%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRI 643
           E+ +      ++IG GSFG+VY GK     +VAVK++  +     + Q F  EV +L + 
Sbjct: 24  EIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 81
Query: 644 HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 703
            H N++  +GY  +  Q  +V ++    +L   LH  + +   + +  + IA   A+G++
Sbjct: 82  RHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMD 138
Query: 704 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL-SRQAEEDLTHISSVARGTVGYLDP 762
           YLH      IIHRD+KS+NI L  ++  K+ DFGL + ++    +H      G++ ++ P
Sbjct: 139 YLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 195
Query: 763 EYYGNQQ---LTEKSDVYSFGVVLLELISGKKPVS 794
           E    Q     + +SDVY+FG+VL EL++G+ P S
Sbjct: 196 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 230

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score =  105 bits (262), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 143/285 (50%), Gaps = 25/285 (8%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRI 643
           E+ +      ++IG GSFG+VY GK     +VAVK++  +     + Q F  EV +L + 
Sbjct: 20  EIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 77
Query: 644 HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 703
            H N++  +GY  +  Q  +V ++    +L   LH S  +  +  L  + IA   A+G++
Sbjct: 78  RHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHASETKFEMKKL--IDIARQTARGMD 134
Query: 704 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL-SRQAEEDLTHISSVARGTVGYLDP 762
           YLH      IIHRD+KS+NI L  +   K+ DFGL + ++    +H      G++ ++ P
Sbjct: 135 YLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 191
Query: 763 EYYGNQQ---LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 819
           E    Q     + +SDVY+FG+VL EL++G+ P S       +N       M+ +G    
Sbjct: 192 EVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS------NINNRDQIIEMVGRGS--- 242
Query: 820 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 864
            + P L   V+     R+  +  +C++++   RP    I+  I++
Sbjct: 243 -LSPDL-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEE 285

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score =  105 bits (262), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 117/215 (54%), Gaps = 14/215 (6%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRI 643
           E+ +      ++IG GSFG+VY GK     +VAVK++  +     + Q F  EV +L + 
Sbjct: 9   EIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 66
Query: 644 HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 703
            H N++  +GY  +  Q  +V ++    +L   LH  + +   + +  + IA   A+G++
Sbjct: 67  RHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMD 123
Query: 704 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR-QAEEDLTHISSVARGTVGYLDP 762
           YLH      IIHRD+KS+NI L  ++  K+ DFGL+  ++    +H      G++ ++ P
Sbjct: 124 YLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 180
Query: 763 EYYGNQQ---LTEKSDVYSFGVVLLELISGKKPVS 794
           E    Q     + +SDVY+FG+VL EL++G+ P S
Sbjct: 181 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 215

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score =  105 bits (262), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 143/290 (49%), Gaps = 29/290 (10%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMK--DGKEVAVKIMADSCSHRTQQ---FVTEVALL 640
           EL+    +  K +G G FG V  G++K    KE++V I      +  +Q   F+ E +++
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 700
            +  H N++ L G   +    ++V EYM NG+L   L     Q  +  +  + +    A 
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIAS 158
Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED--LTHISSVARGTVG 758
           G++YL    + G +HRD+ + NIL++ N+  KVSDFGLSR  E+D    + +   +  + 
Sbjct: 159 GMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 759 YLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDV 817
           +  PE    ++ T  SDV+S+G+VL E++S G++P             +W  S     DV
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP-------------YWEMS---NQDV 259
Query: 818 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 867
           I  VD        ++    + ++ + C ++   +RPK ++IV  +   I+
Sbjct: 260 IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score =  105 bits (262), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 71/211 (33%), Positives = 116/211 (54%), Gaps = 13/211 (6%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 645
           EL+       K++G G FG V  GK K   +VAVK++ +  S    +F  E   + ++ H
Sbjct: 4   ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEG-SMSEDEFFQEAQTMMKLSH 62
Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLE 703
             LV   G C +E+   +V EY+ NG L + L  HG    K L+    L++ +D  +G+ 
Sbjct: 63  PKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHG----KGLEPSQLLEMCYDVCEGMA 118
Query: 704 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA-RGTVGYLDP 762
           +L +      IHRD+ + N L+D ++  KVSDFG++R   +D  ++SSV  +  V +  P
Sbjct: 119 FLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD-QYVSSVGTKFPVKWSAP 174
Query: 763 EYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
           E +   + + KSDV++FG+++ E+ S GK P
Sbjct: 175 EVFHYFKYSSKSDVWAFGILMWEVFSLGKMP 205

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score =  105 bits (262), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 83/293 (28%), Positives = 143/293 (48%), Gaps = 35/293 (11%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMK--DGKEVAVKIMADSCSHRTQQ---FVTEVALL 640
           EL+    +  K +G G FG V  G++K    KE++V I      +  +Q   F+ E +++
Sbjct: 39  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 98
Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HD 697
            +  H N++ L G   +    ++V EYM NG+L   L     Q      T +Q+      
Sbjct: 99  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-----FTVIQLVGMLRG 153
Query: 698 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED--LTHISSVARG 755
            A G++YL    + G +HRD+ + NIL++ N+  KVSDFGLSR  E+D    + +   + 
Sbjct: 154 IASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 210
Query: 756 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKK 814
            + +  PE    ++ T  SDV+S+G+VL E++S G++P             +W  S    
Sbjct: 211 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP-------------YWEMS---N 254
Query: 815 GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 867
            DVI  VD        ++    + ++ + C ++   +RPK ++IV  +   I+
Sbjct: 255 QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 307

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score =  105 bits (262), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 117/215 (54%), Gaps = 14/215 (6%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRI 643
           E+ +      ++IG GSFG+VY GK     +VAVK++  +     + Q F  EV +L + 
Sbjct: 6   EIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 63
Query: 644 HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 703
            H N++  +GY  +  Q  +V ++    +L   LH  + +   + +  + IA   A+G++
Sbjct: 64  RHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMD 120
Query: 704 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR-QAEEDLTHISSVARGTVGYLDP 762
           YLH      IIHRD+KS+NI L  ++  K+ DFGL+  ++    +H      G++ ++ P
Sbjct: 121 YLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 177
Query: 763 EYYGNQQ---LTEKSDVYSFGVVLLELISGKKPVS 794
           E    Q     + +SDVY+FG+VL EL++G+ P S
Sbjct: 178 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 212

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score =  105 bits (262), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 117/215 (54%), Gaps = 14/215 (6%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRI 643
           E+ +      ++IG GSFG+VY GK     +VAVK++  +     + Q F  EV +L + 
Sbjct: 9   EIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 66
Query: 644 HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 703
            H N++  +GY  +  Q  +V ++    +L   LH  + +   + +  + IA   A+G++
Sbjct: 67  RHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMD 123
Query: 704 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR-QAEEDLTHISSVARGTVGYLDP 762
           YLH      IIHRD+KS+NI L  ++  K+ DFGL+  ++    +H      G++ ++ P
Sbjct: 124 YLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 180
Query: 763 EYYGNQQ---LTEKSDVYSFGVVLLELISGKKPVS 794
           E    Q     + +SDVY+FG+VL EL++G+ P S
Sbjct: 181 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 215

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score =  105 bits (262), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 143/290 (49%), Gaps = 29/290 (10%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMK--DGKEVAVKIMADSCSHRTQQ---FVTEVALL 640
           EL+    +  K +G G FG V  G++K    KE++V I      +  +Q   F+ E +++
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 700
            +  H N++ L G   +    ++V EYM NG+L   L     Q  +  +  + +    A 
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIAS 158
Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED--LTHISSVARGTVG 758
           G++YL    + G +HRD+ + NIL++ N+  KVSDFGLSR  E+D    + +   +  + 
Sbjct: 159 GMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 759 YLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDV 817
           +  PE    ++ T  SDV+S+G+VL E++S G++P             +W  S     DV
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP-------------YWEMS---NQDV 259
Query: 818 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 867
           I  VD        ++    + ++ + C ++   +RPK ++IV  +   I+
Sbjct: 260 IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score =  105 bits (262), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 143/290 (49%), Gaps = 29/290 (10%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMK--DGKEVAVKIMADSCSHRTQQ---FVTEVALL 640
           EL+    +  K +G G FG V  G++K    KE++V I      +  +Q   F+ E +++
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 700
            +  H N++ L G   +    ++V EYM NG+L   L     Q  +  +  + +    A 
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIAS 158
Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED--LTHISSVARGTVG 758
           G++YL    + G +HRD+ + NIL++ N+  KVSDFGLSR  E+D    + +   +  + 
Sbjct: 159 GMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 759 YLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDV 817
           +  PE    ++ T  SDV+S+G+VL E++S G++P             +W  S     DV
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP-------------YWEMS---NQDV 259
Query: 818 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 867
           I  VD        ++    + ++ + C ++   +RPK ++IV  +   I+
Sbjct: 260 IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score =  105 bits (262), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 117/215 (54%), Gaps = 14/215 (6%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRI 643
           E+ +      ++IG GSFG+VY GK     +VAVK++  +     + Q F  EV +L + 
Sbjct: 32  EIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 89
Query: 644 HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 703
            H N++  +GY  +  Q  +V ++    +L   LH  + +   + +  + IA   A+G++
Sbjct: 90  RHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMD 146
Query: 704 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL-SRQAEEDLTHISSVARGTVGYLDP 762
           YLH      IIHRD+KS+NI L  ++  K+ DFGL + ++    +H      G++ ++ P
Sbjct: 147 YLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 203
Query: 763 EYYGNQQ---LTEKSDVYSFGVVLLELISGKKPVS 794
           E    Q     + +SDVY+FG+VL EL++G+ P S
Sbjct: 204 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 238

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score =  105 bits (262), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 142/285 (49%), Gaps = 25/285 (8%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRI 643
           E+ +      ++IG GSFG+VY GK     +VAVK++  +     + Q F  EV +L + 
Sbjct: 20  EIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 77
Query: 644 HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 703
            H N++  +GY     Q  +V ++    +L   LH S  +  +  L  + IA   A+G++
Sbjct: 78  RHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHASETKFEMKKL--IDIARQTARGMD 134
Query: 704 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL-SRQAEEDLTHISSVARGTVGYLDP 762
           YLH      IIHRD+KS+NI L  +   K+ DFGL + ++    +H      G++ ++ P
Sbjct: 135 YLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 191
Query: 763 EYYGNQQ---LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 819
           E    Q     + +SDVY+FG+VL EL++G+ P S       +N       M+ +G    
Sbjct: 192 EVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS------NINNRDQIIEMVGRGS--- 242
Query: 820 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 864
            + P L   V+     R+  +  +C++++   RP    I+  I++
Sbjct: 243 -LSPDL-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEE 285

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score =  105 bits (262), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 83/293 (28%), Positives = 143/293 (48%), Gaps = 35/293 (11%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMK--DGKEVAVKIMADSCSHRTQQ---FVTEVALL 640
           EL+    +  K +G G FG V  G++K    KE++V I      +  +Q   F+ E +++
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HD 697
            +  H N++ L G   +    ++V EYM NG+L   L     Q      T +Q+      
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-----FTVIQLVGMLRG 155
Query: 698 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED--LTHISSVARG 755
            A G++YL    + G +HRD+ + NIL++ N+  KVSDFGLSR  E+D    + +   + 
Sbjct: 156 IASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212
Query: 756 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKK 814
            + +  PE    ++ T  SDV+S+G+VL E++S G++P             +W  S    
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP-------------YWEMS---N 256
Query: 815 GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 867
            DVI  VD        ++    + ++ + C ++   +RPK ++IV  +   I+
Sbjct: 257 QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score =  105 bits (262), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 71/212 (33%), Positives = 108/212 (50%), Gaps = 14/212 (6%)
Query: 586 ELEEATNNFCKKIGKGSFGSV---YYGKMKD--GKEVAVKIMADSCSHRTQQFVTEVALL 640
           + EE    F +++GKG+FGSV    Y  ++D  G+ VAVK +  S     + F  E+ +L
Sbjct: 9   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 68
Query: 641 SRIHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDA 698
             + H N+V   G C    +R   L+ EY+  G+LRD L     +  +D +  LQ     
Sbjct: 69  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAER--IDHIKLLQYTSQI 126
Query: 699 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED--LTHISSVARGT 756
            KG+EYL T      IHRD+ + NIL++   R K+ DFGL++   +D     +       
Sbjct: 127 CKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 183
Query: 757 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
           + +  PE     + +  SDV+SFGVVL EL +
Sbjct: 184 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 116/215 (53%), Gaps = 14/215 (6%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRI 643
           E+ +      ++IG GSFG+VY GK     +VAVK++  +     + Q F  EV +L + 
Sbjct: 4   EIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61
Query: 644 HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 703
            H N++  +GY     Q  +V ++    +L   LH  + +   + +  + IA   A+G++
Sbjct: 62  RHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMD 118
Query: 704 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR-QAEEDLTHISSVARGTVGYLDP 762
           YLH      IIHRD+KS+NI L  ++  K+ DFGL+  ++    +H      G++ ++ P
Sbjct: 119 YLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175
Query: 763 EYYGNQQ---LTEKSDVYSFGVVLLELISGKKPVS 794
           E    Q     + +SDVY+FG+VL EL++G+ P S
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 210

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 117/215 (54%), Gaps = 14/215 (6%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRI 643
           E+ +      ++IG GSFG+VY GK     +VAVK++  +     + Q F  EV +L + 
Sbjct: 31  EIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 88
Query: 644 HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 703
            H N++  +GY  +  Q  +V ++    +L   LH  + +   + +  + IA   A+G++
Sbjct: 89  RHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMD 145
Query: 704 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR-QAEEDLTHISSVARGTVGYLDP 762
           YLH      IIHRD+KS+NI L  ++  K+ DFGL+  ++    +H      G++ ++ P
Sbjct: 146 YLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 202
Query: 763 EYYGNQQ---LTEKSDVYSFGVVLLELISGKKPVS 794
           E    Q     + +SDVY+FG+VL EL++G+ P S
Sbjct: 203 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 237

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 117/215 (54%), Gaps = 14/215 (6%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRI 643
           E+ +      ++IG GSFG+VY GK     +VAVK++  +     + Q F  EV +L + 
Sbjct: 32  EIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 89
Query: 644 HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 703
            H N++  +GY  +  Q  +V ++    +L   LH  + +   + +  + IA   A+G++
Sbjct: 90  RHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMD 146
Query: 704 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR-QAEEDLTHISSVARGTVGYLDP 762
           YLH      IIHRD+KS+NI L  ++  K+ DFGL+  ++    +H      G++ ++ P
Sbjct: 147 YLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 203
Query: 763 EYYGNQQ---LTEKSDVYSFGVVLLELISGKKPVS 794
           E    Q     + +SDVY+FG+VL EL++G+ P S
Sbjct: 204 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 238

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 71/212 (33%), Positives = 110/212 (51%), Gaps = 14/212 (6%)
Query: 586 ELEEATNNFCKKIGKGSFGSV---YYGKMKD--GKEVAVKIMADSCSHRTQQFVTEVALL 640
           + EE    F +++GKG+FGSV    Y  ++D  G+ VAVK +  S     + F  E+ +L
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65
Query: 641 SRIHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDA 698
             + H N+V   G C    +R   L+ EY+  G+LRD L    +++ +D +  LQ     
Sbjct: 66  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQI 123
Query: 699 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED--LTHISSVARGT 756
            KG+EYL T      IHRD+ + NIL++   R K+ DFGL++   +D     +       
Sbjct: 124 CKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESP 180
Query: 757 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
           + +  PE     + +  SDV+SFGVVL EL +
Sbjct: 181 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 71/212 (33%), Positives = 110/212 (51%), Gaps = 14/212 (6%)
Query: 586 ELEEATNNFCKKIGKGSFGSV---YYGKMKD--GKEVAVKIMADSCSHRTQQFVTEVALL 640
           + EE    F +++GKG+FGSV    Y  ++D  G+ VAVK +  S     + F  E+ +L
Sbjct: 10  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 69
Query: 641 SRIHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDA 698
             + H N+V   G C    +R   L+ EY+  G+LRD L    +++ +D +  LQ     
Sbjct: 70  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQI 127
Query: 699 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED--LTHISSVARGT 756
            KG+EYL T      IHRD+ + NIL++   R K+ DFGL++   +D     +       
Sbjct: 128 CKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 184
Query: 757 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
           + +  PE     + +  SDV+SFGVVL EL +
Sbjct: 185 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score =  105 bits (261), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 110/208 (52%), Gaps = 7/208 (3%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 645
           E++     F K++G G FG V YGK +   +VA+K++ +  S    +F+ E  ++  + H
Sbjct: 20  EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSH 78
Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 705
             LV L G C ++    ++ EYM NG L + L    ++     L  L++  D  + +EYL
Sbjct: 79  EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL--LEMCKDVCEAMEYL 136
Query: 706 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 765
            +      +HRD+ + N L++     KVSDFGLSR   +D    S  ++  V +  PE  
Sbjct: 137 ES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVL 193
Query: 766 GNQQLTEKSDVYSFGVVLLELIS-GKKP 792
              + + KSD+++FGV++ E+ S GK P
Sbjct: 194 MYSKFSSKSDIWAFGVLMWEIYSLGKMP 221

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score =  105 bits (261), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 110/208 (52%), Gaps = 7/208 (3%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 645
           E++     F K++G G FG V YGK +   +VA+K++ +  S    +F+ E  ++  + H
Sbjct: 5   EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSH 63
Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 705
             LV L G C ++    ++ EYM NG L + L    ++     L  L++  D  + +EYL
Sbjct: 64  EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL--LEMCKDVCEAMEYL 121
Query: 706 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 765
            +      +HRD+ + N L++     KVSDFGLSR   +D    S  ++  V +  PE  
Sbjct: 122 ES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVL 178
Query: 766 GNQQLTEKSDVYSFGVVLLELIS-GKKP 792
              + + KSD+++FGV++ E+ S GK P
Sbjct: 179 MYSKFSSKSDIWAFGVLMWEIYSLGKMP 206

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score =  104 bits (260), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 75/231 (32%), Positives = 115/231 (49%), Gaps = 24/231 (10%)
Query: 567 IARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSV---YYGKMKD--GKEVAVKI 621
           + RG H M           + EE    F +++GKG+FGSV    Y  ++D  G+ VAVK 
Sbjct: 15  VPRGSHNM----------TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK 64
Query: 622 MADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHG 679
           +  S     + F  E+ +L  + H N+V   G C    +R   L+ EY+  G+LRD L  
Sbjct: 65  LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK 124
Query: 680 SVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 739
             +++ +D +  LQ      KG+EYL T      IHRD+ + NIL++   R K+ DFGL+
Sbjct: 125 --HKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLT 179
Query: 740 RQAEED--LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
           +   +D     +       + +  PE     + +  SDV+SFGVVL EL +
Sbjct: 180 KVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score =  104 bits (260), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 110/208 (52%), Gaps = 7/208 (3%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 645
           E++     F K++G G FG V YGK +   +VA+K++ +  S    +F+ E  ++  + H
Sbjct: 4   EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSH 62
Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 705
             LV L G C ++    ++ EYM NG L + L    ++     L  L++  D  + +EYL
Sbjct: 63  EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL--LEMCKDVCEAMEYL 120
Query: 706 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 765
            +      +HRD+ + N L++     KVSDFGLSR   +D    S  ++  V +  PE  
Sbjct: 121 ES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVL 177
Query: 766 GNQQLTEKSDVYSFGVVLLELIS-GKKP 792
              + + KSD+++FGV++ E+ S GK P
Sbjct: 178 MYSKFSSKSDIWAFGVLMWEIYSLGKMP 205

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score =  104 bits (260), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 71/212 (33%), Positives = 110/212 (51%), Gaps = 14/212 (6%)
Query: 586 ELEEATNNFCKKIGKGSFGSV---YYGKMKD--GKEVAVKIMADSCSHRTQQFVTEVALL 640
           + EE    F +++GKG+FGSV    Y  ++D  G+ VAVK +  S     + F  E+ +L
Sbjct: 12  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 71
Query: 641 SRIHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDA 698
             + H N+V   G C    +R   L+ EY+  G+LRD L    +++ +D +  LQ     
Sbjct: 72  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQI 129
Query: 699 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED--LTHISSVARGT 756
            KG+EYL T      IHRD+ + NIL++   R K+ DFGL++   +D     +       
Sbjct: 130 CKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 186
Query: 757 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
           + +  PE     + +  SDV+SFGVVL EL +
Sbjct: 187 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score =  104 bits (260), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 71/212 (33%), Positives = 110/212 (51%), Gaps = 14/212 (6%)
Query: 586 ELEEATNNFCKKIGKGSFGSV---YYGKMKD--GKEVAVKIMADSCSHRTQQFVTEVALL 640
           + EE    F +++GKG+FGSV    Y  ++D  G+ VAVK +  S     + F  E+ +L
Sbjct: 5   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 64
Query: 641 SRIHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDA 698
             + H N+V   G C    +R   L+ EY+  G+LRD L    +++ +D +  LQ     
Sbjct: 65  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQI 122
Query: 699 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED--LTHISSVARGT 756
            KG+EYL T      IHRD+ + NIL++   R K+ DFGL++   +D     +       
Sbjct: 123 CKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 179
Query: 757 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
           + +  PE     + +  SDV+SFGVVL EL +
Sbjct: 180 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score =  104 bits (260), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 75/231 (32%), Positives = 115/231 (49%), Gaps = 24/231 (10%)
Query: 567 IARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSV---YYGKMKD--GKEVAVKI 621
           + RG H M           + EE    F +++GKG+FGSV    Y  ++D  G+ VAVK 
Sbjct: 15  VPRGSHNM----------TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK 64
Query: 622 MADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHG 679
           +  S     + F  E+ +L  + H N+V   G C    +R   L+ EY+  G+LRD L  
Sbjct: 65  LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK 124
Query: 680 SVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 739
             +++ +D +  LQ      KG+EYL T      IHRD+ + NIL++   R K+ DFGL+
Sbjct: 125 --HKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLT 179
Query: 740 RQAEED--LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
           +   +D     +       + +  PE     + +  SDV+SFGVVL EL +
Sbjct: 180 KVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score =  104 bits (260), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 110/208 (52%), Gaps = 7/208 (3%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 645
           E++     F K++G G FG V YGK +   +VA+K++ +  S    +F+ E  ++  + H
Sbjct: 20  EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSH 78
Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 705
             LV L G C ++    ++ EYM NG L + L    ++     L  L++  D  + +EYL
Sbjct: 79  EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL--LEMCKDVCEAMEYL 136
Query: 706 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 765
            +      +HRD+ + N L++     KVSDFGLSR   +D    S  ++  V +  PE  
Sbjct: 137 ES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVL 193
Query: 766 GNQQLTEKSDVYSFGVVLLELIS-GKKP 792
              + + KSD+++FGV++ E+ S GK P
Sbjct: 194 MYSKFSSKSDIWAFGVLMWEIYSLGKMP 221

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score =  104 bits (260), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 71/212 (33%), Positives = 110/212 (51%), Gaps = 14/212 (6%)
Query: 586 ELEEATNNFCKKIGKGSFGSV---YYGKMKD--GKEVAVKIMADSCSHRTQQFVTEVALL 640
           + EE    F +++GKG+FGSV    Y  ++D  G+ VAVK +  S     + F  E+ +L
Sbjct: 11  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 70
Query: 641 SRIHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDA 698
             + H N+V   G C    +R   L+ EY+  G+LRD L    +++ +D +  LQ     
Sbjct: 71  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQI 128
Query: 699 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED--LTHISSVARGT 756
            KG+EYL T      IHRD+ + NIL++   R K+ DFGL++   +D     +       
Sbjct: 129 CKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 185
Query: 757 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
           + +  PE     + +  SDV+SFGVVL EL +
Sbjct: 186 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score =  104 bits (260), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 71/212 (33%), Positives = 110/212 (51%), Gaps = 14/212 (6%)
Query: 586 ELEEATNNFCKKIGKGSFGSV---YYGKMKD--GKEVAVKIMADSCSHRTQQFVTEVALL 640
           + EE    F +++GKG+FGSV    Y  ++D  G+ VAVK +  S     + F  E+ +L
Sbjct: 4   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 63
Query: 641 SRIHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDA 698
             + H N+V   G C    +R   L+ EY+  G+LRD L    +++ +D +  LQ     
Sbjct: 64  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQI 121
Query: 699 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED--LTHISSVARGT 756
            KG+EYL T      IHRD+ + NIL++   R K+ DFGL++   +D     +       
Sbjct: 122 CKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 178
Query: 757 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
           + +  PE     + +  SDV+SFGVVL EL +
Sbjct: 179 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score =  104 bits (260), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 71/212 (33%), Positives = 110/212 (51%), Gaps = 14/212 (6%)
Query: 586 ELEEATNNFCKKIGKGSFGSV---YYGKMKD--GKEVAVKIMADSCSHRTQQFVTEVALL 640
           + EE    F +++GKG+FGSV    Y  ++D  G+ VAVK +  S     + F  E+ +L
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65
Query: 641 SRIHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDA 698
             + H N+V   G C    +R   L+ EY+  G+LRD L    +++ +D +  LQ     
Sbjct: 66  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQI 123
Query: 699 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED--LTHISSVARGT 756
            KG+EYL T      IHRD+ + NIL++   R K+ DFGL++   +D     +       
Sbjct: 124 CKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 180
Query: 757 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
           + +  PE     + +  SDV+SFGVVL EL +
Sbjct: 181 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score =  104 bits (260), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 110/208 (52%), Gaps = 7/208 (3%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 645
           E++     F K++G G FG V YGK +   +VA+K++ +  S    +F+ E  ++  + H
Sbjct: 5   EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSH 63
Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 705
             LV L G C ++    ++ EYM NG L + L    ++     L  L++  D  + +EYL
Sbjct: 64  EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL--LEMCKDVCEAMEYL 121
Query: 706 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 765
            +      +HRD+ + N L++     KVSDFGLSR   +D    S  ++  V +  PE  
Sbjct: 122 ES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVL 178
Query: 766 GNQQLTEKSDVYSFGVVLLELIS-GKKP 792
              + + KSD+++FGV++ E+ S GK P
Sbjct: 179 MYSKFSSKSDIWAFGVLMWEIYSLGKMP 206

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score =  104 bits (260), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 71/212 (33%), Positives = 110/212 (51%), Gaps = 14/212 (6%)
Query: 586 ELEEATNNFCKKIGKGSFGSV---YYGKMKD--GKEVAVKIMADSCSHRTQQFVTEVALL 640
           + EE    F +++GKG+FGSV    Y  ++D  G+ VAVK +  S     + F  E+ +L
Sbjct: 13  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 72
Query: 641 SRIHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDA 698
             + H N+V   G C    +R   L+ EY+  G+LRD L    +++ +D +  LQ     
Sbjct: 73  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQI 130
Query: 699 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED--LTHISSVARGT 756
            KG+EYL T      IHRD+ + NIL++   R K+ DFGL++   +D     +       
Sbjct: 131 CKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 187
Query: 757 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
           + +  PE     + +  SDV+SFGVVL EL +
Sbjct: 188 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score =  104 bits (260), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 80/290 (27%), Positives = 143/290 (49%), Gaps = 29/290 (10%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMK--DGKEVAVKIMADSCSHRTQQ---FVTEVALL 640
           EL+    +  K +G G FG V  G++K    KE++V I      +  +Q   F+ E +++
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 700
            +  H N++ L G   +    ++V EYM NG+L   L     Q  +  +  + +    A 
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIAS 158
Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED--LTHISSVARGTVG 758
           G++YL    + G +HRD+ + NIL++ N+  KVSDFGL+R  E+D    + +   +  + 
Sbjct: 159 GMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIR 215
Query: 759 YLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDV 817
           +  PE    ++ T  SDV+S+G+VL E++S G++P             +W  S     DV
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP-------------YWEMS---NQDV 259
Query: 818 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 867
           I  VD        ++    + ++ + C ++   +RPK ++IV  +   I+
Sbjct: 260 IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 110/208 (52%), Gaps = 7/208 (3%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 645
           E++     F K++G G FG V YGK +   +VA+K++ +  S    +F+ E  ++  + H
Sbjct: 11  EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSH 69
Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 705
             LV L G C ++    ++ EYM NG L + L    ++     L  L++  D  + +EYL
Sbjct: 70  EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL--LEMCKDVCEAMEYL 127
Query: 706 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 765
            +      +HRD+ + N L++     KVSDFGLSR   +D    S  ++  V +  PE  
Sbjct: 128 ES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVL 184
Query: 766 GNQQLTEKSDVYSFGVVLLELIS-GKKP 792
              + + KSD+++FGV++ E+ S GK P
Sbjct: 185 MYSKFSSKSDIWAFGVLMWEIYSLGKMP 212

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 65/201 (32%), Positives = 107/201 (53%), Gaps = 7/201 (3%)
Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 652
            F K++G G FG V YGK +   +VA+K++ +  S    +F+ E  ++  + H  LV L 
Sbjct: 7   TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLY 65
Query: 653 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 712
           G C ++    ++ EYM NG L + L    ++     L  L++  D  + +EYL +     
Sbjct: 66  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL--LEMCKDVCEAMEYLES---KQ 120
Query: 713 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 772
            +HRD+ + N L++     KVSDFGLSR   +D    S  ++  V +  PE     + + 
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180
Query: 773 KSDVYSFGVVLLELIS-GKKP 792
           KSD+++FGV++ E+ S GK P
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMP 201

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 71/212 (33%), Positives = 110/212 (51%), Gaps = 14/212 (6%)
Query: 586 ELEEATNNFCKKIGKGSFGSV---YYGKMKD--GKEVAVKIMADSCSHRTQQFVTEVALL 640
           + EE    F +++GKG+FGSV    Y  ++D  G+ VAVK +  S     + F  E+ +L
Sbjct: 9   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 68
Query: 641 SRIHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDA 698
             + H N+V   G C    +R   L+ EY+  G+LRD L    +++ +D +  LQ     
Sbjct: 69  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQI 126
Query: 699 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED--LTHISSVARGT 756
            KG+EYL T      IHRD+ + NIL++   R K+ DFGL++   +D     +       
Sbjct: 127 CKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 183
Query: 757 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
           + +  PE     + +  SDV+SFGVVL EL +
Sbjct: 184 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 71/212 (33%), Positives = 110/212 (51%), Gaps = 14/212 (6%)
Query: 586 ELEEATNNFCKKIGKGSFGSV---YYGKMKD--GKEVAVKIMADSCSHRTQQFVTEVALL 640
           + EE    F +++GKG+FGSV    Y  ++D  G+ VAVK +  S     + F  E+ +L
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65
Query: 641 SRIHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDA 698
             + H N+V   G C    +R   L+ EY+  G+LRD L    +++ +D +  LQ     
Sbjct: 66  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQI 123
Query: 699 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED--LTHISSVARGT 756
            KG+EYL T      IHRD+ + NIL++   R K+ DFGL++   +D     +       
Sbjct: 124 CKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 180
Query: 757 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
           + +  PE     + +  SDV+SFGVVL EL +
Sbjct: 181 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score =  103 bits (258), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 80/290 (27%), Positives = 142/290 (48%), Gaps = 29/290 (10%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMK--DGKEVAVKIMADSCSHRTQQ---FVTEVALL 640
           EL+    +  K +G G FG V  G++K    KE++V I      +  +Q   F+ E +++
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 700
            +  H N++ L G   +    ++V EYM NG+L   L     Q  +  +  + +    A 
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIAS 158
Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED--LTHISSVARGTVG 758
           G++YL    + G +HRD+ + NIL++ N+  KVSDFGL R  E+D    + +   +  + 
Sbjct: 159 GMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIR 215
Query: 759 YLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDV 817
           +  PE    ++ T  SDV+S+G+VL E++S G++P             +W  S     DV
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP-------------YWEMS---NQDV 259
Query: 818 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 867
           I  VD        ++    + ++ + C ++   +RPK ++IV  +   I+
Sbjct: 260 IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  103 bits (257), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 103/204 (50%), Gaps = 6/204 (2%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIH 644
           E+E        K+G G FG VY G  K     VAVK + +  +   ++F+ E A++  I 
Sbjct: 7   EMERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIK 65
Query: 645 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 704
           H NLV L+G C  E    ++ E+M  G L D L    N++ +  +  L +A   +  +EY
Sbjct: 66  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISSAMEY 124
Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
           L        IHRD+ + N L+  N   KV+DFGLSR    D     + A+  + +  PE 
Sbjct: 125 LE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPES 181
Query: 765 YGNQQLTEKSDVYSFGVVLLELIS 788
               + + KSDV++FGV+L E+ +
Sbjct: 182 LAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score =  103 bits (256), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 104/204 (50%), Gaps = 6/204 (2%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIH 644
           E+E        K+G G +G VY G  K     VAVK + +  +   ++F+ E A++  I 
Sbjct: 10  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIK 68
Query: 645 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 704
           H NLV L+G C  E    ++ E+M  G L D L    N++ ++ +  L +A   +  +EY
Sbjct: 69  HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISSAMEY 127
Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
           L        IHRD+ + N L+  N   KV+DFGLSR    D     + A+  + +  PE 
Sbjct: 128 LE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPES 184
Query: 765 YGNQQLTEKSDVYSFGVVLLELIS 788
               + + KSDV++FGV+L E+ +
Sbjct: 185 LAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score =  103 bits (256), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 70/212 (33%), Positives = 111/212 (52%), Gaps = 14/212 (6%)
Query: 586 ELEEATNNFCKKIGKGSFGSV---YYGKMKD--GKEVAVKIMADSCSHRTQQFVTEVALL 640
           + EE    F +++GKG+FGSV    Y  ++D  G+ VAVK +  S     + F  E+ +L
Sbjct: 7   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 66
Query: 641 SRIHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDA 698
             + H N+V   G C    +R   L+ EY+  G+LRD L    +++ +D +  LQ     
Sbjct: 67  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQI 124
Query: 699 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH--ISSVARGT 756
            KG+EYL T      IHR++ + NIL++   R K+ DFGL++   +D  +  +       
Sbjct: 125 CKGMEYLGT---KRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESP 181
Query: 757 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
           + +  PE     + +  SDV+SFGVVL EL +
Sbjct: 182 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score =  103 bits (256), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 104/204 (50%), Gaps = 6/204 (2%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIH 644
           E+E        K+G G +G VY G  K     VAVK + +  +   ++F+ E A++  I 
Sbjct: 14  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIK 72
Query: 645 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 704
           H NLV L+G C  E    ++ E+M  G L D L    N++ ++ +  L +A   +  +EY
Sbjct: 73  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISSAMEY 131
Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
           L        IHRD+ + N L+  N   KV+DFGLSR    D     + A+  + +  PE 
Sbjct: 132 LE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPES 188
Query: 765 YGNQQLTEKSDVYSFGVVLLELIS 788
               + + KSDV++FGV+L E+ +
Sbjct: 189 LAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score =  102 bits (255), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 106/209 (50%), Gaps = 7/209 (3%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIH 644
           E+E        K+G G +G VY G  K     VAVK + +  +   ++F+ E A++  I 
Sbjct: 14  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIK 72
Query: 645 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 704
           H NLV L+G C  E    ++ E+M  G L D L    N++ ++ +  L +A   +  +EY
Sbjct: 73  HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISSAMEY 131
Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
           L        IHRD+ + N L+  N   KV+DFGLSR    D     + A+  + +  PE 
Sbjct: 132 LE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 188
Query: 765 YGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
               + + KSDV++FGV+L E+ + G  P
Sbjct: 189 LAYNKFSIKSDVWAFGVLLWEIATYGMSP 217

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score =  102 bits (255), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 104/204 (50%), Gaps = 6/204 (2%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIH 644
           E+E        K+G G +G VY G  K     VAVK + +  +   ++F+ E A++  I 
Sbjct: 10  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIK 68
Query: 645 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 704
           H NLV L+G C  E    ++ E+M  G L D L    N++ ++ +  L +A   +  +EY
Sbjct: 69  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISSAMEY 127
Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
           L        IHRD+ + N L+  N   KV+DFGLSR    D     + A+  + +  PE 
Sbjct: 128 LE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPES 184
Query: 765 YGNQQLTEKSDVYSFGVVLLELIS 788
               + + KSDV++FGV+L E+ +
Sbjct: 185 LAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score =  102 bits (255), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 106/209 (50%), Gaps = 7/209 (3%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIH 644
           E+E        K+G G +G VY G  K     VAVK + +  +   ++F+ E A++  I 
Sbjct: 9   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIK 67
Query: 645 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 704
           H NLV L+G C  E    ++ E+M  G L D L    N++ ++ +  L +A   +  +EY
Sbjct: 68  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISSAMEY 126
Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
           L        IHRD+ + N L+  N   KV+DFGLSR    D     + A+  + +  PE 
Sbjct: 127 LE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 183
Query: 765 YGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
               + + KSDV++FGV+L E+ + G  P
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score =  102 bits (255), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 106/209 (50%), Gaps = 7/209 (3%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIH 644
           E+E        K+G G +G VY G  K     VAVK + +  +   ++F+ E A++  I 
Sbjct: 9   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIK 67
Query: 645 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 704
           H NLV L+G C  E    ++ E+M  G L D L    N++ ++ +  L +A   +  +EY
Sbjct: 68  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISSAMEY 126
Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
           L        IHRD+ + N L+  N   KV+DFGLSR    D     + A+  + +  PE 
Sbjct: 127 LE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 183
Query: 765 YGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
               + + KSDV++FGV+L E+ + G  P
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score =  102 bits (255), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 104/204 (50%), Gaps = 6/204 (2%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIH 644
           E+E        K+G G +G VY G  K     VAVK + +  +   ++F+ E A++  I 
Sbjct: 14  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIK 72
Query: 645 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 704
           H NLV L+G C  E    ++ E+M  G L D L    N++ ++ +  L +A   +  +EY
Sbjct: 73  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISSAMEY 131
Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
           L        IHRD+ + N L+  N   KV+DFGLSR    D     + A+  + +  PE 
Sbjct: 132 LE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 188
Query: 765 YGNQQLTEKSDVYSFGVVLLELIS 788
               + + KSDV++FGV+L E+ +
Sbjct: 189 LAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score =  102 bits (254), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 80/290 (27%), Positives = 142/290 (48%), Gaps = 29/290 (10%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMK--DGKEVAVKIMADSCSHRTQQ---FVTEVALL 640
           EL+    +  K +G G FG V  G++K    KE++V I      +  +Q   F+ E +++
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 700
            +  H N++ L G   +    ++V E M NG+L   L     Q  +  +  + +    A 
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTV--IQLVGMLRGIAS 158
Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED--LTHISSVARGTVG 758
           G++YL    + G +HRD+ + NIL++ N+  KVSDFGLSR  E+D    + +   +  + 
Sbjct: 159 GMKYL---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 759 YLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDV 817
           +  PE    ++ T  SDV+S+G+VL E++S G++P             +W  S     DV
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP-------------YWEMS---NQDV 259
Query: 818 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 867
           I  VD        ++    + ++ + C ++   +RPK ++IV  +   I+
Sbjct: 260 IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score =  102 bits (254), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 104/204 (50%), Gaps = 6/204 (2%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIH 644
           E+E        K+G G +G VY G  K     VAVK + +  +   ++F+ E A++  I 
Sbjct: 13  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIK 71
Query: 645 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 704
           H NLV L+G C  E    ++ E+M  G L D L    N++ ++ +  L +A   +  +EY
Sbjct: 72  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISSAMEY 130
Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
           L        IHRD+ + N L+  N   KV+DFGLSR    D     + A+  + +  PE 
Sbjct: 131 LE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 187
Query: 765 YGNQQLTEKSDVYSFGVVLLELIS 788
               + + KSDV++FGV+L E+ +
Sbjct: 188 LAYNKFSIKSDVWAFGVLLWEIAT 211

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score =  102 bits (254), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 80/290 (27%), Positives = 142/290 (48%), Gaps = 29/290 (10%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMK--DGKEVAVKIMADSCSHRTQQ---FVTEVALL 640
           EL+    +  K +G G FG V  G++K    KE++V I      +  +Q   F+ E +++
Sbjct: 12  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 71
Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 700
            +  H N++ L G   +    ++V E M NG+L   L     Q  +  +  + +    A 
Sbjct: 72  GQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTV--IQLVGMLRGIAS 129
Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED--LTHISSVARGTVG 758
           G++YL    + G +HRD+ + NIL++ N+  KVSDFGLSR  E+D    + +   +  + 
Sbjct: 130 GMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 186
Query: 759 YLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDV 817
           +  PE    ++ T  SDV+S+G+VL E++S G++P             +W  S     DV
Sbjct: 187 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP-------------YWEMS---NQDV 230
Query: 818 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 867
           I  VD        ++    + ++ + C ++   +RPK ++IV  +   I+
Sbjct: 231 IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 280

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score =  102 bits (254), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 104/204 (50%), Gaps = 6/204 (2%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIH 644
           E+E        K+G G +G VY G  K     VAVK + +  +   ++F+ E A++  I 
Sbjct: 11  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIK 69
Query: 645 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 704
           H NLV L+G C  E    ++ E+M  G L D L    N++ ++ +  L +A   +  +EY
Sbjct: 70  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISSAMEY 128
Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
           L        IHRD+ + N L+  N   KV+DFGLSR    D     + A+  + +  PE 
Sbjct: 129 LE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 185
Query: 765 YGNQQLTEKSDVYSFGVVLLELIS 788
               + + KSDV++FGV+L E+ +
Sbjct: 186 LAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score =  102 bits (254), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 103/204 (50%), Gaps = 6/204 (2%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIH 644
           E+E        K+G G +G VY G  K     VAVK + +  +   ++F+ E A++  I 
Sbjct: 7   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIK 65
Query: 645 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 704
           H NLV L+G C  E    ++ E+M  G L D L    N++ +  +  L +A   +  +EY
Sbjct: 66  HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISSAMEY 124
Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
           L        IHRD+ + N L+  N   KV+DFGLSR    D     + A+  + +  PE 
Sbjct: 125 LE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPES 181
Query: 765 YGNQQLTEKSDVYSFGVVLLELIS 788
               + + KSDV++FGV+L E+ +
Sbjct: 182 LAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  102 bits (254), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 104/204 (50%), Gaps = 6/204 (2%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIH 644
           E+E        K+G G +G VY G  K     VAVK + +  +   ++F+ E A++  I 
Sbjct: 11  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIK 69
Query: 645 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 704
           H NLV L+G C  E    ++ E+M  G L D L    N++ ++ +  L +A   +  +EY
Sbjct: 70  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISSAMEY 128
Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
           L        IHRD+ + N L+  N   KV+DFGLSR    D     + A+  + +  PE 
Sbjct: 129 LE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPES 185
Query: 765 YGNQQLTEKSDVYSFGVVLLELIS 788
               + + KSDV++FGV+L E+ +
Sbjct: 186 LAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 82/293 (27%), Positives = 142/293 (48%), Gaps = 35/293 (11%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMK--DGKEVAVKIMADSCSHRTQQ---FVTEVALL 640
           EL+    +  K +G G FG V  G++K    KE++V I      +  +Q   F+ E +++
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HD 697
            +  H N++ L G   +    ++V E M NG+L   L     Q      T +Q+      
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQ-----FTVIQLVGMLRG 155
Query: 698 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED--LTHISSVARG 755
            A G++YL    + G +HRD+ + NIL++ N+  KVSDFGLSR  E+D    + +   + 
Sbjct: 156 IASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212
Query: 756 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKK 814
            + +  PE    ++ T  SDV+S+G+VL E++S G++P             +W  S    
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP-------------YWEMS---N 256
Query: 815 GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 867
            DVI  VD        ++    + ++ + C ++   +RPK ++IV  +   I+
Sbjct: 257 QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 104/204 (50%), Gaps = 6/204 (2%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIH 644
           E+E        K+G G +G VY G  K     VAVK + +  +   ++F+ E A++  I 
Sbjct: 14  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIK 72
Query: 645 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 704
           H NLV L+G C  E    ++ E+M  G L D L    N++ ++ +  L +A   +  +EY
Sbjct: 73  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISSAMEY 131
Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
           L        IHRD+ + N L+  N   KV+DFGLSR    D     + A+  + +  PE 
Sbjct: 132 LE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 188
Query: 765 YGNQQLTEKSDVYSFGVVLLELIS 788
               + + KSDV++FGV+L E+ +
Sbjct: 189 LAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 82/245 (33%), Positives = 129/245 (52%), Gaps = 21/245 (8%)
Query: 551 ADSLRTS-TKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYG 609
           AD L T   KP     ++A    F   G A  + + EL+       + IGKG FG V  G
Sbjct: 160 ADGLCTRLIKPKVMEGTVAAQDEFYRSGWA--LNMKELK-----LLQTIGKGEFGDVMLG 212
Query: 610 KMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI-LVYEYM 668
             + G +VAVK + +  +   Q F+ E ++++++ H NLV L+G   EE   + +V EYM
Sbjct: 213 DYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269
Query: 669 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN 728
             G+L D L  S  +  L     L+ + D  + +EYL  G N   +HRD+ + N+L+  +
Sbjct: 270 AKGSLVDYLR-SRGRSVLGGDCLLKFSLDVCEAMEYLE-GNN--FVHRDLAARNVLVSED 325
Query: 729 MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
             AKVSDFGL+++A    +      +  V +  PE    ++ + KSDV+SFG++L E+ S
Sbjct: 326 NVAKVSDFGLTKEA----SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 381
Query: 789 -GKKP 792
            G+ P
Sbjct: 382 FGRVP 386

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 104/204 (50%), Gaps = 6/204 (2%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIH 644
           E+E        K+G G +G VY G  K     VAVK + +  +   ++F+ E A++  I 
Sbjct: 22  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIK 80
Query: 645 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 704
           H NLV L+G C  E    ++ E+M  G L D L    N++ ++ +  L +A   +  +EY
Sbjct: 81  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISSAMEY 139
Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
           L        IHRD+ + N L+  N   KV+DFGLSR    D     + A+  + +  PE 
Sbjct: 140 LE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 196
Query: 765 YGNQQLTEKSDVYSFGVVLLELIS 788
               + + KSDV++FGV+L E+ +
Sbjct: 197 LAYNKFSIKSDVWAFGVLLWEIAT 220

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 110/212 (51%), Gaps = 14/212 (6%)
Query: 586 ELEEATNNFCKKIGKGSFGSV---YYGKMKD--GKEVAVKIMADSCSHRTQQFVTEVALL 640
           + EE    F +++GKG+FGSV    Y  ++D  G+ VAVK +  S     + F  E+ +L
Sbjct: 9   QFEERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 68
Query: 641 SRIHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDA 698
             + H N+V   G C    +R   L+ E++  G+LR+ L    +++ +D +  LQ     
Sbjct: 69  KSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQK--HKERIDHIKLLQYTSQI 126
Query: 699 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED--LTHISSVARGT 756
            KG+EYL T      IHRD+ + NIL++   R K+ DFGL++   +D     +       
Sbjct: 127 CKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 183
Query: 757 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
           + +  PE     + +  SDV+SFGVVL EL +
Sbjct: 184 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 104/204 (50%), Gaps = 6/204 (2%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIH 644
           E+E        K+G G +G VY G  K     VAVK + +  +   ++F+ E A++  I 
Sbjct: 11  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIK 69
Query: 645 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 704
           H NLV L+G C  E    ++ E+M  G L D L    N++ ++ +  L +A   +  +EY
Sbjct: 70  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISSAMEY 128
Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
           L        IHRD+ + N L+  N   KV+DFGLSR    D     + A+  + +  PE 
Sbjct: 129 LE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 185
Query: 765 YGNQQLTEKSDVYSFGVVLLELIS 788
               + + KSDV++FGV+L E+ +
Sbjct: 186 LAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 103/204 (50%), Gaps = 6/204 (2%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIH 644
           E+E        K+G G +G VY G  K     VAVK + +  +   ++F+ E A++  I 
Sbjct: 9   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIK 67
Query: 645 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 704
           H NLV L+G C  E    ++ E+M  G L D L    N++ +  +  L +A   +  +EY
Sbjct: 68  HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISSAMEY 126
Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
           L        IHRD+ + N L+  N   KV+DFGLSR    D     + A+  + +  PE 
Sbjct: 127 LE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 183
Query: 765 YGNQQLTEKSDVYSFGVVLLELIS 788
               + + KSDV++FGV+L E+ +
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score =  101 bits (252), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 103/204 (50%), Gaps = 6/204 (2%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIH 644
           E+E        K+G G +G VY G  K     VAVK + +  +   ++F+ E A++  I 
Sbjct: 9   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIK 67
Query: 645 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 704
           H NLV L+G C  E    ++ E+M  G L D L    N++ +  +  L +A   +  +EY
Sbjct: 68  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISSAMEY 126
Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
           L        IHRD+ + N L+  N   KV+DFGLSR    D     + A+  + +  PE 
Sbjct: 127 LE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 183
Query: 765 YGNQQLTEKSDVYSFGVVLLELIS 788
               + + KSDV++FGV+L E+ +
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score =  101 bits (252), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 103/204 (50%), Gaps = 6/204 (2%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIH 644
           E+E        K+G G +G VY G  K     VAVK + +  +   ++F+ E A++  I 
Sbjct: 14  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIK 72
Query: 645 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 704
           H NLV L+G C  E    ++ E+M  G L D L    N++ +  +  L +A   +  +EY
Sbjct: 73  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISSAMEY 131
Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
           L        IHRD+ + N L+  N   KV+DFGLSR    D     + A+  + +  PE 
Sbjct: 132 LE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 188
Query: 765 YGNQQLTEKSDVYSFGVVLLELIS 788
               + + KSDV++FGV+L E+ +
Sbjct: 189 LAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  101 bits (252), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 103/204 (50%), Gaps = 6/204 (2%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIH 644
           E+E        K+G G +G VY G  K     VAVK + +  +   ++F+ E A++  I 
Sbjct: 7   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIK 65
Query: 645 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 704
           H NLV L+G C  E    ++ E+M  G L D L    N++ +  +  L +A   +  +EY
Sbjct: 66  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISSAMEY 124
Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
           L        IHRD+ + N L+  N   KV+DFGLSR    D     + A+  + +  PE 
Sbjct: 125 LE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPES 181
Query: 765 YGNQQLTEKSDVYSFGVVLLELIS 788
               + + KSDV++FGV+L E+ +
Sbjct: 182 LAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score =  101 bits (252), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 103/204 (50%), Gaps = 6/204 (2%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIH 644
           E+E        K+G G +G VY G  K     VAVK + +  +   ++F+ E A++  I 
Sbjct: 9   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIK 67
Query: 645 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 704
           H NLV L+G C  E    ++ E+M  G L D L    N++ +  +  L +A   +  +EY
Sbjct: 68  HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISSAMEY 126
Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
           L        IHRD+ + N L+  N   KV+DFGLSR    D     + A+  + +  PE 
Sbjct: 127 LE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 183
Query: 765 YGNQQLTEKSDVYSFGVVLLELIS 788
               + + KSDV++FGV+L E+ +
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score =  101 bits (252), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 70/209 (33%), Positives = 104/209 (49%), Gaps = 7/209 (3%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIH 644
           E+E        K+G G +G VY G  K     VAVK + +  +   ++F+ E A++  I 
Sbjct: 28  EMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIK 86
Query: 645 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 704
           H NLV L+G C  E    +V EYM  G L D L    N++ +  +  L +A   +  +EY
Sbjct: 87  HPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLR-ECNREEVTAVVLLYMATQISSAMEY 145
Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
           L        IHRD+ + N L+  N   KV+DFGLSR    D     + A+  + +  PE 
Sbjct: 146 LE---KKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 202
Query: 765 YGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
                 + KSDV++FGV+L E+ + G  P
Sbjct: 203 LAYNTFSIKSDVWAFGVLLWEIATYGMSP 231

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 103/204 (50%), Gaps = 6/204 (2%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIH 644
           E+E        K+G G +G VY G  K     VAVK + +  +   ++F+ E A++  I 
Sbjct: 9   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIK 67
Query: 645 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 704
           H NLV L+G C  E    ++ E+M  G L D L    N++ +  +  L +A   +  +EY
Sbjct: 68  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISSAMEY 126
Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
           L        IHRD+ + N L+  N   KV+DFGLSR    D     + A+  + +  PE 
Sbjct: 127 LE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 183
Query: 765 YGNQQLTEKSDVYSFGVVLLELIS 788
               + + KSDV++FGV+L E+ +
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 70/199 (35%), Positives = 112/199 (56%), Gaps = 13/199 (6%)
Query: 596 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 655
           + IGKG FG V  G  + G +VAVK + +  +   Q F+ E ++++++ H NLV L+G  
Sbjct: 12  QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 656 EEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 714
            EE   + +V EYM  G+L D L  S  +  L     L+ + D  + +EYL  G N   +
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYLR-SRGRSVLGGDCLLKFSLDVCEAMEYLE-GNN--FV 124
Query: 715 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 774
           HRD+ + N+L+  +  AKVSDFGL+++A    +      +  V +  PE    ++ + KS
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKWTAPEALREKKFSTKS 180
Query: 775 DVYSFGVVLLELIS-GKKP 792
           DV+SFG++L E+ S G+ P
Sbjct: 181 DVWSFGILLWEIYSFGRVP 199

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 70/199 (35%), Positives = 112/199 (56%), Gaps = 13/199 (6%)
Query: 596 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 655
           + IGKG FG V  G  + G +VAVK + +  +   Q F+ E ++++++ H NLV L+G  
Sbjct: 27  QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 656 EEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 714
            EE   + +V EYM  G+L D L  S  +  L     L+ + D  + +EYL  G N   +
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLR-SRGRSVLGGDCLLKFSLDVCEAMEYLE-GNN--FV 139
Query: 715 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 774
           HRD+ + N+L+  +  AKVSDFGL+++A    +      +  V +  PE    ++ + KS
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKWTAPEALREKKFSTKS 195
Query: 775 DVYSFGVVLLELIS-GKKP 792
           DV+SFG++L E+ S G+ P
Sbjct: 196 DVWSFGILLWEIYSFGRVP 214

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score =  100 bits (250), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 142/285 (49%), Gaps = 35/285 (12%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMK-DGKE---VAVKIMADSCSHRTQQ-FVTEVALL 640
           E+E +     + IG G FG V  G++K  GK    VA+K +    + + ++ F+ E +++
Sbjct: 18  EIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIM 77
Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HD 697
            +  H N++ L G   +    ++V EYM NG+L   L  +  Q      T +Q+      
Sbjct: 78  GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQ-----FTVIQLVGMLRG 132
Query: 698 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED--LTHISSVARG 755
            + G++YL    + G +HRD+ + NIL++ N+  KVSDFGLSR  E+D    + +   + 
Sbjct: 133 ISAGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 189
Query: 756 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKK 814
            + +  PE    ++ T  SDV+S+G+V+ E++S G++P             +W    +  
Sbjct: 190 PIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERP-------------YWE---MTN 233
Query: 815 GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 859
            DVI  V+        ++    + ++ + C ++   SRPK  EIV
Sbjct: 234 QDVIKAVEEGYRLPSPMDCPAALYQLMLDCWQKERNSRPKFDEIV 278

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score =  100 bits (248), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 80/290 (27%), Positives = 139/290 (47%), Gaps = 29/290 (10%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMK--DGKEVAVKIMADSCSHRTQQ---FVTEVALL 640
           EL+ +     + IG G FG V  G++K    ++VAV I      +  +Q   F+ E +++
Sbjct: 39  ELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIM 98
Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 700
            +  H N+V L G        ++V E+M NG L   L     Q  +  +  + +    A 
Sbjct: 99  GQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTV--IQLVGMLRGIAA 156
Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT--VG 758
           G+ YL    + G +HRD+ + NIL++ N+  KVSDFGLSR  E+D   + +   G   V 
Sbjct: 157 GMRYL---ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVR 213
Query: 759 YLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDV 817
           +  PE    ++ T  SDV+S+G+V+ E++S G++P             +W  S     DV
Sbjct: 214 WTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP-------------YWDMS---NQDV 257
Query: 818 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 867
           I  ++        ++    + ++ + C ++    RPK ++IV  +   I+
Sbjct: 258 IKAIEEGYRLPAPMDCPAGLHQLMLDCWQKERAERPKFEQIVGILDKMIR 307

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 99.8 bits (247), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 70/199 (35%), Positives = 110/199 (55%), Gaps = 13/199 (6%)
Query: 596 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 655
           + IGKG FG V  G  + G +VAVK + +  +   Q F+ E ++++++ H NLV L+G  
Sbjct: 18  QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVI 74
Query: 656 EEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 714
            EE   + +V EYM  G+L D L  S  +  L     L+ + D  + +EYL  G N   +
Sbjct: 75  VEEKGGLYIVTEYMAKGSLVDYLR-SRGRSVLGGDCLLKFSLDVCEAMEYLE-GNN--FV 130
Query: 715 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 774
           HRD+ + N+L+  +  AKVSDFGL+++A    +      +  V +  PE       + KS
Sbjct: 131 HRDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKWTAPEALREAAFSTKS 186
Query: 775 DVYSFGVVLLELIS-GKKP 792
           DV+SFG++L E+ S G+ P
Sbjct: 187 DVWSFGILLWEIYSFGRVP 205

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 99.4 bits (246), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 106/209 (50%), Gaps = 14/209 (6%)
Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT-----QQFVTEVALLSRIHHRN 647
           +F + IG+G FG VY+G + D     +     S +  T      QF+TE  ++    H N
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 648 LVPLIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           ++ L+G C   E   ++V  YM +G LR+ +    +   +  L    +    AKG+++L 
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKFL- 208
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA---EEDLTHISSVARGTVGYLDPE 763
              +   +HRD+ + N +LD     KV+DFGL+R     E D  H  + A+  V ++  E
Sbjct: 209 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 266
Query: 764 YYGNQQLTEKSDVYSFGVVLLELISGKKP 792
               Q+ T KSDV+SFGV+L EL++   P
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMTRGAP 295

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 99.4 bits (246), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 106/209 (50%), Gaps = 14/209 (6%)
Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT-----QQFVTEVALLSRIHHRN 647
           +F + IG+G FG VY+G + D     +     S +  T      QF+TE  ++    H N
Sbjct: 34  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 93
Query: 648 LVPLIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           ++ L+G C   E   ++V  YM +G LR+ +    +   +  L    +    AKG+++L 
Sbjct: 94  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKFL- 150
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA---EEDLTHISSVARGTVGYLDPE 763
              +   +HRD+ + N +LD     KV+DFGL+R     E D  H  + A+  V ++  E
Sbjct: 151 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALE 208
Query: 764 YYGNQQLTEKSDVYSFGVVLLELISGKKP 792
               Q+ T KSDV+SFGV+L EL++   P
Sbjct: 209 SLQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 99.4 bits (246), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 106/209 (50%), Gaps = 14/209 (6%)
Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT-----QQFVTEVALLSRIHHRN 647
           +F + IG+G FG VY+G + D     +     S +  T      QF+TE  ++    H N
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 648 LVPLIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           ++ L+G C   E   ++V  YM +G LR+ +    +   +  L    +    AKG+++L 
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKFL- 149
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA---EEDLTHISSVARGTVGYLDPE 763
              +   +HRD+ + N +LD     KV+DFGL+R     E D  H  + A+  V ++  E
Sbjct: 150 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 207
Query: 764 YYGNQQLTEKSDVYSFGVVLLELISGKKP 792
               Q+ T KSDV+SFGV+L EL++   P
Sbjct: 208 SLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 99.4 bits (246), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 139/290 (47%), Gaps = 29/290 (10%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMK--DGKEVAVKIMADSCSHRTQQ---FVTEVALL 640
           E+E +  +  K IG G  G V YG+++    ++V V I A    +  +Q   F++E +++
Sbjct: 45  EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIM 104
Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 700
            +  H N++ L G        ++V EYM NG+L   L     Q  +  +  + +      
Sbjct: 105 GQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI--MQLVGMLRGVGA 162
Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG-- 758
           G+ YL    + G +HRD+ + N+L+D N+  KVSDFGLSR  E+D     +   G +   
Sbjct: 163 GMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIR 219
Query: 759 YLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDV 817
           +  PE    +  +  SDV+SFGVV+ E+++ G++P             +W  +M  + DV
Sbjct: 220 WTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP-------------YW--NMTNR-DV 263
Query: 818 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 867
           IS V+        +     + ++ + C  +    RP+  +IV  +   I+
Sbjct: 264 ISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 99.4 bits (246), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 106/209 (50%), Gaps = 14/209 (6%)
Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT-----QQFVTEVALLSRIHHRN 647
           +F + IG+G FG VY+G + D     +     S +  T      QF+TE  ++    H N
Sbjct: 34  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 93
Query: 648 LVPLIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           ++ L+G C   E   ++V  YM +G LR+ +    +   +  L    +    AKG+++L 
Sbjct: 94  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKFL- 150
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA---EEDLTHISSVARGTVGYLDPE 763
              +   +HRD+ + N +LD     KV+DFGL+R     E D  H  + A+  V ++  E
Sbjct: 151 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 208
Query: 764 YYGNQQLTEKSDVYSFGVVLLELISGKKP 792
               Q+ T KSDV+SFGV+L EL++   P
Sbjct: 209 SLQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 99.4 bits (246), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 106/209 (50%), Gaps = 14/209 (6%)
Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT-----QQFVTEVALLSRIHHRN 647
           +F + IG+G FG VY+G + D     +     S +  T      QF+TE  ++    H N
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 648 LVPLIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           ++ L+G C   E   ++V  YM +G LR+ +    +   +  L    +    AKG+++L 
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKFL- 149
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA---EEDLTHISSVARGTVGYLDPE 763
              +   +HRD+ + N +LD     KV+DFGL+R     E D  H  + A+  V ++  E
Sbjct: 150 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 207
Query: 764 YYGNQQLTEKSDVYSFGVVLLELISGKKP 792
               Q+ T KSDV+SFGV+L EL++   P
Sbjct: 208 SLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 99.4 bits (246), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 106/209 (50%), Gaps = 14/209 (6%)
Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT-----QQFVTEVALLSRIHHRN 647
           +F + IG+G FG VY+G + D     +     S +  T      QF+TE  ++    H N
Sbjct: 31  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 90
Query: 648 LVPLIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           ++ L+G C   E   ++V  YM +G LR+ +    +   +  L    +    AKG+++L 
Sbjct: 91  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKFL- 147
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA---EEDLTHISSVARGTVGYLDPE 763
              +   +HRD+ + N +LD     KV+DFGL+R     E D  H  + A+  V ++  E
Sbjct: 148 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 205
Query: 764 YYGNQQLTEKSDVYSFGVVLLELISGKKP 792
               Q+ T KSDV+SFGV+L EL++   P
Sbjct: 206 SLQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 99.4 bits (246), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 141/290 (48%), Gaps = 29/290 (10%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMK--DGKEVAVKIMADSCSHRTQQ---FVTEVALL 640
           E+E +  +  K IG G  G V YG+++    ++V V I A    +  +Q   F++E +++
Sbjct: 45  EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIM 104
Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 700
            +  H N++ L G        ++V EYM NG+L   L     Q  +  +  + +      
Sbjct: 105 GQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI--MQLVGMLRGVGA 162
Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE--DLTHISSVARGTVG 758
           G+ YL    + G +HRD+ + N+L+D N+  KVSDFGLSR  E+  D  + ++  +  + 
Sbjct: 163 GMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIR 219
Query: 759 YLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDV 817
           +  PE    +  +  SDV+SFGVV+ E+++ G++P             +W  +M  + DV
Sbjct: 220 WTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP-------------YW--NMTNR-DV 263
Query: 818 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 867
           IS V+        +     + ++ + C  +    RP+  +IV  +   I+
Sbjct: 264 ISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 99.0 bits (245), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 106/209 (50%), Gaps = 14/209 (6%)
Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT-----QQFVTEVALLSRIHHRN 647
           +F + IG+G FG VY+G + D     +     S +  T      QF+TE  ++    H N
Sbjct: 38  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 97
Query: 648 LVPLIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           ++ L+G C   E   ++V  YM +G LR+ +    +   +  L    +    AKG+++L 
Sbjct: 98  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKFL- 154
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA---EEDLTHISSVARGTVGYLDPE 763
              +   +HRD+ + N +LD     KV+DFGL+R     E D  H  + A+  V ++  E
Sbjct: 155 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 212
Query: 764 YYGNQQLTEKSDVYSFGVVLLELISGKKP 792
               Q+ T KSDV+SFGV+L EL++   P
Sbjct: 213 SLQTQKFTTKSDVWSFGVLLWELMTRGAP 241

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 71/226 (31%), Positives = 114/226 (50%), Gaps = 15/226 (6%)
Query: 571 GHFMDEGVA---YFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS 627
           GH   +G+A   + IP   L         K+G+G FG V+ G       VA+K +    +
Sbjct: 1   GHMQTQGLAKDAWEIPRESLRLEV-----KLGQGCFGEVWMGTWNGTTRVAIKTLKPG-T 54
Query: 628 HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD 687
              + F+ E  ++ ++ H  LV L     EE   I++ EYM  G+L D L G +  K L 
Sbjct: 55  MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVI-EYMSKGSLLDFLKGEMG-KYLR 112
Query: 688 WLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 747
               + +A   A G+ Y+        +HRD++++NIL+  N+  KV+DFGL+R  E++  
Sbjct: 113 LPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEX 169
Query: 748 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
                A+  + +  PE     + T KSDV+SFG++L EL + G+ P
Sbjct: 170 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/226 (32%), Positives = 113/226 (50%), Gaps = 15/226 (6%)
Query: 571 GHFMDEGVA---YFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS 627
           GH   +G+A   + IP   L         K+G+G FG V+ G       VA+K +    +
Sbjct: 1   GHMQTQGLAKDAWEIPRESLRLEV-----KLGQGCFGEVWMGTWNGTTRVAIKTLKPG-T 54
Query: 628 HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD 687
              + F+ E  ++ +I H  LV L     EE   I V EYM  G+L D L G +  K L 
Sbjct: 55  MSPEAFLQEAQVMKKIRHEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGEMG-KYLR 112
Query: 688 WLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 747
               + +A   A G+ Y+        +HRD++++NIL+  N+  KV+DFGL+R  E++  
Sbjct: 113 LPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 169
Query: 748 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
                A+  + +  PE     + T KSDV+SFG++L EL + G+ P
Sbjct: 170 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 103/204 (50%), Gaps = 6/204 (2%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIH 644
           E+E        K+G G +G VY G  K     VAVK + +  +   ++F+ E A++  I 
Sbjct: 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIK 274
Query: 645 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 704
           H NLV L+G C  E    ++ E+M  G L D L    N++ +  +  L +A   +  +EY
Sbjct: 275 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISSAMEY 333
Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
           L        IHR++ + N L+  N   KV+DFGLSR    D     + A+  + +  PE 
Sbjct: 334 LE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 390
Query: 765 YGNQQLTEKSDVYSFGVVLLELIS 788
               + + KSDV++FGV+L E+ +
Sbjct: 391 LAYNKFSIKSDVWAFGVLLWEIAT 414

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 105/209 (50%), Gaps = 14/209 (6%)
Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT-----QQFVTEVALLSRIHHRN 647
           +F + IG+G FG VY+G + D     +     S +  T      QF+TE  ++    H N
Sbjct: 32  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 91
Query: 648 LVPLIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           ++ L+G C   E   ++V  YM +G LR+ +    +   +  L    +    AKG++YL 
Sbjct: 92  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL- 148
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA---EEDLTHISSVARGTVGYLDPE 763
              +   +HRD+ + N +LD     KV+DFGL+R     E    H  + A+  V ++  E
Sbjct: 149 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALE 206
Query: 764 YYGNQQLTEKSDVYSFGVVLLELISGKKP 792
               Q+ T KSDV+SFGV+L EL++   P
Sbjct: 207 SLQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 102/197 (51%), Gaps = 7/197 (3%)
Query: 597 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 656
           K+G+G FG V+ G       VA+K +    +   + F+ E  ++ ++ H  LV L     
Sbjct: 15  KLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 73
Query: 657 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHR 716
           EE   I V EYM  G+L D L G    K L     + +A   A G+ Y+        +HR
Sbjct: 74  EEPIXI-VTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 128
Query: 717 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDV 776
           D++++NIL+  N+  KV+DFGL+R  E++       A+  + +  PE     + T KSDV
Sbjct: 129 DLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDV 188
Query: 777 YSFGVVLLELIS-GKKP 792
           +SFG++L EL + G+ P
Sbjct: 189 WSFGILLTELTTKGRVP 205

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 71/226 (31%), Positives = 114/226 (50%), Gaps = 15/226 (6%)
Query: 571 GHFMDEGVA---YFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS 627
           GH   +G+A   + IP   L         K+G+G FG V+ G       VA+K +    +
Sbjct: 1   GHMQTQGLAKDAWEIPRESLRLEV-----KLGQGCFGEVWMGTWNGTTRVAIKTLKPG-T 54
Query: 628 HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD 687
              + F+ E  ++ ++ H  LV L     EE   I++ EYM  G+L D L G +  K L 
Sbjct: 55  MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVI-EYMSKGSLLDFLKGEMG-KYLR 112
Query: 688 WLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 747
               + +A   A G+ Y+        +HRD++++NIL+  N+  KV+DFGL+R  E++  
Sbjct: 113 LPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 169
Query: 748 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
                A+  + +  PE     + T KSDV+SFG++L EL + G+ P
Sbjct: 170 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 104/204 (50%), Gaps = 6/204 (2%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIH 644
           E+E        K+G G +G VY G  K     VAVK + +  +   ++F+ E A++  I 
Sbjct: 255 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIK 313
Query: 645 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 704
           H NLV L+G C  E    ++ E+M  G L D L    N++ ++ +  L +A   +  +EY
Sbjct: 314 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISSAMEY 372
Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
           L        IHR++ + N L+  N   KV+DFGLSR    D     + A+  + +  PE 
Sbjct: 373 LE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 429
Query: 765 YGNQQLTEKSDVYSFGVVLLELIS 788
               + + KSDV++FGV+L E+ +
Sbjct: 430 LAYNKFSIKSDVWAFGVLLWEIAT 453

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 106/209 (50%), Gaps = 8/209 (3%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 645
           E+   +    K++G G FG V+ G   +  +VAVK +    +   Q F+ E  L+  + H
Sbjct: 9   EIPRESIKLVKRLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQH 67
Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRL-QIAHDAAKGLEY 704
             LV L      E    ++ EYM  G+L D L      K L  L +L   +   A+G+ Y
Sbjct: 68  DKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVL--LPKLIDFSAQIAEGMAY 125
Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
           +        IHRD++++N+L+  ++  K++DFGL+R  E++       A+  + +  PE 
Sbjct: 126 IE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 182
Query: 765 YGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
                 T KSDV+SFG++L E+++ GK P
Sbjct: 183 INFGCFTIKSDVWSFGILLYEIVTYGKIP 211

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 76/221 (34%), Positives = 109/221 (49%), Gaps = 20/221 (9%)
Query: 584 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMA----DSCSHRTQQFVTEVAL 639
           L E++ A     + IG G FG VY      G EVAVK       +  S   +    E  L
Sbjct: 1   LLEIDFAELTLEEIIGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKL 59
Query: 640 LSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA 699
            + + H N++ L G C +E    LV E+   G L   L G   + P D L    +    A
Sbjct: 60  FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG--KRIPPDILVNWAV--QIA 115
Query: 700 KGLEYLHTGCNPGIIHRDVKSSNILL-------DI-NMRAKVSDFGLSRQAEEDLTHISS 751
           +G+ YLH      IIHRD+KSSNIL+       D+ N   K++DFGL+R+     T +S 
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT-TKMS- 173
Query: 752 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
            A G   ++ PE       ++ SDV+S+GV+L EL++G+ P
Sbjct: 174 -AAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 113/226 (50%), Gaps = 15/226 (6%)
Query: 571 GHFMDEGVA---YFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS 627
           GH   +G+A   + IP   L         K+G+G FG V+ G       VA+K +    +
Sbjct: 1   GHMQTQGLAKDAWEIPRESLRLEV-----KLGQGCFGEVWMGTWNGTTRVAIKTLKPG-T 54
Query: 628 HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD 687
              + F+ E  ++ ++ H  LV L     EE   I V EYM  G+L D L G +  K L 
Sbjct: 55  MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGEMG-KYLR 112
Query: 688 WLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 747
               + +A   A G+ Y+        +HRD++++NIL+  N+  KV+DFGL+R  E++  
Sbjct: 113 LPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 169
Query: 748 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
                A+  + +  PE     + T KSDV+SFG++L EL + G+ P
Sbjct: 170 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 113/226 (50%), Gaps = 15/226 (6%)
Query: 571 GHFMDEGVA---YFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS 627
           GH   +G+A   + IP   L         K+G+G FG V+ G       VA+K +    +
Sbjct: 1   GHMQTQGLAKDAWEIPRESLRLEV-----KLGQGCFGEVWMGTWNGTTRVAIKTLKPG-T 54
Query: 628 HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD 687
              + F+ E  ++ ++ H  LV L     EE   I V EYM  G+L D L G +  K L 
Sbjct: 55  MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYI-VCEYMSKGSLLDFLKGEMG-KYLR 112
Query: 688 WLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 747
               + +A   A G+ Y+        +HRD++++NIL+  N+  KV+DFGL+R  E++  
Sbjct: 113 LPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 169
Query: 748 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
                A+  + +  PE     + T KSDV+SFG++L EL + G+ P
Sbjct: 170 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 103/197 (52%), Gaps = 7/197 (3%)
Query: 597 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 656
           K+G+G FG V+ G       VA+K +    +   + F+ E  ++ ++ H  LV L     
Sbjct: 16  KLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 74
Query: 657 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHR 716
           EE   I V EYM  G+L D L G +  K L     + +A   A G+ Y+        +HR
Sbjct: 75  EEPIYI-VTEYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 129
Query: 717 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDV 776
           D++++NIL+  N+  KV+DFGL+R  E++       A+  + +  PE     + T KSDV
Sbjct: 130 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 189
Query: 777 YSFGVVLLELIS-GKKP 792
           +SFG++L EL + G+ P
Sbjct: 190 WSFGILLTELTTKGRVP 206

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 103/197 (52%), Gaps = 7/197 (3%)
Query: 597 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 656
           K+G+G FG V+ G       VA+K +    +   + F+ E  ++ ++ H  LV L     
Sbjct: 14  KLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 72
Query: 657 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHR 716
           EE   I V EYM  G+L D L G +  K L     + +A   A G+ Y+        +HR
Sbjct: 73  EEPIYI-VTEYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 127
Query: 717 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDV 776
           D++++NIL+  N+  KV+DFGL+R  E++       A+  + +  PE     + T KSDV
Sbjct: 128 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 187
Query: 777 YSFGVVLLELIS-GKKP 792
           +SFG++L EL + G+ P
Sbjct: 188 WSFGILLTELTTKGRVP 204

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 112/226 (49%), Gaps = 15/226 (6%)
Query: 571 GHFMDEGVA---YFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS 627
           GH   +G+A   + IP   L         K+G+G FG V+ G       VA+K +    +
Sbjct: 1   GHMQTQGLAKDAWEIPRESLRLEV-----KLGQGCFGEVWMGTWNGTTRVAIKTLKPG-T 54
Query: 628 HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD 687
              + F+ E  ++ ++ H  LV L     EE   I V EYM  G L D L G +  K L 
Sbjct: 55  MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYI-VMEYMSKGCLLDFLKGEMG-KYLR 112
Query: 688 WLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 747
               + +A   A G+ Y+        +HRD++++NIL+  N+  KV+DFGL+R  E++  
Sbjct: 113 LPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 169
Query: 748 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
                A+  + +  PE     + T KSDV+SFG++L EL + G+ P
Sbjct: 170 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 97.8 bits (242), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 102/197 (51%), Gaps = 7/197 (3%)
Query: 597 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 656
           K+G+G FG V+ G       VA+K +    +   + F+ E  ++ ++ H  LV L     
Sbjct: 18  KLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 76
Query: 657 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHR 716
           EE   I V EYM  G+L D L G    K L     + +A   A G+ Y+        +HR
Sbjct: 77  EEPIYI-VTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 131
Query: 717 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDV 776
           D++++NIL+  N+  KV+DFGL+R  E++       A+  + +  PE     + T KSDV
Sbjct: 132 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 191
Query: 777 YSFGVVLLELIS-GKKP 792
           +SFG++L EL + G+ P
Sbjct: 192 WSFGILLTELTTKGRVP 208

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 105/209 (50%), Gaps = 14/209 (6%)
Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT-----QQFVTEVALLSRIHHRN 647
           +F + IG+G FG VY+G + D     +     S +  T      QF+TE  ++    H N
Sbjct: 52  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 111
Query: 648 LVPLIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           ++ L+G C   E   ++V  YM +G LR+ +    +   +  L    +    AKG++YL 
Sbjct: 112 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL- 168
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA---EEDLTHISSVARGTVGYLDPE 763
              +   +HRD+ + N +LD     KV+DFGL+R     E    H  + A+  V ++  E
Sbjct: 169 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 226
Query: 764 YYGNQQLTEKSDVYSFGVVLLELISGKKP 792
               Q+ T KSDV+SFGV+L EL++   P
Sbjct: 227 SLQTQKFTTKSDVWSFGVLLWELMTRGAP 255

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 112/226 (49%), Gaps = 15/226 (6%)
Query: 571 GHFMDEGVA---YFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS 627
           GH   +G+A   + IP   L         K+G+G FG V+ G       VA+K +    +
Sbjct: 1   GHMQTQGLAKDAWEIPRESLRLEV-----KLGQGCFGEVWMGTWNGTTRVAIKTLKPG-T 54
Query: 628 HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD 687
              + F+ E  ++ ++ H  LV L     EE   I V EYM  G L D L G +  K L 
Sbjct: 55  MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYI-VTEYMSKGCLLDFLKGEMG-KYLR 112
Query: 688 WLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 747
               + +A   A G+ Y+        +HRD++++NIL+  N+  KV+DFGL+R  E++  
Sbjct: 113 LPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 169
Query: 748 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
                A+  + +  PE     + T KSDV+SFG++L EL + G+ P
Sbjct: 170 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 108/212 (50%), Gaps = 8/212 (3%)
Query: 583 PLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSR 642
           P  E+   +    KK+G G FG V+ G   +  +VAVK +    +   Q F+ E  L+  
Sbjct: 5   PAWEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKT 63
Query: 643 IHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRL-QIAHDAAKG 701
           + H  LV L     +E    ++ E+M  G+L D L      K L  L +L   +   A+G
Sbjct: 64  LQHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVL--LPKLIDFSAQIAEG 121
Query: 702 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 761
           + Y+        IHRD++++N+L+  ++  K++DFGL+R  E++       A+  + +  
Sbjct: 122 MAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTA 178
Query: 762 PEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
           PE       T KS+V+SFG++L E+++ GK P
Sbjct: 179 PEAINFGCFTIKSNVWSFGILLYEIVTYGKIP 210

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 105/209 (50%), Gaps = 14/209 (6%)
Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT-----QQFVTEVALLSRIHHRN 647
           +F + IG+G FG VY+G + D     +     S +  T      QF+TE  ++    H N
Sbjct: 25  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 84
Query: 648 LVPLIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           ++ L+G C   E   ++V  YM +G LR+ +    +   +  L    +    AKG++YL 
Sbjct: 85  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL- 141
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA---EEDLTHISSVARGTVGYLDPE 763
              +   +HRD+ + N +LD     KV+DFGL+R     E    H  + A+  V ++  E
Sbjct: 142 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 199
Query: 764 YYGNQQLTEKSDVYSFGVVLLELISGKKP 792
               Q+ T KSDV+SFGV+L EL++   P
Sbjct: 200 SLQTQKFTTKSDVWSFGVLLWELMTRGAP 228

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 105/209 (50%), Gaps = 14/209 (6%)
Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT-----QQFVTEVALLSRIHHRN 647
           +F + IG+G FG VY+G + D     +     S +  T      QF+TE  ++    H N
Sbjct: 30  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89
Query: 648 LVPLIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           ++ L+G C   E   ++V  YM +G LR+ +    +   +  L    +    AKG++YL 
Sbjct: 90  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL- 146
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA---EEDLTHISSVARGTVGYLDPE 763
              +   +HRD+ + N +LD     KV+DFGL+R     E    H  + A+  V ++  E
Sbjct: 147 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 204
Query: 764 YYGNQQLTEKSDVYSFGVVLLELISGKKP 792
               Q+ T KSDV+SFGV+L EL++   P
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRGAP 233

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 105/209 (50%), Gaps = 14/209 (6%)
Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT-----QQFVTEVALLSRIHHRN 647
           +F + IG+G FG VY+G + D     +     S +  T      QF+TE  ++    H N
Sbjct: 51  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 110
Query: 648 LVPLIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           ++ L+G C   E   ++V  YM +G LR+ +    +   +  L    +    AKG++YL 
Sbjct: 111 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL- 167
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA---EEDLTHISSVARGTVGYLDPE 763
              +   +HRD+ + N +LD     KV+DFGL+R     E    H  + A+  V ++  E
Sbjct: 168 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 225
Query: 764 YYGNQQLTEKSDVYSFGVVLLELISGKKP 792
               Q+ T KSDV+SFGV+L EL++   P
Sbjct: 226 SLQTQKFTTKSDVWSFGVLLWELMTRGAP 254

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 108/215 (50%), Gaps = 21/215 (9%)
Query: 596 KKIGKGSFGSVYYGKM------KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLV 649
           +++G+G+FG V+  +       +D   VAVK + D+  +  + F  E  LL+ + H ++V
Sbjct: 19  RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIV 78
Query: 650 PLIGYCEEEHQRILVYEYMHNGTLRD--RLHGS-----VNQKPLDWLTR---LQIAHDAA 699
              G C E    I+V+EYM +G L    R HG          P   LT+   L IA   A
Sbjct: 79  KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIA 138
Query: 700 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTVG 758
            G+ YL    +   +HRD+ + N L+  N+  K+ DFG+SR     D   +       + 
Sbjct: 139 AGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 195
Query: 759 YLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
           ++ PE    ++ T +SDV+S GVVL E+ + GK+P
Sbjct: 196 WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 230

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 108/218 (49%), Gaps = 24/218 (11%)
Query: 596 KKIGKGSFGSVYYGKM------KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLV 649
           +++G+G+FG V+  +       KD   VAVK + D      + F  E  LL+ + H ++V
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 650 PLIGYCEEEHQRILVYEYMHNGTLRD--RLHGS-----VNQKP------LDWLTRLQIAH 696
              G C +    I+V+EYM +G L    R HG      V+ +P      L     L IA 
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 697 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARG 755
             A G+ YL    +   +HRD+ + N L+  N+  K+ DFG+SR     D   +      
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 197
Query: 756 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
            + ++ PE    ++ T +SDV+SFGV+L E+ + GK+P
Sbjct: 198 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 105/209 (50%), Gaps = 14/209 (6%)
Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT-----QQFVTEVALLSRIHHRN 647
           +F + IG+G FG VY+G + D     +     S +  T      QF+TE  ++    H N
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 648 LVPLIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           ++ L+G C   E   ++V  YM +G LR+ +    +   +  L    +    AKG++YL 
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL- 149
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA---EEDLTHISSVARGTVGYLDPE 763
              +   +HRD+ + N +LD     KV+DFGL+R     E    H  + A+  V ++  E
Sbjct: 150 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 207
Query: 764 YYGNQQLTEKSDVYSFGVVLLELISGKKP 792
               Q+ T KSDV+SFGV+L EL++   P
Sbjct: 208 SLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 105/209 (50%), Gaps = 14/209 (6%)
Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT-----QQFVTEVALLSRIHHRN 647
           +F + IG+G FG VY+G + D     +     S +  T      QF+TE  ++    H N
Sbjct: 31  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 90
Query: 648 LVPLIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           ++ L+G C   E   ++V  YM +G LR+ +    +   +  L    +    AKG++YL 
Sbjct: 91  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL- 147
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA---EEDLTHISSVARGTVGYLDPE 763
              +   +HRD+ + N +LD     KV+DFGL+R     E    H  + A+  V ++  E
Sbjct: 148 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 205
Query: 764 YYGNQQLTEKSDVYSFGVVLLELISGKKP 792
               Q+ T KSDV+SFGV+L EL++   P
Sbjct: 206 SLQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 105/209 (50%), Gaps = 14/209 (6%)
Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT-----QQFVTEVALLSRIHHRN 647
           +F + IG+G FG VY+G + D     +     S +  T      QF+TE  ++    H N
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 648 LVPLIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           ++ L+G C   E   ++V  YM +G LR+ +    +   +  L    +    AKG++YL 
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL- 149
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA---EEDLTHISSVARGTVGYLDPE 763
              +   +HRD+ + N +LD     KV+DFGL+R     E    H  + A+  V ++  E
Sbjct: 150 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 207
Query: 764 YYGNQQLTEKSDVYSFGVVLLELISGKKP 792
               Q+ T KSDV+SFGV+L EL++   P
Sbjct: 208 SLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 105/209 (50%), Gaps = 14/209 (6%)
Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT-----QQFVTEVALLSRIHHRN 647
           +F + IG+G FG VY+G + D     +     S +  T      QF+TE  ++    H N
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 648 LVPLIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           ++ L+G C   E   ++V  YM +G LR+ +    +   +  L    +    AKG++YL 
Sbjct: 88  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL- 144
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA---EEDLTHISSVARGTVGYLDPE 763
              +   +HRD+ + N +LD     KV+DFGL+R     E    H  + A+  V ++  E
Sbjct: 145 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 202
Query: 764 YYGNQQLTEKSDVYSFGVVLLELISGKKP 792
               Q+ T KSDV+SFGV+L EL++   P
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMTRGAP 231

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 105/209 (50%), Gaps = 14/209 (6%)
Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT-----QQFVTEVALLSRIHHRN 647
           +F + IG+G FG VY+G + D     +     S +  T      QF+TE  ++    H N
Sbjct: 32  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 91
Query: 648 LVPLIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           ++ L+G C   E   ++V  YM +G LR+ +    +   +  L    +    AKG++YL 
Sbjct: 92  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL- 148
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA---EEDLTHISSVARGTVGYLDPE 763
              +   +HRD+ + N +LD     KV+DFGL+R     E    H  + A+  V ++  E
Sbjct: 149 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 206
Query: 764 YYGNQQLTEKSDVYSFGVVLLELISGKKP 792
               Q+ T KSDV+SFGV+L EL++   P
Sbjct: 207 SLQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 103/197 (52%), Gaps = 7/197 (3%)
Query: 597 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 656
           K+G+G FG V+ G       VA+K +    +   + F+ E  ++ ++ H  LV L     
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 657 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHR 716
           EE   I V EYM+ G+L D L G    K L     + ++   A G+ Y+        +HR
Sbjct: 81  EEPIYI-VTEYMNKGSLLDFLKGETG-KYLRLPQLVDMSAQIASGMAYVE---RMNYVHR 135
Query: 717 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDV 776
           D++++NIL+  N+  KV+DFGL+R  E++       A+  + +  PE     + T KSDV
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRFTIKSDV 195
Query: 777 YSFGVVLLELIS-GKKP 792
           +SFG++L EL + G+ P
Sbjct: 196 WSFGILLTELTTKGRVP 212

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 112/226 (49%), Gaps = 15/226 (6%)
Query: 571 GHFMDEGVA---YFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS 627
           GH   +G+A   + IP   L         K+G+G FG V+ G       VA+K +    +
Sbjct: 1   GHMQTQGLAKDAWEIPRESLRLEV-----KLGQGCFGEVWMGTWNGTTRVAIKTLKPG-T 54
Query: 628 HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD 687
              + F+ E  ++ ++ H  LV L     EE   I V EYM  G+L D L G +  K L 
Sbjct: 55  MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGEMG-KYLR 112
Query: 688 WLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 747
               + +A   A G+ Y+        +HRD+ ++NIL+  N+  KV+DFGL+R  E++  
Sbjct: 113 LPQLVDMAAQIASGMAYVE---RMNYVHRDLAAANILVGENLVCKVADFGLARLIEDNEY 169
Query: 748 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
                A+  + +  PE     + T KSDV+SFG++L EL + G+ P
Sbjct: 170 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 103/197 (52%), Gaps = 7/197 (3%)
Query: 597 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 656
           K+G+G FG V+ G       VA+K +    +   + F+ E  ++ ++ H  LV L     
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 657 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHR 716
           EE   I V EYM+ G+L D L G    K L     + ++   A G+ Y+        +HR
Sbjct: 81  EEPIYI-VTEYMNKGSLLDFLKGETG-KYLRLPQLVDMSAQIASGMAYVE---RMNYVHR 135
Query: 717 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDV 776
           D++++NIL+  N+  KV+DFGL+R  E++       A+  + +  PE     + T KSDV
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 195
Query: 777 YSFGVVLLELIS-GKKP 792
           +SFG++L EL + G+ P
Sbjct: 196 WSFGILLTELTTKGRVP 212

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 96.7 bits (239), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 102/197 (51%), Gaps = 7/197 (3%)
Query: 597 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 656
           K+G+G FG V+ G       VA+K +    +   + F+ E  ++ ++ H  LV L     
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 657 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHR 716
           EE   I V EYM  G+L D L G    K L     + +A   A G+ Y+        +HR
Sbjct: 250 EEPIYI-VTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 304
Query: 717 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDV 776
           D++++NIL+  N+  KV+DFGL+R  E++       A+  + +  PE     + T KSDV
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364
Query: 777 YSFGVVLLELIS-GKKP 792
           +SFG++L EL + G+ P
Sbjct: 365 WSFGILLTELTTKGRVP 381

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 102/197 (51%), Gaps = 7/197 (3%)
Query: 597 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 656
           K+G+G FG V+ G       VA+K +    +   + F+ E  ++ ++ H  LV L     
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 657 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHR 716
           EE   I V EYM  G+L D L G    K L     + +A   A G+ Y+        +HR
Sbjct: 250 EEPIYI-VTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 304
Query: 717 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDV 776
           D++++NIL+  N+  KV+DFGL+R  E++       A+  + +  PE     + T KSDV
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364
Query: 777 YSFGVVLLELIS-GKKP 792
           +SFG++L EL + G+ P
Sbjct: 365 WSFGILLTELTTKGRVP 381

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 107/216 (49%), Gaps = 23/216 (10%)
Query: 597 KIGKGSFGSVYYGKM------KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVP 650
           ++G+G+FG V+  +       +D   VAVK + ++     Q F  E  LL+ + H+++V 
Sbjct: 25  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 84
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRD--RLHG----------SVNQKPLDWLTRLQIAHDA 698
             G C E    ++V+EYM +G L    R HG           V   PL     L +A   
Sbjct: 85  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 699 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTV 757
           A G+ YL  G +   +HRD+ + N L+   +  K+ DFG+SR     D   +       +
Sbjct: 145 AAGMVYL-AGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 201
Query: 758 GYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
            ++ PE    ++ T +SDV+SFGVVL E+ + GK+P
Sbjct: 202 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 237

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 96.3 bits (238), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 111/205 (54%), Gaps = 15/205 (7%)
Query: 598 IGKGSFGSVYYGKMK-DGKE---VAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNLVPLI 652
           IG G FG V  G++K  GK+   VA+K +    + R + +F++E +++ +  H N++ L 
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 81
Query: 653 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 712
           G        +++ E+M NG L   L   +N      +  + +    A G+ YL       
Sbjct: 82  GVVTNSMPVMILTEFMENGALDSFLR--LNDGQFTVIQLVGMLRGIASGMRYL---AEMS 136
Query: 713 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEE---DLTHISSV-ARGTVGYLDPEYYGNQ 768
            +HRD+ + NIL++ N+  KVSDFGLSR  EE   D T+ SS+  +  + +  PE    +
Sbjct: 137 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFR 196
Query: 769 QLTEKSDVYSFGVVLLELIS-GKKP 792
           + T  SD +S+G+V+ E++S G++P
Sbjct: 197 KFTSASDAWSYGIVMWEVMSFGERP 221

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 96.3 bits (238), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 106/208 (50%), Gaps = 7/208 (3%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 645
           E+   T    +++G G FG V+ G      +VAVK +    S     F+ E  L+ ++ H
Sbjct: 18  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQH 76
Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 705
           + LV L     +E   I+  EYM NG+L D L      K L     L +A   A+G+ ++
Sbjct: 77  QRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFI 134
Query: 706 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 765
                   IHRD++++NIL+   +  K++DFGL+R  E++       A+  + +  PE  
Sbjct: 135 E---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAI 191
Query: 766 GNQQLTEKSDVYSFGVVLLELIS-GKKP 792
                T KSDV+SFG++L E+++ G+ P
Sbjct: 192 NYGTFTIKSDVWSFGILLTEIVTHGRIP 219

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 96.3 bits (238), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 106/208 (50%), Gaps = 7/208 (3%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 645
           E+   +    K++G G FG V+ G      +VA+K +    +   + F+ E  ++ ++ H
Sbjct: 5   EIPRESLQLIKRLGNGQFGEVWMGTWNGNTKVAIKTLKPG-TMSPESFLEEAQIMKKLKH 63
Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 705
             LV L     EE   I V EYM+ G+L D L      + L     + +A   A G+ Y+
Sbjct: 64  DKLVQLYAVVSEEPIYI-VTEYMNKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYI 121
Query: 706 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 765
                   IHRD++S+NIL+   +  K++DFGL+R  E++       A+  + +  PE  
Sbjct: 122 E---RMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAA 178
Query: 766 GNQQLTEKSDVYSFGVVLLELIS-GKKP 792
              + T KSDV+SFG++L EL++ G+ P
Sbjct: 179 LYGRFTIKSDVWSFGILLTELVTKGRVP 206

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 96.3 bits (238), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 106/208 (50%), Gaps = 7/208 (3%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 645
           E+   T    +++G G FG V+ G      +VAVK +    S     F+ E  L+ ++ H
Sbjct: 11  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQH 69
Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 705
           + LV L     +E   I+  EYM NG+L D L      K L     L +A   A+G+ ++
Sbjct: 70  QRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFI 127
Query: 706 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 765
                   IHRD++++NIL+   +  K++DFGL+R  E++       A+  + +  PE  
Sbjct: 128 E---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAI 184
Query: 766 GNQQLTEKSDVYSFGVVLLELIS-GKKP 792
                T KSDV+SFG++L E+++ G+ P
Sbjct: 185 NYGTFTIKSDVWSFGILLTEIVTHGRIP 212

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 96.3 bits (238), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 107/216 (49%), Gaps = 23/216 (10%)
Query: 597 KIGKGSFGSVYYGKM------KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVP 650
           ++G+G+FG V+  +       +D   VAVK + ++     Q F  E  LL+ + H+++V 
Sbjct: 19  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 78
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRD--RLHG----------SVNQKPLDWLTRLQIAHDA 698
             G C E    ++V+EYM +G L    R HG           V   PL     L +A   
Sbjct: 79  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 699 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTV 757
           A G+ YL  G +   +HRD+ + N L+   +  K+ DFG+SR     D   +       +
Sbjct: 139 AAGMVYL-AGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 195
Query: 758 GYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
            ++ PE    ++ T +SDV+SFGVVL E+ + GK+P
Sbjct: 196 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 231

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 96.3 bits (238), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 106/208 (50%), Gaps = 7/208 (3%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 645
           E+   T    +++G G FG V+ G      +VAVK +    S     F+ E  L+ ++ H
Sbjct: 9   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQH 67
Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 705
           + LV L     +E   I+  EYM NG+L D L      K L     L +A   A+G+ ++
Sbjct: 68  QRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFI 125
Query: 706 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 765
                   IHRD++++NIL+   +  K++DFGL+R  E++       A+  + +  PE  
Sbjct: 126 E---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAI 182
Query: 766 GNQQLTEKSDVYSFGVVLLELIS-GKKP 792
                T KSDV+SFG++L E+++ G+ P
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIP 210

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 95.9 bits (237), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 106/208 (50%), Gaps = 7/208 (3%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 645
           E+   T    +++G G FG V+ G      +VAVK +    S     F+ E  L+ ++ H
Sbjct: 10  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQH 68
Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 705
           + LV L     +E   I+  EYM NG+L D L      K L     L +A   A+G+ ++
Sbjct: 69  QRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFI 126
Query: 706 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 765
                   IHRD++++NIL+   +  K++DFGL+R  E++       A+  + +  PE  
Sbjct: 127 E---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAI 183
Query: 766 GNQQLTEKSDVYSFGVVLLELIS-GKKP 792
                T KSDV+SFG++L E+++ G+ P
Sbjct: 184 NYGTFTIKSDVWSFGILLTEIVTHGRIP 211

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 95.9 bits (237), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 102/197 (51%), Gaps = 7/197 (3%)
Query: 597 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 656
           K+G+G FG V+ G       VA+K +    +   + F+ E  ++ ++ H  LV L     
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 657 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHR 716
           EE   I V EYM  G+L D L G    K L     + +A   A G+ Y+        +HR
Sbjct: 250 EEPIYI-VGEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 304
Query: 717 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDV 776
           D++++NIL+  N+  KV+DFGL+R  E++       A+  + +  PE     + T KSDV
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364
Query: 777 YSFGVVLLELIS-GKKP 792
           +SFG++L EL + G+ P
Sbjct: 365 WSFGILLTELTTKGRVP 381

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 95.9 bits (237), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 106/208 (50%), Gaps = 7/208 (3%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 645
           E+   T    +++G G FG V+ G      +VAVK +    S     F+ E  L+ ++ H
Sbjct: 15  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQH 73
Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 705
           + LV L     +E   I+  EYM NG+L D L      K L     L +A   A+G+ ++
Sbjct: 74  QRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFI 131
Query: 706 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 765
                   IHRD++++NIL+   +  K++DFGL+R  E++       A+  + +  PE  
Sbjct: 132 E---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAI 188
Query: 766 GNQQLTEKSDVYSFGVVLLELIS-GKKP 792
                T KSDV+SFG++L E+++ G+ P
Sbjct: 189 NYGTFTIKSDVWSFGILLTEIVTHGRIP 216

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 95.9 bits (237), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 106/208 (50%), Gaps = 7/208 (3%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 645
           E+   T    +++G G FG V+ G      +VAVK +    S     F+ E  L+ ++ H
Sbjct: 9   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQH 67
Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 705
           + LV L     +E   I+  EYM NG+L D L      K L     L +A   A+G+ ++
Sbjct: 68  QRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFI 125
Query: 706 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 765
                   IHRD++++NIL+   +  K++DFGL+R  E++       A+  + +  PE  
Sbjct: 126 E---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAI 182
Query: 766 GNQQLTEKSDVYSFGVVLLELIS-GKKP 792
                T KSDV+SFG++L E+++ G+ P
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIP 210

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 95.9 bits (237), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 107/216 (49%), Gaps = 23/216 (10%)
Query: 597 KIGKGSFGSVYYGKM------KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVP 650
           ++G+G+FG V+  +       +D   VAVK + ++     Q F  E  LL+ + H+++V 
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRD--RLHG----------SVNQKPLDWLTRLQIAHDA 698
             G C E    ++V+EYM +G L    R HG           V   PL     L +A   
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 699 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTV 757
           A G+ YL  G +   +HRD+ + N L+   +  K+ DFG+SR     D   +       +
Sbjct: 168 AAGMVYL-AGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 224
Query: 758 GYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
            ++ PE    ++ T +SDV+SFGVVL E+ + GK+P
Sbjct: 225 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 95.9 bits (237), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 106/208 (50%), Gaps = 7/208 (3%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 645
           E+   T    +++G G FG V+ G      +VAVK +    S     F+ E  L+ ++ H
Sbjct: 17  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQH 75
Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 705
           + LV L     +E   I+  EYM NG+L D L      K L     L +A   A+G+ ++
Sbjct: 76  QRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFI 133
Query: 706 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 765
                   IHRD++++NIL+   +  K++DFGL+R  E++       A+  + +  PE  
Sbjct: 134 E---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAI 190
Query: 766 GNQQLTEKSDVYSFGVVLLELIS-GKKP 792
                T KSDV+SFG++L E+++ G+ P
Sbjct: 191 NYGTFTIKSDVWSFGILLTEIVTHGRIP 218

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 95.9 bits (237), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 102/197 (51%), Gaps = 7/197 (3%)
Query: 597 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 656
           K+G+G FG V+ G       VA+K +    +   + F+ E  ++ ++ H  LV L     
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 657 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHR 716
           EE   I V EYM  G+L D L G    K L     + +A   A G+ Y+        +HR
Sbjct: 333 EEPIYI-VTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 387
Query: 717 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDV 776
           D++++NIL+  N+  KV+DFGL+R  E++       A+  + +  PE     + T KSDV
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 447
Query: 777 YSFGVVLLELIS-GKKP 792
           +SFG++L EL + G+ P
Sbjct: 448 WSFGILLTELTTKGRVP 464

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 95.9 bits (237), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 102/197 (51%), Gaps = 7/197 (3%)
Query: 597 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 656
           K+G+G FG V+ G       VA+K +    +   + F+ E  ++ ++ H  LV L     
Sbjct: 192 KLGQGCFGEVWMGTWNGTTRVAIKTLKPG-NMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 250
Query: 657 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHR 716
           EE   I V EYM  G+L D L G +  K L     + +A   A G+ Y+        +HR
Sbjct: 251 EEPIYI-VTEYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 305
Query: 717 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDV 776
           D++++NIL+  N+  KV+DFGL R  E++       A+  + +  PE     + T KSDV
Sbjct: 306 DLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 365
Query: 777 YSFGVVLLELIS-GKKP 792
           +SFG++L EL + G+ P
Sbjct: 366 WSFGILLTELTTKGRVP 382

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 95.9 bits (237), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 106/208 (50%), Gaps = 7/208 (3%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 645
           E+   T    +++G G FG V+ G      +VAVK +    S     F+ E  L+ ++ H
Sbjct: 15  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQH 73
Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 705
           + LV L     +E   I+  EYM NG+L D L      K L     L +A   A+G+ ++
Sbjct: 74  QRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFI 131
Query: 706 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 765
                   IHRD++++NIL+   +  K++DFGL+R  E++       A+  + +  PE  
Sbjct: 132 E---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 188
Query: 766 GNQQLTEKSDVYSFGVVLLELIS-GKKP 792
                T KSDV+SFG++L E+++ G+ P
Sbjct: 189 NYGTFTIKSDVWSFGILLTEIVTHGRIP 216

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 106/208 (50%), Gaps = 7/208 (3%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 645
           E+   T    +++G G FG V+ G      +VAVK +    S     F+ E  L+ ++ H
Sbjct: 9   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQH 67
Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 705
           + LV L     +E   I+  EYM NG+L D L      K L     L +A   A+G+ ++
Sbjct: 68  QRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFI 125
Query: 706 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 765
                   IHRD++++NIL+   +  K++DFGL+R  E++       A+  + +  PE  
Sbjct: 126 E---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 182
Query: 766 GNQQLTEKSDVYSFGVVLLELIS-GKKP 792
                T KSDV+SFG++L E+++ G+ P
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIP 210

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 106/208 (50%), Gaps = 7/208 (3%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 645
           E+   T    +++G G FG V+ G      +VAVK +    S     F+ E  L+ ++ H
Sbjct: 14  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQH 72
Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 705
           + LV L     +E   I+  EYM NG+L D L      K L     L +A   A+G+ ++
Sbjct: 73  QRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFI 130
Query: 706 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 765
                   IHRD++++NIL+   +  K++DFGL+R  E++       A+  + +  PE  
Sbjct: 131 E---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 187
Query: 766 GNQQLTEKSDVYSFGVVLLELIS-GKKP 792
                T KSDV+SFG++L E+++ G+ P
Sbjct: 188 NYGTFTIKSDVWSFGILLTEIVTHGRIP 215

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 105/201 (52%), Gaps = 9/201 (4%)
Query: 596 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNLVPLIG 653
           ++IG+G+FG V+ G+++ D   VAVK   ++     + +F+ E  +L +  H N+V LIG
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 654 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 713
            C ++    +V E +  G     L        L   T LQ+  DAA G+EYL + C    
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLR--TEGARLRVKTLLQMVGDAAAGMEYLESKC---C 234
Query: 714 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT-VGYLDPEYYGNQQLTE 772
           IHRD+ + N L+      K+SDFG+SR+  + +   S   R   V +  PE     + + 
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYSS 294
Query: 773 KSDVYSFGVVLLELIS-GKKP 792
           +SDV+SFG++L E  S G  P
Sbjct: 295 ESDVWSFGILLWETFSLGASP 315

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 138/280 (49%), Gaps = 31/280 (11%)
Query: 598 IGKGSFGSVYYGKMK-DGKE---VAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNLVPLI 652
           IG G FG V  G++K  GK+   VA+K +    + R + +F++E +++ +  H N++ L 
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 83
Query: 653 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 712
           G        +++ E+M NG L   L   +N      +  + +    A G+ YL       
Sbjct: 84  GVVTNSMPVMILTEFMENGALDSFLR--LNDGQFTVIQLVGMLRGIASGMRYL---AEMS 138
Query: 713 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEE---DLTHISSV-ARGTVGYLDPEYYGNQ 768
            +HRD+ + NIL++ N+  KVSDFGLSR  EE   D T  SS+  +  + +  PE    +
Sbjct: 139 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFR 198
Query: 769 QLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 827
           + T  SD +S+G+V+ E++S G++P             +W  S     DVI+ ++     
Sbjct: 199 KFTSASDAWSYGIVMWEVMSFGERP-------------YWDMS---NQDVINAIEQDYRL 242
Query: 828 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 867
               +    + ++ + C ++   +RP+  ++V A+   I+
Sbjct: 243 PPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKMIR 282

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 106/208 (50%), Gaps = 7/208 (3%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 645
           E+   T    +++G G FG V+ G      +VAVK +    S     F+ E  L+ ++ H
Sbjct: 4   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQH 62
Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 705
           + LV L     +E   I+  EYM NG+L D L      K L     L +A   A+G+ ++
Sbjct: 63  QRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFI 120
Query: 706 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 765
                   IHRD++++NIL+   +  K++DFGL+R  E++       A+  + +  PE  
Sbjct: 121 E---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 177
Query: 766 GNQQLTEKSDVYSFGVVLLELIS-GKKP 792
                T KSDV+SFG++L E+++ G+ P
Sbjct: 178 NYGTFTIKSDVWSFGILLTEIVTHGRIP 205

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 95.1 bits (235), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 106/208 (50%), Gaps = 7/208 (3%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 645
           E+   T    +++G G FG V+ G      +VAVK +    S     F+ E  L+ ++ H
Sbjct: 19  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQH 77
Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 705
           + LV L     +E   I+  EYM NG+L D L      K L     L +A   A+G+ ++
Sbjct: 78  QRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFI 135
Query: 706 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 765
                   IHRD++++NIL+   +  K++DFGL+R  E++       A+  + +  PE  
Sbjct: 136 E---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 192
Query: 766 GNQQLTEKSDVYSFGVVLLELIS-GKKP 792
                T KSDV+SFG++L E+++ G+ P
Sbjct: 193 NYGTFTIKSDVWSFGILLTEIVTHGRIP 220

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 105/201 (52%), Gaps = 9/201 (4%)
Query: 596 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNLVPLIG 653
           ++IG+G+FG V+ G+++ D   VAVK   ++     + +F+ E  +L +  H N+V LIG
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 654 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 713
            C ++    +V E +  G     L        L   T LQ+  DAA G+EYL + C    
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLR--TEGARLRVKTLLQMVGDAAAGMEYLESKC---C 234
Query: 714 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT-VGYLDPEYYGNQQLTE 772
           IHRD+ + N L+      K+SDFG+SR+  + +   S   R   V +  PE     + + 
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSS 294
Query: 773 KSDVYSFGVVLLELIS-GKKP 792
           +SDV+SFG++L E  S G  P
Sbjct: 295 ESDVWSFGILLWETFSLGASP 315

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 81/283 (28%), Positives = 134/283 (47%), Gaps = 38/283 (13%)
Query: 598 IGKGSFGSVYYGKMKDGK----EVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLI 652
           +G+G FG VY G   + K     VAVK     C+    ++F++E  ++  + H ++V LI
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 75
Query: 653 GYCEEEHQRIL--VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 710
           G  EEE   I+  +Y Y   G   +R     N+  L  LT +  +    K + YL +   
Sbjct: 76  GIIEEEPTWIIMELYPYGELGHYLER-----NKNSLKVLTLVLYSLQICKAMAYLES--- 127
Query: 711 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 770
              +HRD+   NIL+      K+ DFGLSR  E++  + +SV R  + ++ PE    ++ 
Sbjct: 128 INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRF 187
Query: 771 TEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVI---SIVDPVLI 826
           T  SDV+ F V + E++S GK+P     F  E   V     +++KGD +    +  PVL 
Sbjct: 188 TTASDVWMFAVCMWEILSFGKQPF----FWLENKDV---IGVLEKGDRLPKPDLCPPVL- 239
Query: 827 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 869
                        +  +C +     RP+  E+V ++ D  ++E
Sbjct: 240 -----------YTLMTRCWDYDPSDRPRFTELVCSLSDVYQME 271

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 81/283 (28%), Positives = 134/283 (47%), Gaps = 38/283 (13%)
Query: 598 IGKGSFGSVYYGKMKDGK----EVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLI 652
           +G+G FG VY G   + K     VAVK     C+    ++F++E  ++  + H ++V LI
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 91
Query: 653 GYCEEEHQRIL--VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 710
           G  EEE   I+  +Y Y   G   +R     N+  L  LT +  +    K + YL +   
Sbjct: 92  GIIEEEPTWIIMELYPYGELGHYLER-----NKNSLKVLTLVLYSLQICKAMAYLES--- 143
Query: 711 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 770
              +HRD+   NIL+      K+ DFGLSR  E++  + +SV R  + ++ PE    ++ 
Sbjct: 144 INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRF 203
Query: 771 TEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVI---SIVDPVLI 826
           T  SDV+ F V + E++S GK+P     F  E   V     +++KGD +    +  PVL 
Sbjct: 204 TTASDVWMFAVCMWEILSFGKQPF----FWLENKDV---IGVLEKGDRLPKPDLCPPVL- 255
Query: 827 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 869
                        +  +C +     RP+  E+V ++ D  ++E
Sbjct: 256 -----------YTLMTRCWDYDPSDRPRFTELVCSLSDVYQME 287

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 81/283 (28%), Positives = 134/283 (47%), Gaps = 38/283 (13%)
Query: 598 IGKGSFGSVYYGKMKDGK----EVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLI 652
           +G+G FG VY G   + K     VAVK     C+    ++F++E  ++  + H ++V LI
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 653 GYCEEEHQRIL--VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 710
           G  EEE   I+  +Y Y   G   +R     N+  L  LT +  +    K + YL +   
Sbjct: 80  GIIEEEPTWIIMELYPYGELGHYLER-----NKNSLKVLTLVLYSLQICKAMAYLES--- 131
Query: 711 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 770
              +HRD+   NIL+      K+ DFGLSR  E++  + +SV R  + ++ PE    ++ 
Sbjct: 132 INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRF 191
Query: 771 TEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVI---SIVDPVLI 826
           T  SDV+ F V + E++S GK+P     F  E   V     +++KGD +    +  PVL 
Sbjct: 192 TTASDVWMFAVCMWEILSFGKQPF----FWLENKDV---IGVLEKGDRLPKPDLCPPVL- 243
Query: 827 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 869
                        +  +C +     RP+  E+V ++ D  ++E
Sbjct: 244 -----------YTLMTRCWDYDPSDRPRFTELVCSLSDVYQME 275

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 94.4 bits (233), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 103/212 (48%), Gaps = 10/212 (4%)
Query: 598 IGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHR---TQQFVTEVALLSRIHHRNLVPLIG 653
           +GKGSF  VY  + +  G EVA+K++     ++    Q+   EV +  ++ H +++ L  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 654 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 713
           Y E+ +   LV E  HNG +   L   V  KP          H    G+ YLH+    GI
Sbjct: 79  YFEDSNYVYLVLEMCHNGEMNRYLKNRV--KPFSENEARHFMHQIITGMLYLHSH---GI 133
Query: 714 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 773
           +HRD+  SN+LL  NM  K++DFGL+ Q +       ++  GT  Y+ PE         +
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC-GTPNYISPEIATRSAHGLE 192
Query: 774 SDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
           SDV+S G +   L+ G+ P   +     LN V
Sbjct: 193 SDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV 224

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 107/211 (50%), Gaps = 7/211 (3%)
Query: 583 PLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSR 642
           P  E+   T    +++G G FG V+ G      +VAVK +    S     F+ E  L+ +
Sbjct: 2   PEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQ 60
Query: 643 IHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGL 702
           + H+ LV L     +E   I+  EYM NG+L D L      K L     L +A   A+G+
Sbjct: 61  LQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGM 118
Query: 703 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDP 762
            ++        IHR+++++NIL+   +  K++DFGL+R  E++       A+  + +  P
Sbjct: 119 AFIE---ERNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAP 175
Query: 763 EYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
           E       T KSDV+SFG++L E+++ G+ P
Sbjct: 176 EAINYGTFTIKSDVWSFGILLTEIVTHGRIP 206

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 94.0 bits (232), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 102/207 (49%), Gaps = 23/207 (11%)
Query: 598 IGKGSFGSVYYGKMKDGKEVAVK---IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 654
           +GKG FG       ++  EV V    I  D  + RT  F+ EV ++  + H N++  IG 
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRT--FLKEVKVMRCLEHPNVLKFIGV 75
Query: 655 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 714
             ++ +   + EY+  GTLR  +    +Q P  W  R+  A D A G+ YLH+     II
Sbjct: 76  LYKDKRLNFITEYIKGGTLRGIIKSMDSQYP--WSQRVSFAKDIASGMAYLHSM---NII 130
Query: 715 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH---ISSVAR----------GTVGYLD 761
           HRD+ S N L+  N    V+DFGL+R   ++ T    + S+ +          G   ++ 
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 762 PEYYGNQQLTEKSDVYSFGVVLLELIS 788
           PE    +   EK DV+SFG+VL E+I 
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIG 217

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 93.6 bits (231), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 108/225 (48%), Gaps = 28/225 (12%)
Query: 584 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGK------EVAVKIMADSCSHRTQ-QFVTE 636
           L E+        + +G G+FG VY G++          +VAVK + + CS + +  F+ E
Sbjct: 25  LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLME 84
Query: 637 VALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKP-----LDWLTR 691
             ++S+++H+N+V  IG   +   R ++ E M  G L+  L      +P     L  L  
Sbjct: 85  ALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLR-ETRPRPSQPSSLAMLDL 143
Query: 692 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQAEEDLTH 748
           L +A D A G +YL        IHRD+ + N LL        AK+ DFG++R    D+  
Sbjct: 144 LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYR 196
Query: 749 ISSVARG-----TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
            S   +G      V ++ PE +     T K+D +SFGV+L E+ S
Sbjct: 197 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 93.2 bits (230), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 78/261 (29%), Positives = 120/261 (45%), Gaps = 37/261 (14%)
Query: 550 KADSLRTSTKPS--NTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVY 607
           K   LRTST  +  N  YS A     + +       L E+        + +G G+FG VY
Sbjct: 2   KLSKLRTSTIMTDYNPNYSFAGKTSSISD-------LKEVPRKNITLIRGLGHGAFGEVY 54
Query: 608 YGKMKDGK------EVAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNLVPLIGYCEEEHQ 660
            G++          +VAVK + + CS + +  F+ E  ++S+ +H+N+V  IG   +   
Sbjct: 55  EGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 114
Query: 661 RILVYEYMHNGTLRDRLHGSVNQKP-----LDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 715
           R ++ E M  G L+  L      +P     L  L  L +A D A G +YL        IH
Sbjct: 115 RFILLELMAGGDLKSFLR-ETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIH 170
Query: 716 RDVKSSNILLDI---NMRAKVSDFGLSRQAEEDLTHISSVARG-----TVGYLDPEYYGN 767
           RD+ + N LL        AK+ DFG++R    D+   S   +G      V ++ PE +  
Sbjct: 171 RDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVKWMPPEAFME 226
Query: 768 QQLTEKSDVYSFGVVLLELIS 788
              T K+D +SFGV+L E+ S
Sbjct: 227 GIFTSKTDTWSFGVLLWEIFS 247

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 93.2 bits (230), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 108/225 (48%), Gaps = 28/225 (12%)
Query: 584 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGK------EVAVKIMADSCSHRTQ-QFVTE 636
           L E+        + +G G+FG VY G++          +VAVK + + CS + +  F+ E
Sbjct: 39  LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLME 98
Query: 637 VALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKP-----LDWLTR 691
             ++S+++H+N+V  IG   +   R ++ E M  G L+  L      +P     L  L  
Sbjct: 99  ALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLR-ETRPRPSQPSSLAMLDL 157
Query: 692 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQAEEDLTH 748
           L +A D A G +YL        IHRD+ + N LL        AK+ DFG++R    D+  
Sbjct: 158 LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYR 210
Query: 749 ISSVARG-----TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
            S   +G      V ++ PE +     T K+D +SFGV+L E+ S
Sbjct: 211 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 76/249 (30%), Positives = 128/249 (51%), Gaps = 36/249 (14%)
Query: 571 GHFMDEGVAYFIPLPELE---EATNNFCKKI-----------GKGSFGSVYYGKMK-DGK 615
           GH M  G+  FI     E   EA   F K+I           G G FG V  G +K  GK
Sbjct: 1   GH-MTPGMKIFIDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGK 59
Query: 616 E---VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 671
               VA+K +    + + ++ F++E +++ +  H N++ L G   +    +++ E+M NG
Sbjct: 60  REIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENG 119
Query: 672 TLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN 728
           +L   L  +  Q      T +Q+       A G++YL    +   +HRD+ + NIL++ N
Sbjct: 120 SLDSFLRQNDGQ-----FTVIQLVGMLRGIAAGMKYL---ADMNYVHRDLAARNILVNSN 171
Query: 729 MRAKVSDFGLSRQAEEDL---THISSV-ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLL 784
           +  KVSDFGLSR  E+D    T+ S++  +  + +  PE    ++ T  SDV+S+G+V+ 
Sbjct: 172 LVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMW 231
Query: 785 ELIS-GKKP 792
           E++S G++P
Sbjct: 232 EVMSYGERP 240

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 135/282 (47%), Gaps = 29/282 (10%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMK--DGKEVAVKIMADSCSHRTQQ---FVTEVALL 640
           E++ +     K IG G FG V  G++K    +E+ V I      +  +Q   F++E +++
Sbjct: 25  EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIM 84
Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 700
            +  H N++ L G   +    +++ EYM NG+L   L    N      +  + +      
Sbjct: 85  GQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRK--NDGRFTVIQLVGMLRGIGS 142
Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED--LTHISSVARGTVG 758
           G++YL    +   +HRD+ + NIL++ N+  KVSDFG+SR  E+D    + +   +  + 
Sbjct: 143 GMKYLS---DMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIR 199
Query: 759 YLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDV 817
           +  PE    ++ T  SDV+S+G+V+ E++S G++P             +W  S     DV
Sbjct: 200 WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP-------------YWDMS---NQDV 243
Query: 818 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 859
           I  ++        ++    + ++ + C ++    RPK  +IV
Sbjct: 244 IKAIEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIV 285

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 107/225 (47%), Gaps = 28/225 (12%)
Query: 584 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGK------EVAVKIMADSCSHRTQ-QFVTE 636
           L E+        + +G G+FG VY G++          +VAVK + + CS + +  F+ E
Sbjct: 24  LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLME 83
Query: 637 VALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKP-----LDWLTR 691
             ++S+ +H+N+V  IG   +   R ++ E M  G L+  L      +P     L  L  
Sbjct: 84  ALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLR-ETRPRPSQPSSLAMLDL 142
Query: 692 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQAEEDLTH 748
           L +A D A G +YL        IHRD+ + N LL        AK+ DFG++R    D+  
Sbjct: 143 LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYR 195
Query: 749 ISSVARG-----TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
            S   +G      V ++ PE +     T K+D +SFGV+L E+ S
Sbjct: 196 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 78/261 (29%), Positives = 120/261 (45%), Gaps = 37/261 (14%)
Query: 550 KADSLRTSTKPS--NTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVY 607
           K   LRTST  +  N  YS A     + +       L E+        + +G G+FG VY
Sbjct: 22  KLSKLRTSTIMTDYNPNYSFAGKTSSISD-------LKEVPRKNITLIRGLGHGAFGEVY 74
Query: 608 YGKMKDGK------EVAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNLVPLIGYCEEEHQ 660
            G++          +VAVK + + CS + +  F+ E  ++S+ +H+N+V  IG   +   
Sbjct: 75  EGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 134
Query: 661 RILVYEYMHNGTLRDRLHGSVNQKP-----LDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 715
           R ++ E M  G L+  L      +P     L  L  L +A D A G +YL        IH
Sbjct: 135 RFILLELMAGGDLKSFLR-ETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIH 190
Query: 716 RDVKSSNILLDI---NMRAKVSDFGLSRQAEEDLTHISSVARG-----TVGYLDPEYYGN 767
           RD+ + N LL        AK+ DFG++R    D+   S   +G      V ++ PE +  
Sbjct: 191 RDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVKWMPPEAFME 246
Query: 768 QQLTEKSDVYSFGVVLLELIS 788
              T K+D +SFGV+L E+ S
Sbjct: 247 GIFTSKTDTWSFGVLLWEIFS 267

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 103/199 (51%), Gaps = 9/199 (4%)
Query: 596 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 655
           KK+G G FG V+        +VAVK M    S   + F+ E  ++  + H  LV L    
Sbjct: 21  KKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVV 79
Query: 656 EEEHQRILVYEYMHNGTLRDRLHGSVNQK-PLDWLTRLQIAHDAAKGLEYLHTGCNPGII 714
            +E   I+  E+M  G+L D L      K PL  L  +  +   A+G+ ++        I
Sbjct: 80  TKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPLPKL--IDFSAQIAEGMAFIE---QRNYI 133
Query: 715 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 774
           HRD++++NIL+  ++  K++DFGL+R  E++       A+  + +  PE       T KS
Sbjct: 134 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 193
Query: 775 DVYSFGVVLLELIS-GKKP 792
           DV+SFG++L+E+++ G+ P
Sbjct: 194 DVWSFGILLMEIVTYGRIP 212

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 107/225 (47%), Gaps = 28/225 (12%)
Query: 584 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGK------EVAVKIMADSCSHRTQ-QFVTE 636
           L E+        + +G G+FG VY G++          +VAVK + + CS + +  F+ E
Sbjct: 24  LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLME 83
Query: 637 VALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKP-----LDWLTR 691
             ++S+ +H+N+V  IG   +   R ++ E M  G L+  L      +P     L  L  
Sbjct: 84  ALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLR-ETRPRPSQPSSLAMLDL 142
Query: 692 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQAEEDLTH 748
           L +A D A G +YL        IHRD+ + N LL        AK+ DFG++R    D+  
Sbjct: 143 LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYR 195
Query: 749 ISSVARG-----TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
            S   +G      V ++ PE +     T K+D +SFGV+L E+ S
Sbjct: 196 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 92.8 bits (229), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 107/225 (47%), Gaps = 28/225 (12%)
Query: 584 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGK------EVAVKIMADSCSHRTQ-QFVTE 636
           L E+        + +G G+FG VY G++          +VAVK + + CS + +  F+ E
Sbjct: 25  LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLME 84
Query: 637 VALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKP-----LDWLTR 691
             ++S+ +H+N+V  IG   +   R ++ E M  G L+  L      +P     L  L  
Sbjct: 85  ALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLR-ETRPRPSQPSSLAMLDL 143
Query: 692 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQAEEDLTH 748
           L +A D A G +YL        IHRD+ + N LL        AK+ DFG++R    D+  
Sbjct: 144 LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYR 196
Query: 749 ISSVARG-----TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
            S   +G      V ++ PE +     T K+D +SFGV+L E+ S
Sbjct: 197 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 92.8 bits (229), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 107/225 (47%), Gaps = 28/225 (12%)
Query: 584 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGK------EVAVKIMADSCSHRTQ-QFVTE 636
           L E+        + +G G+FG VY G++          +VAVK + + CS + +  F+ E
Sbjct: 39  LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLME 98
Query: 637 VALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKP-----LDWLTR 691
             ++S+ +H+N+V  IG   +   R ++ E M  G L+  L      +P     L  L  
Sbjct: 99  ALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLR-ETRPRPSQPSSLAMLDL 157
Query: 692 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQAEEDLTH 748
           L +A D A G +YL        IHRD+ + N LL        AK+ DFG++R    D+  
Sbjct: 158 LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYR 210
Query: 749 ISSVARG-----TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
            S   +G      V ++ PE +     T K+D +SFGV+L E+ S
Sbjct: 211 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 92.8 bits (229), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 107/225 (47%), Gaps = 28/225 (12%)
Query: 584 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGK------EVAVKIMADSCSHRTQ-QFVTE 636
           L E+        + +G G+FG VY G++          +VAVK + + CS + +  F+ E
Sbjct: 41  LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLME 100
Query: 637 VALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKP-----LDWLTR 691
             ++S+ +H+N+V  IG   +   R ++ E M  G L+  L      +P     L  L  
Sbjct: 101 ALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLR-ETRPRPSQPSSLAMLDL 159
Query: 692 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQAEEDLTH 748
           L +A D A G +YL        IHRD+ + N LL        AK+ DFG++R    D+  
Sbjct: 160 LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYR 212
Query: 749 ISSVARG-----TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
            S   +G      V ++ PE +     T K+D +SFGV+L E+ S
Sbjct: 213 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 92.8 bits (229), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 107/225 (47%), Gaps = 28/225 (12%)
Query: 584 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGK------EVAVKIMADSCSHRTQ-QFVTE 636
           L E+        + +G G+FG VY G++          +VAVK + + CS + +  F+ E
Sbjct: 16  LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLME 75
Query: 637 VALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKP-----LDWLTR 691
             ++S+ +H+N+V  IG   +   R ++ E M  G L+  L      +P     L  L  
Sbjct: 76  ALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLR-ETRPRPSQPSSLAMLDL 134
Query: 692 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQAEEDLTH 748
           L +A D A G +YL        IHRD+ + N LL        AK+ DFG++R    D+  
Sbjct: 135 LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYR 187
Query: 749 ISSVARG-----TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
            S   +G      V ++ PE +     T K+D +SFGV+L E+ S
Sbjct: 188 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 92.4 bits (228), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 112/215 (52%), Gaps = 13/215 (6%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMK--DGKEVAVKIMADSCSHRTQQ---FVTEVALL 640
           E++ +     K IG G FG V  G++K    +E+ V I      +  +Q   F++E +++
Sbjct: 4   EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIM 63
Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 700
            +  H N++ L G   +    +++ EYM NG+L   L    N      +  + +      
Sbjct: 64  GQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRK--NDGRFTVIQLVGMLRGIGS 121
Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED--LTHISSVARGTVG 758
           G++YL    +   +HRD+ + NIL++ N+  KVSDFG+SR  E+D    + +   +  + 
Sbjct: 122 GMKYLS---DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIR 178
Query: 759 YLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
           +  PE    ++ T  SDV+S+G+V+ E++S G++P
Sbjct: 179 WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 213

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 112/215 (52%), Gaps = 13/215 (6%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMK--DGKEVAVKIMADSCSHRTQQ---FVTEVALL 640
           E++ +     K IG G FG V  G++K    +E+ V I      +  +Q   F++E +++
Sbjct: 10  EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIM 69
Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 700
            +  H N++ L G   +    +++ EYM NG+L   L    N      +  + +      
Sbjct: 70  GQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRK--NDGRFTVIQLVGMLRGIGS 127
Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED--LTHISSVARGTVG 758
           G++YL    +   +HRD+ + NIL++ N+  KVSDFG+SR  E+D    + +   +  + 
Sbjct: 128 GMKYLS---DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIR 184
Query: 759 YLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
           +  PE    ++ T  SDV+S+G+V+ E++S G++P
Sbjct: 185 WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 219

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 111/217 (51%), Gaps = 27/217 (12%)
Query: 596 KKIGKGSFGSVYYG--------KMKDGKEVAVKIMADSCSHRT-QQFVTEVALLSRI-HH 645
           K +G+G+FG V           K K+   VAVK++ D  + +     V+E+ ++  I  H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG----------SVNQKPLDWLT---RL 692
           +N++ L+G C ++    ++ EY   G LR+ L             +N+ P + +T    +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLV 160
Query: 693 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-DLTHISS 751
              +  A+G+EYL    +   IHRD+ + N+L+  N   K++DFGL+R     D    ++
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTT 217
Query: 752 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
             R  V ++ PE   ++  T +SDV+SFGV++ E+ +
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 111/217 (51%), Gaps = 27/217 (12%)
Query: 596 KKIGKGSFGSVYYG--------KMKDGKEVAVKIMADSCSHRT-QQFVTEVALLSRI-HH 645
           K +G+G+FG V           K K+   VAVK++ D  + +     V+E+ ++  I  H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG----------SVNQKPLDWLT---RL 692
           +N++ L+G C ++    ++ EY   G LR+ L             +N+ P + +T    +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 693 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-DLTHISS 751
              +  A+G+EYL    +   IHRD+ + N+L+  N   K++DFGL+R     D    ++
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTT 217
Query: 752 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
             R  V ++ PE   ++  T +SDV+SFGV++ E+ +
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 111/217 (51%), Gaps = 27/217 (12%)
Query: 596 KKIGKGSFGSVYYG--------KMKDGKEVAVKIMADSCSHRT-QQFVTEVALLSRI-HH 645
           K +G+G+FG V           K K+   VAVK++ D  + +     V+E+ ++  I  H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG----------SVNQKPLDWLT---RL 692
           +N++ L+G C ++    ++ EY   G LR+ L             +N+ P + +T    +
Sbjct: 101 KNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 693 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-DLTHISS 751
              +  A+G+EYL    +   IHRD+ + N+L+  N   K++DFGL+R     D    ++
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 752 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
             R  V ++ PE   ++  T +SDV+SFGV++ E+ +
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 7/208 (3%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 645
           E+   T    +++G G  G V+ G      +VAVK +    S     F+ E  L+ ++ H
Sbjct: 9   EVPRETLKLVERLGAGQAGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQH 67
Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 705
           + LV L     +E   I+  EYM NG+L D L      K L     L +A   A+G+ ++
Sbjct: 68  QRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFI 125
Query: 706 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 765
                   IHRD++++NIL+   +  K++DFGL+R  E+        A+  + +  PE  
Sbjct: 126 E---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAI 182
Query: 766 GNQQLTEKSDVYSFGVVLLELIS-GKKP 792
                T KSDV+SFG++L E+++ G+ P
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIP 210

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 110/217 (50%), Gaps = 27/217 (12%)
Query: 596 KKIGKGSFGSVYYG--------KMKDGKEVAVKIMADSCSHRT-QQFVTEVALLSRI-HH 645
           K +G+G FG V           K K+   VAVK++ D  + +     V+E+ ++  I  H
Sbjct: 87  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG----------SVNQKPLDWLT---RL 692
           +N++ L+G C ++    ++ EY   G LR+ L             +N+ P + +T    +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 693 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-DLTHISS 751
              +  A+G+EYL    +   IHRD+ + N+L+  N   K++DFGL+R     D    ++
Sbjct: 207 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 263
Query: 752 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
             R  V ++ PE   ++  T +SDV+SFGV++ E+ +
Sbjct: 264 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 111/217 (51%), Gaps = 27/217 (12%)
Query: 596 KKIGKGSFGSVYYG--------KMKDGKEVAVKIMADSCSHRT-QQFVTEVALLSRI-HH 645
           K +G+G+FG V           K K+   VAVK++ D  + +     V+E+ ++  I  H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG----------SVNQKPLDWLT---RL 692
           +N++ L+G C ++    ++ EY   G LR+ L             +N+ P + +T    +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 693 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-DLTHISS 751
              +  A+G+EYL    +   IHRD+ + N+L+  N   K++DFGL+R     D    ++
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTT 217
Query: 752 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
             R  V ++ PE   ++  T +SDV+SFGV++ E+ +
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 111/217 (51%), Gaps = 27/217 (12%)
Query: 596 KKIGKGSFGSVYYG--------KMKDGKEVAVKIMADSCSHRT-QQFVTEVALLSRI-HH 645
           K +G+G+FG V           K K+   VAVK++ D  + +     V+E+ ++  I  H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG----------SVNQKPLDWLT---RL 692
           +N++ L+G C ++    ++ EY   G LR+ L             +N+ P + +T    +
Sbjct: 101 KNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 693 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-DLTHISS 751
              +  A+G+EYL    +   IHRD+ + N+L+  N   K++DFGL+R     D    ++
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 752 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
             R  V ++ PE   ++  T +SDV+SFGV++ E+ +
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 110/217 (50%), Gaps = 27/217 (12%)
Query: 596 KKIGKGSFGSVYYG--------KMKDGKEVAVKIMADSCSHRT-QQFVTEVALLSRI-HH 645
           K +G+G FG V           K K+   VAVK++ D  + +     V+E+ ++  I  H
Sbjct: 30  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 89
Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG----------SVNQKPLDWLT---RL 692
           +N++ L+G C ++    ++ EY   G LR+ L             +N+ P + +T    +
Sbjct: 90  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 149
Query: 693 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-DLTHISS 751
              +  A+G+EYL    +   IHRD+ + N+L+  N   K++DFGL+R     D    ++
Sbjct: 150 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 206
Query: 752 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
             R  V ++ PE   ++  T +SDV+SFGV++ E+ +
Sbjct: 207 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/233 (31%), Positives = 115/233 (49%), Gaps = 19/233 (8%)
Query: 568 ARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGK-MKDGKEVAVKIMADS- 625
            R G   D  VA      + E+  ++  ++IG GSFG+VY+ + +++ + VA+K M+ S 
Sbjct: 33  GRAGSLKDPDVAELFFKDDPEKLFSDL-REIGHGSFGAVYFARDVRNSEVVAIKKMSYSG 91
Query: 626 --CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQ 683
              + + Q  + EV  L ++ H N +   G    EH   LV EY   G+  D L   V++
Sbjct: 92  KQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLL--EVHK 148
Query: 684 KPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 743
           KPL  +    + H A +GL YLH+     +IHRDVK+ NILL      K+ DFG +    
Sbjct: 149 KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA---- 201
Query: 744 EDLTHISSVARGTVGYLDPEY---YGNQQLTEKSDVYSFGVVLLELISGKKPV 793
             +   ++   GT  ++ PE        Q   K DV+S G+  +EL   K P+
Sbjct: 202 -SIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 253

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 103/221 (46%), Gaps = 20/221 (9%)
Query: 584 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGK------EVAVKIMADSCSHRTQ-QFVTE 636
           L E+        + +G G+FG VY G++          +VAVK + + CS + +  F+ E
Sbjct: 65  LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLME 124
Query: 637 VALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKP-----LDWLTR 691
             ++S+ +H+N+V  IG   +   R ++ E M  G L+  L      +P     L  L  
Sbjct: 125 ALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLR-ETRPRPSQPSSLAMLDL 183
Query: 692 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQA-EEDLT 747
           L +A D A G +YL        IHRD+ + N LL        AK+ DFG++R        
Sbjct: 184 LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY 240
Query: 748 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
                A   V ++ PE +     T K+D +SFGV+L E+ S
Sbjct: 241 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 107/225 (47%), Gaps = 28/225 (12%)
Query: 584 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGK------EVAVKIMADSCSHRTQ-QFVTE 636
           L E+        + +G G+FG VY G++          +VAVK + + CS + +  F+ E
Sbjct: 25  LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLME 84
Query: 637 VALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKP-----LDWLTR 691
             ++S+ +H+N+V  IG   +   R ++ E M  G L+  L      +P     L  L  
Sbjct: 85  ALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLR-ETRPRPSQPSSLAMLDL 143
Query: 692 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQAEEDLTH 748
           L +A D A G +YL        IHRD+ + N LL        AK+ DFG++    +D+  
Sbjct: 144 LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA----QDIYR 196
Query: 749 ISSVARG-----TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
            S   +G      V ++ PE +     T K+D +SFGV+L E+ S
Sbjct: 197 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 103/221 (46%), Gaps = 20/221 (9%)
Query: 584 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGK------EVAVKIMADSCSHRTQ-QFVTE 636
           L E+        + +G G+FG VY G++          +VAVK + + CS + +  F+ E
Sbjct: 42  LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLME 101
Query: 637 VALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKP-----LDWLTR 691
             ++S+ +H+N+V  IG   +   R ++ E M  G L+  L      +P     L  L  
Sbjct: 102 ALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLR-ETRPRPSQPSSLAMLDL 160
Query: 692 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQA-EEDLT 747
           L +A D A G +YL        IHRD+ + N LL        AK+ DFG++R        
Sbjct: 161 LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY 217
Query: 748 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
                A   V ++ PE +     T K+D +SFGV+L E+ S
Sbjct: 218 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 110/217 (50%), Gaps = 27/217 (12%)
Query: 596 KKIGKGSFGSVYYG--------KMKDGKEVAVKIMADSCSHRT-QQFVTEVALLSRI-HH 645
           K +G+G FG V           K K+   VAVK++ D  + +     V+E+ ++  I  H
Sbjct: 33  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 92
Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG----------SVNQKPLDWLT---RL 692
           +N++ L+G C ++    ++ EY   G LR+ L             +N+ P + +T    +
Sbjct: 93  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 152
Query: 693 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-DLTHISS 751
              +  A+G+EYL    +   IHRD+ + N+L+  N   K++DFGL+R     D    ++
Sbjct: 153 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 209
Query: 752 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
             R  V ++ PE   ++  T +SDV+SFGV++ E+ +
Sbjct: 210 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 110/217 (50%), Gaps = 27/217 (12%)
Query: 596 KKIGKGSFGSVYYG--------KMKDGKEVAVKIMADSCSHRT-QQFVTEVALLSRI-HH 645
           K +G+G FG V           K K+   VAVK++ D  + +     V+E+ ++  I  H
Sbjct: 28  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 87
Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG----------SVNQKPLDWLT---RL 692
           +N++ L+G C ++    ++ EY   G LR+ L             +N+ P + +T    +
Sbjct: 88  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 147
Query: 693 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-DLTHISS 751
              +  A+G+EYL    +   IHRD+ + N+L+  N   K++DFGL+R     D    ++
Sbjct: 148 SCTYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTT 204
Query: 752 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
             R  V ++ PE   ++  T +SDV+SFGV++ E+ +
Sbjct: 205 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 103/199 (51%), Gaps = 9/199 (4%)
Query: 596 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 655
           KK+G G FG V+        +VAVK M    S   + F+ E  ++  + H  LV L    
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 656 EEEHQRILVYEYMHNGTLRDRLHGSVNQK-PLDWLTRLQIAHDAAKGLEYLHTGCNPGII 714
            +E   I+  E+M  G+L D L      K PL  L  +  +   A+G+ ++        I
Sbjct: 253 TKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPLPKL--IDFSAQIAEGMAFIE---QRNYI 306
Query: 715 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 774
           HRD++++NIL+  ++  K++DFGL+R  E++       A+  + +  PE       T KS
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 366
Query: 775 DVYSFGVVLLELIS-GKKP 792
           DV+SFG++L+E+++ G+ P
Sbjct: 367 DVWSFGILLMEIVTYGRIP 385

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 110/217 (50%), Gaps = 27/217 (12%)
Query: 596 KKIGKGSFGSVYYG--------KMKDGKEVAVKIMADSCSHRT-QQFVTEVALLSRI-HH 645
           K +G+G+FG V           K K+   VAVK++ D  +       V+E+ ++  I  H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKH 100
Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG----------SVNQKPLDWLT---RL 692
           +N++ L+G C ++    ++ EY   G LR+ L             +N+ P + +T    +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 693 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-DLTHISS 751
              +  A+G+EYL    +   IHRD+ + N+L+  N   K++DFGL+R     D    ++
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 752 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
             R  V ++ PE   ++  T +SDV+SFGV++ E+ +
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 111/217 (51%), Gaps = 27/217 (12%)
Query: 596 KKIGKGSFGSVYYG--------KMKDGKEVAVKIMADSCSHRT-QQFVTEVALLSRI-HH 645
           K +G+G+FG V           K K+   VAVK++ D  + +     V+E+ ++  I  H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG----------SVNQKPLDWLT---RL 692
           +N++ L+G C ++    ++ EY   G LR+ L             +N+ P + +T    +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 693 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-DLTHISS 751
              +  A+G+EYL    +   IHRD+ + N+L+  N   +++DFGL+R     D    ++
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTT 217
Query: 752 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
             R  V ++ PE   ++  T +SDV+SFGV++ E+ +
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 103/206 (50%), Gaps = 12/206 (5%)
Query: 589 EATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRN 647
           E   NF K IG+GS G V     K  GK+VAVK M      R +    EV ++   HH N
Sbjct: 45  EYLANFIK-IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDN 103
Query: 648 LVPLIGYCEEEHQRILVYEYMHNGTLRDRL-HGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           +V +        +  +V E++  G L D + H  +N++ +       +     + L YLH
Sbjct: 104 VVDMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----TVCLSVLRALSYLH 158
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 766
              N G+IHRD+KS +ILL  + R K+SDFG   Q  +++     +  GT  ++ PE   
Sbjct: 159 ---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLV-GTPYWMAPEVIS 214
Query: 767 NQQLTEKSDVYSFGVVLLELISGKKP 792
                 + D++S G++++E+I G+ P
Sbjct: 215 RLPYGTEVDIWSLGIMVIEMIDGEPP 240

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 74/224 (33%), Positives = 111/224 (49%), Gaps = 27/224 (12%)
Query: 585 PELEEATNNFCKKIGKGSFGSVYYGKMK-DG--KEVAVKIMADSCS---HRTQQFVTEVA 638
           P L+     F   IG+G+FG V   ++K DG   + A+K M +  S   HR   F  E+ 
Sbjct: 20  PVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR--DFAGELE 77
Query: 639 LLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGS----------VNQKPLD 687
           +L ++ HH N++ L+G CE      L  EY  +G L D L  S          +      
Sbjct: 78  VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 137
Query: 688 WLTRLQIAH---DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 744
            L+  Q+ H   D A+G++YL        IHRD+ + NIL+  N  AK++DFGLSR  E 
Sbjct: 138 TLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV 194
Query: 745 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
            +    ++ R  V ++  E       T  SDV+S+GV+L E++S
Sbjct: 195 YVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 105/205 (51%), Gaps = 18/205 (8%)
Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPL 651
           ++IG GSFG+VY+ + +++ + VA+K M+ S    + + Q  + EV  L ++ H N +  
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 711
            G    EH   LV EY   G+  D L   V++KPL  +    + H A +GL YLH+    
Sbjct: 81  RGCYLREHTAWLVMEYC-LGSASDLL--EVHKKPLQEVEIAAVTHGALQGLAYLHSH--- 134
Query: 712 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY---YGNQ 768
            +IHRDVK+ NILL      K+ DFG +      +   ++   GT  ++ PE        
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSA-----SIMAPANXFVGTPYWMAPEVILAMDEG 189
Query: 769 QLTEKSDVYSFGVVLLELISGKKPV 793
           Q   K DV+S G+  +EL   K P+
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPL 214

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 74/224 (33%), Positives = 111/224 (49%), Gaps = 27/224 (12%)
Query: 585 PELEEATNNFCKKIGKGSFGSVYYGKMK-DG--KEVAVKIMADSCS---HRTQQFVTEVA 638
           P L+     F   IG+G+FG V   ++K DG   + A+K M +  S   HR   F  E+ 
Sbjct: 10  PVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR--DFAGELE 67
Query: 639 LLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGS----------VNQKPLD 687
           +L ++ HH N++ L+G CE      L  EY  +G L D L  S          +      
Sbjct: 68  VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 127
Query: 688 WLTRLQIAH---DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 744
            L+  Q+ H   D A+G++YL        IHRD+ + NIL+  N  AK++DFGLSR  E 
Sbjct: 128 TLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV 184
Query: 745 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
            +    ++ R  V ++  E       T  SDV+S+GV+L E++S
Sbjct: 185 YVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 101/198 (51%), Gaps = 11/198 (5%)
Query: 597 KIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI-GY 654
           KIG+GS G V   + K  G++VAVK+M      R +    EV ++    H N+V +   Y
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 655 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 714
              E   +L+ E++  G L D     V+Q  L+      +     + L YLH     G+I
Sbjct: 112 LVGEELWVLM-EFLQGGALTD----IVSQVRLNEEQIATVCEAVLQALAYLHA---QGVI 163
Query: 715 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 774
           HRD+KS +ILL ++ R K+SDFG   Q  +D+     +  GT  ++ PE         + 
Sbjct: 164 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLV-GTPYWMAPEVISRSLYATEV 222
Query: 775 DVYSFGVVLLELISGKKP 792
           D++S G++++E++ G+ P
Sbjct: 223 DIWSLGIMVIEMVDGEPP 240

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 110/217 (50%), Gaps = 27/217 (12%)
Query: 596 KKIGKGSFGSVYYG--------KMKDGKEVAVKIMADSCSHRT-QQFVTEVALLSRI-HH 645
           K +G+G+FG V           K K+   VAVK++ D  + +     V+E+ ++  I  H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG----------SVNQKPLDWLT---RL 692
           +N++ L+G C ++    ++  Y   G LR+ L             +N+ P + +T    +
Sbjct: 101 KNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 693 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-DLTHISS 751
              +  A+G+EYL    +   IHRD+ + N+L+  N   K++DFGL+R     D    ++
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 752 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
             R  V ++ PE   ++  T +SDV+SFGV++ E+ +
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 105/208 (50%), Gaps = 22/208 (10%)
Query: 596 KKIGKGSFGSVYYGKMK--DGK--EVAVKIMA-DSCSHR-TQQFVTEVALLSRIHHRNLV 649
           K +G+G FGSV  G +K  DG   +VAVK M  D+ S R  ++F++E A +    H N++
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 650 PLIGYCEEEHQR----------ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA 699
            L+G C E   +           + Y  +H   L  RL       PL  L +  +  D A
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMV--DIA 157
Query: 700 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTVG 758
            G+EYL    N   +HRD+ + N +L  +M   V+DFGLS++    D      +A+  V 
Sbjct: 158 LGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 214
Query: 759 YLDPEYYGNQQLTEKSDVYSFGVVLLEL 786
           ++  E   ++  T KSDV++FGV + E+
Sbjct: 215 WIAIESLADRVYTSKSDVWAFGVTMWEI 242

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 114/208 (54%), Gaps = 21/208 (10%)
Query: 598 IGKGSFGSVYYGKMK-DGKE---VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNLVPLI 652
           IG G FG V  G +K  GK    VA+K +    + + ++ F++E +++ +  H N++ L 
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 74
Query: 653 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGC 709
           G   +    +++ E+M NG+L   L  +  Q      T +Q+       A G++YL    
Sbjct: 75  GVVTKSTPVMIITEFMENGSLDSFLRQNDGQ-----FTVIQLVGMLRGIAAGMKYL---A 126
Query: 710 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL---THISSV-ARGTVGYLDPEYY 765
           +   +HR + + NIL++ N+  KVSDFGLSR  E+D    T+ S++  +  + +  PE  
Sbjct: 127 DMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI 186
Query: 766 GNQQLTEKSDVYSFGVVLLELIS-GKKP 792
             ++ T  SDV+S+G+V+ E++S G++P
Sbjct: 187 QYRKFTSASDVWSYGIVMWEVMSYGERP 214

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 110/217 (50%), Gaps = 27/217 (12%)
Query: 596 KKIGKGSFGSVYYG--------KMKDGKEVAVKIMADSCSHRT-QQFVTEVALLSRI-HH 645
           K +G+G+FG V           K K+   VAVK++ D  + +     V+E+ ++  I  H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG----------SVNQKPLDWLT---RL 692
           +N++ L+G C ++    ++  Y   G LR+ L             +N+ P + +T    +
Sbjct: 101 KNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 693 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-DLTHISS 751
              +  A+G+EYL    +   IHRD+ + N+L+  N   K++DFGL+R     D    ++
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 752 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
             R  V ++ PE   ++  T +SDV+SFGV++ E+ +
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 101/205 (49%), Gaps = 16/205 (7%)
Query: 598 IGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQ---QFVTEVALLSRIHHRNLVPLIG 653
           +G G    V+  + ++D ++VAVK++    +       +F  E    + ++H  +V +  
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 654 YCEEEHQR----ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 709
             E E        +V EY+   TLRD +H    + P+     +++  DA + L + H   
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQN- 135
Query: 710 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGYLDPEYYGN 767
             GIIHRDVK +NI++      KV DFG++R   +    ++  A   GT  YL PE    
Sbjct: 136 --GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 768 QQLTEKSDVYSFGVVLLELISGKKP 792
             +  +SDVYS G VL E+++G+ P
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/205 (33%), Positives = 102/205 (49%), Gaps = 16/205 (7%)
Query: 594 FCKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVP 650
             K IGKG+F  V   + +  GKEVAVKI+  +   S   Q+   EV ++  ++H N+V 
Sbjct: 18  LLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVK 77
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    E E    LV EY   G + D L  HG + +K      R  ++      ++Y H  
Sbjct: 78  LFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS-----AVQYCHQK 132
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY-GN 767
               I+HRD+K+ N+LLD +M  K++DFG S   E    +      G+  Y  PE + G 
Sbjct: 133 F---IVHRDLKAENLLLDADMNIKIADFGFSN--EFTFGNKLDTFCGSPPYAAPELFQGK 187
Query: 768 QQLTEKSDVYSFGVVLLELISGKKP 792
           +    + DV+S GV+L  L+SG  P
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSGSLP 212

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 102/207 (49%), Gaps = 16/207 (7%)
Query: 598 IGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQ---QFVTEVALLSRIHHRNLVPLIG 653
           +G G    V+  + ++D ++VAVK++    +       +F  E    + ++H  +V +  
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 654 YCEEEHQR----ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 709
             E E        +V EY+   TLRD +H    + P+     +++  DA + L + H   
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQN- 135
Query: 710 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGYLDPEYYGN 767
             GIIHRDVK +NI++      KV DFG++R   +    ++  A   GT  YL PE    
Sbjct: 136 --GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVS 794
             +  +SDVYS G VL E+++G+ P +
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPPFT 220

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 16/205 (7%)
Query: 598 IGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQ---QFVTEVALLSRIHHRNLVPLIG 653
           +G G    V+  + ++D ++VAVK++    +       +F  E    + ++H  +V +  
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 654 YCEEEHQR----ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 709
             E E        +V EY+   TLRD +H    + P+     +++  DA + L + H   
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQN- 135
Query: 710 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGYLDPEYYGN 767
             GIIHRDVK +NIL+      KV DFG++R   +    +   A   GT  YL PE    
Sbjct: 136 --GIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARG 193
Query: 768 QQLTEKSDVYSFGVVLLELISGKKP 792
             +  +SDVYS G VL E+++G+ P
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/205 (33%), Positives = 102/205 (49%), Gaps = 16/205 (7%)
Query: 594 FCKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVP 650
             K IGKG+F  V   + +  GKEVAVKI+  +   S   Q+   EV ++  ++H N+V 
Sbjct: 18  LLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVK 77
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    E E    LV EY   G + D L  HG + +K      R  ++      ++Y H  
Sbjct: 78  LFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS-----AVQYCHQK 132
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY-GN 767
               I+HRD+K+ N+LLD +M  K++DFG S   E    +      G+  Y  PE + G 
Sbjct: 133 F---IVHRDLKAENLLLDADMNIKIADFGFSN--EFTFGNKLDTFCGSPPYAAPELFQGK 187
Query: 768 QQLTEKSDVYSFGVVLLELISGKKP 792
           +    + DV+S GV+L  L+SG  P
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSGSLP 212

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 105/215 (48%), Gaps = 16/215 (7%)
Query: 584 LPELEEATNNFCKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSC--SHRTQQFVTEVALL 640
           + +L        K IGKG+F  V   + +  GKEVAVKI+  +   S   Q+   EV ++
Sbjct: 1   MADLHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIM 60
Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDA 698
             ++H N+V L    E E    LV EY   G + D L  HG + +K      R  ++   
Sbjct: 61  KVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVS--- 117
Query: 699 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG 758
              ++Y H      I+HRD+K+ N+LLD +M  K++DFG S   E    +      G+  
Sbjct: 118 --AVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSN--EFTFGNKLDTFCGSPP 170
Query: 759 YLDPEYY-GNQQLTEKSDVYSFGVVLLELISGKKP 792
           Y  PE + G +    + DV+S GV+L  L+SG  P
Sbjct: 171 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 205

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/205 (33%), Positives = 101/205 (49%), Gaps = 16/205 (7%)
Query: 594 FCKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVP 650
             K IGKG+F  V   + +  GKEVAVKI+  +   S   Q+   EV ++  ++H N+V 
Sbjct: 18  LLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVK 77
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    E E    LV EY   G + D L  HG + +K      R  ++      ++Y H  
Sbjct: 78  LFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS-----AVQYCHQK 132
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY-GN 767
               I+HRD+K+ N+LLD +M  K++DFG S   E    +      G   Y  PE + G 
Sbjct: 133 F---IVHRDLKAENLLLDADMNIKIADFGFSN--EFTFGNKLDAFCGAPPYAAPELFQGK 187
Query: 768 QQLTEKSDVYSFGVVLLELISGKKP 792
           +    + DV+S GV+L  L+SG  P
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSGSLP 212

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/224 (32%), Positives = 111/224 (49%), Gaps = 27/224 (12%)
Query: 585 PELEEATNNFCKKIGKGSFGSVYYGKMK-DG--KEVAVKIMADSCS---HRTQQFVTEVA 638
           P L+     F   IG+G+FG V   ++K DG   + A+K M +  S   HR   F  E+ 
Sbjct: 17  PVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR--DFAGELE 74
Query: 639 LLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGS----------VNQKPLD 687
           +L ++ HH N++ L+G CE      L  EY  +G L D L  S          +      
Sbjct: 75  VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 134
Query: 688 WLTRLQIAH---DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 744
            L+  Q+ H   D A+G++YL        IHR++ + NIL+  N  AK++DFGLSR  E 
Sbjct: 135 TLSSQQLLHFAADVARGMDYLS---QKQFIHRNLAARNILVGENYVAKIADFGLSRGQEV 191
Query: 745 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
            +    ++ R  V ++  E       T  SDV+S+GV+L E++S
Sbjct: 192 YVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 106/210 (50%), Gaps = 16/210 (7%)
Query: 594 FCKKIGKGSFGSVYYGKMKD-GKEVAVK---IMADSCSHRTQQFVTEVALLSRIHHRNLV 649
              K+G G   +VY  +      +VA+K   I         ++F  EV   S++ H+N+V
Sbjct: 15  IVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 650 PLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
            +I   EE+    LV EY+   TL + +  HG     PL   T +   +    G+++ H 
Sbjct: 75  SMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG-----PLSVDTAINFTNQILDGIKHAH- 128
Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYLDPEYYG 766
             +  I+HRD+K  NIL+D N   K+ DFG+++  +E  LT  + V  GTV Y  PE   
Sbjct: 129 --DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVL-GTVQYFSPEQAK 185
Query: 767 NQQLTEKSDVYSFGVVLLELISGKKPVSVE 796
            +   E +D+YS G+VL E++ G+ P + E
Sbjct: 186 GEATDECTDIYSIGIVLYEMLVGEPPFNGE 215

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 106/225 (47%), Gaps = 28/225 (12%)
Query: 584 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGK------EVAVKIMADSCSHRTQ-QFVTE 636
           L E+        + +G G+FG VY G++          +VAVK + +  S + +  F+ E
Sbjct: 39  LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLME 98
Query: 637 VALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKP-----LDWLTR 691
             ++S+ +H+N+V  IG   +   R ++ E M  G L+  L      +P     L  L  
Sbjct: 99  ALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLR-ETRPRPSQPSSLAMLDL 157
Query: 692 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQAEEDLTH 748
           L +A D A G +YL        IHRD+ + N LL        AK+ DFG++R    D+  
Sbjct: 158 LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYR 210
Query: 749 ISSVARG-----TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
            S   +G      V ++ PE +     T K+D +SFGV+L E+ S
Sbjct: 211 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 102/205 (49%), Gaps = 16/205 (7%)
Query: 594 FCKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVP 650
             K IGKG+F  V   + +  GKEVAV+I+  +   S   Q+   EV ++  ++H N+V 
Sbjct: 18  LLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVK 77
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    E E    LV EY   G + D L  HG + +K      R  ++      ++Y H  
Sbjct: 78  LFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS-----AVQYCHQK 132
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY-GN 767
               I+HRD+K+ N+LLD +M  K++DFG S   E    +      G+  Y  PE + G 
Sbjct: 133 F---IVHRDLKAENLLLDADMNIKIADFGFSN--EFTFGNKLDTFCGSPPYAAPELFQGK 187
Query: 768 QQLTEKSDVYSFGVVLLELISGKKP 792
           +    + DV+S GV+L  L+SG  P
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSGSLP 212

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 104/207 (50%), Gaps = 20/207 (9%)
Query: 594 FCKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVP 650
             K IGKG+F  V   + +  GKEVAV+I+  +   S   Q+   EV ++  ++H N+V 
Sbjct: 18  LLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVK 77
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    E E    LV EY   G + D L  HG + +K      R  ++      ++Y H  
Sbjct: 78  LFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS-----AVQYCHQK 132
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGYLDPEYY- 765
               I+HRD+K+ N+LLD +M  K++DFG S +     T  + +    G+  Y  PE + 
Sbjct: 133 F---IVHRDLKAENLLLDADMNIKIADFGFSNE----FTFGNKLDEFCGSPPYAAPELFQ 185
Query: 766 GNQQLTEKSDVYSFGVVLLELISGKKP 792
           G +    + DV+S GV+L  L+SG  P
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSGSLP 212

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 69/235 (29%), Positives = 120/235 (51%), Gaps = 39/235 (16%)
Query: 596 KKIGKGSFGSVYY----GKMKDG----KEVAVKIM-ADSCSHRTQQFVTEVALLSRI-HH 645
           K +G+G+FG V      G  KD      +VAVK++ +D+        ++E+ ++  I  H
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG----------SVNQKPLDWLTR---L 692
           +N++ L+G C ++    ++ EY   G LR+ L            + +  P + L+    +
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLV 153
Query: 693 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV 752
             A+  A+G+EYL    +   IHRD+ + N+L+  +   K++DFGL+R    D+ HI   
Sbjct: 154 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDXX 206
Query: 753 ARGTVG-----YLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP---VSVEDF 798
            + T G     ++ PE   ++  T +SDV+SFGV+L E+ + G  P   V VE+ 
Sbjct: 207 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 261

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 100/214 (46%), Gaps = 27/214 (12%)
Query: 596 KKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPL 651
           + +GKG FG+VY  + K  K + A+K++  +   +     Q   EV + S + H N++ L
Sbjct: 40  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 99
Query: 652 IGYCEEEHQRILVYEYMHNGTLR---DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
            GY  +  +  L+ EY   GT+     +L     Q+   ++T L      A  L Y H+ 
Sbjct: 100 YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANALSYCHSK 153
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDPEY 764
               +IHRD+K  N+LL      K++DFG S        H  S  R    GT+ YL PE 
Sbjct: 154 ---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTLCGTLDYLPPEM 203
Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF 798
              +   EK D++S GV+  E + GK P     +
Sbjct: 204 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY 237

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 100/214 (46%), Gaps = 27/214 (12%)
Query: 596 KKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPL 651
           + +GKG FG+VY  + K  K + A+K++  +   +     Q   EV + S + H N++ L
Sbjct: 40  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 99
Query: 652 IGYCEEEHQRILVYEYMHNGTLR---DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
            GY  +  +  L+ EY   GT+     +L     Q+   ++T L      A  L Y H+ 
Sbjct: 100 YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANALSYCHSK 153
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDPEY 764
               +IHRD+K  N+LL      K++DFG S        H  S  R    GT+ YL PE 
Sbjct: 154 ---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRDDLCGTLDYLPPEM 203
Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF 798
              +   EK D++S GV+  E + GK P     +
Sbjct: 204 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY 237

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 106/229 (46%), Gaps = 33/229 (14%)
Query: 594 FCKKIGKGSFGSVYYGKM------KDGKEVAVKIMADSCSHRTQ-QFVTEVALLSRIHHR 646
           + + IG+G+FG V+  +       +    VAVK++ +  S   Q  F  E AL++   + 
Sbjct: 51  YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 647 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRL------------HGSVNQK---------P 685
           N+V L+G C       L++EYM  G L + L            H  ++ +         P
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 686 LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EE 744
           L    +L IA   A G+ YL        +HRD+ + N L+  NM  K++DFGLSR     
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227
Query: 745 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
           D           + ++ PE     + T +SDV+++GVVL E+ S G +P
Sbjct: 228 DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 105/211 (49%), Gaps = 14/211 (6%)
Query: 587 LEEATNNFCKKIGKGSFGSV---YYGKMKD--GKEVAVKIMADSCSHRTQQFVTEVALLS 641
            EE    +  ++GKG+FGSV    Y  + D  G  VAVK +  S   + + F  E+ +L 
Sbjct: 7   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 66
Query: 642 RIHHRNLVPLIG--YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA 699
            +H   +V   G  Y        LV EY+ +G LRD L    ++  LD    L  +    
Sbjct: 67  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ--RHRARLDASRLLLYSSQIC 124
Query: 700 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTV 757
           KG+EYL +      +HRD+ + NIL++     K++DFGL++    ++D   +    +  +
Sbjct: 125 KGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPI 181
Query: 758 GYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
            +  PE   +   + +SDV+SFGVVL EL +
Sbjct: 182 FWYAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 27/214 (12%)
Query: 596 KKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPL 651
           + +GKG FG+VY  + K+ K + A+K++  +   +     Q   EV + S + H N++ L
Sbjct: 14  RPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 652 IGYCEEEHQRILVYEYMHNGTLR---DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
            GY  +  +  L+ EY   GT+     +L     Q+   ++T L      A  L Y H+ 
Sbjct: 74  YGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANALSYCHSK 127
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDPEY 764
               +IHRD+K  N+LL      K++DFG S        H  S  R    GT+ YL PE 
Sbjct: 128 ---KVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRAALCGTLDYLPPEM 177
Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF 798
              +   EK D++S GV+  E + GK P     +
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY 211

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 105/211 (49%), Gaps = 14/211 (6%)
Query: 587 LEEATNNFCKKIGKGSFGSV---YYGKMKD--GKEVAVKIMADSCSHRTQQFVTEVALLS 641
            EE    +  ++GKG+FGSV    Y  + D  G  VAVK +  S   + + F  E+ +L 
Sbjct: 8   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 67
Query: 642 RIHHRNLVPLIG--YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA 699
            +H   +V   G  Y        LV EY+ +G LRD L    ++  LD    L  +    
Sbjct: 68  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ--RHRARLDASRLLLYSSQIC 125
Query: 700 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTV 757
           KG+EYL +      +HRD+ + NIL++     K++DFGL++    ++D   +    +  +
Sbjct: 126 KGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPI 182
Query: 758 GYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
            +  PE   +   + +SDV+SFGVVL EL +
Sbjct: 183 FWYAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 73/234 (31%), Positives = 111/234 (47%), Gaps = 43/234 (18%)
Query: 585 PELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTE--VALLSR 642
           P L+       + IG+G +G+VY G + D + VAVK+   S ++R Q F+ E  +  +  
Sbjct: 8   PSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVF--SFANR-QNFINEKNIYRVPL 63
Query: 643 IHHRNLVPLIGYCEE-----EHQRILVYEYMHNGTLRD--RLHGSVNQKPLDWLTRLQIA 695
           + H N+   I   E        + +LV EY  NG+L     LH S      DW++  ++A
Sbjct: 64  MEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS------DWVSSCRLA 117
Query: 696 HDAAKGLEYLHTGC------NPGIIHRDVKSSNILLDINMRAKVSDFGLS---------R 740
           H   +GL YLHT         P I HRD+ S N+L+  +    +SDFGLS         R
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVR 177
Query: 741 QAEEDLTHISSVARGTVGYLDPEYY-------GNQQLTEKSDVYSFGVVLLELI 787
             EED   IS V  GT+ Y+ PE           +   ++ D+Y+ G++  E+ 
Sbjct: 178 PGEEDNAAISEV--GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 104/203 (51%), Gaps = 16/203 (7%)
Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 652
           K IGKG+F  V   + +  G+EVAVKI+  +  + T  Q+   EV ++  ++H N+V L 
Sbjct: 21  KTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 80
Query: 653 GYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 710
              E E    LV EY   G + D L  HG + +K      R  ++      ++Y H    
Sbjct: 81  EVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS-----AVQYCHQKY- 134
Query: 711 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY-GNQQ 769
             I+HRD+K+ N+LLD +M  K++DFG S   E  + +      G+  Y  PE + G + 
Sbjct: 135 --IVHRDLKAENLLLDGDMNIKIADFGFSN--EFTVGNKLDTFCGSPPYAAPELFQGKKY 190
Query: 770 LTEKSDVYSFGVVLLELISGKKP 792
              + DV+S GV+L  L+SG  P
Sbjct: 191 DGPEVDVWSLGVILYTLVSGSLP 213

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 104/213 (48%), Gaps = 12/213 (5%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT-----QQFVTEVALL 640
           E++       + IG+G FG V+ G     +  A+ +   +C + T     ++F+ E   +
Sbjct: 34  EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 93
Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 700
            +  H ++V LIG   E    I++ E    G LR  L   V +  LD  + +  A+  + 
Sbjct: 94  RQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFLQ--VRKYSLDLASLILYAYQLST 150
Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYL 760
            L YL +      +HRD+ + N+L+  N   K+ DFGLSR  E+   + +S  +  + ++
Sbjct: 151 ALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 207
Query: 761 DPEYYGNQQLTEKSDVYSFGVVLLE-LISGKKP 792
            PE    ++ T  SDV+ FGV + E L+ G KP
Sbjct: 208 APESINFRRFTSASDVWMFGVCMWEILMHGVKP 240

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 105/211 (49%), Gaps = 14/211 (6%)
Query: 587 LEEATNNFCKKIGKGSFGSV---YYGKMKD--GKEVAVKIMADSCSHRTQQFVTEVALLS 641
            EE    +  ++GKG+FGSV    Y  + D  G  VAVK +  S   + + F  E+ +L 
Sbjct: 20  FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 79
Query: 642 RIHHRNLVPLIG--YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA 699
            +H   +V   G  Y        LV EY+ +G LRD L    ++  LD    L  +    
Sbjct: 80  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ--RHRARLDASRLLLYSSQIC 137
Query: 700 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTV 757
           KG+EYL +      +HRD+ + NIL++     K++DFGL++    ++D   +    +  +
Sbjct: 138 KGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPI 194
Query: 758 GYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
            +  PE   +   + +SDV+SFGVVL EL +
Sbjct: 195 FWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 86.3 bits (212), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 104/213 (48%), Gaps = 12/213 (5%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT-----QQFVTEVALL 640
           E++       + IG+G FG V+ G     +  A+ +   +C + T     ++F+ E   +
Sbjct: 6   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 65
Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 700
            +  H ++V LIG   E    I++ E    G LR  L   V +  LD  + +  A+  + 
Sbjct: 66  RQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFLQ--VRKYSLDLASLILYAYQLST 122
Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYL 760
            L YL +      +HRD+ + N+L+  N   K+ DFGLSR  E+   + +S  +  + ++
Sbjct: 123 ALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 179
Query: 761 DPEYYGNQQLTEKSDVYSFGVVLLE-LISGKKP 792
            PE    ++ T  SDV+ FGV + E L+ G KP
Sbjct: 180 APESINFRRFTSASDVWMFGVCMWEILMHGVKP 212

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 86.3 bits (212), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 104/213 (48%), Gaps = 12/213 (5%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT-----QQFVTEVALL 640
           E++       + IG+G FG V+ G     +  A+ +   +C + T     ++F+ E   +
Sbjct: 6   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 65
Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 700
            +  H ++V LIG   E    I++ E    G LR  L   V +  LD  + +  A+  + 
Sbjct: 66  RQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFLQ--VRKYSLDLASLILYAYQLST 122
Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYL 760
            L YL +      +HRD+ + N+L+  N   K+ DFGLSR  E+   + +S  +  + ++
Sbjct: 123 ALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 179
Query: 761 DPEYYGNQQLTEKSDVYSFGVVLLE-LISGKKP 792
            PE    ++ T  SDV+ FGV + E L+ G KP
Sbjct: 180 APESINFRRFTSASDVWMFGVCMWEILMHGVKP 212

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 107/229 (46%), Gaps = 29/229 (12%)
Query: 583 PLPELEEATNNF--CKKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRT---QQFVTE 636
           PL   + A  +F   + +GKG FG+VY  + K  K + A+K++  +   +     Q   E
Sbjct: 2   PLGSRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 637 VALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLR---DRLHGSVNQKPLDWLTRLQ 693
           V + S + H N++ L GY  +  +  L+ EY   GT+     +L     Q+   ++T L 
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL- 120
Query: 694 IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA----EEDLTHI 749
                A  L Y H+     +IHRD+K  N+LL      K++DFG S  A     +DL   
Sbjct: 121 -----ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC-- 170
Query: 750 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF 798
                GT+ YL PE    +   EK D++S GV+  E + GK P     +
Sbjct: 171 -----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY 214

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 69/235 (29%), Positives = 120/235 (51%), Gaps = 39/235 (16%)
Query: 596 KKIGKGSFGSVYY----GKMKDG----KEVAVKIM-ADSCSHRTQQFVTEVALLSRI-HH 645
           K +G+G+FG V      G  KD      +VAVK++ +D+        ++E+ ++  I  H
Sbjct: 75  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG----------SVNQKPLDWLTR---L 692
           +N++ L+G C ++    ++ EY   G LR+ L            + +  P + L+    +
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 693 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV 752
             A+  A+G+EYL    +   IHRD+ + N+L+  +   K++DFGL+R    D+ HI   
Sbjct: 195 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYY 247
Query: 753 ARGTVG-----YLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP---VSVEDF 798
            + T G     ++ PE   ++  T +SDV+SFGV+L E+ + G  P   V VE+ 
Sbjct: 248 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 302

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 100/214 (46%), Gaps = 27/214 (12%)
Query: 596 KKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPL 651
           + +GKG FG+VY  + K  K + A+K++  +   +     Q   EV + S + H N++ L
Sbjct: 31  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 90
Query: 652 IGYCEEEHQRILVYEYMHNGTLR---DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
            GY  +  +  L+ EY   GT+     +L     Q+   ++T L      A  L Y H+ 
Sbjct: 91  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANALSYCHSK 144
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDPEY 764
               +IHRD+K  N+LL      K++DFG S        H  S  R    GT+ YL PE 
Sbjct: 145 ---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTLCGTLDYLPPEM 194
Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF 798
              +   EK D++S GV+  E + GK P     +
Sbjct: 195 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY 228

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Composition-based stats.
 Identities = 66/211 (31%), Positives = 106/211 (50%), Gaps = 14/211 (6%)
Query: 587 LEEATNNFCKKIGKGSFGSV---YYGKMKD--GKEVAVKIMADSCSHRTQQFVTEVALLS 641
            EE    +  ++GKG+FGSV    Y  + D  G  VAVK +  S   + + F  E+ +L 
Sbjct: 4   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 63
Query: 642 RIHHRNLVPLIG--YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA 699
            +H   +V   G  Y     +  LV EY+ +G LRD L    ++  LD    L  +    
Sbjct: 64  ALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQR--HRARLDASRLLLYSSQIC 121
Query: 700 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTV 757
           KG+EYL +      +HRD+ + NIL++     K++DFGL++    ++D   +    +  +
Sbjct: 122 KGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPI 178
Query: 758 GYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
            +  PE   +   + +SDV+SFGVVL EL +
Sbjct: 179 FWYAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 594 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 652
           F + +G G+F  V+  K +  GK  A+K +  S + R      E+A+L +I H N+V L 
Sbjct: 13  FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLE 72
Query: 653 GYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 710
              E      LV + +  G L DR+   G   +K    + +  ++      ++YLH    
Sbjct: 73  DIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLS-----AVKYLHEN-- 125
Query: 711 PGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 767
            GI+HRD+K  N+L    + N +  ++DFGLS+  +     I S A GT GY+ PE    
Sbjct: 126 -GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG---IMSTACGTPGYVAPEVLAQ 181
Query: 768 QQLTEKSDVYSFGVVLLELISGKKP 792
           +  ++  D +S GV+   L+ G  P
Sbjct: 182 KPYSKAVDCWSIGVITYILLCGYPP 206

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/235 (29%), Positives = 120/235 (51%), Gaps = 39/235 (16%)
Query: 596 KKIGKGSFGSVYY----GKMKDG----KEVAVKIM-ADSCSHRTQQFVTEVALLSRI-HH 645
           K +G+G+FG V      G  KD      +VAVK++ +D+        ++E+ ++  I  H
Sbjct: 23  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 82
Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG----------SVNQKPLDWLTR---L 692
           +N++ L+G C ++    ++ EY   G LR+ L            + +  P + L+    +
Sbjct: 83  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 142
Query: 693 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV 752
             A+  A+G+EYL    +   IHRD+ + N+L+  +   K++DFGL+R    D+ HI   
Sbjct: 143 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYY 195
Query: 753 ARGTVG-----YLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP---VSVEDF 798
            + T G     ++ PE   ++  T +SDV+SFGV+L E+ + G  P   V VE+ 
Sbjct: 196 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 250

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 103/198 (52%), Gaps = 9/198 (4%)
Query: 596 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 654
           +KIG+G+ G+VY    +  G+EVA++ M      + +  + E+ ++    + N+V  +  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 655 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 714
                +  +V EY+  G+L D     V +  +D      +  +  + LE+LH+     +I
Sbjct: 86  YLVGDELWVVMEYLAGGSLTD----VVTETCMDEGQIAAVCRECLQALEFLHSN---QVI 138
Query: 715 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 774
           HRD+KS NILL ++   K++DFG   Q   + +  S++  GT  ++ PE    +    K 
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 197
Query: 775 DVYSFGVVLLELISGKKP 792
           D++S G++ +E+I G+ P
Sbjct: 198 DIWSLGIMAIEMIEGEPP 215

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 104/213 (48%), Gaps = 12/213 (5%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT-----QQFVTEVALL 640
           E++       + IG+G FG V+ G     +  A+ +   +C + T     ++F+ E   +
Sbjct: 8   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 67
Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 700
            +  H ++V LIG   E    I++ E    G LR  L   V +  LD  + +  A+  + 
Sbjct: 68  RQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFLQ--VRKYSLDLASLILYAYQLST 124
Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYL 760
            L YL +      +HRD+ + N+L+  N   K+ DFGLSR  E+   + +S  +  + ++
Sbjct: 125 ALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 181
Query: 761 DPEYYGNQQLTEKSDVYSFGVVLLE-LISGKKP 792
            PE    ++ T  SDV+ FGV + E L+ G KP
Sbjct: 182 APESINFRRFTSASDVWMFGVCMWEILMHGVKP 214

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 104/213 (48%), Gaps = 12/213 (5%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT-----QQFVTEVALL 640
           E++       + IG+G FG V+ G     +  A+ +   +C + T     ++F+ E   +
Sbjct: 11  EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 70
Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 700
            +  H ++V LIG   E    I++ E    G LR  L   V +  LD  + +  A+  + 
Sbjct: 71  RQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFLQ--VRKYSLDLASLILYAYQLST 127
Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYL 760
            L YL +      +HRD+ + N+L+  N   K+ DFGLSR  E+   + +S  +  + ++
Sbjct: 128 ALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 184
Query: 761 DPEYYGNQQLTEKSDVYSFGVVLLE-LISGKKP 792
            PE    ++ T  SDV+ FGV + E L+ G KP
Sbjct: 185 APESINFRRFTSASDVWMFGVCMWEILMHGVKP 217

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 100/214 (46%), Gaps = 27/214 (12%)
Query: 596 KKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPL 651
           + +GKG FG+VY  + K  K + A+K++  +   +     Q   EV + S + H N++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 652 IGYCEEEHQRILVYEYMHNGTLR---DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
            GY  +  +  L+ EY   GT+     +L     Q+   ++T L      A  L Y H+ 
Sbjct: 74  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANALSYCHSK 127
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDPEY 764
               +IHRD+K  N+LL      K++DFG S        H  S  R    GT+ YL PE 
Sbjct: 128 ---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDLCGTLDYLPPEM 177
Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF 798
              +   EK D++S GV+  E + GK P     +
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY 211

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 100/210 (47%), Gaps = 19/210 (9%)
Query: 596 KKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPL 651
           + +GKG FG+VY  + K  K + A+K++  +   +     Q   EV + S + H N++ L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 652 IGYCEEEHQRILVYEYMHNGTLR---DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
            GY  +  +  L+ EY   GT+     +L     Q+   ++T L      A  L Y H+ 
Sbjct: 75  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANALSYCHS- 127
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
               +IHRD+K  N+LL      K++DFG S  A    +   +   GT+ YL PE    +
Sbjct: 128 --KRVIHRDIKPENLLLGSAGELKIADFGWSCHAP---SSRRTTLSGTLDYLPPEMIEGR 182
Query: 769 QLTEKSDVYSFGVVLLELISGKKPVSVEDF 798
              EK D++S GV+  E + GK P     +
Sbjct: 183 MHDEKVDLWSLGVLCYEFLVGKPPFEANTY 212

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 100/214 (46%), Gaps = 27/214 (12%)
Query: 596 KKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPL 651
           + +GKG FG+VY  + K  K + A+K++  +   +     Q   EV + S + H N++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 652 IGYCEEEHQRILVYEYMHNGTLR---DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
            GY  +  +  L+ EY   GT+     +L     Q+   ++T L      A  L Y H+ 
Sbjct: 74  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANALSYCHSK 127
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDPEY 764
               +IHRD+K  N+LL      K++DFG S        H  S  R    GT+ YL PE 
Sbjct: 128 ---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTLCGTLDYLPPEM 177
Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF 798
              +   EK D++S GV+  E + GK P     +
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY 211

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/235 (29%), Positives = 120/235 (51%), Gaps = 39/235 (16%)
Query: 596 KKIGKGSFGSVYY----GKMKDG----KEVAVKIM-ADSCSHRTQQFVTEVALLSRI-HH 645
           K +G+G+FG V      G  KD      +VAVK++ +D+        ++E+ ++  I  H
Sbjct: 27  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 86
Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG----------SVNQKPLDWLTR---L 692
           +N++ L+G C ++    ++ EY   G LR+ L            + +  P + L+    +
Sbjct: 87  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 146
Query: 693 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV 752
             A+  A+G+EYL    +   IHRD+ + N+L+  +   K++DFGL+R    D+ HI   
Sbjct: 147 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYY 199
Query: 753 ARGTVG-----YLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP---VSVEDF 798
            + T G     ++ PE   ++  T +SDV+SFGV+L E+ + G  P   V VE+ 
Sbjct: 200 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 254

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/235 (29%), Positives = 120/235 (51%), Gaps = 39/235 (16%)
Query: 596 KKIGKGSFGSVYY----GKMKDG----KEVAVKIM-ADSCSHRTQQFVTEVALLSRI-HH 645
           K +G+G+FG V      G  KD      +VAVK++ +D+        ++E+ ++  I  H
Sbjct: 26  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 85
Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG----------SVNQKPLDWLTR---L 692
           +N++ L+G C ++    ++ EY   G LR+ L            + +  P + L+    +
Sbjct: 86  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 145
Query: 693 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV 752
             A+  A+G+EYL    +   IHRD+ + N+L+  +   K++DFGL+R    D+ HI   
Sbjct: 146 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYY 198
Query: 753 ARGTVG-----YLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP---VSVEDF 798
            + T G     ++ PE   ++  T +SDV+SFGV+L E+ + G  P   V VE+ 
Sbjct: 199 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 253

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 100/214 (46%), Gaps = 27/214 (12%)
Query: 596 KKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPL 651
           + +GKG FG+VY  + K  K + A+K++  +   +     Q   EV + S + H N++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 652 IGYCEEEHQRILVYEYMHNGTLR---DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
            GY  +  +  L+ EY   GT+     +L     Q+   ++T L      A  L Y H+ 
Sbjct: 77  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANALSYCHSK 130
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDPEY 764
               +IHRD+K  N+LL      K++DFG S        H  S  R    GT+ YL PE 
Sbjct: 131 ---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTLCGTLDYLPPEM 180
Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF 798
              +   EK D++S GV+  E + GK P     +
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY 214

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 100/201 (49%), Gaps = 12/201 (5%)
Query: 598 IGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT-----QQFVTEVALLSRIHHRNLVPLI 652
           IG+G FG V+ G     +  A+ +   +C + T     ++F+ E   + +  H ++V LI
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 653 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 712
           G   E    I++ E    G LR  L   V +  LD  + +  A+  +  L YL +     
Sbjct: 75  GVITENPVWIIM-ELCTLGELRSFLQ--VRKYSLDLASLILYAYQLSTALAYLESK---R 128
Query: 713 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 772
            +HRD+ + N+L+  N   K+ DFGLSR  E+   + +S  +  + ++ PE    ++ T 
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 188
Query: 773 KSDVYSFGVVLLE-LISGKKP 792
            SDV+ FGV + E L+ G KP
Sbjct: 189 ASDVWMFGVCMWEILMHGVKP 209

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 100/201 (49%), Gaps = 12/201 (5%)
Query: 598 IGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT-----QQFVTEVALLSRIHHRNLVPLI 652
           IG+G FG V+ G     +  A+ +   +C + T     ++F+ E   + +  H ++V LI
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 653 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 712
           G   E    I++ E    G LR  L   V +  LD  + +  A+  +  L YL +     
Sbjct: 81  GVITENPVWIIM-ELCTLGELRSFLQ--VRKYSLDLASLILYAYQLSTALAYLES---KR 134
Query: 713 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 772
            +HRD+ + N+L+  N   K+ DFGLSR  E+   + +S  +  + ++ PE    ++ T 
Sbjct: 135 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 194
Query: 773 KSDVYSFGVVLLE-LISGKKP 792
            SDV+ FGV + E L+ G KP
Sbjct: 195 ASDVWMFGVCMWEILMHGVKP 215

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 106/213 (49%), Gaps = 21/213 (9%)
Query: 593 NFCKKIGKGSFGSVY------YGKMKDGKEVAVKIMADSCSHRTQQ--FVTEVALLSRI- 643
            F K +G G+FG V        GK     +VAVK M  S +H  ++   ++E+ ++S + 
Sbjct: 41  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVK-MLKSTAHADEKEALMSELKIMSHLG 99
Query: 644 HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSV-------NQKPLDWLTRLQIAH 696
            H N+V L+G C      +++ EY   G L + L           + +PL+    L  + 
Sbjct: 100 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSS 159
Query: 697 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSVARG 755
             A+G+ +L    +   IHRDV + N+LL     AK+ DFGL+R    D  +I    AR 
Sbjct: 160 QVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 216
Query: 756 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
            V ++ PE   +   T +SDV+S+G++L E+ S
Sbjct: 217 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/235 (29%), Positives = 120/235 (51%), Gaps = 39/235 (16%)
Query: 596 KKIGKGSFGSVYY----GKMKDG----KEVAVKIM-ADSCSHRTQQFVTEVALLSRI-HH 645
           K +G+G+FG V      G  KD      +VAVK++ +D+        ++E+ ++  I  H
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG----------SVNQKPLDWLTR---L 692
           +N++ L+G C ++    ++ EY   G LR+ L            + +  P + L+    +
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLV 153
Query: 693 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV 752
             A+  A+G+EYL    +   IHRD+ + N+L+  +   K++DFGL+R    D+ HI   
Sbjct: 154 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYY 206
Query: 753 ARGTVG-----YLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP---VSVEDF 798
            + T G     ++ PE   ++  T +SDV+SFGV+L E+ + G  P   V VE+ 
Sbjct: 207 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 261

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 100/214 (46%), Gaps = 27/214 (12%)
Query: 596 KKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPL 651
           + +GKG FG+VY  + K  K + A+K++  +   +     Q   EV + S + H N++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 652 IGYCEEEHQRILVYEYMHNGTLR---DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
            GY  +  +  L+ EY   GT+     +L     Q+   ++T L      A  L Y H+ 
Sbjct: 74  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANALSYCHSK 127
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDPEY 764
               +IHRD+K  N+LL      K++DFG S        H  S  R    GT+ YL PE 
Sbjct: 128 ---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTELCGTLDYLPPEM 177
Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF 798
              +   EK D++S GV+  E + GK P     +
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY 211

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 16/205 (7%)
Query: 598 IGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQ---QFVTEVALLSRIHHRNLVPLIG 653
           +G G    V+  + ++  ++VAVK++    +       +F  E    + ++H  +V +  
Sbjct: 20  LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYA 79
Query: 654 YCEEEHQR----ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 709
             E E        +V EY+   TLRD +H    + P+     +++  DA + L + H   
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQN- 135
Query: 710 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGYLDPEYYGN 767
             GIIHRDVK +NI++      KV DFG++R   +    ++  A   GT  YL PE    
Sbjct: 136 --GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 768 QQLTEKSDVYSFGVVLLELISGKKP 792
             +  +SDVYS G VL E+++G+ P
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/235 (29%), Positives = 120/235 (51%), Gaps = 39/235 (16%)
Query: 596 KKIGKGSFGSVYY----GKMKDG----KEVAVKIM-ADSCSHRTQQFVTEVALLSRI-HH 645
           K +G+G+FG V      G  KD      +VAVK++ +D+        ++E+ ++  I  H
Sbjct: 19  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG----------SVNQKPLDWLTR---L 692
           +N++ L+G C ++    ++ EY   G LR+ L            + +  P + L+    +
Sbjct: 79  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLV 138
Query: 693 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV 752
             A+  A+G+EYL    +   IHRD+ + N+L+  +   K++DFGL+R    D+ HI   
Sbjct: 139 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYY 191
Query: 753 ARGTVG-----YLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP---VSVEDF 798
            + T G     ++ PE   ++  T +SDV+SFGV+L E+ + G  P   V VE+ 
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 246

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/235 (29%), Positives = 120/235 (51%), Gaps = 39/235 (16%)
Query: 596 KKIGKGSFGSVYY----GKMKDG----KEVAVKIM-ADSCSHRTQQFVTEVALLSRI-HH 645
           K +G+G+FG V      G  KD      +VAVK++ +D+        ++E+ ++  I  H
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG----------SVNQKPLDWLTR---L 692
           +N++ L+G C ++    ++ EY   G LR+ L            + +  P + L+    +
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 153
Query: 693 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV 752
             A+  A+G+EYL    +   IHRD+ + N+L+  +   K++DFGL+R    D+ HI   
Sbjct: 154 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYY 206
Query: 753 ARGTVG-----YLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP---VSVEDF 798
            + T G     ++ PE   ++  T +SDV+SFGV+L E+ + G  P   V VE+ 
Sbjct: 207 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 261

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/235 (29%), Positives = 120/235 (51%), Gaps = 39/235 (16%)
Query: 596 KKIGKGSFGSVYY----GKMKDG----KEVAVKIM-ADSCSHRTQQFVTEVALLSRI-HH 645
           K +G+G+FG V      G  KD      +VAVK++ +D+        ++E+ ++  I  H
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG----------SVNQKPLDWLTR---L 692
           +N++ L+G C ++    ++ EY   G LR+ L            + +  P + L+    +
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLV 153
Query: 693 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV 752
             A+  A+G+EYL    +   IHRD+ + N+L+  +   K++DFGL+R    D+ HI   
Sbjct: 154 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYY 206
Query: 753 ARGTVG-----YLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP---VSVEDF 798
            + T G     ++ PE   ++  T +SDV+SFGV+L E+ + G  P   V VE+ 
Sbjct: 207 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 261

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 100/214 (46%), Gaps = 27/214 (12%)
Query: 596 KKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPL 651
           + +GKG FG+VY  + K  K + A+K++  +   +     Q   EV + S + H N++ L
Sbjct: 16  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 75
Query: 652 IGYCEEEHQRILVYEYMHNGTLR---DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
            GY  +  +  L+ EY   GT+     +L     Q+   ++T L      A  L Y H+ 
Sbjct: 76  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANALSYCHSK 129
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDPEY 764
               +IHRD+K  N+LL      K++DFG S        H  S  R    GT+ YL PE 
Sbjct: 130 ---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRXXLCGTLDYLPPEM 179
Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF 798
              +   EK D++S GV+  E + GK P     +
Sbjct: 180 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY 213

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 100/214 (46%), Gaps = 27/214 (12%)
Query: 596 KKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPL 651
           + +GKG FG+VY  + K  K + A+K++  +   +     Q   EV + S + H N++ L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 652 IGYCEEEHQRILVYEYMHNGTLR---DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
            GY  +  +  L+ EY   GT+     +L     Q+   ++T L      A  L Y H+ 
Sbjct: 75  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANALSYCHSK 128
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDPEY 764
               +IHRD+K  N+LL      K++DFG S        H  S  R    GT+ YL PE 
Sbjct: 129 ---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRDTLCGTLDYLPPEM 178
Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF 798
              +   EK D++S GV+  E + GK P     +
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY 212

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 100/214 (46%), Gaps = 27/214 (12%)
Query: 596 KKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPL 651
           + +GKG FG+VY  + K  K + A+K++  +   +     Q   EV + S + H N++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 652 IGYCEEEHQRILVYEYMHNGTLR---DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
            GY  +  +  L+ EY   GT+     +L     Q+   ++T L      A  L Y H+ 
Sbjct: 79  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANALSYCHS- 131
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDPEY 764
               +IHRD+K  N+LL      K++DFG S        H  S  R    GT+ YL PE 
Sbjct: 132 --KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTLCGTLDYLPPEM 182
Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF 798
              +   EK D++S GV+  E + GK P     +
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY 216

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 100/214 (46%), Gaps = 27/214 (12%)
Query: 596 KKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPL 651
           + +GKG FG+VY  + K  K + A+K++  +   +     Q   EV + S + H N++ L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 652 IGYCEEEHQRILVYEYMHNGTLR---DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
            GY  +  +  L+ EY   GT+     +L     Q+   ++T L      A  L Y H+ 
Sbjct: 75  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANALSYCHSK 128
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDPEY 764
               +IHRD+K  N+LL      K++DFG S        H  S  R    GT+ YL PE 
Sbjct: 129 ---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDLCGTLDYLPPEM 178
Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF 798
              +   EK D++S GV+  E + GK P     +
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY 212

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 100/214 (46%), Gaps = 27/214 (12%)
Query: 596 KKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPL 651
           + +GKG FG+VY  + K  K + A+K++  +   +     Q   EV + S + H N++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 652 IGYCEEEHQRILVYEYMHNGTLR---DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
            GY  +  +  L+ EY   GT+     +L     Q+   ++T L      A  L Y H+ 
Sbjct: 74  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANALSYCHSK 127
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDPEY 764
               +IHRD+K  N+LL      K++DFG S        H  S  R    GT+ YL PE 
Sbjct: 128 ---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRAALCGTLDYLPPEM 177
Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF 798
              +   EK D++S GV+  E + GK P     +
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY 211

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 100/214 (46%), Gaps = 27/214 (12%)
Query: 596 KKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPL 651
           + +GKG FG+VY  + K  K + A+K++  +   +     Q   EV + S + H N++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 652 IGYCEEEHQRILVYEYMHNGTLR---DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
            GY  +  +  L+ EY   GT+     +L     Q+   ++T L      A  L Y H+ 
Sbjct: 74  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANALSYCHSK 127
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDPEY 764
               +IHRD+K  N+LL      K++DFG S        H  S  R    GT+ YL PE 
Sbjct: 128 ---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDLCGTLDYLPPEM 177
Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF 798
              +   EK D++S GV+  E + GK P     +
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY 211

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 100/199 (50%), Gaps = 19/199 (9%)
Query: 596 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 655
           KK+G G FG V+        +VAVK M    S   + F+ E  ++  + H  LV L    
Sbjct: 188 KKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVV 246
Query: 656 EEEHQRILVYEYMHNGTLRDRLHGSVNQK-PLDWLTRLQIAHDAAKGLEYLHTGCNPGII 714
            +E   I+  E+M  G+L D L      K PL  L  +  +   A+G+ ++        I
Sbjct: 247 TKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPLPKL--IDFSAQIAEGMAFIE---QRNYI 300
Query: 715 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 774
           HRD++++NIL+  ++  K++DFGL+R            A+  + +  PE       T KS
Sbjct: 301 HRDLRAANILVSASLVCKIADFGLARVG----------AKFPIKWTAPEAINFGSFTIKS 350
Query: 775 DVYSFGVVLLELIS-GKKP 792
           DV+SFG++L+E+++ G+ P
Sbjct: 351 DVWSFGILLMEIVTYGRIP 369

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 100/214 (46%), Gaps = 27/214 (12%)
Query: 596 KKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPL 651
           + +GKG FG+VY  + K  K + A+K++  +   +     Q   EV + S + H N++ L
Sbjct: 13  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 72
Query: 652 IGYCEEEHQRILVYEYMHNGTLR---DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
            GY  +  +  L+ EY   GT+     +L     Q+   ++T L      A  L Y H+ 
Sbjct: 73  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANALSYCHSK 126
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDPEY 764
               +IHRD+K  N+LL      K++DFG S        H  S  R    GT+ YL PE 
Sbjct: 127 ---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTLCGTLDYLPPEM 176
Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF 798
              +   EK D++S GV+  E + GK P     +
Sbjct: 177 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY 210

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 100/214 (46%), Gaps = 27/214 (12%)
Query: 596 KKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPL 651
           + +GKG FG+VY  + K  K + A+K++  +   +     Q   EV + S + H N++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 652 IGYCEEEHQRILVYEYMHNGTLR---DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
            GY  +  +  L+ EY   GT+     +L     Q+   ++T L      A  L Y H+ 
Sbjct: 77  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANALSYCHS- 129
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDPEY 764
               +IHRD+K  N+LL      K++DFG S        H  S  R    GT+ YL PE 
Sbjct: 130 --KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRAALCGTLDYLPPEM 180
Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF 798
              +   EK D++S GV+  E + GK P     +
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY 214

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/220 (32%), Positives = 115/220 (52%), Gaps = 23/220 (10%)
Query: 593 NFCKKIGKGSFGSVY----YG--KMKDGKEVAVKIMADSCSHRTQQ-FVTEVALLSRI-H 644
           N  K +G+G+FG V     +G  K    + VAVK++ +  +H   +  ++E+ +L  I H
Sbjct: 30  NLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 645 HRNLVPLIGYCEEEHQRILV-YEYMHNGTLRDRLHGSVNQ----KPL--DWLTR---LQI 694
           H N+V L+G C +    ++V  E+   G L   L    N+    K L  D+LT    +  
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXY 149
Query: 695 AHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSVA 753
           +   AKG+E+L    +   IHRD+ + NILL      K+ DFGL+R   +D  ++    A
Sbjct: 150 SFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDA 206
Query: 754 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
           R  + ++ PE   ++  T +SDV+SFGV+L E+ S G  P
Sbjct: 207 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 246

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 103/213 (48%), Gaps = 12/213 (5%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT-----QQFVTEVALL 640
           E++       + IG+G FG V+ G     +  A+ +   +C + T     ++F+ E   +
Sbjct: 6   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 65
Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 700
            +  H ++V LIG   E    I++ E    G LR  L   V +  LD  + +  A+  + 
Sbjct: 66  RQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFLQ--VRKFSLDLASLILYAYQLST 122
Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYL 760
            L YL +      +HRD+ + N+L+  N   K+ DFGLSR  E+     +S  +  + ++
Sbjct: 123 ALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWM 179
Query: 761 DPEYYGNQQLTEKSDVYSFGVVLLE-LISGKKP 792
            PE    ++ T  SDV+ FGV + E L+ G KP
Sbjct: 180 APESINFRRFTSASDVWMFGVCMWEILMHGVKP 212

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 100/214 (46%), Gaps = 27/214 (12%)
Query: 596 KKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPL 651
           + +GKG FG+VY  + K  K + A+K++  +   +     Q   EV + S + H N++ L
Sbjct: 18  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 77
Query: 652 IGYCEEEHQRILVYEYMHNGTLR---DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
            GY  +  +  L+ EY   GT+     +L     Q+   ++T L      A  L Y H+ 
Sbjct: 78  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANALSYCHS- 130
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDPEY 764
               +IHRD+K  N+LL      K++DFG S        H  S  R    GT+ YL PE 
Sbjct: 131 --KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTLCGTLDYLPPEM 181
Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF 798
              +   EK D++S GV+  E + GK P     +
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY 215

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 100/214 (46%), Gaps = 27/214 (12%)
Query: 596 KKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPL 651
           + +GKG FG+VY  + K  K + A+K++  +   +     Q   EV + S + H N++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 652 IGYCEEEHQRILVYEYMHNGTLR---DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
            GY  +  +  L+ EY   GT+     +L     Q+   ++T L      A  L Y H+ 
Sbjct: 77  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANALSYCHS- 129
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDPEY 764
               +IHRD+K  N+LL      K++DFG S        H  S  R    GT+ YL PE 
Sbjct: 130 --KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTLCGTLDYLPPEM 180
Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF 798
              +   EK D++S GV+  E + GK P     +
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY 214

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 100/214 (46%), Gaps = 27/214 (12%)
Query: 596 KKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPL 651
           + +GKG FG+VY  + K  K + A+K++  +   +     Q   EV + S + H N++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 652 IGYCEEEHQRILVYEYMHNGTLR---DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
            GY  +  +  L+ EY   GT+     +L     Q+   ++T L      A  L Y H+ 
Sbjct: 79  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANALSYCHS- 131
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDPEY 764
               +IHRD+K  N+LL      K++DFG S        H  S  R    GT+ YL PE 
Sbjct: 132 --KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDLCGTLDYLPPEM 182
Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF 798
              +   EK D++S GV+  E + GK P     +
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY 216

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 102/198 (51%), Gaps = 9/198 (4%)
Query: 596 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 654
           +KIG+G+ G+VY    +  G+EVA++ M      + +  + E+ ++    + N+V  +  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 655 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 714
                +  +V EY+  G+L D     V +  +D      +  +  + LE+LH+     +I
Sbjct: 86  YLVGDELWVVMEYLAGGSLTD----VVTETCMDEGQIAAVCRECLQALEFLHSN---QVI 138
Query: 715 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 774
           HRD+KS NILL ++   K++DFG   Q   + +  S +  GT  ++ PE    +    K 
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMV-GTPYWMAPEVVTRKAYGPKV 197
Query: 775 DVYSFGVVLLELISGKKP 792
           D++S G++ +E+I G+ P
Sbjct: 198 DIWSLGIMAIEMIEGEPP 215

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 106/213 (49%), Gaps = 21/213 (9%)
Query: 593 NFCKKIGKGSFGSVY------YGKMKDGKEVAVKIMADSCSHRTQQ--FVTEVALLSRI- 643
            F K +G G+FG V        GK     +VAVK M  S +H  ++   ++E+ ++S + 
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVK-MLKSTAHADEKEALMSELKIMSHLG 107
Query: 644 HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSV-------NQKPLDWLTRLQIAH 696
            H N+V L+G C      +++ EY   G L + L           + +PL+    L  + 
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSS 167
Query: 697 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSVARG 755
             A+G+ +L    +   IHRDV + N+LL     AK+ DFGL+R    D  +I    AR 
Sbjct: 168 QVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 224
Query: 756 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
            V ++ PE   +   T +SDV+S+G++L E+ S
Sbjct: 225 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 102/198 (51%), Gaps = 9/198 (4%)
Query: 596 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 654
           +KIG+G+ G+VY    +  G+EVA++ M      + +  + E+ ++    + N+V  +  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 655 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 714
                +  +V EY+  G+L D     V +  +D      +  +  + LE+LH+     +I
Sbjct: 86  YLVGDELWVVMEYLAGGSLTD----VVTETCMDEGQIAAVCRECLQALEFLHSN---QVI 138
Query: 715 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 774
           HRD+KS NILL ++   K++DFG   Q   + +  S +  GT  ++ PE    +    K 
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV-GTPYWMAPEVVTRKAYGPKV 197
Query: 775 DVYSFGVVLLELISGKKP 792
           D++S G++ +E+I G+ P
Sbjct: 198 DIWSLGIMAIEMIEGEPP 215

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 100/214 (46%), Gaps = 27/214 (12%)
Query: 596 KKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPL 651
           + +GKG FG+VY  + K  K + A+K++  +   +     Q   EV + S + H N++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 652 IGYCEEEHQRILVYEYMHNGTLR---DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
            GY  +  +  L+ EY   GT+     +L     Q+   ++T L      A  L Y H+ 
Sbjct: 79  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANALSYCHS- 131
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDPEY 764
               +IHRD+K  N+LL      K++DFG S        H  S  R    GT+ YL PE 
Sbjct: 132 --KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTLCGTLDYLPPEX 182
Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF 798
              +   EK D++S GV+  E + GK P     +
Sbjct: 183 IEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANTY 216

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 100/214 (46%), Gaps = 27/214 (12%)
Query: 596 KKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPL 651
           + +GKG FG+VY  + K  K + A+K++  +   +     Q   EV + S + H N++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 652 IGYCEEEHQRILVYEYMHNGTLR---DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
            GY  +  +  L+ EY   GT+     +L     Q+   ++T L      A  L Y H+ 
Sbjct: 74  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANALSYCHSK 127
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDPEY 764
               +IHRD+K  N+LL      K++DFG S        H  S  R    GT+ YL PE 
Sbjct: 128 ---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRXXLCGTLDYLPPEM 177
Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF 798
              +   EK D++S GV+  E + GK P     +
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY 211

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 100/214 (46%), Gaps = 27/214 (12%)
Query: 596 KKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPL 651
           + +GKG FG+VY  + K  K + A+K++  +   +     Q   EV + S + H N++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 652 IGYCEEEHQRILVYEYMHNGTLR---DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
            GY  +  +  L+ EY   GT+     +L     Q+   ++T L      A  L Y H+ 
Sbjct: 74  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANALSYCHSK 127
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDPEY 764
               +IHRD+K  N+LL      K++DFG S        H  S  R    GT+ YL PE 
Sbjct: 128 ---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTXLCGTLDYLPPEM 177
Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF 798
              +   EK D++S GV+  E + GK P     +
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY 211

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 100/214 (46%), Gaps = 27/214 (12%)
Query: 596 KKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPL 651
           + +GKG FG+VY  + K  K + A+K++  +   +     Q   EV + S + H N++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 652 IGYCEEEHQRILVYEYMHNGTLR---DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
            GY  +  +  L+ EY   GT+     +L     Q+   ++T L      A  L Y H+ 
Sbjct: 77  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANALSYCHS- 129
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDPEY 764
               +IHRD+K  N+LL      K++DFG S        H  S  R    GT+ YL PE 
Sbjct: 130 --KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRXXLCGTLDYLPPEM 180
Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF 798
              +   EK D++S GV+  E + GK P     +
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY 214

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 102/198 (51%), Gaps = 9/198 (4%)
Query: 596 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 654
           +KIG+G+ G+VY    +  G+EVA++ M      + +  + E+ ++    + N+V  +  
Sbjct: 27  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 86
Query: 655 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 714
                +  +V EY+  G+L D     V +  +D      +  +  + LE+LH+     +I
Sbjct: 87  YLVGDELWVVMEYLAGGSLTD----VVTETCMDEGQIAAVCRECLQALEFLHSN---QVI 139
Query: 715 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 774
           HRD+KS NILL ++   K++DFG   Q   + +  S +  GT  ++ PE    +    K 
Sbjct: 140 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV-GTPYWMAPEVVTRKAYGPKV 198
Query: 775 DVYSFGVVLLELISGKKP 792
           D++S G++ +E+I G+ P
Sbjct: 199 DIWSLGIMAIEMIEGEPP 216

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 110/203 (54%), Gaps = 13/203 (6%)
Query: 597 KIGKGSFGSVYYG--KMKDGK-EVAVKIMADSCSHR-TQQFVTEVALLSRIHHRNLVPLI 652
           ++G G+FGSV  G  +M+  + +VA+K++        T++ + E  ++ ++ +  +V LI
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 653 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 712
           G C+ E   +LV E    G L   L G   + P+  +  L   H  + G++YL       
Sbjct: 77  GVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAEL--LHQVSMGMKYLE---EKN 130
Query: 713 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT--VGYLDPEYYGNQQL 770
            +HRD+ + N+LL     AK+SDFGLS+    D ++ ++ + G   + +  PE    ++ 
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 190
Query: 771 TEKSDVYSFGVVLLELIS-GKKP 792
           + +SDV+S+GV + E +S G+KP
Sbjct: 191 SSRSDVWSYGVTMWEALSYGQKP 213

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 16/205 (7%)
Query: 598 IGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQ---QFVTEVALLSRIHHRNLVPLIG 653
           +G G    V+  + ++  ++VAVK++    +       +F  E    + ++H  +V +  
Sbjct: 20  LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 654 YCEEEHQR----ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 709
             E E        +V EY+   TLRD +H    + P+     +++  DA + L + H   
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQN- 135
Query: 710 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGYLDPEYYGN 767
             GIIHRDVK +NI++      KV DFG++R   +    ++  A   GT  YL PE    
Sbjct: 136 --GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 768 QQLTEKSDVYSFGVVLLELISGKKP 792
             +  +SDVYS G VL E+++G+ P
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 103/205 (50%), Gaps = 16/205 (7%)
Query: 594 FCKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVP 650
             K IGKG+F  V   + +  G+EVA+KI+  +  + T  Q+   EV ++  ++H N+V 
Sbjct: 16  LLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVK 75
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    E E    L+ EY   G + D L  HG + +K      R  ++      ++Y H  
Sbjct: 76  LFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS-----AVQYCH-- 128
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY-GN 767
               I+HRD+K+ N+LLD +M  K++DFG S   E  +        G+  Y  PE + G 
Sbjct: 129 -QKRIVHRDLKAENLLLDADMNIKIADFGFSN--EFTVGGKLDTFCGSPPYAAPELFQGK 185
Query: 768 QQLTEKSDVYSFGVVLLELISGKKP 792
           +    + DV+S GV+L  L+SG  P
Sbjct: 186 KYDGPEVDVWSLGVILYTLVSGSLP 210

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/220 (32%), Positives = 115/220 (52%), Gaps = 23/220 (10%)
Query: 593 NFCKKIGKGSFGSVY----YG--KMKDGKEVAVKIMADSCSHRTQQ-FVTEVALLSRI-H 644
           N  K +G+G+FG V     +G  K    + VAVK++ +  +H   +  ++E+ +L  I H
Sbjct: 30  NLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 645 HRNLVPLIGYCEEEHQRILV-YEYMHNGTLRDRLHGSVNQ----KPL--DWLTRLQI--- 694
           H N+V L+G C +    ++V  E+   G L   L    N+    K L  D+LT   +   
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICY 149
Query: 695 AHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSVA 753
           +   AKG+E+L    +   IHRD+ + NILL      K+ DFGL+R   +D  ++    A
Sbjct: 150 SFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 206
Query: 754 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
           R  + ++ PE   ++  T +SDV+SFGV+L E+ S G  P
Sbjct: 207 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 246

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 110/231 (47%), Gaps = 15/231 (6%)
Query: 571 GHFMDEGVAYFIPLP---ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS 627
              +DE   Y +P     E++       + IG+G FG V+ G     +  A+ +   +C 
Sbjct: 368 AEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCK 427
Query: 628 HRT-----QQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVN 682
           + T     ++F+ E   + +  H ++V LIG   E    I++ E    G LR  L   V 
Sbjct: 428 NCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFLQ--VR 484
Query: 683 QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 742
           +  LD  + +  A+  +  L YL +      +HRD+ + N+L+  N   K+ DFGLSR  
Sbjct: 485 KFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541
Query: 743 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLE-LISGKKP 792
           E+   + +S  +  + ++ PE    ++ T  SDV+ FGV + E L+ G KP
Sbjct: 542 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 102/205 (49%), Gaps = 16/205 (7%)
Query: 594 FCKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVP 650
             K IGKG+F  V   + +  G+EVA+KI+  +  + T  Q+   EV ++  ++H N+V 
Sbjct: 19  LLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVK 78
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    E E    L+ EY   G + D L  HG + +K      R  ++      ++Y H  
Sbjct: 79  LFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS-----AVQYCH-- 131
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY-GN 767
               I+HRD+K+ N+LLD +M  K++DFG S   E  +        G   Y  PE + G 
Sbjct: 132 -QKRIVHRDLKAENLLLDADMNIKIADFGFSN--EFTVGGKLDAFCGAPPYAAPELFQGK 188
Query: 768 QQLTEKSDVYSFGVVLLELISGKKP 792
           +    + DV+S GV+L  L+SG  P
Sbjct: 189 KYDGPEVDVWSLGVILYTLVSGSLP 213

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 27/214 (12%)
Query: 596 KKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPL 651
           + +GKG FG+VY  + K  K + A+K++  +   +     Q   EV + S + H N++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVN---QKPLDWLTRLQIAHDAAKGLEYLHTG 708
            GY  +  +  L+ EY   G +   L        Q+   ++T L      A  L Y H+ 
Sbjct: 79  YGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITEL------ANALSYCHS- 131
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDPEY 764
               +IHRD+K  N+LL      K++DFG S        H  S  R    GT+ YL PE 
Sbjct: 132 --KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTLCGTLDYLPPEM 182
Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF 798
              +   EK D++S GV+  E + GK P     +
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY 216

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 107/206 (51%), Gaps = 24/206 (11%)
Query: 596 KKIGKGSFG-SVYYGKMKDGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLI 652
           +KIG+GSFG ++     +DG++  +K +  S   S   ++   EVA+L+ + H N+V   
Sbjct: 30  QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 653 GYCEEEHQRILVYEYMHNGTLRDRLH---GSVNQKP--LDWLTRLQIAHDAAKGLEYLHT 707
              EE     +V +Y   G L  R++   G + Q+   LDW  ++ +A      L+++H 
Sbjct: 90  ESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLA------LKHVH- 142
Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLDPEY 764
             +  I+HRD+KS NI L  +   ++ DFG++R     L     +AR  +G   YL PE 
Sbjct: 143 --DRKILHRDIKSQNIFLTKDGTVQLGDFGIARV----LNSTVELARACIGTPYYLSPEI 196
Query: 765 YGNQQLTEKSDVYSFGVVLLELISGK 790
             N+    KSD+++ G VL EL + K
Sbjct: 197 CENKPYNNKSDIWALGCVLYELCTLK 222

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 18/208 (8%)
Query: 596 KKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNL 648
           +++G+GSFG VY G  +D         VAVK + +S S R + +F+ E +++      ++
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 649 VPLIGYCEEEHQRILVYEYMHNG-------TLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 701
           V L+G   +    ++V E M +G       +LR     +  + P      +Q+A + A G
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 702 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYL 760
           + YL+       +HRD+ + N ++  +   K+ DFG++R   E D           V ++
Sbjct: 143 MAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 199
Query: 761 DPEYYGNQQLTEKSDVYSFGVVLLELIS 788
            PE   +   T  SD++SFGVVL E+ S
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 18/208 (8%)
Query: 596 KKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNL 648
           +++G+GSFG VY G  +D         VAVK + +S S R + +F+ E +++      ++
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 649 VPLIGYCEEEHQRILVYEYMHNG-------TLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 701
           V L+G   +    ++V E M +G       +LR     +  + P      +Q+A + A G
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 702 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYL 760
           + YL+       +HRD+ + N ++  +   K+ DFG++R   E D           V ++
Sbjct: 143 MAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 199
Query: 761 DPEYYGNQQLTEKSDVYSFGVVLLELIS 788
            PE   +   T  SD++SFGVVL E+ S
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 100/203 (49%), Gaps = 12/203 (5%)
Query: 592 NNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVP 650
           +NF K IG+GS G V    ++  GK VAVK M      R +    EV ++    H N+V 
Sbjct: 32  DNFIK-IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 90
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRL-HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 709
           +        +  +V E++  G L D + H  +N++        QIA      L+ L    
Sbjct: 91  MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE--------QIAAVCLAVLQALSVLH 142
Query: 710 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQ 769
             G+IHRD+KS +ILL  + R K+SDFG   Q  +++     +  GT  ++ PE      
Sbjct: 143 AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAPELISRLP 201
Query: 770 LTEKSDVYSFGVVLLELISGKKP 792
              + D++S G++++E++ G+ P
Sbjct: 202 YGPEVDIWSLGIMVIEMVDGEPP 224

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 100/214 (46%), Gaps = 27/214 (12%)
Query: 596 KKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPL 651
           + +GKG FG+VY  + K  K + A+K++  +   +     Q   EV + S + H N++ L
Sbjct: 11  RPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 70
Query: 652 IGYCEEEHQRILVYEYMHNGTLR---DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
            GY  +  +  L+ EY   GT+     +L     Q+   ++T L      A  L Y H+ 
Sbjct: 71  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANALSYCHS- 123
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDPEY 764
               +IHRD+K  N+LL      K++DFG S        H  S  R    GT+ YL PE 
Sbjct: 124 --KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTLCGTLDYLPPEM 174
Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF 798
              +   EK D++S GV+  E + GK P     +
Sbjct: 175 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY 208

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 27/214 (12%)
Query: 596 KKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPL 651
           + +GKG FG+VY  + K  K + A+K++  +   +     Q   EV + S + H N++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVN---QKPLDWLTRLQIAHDAAKGLEYLHTG 708
            GY  +  +  L+ EY   G +   L        Q+   ++T L      A  L Y H+ 
Sbjct: 79  YGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITEL------ANALSYCHS- 131
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDPEY 764
               +IHRD+K  N+LL      K++DFG S        H  S  R    GT+ YL PE 
Sbjct: 132 --KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRXXLXGTLDYLPPEM 182
Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF 798
              +   EK D++S GV+  E + GK P     +
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY 216

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 18/208 (8%)
Query: 596 KKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNL 648
           +++G+GSFG VY G  +D         VAVK + +S S R + +F+ E +++      ++
Sbjct: 20  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 79
Query: 649 VPLIGYCEEEHQRILVYEYMHNG-------TLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 701
           V L+G   +    ++V E M +G       +LR     +  + P      +Q+A + A G
Sbjct: 80  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 139
Query: 702 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYL 760
           + YL+       +HRD+ + N ++  +   K+ DFG++R   E D           V ++
Sbjct: 140 MAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 196
Query: 761 DPEYYGNQQLTEKSDVYSFGVVLLELIS 788
            PE   +   T  SD++SFGVVL E+ S
Sbjct: 197 APESLKDGVFTTSSDMWSFGVVLWEITS 224

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 100/203 (49%), Gaps = 12/203 (5%)
Query: 592 NNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVP 650
           +NF K IG+GS G V    ++  GK VAVK M      R +    EV ++    H N+V 
Sbjct: 23  DNFIK-IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 81
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRL-HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 709
           +        +  +V E++  G L D + H  +N++        QIA      L+ L    
Sbjct: 82  MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE--------QIAAVCLAVLQALSVLH 133
Query: 710 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQ 769
             G+IHRD+KS +ILL  + R K+SDFG   Q  +++     +  GT  ++ PE      
Sbjct: 134 AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAPELISRLP 192
Query: 770 LTEKSDVYSFGVVLLELISGKKP 792
              + D++S G++++E++ G+ P
Sbjct: 193 YGPEVDIWSLGIMVIEMVDGEPP 215

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 100/203 (49%), Gaps = 12/203 (5%)
Query: 592 NNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVP 650
           +NF K IG+GS G V    ++  GK VAVK M      R +    EV ++    H N+V 
Sbjct: 34  DNFIK-IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 92
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRL-HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 709
           +        +  +V E++  G L D + H  +N++        QIA      L+ L    
Sbjct: 93  MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE--------QIAAVCLAVLQALSVLH 144
Query: 710 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQ 769
             G+IHRD+KS +ILL  + R K+SDFG   Q  +++     +  GT  ++ PE      
Sbjct: 145 AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAPELISRLP 203
Query: 770 LTEKSDVYSFGVVLLELISGKKP 792
              + D++S G++++E++ G+ P
Sbjct: 204 YGPEVDIWSLGIMVIEMVDGEPP 226

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 100/214 (46%), Gaps = 27/214 (12%)
Query: 596 KKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPL 651
           + +GKG FG+VY  + +  K + A+K++  +   +     Q   EV + S + H N++ L
Sbjct: 18  RPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRL 77
Query: 652 IGYCEEEHQRILVYEYMHNGTLR---DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
            GY  +  +  L+ EY   GT+     +L     Q+   ++T L      A  L Y H+ 
Sbjct: 78  YGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITEL------ANALSYCHS- 130
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDPEY 764
               +IHRD+K  N+LL  N   K++DFG S        H  S  R    GT+ YL PE 
Sbjct: 131 --KRVIHRDIKPENLLLGSNGELKIADFGWS-------VHAPSSRRTTLCGTLDYLPPEM 181
Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF 798
              +   EK D++S GV+  E + G  P     +
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTY 215

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 100/214 (46%), Gaps = 27/214 (12%)
Query: 596 KKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPL 651
           + +GKG FG+VY  + +  K + A+K++  +   +     Q   EV + S + H N++ L
Sbjct: 18  RPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRL 77
Query: 652 IGYCEEEHQRILVYEYMHNGTLR---DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
            GY  +  +  L+ EY   GT+     +L     Q+   ++T L      A  L Y H+ 
Sbjct: 78  YGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITEL------ANALSYCHS- 130
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDPEY 764
               +IHRD+K  N+LL  N   K++DFG S        H  S  R    GT+ YL PE 
Sbjct: 131 --KRVIHRDIKPENLLLGSNGELKIADFGWS-------VHAPSSRRDTLCGTLDYLPPEM 181
Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF 798
              +   EK D++S GV+  E + G  P     +
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTY 215

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 103/213 (48%), Gaps = 12/213 (5%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT-----QQFVTEVALL 640
           E++       + IG+G FG V+ G     +  A+ +   +C + T     ++F+ E   +
Sbjct: 6   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 65
Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 700
            +  H ++V LIG   E    I++ E    G LR  L   V +  LD  + +  A+  + 
Sbjct: 66  RQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFLQ--VRKFSLDLASLILYAYQLST 122
Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYL 760
            L YL +      +HRD+ + N+L+      K+ DFGLSR  E+   + +S  +  + ++
Sbjct: 123 ALAYLESK---RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 179
Query: 761 DPEYYGNQQLTEKSDVYSFGVVLLE-LISGKKP 792
            PE    ++ T  SDV+ FGV + E L+ G KP
Sbjct: 180 APESINFRRFTSASDVWMFGVCMWEILMHGVKP 212

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 100/203 (49%), Gaps = 12/203 (5%)
Query: 592 NNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVP 650
           +NF K IG+GS G V    ++  GK VAVK M      R +    EV ++    H N+V 
Sbjct: 154 DNFIK-IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 212
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRL-HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 709
           +        +  +V E++  G L D + H  +N++        QIA      L+ L    
Sbjct: 213 MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE--------QIAAVCLAVLQALSVLH 264
Query: 710 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQ 769
             G+IHRD+KS +ILL  + R K+SDFG   Q  +++     +  GT  ++ PE      
Sbjct: 265 AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAPELISRLP 323
Query: 770 LTEKSDVYSFGVVLLELISGKKP 792
              + D++S G++++E++ G+ P
Sbjct: 324 YGPEVDIWSLGIMVIEMVDGEPP 346

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 103/198 (52%), Gaps = 9/198 (4%)
Query: 596 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 654
           +KIG+G+ G+VY    +  G+EVA++ M      + +  + E+ ++    + N+V  +  
Sbjct: 27  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 86
Query: 655 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 714
                +  +V EY+  G+L D     V +  +D      +  +  + LE+LH+     +I
Sbjct: 87  YLVGDELWVVMEYLAGGSLTD----VVTETCMDEGQIAAVCRECLQALEFLHSN---QVI 139
Query: 715 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 774
           HR++KS NILL ++   K++DFG   Q   + +  S++  GT  ++ PE    +    K 
Sbjct: 140 HRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 198
Query: 775 DVYSFGVVLLELISGKKP 792
           D++S G++ +E+I G+ P
Sbjct: 199 DIWSLGIMAIEMIEGEPP 216

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 112/224 (50%), Gaps = 35/224 (15%)
Query: 594 FCKKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIH-HRNLV 649
             KK+GKG++G V+     + G+ VAVK + D+  + T  Q+   E+ +L+ +  H N+V
Sbjct: 13  LVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIV 72
Query: 650 PLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
            L+     ++ R   LV++YM        LH  +    L+ + +  + +   K ++YLH+
Sbjct: 73  NLLNVLRADNDRDVYLVFDYMETD-----LHAVIRANILEPVHKQYVVYQLIKVIKYLHS 127
Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--------------------QAEEDLT 747
           G   G++HRD+K SNILL+     KV+DFGLSR                    +  +D  
Sbjct: 128 G---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184
Query: 748 HISSVARGTVGYLDPE-YYGNQQLTEKSDVYSFGVVLLELISGK 790
            I +    T  Y  PE   G+ + T+  D++S G +L E++ GK
Sbjct: 185 PILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 100/214 (46%), Gaps = 27/214 (12%)
Query: 596 KKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPL 651
           + +GKG FG+VY  + K  K + A+K++  +   +     Q   EV + S + H N++ L
Sbjct: 16  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 75
Query: 652 IGYCEEEHQRILVYEYMHNGTLR---DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
            GY  +  +  L+ EY   GT+     +L     Q+   ++T L      A  L Y H+ 
Sbjct: 76  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANALSYCHSK 129
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDPEY 764
               +IHRD+K  N+LL      K+++FG S        H  S  R    GT+ YL PE 
Sbjct: 130 ---RVIHRDIKPENLLLGSAGELKIANFGWS-------VHAPSSRRTTLCGTLDYLPPEM 179
Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF 798
              +   EK D++S GV+  E + GK P     +
Sbjct: 180 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY 213

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 598 IGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQ---QFVTEVALLSRIHHRNLVPLIG 653
           +G G    V+  + ++  ++VAVK++    +       +F  E    + ++H  +V +  
Sbjct: 37  LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 96
Query: 654 YCEEEHQR----ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 709
             E E        +V EY+   TLRD +H    + P+     +++  DA + L + H   
Sbjct: 97  TGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQN- 152
Query: 710 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGYLDPEYYGN 767
             GIIHRDVK +NI++      KV DFG++R   +    ++  A   GT  YL PE    
Sbjct: 153 --GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 210
Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVS 794
             +  +SDVYS G VL E+++G+ P +
Sbjct: 211 DSVDARSDVYSLGCVLYEVLTGEPPFT 237

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 100/214 (46%), Gaps = 27/214 (12%)
Query: 596 KKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPL 651
           + +GKG FG+VY  + K  K + A+K++  +   +     Q   EV + S + H N++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 652 IGYCEEEHQRILVYEYMHNGTLR---DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
            GY  +  +  L+ EY   GT+     +L     Q+   ++T L      A  L Y H+ 
Sbjct: 77  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANALSYCHSK 130
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDPEY 764
               +IHRD+K  N+LL      K+++FG S        H  S  R    GT+ YL PE 
Sbjct: 131 ---RVIHRDIKPENLLLGSAGELKIANFGWS-------VHAPSSRRTTLCGTLDYLPPEM 180
Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF 798
              +   EK D++S GV+  E + GK P     +
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY 214

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 100/203 (49%), Gaps = 12/203 (5%)
Query: 592 NNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVP 650
           +NF K IG+GS G V    ++  GK VAVK M      R +    EV ++    H N+V 
Sbjct: 27  DNFIK-IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 85
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRL-HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 709
           +        +  +V E++  G L D + H  +N++        QIA      L+ L    
Sbjct: 86  MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE--------QIAAVCLAVLQALSVLH 137
Query: 710 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQ 769
             G+IHRD+KS +ILL  + R K+SDFG   Q  +++     +  GT  ++ PE      
Sbjct: 138 AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAPELISRLP 196
Query: 770 LTEKSDVYSFGVVLLELISGKKP 792
              + D++S G++++E++ G+ P
Sbjct: 197 YGPEVDIWSLGIMVIEMVDGEPP 219

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 115/235 (48%), Gaps = 34/235 (14%)
Query: 585 PELEEATNNFC--KKIGKGSFGSV-----YYGKMKDG-KEVAVKIMADSCS-HRTQQFVT 635
           P+ E    N    K +G+G FG V     ++ K + G   VAVK++ ++ S    +  ++
Sbjct: 16  PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLS 75
Query: 636 EVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGS--------------- 680
           E  +L +++H +++ L G C ++   +L+ EY   G+LR  L  S               
Sbjct: 76  EFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRN 135
Query: 681 ------VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVS 734
                  +++ L     +  A   ++G++YL       ++HRD+ + NIL+    + K+S
Sbjct: 136 SSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMSLVHRDLAARNILVAEGRKMKIS 192
Query: 735 DFGLSRQA-EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
           DFGLSR   EED     S  R  V ++  E   +   T +SDV+SFGV+L E+++
Sbjct: 193 DFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 100/203 (49%), Gaps = 12/203 (5%)
Query: 592 NNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVP 650
           +NF K IG+GS G V    ++  GK VAVK M      R +    EV ++    H N+V 
Sbjct: 77  DNFIK-IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 135
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRL-HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 709
           +        +  +V E++  G L D + H  +N++        QIA      L+ L    
Sbjct: 136 MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE--------QIAAVCLAVLQALSVLH 187
Query: 710 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQ 769
             G+IHRD+KS +ILL  + R K+SDFG   Q  +++     +  GT  ++ PE      
Sbjct: 188 AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAPELISRLP 246
Query: 770 LTEKSDVYSFGVVLLELISGKKP 792
              + D++S G++++E++ G+ P
Sbjct: 247 YGPEVDIWSLGIMVIEMVDGEPP 269

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 98/205 (47%), Gaps = 16/205 (7%)
Query: 594 FCKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVP 650
             K IGKG+F  V   + +  GKEVAVKI+  +   S   Q+   EV +   ++H N+V 
Sbjct: 18  LLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVK 77
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    E E    LV EY   G + D L  HG   +K      R  ++      ++Y H  
Sbjct: 78  LFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVS-----AVQYCHQK 132
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY-GN 767
               I+HRD+K+ N+LLD +   K++DFG S   E    +      G   Y  PE + G 
Sbjct: 133 F---IVHRDLKAENLLLDADXNIKIADFGFSN--EFTFGNKLDAFCGAPPYAAPELFQGK 187
Query: 768 QQLTEKSDVYSFGVVLLELISGKKP 792
           +    + DV+S GV+L  L+SG  P
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSGSLP 212

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 18/208 (8%)
Query: 596 KKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNL 648
           +++G+GSFG VY G  +D         VAVK + +S S R + +F+ E +++      ++
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 649 VPLIGYCEEEHQRILVYEYMHNG-------TLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 701
           V L+G   +    ++V E M +G       +LR     +  + P      +Q+A + A G
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 702 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTVGYL 760
           + YL+       +HRD+ + N ++  +   K+ DFG++R   E D           V ++
Sbjct: 143 MAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 199
Query: 761 DPEYYGNQQLTEKSDVYSFGVVLLELIS 788
            PE   +   T  SD++SFGVVL E+ S
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 104/208 (50%), Gaps = 18/208 (8%)
Query: 596 KKIGKGSFGSVY----YGKMKDGKE--VAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNL 648
           +++G+GSFG VY     G +KD  E  VA+K + ++ S R + +F+ E +++   +  ++
Sbjct: 16  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 75
Query: 649 VPLIGYCEEEHQRILVYEYMHNG-------TLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 701
           V L+G   +    +++ E M  G       +LR  +  +    P      +Q+A + A G
Sbjct: 76  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 135
Query: 702 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYL 760
           + YL+       +HRD+ + N ++  +   K+ DFG++R   E D           V ++
Sbjct: 136 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 192
Query: 761 DPEYYGNQQLTEKSDVYSFGVVLLELIS 788
            PE   +   T  SDV+SFGVVL E+ +
Sbjct: 193 SPESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 109/214 (50%), Gaps = 19/214 (8%)
Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEV----AVKIMADSCSHRTQQFVTEVA--LLSRIHHR 646
              K +G+GSFG V+  K   G +     A+K++  +      +  T++   +L  ++H 
Sbjct: 27  ELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHP 86
Query: 647 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD---WLTRLQIAHDAAKGLE 703
            +V L    + E +  L+ +++  G L  RL   V     D   +L  L +A      L+
Sbjct: 87  FIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALA------LD 140
Query: 704 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 763
           +LH+    GII+RD+K  NILLD     K++DFGLS+++ +      S   GTV Y+ PE
Sbjct: 141 HLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMAPE 196
Query: 764 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 797
               +  T+ +D +SFGV++ E+++G  P   +D
Sbjct: 197 VVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD 230

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 104/208 (50%), Gaps = 18/208 (8%)
Query: 596 KKIGKGSFGSVY----YGKMKDGKE--VAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNL 648
           +++G+GSFG VY     G +KD  E  VA+K + ++ S R + +F+ E +++   +  ++
Sbjct: 25  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 84
Query: 649 VPLIGYCEEEHQRILVYEYMHNG-------TLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 701
           V L+G   +    +++ E M  G       +LR  +  +    P      +Q+A + A G
Sbjct: 85  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 144
Query: 702 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYL 760
           + YL+       +HRD+ + N ++  +   K+ DFG++R   E D           V ++
Sbjct: 145 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 201
Query: 761 DPEYYGNQQLTEKSDVYSFGVVLLELIS 788
            PE   +   T  SDV+SFGVVL E+ +
Sbjct: 202 SPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 117/235 (49%), Gaps = 34/235 (14%)
Query: 585 PELEEATNNFC--KKIGKGSFGSV-----YYGKMKDG-KEVAVKIMADSCS-HRTQQFVT 635
           P+ E    N    K +G+G FG V     ++ K + G   VAVK++ ++ S    +  ++
Sbjct: 16  PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLS 75
Query: 636 EVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGS--------------- 680
           E  +L +++H +++ L G C ++   +L+ EY   G+LR  L  S               
Sbjct: 76  EFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRN 135
Query: 681 ------VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVS 734
                  +++ L     +  A   ++G++YL       ++HRD+ + NIL+    + K+S
Sbjct: 136 SSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKIS 192
Query: 735 DFGLSRQAEEDLTHIS-SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
           DFGLSR   E+ +++  S  R  V ++  E   +   T +SDV+SFGV+L E+++
Sbjct: 193 DFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 109/231 (47%), Gaps = 15/231 (6%)
Query: 571 GHFMDEGVAYFIPLP---ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS 627
              +DE   Y +P     E++       + IG+G FG V+ G     +  A+ +   +C 
Sbjct: 368 AEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCK 427
Query: 628 HRT-----QQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVN 682
           + T     ++F+ E   + +  H ++V LIG   E    I++ E    G LR  L   V 
Sbjct: 428 NCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFLQ--VR 484
Query: 683 QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 742
           +  LD  + +  A+  +  L YL +      +HRD+ + N+L+      K+ DFGLSR  
Sbjct: 485 KFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSATDCVKLGDFGLSRYM 541
Query: 743 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLE-LISGKKP 792
           E+   + +S  +  + ++ PE    ++ T  SDV+ FGV + E L+ G KP
Sbjct: 542 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 115/235 (48%), Gaps = 34/235 (14%)
Query: 585 PELEEATNNFC--KKIGKGSFGSV-----YYGKMKDG-KEVAVKIMADSCS-HRTQQFVT 635
           P+ E    N    K +G+G FG V     ++ K + G   VAVK++ ++ S    +  ++
Sbjct: 16  PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLS 75
Query: 636 EVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGS--------------- 680
           E  +L +++H +++ L G C ++   +L+ EY   G+LR  L  S               
Sbjct: 76  EFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRN 135
Query: 681 ------VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVS 734
                  +++ L     +  A   ++G++YL       ++HRD+ + NIL+    + K+S
Sbjct: 136 SSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKIS 192
Query: 735 DFGLSRQA-EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
           DFGLSR   EED     S  R  V ++  E   +   T +SDV+SFGV+L E+++
Sbjct: 193 DFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 83.2 bits (204), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 105/212 (49%), Gaps = 26/212 (12%)
Query: 596 KKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNL 648
           +++G+GSFG VY G  +D         VAVK + +S S R + +F+ E +++      ++
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 649 VPLIGYCEEEHQRILVYEYMHNG-------TLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 701
           V L+G   +    ++V E M +G       +LR     +  + P      +Q+A + A G
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 702 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG--- 758
           + YL+       +HRD+ + N ++  +   K+ DFG++R    D+   +   +G  G   
Sbjct: 143 MAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETAYYRKGGKGLLP 195
Query: 759 --YLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
             ++ PE   +   T  SD++SFGVVL E+ S
Sbjct: 196 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 83.2 bits (204), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 71/219 (32%), Positives = 112/219 (51%), Gaps = 25/219 (11%)
Query: 596 KKIGKGSFGSVY----YG--KMKDGKEVAVKIMADSCSHRTQQ-FVTEVALLSRI-HHRN 647
           K +G+G+FG V     +G  K    + VAVK++ +  +H   +  ++E+ +L  I HH N
Sbjct: 35  KPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 94
Query: 648 LVPLIGYCEEEHQRILV-YEYMHNGTLRDRLHGSVNQ----KPLD-WLTRLQIAH----- 696
           +V L+G C +    ++V  E+   G L   L    N+    KP D +   L + H     
Sbjct: 95  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYS 154
Query: 697 -DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSVAR 754
              AKG+E+L    +   IHRD+ + NILL      K+ DFGL+R   +D   +    AR
Sbjct: 155 FQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 755 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
             + ++ PE   ++  T +SDV+SFGV+L E+ S G  P
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 18/208 (8%)
Query: 596 KKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNL 648
           +++G+GSFG VY G  +D         VAVK + +S S R + +F+ E +++      ++
Sbjct: 22  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 81
Query: 649 VPLIGYCEEEHQRILVYEYMHNG-------TLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 701
           V L+G   +    ++V E M +G       +LR     +  + P      +Q+A + A G
Sbjct: 82  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 141
Query: 702 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTVGYL 760
           + YL+       +HRD+ + N ++  +   K+ DFG++R   E D           V ++
Sbjct: 142 MAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 198
Query: 761 DPEYYGNQQLTEKSDVYSFGVVLLELIS 788
            PE   +   T  SD++SFGVVL E+ S
Sbjct: 199 APESLKDGVFTTSSDMWSFGVVLWEITS 226

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 110/203 (54%), Gaps = 13/203 (6%)
Query: 597 KIGKGSFGSVYYG--KMKDGK-EVAVKIMADSCSHR-TQQFVTEVALLSRIHHRNLVPLI 652
           ++G G+FGSV  G  +M+  + +VA+K++        T++ + E  ++ ++ +  +V LI
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 653 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 712
           G C+ E   +LV E    G L   L G   + P+  +  L   H  + G++YL       
Sbjct: 403 GVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAEL--LHQVSMGMKYLE---EKN 456
Query: 713 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT--VGYLDPEYYGNQQL 770
            +HR++ + N+LL     AK+SDFGLS+    D ++ ++ + G   + +  PE    ++ 
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 516
Query: 771 TEKSDVYSFGVVLLELIS-GKKP 792
           + +SDV+S+GV + E +S G+KP
Sbjct: 517 SSRSDVWSYGVTMWEALSYGQKP 539

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 109/214 (50%), Gaps = 19/214 (8%)
Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEV----AVKIMADSCSHRTQQFVTEVA--LLSRIHHR 646
              K +G+GSFG V+  K   G +     A+K++  +      +  T++   +L  ++H 
Sbjct: 27  ELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHP 86
Query: 647 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD---WLTRLQIAHDAAKGLE 703
            +V L    + E +  L+ +++  G L  RL   V     D   +L  L +A      L+
Sbjct: 87  FIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALA------LD 140
Query: 704 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 763
           +LH+    GII+RD+K  NILLD     K++DFGLS+++ +      S   GTV Y+ PE
Sbjct: 141 HLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMAPE 196
Query: 764 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 797
               +  T+ +D +SFGV++ E+++G  P   +D
Sbjct: 197 VVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD 230

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 109/214 (50%), Gaps = 19/214 (8%)
Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEV----AVKIMADSCSHRTQQFVTEVA--LLSRIHHR 646
              K +G+GSFG V+  K   G +     A+K++  +      +  T++   +L  ++H 
Sbjct: 28  ELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHP 87
Query: 647 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD---WLTRLQIAHDAAKGLE 703
            +V L    + E +  L+ +++  G L  RL   V     D   +L  L +A      L+
Sbjct: 88  FIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALA------LD 141
Query: 704 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 763
           +LH+    GII+RD+K  NILLD     K++DFGLS+++ +      S   GTV Y+ PE
Sbjct: 142 HLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMAPE 197
Query: 764 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 797
               +  T+ +D +SFGV++ E+++G  P   +D
Sbjct: 198 VVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD 231

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 104/208 (50%), Gaps = 18/208 (8%)
Query: 596 KKIGKGSFGSVY----YGKMKDGKE--VAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNL 648
           +++G+GSFG VY     G +KD  E  VA+K + ++ S R + +F+ E +++   +  ++
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 649 VPLIGYCEEEHQRILVYEYMHNG-------TLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 701
           V L+G   +    +++ E M  G       +LR  +  +    P      +Q+A + A G
Sbjct: 91  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 150
Query: 702 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTVGYL 760
           + YL+       +HRD+ + N ++  +   K+ DFG++R   E D           V ++
Sbjct: 151 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 207
Query: 761 DPEYYGNQQLTEKSDVYSFGVVLLELIS 788
            PE   +   T  SDV+SFGVVL E+ +
Sbjct: 208 SPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 104/208 (50%), Gaps = 18/208 (8%)
Query: 596 KKIGKGSFGSVY----YGKMKDGKE--VAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNL 648
           +++G+GSFG VY     G +KD  E  VA+K + ++ S R + +F+ E +++   +  ++
Sbjct: 24  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 83
Query: 649 VPLIGYCEEEHQRILVYEYMHNG-------TLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 701
           V L+G   +    +++ E M  G       +LR  +  +    P      +Q+A + A G
Sbjct: 84  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 143
Query: 702 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTVGYL 760
           + YL+       +HRD+ + N ++  +   K+ DFG++R   E D           V ++
Sbjct: 144 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 200
Query: 761 DPEYYGNQQLTEKSDVYSFGVVLLELIS 788
            PE   +   T  SDV+SFGVVL E+ +
Sbjct: 201 SPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 114/223 (51%), Gaps = 13/223 (5%)
Query: 593 NFCKKIGKGSFGSVYYGKM----KDGKEVAVKIMADSCSHRTQQFVTEVA--LLSRIHHR 646
              K +G+GSFG V+  +       G   A+K++  +      +  T++   +L+ ++H 
Sbjct: 31  ELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHP 90
Query: 647 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
            +V L    + E +  L+ +++  G L  RL   V     D   +  +A + A GL++LH
Sbjct: 91  FVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED--VKFYLA-ELALGLDHLH 147
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 766
           +    GII+RD+K  NILLD     K++DFGLS++A +      S   GTV Y+ PE   
Sbjct: 148 S---LGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFC-GTVEYMAPEVVN 203
Query: 767 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR 809
            Q  +  +D +S+GV++ E+++G  P   +D    + ++  A+
Sbjct: 204 RQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAK 246

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 104/208 (50%), Gaps = 18/208 (8%)
Query: 596 KKIGKGSFGSVY----YGKMKDGKE--VAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNL 648
           +++G+GSFG VY     G +KD  E  VA+K + ++ S R + +F+ E +++   +  ++
Sbjct: 22  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 81
Query: 649 VPLIGYCEEEHQRILVYEYMHNG-------TLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 701
           V L+G   +    +++ E M  G       +LR  +  +    P      +Q+A + A G
Sbjct: 82  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 141
Query: 702 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTVGYL 760
           + YL+       +HRD+ + N ++  +   K+ DFG++R   E D           V ++
Sbjct: 142 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 198
Query: 761 DPEYYGNQQLTEKSDVYSFGVVLLELIS 788
            PE   +   T  SDV+SFGVVL E+ +
Sbjct: 199 SPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/223 (31%), Positives = 112/223 (50%), Gaps = 26/223 (11%)
Query: 593 NFCKKIGKGSFGSVY----YG--KMKDGKEVAVKIMADSCSHRTQQ-FVTEVALLSRI-H 644
           N  K +G+G+FG V     +G  K    + VAVK++ +  +H   +  ++E+ +L  I H
Sbjct: 31  NLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 90
Query: 645 HRNLVPLIGYCEEEHQRILV-YEYMHNGTLRDRLHGSVNQ-----KPLD-WLTRLQIAH- 696
           H N+V L+G C +    ++V  E+   G L   L    N+      P D +   L + H 
Sbjct: 91  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHL 150
Query: 697 -----DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-S 750
                  AKG+E+L    +   IHRD+ + NILL      K+ DFGL+R   +D   +  
Sbjct: 151 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK 207
Query: 751 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
             AR  + ++ PE   ++  T +SDV+SFGV+L E+ S G  P
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 104/208 (50%), Gaps = 18/208 (8%)
Query: 596 KKIGKGSFGSVY----YGKMKDGKE--VAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNL 648
           +++G+GSFG VY     G +KD  E  VA+K + ++ S R + +F+ E +++   +  ++
Sbjct: 25  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 84
Query: 649 VPLIGYCEEEHQRILVYEYMHNG-------TLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 701
           V L+G   +    +++ E M  G       +LR  +  +    P      +Q+A + A G
Sbjct: 85  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 144
Query: 702 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTVGYL 760
           + YL+       +HRD+ + N ++  +   K+ DFG++R   E D           V ++
Sbjct: 145 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 201
Query: 761 DPEYYGNQQLTEKSDVYSFGVVLLELIS 788
            PE   +   T  SDV+SFGVVL E+ +
Sbjct: 202 SPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 104/208 (50%), Gaps = 18/208 (8%)
Query: 596 KKIGKGSFGSVY----YGKMKDGKE--VAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNL 648
           +++G+GSFG VY     G +KD  E  VA+K + ++ S R + +F+ E +++   +  ++
Sbjct: 18  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 77
Query: 649 VPLIGYCEEEHQRILVYEYMHNG-------TLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 701
           V L+G   +    +++ E M  G       +LR  +  +    P      +Q+A + A G
Sbjct: 78  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 137
Query: 702 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTVGYL 760
           + YL+       +HRD+ + N ++  +   K+ DFG++R   E D           V ++
Sbjct: 138 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 194
Query: 761 DPEYYGNQQLTEKSDVYSFGVVLLELIS 788
            PE   +   T  SDV+SFGVVL E+ +
Sbjct: 195 SPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 104/208 (50%), Gaps = 18/208 (8%)
Query: 596 KKIGKGSFGSVY----YGKMKDGKE--VAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNL 648
           +++G+GSFG VY     G +KD  E  VA+K + ++ S R + +F+ E +++   +  ++
Sbjct: 24  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 83
Query: 649 VPLIGYCEEEHQRILVYEYMHNG-------TLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 701
           V L+G   +    +++ E M  G       +LR  +  +    P      +Q+A + A G
Sbjct: 84  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 143
Query: 702 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTVGYL 760
           + YL+       +HRD+ + N ++  +   K+ DFG++R   E D           V ++
Sbjct: 144 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 200
Query: 761 DPEYYGNQQLTEKSDVYSFGVVLLELIS 788
            PE   +   T  SDV+SFGVVL E+ +
Sbjct: 201 SPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 104/208 (50%), Gaps = 18/208 (8%)
Query: 596 KKIGKGSFGSVY----YGKMKDGKE--VAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNL 648
           +++G+GSFG VY     G +KD  E  VA+K + ++ S R + +F+ E +++   +  ++
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 649 VPLIGYCEEEHQRILVYEYMHNG-------TLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 701
           V L+G   +    +++ E M  G       +LR  +  +    P      +Q+A + A G
Sbjct: 91  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 702 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTVGYL 760
           + YL+       +HRD+ + N ++  +   K+ DFG++R   E D           V ++
Sbjct: 151 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 207
Query: 761 DPEYYGNQQLTEKSDVYSFGVVLLELIS 788
            PE   +   T  SDV+SFGVVL E+ +
Sbjct: 208 SPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 108/224 (48%), Gaps = 32/224 (14%)
Query: 594 FCKKIGKGSFGSVY----YGKMKDGK--EVAVKIMADSC-SHRTQQFVTEVALLSRI-HH 645
           F K +G G+FG V     YG  K G   +VAVK++ +   S   +  ++E+ +++++  H
Sbjct: 49  FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 108
Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGS-----------VNQKPLDWLTRLQI 694
            N+V L+G C       L++EY   G L + L               NQK L+    L +
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 695 ---------AHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 745
                    A+  AKG+E+L        +HRD+ + N+L+      K+ DFGL+R    D
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225
Query: 746 LTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
             + +   AR  V ++ PE       T KSDV+S+G++L E+ S
Sbjct: 226 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 104/208 (50%), Gaps = 18/208 (8%)
Query: 596 KKIGKGSFGSVY----YGKMKDGKE--VAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNL 648
           +++G+GSFG VY     G +KD  E  VA+K + ++ S R + +F+ E +++   +  ++
Sbjct: 53  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 112
Query: 649 VPLIGYCEEEHQRILVYEYMHNG-------TLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 701
           V L+G   +    +++ E M  G       +LR  +  +    P      +Q+A + A G
Sbjct: 113 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 172
Query: 702 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTVGYL 760
           + YL+       +HRD+ + N ++  +   K+ DFG++R   E D           V ++
Sbjct: 173 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 229
Query: 761 DPEYYGNQQLTEKSDVYSFGVVLLELIS 788
            PE   +   T  SDV+SFGVVL E+ +
Sbjct: 230 SPESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 18/208 (8%)
Query: 596 KKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNL 648
           +++G+GSFG VY G  +D         VAVK + +S S R + +F+ E +++      ++
Sbjct: 24  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 83
Query: 649 VPLIGYCEEEHQRILVYEYMHNG-------TLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 701
           V L+G   +    ++V E M +G       +LR     +  + P      +Q+A + A G
Sbjct: 84  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 143
Query: 702 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTVGYL 760
           + YL+       +HR++ + N ++  +   K+ DFG++R   E D           V ++
Sbjct: 144 MAYLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 200
Query: 761 DPEYYGNQQLTEKSDVYSFGVVLLELIS 788
            PE   +   T  SD++SFGVVL E+ S
Sbjct: 201 APESLKDGVFTTSSDMWSFGVVLWEITS 228

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 18/208 (8%)
Query: 596 KKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNL 648
           +++G+GSFG VY G  +D         VAVK + +S S R + +F+ E +++      ++
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 649 VPLIGYCEEEHQRILVYEYMHNG-------TLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 701
           V L+G   +    ++V E M +G       +LR     +  + P      +Q+A + A G
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 702 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTVGYL 760
           + YL+       +HR++ + N ++  +   K+ DFG++R   E D           V ++
Sbjct: 143 MAYLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 199
Query: 761 DPEYYGNQQLTEKSDVYSFGVVLLELIS 788
            PE   +   T  SD++SFGVVL E+ S
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 16/204 (7%)
Query: 596 KKIGKGSFGSVYYG-KMKDGKEVAVKIM----ADSCSHRTQQFVTEVALLSRIHHRNLVP 650
           +KIGKGSFG V+ G   +  K VA+KI+    A+      QQ   E+ +LS+     +  
Sbjct: 33  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSPYVTK 89
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 710
             G   ++ +  ++ EY+  G+  D L       PLD      I  +  KGL+YLH+   
Sbjct: 90  YYGSYLKDTKLWIIMEYLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSEKK 145
Query: 711 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 770
              IHRD+K++N+LL  +   K++DFG++ Q  +     ++   GT  ++ PE       
Sbjct: 146 ---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAY 201
Query: 771 TEKSDVYSFGVVLLELISGKKPVS 794
             K+D++S G+  +EL  G+ P S
Sbjct: 202 DSKADIWSLGITAIELARGEPPHS 225

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 113/218 (51%), Gaps = 22/218 (10%)
Query: 587 LEEATNNFCKKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHRTQ-QFVTEVALL 640
           L+E      K +G G+FG+VY G      E     VA+KI+ ++   +   +F+ E  ++
Sbjct: 35  LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIM 94
Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVN----QKPLDWLTRLQIAH 696
           + + H +LV L+G C     + LV + M +G L + +H   +    Q  L+W  ++    
Sbjct: 95  ASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQI---- 149
Query: 697 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS-VARG 755
             AKG+ YL       ++HRD+ + N+L+      K++DFGL+R  E D    ++   + 
Sbjct: 150 --AKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKM 204
Query: 756 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
            + ++  E    ++ T +SDV+S+GV + EL++ G KP
Sbjct: 205 PIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKP 242

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 104/208 (50%), Gaps = 18/208 (8%)
Query: 596 KKIGKGSFGSVY----YGKMKDGKE--VAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNL 648
           +++G+GSFG VY     G +KD  E  VA+K + ++ S R + +F+ E +++   +  ++
Sbjct: 21  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 80
Query: 649 VPLIGYCEEEHQRILVYEYMHNG-------TLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 701
           V L+G   +    +++ E M  G       +LR  +  +    P      +Q+A + A G
Sbjct: 81  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 140
Query: 702 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTVGYL 760
           + YL+       +HRD+ + N ++  +   K+ DFG++R   E D           V ++
Sbjct: 141 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 197
Query: 761 DPEYYGNQQLTEKSDVYSFGVVLLELIS 788
            PE   +   T  SDV+SFGVVL E+ +
Sbjct: 198 SPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 16/204 (7%)
Query: 596 KKIGKGSFGSVYYG-KMKDGKEVAVKIM----ADSCSHRTQQFVTEVALLSRIHHRNLVP 650
           +KIGKGSFG V+ G   +  K VA+KI+    A+      QQ   E+ +LS+     +  
Sbjct: 13  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSPYVTK 69
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 710
             G   ++ +  ++ EY+  G+  D L       PLD      I  +  KGL+YLH+   
Sbjct: 70  YYGSYLKDTKLWIIMEYLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSEKK 125
Query: 711 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 770
              IHRD+K++N+LL  +   K++DFG++ Q  +     ++   GT  ++ PE       
Sbjct: 126 ---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAY 181
Query: 771 TEKSDVYSFGVVLLELISGKKPVS 794
             K+D++S G+  +EL  G+ P S
Sbjct: 182 DSKADIWSLGITAIELARGEPPHS 205

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 113/218 (51%), Gaps = 22/218 (10%)
Query: 587 LEEATNNFCKKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHRTQ-QFVTEVALL 640
           L+E      K +G G+FG+VY G      E     VA+KI+ ++   +   +F+ E  ++
Sbjct: 12  LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIM 71
Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVN----QKPLDWLTRLQIAH 696
           + + H +LV L+G C     + LV + M +G L + +H   +    Q  L+W  ++    
Sbjct: 72  ASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQI---- 126
Query: 697 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS-VARG 755
             AKG+ YL       ++HRD+ + N+L+      K++DFGL+R  E D    ++   + 
Sbjct: 127 --AKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKM 181
Query: 756 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
            + ++  E    ++ T +SDV+S+GV + EL++ G KP
Sbjct: 182 PIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKP 219

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 102/205 (49%), Gaps = 9/205 (4%)
Query: 589 EATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRN 647
           E   +  +K+G+GS+GSVY    K+ G+ VA+K +        Q+ + E++++ +    +
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP--VESDLQEIIKEISIMQQCDSPH 85
Query: 648 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
           +V   G   +     +V EY   G++ D +   +  K L       I     KGLEYLH 
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIR--LRNKTLTEDEIATILQSTLKGLEYLHF 143
Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 767
                 IHRD+K+ NILL+    AK++DFG++ Q  + +   + V  GT  ++ PE    
Sbjct: 144 MRK---IHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVI-GTPFWMAPEVIQE 199
Query: 768 QQLTEKSDVYSFGVVLLELISGKKP 792
                 +D++S G+  +E+  GK P
Sbjct: 200 IGYNCVADIWSLGITAIEMAEGKPP 224

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/221 (31%), Positives = 112/221 (50%), Gaps = 27/221 (12%)
Query: 596 KKIGKGSFGSVY----YG--KMKDGKEVAVKIMADSCSHRTQQ-FVTEVALLSRI-HHRN 647
           K +G+G+FG V     +G  K    + VAVK++ +  +H   +  ++E+ +L  I HH N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 648 LVPLIGYCEEEHQRILV-YEYMHNGTLRDRLHGSVNQ------KPLD-WLTRLQIAH--- 696
           +V L+G C +    ++V  E+   G L   L    N+       P D +   L + H   
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 697 ---DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSV 752
                AKG+E+L    +   IHRD+ + NILL      K+ DFGL+R   +D  ++    
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209
Query: 753 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
           AR  + ++ PE   ++  T +SDV+SFGV+L E+ S G  P
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 102/204 (50%), Gaps = 19/204 (9%)
Query: 596 KKIGKGSFGSV---YYGKMKDG--KEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNL 648
           + +G+G FG V    Y    DG  + VAVK +   C   HR+  +  E+ +L  ++H ++
Sbjct: 20  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSG-WKQEIDILRTLYHEHI 78
Query: 649 VPLIGYCEEEHQRIL--VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           +   G CE++ ++ L  V EY+  G+LRD L     +  +     L  A    +G+ YLH
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLH 134
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE--DLTHISSVARGTVGYLDPEY 764
           +      IHR++ + N+LLD +   K+ DFGL++   E  +   +       V +  PE 
Sbjct: 135 S---QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 191
Query: 765 YGNQQLTEKSDVYSFGVVLLELIS 788
               +    SDV+SFGV L EL++
Sbjct: 192 LKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 109/205 (53%), Gaps = 15/205 (7%)
Query: 596 KKIGKGSFGSV---YYGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVP 650
           K++G G+FG+V   YY   K  K VAVKI+ +  +      + + E  ++ ++ +  +V 
Sbjct: 33  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 92
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 710
           +IG CE E   +LV E    G L   L  + + K  +    +++ H  + G++YL     
Sbjct: 93  MIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKN---IIELVHQVSMGMKYLEES-- 146
Query: 711 PGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPEYYGNQ 768
              +HRD+ + N+LL     AK+SDFGLS+  +A+E+     +  +  V +  PE     
Sbjct: 147 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 205
Query: 769 QLTEKSDVYSFGVVLLELIS-GKKP 792
           + + KSDV+SFGV++ E  S G+KP
Sbjct: 206 KFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 109/205 (53%), Gaps = 15/205 (7%)
Query: 596 KKIGKGSFGSV---YYGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVP 650
           K++G G+FG+V   YY   K  K VAVKI+ +  +      + + E  ++ ++ +  +V 
Sbjct: 33  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 92
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 710
           +IG CE E   +LV E    G L   L  + + K  +    +++ H  + G++YL     
Sbjct: 93  MIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKN---IIELVHQVSMGMKYLEES-- 146
Query: 711 PGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPEYYGNQ 768
              +HRD+ + N+LL     AK+SDFGLS+  +A+E+     +  +  V +  PE     
Sbjct: 147 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 205
Query: 769 QLTEKSDVYSFGVVLLELIS-GKKP 792
           + + KSDV+SFGV++ E  S G+KP
Sbjct: 206 KFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/221 (31%), Positives = 112/221 (50%), Gaps = 27/221 (12%)
Query: 596 KKIGKGSFGSVY----YG--KMKDGKEVAVKIMADSCSHRTQQ-FVTEVALLSRI-HHRN 647
           K +G+G+FG V     +G  K    + VAVK++ +  +H   +  ++E+ +L  I HH N
Sbjct: 70  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 129
Query: 648 LVPLIGYCEEEHQRILV-YEYMHNGTLRDRLHGSVNQ------KPLD-WLTRLQIAH--- 696
           +V L+G C +    ++V  E+   G L   L    N+       P D +   L + H   
Sbjct: 130 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 189
Query: 697 ---DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSV 752
                AKG+E+L    +   IHRD+ + NILL      K+ DFGL+R   +D  ++    
Sbjct: 190 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 246
Query: 753 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
           AR  + ++ PE   ++  T +SDV+SFGV+L E+ S G  P
Sbjct: 247 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 287

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/221 (31%), Positives = 112/221 (50%), Gaps = 27/221 (12%)
Query: 596 KKIGKGSFGSVY----YG--KMKDGKEVAVKIMADSCSHRTQQ-FVTEVALLSRI-HHRN 647
           K +G+G+FG V     +G  K    + VAVK++ +  +H   +  ++E+ +L  I HH N
Sbjct: 35  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 94
Query: 648 LVPLIGYCEEEHQRILV-YEYMHNGTLRDRLHGSVNQ------KPLD-WLTRLQIAH--- 696
           +V L+G C +    ++V  E+   G L   L    N+       P D +   L + H   
Sbjct: 95  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLIC 154
Query: 697 ---DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSV 752
                AKG+E+L    +   IHRD+ + NILL      K+ DFGL+R   +D  ++    
Sbjct: 155 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 211
Query: 753 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
           AR  + ++ PE   ++  T +SDV+SFGV+L E+ S G  P
Sbjct: 212 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 252

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 106/226 (46%), Gaps = 34/226 (15%)
Query: 593 NFCKKIGKGSFGSVY------YGKMKDGKEVAVKIMADSCSHRTQQ--FVTEVALLSRI- 643
            F K +G G+FG V        GK     +VAVK M  S +H  ++   ++E+ ++S + 
Sbjct: 34  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVK-MLKSTAHADEKEALMSELKIMSHLG 92
Query: 644 HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSV--------------------NQ 683
            H N+V L+G C      +++ EY   G L + L                        + 
Sbjct: 93  QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDG 152
Query: 684 KPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 743
           +PL+    L  +   A+G+ +L    +   IHRDV + N+LL     AK+ DFGL+R   
Sbjct: 153 RPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIM 209
Query: 744 EDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
            D  +I    AR  V ++ PE   +   T +SDV+S+G++L E+ S
Sbjct: 210 NDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/221 (31%), Positives = 112/221 (50%), Gaps = 27/221 (12%)
Query: 596 KKIGKGSFGSVY----YG--KMKDGKEVAVKIMADSCSHRTQQ-FVTEVALLSRI-HHRN 647
           K +G+G+FG V     +G  K    + VAVK++ +  +H   +  ++E+ +L  I HH N
Sbjct: 24  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 83
Query: 648 LVPLIGYCEEEHQRILVY-EYMHNGTLRDRLHGSVNQ------KPLD-WLTRLQIAH--- 696
           +V L+G C +    ++V  E+   G L   L    N+       P D +   L + H   
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 697 ---DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSV 752
                AKG+E+L    +   IHRD+ + NILL      K+ DFGL+R   +D  ++    
Sbjct: 144 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 200
Query: 753 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
           AR  + ++ PE   ++  T +SDV+SFGV+L E+ S G  P
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 241

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/221 (31%), Positives = 112/221 (50%), Gaps = 27/221 (12%)
Query: 596 KKIGKGSFGSVY----YG--KMKDGKEVAVKIMADSCSHRTQQ-FVTEVALLSRI-HHRN 647
           K +G+G+FG V     +G  K    + VAVK++ +  +H   +  ++E+ +L  I HH N
Sbjct: 24  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 83
Query: 648 LVPLIGYCEEEHQRILVY-EYMHNGTLRDRLHGSVNQ------KPLD-WLTRLQIAH--- 696
           +V L+G C +    ++V  E+   G L   L    N+       P D +   L + H   
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 697 ---DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSV 752
                AKG+E+L    +   IHRD+ + NILL      K+ DFGL+R   +D  ++    
Sbjct: 144 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 200
Query: 753 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
           AR  + ++ PE   ++  T +SDV+SFGV+L E+ S G  P
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 241

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 103/208 (49%), Gaps = 18/208 (8%)
Query: 596 KKIGKGSFGSVY----YGKMKDGKE--VAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNL 648
           +++G+GSFG VY     G +KD  E  VA+K + ++ S R + +F+ E +++   +  ++
Sbjct: 18  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 77
Query: 649 VPLIGYCEEEHQRILVYEYMHNG-------TLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 701
           V L+G   +    +++ E M  G       +LR  +  +    P      +Q+A + A G
Sbjct: 78  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 137
Query: 702 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTVGYL 760
           + YL+       +HRD+ + N  +  +   K+ DFG++R   E D           V ++
Sbjct: 138 MAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 194
Query: 761 DPEYYGNQQLTEKSDVYSFGVVLLELIS 788
            PE   +   T  SDV+SFGVVL E+ +
Sbjct: 195 SPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 101/204 (49%), Gaps = 19/204 (9%)
Query: 596 KKIGKGSFGSV---YYGKMKDG--KEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNL 648
           + +G+G FG V    Y    DG  + VAVK +   C   HR+  +  E+ +L  ++H ++
Sbjct: 20  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSG-WKQEIDILRTLYHEHI 78
Query: 649 VPLIGYCEEEHQRIL--VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           +   G CE++ ++ L  V EY+  G+LRD L     +  +     L  A    +G+ YLH
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLH 134
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE--DLTHISSVARGTVGYLDPEY 764
                  IHR++ + N+LLD +   K+ DFGL++   E  +   +       V +  PE 
Sbjct: 135 A---QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 191
Query: 765 YGNQQLTEKSDVYSFGVVLLELIS 788
               +    SDV+SFGV L EL++
Sbjct: 192 LKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 104/205 (50%), Gaps = 18/205 (8%)
Query: 596 KKIGKGSFGSVYYG-KMKDGKEVAVKIM----ADSCSHRTQQFVTEVALLSRIHHRNLVP 650
           +KIGKGSFG V+ G   +  K VA+KI+    A+      QQ   E+ +LS+     +  
Sbjct: 28  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSPYVTK 84
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 710
             G   ++ +  ++ EY+  G+  D L       PLD      I  +  KGL+YLH+   
Sbjct: 85  YYGSYLKDTKLWIIMEYLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSEKK 140
Query: 711 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS-SVARGTVGYLDPEYYGNQQ 769
              IHRD+K++N+LL  +   K++DFG++ Q  +  T I  +   GT  ++ PE      
Sbjct: 141 ---IHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNXFVGTPFWMAPEVIKQSA 195
Query: 770 LTEKSDVYSFGVVLLELISGKKPVS 794
              K+D++S G+  +EL  G+ P S
Sbjct: 196 YDSKADIWSLGITAIELARGEPPHS 220

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 593 NFCKKIGKGSFGSVYYGKMKDGKE-VAVKIM----ADSCSHRTQQFVTEVALLSRIHHRN 647
           +  + +G+G++G V     +  +E VAVKI+    A  C    ++   E+ +   ++H N
Sbjct: 9   DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHEN 65
Query: 648 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
           +V   G+  E + + L  EY   G L DR+   +     D     +  H    G+ YLH 
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD---AQRFFHQLMAGVVYLH- 121
Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE-EDLTHISSVARGTVGYLDPEYYG 766
               GI HRD+K  N+LLD     K+SDFGL+      +   + +   GT+ Y+ PE   
Sbjct: 122 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 767 NQQL-TEKSDVYSFGVVLLELISGKKP 792
            ++   E  DV+S G+VL  +++G+ P
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 593 NFCKKIGKGSFGSVYYGKMKDGKE-VAVKIM----ADSCSHRTQQFVTEVALLSRIHHRN 647
           +  + +G+G++G V     +  +E VAVKI+    A  C    ++   E+ +   ++H N
Sbjct: 9   DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHEN 65
Query: 648 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
           +V   G+  E + + L  EY   G L DR+   +     D     +  H    G+ YLH 
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD---AQRFFHQLMAGVVYLH- 121
Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE-EDLTHISSVARGTVGYLDPEYYG 766
               GI HRD+K  N+LLD     K+SDFGL+      +   + +   GT+ Y+ PE   
Sbjct: 122 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 767 NQQL-TEKSDVYSFGVVLLELISGKKP 792
            ++   E  DV+S G+VL  +++G+ P
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 104/205 (50%), Gaps = 18/205 (8%)
Query: 596 KKIGKGSFGSVYYG-KMKDGKEVAVKIM----ADSCSHRTQQFVTEVALLSRIHHRNLVP 650
           +KIGKGSFG V+ G   +  K VA+KI+    A+      QQ   E+ +LS+     +  
Sbjct: 13  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSPYVTK 69
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 710
             G   ++ +  ++ EY+  G+  D L       PLD      I  +  KGL+YLH+   
Sbjct: 70  YYGSYLKDTKLWIIMEYLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSEKK 125
Query: 711 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS-SVARGTVGYLDPEYYGNQQ 769
              IHRD+K++N+LL  +   K++DFG++ Q  +  T I  +   GT  ++ PE      
Sbjct: 126 ---IHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNXFVGTPFWMAPEVIKQSA 180
Query: 770 LTEKSDVYSFGVVLLELISGKKPVS 794
              K+D++S G+  +EL  G+ P S
Sbjct: 181 YDSKADIWSLGITAIELARGEPPHS 205

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 593 NFCKKIGKGSFGSVYYGKMKDGKE-VAVKIM----ADSCSHRTQQFVTEVALLSRIHHRN 647
           +  + +G+G++G V     +  +E VAVKI+    A  C    ++   E+ +   ++H N
Sbjct: 9   DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHEN 65
Query: 648 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
           +V   G+  E + + L  EY   G L DR+   +     D     +  H    G+ YLH 
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD---AQRFFHQLMAGVVYLH- 121
Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE-EDLTHISSVARGTVGYLDPEYYG 766
               GI HRD+K  N+LLD     K+SDFGL+      +   + +   GT+ Y+ PE   
Sbjct: 122 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 767 NQQL-TEKSDVYSFGVVLLELISGKKP 792
            ++   E  DV+S G+VL  +++G+ P
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 109/205 (53%), Gaps = 15/205 (7%)
Query: 596 KKIGKGSFGSV---YYGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVP 650
           K++G G+FG+V   YY   K  K VAVKI+ +  +      + + E  ++ ++ +  +V 
Sbjct: 17  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 76
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 710
           +IG CE E   +LV E    G L   L  + + K  +    +++ H  + G++YL     
Sbjct: 77  MIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKN---IIELVHQVSMGMKYLEES-- 130
Query: 711 PGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPEYYGNQ 768
              +HRD+ + N+LL     AK+SDFGLS+  +A+E+     +  +  V +  PE     
Sbjct: 131 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 189
Query: 769 QLTEKSDVYSFGVVLLELIS-GKKP 792
           + + KSDV+SFGV++ E  S G+KP
Sbjct: 190 KFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 103/202 (50%), Gaps = 14/202 (6%)
Query: 595 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFV---TEVALLSRIHHRNLVP 650
            + +G GSFG V+  + + +G+  A+K++      R +Q      E  +LS + H  ++ 
Sbjct: 11  LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIR 70
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 710
           + G  ++  Q  ++ +Y+  G L   L  S  Q+  + + +   A +    LEYLH+   
Sbjct: 71  MWGTFQDAQQIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAA-EVCLALEYLHSK-- 125
Query: 711 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 770
             II+RD+K  NILLD N   K++DFG ++   +    ++    GT  Y+ PE    +  
Sbjct: 126 -DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYXLCGTPDYIAPEVVSTKPY 180
Query: 771 TEKSDVYSFGVVLLELISGKKP 792
            +  D +SFG+++ E+++G  P
Sbjct: 181 NKSIDWWSFGILIYEMLAGYTP 202

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 70/221 (31%), Positives = 111/221 (50%), Gaps = 27/221 (12%)
Query: 596 KKIGKGSFGSVY----YG--KMKDGKEVAVKIMADSCSHRTQQ-FVTEVALLSRI-HHRN 647
           K +G+G+FG V     +G  K    + VAVK++ +  +H   +  ++E+ +L  I HH N
Sbjct: 24  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 83
Query: 648 LVPLIGYCEEEHQRILVY-EYMHNGTLRDRLHGSVNQ------KPLD-WLTRLQIAH--- 696
           +V L+G C +    ++V  E+   G L   L    N+       P D +   L + H   
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 697 ---DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSV 752
                AKG+E+L    +   IHRD+ + NILL      K+ DFGL+R   +D   +    
Sbjct: 144 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 200
Query: 753 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
           AR  + ++ PE   ++  T +SDV+SFGV+L E+ S G  P
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 241

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 70/221 (31%), Positives = 111/221 (50%), Gaps = 27/221 (12%)
Query: 596 KKIGKGSFGSVY----YG--KMKDGKEVAVKIMADSCSHRTQQ-FVTEVALLSRI-HHRN 647
           K +G+G+FG V     +G  K    + VAVK++ +  +H   +  ++E+ +L  I HH N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 648 LVPLIGYCEEEHQRILV-YEYMHNGTLRDRLHGSVNQ------KPLD-WLTRLQIAH--- 696
           +V L+G C +    ++V  E+   G L   L    N+       P D +   L + H   
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 697 ---DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSV 752
                AKG+E+L    +   IHRD+ + NILL      K+ DFGL+R   +D   +    
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 753 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
           AR  + ++ PE   ++  T +SDV+SFGV+L E+ S G  P
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 109/205 (53%), Gaps = 15/205 (7%)
Query: 596 KKIGKGSFGSV---YYGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVP 650
           K++G G+FG+V   YY   K  K VAVKI+ +  +      + + E  ++ ++ +  +V 
Sbjct: 17  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 76
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 710
           +IG CE E   +LV E    G L   L  + + K  +    +++ H  + G++YL     
Sbjct: 77  MIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKN---IIELVHQVSMGMKYLEES-- 130
Query: 711 PGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPEYYGNQ 768
              +HRD+ + N+LL     AK+SDFGLS+  +A+E+     +  +  V +  PE     
Sbjct: 131 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINYY 189
Query: 769 QLTEKSDVYSFGVVLLELIS-GKKP 792
           + + KSDV+SFGV++ E  S G+KP
Sbjct: 190 KFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 70/221 (31%), Positives = 111/221 (50%), Gaps = 27/221 (12%)
Query: 596 KKIGKGSFGSVY----YG--KMKDGKEVAVKIMADSCSHRTQQ-FVTEVALLSRI-HHRN 647
           K +G+G+FG V     +G  K    + VAVK++ +  +H   +  ++E+ +L  I HH N
Sbjct: 24  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 83
Query: 648 LVPLIGYCEEEHQRILV-YEYMHNGTLRDRLHGSVNQ------KPLD-WLTRLQIAH--- 696
           +V L+G C +    ++V  E+   G L   L    N+       P D +   L + H   
Sbjct: 84  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 697 ---DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSV 752
                AKG+E+L    +   IHRD+ + NILL      K+ DFGL+R   +D   +    
Sbjct: 144 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 200
Query: 753 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
           AR  + ++ PE   ++  T +SDV+SFGV+L E+ S G  P
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 241

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 593 NFCKKIGKGSFGSVYYGKMKDGKE-VAVKIM----ADSCSHRTQQFVTEVALLSRIHHRN 647
           +  + +G+G++G V     +  +E VAVKI+    A  C    ++   E+ +   ++H N
Sbjct: 9   DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EIXINKMLNHEN 65
Query: 648 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
           +V   G+  E + + L  EY   G L DR+   +     D     +  H    G+ YLH 
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD---AQRFFHQLMAGVVYLH- 121
Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE-EDLTHISSVARGTVGYLDPEYYG 766
               GI HRD+K  N+LLD     K+SDFGL+      +   + +   GT+ Y+ PE   
Sbjct: 122 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 767 NQQL-TEKSDVYSFGVVLLELISGKKP 792
            ++   E  DV+S G+VL  +++G+ P
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 109/205 (53%), Gaps = 15/205 (7%)
Query: 596 KKIGKGSFGSV---YYGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVP 650
           K++G G+FG+V   YY   K  K VAVKI+ +  +      + + E  ++ ++ +  +V 
Sbjct: 31  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 90
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 710
           +IG CE E   +LV E    G L   L  + + K  +    +++ H  + G++YL     
Sbjct: 91  MIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKN---IIELVHQVSMGMKYLEES-- 144
Query: 711 PGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPEYYGNQ 768
              +HRD+ + N+LL     AK+SDFGLS+  +A+E+     +  +  V +  PE     
Sbjct: 145 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 203
Query: 769 QLTEKSDVYSFGVVLLELIS-GKKP 792
           + + KSDV+SFGV++ E  S G+KP
Sbjct: 204 KFSSKSDVWSFGVLMWEAFSYGQKP 228

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 109/205 (53%), Gaps = 15/205 (7%)
Query: 596 KKIGKGSFGSV---YYGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVP 650
           K++G G+FG+V   YY   K  K VAVKI+ +  +      + + E  ++ ++ +  +V 
Sbjct: 23  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 710
           +IG CE E   +LV E    G L   L  + + K  +    +++ H  + G++YL     
Sbjct: 83  MIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKN---IIELVHQVSMGMKYLEES-- 136
Query: 711 PGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPEYYGNQ 768
              +HRD+ + N+LL     AK+SDFGLS+  +A+E+     +  +  V +  PE     
Sbjct: 137 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 195
Query: 769 QLTEKSDVYSFGVVLLELIS-GKKP 792
           + + KSDV+SFGV++ E  S G+KP
Sbjct: 196 KFSSKSDVWSFGVLMWEAFSYGQKP 220

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 102/207 (49%), Gaps = 16/207 (7%)
Query: 593 NFCKKIGKGSFGSVYYGKMKDGKE-VAVKIM----ADSCSHRTQQFVTEVALLSRIHHRN 647
           +  + +G+G++G V     +  +E VAVKI+    A  C    ++   E+ + + ++H N
Sbjct: 10  DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINAMLNHEN 66
Query: 648 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
           +V   G+  E + + L  EY   G L DR+   +     D     +  H    G+ YLH 
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD---AQRFFHQLMAGVVYLH- 122
Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE-EDLTHISSVARGTVGYLDPEYYG 766
               GI HRD+K  N+LLD     K+SDFGL+      +   + +   GT+ Y+ PE   
Sbjct: 123 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 767 NQQL-TEKSDVYSFGVVLLELISGKKP 792
            ++   E  DV+S G+VL  +++G+ P
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 109/205 (53%), Gaps = 15/205 (7%)
Query: 596 KKIGKGSFGSV---YYGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVP 650
           K++G G+FG+V   YY   K  K VAVKI+ +  +      + + E  ++ ++ +  +V 
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 710
           +IG CE E   +LV E    G L   L  + + K  +    +++ H  + G++YL     
Sbjct: 73  MIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKN---IIELVHQVSMGMKYLEES-- 126
Query: 711 PGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPEYYGNQ 768
              +HRD+ + N+LL     AK+SDFGLS+  +A+E+     +  +  V +  PE     
Sbjct: 127 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 769 QLTEKSDVYSFGVVLLELIS-GKKP 792
           + + KSDV+SFGV++ E  S G+KP
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKP 210

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 80.1 bits (196), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 593 NFCKKIGKGSFGSVYYGKMKDGKE-VAVKIM----ADSCSHRTQQFVTEVALLSRIHHRN 647
           +  + +G+G++G V     +  +E VAVKI+    A  C    ++   E+ +   ++H N
Sbjct: 10  DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EIXINKMLNHEN 66
Query: 648 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
           +V   G+  E + + L  EY   G L DR+   +     D     +  H    G+ YLH 
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD---AQRFFHQLMAGVVYLH- 122
Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE-EDLTHISSVARGTVGYLDPEYYG 766
               GI HRD+K  N+LLD     K+SDFGL+      +   + +   GT+ Y+ PE   
Sbjct: 123 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 180
Query: 767 NQQL-TEKSDVYSFGVVLLELISGKKP 792
            ++   E  DV+S G+VL  +++G+ P
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 80.1 bits (196), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 593 NFCKKIGKGSFGSVYYGKMKDGKE-VAVKIM----ADSCSHRTQQFVTEVALLSRIHHRN 647
           +  + +G+G++G V     +  +E VAVKI+    A  C    ++   E+ +   ++H N
Sbjct: 10  DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHEN 66
Query: 648 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
           +V   G+  E + + L  EY   G L DR+   +     D     +  H    G+ YLH 
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD---AQRFFHQLMAGVVYLH- 122
Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE-EDLTHISSVARGTVGYLDPEYYG 766
               GI HRD+K  N+LLD     K+SDFGL+      +   + +   GT+ Y+ PE   
Sbjct: 123 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 767 NQQL-TEKSDVYSFGVVLLELISGKKP 792
            ++   E  DV+S G+VL  +++G+ P
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 80.1 bits (196), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 104/217 (47%), Gaps = 25/217 (11%)
Query: 593 NFCKKIGKGSFGSVY------YGKMKDGKEVAVKIMADSCSHRTQQ--FVTEVALLSRI- 643
            F K +G G+FG V        GK     +VAVK M  S +H  ++   ++E+ ++S + 
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVK-MLKSTAHADEKEALMSELKIMSHLG 107
Query: 644 HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG-----------SVNQKPLDWLTRL 692
            H N+V L+G C      +++ EY   G L + L             ++    L     L
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLL 167
Query: 693 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SS 751
             +   A+G+ +L    +   IHRDV + N+LL     AK+ DFGL+R    D  +I   
Sbjct: 168 HFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG 224
Query: 752 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
            AR  V ++ PE   +   T +SDV+S+G++L E+ S
Sbjct: 225 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 109/205 (53%), Gaps = 15/205 (7%)
Query: 596 KKIGKGSFGSV---YYGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVP 650
           K++G G+FG+V   YY   K  K VAVKI+ +  +      + + E  ++ ++ +  +V 
Sbjct: 11  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 70
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 710
           +IG CE E   +LV E    G L   L  + + K  +    +++ H  + G++YL     
Sbjct: 71  MIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKN---IIELVHQVSMGMKYLEES-- 124
Query: 711 PGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPEYYGNQ 768
              +HRD+ + N+LL     AK+SDFGLS+  +A+E+     +  +  V +  PE     
Sbjct: 125 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 183
Query: 769 QLTEKSDVYSFGVVLLELIS-GKKP 792
           + + KSDV+SFGV++ E  S G+KP
Sbjct: 184 KFSSKSDVWSFGVLMWEAFSYGQKP 208

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 593 NFCKKIGKGSFGSVYYGKMKDGKE-VAVKIM----ADSCSHRTQQFVTEVALLSRIHHRN 647
           +  + +G+G++G V     +  +E VAVKI+    A  C    ++   E+ +   ++H N
Sbjct: 8   DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHEN 64
Query: 648 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
           +V   G+  E + + L  EY   G L DR+   +     D     +  H    G+ YLH 
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD---AQRFFHQLMAGVVYLH- 120
Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE-EDLTHISSVARGTVGYLDPEYYG 766
               GI HRD+K  N+LLD     K+SDFGL+      +   + +   GT+ Y+ PE   
Sbjct: 121 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 767 NQQL-TEKSDVYSFGVVLLELISGKKP 792
            ++   E  DV+S G+VL  +++G+ P
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELP 205

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 593 NFCKKIGKGSFGSVYYGKMKDGKE-VAVKIM----ADSCSHRTQQFVTEVALLSRIHHRN 647
           +  + +G+G++G V     +  +E VAVKI+    A  C    ++   E+ +   ++H N
Sbjct: 9   DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHEN 65
Query: 648 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
           +V   G+  E + + L  EY   G L DR+   +     D     +  H    G+ YLH 
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD---AQRFFHQLMAGVVYLH- 121
Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE-EDLTHISSVARGTVGYLDPEYYG 766
               GI HRD+K  N+LLD     K+SDFGL+      +   + +   GT+ Y+ PE   
Sbjct: 122 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 767 NQQL-TEKSDVYSFGVVLLELISGKKP 792
            ++   E  DV+S G+VL  +++G+ P
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 593 NFCKKIGKGSFGSVYYGKMKDGKE-VAVKIM----ADSCSHRTQQFVTEVALLSRIHHRN 647
           +  + +G+G++G V     +  +E VAVKI+    A  C    ++   E+ +   ++H N
Sbjct: 9   DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHEN 65
Query: 648 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
           +V   G+  E + + L  EY   G L DR+   +     D     +  H    G+ YLH 
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD---AQRFFHQLMAGVVYLH- 121
Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE-EDLTHISSVARGTVGYLDPEYYG 766
               GI HRD+K  N+LLD     K+SDFGL+      +   + +   GT+ Y+ PE   
Sbjct: 122 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 767 NQQL-TEKSDVYSFGVVLLELISGKKP 792
            ++   E  DV+S G+VL  +++G+ P
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 70/221 (31%), Positives = 111/221 (50%), Gaps = 27/221 (12%)
Query: 596 KKIGKGSFGSVY----YG--KMKDGKEVAVKIMADSCSHRTQQ-FVTEVALLSRI-HHRN 647
           K +G+G+FG V     +G  K    + VAVK++ +  +H   +  ++E+ +L  I HH N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 648 LVPLIGYCEEEHQRILV-YEYMHNGTLRDRLHGSVNQ------KPLD-WLTRLQIAH--- 696
           +V L+G C +    ++V  E+   G L   L    N+       P D +   L + H   
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 697 ---DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSV 752
                AKG+E+L    +   IHRD+ + NILL      K+ DFGL+R   +D   +    
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGD 209
Query: 753 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
           AR  + ++ PE   ++  T +SDV+SFGV+L E+ S G  P
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 79.7 bits (195), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 111/226 (49%), Gaps = 30/226 (13%)
Query: 593 NFCKKIGKGSFGSVY----YGKMKD--GKEVAVKIMADSCSHRTQQ--FVTEVALLSRI- 643
           +F K +G G+FG V     YG +K      VAVK++  S +H T++   ++E+ +LS + 
Sbjct: 49  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLG 107
Query: 644 HHRNLVPLIGYCEEEHQRILVYEYMHNGTL-------RDRLHGSVNQKPL--------DW 688
           +H N+V L+G C      +++ EY   G L       RD    S     +        D 
Sbjct: 108 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 167
Query: 689 LTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 748
              L  ++  AKG+ +L    +   IHRD+ + NILL      K+ DFGL+R  + D  +
Sbjct: 168 EDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNY 224
Query: 749 -ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
            +   AR  V ++ PE   N   T +SDV+S+G+ L EL S G  P
Sbjct: 225 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 270

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 79.7 bits (195), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 111/226 (49%), Gaps = 30/226 (13%)
Query: 593 NFCKKIGKGSFGSVY----YGKMKD--GKEVAVKIMADSCSHRTQQ--FVTEVALLSRI- 643
           +F K +G G+FG V     YG +K      VAVK++  S +H T++   ++E+ +LS + 
Sbjct: 42  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLG 100
Query: 644 HHRNLVPLIGYCEEEHQRILVYEYMHNGTL-------RDRLHGSVNQKPL--------DW 688
           +H N+V L+G C      +++ EY   G L       RD    S     +        D 
Sbjct: 101 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 160
Query: 689 LTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 748
              L  ++  AKG+ +L    +   IHRD+ + NILL      K+ DFGL+R  + D  +
Sbjct: 161 EDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 217
Query: 749 -ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
            +   AR  V ++ PE   N   T +SDV+S+G+ L EL S G  P
Sbjct: 218 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 263

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 79.7 bits (195), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 109/218 (50%), Gaps = 15/218 (6%)
Query: 596 KKIGKGSFGSVYYGKMKDGKEV-AVKIM-ADSCSHRTQ--QFVTEVALLSRIHHRNLVPL 651
           + IGKGSFG V   +  D K++ A+K M    C  R +      E+ ++  + H  LV L
Sbjct: 21  RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 711
               ++E    +V + +  G LR  L  +V+ K  +   +L I  +    L+YL    N 
Sbjct: 81  WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFK--EETVKLFIC-ELVMALDYLQ---NQ 134
Query: 712 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 771
            IIHRD+K  NILLD +    ++DF ++     + T I+++A GT  Y+ PE + +++  
Sbjct: 135 RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-TQITTMA-GTKPYMAPEMFSSRKGA 192
Query: 772 EKS---DVYSFGVVLLELISGKKPVSVEDFGAELNIVH 806
             S   D +S GV   EL+ G++P  +    +   IVH
Sbjct: 193 GYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVH 230

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 79.7 bits (195), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 108/219 (49%), Gaps = 27/219 (12%)
Query: 593 NFCKKIGKGSFGSVY------YGKMKDGKEVAVKIMADSCSHRTQQ--FVTEVALLSRI- 643
            F K +G G+FG V        GK     +VAVK M  S +H  ++   ++E+ ++S + 
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVK-MLKSTAHADEKEALMSELKIMSHLG 107
Query: 644 HHRNLVPLIGYCEEEHQRILVYEYMHNGTL-----RDRLHG-----SVNQKPLDWLTRLQ 693
            H N+V L+G C      +++ EY   G L     R R  G     + +  P + L+   
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRD 167
Query: 694 IAH---DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI- 749
           + H     A+G+ +L    +   IHRDV + N+LL     AK+ DFGL+R    D  +I 
Sbjct: 168 LLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 224
Query: 750 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
              AR  V ++ PE   +   T +SDV+S+G++L E+ S
Sbjct: 225 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 79.7 bits (195), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 593 NFCKKIGKGSFGSVYYGKMKDGKE-VAVKIM----ADSCSHRTQQFVTEVALLSRIHHRN 647
           +  + +G+G++G V     +  +E VAVKI+    A  C    ++   E+ +   ++H N
Sbjct: 10  DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHEN 66
Query: 648 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
           +V   G+  E + + L  EY   G L DR+   +     D     +  H    G+ YLH 
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD---AQRFFHQLMAGVVYLH- 122
Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE-EDLTHISSVARGTVGYLDPEYYG 766
               GI HRD+K  N+LLD     K+SDFGL+      +   + +   GT+ Y+ PE   
Sbjct: 123 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 767 NQQL-TEKSDVYSFGVVLLELISGKKP 792
            ++   E  DV+S G+VL  +++G+ P
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 79.7 bits (195), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 593 NFCKKIGKGSFGSVYYGKMKDGKE-VAVKIM----ADSCSHRTQQFVTEVALLSRIHHRN 647
           +  + +G+G++G V     +  +E VAVKI+    A  C    ++   E+ +   ++H N
Sbjct: 10  DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHEN 66
Query: 648 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
           +V   G+  E + + L  EY   G L DR+   +     D     +  H    G+ YLH 
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD---AQRFFHQLMAGVVYLH- 122
Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE-EDLTHISSVARGTVGYLDPEYYG 766
               GI HRD+K  N+LLD     K+SDFGL+      +   + +   GT+ Y+ PE   
Sbjct: 123 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 767 NQQL-TEKSDVYSFGVVLLELISGKKP 792
            ++   E  DV+S G+VL  +++G+ P
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 79.7 bits (195), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 593 NFCKKIGKGSFGSVYYGKMKDGKE-VAVKIM----ADSCSHRTQQFVTEVALLSRIHHRN 647
           +  + +G+G++G V     +  +E VAVKI+    A  C    ++   E+ +   ++H N
Sbjct: 10  DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHEN 66
Query: 648 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
           +V   G+  E + + L  EY   G L DR+   +     D     +  H    G+ YLH 
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD---AQRFFHQLMAGVVYLH- 122
Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE-EDLTHISSVARGTVGYLDPEYYG 766
               GI HRD+K  N+LLD     K+SDFGL+      +   + +   GT+ Y+ PE   
Sbjct: 123 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 767 NQQL-TEKSDVYSFGVVLLELISGKKP 792
            ++   E  DV+S G+VL  +++G+ P
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 79.7 bits (195), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 111/226 (49%), Gaps = 30/226 (13%)
Query: 593 NFCKKIGKGSFGSVY----YGKMKD--GKEVAVKIMADSCSHRTQQ--FVTEVALLSRI- 643
           +F K +G G+FG V     YG +K      VAVK++  S +H T++   ++E+ +LS + 
Sbjct: 26  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLG 84
Query: 644 HHRNLVPLIGYCEEEHQRILVYEYMHNGTL-------RDRLHGSVNQKPL--------DW 688
           +H N+V L+G C      +++ EY   G L       RD    S     +        D 
Sbjct: 85  NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 689 LTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 748
              L  ++  AKG+ +L    +   IHRD+ + NILL      K+ DFGL+R  + D  +
Sbjct: 145 EDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 749 -ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
            +   AR  V ++ PE   N   T +SDV+S+G+ L EL S G  P
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 79.7 bits (195), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 593 NFCKKIGKGSFGSVYYGKMKDGKE-VAVKIM----ADSCSHRTQQFVTEVALLSRIHHRN 647
           +  + +G+G++G V     +  +E VAVKI+    A  C    ++   E+ +   ++H N
Sbjct: 9   DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHEN 65
Query: 648 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
           +V   G+  E + + L  EY   G L DR+   +     D     +  H    G+ YLH 
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD---AQRFFHQLMAGVVYLH- 121
Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE-EDLTHISSVARGTVGYLDPEYYG 766
               GI HRD+K  N+LLD     K+SDFGL+      +   + +   GT+ Y+ PE   
Sbjct: 122 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 767 NQQL-TEKSDVYSFGVVLLELISGKKP 792
            ++   E  DV+S G+VL  +++G+ P
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 593 NFCKKIGKGSFGSVYYGKMKDGKE-VAVKIM----ADSCSHRTQQFVTEVALLSRIHHRN 647
           +  + +G+G++G V     +  +E VAVKI+    A  C    ++   E+ +   ++H N
Sbjct: 9   DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHEN 65
Query: 648 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
           +V   G+  E + + L  EY   G L DR+   +     D     +  H    G+ YLH 
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD---AQRFFHQLMAGVVYLH- 121
Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE-EDLTHISSVARGTVGYLDPEYYG 766
               GI HRD+K  N+LLD     K+SDFGL+      +   + +   GT+ Y+ PE   
Sbjct: 122 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 767 NQQL-TEKSDVYSFGVVLLELISGKKP 792
            ++   E  DV+S G+VL  +++G+ P
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 593 NFCKKIGKGSFGSVYYGKMKDGKE-VAVKIM----ADSCSHRTQQFVTEVALLSRIHHRN 647
           +  + +G+G++G V     +  +E VAVKI+    A  C    ++   E+ +   ++H N
Sbjct: 10  DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHEN 66
Query: 648 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
           +V   G+  E + + L  EY   G L DR+   +     D     +  H    G+ YLH 
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD---AQRFFHQLMAGVVYLH- 122
Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE-EDLTHISSVARGTVGYLDPEYYG 766
               GI HRD+K  N+LLD     K+SDFGL+      +   + +   GT+ Y+ PE   
Sbjct: 123 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 767 NQQL-TEKSDVYSFGVVLLELISGKKP 792
            ++   E  DV+S G+VL  +++G+ P
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 111/226 (49%), Gaps = 30/226 (13%)
Query: 593 NFCKKIGKGSFGSVY----YGKMKD--GKEVAVKIMADSCSHRTQQ--FVTEVALLSRI- 643
           +F K +G G+FG V     YG +K      VAVK++  S +H T++   ++E+ +LS + 
Sbjct: 49  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLG 107
Query: 644 HHRNLVPLIGYCEEEHQRILVYEYMHNGTL-------RDRLHGSVNQKPL--------DW 688
           +H N+V L+G C      +++ EY   G L       RD    S     +        D 
Sbjct: 108 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 167
Query: 689 LTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 748
              L  ++  AKG+ +L    +   IHRD+ + NILL      K+ DFGL+R  + D  +
Sbjct: 168 EDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 224
Query: 749 -ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
            +   AR  V ++ PE   N   T +SDV+S+G+ L EL S G  P
Sbjct: 225 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 270

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 100/203 (49%), Gaps = 17/203 (8%)
Query: 596 KKIGKGSFGSV---YYGKMKDG--KEVAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNLV 649
           + +G+G FG V    Y    DG  + VAVK + + C  + +  +  E+ +L  ++H ++V
Sbjct: 15  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIV 74
Query: 650 PLIGYCEEEHQRI--LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
              G CE++ ++   LV EY+  G+LRD L     +  +     L  A    +G+ YLH 
Sbjct: 75  KYKGCCEDQGEKSVQLVMEYVPLGSLRDYL----PRHCVGLAQLLLFAQQICEGMAYLHA 130
Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE--DLTHISSVARGTVGYLDPEYY 765
                 IHR + + N+LLD +   K+ DFGL++   E  +   +       V +  PE  
Sbjct: 131 ---QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 187
Query: 766 GNQQLTEKSDVYSFGVVLLELIS 788
              +    SDV+SFGV L EL++
Sbjct: 188 KECKFYYASDVWSFGVTLYELLT 210

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 593 NFCKKIGKGSFGSVYYGKMKDGKE-VAVKIM----ADSCSHRTQQFVTEVALLSRIHHRN 647
           +  + +G+G++G V     +  +E VAVKI+    A  C    ++   E+ +   ++H N
Sbjct: 9   DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHEN 65
Query: 648 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
           +V   G+  E + + L  EY   G L DR+   +     D     +  H    G+ YLH 
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD---AQRFFHQLMAGVVYLH- 121
Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE-EDLTHISSVARGTVGYLDPEYYG 766
               GI HRD+K  N+LLD     K+SDFGL+      +   + +   GT+ Y+ PE   
Sbjct: 122 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 767 NQQL-TEKSDVYSFGVVLLELISGKKP 792
            ++   E  DV+S G+VL  +++G+ P
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 593 NFCKKIGKGSFGSVYYGKMKDGKE-VAVKIM----ADSCSHRTQQFVTEVALLSRIHHRN 647
           +  + +G+G++G V     +  +E VAVKI+    A  C    ++   E+ +   ++H N
Sbjct: 9   DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHEN 65
Query: 648 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
           +V   G+  E + + L  EY   G L DR+   +     D     +  H    G+ YLH 
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD---AQRFFHQLMAGVVYLH- 121
Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE-EDLTHISSVARGTVGYLDPEYYG 766
               GI HRD+K  N+LLD     K+SDFGL+      +   + +   GT+ Y+ PE   
Sbjct: 122 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 767 NQQL-TEKSDVYSFGVVLLELISGKKP 792
            ++   E  DV+S G+VL  +++G+ P
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 100/203 (49%), Gaps = 17/203 (8%)
Query: 596 KKIGKGSFGSV---YYGKMKDG--KEVAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNLV 649
           + +G+G FG V    Y    DG  + VAVK + + C  + +  +  E+ +L  ++H ++V
Sbjct: 14  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIV 73
Query: 650 PLIGYCEEEHQRI--LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
              G CE++ ++   LV EY+  G+LRD L     +  +     L  A    +G+ YLH 
Sbjct: 74  KYKGCCEDQGEKSVQLVMEYVPLGSLRDYL----PRHCVGLAQLLLFAQQICEGMAYLHA 129
Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE--DLTHISSVARGTVGYLDPEYY 765
                 IHR + + N+LLD +   K+ DFGL++   E  +   +       V +  PE  
Sbjct: 130 ---QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 186
Query: 766 GNQQLTEKSDVYSFGVVLLELIS 788
              +    SDV+SFGV L EL++
Sbjct: 187 KECKFYYASDVWSFGVTLYELLT 209

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 102/204 (50%), Gaps = 20/204 (9%)
Query: 598 IGKGSFGSVYYGKMK-DGKEVAVKIMAD-SCSHRT--QQFVTEVALLSRIHHRNLVPLIG 653
           +GKGSFG V   K K  G+E AVK+++      +T  +  + EV LL ++ H N++ L  
Sbjct: 40  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 99
Query: 654 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 713
           + E++    LV E    G L D +   +++K    +   +I      G+ Y+H      I
Sbjct: 100 FFEDKGYFYLVGEVYTGGELFDEI---ISRKRFSEVDAARIIRQVLSGITYMHKN---KI 153
Query: 714 IHRDVKSSNILL-----DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
           +HRD+K  N+LL     D N+R  + DFGLS   E        +  GT  Y+ PE   + 
Sbjct: 154 VHRDLKPENLLLESKSKDANIR--IIDFGLSTHFEASKKMKDKI--GTAYYIAPEVL-HG 208
Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
              EK DV+S GV+L  L+SG  P
Sbjct: 209 TYDEKCDVWSTGVILYILLSGCPP 232

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 593 NFCKKIGKGSFGSVYYGKMKDGKE-VAVKIM----ADSCSHRTQQFVTEVALLSRIHHRN 647
           +  + +G+G++G V     +  +E VAVKI+    A  C    ++   E+ +   ++H N
Sbjct: 10  DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHEN 66
Query: 648 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
           +V   G+  E + + L  EY   G L DR+   +     D     +  H    G+ YLH 
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD---AQRFFHQLMAGVVYLH- 122
Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE-EDLTHISSVARGTVGYLDPEYYG 766
               GI HRD+K  N+LLD     K+SDFGL+      +   + +   GT+ Y+ PE   
Sbjct: 123 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 767 NQQL-TEKSDVYSFGVVLLELISGKKP 792
            ++   E  DV+S G+VL  +++G+ P
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 593 NFCKKIGKGSFGSVYYGKMKDGKE-VAVKIM----ADSCSHRTQQFVTEVALLSRIHHRN 647
           +  + +G+G++G V     +  +E VAVKI+    A  C    ++   E+ +   ++H N
Sbjct: 9   DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EIXINKMLNHEN 65
Query: 648 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
           +V   G+  E + + L  EY   G L DR+   +     D     +  H    G+ YLH 
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD---AQRFFHQLMAGVVYLH- 121
Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE-EDLTHISSVARGTVGYLDPEYYG 766
               GI HRD+K  N+LLD     K+SDFGL+      +   + +   GT+ Y+ PE   
Sbjct: 122 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 767 NQQL-TEKSDVYSFGVVLLELISGKKP 792
            ++   E  DV+S G+VL  +++G+ P
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 111/226 (49%), Gaps = 30/226 (13%)
Query: 593 NFCKKIGKGSFGSVY----YGKMKD--GKEVAVKIMADSCSHRTQQ--FVTEVALLSRI- 643
           +F K +G G+FG V     YG +K      VAVK++  S +H T++   ++E+ +LS + 
Sbjct: 44  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLG 102
Query: 644 HHRNLVPLIGYCEEEHQRILVYEYMHNGTL-------RDRLHGSVNQKPL--------DW 688
           +H N+V L+G C      +++ EY   G L       RD    S     +        D 
Sbjct: 103 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 162
Query: 689 LTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 748
              L  ++  AKG+ +L    +   IHRD+ + NILL      K+ DFGL+R  + D  +
Sbjct: 163 EDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 219
Query: 749 -ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
            +   AR  V ++ PE   N   T +SDV+S+G+ L EL S G  P
Sbjct: 220 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 265

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 102/204 (50%), Gaps = 20/204 (9%)
Query: 598 IGKGSFGSVYYGKMK-DGKEVAVKIMAD-SCSHRT--QQFVTEVALLSRIHHRNLVPLIG 653
           +GKGSFG V   K K  G+E AVK+++      +T  +  + EV LL ++ H N++ L  
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 654 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 713
           + E++    LV E    G L D +   +++K    +   +I      G+ Y+H      I
Sbjct: 94  FFEDKGYFYLVGEVYTGGELFDEI---ISRKRFSEVDAARIIRQVLSGITYMHKN---KI 147
Query: 714 IHRDVKSSNILL-----DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
           +HRD+K  N+LL     D N+R  + DFGLS   E        +  GT  Y+ PE   + 
Sbjct: 148 VHRDLKPENLLLESKSKDANIR--IIDFGLSTHFEASKKMKDKI--GTAYYIAPEVL-HG 202
Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
              EK DV+S GV+L  L+SG  P
Sbjct: 203 TYDEKCDVWSTGVILYILLSGCPP 226

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 101/212 (47%), Gaps = 24/212 (11%)
Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 652
              K+IGKG +G V+ GK + G++VAVK+   +    +    TE+     + H N++  I
Sbjct: 40  QMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT-EEASWFRETEIYQTVLMRHENILGFI 97
Query: 653 GY----CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
                      Q  L+ +Y  NG+L D L  +     LD  + L++A+ +  GL +LHT 
Sbjct: 98  AADIKGTGSWTQLYLITDYHENGSLYDYLKSTT----LDAKSMLKLAYSSVSGLCHLHTE 153
Query: 709 C-----NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS---SVARGTVGYL 760
                  P I HRD+KS NIL+  N    ++D GL+ +   D   +    +   GT  Y+
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213
Query: 761 DPEYYGNQ------QLTEKSDVYSFGVVLLEL 786
            PE           Q    +D+YSFG++L E+
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 102/204 (50%), Gaps = 20/204 (9%)
Query: 598 IGKGSFGSVYYGKMK-DGKEVAVKIMAD-SCSHRT--QQFVTEVALLSRIHHRNLVPLIG 653
           +GKGSFG V   K K  G+E AVK+++      +T  +  + EV LL ++ H N++ L  
Sbjct: 57  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 116
Query: 654 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 713
           + E++    LV E    G L D +   +++K    +   +I      G+ Y+H      I
Sbjct: 117 FFEDKGYFYLVGEVYTGGELFDEI---ISRKRFSEVDAARIIRQVLSGITYMH---KNKI 170
Query: 714 IHRDVKSSNILL-----DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
           +HRD+K  N+LL     D N+R  + DFGLS   E        +  GT  Y+ PE   + 
Sbjct: 171 VHRDLKPENLLLESKSKDANIR--IIDFGLSTHFEASKKMKDKI--GTAYYIAPEVL-HG 225
Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
              EK DV+S GV+L  L+SG  P
Sbjct: 226 TYDEKCDVWSTGVILYILLSGCPP 249

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 109/205 (53%), Gaps = 15/205 (7%)
Query: 596 KKIGKGSFGSV---YYGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVP 650
           K++G G+FG+V   YY   K  K VAVKI+ +  +      + + E  ++ ++ +  +V 
Sbjct: 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 434
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 710
           +IG CE E   +LV E    G L   L  + + K  +    +++ H  + G++YL     
Sbjct: 435 MIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKN---IIELVHQVSMGMKYLEES-- 488
Query: 711 PGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPEYYGNQ 768
              +HRD+ + N+LL     AK+SDFGLS+  +A+E+     +  +  V +  PE     
Sbjct: 489 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 547
Query: 769 QLTEKSDVYSFGVVLLELIS-GKKP 792
           + + KSDV+SFGV++ E  S G+KP
Sbjct: 548 KFSSKSDVWSFGVLMWEAFSYGQKP 572

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 102/204 (50%), Gaps = 20/204 (9%)
Query: 598 IGKGSFGSVYYGKMK-DGKEVAVKIMAD-SCSHRT--QQFVTEVALLSRIHHRNLVPLIG 653
           +GKGSFG V   K K  G+E AVK+++      +T  +  + EV LL ++ H N++ L  
Sbjct: 58  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 117
Query: 654 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 713
           + E++    LV E    G L D +   +++K    +   +I      G+ Y+H      I
Sbjct: 118 FFEDKGYFYLVGEVYTGGELFDEI---ISRKRFSEVDAARIIRQVLSGITYMH---KNKI 171
Query: 714 IHRDVKSSNILL-----DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
           +HRD+K  N+LL     D N+R  + DFGLS   E        +  GT  Y+ PE   + 
Sbjct: 172 VHRDLKPENLLLESKSKDANIR--IIDFGLSTHFEASKKMKDKI--GTAYYIAPEVL-HG 226
Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
              EK DV+S GV+L  L+SG  P
Sbjct: 227 TYDEKCDVWSTGVILYILLSGCPP 250

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 106/211 (50%), Gaps = 23/211 (10%)
Query: 593 NFCKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQ--FVT-EVALLSRIHHRNL 648
            F K +G+GSF +V   + +   +E A+KI+      +  +  +VT E  ++SR+ H   
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 94
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           V L    +++ +      Y  NG L    R  GS ++      TR   A +    LEYLH
Sbjct: 95  VKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDET----CTRFYTA-EIVSALEYLH 149
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR-----GTVGYLD 761
                GIIHRD+K  NILL+ +M  +++DFG ++     L+  S  AR     GT  Y+ 
Sbjct: 150 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKV----LSPESKQARANSFVGTAQYVS 202
Query: 762 PEYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           PE    +  ++ SD+++ G ++ +L++G  P
Sbjct: 203 PELLTEKSASKSSDLWALGCIIYQLVAGLPP 233

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 94/205 (45%), Gaps = 21/205 (10%)
Query: 596 KKIGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPL 651
           + +GKG FG+VY  + K     VA+K++  S   +     Q   E+ + + +HH N++ L
Sbjct: 29  RPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRL 88
Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 711
             Y  +  +  L+ EY   G L   L  S      D      I  + A  L Y H     
Sbjct: 89  YNYFYDRRRIYLILEYAPRGELYKELQKSCT---FDEQRTATIMEELADALMYCH---GK 142
Query: 712 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDPEYYGN 767
            +IHRD+K  N+LL +    K++DFG S        H  S+ R    GT+ YL PE    
Sbjct: 143 KVIHRDIKPENLLLGLKGELKIADFGWS-------VHAPSLRRKTMCGTLDYLPPEMIEG 195
Query: 768 QQLTEKSDVYSFGVVLLELISGKKP 792
           +   EK D++  GV+  EL+ G  P
Sbjct: 196 RMHNEKVDLWCIGVLCYELLVGNPP 220

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 109/205 (53%), Gaps = 15/205 (7%)
Query: 596 KKIGKGSFGSV---YYGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVP 650
           K++G G+FG+V   YY   K  K VAVKI+ +  +      + + E  ++ ++ +  +V 
Sbjct: 376 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 435
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 710
           +IG CE E   +LV E    G L   L  + + K  +    +++ H  + G++YL     
Sbjct: 436 MIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKN---IIELVHQVSMGMKYLEES-- 489
Query: 711 PGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPEYYGNQ 768
              +HRD+ + N+LL     AK+SDFGLS+  +A+E+     +  +  V +  PE     
Sbjct: 490 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 548
Query: 769 QLTEKSDVYSFGVVLLELIS-GKKP 792
           + + KSDV+SFGV++ E  S G+KP
Sbjct: 549 KFSSKSDVWSFGVLMWEAFSYGQKP 573

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 598 IGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYC 655
           +G G++G VY G+ +K G+  A+K+M D      ++   E+ +L +  HHRN+    G  
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 90
Query: 656 EEEH------QRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTG 708
            +++      Q  LV E+   G++ D +  +  N    +W+    I  +  +GL +LH  
Sbjct: 91  IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA--YICREILRGLSHLH-- 146
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
               +IHRD+K  N+LL  N   K+ DFG+S Q +  +   ++   GT  ++ PE     
Sbjct: 147 -QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACD 204
Query: 769 QLTE-----KSDVYSFGVVLLELISGKKPV 793
           +  +     KSD++S G+  +E+  G  P+
Sbjct: 205 ENPDATYDFKSDLWSLGITAIEMAEGAPPL 234

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 103/207 (49%), Gaps = 17/207 (8%)
Query: 593 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVP 650
           +F   +G G+F  V   + K   K VA+K +A ++   +      E+A+L +I H N+V 
Sbjct: 21  DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVA 80
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    E      L+ + +  G L DR+   G   ++    L   Q+  DA K   YLH  
Sbjct: 81  LDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLI-FQVL-DAVK---YLH-- 133
Query: 709 CNPGIIHRDVKSSNIL---LDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 765
            + GI+HRD+K  N+L   LD + +  +SDFGLS+   ED   + S A GT GY+ PE  
Sbjct: 134 -DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGTPGYVAPEVL 190
Query: 766 GNQQLTEKSDVYSFGVVLLELISGKKP 792
             +  ++  D +S GV+   L+ G  P
Sbjct: 191 AQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 105/211 (49%), Gaps = 23/211 (10%)
Query: 593 NFCKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQ--FVT-EVALLSRIHHRNL 648
            F K +G+GSF +V   + +   +E A+KI+      +  +  +VT E  ++SR+ H   
Sbjct: 13  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 72
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           V L    +++ +      Y  NG L    R  GS ++      TR   A +    LEYLH
Sbjct: 73  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTA-EIVSALEYLH 127
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR-----GTVGYLD 761
                GIIHRD+K  NILL+ +M  +++DFG ++     L+  S  AR     GT  Y+ 
Sbjct: 128 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKV----LSPESKQARANXFVGTAQYVS 180
Query: 762 PEYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           PE    +   + SD+++ G ++ +L++G  P
Sbjct: 181 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 211

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 103/207 (49%), Gaps = 17/207 (8%)
Query: 593 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVP 650
           +F   +G G+F  V   + K   K VA+K +A ++   +      E+A+L +I H N+V 
Sbjct: 21  DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVA 80
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    E      L+ + +  G L DR+   G   ++    L   Q+  DA K   YLH  
Sbjct: 81  LDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLI-FQVL-DAVK---YLH-- 133
Query: 709 CNPGIIHRDVKSSNIL---LDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 765
            + GI+HRD+K  N+L   LD + +  +SDFGLS+   ED   + S A GT GY+ PE  
Sbjct: 134 -DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGTPGYVAPEVL 190
Query: 766 GNQQLTEKSDVYSFGVVLLELISGKKP 792
             +  ++  D +S GV+   L+ G  P
Sbjct: 191 AQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 103/207 (49%), Gaps = 17/207 (8%)
Query: 593 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVP 650
           +F   +G G+F  V   + K   K VA+K +A ++   +      E+A+L +I H N+V 
Sbjct: 21  DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVA 80
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    E      L+ + +  G L DR+   G   ++    L   Q+  DA K   YLH  
Sbjct: 81  LDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLI-FQVL-DAVK---YLH-- 133
Query: 709 CNPGIIHRDVKSSNIL---LDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 765
            + GI+HRD+K  N+L   LD + +  +SDFGLS+   ED   + S A GT GY+ PE  
Sbjct: 134 -DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGTPGYVAPEVL 190
Query: 766 GNQQLTEKSDVYSFGVVLLELISGKKP 792
             +  ++  D +S GV+   L+ G  P
Sbjct: 191 AQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 105/211 (49%), Gaps = 23/211 (10%)
Query: 593 NFCKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQ--FVT-EVALLSRIHHRNL 648
            F K +G+GSF +V   + +   +E A+KI+      +  +  +VT E  ++SR+ H   
Sbjct: 12  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 71
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           V L    +++ +      Y  NG L    R  GS ++      TR   A +    LEYLH
Sbjct: 72  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTA-EIVSALEYLH 126
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR-----GTVGYLD 761
                GIIHRD+K  NILL+ +M  +++DFG ++     L+  S  AR     GT  Y+ 
Sbjct: 127 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKV----LSPESKQARANXFVGTAQYVS 179
Query: 762 PEYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           PE    +   + SD+++ G ++ +L++G  P
Sbjct: 180 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 210

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 105/211 (49%), Gaps = 23/211 (10%)
Query: 593 NFCKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQ--FVT-EVALLSRIHHRNL 648
            F K +G+GSF +V   + +   +E A+KI+      +  +  +VT E  ++SR+ H   
Sbjct: 10  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 69
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           V L    +++ +      Y  NG L    R  GS ++      TR   A +    LEYLH
Sbjct: 70  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTA-EIVSALEYLH 124
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR-----GTVGYLD 761
                GIIHRD+K  NILL+ +M  +++DFG ++     L+  S  AR     GT  Y+ 
Sbjct: 125 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKV----LSPESKQARANXFVGTAQYVS 177
Query: 762 PEYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           PE    +   + SD+++ G ++ +L++G  P
Sbjct: 178 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 208

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 97/203 (47%), Gaps = 17/203 (8%)
Query: 596 KKIGKGSFGSV---YYGKMKDG--KEVAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLV 649
           + +G+G FG V    Y    DG  + VAVK + AD+       +  E+ +L  ++H +++
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 650 PLIGYCEEEHQRIL--VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
              G CE+     L  V EY+  G+LRD L     +  +     L  A    +G+ YLH 
Sbjct: 97  KYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLHA 152
Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE--DLTHISSVARGTVGYLDPEYY 765
                 IHRD+ + N+LLD +   K+ DFGL++   E  +   +       V +  PE  
Sbjct: 153 ---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECL 209
Query: 766 GNQQLTEKSDVYSFGVVLLELIS 788
              +    SDV+SFGV L EL++
Sbjct: 210 KEYKFYYASDVWSFGVTLYELLT 232

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 102/202 (50%), Gaps = 17/202 (8%)
Query: 598 IGKGSFGSVYYGKMKDGKEV-AVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIG 653
           +GKG F   Y     D KEV A K++  S     H+ ++  TE+A+   + + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 654 YCEEEHQRILVYEYMHNGTLRDRLHG---SVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 710
           + E++    +V E     +L + LH    +V +    +  R  I     +G++YLH   N
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTI-----QGVQYLH---N 160
Query: 711 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 770
             +IHRD+K  N+ L+ +M  K+ DFGL+ + E D     ++  GT  Y+ PE    +  
Sbjct: 161 NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLC-GTPNYIAPEVLCKKGH 219
Query: 771 TEKSDVYSFGVVLLELISGKKP 792
           + + D++S G +L  L+ GK P
Sbjct: 220 SFEVDIWSLGCILYTLLVGKPP 241

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 104/207 (50%), Gaps = 15/207 (7%)
Query: 593 NFCKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQ--FVT-EVALLSRIHHRNL 648
            F K +G+GSF +V   + +   +E A+KI+      +  +  +VT E  ++SR+ H   
Sbjct: 33  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           V L    +++ +      Y  NG L    R  GS ++      TR   A +    LEYLH
Sbjct: 93  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTA-EIVSALEYLH 147
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR-QAEEDLTHISSVARGTVGYLDPEYY 765
                GIIHRD+K  NILL+ +M  +++DFG ++  + E     ++   GT  Y+ PE  
Sbjct: 148 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELL 204
Query: 766 GNQQLTEKSDVYSFGVVLLELISGKKP 792
             +   + SD+++ G ++ +L++G  P
Sbjct: 205 TEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 105/211 (49%), Gaps = 23/211 (10%)
Query: 593 NFCKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQ--FVT-EVALLSRIHHRNL 648
            F K +G+GSF +V   + +   +E A+KI+      +  +  +VT E  ++SR+ H   
Sbjct: 11  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 70
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           V L    +++ +      Y  NG L    R  GS ++      TR   A +    LEYLH
Sbjct: 71  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTA-EIVSALEYLH 125
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR-----GTVGYLD 761
                GIIHRD+K  NILL+ +M  +++DFG ++     L+  S  AR     GT  Y+ 
Sbjct: 126 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKV----LSPESKQARANXFVGTAQYVS 178
Query: 762 PEYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           PE    +   + SD+++ G ++ +L++G  P
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 209

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 105/211 (49%), Gaps = 23/211 (10%)
Query: 593 NFCKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQ--FVT-EVALLSRIHHRNL 648
            F K +G+GSF +V   + +   +E A+KI+      +  +  +VT E  ++SR+ H   
Sbjct: 38  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 97
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           V L    +++ +      Y  NG L    R  GS ++      TR   A +    LEYLH
Sbjct: 98  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTA-EIVSALEYLH 152
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR-----GTVGYLD 761
                GIIHRD+K  NILL+ +M  +++DFG ++     L+  S  AR     GT  Y+ 
Sbjct: 153 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKV----LSPESKQARANXFVGTAQYVS 205
Query: 762 PEYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           PE    +   + SD+++ G ++ +L++G  P
Sbjct: 206 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 236

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 98/211 (46%), Gaps = 17/211 (8%)
Query: 594 FCKKIGKGSFGSVYYGKMK-DGKEVAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPL 651
           F + +G G+F  V   + K  GK  AVK I   +   +      E+A+L +I H N+V L
Sbjct: 26  FKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIVAL 85
Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 709
               E  +   LV + +  G L DR+   G   +K    L R  +       + YLH   
Sbjct: 86  EDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVL-----DAVYYLH--- 137
Query: 710 NPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 766
             GI+HRD+K  N+L    D   +  +SDFGLS+   E    + S A GT GY+ PE   
Sbjct: 138 RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKM--EGKGDVMSTACGTPGYVAPEVLA 195
Query: 767 NQQLTEKSDVYSFGVVLLELISGKKPVSVED 797
            +  ++  D +S GV+   L+ G  P   E+
Sbjct: 196 QKPYSKAVDCWSIGVIAYILLCGYPPFYDEN 226

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 98/204 (48%), Gaps = 16/204 (7%)
Query: 596 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQ---FVTEVALLSRIHHRNLVPL 651
           KK+G G++G V   K K  G E A+KI+  S    T      + EVA+L ++ H N++ L
Sbjct: 27  KKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKL 86
Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 711
             + E++    LV E    G L D +   + ++    +    I      G  YLH     
Sbjct: 87  YEFFEDKRNYYLVMEVYRGGELFDEI---ILRQKFSEVDAAVIMKQVLSGTTYLH---KH 140
Query: 712 GIIHRDVKSSNILLDINMR---AKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
            I+HRD+K  N+LL+   R    K+ DFGLS  A  ++        GT  Y+ PE    +
Sbjct: 141 NIVHRDLKPENLLLESKSRDALIKIVDFGLS--AHFEVGGKMKERLGTAYYIAPEVL-RK 197
Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
           +  EK DV+S GV+L  L+ G  P
Sbjct: 198 KYDEKCDVWSCGVILYILLCGYPP 221

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 25/217 (11%)
Query: 593 NFCKKIGKGSFGSVY------YGKMKDGKEVAVKIMADSCSHRTQQ--FVTEVALLSRI- 643
            F K +G G+FG V        GK     +VAVK M  S +H  ++   ++E+ ++S + 
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVK-MLKSTAHADEKEALMSELKIMSHLG 107
Query: 644 HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG-----------SVNQKPLDWLTRL 692
            H N+V L+G C      +++ EY   G L + L             ++          L
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167
Query: 693 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SS 751
             +   A+G+ +L    +   IHRDV + N+LL     AK+ DFGL+R    D  +I   
Sbjct: 168 HFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG 224
Query: 752 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
            AR  V ++ PE   +   T +SDV+S+G++L E+ S
Sbjct: 225 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 107/218 (49%), Gaps = 23/218 (10%)
Query: 593 NFCKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQ--FVT-EVALLSRIHHRNL 648
            F K +G+GSF +V   + +   +E A+KI+      +  +  +VT E  ++SR+ H   
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 94
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           V L    +++ +      Y  NG L    R  GS ++      TR   A +    LEYLH
Sbjct: 95  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTA-EIVSALEYLH 149
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR-----GTVGYLD 761
                GIIHRD+K  NILL+ +M  +++DFG ++     L+  S  AR     GT  Y+ 
Sbjct: 150 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKV----LSPESKQARANXFVGTAQYVS 202
Query: 762 PEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG 799
           PE    +   + SD+++ G ++ +L++G  P    + G
Sbjct: 203 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG 240

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 105/211 (49%), Gaps = 23/211 (10%)
Query: 593 NFCKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQ--FVT-EVALLSRIHHRNL 648
            F K +G+GSF +V   + +   +E A+KI+      +  +  +VT E  ++SR+ H   
Sbjct: 36  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 95
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           V L    +++ +      Y  NG L    R  GS ++      TR   A +    LEYLH
Sbjct: 96  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTA-EIVSALEYLH 150
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR-----GTVGYLD 761
                GIIHRD+K  NILL+ +M  +++DFG ++     L+  S  AR     GT  Y+ 
Sbjct: 151 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKV----LSPESKQARANXFVGTAQYVS 203
Query: 762 PEYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           PE    +   + SD+++ G ++ +L++G  P
Sbjct: 204 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 105/211 (49%), Gaps = 23/211 (10%)
Query: 593 NFCKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQ--FVT-EVALLSRIHHRNL 648
            F K +G+GSF +V   + +   +E A+KI+      +  +  +VT E  ++SR+ H   
Sbjct: 33  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           V L    +++ +      Y  NG L    R  GS ++      TR   A +    LEYLH
Sbjct: 93  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTA-EIVSALEYLH 147
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR-----GTVGYLD 761
                GIIHRD+K  NILL+ +M  +++DFG ++     L+  S  AR     GT  Y+ 
Sbjct: 148 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKV----LSPESKQARANXFVGTAQYVS 200
Query: 762 PEYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           PE    +   + SD+++ G ++ +L++G  P
Sbjct: 201 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 105/211 (49%), Gaps = 23/211 (10%)
Query: 593 NFCKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQ--FVT-EVALLSRIHHRNL 648
            F K +G+GSF +V   + +   +E A+KI+      +  +  +VT E  ++SR+ H   
Sbjct: 36  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 95
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           V L    +++ +      Y  NG L    R  GS ++      TR   A +    LEYLH
Sbjct: 96  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTA-EIVSALEYLH 150
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR-----GTVGYLD 761
                GIIHRD+K  NILL+ +M  +++DFG ++     L+  S  AR     GT  Y+ 
Sbjct: 151 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKV----LSPESKQARANSFVGTAQYVS 203
Query: 762 PEYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           PE    +   + SD+++ G ++ +L++G  P
Sbjct: 204 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 107/218 (49%), Gaps = 23/218 (10%)
Query: 593 NFCKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQ--FVT-EVALLSRIHHRNL 648
            F K +G+GSF +V   + +   +E A+KI+      +  +  +VT E  ++SR+ H   
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 94
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           V L    +++ +      Y  NG L    R  GS ++      TR   A +    LEYLH
Sbjct: 95  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTA-EIVSALEYLH 149
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR-----GTVGYLD 761
                GIIHRD+K  NILL+ +M  +++DFG ++     L+  S  AR     GT  Y+ 
Sbjct: 150 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKV----LSPESKQARANXFVGTAQYVS 202
Query: 762 PEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG 799
           PE    +   + SD+++ G ++ +L++G  P    + G
Sbjct: 203 PELLTEKSAXKSSDLWALGCIIYQLVAGLPPFRAGNEG 240

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 105/211 (49%), Gaps = 23/211 (10%)
Query: 593 NFCKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQ--FVT-EVALLSRIHHRNL 648
            F K +G+GSF +V   + +   +E A+KI+      +  +  +VT E  ++SR+ H   
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 94
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           V L    +++ +      Y  NG L    R  GS ++      TR   A +    LEYLH
Sbjct: 95  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTA-EIVSALEYLH 149
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR-----GTVGYLD 761
                GIIHRD+K  NILL+ +M  +++DFG ++     L+  S  AR     GT  Y+ 
Sbjct: 150 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKV----LSPESKQARANXFVGTAQYVS 202
Query: 762 PEYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           PE    +   + SD+++ G ++ +L++G  P
Sbjct: 203 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 102/203 (50%), Gaps = 15/203 (7%)
Query: 596 KKIGKGSFGSVYYGKM-----KDGKEVAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLV 649
           + +G+G FG V   +        G++VAVK +  +S  +       E+ +L  ++H N+V
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 650 PLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
              G C E+      L+ E++ +G+L++ L    N+  ++   +L+ A    KG++YL +
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLGS 144
Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED--LTHISSVARGTVGYLDPEYY 765
                 +HRD+ + N+L++   + K+ DFGL++  E D     +       V +  PE  
Sbjct: 145 ---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECL 201
Query: 766 GNQQLTEKSDVYSFGVVLLELIS 788
              +    SDV+SFGV L EL++
Sbjct: 202 MQSKFYIASDVWSFGVTLHELLT 224

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 105/211 (49%), Gaps = 23/211 (10%)
Query: 593 NFCKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQ--FVT-EVALLSRIHHRNL 648
            F K +G+GSF +V   + +   +E A+KI+      +  +  +VT E  ++SR+ H   
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 94
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           V L    +++ +      Y  NG L    R  GS ++      TR   A +    LEYLH
Sbjct: 95  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTA-EIVSALEYLH 149
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR-----GTVGYLD 761
                GIIHRD+K  NILL+ +M  +++DFG ++     L+  S  AR     GT  Y+ 
Sbjct: 150 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKV----LSPESKQARANXFVGTAQYVS 202
Query: 762 PEYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           PE    +   + SD+++ G ++ +L++G  P
Sbjct: 203 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 16/207 (7%)
Query: 593 NFCKKIGKGSFGSVYYGKMKDGKE-VAVKIM----ADSCSHRTQQFVTEVALLSRIHHRN 647
           +  + +G+G+ G V     +  +E VAVKI+    A  C    ++   E+ +   ++H N
Sbjct: 9   DLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHEN 65
Query: 648 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
           +V   G+  E + + L  EY   G L DR+   +     D     +  H    G+ YLH 
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD---AQRFFHQLMAGVVYLH- 121
Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE-EDLTHISSVARGTVGYLDPEYYG 766
               GI HRD+K  N+LLD     K+SDFGL+      +   + +   GT+ Y+ PE   
Sbjct: 122 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 767 NQQL-TEKSDVYSFGVVLLELISGKKP 792
            ++   E  DV+S G+VL  +++G+ P
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 105/211 (49%), Gaps = 23/211 (10%)
Query: 593 NFCKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQ--FVT-EVALLSRIHHRNL 648
            F K +G+GSF +V   + +   +E A+KI+      +  +  +VT E  ++SR+ H   
Sbjct: 33  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           V L    +++ +      Y  NG L    R  GS ++      TR   A +    LEYLH
Sbjct: 93  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTA-EIVSALEYLH 147
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR-----GTVGYLD 761
                GIIHRD+K  NILL+ +M  +++DFG ++     L+  S  AR     GT  Y+ 
Sbjct: 148 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKV----LSPESKQARANXFVGTAQYVS 200
Query: 762 PEYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           PE    +   + SD+++ G ++ +L++G  P
Sbjct: 201 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 105/211 (49%), Gaps = 23/211 (10%)
Query: 593 NFCKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQ--FVT-EVALLSRIHHRNL 648
            F K +G+GSF +V   + +   +E A+KI+      +  +  +VT E  ++SR+ H   
Sbjct: 40  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 99
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           V L    +++ +      Y  NG L    R  GS ++      TR   A +    LEYLH
Sbjct: 100 VKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTA-EIVSALEYLH 154
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR-----GTVGYLD 761
                GIIHRD+K  NILL+ +M  +++DFG ++     L+  S  AR     GT  Y+ 
Sbjct: 155 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKV----LSPESKQARANXFVGTAQYVS 207
Query: 762 PEYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           PE    +   + SD+++ G ++ +L++G  P
Sbjct: 208 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 238

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 95/210 (45%), Gaps = 25/210 (11%)
Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRT---QQFVTEVALLSRIHHRNL 648
           +  + +GKG FG+VY  + K  K + A+K++  S   +     Q   E+ + S + H N+
Sbjct: 17  DIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNI 76
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           + +  Y  +  +  L+ E+   G L   L  HG  +++            + A  L Y H
Sbjct: 77  LRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQ-----RSATFMEELADALHYCH 131
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDP 762
                 +IHRD+K  N+L+      K++DFG S        H  S+ R    GT+ YL P
Sbjct: 132 ER---KVIHRDIKPENLLMGYKGELKIADFGWS-------VHAPSLRRRXMCGTLDYLPP 181
Query: 763 EYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           E    +   EK D++  GV+  E + G  P
Sbjct: 182 EMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 102/203 (50%), Gaps = 15/203 (7%)
Query: 596 KKIGKGSFGSVYYGKM-----KDGKEVAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLV 649
           + +G+G FG V   +        G++VAVK +  +S  +       E+ +L  ++H N+V
Sbjct: 15  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 74
Query: 650 PLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
              G C E+      L+ E++ +G+L++ L    N+  ++   +L+ A    KG++YL +
Sbjct: 75  KYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLGS 132
Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED--LTHISSVARGTVGYLDPEYY 765
                 +HRD+ + N+L++   + K+ DFGL++  E D     +       V +  PE  
Sbjct: 133 ---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECL 189
Query: 766 GNQQLTEKSDVYSFGVVLLELIS 788
              +    SDV+SFGV L EL++
Sbjct: 190 MQSKFYIASDVWSFGVTLHELLT 212

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 105/211 (49%), Gaps = 23/211 (10%)
Query: 593 NFCKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQ--FVT-EVALLSRIHHRNL 648
            F K +G+GSF +V   + +   +E A+KI+      +  +  +VT E  ++SR+ H   
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 94
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           V L    +++ +      Y  NG L    R  GS ++      TR   A +    LEYLH
Sbjct: 95  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTA-EIVSALEYLH 149
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR-----GTVGYLD 761
                GIIHRD+K  NILL+ +M  +++DFG ++     L+  S  AR     GT  Y+ 
Sbjct: 150 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKV----LSPESKQARANXFVGTAQYVS 202
Query: 762 PEYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           PE    +   + SD+++ G ++ +L++G  P
Sbjct: 203 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 26/214 (12%)
Query: 596 KKIGKGSFGSVYYGKMKDGK-EVAVKIMADSCSHRT-------------QQFVTEVALLS 641
           +K+G G++G V   K K+G  E A+K++  S   +              ++   E++LL 
Sbjct: 42  RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 642 RIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 701
            + H N++ L    E++    LV E+   G L +++   +N+   D      I      G
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI---INRHKFDECDAANIMKQILSG 158
Query: 702 LEYLHTGCNPGIIHRDVKSSNILLDIN---MRAKVSDFGLSRQAEEDLTHISSVARGTVG 758
           + YLH      I+HRD+K  NILL+     +  K+ DFGLS    +D      +  GT  
Sbjct: 159 ICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL--GTAY 213
Query: 759 YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           Y+ PE    ++  EK DV+S GV++  L+ G  P
Sbjct: 214 YIAPEVL-KKKYNEKCDVWSCGVIMYILLCGYPP 246

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 101/202 (50%), Gaps = 17/202 (8%)
Query: 598 IGKGSFGSVYYGKMKDGKEV-AVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIG 653
           +GKG F   Y     D KEV A K++  S     H+ ++  TE+A+   + + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 654 YCEEEHQRILVYEYMHNGTLRDRLHG---SVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 710
           + E++    +V E     +L + LH    +V +    +  R  I     +G++YLH   N
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTI-----QGVQYLH---N 160
Query: 711 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 770
             +IHRD+K  N+ L+ +M  K+ DFGL+ + E D      +  GT  Y+ PE    +  
Sbjct: 161 NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLC-GTPNYIAPEVLCKKGH 219
Query: 771 TEKSDVYSFGVVLLELISGKKP 792
           + + D++S G +L  L+ GK P
Sbjct: 220 SFEVDIWSLGCILYTLLVGKPP 241

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 101/202 (50%), Gaps = 17/202 (8%)
Query: 598 IGKGSFGSVYYGKMKDGKEV-AVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIG 653
           +GKG F   Y     D KEV A K++  S     H+ ++  TE+A+   + + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 654 YCEEEHQRILVYEYMHNGTLRDRLHG---SVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 710
           + E++    +V E     +L + LH    +V +    +  R  I     +G++YLH   N
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTI-----QGVQYLH---N 160
Query: 711 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 770
             +IHRD+K  N+ L+ +M  K+ DFGL+ + E D      +  GT  Y+ PE    +  
Sbjct: 161 NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLC-GTPNYIAPEVLCKKGH 219
Query: 771 TEKSDVYSFGVVLLELISGKKP 792
           + + D++S G +L  L+ GK P
Sbjct: 220 SFEVDIWSLGCILYTLLVGKPP 241

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 105/211 (49%), Gaps = 23/211 (10%)
Query: 593 NFCKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQ--FVT-EVALLSRIHHRNL 648
            F K +G+GSF +V   + +   +E A+KI+      +  +  +VT E  ++SR+ H   
Sbjct: 32  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 91
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           V L    +++ +      Y  NG L   +   GS ++      TR   A +    LEYLH
Sbjct: 92  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTA-EIVSALEYLH 146
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR-----GTVGYLD 761
                GIIHRD+K  NILL+ +M  +++DFG ++     L+  S  AR     GT  Y+ 
Sbjct: 147 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKV----LSPESKQARANSFVGTAQYVS 199
Query: 762 PEYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           PE    +   + SD+++ G ++ +L++G  P
Sbjct: 200 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 230

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 105/211 (49%), Gaps = 23/211 (10%)
Query: 593 NFCKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQ--FVT-EVALLSRIHHRNL 648
            F K +G+GSF +V   + +   +E A+KI+      +  +  +VT E  ++SR+ H   
Sbjct: 17  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 76
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           V L    +++ +      Y  NG L    R  GS ++      TR   A +    LEYLH
Sbjct: 77  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTA-EIVSALEYLH 131
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR-----GTVGYLD 761
                GIIHRD+K  NILL+ +M  +++DFG ++     L+  S  AR     GT  Y+ 
Sbjct: 132 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKV----LSPESKQARANXFVGTAQYVS 184
Query: 762 PEYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           PE    +   + SD+++ G ++ +L++G  P
Sbjct: 185 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 215

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 16/204 (7%)
Query: 596 KKIGKGSFGSVYYG-KMKDGKEVAVKIM----ADSCSHRTQQFVTEVALLSRIHHRNLVP 650
           ++IGKGSFG V+ G   +  + VA+KI+    A+      QQ   E+ +LS+     +  
Sbjct: 29  ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSSYVTK 85
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 710
             G   +  +  ++ EY+  G+  D L       P D      +  +  KGL+YLH+   
Sbjct: 86  YYGSYLKGSKLWIIMEYLGGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLHSEKK 141
Query: 711 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 770
              IHRD+K++N+LL      K++DFG++ Q  +     ++   GT  ++ PE       
Sbjct: 142 ---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSAY 197
Query: 771 TEKSDVYSFGVVLLELISGKKPVS 794
             K+D++S G+  +EL  G+ P S
Sbjct: 198 DSKADIWSLGITAIELAKGEPPNS 221

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 107/204 (52%), Gaps = 18/204 (8%)
Query: 598 IGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 656
           +GKG++G VY G+ + +   +A+K + +  S  +Q    E+AL   + H+N+V  +G   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 657 EEHQRILVYEYMHNGTLRDRLHGSV-----NQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 711
           E     +  E +  G+L   L         N++ + + T+ QI     +GL+YLH   + 
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK-QI----LEGLKYLH---DN 141
Query: 712 GIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY--GNQ 768
            I+HRD+K  N+L++  +   K+SDFG S++    +   +    GT+ Y+ PE    G +
Sbjct: 142 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRL-AGINPCTETFTGTLQYMAPEIIDKGPR 200
Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
              + +D++S G  ++E+ +GK P
Sbjct: 201 GYGKAADIWSLGCTIIEMATGKPP 224

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 104/212 (49%), Gaps = 17/212 (8%)
Query: 593 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMAD-SCSHRTQQFVTEVALLSRIHHRNLVP 650
           +F   +G G+F  V   + K   K VA+K +A  +   +      E+A+L +I H N+V 
Sbjct: 21  DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVA 80
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    E      L+ + +  G L DR+   G   ++    L   Q+  DA K   YLH  
Sbjct: 81  LDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLI-FQVL-DAVK---YLH-- 133
Query: 709 CNPGIIHRDVKSSNIL---LDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 765
            + GI+HRD+K  N+L   LD + +  +SDFGLS+   ED   + S A GT GY+ PE  
Sbjct: 134 -DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGTPGYVAPEVL 190
Query: 766 GNQQLTEKSDVYSFGVVLLELISGKKPVSVED 797
             +  ++  D +S GV+   L+ G  P   E+
Sbjct: 191 AQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN 222

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 105/211 (49%), Gaps = 23/211 (10%)
Query: 593 NFCKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQ--FVT-EVALLSRIHHRNL 648
            F K +G+GSF +V   + +   +E A+KI+      +  +  +VT E  ++SR+ H   
Sbjct: 32  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 91
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           V L    +++ +      Y  NG L   +   GS ++      TR   A +    LEYLH
Sbjct: 92  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTA-EIVSALEYLH 146
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR-----GTVGYLD 761
                GIIHRD+K  NILL+ +M  +++DFG ++     L+  S  AR     GT  Y+ 
Sbjct: 147 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKV----LSPESKQARANXFVGTAQYVS 199
Query: 762 PEYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           PE    +   + SD+++ G ++ +L++G  P
Sbjct: 200 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 230

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 101/202 (50%), Gaps = 17/202 (8%)
Query: 598 IGKGSFGSVYYGKMKDGKEV-AVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIG 653
           +GKG F   Y     D KEV A K++  S     H+ ++  TE+A+   + + ++V   G
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 93
Query: 654 YCEEEHQRILVYEYMHNGTLRDRLHG---SVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 710
           + E++    +V E     +L + LH    +V +    +  R  I     +G++YLH   N
Sbjct: 94  FFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTI-----QGVQYLH---N 144
Query: 711 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 770
             +IHRD+K  N+ L+ +M  K+ DFGL+ + E D      +  GT  Y+ PE    +  
Sbjct: 145 NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLC-GTPNYIAPEVLCKKGH 203
Query: 771 TEKSDVYSFGVVLLELISGKKP 792
           + + D++S G +L  L+ GK P
Sbjct: 204 SFEVDIWSLGCILYTLLVGKPP 225

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 100/204 (49%), Gaps = 20/204 (9%)
Query: 598 IGKGSFGSVYYGKMK-DGKEVAVKIMAD-SCSHRT--QQFVTEVALLSRIHHRNLVPLIG 653
           +GKGSFG V   K K  G+E AVK+++      +T  +  + EV LL ++ H N+  L  
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLYE 93
Query: 654 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 713
           + E++    LV E    G L D +   +++K    +   +I      G+ Y H      I
Sbjct: 94  FFEDKGYFYLVGEVYTGGELFDEI---ISRKRFSEVDAARIIRQVLSGITYXHKN---KI 147
Query: 714 IHRDVKSSNILL-----DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
           +HRD+K  N+LL     D N+R  + DFGLS   E        +  GT  Y+ PE   + 
Sbjct: 148 VHRDLKPENLLLESKSKDANIR--IIDFGLSTHFEASKKXKDKI--GTAYYIAPEVL-HG 202
Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
              EK DV+S GV+L  L+SG  P
Sbjct: 203 TYDEKCDVWSTGVILYILLSGCPP 226

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 25/207 (12%)
Query: 596 KKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPL 651
           + +GKG FG+VY  + K  K + A+K++  S   +     Q   E+ + S + H N++ +
Sbjct: 21  RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 80
Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 709
             Y  +  +  L+ E+   G L   L  HG  +++            + A  L Y H   
Sbjct: 81  YNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQ-----RSATFMEELADALHYCHER- 134
Query: 710 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDPEYY 765
              +IHRD+K  N+L+      K++DFG S        H  S+ R    GT+ YL PE  
Sbjct: 135 --KVIHRDIKPENLLMGYKGELKIADFGWS-------VHAPSLRRRXMCGTLDYLPPEMI 185
Query: 766 GNQQLTEKSDVYSFGVVLLELISGKKP 792
             +   EK D++  GV+  E + G  P
Sbjct: 186 EGKTHDEKVDLWCAGVLCYEFLVGMPP 212

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 107/204 (52%), Gaps = 18/204 (8%)
Query: 598 IGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 656
           +GKG++G VY G+ + +   +A+K + +  S  +Q    E+AL   + H+N+V  +G   
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 75
Query: 657 EEHQRILVYEYMHNGTLRDRLHGSV-----NQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 711
           E     +  E +  G+L   L         N++ + + T+ QI     +GL+YLH   + 
Sbjct: 76  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK-QI----LEGLKYLH---DN 127
Query: 712 GIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY--GNQ 768
            I+HRD+K  N+L++  +   K+SDFG S++    +   +    GT+ Y+ PE    G +
Sbjct: 128 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRL-AGINPCTETFTGTLQYMAPEIIDKGPR 186
Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
              + +D++S G  ++E+ +GK P
Sbjct: 187 GYGKAADIWSLGCTIIEMATGKPP 210

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 99/208 (47%), Gaps = 19/208 (9%)
Query: 593 NFCKKIGKGSFGSVYYGKMKD---GKEVAVKIM--ADSCSHRTQQFVTEVALLSRIHHRN 647
           N    +GKGSFG V   K KD    +E AVK++  A + +  T   + EV LL ++ H N
Sbjct: 25  NIVCMLGKGSFGEVL--KCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPN 82
Query: 648 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
           ++ L    E+     +V E    G L D +   + +K        +I      G+ Y+H 
Sbjct: 83  IMKLFEILEDSSSFYIVGELYTGGELFDEI---IKRKRFSEHDAARIIKQVFSGITYMH- 138
Query: 708 GCNPGIIHRDVKSSNILLDINMR---AKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
                I+HRD+K  NILL+   +    K+ DFGLS   +++      +  GT  Y+ PE 
Sbjct: 139 --KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIAPEV 194
Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKP 792
                  EK DV+S GV+L  L+SG  P
Sbjct: 195 LRGT-YDEKCDVWSAGVILYILLSGTPP 221

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 101/204 (49%), Gaps = 18/204 (8%)
Query: 597 KIGKGSFGSVYYGKMKDGKEV-AVKIM----ADSCSHRTQQFVTEVALLSRIHHRNLVPL 651
           +IGKGSFG VY G     KEV A+KI+    A+      QQ   E+ +LS+     +   
Sbjct: 26  RIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSPYITRY 82
Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 711
            G   +  +  ++ EY+  G+  D L       PL+      I  +  KGL+YLH+    
Sbjct: 83  FGSYLKSTKLWIIMEYLGGGSALDLL----KPGPLEETYIATILREILKGLDYLHSERK- 137
Query: 712 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS-SVARGTVGYLDPEYYGNQQL 770
             IHRD+K++N+LL      K++DFG++ Q  +  T I  +   GT  ++ PE       
Sbjct: 138 --IHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNXFVGTPFWMAPEVIKQSAY 193
Query: 771 TEKSDVYSFGVVLLELISGKKPVS 794
             K+D++S G+  +EL  G+ P S
Sbjct: 194 DFKADIWSLGITAIELAKGEPPNS 217

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 99/214 (46%), Gaps = 14/214 (6%)
Query: 588 EEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQ-----FVTEVALLSR 642
           E    +  + IGKG FG VY+G+  D  +  ++    S S  T+      F+ E  L+  
Sbjct: 19  ERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRG 78
Query: 643 IHHRNLVPLIG-YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 701
           ++H N++ LIG     E    ++  YM +G L   +        +  L    +    A+G
Sbjct: 79  LNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGL--QVARG 136
Query: 702 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA---EEDLTHISSVARGTVG 758
           +EYL        +HRD+ + N +LD +   KV+DFGL+R     E         AR  V 
Sbjct: 137 MEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVK 193
Query: 759 YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           +   E     + T KSDV+SFGV+L EL++   P
Sbjct: 194 WTALESLQTYRFTTKSDVWSFGVLLWELLTRGAP 227

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 97/204 (47%), Gaps = 16/204 (7%)
Query: 596 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQ---FVTEVALLSRIHHRNLVPL 651
           KK+G G++G V   K K  G E A+KI+  S    T      + EVA+L ++ H N++ L
Sbjct: 10  KKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKL 69
Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 711
             + E++    LV E    G L D +   + ++    +    I      G  YLH     
Sbjct: 70  YEFFEDKRNYYLVMEVYRGGELFDEI---ILRQKFSEVDAAVIMKQVLSGTTYLH---KH 123
Query: 712 GIIHRDVKSSNILLDINMR---AKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
            I+HRD+K  N+LL+   R    K+ DFGLS   E  +        GT  Y+ PE    +
Sbjct: 124 NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFE--VGGKMKERLGTAYYIAPEVL-RK 180
Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
           +  EK DV+S GV+L  L+ G  P
Sbjct: 181 KYDEKCDVWSCGVILYILLCGYPP 204

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 99/208 (47%), Gaps = 19/208 (9%)
Query: 593 NFCKKIGKGSFGSVYYGKMKD---GKEVAVKIM--ADSCSHRTQQFVTEVALLSRIHHRN 647
           N    +GKGSFG V   K KD    +E AVK++  A + +  T   + EV LL ++ H N
Sbjct: 25  NIVCMLGKGSFGEVL--KCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPN 82
Query: 648 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
           ++ L    E+     +V E    G L D +   + +K        +I      G+ Y+H 
Sbjct: 83  IMKLFEILEDSSSFYIVGELYTGGELFDEI---IKRKRFSEHDAARIIKQVFSGITYMH- 138
Query: 708 GCNPGIIHRDVKSSNILLDINMR---AKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
                I+HRD+K  NILL+   +    K+ DFGLS   +++      +  GT  Y+ PE 
Sbjct: 139 --KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIAPEV 194
Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKP 792
                  EK DV+S GV+L  L+SG  P
Sbjct: 195 L-RGTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 99/208 (47%), Gaps = 19/208 (9%)
Query: 593 NFCKKIGKGSFGSVYYGKMKD---GKEVAVKIM--ADSCSHRTQQFVTEVALLSRIHHRN 647
           N    +GKGSFG V   K KD    +E AVK++  A + +  T   + EV LL ++ H N
Sbjct: 25  NIVCMLGKGSFGEVL--KCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPN 82
Query: 648 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
           ++ L    E+     +V E    G L D +   + +K        +I      G+ Y+H 
Sbjct: 83  IMKLFEILEDSSSFYIVGELYTGGELFDEI---IKRKRFSEHDAARIIKQVFSGITYMH- 138
Query: 708 GCNPGIIHRDVKSSNILLDINMR---AKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
                I+HRD+K  NILL+   +    K+ DFGLS   +++      +  GT  Y+ PE 
Sbjct: 139 --KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIAPEV 194
Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKP 792
                  EK DV+S GV+L  L+SG  P
Sbjct: 195 L-RGTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 104/209 (49%), Gaps = 24/209 (11%)
Query: 596 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 655
           + IGKG FG V+ GK + G+EVAVKI + S   R+     E+     + H N++  I   
Sbjct: 48  ESIGKGRFGEVWRGKWR-GEEVAVKIFS-SREERSWFREAEIYQTVMLRHENILGFIAAD 105
Query: 656 EEEH----QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH----- 706
            +++    Q  LV +Y  +G+L D L    N+  +     +++A   A GL +LH     
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVG 161
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS--RQAEEDLTHISSVAR-GTVGYLDPE 763
           T   P I HRD+KS NIL+  N    ++D GL+    +  D   I+   R GT  Y+ PE
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221
Query: 764 YYGNQ------QLTEKSDVYSFGVVLLEL 786
              +       +  +++D+Y+ G+V  E+
Sbjct: 222 VLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 104/211 (49%), Gaps = 23/211 (10%)
Query: 593 NFCKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQ--FVT-EVALLSRIHHRNL 648
            F K +G+GSF +    + +   +E A+KI+      +  +  +VT E  ++SR+ H   
Sbjct: 33  KFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           V L    +++ +      Y  NG L    R  GS ++      TR   A +    LEYLH
Sbjct: 93  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTA-EIVSALEYLH 147
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR-----GTVGYLD 761
                GIIHRD+K  NILL+ +M  +++DFG ++     L+  S  AR     GT  Y+ 
Sbjct: 148 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKV----LSPESKQARANXFVGTAQYVS 200
Query: 762 PEYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           PE    +   + SD+++ G ++ +L++G  P
Sbjct: 201 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 108/218 (49%), Gaps = 24/218 (11%)
Query: 596 KKIGKGSFGSVYYGKMK--DGK--EVAVKIM-ADS-CSHRTQQFVTEVALLSRIHHRNLV 649
           + +GKG FGSV   ++K  DG   +VAVK++ AD   S   ++F+ E A +    H ++ 
Sbjct: 29  RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 650 PLIGYCEEEHQR------ILVYEYMHNGTLR-----DRLHGSVNQKPLDWLTRLQIAHDA 698
            L+G       +      +++  +M +G L       R+  +    PL  L R  +  D 
Sbjct: 89  KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV--DI 146
Query: 699 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTV 757
           A G+EYL +      IHRD+ + N +L  +M   V+DFGLSR+    D       ++  V
Sbjct: 147 ACGMEYLSS---RNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPV 203
Query: 758 GYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVS 794
            +L  E   +   T  SDV++FGV + E+++ G+ P +
Sbjct: 204 KWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYA 241

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 104/209 (49%), Gaps = 24/209 (11%)
Query: 596 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 655
           + IGKG FG V+ GK + G+EVAVKI + S   R+     E+     + H N++  I   
Sbjct: 35  ESIGKGRFGEVWRGKWR-GEEVAVKIFS-SREERSWFREAEIYQTVMLRHENILGFIAAD 92
Query: 656 EEEH----QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH----- 706
            +++    Q  LV +Y  +G+L D L    N+  +     +++A   A GL +LH     
Sbjct: 93  NKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVG 148
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS--RQAEEDLTHISSVAR-GTVGYLDPE 763
           T   P I HRD+KS NIL+  N    ++D GL+    +  D   I+   R GT  Y+ PE
Sbjct: 149 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 208
Query: 764 YYGNQ------QLTEKSDVYSFGVVLLEL 786
              +       +  +++D+Y+ G+V  E+
Sbjct: 209 VLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 103/207 (49%), Gaps = 24/207 (11%)
Query: 598 IGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE 657
           IGKG FG V+ GK + G+EVAVKI + S   R+     E+     + H N++  I    +
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVKIFS-SREERSWFREAEIYQTVMLRHENILGFIAADNK 69
Query: 658 EH----QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH-----TG 708
           ++    Q  LV +Y  +G+L D L    N+  +     +++A   A GL +LH     T 
Sbjct: 70  DNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 125
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLS--RQAEEDLTHISSVAR-GTVGYLDPEYY 765
             P I HRD+KS NIL+  N    ++D GL+    +  D   I+   R GT  Y+ PE  
Sbjct: 126 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 185
Query: 766 GNQ------QLTEKSDVYSFGVVLLEL 786
            +       +  +++D+Y+ G+V  E+
Sbjct: 186 DDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 103/207 (49%), Gaps = 24/207 (11%)
Query: 598 IGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE 657
           IGKG FG V+ GK + G+EVAVKI + S   R+     E+     + H N++  I    +
Sbjct: 17  IGKGRFGEVWRGKWR-GEEVAVKIFS-SREERSWFREAEIYQTVMLRHENILGFIAADNK 74
Query: 658 EH----QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH-----TG 708
           ++    Q  LV +Y  +G+L D L    N+  +     +++A   A GL +LH     T 
Sbjct: 75  DNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 130
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLS--RQAEEDLTHISSVAR-GTVGYLDPEYY 765
             P I HRD+KS NIL+  N    ++D GL+    +  D   I+   R GT  Y+ PE  
Sbjct: 131 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 190
Query: 766 GNQ------QLTEKSDVYSFGVVLLEL 786
            +       +  +++D+Y+ G+V  E+
Sbjct: 191 DDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 103/207 (49%), Gaps = 24/207 (11%)
Query: 598 IGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE 657
           IGKG FG V+ GK + G+EVAVKI + S   R+     E+     + H N++  I    +
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVKIFS-SREERSWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 658 EH----QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH-----TG 708
           ++    Q  LV +Y  +G+L D L    N+  +     +++A   A GL +LH     T 
Sbjct: 69  DNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLS--RQAEEDLTHISSVAR-GTVGYLDPEYY 765
             P I HRD+KS NIL+  N    ++D GL+    +  D   I+   R GT  Y+ PE  
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184
Query: 766 GNQ------QLTEKSDVYSFGVVLLEL 786
            +       +  +++D+Y+ G+V  E+
Sbjct: 185 DDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 101/214 (47%), Gaps = 21/214 (9%)
Query: 593 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIM-------ADSCSHRTQQFVTEVALLSRIH 644
           ++ K +GKG+FG V   + K  G+  A+KI+        D  +H     VTE  +L    
Sbjct: 8   DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT----VTESRVLQNTR 63
Query: 645 HRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 703
           H  L  L  Y  + H R+  V EY + G L    H S  +   +   R   A +    LE
Sbjct: 64  HPFLTAL-KYAFQTHDRLCFVMEYANGGELF--FHLSRERVFTEERARFYGA-EIVSALE 119
Query: 704 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 763
           YLH+     +++RD+K  N++LD +   K++DFGL ++   D   + +   GT  YL PE
Sbjct: 120 YLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPE 175
Query: 764 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 797
              +       D +  GVV+ E++ G+ P   +D
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 103/207 (49%), Gaps = 24/207 (11%)
Query: 598 IGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE 657
           IGKG FG V+ GK + G+EVAVKI + S   R+     E+     + H N++  I    +
Sbjct: 14  IGKGRFGEVWRGKWR-GEEVAVKIFS-SREERSWFREAEIYQTVMLRHENILGFIAADNK 71
Query: 658 EH----QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH-----TG 708
           ++    Q  LV +Y  +G+L D L    N+  +     +++A   A GL +LH     T 
Sbjct: 72  DNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 127
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLS--RQAEEDLTHISSVAR-GTVGYLDPEYY 765
             P I HRD+KS NIL+  N    ++D GL+    +  D   I+   R GT  Y+ PE  
Sbjct: 128 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 187
Query: 766 GNQ------QLTEKSDVYSFGVVLLEL 786
            +       +  +++D+Y+ G+V  E+
Sbjct: 188 DDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 101/214 (47%), Gaps = 21/214 (9%)
Query: 593 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIM-------ADSCSHRTQQFVTEVALLSRIH 644
           ++ K +GKG+FG V   + K  G+  A+KI+        D  +H     VTE  +L    
Sbjct: 11  DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT----VTESRVLQNTR 66
Query: 645 HRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 703
           H  L  L  Y  + H R+  V EY + G L    H S  +   +   R   A +    LE
Sbjct: 67  HPFLTAL-KYAFQTHDRLCFVMEYANGGELF--FHLSRERVFTEERARFYGA-EIVSALE 122
Query: 704 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 763
           YLH+     +++RD+K  N++LD +   K++DFGL ++   D   + +   GT  YL PE
Sbjct: 123 YLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPE 178
Query: 764 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 797
              +       D +  GVV+ E++ G+ P   +D
Sbjct: 179 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 212

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 101/214 (47%), Gaps = 21/214 (9%)
Query: 593 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIM-------ADSCSHRTQQFVTEVALLSRIH 644
           ++ K +GKG+FG V   + K  G+  A+KI+        D  +H     VTE  +L    
Sbjct: 8   DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT----VTESRVLQNTR 63
Query: 645 HRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 703
           H  L  L  Y  + H R+  V EY + G L    H S  +   +   R   A +    LE
Sbjct: 64  HPFLTAL-KYAFQTHDRLCFVMEYANGGELF--FHLSRERVFTEERARFYGA-EIVSALE 119
Query: 704 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 763
           YLH+     +++RD+K  N++LD +   K++DFGL ++   D   + +   GT  YL PE
Sbjct: 120 YLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPE 175
Query: 764 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 797
              +       D +  GVV+ E++ G+ P   +D
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 97/204 (47%), Gaps = 17/204 (8%)
Query: 598 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPLIG 653
           +G+G FG V+  +MK  GK  A K +      +    Q  + E  +L+++H R +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 654 YCEEEHQRILVYEYMHNGTLRDRLHGSVN-----QKPLDWLTRLQIAHDAAKGLEYLHTG 708
             E +    LV   M+ G +R  ++         Q+P       QI      GLE+LH  
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIV----SGLEHLH-- 306
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
               II+RD+K  N+LLD +   ++SD GL+ + +   T     A GT G++ PE    +
Sbjct: 307 -QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPELLLGE 364
Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
           +     D ++ GV L E+I+ + P
Sbjct: 365 EYDFSVDYFALGVTLYEMIAARGP 388

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 27/207 (13%)
Query: 598 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG--- 653
           IG G FG V+  K + DGK   +K       +  ++   EV  L+++ H N+V   G   
Sbjct: 19  IGSGGFGQVFKAKHRIDGKTYVIK----RVKYNNEKAEREVKALAKLDHVNIVHYNGCWD 74
Query: 654 ---YCEEEHQR----------ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 700
              Y  E   +           +  E+   GTL   +     +K LD +  L++     K
Sbjct: 75  GFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK-LDKVLALELFEQITK 133
Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYL 760
           G++Y+H+     +I+RD+K SNI L    + K+ DFGL    + D     S  +GT+ Y+
Sbjct: 134 GVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRS--KGTLRYM 188
Query: 761 DPEYYGNQQLTEKSDVYSFGVVLLELI 787
            PE   +Q   ++ D+Y+ G++L EL+
Sbjct: 189 SPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 97/204 (47%), Gaps = 17/204 (8%)
Query: 598 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPLIG 653
           +G+G FG V+  +MK  GK  A K +      +    Q  + E  +L+++H R +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 654 YCEEEHQRILVYEYMHNGTLRDRLHGSVN-----QKPLDWLTRLQIAHDAAKGLEYLHTG 708
             E +    LV   M+ G +R  ++         Q+P       QI      GLE+LH  
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIV----SGLEHLH-- 306
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
               II+RD+K  N+LLD +   ++SD GL+ + +   T     A GT G++ PE    +
Sbjct: 307 -QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPELLLGE 364
Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
           +     D ++ GV L E+I+ + P
Sbjct: 365 EYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 97/204 (47%), Gaps = 17/204 (8%)
Query: 598 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPLIG 653
           +G+G FG V+  +MK  GK  A K +      +    Q  + E  +L+++H R +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 654 YCEEEHQRILVYEYMHNGTLRDRLHGSVN-----QKPLDWLTRLQIAHDAAKGLEYLHTG 708
             E +    LV   M+ G +R  ++         Q+P       QI      GLE+LH  
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIV----SGLEHLH-- 306
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
               II+RD+K  N+LLD +   ++SD GL+ + +   T     A GT G++ PE    +
Sbjct: 307 -QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPELLLGE 364
Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
           +     D ++ GV L E+I+ + P
Sbjct: 365 EYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 97/204 (47%), Gaps = 17/204 (8%)
Query: 598 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPLIG 653
           +G+G FG V+  +MK  GK  A K +      +    Q  + E  +L+++H R +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 654 YCEEEHQRILVYEYMHNGTLRDRLHGSVN-----QKPLDWLTRLQIAHDAAKGLEYLHTG 708
             E +    LV   M+ G +R  ++         Q+P       QI      GLE+LH  
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIV----SGLEHLH-- 306
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
               II+RD+K  N+LLD +   ++SD GL+ + +   T     A GT G++ PE    +
Sbjct: 307 -QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPELLLGE 364
Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
           +     D ++ GV L E+I+ + P
Sbjct: 365 EYDFSVDYFALGVTLYEMIAARGP 388

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 100/214 (46%), Gaps = 21/214 (9%)
Query: 593 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIM-------ADSCSHRTQQFVTEVALLSRIH 644
           ++ K +GKG+FG V   + K  G+  A+KI+        D  +H     VTE  +L    
Sbjct: 13  DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT----VTESRVLQNTR 68
Query: 645 HRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 703
           H  L  L  Y  + H R+  V EY + G L    H S  +   +   R   A +    LE
Sbjct: 69  HPFLTAL-KYAFQTHDRLCFVMEYANGGELF--FHLSRERVFTEERARFYGA-EIVSALE 124
Query: 704 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 763
           YLH+     +++RD+K  N++LD +   K++DFGL ++   D   +     GT  YL PE
Sbjct: 125 YLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFC-GTPEYLAPE 180
Query: 764 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 797
              +       D +  GVV+ E++ G+ P   +D
Sbjct: 181 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 214

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 95/208 (45%), Gaps = 15/208 (7%)
Query: 598 IGKGSFGSVYYGKMK-DGKEVAVKIM--ADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 654
           IG GS+G     + K DGK +  K +          Q  V+EV LL  + H N+V     
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 655 CEEEHQRIL--VYEYMHNGTLRDRL-HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 711
             +     L  V EY   G L   +  G+  ++ LD    L++       L+  H   + 
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 712 G--IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLDPEYYG 766
           G  ++HRD+K +N+ LD     K+ DFGL+R     L H +S A+  VG   Y+ PE   
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARI----LNHDTSFAKAFVGTPYYMSPEQMN 189
Query: 767 NQQLTEKSDVYSFGVVLLELISGKKPVS 794
                EKSD++S G +L EL +   P +
Sbjct: 190 RMSYNEKSDIWSLGCLLYELCALMPPFT 217

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 107/225 (47%), Gaps = 26/225 (11%)
Query: 596 KKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHR---TQQFVTEVALLSRIHHRNLVPL 651
           K IG+G+FG V   K+K+  +V A+KI+      +   T  F  E  +L     + +  L
Sbjct: 80  KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139
Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD----WLTRLQIAHDAAKGLEYLHT 707
               ++++   LV +Y   G L   L    ++ P +    +L  + IA D+   L Y   
Sbjct: 140 HYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHY--- 196
Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY-- 765
                 +HRD+K  NIL+D+N   +++DFG   +  ED T  SSVA GT  Y+ PE    
Sbjct: 197 ------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 250
Query: 766 ---GNQQLTEKSDVYSFGVVLLELISGKKPVS----VEDFGAELN 803
              G  +   + D +S GV + E++ G+ P      VE +G  +N
Sbjct: 251 MEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 295

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 100/214 (46%), Gaps = 21/214 (9%)
Query: 593 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIM-------ADSCSHRTQQFVTEVALLSRIH 644
           ++ K +GKG+FG V   + K  G+  A+KI+        D  +H     VTE  +L    
Sbjct: 8   DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT----VTESRVLQNTR 63
Query: 645 HRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 703
           H  L  L  Y  + H R+  V EY + G L    H S  +   +   R   A +    LE
Sbjct: 64  HPFLTAL-KYAFQTHDRLCFVMEYANGGELF--FHLSRERVFTEERARFYGA-EIVSALE 119
Query: 704 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 763
           YLH+     +++RD+K  N++LD +   K++DFGL ++   D   +     GT  YL PE
Sbjct: 120 YLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFC-GTPEYLAPE 175
Query: 764 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 797
              +       D +  GVV+ E++ G+ P   +D
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 109/231 (47%), Gaps = 25/231 (10%)
Query: 584 LPELEEATNNFCKKIGKGSFGSVYYGKM------KDGKEVAVKIMADSCSHRT-QQFVTE 636
           L E+  +   F +++G+  FG VY G +      +  + VA+K + D       ++F  E
Sbjct: 20  LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHE 79
Query: 637 VALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL-----HGSVNQKPLDWLTR 691
             L +R+ H N+V L+G   ++    +++ Y  +G L + L     H  V     D   +
Sbjct: 80  AMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 139
Query: 692 --------LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA- 742
                   + +    A G+EYL +     ++H+D+ + N+L+   +  K+SD GL R+  
Sbjct: 140 SALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVY 196
Query: 743 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
             D   +   +   + ++ PE     + +  SD++S+GVVL E+ S G +P
Sbjct: 197 AADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 247

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 109/231 (47%), Gaps = 25/231 (10%)
Query: 584 LPELEEATNNFCKKIGKGSFGSVYYGKM------KDGKEVAVKIMADSCSHRT-QQFVTE 636
           L E+  +   F +++G+  FG VY G +      +  + VA+K + D       ++F  E
Sbjct: 3   LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHE 62
Query: 637 VALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL-----HGSVNQKPLDWLTR 691
             L +R+ H N+V L+G   ++    +++ Y  +G L + L     H  V     D   +
Sbjct: 63  AMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 122
Query: 692 --------LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA- 742
                   + +    A G+EYL +     ++H+D+ + N+L+   +  K+SD GL R+  
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVY 179
Query: 743 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
             D   +   +   + ++ PE     + +  SD++S+GVVL E+ S G +P
Sbjct: 180 AADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 100/214 (46%), Gaps = 21/214 (9%)
Query: 593 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIM-------ADSCSHRTQQFVTEVALLSRIH 644
           ++ K +GKG+FG V   + K  G+  A+KI+        D  +H     VTE  +L    
Sbjct: 8   DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT----VTESRVLQNTR 63
Query: 645 HRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 703
           H  L  L  Y  + H R+  V EY + G L    H S  +   +   R   A +    LE
Sbjct: 64  HPFLTAL-KYAFQTHDRLCFVMEYANGGELF--FHLSRERVFTEERARFYGA-EIVSALE 119
Query: 704 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 763
           YLH+     +++RD+K  N++LD +   K++DFGL ++   D   +     GT  YL PE
Sbjct: 120 YLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFC-GTPEYLAPE 175
Query: 764 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 797
              +       D +  GVV+ E++ G+ P   +D
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 100/214 (46%), Gaps = 21/214 (9%)
Query: 593 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIM-------ADSCSHRTQQFVTEVALLSRIH 644
           ++ K +GKG+FG V   + K  G+  A+KI+        D  +H     VTE  +L    
Sbjct: 8   DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT----VTESRVLQNTR 63
Query: 645 HRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 703
           H  L  L  Y  + H R+  V EY + G L    H S  +   +   R   A +    LE
Sbjct: 64  HPFLTAL-KYAFQTHDRLCFVMEYANGGELF--FHLSRERVFTEERARFYGA-EIVSALE 119
Query: 704 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 763
           YLH+     +++RD+K  N++LD +   K++DFGL ++   D   +     GT  YL PE
Sbjct: 120 YLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFC-GTPEYLAPE 175
Query: 764 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 797
              +       D +  GVV+ E++ G+ P   +D
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 111/233 (47%), Gaps = 42/233 (18%)
Query: 596 KKIGKGSFGSVYYGKMKDGKEV-AVKIM--------ADSCSHRTQQFVT---EVALLSRI 643
           K IG+G+FG V   KMK+ + + A+KI+        A++   R ++ V    +   ++ +
Sbjct: 80  KVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITAL 139
Query: 644 HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD----WLTRLQIAHDAA 699
           H+          ++E+   LV +Y   G L   L    ++ P D    ++  + +A D+ 
Sbjct: 140 HYA--------FQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSI 191
Query: 700 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 759
             L Y         +HRD+K  N+LLD+N   +++DFG   +  +D T  SSVA GT  Y
Sbjct: 192 HQLHY---------VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDY 242
Query: 760 LDPEYY-----GNQQLTEKSDVYSFGVVLLELISGKKPVS----VEDFGAELN 803
           + PE       G  +   + D +S GV + E++ G+ P      VE +G  +N
Sbjct: 243 ISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 295

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 95/208 (45%), Gaps = 15/208 (7%)
Query: 598 IGKGSFGSVYYGKMK-DGKEVAVKIM--ADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 654
           IG GS+G     + K DGK +  K +          Q  V+EV LL  + H N+V     
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 655 CEEEHQRIL--VYEYMHNGTLRDRL-HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 711
             +     L  V EY   G L   +  G+  ++ LD    L++       L+  H   + 
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 712 G--IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLDPEYYG 766
           G  ++HRD+K +N+ LD     K+ DFGL+R     L H +S A+  VG   Y+ PE   
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARI----LNHDTSFAKTFVGTPYYMSPEQMN 189
Query: 767 NQQLTEKSDVYSFGVVLLELISGKKPVS 794
                EKSD++S G +L EL +   P +
Sbjct: 190 RMSYNEKSDIWSLGCLLYELCALMPPFT 217

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 111/233 (47%), Gaps = 42/233 (18%)
Query: 596 KKIGKGSFGSVYYGKMKDGKEV-AVKIM--------ADSCSHRTQQFVT---EVALLSRI 643
           K IG+G+FG V   KMK+ + + A+KI+        A++   R ++ V    +   ++ +
Sbjct: 96  KVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITAL 155
Query: 644 HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD----WLTRLQIAHDAA 699
           H+          ++E+   LV +Y   G L   L    ++ P D    ++  + +A D+ 
Sbjct: 156 HYA--------FQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSI 207
Query: 700 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 759
             L Y         +HRD+K  N+LLD+N   +++DFG   +  +D T  SSVA GT  Y
Sbjct: 208 HQLHY---------VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDY 258
Query: 760 LDPEYY-----GNQQLTEKSDVYSFGVVLLELISGKKPVS----VEDFGAELN 803
           + PE       G  +   + D +S GV + E++ G+ P      VE +G  +N
Sbjct: 259 ISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 311

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 102/220 (46%), Gaps = 38/220 (17%)
Query: 598 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH----------- 645
           +G+G+FG V   +   D +  A+K +  +   +    ++EV LL+ ++H           
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWL 72
Query: 646 --RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG-SVNQKPLD-WLTRLQIAHDAAKG 701
             RN V  +   +++    +  EY  NGTL D +H  ++NQ+  + W    QI     + 
Sbjct: 73  ERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL----EA 128
Query: 702 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS----------- 750
           L Y+H+    GIIHRD+K  NI +D +   K+ DFGL++     L  +            
Sbjct: 129 LSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 751 --SVARGTVGYLDPEYY-GNQQLTEKSDVYSFGVVLLELI 787
             + A GT  Y+  E   G     EK D+YS G++  E+I
Sbjct: 186 NLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 98/207 (47%), Gaps = 15/207 (7%)
Query: 598 IGKGSFGSVYYGKMKDGKE-VAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 655
           IG G+   V        KE VA+K I  + C     + + E+  +S+ HH N+V      
Sbjct: 18  IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 77
Query: 656 EEEHQRILVYEYMHNGTLRDRLH-----GSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 710
             + +  LV + +  G++ D +      G      LD  T   I  +  +GLEYLH    
Sbjct: 78  VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN-- 135
Query: 711 PGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTH--ISSVARGTVGYLDPEYYG 766
            G IHRDVK+ NILL  +   +++DFG+S       D+T   +     GT  ++ PE   
Sbjct: 136 -GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVME 194
Query: 767 NQQLTE-KSDVYSFGVVLLELISGKKP 792
             +  + K+D++SFG+  +EL +G  P
Sbjct: 195 QVRGYDFKADIWSFGITAIELATGAAP 221

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 98/207 (47%), Gaps = 15/207 (7%)
Query: 598 IGKGSFGSVYYGKMKDGKE-VAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 655
           IG G+   V        KE VA+K I  + C     + + E+  +S+ HH N+V      
Sbjct: 23  IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82
Query: 656 EEEHQRILVYEYMHNGTLRDRLH-----GSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 710
             + +  LV + +  G++ D +      G      LD  T   I  +  +GLEYLH    
Sbjct: 83  VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN-- 140
Query: 711 PGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTH--ISSVARGTVGYLDPEYYG 766
            G IHRDVK+ NILL  +   +++DFG+S       D+T   +     GT  ++ PE   
Sbjct: 141 -GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVME 199
Query: 767 NQQLTE-KSDVYSFGVVLLELISGKKP 792
             +  + K+D++SFG+  +EL +G  P
Sbjct: 200 QVRGYDFKADIWSFGITAIELATGAAP 226

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 110/226 (48%), Gaps = 25/226 (11%)
Query: 588 EEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR 646
           +E +    K IG GSFG VY  K+ D G+ VA+K +    + + +    E+ ++ ++ H 
Sbjct: 18  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR----ELQIMRKLDHC 73
Query: 647 NLVPL------IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 700
           N+V L       G  ++E    LV +Y+     R   H S  ++ L  +      +   +
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDINMRA-KVSDFGLSRQ---AEEDLTHISSVARGT 756
            L Y+H+    GI HRD+K  N+LLD +    K+ DFG ++Q    E ++++I S     
Sbjct: 134 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--- 187
Query: 757 VGYLDPEY-YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 801
             Y  PE  +G    T   DV+S G VL EL+ G +P+   D G +
Sbjct: 188 --YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVD 230

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 107/223 (47%), Gaps = 19/223 (8%)
Query: 588 EEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR 646
           +E +    K IG GSFG VY  K+ D G+ VA+K +      + +    E+ ++ ++ H 
Sbjct: 18  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHC 73
Query: 647 NLVPL--IGYCEEEHQRI----LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 700
           N+V L    Y   E + +    LV +Y+     R   H S  ++ L  +      +   +
Sbjct: 74  NIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDINMRA-KVSDFGLSRQAEEDLTHISSVARGTVGY 759
            L Y+H+    GI HRD+K  N+LLD +    K+ DFG ++Q      ++S +   +  Y
Sbjct: 134 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRYY 188
Query: 760 LDPEY-YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 801
             PE  +G    T   DV+S G VL EL+ G +P+   D G +
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVD 230

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 110/226 (48%), Gaps = 25/226 (11%)
Query: 588 EEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR 646
           +E +    K IG GSFG VY  K+ D G+ VA+K +    + + +    E+ ++ ++ H 
Sbjct: 18  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR----ELQIMRKLDHC 73
Query: 647 NLVPL------IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 700
           N+V L       G  ++E    LV +Y+     R   H S  ++ L  +      +   +
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDINMRA-KVSDFGLSRQ---AEEDLTHISSVARGT 756
            L Y+H+    GI HRD+K  N+LLD +    K+ DFG ++Q    E ++++I S     
Sbjct: 134 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--- 187
Query: 757 VGYLDPEY-YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 801
             Y  PE  +G    T   DV+S G VL EL+ G +P+   D G +
Sbjct: 188 --YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVD 230

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 102/209 (48%), Gaps = 28/209 (13%)
Query: 598 IGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI--HHRNLVPLIGY- 654
           +GKG +G V+ G +  G+ VAVKI +   S   Q +  E  + + +   H N++  I   
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFS---SRDEQSWFRETEIYNTVLLRHDNILGFIASD 71
Query: 655 ---CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH----- 706
                   Q  L+  Y  +G+L D L     ++ L+    L++A  AA GL +LH     
Sbjct: 72  MTSRNSSTQLWLITHYHEHGSLYDFLQ----RQTLEPHLALRLAVSAACGLAHLHVEIFG 127
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE--DLTHISSVAR-GTVGYLDPE 763
           T   P I HRD KS N+L+  N++  ++D GL+    +  D   I +  R GT  Y+ PE
Sbjct: 128 TQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPE 187
Query: 764 YYGNQQLTE------KSDVYSFGVVLLEL 786
               Q  T+       +D+++FG+VL E+
Sbjct: 188 VLDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 111/214 (51%), Gaps = 14/214 (6%)
Query: 587 LEEATNNFCKKIGKGSFGSVYYGK-MKDGKEV----AVKIMADSCSHRT-QQFVTEVALL 640
           L+E      K +G G+FG+VY G  + DG+ V    A+K++ ++ S +  ++ + E  ++
Sbjct: 14  LKETELRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVM 73
Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 700
           + +    +  L+G C     + LV + M  G L D  H   N+  L     L      AK
Sbjct: 74  AGVGSPYVSRLLGICLTSTVQ-LVTQLMPYGCLLD--HVRENRGRLGSQDLLNWCMQIAK 130
Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGY 759
           G+ YL    +  ++HRD+ + N+L+      K++DFGL+R  + D T + +   +  + +
Sbjct: 131 GMSYLE---DVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKW 187
Query: 760 LDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
           +  E    ++ T +SDV+S+GV + EL++ G KP
Sbjct: 188 MALESILRRRFTHQSDVWSYGVTVWELMTFGAKP 221

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 95/199 (47%), Gaps = 11/199 (5%)
Query: 598 IGKGSFGSVYYGKMKDGKEV-AVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIG 653
           +GKG F   +     D KEV A KI+  S     H+ ++   E+++   + H+++V   G
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 654 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 713
           + E+     +V E     +L + LH    +K L              G +YLH      +
Sbjct: 89  FFEDNDFVFVVLELCRRRSLLE-LHK--RRKALTEPEARYYLRQIVLGCQYLHRN---RV 142
Query: 714 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 773
           IHRD+K  N+ L+ ++  K+ DFGL+ + E D     ++  GT  Y+ PE    +  + +
Sbjct: 143 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLC-GTPNYIAPEVLSKKGHSFE 201
Query: 774 SDVYSFGVVLLELISGKKP 792
            DV+S G ++  L+ GK P
Sbjct: 202 VDVWSIGCIMYTLLVGKPP 220

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 108/223 (48%), Gaps = 19/223 (8%)
Query: 588 EEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR 646
           +E +    K IG GSFG VY  K+ D G+ VA+K +    + + +    E+ ++ ++ H 
Sbjct: 18  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR----ELQIMRKLDHC 73
Query: 647 NLVPL------IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 700
           N+V L       G  ++E    LV +Y+     R   H S  ++ L  +      +   +
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDINMRA-KVSDFGLSRQAEEDLTHISSVARGTVGY 759
            L Y+H+    GI HRD+K  N+LLD +    K+ DFG ++Q      ++S +   +  Y
Sbjct: 134 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRYY 188
Query: 760 LDPEY-YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 801
             PE  +G    T   DV+S G VL EL+ G +P+   D G +
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVD 230

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 94/199 (47%), Gaps = 11/199 (5%)
Query: 598 IGKGSFGSVYYGKMKDGKEV-AVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIG 653
           +GKG F   +     D KEV A KI+  S     H+ ++   E+++   + H+++V   G
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 654 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 713
           + E+     +V E     +L + LH    +K L              G +YLH      +
Sbjct: 107 FFEDNDFVFVVLELCRRRSLLE-LHK--RRKALTEPEARYYLRQIVLGCQYLHRN---RV 160
Query: 714 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 773
           IHRD+K  N+ L+ ++  K+ DFGL+ + E D      V  GT  Y+ PE    +  + +
Sbjct: 161 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-GERKKVLCGTPNYIAPEVLSKKGHSFE 219
Query: 774 SDVYSFGVVLLELISGKKP 792
            DV+S G ++  L+ GK P
Sbjct: 220 VDVWSIGCIMYTLLVGKPP 238

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 94/199 (47%), Gaps = 11/199 (5%)
Query: 598 IGKGSFGSVYYGKMKDGKEV-AVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIG 653
           +GKG F   +     D KEV A KI+  S     H+ ++   E+++   + H+++V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 654 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 713
           + E+     +V E     +L + LH    +K L              G +YLH      +
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLE-LHK--RRKALTEPEARYYLRQIVLGCQYLHRN---RV 162
Query: 714 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 773
           IHRD+K  N+ L+ ++  K+ DFGL+ + E D      V  GT  Y+ PE    +  + +
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-GERKKVLCGTPNYIAPEVLSKKGHSFE 221
Query: 774 SDVYSFGVVLLELISGKKP 792
            DV+S G ++  L+ GK P
Sbjct: 222 VDVWSIGCIMYTLLVGKPP 240

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 95/199 (47%), Gaps = 11/199 (5%)
Query: 598 IGKGSFGSVYYGKMKDGKEV-AVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIG 653
           +GKG F   +     D KEV A KI+  S     H+ ++   E+++   + H+++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 654 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 713
           + E+     +V E     +L + LH    +K L              G +YLH      +
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLE-LHK--RRKALTEPEARYYLRQIVLGCQYLHRN---RV 138
Query: 714 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 773
           IHRD+K  N+ L+ ++  K+ DFGL+ + E D     ++  GT  Y+ PE    +  + +
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLC-GTPNYIAPEVLSKKGHSFE 197
Query: 774 SDVYSFGVVLLELISGKKP 792
            DV+S G ++  L+ GK P
Sbjct: 198 VDVWSIGCIMYTLLVGKPP 216

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 15/203 (7%)
Query: 596 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLI 652
           KK+G G++G V   + K    E A+KI+  +   +    + + EVA+L  + H N++ L 
Sbjct: 43  KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102
Query: 653 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 712
            + E++    LV E    G L D +   +++   + +    I      G+ YLH      
Sbjct: 103 DFFEDKRNYYLVMECYKGGELFDEI---IHRMKFNEVDAAVIIKQVLSGVTYLH---KHN 156
Query: 713 IIHRDVKSSNILLDINMR---AKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQ 769
           I+HRD+K  N+LL+   +    K+ DFGLS   E        +  GT  Y+ PE    ++
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL--GTAYYIAPEVL-RKK 213
Query: 770 LTEKSDVYSFGVVLLELISGKKP 792
             EK DV+S GV+L  L++G  P
Sbjct: 214 YDEKCDVWSIGVILFILLAGYPP 236

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 111/250 (44%), Gaps = 21/250 (8%)
Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNLVPL-- 651
           +++G G FG V     +D G++VA+K      S + ++ +  E+ ++ +++H N+V    
Sbjct: 21  ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE 80
Query: 652 ----IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
               +         +L  EY   G LR  L+   N   L       +  D +  L YLH 
Sbjct: 81  VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE 140
Query: 708 GCNPGIIHRDVKSSNILLD---INMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
                IIHRD+K  NI+L      +  K+ D G ++  E D   + +   GT+ YL PE 
Sbjct: 141 N---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK--ELDQGELCTEFVGTLQYLAPEL 195
Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 824
              ++ T   D +SFG +  E I+G +P     F      V W   + +K +   +V   
Sbjct: 196 LEQKKYTVTVDYWSFGTLAFECITGFRP-----FLPNWQPVQWHGKVREKSNEHIVVYDD 250
Query: 825 LIGNVKIESI 834
           L G VK  S+
Sbjct: 251 LTGAVKFSSV 260

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 111/250 (44%), Gaps = 21/250 (8%)
Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNLVPL-- 651
           +++G G FG V     +D G++VA+K      S + ++ +  E+ ++ +++H N+V    
Sbjct: 20  ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE 79
Query: 652 ----IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
               +         +L  EY   G LR  L+   N   L       +  D +  L YLH 
Sbjct: 80  VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE 139
Query: 708 GCNPGIIHRDVKSSNILLD---INMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
                IIHRD+K  NI+L      +  K+ D G ++  E D   + +   GT+ YL PE 
Sbjct: 140 N---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK--ELDQGELCTEFVGTLQYLAPEL 194
Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 824
              ++ T   D +SFG +  E I+G +P     F      V W   + +K +   +V   
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECITGFRP-----FLPNWQPVQWHGKVREKSNEHIVVYDD 249
Query: 825 LIGNVKIESI 834
           L G VK  S+
Sbjct: 250 LTGAVKFSSV 259

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 95/199 (47%), Gaps = 11/199 (5%)
Query: 598 IGKGSFGSVYYGKMKDGKEV-AVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIG 653
           +GKG F   +     D KEV A KI+  S     H+ ++   E+++   + H+++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 654 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 713
           + E+     +V E     +L + LH    +K L              G +YLH      +
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLE-LHK--RRKALTEPEARYYLRQIVLGCQYLHRN---RV 138
Query: 714 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 773
           IHRD+K  N+ L+ ++  K+ DFGL+ + E D     ++  GT  Y+ PE    +  + +
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLC-GTPNYIAPEVLSKKGHSFE 197
Query: 774 SDVYSFGVVLLELISGKKP 792
            DV+S G ++  L+ GK P
Sbjct: 198 VDVWSIGCIMYTLLVGKPP 216

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 97/199 (48%), Gaps = 10/199 (5%)
Query: 598 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQ---QFVTEVALLSRIHHRNLVPLIG 653
           +GKG FG V   +++  GK  A K +      + +     + E  +L +++ R +V L  
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251
Query: 654 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 713
             E +    LV   M+ G L+  ++  + Q        +  A +   GLE LH      I
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIY-HMGQAGFPEARAVFYAAEICCGLEDLH---RERI 307
Query: 714 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 773
           ++RD+K  NILLD +   ++SD GL+    E  T    V  GTVGY+ PE   N++ T  
Sbjct: 308 VYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV--GTVGYMAPEVVKNERYTFS 365
Query: 774 SDVYSFGVVLLELISGKKP 792
            D ++ G +L E+I+G+ P
Sbjct: 366 PDWWALGCLLYEMIAGQSP 384

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 109/226 (48%), Gaps = 25/226 (11%)
Query: 588 EEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR 646
           +E +    K IG GSFG VY  K+ D G+ VA+K +      + +    E+ ++ ++ H 
Sbjct: 31  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHC 86
Query: 647 NLVPL------IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 700
           N+V L       G  ++E    LV +Y+     R   H S  ++ L  +      +   +
Sbjct: 87  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 146
Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDINMRA-KVSDFGLSRQ---AEEDLTHISSVARGT 756
            L Y+H+    GI HRD+K  N+LLD +    K+ DFG ++Q    E ++++I S     
Sbjct: 147 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--- 200
Query: 757 VGYLDPEY-YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 801
             Y  PE  +G    T   DV+S G VL EL+ G +P+   D G +
Sbjct: 201 --YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVD 243

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 109/226 (48%), Gaps = 25/226 (11%)
Query: 588 EEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR 646
           +E +    K IG GSFG VY  K+ D G+ VA+K +      + +    E+ ++ ++ H 
Sbjct: 18  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHC 73
Query: 647 NLVPL------IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 700
           N+V L       G  ++E    LV +Y+     R   H S  ++ L  +      +   +
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDINMRA-KVSDFGLSRQ---AEEDLTHISSVARGT 756
            L Y+H+    GI HRD+K  N+LLD +    K+ DFG ++Q    E ++++I S     
Sbjct: 134 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--- 187
Query: 757 VGYLDPEY-YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 801
             Y  PE  +G    T   DV+S G VL EL+ G +P+   D G +
Sbjct: 188 --YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVD 230

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 101/202 (50%), Gaps = 13/202 (6%)
Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 653
           +K+G G++ +VY G  K  G  VA+K +  DS        + E++L+  + H N+V L  
Sbjct: 11  EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYD 70
Query: 654 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKP----LDWLTRLQIAHDAAKGLEYLHTGC 709
               E++  LV+E+M N   +     +V   P    L+ +   Q      +GL + H   
Sbjct: 71  VIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQW--QLLQGLAFCHEN- 127
Query: 710 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYGNQ 768
              I+HRD+K  N+L++   + K+ DFGL+R     +   SS    T+ Y  P+   G++
Sbjct: 128 --KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYRAPDVLMGSR 184
Query: 769 QLTEKSDVYSFGVVLLELISGK 790
             +   D++S G +L E+I+GK
Sbjct: 185 TYSTSIDIWSCGCILAEMITGK 206

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 12/207 (5%)
Query: 596 KKIGKGSFGSVYYGKMKDGKEV-AVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVP 650
           K +GKGSFG V+  + K   +  A+K +           +  + E  +LS    H  L  
Sbjct: 23  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 82
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 710
           +    + +     V EY++ G L   +         D       A +   GL++LH+   
Sbjct: 83  MFCTFQTKENLFFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHS--- 136
Query: 711 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 770
            GI++RD+K  NILLD +   K++DFG+ ++        +    GT  Y+ PE    Q+ 
Sbjct: 137 KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFC-GTPDYIAPEILLGQKY 195
Query: 771 TEKSDVYSFGVVLLELISGKKPVSVED 797
               D +SFGV+L E++ G+ P   +D
Sbjct: 196 NHSVDWWSFGVLLYEMLIGQSPFHGQD 222

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 109/226 (48%), Gaps = 25/226 (11%)
Query: 588 EEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR 646
           +E +    K IG GSFG VY  K+ D G+ VA+K +      + +    E+ ++ ++ H 
Sbjct: 46  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHC 101
Query: 647 NLVPL------IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 700
           N+V L       G  ++E    LV +Y+     R   H S  ++ L  +      +   +
Sbjct: 102 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 161
Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDINMRA-KVSDFGLSRQ---AEEDLTHISSVARGT 756
            L Y+H+    GI HRD+K  N+LLD +    K+ DFG ++Q    E ++++I S     
Sbjct: 162 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--- 215
Query: 757 VGYLDPEY-YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 801
             Y  PE  +G    T   DV+S G VL EL+ G +P+   D G +
Sbjct: 216 --YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVD 258

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 107/223 (47%), Gaps = 19/223 (8%)
Query: 588 EEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR 646
           +E +    K IG GSFG VY  K+ D G+ VA+K +      + +    E+ ++ ++ H 
Sbjct: 19  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHC 74
Query: 647 NLVPL------IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 700
           N+V L       G  ++E    LV +Y+     R   H S  ++ L  +      +   +
Sbjct: 75  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 134
Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDINMRA-KVSDFGLSRQAEEDLTHISSVARGTVGY 759
            L Y+H+    GI HRD+K  N+LLD +    K+ DFG ++Q      ++S +   +  Y
Sbjct: 135 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRYY 189
Query: 760 LDPEY-YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 801
             PE  +G    T   DV+S G VL EL+ G +P+   D G +
Sbjct: 190 RAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVD 231

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 97/199 (48%), Gaps = 10/199 (5%)
Query: 598 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQ---QFVTEVALLSRIHHRNLVPLIG 653
           +GKG FG V   +++  GK  A K +      + +     + E  +L +++ R +V L  
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251
Query: 654 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 713
             E +    LV   M+ G L+  ++  + Q        +  A +   GLE LH      I
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIY-HMGQAGFPEARAVFYAAEICCGLEDLH---RERI 307
Query: 714 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 773
           ++RD+K  NILLD +   ++SD GL+    E  T    V  GTVGY+ PE   N++ T  
Sbjct: 308 VYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV--GTVGYMAPEVVKNERYTFS 365
Query: 774 SDVYSFGVVLLELISGKKP 792
            D ++ G +L E+I+G+ P
Sbjct: 366 PDWWALGCLLYEMIAGQSP 384

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 107/223 (47%), Gaps = 19/223 (8%)
Query: 588 EEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR 646
           +E +    K IG GSFG VY  K+ D G+ VA+K +      + +    E+ ++ ++ H 
Sbjct: 18  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHC 73
Query: 647 NLVPL------IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 700
           N+V L       G  ++E    LV +Y+     R   H S  ++ L  +      +   +
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDINMRA-KVSDFGLSRQAEEDLTHISSVARGTVGY 759
            L Y+H+    GI HRD+K  N+LLD +    K+ DFG ++Q      ++S +   +  Y
Sbjct: 134 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRYY 188
Query: 760 LDPEY-YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 801
             PE  +G    T   DV+S G VL EL+ G +P+   D G +
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVD 230

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 107/223 (47%), Gaps = 19/223 (8%)
Query: 588 EEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR 646
           +E +    K IG GSFG VY  K+ D G+ VA+K +      + +    E+ ++ ++ H 
Sbjct: 26  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHC 81
Query: 647 NLVPL------IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 700
           N+V L       G  ++E    LV +Y+     R   H S  ++ L  +      +   +
Sbjct: 82  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 141
Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDINMRA-KVSDFGLSRQAEEDLTHISSVARGTVGY 759
            L Y+H+    GI HRD+K  N+LLD +    K+ DFG ++Q      ++S +   +  Y
Sbjct: 142 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRYY 196
Query: 760 LDPEY-YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 801
             PE  +G    T   DV+S G VL EL+ G +P+   D G +
Sbjct: 197 RAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVD 238

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 107/223 (47%), Gaps = 19/223 (8%)
Query: 588 EEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR 646
           +E +    K IG GSFG VY  K+ D G+ VA+K +      + +    E+ ++ ++ H 
Sbjct: 22  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHC 77
Query: 647 NLVPL------IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 700
           N+V L       G  ++E    LV +Y+     R   H S  ++ L  +      +   +
Sbjct: 78  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 137
Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDINMRA-KVSDFGLSRQAEEDLTHISSVARGTVGY 759
            L Y+H+    GI HRD+K  N+LLD +    K+ DFG ++Q      ++S +   +  Y
Sbjct: 138 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRYY 192
Query: 760 LDPEY-YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 801
             PE  +G    T   DV+S G VL EL+ G +P+   D G +
Sbjct: 193 RAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVD 234

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 107/223 (47%), Gaps = 19/223 (8%)
Query: 588 EEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR 646
           +E +    K IG GSFG VY  K+ D G+ VA+K +      + +    E+ ++ ++ H 
Sbjct: 30  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHC 85
Query: 647 NLVPL------IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 700
           N+V L       G  ++E    LV +Y+     R   H S  ++ L  +      +   +
Sbjct: 86  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 145
Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDINMRA-KVSDFGLSRQAEEDLTHISSVARGTVGY 759
            L Y+H+    GI HRD+K  N+LLD +    K+ DFG ++Q      ++S +   +  Y
Sbjct: 146 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRYY 200
Query: 760 LDPEY-YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 801
             PE  +G    T   DV+S G VL EL+ G +P+   D G +
Sbjct: 201 RAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVD 242

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 107/223 (47%), Gaps = 19/223 (8%)
Query: 588 EEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR 646
           +E +    K IG GSFG VY  K+ D G+ VA+K +      + +    E+ ++ ++ H 
Sbjct: 18  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHC 73
Query: 647 NLVPL------IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 700
           N+V L       G  ++E    LV +Y+     R   H S  ++ L  +      +   +
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDINMRA-KVSDFGLSRQAEEDLTHISSVARGTVGY 759
            L Y+H+    GI HRD+K  N+LLD +    K+ DFG ++Q      ++S +   +  Y
Sbjct: 134 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRYY 188
Query: 760 LDPEY-YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 801
             PE  +G    T   DV+S G VL EL+ G +P+   D G +
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVD 230

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 12/207 (5%)
Query: 596 KKIGKGSFGSVYYGKMKDGKEV-AVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVP 650
           K +GKGSFG V+  + K   +  A+K +           +  + E  +LS    H  L  
Sbjct: 24  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 83
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 710
           +    + +     V EY++ G L   +         D       A +   GL++LH+   
Sbjct: 84  MFCTFQTKENLFFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSK-- 138
Query: 711 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 770
            GI++RD+K  NILLD +   K++DFG+ ++        +    GT  Y+ PE    Q+ 
Sbjct: 139 -GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFC-GTPDYIAPEILLGQKY 196
Query: 771 TEKSDVYSFGVVLLELISGKKPVSVED 797
               D +SFGV+L E++ G+ P   +D
Sbjct: 197 NHSVDWWSFGVLLYEMLIGQSPFHGQD 223

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 109/226 (48%), Gaps = 25/226 (11%)
Query: 588 EEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR 646
           +E +    K IG GSFG VY  K+ D G+ VA+K +      + +    E+ ++ ++ H 
Sbjct: 23  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHC 78
Query: 647 NLVPL------IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 700
           N+V L       G  ++E    LV +Y+     R   H S  ++ L  +      +   +
Sbjct: 79  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 138
Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDINMRA-KVSDFGLSRQ---AEEDLTHISSVARGT 756
            L Y+H+    GI HRD+K  N+LLD +    K+ DFG ++Q    E ++++I S     
Sbjct: 139 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--- 192
Query: 757 VGYLDPEY-YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 801
             Y  PE  +G    T   DV+S G VL EL+ G +P+   D G +
Sbjct: 193 --YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVD 235

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 107/223 (47%), Gaps = 19/223 (8%)
Query: 588 EEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR 646
           +E +    K IG GSFG VY  K+ D G+ VA+K +      + +    E+ ++ ++ H 
Sbjct: 37  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHC 92
Query: 647 NLVPL------IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 700
           N+V L       G  ++E    LV +Y+     R   H S  ++ L  +      +   +
Sbjct: 93  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 152
Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDINMRA-KVSDFGLSRQAEEDLTHISSVARGTVGY 759
            L Y+H+    GI HRD+K  N+LLD +    K+ DFG ++Q      ++S +   +  Y
Sbjct: 153 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRYY 207
Query: 760 LDPEY-YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 801
             PE  +G    T   DV+S G VL EL+ G +P+   D G +
Sbjct: 208 RAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVD 249

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 107/223 (47%), Gaps = 19/223 (8%)
Query: 588 EEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR 646
           +E +    K IG GSFG VY  K+ D G+ VA+K +      + +    E+ ++ ++ H 
Sbjct: 30  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHC 85
Query: 647 NLVPL------IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 700
           N+V L       G  ++E    LV +Y+     R   H S  ++ L  +      +   +
Sbjct: 86  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 145
Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDINMRA-KVSDFGLSRQAEEDLTHISSVARGTVGY 759
            L Y+H+    GI HRD+K  N+LLD +    K+ DFG ++Q      ++S +   +  Y
Sbjct: 146 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRYY 200
Query: 760 LDPEY-YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 801
             PE  +G    T   DV+S G VL EL+ G +P+   D G +
Sbjct: 201 RAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVD 242

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 16/207 (7%)
Query: 596 KKIGKGSFGSVYYGKMK--DGKEVAVKIMA---DSCSH--RTQQFVTEVALLSRIHHRNL 648
           +K+G GSFG V  G+     GK V+V +     D  S       F+ EV  +  + HRNL
Sbjct: 18  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           + L G       + +V E    G+L DRL        L  L+R  +    A+G+ YL + 
Sbjct: 78  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLES- 133
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH--ISSVARGTVGYLDPEYYG 766
                IHRD+ + N+LL      K+ DFGL R   ++  H  +    +    +  PE   
Sbjct: 134 --KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 191
Query: 767 NQQLTEKSDVYSFGVVLLELIS-GKKP 792
            +  +  SD + FGV L E+ + G++P
Sbjct: 192 TRTFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 109/226 (48%), Gaps = 25/226 (11%)
Query: 588 EEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR 646
           +E +    K IG GSFG VY  K+ D G+ VA+K +      + +    E+ ++ ++ H 
Sbjct: 52  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHC 107
Query: 647 NLVPL------IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 700
           N+V L       G  ++E    LV +Y+     R   H S  ++ L  +      +   +
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 167
Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDINMRA-KVSDFGLSRQ---AEEDLTHISSVARGT 756
            L Y+H+    GI HRD+K  N+LLD +    K+ DFG ++Q    E ++++I S     
Sbjct: 168 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--- 221
Query: 757 VGYLDPEY-YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 801
             Y  PE  +G    T   DV+S G VL EL+ G +P+   D G +
Sbjct: 222 --YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVD 264

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 94/199 (47%), Gaps = 11/199 (5%)
Query: 598 IGKGSFGSVYYGKMKDGKEV-AVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIG 653
           +GKG F   +     D KEV A KI+  S     H+ ++   E+++   + H+++V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 654 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 713
           + E+     +V E     +L + LH    +K L              G +YLH      +
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLE-LHK--RRKALTEPEARYYLRQIVLGCQYLHRN---RV 136
Query: 714 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 773
           IHRD+K  N+ L+ ++  K+ DFGL+ + E D      V  GT  Y+ PE    +  + +
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-GERKKVLCGTPNYIAPEVLSKKGHSFE 195
Query: 774 SDVYSFGVVLLELISGKKP 792
            DV+S G ++  L+ GK P
Sbjct: 196 VDVWSIGCIMYTLLVGKPP 214

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 109/226 (48%), Gaps = 25/226 (11%)
Query: 588 EEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR 646
           +E +    K IG GSFG VY  K+ D G+ VA+K +      + +    E+ ++ ++ H 
Sbjct: 56  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHC 111
Query: 647 NLVPL------IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 700
           N+V L       G  ++E    LV +Y+     R   H S  ++ L  +      +   +
Sbjct: 112 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 171
Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDINMRA-KVSDFGLSRQ---AEEDLTHISSVARGT 756
            L Y+H+    GI HRD+K  N+LLD +    K+ DFG ++Q    E ++++I S     
Sbjct: 172 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--- 225
Query: 757 VGYLDPEY-YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 801
             Y  PE  +G    T   DV+S G VL EL+ G +P+   D G +
Sbjct: 226 --YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVD 268

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 109/226 (48%), Gaps = 25/226 (11%)
Query: 588 EEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR 646
           +E +    K IG GSFG VY  K+ D G+ VA+K +      + +    E+ ++ ++ H 
Sbjct: 54  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHC 109
Query: 647 NLVPL------IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 700
           N+V L       G  ++E    LV +Y+     R   H S  ++ L  +      +   +
Sbjct: 110 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 169
Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDINMRA-KVSDFGLSRQ---AEEDLTHISSVARGT 756
            L Y+H+    GI HRD+K  N+LLD +    K+ DFG ++Q    E ++++I S     
Sbjct: 170 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--- 223
Query: 757 VGYLDPEY-YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 801
             Y  PE  +G    T   DV+S G VL EL+ G +P+   D G +
Sbjct: 224 --YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVD 266

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 102/213 (47%), Gaps = 20/213 (9%)
Query: 594 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMA-------DSCSHRTQQFVTEVALLSRIHH 645
           + K +GKG+FG V   K K  G+  A+KI+        D  +H     +TE  +L    H
Sbjct: 152 YLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT----LTENRVLQNSRH 207
Query: 646 RNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 704
             L  L  Y  + H R+  V EY + G L    H S  +   +   R   A +    L+Y
Sbjct: 208 PFLTAL-KYSFQTHDRLCFVMEYANGGELF--FHLSRERVFSEDRARFYGA-EIVSALDY 263
Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
           LH+  N  +++RD+K  N++LD +   K++DFGL ++  +D   + +   GT  YL PE 
Sbjct: 264 LHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLAPEV 320
Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 797
             +       D +  GVV+ E++ G+ P   +D
Sbjct: 321 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 353

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 102/213 (47%), Gaps = 20/213 (9%)
Query: 594 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMA-------DSCSHRTQQFVTEVALLSRIHH 645
           + K +GKG+FG V   K K  G+  A+KI+        D  +H     +TE  +L    H
Sbjct: 155 YLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT----LTENRVLQNSRH 210
Query: 646 RNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 704
             L  L  Y  + H R+  V EY + G L    H S  +   +   R   A +    L+Y
Sbjct: 211 PFLTAL-KYSFQTHDRLCFVMEYANGGELF--FHLSRERVFSEDRARFYGA-EIVSALDY 266
Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
           LH+  N  +++RD+K  N++LD +   K++DFGL ++  +D   + +   GT  YL PE 
Sbjct: 267 LHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLAPEV 323
Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 797
             +       D +  GVV+ E++ G+ P   +D
Sbjct: 324 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 356

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 104/202 (51%), Gaps = 18/202 (8%)
Query: 596 KKIGKGSFGSVYYGKMKDGKEVAVK-IMADSCSHRT-QQFVTEVALLSRIHHRNLVPLIG 653
           +K+G+G++G VY  K   G+ VA+K I  D+         + E++LL  +HH N+V LI 
Sbjct: 27  EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 654 YCEEEHQRILVYEYMHNG---TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 710
               E    LV+E+M       L +   G  + +   +L +L       +G+ + H    
Sbjct: 87  VIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQL------LRGVAHCH---Q 137
Query: 711 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPE-YYGNQ 768
             I+HRD+K  N+L++ +   K++DFGL+R     + ++   V   T+ Y  P+   G++
Sbjct: 138 HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV--TLWYRAPDVLMGSK 195
Query: 769 QLTEKSDVYSFGVVLLELISGK 790
           + +   D++S G +  E+I+GK
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGK 217

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 111/231 (48%), Gaps = 26/231 (11%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYC 655
           +G+G++  V     +++GKE AVKI+     H   +   EV  L +   ++N++ LI + 
Sbjct: 21  LGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFF 80
Query: 656 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 715
           E++ +  LV+E +  G++   +     QK  +     ++  D A  L++LHT    GI H
Sbjct: 81  EDDTRFYLVFEKLQGGSILAHIQ---KQKHFNEREASRVVRDVAAALDFLHT---KGIAH 134
Query: 716 RDVKSSNILLDINMR---AKVSDF--GLSRQAEEDLTHIS----SVARGTVGYLDP---E 763
           RD+K  NIL +   +    K+ DF  G   +     T I+    +   G+  Y+ P   E
Sbjct: 135 RDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVE 194
Query: 764 YYGNQQ--LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI 812
            + +Q     ++ D++S GVVL  ++SG  P  V   GA+     W R  +
Sbjct: 195 VFTDQATFYDKRCDLWSLGVVLYIMLSGYPPF-VGHCGADCG---WDRGEV 241

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 40/220 (18%)
Query: 598 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG--- 653
           IG G FG V+  K + DGK   ++       +  ++   EV  L+++ H N+V   G   
Sbjct: 20  IGSGGFGQVFKAKHRIDGKTYVIR----RVKYNNEKAEREVKALAKLDHVNIVHYNGCWD 75
Query: 654 -----------------YCEEEHQR---------ILVYEYMHNGTLRDRLHGSVNQKPLD 687
                            Y  E  +           +  E+   GTL   +     +K LD
Sbjct: 76  GFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK-LD 134
Query: 688 WLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 747
            +  L++     KG++Y+H+     +IHRD+K SNI L    + K+ DFGL    + D  
Sbjct: 135 KVLALELFEQITKGVDYIHS---KKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK 191
Query: 748 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELI 787
              S  +GT+ Y+ PE   +Q   ++ D+Y+ G++L EL+
Sbjct: 192 RTRS--KGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 107/223 (47%), Gaps = 19/223 (8%)
Query: 588 EEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR 646
           +E +    K IG GSFG VY  K+ D G+ VA+K +      + +    E+ ++ ++ H 
Sbjct: 52  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHC 107
Query: 647 NLVPL------IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 700
           N+V L       G  ++E    LV +Y+     R   H S  ++ L  +      +   +
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 167
Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDINMRA-KVSDFGLSRQAEEDLTHISSVARGTVGY 759
            L Y+H+    GI HRD+K  N+LLD +    K+ DFG ++Q      ++S +   +  Y
Sbjct: 168 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRYY 222
Query: 760 LDPEY-YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 801
             PE  +G    T   DV+S G VL EL+ G +P+   D G +
Sbjct: 223 RAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVD 264

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 99/208 (47%), Gaps = 25/208 (12%)
Query: 599 GKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE 658
            +G FG V+  ++ + + VAVKI       ++ Q   EV  L  + H N++  IG  E+ 
Sbjct: 33  ARGRFGCVWKAQLLN-EYVAVKIFPIQ-DKQSWQNEYEVYSLPGMKHENILQFIG-AEKR 89
Query: 659 HQRI-----LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT------ 707
              +     L+  +   G+L D L  +V    + W     IA   A+GL YLH       
Sbjct: 90  GTSVDVDLWLITAFHEKGSLSDFLKANV----VSWNELCHIAETMARGLAYLHEDIPGLK 145
Query: 708 -GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR-GTVGYLDPEYY 765
            G  P I HRD+KS N+LL  N+ A ++DFGL+ + E   +   +  + GT  Y+ PE  
Sbjct: 146 DGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVL 205
Query: 766 GNQQLTEKS-----DVYSFGVVLLELIS 788
                 ++      D+Y+ G+VL EL S
Sbjct: 206 EGAINFQRDAFLRIDMYAMGLVLWELAS 233

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 104/202 (51%), Gaps = 18/202 (8%)
Query: 596 KKIGKGSFGSVYYGKMKDGKEVAVK-IMADSCSHRT-QQFVTEVALLSRIHHRNLVPLIG 653
           +K+G+G++G VY  K   G+ VA+K I  D+         + E++LL  +HH N+V LI 
Sbjct: 27  EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 654 YCEEEHQRILVYEYMHNG---TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 710
               E    LV+E+M       L +   G  + +   +L +L       +G+ + H    
Sbjct: 87  VIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQL------LRGVAHCH---Q 137
Query: 711 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPE-YYGNQ 768
             I+HRD+K  N+L++ +   K++DFGL+R     + ++   V   T+ Y  P+   G++
Sbjct: 138 HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV--TLWYRAPDVLMGSK 195
Query: 769 QLTEKSDVYSFGVVLLELISGK 790
           + +   D++S G +  E+I+GK
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGK 217

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 16/207 (7%)
Query: 596 KKIGKGSFGSVYYGKMK--DGKEVAVKIMA---DSCSH--RTQQFVTEVALLSRIHHRNL 648
           +K+G GSFG V  G+     GK V+V +     D  S       F+ EV  +  + HRNL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           + L G       + +V E    G+L DRL        L  L+R  +    A+G+ YL + 
Sbjct: 84  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLES- 139
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH--ISSVARGTVGYLDPEYYG 766
                IHRD+ + N+LL      K+ DFGL R   ++  H  +    +    +  PE   
Sbjct: 140 --KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLK 197
Query: 767 NQQLTEKSDVYSFGVVLLELIS-GKKP 792
            +  +  SD + FGV L E+ + G++P
Sbjct: 198 TRTFSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 16/207 (7%)
Query: 596 KKIGKGSFGSVYYGKMK--DGKEVAVKIMA---DSCSH--RTQQFVTEVALLSRIHHRNL 648
           +K+G GSFG V  G+     GK V+V +     D  S       F+ EV  +  + HRNL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           + L G       + +V E    G+L DRL        L  L+R  +    A+G+ YL + 
Sbjct: 74  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 130
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH--ISSVARGTVGYLDPEYYG 766
                IHRD+ + N+LL      K+ DFGL R   ++  H  +    +    +  PE   
Sbjct: 131 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLK 187
Query: 767 NQQLTEKSDVYSFGVVLLELIS-GKKP 792
            +  +  SD + FGV L E+ + G++P
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 109/226 (48%), Gaps = 25/226 (11%)
Query: 588 EEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR 646
           +E +    K IG GSFG VY  K+ D G+ VA+K +      + +    E+ ++ ++ H 
Sbjct: 97  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHC 152
Query: 647 NLVPL------IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 700
           N+V L       G  ++E    LV +Y+     R   H S  ++ L  +      +   +
Sbjct: 153 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 212
Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDINMRA-KVSDFGLSRQ---AEEDLTHISSVARGT 756
            L Y+H+    GI HRD+K  N+LLD +    K+ DFG ++Q    E ++++I S     
Sbjct: 213 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--- 266
Query: 757 VGYLDPEY-YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 801
             Y  PE  +G    T   DV+S G VL EL+ G +P+   D G +
Sbjct: 267 --YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVD 309

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 14/207 (6%)
Query: 589 EATNNFCK--KIGKGSFGSVYYGKMKDGKEVAV--KIMADSCSHRT-QQFVTEVALLSRI 643
           E   NF K  KIG+G++G VY  + K   EV    KI  D+ +       + E++LL  +
Sbjct: 7   EFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 66
Query: 644 HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 703
           +H N+V L+     E++  LV+E++H    +     ++   PL  +          +GL 
Sbjct: 67  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 124
Query: 704 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDP 762
           + H+     ++HRD+K  N+L++     K++DFGL+R     + T+   V   T+ Y  P
Sbjct: 125 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAP 179
Query: 763 E-YYGNQQLTEKSDVYSFGVVLLELIS 788
           E   G +  +   D++S G +  E+++
Sbjct: 180 EILLGXKYYSTAVDIWSLGCIFAEMVT 206

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 16/207 (7%)
Query: 596 KKIGKGSFGSVYYGKMK--DGKEVAVKIMA---DSCSH--RTQQFVTEVALLSRIHHRNL 648
           +K+G GSFG V  G+     GK V+V +     D  S       F+ EV  +  + HRNL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           + L G       + +V E    G+L DRL        L  L+R  +    A+G+ YL + 
Sbjct: 84  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLES- 139
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH--ISSVARGTVGYLDPEYYG 766
                IHRD+ + N+LL      K+ DFGL R   ++  H  +    +    +  PE   
Sbjct: 140 --KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 197
Query: 767 NQQLTEKSDVYSFGVVLLELIS-GKKP 792
            +  +  SD + FGV L E+ + G++P
Sbjct: 198 TRTFSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 96/214 (44%), Gaps = 16/214 (7%)
Query: 589 EATNNFCKKIGKGSFGSVYYGKMK--DGKEVAVKIMADSCSHRTQ-----QFVTEVALLS 641
           E      +K+G GSFG V  G+     GK V+V +        +Q      F+ EV  + 
Sbjct: 7   EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 66
Query: 642 RIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 701
            + HRNL+ L G       + +V E    G+L DRL        L  L+R  +    A+G
Sbjct: 67  SLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEG 123
Query: 702 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH--ISSVARGTVGY 759
           + YL +      IHRD+ + N+LL      K+ DFGL R   ++  H  +    +    +
Sbjct: 124 MGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 760 LDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
             PE    +  +  SD + FGV L E+ + G++P
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 102/202 (50%), Gaps = 12/202 (5%)
Query: 597 KIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 655
           ++G G+FG VY  K K+ G   A K++        + ++ E+ +L+   H  +V L+G  
Sbjct: 18  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 77
Query: 656 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 715
             + +  ++ E+   G + D +   +++     LT  QI     + LE L+   +  IIH
Sbjct: 78  YHDGKLWIMIEFCPGGAV-DAIMLELDRG----LTEPQIQVVCRQMLEALNFLHSKRIIH 132
Query: 716 RDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE--- 772
           RD+K+ N+L+ +    +++DFG+S +  + L    S   GT  ++ PE    + + +   
Sbjct: 133 RDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMCETMKDTPY 191
Query: 773 --KSDVYSFGVVLLELISGKKP 792
             K+D++S G+ L+E+   + P
Sbjct: 192 DYKADIWSLGITLIEMAQIEPP 213

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 95/207 (45%), Gaps = 16/207 (7%)
Query: 596 KKIGKGSFGSVYYGKMK--DGKEVAVKIMADSCSHRTQ-----QFVTEVALLSRIHHRNL 648
           +K+G GSFG V  G+     GK V+V +        +Q      F+ EV  +  + HRNL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           + L G       + +V E    G+L DRL        L  L+R  +    A+G+ YL + 
Sbjct: 74  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLES- 129
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH--ISSVARGTVGYLDPEYYG 766
                IHRD+ + N+LL      K+ DFGL R   ++  H  +    +    +  PE   
Sbjct: 130 --KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187
Query: 767 NQQLTEKSDVYSFGVVLLELIS-GKKP 792
            +  +  SD + FGV L E+ + G++P
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 102/202 (50%), Gaps = 12/202 (5%)
Query: 597 KIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 655
           ++G G+FG VY  K K+ G   A K++        + ++ E+ +L+   H  +V L+G  
Sbjct: 26  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 656 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 715
             + +  ++ E+   G + D +   +++     LT  QI     + LE L+   +  IIH
Sbjct: 86  YHDGKLWIMIEFCPGGAV-DAIMLELDRG----LTEPQIQVVCRQMLEALNFLHSKRIIH 140
Query: 716 RDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE--- 772
           RD+K+ N+L+ +    +++DFG+S +  + L    S   GT  ++ PE    + + +   
Sbjct: 141 RDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMCETMKDTPY 199
Query: 773 --KSDVYSFGVVLLELISGKKP 792
             K+D++S G+ L+E+   + P
Sbjct: 200 DYKADIWSLGITLIEMAQIEPP 221

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 16/207 (7%)
Query: 596 KKIGKGSFGSVYYGKMK--DGKEVAVKIMA---DSCSH--RTQQFVTEVALLSRIHHRNL 648
           +K+G GSFG V  G+     GK V+V +     D  S       F+ EV  +  + HRNL
Sbjct: 18  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           + L G       + +V E    G+L DRL        L  L+R  +    A+G+ YL + 
Sbjct: 78  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLES- 133
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH--ISSVARGTVGYLDPEYYG 766
                IHRD+ + N+LL      K+ DFGL R   ++  H  +    +    +  PE   
Sbjct: 134 --KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 191
Query: 767 NQQLTEKSDVYSFGVVLLELIS-GKKP 792
            +  +  SD + FGV L E+ + G++P
Sbjct: 192 TRTFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 115/217 (52%), Gaps = 30/217 (13%)
Query: 596 KKIGKGSFGSVYYGK-MKDGKE----VAVKIMADSCSHRTQQFVTEVAL-LSRIHHRNLV 649
           K +G G FG+V+ G  + +G+     V +K++ D    ++ Q VT+  L +  + H ++V
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 650 PLIGYCEEEHQRILVYEYMHNGTLRD--RLH-GSVN-QKPLDWLTRLQIAHDAAKGLEYL 705
            L+G C     + LV +Y+  G+L D  R H G++  Q  L+W  ++      AKG+ YL
Sbjct: 97  RLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI------AKGMYYL 149
Query: 706 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR-QAEEDLTHISSVARGTVGYLDPEY 764
                 G++HR++ + N+LL    + +V+DFG++     +D   + S A+  + ++  E 
Sbjct: 150 E---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALES 206
Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 801
               + T +SDV+S+GV + EL++         FGAE
Sbjct: 207 IHFGKYTHQSDVWSYGVTVWELMT---------FGAE 234

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 14/207 (6%)
Query: 589 EATNNFCK--KIGKGSFGSVYYGKMKDGKEVAV--KIMADSCSHRT-QQFVTEVALLSRI 643
           E   NF K  KIG+G++G VY  + K   EV    KI  D+ +       + E++LL  +
Sbjct: 7   EFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 66
Query: 644 HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 703
           +H N+V L+     E++  LV+E++H    +     ++   PL  +          +GL 
Sbjct: 67  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 124
Query: 704 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDP 762
           + H+     ++HRD+K  N+L++     K++DFGL+R     + T+   V   T+ Y  P
Sbjct: 125 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAP 179
Query: 763 E-YYGNQQLTEKSDVYSFGVVLLELIS 788
           E   G +  +   D++S G +  E+++
Sbjct: 180 EILLGCKYYSTAVDIWSLGCIFAEMVT 206

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 12/207 (5%)
Query: 594 FCKKIGKGSFGSVYYGKMKD-GKEVAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPL 651
           F +K+G G+FG V+  + +  G E  +K I  D      +Q   E+ +L  + H N++ +
Sbjct: 26  FKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKI 85
Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRL-HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 710
               E+ H   +V E    G L +R+       K L      ++       L Y H+   
Sbjct: 86  FEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS--- 142
Query: 711 PGIIHRDVKSSNILL-DINMRA--KVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 767
             ++H+D+K  NIL  D +  +  K+ DFGL+   + D    S+ A GT  Y+ PE +  
Sbjct: 143 QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD--EHSTNAAGTALYMAPEVF-K 199
Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVS 794
           + +T K D++S GVV+  L++G  P +
Sbjct: 200 RDVTFKCDIWSAGVVMYFLLTGCLPFT 226

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 115/217 (52%), Gaps = 30/217 (13%)
Query: 596 KKIGKGSFGSVYYGK-MKDGKE----VAVKIMADSCSHRTQQFVTEVAL-LSRIHHRNLV 649
           K +G G FG+V+ G  + +G+     V +K++ D    ++ Q VT+  L +  + H ++V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 650 PLIGYCEEEHQRILVYEYMHNGTLRD--RLH-GSVN-QKPLDWLTRLQIAHDAAKGLEYL 705
            L+G C     + LV +Y+  G+L D  R H G++  Q  L+W  ++      AKG+ YL
Sbjct: 79  RLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI------AKGMYYL 131
Query: 706 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR-QAEEDLTHISSVARGTVGYLDPEY 764
                 G++HR++ + N+LL    + +V+DFG++     +D   + S A+  + ++  E 
Sbjct: 132 E---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALES 188
Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 801
               + T +SDV+S+GV + EL++         FGAE
Sbjct: 189 IHFGKYTHQSDVWSYGVTVWELMT---------FGAE 216

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 93/208 (44%), Gaps = 15/208 (7%)
Query: 598 IGKGSFGSVYYGKMK-DGKEVAVKIM--ADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 654
           IG GS+G     + K DGK +  K +          Q  V+EV LL  + H N+V     
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 655 CEEEHQRIL--VYEYMHNGTLRDRL-HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 711
             +     L  V EY   G L   +  G+  ++ LD    L++       L+  H   + 
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 712 G--IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLDPEYYG 766
           G  ++HRD+K +N+ LD     K+ DFGL+R     L H    A+  VG   Y+ PE   
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARI----LNHDEDFAKEFVGTPYYMSPEQMN 189
Query: 767 NQQLTEKSDVYSFGVVLLELISGKKPVS 794
                EKSD++S G +L EL +   P +
Sbjct: 190 RMSYNEKSDIWSLGCLLYELCALMPPFT 217

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 105/207 (50%), Gaps = 16/207 (7%)
Query: 590 ATNNFCK--KIGKGSFGSVYYGKMKDGKEVAV--KIMADSCSHRT-QQFVTEVALLSRIH 644
           +  NF K  KIG+G++G VY  + K   EV    KI  D+ +       + E++LL  ++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 645 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGS-VNQKPLDWLTRLQIAHDAAKGLE 703
           H N+V L+     E++  LV+E++H   L+D +  S +   PL  +          +GL 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKDFMDASALTGIPLPLIK--SYLFQLLQGLA 117
Query: 704 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDP 762
           + H+     ++HRD+K  N+L++     K++DFGL+R     + T+   V   T+ Y  P
Sbjct: 118 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 172
Query: 763 E-YYGNQQLTEKSDVYSFGVVLLELIS 788
           E   G +  +   D++S G +  E+++
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 101/214 (47%), Gaps = 20/214 (9%)
Query: 593 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMA-------DSCSHRTQQFVTEVALLSRIH 644
            + K +GKG+FG V   K K  G+  A+KI+        D  +H     +TE  +L    
Sbjct: 13  EYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT----LTENRVLQNSR 68
Query: 645 HRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 703
           H  L  L  Y  + H R+  V EY + G L    H S  +   +   R   A +    L+
Sbjct: 69  HPFLTAL-KYSFQTHDRLCFVMEYANGGELF--FHLSRERVFSEDRARFYGA-EIVSALD 124
Query: 704 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 763
           YLH+  N  +++RD+K  N++LD +   K++DFGL ++  +D   +     GT  YL PE
Sbjct: 125 YLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFC-GTPEYLAPE 181
Query: 764 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 797
              +       D +  GVV+ E++ G+ P   +D
Sbjct: 182 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 215

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 28/215 (13%)
Query: 598 IGKGSFGSVYYGKMK-DGKEVAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 655
           +G+G FG V+  K K D    A+K I   +     ++ + EV  L+++ H  +V      
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 72
Query: 656 EEEHQ---------RILVYEYMH---NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 703
            E++          ++ +Y  M       L+D ++G    +  +    L I    A+ +E
Sbjct: 73  LEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVE 132
Query: 704 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED------LTHISSVAR--G 755
           +LH+    G++HRD+K SNI   ++   KV DFGL    ++D      LT + + AR  G
Sbjct: 133 FLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTG 189
Query: 756 TVG---YLDPEYYGNQQLTEKSDVYSFGVVLLELI 787
            VG   Y+ PE       + K D++S G++L EL+
Sbjct: 190 QVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 101/214 (47%), Gaps = 20/214 (9%)
Query: 593 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMA-------DSCSHRTQQFVTEVALLSRIH 644
            + K +GKG+FG V   K K  G+  A+KI+        D  +H     +TE  +L    
Sbjct: 11  EYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT----LTENRVLQNSR 66
Query: 645 HRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 703
           H  L  L  Y  + H R+  V EY + G L    H S  +   +   R   A +    L+
Sbjct: 67  HPFLTAL-KYSFQTHDRLCFVMEYANGGELF--FHLSRERVFSEDRARFYGA-EIVSALD 122
Query: 704 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 763
           YLH+  N  +++RD+K  N++LD +   K++DFGL ++  +D   +     GT  YL PE
Sbjct: 123 YLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFC-GTPEYLAPE 179
Query: 764 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 797
              +       D +  GVV+ E++ G+ P   +D
Sbjct: 180 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 213

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 101/214 (47%), Gaps = 20/214 (9%)
Query: 593 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMA-------DSCSHRTQQFVTEVALLSRIH 644
            + K +GKG+FG V   K K  G+  A+KI+        D  +H     +TE  +L    
Sbjct: 12  EYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT----LTENRVLQNSR 67
Query: 645 HRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 703
           H  L  L  Y  + H R+  V EY + G L    H S  +   +   R   A +    L+
Sbjct: 68  HPFLTAL-KYSFQTHDRLCFVMEYANGGELF--FHLSRERVFSEDRARFYGA-EIVSALD 123
Query: 704 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 763
           YLH+  N  +++RD+K  N++LD +   K++DFGL ++  +D   +     GT  YL PE
Sbjct: 124 YLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFC-GTPEYLAPE 180
Query: 764 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 797
              +       D +  GVV+ E++ G+ P   +D
Sbjct: 181 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 214

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 101/203 (49%), Gaps = 14/203 (6%)
Query: 593 NFCK--KIGKGSFGSVYYGKMKDGKEVAV--KIMADSCSHRT-QQFVTEVALLSRIHHRN 647
           NF K  KIG+G++G VY  + K   EV    KI  D+ +       + E++LL  ++H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 648 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
           +V L+     E++  LV+E++H    +     ++   PL  +          +GL + H+
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCHS 121
Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPE-YY 765
                ++HRD+K  N+L++     K++DFGL+R     + T+   V   T+ Y  PE   
Sbjct: 122 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 176
Query: 766 GNQQLTEKSDVYSFGVVLLELIS 788
           G +  +   D++S G +  E+++
Sbjct: 177 GXKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 18/213 (8%)
Query: 583 PLPELEEATNNFCK--KIGKGSFGSVYYGKMKDGKEVAV--KIMADSCSHRT-QQFVTEV 637
           PL ++E    NF K  KIG+G++G VY  + K   EV    KI  D+ +       + E+
Sbjct: 2   PLVDME----NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI 57
Query: 638 ALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHD 697
           +LL  ++H N+V L+     E++  LV+E++H    +     ++   PL  +        
Sbjct: 58  SLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQ 115
Query: 698 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGT 756
             +GL + H+     ++HRD+K  N+L++     K++DFGL+R     + T+   V   T
Sbjct: 116 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--T 170
Query: 757 VGYLDPE-YYGNQQLTEKSDVYSFGVVLLELIS 788
           + Y  PE   G +  +   D++S G +  E+++
Sbjct: 171 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 107/224 (47%), Gaps = 33/224 (14%)
Query: 598 IGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI--HHRNLVPLIGY- 654
           +GKG +G V+ G  + G+ VAVKI +   S   + +  E  L + +   H N++  I   
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 655 CEEEH---QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH----- 706
               H   Q  L+  Y   G+L D L  +     LD ++ L+I    A GL +LH     
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQLTT----LDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS---RQAEEDLTHISSVARGTVGYLDPE 763
           T   P I HRD+KS NIL+  N +  ++D GL+    Q+   L   ++   GT  Y+ PE
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187
Query: 764 YYGNQQLTE------KSDVYSFGVVLLELISGKKPVS---VEDF 798
                   +      + D+++FG+VL E+   ++ VS   VED+
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEV--ARRMVSNGIVEDY 229

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 102/206 (49%), Gaps = 14/206 (6%)
Query: 590 ATNNFCK--KIGKGSFGSVYYGKMKDGKEVAV--KIMADSCSHRT-QQFVTEVALLSRIH 644
           +  NF K  KIG+G++G VY  + K   EV    KI  D+ +       + E++LL  ++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 645 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 704
           H N+V L+     E++  LV+E++H    +     ++   PL  +          +GL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAF 121
Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPE 763
            H+     ++HRD+K  N+L++     K++DFGL+R     + T+   V   T+ Y  PE
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 176
Query: 764 -YYGNQQLTEKSDVYSFGVVLLELIS 788
              G +  +   D++S G +  E+++
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 101/203 (49%), Gaps = 14/203 (6%)
Query: 593 NFCK--KIGKGSFGSVYYGKMKDGKEVAV--KIMADSCSHRT-QQFVTEVALLSRIHHRN 647
           NF K  KIG+G++G VY  + K   EV    KI  D+ +       + E++LL  ++H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 648 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
           +V L+     E++  LV+E++H    +     ++   PL  +          +GL + H+
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLSFCHS 121
Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPE-YY 765
                ++HRD+K  N+L++     K++DFGL+R     + T+   V   T+ Y  PE   
Sbjct: 122 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 176
Query: 766 GNQQLTEKSDVYSFGVVLLELIS 788
           G +  +   D++S G +  E+++
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 102/206 (49%), Gaps = 14/206 (6%)
Query: 590 ATNNFCK--KIGKGSFGSVYYGKMKDGKEVAV--KIMADSCSHRT-QQFVTEVALLSRIH 644
           +  NF K  KIG+G++G VY  + K   EV    KI  D+ +       + E++LL  ++
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 645 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 704
           H N+V L+     E++  LV+E++H    +     ++   PL  +          +GL +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAF 120
Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPE 763
            H+     ++HRD+K  N+L++     K++DFGL+R     + T+   V   T+ Y  PE
Sbjct: 121 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 175
Query: 764 -YYGNQQLTEKSDVYSFGVVLLELIS 788
              G +  +   D++S G +  E+++
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 102/206 (49%), Gaps = 14/206 (6%)
Query: 590 ATNNFCK--KIGKGSFGSVYYGKMKDGKEVAV--KIMADSCSHRT-QQFVTEVALLSRIH 644
           +  NF K  KIG+G++G VY  + K   EV    KI  D+ +       + E++LL  ++
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 645 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 704
           H N+V L+     E++  LV+E++H    +     ++   PL  +          +GL +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAF 120
Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPE 763
            H+     ++HRD+K  N+L++     K++DFGL+R     + T+   V   T+ Y  PE
Sbjct: 121 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 175
Query: 764 -YYGNQQLTEKSDVYSFGVVLLELIS 788
              G +  +   D++S G +  E+++
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 102/206 (49%), Gaps = 14/206 (6%)
Query: 590 ATNNFCK--KIGKGSFGSVYYGKMKDGKEVAV--KIMADSCSHRT-QQFVTEVALLSRIH 644
           +  NF K  KIG+G++G VY  + K   EV    KI  D+ +       + E++LL  ++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 645 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 704
           H N+V L+     E++  LV+E++H    +     ++   PL  +          +GL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAF 118
Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPE 763
            H+     ++HRD+K  N+L++     K++DFGL+R     + T+   V   T+ Y  PE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 173
Query: 764 -YYGNQQLTEKSDVYSFGVVLLELIS 788
              G +  +   D++S G +  E+++
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 102/206 (49%), Gaps = 14/206 (6%)
Query: 590 ATNNFCK--KIGKGSFGSVYYGKMKDGKEVAV--KIMADSCSHRT-QQFVTEVALLSRIH 644
           +  NF K  KIG+G++G VY  + K   EV    KI  D+ +       + E++LL  ++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 645 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 704
           H N+V L+     E++  LV+E++H    +     ++   PL  +          +GL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAF 118
Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPE 763
            H+     ++HRD+K  N+L++     K++DFGL+R     + T+   V   T+ Y  PE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 173
Query: 764 -YYGNQQLTEKSDVYSFGVVLLELIS 788
              G +  +   D++S G +  E+++
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 102/206 (49%), Gaps = 14/206 (6%)
Query: 590 ATNNFCK--KIGKGSFGSVYYGKMKDGKEVAV--KIMADSCSHRT-QQFVTEVALLSRIH 644
           +  NF K  KIG+G++G VY  + K   EV    KI  D+ +       + E++LL  ++
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 645 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 704
           H N+V L+     E++  LV+E++H    +     ++   PL  +          +GL +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAF 120
Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPE 763
            H+     ++HRD+K  N+L++     K++DFGL+R     + T+   V   T+ Y  PE
Sbjct: 121 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 175
Query: 764 -YYGNQQLTEKSDVYSFGVVLLELIS 788
              G +  +   D++S G +  E+++
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 102/206 (49%), Gaps = 14/206 (6%)
Query: 590 ATNNFCK--KIGKGSFGSVYYGKMKDGKEVAV--KIMADSCSHRT-QQFVTEVALLSRIH 644
           +  NF K  KIG+G++G VY  + K   EV    KI  D+ +       + E++LL  ++
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 645 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 704
           H N+V L+     E++  LV+E++H    +     ++   PL  +          +GL +
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAF 119
Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPE 763
            H+     ++HRD+K  N+L++     K++DFGL+R     + T+   V   T+ Y  PE
Sbjct: 120 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPE 174
Query: 764 -YYGNQQLTEKSDVYSFGVVLLELIS 788
              G +  +   D++S G +  E+++
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 38/220 (17%)
Query: 598 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH----------- 645
           +G+G+FG V   +   D +  A+K +  +   +    ++EV LL+ ++H           
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWL 72
Query: 646 --RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG-SVNQKPLD-WLTRLQIAHDAAKG 701
             RN V  +   +++    +  EY  N TL D +H  ++NQ+  + W    QI     + 
Sbjct: 73  ERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQIL----EA 128
Query: 702 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS----------- 750
           L Y+H+    GIIHRD+K  NI +D +   K+ DFGL++     L  +            
Sbjct: 129 LSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 751 --SVARGTVGYLDPEYY-GNQQLTEKSDVYSFGVVLLELI 787
             + A GT  Y+  E   G     EK D+YS G++  E+I
Sbjct: 186 NLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 102/206 (49%), Gaps = 14/206 (6%)
Query: 590 ATNNFCK--KIGKGSFGSVYYGKMKDGKEVAV--KIMADSCSHRT-QQFVTEVALLSRIH 644
           +  NF K  KIG+G++G VY  + K   EV    KI  D+ +       + E++LL  ++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 645 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 704
           H N+V L+     E++  LV+E++H    +     ++   PL  +          +GL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAF 118
Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPE 763
            H+     ++HRD+K  N+L++     K++DFGL+R     + T+   V   T+ Y  PE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 173
Query: 764 -YYGNQQLTEKSDVYSFGVVLLELIS 788
              G +  +   D++S G +  E+++
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 107/224 (47%), Gaps = 33/224 (14%)
Query: 598 IGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI--HHRNLVPLIGY- 654
           +GKG +G V+ G  + G+ VAVKI +   S   + +  E  L + +   H N++  I   
Sbjct: 45  VGKGRYGEVWRGSWQ-GENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIASD 100
Query: 655 CEEEH---QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH----- 706
               H   Q  L+  Y   G+L D L  +     LD ++ L+I    A GL +LH     
Sbjct: 101 MTSRHSSTQLWLITHYHEMGSLYDYLQLTT----LDTVSCLRIVLSIASGLAHLHIEIFG 156
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS---RQAEEDLTHISSVARGTVGYLDPE 763
           T   P I HRD+KS NIL+  N +  ++D GL+    Q+   L   ++   GT  Y+ PE
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 216
Query: 764 YYGNQQLTE------KSDVYSFGVVLLELISGKKPVS---VEDF 798
                   +      + D+++FG+VL E+   ++ VS   VED+
Sbjct: 217 VLDETIQVDCFDSYKRVDIWAFGLVLWEV--ARRMVSNGIVEDY 258

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 102/206 (49%), Gaps = 14/206 (6%)
Query: 590 ATNNFCK--KIGKGSFGSVYYGKMKDGKEVAV--KIMADSCSHRT-QQFVTEVALLSRIH 644
           +  NF K  KIG+G++G VY  + K   EV    KI  D+ +       + E++LL  ++
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 645 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 704
           H N+V L+     E++  LV+E++H    +     ++   PL  +          +GL +
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAF 119
Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPE 763
            H+     ++HRD+K  N+L++     K++DFGL+R     + T+   V   T+ Y  PE
Sbjct: 120 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 174
Query: 764 -YYGNQQLTEKSDVYSFGVVLLELIS 788
              G +  +   D++S G +  E+++
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 102/206 (49%), Gaps = 14/206 (6%)
Query: 590 ATNNFCK--KIGKGSFGSVYYGKMKDGKEVAV--KIMADSCSHRT-QQFVTEVALLSRIH 644
           +  NF K  KIG+G++G VY  + K   EV    KI  D+ +       + E++LL  ++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 645 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 704
           H N+V L+     E++  LV+E++H    +     ++   PL  +          +GL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAF 118
Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPE 763
            H+     ++HRD+K  N+L++     K++DFGL+R     + T+   V   T+ Y  PE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 173
Query: 764 -YYGNQQLTEKSDVYSFGVVLLELIS 788
              G +  +   D++S G +  E+++
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 101/203 (49%), Gaps = 14/203 (6%)
Query: 593 NFCK--KIGKGSFGSVYYGKMKDGKEVAV--KIMADSCSHRT-QQFVTEVALLSRIHHRN 647
           NF K  KIG+G++G VY  + K   EV    KI  D+ +       + E++LL  ++H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 648 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
           +V L+     E++  LV+E++H    +     ++   PL  +          +GL + H+
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCHS 120
Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPE-YY 765
                ++HRD+K  N+L++     K++DFGL+R     + T+   V   T+ Y  PE   
Sbjct: 121 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILL 175
Query: 766 GNQQLTEKSDVYSFGVVLLELIS 788
           G +  +   D++S G +  E+++
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 102/206 (49%), Gaps = 14/206 (6%)
Query: 590 ATNNFCK--KIGKGSFGSVYYGKMKDGKEVAV--KIMADSCSHRT-QQFVTEVALLSRIH 644
           +  NF K  KIG+G++G VY  + K   EV    KI  D+ +       + E++LL  ++
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 645 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 704
           H N+V L+     E++  LV+E++H    +     ++   PL  +          +GL +
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAF 119
Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPE 763
            H+     ++HRD+K  N+L++     K++DFGL+R     + T+   V   T+ Y  PE
Sbjct: 120 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 174
Query: 764 -YYGNQQLTEKSDVYSFGVVLLELIS 788
              G +  +   D++S G +  E+++
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 101/203 (49%), Gaps = 14/203 (6%)
Query: 593 NFCK--KIGKGSFGSVYYGKMKDGKEVAV--KIMADSCSHRT-QQFVTEVALLSRIHHRN 647
           NF K  KIG+G++G VY  + K   EV    KI  D+ +       + E++LL  ++H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 648 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
           +V L+     E++  LV+E++H    +     ++   PL  +          +GL + H+
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCHS 120
Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPE-YY 765
                ++HRD+K  N+L++     K++DFGL+R     + T+   V   T+ Y  PE   
Sbjct: 121 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 175
Query: 766 GNQQLTEKSDVYSFGVVLLELIS 788
           G +  +   D++S G +  E+++
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 102/206 (49%), Gaps = 14/206 (6%)
Query: 590 ATNNFCK--KIGKGSFGSVYYGKMKDGKEVAV--KIMADSCSHRT-QQFVTEVALLSRIH 644
           +  NF K  KIG+G++G VY  + K   EV    KI  D+ +       + E++LL  ++
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 645 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 704
           H N+V L+     E++  LV+E++H    +     ++   PL  +          +GL +
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAF 122
Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPE 763
            H+     ++HRD+K  N+L++     K++DFGL+R     + T+   V   T+ Y  PE
Sbjct: 123 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 177
Query: 764 -YYGNQQLTEKSDVYSFGVVLLELIS 788
              G +  +   D++S G +  E+++
Sbjct: 178 ILLGCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 101/203 (49%), Gaps = 14/203 (6%)
Query: 593 NFCK--KIGKGSFGSVYYGKMKDGKEVAV--KIMADSCSHRT-QQFVTEVALLSRIHHRN 647
           NF K  KIG+G++G VY  + K   EV    KI  D+ +       + E++LL  ++H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 648 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
           +V L+     E++  LV+E++H    +     ++   PL  +          +GL + H+
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCHS 121
Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPE-YY 765
                ++HRD+K  N+L++     K++DFGL+R     + T+   V   T+ Y  PE   
Sbjct: 122 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 176
Query: 766 GNQQLTEKSDVYSFGVVLLELIS 788
           G +  +   D++S G +  E+++
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 99/212 (46%), Gaps = 16/212 (7%)
Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMADSC---SHRTQQFVTEVALLSRIHHRNL 648
           NF   +GKGSFG V     K  +E+ A+KI+           +  + E  +L+ +     
Sbjct: 22  NFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPF 81
Query: 649 VPLIGYCEEEHQRI-LVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYL 705
           +  +  C +   R+  V EY++ G L   +   G   +        +  A + + GL +L
Sbjct: 82  LTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEP-----QAVFYAAEISIGLFFL 136
Query: 706 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 765
           H     GII+RD+K  N++LD     K++DFG+ ++   D         GT  Y+ PE  
Sbjct: 137 H---KRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFC-GTPDYIAPEII 192
Query: 766 GNQQLTEKSDVYSFGVVLLELISGKKPVSVED 797
             Q   +  D +++GV+L E+++G+ P   ED
Sbjct: 193 AYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED 224

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 101/203 (49%), Gaps = 14/203 (6%)
Query: 593 NFCK--KIGKGSFGSVYYGKMKDGKEVAV--KIMADSCSHRT-QQFVTEVALLSRIHHRN 647
           NF K  KIG+G++G VY  + K   EV    KI  D+ +       + E++LL  ++H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 648 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
           +V L+     E++  LV+E++H    +     ++   PL  +          +GL + H+
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCHS 120
Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPE-YY 765
                ++HRD+K  N+L++     K++DFGL+R     + T+   V   T+ Y  PE   
Sbjct: 121 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 175
Query: 766 GNQQLTEKSDVYSFGVVLLELIS 788
           G +  +   D++S G +  E+++
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 102/206 (49%), Gaps = 14/206 (6%)
Query: 590 ATNNFCK--KIGKGSFGSVYYGKMKDGKEVAV--KIMADSCSHRT-QQFVTEVALLSRIH 644
           +  NF K  KIG+G++G VY  + K   EV    KI  D+ +       + E++LL  ++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 645 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 704
           H N+V L+     E++  LV+E++H    +     ++   PL  +          +GL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAF 121
Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPE 763
            H+     ++HRD+K  N+L++     K++DFGL+R     + T+   V   T+ Y  PE
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 176
Query: 764 -YYGNQQLTEKSDVYSFGVVLLELIS 788
              G +  +   D++S G +  E+++
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 121/251 (48%), Gaps = 21/251 (8%)
Query: 598 IGKGSFGSVYY-GKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 656
           +G G FG V+   +   G ++A KI+        ++   E+++++++ H NL+ L    E
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE 156
Query: 657 EEHQRILVYEYMHNGTLRDR-LHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 715
            ++  +LV EY+  G L DR +  S N   LD +  ++      +G+ ++H      I+H
Sbjct: 157 SKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMK---QICEGIRHMHQMY---ILH 210
Query: 716 RDVKSSNILLDINMRA---KVSDFGLSR--QAEEDLTHISSVARGTVGYLDPEYYGNQQL 770
            D+K  NIL  +N  A   K+ DFGL+R  +  E L     V  GT  +L PE      +
Sbjct: 211 LDLKPENILC-VNRDAKQIKIIDFGLARRYKPREKL----KVNFGTPEFLAPEVVNYDFV 265
Query: 771 TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV--LIGN 828
           +  +D++S GV+   L+SG  P   ++    LN +   R  ++  +   I +     I  
Sbjct: 266 SFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISK 325
Query: 829 VKI-ESIWRIA 838
           + I E  WRI+
Sbjct: 326 LLIKEKSWRIS 336

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 101/203 (49%), Gaps = 14/203 (6%)
Query: 593 NFCK--KIGKGSFGSVYYGKMKDGKEVAV--KIMADSCSHRT-QQFVTEVALLSRIHHRN 647
           NF K  KIG+G++G VY  + K   EV    KI  D+ +       + E++LL  ++H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 648 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
           +V L+     E++  LV+E++H    +     ++   PL  +          +GL + H+
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCHS 121
Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPE-YY 765
                ++HRD+K  N+L++     K++DFGL+R     + T+   V   T+ Y  PE   
Sbjct: 122 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 176
Query: 766 GNQQLTEKSDVYSFGVVLLELIS 788
           G +  +   D++S G +  E+++
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 101/203 (49%), Gaps = 14/203 (6%)
Query: 593 NFCK--KIGKGSFGSVYYGKMKDGKEVAV--KIMADSCSHRT-QQFVTEVALLSRIHHRN 647
           NF K  KIG+G++G VY  + K   EV    KI  D+ +       + E++LL  ++H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 648 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
           +V L+     E++  LV+E++H    +     ++   PL  +          +GL + H+
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCHS 120
Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPE-YY 765
                ++HRD+K  N+L++     K++DFGL+R     + T+   V   T+ Y  PE   
Sbjct: 121 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 175
Query: 766 GNQQLTEKSDVYSFGVVLLELIS 788
           G +  +   D++S G +  E+++
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 116/219 (52%), Gaps = 24/219 (10%)
Query: 587 LEEATNNFCKKIGKGSFGSVYYGK-MKDGKEV----AVKIMADSCSHRT-QQFVTEVALL 640
           L+E      K +G G+FG+VY G  + +G++V    A+K + ++ S +  ++ + E  ++
Sbjct: 16  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 75
Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGS--VNQKPLDWLTRLQIAH 696
           + + + ++  L+G C     + L+ + M  G L D  R H     +Q  L+W  ++    
Sbjct: 76  ASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI---- 130
Query: 697 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVAR 754
             AKG+ YL    +  ++HRD+ + N+L+      K++DFGL++   AEE   H     +
Sbjct: 131 --AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-GK 184
Query: 755 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
             + ++  E   ++  T +SDV+S+GV + EL++ G KP
Sbjct: 185 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 223

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 100/208 (48%), Gaps = 10/208 (4%)
Query: 593 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 651
           +  +++G G+FG V+    K  G+    K +             E+++++++HH  L+ L
Sbjct: 54  DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINL 113
Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 711
               E++++ +L+ E++  G L DR+  +     +     +     A +GL+++H     
Sbjct: 114 HDAFEDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMHEH--- 168
Query: 712 GIIHRDVKSSNILLDINMRA--KVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQ 769
            I+H D+K  NI+ +    +  K+ DFGL+ +   D   I  V   T  +  PE    + 
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVKVTTATAEFAAPEIVDREP 226
Query: 770 LTEKSDVYSFGVVLLELISGKKPVSVED 797
           +   +D+++ GV+   L+SG  P + ED
Sbjct: 227 VGFYTDMWAIGVLGYVLLSGLSPFAGED 254

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 101/203 (49%), Gaps = 14/203 (6%)
Query: 593 NFCK--KIGKGSFGSVYYGKMKDGKEVAV--KIMADSCSHRT-QQFVTEVALLSRIHHRN 647
           NF K  KIG+G++G VY  + K   EV    KI  D+ +       + E++LL  ++H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 648 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
           +V L+     E++  LV+E++H    +     ++   PL  +          +GL + H+
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCHS 121
Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPE-YY 765
                ++HRD+K  N+L++     K++DFGL+R     + T+   V   T+ Y  PE   
Sbjct: 122 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 176
Query: 766 GNQQLTEKSDVYSFGVVLLELIS 788
           G +  +   D++S G +  E+++
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 101/203 (49%), Gaps = 14/203 (6%)
Query: 593 NFCK--KIGKGSFGSVYYGKMKDGKEVAV--KIMADSCSHRT-QQFVTEVALLSRIHHRN 647
           NF K  KIG+G++G VY  + K   EV    KI  D+ +       + E++LL  ++H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 648 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
           +V L+     E++  LV+E++H    +     ++   PL  +          +GL + H+
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCHS 120
Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPE-YY 765
                ++HRD+K  N+L++     K++DFGL+R     + T+   V   T+ Y  PE   
Sbjct: 121 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILL 175
Query: 766 GNQQLTEKSDVYSFGVVLLELIS 788
           G +  +   D++S G +  E+++
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 74/248 (29%), Positives = 114/248 (45%), Gaps = 43/248 (17%)
Query: 574 MDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQF 633
           M   VA+ I L E           +GKG +G V+ G  + G+ VAVKI +   S   + +
Sbjct: 2   MQRTVAHQITLLEC----------VGKGRYGEVWRGSWQ-GENVAVKIFS---SRDEKSW 47
Query: 634 VTEVALLSRI--HHRNLVPLIGY-CEEEH---QRILVYEYMHNGTLRDRLHGSVNQKPLD 687
             E  L + +   H N++  I       H   Q  L+  Y   G+L D L  +     LD
Sbjct: 48  FRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT----LD 103
Query: 688 WLTRLQIAHDAAKGLEYLH-----TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS--- 739
            ++ L+I    A GL +LH     T   P I HRD+KS NIL+  N +  ++D GL+   
Sbjct: 104 TVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMH 163
Query: 740 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE------KSDVYSFGVVLLELISGKKPV 793
            Q+   L   ++   GT  Y+ PE        +      + D+++FG+VL E+   ++ V
Sbjct: 164 SQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV--ARRMV 221
Query: 794 S---VEDF 798
           S   VED+
Sbjct: 222 SNGIVEDY 229

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 116/219 (52%), Gaps = 24/219 (10%)
Query: 587 LEEATNNFCKKIGKGSFGSVYYGK-MKDGKEV----AVKIMADSCSHRT-QQFVTEVALL 640
           L+E      K +G G+FG+VY G  + +G++V    A+K + ++ S +  ++ + E  ++
Sbjct: 13  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 72
Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGS--VNQKPLDWLTRLQIAH 696
           + + + ++  L+G C     + L+ + M  G L D  R H     +Q  L+W  ++    
Sbjct: 73  ASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI---- 127
Query: 697 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVAR 754
             AKG+ YL    +  ++HRD+ + N+L+      K++DFGL++   AEE   H     +
Sbjct: 128 --AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-GK 181
Query: 755 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
             + ++  E   ++  T +SDV+S+GV + EL++ G KP
Sbjct: 182 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 220

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 100/216 (46%), Gaps = 18/216 (8%)
Query: 585 PELEEATNNFCKKIGKGSFGSVYYGKMKDGKEV--AVKIMADSC---SHRTQQFVTEV-A 638
           P  + +  +F K IGKGSFG V   + K  +EV  AVK++           +  ++E   
Sbjct: 33  PHAKPSDFHFLKVIGKGSFGKVLLARHK-AEEVFYAVKVLQKKAILKKKEEKHIMSERNV 91
Query: 639 LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDA 698
           LL  + H  LV L    +   +   V +Y++ G L    H    +  L+   R   A + 
Sbjct: 92  LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELF--YHLQRERCFLEPRARFYAA-EI 148
Query: 699 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GT 756
           A  L YLH+     I++RD+K  NILLD      ++DFGL +   E++ H S+ +   GT
Sbjct: 149 ASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNSTTSTFCGT 202
Query: 757 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
             YL PE    Q      D +  G VL E++ G  P
Sbjct: 203 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 116/219 (52%), Gaps = 24/219 (10%)
Query: 587 LEEATNNFCKKIGKGSFGSVYYGK-MKDGKEV----AVKIMADSCSHRT-QQFVTEVALL 640
           L+E      K +G G+FG+VY G  + +G++V    A+K + ++ S +  ++ + E  ++
Sbjct: 14  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 73
Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGS--VNQKPLDWLTRLQIAH 696
           + + + ++  L+G C     + L+ + M  G L D  R H     +Q  L+W  ++    
Sbjct: 74  ASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI---- 128
Query: 697 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVAR 754
             AKG+ YL    +  ++HRD+ + N+L+      K++DFGL++   AEE   H     +
Sbjct: 129 --AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-GK 182
Query: 755 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
             + ++  E   ++  T +SDV+S+GV + EL++ G KP
Sbjct: 183 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 106/214 (49%), Gaps = 17/214 (7%)
Query: 594 FCKKIGKGSFGSVYYGK----MKDGKEVAVKIMADSC----SHRTQQFVTEVALLSRIHH 645
             K +G G++G V+  +       GK  A+K++  +     +  T+   TE  +L  I  
Sbjct: 58  LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 117
Query: 646 RNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 704
              +  + Y  +   ++ L+ +Y++ G L   L  S  ++  +   ++ +  +    LE+
Sbjct: 118 SPFLVTLHYAFQTETKLHLILDYINGGELFTHL--SQRERFTEHEVQIYVG-EIVLALEH 174
Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
           LH     GII+RD+K  NILLD N    ++DFGLS++   D T  +    GT+ Y+ P+ 
Sbjct: 175 LH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDI 231
Query: 765 Y--GNQQLTEKSDVYSFGVVLLELISGKKPVSVE 796
              G+    +  D +S GV++ EL++G  P +V+
Sbjct: 232 VRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD 265

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 116/219 (52%), Gaps = 24/219 (10%)
Query: 587 LEEATNNFCKKIGKGSFGSVYYGK-MKDGKEV----AVKIMADSCSHRT-QQFVTEVALL 640
           L+E      K +G G+FG+VY G  + +G++V    A+K + ++ S +  ++ + E  ++
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGS--VNQKPLDWLTRLQIAH 696
           + + + ++  L+G C     + L+ + M  G L D  R H     +Q  L+W  ++    
Sbjct: 72  ASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI---- 126
Query: 697 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVAR 754
             AKG+ YL    +  ++HRD+ + N+L+      K++DFGL++   AEE   H     +
Sbjct: 127 --AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-GK 180
Query: 755 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
             + ++  E   ++  T +SDV+S+GV + EL++ G KP
Sbjct: 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 116/219 (52%), Gaps = 24/219 (10%)
Query: 587 LEEATNNFCKKIGKGSFGSVYYGK-MKDGKEV----AVKIMADSCSHRT-QQFVTEVALL 640
           L+E      K +G G+FG+VY G  + +G++V    A+K + ++ S +  ++ + E  ++
Sbjct: 13  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 72
Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGS--VNQKPLDWLTRLQIAH 696
           + + + ++  L+G C     + L+ + M  G L D  R H     +Q  L+W  ++    
Sbjct: 73  ASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQI---- 127
Query: 697 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVAR 754
             AKG+ YL    +  ++HRD+ + N+L+      K++DFGL++   AEE   H     +
Sbjct: 128 --AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-GK 181
Query: 755 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
             + ++  E   ++  T +SDV+S+GV + EL++ G KP
Sbjct: 182 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 220

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 116/219 (52%), Gaps = 24/219 (10%)
Query: 587 LEEATNNFCKKIGKGSFGSVYYGK-MKDGKEV----AVKIMADSCSHRT-QQFVTEVALL 640
           L+E      K +G G+FG+VY G  + +G++V    A+K + ++ S +  ++ + E  ++
Sbjct: 6   LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 65
Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGS--VNQKPLDWLTRLQIAH 696
           + + + ++  L+G C     + L+ + M  G L D  R H     +Q  L+W  ++    
Sbjct: 66  ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI---- 120
Query: 697 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVAR 754
             AKG+ YL    +  ++HRD+ + N+L+      K++DFGL++   AEE   H     +
Sbjct: 121 --AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-GK 174
Query: 755 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
             + ++  E   ++  T +SDV+S+GV + EL++ G KP
Sbjct: 175 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 213

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 116/219 (52%), Gaps = 24/219 (10%)
Query: 587 LEEATNNFCKKIGKGSFGSVYYGK-MKDGKEV----AVKIMADSCSHRT-QQFVTEVALL 640
           L+E      K +G G+FG+VY G  + +G++V    A+K + ++ S +  ++ + E  ++
Sbjct: 15  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 74
Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGS--VNQKPLDWLTRLQIAH 696
           + + + ++  L+G C     + L+ + M  G L D  R H     +Q  L+W  ++    
Sbjct: 75  ASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI---- 129
Query: 697 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVAR 754
             AKG+ YL    +  ++HRD+ + N+L+      K++DFGL++   AEE   H     +
Sbjct: 130 --AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-GK 183
Query: 755 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
             + ++  E   ++  T +SDV+S+GV + EL++ G KP
Sbjct: 184 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 222

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 101/203 (49%), Gaps = 14/203 (6%)
Query: 593 NFCK--KIGKGSFGSVYYGKMKDGKEVAV--KIMADSCSHRT-QQFVTEVALLSRIHHRN 647
           NF K  KIG+G++G VY  + K   EV    KI  D+ +       + E++LL  ++H N
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 64
Query: 648 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
           +V L+     E++  LV+E++H    +     ++   PL  +          +GL + H+
Sbjct: 65  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF--QLLQGLAFCHS 122
Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPE-YY 765
                ++HRD+K  N+L++     K++DFGL+R     + T+   V   T+ Y  PE   
Sbjct: 123 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILL 177
Query: 766 GNQQLTEKSDVYSFGVVLLELIS 788
           G +  +   D++S G +  E+++
Sbjct: 178 GCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 116/219 (52%), Gaps = 24/219 (10%)
Query: 587 LEEATNNFCKKIGKGSFGSVYYGK-MKDGKEV----AVKIMADSCSHRT-QQFVTEVALL 640
           L+E      K +G G+FG+VY G  + +G++V    A+K + ++ S +  ++ + E  ++
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGS--VNQKPLDWLTRLQIAH 696
           + + + ++  L+G C     + L+ + M  G L D  R H     +Q  L+W  ++    
Sbjct: 72  ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI---- 126
Query: 697 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVAR 754
             AKG+ YL    +  ++HRD+ + N+L+      K++DFGL++   AEE   H     +
Sbjct: 127 --AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-GK 180
Query: 755 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
             + ++  E   ++  T +SDV+S+GV + EL++ G KP
Sbjct: 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 12/209 (5%)
Query: 594 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLV 649
           F + +GKGSFG V   ++K+ G   AVK++           +  +TE  +LS   +   +
Sbjct: 27  FIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFL 86
Query: 650 PLIGYCEEEHQRIL-VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
             +  C +   R+  V E+++ G L   +  S   +  D       A +    L +LH  
Sbjct: 87  TQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLH-- 141
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
            + GII+RD+K  N+LLD     K++DFG+ ++   +    ++   GT  Y+ PE     
Sbjct: 142 -DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFC-GTPDYIAPEILQEM 199
Query: 769 QLTEKSDVYSFGVVLLELISGKKPVSVED 797
                 D ++ GV+L E++ G  P   E+
Sbjct: 200 LYGPAVDWWAMGVLLYEMLCGHAPFEAEN 228

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 116/219 (52%), Gaps = 24/219 (10%)
Query: 587 LEEATNNFCKKIGKGSFGSVYYGK-MKDGKEV----AVKIMADSCSHRT-QQFVTEVALL 640
           L+E      K +G G+FG+VY G  + +G++V    A+K + ++ S +  ++ + E  ++
Sbjct: 22  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 81
Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGS--VNQKPLDWLTRLQIAH 696
           + + + ++  L+G C     + L+ + M  G L D  R H     +Q  L+W  ++    
Sbjct: 82  ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI---- 136
Query: 697 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVAR 754
             AKG+ YL    +  ++HRD+ + N+L+      K++DFGL++   AEE   H     +
Sbjct: 137 --AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-GK 190
Query: 755 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
             + ++  E   ++  T +SDV+S+GV + EL++ G KP
Sbjct: 191 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 229

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 116/219 (52%), Gaps = 24/219 (10%)
Query: 587 LEEATNNFCKKIGKGSFGSVYYGK-MKDGKEV----AVKIMADSCSHRT-QQFVTEVALL 640
           L+E      K +G G+FG+VY G  + +G++V    A+K + ++ S +  ++ + E  ++
Sbjct: 14  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 73
Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGS--VNQKPLDWLTRLQIAH 696
           + + + ++  L+G C     + L+ + M  G L D  R H     +Q  L+W  ++    
Sbjct: 74  ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI---- 128
Query: 697 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVAR 754
             AKG+ YL    +  ++HRD+ + N+L+      K++DFGL++   AEE   H     +
Sbjct: 129 --AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-GK 182
Query: 755 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
             + ++  E   ++  T +SDV+S+GV + EL++ G KP
Sbjct: 183 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 116/219 (52%), Gaps = 24/219 (10%)
Query: 587 LEEATNNFCKKIGKGSFGSVYYGK-MKDGKEV----AVKIMADSCSHRT-QQFVTEVALL 640
           L+E      K +G G+FG+VY G  + +G++V    A+K + ++ S +  ++ + E  ++
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGS--VNQKPLDWLTRLQIAH 696
           + + + ++  L+G C     + L+ + M  G L D  R H     +Q  L+W  ++    
Sbjct: 72  ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI---- 126
Query: 697 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVAR 754
             AKG+ YL    +  ++HRD+ + N+L+      K++DFGL++   AEE   H     +
Sbjct: 127 --AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-GK 180
Query: 755 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
             + ++  E   ++  T +SDV+S+GV + EL++ G KP
Sbjct: 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 116/219 (52%), Gaps = 24/219 (10%)
Query: 587 LEEATNNFCKKIGKGSFGSVYYGK-MKDGKEV----AVKIMADSCSHRT-QQFVTEVALL 640
           L+E      K +G G+FG+VY G  + +G++V    A+K + ++ S +  ++ + E  ++
Sbjct: 15  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 74
Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGS--VNQKPLDWLTRLQIAH 696
           + + + ++  L+G C     + L+ + M  G L D  R H     +Q  L+W  ++    
Sbjct: 75  ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI---- 129
Query: 697 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVAR 754
             AKG+ YL    +  ++HRD+ + N+L+      K++DFGL++   AEE   H     +
Sbjct: 130 --AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-GK 183
Query: 755 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
             + ++  E   ++  T +SDV+S+GV + EL++ G KP
Sbjct: 184 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 222

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 116/219 (52%), Gaps = 24/219 (10%)
Query: 587 LEEATNNFCKKIGKGSFGSVYYGK-MKDGKEV----AVKIMADSCSHRT-QQFVTEVALL 640
           L+E      K +G G+FG+VY G  + +G++V    A+K + ++ S +  ++ + E  ++
Sbjct: 15  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 74
Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGS--VNQKPLDWLTRLQIAH 696
           + + + ++  L+G C     + L+ + M  G L D  R H     +Q  L+W  ++    
Sbjct: 75  ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI---- 129
Query: 697 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVAR 754
             AKG+ YL    +  ++HRD+ + N+L+      K++DFGL++   AEE   H     +
Sbjct: 130 --AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-GK 183
Query: 755 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
             + ++  E   ++  T +SDV+S+GV + EL++ G KP
Sbjct: 184 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 222

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 116/219 (52%), Gaps = 24/219 (10%)
Query: 587 LEEATNNFCKKIGKGSFGSVYYGK-MKDGKEV----AVKIMADSCSHRT-QQFVTEVALL 640
           L+E      K +G G+FG+VY G  + +G++V    A+K + ++ S +  ++ + E  ++
Sbjct: 19  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 78
Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGS--VNQKPLDWLTRLQIAH 696
           + + + ++  L+G C     + L+ + M  G L D  R H     +Q  L+W  ++    
Sbjct: 79  ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI---- 133
Query: 697 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVAR 754
             AKG+ YL    +  ++HRD+ + N+L+      K++DFGL++   AEE   H     +
Sbjct: 134 --AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-GK 187
Query: 755 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
             + ++  E   ++  T +SDV+S+GV + EL++ G KP
Sbjct: 188 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 226

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 116/219 (52%), Gaps = 24/219 (10%)
Query: 587 LEEATNNFCKKIGKGSFGSVYYGK-MKDGKEV----AVKIMADSCSHRT-QQFVTEVALL 640
           L+E      K +G G+FG+VY G  + +G++V    A+K + ++ S +  ++ + E  ++
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGS--VNQKPLDWLTRLQIAH 696
           + + + ++  L+G C     + L+ + M  G L D  R H     +Q  L+W  ++    
Sbjct: 72  ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQI---- 126
Query: 697 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVAR 754
             AKG+ YL    +  ++HRD+ + N+L+      K++DFGL++   AEE   H     +
Sbjct: 127 --AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-GK 180
Query: 755 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
             + ++  E   ++  T +SDV+S+GV + EL++ G KP
Sbjct: 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 116/219 (52%), Gaps = 24/219 (10%)
Query: 587 LEEATNNFCKKIGKGSFGSVYYGK-MKDGKEV----AVKIMADSCSHRT-QQFVTEVALL 640
           L+E      K +G G+FG+VY G  + +G++V    A+K + ++ S +  ++ + E  ++
Sbjct: 15  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 74
Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGS--VNQKPLDWLTRLQIAH 696
           + + + ++  L+G C     + L+ + M  G L D  R H     +Q  L+W  ++    
Sbjct: 75  ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI---- 129
Query: 697 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVAR 754
             AKG+ YL    +  ++HRD+ + N+L+      K++DFGL++   AEE   H     +
Sbjct: 130 --AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-GK 183
Query: 755 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
             + ++  E   ++  T +SDV+S+GV + EL++ G KP
Sbjct: 184 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 222

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 73/287 (25%), Positives = 145/287 (50%), Gaps = 40/287 (13%)
Query: 587 LEEATNNFCKKIGKGSFGSVYYGK-MKDGKEV----AVKIMADSCSHRT-QQFVTEVALL 640
           L+E      K +G G+FG+VY G  + +G++V    A+K + ++ S +  ++ + E  ++
Sbjct: 37  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 96
Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGS--VNQKPLDWLTRLQIAH 696
           + + + ++  L+G C     + L+ + M  G L D  R H     +Q  L+W  ++    
Sbjct: 97  ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI---- 151
Query: 697 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVAR 754
             AKG+ YL    +  ++HRD+ + N+L+      K++DFGL++   AEE   H     +
Sbjct: 152 --AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-GK 205
Query: 755 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIK 813
             + ++  E   ++  T +SDV+S+GV + EL++ G KP      G   + +    S+++
Sbjct: 206 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD----GIPASEI---SSILE 258
Query: 814 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 860
           KG+ +    P+   +V +        + ++C      SRPK +E+++
Sbjct: 259 KGERLP-QPPICTIDVYM--------IMVKCWMIDADSRPKFRELII 296

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 116/219 (52%), Gaps = 24/219 (10%)
Query: 587 LEEATNNFCKKIGKGSFGSVYYGK-MKDGKEV----AVKIMADSCSHRT-QQFVTEVALL 640
           L+E      K +G G+FG+VY G  + +G++V    A+K + ++ S +  ++ + E  ++
Sbjct: 18  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 77
Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGS--VNQKPLDWLTRLQIAH 696
           + + + ++  L+G C     + L+ + M  G L D  R H     +Q  L+W  ++    
Sbjct: 78  ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI---- 132
Query: 697 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVAR 754
             AKG+ YL    +  ++HRD+ + N+L+      K++DFGL++   AEE   H     +
Sbjct: 133 --AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-GK 186
Query: 755 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
             + ++  E   ++  T +SDV+S+GV + EL++ G KP
Sbjct: 187 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 225

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 12/210 (5%)
Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMADSC---SHRTQQFVTEVALLSRIHHRNL 648
           NF   +GKGSFG V   + K   E+ AVKI+           +  + E  +L+       
Sbjct: 23  NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPF 82
Query: 649 VPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
           +  +  C +   R+  V EY++ G L   +      K    +     A + A GL +L +
Sbjct: 83  LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVF---YAAEIAIGLFFLQS 139
Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 767
               GII+RD+K  N++LD     K++DFG+ ++   D         GT  Y+ PE    
Sbjct: 140 ---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFC-GTPDYIAPEIIAY 195
Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVSVED 797
           Q   +  D ++FGV+L E+++G+ P   ED
Sbjct: 196 QPYGKSVDWWAFGVLLYEMLAGQAPFEGED 225

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 100/198 (50%), Gaps = 13/198 (6%)
Query: 598 IGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVT--EVALLSRIHHRNLVPLIGY 654
           +G+GS+G V   + KD G+ VA+K   +S   +  + +   E+ LL ++ H NLV L+  
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 655 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 714
           C+++ +  LV+E++ +  L D     +    LD+    +       G+ + H+     II
Sbjct: 93  CKKKKRWYLVFEFVDHTILDDL---ELFPNGLDYQVVQKYLFQIINGIGFCHSH---NII 146
Query: 715 HRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYLDPEYY-GNQQLTE 772
           HRD+K  NIL+  +   K+ DFG +R  A     +   VA  T  Y  PE   G+ +  +
Sbjct: 147 HRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA--TRWYRAPELLVGDVKYGK 204
Query: 773 KSDVYSFGVVLLELISGK 790
             DV++ G ++ E+  G+
Sbjct: 205 AVDVWAIGCLVTEMFMGE 222

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 106/227 (46%), Gaps = 20/227 (8%)
Query: 580 YFIPLPELEEATNNF--------CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT- 630
           YF  + + E  T +           ++G G+FG VY  + K+   +A   + D+ S    
Sbjct: 19  YFQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEEL 78
Query: 631 QQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLT 690
           + ++ E+ +L+   H N+V L+     E+   ++ E+   G + D +   + ++PL    
Sbjct: 79  EDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAV-DAVMLEL-ERPLTESQ 136
Query: 691 RLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 750
              +       L YLH   +  IIHRD+K+ NIL  ++   K++DFG+S +    +    
Sbjct: 137 IQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRD 193
Query: 751 SVARGTVGYLDPEYY-----GNQQLTEKSDVYSFGVVLLELISGKKP 792
           S   GT  ++ PE        ++    K+DV+S G+ L+E+   + P
Sbjct: 194 SFI-GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 101/206 (49%), Gaps = 14/206 (6%)
Query: 590 ATNNFCK--KIGKGSFGSVYYGKMKDGKEVAV--KIMADSCSHRT-QQFVTEVALLSRIH 644
           +  NF K  KIG+G++G VY  + K   EV    KI  D+ +       + E++LL  ++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 645 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 704
           H N+V L+     E++  LV+E++H          ++   PL  +          +GL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIK--SYLFQLLQGLAF 121
Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPE 763
            H+     ++HRD+K  N+L++     K++DFGL+R     + T+   V   T+ Y  PE
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 176
Query: 764 -YYGNQQLTEKSDVYSFGVVLLELIS 788
              G +  +   D++S G +  E+++
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 106/227 (46%), Gaps = 20/227 (8%)
Query: 580 YFIPLPELEEATNNF--------CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT- 630
           YF  + + E  T +           ++G G+FG VY  + K+   +A   + D+ S    
Sbjct: 19  YFQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEEL 78
Query: 631 QQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLT 690
           + ++ E+ +L+   H N+V L+     E+   ++ E+   G + D +   + ++PL    
Sbjct: 79  EDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAV-DAVMLEL-ERPLTESQ 136
Query: 691 RLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 750
              +       L YLH   +  IIHRD+K+ NIL  ++   K++DFG+S +    +    
Sbjct: 137 IQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD 193
Query: 751 SVARGTVGYLDPEYY-----GNQQLTEKSDVYSFGVVLLELISGKKP 792
           S   GT  ++ PE        ++    K+DV+S G+ L+E+   + P
Sbjct: 194 SFI-GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 104/208 (50%), Gaps = 14/208 (6%)
Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMA--DSCSHRTQQFVTEVALLSRIHHRNLVP 650
           NF  K+ +   G ++ G+ + G ++ VK++   D  + +++ F  E   L    H N++P
Sbjct: 13  NFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP 71
Query: 651 LIGYCEE--EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           ++G C+        L+  +M  G+L + LH   N   +D    ++ A D A+G+ +LHT 
Sbjct: 72  VLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV-VDQSQAVKFALDMARGMAFLHT- 129
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVS--DFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 766
             P I    + S ++++D +M A++S  D   S Q+   +   + VA   +    PE   
Sbjct: 130 LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAPAWVAPEALQK-KPEDTN 188
Query: 767 NQQLTEKSDVYSFGVVLLELISGKKPVS 794
            +     +D++SF V+L EL++ + P +
Sbjct: 189 RRS----ADMWSFAVLLWELVTREVPFA 212

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 101/225 (44%), Gaps = 21/225 (9%)
Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVK---IMADSCSHRTQQFVTEVALLSRIHHRNLVPL 651
           KKIG+G F  VY    + DG  VA+K   I     +      + E+ LL +++H N++  
Sbjct: 38  KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97
Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD-----WLTRLQIAHDAAKGLEYLH 706
                E+++  +V E    G L   +     QK L      W   +Q+       LE++H
Sbjct: 98  YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLC----SALEHMH 153
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 766
           +     ++HRD+K +N+ +      K+ D GL R      T   S+  GT  Y+ PE   
Sbjct: 154 SR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIH 209
Query: 767 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM 811
                 KSD++S G +L E+ + + P     +G ++N+    + +
Sbjct: 210 ENGYNFKSDIWSLGCLLYEMAALQSPF----YGDKMNLYSLCKKI 250

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 98/216 (45%), Gaps = 24/216 (11%)
Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMADSC---SHRTQQFVTEVALLSRIHHRNL 648
           NF   +GKGSFG V   + K   E+ AVKI+           +  + E  +L+       
Sbjct: 344 NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPF 403
Query: 649 VPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH------DAAKG 701
           +  +  C +   R+  V EY++ G L   +           + R +  H      + A G
Sbjct: 404 LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ---------VGRFKEPHAVFYAAEIAIG 454
Query: 702 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 761
           L +L +    GII+RD+K  N++LD     K++DFG+ ++   D         GT  Y+ 
Sbjct: 455 LFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFC-GTPDYIA 510
Query: 762 PEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 797
           PE    Q   +  D ++FGV+L E+++G+ P   ED
Sbjct: 511 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 546

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 90/201 (44%), Gaps = 37/201 (18%)
Query: 614 GKEVAVKIMADSCSHRTQQFVTEVALLSRIH---------HRNLVPLIGYCEEEHQRILV 664
           G E AVKIM  +    + + + EV   +R           H +++ LI   E      LV
Sbjct: 119 GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLV 178
Query: 665 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNIL 724
           ++ M  G L D L   V     +  TR  I     + + +LH      I+HRD+K  NIL
Sbjct: 179 FDLMRKGELFDYLTEKVALSEKE--TR-SIMRSLLEAVSFLHAN---NIVHRDLKPENIL 232
Query: 725 LDINMRAKVSDFGLSRQAE--EDLTHISSVARGTVGYLDPEY-----------YGNQQLT 771
           LD NM+ ++SDFG S   E  E L  +     GT GYL PE            YG +   
Sbjct: 233 LDDNMQIRLSDFGFSCHLEPGEKLRELC----GTPGYLAPEILKCSMDETHPGYGKE--- 285
Query: 772 EKSDVYSFGVVLLELISGKKP 792
              D+++ GV+L  L++G  P
Sbjct: 286 --VDLWACGVILFTLLAGSPP 304

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 97/225 (43%), Gaps = 13/225 (5%)
Query: 596 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 654
           K +G+GSF         K  +  AVKI++      TQ+ +T + L     H N+V L   
Sbjct: 17  KPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEG--HPNIVKLHEV 74
Query: 655 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 714
             ++    LV E ++ G L +R+     +K         I       + ++H   + G++
Sbjct: 75  FHDQLHTFLVMELLNGGELFERIK---KKKHFSETEASYIMRKLVSAVSHMH---DVGVV 128
Query: 715 HRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 771
           HRD+K  N+L    + N+  K+ DFG +R    D   + +    T+ Y  PE        
Sbjct: 129 HRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF-TLHYAAPELLNQNGYD 187
Query: 772 EKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 816
           E  D++S GV+L  ++SG+ P    D              IKKGD
Sbjct: 188 ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD 232

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 111/219 (50%), Gaps = 24/219 (10%)
Query: 587 LEEATNNFCKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT-----QQFVTEVALL 640
           L+E      K +G G+FG+VY G  + +G++V + +        T     ++ + E  ++
Sbjct: 46  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVM 105
Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGS--VNQKPLDWLTRLQIAH 696
           + + + ++  L+G C     + L+ + M  G L D  R H     +Q  L+W  ++    
Sbjct: 106 ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI---- 160
Query: 697 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVAR 754
             AKG+ YL    +  ++HRD+ + N+L+      K++DFGL++   AEE   H     +
Sbjct: 161 --AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-GK 214
Query: 755 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
             + ++  E   ++  T +SDV+S+GV + EL++ G KP
Sbjct: 215 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 253

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 99/216 (45%), Gaps = 23/216 (10%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 645
           E  E     CK IG GSFG V+  K+ +  EVA+K +      + +    E+ ++  + H
Sbjct: 36  EQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR----ELQIMRIVKH 91
Query: 646 RNLVPLIGYC------EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA 699
            N+V L  +       ++E    LV EY+     R   H +  ++ +  L      +   
Sbjct: 92  PNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLL 151
Query: 700 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRA-KVSDFGLSR---QAEEDLTHISSVARG 755
           + L Y+H+    GI HRD+K  N+LLD      K+ DFG ++     E +++ I S    
Sbjct: 152 RSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRY-- 206
Query: 756 TVGYLDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 790
              Y  PE  +G    T   D++S G V+ EL+ G+
Sbjct: 207 ---YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 107/216 (49%), Gaps = 18/216 (8%)
Query: 596 KKIGKGSFGSV---YYGKMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLV 649
           + +G G++GSV   Y  +++  ++VAVK ++    S  H  + +  E+ LL  + H N++
Sbjct: 26  RPVGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTY-RELRLLKHLKHENVI 82
Query: 650 PLIG-YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
            L+  +            Y+    +   L+  V  + L       + +   +GL+Y+H+ 
Sbjct: 83  GLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSA 142
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN- 767
              GIIHRD+K SN+ ++ +   ++ DFGL+RQA+E++T   +    T  Y  PE   N 
Sbjct: 143 ---GIIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGYVA----TRWYRAPEIMLNW 195
Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN 803
               +  D++S G ++ EL+ GK      D+  +L 
Sbjct: 196 MHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLK 231

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 97/202 (48%), Gaps = 18/202 (8%)
Query: 596 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 652
           K IG G+ G V        G  VAVK ++    ++T  ++   E+ LL  ++H+N++ L+
Sbjct: 28  KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 87
Query: 653 GYCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
                    EE Q + +   + +  L   +H  ++ + + +L    +      G+++LH+
Sbjct: 88  NVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLC-----GIKHLHS 142
Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 767
               GIIHRD+K SNI++  +   K+ DFGL+R A  +      V   T  Y  PE    
Sbjct: 143 A---GIIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVV--TRYYRAPEVILG 197
Query: 768 QQLTEKSDVYSFGVVLLELISG 789
               E  D++S G ++ EL+ G
Sbjct: 198 MGYKENVDIWSVGCIMGELVKG 219

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 83/166 (50%), Gaps = 8/166 (4%)
Query: 632 QFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR 691
           Q + E+ +L   +   +V   G    + +  +  E+M  G+L D++     + P   L +
Sbjct: 112 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGK 170
Query: 692 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 751
           + IA    KGL YL       I+HRDVK SNIL++     K+ DFG+S Q    +  +++
Sbjct: 171 VSIA--VIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMAN 223
Query: 752 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 797
              GT  Y+ PE       + +SD++S G+ L+E+  G+ P+   D
Sbjct: 224 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 269

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 116/219 (52%), Gaps = 24/219 (10%)
Query: 587 LEEATNNFCKKIGKGSFGSVYYGK-MKDGKEV----AVKIMADSCSHRT-QQFVTEVALL 640
           L+E      K +G G+FG+VY G  + +G++V    A+K + ++ S +  ++ + E  ++
Sbjct: 9   LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 68
Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGS--VNQKPLDWLTRLQIAH 696
           + + + ++  L+G C     + L+ + M  G L D  R H     +Q  L+W  ++    
Sbjct: 69  ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI---- 123
Query: 697 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVAR 754
             A+G+ YL    +  ++HRD+ + N+L+      K++DFGL++   AEE   H     +
Sbjct: 124 --AEGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-GK 177
Query: 755 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
             + ++  E   ++  T +SDV+S+GV + EL++ G KP
Sbjct: 178 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 216

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 109/221 (49%), Gaps = 26/221 (11%)
Query: 595 CKKIGKGSFGSV---YYGKMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNL 648
            + +G G++GSV   Y  +++  ++VAVK ++    S  H  + +  E+ LL  + H N+
Sbjct: 33  LRPVGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTY-RELRLLKHLKHENV 89
Query: 649 VPLIGYCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 703
           + L+         E+   +    Y+    +   L+  V  + L       + +   +GL+
Sbjct: 90  IGLLDVFTPATSIEDFSEV----YLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLK 145
Query: 704 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 763
           Y+H+    GIIHRD+K SN+ ++ +   ++ DFGL+RQA+E++T   +    T  Y  PE
Sbjct: 146 YIHSA---GIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVA----TRWYRAPE 198
Query: 764 YYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN 803
              N     +  D++S G ++ EL+ GK      D+  +L 
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLK 239

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 105/207 (50%), Gaps = 16/207 (7%)
Query: 590 ATNNFCK--KIGKGSFGSVYYGKMKDGKEVAV--KIMADSCSHRT-QQFVTEVALLSRIH 644
           +  NF K  KIG+G++G VY  + K   EV    KI  D+ +       + E++LL  ++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 645 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGS-VNQKPLDWLTRLQIAHDAAKGLE 703
           H N+V L+     E++  LV+E++ +  L+D +  S +   PL  +          +GL 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIK--SYLFQLLQGLA 120
Query: 704 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDP 762
           + H+     ++HRD+K  N+L++     K++DFGL+R     + T+   V   T+ Y  P
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 175
Query: 763 E-YYGNQQLTEKSDVYSFGVVLLELIS 788
           E   G +  +   D++S G +  E+++
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 13/206 (6%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVKIM-ADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGY 654
           IGKG+F  V    K+  G E A KI+     S R  Q +   A + R+  H N+V L   
Sbjct: 12  IGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDS 71
Query: 655 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 714
             EE    LV++ +  G L + +         ++ +    +H   + LE +      G++
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIVAR------EYYSEADASHCIQQILEAVLHCHQMGVV 125
Query: 715 HRDVKSSNILLDINMRA---KVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 771
           HRD+K  N+LL    +    K++DFGL+ + + D       A GT GYL PE    +   
Sbjct: 126 HRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFA-GTPGYLSPEVLRKEAYG 184
Query: 772 EKSDVYSFGVVLLELISGKKPVSVED 797
           +  D+++ GV+L  L+ G  P   ED
Sbjct: 185 KPVDIWACGVILYILLVGYPPFWDED 210

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 115/219 (52%), Gaps = 24/219 (10%)
Query: 587 LEEATNNFCKKIGKGSFGSVYYGK-MKDGKEV----AVKIMADSCSHRT-QQFVTEVALL 640
           L+E      K +G G+FG+VY G  + +G++V    A+K + ++ S +  ++ + E  ++
Sbjct: 16  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 75
Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGS--VNQKPLDWLTRLQIAH 696
           + + + ++  L+G C     + L+ + M  G L D  R H     +Q  L+W  ++    
Sbjct: 76  ASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI---- 130
Query: 697 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVAR 754
             AKG+ YL    +  ++HRD+ + N+L+      K++DFG ++   AEE   H     +
Sbjct: 131 --AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEG-GK 184
Query: 755 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
             + ++  E   ++  T +SDV+S+GV + EL++ G KP
Sbjct: 185 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 223

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 92/201 (45%), Gaps = 15/201 (7%)
Query: 598 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFV----TEVALLSRIHHRNLVPLI 652
           +G G+FG V  GK +  G +VAVKI+ +    R+   V     E+  L    H +++ L 
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKIL-NRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 653 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 712
                     +V EY+  G L D +        LD     ++      G++Y H      
Sbjct: 83  QVISTPSDIFMVMEYVSGGELFDYI---CKNGRLDEKESRRLFQQILSGVDYCHRHM--- 136
Query: 713 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY-GNQQLT 771
           ++HRD+K  N+LLD +M AK++DFGLS    +        + G+  Y  PE   G     
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD--GEFLRXSCGSPNYAAPEVISGRLYAG 194
Query: 772 EKSDVYSFGVVLLELISGKKP 792
            + D++S GV+L  L+ G  P
Sbjct: 195 PEVDIWSSGVILYALLCGTLP 215

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 105/207 (50%), Gaps = 16/207 (7%)
Query: 590 ATNNFCK--KIGKGSFGSVYYGKMKDGKEVAV--KIMADSCSHRT-QQFVTEVALLSRIH 644
           +  NF K  KIG+G++G VY  + K   EV    KI  D+ +       + E++LL  ++
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 645 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGS-VNQKPLDWLTRLQIAHDAAKGLE 703
           H N+V L+     E++  LV+E++ +  L+D +  S +   PL  +          +GL 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIK--SYLFQLLQGLA 119
Query: 704 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDP 762
           + H+     ++HRD+K  N+L++     K++DFGL+R     + T+   V   T+ Y  P
Sbjct: 120 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 174
Query: 763 E-YYGNQQLTEKSDVYSFGVVLLELIS 788
           E   G +  +   D++S G +  E+++
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 100/203 (49%), Gaps = 14/203 (6%)
Query: 593 NFCK--KIGKGSFGSVYYGKMKDGKEVAV--KIMADSCSHRT-QQFVTEVALLSRIHHRN 647
           NF K  KIG+G++G VY  + K   EV    KI  D+ +       + E++LL  ++H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 648 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
           +V L+     E++  LV+E++H          ++   PL  +          +GL + H+
Sbjct: 63  IVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLF--QLLQGLAFCHS 120
Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPE-YY 765
                ++HRD+K  N+L++     K++DFGL+R     + T+   V   T+ Y  PE   
Sbjct: 121 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 175
Query: 766 GNQQLTEKSDVYSFGVVLLELIS 788
           G +  +   D++S G +  E+++
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 115/219 (52%), Gaps = 24/219 (10%)
Query: 587 LEEATNNFCKKIGKGSFGSVYYGK-MKDGKEV----AVKIMADSCSHRT-QQFVTEVALL 640
           L+E      K +  G+FG+VY G  + +G++V    A+K + ++ S +  ++ + E  ++
Sbjct: 19  LKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 78
Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGS--VNQKPLDWLTRLQIAH 696
           + + + ++  L+G C     + L+ + M  G L D  R H     +Q  L+W  ++    
Sbjct: 79  ASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI---- 133
Query: 697 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVAR 754
             AKG+ YL    +  ++HRD+ + N+L+      K++DFGL++   AEE   H     +
Sbjct: 134 --AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-GK 187
Query: 755 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
             + ++  E   ++  T +SDV+S+GV + EL++ G KP
Sbjct: 188 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 226

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 83/166 (50%), Gaps = 8/166 (4%)
Query: 632 QFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR 691
           Q + E+ +L   +   +V   G    + +  +  E+M  G+L D++     + P   L +
Sbjct: 50  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGK 108
Query: 692 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 751
           + IA    KGL YL       I+HRDVK SNIL++     K+ DFG+S Q    +  +++
Sbjct: 109 VSIA--VIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMAN 161
Query: 752 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 797
              GT  Y+ PE       + +SD++S G+ L+E+  G+ P+   D
Sbjct: 162 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 83/166 (50%), Gaps = 8/166 (4%)
Query: 632 QFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR 691
           Q + E+ +L   +   +V   G    + +  +  E+M  G+L D++     + P   L +
Sbjct: 77  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGK 135
Query: 692 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 751
           + IA    KGL YL       I+HRDVK SNIL++     K+ DFG+S Q    +  +++
Sbjct: 136 VSIA--VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMAN 188
Query: 752 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 797
              GT  Y+ PE       + +SD++S G+ L+E+  G+ P+   D
Sbjct: 189 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 234

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 83/166 (50%), Gaps = 8/166 (4%)
Query: 632 QFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR 691
           Q + E+ +L   +   +V   G    + +  +  E+M  G+L D++     + P   L +
Sbjct: 50  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGK 108
Query: 692 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 751
           + IA    KGL YL       I+HRDVK SNIL++     K+ DFG+S Q    +  +++
Sbjct: 109 VSIA--VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMAN 161
Query: 752 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 797
              GT  Y+ PE       + +SD++S G+ L+E+  G+ P+   D
Sbjct: 162 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 84/166 (50%), Gaps = 8/166 (4%)
Query: 632 QFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR 691
           Q + E+ +L   +   +V   G    + +  +  E+M  G+L D++     + P + L +
Sbjct: 60  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKEAKRIPEEILGK 118
Query: 692 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 751
           + IA    +GL YL       I+HRDVK SNIL++     K+ DFG+S Q    +  +++
Sbjct: 119 VSIA--VLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMAN 171
Query: 752 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 797
              GT  Y+ PE       + +SD++S G+ L+EL  G+ P+   D
Sbjct: 172 SFVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPIPPPD 217

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 83/166 (50%), Gaps = 8/166 (4%)
Query: 632 QFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR 691
           Q + E+ +L   +   +V   G    + +  +  E+M  G+L D++     + P   L +
Sbjct: 50  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGK 108
Query: 692 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 751
           + IA    KGL YL       I+HRDVK SNIL++     K+ DFG+S Q    +  +++
Sbjct: 109 VSIA--VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMAN 161
Query: 752 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 797
              GT  Y+ PE       + +SD++S G+ L+E+  G+ P+   D
Sbjct: 162 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 83/166 (50%), Gaps = 8/166 (4%)
Query: 632 QFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR 691
           Q + E+ +L   +   +V   G    + +  +  E+M  G+L D++     + P   L +
Sbjct: 50  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGK 108
Query: 692 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 751
           + IA    KGL YL       I+HRDVK SNIL++     K+ DFG+S Q    +  +++
Sbjct: 109 VSIA--VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMAN 161
Query: 752 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 797
              GT  Y+ PE       + +SD++S G+ L+E+  G+ P+   D
Sbjct: 162 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 83/166 (50%), Gaps = 8/166 (4%)
Query: 632 QFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR 691
           Q + E+ +L   +   +V   G    + +  +  E+M  G+L D++     + P   L +
Sbjct: 50  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGK 108
Query: 692 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 751
           + IA    KGL YL       I+HRDVK SNIL++     K+ DFG+S Q    +  +++
Sbjct: 109 VSIA--VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMAN 161
Query: 752 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 797
              GT  Y+ PE       + +SD++S G+ L+E+  G+ P+   D
Sbjct: 162 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 115/219 (52%), Gaps = 24/219 (10%)
Query: 587 LEEATNNFCKKIGKGSFGSVYYGK-MKDGKEV----AVKIMADSCSHRT-QQFVTEVALL 640
           L+E      K +G G+FG+VY G  + +G++V    A+K + ++ S +  ++ + E  ++
Sbjct: 14  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 73
Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGS--VNQKPLDWLTRLQIAH 696
           + + + ++  L+G C     + L+ + M  G L D  R H     +Q  L+W  ++    
Sbjct: 74  ASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI---- 128
Query: 697 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVAR 754
             AKG+ YL    +  ++HRD+ + N+L+      K++DFG ++   AEE   H     +
Sbjct: 129 --AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEG-GK 182
Query: 755 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
             + ++  E   ++  T +SDV+S+GV + EL++ G KP
Sbjct: 183 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 26/206 (12%)
Query: 597 KIGKGSFGSVYYGKMKDG-KEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 655
           ++G+G+   VY  K K   K  A+K++  +   +  +  TE+ +L R+ H N++ L    
Sbjct: 60  ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVR--TEIGVLLRLSHPNIIKLKEIF 117
Query: 656 EEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAK----GLEYLHTGC 709
           E   +  LV E +  G L DR+   G  +++          A DA K     + YLH   
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVEKGYYSERD---------AADAVKQILEAVAYLHEN- 167
Query: 710 NPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 766
             GI+HRD+K  N+L      +   K++DFGLS+  E  +  +     GT GY  PE   
Sbjct: 168 --GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV--LMKTVCGTPGYCAPEILR 223
Query: 767 NQQLTEKSDVYSFGVVLLELISGKKP 792
                 + D++S G++   L+ G +P
Sbjct: 224 GCAYGPEVDMWSVGIITYILLCGFEP 249

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 103/233 (44%), Gaps = 34/233 (14%)
Query: 582 IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQ--QFVTEVAL 639
           IP  +LE       + IGKG FG VY+G+     EVA++++     +  Q   F  EV  
Sbjct: 30  IPFEQLE-----IGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMA 82
Query: 640 LSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA 699
             +  H N+V  +G C       ++       TL   +  +  +  LD     QIA +  
Sbjct: 83  YRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIV 140
Query: 700 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR-----QA--EEDLTHISSV 752
           KG+ YLH     GI+H+D+KS N+  D N +  ++DFGL       QA   ED   I + 
Sbjct: 141 KGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQN- 195
Query: 753 ARGTVGYLDPEYYGNQQ---------LTEKSDVYSFGVVLLELISGKKPVSVE 796
             G + +L PE                ++ SDV++ G +  EL + + P   +
Sbjct: 196 --GWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ 246

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 115/219 (52%), Gaps = 24/219 (10%)
Query: 587 LEEATNNFCKKIGKGSFGSVYYGK-MKDGKEV----AVKIMADSCSHRT-QQFVTEVALL 640
           L+E      K +G G+FG+VY G  + +G++V    A+K + ++ S +  ++ + E  ++
Sbjct: 14  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 73
Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGS--VNQKPLDWLTRLQIAH 696
           + + + ++  L+G C     + L+ + M  G L D  R H     +Q  L+W  ++    
Sbjct: 74  ASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI---- 128
Query: 697 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVAR 754
             AKG+ YL    +  ++HRD+ + N+L+      K++DFG ++   AEE   H     +
Sbjct: 129 --AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEG-GK 182
Query: 755 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
             + ++  E   ++  T +SDV+S+GV + EL++ G KP
Sbjct: 183 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/245 (27%), Positives = 105/245 (42%), Gaps = 53/245 (21%)
Query: 598 IGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHR-----TQQFVTEVALLSRIHHRNLVPL 651
           IG+GS+G V        + + A+KIM  +   +      ++  TEV L+ ++HH N+  L
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLH-------------------------------GS 680
               E+E    LV E  H G L D+L+                               GS
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 681 VN--QKPLDWLTRLQIAHDAAK----GLEYLHTGCNPGIIHRDVKSSNILLDIN--MRAK 732
           ++  ++ LD++ R ++  +  +     L YLH   N GI HRD+K  N L   N     K
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIK 210
Query: 733 VSDFGLSRQ---AEEDLTHISSVARGTVGYLDPEYYG--NQQLTEKSDVYSFGVVLLELI 787
           + DFGLS++         +  +   GT  ++ PE     N+    K D +S GV+L  L+
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLL 270
Query: 788 SGKKP 792
            G  P
Sbjct: 271 MGAVP 275

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 115/219 (52%), Gaps = 24/219 (10%)
Query: 587 LEEATNNFCKKIGKGSFGSVYYGK-MKDGKEV----AVKIMADSCSHRT-QQFVTEVALL 640
           L+E      K +  G+FG+VY G  + +G++V    A+K + ++ S +  ++ + E  ++
Sbjct: 12  LKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGS--VNQKPLDWLTRLQIAH 696
           + + + ++  L+G C     + L+ + M  G L D  R H     +Q  L+W  ++    
Sbjct: 72  ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI---- 126
Query: 697 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVAR 754
             AKG+ YL    +  ++HRD+ + N+L+      K++DFGL++   AEE   H     +
Sbjct: 127 --AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-GK 180
Query: 755 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
             + ++  E   ++  T +SDV+S+GV + EL++ G KP
Sbjct: 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 105/227 (46%), Gaps = 20/227 (8%)
Query: 580 YFIPLPELEEATNNF--------CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT- 630
           YF  + + E  T +           ++G G+FG VY  + K+   +A   + D+ S    
Sbjct: 19  YFQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEEL 78
Query: 631 QQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLT 690
           + ++ E+ +L+   H N+V L+     E+   ++ E+   G + D +   + ++PL    
Sbjct: 79  EDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAV-DAVMLEL-ERPLTESQ 136
Query: 691 RLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 750
              +       L YLH   +  IIHRD+K+ NIL  ++   K++DFG+S +    +    
Sbjct: 137 IQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRD 193
Query: 751 SVARGTVGYLDPEYY-----GNQQLTEKSDVYSFGVVLLELISGKKP 792
               GT  ++ PE        ++    K+DV+S G+ L+E+   + P
Sbjct: 194 XFI-GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 107/216 (49%), Gaps = 18/216 (8%)
Query: 596 KKIGKGSFGSV---YYGKMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLV 649
           + +G G++GSV   Y  +++  ++VAVK ++    S  H  + +  E+ LL  + H N++
Sbjct: 34  RPVGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTY-RELRLLKHLKHENVI 90
Query: 650 PLIG-YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
            L+  +            Y+    +   L+  V  + L       + +   +GL+Y+H+ 
Sbjct: 91  GLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSA 150
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN- 767
              GIIHRD+K SN+ ++ +   ++ DFGL+RQA+E++T   +    T  Y  PE   N 
Sbjct: 151 ---GIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVA----TRWYRAPEIMLNW 203
Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN 803
               +  D++S G ++ EL+ GK      D+  +L 
Sbjct: 204 MHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLK 239

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 115/219 (52%), Gaps = 24/219 (10%)
Query: 587 LEEATNNFCKKIGKGSFGSVYYGK-MKDGKEV----AVKIMADSCSHRT-QQFVTEVALL 640
           L+E      K +  G+FG+VY G  + +G++V    A+K + ++ S +  ++ + E  ++
Sbjct: 19  LKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 78
Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGS--VNQKPLDWLTRLQIAH 696
           + + + ++  L+G C     + L+ + M  G L D  R H     +Q  L+W  ++    
Sbjct: 79  ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI---- 133
Query: 697 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVAR 754
             AKG+ YL    +  ++HRD+ + N+L+      K++DFGL++   AEE   H     +
Sbjct: 134 --AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-GK 187
Query: 755 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
             + ++  E   ++  T +SDV+S+GV + EL++ G KP
Sbjct: 188 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 226

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 115/219 (52%), Gaps = 24/219 (10%)
Query: 587 LEEATNNFCKKIGKGSFGSVYYGK-MKDGKEV----AVKIMADSCSHRT-QQFVTEVALL 640
           L+E      K +G G+FG+VY G  + +G++V    A+K + ++ S +  ++ + E  ++
Sbjct: 14  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 73
Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGS--VNQKPLDWLTRLQIAH 696
           + + + ++  L+G C     + L+ + M  G L D  R H     +Q  L+W  ++    
Sbjct: 74  ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI---- 128
Query: 697 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVAR 754
             AKG+ YL    +  ++HRD+ + N+L+      K++DFG ++   AEE   H     +
Sbjct: 129 --AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEG-GK 182
Query: 755 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
             + ++  E   ++  T +SDV+S+GV + EL++ G KP
Sbjct: 183 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 115/219 (52%), Gaps = 24/219 (10%)
Query: 587 LEEATNNFCKKIGKGSFGSVYYGK-MKDGKEV----AVKIMADSCSHRT-QQFVTEVALL 640
           L+E      K +G G+FG+VY G  + +G++V    A+K + ++ S +  ++ + E  ++
Sbjct: 19  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 78
Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGS--VNQKPLDWLTRLQIAH 696
           + + + ++  L+G C     + L+ + M  G L D  R H     +Q  L+W  ++    
Sbjct: 79  ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI---- 133
Query: 697 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVAR 754
             AKG+ YL    +  ++HRD+ + N+L+      K++DFG ++   AEE   H     +
Sbjct: 134 --AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEG-GK 187
Query: 755 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
             + ++  E   ++  T +SDV+S+GV + EL++ G KP
Sbjct: 188 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 226

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 43/107 (40%), Positives = 57/107 (53%), Gaps = 1/107 (0%)
Query: 406 LKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSL 464
           L+GEIP EL  ++ L  L LD N LTG +P  +S   +L  + L NN LTG +P ++G L
Sbjct: 454 LEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRL 513
Query: 465 PNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFK 511
            NL  L + NNSF G IP  L   + +   D N  L   +     FK
Sbjct: 514 ENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFK 560

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 13/208 (6%)
Query: 596 KKIGKGSFGSVYYG-KMKDGKEVAVKIM-ADSCSHRTQQFVTEVALLSRI-HHRNLVPLI 652
           +++GKG+F  V    K+  G+E A KI+     S R  Q +   A + R+  H N+V L 
Sbjct: 10  EELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 69
Query: 653 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 712
               EE    LV++ +  G L + +         ++ +    +H   + LE ++     G
Sbjct: 70  DSISEEGFHYLVFDLVTGGELFEDIVAR------EYYSEADASHCIQQILESVNHCHLNG 123
Query: 713 IIHRDVKSSNILLDINMRA---KVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQ 769
           I+HRD+K  N+LL    +    K++DFGL+ + + D       A GT GYL PE      
Sbjct: 124 IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFA-GTPGYLSPEVLRKDP 182
Query: 770 LTEKSDVYSFGVVLLELISGKKPVSVED 797
             +  D+++ GV+L  L+ G  P   ED
Sbjct: 183 YGKPVDMWACGVILYILLVGYPPFWDED 210

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 43/107 (40%), Positives = 57/107 (53%), Gaps = 1/107 (0%)
Query: 406 LKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSL 464
           L+GEIP EL  ++ L  L LD N LTG +P  +S   +L  + L NN LTG +P ++G L
Sbjct: 451 LEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRL 510
Query: 465 PNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFK 511
            NL  L + NNSF G IP  L   + +   D N  L   +     FK
Sbjct: 511 ENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFK 557

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 115/219 (52%), Gaps = 24/219 (10%)
Query: 587 LEEATNNFCKKIGKGSFGSVYYGK-MKDGKEV----AVKIMADSCSHRT-QQFVTEVALL 640
           L+E      K +G G+FG+VY G  + +G++V    A+K + ++ S +  ++ + E  ++
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGS--VNQKPLDWLTRLQIAH 696
           + + + ++  L+G C     + L+ + M  G L D  R H     +Q  L+W  ++    
Sbjct: 72  ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI---- 126
Query: 697 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVAR 754
             AKG+ YL    +  ++HRD+ + N+L+      K++DFG ++   AEE   H     +
Sbjct: 127 --AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEG-GK 180
Query: 755 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
             + ++  E   ++  T +SDV+S+GV + EL++ G KP
Sbjct: 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 13/208 (6%)
Query: 596 KKIGKGSFGSVYYG-KMKDGKEVAVKIM-ADSCSHRTQQFVTEVALLSRI-HHRNLVPLI 652
           +++GKG+F  V    K+  G+E A KI+     S R  Q +   A + R+  H N+V L 
Sbjct: 10  EELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 69
Query: 653 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 712
               EE    LV++ +  G L + +         ++ +    +H   + LE ++     G
Sbjct: 70  DSISEEGFHYLVFDLVTGGELFEDIVAR------EYYSEADASHCIQQILESVNHCHLNG 123
Query: 713 IIHRDVKSSNILLDINMRA---KVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQ 769
           I+HRD+K  N+LL    +    K++DFGL+ + + D       A GT GYL PE      
Sbjct: 124 IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFA-GTPGYLSPEVLRKDP 182
Query: 770 LTEKSDVYSFGVVLLELISGKKPVSVED 797
             +  D+++ GV+L  L+ G  P   ED
Sbjct: 183 YGKPVDMWACGVILYILLVGYPPFWDED 210

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 598 IGKGSFGSVYYGK----MKDGKEVAVKIMADSCSHR----TQQFVTEVALLSRIHHRNLV 649
           +GKG +G V+  +       GK  A+K++  +   R    T     E  +L  + H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 650 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGS---VNQKPLDWLTRLQIAHDAAKGLEYLH 706
            LI   +   +  L+ EY+  G L  +L      +      +L  + +A      L +LH
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMA------LGHLH 138
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 766
                GII+RD+K  NI+L+     K++DFGL +++  D T ++    GT+ Y+ PE   
Sbjct: 139 ---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT-VTHTFCGTIEYMAPEILM 194
Query: 767 NQQLTEKSDVYSFGVVLLELISGKKPVSVED 797
                   D +S G ++ ++++G  P + E+
Sbjct: 195 RSGHNRAVDWWSLGALMYDMLTGAPPFTGEN 225

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 28/210 (13%)
Query: 599 GKGSFGSVYYGKMKDGKEVAVKI--MADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 656
            +G FG V+  ++ +   VAVKI  + D  S ++++   E+     + H NL+  I   +
Sbjct: 24  ARGRFGCVWKAQLMN-DFVAVKIFPLQDKQSWQSER---EIFSTPGMKHENLLQFIAAEK 79
Query: 657 E----EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT----- 707
                E +  L+  +   G+L D L G++    + W     +A   ++GL YLH      
Sbjct: 80  RGSNLEVELWLITAFHDKGSLTDYLKGNI----ITWNELCHVAETMSRGLSYLHEDVPWC 135
Query: 708 ---GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR-GTVGYLDPE 763
              G  P I HRD KS N+LL  ++ A ++DFGL+ + E       +  + GT  Y+ PE
Sbjct: 136 RGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPE 195
Query: 764 YYGNQQLTEKS-----DVYSFGVVLLELIS 788
                   ++      D+Y+ G+VL EL+S
Sbjct: 196 VLEGAINFQRDAFLRIDMYAMGLVLWELVS 225

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 82/163 (50%), Gaps = 8/163 (4%)
Query: 632 QFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR 691
           Q + E+ +L   +   +V   G    + +  +  E+M  G+L D++     + P   L +
Sbjct: 69  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGK 127
Query: 692 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 751
           + IA    KGL YL       I+HRDVK SNIL++     K+ DFG+S Q    +  +++
Sbjct: 128 VSIA--VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMAN 180
Query: 752 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVS 794
              GT  Y+ PE       + +SD++S G+ L+E+  G+ P+ 
Sbjct: 181 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIG 223

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 13/208 (6%)
Query: 596 KKIGKGSFGSVYYG-KMKDGKEVAVKIM-ADSCSHRTQQFVTEVALLSRI-HHRNLVPLI 652
           +++GKG+F  V    K+  G+E A KI+     S R  Q +   A + R+  H N+V L 
Sbjct: 28  EELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 87
Query: 653 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 712
               EE    L+++ +  G L + +         ++ +    +H   + LE +      G
Sbjct: 88  DSISEEGHHYLIFDLVTGGELFEDIVAR------EYYSEADASHCIQQILEAVLHCHQMG 141
Query: 713 IIHRDVKSSNILLDINMRA---KVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQ 769
           ++HRD+K  N+LL   ++    K++DFGL+ + E +       A GT GYL PE      
Sbjct: 142 VVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYLSPEVLRKDP 200
Query: 770 LTEKSDVYSFGVVLLELISGKKPVSVED 797
             +  D+++ GV+L  L+ G  P   ED
Sbjct: 201 YGKPVDLWACGVILYILLVGYPPFWDED 228

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 598 IGKGSFGSVYYGK----MKDGKEVAVKIMADSCSHR----TQQFVTEVALLSRIHHRNLV 649
           +GKG +G V+  +       GK  A+K++  +   R    T     E  +L  + H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 650 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGS---VNQKPLDWLTRLQIAHDAAKGLEYLH 706
            LI   +   +  L+ EY+  G L  +L      +      +L  + +A      L +LH
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMA------LGHLH 138
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 766
                GII+RD+K  NI+L+     K++DFGL +++  D T ++    GT+ Y+ PE   
Sbjct: 139 ---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT-VTHXFCGTIEYMAPEILM 194
Query: 767 NQQLTEKSDVYSFGVVLLELISGKKPVSVED 797
                   D +S G ++ ++++G  P + E+
Sbjct: 195 RSGHNRAVDWWSLGALMYDMLTGAPPFTGEN 225

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 101/206 (49%), Gaps = 14/206 (6%)
Query: 590 ATNNFCK--KIGKGSFGSVYYGKMKDGKEVAV--KIMADSCSHRT-QQFVTEVALLSRIH 644
           +  NF K  KIG+G++G VY  + K   EV    KI  D+ +       + E++LL  ++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 645 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 704
           H N+V L+     E++  LV+E++     +     ++   PL  +          +GL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAF 121
Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPE 763
            H+     ++HRD+K  N+L++     K++DFGL+R     + T+   V   T+ Y  PE
Sbjct: 122 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 176
Query: 764 -YYGNQQLTEKSDVYSFGVVLLELIS 788
              G +  +   D++S G +  E+++
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 104/205 (50%), Gaps = 17/205 (8%)
Query: 596 KKIGKGSFGSVYYGKMKDGKE-VAVKI--MADSCSHRTQQFVTEVALLSRIHHRNLVPLI 652
           +KIG+G++G+V+  K ++  E VA+K   + D         + E+ LL  + H+N+V L 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 653 GYCEEEHQRILVYEYMHNGTLR--DRLHGSVNQKPL-DWLTRLQIAHDAAKGLEYLHTGC 709
                + +  LV+E+      +  D  +G ++ + +  +L +L       KGL + H+  
Sbjct: 68  DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQL------LKGLGFCHSR- 120
Query: 710 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYGNQ 768
              ++HRD+K  N+L++ N   K++DFGL+R A        S    T+ Y  P+  +G +
Sbjct: 121 --NVLHRDLKPQNLLINRNGELKLADFGLAR-AFGIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 769 QLTEKSDVYSFGVVLLELISGKKPV 793
             +   D++S G +  EL +  +P+
Sbjct: 178 LYSTSIDMWSAGCIFAELANAARPL 202

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 101/206 (49%), Gaps = 14/206 (6%)
Query: 590 ATNNFCK--KIGKGSFGSVYYGKMKDGKEVAV--KIMADSCSHRT-QQFVTEVALLSRIH 644
           +  NF K  KIG+G++G VY  + K   EV    KI  D+ +       + E++LL  ++
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 645 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 704
           H N+V L+     E++  LV+E++     +     ++   PL  +          +GL +
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAF 119
Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPE 763
            H+     ++HRD+K  N+L++     K++DFGL+R     + T+   V   T+ Y  PE
Sbjct: 120 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 174
Query: 764 -YYGNQQLTEKSDVYSFGVVLLELIS 788
              G +  +   D++S G +  E+++
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 98/220 (44%), Gaps = 38/220 (17%)
Query: 598 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH----------- 645
           +G+G+FG V   +   D +  A+K +  +   +    ++EV LL+ ++H           
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVXLLASLNHQYVVRYYAAWL 72
Query: 646 --RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG-SVNQKPLD-WLTRLQIAHDAAKG 701
             RN V      +++    +  EY  N TL D +H  ++NQ+  + W    QI     + 
Sbjct: 73  ERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQIL----EA 128
Query: 702 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS----------- 750
           L Y+H+    GIIHR++K  NI +D +   K+ DFGL++     L  +            
Sbjct: 129 LSYIHS---QGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 751 --SVARGTVGYLDPEYY-GNQQLTEKSDVYSFGVVLLELI 787
             + A GT  Y+  E   G     EK D YS G++  E I
Sbjct: 186 NLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 117/254 (46%), Gaps = 28/254 (11%)
Query: 567 IARGGHFMDEGVAYF-----IPLPELEEATNNFCKKIGKGSFGSVYYG-KMKDGKEVAVK 620
           + RG H   E   ++       + E+ E   N    +G G++GSV      K G  VAVK
Sbjct: 14  VPRGSHMSQERPTFYRQELNKTIWEVPERYQNLSP-VGSGAYGSVCAAFDTKTGHRVAVK 72
Query: 621 IMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLI-----GYCEEEHQRILVYEYMHNGT 672
            ++    S  H  + +  E+ LL  + H N++ L+         EE   + +  ++    
Sbjct: 73  KLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD 131
Query: 673 LRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK 732
           L + +     QK  D   +  I +   +GL+Y+H+     IIHRD+K SN+ ++ +   K
Sbjct: 132 LNNIVKC---QKLTDDHVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELK 184
Query: 733 VSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKK 791
           + DFGL+R  ++++T   +    T  Y  PE   N     +  D++S G ++ EL++G+ 
Sbjct: 185 ILDFGLARHTDDEMTGYVA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 240
Query: 792 PVSVEDFGAELNIV 805
                D   +L ++
Sbjct: 241 LFPGTDHIDQLKLI 254

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 103/217 (47%), Gaps = 18/217 (8%)
Query: 582 IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT------QQFVT 635
           + L EL++       ++G G+ G V+    K   + +  +MA    H         Q + 
Sbjct: 1   MALGELKDDDFEKISELGAGNGGVVF----KVSHKPSGLVMARKLIHLEIKPAIRNQIIR 56
Query: 636 EVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA 695
           E+ +L   +   +V   G    + +  +  E+M  G+L D++     + P   L ++ IA
Sbjct: 57  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIA 115
Query: 696 HDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARG 755
               KGL YL       I+HRDVK SNIL++     K+ DFG+S Q  +++   ++   G
Sbjct: 116 --VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEM---ANEFVG 168
Query: 756 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           T  Y+ PE       + +SD++S G+ L+E+  G+ P
Sbjct: 169 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 205

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 117/254 (46%), Gaps = 28/254 (11%)
Query: 567 IARGGHFMDEGVAYF-----IPLPELEEATNNFCKKIGKGSFGSVYYG-KMKDGKEVAVK 620
           + RG H   E   ++       + E+ E   N    +G G++GSV      K G  VAVK
Sbjct: 15  VPRGSHMSQERPTFYRQELNKTIWEVPERYQNLSP-VGSGAYGSVCAAFDTKTGHRVAVK 73
Query: 621 IMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLI-----GYCEEEHQRILVYEYMHNGT 672
            ++    S  H  + +  E+ LL  + H N++ L+         EE   + +  ++    
Sbjct: 74  KLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD 132
Query: 673 LRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK 732
           L + +     QK  D   +  I +   +GL+Y+H+     IIHRD+K SN+ ++ +   K
Sbjct: 133 LNNIVKC---QKLTDDHVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELK 185
Query: 733 VSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKK 791
           + DFGL+R  ++++T   +    T  Y  PE   N     +  D++S G ++ EL++G+ 
Sbjct: 186 ILDFGLARHTDDEMTGYVA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 241
Query: 792 PVSVEDFGAELNIV 805
                D   +L ++
Sbjct: 242 LFPGTDHIDQLKLI 255

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 99/204 (48%), Gaps = 20/204 (9%)
Query: 595 CKKIGKGSFGSVY--YGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVP 650
            K IG G+ G V   Y  + + + VA+K ++    ++T  ++   E+ L+  ++H+N++ 
Sbjct: 29  LKPIGSGAQGIVVAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIG 87
Query: 651 LIGYCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 705
           L+         EE Q + +   + +  L   +   ++ + + +L    +      G+++L
Sbjct: 88  LLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLV-----GIKHL 142
Query: 706 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 765
           H+    GIIHRD+K SNI++  +   K+ DFGL+R A         V   T  Y  PE  
Sbjct: 143 HSA---GIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVI 197
Query: 766 GNQQLTEKSDVYSFGVVLLELISG 789
                 E  D++S GV++ E+I G
Sbjct: 198 LGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 101/214 (47%), Gaps = 24/214 (11%)
Query: 596 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADS----CSHRTQ----QFVTEVALLSRIHHR 646
           K +G G+ G V    + K  K+VA+KI++       S R         TE+ +L +++H 
Sbjct: 15  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 74
Query: 647 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
            ++ +  + + E   I V E M  G L D++ G  N++  +   +L   +     ++YLH
Sbjct: 75  CIIKIKNFFDAEDYYI-VLELMEGGELFDKVVG--NKRLKEATCKLYF-YQMLLAVQYLH 130
Query: 707 TGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 763
                GIIHRD+K  N+LL   + +   K++DFG S+   E  T +     GT  YL PE
Sbjct: 131 EN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLCGTPTYLAPE 185
Query: 764 YY---GNQQLTEKSDVYSFGVVLLELISGKKPVS 794
                G        D +S GV+L   +SG  P S
Sbjct: 186 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 219

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 101/214 (47%), Gaps = 24/214 (11%)
Query: 596 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADS----CSHRTQ----QFVTEVALLSRIHHR 646
           K +G G+ G V    + K  K+VA+KI++       S R         TE+ +L +++H 
Sbjct: 16  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 647 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
            ++ +  + + E   I V E M  G L D++ G  N++  +   +L   +     ++YLH
Sbjct: 76  CIIKIKNFFDAEDYYI-VLELMEGGELFDKVVG--NKRLKEATCKLYF-YQMLLAVQYLH 131
Query: 707 TGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 763
                GIIHRD+K  N+LL   + +   K++DFG S+   E  T +     GT  YL PE
Sbjct: 132 EN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLCGTPTYLAPE 186
Query: 764 YY---GNQQLTEKSDVYSFGVVLLELISGKKPVS 794
                G        D +S GV+L   +SG  P S
Sbjct: 187 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 220

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 101/214 (47%), Gaps = 24/214 (11%)
Query: 596 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADS----CSHRTQ----QFVTEVALLSRIHHR 646
           K +G G+ G V    + K  K+VA+KI++       S R         TE+ +L +++H 
Sbjct: 16  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 647 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
            ++ +  + + E   I V E M  G L D++ G  N++  +   +L   +     ++YLH
Sbjct: 76  CIIKIKNFFDAEDYYI-VLELMEGGELFDKVVG--NKRLKEATCKLYF-YQMLLAVQYLH 131
Query: 707 TGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 763
                GIIHRD+K  N+LL   + +   K++DFG S+   E  T +     GT  YL PE
Sbjct: 132 EN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLCGTPTYLAPE 186
Query: 764 YY---GNQQLTEKSDVYSFGVVLLELISGKKPVS 794
                G        D +S GV+L   +SG  P S
Sbjct: 187 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 220

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 96/202 (47%), Gaps = 18/202 (8%)
Query: 596 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 652
           K IG G+ G V        G  VAVK ++    ++T  ++   E+ LL  ++H+N++ L+
Sbjct: 30  KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 89
Query: 653 GYCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
                    EE Q + +   + +  L   +H  ++ + + +L    +      G+++LH+
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLC-----GIKHLHS 144
Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 767
               GIIHRD+K SNI++  +   K+ DFGL+R A  +      V   T  Y  PE    
Sbjct: 145 A---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV--TRYYRAPEVILG 199
Query: 768 QQLTEKSDVYSFGVVLLELISG 789
                  D++S G ++ EL+ G
Sbjct: 200 MGYAANVDIWSVGCIMGELVKG 221

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 101/214 (47%), Gaps = 24/214 (11%)
Query: 596 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADS----CSHRTQ----QFVTEVALLSRIHHR 646
           K +G G+ G V    + K  K+VA+KI++       S R         TE+ +L +++H 
Sbjct: 16  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 647 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
            ++ +  + + E   I V E M  G L D++ G  N++  +   +L   +     ++YLH
Sbjct: 76  CIIKIKNFFDAEDYYI-VLELMEGGELFDKVVG--NKRLKEATCKLYF-YQMLLAVQYLH 131
Query: 707 TGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 763
                GIIHRD+K  N+LL   + +   K++DFG S+   E  T +     GT  YL PE
Sbjct: 132 EN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLCGTPTYLAPE 186
Query: 764 YY---GNQQLTEKSDVYSFGVVLLELISGKKPVS 794
                G        D +S GV+L   +SG  P S
Sbjct: 187 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 220

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 99/204 (48%), Gaps = 20/204 (9%)
Query: 595 CKKIGKGSFGSV--YYGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVP 650
            K IG G+ G V   Y  + + + VA+K ++    ++T  ++   E+ L+  ++H+N++ 
Sbjct: 29  LKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIG 87
Query: 651 LIGYCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 705
           L+         EE Q + +   + +  L   +   ++ + + +L    +      G+++L
Sbjct: 88  LLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLV-----GIKHL 142
Query: 706 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 765
           H+    GIIHRD+K SNI++  +   K+ DFGL+R A         V   T  Y  PE  
Sbjct: 143 HSA---GIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVI 197
Query: 766 GNQQLTEKSDVYSFGVVLLELISG 789
                 E  D++S GV++ E+I G
Sbjct: 198 LGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 10/212 (4%)
Query: 598 IGKGSFGSVYYGKMKDGK-EVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLIGY 654
           IG+G++G V        K  VA+K ++    H+T  Q+ + E+ +L R  H N++ +   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILLRFRHENIIGINDI 89
Query: 655 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 714
                   +   Y+    +   L+  +  + L         +   +GL+Y+H+     ++
Sbjct: 90  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVL 146
Query: 715 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGYLDPEYYGNQQLTE 772
           HRD+K SN+LL+     K+ DFGL+R A+ D  H   +     T  Y  PE   N +   
Sbjct: 147 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 206
Query: 773 KS-DVYSFGVVLLELISGKKPVSVEDFGAELN 803
           KS D++S G +L E++S +     + +  +LN
Sbjct: 207 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 238

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 10/212 (4%)
Query: 598 IGKGSFGSVYYGKMKDGK-EVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLIGY 654
           IG+G++G V        K  VA+K ++    H+T  Q+ + E+ +L R  H N++ +   
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILLRFRHENIIGINDI 91
Query: 655 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 714
                   +   Y+    +   L+  +  + L         +   +GL+Y+H+     ++
Sbjct: 92  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVL 148
Query: 715 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGYLDPEYYGNQQLTE 772
           HRD+K SN+LL+     K+ DFGL+R A+ D  H   +     T  Y  PE   N +   
Sbjct: 149 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 208
Query: 773 KS-DVYSFGVVLLELISGKKPVSVEDFGAELN 803
           KS D++S G +L E++S +     + +  +LN
Sbjct: 209 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 240

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 106/218 (48%), Gaps = 22/218 (10%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLI- 652
           +G G++GSV      K G  VAVK ++    S  H  + +  E+ LL  + H N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 653 ----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
                   EE   + +  ++    L + +     QK  D   +  I +   +GL+Y+H+ 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLI-YQILRGLKYIHSA 144
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN- 767
               IIHRD+K SN+ ++ +   K+ DFGL+R  ++++T    VA  T  Y  PE   N 
Sbjct: 145 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GXVA--TRWYRAPEIMLNW 197
Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
               +  D++S G ++ EL++G+      D   +L ++
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 10/212 (4%)
Query: 598 IGKGSFGSVYYGKMKDGK-EVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLIGY 654
           IG+G++G V        K  VA+K ++    H+T  Q+ + E+ +L R  H N++ +   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILLRFRHENIIGINDI 89
Query: 655 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 714
                   +   Y+    +   L+  +  + L         +   +GL+Y+H+     ++
Sbjct: 90  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVL 146
Query: 715 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGYLDPEYYGNQQLTE 772
           HRD+K SN+LL+     K+ DFGL+R A+ D  H   +     T  Y  PE   N +   
Sbjct: 147 HRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 206
Query: 773 KS-DVYSFGVVLLELISGKKPVSVEDFGAELN 803
           KS D++S G +L E++S +     + +  +LN
Sbjct: 207 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 238

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 96/213 (45%), Gaps = 8/213 (3%)
Query: 598 IGKGSFGSV--YYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 655
           IG+G++G V   Y  +   +    KI         Q+ + E+ +L R  H N++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 656 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 715
                  +   Y+    +   L+  +  + L         +   +GL+Y+H+     ++H
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 152
Query: 716 RDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGYLDPEYYGNQQLTEK 773
           RD+K SN+LL+     K+ DFGL+R A+ D  H   +     T  Y  PE   N +   K
Sbjct: 153 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 212
Query: 774 S-DVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
           S D++S G +L E++S +     + +  +LN +
Sbjct: 213 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 245

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 96/213 (45%), Gaps = 8/213 (3%)
Query: 598 IGKGSFGSV--YYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 655
           IG+G++G V   Y  +   +    KI         Q+ + E+ +L R  H N++ +    
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 96
Query: 656 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 715
                  +   Y+    +   L+  +  + L         +   +GL+Y+H+     ++H
Sbjct: 97  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 153
Query: 716 RDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGYLDPEYYGNQQLTEK 773
           RD+K SN+LL+     K+ DFGL+R A+ D  H   +     T  Y  PE   N +   K
Sbjct: 154 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 213
Query: 774 S-DVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
           S D++S G +L E++S +     + +  +LN +
Sbjct: 214 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 246

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 96/213 (45%), Gaps = 8/213 (3%)
Query: 598 IGKGSFGSV--YYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 655
           IG+G++G V   Y  +   +    KI         Q+ + E+ +L R  H N++ +    
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 87
Query: 656 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 715
                  +   Y+    +   L+  +  + L         +   +GL+Y+H+     ++H
Sbjct: 88  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 144
Query: 716 RDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGYLDPEYYGNQQLTEK 773
           RD+K SN+LL+     K+ DFGL+R A+ D  H   +     T  Y  PE   N +   K
Sbjct: 145 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 204
Query: 774 S-DVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
           S D++S G +L E++S +     + +  +LN +
Sbjct: 205 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 237

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 96/213 (45%), Gaps = 8/213 (3%)
Query: 598 IGKGSFGSV--YYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 655
           IG+G++G V   Y  +   +    KI         Q+ + E+ +L R  H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 656 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 715
                  +   Y+    +   L+  +  + L         +   +GL+Y+H+     ++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 151
Query: 716 RDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGYLDPEYYGNQQLTEK 773
           RD+K SN+LL+     K+ DFGL+R A+ D  H   +     T  Y  PE   N +   K
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 774 S-DVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
           S D++S G +L E++S +     + +  +LN +
Sbjct: 212 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 244

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 96/213 (45%), Gaps = 8/213 (3%)
Query: 598 IGKGSFGSV--YYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 655
           IG+G++G V   Y  +   +    KI         Q+ + E+ +L R  H N++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 656 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 715
                  +   Y+    +   L+  +  + L         +   +GL+Y+H+     ++H
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 145
Query: 716 RDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGYLDPEYYGNQQLTEK 773
           RD+K SN+LL+     K+ DFGL+R A+ D  H   +     T  Y  PE   N +   K
Sbjct: 146 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 205
Query: 774 S-DVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
           S D++S G +L E++S +     + +  +LN +
Sbjct: 206 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 238

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLIG 653
           +G G++GSV      K G  VAVK ++    S  H  + +  E+ LL  + H N++ L+ 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 84
Query: 654 YCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
                   EE   + +  ++    L + +     QK  D   +  I +   +GL+Y+H+ 
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLI-YQILRGLKYIHSA 140
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN- 767
               IIHRD+K SN+ ++ +   K+ DFGL+R  ++++T   +    T  Y  PE   N 
Sbjct: 141 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPEIMLNW 193
Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
               +  D++S G ++ EL++G+      D   +L ++
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 231

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 96/213 (45%), Gaps = 8/213 (3%)
Query: 598 IGKGSFGSV--YYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 655
           IG+G++G V   Y  +   +    KI         Q+ + E+ +L R  H N++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 656 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 715
                  +   Y+    +   L+  +  + L         +   +GL+Y+H+     ++H
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 145
Query: 716 RDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGYLDPEYYGNQQLTEK 773
           RD+K SN+LL+     K+ DFGL+R A+ D  H   +     T  Y  PE   N +   K
Sbjct: 146 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 205
Query: 774 S-DVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
           S D++S G +L E++S +     + +  +LN +
Sbjct: 206 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 238

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLIG 653
           IG G++GSV      K G  VAVK ++    S  H  + +  E+ LL  + H N++ L+ 
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 93
Query: 654 YCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
                   EE   + +  ++    L + +     QK  D   +  I +   +GL+Y+H+ 
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLI-YQILRGLKYIHSA 149
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN- 767
               IIHRD+K SN+ ++ +   K+ DFGL+R  ++++T   +    T  Y  PE   N 
Sbjct: 150 ---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVA----TRWYRAPEIMLNW 202
Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
               +  D++S G ++ EL++G+      D   +L ++
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 240

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 101/214 (47%), Gaps = 10/214 (4%)
Query: 598 IGKGSFGSVYYGKMKDGK-EVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLIGY 654
           IG+G++G V        K  VA+K ++    H+T  Q+ + E+ +L R  H N++ +   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLREIKILLRFRHENIIGINDI 93
Query: 655 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 714
                   +   Y+    +   L+  +  + L         +   +GL+Y+H+     ++
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVL 150
Query: 715 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGYLDPEYYGNQQLTE 772
           HRD+K SN+LL+     K+ DFGL+R A+ D  H   +     T  Y  PE   N +   
Sbjct: 151 HRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 210
Query: 773 KS-DVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
           KS D++S G +L E++S +     + +  +LN +
Sbjct: 211 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 244

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 106/219 (48%), Gaps = 20/219 (9%)
Query: 598 IGKGSFGSVYYGKMKDGK-EVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLIGY 654
           IG+G++G V        K  VA+K ++    H+T  Q+ + E+ +L R  H N++ +   
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILLRFRHENIIGI--- 106
Query: 655 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPL--DWLTRLQIAH---DAAKGLEYLHTGC 709
              +  R    E M +  L   L G+   K L    L+   I +      +GL+Y+H+  
Sbjct: 107 --NDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA- 163
Query: 710 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGYLDPEYYGN 767
              ++HRD+K SN+LL+     K+ DFGL+R A+ D  H   +     T  Y  PE   N
Sbjct: 164 --NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 221
Query: 768 QQLTEKS-DVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
            +   KS D++S G +L E++S +     + +  +LN +
Sbjct: 222 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 260

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 117/254 (46%), Gaps = 28/254 (11%)
Query: 567 IARGGHFMDEGVAYF-----IPLPELEEATNNFCKKIGKGSFGSVYYG-KMKDGKEVAVK 620
           + RG H   E   ++       + E+ E   N    +G G++GSV      K G  VAVK
Sbjct: 15  VPRGSHMSQERPTFYRQELNKTIWEVPERYQNLSP-VGSGAYGSVCAAFDTKTGLRVAVK 73
Query: 621 IMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLI-----GYCEEEHQRILVYEYMHNGT 672
            ++    S  H  + +  E+ LL  + H N++ L+         EE   + +  ++    
Sbjct: 74  KLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD 132
Query: 673 LRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK 732
           L + +     QK  D   +  I +   +GL+Y+H+     IIHRD+K SN+ ++ +   K
Sbjct: 133 LNNIVKC---QKLTDDHVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELK 185
Query: 733 VSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKK 791
           + DFGL+R  ++++T   +    T  Y  PE   N     +  D++S G ++ EL++G+ 
Sbjct: 186 ILDFGLARHTDDEMTGYVA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 241
Query: 792 PVSVEDFGAELNIV 805
                D   +L ++
Sbjct: 242 LFPGTDHIDQLKLI 255

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 98/214 (45%), Gaps = 24/214 (11%)
Query: 596 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADS----CSHRTQ----QFVTEVALLSRIHHR 646
           K +G G+ G V    + K  K+VA+KI++       S R         TE+ +L +++H 
Sbjct: 22  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 81
Query: 647 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
            ++ +  + + E   I V E M  G L D++   V  K L   T     +     ++YLH
Sbjct: 82  CIIKIKNFFDAEDYYI-VLELMEGGELFDKV---VGNKRLKEATCKLYFYQMLLAVQYLH 137
Query: 707 TGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 763
                GIIHRD+K  N+LL   + +   K++DFG S+   E  T +     GT  YL PE
Sbjct: 138 EN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLCGTPTYLAPE 192
Query: 764 YY---GNQQLTEKSDVYSFGVVLLELISGKKPVS 794
                G        D +S GV+L   +SG  P S
Sbjct: 193 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 226

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 96/213 (45%), Gaps = 8/213 (3%)
Query: 598 IGKGSFGSV--YYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 655
           IG+G++G V   Y  +   +    KI         Q+ + E+ +L R  H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 656 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 715
                  +   Y+    +   L+  +  + L         +   +GL+Y+H+     ++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 151
Query: 716 RDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGYLDPEYYGNQQLTEK 773
           RD+K SN+LL+     K+ DFGL+R A+ D  H   +     T  Y  PE   N +   K
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 774 S-DVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
           S D++S G +L E++S +     + +  +LN +
Sbjct: 212 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 244

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 10/212 (4%)
Query: 598 IGKGSFGSVYYGKMKDGK-EVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLIGY 654
           IG+G++G V        K  VA+K ++    H+T  Q+ + E+ +L R  H N++ +   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILLRFRHENIIGINDI 89
Query: 655 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 714
                   +   Y+    +   L+  +  + L         +   +GL+Y+H+     ++
Sbjct: 90  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVL 146
Query: 715 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGYLDPEYYGNQQLTE 772
           HRD+K SN+LL+     K+ DFGL+R A+ D  H   +     T  Y  PE   N +   
Sbjct: 147 HRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 206
Query: 773 KS-DVYSFGVVLLELISGKKPVSVEDFGAELN 803
           KS D++S G +L E++S +     + +  +LN
Sbjct: 207 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 238

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLI- 652
           +G G++GSV      K G  VAVK ++    S  H  + +  E+ LL  + H N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 653 ----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
                   EE   + +  ++    L + +     QK  D   +  I +   +GL+Y+H+ 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLI-YQILRGLKYIHSA 144
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN- 767
               IIHRD+K SN+ ++ +   K+ DFGL+R  ++++T   +    T  Y  PE   N 
Sbjct: 145 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPEIMLNW 197
Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
               +  D++S G ++ EL++G+      D   +L ++
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 117/254 (46%), Gaps = 28/254 (11%)
Query: 567 IARGGHFMDEGVAYF-----IPLPELEEATNNFCKKIGKGSFGSVYYG-KMKDGKEVAVK 620
           + RG H   E   ++       + E+ E   N    +G G++GSV      K G  VAVK
Sbjct: 14  VPRGSHMSQERPTFYRQELNKTIWEVPERYQNLSP-VGSGAYGSVCAAFDTKTGLRVAVK 72
Query: 621 IMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLI-----GYCEEEHQRILVYEYMHNGT 672
            ++    S  H  + +  E+ LL  + H N++ L+         EE   + +  ++    
Sbjct: 73  KLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD 131
Query: 673 LRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK 732
           L + +     QK  D   +  I +   +GL+Y+H+     IIHRD+K SN+ ++ +   K
Sbjct: 132 LNNIVKC---QKLTDDHVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELK 184
Query: 733 VSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKK 791
           + DFGL+R  ++++T   +    T  Y  PE   N     +  D++S G ++ EL++G+ 
Sbjct: 185 ILDFGLARHTDDEMTGYVA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 240
Query: 792 PVSVEDFGAELNIV 805
                D   +L ++
Sbjct: 241 LFPGTDHIDQLKLI 254

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 101/206 (49%), Gaps = 14/206 (6%)
Query: 590 ATNNFCK--KIGKGSFGSVYYGKMKDGKEVAV--KIMADSCSHRT-QQFVTEVALLSRIH 644
           +  NF K  KIG+G++G VY  + K   EV    KI  D+ +       + E++LL  ++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 645 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 704
           H N+V L+     E++  LV+E++     +     ++   PL  +          +GL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAF 121
Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPE 763
            H+     ++HRD+K  N+L++     K++DFGL+R     + T+   V   T+ Y  PE
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 176
Query: 764 -YYGNQQLTEKSDVYSFGVVLLELIS 788
              G +  +   D++S G +  E+++
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLI- 652
           +G G++GSV      K G  VAVK ++    S  H  + +  E+ LL  + H N++ L+ 
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 98
Query: 653 ----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
                   EE   + +  ++    L + +     QK  D   +  I +   +GL+Y+H+ 
Sbjct: 99  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLI-YQILRGLKYIHSA 154
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN- 767
               IIHRD+K SN+ ++ +   K+ DFGL+R  ++++T   +    T  Y  PE   N 
Sbjct: 155 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPEIMLNW 207
Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
               +  D++S G ++ EL++G+      D   +L ++
Sbjct: 208 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 245

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 101/214 (47%), Gaps = 10/214 (4%)
Query: 598 IGKGSFGSVYYGKMKDGK-EVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLIGY 654
           IG+G++G V        K  VA+K ++    H+T  Q+ + E+ +L R  H N++ +   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYXQRTLREIKILLRFRHENIIGINDI 93
Query: 655 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 714
                   +   Y+    +   L+  +  + L         +   +GL+Y+H+     ++
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVL 150
Query: 715 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGYLDPEYYGNQQLTE 772
           HRD+K SN+LL+     K+ DFGL+R A+ D  H   +     T  Y  PE   N +   
Sbjct: 151 HRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 210
Query: 773 KS-DVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
           KS D++S G +L E++S +     + +  +LN +
Sbjct: 211 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 244

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 95/211 (45%), Gaps = 8/211 (3%)
Query: 598 IGKGSFGSV--YYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 655
           IG+G++G V   Y  +   +    KI         Q+ + E+ +L R  H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 656 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 715
                  +   Y+    +   L+  +  + L         +   +GL+Y+H+     ++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 151
Query: 716 RDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGYLDPEYYGNQQLTEK 773
           RD+K SN+LL+     K+ DFGL+R A+ D  H   +     T  Y  PE   N +   K
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTK 211
Query: 774 S-DVYSFGVVLLELISGKKPVSVEDFGAELN 803
           S D++S G +L E++S +     + +  +LN
Sbjct: 212 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 242

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 95/211 (45%), Gaps = 8/211 (3%)
Query: 598 IGKGSFGSV--YYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 655
           IG+G++G V   Y  +   +    KI         Q+ + E+ +L R  H N++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 656 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 715
                  +   Y+    +   L+  +  + L         +   +GL+Y+H+     ++H
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 152
Query: 716 RDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGYLDPEYYGNQQLTEK 773
           RD+K SN+LL+     K+ DFGL+R A+ D  H   +     T  Y  PE   N +   K
Sbjct: 153 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTK 212
Query: 774 S-DVYSFGVVLLELISGKKPVSVEDFGAELN 803
           S D++S G +L E++S +     + +  +LN
Sbjct: 213 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 243

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 10/212 (4%)
Query: 598 IGKGSFGSVYYGKMKDGK-EVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLIGY 654
           IG+G++G V        K  VA+K ++    H+T  Q+ + E+ +L R  H N++ +   
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILLRFRHENIIGINDI 97
Query: 655 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 714
                   +   Y+    +   L+  +  + L         +   +GL+Y+H+     ++
Sbjct: 98  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVL 154
Query: 715 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGYLDPEYYGNQQLTE 772
           HRD+K SN+LL+     K+ DFGL+R A+ D  H   +     T  Y  PE   N +   
Sbjct: 155 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 214
Query: 773 KS-DVYSFGVVLLELISGKKPVSVEDFGAELN 803
           KS D++S G +L E++S +     + +  +LN
Sbjct: 215 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 246

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 10/212 (4%)
Query: 598 IGKGSFGSVYYGKMKDGK-EVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLIGY 654
           IG+G++G V        K  VA+K ++    H+T  Q+ + E+ +L R  H N++ +   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILLRFRHENIIGINDI 89
Query: 655 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 714
                   +   Y+    +   L+  +  + L         +   +GL+Y+H+     ++
Sbjct: 90  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVL 146
Query: 715 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGYLDPEYYGNQQLTE 772
           HRD+K SN+LL+     K+ DFGL+R A+ D  H   +     T  Y  PE   N +   
Sbjct: 147 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 206
Query: 773 KS-DVYSFGVVLLELISGKKPVSVEDFGAELN 803
           KS D++S G +L E++S +     + +  +LN
Sbjct: 207 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 238

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 99/214 (46%), Gaps = 24/214 (11%)
Query: 596 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADS----CSHRTQ----QFVTEVALLSRIHHR 646
           K +G G+ G V    + K  K+VA++I++       S R         TE+ +L +++H 
Sbjct: 155 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 214
Query: 647 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
            ++ +  + + E   I V E M  G L D++ G+   K L   T     +     ++YLH
Sbjct: 215 CIIKIKNFFDAEDYYI-VLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLH 270
Query: 707 TGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 763
                GIIHRD+K  N+LL   + +   K++DFG S+   E  T +     GT  YL PE
Sbjct: 271 EN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLCGTPTYLAPE 325
Query: 764 YY---GNQQLTEKSDVYSFGVVLLELISGKKPVS 794
                G        D +S GV+L   +SG  P S
Sbjct: 326 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 359

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 10/212 (4%)
Query: 598 IGKGSFGSVYYGKMKDGK-EVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLIGY 654
           IG+G++G V        K  VA+K ++    H+T  Q+ + E+ +L R  H N++ +   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILLRFRHENIIGINDI 89
Query: 655 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 714
                   +   Y+    +   L+  +  + L         +   +GL+Y+H+     ++
Sbjct: 90  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVL 146
Query: 715 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGYLDPEYYGNQQLTE 772
           HRD+K SN+LL+     K+ DFGL+R A+ D  H   +     T  Y  PE   N +   
Sbjct: 147 HRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 206
Query: 773 KS-DVYSFGVVLLELISGKKPVSVEDFGAELN 803
           KS D++S G +L E++S +     + +  +LN
Sbjct: 207 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 238

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLIG 653
           +G G++GSV      K G  VAVK ++    S  H  + +  E+ LL  + H N++ L+ 
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 84
Query: 654 YCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
                   EE   + +  ++    L + +     QK  D   +  I +   +GL+Y+H+ 
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLI-YQILRGLKYIHSA 140
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN- 767
               IIHRD+K SN+ ++ +   K+ DFGL+R  ++++T   +    T  Y  PE   N 
Sbjct: 141 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPEIMLNW 193
Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
               +  D++S G ++ EL++G+      D   +L ++
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 231

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 99/214 (46%), Gaps = 24/214 (11%)
Query: 596 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADS----CSHRTQ----QFVTEVALLSRIHHR 646
           K +G G+ G V    + K  K+VA++I++       S R         TE+ +L +++H 
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 200
Query: 647 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
            ++ +  + + E   I V E M  G L D++ G+   K L   T     +     ++YLH
Sbjct: 201 CIIKIKNFFDAEDYYI-VLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLH 256
Query: 707 TGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 763
                GIIHRD+K  N+LL   + +   K++DFG S+   E  T +     GT  YL PE
Sbjct: 257 EN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLCGTPTYLAPE 311
Query: 764 YY---GNQQLTEKSDVYSFGVVLLELISGKKPVS 794
                G        D +S GV+L   +SG  P S
Sbjct: 312 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 345

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 95/205 (46%), Gaps = 27/205 (13%)
Query: 597 KIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVT--EVALLSRIHHRNLVPLIG 653
           KIG+GS+G V+  + +D G+ VA+K   +S      + +   E+ +L ++ H NLV L+ 
Sbjct: 10  KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 654 YCEEEHQRILVYEYMHNGTLR--DRLHGSVNQ---KPLDWLTRLQIAHDAAKGLEYLHTG 708
               + +  LV+EY  +  L   DR    V +   K + W T         + + + H  
Sbjct: 70  VFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQT--------LQAVNFCHKH 121
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLDPEYY 765
                IHRDVK  NIL+  +   K+ DFG +R     LT  S      V    Y  PE  
Sbjct: 122 ---NCIHRDVKPENILITKHSVIKLCDFGFARL----LTGPSDYYDDEVATRWYRSPELL 174
Query: 766 -GNQQLTEKSDVYSFGVVLLELISG 789
            G+ Q     DV++ G V  EL+SG
Sbjct: 175 VGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 19/207 (9%)
Query: 598 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVT----EVALLSRIHHRNLVPLI 652
           +G G+FG V  G+ +  G +VAVKI+ +    R+   V     E+  L    H +++ L 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKIL-NRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 653 GYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 710
                     +V EY+  G L D +  HG V +     +   ++       ++Y H    
Sbjct: 78  QVISTPTDFFMVMEYVSGGELFDYICKHGRVEE-----MEARRLFQQILSAVDYCHRHM- 131
Query: 711 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY-GNQQ 769
             ++HRD+K  N+LLD +M AK++DFGLS    +        + G+  Y  PE   G   
Sbjct: 132 --VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFLRTSCGSPNYAAPEVISGRLY 187
Query: 770 LTEKSDVYSFGVVLLELISGKKPVSVE 796
              + D++S GV+L  L+ G  P   E
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPFDDE 214

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLIG 653
           +G G++GSV      K G  VAVK ++    S  H  + +  E+ LL  + H N++ L+ 
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 85
Query: 654 YCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
                   EE   + +  ++    L + +     QK  D   +  I +   +GL+Y+H+ 
Sbjct: 86  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLI-YQILRGLKYIHSA 141
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN- 767
               IIHRD+K SN+ ++ +   K+ DFGL+R  ++++T   +    T  Y  PE   N 
Sbjct: 142 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPEIMLNW 194
Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
               +  D++S G ++ EL++G+      D   +L ++
Sbjct: 195 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 232

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 101/214 (47%), Gaps = 10/214 (4%)
Query: 598 IGKGSFGSVYYGKMKDGK-EVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLIGY 654
           IG+G++G V        K  VA+K ++    H+T  Q+ + E+ +L R  H N++ +   
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILLRFRHENIIGINDI 109
Query: 655 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 714
                   +   Y+    +   L+  +  + L         +   +GL+Y+H+     ++
Sbjct: 110 IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVL 166
Query: 715 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGYLDPEYYGNQQLTE 772
           HRD+K SN+LL+     K+ DFGL+R A+ D  H   +     T  Y  PE   N +   
Sbjct: 167 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 226
Query: 773 KS-DVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
           KS D++S G +L E++S +     + +  +LN +
Sbjct: 227 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 260

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLI- 652
           +G G++GSV      K G  VAVK ++    S  H  + +  E+ LL  + H N++ L+ 
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 86
Query: 653 ----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
                   EE   + +  ++    L + +     QK  D   +  I +   +GL+Y+H+ 
Sbjct: 87  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLI-YQILRGLKYIHSA 142
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN- 767
               IIHRD+K SN+ ++ +   K+ DFGL+R  ++++T   +    T  Y  PE   N 
Sbjct: 143 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPEIMLNW 195
Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
               +  D++S G ++ EL++G+      D   +L ++
Sbjct: 196 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 233

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLIG 653
           +G G++GSV      K G  VAVK ++    S  H  + +  E+ LL  + H N++ L+ 
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 85
Query: 654 YCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
                   EE   + +  ++    L + +     QK  D   +  I +   +GL+Y+H+ 
Sbjct: 86  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLI-YQILRGLKYIHSA 141
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN- 767
               IIHRD+K SN+ ++ +   K+ DFGL+R  ++++T   +    T  Y  PE   N 
Sbjct: 142 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPEIMLNW 194
Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
               +  D++S G ++ EL++G+      D   +L ++
Sbjct: 195 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 232

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 95/211 (45%), Gaps = 8/211 (3%)
Query: 598 IGKGSFGSVY--YGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 655
           IG+G++G V   Y  +   +    KI         Q+ + E+ +L R  H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 656 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 715
                  +   Y+    +   L+  +  + L         +   +GL+Y+H+     ++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIHSA---NVLH 151
Query: 716 RDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGYLDPEYYGNQQLTEK 773
           RD+K SN+LL+     K+ DFGL+R A+ D  H   +     T  Y  PE   N +   K
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 774 S-DVYSFGVVLLELISGKKPVSVEDFGAELN 803
           S D++S G +L E++S +     + +  +LN
Sbjct: 212 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 242

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLIG 653
           +G G++GSV      K G  VAVK ++    S  H  + +  E+ LL  + H N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 654 YCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
                   EE   + +  ++    L + +     QK  D   +  I +   +GL+Y+H+ 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK---XQKLTDDHVQFLI-YQILRGLKYIHSA 144
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN- 767
               IIHRD+K SN+ ++ +   K+ DFGL+R  ++++T   +    T  Y  PE   N 
Sbjct: 145 ---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVA----TRWYRAPEIMLNW 197
Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
               +  D++S G ++ EL++G+      D   +L ++
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLIG 653
           +G G++GSV      K G  VAVK ++    S  H  + +  E+ LL  + H N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 654 YCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
                   EE   + +  ++    L + +     QK  D   +  I +   +GL+Y+H+ 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLI-YQILRGLKYIHSA 144
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN- 767
               IIHRD+K SN+ ++ +   K+ DFGL+R  ++++T   +    T  Y  PE   N 
Sbjct: 145 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPEIMLNW 197
Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
               +  D++S G ++ EL++G+      D   +L ++
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLIG 653
           +G G++GSV      K G  VAVK ++    S  H  + +  E+ LL  + H N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 654 YCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
                   EE   + +  ++    L + +     QK  D   +  I +   +GL+Y+H+ 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLI-YQILRGLKYIHSA 144
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN- 767
               IIHRD+K SN+ ++ +   K+ DFGL+R  ++++T   +    T  Y  PE   N 
Sbjct: 145 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPEIMLNW 197
Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
               +  D++S G ++ EL++G+      D   +L ++
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLIG 653
           +G G++GSV      K G  VAVK ++    S  H  + +  E+ LL  + H N++ L+ 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 90
Query: 654 YCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
                   EE   + +  ++    L + +     QK  D   +  I +   +GL+Y+H+ 
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLI-YQILRGLKYIHSA 146
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN- 767
               IIHRD+K SN+ ++ +   K+ DFGL+R  ++++T   +    T  Y  PE   N 
Sbjct: 147 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPEIMLNW 199
Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
               +  D++S G ++ EL++G+      D   +L ++
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 237

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLI- 652
           +G G++GSV      K G  VAVK ++    S  H  + +  E+ LL  + H N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 653 ----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
                   EE   + +  ++    L + +     QK  D   +  I +   +GL+Y+H+ 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLI-YQILRGLKYIHSA 144
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN- 767
               IIHRD+K SN+ ++ +   K+ DFGL+R  ++++T   +    T  Y  PE   N 
Sbjct: 145 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPEIMLNW 197
Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
               +  D++S G ++ EL++G+      D   +L ++
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLIG 653
           +G G++GSV      K G  VAVK ++    S  H  + +  E+ LL  + H N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 654 YCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
                   EE   + +  ++    L + +     QK  D   +  I +   +GL+Y+H+ 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK---XQKLTDDHVQFLI-YQILRGLKYIHSA 144
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN- 767
               IIHRD+K SN+ ++ +   K+ DFGL+R  ++++T   +    T  Y  PE   N 
Sbjct: 145 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPEIMLNW 197
Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
               +  D++S G ++ EL++G+      D   +L ++
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 105/234 (44%), Gaps = 14/234 (5%)
Query: 570 GGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIM-ADSCS 627
           GG  M  G  + +          +  +++GKG+F  V     K  G E A KI+     S
Sbjct: 9   GGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS 68
Query: 628 HRT-QQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPL 686
            R  Q+   E  +  ++ H N+V L    +EE    LV++ +  G L + +         
Sbjct: 69  ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR------ 122
Query: 687 DWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRA---KVSDFGLSRQAE 743
           ++ +    +H   + LE +    + GI+HR++K  N+LL    +    K++DFGL+ +  
Sbjct: 123 EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182
Query: 744 EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 797
           +  +       GT GYL PE       ++  D+++ GV+L  L+ G  P   ED
Sbjct: 183 D--SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 234

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 82/179 (45%), Gaps = 12/179 (6%)
Query: 625 SCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGT-LRDRLHGSVNQ 683
           S   +   F  E+ +++ I +   +   G      +  ++YEYM N + L+   +  V  
Sbjct: 82  SIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLD 141
Query: 684 KPLDWLTRLQ----IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 739
           K       +Q    I         Y+H   N  I HRDVK SNIL+D N R K+SDFG  
Sbjct: 142 KNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFG-- 197
Query: 740 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE--KSDVYSFGVVLLELISGKKPVSVE 796
            ++E  +      +RGT  ++ PE++ N+      K D++S G+ L  +     P S++
Sbjct: 198 -ESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLK 255

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLIG 653
           +G G++GSV      K G  VAVK ++    S  H  + +  E+ LL  + H N++ L+ 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 95
Query: 654 YCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
                   EE   + +  ++    L + +     QK  D   +  I +   +GL+Y+H+ 
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLI-YQILRGLKYIHSA 151
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN- 767
               IIHRD+K SN+ ++ +   K+ DFGL+R  ++++T   +    T  Y  PE   N 
Sbjct: 152 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPEIMLNW 204
Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
               +  D++S G ++ EL++G+      D   +L ++
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 242

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 93/205 (45%), Gaps = 10/205 (4%)
Query: 596 KKIGKGSFGSVY-YGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 654
           +++G G+FG V+   +   G   A K +        +    E+  +S + H  LV L   
Sbjct: 163 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 222
Query: 655 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 714
            E++++ +++YE+M  G L +++    N+   D    ++      KGL ++H       +
Sbjct: 223 FEDDNEMVMIYEFMSGGELFEKVADEHNKMSED--EAVEYMRQVCKGLCHMHEN---NYV 277
Query: 715 HRDVKSSNILLDINM--RAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 772
           H D+K  NI+         K+ DFGL+  A  D      V  GT  +  PE    + +  
Sbjct: 278 HLDLKPENIMFTTKRSNELKLIDFGLT--AHLDPKQSVKVTTGTAEFAAPEVAEGKPVGY 335
Query: 773 KSDVYSFGVVLLELISGKKPVSVED 797
            +D++S GV+   L+SG  P   E+
Sbjct: 336 YTDMWSVGVLSYILLSGLSPFGGEN 360

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLIG 653
           +G G++GSV      K G  VAVK ++    S  H  + +  E+ LL  + H N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 654 YCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
                   EE   + +  ++    L + +     QK  D   +  I +   +GL+Y+H+ 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLI-YQILRGLKYIHSA 144
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN- 767
               IIHRD+K SN+ ++ +   K+ DFGL+R  ++++T   +    T  Y  PE   N 
Sbjct: 145 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPEIMLNW 197
Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
               +  D++S G ++ EL++G+      D   +L ++
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHR--TQQFVTEVALLSRIHHRNLVPLIGY 654
           +G G++G+V      + G +VA+K +          ++   E+ LL  + H N++ L+  
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 655 ------CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
                  ++     LV  +M     +   H  + +  + +L      +   KGL Y+H  
Sbjct: 93  FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLV-----YQMLKGLRYIHAA 147
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN- 767
              GIIHRD+K  N+ ++ +   K+ DFGL+RQA+ ++         T  Y  PE   N 
Sbjct: 148 ---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMXGXVV----TRWYRAPEVILNW 200
Query: 768 QQLTEKSDVYSFGVVLLELISGK 790
            + T+  D++S G ++ E+I+GK
Sbjct: 201 MRYTQTVDIWSVGCIMAEMITGK 223

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLIG 653
           +G G++GSV      K G  VAVK ++    S  H  + +  E+ LL  + H N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 654 YCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
                   EE   + +  ++    L + +     QK  D   +  I +   +GL+Y+H+ 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLI-YQILRGLKYIHSA 144
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN- 767
               IIHRD+K SN+ ++ +   K+ DFGL+R  ++++T   +    T  Y  PE   N 
Sbjct: 145 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPEIMLNW 197
Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
               +  D++S G ++ EL++G+      D   +L ++
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLI- 652
           +G G++GSV      K G  VAVK ++    S  H  + +  E+ LL  + H N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 653 ----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
                   EE   + +  ++    L + +     QK  D   +  I +   +GL+Y+H+ 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLI-YQILRGLKYIHSA 144
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN- 767
               IIHRD+K SN+ ++ +   K+ DFGL+R  ++++T   +    T  Y  PE   N 
Sbjct: 145 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPEIMLNW 197
Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
               +  D++S G ++ EL++G+      D   +L ++
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLIG 653
           +G G++GSV      K G  VAVK ++    S  H  + +  E+ LL  + H N++ L+ 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 93
Query: 654 YCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
                   EE   + +  ++    L + +     QK  D   +  I +   +GL+Y+H+ 
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLI-YQILRGLKYIHSA 149
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN- 767
               IIHRD+K SN+ ++ +   K+ DFGL+R  ++++T   +    T  Y  PE   N 
Sbjct: 150 ---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVA----TRWYRAPEIMLNW 202
Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
               +  D++S G ++ EL++G+      D   +L ++
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 240

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLIG 653
           +G G++GSV      K G  VAVK ++    S  H  + +  E+ LL  + H N++ L+ 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 93
Query: 654 YCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
                   EE   + +  ++    L + +     QK  D   +  I +   +GL+Y+H+ 
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLI-YQILRGLKYIHSA 149
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN- 767
               IIHRD+K SN+ ++ +   K+ DFGL+R  ++++T   +    T  Y  PE   N 
Sbjct: 150 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPEIMLNW 202
Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
               +  D++S G ++ EL++G+      D   +L ++
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 240

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLI- 652
           +G G++GSV      K G  VAVK ++    S  H  + +  E+ LL  + H N++ L+ 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 90
Query: 653 ----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
                   EE   + +  ++    L + +     QK  D   +  I +   +GL+Y+H+ 
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLI-YQILRGLKYIHSA 146
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN- 767
               IIHRD+K SN+ ++ +   K+ DFGL+R  ++++T   +    T  Y  PE   N 
Sbjct: 147 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPEIMLNW 199
Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
               +  D++S G ++ EL++G+      D   +L ++
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 237

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLIG 653
           +G G++GSV      K G  VAVK ++    S  H  + +  E+ LL  + H N++ L+ 
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 87
Query: 654 YCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
                   EE   + +  ++    L + +     QK  D   +  I +   +GL+Y+H+ 
Sbjct: 88  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLI-YQILRGLKYIHSA 143
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN- 767
               IIHRD+K SN+ ++ +   K+ DFGL+R  ++++T   +    T  Y  PE   N 
Sbjct: 144 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPEIMLNW 196
Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
               +  D++S G ++ EL++G+      D   +L ++
Sbjct: 197 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 234

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLIG 653
           +G G++GSV      K G  VAVK ++    S  H  + +  E+ LL  + H N++ L+ 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 93
Query: 654 YCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
                   EE   + +  ++    L + +     QK  D   +  I +   +GL+Y+H+ 
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLI-YQILRGLKYIHSA 149
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN- 767
               IIHRD+K SN+ ++ +   K+ DFGL+R  ++++T   +    T  Y  PE   N 
Sbjct: 150 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPEIMLNW 202
Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
               +  D++S G ++ EL++G+      D   +L ++
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 240

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLI- 652
           +G G++GSV      K G  VAVK ++    S  H  + +  E+ LL  + H N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 653 ----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
                   EE   + +  ++    L + +     QK  D   +  I +   +GL+Y+H+ 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLI-YQILRGLKYIHSA 144
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN- 767
               IIHRD+K SN+ ++ +   K+ DFGL+R  ++++T   +    T  Y  PE   N 
Sbjct: 145 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPEIMLNW 197
Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
               +  D++S G ++ EL++G+      D   +L ++
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLI- 652
           +G G++GSV      K G  VAVK ++    S  H  + +  E+ LL  + H N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 653 ----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
                   EE   + +  ++    L + +     QK  D   +  I +   +GL+Y+H+ 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLI-YQILRGLKYIHSA 144
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN- 767
               IIHRD+K SN+ ++ +   K+ DFGL+R  ++++T   +    T  Y  PE   N 
Sbjct: 145 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPEIMLNA 197
Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
               +  D++S G ++ EL++G+      D   +L ++
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLI- 652
           +G G++GSV      K G  VAVK ++    S  H  + +  E+ LL  + H N++ L+ 
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 99
Query: 653 ----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
                   EE   + +  ++    L + +     QK  D   +  I +   +GL+Y+H+ 
Sbjct: 100 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLI-YQILRGLKYIHSA 155
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN- 767
               IIHRD+K SN+ ++ +   K+ DFGL+R  ++++T   +    T  Y  PE   N 
Sbjct: 156 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPEIMLNW 208
Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
               +  D++S G ++ EL++G+      D   +L ++
Sbjct: 209 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 246

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLI- 652
           +G G++GSV      K G  VAVK ++    S  H  + +  E+ LL  + H N++ L+ 
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 99
Query: 653 ----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
                   EE   + +  ++    L + +     QK  D   +  I +   +GL+Y+H+ 
Sbjct: 100 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLI-YQILRGLKYIHSA 155
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN- 767
               IIHRD+K SN+ ++ +   K+ DFGL+R  ++++T   +    T  Y  PE   N 
Sbjct: 156 ---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVA----TRWYRAPEIMLNW 208
Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
               +  D++S G ++ EL++G+      D   +L ++
Sbjct: 209 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 246

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLI- 652
           +G G++GSV      K G  VAVK ++    S  H  + +  E+ LL  + H N++ L+ 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 100
Query: 653 ----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
                   EE   + +  ++    L + +     QK  D   +  I +   +GL+Y+H+ 
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLI-YQILRGLKYIHSA 156
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN- 767
               IIHRD+K SN+ ++ +   K+ DFGL+R  ++++T   +    T  Y  PE   N 
Sbjct: 157 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPEIMLNW 209
Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
               +  D++S G ++ EL++G+      D   +L ++
Sbjct: 210 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 247

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLI- 652
           +G G++GSV      K G  VAVK ++    S  H  + +  E+ LL  + H N++ L+ 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 100
Query: 653 ----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
                   EE   + +  ++    L + +     QK  D   +  I +   +GL+Y+H+ 
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLI-YQILRGLKYIHSA 156
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN- 767
               IIHRD+K SN+ ++ +   K+ DFGL+R  ++++T   +    T  Y  PE   N 
Sbjct: 157 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPEIMLNW 209
Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
               +  D++S G ++ EL++G+      D   +L ++
Sbjct: 210 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 247

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLI- 652
           +G G++GSV      K G  VAVK ++    S  H  + +  E+ LL  + H N++ L+ 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 100
Query: 653 ----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
                   EE   + +  ++    L + +     QK  D   +  I +   +GL+Y+H+ 
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLI-YQILRGLKYIHSA 156
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN- 767
               IIHRD+K SN+ ++ +   K+ DFGL+R  ++++T   +    T  Y  PE   N 
Sbjct: 157 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPEIMLNW 209
Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
               +  D++S G ++ EL++G+      D   +L ++
Sbjct: 210 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 247

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 96/211 (45%), Gaps = 8/211 (3%)
Query: 598 IGKGSFGSV--YYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 655
           IG+G++G V   Y  ++  +    KI         Q+ + E+ +L R  H N++ +    
Sbjct: 51  IGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDIL 110
Query: 656 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 715
                  +   Y+    +   L+  +  + L         +   +GL+Y+H+     ++H
Sbjct: 111 RASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSA---NVLH 167
Query: 716 RDVKSSNILLDINMRAKVSDFGLSRQA--EEDLTHISSVARGTVGYLDPEYYGNQQLTEK 773
           RD+K SN+L++     K+ DFGL+R A  E D T   +    T  Y  PE   N +   K
Sbjct: 168 RDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNSKGYTK 227
Query: 774 S-DVYSFGVVLLELISGKKPVSVEDFGAELN 803
           S D++S G +L E++S +     + +  +LN
Sbjct: 228 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 258

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 102/215 (47%), Gaps = 15/215 (6%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMAD-SCSHRTQQ--FVTEVALLS 641
           +++    +  K IG+G+FG V   + K  ++V A+K+++      R+    F  E  +++
Sbjct: 71  QMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 130
Query: 642 RIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 701
             +   +V L    +++    +V EYM  G L + +  S    P  W  +   A +    
Sbjct: 131 FANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM--SNYDVPEKW-AKFYTA-EVVLA 186
Query: 702 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 761
           L+ +H+    G+IHRDVK  N+LLD +   K++DFG   + +E        A GT  Y+ 
Sbjct: 187 LDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYIS 243
Query: 762 PEYY----GNQQLTEKSDVYSFGVVLLELISGKKP 792
           PE      G+     + D +S GV L E++ G  P
Sbjct: 244 PEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 278

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLI- 652
           +G G++GSV      K G  VAVK ++    S  H  + +  E+ LL  + H N++ L+ 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 90
Query: 653 ----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
                   EE   + +  ++    L + +     QK  D   +  I +   +GL+Y+H+ 
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLI-YQILRGLKYIHSA 146
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN- 767
               IIHRD+K SN+ ++ +   K+ DFGL+R  ++++T   +    T  Y  PE   N 
Sbjct: 147 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPEIMLNW 199
Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
               +  D++S G ++ EL++G+      D   +L ++
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 237

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLI- 652
           +G G++GSV      K G  VAVK ++    S  H  + +  E+ LL  + H N++ L+ 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 94
Query: 653 ----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
                   EE   + +  ++    L + +     QK  D   +  I +   +GL+Y+H+ 
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLI-YQILRGLKYIHSA 150
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN- 767
               IIHRD+K SN+ ++ +   K+ DFGL+R  ++++T   +    T  Y  PE   N 
Sbjct: 151 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPEIMLNW 203
Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
               +  D++S G ++ EL++G+      D   +L ++
Sbjct: 204 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 241

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 106/218 (48%), Gaps = 22/218 (10%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLI- 652
           +G G++GSV      K G  VAVK ++    S  H  + +  E+ LL  + H N++ L+ 
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 94
Query: 653 ----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
                   EE   + +  ++    L + +     QK  D   +  I +   +GL+Y+H+ 
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLI-YQILRGLKYIHSA 150
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN- 767
               IIHRD+K SN+ ++ +   K+ DFGL+R  ++++T    VA  T  Y  PE   N 
Sbjct: 151 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVA--TRWYRAPEIMLNW 203
Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
               +  D++S G ++ EL++G+      D   +L ++
Sbjct: 204 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 241

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 104/218 (47%), Gaps = 22/218 (10%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLIG 653
           +G G++GSV      K G  VAVK ++    S  H  + +  E+ LL  + H N++ L+ 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 84
Query: 654 YCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
                   EE   + +  ++    L + +     QK  D   +  I +   +GL+Y+H+ 
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLI-YQILRGLKYIHSA 140
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN- 767
               IIHRD+K SN+ ++ +   K+ DFGL+R  ++++    +    T  Y  PE   N 
Sbjct: 141 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVA----TRWYRAPEIMLNW 193
Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
               +  D++S G ++ EL++G+      D   +L ++
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 231

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLIG 653
           +G G++GSV      K G  VAVK ++    S  H  + +  E+ LL  + H N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 654 YCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
                   EE   + +  ++    L + +    +QK  D   +  I +   +GL+Y+H+ 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK---SQKLTDDHVQFLI-YQILRGLKYIHSA 144
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN- 767
               IIHRD+K SN+ ++ +   K+ DFGL R  ++++T   +    T  Y  PE   N 
Sbjct: 145 ---DIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTGYVA----TRWYRAPEIMLNW 197
Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
               +  D++S G ++ EL++G+      D   +L ++
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 21/211 (9%)
Query: 598 IGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQF-VTEVALLSRIHHRNLVPLIGYC 655
           +G+G+  +V+ G+ K  G   A+K+  +    R     + E  +L +++H+N+V L    
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 656 EEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 713
           EE   R  +L+ E+   G+L   L    N   L     L +  D   G+ +L      GI
Sbjct: 77  EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GI 133
Query: 714 IHRDVKSSNILLDINMRA----KVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQ 769
           +HR++K  NI+  I        K++DFG +R+ E+D   +S    GT  YL P+ Y    
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LYGTEEYLHPDMYERAV 191
Query: 770 LTEKS--------DVYSFGVVLLELISGKKP 792
           L +          D++S GV      +G  P
Sbjct: 192 LRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLI- 652
           +G G++GSV      K G  VAVK ++    S  H  + +  E+ LL  + H N++ L+ 
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 111
Query: 653 ----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
                   EE   + +  ++    L + +     QK  D   +  I +   +GL+Y+H+ 
Sbjct: 112 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLI-YQILRGLKYIHSA 167
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN- 767
               IIHRD+K SN+ ++ +   K+ DFGL+R  ++++T   +    T  Y  PE   N 
Sbjct: 168 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPEIMLNW 220
Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
               +  D++S G ++ EL++G+      D   +L ++
Sbjct: 221 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 258

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 98/204 (48%), Gaps = 20/204 (9%)
Query: 596 KKIGKGSFGSV--YYGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPL 651
           K IG G+ G V   Y  + D + VA+K ++    ++T  ++   E+ L+  ++H+N++ L
Sbjct: 30  KPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISL 88
Query: 652 IGYCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           +         EE Q + +   + +  L   +   ++ + + +L      +    G+++LH
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLL-----YQMLXGIKHLH 143
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 766
           +    GIIHRD+K SNI++  +   K+ DFGL+R A         V   T  Y  PE   
Sbjct: 144 SA---GIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVIL 198
Query: 767 NQQLTEKSDVYSFGVVLLELISGK 790
                E  D++S G ++ E++  K
Sbjct: 199 GMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLI- 652
           +G G++GSV      K G  VAVK ++    S  H  + +  E+ LL  + H N++ L+ 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 90
Query: 653 ----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
                   EE   + +  ++    L + +     QK  D   +  I +   +GL+Y+H+ 
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLI-YQILRGLKYIHSA 146
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN- 767
               IIHRD+K SN+ ++ +   K+ DFGL+R  ++++T   +    T  Y  PE   N 
Sbjct: 147 ---DIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVA----TRWYRAPEIMLNW 199
Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
               +  D++S G ++ EL++G+      D   +L ++
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 237

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 95/207 (45%), Gaps = 19/207 (9%)
Query: 598 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVT----EVALLSRIHHRNLVPLI 652
           +G G+FG V  G+ +  G +VAVKI+ +    R+   V     E+  L    H +++ L 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKIL-NRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 653 GYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 710
                     +V EY+  G L D +  HG V +     +   ++       ++Y H    
Sbjct: 78  QVISTPTDFFMVMEYVSGGELFDYICKHGRVEE-----MEARRLFQQILSAVDYCHRHM- 131
Query: 711 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY-GNQQ 769
             ++HRD+K  N+LLD +M AK++DFGLS    +      S   G+  Y  PE   G   
Sbjct: 132 --VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSC--GSPNYAAPEVISGRLY 187
Query: 770 LTEKSDVYSFGVVLLELISGKKPVSVE 796
              + D++S GV+L  L+ G  P   E
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPFDDE 214

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 117/254 (46%), Gaps = 28/254 (11%)
Query: 567 IARGGHFMDEGVAYF-----IPLPELEEATNNFCKKIGKGSFGSVYYG-KMKDGKEVAVK 620
           + RG H   E   ++       + E+ E   N    +G G++GSV      K G  VAVK
Sbjct: 15  VPRGSHMSQERPTFYRQELNKTIWEVPERYQNLSP-VGSGAYGSVCAAFDTKTGHRVAVK 73
Query: 621 IMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLI-----GYCEEEHQRILVYEYMHNGT 672
            ++    S  H  + +  E+ LL  + H N++ L+         EE   + +  ++    
Sbjct: 74  KLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD 132
Query: 673 LRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK 732
           L + +     QK  D   +  I +   +GL+Y+H+     IIHRD+K SN+ ++ +   K
Sbjct: 133 LNNIVKC---QKLTDDHVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELK 185
Query: 733 VSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKK 791
           + DFGL+R  ++++     VA  T  Y  PE   N     +  D++S G ++ EL++G+ 
Sbjct: 186 ILDFGLARHTDDEMX--GXVA--TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 241
Query: 792 PVSVEDFGAELNIV 805
                D   +L ++
Sbjct: 242 LFPGTDHIDQLKLI 255

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 104/218 (47%), Gaps = 22/218 (10%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLI- 652
           +G G++GSV      K G  VAVK ++    S  H  + +  E+ LL  + H N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 653 ----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
                   EE   + +  ++    L + +     QK  D   +  I +   +GL+Y+H+ 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLI-YQILRGLKYIHSA 144
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN- 767
               IIHRD+K SN+ ++ +   K+ DFGL+R  ++++    +    T  Y  PE   N 
Sbjct: 145 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVA----TRWYRAPEIMLNW 197
Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
               +  D++S G ++ EL++G+      D   +L ++
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 596 KKIGKGSFGSV--YYGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPL 651
           K IG G+ G V   Y  + + + VA+K ++    ++T  ++   E+ L+  ++H+N++ L
Sbjct: 32  KPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 90
Query: 652 IGYCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           +         EE Q + +   + +  L   +   ++ + + +L    +      G+++LH
Sbjct: 91  LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLH 145
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 766
           +    GIIHRD+K SNI++  +   K+ DFGL+R A      +  V   T  Y  PE   
Sbjct: 146 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVV--TRYYRAPEVIL 200
Query: 767 NQQLTEKSDVYSFGVVLLELISG 789
                E  D++S G ++ E+I G
Sbjct: 201 GMGYKENVDIWSVGCIMGEMIKG 223

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 98/203 (48%), Gaps = 20/203 (9%)
Query: 596 KKIGKGSFGSV--YYGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPL 651
           K IG G+ G V   Y  + + + VA+K ++    ++T  ++   E+ L+  ++H+N++ L
Sbjct: 30  KPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 652 IGYCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           +         EE Q + +   + +  L   +   ++ + + +L    +      G+++LH
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLH 143
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 766
           +    GIIHRD+K SNI++  +   K+ DFGL+R A         V   T  Y  PE   
Sbjct: 144 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEVV--TRYYRAPEVIL 198
Query: 767 NQQLTEKSDVYSFGVVLLELISG 789
                E  D++S G ++ E+I G
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 104/218 (47%), Gaps = 22/218 (10%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLI- 652
           +G G++GSV      K G  VAVK ++    S  H  + +  E+ LL  + H N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 653 ----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
                   EE   + +  ++    L + +     QK  D   +  I +   +GL+Y+H+ 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLI-YQILRGLKYIHSA 144
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN- 767
               IIHRD+K SN+ ++ +   K+ DFGL+R  ++++    +    T  Y  PE   N 
Sbjct: 145 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVA----TRWYRAPEIMLNW 197
Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
               +  D++S G ++ EL++G+      D   +L ++
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLI- 652
           +G G++GSV      K G  VAVK ++    S  H  + +  E+ LL  + H N++ L+ 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 94
Query: 653 ----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
                   EE   + +  ++    L + +     QK  D   +  I +   +GL+Y+H+ 
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLI-YQILRGLKYIHSA 150
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN- 767
               IIHRD+K SN+ ++ +   K+ DFGL+R  ++++T   +    T  Y  PE   N 
Sbjct: 151 ---DIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVA----TRWYRAPEIMLNW 203
Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
               +  D++S G ++ EL++G+      D   +L ++
Sbjct: 204 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 241

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 14/208 (6%)
Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVKIM-ADSCSHRT-QQFVTEVALLSRIHHRNLVPLI 652
           +++GKG+F  V     K  G E A KI+     S R  Q+   E  +  ++ H N+V L 
Sbjct: 12  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71
Query: 653 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 712
              +EE    LV++ +  G L + +         ++ +    +H   + LE +    + G
Sbjct: 72  DSIQEESFHYLVFDLVTGGELFEDIVAR------EFYSEADASHCIQQILESIAYCHSNG 125
Query: 713 IIHRDVKSSNILLDINMRA---KVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQ 769
           I+HR++K  N+LL    +    K++DFGL+ +  +  +       GT GYL PE      
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--SEAWHGFAGTPGYLSPEVLKKDP 183
Query: 770 LTEKSDVYSFGVVLLELISGKKPVSVED 797
            ++  D+++ GV+L  L+ G  P   ED
Sbjct: 184 YSKPVDIWACGVILYILLVGYPPFWDED 211

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 94/209 (44%), Gaps = 15/209 (7%)
Query: 596 KKIGKGSFGSVY-YGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 654
           +++G G+FG V+   +   G   A K +        +    E+  +S + H  LV L   
Sbjct: 57  EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 116
Query: 655 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 714
            E++++ +++YE+M  G L +++    N+   D    ++      KGL ++H       +
Sbjct: 117 FEDDNEMVMIYEFMSGGELFEKVADEHNKMSED--EAVEYMRQVCKGLCHMHEN---NYV 171
Query: 715 HRDVKSSNILLDINM--RAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 772
           H D+K  NI+         K+ DFGL+  A  D      V  GT  +  PE    + +  
Sbjct: 172 HLDLKPENIMFTTKRSNELKLIDFGLT--AHLDPKQSVKVTTGTAEFAAPEVAEGKPVGY 229
Query: 773 KSDVYSFGVVLLELISGKKPVSVEDFGAE 801
            +D++S GV+   L+SG  P     FG E
Sbjct: 230 YTDMWSVGVLSYILLSGLSP-----FGGE 253

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLI- 652
           +G G++GSV      K G  VAVK ++    S  H  + +  E+ LL  + H N++ L+ 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 84
Query: 653 ----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
                   EE   + +  ++    L + +  +   K  D   +  I +   +GL+Y+H+ 
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCA---KLTDDHVQFLI-YQILRGLKYIHSA 140
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN- 767
               IIHRD+K SN+ ++ +   K+ DFGL+R  ++++T   +    T  Y  PE   N 
Sbjct: 141 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPEIMLNW 193
Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
               +  D++S G ++ EL++G+      D   +L ++
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 231

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 100/204 (49%), Gaps = 15/204 (7%)
Query: 596 KKIGKGSFGSVYYGKMKDGKE-VAVKI--MADSCSHRTQQFVTEVALLSRIHHRNLVPLI 652
           +KIG+G++G+V+  K ++  E VA+K   + D         + E+ LL  + H+N+V L 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 653 GYCEEEHQRILVYEYMHNGTLR--DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 710
                + +  LV+E+      +  D  +G ++ + +             KGL + H+   
Sbjct: 68  DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVK-----SFLFQLLKGLGFCHSR-- 120
Query: 711 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYGNQQ 769
             ++HRD+K  N+L++ N   K+++FGL+R A        S    T+ Y  P+  +G + 
Sbjct: 121 -NVLHRDLKPQNLLINRNGELKLANFGLAR-AFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178
Query: 770 LTEKSDVYSFGVVLLELISGKKPV 793
            +   D++S G +  EL +  +P+
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPL 202

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 104/218 (47%), Gaps = 22/218 (10%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLI- 652
           +G G++GSV      K G  VAVK ++    S  H  + +  E+ LL  + H N++ L+ 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 95
Query: 653 ----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
                   EE   + +  ++    L + +     QK  D   +  I +   +GL+Y+H+ 
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLI-YQILRGLKYIHSA 151
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN- 767
               IIHRD+K SN+ ++ +   K+ DFGL+R   +++T   +    T  Y  PE   N 
Sbjct: 152 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVA----TRWYRAPEIMLNW 204
Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
               +  D++S G ++ EL++G+      D   +L ++
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 242

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 104/218 (47%), Gaps = 22/218 (10%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLI- 652
           +G G++GSV      K G  VAVK ++    S  H  + +  E+ LL  + H N++ L+ 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 95
Query: 653 ----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
                   EE   + +  ++    L + +     QK  D   +  I +   +GL+Y+H+ 
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLI-YQILRGLKYIHSA 151
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN- 767
               IIHRD+K SN+ ++ +   K+ DFGL+R   +++T   +    T  Y  PE   N 
Sbjct: 152 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVA----TRWYRAPEIMLNW 204
Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
               +  D++S G ++ EL++G+      D   +L ++
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 242

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 104/218 (47%), Gaps = 22/218 (10%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLI- 652
           +G G++GSV      K G  VAVK ++    S  H  + +  E+ LL  + H N++ L+ 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 95
Query: 653 ----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
                   EE   + +  ++    L + +     QK  D   +  I +   +GL+Y+H+ 
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLI-YQILRGLKYIHSA 151
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN- 767
               IIHRD+K SN+ ++ +   K+ DFGL+R   +++T   +    T  Y  PE   N 
Sbjct: 152 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVA----TRWYRAPEIMLNW 204
Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
               +  D++S G ++ EL++G+      D   +L ++
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 242

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 14/208 (6%)
Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVKIM-ADSCSHRT-QQFVTEVALLSRIHHRNLVPLI 652
           +++GKG+F  V     K  G E A KI+     S R  Q+   E  +  ++ H N+V L 
Sbjct: 12  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71
Query: 653 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 712
              +EE    LV++ +  G L + +         ++ +    +H   + LE +    + G
Sbjct: 72  DSIQEESFHYLVFDLVTGGELFEDIVAR------EFYSEADASHCIQQILESIAYCHSNG 125
Query: 713 IIHRDVKSSNILLDINMRA---KVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQ 769
           I+HR++K  N+LL    +    K++DFGL+ +  +  +       GT GYL PE      
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--SEAWHGFAGTPGYLSPEVLKKDP 183
Query: 770 LTEKSDVYSFGVVLLELISGKKPVSVED 797
            ++  D+++ GV+L  L+ G  P   ED
Sbjct: 184 YSKPVDIWACGVILYILLVGYPPFWDED 211

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 106/218 (48%), Gaps = 22/218 (10%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLI- 652
           +G G++GSV      K G  VAVK ++    S  H  + +  E+ LL  + H N++ L+ 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 94
Query: 653 ----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
                   EE   + +  ++    L + +     QK  D   +  I +   +GL+Y+H+ 
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLI-YQILRGLKYIHSA 150
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN- 767
               IIHRD+K SN+ ++ +   K+ DFGL+R  ++++T    VA  T  Y  PE   N 
Sbjct: 151 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVA--TRWYRAPEIMLNW 203
Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
               +  D++S G ++ EL++G+      D   +L ++
Sbjct: 204 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 241

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 107/218 (49%), Gaps = 20/218 (9%)
Query: 594 FCKKIGKGSFGSVY---------YGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH 644
           F + +G+G+F  ++         YG++ +  EV +K++  +  + ++ F    +++S++ 
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHE-TEVLLKVLDKAHRNYSESFFEAASMMSKLS 70
Query: 645 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 704
           H++LV   G C    + ILV E++  G+L   L    N+  ++ L +L++A   A  + +
Sbjct: 71  HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK--NKNCINILWKLEVAKQLAAAMHF 128
Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI---SSVARGTVGYLD 761
           L       +IH +V + NILL      K  +    + ++  ++       + +  + ++ 
Sbjct: 129 LEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVP 185
Query: 762 PEYYGN-QQLTEKSDVYSFGVVLLELIS-GKKPVSVED 797
           PE   N + L   +D +SFG  L E+ S G KP+S  D
Sbjct: 186 PECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD 223

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 85/167 (50%), Gaps = 13/167 (7%)
Query: 631 QQFVTEVALLSRIHHRNLVPLIGYCEE--EHQRILVYEYMHNGTLRDRLHGSVNQKPLDW 688
           +Q   E+A+L ++ H N+V L+   ++  E    +V+E ++ G + +        KPL  
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME----VPTLKPLSE 136
Query: 689 LTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 748
                   D  KG+EYLH      IIHRD+K SN+L+  +   K++DFG+S + +     
Sbjct: 137 DQARFYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL 193
Query: 749 ISSVARGTVGYLDPEYYGNQQ--LTEKS-DVYSFGVVLLELISGKKP 792
           +S+   GT  ++ PE     +   + K+ DV++ GV L   + G+ P
Sbjct: 194 LSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 25/210 (11%)
Query: 596 KKIGKGSFGSVYYGKMKDGKEV-AVKIMAD-SCSHRTQQ--FVTEVALLSRIHHRNLVPL 651
           K IG+G+FG V   + K  ++V A+K+++      R+    F  E  +++  +   +V L
Sbjct: 75  KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 134
Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 711
               +++    +V EYM  G L + +  S    P  W  R   A +    L+ +H+    
Sbjct: 135 FYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKW-ARFYTA-EVVLALDAIHS---M 187
Query: 712 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-------- 763
           G IHRDVK  N+LLD +   K++DFG   +  ++       A GT  Y+ PE        
Sbjct: 188 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 247
Query: 764 -YYGNQQLTEKSDVYSFGVVLLELISGKKP 792
            YYG +      D +S GV L E++ G  P
Sbjct: 248 GYYGRE-----CDWWSVGVFLYEMLVGDTP 272

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 103/219 (47%), Gaps = 20/219 (9%)
Query: 596 KKIGKGSFGSV--YYGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPL 651
           K IG G+ G V   Y  + D + VA+K ++    ++T  ++   E+ L+  ++H+N++ L
Sbjct: 30  KPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISL 88
Query: 652 IGYCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           +         EE Q + +   + +  L   +   ++ + + +L    +      G+++LH
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLC-----GIKHLH 143
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 766
           +    GIIHRD+K SNI++  +   K+ DFGL+R A         V   T  Y  PE   
Sbjct: 144 SA---GIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVIL 198
Query: 767 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
                E  D++S G ++ E++  K      D+  + N V
Sbjct: 199 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 237

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 98/203 (48%), Gaps = 20/203 (9%)
Query: 596 KKIGKGSFGSV--YYGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPL 651
           K IG G+ G V   Y  + + + VA+K ++    ++T  ++   E+ L+  ++H+N++ L
Sbjct: 30  KPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGL 88
Query: 652 IGYCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           +         EE Q + +   + +  L   +   ++ + + +L    +      G+++LH
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLC-----GIKHLH 143
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 766
           +    GIIHRD+K SNI++  +   K+ DFGL+R A         V   T  Y  PE   
Sbjct: 144 SA---GIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVIL 198
Query: 767 NQQLTEKSDVYSFGVVLLELISG 789
                E  D++S G ++ E+I G
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 14/208 (6%)
Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVKIM-ADSCSHRT-QQFVTEVALLSRIHHRNLVPLI 652
           +++GKG+F  V     K  G E A KI+     S R  Q+   E  +  ++ H N+V L 
Sbjct: 11  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 70
Query: 653 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 712
              +EE    LV++ +  G L + +         ++ +    +H   + LE +    + G
Sbjct: 71  DSIQEESFHYLVFDLVTGGELFEDIVAR------EFYSEADASHCIQQILESIAYCHSNG 124
Query: 713 IIHRDVKSSNILLDINMRA---KVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQ 769
           I+HR++K  N+LL    +    K++DFGL+ +  +  +       GT GYL PE      
Sbjct: 125 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--SEAWHGFAGTPGYLSPEVLKKDP 182
Query: 770 LTEKSDVYSFGVVLLELISGKKPVSVED 797
            ++  D+++ GV+L  L+ G  P   ED
Sbjct: 183 YSKPVDIWACGVILYILLVGYPPFWDED 210

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 98/204 (48%), Gaps = 20/204 (9%)
Query: 595 CKKIGKGSFGSV--YYGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVP 650
            K IG G+ G V   Y  + + + VA+K ++    ++T  ++   E+ L+  ++H+N++ 
Sbjct: 29  LKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIG 87
Query: 651 LIGYCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 705
           L+         EE Q + +   + +  L   +   ++ + + +L    +      G+++L
Sbjct: 88  LLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLV-----GIKHL 142
Query: 706 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 765
           H+    GIIHRD+K SNI++  +   K+ DFGL+R A         V   T  Y  PE  
Sbjct: 143 HSA---GIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVI 197
Query: 766 GNQQLTEKSDVYSFGVVLLELISG 789
                 E  D++S G ++ E+I G
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 103/219 (47%), Gaps = 20/219 (9%)
Query: 596 KKIGKGSFGSV--YYGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPL 651
           K IG G+ G V   Y  + D + VA+K ++    ++T  ++   E+ L+  ++H+N++ L
Sbjct: 23  KPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 81
Query: 652 IGYCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           +         EE Q + +   + +  L   +   ++ + + +L      +    G+++LH
Sbjct: 82  LNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLL-----YQMLXGIKHLH 136
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 766
           +    GIIHRD+K SNI++  +   K+ DFGL+R A         V   T  Y  PE   
Sbjct: 137 SA---GIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVIL 191
Query: 767 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
                E  D++S G ++ E++  K      D+  + N V
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 230

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 25/210 (11%)
Query: 596 KKIGKGSFGSVYYGKMKDGKEV-AVKIMAD-SCSHRTQQ--FVTEVALLSRIHHRNLVPL 651
           K IG+G+FG V   + K  ++V A+K+++      R+    F  E  +++  +   +V L
Sbjct: 80  KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 139
Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 711
               +++    +V EYM  G L + +  S    P  W  R   A +    L+ +H+    
Sbjct: 140 FYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKW-ARFYTA-EVVLALDAIHS---M 192
Query: 712 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-------- 763
           G IHRDVK  N+LLD +   K++DFG   +  ++       A GT  Y+ PE        
Sbjct: 193 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 252
Query: 764 -YYGNQQLTEKSDVYSFGVVLLELISGKKP 792
            YYG +      D +S GV L E++ G  P
Sbjct: 253 GYYGRE-----CDWWSVGVFLYEMLVGDTP 277

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 98/203 (48%), Gaps = 20/203 (9%)
Query: 596 KKIGKGSFGSV--YYGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPL 651
           K IG G+ G V   Y  + + + VA+K ++    ++T  ++   E+ L+  ++H+N++ L
Sbjct: 30  KPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 652 IGYCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           +         EE Q + +   + +  L   +   ++ + + +L    +      G+++LH
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLC-----GIKHLH 143
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 766
           +    GIIHRD+K SNI++  +   K+ DFGL+R A         V   T  Y  PE   
Sbjct: 144 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVIL 198
Query: 767 NQQLTEKSDVYSFGVVLLELISG 789
                E  D++S G ++ E+I G
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 98/203 (48%), Gaps = 20/203 (9%)
Query: 596 KKIGKGSFGSV--YYGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPL 651
           K IG G+ G V   Y  + + + VA+K ++    ++T  ++   E+ L+  ++H+N++ L
Sbjct: 30  KPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 652 IGYCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           +         EE Q + +   + +  L   +   ++ + + +L    +      G+++LH
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLC-----GIKHLH 143
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 766
           +    GIIHRD+K SNI++  +   K+ DFGL+R A         V   T  Y  PE   
Sbjct: 144 SA---GIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVIL 198
Query: 767 NQQLTEKSDVYSFGVVLLELISG 789
                E  D++S G ++ E+I G
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 103/219 (47%), Gaps = 20/219 (9%)
Query: 596 KKIGKGSFGSV--YYGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPL 651
           K IG G+ G V   Y  + D + VA+K ++    ++T  ++   E+ L+  ++H+N++ L
Sbjct: 30  KPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 88
Query: 652 IGYCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           +         EE Q + +   + +  L   +   ++ + + +L      +    G+++LH
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLL-----YQMLXGIKHLH 143
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 766
           +    GIIHRD+K SNI++  +   K+ DFGL+R A         V   T  Y  PE   
Sbjct: 144 SA---GIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVIL 198
Query: 767 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
                E  D++S G ++ E++  K      D+  + N V
Sbjct: 199 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 237

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 102/203 (50%), Gaps = 22/203 (10%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLI- 652
           +G G++GSV     +K G ++AVK ++    S  H  + +  E+ LL  + H N++ L+ 
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 117
Query: 653 ----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
                   EE   + +  ++    L + +     QK  D   +  I +   +GL+Y+H+ 
Sbjct: 118 VFTPATSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLI-YQILRGLKYIHSA 173
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN- 767
               IIHRD+K SN+ ++ +   K+ DFGL+R  ++++T    VA  T  Y  PE   N 
Sbjct: 174 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVA--TRWYRAPEIMLNW 226
Query: 768 QQLTEKSDVYSFGVVLLELISGK 790
                  D++S G ++ EL++G+
Sbjct: 227 MHYNMTVDIWSVGCIMAELLTGR 249

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLI- 652
           +G G++GSV      K G  VAVK ++    S  H  + +  E+ LL  + H N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 653 ----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
                   EE   + +  ++    L + +     QK  D   +  I +   +GL+Y+H+ 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLI-YQILRGLKYIHSA 144
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN- 767
               IIHRD+K SN+ ++ +   K+ D+GL+R  ++++T   +    T  Y  PE   N 
Sbjct: 145 ---DIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTGYVA----TRWYRAPEIMLNW 197
Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
               +  D++S G ++ EL++G+      D   +L ++
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 25/211 (11%)
Query: 597 KIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQF--VTEVALLSRIH---HRNLVP 650
           +IG G++G+VY  +    G  VA+K +             V EVALL R+    H N+V 
Sbjct: 11  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVR 70
Query: 651 LIGYC-----EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWL---TRLQIAHDAAKGL 702
           L+  C     + E +  LV+E++        L   +++ P   L   T   +     +GL
Sbjct: 71  LMDVCATSRTDREIKVTLVFEHVDQD-----LRTYLDKAPPPGLPAETIKDLMRQFLRGL 125
Query: 703 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDP 762
           ++LH  C   I+HRD+K  NIL+      K++DFGL+R     +     V   T+ Y  P
Sbjct: 126 DFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVV--TLWYRAP 180
Query: 763 EYYGNQQLTEKSDVYSFGVVLLELISGKKPV 793
           E           D++S G +  E+   +KP+
Sbjct: 181 EVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 15/205 (7%)
Query: 596 KKIGKGSFGSVYYGKMKDGKEV-AVKIMAD-SCSHRTQQ--FVTEVALLSRIHHRNLVPL 651
           K IG+G+FG V   + K  ++V A+K+++      R+    F  E  +++  +   +V L
Sbjct: 80  KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 139
Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 711
               +++    +V EYM  G L + +  S    P  W  R   A +    L+ +H+    
Sbjct: 140 FYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKW-ARFYTA-EVVLALDAIHS---M 192
Query: 712 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY----GN 767
           G IHRDVK  N+LLD +   K++DFG   +  ++       A GT  Y+ PE      G+
Sbjct: 193 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 252
Query: 768 QQLTEKSDVYSFGVVLLELISGKKP 792
                + D +S GV L E++ G  P
Sbjct: 253 GYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/195 (31%), Positives = 96/195 (49%), Gaps = 25/195 (12%)
Query: 615 KEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMHNGTL 673
           +E AVKI+     H   +   EV +L +   HRN++ LI + EEE +  LV+E M  G++
Sbjct: 39  QEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI 98
Query: 674 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR--- 730
              +H    ++  + L    +  D A  L++LH   N GI HRD+K  NIL +   +   
Sbjct: 99  LSHIH---KRRHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSP 152
Query: 731 AKVSDFGLSR--QAEEDLTHISS----VARGTVGYLDPEYYGNQQLTE-------KSDVY 777
            K+ DFGL    +   D + IS+       G+  Y+ PE    +  +E       + D++
Sbjct: 153 VKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVV--EAFSEEASIYDKRCDLW 210
Query: 778 SFGVVLLELISGKKP 792
           S GV+L  L+SG  P
Sbjct: 211 SLGVILYILLSGYPP 225

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 107/218 (49%), Gaps = 20/218 (9%)
Query: 594 FCKKIGKGSFGSVY---------YGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH 644
           F + +G+G+F  ++         YG++ +  EV +K++  +  + ++ F    +++S++ 
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHE-TEVLLKVLDKAHRNYSESFFEAASMMSKLS 70
Query: 645 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 704
           H++LV   G C    + ILV E++  G+L   L    N+  ++ L +L++A   A  + +
Sbjct: 71  HKHLVLNYGVCFCGDENILVQEFVKFGSLDTYL--KKNKNCINILWKLEVAKQLAWAMHF 128
Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI---SSVARGTVGYLD 761
           L       +IH +V + NILL      K  +    + ++  ++       + +  + ++ 
Sbjct: 129 LEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVP 185
Query: 762 PEYYGN-QQLTEKSDVYSFGVVLLELIS-GKKPVSVED 797
           PE   N + L   +D +SFG  L E+ S G KP+S  D
Sbjct: 186 PECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD 223

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 95/211 (45%), Gaps = 21/211 (9%)
Query: 598 IGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQF-VTEVALLSRIHHRNLVPLIGYC 655
           +G+G+  +V+ G+ K  G   A+K+  +    R     + E  +L +++H+N+V L    
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 656 EEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 713
           EE   R  +L+ E+   G+L   L    N   L     L +  D   G+ +L      GI
Sbjct: 77  EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GI 133
Query: 714 IHRDVKSSNILLDINMRA----KVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQ 769
           +HR++K  NI+  I        K++DFG +R+ E+D   +     GT  YL P+ Y    
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVX--LYGTEEYLHPDMYERAV 191
Query: 770 LTEKS--------DVYSFGVVLLELISGKKP 792
           L +          D++S GV      +G  P
Sbjct: 192 LRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/224 (22%), Positives = 107/224 (47%), Gaps = 35/224 (15%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHR--TQQFVTEVALLSRIHHRNLVPLI-- 652
           +G G++GSV      + G++VA+K ++         ++   E+ LL  + H N++ L+  
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 653 ----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
                     +   LV  +M    L+  +    +++ + +L      +   KGL+Y+H+ 
Sbjct: 110 FTPASSLRNFYDFYLVMPFMQTD-LQKIMGMEFSEEKIQYLV-----YQMLKGLKYIHSA 163
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
              G++HRD+K  N+ ++ +   K+ DFGL+R A+ ++T          GY+   +Y   
Sbjct: 164 ---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMT----------GYVVTRWYRAP 210
Query: 769 QL-------TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
           ++        +  D++S G ++ E+++GK     +D+  +L  +
Sbjct: 211 EVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI 254

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 98/203 (48%), Gaps = 20/203 (9%)
Query: 596 KKIGKGSFGSV--YYGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPL 651
           K IG G+ G V   Y  + + + VA+K ++    ++T  ++   E+ L+  ++H+N++ L
Sbjct: 30  KPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 652 IGYCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           +         EE Q + +   + +  L   +   ++ + + +L    +      G+++LH
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLH 143
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 766
           +    GIIHRD+K SNI++  +   K+ DFGL+R A         V   T  Y  PE   
Sbjct: 144 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVIL 198
Query: 767 NQQLTEKSDVYSFGVVLLELISG 789
                E  D++S G ++ E+I G
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 13/208 (6%)
Query: 596 KKIGKGSFGSVYYG-KMKDGKEVAVKIM-ADSCSHRTQQFVTEVALLSRI-HHRNLVPLI 652
           +++GKG+F  V    K+  G+E A  I+     S R  Q +   A + R+  H N+V L 
Sbjct: 17  EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 76
Query: 653 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 712
               EE    L+++ +  G L + +         ++ +    +H   + LE +      G
Sbjct: 77  DSISEEGHHYLIFDLVTGGELFEDIVAR------EYYSEADASHCIQQILEAVLHCHQMG 130
Query: 713 IIHRDVKSSNILLDINMRA---KVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQ 769
           ++HR++K  N+LL   ++    K++DFGL+ + E +       A GT GYL PE      
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYLSPEVLRKDP 189
Query: 770 LTEKSDVYSFGVVLLELISGKKPVSVED 797
             +  D+++ GV+L  L+ G  P   ED
Sbjct: 190 YGKPVDLWACGVILYILLVGYPPFWDED 217

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 128/288 (44%), Gaps = 33/288 (11%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH 644
           EL E      + + +G F  VY  + +  G+E A+K +  +   + +  + EV  + ++ 
Sbjct: 24  ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLS 83
Query: 645 -HRNLVPL-----IGYCEEE--HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH 696
            H N+V       IG  E +      L+   +  G L + L    ++ PL   T L+I +
Sbjct: 84  GHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFY 143
Query: 697 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG--------------LSRQA 742
              + ++++H    P IIHRD+K  N+LL      K+ DFG                R+A
Sbjct: 144 QTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRA 202
Query: 743 --EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA 800
             EE++T  ++    T   +D   Y N  + EK D+++ G +L  L   + P   ED GA
Sbjct: 203 LVEEEITRNTTPMYRTPEIID--LYSNFPIGEKQDIWALGCILYLLCFRQHP--FED-GA 257
Query: 801 ELNIVHWARSMIKKGDVISIVDPVLIGNVKI--ESIWRIAEVAIQCVE 846
           +L IV+   S+       ++   ++   +++  E    IAEV  Q  E
Sbjct: 258 KLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQE 305

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 99/212 (46%), Gaps = 10/212 (4%)
Query: 598 IGKGSFGSVYYGKMKDGK-EVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLIGY 654
           IG+G++G V        K  VA+K ++    H+T  Q+ + E+ +L    H N++ +   
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILLAFRHENIIGINDI 91
Query: 655 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 714
                   +   Y+    +   L+  +  + L         +   +GL+Y+H+     ++
Sbjct: 92  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVL 148
Query: 715 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGYLDPEYYGNQQLTE 772
           HRD+K SN+LL+     K+ DFGL+R A+ D  H   +     T  Y  PE   N +   
Sbjct: 149 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 208
Query: 773 KS-DVYSFGVVLLELISGKKPVSVEDFGAELN 803
           KS D++S G +L E++S +     + +  +LN
Sbjct: 209 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 240

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 50/224 (22%), Positives = 107/224 (47%), Gaps = 35/224 (15%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHR--TQQFVTEVALLSRIHHRNLVPLI-- 652
           +G G++GSV      + G++VA+K ++         ++   E+ LL  + H N++ L+  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 653 ----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
                     +   LV  +M    L+  +    +++ + +L      +   KGL+Y+H+ 
Sbjct: 92  FTPASSLRNFYDFYLVMPFMQTD-LQKIMGLKFSEEKIQYLV-----YQMLKGLKYIHSA 145
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
              G++HRD+K  N+ ++ +   K+ DFGL+R A+ ++T          GY+   +Y   
Sbjct: 146 ---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMT----------GYVVTRWYRAP 192
Query: 769 QL-------TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
           ++        +  D++S G ++ E+++GK     +D+  +L  +
Sbjct: 193 EVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI 236

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 98/203 (48%), Gaps = 20/203 (9%)
Query: 596 KKIGKGSFGSV--YYGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPL 651
           K IG G+ G V   Y  + + + VA+K ++    ++T  ++   E+ L+  ++H+N++ L
Sbjct: 31  KPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 89
Query: 652 IGYCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           +         EE Q + +   + +  L   +   ++ + + +L    +      G+++LH
Sbjct: 90  LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLH 144
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 766
           +    GIIHRD+K SNI++  +   K+ DFGL+R A         V   T  Y  PE   
Sbjct: 145 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVIL 199
Query: 767 NQQLTEKSDVYSFGVVLLELISG 789
                E  D++S G ++ E+I G
Sbjct: 200 GMGYKENVDIWSVGCIMGEMIKG 222

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 98/203 (48%), Gaps = 20/203 (9%)
Query: 596 KKIGKGSFGSV--YYGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPL 651
           K IG G+ G V   Y  + + + VA+K ++    ++T  ++   E+ L+  ++H+N++ L
Sbjct: 30  KPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 652 IGYCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           +         EE Q + +   + +  L   +   ++ + + +L    +      G+++LH
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLH 143
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 766
           +    GIIHRD+K SNI++  +   K+ DFGL+R A         V   T  Y  PE   
Sbjct: 144 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVIL 198
Query: 767 NQQLTEKSDVYSFGVVLLELISG 789
                E  D++S G ++ E+I G
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 25/211 (11%)
Query: 597 KIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQF--VTEVALLSRIH---HRNLVP 650
           +IG G++G+VY  +    G  VA+K +             V EVALL R+    H N+V 
Sbjct: 11  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVR 70
Query: 651 LIGYC-----EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWL---TRLQIAHDAAKGL 702
           L+  C     + E +  LV+E++        L   +++ P   L   T   +     +GL
Sbjct: 71  LMDVCATSRTDREIKVTLVFEHVDQD-----LRTYLDKAPPPGLPAETIKDLMRQFLRGL 125
Query: 703 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDP 762
           ++LH  C   I+HRD+K  NIL+      K++DFGL+R     +     V   T+ Y  P
Sbjct: 126 DFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVV--TLWYRAP 180
Query: 763 EYYGNQQLTEKSDVYSFGVVLLELISGKKPV 793
           E           D++S G +  E+   +KP+
Sbjct: 181 EVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 103/219 (47%), Gaps = 20/219 (9%)
Query: 596 KKIGKGSFGSV--YYGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPL 651
           K IG G+ G V   Y  + D + VA+K ++    ++T  ++   E+ L+  ++H+N++ L
Sbjct: 30  KPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISL 88
Query: 652 IGYCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           +         EE Q + +   + +  L   +   ++ + + +L    +      G+++LH
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLH 143
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 766
           +    GIIHRD+K SNI++  +   K+ DFGL+R A         V   T  Y  PE   
Sbjct: 144 SA---GIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVIL 198
Query: 767 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
                E  D++S G ++ E++  K      D+  + N V
Sbjct: 199 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 237

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 104/218 (47%), Gaps = 22/218 (10%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLIG 653
           +G G++GSV      K G  VAVK ++    S  H  + +  E+ LL  + H N++ L+ 
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 111
Query: 654 YCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
                   EE   + +  ++    L + +     QK  D   +  I +   +GL+Y+H+ 
Sbjct: 112 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLI-YQILRGLKYIHSA 167
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN- 767
               IIHRD+K SN+ ++ +   K+ DFGL+R  ++++    +    T  Y  PE   N 
Sbjct: 168 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGYVA----TRWYRAPEIMLNW 220
Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
               +  D++S G ++ EL++G+      D   +L ++
Sbjct: 221 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 258

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 103/219 (47%), Gaps = 20/219 (9%)
Query: 596 KKIGKGSFGSV--YYGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPL 651
           K IG G+ G V   Y  + D + VA+K ++    ++T  ++   E+ L+  ++H+N++ L
Sbjct: 30  KPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 88
Query: 652 IGYCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           +         EE Q + +   + +  L   +   ++ + + +L    +      G+++LH
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLH 143
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 766
           +    GIIHRD+K SNI++  +   K+ DFGL+R A         V   T  Y  PE   
Sbjct: 144 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVIL 198
Query: 767 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
                E  D++S G ++ E++  K      D+  + N V
Sbjct: 199 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 237

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 103/219 (47%), Gaps = 20/219 (9%)
Query: 596 KKIGKGSFGSV--YYGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPL 651
           K IG G+ G V   Y  + D + VA+K ++    ++T  ++   E+ L+  ++H+N++ L
Sbjct: 31  KPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 89
Query: 652 IGYCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           +         EE Q + +   + +  L   +   ++ + + +L    +      G+++LH
Sbjct: 90  LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLH 144
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 766
           +    GIIHRD+K SNI++  +   K+ DFGL+R A         V   T  Y  PE   
Sbjct: 145 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVIL 199
Query: 767 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
                E  D++S G ++ E++  K      D+  + N V
Sbjct: 200 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 238

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 103/219 (47%), Gaps = 20/219 (9%)
Query: 596 KKIGKGSFGSV--YYGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPL 651
           K IG G+ G V   Y  + D + VA+K ++    ++T  ++   E+ L+  ++H+N++ L
Sbjct: 30  KPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 88
Query: 652 IGYCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           +         EE Q + +   + +  L   +   ++ + + +L    +      G+++LH
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLH 143
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 766
           +    GIIHRD+K SNI++  +   K+ DFGL+R A         V   T  Y  PE   
Sbjct: 144 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVIL 198
Query: 767 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
                E  D++S G ++ E++  K      D+  + N V
Sbjct: 199 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 237

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 103/219 (47%), Gaps = 20/219 (9%)
Query: 596 KKIGKGSFGSV--YYGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPL 651
           K IG G+ G V   Y  + D + VA+K ++    ++T  ++   E+ L+  ++H+N++ L
Sbjct: 24  KPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 82
Query: 652 IGYCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           +         EE Q + +   + +  L   +   ++ + + +L    +      G+++LH
Sbjct: 83  LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLH 137
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 766
           +    GIIHRD+K SNI++  +   K+ DFGL+R A         V   T  Y  PE   
Sbjct: 138 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVIL 192
Query: 767 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
                E  D++S G ++ E++  K      D+  + N V
Sbjct: 193 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 231

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 103/219 (47%), Gaps = 20/219 (9%)
Query: 596 KKIGKGSFGSV--YYGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPL 651
           K IG G+ G V   Y  + D + VA+K ++    ++T  ++   E+ L+  ++H+N++ L
Sbjct: 29  KPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 87
Query: 652 IGYCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           +         EE Q + +   + +  L   +   ++ + + +L    +      G+++LH
Sbjct: 88  LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLH 142
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 766
           +    GIIHRD+K SNI++  +   K+ DFGL+R A         V   T  Y  PE   
Sbjct: 143 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVIL 197
Query: 767 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
                E  D++S G ++ E++  K      D+  + N V
Sbjct: 198 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 236

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 103/219 (47%), Gaps = 20/219 (9%)
Query: 596 KKIGKGSFGSV--YYGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPL 651
           K IG G+ G V   Y  + D + VA+K ++    ++T  ++   E+ L+  ++H+N++ L
Sbjct: 23  KPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 81
Query: 652 IGYCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           +         EE Q + +   + +  L   +   ++ + + +L    +      G+++LH
Sbjct: 82  LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLH 136
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 766
           +    GIIHRD+K SNI++  +   K+ DFGL+R A         V   T  Y  PE   
Sbjct: 137 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVIL 191
Query: 767 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
                E  D++S G ++ E++  K      D+  + N V
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 230

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 103/219 (47%), Gaps = 20/219 (9%)
Query: 596 KKIGKGSFGSV--YYGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPL 651
           K IG G+ G V   Y  + D + VA+K ++    ++T  ++   E+ L+  ++H+N++ L
Sbjct: 24  KPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 82
Query: 652 IGYCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           +         EE Q + +   + +  L   +   ++ + + +L    +      G+++LH
Sbjct: 83  LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLH 137
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 766
           +    GIIHRD+K SNI++  +   K+ DFGL+R A         V   T  Y  PE   
Sbjct: 138 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVIL 192
Query: 767 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
                E  D++S G ++ E++  K      D+  + N V
Sbjct: 193 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 231

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 98/204 (48%), Gaps = 20/204 (9%)
Query: 596 KKIGKGSFGSVY--YGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPL 651
           K IG G+ G V   Y  + D + VA+K ++    ++T  ++   E+ L+  ++H+N++ L
Sbjct: 68  KPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 126
Query: 652 IGYCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           +         EE Q + +   + +  L   +   ++ + + +L    +      G+++LH
Sbjct: 127 LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLH 181
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 766
           +    GIIHRD+K SNI++  +   K+ DFGL+R A         V   T  Y  PE   
Sbjct: 182 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVIL 236
Query: 767 NQQLTEKSDVYSFGVVLLELISGK 790
                E  D++S G ++ E++  K
Sbjct: 237 GMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 97/218 (44%), Gaps = 24/218 (11%)
Query: 594 FCKKIGKGSFGSV-YYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 652
           F +K+G+G F  V     + DG   A+K +        ++   E  +    +H N++ L+
Sbjct: 33  FIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLV 92
Query: 653 GYCEEE----HQRILVYEYMHNGTLR---DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 705
            YC  E    H+  L+  +   GTL    +RL    N    D +  L +     +GLE +
Sbjct: 93  AYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLG--ICRGLEAI 150
Query: 706 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-------EEDLTHISSVA-RGTV 757
           H     G  HRD+K +NILL    +  + D G   QA        + LT     A R T+
Sbjct: 151 HA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207
Query: 758 GYLDPEYYGNQQ---LTEKSDVYSFGVVLLELISGKKP 792
            Y  PE +  Q    + E++DV+S G VL  ++ G+ P
Sbjct: 208 SYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 100/214 (46%), Gaps = 10/214 (4%)
Query: 598 IGKGSFGSVYYGKMKDGK-EVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLIGY 654
           IG+G++G V        K  VA+K ++    H+T  Q+ + E+ +L    H N++ +   
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILLAFRHENIIGINDI 91
Query: 655 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 714
                   +   Y+    +   L+  +  + L         +   +GL+Y+H+     ++
Sbjct: 92  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVL 148
Query: 715 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGYLDPEYYGNQQLTE 772
           HRD+K SN+LL+     K+ DFGL+R A+ D  H   +     T  Y  PE   N +   
Sbjct: 149 HRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 208
Query: 773 KS-DVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
           KS D++S G +L E++S +     + +  +LN +
Sbjct: 209 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 242

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 103/219 (47%), Gaps = 20/219 (9%)
Query: 596 KKIGKGSFGSV--YYGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPL 651
           K IG G+ G V   Y  + D + VA+K ++    ++T  ++   E+ L+  ++H+N++ L
Sbjct: 31  KPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 89
Query: 652 IGYCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           +         EE Q + +   + +  L   +   ++ + + +L    +      G+++LH
Sbjct: 90  LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLH 144
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 766
           +    GIIHRD+K SNI++  +   K+ DFGL+R A         V   T  Y  PE   
Sbjct: 145 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVIL 199
Query: 767 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
                E  D++S G ++ E++  K      D+  + N V
Sbjct: 200 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 238

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 97/228 (42%), Gaps = 28/228 (12%)
Query: 583 PLPELEEATNNFCKKIGKGSFGSVY------YGKMKDGKEVAVKIMADSCSHRTQQFVTE 636
           PL  +  +      +IG G++G+VY       G     K V V              V E
Sbjct: 2   PLGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVRE 61
Query: 637 VALLSRIH---HRNLVPLIGYC-----EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDW 688
           VALL R+    H N+V L+  C     + E +  LV+E++        L   +++ P   
Sbjct: 62  VALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQD-----LRTYLDKAPPPG 116
Query: 689 L---TRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 745
           L   T   +     +GL++LH  C   I+HRD+K  NIL+      K++DFGL+R     
Sbjct: 117 LPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ 173
Query: 746 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPV 793
           +     V   T+ Y  PE           D++S G +  E+   +KP+
Sbjct: 174 MALTPVVV--TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 218

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 103/219 (47%), Gaps = 20/219 (9%)
Query: 596 KKIGKGSFGSV--YYGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPL 651
           K IG G+ G V   Y  + D + VA+K ++    ++T  ++   E+ L+  ++H+N++ L
Sbjct: 68  KPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 126
Query: 652 IGYCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           +         EE Q + +   + +  L   +   ++ + + +L    +      G+++LH
Sbjct: 127 LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLH 181
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 766
           +    GIIHRD+K SNI++  +   K+ DFGL+R A         V   T  Y  PE   
Sbjct: 182 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVIL 236
Query: 767 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
                E  D++S G ++ E++  K      D+  + N V
Sbjct: 237 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 275

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 98/210 (46%), Gaps = 23/210 (10%)
Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVKIMAD---SCSHR---TQQFVTEVALLSRIHHRNL 648
           +++G G F  V   + K  GKE A K +     S S R    ++   EV +L  I H N+
Sbjct: 18  EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 77
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           + L    E +   +L+ E +  G L D L     ++ L      Q       G+ YLH+ 
Sbjct: 78  ITLHDIFENKTDVVLILELVSGGELFDFL---AEKESLTEDEATQFLKQILDGVHYLHS- 133
Query: 709 CNPGIIHRDVKSSNI-LLDINM---RAKVSDFGLSRQAE--EDLTHISSVARGTVGYLDP 762
               I H D+K  NI LLD N+   R K+ DFG++ + E   +  +I     GT  ++ P
Sbjct: 134 --KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF----GTPEFVAP 187
Query: 763 EYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           E    + L  ++D++S GV+   L+SG  P
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/127 (33%), Positives = 63/127 (49%), Gaps = 24/127 (18%)
Query: 672 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRA 731
           +L DR HG            L I    A+ +E+LH+    G++HRD+K SNI   ++   
Sbjct: 157 SLEDREHGVC----------LHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVV 203
Query: 732 KVSDFGLSRQAEED------LTHISSVA--RGTVG---YLDPEYYGNQQLTEKSDVYSFG 780
           KV DFGL    ++D      LT + + A   G VG   Y+ PE       + K D++S G
Sbjct: 204 KVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLG 263
Query: 781 VVLLELI 787
           ++L EL+
Sbjct: 264 LILFELL 270

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 99/212 (46%), Gaps = 20/212 (9%)
Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSH--------RTQQFVTEVALLSRI 643
           +  + IG+GS+  V   ++K    + A+K++     +        +T++ V E A     
Sbjct: 23  DLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA----S 78
Query: 644 HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 703
           +H  LV L    + E +   V EY++ G L    H    +K  +   R   A + +  L 
Sbjct: 79  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLM--FHMQRQRKLPEEHARFYSA-EISLALN 135
Query: 704 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 763
           YLH     GII+RD+K  N+LLD     K++D+G+ ++        +S   GT  Y+ PE
Sbjct: 136 YLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDTTSXFCGTPNYIAPE 191
Query: 764 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSV 795
               +      D ++ GV++ E+++G+ P  +
Sbjct: 192 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 223

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 100/219 (45%), Gaps = 20/219 (9%)
Query: 587 LEEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIM-----ADSCSHRTQQFVTEVALL 640
           L E     C+ IGKG+F  V     ++ G++ AVKI+       S    T+    E ++ 
Sbjct: 21  LFEDVYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASIC 80
Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA-HDAA 699
             + H ++V L+     +    +V+E+M    L   +   V +    ++    +A H   
Sbjct: 81  HMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEI---VKRADAGFVYSEAVASHYMR 137
Query: 700 KGLEYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGT 756
           + LE L    +  IIHRDVK  N+LL   + +   K+ DFG++ Q  E       VA G 
Sbjct: 138 QILEALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGES----GLVAGGR 193
Query: 757 VG---YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           VG   ++ PE    +   +  DV+  GV+L  L+SG  P
Sbjct: 194 VGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 93/218 (42%), Gaps = 40/218 (18%)
Query: 597 KIGKGSFGSVYYG-KMKDGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIG 653
           +IG+GSF +VY G   +   EVA   + D        Q+F  E   L  + H N+V    
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYD 92
Query: 654 YCEEEHQR----ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI---------AHDAAK 700
             E   +     +LV E   +GTL+             +L R ++              K
Sbjct: 93  SWESTVKGKKCIVLVTELXTSGTLKT------------YLKRFKVXKIKVLRSWCRQILK 140
Query: 701 GLEYLHTGCNPGIIHRDVKSSNILL-DINMRAKVSDFGLSRQAEEDLTHISSVARGTVG- 758
           GL++LHT   P IIHRD+K  NI +       K+ D GL+          +S A+  +G 
Sbjct: 141 GLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR------ASFAKAVIGT 193
Query: 759 --YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVS 794
             +  PE Y  ++  E  DVY+FG   LE  + + P S
Sbjct: 194 PEFXAPEXY-EEKYDESVDVYAFGXCXLEXATSEYPYS 230

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 104/218 (47%), Gaps = 22/218 (10%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLI- 652
           +G G++GSV      K G  VAVK ++    S  H  + +  E+ LL  + H N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 653 ----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
                   EE   + +  ++    L + +     QK  D   +  I +   +GL+Y+H+ 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLI-YQILRGLKYIHSA 144
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN- 767
               IIHRD+K SN+ ++ +   K+  FGL+R  ++++T   +    T  Y  PE   N 
Sbjct: 145 ---DIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTGYVA----TRWYRAPEIMLNW 197
Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
               +  D++S G ++ EL++G+      D   +L ++
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 104/218 (47%), Gaps = 22/218 (10%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLIG 653
           +G G++GSV      K G  VAVK ++    S  H  + +  E+ LL  + H N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 654 YCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
                   EE   + +  ++    L + +     QK  D   +  I +   +GL+Y+H+ 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLI-YQILRGLKYIHSA 144
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN- 767
               IIHRD+K SN+ ++ +   K+ DF L+R  ++++T   +    T  Y  PE   N 
Sbjct: 145 ---DIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMTGYVA----TRWYRAPEIMLNW 197
Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
               +  D++S G ++ EL++G+      D   +L ++
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 98/210 (46%), Gaps = 23/210 (10%)
Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVKIMAD---SCSHR---TQQFVTEVALLSRIHHRNL 648
           +++G G F  V   + K  GKE A K +     S S R    ++   EV +L  I H N+
Sbjct: 11  EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 70
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           + L    E +   +L+ E +  G L D L     ++ L      Q       G+ YLH+ 
Sbjct: 71  ITLHDIFENKTDVVLILELVSGGELFDFL---AEKESLTEDEATQFLKQILDGVHYLHS- 126
Query: 709 CNPGIIHRDVKSSNI-LLDINM---RAKVSDFGLSRQAE--EDLTHISSVARGTVGYLDP 762
               I H D+K  NI LLD N+   R K+ DFG++ + E   +  +I     GT  ++ P
Sbjct: 127 --KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF----GTPEFVAP 180
Query: 763 EYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           E    + L  ++D++S GV+   L+SG  P
Sbjct: 181 EIVNYEPLGLEADMWSIGVITYILLSGASP 210

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 99/212 (46%), Gaps = 20/212 (9%)
Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSH--------RTQQFVTEVALLSRI 643
           +  + IG+GS+  V   ++K    + A+K++     +        +T++ V E A     
Sbjct: 12  DLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA----S 67
Query: 644 HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 703
           +H  LV L    + E +   V EY++ G L    H    +K  +   R   A + +  L 
Sbjct: 68  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLM--FHMQRQRKLPEEHARFYSA-EISLALN 124
Query: 704 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 763
           YLH     GII+RD+K  N+LLD     K++D+G+ ++        +S   GT  Y+ PE
Sbjct: 125 YLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDTTSXFCGTPNYIAPE 180
Query: 764 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSV 795
               +      D ++ GV++ E+++G+ P  +
Sbjct: 181 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 99/212 (46%), Gaps = 20/212 (9%)
Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSH--------RTQQFVTEVALLSRI 643
           +  + IG+GS+  V   ++K    + A+K++     +        +T++ V E A     
Sbjct: 8   DLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA----S 63
Query: 644 HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 703
           +H  LV L    + E +   V EY++ G L    H    +K  +   R   A + +  L 
Sbjct: 64  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLM--FHMQRQRKLPEEHARFYSA-EISLALN 120
Query: 704 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 763
           YLH     GII+RD+K  N+LLD     K++D+G+ ++        +S   GT  Y+ PE
Sbjct: 121 YLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDTTSXFCGTPNYIAPE 176
Query: 764 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSV 795
               +      D ++ GV++ E+++G+ P  +
Sbjct: 177 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 208

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 25/211 (11%)
Query: 597 KIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQF--VTEVALLSRIH---HRNLVP 650
           +IG G++G+VY  +    G  VA+K +             V EVALL R+    H N+V 
Sbjct: 11  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVR 70
Query: 651 LIGYC-----EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWL---TRLQIAHDAAKGL 702
           L+  C     + E +  LV+E++        L   +++ P   L   T   +     +GL
Sbjct: 71  LMDVCATSRTDREIKVTLVFEHVDQD-----LRTYLDKAPPPGLPAETIKDLMRQFLRGL 125
Query: 703 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDP 762
           ++LH  C   I+HRD+K  NIL+      K++DFGL+R     +     V   T+ Y  P
Sbjct: 126 DFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVV--TLWYRAP 180
Query: 763 EYYGNQQLTEKSDVYSFGVVLLELISGKKPV 793
           E           D++S G +  E+   +KP+
Sbjct: 181 EVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 20/186 (10%)
Query: 616 EVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHNGTLR 674
           E AVK++  S    ++    E+ +L R   H N++ L    ++     LV E M  G L 
Sbjct: 54  EYAVKVIDKSKRDPSE----EIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELL 109
Query: 675 DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNIL-LDINMRA-- 731
           D++   + QK         + H   K +EYLH+    G++HRD+K SNIL +D +     
Sbjct: 110 DKI---LRQKFFSEREASFVLHTIGKTVEYLHS---QGVVHRDLKPSNILYVDESGNPEC 163
Query: 732 -KVSDFGLSRQ--AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
            ++ DFG ++Q  AE  L         T  ++ PE    Q   E  D++S G++L  +++
Sbjct: 164 LRICDFGFAKQLRAENGLLMTPCY---TANFVAPEVLKRQGYDEGCDIWSLGILLYTMLA 220
Query: 789 GKKPVS 794
           G  P +
Sbjct: 221 GYTPFA 226

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 99/212 (46%), Gaps = 20/212 (9%)
Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSH--------RTQQFVTEVALLSRI 643
           +  + IG+GS+  V   ++K    + A++++     +        +T++ V E A     
Sbjct: 55  DLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQA----S 110
Query: 644 HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 703
           +H  LV L    + E +   V EY++ G L    H    +K  +   R   A + +  L 
Sbjct: 111 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLM--FHMQRQRKLPEEHARFYSA-EISLALN 167
Query: 704 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 763
           YLH     GII+RD+K  N+LLD     K++D+G+ ++        S+   GT  Y+ PE
Sbjct: 168 YLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPE 223
Query: 764 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSV 795
               +      D ++ GV++ E+++G+ P  +
Sbjct: 224 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 255

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 19/208 (9%)
Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVT------EVALLSRIHHRNL 648
           +++G G F  V   + K  G E A K +    S  +++ V+      EV++L ++ H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           + L    E     +L+ E +  G L D L     ++ L              G+ YLHT 
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHT- 133
Query: 709 CNPGIIHRDVKSSNI-LLDINM---RAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
               I H D+K  NI LLD N+     K+ DFGL+ + E+ +   +    GT  ++ PE 
Sbjct: 134 --KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF--GTPEFVAPEI 189
Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKP 792
              + L  ++D++S GV+   L+SG  P
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 19/208 (9%)
Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVT------EVALLSRIHHRNL 648
           +++G G F  V   + K  G E A K +    S  +++ V+      EV++L ++ H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           + L    E     +L+ E +  G L D L     ++ L              G+ YLHT 
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHT- 133
Query: 709 CNPGIIHRDVKSSNI-LLDINM---RAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
               I H D+K  NI LLD N+     K+ DFGL+ + E+ +   +    GT  ++ PE 
Sbjct: 134 --KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF--GTPEFVAPEI 189
Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKP 792
              + L  ++D++S GV+   L+SG  P
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 20/186 (10%)
Query: 616 EVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHNGTLR 674
           E AVK++  S    ++    E+ +L R   H N++ L    ++     LV E M  G L 
Sbjct: 54  EYAVKVIDKSKRDPSE----EIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELL 109
Query: 675 DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNIL-LDINMRA-- 731
           D++   + QK         + H   K +EYLH+    G++HRD+K SNIL +D +     
Sbjct: 110 DKI---LRQKFFSEREASFVLHTIGKTVEYLHS---QGVVHRDLKPSNILYVDESGNPEC 163
Query: 732 -KVSDFGLSRQ--AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
            ++ DFG ++Q  AE  L         T  ++ PE    Q   E  D++S G++L  +++
Sbjct: 164 LRICDFGFAKQLRAENGLLMTPCY---TANFVAPEVLKRQGYDEGCDIWSLGILLYTMLA 220
Query: 789 GKKPVS 794
           G  P +
Sbjct: 221 GYTPFA 226

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 98/206 (47%), Gaps = 19/206 (9%)
Query: 597 KIGKGSFGSVYYGKM-KDGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHH-RNLVPLIG 653
           ++G G+ G V+  +  K G  +AVK M  S +    ++ + ++ ++ + H    +V   G
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 654 YCEEEHQRILVYEYMHNGT--LRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 711
                    +  E M      L+ R+ G +   P   L ++ +A    K L YL      
Sbjct: 92  TFITNTDVFIAMELMGTCAEKLKKRMQGPI---PERILGKMTVA--IVKALYYLKE--KH 144
Query: 712 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 771
           G+IHRDVK SNILLD   + K+ DFG+S +  +D     S   G   Y+ PE       T
Sbjct: 145 GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA--GCAAYMAPERIDPPDPT 202
Query: 772 E-----KSDVYSFGVVLLELISGKKP 792
           +     ++DV+S G+ L+EL +G+ P
Sbjct: 203 KPDYDIRADVWSLGISLVELATGQFP 228

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 19/208 (9%)
Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVT------EVALLSRIHHRNL 648
           +++G G F  V   + K  G E A K +    S  +++ V+      EV++L ++ H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           + L    E     +L+ E +  G L D L     ++ L              G+ YLHT 
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHT- 133
Query: 709 CNPGIIHRDVKSSNI-LLDINM---RAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
               I H D+K  NI LLD N+     K+ DFGL+ + E+ +   +    GT  ++ PE 
Sbjct: 134 --KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF--GTPEFVAPEI 189
Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKP 792
              + L  ++D++S GV+   L+SG  P
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 104/218 (47%), Gaps = 22/218 (10%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLI- 652
           +G G++GSV      K G  VAVK ++    S  H  + +  E+ LL  + H N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 653 ----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
                   EE   + +  ++    L + +     QK  D   +  I +   +GL+Y+H+ 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLI-YQILRGLKYIHSA 144
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN- 767
               IIHRD+K SN+ ++ +   K+ D GL+R  ++++T   +    T  Y  PE   N 
Sbjct: 145 ---DIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTGYVA----TRWYRAPEIMLNW 197
Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
               +  D++S G ++ EL++G+      D   +L ++
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 100/199 (50%), Gaps = 14/199 (7%)
Query: 596 KKIGKGSFGSVYYGKMKDGKEVAVKIM----ADSCSHRTQQFVTEVALLSRIHHRNLVPL 651
           +KIG+G++G VY  +   G+  A+K +     D     T   + E+++L  + H N+V L
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTT--IREISILKELKHSNIVKL 65
Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 711
                 + + +LV+E++ +  L+  L   V +  L+ +T          G+ Y H   + 
Sbjct: 66  YDVIHTKKRLVLVFEHL-DQDLKKLL--DVCEGGLESVTAKSFLLQLLNGIAYCH---DR 119
Query: 712 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYGNQQL 770
            ++HRD+K  N+L++     K++DFGL+R     +   +     T+ Y  P+   G+++ 
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-TLWYRAPDVLMGSKKY 178
Query: 771 TEKSDVYSFGVVLLELISG 789
           +   D++S G +  E+++G
Sbjct: 179 STTIDIWSVGCIFAEMVNG 197

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 19/208 (9%)
Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVT------EVALLSRIHHRNL 648
           +++G G F  V   + K  G E A K +    S  +++ V+      EV++L ++ H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           + L    E     +L+ E +  G L D L     ++ L              G+ YLHT 
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHT- 133
Query: 709 CNPGIIHRDVKSSNI-LLDINM---RAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
               I H D+K  NI LLD N+     K+ DFGL+ + E+ +   +    GT  ++ PE 
Sbjct: 134 --KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF--GTPEFVAPEI 189
Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKP 792
              + L  ++D++S GV+   L+SG  P
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 19/211 (9%)
Query: 593 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVT------EVALLSRIHH 645
           +  +++G G F  V   + K  G E A K +    S  +++ V+      EV++L ++ H
Sbjct: 15  DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLH 74
Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 705
            N++ L    E     +L+ E +  G L D L     ++ L              G+ YL
Sbjct: 75  HNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYL 131
Query: 706 HTGCNPGIIHRDVKSSNI-LLDINM---RAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 761
           HT     I H D+K  NI LLD N+     K+ DFGL+ + E+ +   +    GT  ++ 
Sbjct: 132 HT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF--GTPEFVA 186
Query: 762 PEYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           PE    + L  ++D++S GV+   L+SG  P
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 100/199 (50%), Gaps = 14/199 (7%)
Query: 596 KKIGKGSFGSVYYGKMKDGKEVAVKIM----ADSCSHRTQQFVTEVALLSRIHHRNLVPL 651
           +KIG+G++G VY  +   G+  A+K +     D     T   + E+++L  + H N+V L
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTT--IREISILKELKHSNIVKL 65
Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 711
                 + + +LV+E++ +  L+  L   V +  L+ +T          G+ Y H   + 
Sbjct: 66  YDVIHTKKRLVLVFEHL-DQDLKKLL--DVCEGGLESVTAKSFLLQLLNGIAYCH---DR 119
Query: 712 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYGNQQL 770
            ++HRD+K  N+L++     K++DFGL+R     +   +     T+ Y  P+   G+++ 
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-TLWYRAPDVLMGSKKY 178
Query: 771 TEKSDVYSFGVVLLELISG 789
           +   D++S G +  E+++G
Sbjct: 179 STTIDIWSVGCIFAEMVNG 197

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 104/218 (47%), Gaps = 22/218 (10%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLI- 652
           +G G++GSV      K G  VAVK ++    S  H  + +  E+ LL  + H N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 653 ----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
                   EE   + +  ++    L + +     QK  D   +  I +   +GL+Y+H+ 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLI-YQILRGLKYIHSA 144
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN- 767
               IIHRD+K SN+ ++ +   K+ D GL+R  ++++T   +    T  Y  PE   N 
Sbjct: 145 ---DIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTGYVA----TRWYRAPEIMLNW 197
Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
               +  D++S G ++ EL++G+      D   +L ++
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 103/219 (47%), Gaps = 20/219 (9%)
Query: 596 KKIGKGSFGSVY--YGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPL 651
           K IG G+ G V   Y  + + + VA+K ++    ++T  ++   E+ L+  ++H+N++ L
Sbjct: 30  KPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 652 IGYCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           +         EE Q + +   + +  L   +   ++ + + +L    +      G+++LH
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLH 143
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 766
           +    GIIHRD+K SNI++  +   K+ DFGL+R A         V   T  Y  PE   
Sbjct: 144 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVV--TRYYRAPEVIL 198
Query: 767 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
                E  D++S G ++ E++  K      D+  + N V
Sbjct: 199 GMGYKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKV 237

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 104/218 (47%), Gaps = 22/218 (10%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLI- 652
           +G G++GSV      K G  VAVK ++    S  H  + +  E+ LL  + H N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 653 ----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
                   EE   + +  ++    L + +     QK  D   +  I +   +GL+Y+H+ 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLI-YQILRGLKYIHSA 144
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN- 767
               IIHRD+K SN+ ++ +   K+ D GL+R  ++++T   +    T  Y  PE   N 
Sbjct: 145 ---DIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTGYVA----TRWYRAPEIMLNW 197
Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
               +  D++S G ++ EL++G+      D   +L ++
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 108/224 (48%), Gaps = 26/224 (11%)
Query: 598 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLV----- 649
           IG G++G V   + +  G++VA+K + ++    T  ++ + E+ +L    H N++     
Sbjct: 63  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDI 122
Query: 650 --PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
             P + Y E   + + V   +    L   +H S   +PL         +   +GL+Y+H+
Sbjct: 123 LRPTVPYGE--FKSVYVVLDLMESDLHQIIHSS---QPLTLEHVRYFLYQLLRGLKYMHS 177
Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR-----QAEEDLTHISSVARGTVGYLDP 762
                +IHRD+K SN+L++ N   K+ DFG++R      AE        VA  T  Y  P
Sbjct: 178 A---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVA--TRWYRAP 232
Query: 763 EYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
           E   +  + T+  D++S G +  E+++ ++    +++  +L ++
Sbjct: 233 ELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLI 276

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 100/202 (49%), Gaps = 20/202 (9%)
Query: 596 KKIGKGSFGSVYYGKMKDGKEVAVKIM----ADSCSHRTQQFVTEVALLSRIHHRNLVPL 651
           +KIG+G++G VY  +   G+  A+K +     D     T   + E+++L  + H N+V L
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTT--IREISILKELKHSNIVKL 65
Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 711
                 + + +LV+E++ +  L+  L   V +  L+ +T          G+ Y H   + 
Sbjct: 66  YDVIHTKKRLVLVFEHL-DQDLKKLL--DVCEGGLESVTAKSFLLQLLNGIAYCH---DR 119
Query: 712 GIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVGYLDPE-YYGN 767
            ++HRD+K  N+L++     K++DFGL+R         TH       T+ Y  P+   G+
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH----EIVTLWYRAPDVLMGS 175
Query: 768 QQLTEKSDVYSFGVVLLELISG 789
           ++ +   D++S G +  E+++G
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNG 197

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/266 (22%), Positives = 125/266 (46%), Gaps = 28/266 (10%)
Query: 556 TSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMK-DG 614
              +P++TA S+A     + +  ++ +     +E      + IG G++G V   + +  G
Sbjct: 22  VKAEPAHTAASVAAKNLALLKARSFDVTFDVGDE--YEIIETIGNGAYGVVSSARRRLTG 79
Query: 615 KEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLV-------PLIGYCEEEHQRILVY 665
           ++VA+K + ++    T  ++ + E+ +L    H N++       P + Y E   + + V 
Sbjct: 80  QQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGE--FKSVYVV 137
Query: 666 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL 725
             +    L   +H S   +PL         +   +GL+Y+H+     +IHRD+K SN+L+
Sbjct: 138 LDLMESDLHQIIHSS---QPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLV 191
Query: 726 DINMRAKVSDFGLSR-----QAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSF 779
           + N   K+ DFG++R      AE        VA  T  Y  PE   +  + T+  D++S 
Sbjct: 192 NENCELKIGDFGMARGLCTSPAEHQYFMTEYVA--TRWYRAPELMLSLHEYTQAIDLWSV 249
Query: 780 GVVLLELISGKKPVSVEDFGAELNIV 805
           G +  E+++ ++    +++  +L ++
Sbjct: 250 GCIFGEMLARRQLFPGKNYVHQLQLI 275

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 103/219 (47%), Gaps = 20/219 (9%)
Query: 596 KKIGKGSFGSVY--YGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPL 651
           K IG G+ G V   Y  + + + VA+K ++    ++T  ++   E+ L+  ++H+N++ L
Sbjct: 24  KPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 82
Query: 652 IGYCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           +         EE Q + +   + +  L   +   ++ + + +L    +      G+++LH
Sbjct: 83  LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLH 137
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 766
           +    GIIHRD+K SNI++  +   K+ DFGL+R A         V   T  Y  PE   
Sbjct: 138 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVIL 192
Query: 767 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
                E  D++S G ++ E++  K      D+  + N V
Sbjct: 193 GMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKV 231

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 19/208 (9%)
Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVT------EVALLSRIHHRNL 648
           +++G G F  V   + K  G + A K +    +  +++ V+      EV++L  I H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           + L    E +   IL+ E +  G L D L     ++ L      +       G+ YLH+ 
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS- 132
Query: 709 CNPGIIHRDVKSSNI-LLDINM---RAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
               I H D+K  NI LLD N+   R K+ DFGL+ +   D  +      GT  ++ PE 
Sbjct: 133 --LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGTPAFVAPEI 188
Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKP 792
              + L  ++D++S GV+   L+SG  P
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 94/204 (46%), Gaps = 18/204 (8%)
Query: 595 CKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVP 650
            K IG GSFG V   K M+ G   A+KI+      + +Q    + E  +L  ++   LV 
Sbjct: 46  IKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    ++     +V EYM  G +   L   G  ++ P       QI        EYLH+ 
Sbjct: 106 LEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSE-PHARFYAAQIVLT----FEYLHS- 159
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
               +I+RD+K  N+L+D     KV+DFG +++ +     +     GT  YL PE   ++
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC----GTPEYLAPEIILSK 213
Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
              +  D ++ GV++ E+ +G  P
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 98/205 (47%), Gaps = 23/205 (11%)
Query: 597 KIGKGSFGSVYYGKMKD---GKEVAVKIMADSCSHRTQQF-VTEVALLSRIHHRNLVPLI 652
           ++G+GSFG V+  +MKD   G + AVK +      R + F V E+   + +    +VPL 
Sbjct: 65  RVGRGSFGEVH--RMKDKQTGFQCAVKKV------RLEVFRVEELVACAGLSSPRIVPLY 116
Query: 653 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 712
           G   E     +  E +  G+L  +L   +   P D    L     A +GLEYLHT     
Sbjct: 117 GAVREGPWVNIFMELLEGGSL-GQLIKQMGCLPED--RALYYLGQALEGLEYLHT---RR 170
Query: 713 IIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDPEYYGN 767
           I+H DVK+ N+LL  +  RA + DFG +   + D    S +      GT  ++ PE    
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230
Query: 768 QQLTEKSDVYSFGVVLLELISGKKP 792
           +    K D++S   ++L +++G  P
Sbjct: 231 KPCDAKVDIWSSCCMMLHMLNGCHP 255

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 103/219 (47%), Gaps = 20/219 (9%)
Query: 596 KKIGKGSFGSV--YYGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPL 651
           K IG G+ G V   Y  + + + VA+K ++    ++T  ++   E+ L+  ++H+N++ L
Sbjct: 35  KPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 93
Query: 652 IGYCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           +         EE Q + +   + +  L   +   ++ + + +L    +      G+++LH
Sbjct: 94  LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLH 148
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 766
           +    GIIHRD+K SNI++  +   K+ DFGL+R A         V   T  Y  PE   
Sbjct: 149 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVIL 203
Query: 767 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
                E  D++S G ++ E++  K      D+  + N V
Sbjct: 204 GMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKV 242

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 94/204 (46%), Gaps = 18/204 (8%)
Query: 595 CKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVP 650
            K IG GSFG V   K M+ G   A+KI+      + +Q    + E  +L  ++   LV 
Sbjct: 46  IKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    ++     +V EYM  G +   L   G  ++ P       QI        EYLH+ 
Sbjct: 106 LEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSE-PHARFYAAQIVLT----FEYLHS- 159
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
               +I+RD+K  N+L+D     KV+DFG +++ +     +     GT  YL PE   ++
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC----GTPEYLAPEIILSK 213
Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
              +  D ++ GV++ E+ +G  P
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 14/204 (6%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRTQQFVT---EVALLSRIHHRNLVPLIG 653
           +G+GSFG V      K  ++VA+K ++     ++   +    E++ L  + H +++ L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 654 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 713
                   ++V EY   G L D +   V +K +      +        +EY H      I
Sbjct: 77  VITTPTDIVMVIEYA-GGELFDYI---VEKKRMTEDEGRRFFQQIICAIEYCHRH---KI 129
Query: 714 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY-GNQQLTE 772
           +HRD+K  N+LLD N+  K++DFGLS    +   +    + G+  Y  PE   G      
Sbjct: 130 VHRDLKPENLLLDDNLNVKIADFGLSNIMTD--GNFLKTSCGSPNYAAPEVINGKLYAGP 187
Query: 773 KSDVYSFGVVLLELISGKKPVSVE 796
           + DV+S G+VL  ++ G+ P   E
Sbjct: 188 EVDVWSCGIVLYVMLVGRLPFDDE 211

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/193 (31%), Positives = 95/193 (49%), Gaps = 21/193 (10%)
Query: 615 KEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMHNGTL 673
           +E AVKI+     H   +   EV +L +   HRN++ LI + EEE +  LV+E M  G++
Sbjct: 39  QEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI 98
Query: 674 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR--- 730
              +H    ++  + L    +  D A  L++LH   N GI HRD+K  NIL +   +   
Sbjct: 99  LSHIH---KRRHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSP 152
Query: 731 AKVSDFGLSR--QAEEDLTHISS----VARGTVGYLDPE----YYGNQQLTEK-SDVYSF 779
            K+ DF L    +   D + IS+       G+  Y+ PE    +     + +K  D++S 
Sbjct: 153 VKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSL 212
Query: 780 GVVLLELISGKKP 792
           GV+L  L+SG  P
Sbjct: 213 GVILYILLSGYPP 225

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 23/210 (10%)
Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVT------EVALLSRIHHRNL 648
           +++G G F  V   + K  GKE A K +       +++ V+      EV +L  I H N+
Sbjct: 32  EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNI 91
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           + L    E +   +L+ E +  G L D L     ++ L      Q       G+ YLH+ 
Sbjct: 92  ITLHDIFENKTDVVLILELVSGGELFDFL---AEKESLTEDEATQFLKQILDGVHYLHS- 147
Query: 709 CNPGIIHRDVKSSNI-LLDINM---RAKVSDFGLSRQAE--EDLTHISSVARGTVGYLDP 762
               I H D+K  NI LLD N+   R K+ DFG++ + E   +  +I     GT  ++ P
Sbjct: 148 --KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF----GTPEFVAP 201
Query: 763 EYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           E    + L  ++D++S GV+   L+SG  P
Sbjct: 202 EIVNYEPLGLEADMWSIGVITYILLSGASP 231

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 14/209 (6%)
Query: 593 NFCKKIGKGSFGSVYYG-KMKDGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNL 648
              K +G+GSFG V        G++VA+KI+       S    +   E++ L  + H ++
Sbjct: 11  QIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHI 70
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           + L    + + + I+V EY  N  L D +   V +  +      +        +EY H  
Sbjct: 71  IKLYDVIKSKDEIIMVIEYAGN-ELFDYI---VQRDKMSEQEARRFFQQIISAVEYCH-- 124
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY-GN 767
               I+HRD+K  N+LLD ++  K++DFGLS    +   +    + G+  Y  PE   G 
Sbjct: 125 -RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD--GNFLKTSCGSPNYAAPEVISGK 181
Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVSVE 796
                + DV+S GV+L  ++  + P   E
Sbjct: 182 LYAGPEVDVWSCGVILYVMLCRRLPFDDE 210

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVT------EVALLSRIHHRNL 648
           +++G G F  V   + K  G E A K +    S  +++ V       EV++L ++ H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           + L    E     +L+ E +  G L D L     ++ L              G+ YLHT 
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHT- 133
Query: 709 CNPGIIHRDVKSSNI-LLDINM---RAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
               I H D+K  NI LLD N+     K+ DFGL+ + E+ +   +    GT  ++ PE 
Sbjct: 134 --KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF--GTPEFVAPEI 189
Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKP 792
              + L  ++D++S GV+   L+SG  P
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 99/210 (47%), Gaps = 24/210 (11%)
Query: 597 KIGKGSFGSVYYGKM---KDGKEVAVKIMADSCSHRTQ-QFVTEVALLSRIHH-RNLVPL 651
           +IG+G++GSV   KM     G+ +AVK +  +   + Q Q + ++ ++ R      +V  
Sbjct: 29  EIGRGAYGSV--NKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQF 86
Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLHGSV-----NQKPLDWLTRLQIAHDAAKGLEYLH 706
            G    E    +  E M   T  D+ +  V     +  P + L ++ +A    K L +L 
Sbjct: 87  YGALFREGDCWICMELM--STSFDKFYKYVYSVLDDVIPEEILGKITLA--TVKALNHLK 142
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY- 765
              N  IIHRD+K SNILLD +   K+ DFG+S Q  + +        G   Y+ PE   
Sbjct: 143 E--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA--GCRPYMAPERID 198
Query: 766 ---GNQQLTEKSDVYSFGVVLLELISGKKP 792
                Q    +SDV+S G+ L EL +G+ P
Sbjct: 199 PSASRQGYDVRSDVWSLGITLYELATGRFP 228

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 14/209 (6%)
Query: 593 NFCKKIGKGSFGSVYYG-KMKDGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNL 648
              K +G+GSFG V        G++VA+KI+       S    +   E++ L  + H ++
Sbjct: 7   QIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHI 66
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           + L    + + + I+V EY  N  L D +   V +  +      +        +EY H  
Sbjct: 67  IKLYDVIKSKDEIIMVIEYAGN-ELFDYI---VQRDKMSEQEARRFFQQIISAVEYCHRH 122
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY-GN 767
               I+HRD+K  N+LLD ++  K++DFGLS    +   +    + G+  Y  PE   G 
Sbjct: 123 ---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD--GNFLKTSCGSPNYAAPEVISGK 177
Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVSVE 796
                + DV+S GV+L  ++  + P   E
Sbjct: 178 LYAGPEVDVWSCGVILYVMLCRRLPFDDE 206

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 98/205 (47%), Gaps = 23/205 (11%)
Query: 597 KIGKGSFGSVYYGKMKD---GKEVAVKIMADSCSHRTQQF-VTEVALLSRIHHRNLVPLI 652
           ++G+GSFG V+  +MKD   G + AVK +      R + F V E+   + +    +VPL 
Sbjct: 81  RVGRGSFGEVH--RMKDKQTGFQCAVKKV------RLEVFRVEELVACAGLSSPRIVPLY 132
Query: 653 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 712
           G   E     +  E +  G+L  +L   +   P D    L     A +GLEYLHT     
Sbjct: 133 GAVREGPWVNIFMELLEGGSL-GQLIKQMGCLPED--RALYYLGQALEGLEYLHT---RR 186
Query: 713 IIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDPEYYGN 767
           I+H DVK+ N+LL  +  RA + DFG +   + D    S +      GT  ++ PE    
Sbjct: 187 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 246
Query: 768 QQLTEKSDVYSFGVVLLELISGKKP 792
           +    K D++S   ++L +++G  P
Sbjct: 247 KPCDAKVDIWSSCCMMLHMLNGCHP 271

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 103/219 (47%), Gaps = 20/219 (9%)
Query: 596 KKIGKGSFGSVY--YGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPL 651
           K IG G+ G V   Y  + + + VA+K ++    ++T  ++   E+ L+  ++H+N++ L
Sbjct: 30  KPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 652 IGYCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           +         EE Q + +   + +  L   +   ++ + + +L    +      G+++LH
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLH 143
Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 766
           +    GIIHRD+K SNI++  +   K+ DFGL+R A         V   T  Y  PE   
Sbjct: 144 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVV--TRYYRAPEVIL 198
Query: 767 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
                E  D++S G ++ E++  K      D+  + N V
Sbjct: 199 GMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKV 237

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 23/206 (11%)
Query: 598 IGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVT----EVALLSRIHHRN--LVP 650
           IG+G FG VY  +  D GK  A+K + D    + +Q  T    E  +LS +   +   + 
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCL-DKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255
Query: 651 LIGYCEEEHQRI-LVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
            + Y      ++  + + M+ G L   L  HG  ++  + +      A +   GLE++H 
Sbjct: 256 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-----YAAEIILGLEHMH- 309
Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 767
             N  +++RD+K +NILLD +   ++SD GL+    +   H S    GT GY+ PE    
Sbjct: 310 --NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQK 364
Query: 768 QQLTEKS-DVYSFGVVLLELISGKKP 792
               + S D +S G +L +L+ G  P
Sbjct: 365 GVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 23/206 (11%)
Query: 598 IGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVT----EVALLSRIHHRN--LVP 650
           IG+G FG VY  +  D GK  A+K + D    + +Q  T    E  +LS +   +   + 
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCL-DKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255
Query: 651 LIGYCEEEHQRI-LVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
            + Y      ++  + + M+ G L   L  HG  ++  + +      A +   GLE++H 
Sbjct: 256 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-----YAAEIILGLEHMH- 309
Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 767
             N  +++RD+K +NILLD +   ++SD GL+    +   H S    GT GY+ PE    
Sbjct: 310 --NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQK 364
Query: 768 QQLTEKS-DVYSFGVVLLELISGKKP 792
               + S D +S G +L +L+ G  P
Sbjct: 365 GVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 14/209 (6%)
Query: 593 NFCKKIGKGSFGSVYYG-KMKDGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNL 648
              K +G+GSFG V        G++VA+KI+       S    +   E++ L  + H ++
Sbjct: 17  QIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHI 76
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           + L    + + + I+V EY  N  L D +   V +  +      +        +EY H  
Sbjct: 77  IKLYDVIKSKDEIIMVIEYAGN-ELFDYI---VQRDKMSEQEARRFFQQIISAVEYCH-- 130
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY-GN 767
               I+HRD+K  N+LLD ++  K++DFGLS    +   +    + G+  Y  PE   G 
Sbjct: 131 -RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD--GNFLKTSCGSPNYAAPEVISGK 187
Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVSVE 796
                + DV+S GV+L  ++  + P   E
Sbjct: 188 LYAGPEVDVWSCGVILYVMLCRRLPFDDE 216

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 98/205 (47%), Gaps = 23/205 (11%)
Query: 597 KIGKGSFGSVYYGKMKD---GKEVAVKIMADSCSHRTQQF-VTEVALLSRIHHRNLVPLI 652
           ++G+GSFG V+  +MKD   G + AVK +      R + F V E+   + +    +VPL 
Sbjct: 79  RLGRGSFGEVH--RMKDKQTGFQCAVKKV------RLEVFRVEELVACAGLSSPRIVPLY 130
Query: 653 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 712
           G   E     +  E +  G+L  +L   +   P D    L     A +GLEYLHT     
Sbjct: 131 GAVREGPWVNIFMELLEGGSL-GQLIKQMGCLPED--RALYYLGQALEGLEYLHT---RR 184
Query: 713 IIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDPEYYGN 767
           I+H DVK+ N+LL  +  RA + DFG +   + D    S +      GT  ++ PE    
Sbjct: 185 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 244
Query: 768 QQLTEKSDVYSFGVVLLELISGKKP 792
           +    K D++S   ++L +++G  P
Sbjct: 245 KPCDAKVDIWSSCCMMLHMLNGCHP 269

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 23/206 (11%)
Query: 598 IGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVT----EVALLSRIHHRN--LVP 650
           IG+G FG VY  +  D GK  A+K + D    + +Q  T    E  +LS +   +   + 
Sbjct: 196 IGRGGFGEVYGCRKADTGKMYAMKCL-DKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 254
Query: 651 LIGYCEEEHQRI-LVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
            + Y      ++  + + M+ G L   L  HG  ++  + +      A +   GLE++H 
Sbjct: 255 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-----YAAEIILGLEHMH- 308
Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 767
             N  +++RD+K +NILLD +   ++SD GL+    +   H S    GT GY+ PE    
Sbjct: 309 --NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQK 363
Query: 768 QQLTEKS-DVYSFGVVLLELISGKKP 792
               + S D +S G +L +L+ G  P
Sbjct: 364 GVAYDSSADWFSLGCMLFKLLRGHSP 389

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 14/209 (6%)
Query: 593 NFCKKIGKGSFGSVYYG-KMKDGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNL 648
              K +G+GSFG V        G++VA+KI+       S    +   E++ L  + H ++
Sbjct: 16  QIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHI 75
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           + L    + + + I+V EY  N  L D +   V +  +      +        +EY H  
Sbjct: 76  IKLYDVIKSKDEIIMVIEYAGN-ELFDYI---VQRDKMSEQEARRFFQQIISAVEYCH-- 129
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY-GN 767
               I+HRD+K  N+LLD ++  K++DFGLS    +   +    + G+  Y  PE   G 
Sbjct: 130 -RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD--GNFLKTSCGSPNYAAPEVISGK 186
Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVSVE 796
                + DV+S GV+L  ++  + P   E
Sbjct: 187 LYAGPEVDVWSCGVILYVMLCRRLPFDDE 215

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 23/206 (11%)
Query: 598 IGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVT----EVALLSRIHHRN--LVP 650
           IG+G FG VY  +  D GK  A+K + D    + +Q  T    E  +LS +   +   + 
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCL-DKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255
Query: 651 LIGYCEEEHQRI-LVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
            + Y      ++  + + M+ G L   L  HG  ++  + +      A +   GLE++H 
Sbjct: 256 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-----YAAEIILGLEHMH- 309
Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 767
             N  +++RD+K +NILLD +   ++SD GL+    +   H S    GT GY+ PE    
Sbjct: 310 --NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQK 364
Query: 768 QQLTEKS-DVYSFGVVLLELISGKKP 792
               + S D +S G +L +L+ G  P
Sbjct: 365 GVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 101/231 (43%), Gaps = 23/231 (9%)
Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQ---FVTEVALLSRIHHRNLVPL 651
           K IG+G+F  V   KMK  G+  A+KIM      +  +   F  E  +L     R +  L
Sbjct: 67  KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL 126
Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 711
               ++E+   LV EY   G L   L     + P + + R  +A +    ++ +H     
Sbjct: 127 HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAE-MARFYLA-EIVMAIDSVH---RL 181
Query: 712 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY------ 765
           G +HRD+K  NILLD     +++DFG   +   D T  S VA GT  YL PE        
Sbjct: 182 GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGG 241
Query: 766 -GNQQLTEKSDVYSFGVVLLELISGKKPV----SVEDFGAELNIVHWARSM 811
            G      + D ++ GV   E+  G+ P     + E +G    IVH+   +
Sbjct: 242 PGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYG---KIVHYKEHL 289

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 103/226 (45%), Gaps = 15/226 (6%)
Query: 580 YFIPLPELEEATNNF--CKKIGKGSFGSVYYG-KMKDGKEVAVKIM-ADSCSHRTQQFVT 635
           YF  +      T+++   +++GKG+F  V    K    +E A KI+     S R  Q + 
Sbjct: 19  YFQXMATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLE 78
Query: 636 EVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI 694
             A + R+  H N+V L     EE    LV++ +  G L + +         ++ +    
Sbjct: 79  REARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAR------EYYSEADA 132
Query: 695 AHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRA---KVSDFGLSRQAEEDLTHISS 751
           +H   + LE ++      I+HRD+K  N+LL    +    K++DFGL+ + + +      
Sbjct: 133 SHCIHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFG 192
Query: 752 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 797
            A GT GYL PE        +  D+++ GV+L  L+ G  P   ED
Sbjct: 193 FA-GTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPPFWDED 237

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 93/199 (46%), Gaps = 18/199 (9%)
Query: 598 IGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQ-------FVTEVALLSRIHHRNLVP 650
           +G+G F +VY  + K+  ++ V I      HR++         + E+ LL  + H N++ 
Sbjct: 18  LGEGQFATVYKARDKNTNQI-VAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 76
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 710
           L+     +    LV+++M           S+   P      + +     +GLEYLH    
Sbjct: 77  LLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMT---LQGLEYLHQHW- 132
Query: 711 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYLDPE-YYGNQ 768
             I+HRD+K +N+LLD N   K++DFGL++     +  +   V   T  Y  PE  +G +
Sbjct: 133 --ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV--TRWYRAPELLFGAR 188
Query: 769 QLTEKSDVYSFGVVLLELI 787
                 D+++ G +L EL+
Sbjct: 189 MYGVGVDMWAVGCILAELL 207

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 19/208 (9%)
Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVT------EVALLSRIHHRNL 648
           +++G G F  V   + K  G + A K +    +  +++ V+      EV++L  I H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           + L    E +   IL+ E +  G L D L     ++ L      +       G+ YLH+ 
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS- 132
Query: 709 CNPGIIHRDVKSSNI-LLDINM---RAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
               I H D+K  NI LLD N+   R K+ DFGL+ +   D  +      GT  ++ PE 
Sbjct: 133 --LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGTPEFVAPEI 188
Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKP 792
              + L  ++D++S GV+   L+SG  P
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 19/208 (9%)
Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVT------EVALLSRIHHRNL 648
           +++G G F  V   + K  G + A K +    +  +++ V+      EV++L  I H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           + L    E +   IL+ E +  G L D L     ++ L      +       G+ YLH+ 
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS- 132
Query: 709 CNPGIIHRDVKSSNI-LLDINM---RAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
               I H D+K  NI LLD N+   R K+ DFGL+ +   D  +      GT  ++ PE 
Sbjct: 133 --LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGTPEFVAPEI 188
Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKP 792
              + L  ++D++S GV+   L+SG  P
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 98/208 (47%), Gaps = 14/208 (6%)
Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMA--DSCSHRTQQFVTEVALLSRIHHRNLVP 650
           NF  K+ +   G ++ G+ + G ++ VK++   D  + +++ F  E   L    H N++P
Sbjct: 13  NFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP 71
Query: 651 LIGYCEEE--HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           ++G C+        L+  +   G+L + LH   N   +D    ++ A D A+G  +LHT 
Sbjct: 72  VLGACQSPPAPHPTLITHWXPYGSLYNVLHEGTNFV-VDQSQAVKFALDXARGXAFLHT- 129
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVS--DFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 766
             P I    + S ++ +D +  A++S  D   S Q+       + VA   +    PE   
Sbjct: 130 LEPLIPRHALNSRSVXIDEDXTARISXADVKFSFQSPGRXYAPAWVAPEALQK-KPEDTN 188
Query: 767 NQQLTEKSDVYSFGVVLLELISGKKPVS 794
            +     +D +SF V+L EL++ + P +
Sbjct: 189 RRS----ADXWSFAVLLWELVTREVPFA 212

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 19/208 (9%)
Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVT------EVALLSRIHHRNL 648
           +++G G F  V   + K  G + A K +    +  +++ V+      EV++L  I H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           + L    E +   IL+ E +  G L D L     ++ L      +       G+ YLH+ 
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS- 132
Query: 709 CNPGIIHRDVKSSNI-LLDINM---RAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
               I H D+K  NI LLD N+   R K+ DFGL+ +   D  +      GT  ++ PE 
Sbjct: 133 --LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGTPEFVAPEI 188
Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKP 792
              + L  ++D++S GV+   L+SG  P
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 19/208 (9%)
Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVT------EVALLSRIHHRNL 648
           +++G G F  V   + K  G + A K +    +  +++ V+      EV++L  I H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           + L    E +   IL+ E +  G L D L     ++ L      +       G+ YLH+ 
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS- 132
Query: 709 CNPGIIHRDVKSSNI-LLDINM---RAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
               I H D+K  NI LLD N+   R K+ DFGL+ +   D  +      GT  ++ PE 
Sbjct: 133 --LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGTPEFVAPEI 188
Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKP 792
              + L  ++D++S GV+   L+SG  P
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 19/208 (9%)
Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVT------EVALLSRIHHRNL 648
           +++G G F  V   + K  G + A K +    +  +++ V+      EV++L  I H N+
Sbjct: 16  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 75
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           + L    E +   IL+ E +  G L D L     ++ L      +       G+ YLH+ 
Sbjct: 76  ITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS- 131
Query: 709 CNPGIIHRDVKSSNI-LLDINM---RAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
               I H D+K  NI LLD N+   R K+ DFGL+ +   D  +      GT  ++ PE 
Sbjct: 132 --LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGTPEFVAPEI 187
Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKP 792
              + L  ++D++S GV+   L+SG  P
Sbjct: 188 VNYEPLGLEADMWSIGVITYILLSGASP 215

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 19/208 (9%)
Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVT------EVALLSRIHHRNL 648
           +++G G F  V   + K  G + A K +    +  +++ V+      EV++L  I H N+
Sbjct: 16  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 75
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           + L    E +   IL+ E +  G L D L     ++ L      +       G+ YLH+ 
Sbjct: 76  ITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS- 131
Query: 709 CNPGIIHRDVKSSNI-LLDINM---RAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
               I H D+K  NI LLD N+   R K+ DFGL+ +   D  +      GT  ++ PE 
Sbjct: 132 --LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGTPEFVAPEI 187
Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKP 792
              + L  ++D++S GV+   L+SG  P
Sbjct: 188 VNYEPLGLEADMWSIGVITYILLSGASP 215

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 19/208 (9%)
Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVT------EVALLSRIHHRNL 648
           +++G G F  V   + K  G + A K +    +  +++ V+      EV++L  I H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           + L    E +   IL+ E +  G L D L     ++ L      +       G+ YLH+ 
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS- 132
Query: 709 CNPGIIHRDVKSSNI-LLDINM---RAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
               I H D+K  NI LLD N+   R K+ DFGL+ +   D  +      GT  ++ PE 
Sbjct: 133 --LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGTPEFVAPEI 188
Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKP 792
              + L  ++D++S GV+   L+SG  P
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 19/208 (9%)
Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVT------EVALLSRIHHRNL 648
           +++G G F  V   + K  G + A K +    +  +++ V+      EV++L  I H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           + L    E +   IL+ E +  G L D L     ++ L      +       G+ YLH+ 
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS- 132
Query: 709 CNPGIIHRDVKSSNI-LLDINM---RAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
               I H D+K  NI LLD N+   R K+ DFGL+ +   D  +      GT  ++ PE 
Sbjct: 133 --LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGTPEFVAPEI 188
Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKP 792
              + L  ++D++S GV+   L+SG  P
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 82/331 (24%), Positives = 135/331 (40%), Gaps = 66/331 (19%)
Query: 584 LPELEEATNNFC---KKIGKGSFGSVYYGKMKDGKEVAVK-IMADSCSHRTQQFVTEVAL 639
           +P  E++  N     K +G GS G+V +     G+ VAVK ++ D C       + E+ L
Sbjct: 24  IPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIA----LMEIKL 79
Query: 640 LSRIH-HRNLVPLIGYCEEEHQRIL-VYEYMHNGTLRDRLHGS----VNQKPLDWLTRLQ 693
           L+    H N++    YC E   R L +   + N  L+D +        N K       + 
Sbjct: 80  LTESDDHPNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPIS 137
Query: 694 IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-------------NMRAKVSDFGLSR 740
           +    A G+ +LH+     IIHRD+K  NIL+               N+R  +SDFGL +
Sbjct: 138 LLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK 194
Query: 741 QAEEDLTHIS---SVARGTVGYLDPEYY---GNQQLTEKSDVYSFGVVLLELIS-GKKPV 793
           + +          +   GT G+  PE       ++LT   D++S G V   ++S GK P 
Sbjct: 195 KLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPF 254
Query: 794 SVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP 853
             + +  E NI+   R +    ++  + D  LI            ++  Q ++     RP
Sbjct: 255 G-DKYSRESNII---RGIFSLDEMKCLHDRSLIAEA--------TDLISQMIDHDPLKRP 302
Query: 854 ---------------KMQEIVLAIQDSIKIE 869
                          K  E +L + D ++IE
Sbjct: 303 TAMKVLRHPLFWPKSKKLEFLLKVSDRLEIE 333

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 19/208 (9%)
Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVT------EVALLSRIHHRNL 648
           +++G G F  V   + K  G + A K +    +  +++ V+      EV++L  I H N+
Sbjct: 17  EELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           + L    E +   IL+ E +  G L D L     ++ L      +       G+ YLH+ 
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS- 132
Query: 709 CNPGIIHRDVKSSNI-LLDINM---RAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
               I H D+K  NI LLD N+   R K+ DFGL+ +   D  +      GT  ++ PE 
Sbjct: 133 --LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGTPEFVAPEI 188
Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKP 792
              + L  ++D++S GV+   L+SG  P
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 82/335 (24%), Positives = 136/335 (40%), Gaps = 70/335 (20%)
Query: 584 LPELEEATNNFC---KKIGKGSFGSVYYGKMKDGKEVAVK-IMADSCSHRTQQFVTEVAL 639
           +P  E++  N     K +G GS G+V +     G+ VAVK ++ D C       + E+ L
Sbjct: 6   IPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIA----LMEIKL 61
Query: 640 LSRIH-HRNLVPLIGYCEEEHQRIL-VYEYMHNGTLRDRLHG----SVNQKPLDWLTRLQ 693
           L+    H N++    YC E   R L +   + N  L+D +        N K       + 
Sbjct: 62  LTESDDHPNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPIS 119
Query: 694 IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-------------NMRAKVSDFGLSR 740
           +    A G+ +LH+     IIHRD+K  NIL+               N+R  +SDFGL +
Sbjct: 120 LLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK 176
Query: 741 QAEEDLTHISSVAR---GTVGYLDPEYY-------GNQQLTEKSDVYSFGVVLLELIS-G 789
           + +   +   +      GT G+  PE           ++LT   D++S G V   ++S G
Sbjct: 177 KLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKG 236
Query: 790 KKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRG 849
           K P   + +  E NI+   R +    ++  + D  LI            ++  Q ++   
Sbjct: 237 KHPFG-DKYSRESNII---RGIFSLDEMKCLHDRSLIAEA--------TDLISQMIDHDP 284
Query: 850 FSRP---------------KMQEIVLAIQDSIKIE 869
             RP               K  E +L + D ++IE
Sbjct: 285 LKRPTAMKVLRHPLFWPKSKKLEFLLKVSDRLEIE 319

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 19/208 (9%)
Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVT------EVALLSRIHHRNL 648
           +++G G F  V   + K  G + A K +    +  +++ V+      EV++L  I H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           + L    E +   IL+ E +  G L D L     ++ L      +       G+ YLH+ 
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS- 132
Query: 709 CNPGIIHRDVKSSNI-LLDINM---RAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
               I H D+K  NI LLD N+   R K+ DFGL+ +   D  +      GT  ++ PE 
Sbjct: 133 --LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGTPEFVAPEI 188
Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKP 792
              + L  ++D++S GV+   L+SG  P
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 82/331 (24%), Positives = 135/331 (40%), Gaps = 66/331 (19%)
Query: 584 LPELEEATNNFC---KKIGKGSFGSVYYGKMKDGKEVAVK-IMADSCSHRTQQFVTEVAL 639
           +P  E++  N     K +G GS G+V +     G+ VAVK ++ D C       + E+ L
Sbjct: 24  IPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIA----LMEIKL 79
Query: 640 LSRIH-HRNLVPLIGYCEEEHQRIL-VYEYMHNGTLRDRLHGS----VNQKPLDWLTRLQ 693
           L+    H N++    YC E   R L +   + N  L+D +        N K       + 
Sbjct: 80  LTESDDHPNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPIS 137
Query: 694 IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-------------NMRAKVSDFGLSR 740
           +    A G+ +LH+     IIHRD+K  NIL+               N+R  +SDFGL +
Sbjct: 138 LLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK 194
Query: 741 QAEEDLTHIS---SVARGTVGYLDPEYY---GNQQLTEKSDVYSFGVVLLELIS-GKKPV 793
           + +          +   GT G+  PE       ++LT   D++S G V   ++S GK P 
Sbjct: 195 KLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPF 254
Query: 794 SVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP 853
             + +  E NI+   R +    ++  + D  LI            ++  Q ++     RP
Sbjct: 255 G-DKYSRESNII---RGIFSLDEMKCLHDRSLIAEA--------TDLISQMIDHDPLKRP 302
Query: 854 ---------------KMQEIVLAIQDSIKIE 869
                          K  E +L + D ++IE
Sbjct: 303 TAMKVLRHPLFWPKSKKLEFLLKVSDRLEIE 333

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 103/228 (45%), Gaps = 34/228 (14%)
Query: 593 NFCKK--IGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLV 649
           +FC K  +G G+ G++ Y  M D ++VAVK +   C     +   EV LL     H N++
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADR---EVQLLRESDEHPNVI 81
Query: 650 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDW--LTRLQIAHDAAKGLEYLHT 707
               +C E+ ++   ++Y+        L   V QK      L  + +      GL +LH+
Sbjct: 82  RY--FCTEKDRQ---FQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS 136
Query: 708 GCNPGIIHRDVKSSNILLDI-----NMRAKVSDFGLSRQ---AEEDLTHISSVARGTVGY 759
                I+HRD+K  NIL+ +      ++A +SDFGL ++        +  S V  GT G+
Sbjct: 137 ---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP-GTEGW 192
Query: 760 LDPEYYG---NQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELN 803
           + PE       +  T   D++S G V   +IS G  P     FG  L 
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHP-----FGKSLQ 235

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 19/208 (9%)
Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVT------EVALLSRIHHRNL 648
           +++G G F  V   + K  G + A K +    +  +++ V+      EV++L  I H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           + L    E +   IL+ E +  G L D L     ++ L      +       G+ YLH+ 
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS- 132
Query: 709 CNPGIIHRDVKSSNI-LLDINM---RAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
               I H D+K  NI LLD N+   R K+ DFGL+ +   D  +      GT  ++ PE 
Sbjct: 133 --LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGTPEFVAPEI 188
Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKP 792
              + L  ++D++S GV+   L+SG  P
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 19/208 (9%)
Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVT------EVALLSRIHHRNL 648
           +++G G F  V   + K  G + A K +    +  +++ V+      EV++L  I H N+
Sbjct: 17  EELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           + L    E +   IL+ E +  G L D L     ++ L      +       G+ YLH+ 
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS- 132
Query: 709 CNPGIIHRDVKSSNI-LLDINM---RAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
               I H D+K  NI LLD N+   R K+ DFGL+ +   D  +      GT  ++ PE 
Sbjct: 133 --LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGTPEFVAPEI 188
Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKP 792
              + L  ++D++S GV+   L+SG  P
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 88/207 (42%), Gaps = 17/207 (8%)
Query: 596 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 654
           +KIG GSFG +Y G  +  G+EVA+K+      H   Q   E      +     +P I +
Sbjct: 15  RKIGSGSFGDIYLGANIASGEEVAIKLECVKTKH--PQLHIESKFYKMMQGGVGIPSIKW 72
Query: 655 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 714
           C  E    ++   +   +L D  +    +  L   T L +A      +EY+H+      I
Sbjct: 73  CGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLK--TVLLLADQMISRIEYIHS---KNFI 127
Query: 715 HRDVKSSNILLDINMRAK---VSDFGLSRQAEEDLTHISSVAR------GTVGYLDPEYY 765
           HRDVK  N L+ +  +     + DFGL+++  +  TH     R      GT  Y     +
Sbjct: 128 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 187
Query: 766 GNQQLTEKSDVYSFGVVLLELISGKKP 792
              + + + D+ S G VL+    G  P
Sbjct: 188 LGIEQSRRDDLESLGYVLMYFNLGSLP 214

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 89/207 (42%), Gaps = 17/207 (8%)
Query: 596 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 654
           +KIG GSFG +Y G  +  G+EVA+K+      H   Q   E  +   +     +P I +
Sbjct: 15  RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRW 72
Query: 655 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 714
           C  E    ++   +   +L D  +    +  L   T L +A      +EY+H+      I
Sbjct: 73  CGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLK--TVLLLADQMISRIEYIHS---KNFI 127
Query: 715 HRDVKSSNILLDINMRAK---VSDFGLSRQAEEDLTHISSVAR------GTVGYLDPEYY 765
           HRDVK  N L+ +  +     + DFGL+++  +  TH     R      GT  Y     +
Sbjct: 128 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 187
Query: 766 GNQQLTEKSDVYSFGVVLLELISGKKP 792
              + + + D+ S G VL+    G  P
Sbjct: 188 LGIEQSRRDDLESLGYVLMYFNLGSLP 214

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 19/208 (9%)
Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVT------EVALLSRIHHRNL 648
           +++G G F  V   + K  G + A K +    +  +++ V+      EV++L  I H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           + L    E +   IL+ E +  G L D L     ++ L      +       G+ YLH+ 
Sbjct: 77  ITLHEVYENKTDVILIGELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS- 132
Query: 709 CNPGIIHRDVKSSNI-LLDINM---RAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
               I H D+K  NI LLD N+   R K+ DFGL+ +   D  +      GT  ++ PE 
Sbjct: 133 --LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGTPEFVAPEI 188
Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKP 792
              + L  ++D++S GV+   L+SG  P
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 18/204 (8%)
Query: 595 CKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVP 650
            K IG GSFG V   K M+ G   A+KI+      + +Q    + E  +L  ++   LV 
Sbjct: 46  IKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    ++     +V EY+  G +   L   G  ++ P       QI        EYLH+ 
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE-PHARFYAAQIVLT----FEYLHS- 159
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
               +I+RD+K  N+L+D     KV+DFG +++ +     +     GT  YL PE   ++
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC----GTPEYLAPEIILSK 213
Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
              +  D ++ GV++ E+ +G  P
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 89/207 (42%), Gaps = 17/207 (8%)
Query: 596 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 654
           +KIG GSFG +Y G  +  G+EVA+K+      H   Q   E  +   +     +P I +
Sbjct: 13  RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRW 70
Query: 655 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 714
           C  E    ++   +   +L D  +    +  L   T L +A      +EY+H+      I
Sbjct: 71  CGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLK--TVLLLADQMISRIEYIHS---KNFI 125
Query: 715 HRDVKSSNILLDINMRAK---VSDFGLSRQAEEDLTHISSVAR------GTVGYLDPEYY 765
           HRDVK  N L+ +  +     + DFGL+++  +  TH     R      GT  Y     +
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 185
Query: 766 GNQQLTEKSDVYSFGVVLLELISGKKP 792
              + + + D+ S G VL+    G  P
Sbjct: 186 LGIEQSRRDDLESLGYVLMYFNLGSLP 212

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 96/214 (44%), Gaps = 27/214 (12%)
Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL--- 651
           K +G G  G V+     D  K VA+K +  +     +  + E+ ++ R+ H N+V +   
Sbjct: 17  KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEI 76
Query: 652 -----------IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 700
                      +G   E +   +V EYM        L   + Q PL         +   +
Sbjct: 77  LGPSGSQLTDDVGSLTELNSVYIVQEYMETD-----LANVLEQGPLLEEHARLFMYQLLR 131
Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEEDLTHISSVARGTVG- 758
           GL+Y+H+     ++HRD+K +N+ ++  ++  K+ DFGL+R  +   +H   ++ G V  
Sbjct: 132 GLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188
Query: 759 -YLDPE-YYGNQQLTEKSDVYSFGVVLLELISGK 790
            Y  P         T+  D+++ G +  E+++GK
Sbjct: 189 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 87/196 (44%), Gaps = 28/196 (14%)
Query: 615 KEVAVKIM---------ADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILV 664
           KE AVKI+         A+      +  + EV +L ++  H N++ L    E      LV
Sbjct: 30  KEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLV 89
Query: 665 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNIL 724
           ++ M  G L D L   V       L+  +        LE +       I+HRD+K  NIL
Sbjct: 90  FDLMKKGELFDYLTEKVT------LSEKETRKIMRALLEVICALHKLNIVHRDLKPENIL 143
Query: 725 LDINMRAKVSDFGLSRQAE--EDLTHISSVARGTVGYLDPEYY------GNQQLTEKSDV 776
           LD +M  K++DFG S Q +  E L  +     GT  YL PE         +    ++ D+
Sbjct: 144 LDDDMNIKLTDFGFSCQLDPGEKLREVC----GTPSYLAPEIIECSMNDNHPGYGKEVDM 199
Query: 777 YSFGVVLLELISGKKP 792
           +S GV++  L++G  P
Sbjct: 200 WSTGVIMYTLLAGSPP 215

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 82/335 (24%), Positives = 135/335 (40%), Gaps = 70/335 (20%)
Query: 584 LPELEEATNNFC---KKIGKGSFGSVYYGKMKDGKEVAVK-IMADSCSHRTQQFVTEVAL 639
           +P  E++  N     K +G GS G+V +     G+ VAVK ++ D C       + E+ L
Sbjct: 6   IPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIA----LMEIKL 61
Query: 640 LSRIH-HRNLVPLIGYCEEEHQRIL-VYEYMHNGTLRDRLHG----SVNQKPLDWLTRLQ 693
           L+    H N++    YC E   R L +   + N  L+D +        N K       + 
Sbjct: 62  LTESDDHPNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPIS 119
Query: 694 IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-------------NMRAKVSDFGLSR 740
           +    A G+ +LH+     IIHRD+K  NIL+               N+R  +SDFGL +
Sbjct: 120 LLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK 176
Query: 741 QAEEDLTHIS---SVARGTVGYLDPEYY-------GNQQLTEKSDVYSFGVVLLELIS-G 789
           + +          +   GT G+  PE           ++LT   D++S G V   ++S G
Sbjct: 177 KLDSGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKG 236
Query: 790 KKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRG 849
           K P   + +  E NI+   R +    ++  + D  LI            ++  Q ++   
Sbjct: 237 KHPFG-DKYSRESNII---RGIFSLDEMKCLHDRSLIAEA--------TDLISQMIDHDP 284
Query: 850 FSRP---------------KMQEIVLAIQDSIKIE 869
             RP               K  E +L + D ++IE
Sbjct: 285 LKRPTAMKVLRHPLFWPKSKKLEFLLKVSDRLEIE 319

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 92/206 (44%), Gaps = 19/206 (9%)
Query: 598 IGKGSFGSVYYGKMKD-GKEVAVKIMA-----DSC---SHRTQQFVTEVALLSRIHHRNL 648
           +G G+FG V+    K+  KEV VK +      + C     +  +   E+A+LSR+ H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKP-LDWLTRLQIAHDAAKGLEYLHT 707
           + ++   E +    LV E   +G     L   +++ P LD      I       + YL  
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSGL---DLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRL 148
Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYG 766
                IIHRD+K  NI++  +   K+ DFG +   E      +    GT+ Y  PE   G
Sbjct: 149 ---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC--GTIEYCAPEVLMG 203
Query: 767 NQQLTEKSDVYSFGVVLLELISGKKP 792
           N     + +++S GV L  L+  + P
Sbjct: 204 NPYRGPELEMWSLGVTLYTLVFEENP 229

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 101/204 (49%), Gaps = 25/204 (12%)
Query: 597 KIGKGSFGSVYYGKMK---DGKEVAVK-IMADSCSHRTQQFVTEVALLSR-IHHRNLVPL 651
           ++G+G++G V   KM+    G+ +AVK I A   S   ++ + ++ +  R +     V  
Sbjct: 14  ELGRGAYGVVE--KMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTF 71
Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQK----PLDWLTRLQIAHDAAKGLEYLHT 707
            G    E    +  E M   T  D+ +  V  K    P D L +  IA    K LE+LH+
Sbjct: 72  YGALFREGDVWICMELMD--TSLDKFYKQVIDKGQTIPEDILGK--IAVSIVKALEHLHS 127
Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 767
             +  +IHRDVK SN+L++   + K+ DFG+S    +D+     +  G   Y+ PE   N
Sbjct: 128 KLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA--KDIDAGCKPYMAPERI-N 182
Query: 768 QQLTE-----KSDVYSFGVVLLEL 786
            +L +     KSD++S G+ ++EL
Sbjct: 183 PELNQKGYSVKSDIWSLGITMIEL 206

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 107/230 (46%), Gaps = 33/230 (14%)
Query: 597 KIGKGSFGSVYYGK-MKDG------KEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLV 649
           +IG+G++G V+  + +K+G      K V V+   +     T + V  +  L    H N+V
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 650 PLIGYC-----EEEHQRILVYEYMHNG--TLRDRLH--GSVNQKPLDWLTRLQIAHDAAK 700
            L   C     + E +  LV+E++     T  D++   G   +   D + +L       +
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL------LR 131
Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYL 760
           GL++LH+     ++HRD+K  NIL+  + + K++DFGL+R     +   S V   T+ Y 
Sbjct: 132 GLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--TLWYR 186
Query: 761 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKPV-----SVEDFGAELNIV 805
            PE           D++S G +  E+   +KP+      V+  G  L+++
Sbjct: 187 APEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQLGKILDVI 235

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/96 (38%), Positives = 56/96 (58%), Gaps = 5/96 (5%)
Query: 699 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSVARGTV 757
           AKG+E+L    +   IHRD+ + NILL      K+ DFGL+R   +D  ++    AR  +
Sbjct: 203 AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 259
Query: 758 GYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
            ++ PE   ++  T +SDV+SFGV+L E+ S G  P
Sbjct: 260 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/96 (38%), Positives = 56/96 (58%), Gaps = 5/96 (5%)
Query: 699 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSVARGTV 757
           AKG+E+L    +   IHRD+ + NILL      K+ DFGL+R   +D  ++    AR  +
Sbjct: 201 AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 257
Query: 758 GYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
            ++ PE   ++  T +SDV+SFGV+L E+ S G  P
Sbjct: 258 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 293

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 107/231 (46%), Gaps = 52/231 (22%)
Query: 598 IGKGSFGSV--YYGKMKDGKEVAVK----IMADSCSHRTQQFVTEVALLSRIHHRNLVPL 651
           IG GS+G V   Y K+ + + VA+K    +  D      ++ + E+A+L+R++H ++V +
Sbjct: 61  IGTGSYGHVCEAYDKL-EKRVVAIKKILRVFEDLID--CKRILREIAILNRLNHDHVVKV 117
Query: 652 IGYC----EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEY 704
           +        E+   + V   + +   +      V      +LT L I    ++   G++Y
Sbjct: 118 LDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPV------YLTELHIKTLLYNLLVGVKY 171
Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA---------------EEDLT-- 747
           +H+    GI+HRD+K +N L++ +   KV DFGL+R                 E+D+   
Sbjct: 172 VHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLV 228
Query: 748 ---HISSVARGTVGYLDPEYYGNQQL-------TEKSDVYSFGVVLLELIS 788
              H  ++ R   G++   +Y   +L       TE  DV+S G +  EL++
Sbjct: 229 TFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 107/230 (46%), Gaps = 33/230 (14%)
Query: 597 KIGKGSFGSVYYGK-MKDG------KEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLV 649
           +IG+G++G V+  + +K+G      K V V+   +     T + V  +  L    H N+V
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 650 PLIGYC-----EEEHQRILVYEYMHNG--TLRDRLH--GSVNQKPLDWLTRLQIAHDAAK 700
            L   C     + E +  LV+E++     T  D++   G   +   D + +L       +
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL------LR 131
Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYL 760
           GL++LH+     ++HRD+K  NIL+  + + K++DFGL+R     +   S V   T+ Y 
Sbjct: 132 GLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--TLWYR 186
Query: 761 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKPV-----SVEDFGAELNIV 805
            PE           D++S G +  E+   +KP+      V+  G  L+++
Sbjct: 187 APEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQLGKILDVI 235

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/91 (38%), Positives = 54/91 (59%), Gaps = 4/91 (4%)
Query: 699 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSVARGTV 757
           AKG+E+L    +   IHRD+ + NILL      K+ DFGL+R   +D  ++    AR  +
Sbjct: 208 AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 264
Query: 758 GYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
            ++ PE   ++  T +SDV+SFGV+L E+ S
Sbjct: 265 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 37/96 (38%), Positives = 56/96 (58%), Gaps = 5/96 (5%)
Query: 699 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSVARGTV 757
           AKG+E+L    +   IHRD+ + NILL      K+ DFGL+R   +D  ++    AR  +
Sbjct: 210 AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 266
Query: 758 GYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
            ++ PE   ++  T +SDV+SFGV+L E+ S G  P
Sbjct: 267 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 302

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 107/230 (46%), Gaps = 33/230 (14%)
Query: 597 KIGKGSFGSVYYGK-MKDG------KEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLV 649
           +IG+G++G V+  + +K+G      K V V+   +     T + V  +  L    H N+V
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 650 PLIGYC-----EEEHQRILVYEYMHNG--TLRDRLH--GSVNQKPLDWLTRLQIAHDAAK 700
            L   C     + E +  LV+E++     T  D++   G   +   D + +L       +
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL------LR 131
Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYL 760
           GL++LH+     ++HRD+K  NIL+  + + K++DFGL+R     +   S V   T+ Y 
Sbjct: 132 GLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--TLWYR 186
Query: 761 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKPV-----SVEDFGAELNIV 805
            PE           D++S G +  E+   +KP+      V+  G  L+++
Sbjct: 187 APEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQLGKILDVI 235

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 18/204 (8%)
Query: 595 CKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVP 650
            K +G GSFG V   K K+ G   A+KI+      + +Q    + E  +L  ++   LV 
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    ++     +V EY+  G +   L   G  ++ P       QI        EYLH+ 
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE-PHARFYAAQIVLT----FEYLHS- 159
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
               +I+RD+K  N+L+D     +V+DFG +++ +     ++    GT  YL PE   ++
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLA----GTPEYLAPEIILSK 213
Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
              +  D ++ GV++ E+ +G  P
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 87/196 (44%), Gaps = 28/196 (14%)
Query: 615 KEVAVKIM---------ADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILV 664
           KE AVKI+         A+      +  + EV +L ++  H N++ L    E      LV
Sbjct: 43  KEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLV 102
Query: 665 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNIL 724
           ++ M  G L D L   V       L+  +        LE +       I+HRD+K  NIL
Sbjct: 103 FDLMKKGELFDYLTEKVT------LSEKETRKIMRALLEVICALHKLNIVHRDLKPENIL 156
Query: 725 LDINMRAKVSDFGLSRQAE--EDLTHISSVARGTVGYLDPEYY------GNQQLTEKSDV 776
           LD +M  K++DFG S Q +  E L  +     GT  YL PE         +    ++ D+
Sbjct: 157 LDDDMNIKLTDFGFSCQLDPGEKLREVC----GTPSYLAPEIIECSMNDNHPGYGKEVDM 212
Query: 777 YSFGVVLLELISGKKP 792
           +S GV++  L++G  P
Sbjct: 213 WSTGVIMYTLLAGSPP 228

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 94/199 (47%), Gaps = 14/199 (7%)
Query: 597 KIGKGSFGSVYYGKMK--DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 654
           K+G+G++ +VY GK K  D      +I  +         + EV+LL  + H N+V L   
Sbjct: 9   KLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 655 CEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 712
              E    LV+EY+ +  L+  L   G++       L   Q+     +GL Y H      
Sbjct: 69  IHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQLL----RGLAYCH---RQK 120
Query: 713 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYGNQQLT 771
           ++HRD+K  N+L++     K++DFGL+R A+   T        T+ Y  P+   G+   +
Sbjct: 121 VLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYDNEVVTLWYRPPDILLGSTDYS 179
Query: 772 EKSDVYSFGVVLLELISGK 790
            + D++  G +  E+ +G+
Sbjct: 180 TQIDMWGVGCIFYEMATGR 198

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 87/194 (44%), Gaps = 24/194 (12%)
Query: 615 KEVAVKIM---------ADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILV 664
           KE AVKI+         A+      +  + EV +L ++  H N++ L    E      LV
Sbjct: 43  KEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLV 102
Query: 665 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNIL 724
           ++ M  G L D L   V       L+  +        LE +       I+HRD+K  NIL
Sbjct: 103 FDLMKKGELFDYLTEKVT------LSEKETRKIMRALLEVICALHKLNIVHRDLKPENIL 156
Query: 725 LDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY------GNQQLTEKSDVYS 778
           LD +M  K++DFG S Q +     + SV  GT  YL PE         +    ++ D++S
Sbjct: 157 LDDDMNIKLTDFGFSCQLDPG-EKLRSVC-GTPSYLAPEIIECSMNDNHPGYGKEVDMWS 214
Query: 779 FGVVLLELISGKKP 792
            GV++  L++G  P
Sbjct: 215 TGVIMYTLLAGSPP 228

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 75/165 (45%), Gaps = 16/165 (9%)
Query: 636 EVALLSRIHHRNLVPLIG--YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ 693
           E+ LL R+ H+N++ L+   Y EE+ +  +V EY   G     +  SV +K         
Sbjct: 56  EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGM--QEMLDSVPEKRFPVCQAHG 113
Query: 694 IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ----AEEDLTHI 749
                  GLEYLH+    GI+H+D+K  N+LL      K+S  G++      A +D    
Sbjct: 114 YFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT 170
Query: 750 SSVARGTVGYLDPEYYGNQQLTE--KSDVYSFGVVLLELISGKKP 792
           S   +G+  +  PE           K D++S GV L  + +G  P
Sbjct: 171 S---QGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 25/204 (12%)
Query: 597 KIGKGSFGSVYYGKMK---DGKEVAVK-IMADSCSHRTQQFVTEVALLSR-IHHRNLVPL 651
           ++G+G++G V   KM+    G+ +AVK I A   S   ++ + ++ +  R +     V  
Sbjct: 58  ELGRGAYGVVE--KMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTF 115
Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQK----PLDWLTRLQIAHDAAKGLEYLHT 707
            G    E    +  E M   T  D+ +  V  K    P D L +  IA    K LE+LH+
Sbjct: 116 YGALFREGDVWICMELMD--TSLDKFYKQVIDKGQTIPEDILGK--IAVSIVKALEHLHS 171
Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 767
             +  +IHRDVK SN+L++   + K+ DFG+S    + +    ++  G   Y+ PE   N
Sbjct: 172 KLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVA--KTIDAGCKPYMAPERI-N 226
Query: 768 QQLTE-----KSDVYSFGVVLLEL 786
            +L +     KSD++S G+ ++EL
Sbjct: 227 PELNQKGYSVKSDIWSLGITMIEL 250

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 18/204 (8%)
Query: 595 CKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVP 650
            K +G GSFG V   K K+ G   A+KI+      + +Q    + E  +L  ++   LV 
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    ++     +V EY+  G +   L   G  ++ P       QI        EYLH+ 
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE-PHARFYAAQIVLT----FEYLHS- 159
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
               +I+RD+K  N+L+D     +V+DFG +++ +     +     GT  YL PE   ++
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSK 213
Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
              +  D ++ GV++ E+ +G  P
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 91/207 (43%), Gaps = 17/207 (8%)
Query: 596 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 654
           +KIG GSFG +Y G  ++  +EVA+K+      H   Q + E  +   +     +P + +
Sbjct: 13  RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRW 70
Query: 655 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 714
              E    ++   +   +L D  +     + L   T L +A      +E++H+      +
Sbjct: 71  FGVEGDYNVLVMDLLGPSLEDLFN--FCSRKLSLKTVLMLADQMINRVEFVHSKS---FL 125
Query: 715 HRDVKSSNILLDINMRAK---VSDFGLSRQAEEDLTHISSVAR------GTVGYLDPEYY 765
           HRD+K  N L+ +  RA    + DFGL+++  +  TH     R      GT  Y     +
Sbjct: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTH 185
Query: 766 GNQQLTEKSDVYSFGVVLLELISGKKP 792
              + + + D+ S G VL+  + G  P
Sbjct: 186 LGIEQSRRDDLESLGYVLMYFLRGSLP 212

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 96/209 (45%), Gaps = 18/209 (8%)
Query: 595 CKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVP 650
            K +G GSFG V   K K+ G   A+KI+      + +Q    + E  +L  ++   LV 
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    ++     +V EY+  G +   L   G  ++ P       QI        EYLH+ 
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE-PHARFYAAQIVLT----FEYLHS- 159
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
               +I+RD+K  N+L+D     +V+DFG +++ +     +     GT  YL PE   ++
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSK 213
Query: 769 QLTEKSDVYSFGVVLLELISGKKPVSVED 797
              +  D ++ GV++ E+ +G  P   ++
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFADE 242

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 18/204 (8%)
Query: 595 CKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVP 650
            K +G GSFG V   K K+ G   A+KI+      + +Q    + E  +L  ++   LV 
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    ++     +V EY+  G +   L   G  ++ P       QI        EYLH+ 
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE-PHARFYAAQIVLT----FEYLHS- 159
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
               +I+RD+K  N+L+D     +V+DFG +++ +     +     GT  YL PE   ++
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLX----GTPEYLAPEIILSK 213
Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
              +  D ++ GV++ E+ +G  P
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 18/204 (8%)
Query: 595 CKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVP 650
            K +G GSFG V   K K+ G   A+KI+      + +Q    + E  +L  ++   LV 
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    ++     +V EY+  G +   L   G  ++ P       QI        EYLH+ 
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE-PHARFYAAQIVLT----FEYLHS- 159
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
               +I+RD+K  N+L+D     +V+DFG +++ +     +     GT  YL PE   ++
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSK 213
Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
              +  D ++ GV++ E+ +G  P
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 18/204 (8%)
Query: 595 CKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVP 650
            K +G GSFG V   K K+ G   A+KI+      + +Q    + E  +L  ++   LV 
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    ++     +V EY+  G +   L   G  ++ P       QI        EYLH+ 
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE-PHARFYAAQIVLT----FEYLHS- 159
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
               +I+RD+K  N+L+D     +V+DFG +++ +     +     GT  YL PE   ++
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSK 213
Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
              +  D ++ GV++ E+ +G  P
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 18/204 (8%)
Query: 595 CKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVP 650
            K +G GSFG V   K K+ G   A+KI+      + +Q    + E  +L  ++   LV 
Sbjct: 33  IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 92
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    ++     +V EY+  G +   L   G  ++ P       QI        EYLH+ 
Sbjct: 93  LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE-PHARFYAAQIVLT----FEYLHS- 146
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
               +I+RD+K  N+L+D     +V+DFG +++ +     +     GT  YL PE   ++
Sbjct: 147 --LDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSK 200
Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
              +  D ++ GV++ E+ +G  P
Sbjct: 201 GYNKAVDWWALGVLIYEMAAGYPP 224

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 18/204 (8%)
Query: 595 CKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVP 650
            K +G GSFG V   K K+ G   A+KI+      + +Q    + E  +L  ++   LV 
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    ++     +V EY+  G +   L   G  ++ P       QI        EYLH+ 
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE-PHARFYAAQIVLT----FEYLHS- 159
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
               +I+RD+K  N+L+D     +V+DFG +++ +     +     GT  YL PE   ++
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSK 213
Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
              +  D ++ GV++ E+ +G  P
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 18/204 (8%)
Query: 595 CKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVP 650
            K +G GSFG V   K K+ G   A+KI+      + +Q    + E  +L  ++   LV 
Sbjct: 47  IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 106
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    ++     +V EY+  G +   L   G  ++ P       QI        EYLH+ 
Sbjct: 107 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE-PHARFYAAQIVLT----FEYLHS- 160
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
               +I+RD+K  N+L+D     +V+DFG +++ +     +     GT  YL PE   ++
Sbjct: 161 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSK 214
Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
              +  D ++ GV++ E+ +G  P
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 18/204 (8%)
Query: 595 CKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVP 650
            K +G GSFG V   K M+ G   A+KI+      + +Q    + E  +L  ++   LV 
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    ++     +V EY+  G +   L   G  ++ P       QI        EYLH+ 
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE-PHARFYAAQIVLT----FEYLHS- 159
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
               +I+RD+K  N+L+D     +V+DFG +++ +     +     GT  YL PE   ++
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSK 213
Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
              +  D ++ GV++ E+ +G  P
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 18/204 (8%)
Query: 595 CKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVP 650
            K +G GSFG V   K M+ G   A+KI+      + +Q    + E  +L  ++   LV 
Sbjct: 47  IKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 106
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    ++     +V EY+  G +   L   G  ++ P       QI        EYLH+ 
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE-PHARFYAAQIVLT----FEYLHS- 160
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
               +I+RD+K  N+L+D     +V+DFG +++ +     +     GT  YL PE   ++
Sbjct: 161 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSK 214
Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
              +  D ++ GV++ E+ +G  P
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 18/204 (8%)
Query: 595 CKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVP 650
            K +G GSFG V   K M+ G   A+KI+      + +Q    + E  +L  ++   LV 
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    ++     +V EY+  G +   L   G  ++ P       QI        EYLH+ 
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE-PHARFYAAQIVLT----FEYLHS- 159
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
               +I+RD+K  N+L+D     +V+DFG +++ +     +     GT  YL PE   ++
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSK 213
Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
              +  D ++ GV++ E+ +G  P
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 18/204 (8%)
Query: 595 CKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVP 650
            K +G GSFG V   K K+ G   A+KI+      + +Q    + E  +L  ++   LV 
Sbjct: 39  IKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 98
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    ++     +V EY+  G +   L   G  ++ P       QI        EYLH+ 
Sbjct: 99  LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE-PHARFYAAQIVLT----FEYLHS- 152
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
               +I+RD+K  N+L+D     +V+DFG +++ +     +     GT  YL PE   ++
Sbjct: 153 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSK 206
Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
              +  D ++ GV++ E+ +G  P
Sbjct: 207 GYNKAVDWWALGVLIYEMAAGYPP 230

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 18/204 (8%)
Query: 595 CKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVP 650
            K +G GSFG V   K K+ G   A+KI+      + +Q    + E  +L  ++   LV 
Sbjct: 46  IKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    ++     +V EY+  G +   L   G  ++ P       QI        EYLH+ 
Sbjct: 106 LEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE-PHARFYAAQIVLT----FEYLHS- 159
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
               +I+RD+K  N+L+D     +V+DFG +++ +     +     GT  YL PE   ++
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSK 213
Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
              +  D ++ GV++ E+ +G  P
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 93/204 (45%), Gaps = 18/204 (8%)
Query: 595 CKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVP 650
            K +G GSFG V   K M+ G   A+KI+      + +Q    + E  +L  ++   LV 
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    ++     +V EY   G +   L   G  ++ P       QI        EYLH+ 
Sbjct: 106 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSE-PHARFYAAQIVLT----FEYLHS- 159
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
               +I+RD+K  N+++D     KV+DFG +++ +     +     GT  YL PE   ++
Sbjct: 160 --LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSK 213
Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
              +  D ++ GV++ E+ +G  P
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 18/204 (8%)
Query: 595 CKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVP 650
            K +G GSFG V   K K+ G   A+KI+      + +Q    + E  +L  ++   LV 
Sbjct: 46  IKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    ++     +V EY+  G +   L   G  ++ P       QI        EYLH+ 
Sbjct: 106 LEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE-PHARFYAAQIVLT----FEYLHS- 159
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
               +I+RD+K  N+L+D     +V+DFG +++ +     +     GT  YL PE   ++
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSK 213
Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
              +  D ++ GV++ E+ +G  P
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 18/204 (8%)
Query: 595 CKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVP 650
            K +G GSFG V   K M+ G   A+KI+      + +Q    + E  +L  ++   LV 
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    ++     +V EY+  G +   L   G  ++ P       QI        EYLH+ 
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE-PHARFYAAQIVLT----FEYLHS- 159
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
               +I+RD+K  N+L+D     +V+DFG +++ +     +     GT  YL PE   ++
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSK 213
Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
              +  D ++ GV++ E+ +G  P
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 18/204 (8%)
Query: 595 CKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVP 650
            K +G GSFG V   K K+ G   A+KI+      + +Q    + E  +L  ++   LV 
Sbjct: 46  IKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    ++     +V EY+  G +   L   G  ++ P       QI        EYLH+ 
Sbjct: 106 LEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE-PHARFYAAQIVLT----FEYLHS- 159
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
               +I+RD+K  N+L+D     +V+DFG +++ +     +     GT  YL PE   ++
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSK 213
Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
              +  D ++ GV++ E+ +G  P
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 86/186 (46%), Gaps = 20/186 (10%)
Query: 616 EVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHNGTLR 674
           E AVKI+  S    T+    E+ +L R   H N++ L    ++     +V E M  G L 
Sbjct: 49  EFAVKIIDKSKRDPTE----EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELL 104
Query: 675 DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNIL-LDINMRA-- 731
           D++   + QK         +     K +EYLH     G++HRD+K SNIL +D +     
Sbjct: 105 DKI---LRQKFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPES 158
Query: 732 -KVSDFGLSRQ--AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
            ++ DFG ++Q  AE  L         T  ++ PE    Q      D++S GV+L  +++
Sbjct: 159 IRICDFGFAKQLRAENGLLMTPCY---TANFVAPEVLERQGYDAACDIWSLGVLLYTMLT 215
Query: 789 GKKPVS 794
           G  P +
Sbjct: 216 GYTPFA 221

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 18/204 (8%)
Query: 595 CKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVP 650
            K +G GSFG V   K M+ G   A+KI+      + +Q    + E  +L  ++   LV 
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    ++     +V EY+  G +   L   G  ++ P       QI        EYLH+ 
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE-PHARFYAAQIVLT----FEYLHS- 159
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
               +I+RD+K  N+L+D     +V+DFG +++ +     +     GT  YL PE   ++
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSK 213
Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
              +  D ++ GV++ E+ +G  P
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 93/204 (45%), Gaps = 18/204 (8%)
Query: 595 CKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVP 650
            K +G GSFG V   K K+ G   A+KI+      + +Q    + E  +L  ++   LV 
Sbjct: 47  IKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 106
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    ++     +V EY   G +   L   G  ++ P       QI        EYLH+ 
Sbjct: 107 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSE-PHARFYAAQIVLT----FEYLHS- 160
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
               +I+RD+K  N+++D     KV+DFG +++ +     +     GT  YL PE   ++
Sbjct: 161 --LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSK 214
Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
              +  D ++ GV++ E+ +G  P
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 18/203 (8%)
Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVPL 651
           K +G GSFG V   K K+ G   A+KI+      + +Q    + E  +L  ++   LV L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 709
               ++     +V EY+  G +   L   G   + P       QI        EYLH+  
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXE-PHARFYAAQIVLT----FEYLHS-- 159
Query: 710 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQ 769
              +I+RD+K  N+L+D     +V+DFG +++ +     +     GT  YL PE   ++ 
Sbjct: 160 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSKG 214
Query: 770 LTEKSDVYSFGVVLLELISGKKP 792
             +  D ++ GV++ E+ +G  P
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 18/204 (8%)
Query: 595 CKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVP 650
            K +G GSFG V   K K+ G   A+KI+      + +Q    + E  +L  ++   LV 
Sbjct: 47  IKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 106
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    ++     +V EY+  G +   L   G  ++ P       QI        EYLH+ 
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE-PHARFYAAQIVLT----FEYLHS- 160
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
               +I+RD+K  N+L+D     +V+DFG +++ +     +     GT  YL PE   ++
Sbjct: 161 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSK 214
Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
              +  D ++ GV++ E+ +G  P
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 93/204 (45%), Gaps = 18/204 (8%)
Query: 595 CKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVP 650
            K +G GSFG V   K K+ G   A+KI+      + +Q    + E  +L  ++   LV 
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    ++     +V EY+  G +   L   G   + P       QI        EYLH+ 
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXE-PHARFYAAQIVLT----FEYLHS- 159
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
               +I+RD+K  N+L+D     +V+DFG +++ +     +     GT  YL PE   ++
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSK 213
Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
              +  D ++ GV++ E+ +G  P
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 18/204 (8%)
Query: 595 CKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVP 650
            K +G GSFG V   K K+ G   A+KI+      + +Q    + E  +L  ++   LV 
Sbjct: 47  IKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 106
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    ++     +V EY+  G +   L   G  ++ P       QI        EYLH+ 
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE-PHARFYAAQIVLT----FEYLHS- 160
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
               +I+RD+K  N+L+D     +V+DFG +++ +     +     GT  YL PE   ++
Sbjct: 161 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSK 214
Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
              +  D ++ GV++ E+ +G  P
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 18/204 (8%)
Query: 595 CKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVP 650
            K +G GSFG V   K K+ G   A+KI+      + +Q    + E  +L  ++   LV 
Sbjct: 47  IKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 106
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    ++     +V EY+  G +   L   G  ++ P       QI        EYLH+ 
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE-PHARFYAAQIVLT----FEYLHS- 160
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
               +I+RD+K  N+L+D     +V+DFG +++ +     +     GT  YL PE   ++
Sbjct: 161 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSK 214
Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
              +  D ++ GV++ E+ +G  P
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 18/204 (8%)
Query: 595 CKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVP 650
            K +G GSFG V   K M+ G   A+KI+      + ++    + E  +L  ++   LV 
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVK 105
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    ++     +V EY   G +   L   G  ++ P       QI        EYLH+ 
Sbjct: 106 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSE-PHARFYAAQIVLT----FEYLHS- 159
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
               +I+RD+K  N+++D     KV+DFGL+++ +     +     GT  YL PE   ++
Sbjct: 160 --LDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLC----GTPEYLAPEIILSK 213
Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
              +  D ++ GV++ E+ +G  P
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 18/204 (8%)
Query: 595 CKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVP 650
            K +G GSFG V   K M+ G   A+KI+      + +Q    + E  +L  ++   LV 
Sbjct: 32  IKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 91
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    ++     +V EY+  G +   L   G  ++ P       QI        EYLH+ 
Sbjct: 92  LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE-PHARFYAAQIVLT----FEYLHS- 145
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
               +I+RD+K  N+L+D     +V+DFG +++ +     +     GT  YL PE   ++
Sbjct: 146 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC----GTPEYLAPEIILSK 199
Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
              +  D ++ GV++ E+ +G  P
Sbjct: 200 GYNKAVDWWALGVLIYEMAAGYPP 223

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 18/204 (8%)
Query: 595 CKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVP 650
            K +G GSFG V   K K+ G   A+KI+      + +Q    + E  +L  ++   LV 
Sbjct: 67  IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 126
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    ++     +V EY+  G +   L   G  ++ P       QI        EYLH+ 
Sbjct: 127 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE-PHARFYAAQIVLT----FEYLHS- 180
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
               +I+RD+K  N+L+D     +V+DFG +++ +     +     GT  YL PE   ++
Sbjct: 181 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWTLC----GTPEYLAPEIILSK 234
Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
              +  D ++ GV++ E+ +G  P
Sbjct: 235 GYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 93/204 (45%), Gaps = 18/204 (8%)
Query: 595 CKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVP 650
            K +G GSFG V   K K+ G   A+KI+      + +Q    + E  +L  ++   LV 
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    ++     +V EY+  G +   L   G   + P       QI        EYLH+ 
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXE-PHARFYAAQIVLT----FEYLHS- 159
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
               +I+RD+K  N+L+D     +V+DFG +++ +     +     GT  YL PE   ++
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSK 213
Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
              +  D ++ GV++ E+ +G  P
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 93/204 (45%), Gaps = 18/204 (8%)
Query: 595 CKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVP 650
            K +G GSFG V   K K+ G   A+KI+      + +Q    + E  +L  ++   LV 
Sbjct: 41  IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 100
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    ++     +V EY+  G +   L   G   + P       QI        EYLH+ 
Sbjct: 101 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXE-PHARFYAAQIVLT----FEYLHS- 154
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
               +I+RD+K  N+L+D     +V+DFG +++ +     +     GT  YL PE   ++
Sbjct: 155 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSK 208
Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
              +  D ++ GV++ E+ +G  P
Sbjct: 209 GYNKAVDWWALGVLIYEMAAGYPP 232

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 18/204 (8%)
Query: 595 CKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVP 650
            K +G GSFG V   K M+ G   A+KI+      + +Q    + E  +L  ++   LV 
Sbjct: 47  IKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 106
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    ++     +V EY+  G +   L   G  ++ P       QI        EYLH+ 
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE-PHARFYAAQIVLT----FEYLHS- 160
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
               +I+RD+K  N+L+D     +V+DFG +++ +     +     GT  YL PE   ++
Sbjct: 161 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC----GTPEYLAPEIILSK 214
Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
              +  D ++ GV++ E+ +G  P
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 93/204 (45%), Gaps = 18/204 (8%)
Query: 595 CKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVP 650
            K +G GSFG V   K K+ G   A+KI+      + +Q    + E  +L  ++   LV 
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    ++     +V EY+  G +   L   G   + P       QI        EYLH+ 
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAE-PHARFYAAQIVLT----FEYLHS- 159
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
               +I+RD+K  N+L+D     +V+DFG +++ +     +     GT  YL PE   ++
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSK 213
Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
              +  D ++ GV++ E+ +G  P
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 18/204 (8%)
Query: 595 CKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVP 650
            K +G GSFG V   K K+ G   A+KI+      + +Q    + E  +L  ++   LV 
Sbjct: 67  IKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 126
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    ++     +V EY+  G +   L   G  ++ P       QI        EYLH+ 
Sbjct: 127 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE-PHARFYAAQIVLT----FEYLHS- 180
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
               +I+RD+K  N+L+D     +V+DFG +++ +     +     GT  YL PE   ++
Sbjct: 181 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSK 234
Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
              +  D ++ GV++ E+ +G  P
Sbjct: 235 GYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 93/204 (45%), Gaps = 18/204 (8%)
Query: 595 CKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVP 650
            K +G GSFG V   K K+ G   A+KI+      + +Q    + E  +L  ++   LV 
Sbjct: 67  IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 126
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    ++     +V EY+  G +   L   G   + P       QI        EYLH+ 
Sbjct: 127 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXE-PHARFYAAQIVLT----FEYLHS- 180
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
               +I+RD+K  N+L+D     +V+DFG +++ +     +     GT  YL PE   ++
Sbjct: 181 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSK 234
Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
              +  D ++ GV++ E+ +G  P
Sbjct: 235 GYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 93/204 (45%), Gaps = 18/204 (8%)
Query: 595 CKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVP 650
            K +G GSFG V   K M+ G   A+KI+      + +Q    + E  +L  ++   LV 
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    ++     +V EY+  G +   L   G   + P       QI        EYLH+ 
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXE-PHARFYAAQIVLT----FEYLHS- 159
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
               +I+RD+K  N+L+D     +V+DFG +++ +     +     GT  YL PE   ++
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSK 213
Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
              +  D ++ GV++ E+ +G  P
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 92/204 (45%), Gaps = 18/204 (8%)
Query: 595 CKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVP 650
            K +G GSFG V   K M+ G   A+KI+      + +Q    + E  +L  ++   LV 
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    ++     +V EY   G +   L   G   + P       QI        EYLH+ 
Sbjct: 106 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXE-PHARFYAAQIVLT----FEYLHS- 159
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
               +I+RD+K  N+++D     KV+DFG +++ +     +     GT  YL PE   ++
Sbjct: 160 --LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSK 213
Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
              +  D ++ GV++ E+ +G  P
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 93/204 (45%), Gaps = 18/204 (8%)
Query: 595 CKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVP 650
            K +G GSFG V   K M+ G   A+KI+      + +Q    + E  +L  ++   LV 
Sbjct: 47  IKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 106
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    ++     +V EY+  G +   L   G   + P       QI        EYLH+ 
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXE-PHARFYAAQIVLT----FEYLHS- 160
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
               +I+RD+K  N+L+D     +V+DFG +++ +     +     GT  YL PE   ++
Sbjct: 161 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSK 214
Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
              +  D ++ GV++ E+ +G  P
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 93/204 (45%), Gaps = 18/204 (8%)
Query: 595 CKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVP 650
            K +G GSFG V   K M+ G   A+KI+      + +Q    + E  +L  ++   LV 
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    ++     +V EY+  G +   L   G   + P       QI        EYLH+ 
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXE-PHARFYAAQIVLT----FEYLHS- 159
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
               +I+RD+K  N+L+D     +V+DFG +++ +     +     GT  YL PE   ++
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSK 213
Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
              +  D ++ GV++ E+ +G  P
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 93/204 (45%), Gaps = 18/204 (8%)
Query: 595 CKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVP 650
            K +G GSFG V   K K+ G   A+KI+      + +Q    + E  +L  ++   LV 
Sbjct: 39  IKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 98
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    ++     +V EY+  G +   L   G   + P       QI        EYLH+ 
Sbjct: 99  LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXE-PHARFYAAQIVLT----FEYLHS- 152
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
               +I+RD+K  N+L+D     +V+DFG +++ +     +     GT  YL PE   ++
Sbjct: 153 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSK 206
Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
              +  D ++ GV++ E+ +G  P
Sbjct: 207 GYNKAVDWWALGVLIYEMAAGYPP 230

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 18/204 (8%)
Query: 595 CKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVP 650
            K +G GSFG V   K K+ G   A+KI+      + +Q    + E  +L  ++   LV 
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    ++     +V EY+  G +   L   G  ++ P       QI        EYLH+ 
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE-PHARFYAAQIVLT----FEYLHS- 159
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
               +I+RD+K  N+++D     +V+DFG +++ +     +     GT  YL PE   ++
Sbjct: 160 --LDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIIISK 213
Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
              +  D ++ GV++ E+ +G  P
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 104/224 (46%), Gaps = 29/224 (12%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYG-KMKDGKEVAVKI------MADSCSHRTQQFVTEVA 638
           E  EA       +GKG FG+V+ G ++ D  +VA+K+      +  S    +     EVA
Sbjct: 27  EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVA 86
Query: 639 LLSRIH----HRNLVPLIGYCEEEHQRILVYEY-MHNGTLRDRL--HGSVNQKPLDWLTR 691
           LL ++     H  ++ L+ + E +   +LV E  +    L D +   G + + P    +R
Sbjct: 87  LLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGP----SR 142
Query: 692 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR-AKVSDFGL-SRQAEEDLTHI 749
                  A  +++ H+    G++HRD+K  NIL+D+    AK+ DFG  +   +E  T  
Sbjct: 143 CFFGQVVA-AIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF 198
Query: 750 SSVARGTVGYLDPEYYGNQQLTE-KSDVYSFGVVLLELISGKKP 792
                GT  Y  PE+    Q     + V+S G++L +++ G  P
Sbjct: 199 D----GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP 238

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 18/204 (8%)
Query: 595 CKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVP 650
            K +G GSFG V   K K+ G   A+KI+      + +Q    + E  +L  ++   LV 
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    ++     +V EY+  G +   L   G  ++ P       QI        EYLH+ 
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE-PHARFYAAQIVLT----FEYLHS- 159
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
               +I+RD+K  N+L+D     +V+DFG +++ +     +     GT  YL PE   ++
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSK 213
Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
              +  D ++ GV++ ++ +G  P
Sbjct: 214 GYNKAVDWWALGVLIYQMAAGYPP 237

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 20/219 (9%)
Query: 587 LEEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIM-----ADSCSHRTQQFVTEVALL 640
           L E     C+ IGKG F  V     ++ G++ AVKI+       S    T+    E ++ 
Sbjct: 23  LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASIC 82
Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA-HDAA 699
             + H ++V L+     +    +V+E+M    L   +   V +    ++    +A H   
Sbjct: 83  HMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEI---VKRADAGFVYSEAVASHYMR 139
Query: 700 KGLEYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGT 756
           + LE L    +  IIHRDVK   +LL   + +   K+  FG++ Q  E       VA G 
Sbjct: 140 QILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES----GLVAGGR 195
Query: 757 VG---YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           VG   ++ PE    +   +  DV+  GV+L  L+SG  P
Sbjct: 196 VGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 234

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 20/219 (9%)
Query: 587 LEEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIM-----ADSCSHRTQQFVTEVALL 640
           L E     C+ IGKG F  V     ++ G++ AVKI+       S    T+    E ++ 
Sbjct: 21  LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASIC 80
Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA-HDAA 699
             + H ++V L+     +    +V+E+M    L   +   V +    ++    +A H   
Sbjct: 81  HMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEI---VKRADAGFVYSEAVASHYMR 137
Query: 700 KGLEYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGT 756
           + LE L    +  IIHRDVK   +LL   + +   K+  FG++ Q  E       VA G 
Sbjct: 138 QILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES----GLVAGGR 193
Query: 757 VG---YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           VG   ++ PE    +   +  DV+  GV+L  L+SG  P
Sbjct: 194 VGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 60/107 (56%), Gaps = 4/107 (3%)
Query: 683 QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 742
           ++P+     +  +   A+G+E+L +      IHRD+ + NILL  N   K+ DFGL+R  
Sbjct: 193 KEPITMEDLISYSFQVARGMEFLSSR---KCIHRDLAARNILLSENNVVKICDFGLARDI 249
Query: 743 EEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
            ++  ++     R  + ++ PE   ++  + KSDV+S+GV+L E+ S
Sbjct: 250 YKNPDYVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 92/206 (44%), Gaps = 17/206 (8%)
Query: 593 NFCKKIGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 651
           +F K IG G+FG     + K  KE VAVK +    +   +    E+     + H N+V  
Sbjct: 23  DFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRF 81
Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 709
                      ++ EY   G L +R+   G  ++    +  +  ++     G+ Y H+  
Sbjct: 82  KEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLS-----GVSYCHSM- 135
Query: 710 NPGIIHRDVKSSNILLDIN--MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 767
              I HRD+K  N LLD +   R K+ DFG S+ +       S+V  GT  Y+ PE    
Sbjct: 136 --QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV--GTPAYIAPEVLLR 191
Query: 768 QQLTEK-SDVYSFGVVLLELISGKKP 792
           Q+   K +DV+S GV L  ++ G  P
Sbjct: 192 QEYDGKIADVWSCGVTLYVMLVGAYP 217

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 93/204 (45%), Gaps = 18/204 (8%)
Query: 595 CKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVP 650
            K +G GSFG V   K M+ G   A+KI+      + +Q    + E  +L  ++   LV 
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    ++     +V EY   G +   L   G  ++ P       QI        EYLH+ 
Sbjct: 106 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSE-PHARFYAAQIVLT----FEYLHS- 159
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
               +I+RD+K  N+++D     +V+DFG +++ +     +     GT  YL PE   ++
Sbjct: 160 --LDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSK 213
Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
              +  D ++ GV++ E+ +G  P
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 106/233 (45%), Gaps = 27/233 (11%)
Query: 576 EGVAYFIPLPELEEATNNFCKKIGKG--SFGSVYYGKMK-DGKEVAVK-IMADSCSHRTQ 631
           +G++ F+P    E         IGKG     +V   + K  G+ V V+ I  ++CS+   
Sbjct: 15  QGMSSFLP----EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMV 70
Query: 632 QFVT-EVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLT 690
            F+  E+ +    +H N+VP       +++  +V  +M  G+ +D     +    +D + 
Sbjct: 71  TFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDL----ICTHFMDGMN 126
Query: 691 RLQIAH---DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDF-----GLSRQA 742
            L IA+      K L+Y+H   + G +HR VK+S+IL+ ++ +  +S        +S   
Sbjct: 127 ELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQ 183
Query: 743 EEDLTH-ISSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKP 792
            + + H     +   + +L PE      Q    KSD+YS G+   EL +G  P
Sbjct: 184 RQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 18/204 (8%)
Query: 595 CKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVP 650
            K +G GSFG V   K M+ G   A+KI+      + ++    + E  +L  ++   LV 
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVK 105
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    ++     +V EY   G +   L   G  ++ P       QI        EYLH+ 
Sbjct: 106 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSE-PHARFYAAQIVLT----FEYLHS- 159
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
               +I+RD+K  N+++D     +V+DFGL+++ +     +     GT  YL PE   ++
Sbjct: 160 --LDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLC----GTPEYLAPEIILSK 213
Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
              +  D ++ GV++ E+ +G  P
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 92/204 (45%), Gaps = 18/204 (8%)
Query: 595 CKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVP 650
            K +G GSFG V   K M+ G   A+KI+      + +Q    + E  +L  ++   L  
Sbjct: 47  IKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTK 106
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    ++     +V EY   G +   L   G  ++ P       QI        EYLH+ 
Sbjct: 107 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSE-PHARFYAAQIVLT----FEYLHS- 160
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
               +I+RD+K  N+++D     KV+DFG +++ +     +     GT  YL PE   ++
Sbjct: 161 --LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSK 214
Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
              +  D ++ GV++ E+ +G  P
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 105/244 (43%), Gaps = 27/244 (11%)
Query: 598 IGKGSFGSVYYGKMKDGKEVAVKIMADSCSH-RT----------QQFVTEVALLSRIHHR 646
           I  GS+G+V  G   +G  VA+K + ++ S  RT          ++ + E+ LL+  HH 
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 647 NLVPL---IGYCEEE--HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ-IAHDAAK 700
           N++ L     + EE   H+  LV E M    L   +H   +Q+ +     +Q   +    
Sbjct: 90  NILGLRDIFVHFEEPAMHKLYLVTELMRTD-LAQVIH---DQRIVISPQHIQYFMYHILL 145
Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYL 760
           GL  LH     G++HRD+   NILL  N    + DF L+R+   D      V      Y 
Sbjct: 146 GLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHR--WYR 200
Query: 761 DPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 819
            PE     +  T+  D++S G V+ E+ + K       F  +LN +       K  DV+ 
Sbjct: 201 APELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVM 260
Query: 820 IVDP 823
              P
Sbjct: 261 FSSP 264

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 92/204 (45%), Gaps = 18/204 (8%)
Query: 595 CKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVP 650
            K +G GSFG V   K M+ G   A+KI+      + +Q    + E  +L  ++   L  
Sbjct: 47  IKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTK 106
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    ++     +V EY   G +   L   G  ++ P       QI        EYLH+ 
Sbjct: 107 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSE-PHARFYAAQIVLT----FEYLHS- 160
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
               +I+RD+K  N+++D     KV+DFG +++ +     +     GT  YL PE   ++
Sbjct: 161 --LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSK 214
Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
              +  D ++ GV++ E+ +G  P
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 93/204 (45%), Gaps = 18/204 (8%)
Query: 595 CKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVP 650
            K +G GSFG V   K K+ G   A+KI+      + +Q    + E  +L  ++   LV 
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    ++     +V EY+  G +   L   G  ++ P       QI        EYLH+ 
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE-PHARFYAAQIVLT----FEYLHS- 159
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
               +I+RD+K  N+L+D     +V+DFG +++ +     +     GT  YL P    ++
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPAIILSK 213
Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
              +  D ++ GV++ E+ +G  P
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 105/244 (43%), Gaps = 27/244 (11%)
Query: 598 IGKGSFGSVYYGKMKDGKEVAVKIMADSCSH-RT----------QQFVTEVALLSRIHHR 646
           I  GS+G+V  G   +G  VA+K + ++ S  RT          ++ + E+ LL+  HH 
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 647 NLVPL---IGYCEEE--HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ-IAHDAAK 700
           N++ L     + EE   H+  LV E M    L   +H   +Q+ +     +Q   +    
Sbjct: 90  NILGLRDIFVHFEEPAMHKLYLVTELMRTD-LAQVIH---DQRIVISPQHIQYFMYHILL 145
Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYL 760
           GL  LH     G++HRD+   NILL  N    + DF L+R+   D      V      Y 
Sbjct: 146 GLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHR--WYR 200
Query: 761 DPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 819
            PE     +  T+  D++S G V+ E+ + K       F  +LN +       K  DV+ 
Sbjct: 201 APELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVM 260
Query: 820 IVDP 823
              P
Sbjct: 261 FSSP 264

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 80/155 (51%), Gaps = 17/155 (10%)
Query: 597 KIGKGSFGSVYYGKM-KDGKEVAVK--IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 653
           KIG+G+FG V+  +  K G++VA+K  +M +         + E+ +L  + H N+V LI 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 654 YCEEE---HQRI-----LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 705
            C  +   + R      LV+++  +  L   L   + +  L  + R  +      GL Y+
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--VMQMLLNGLYYI 141
Query: 706 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 740
           H      I+HRD+K++N+L+  +   K++DFGL+R
Sbjct: 142 HRN---KILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 91/204 (44%), Gaps = 18/204 (8%)
Query: 595 CKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVP 650
            K +G GSFG V   K M+ G   A+KI+      + +Q    + E  +L  ++   L  
Sbjct: 47  IKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTK 106
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    ++     +V EY   G +   L   G   + P       QI        EYLH+ 
Sbjct: 107 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXE-PHARFYAAQIVLT----FEYLHS- 160
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
               +I+RD+K  N+++D     KV+DFG +++ +     +     GT  YL PE   ++
Sbjct: 161 --LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSK 214
Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
              +  D ++ GV++ E+ +G  P
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 53/105 (50%), Gaps = 5/105 (4%)
Query: 715 HRDVKSSNILLDINMRAKVSDFGL-SRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 773
           HRDVK  NIL+  +  A + DFG+ S   +E LT + +   GT+ Y  PE +     T +
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYXAPERFSESHATYR 215
Query: 774 SDVYSFGVVLLELISGKKPVSVEDF---GAELNIVHWARSMIKKG 815
           +D+Y+   VL E ++G  P   +     GA +N      S ++ G
Sbjct: 216 ADIYALTCVLYECLTGSPPYQGDQLSVXGAHINQAIPRPSTVRPG 260

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 80/155 (51%), Gaps = 17/155 (10%)
Query: 597 KIGKGSFGSVYYGKM-KDGKEVAVK--IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 653
           KIG+G+FG V+  +  K G++VA+K  +M +         + E+ +L  + H N+V LI 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 654 YCEEE---HQRI-----LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 705
            C  +   + R      LV+++  +  L   L   + +  L  + R  +      GL Y+
Sbjct: 85  ICRTKASPYNRCKASIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--VMQMLLNGLYYI 141
Query: 706 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 740
           H      I+HRD+K++N+L+  +   K++DFGL+R
Sbjct: 142 HRN---KILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 80/155 (51%), Gaps = 17/155 (10%)
Query: 597 KIGKGSFGSVYYGKM-KDGKEVAVK--IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 653
           KIG+G+FG V+  +  K G++VA+K  +M +         + E+ +L  + H N+V LI 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 654 YCEEE---HQRI-----LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 705
            C  +   + R      LV+++  +  L   L   + +  L  + R  +      GL Y+
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--VMQMLLNGLYYI 141
Query: 706 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 740
           H      I+HRD+K++N+L+  +   K++DFGL+R
Sbjct: 142 HRN---KILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 80/155 (51%), Gaps = 17/155 (10%)
Query: 597 KIGKGSFGSVYYGKM-KDGKEVAVK--IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 653
           KIG+G+FG V+  +  K G++VA+K  +M +         + E+ +L  + H N+V LI 
Sbjct: 24  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 83
Query: 654 YCEEE---HQRI-----LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 705
            C  +   + R      LV+++  +  L   L   + +  L  + R  +      GL Y+
Sbjct: 84  ICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--VMQMLLNGLYYI 140
Query: 706 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 740
           H      I+HRD+K++N+L+  +   K++DFGL+R
Sbjct: 141 HRN---KILHRDMKAANVLITRDGVLKLADFGLAR 172

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 99/216 (45%), Gaps = 25/216 (11%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKD---GKEVAVKIMADSCSHRTQQF-VTEVALLS 641
           E+  AT+    ++G+GSFG V+  +M+D   G + AVK +      R + F   E+   +
Sbjct: 91  EVHWATHQL--RLGRGSFGEVH--RMEDKQTGFQCAVKKV------RLEVFRAEELMACA 140
Query: 642 RIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 701
            +    +VPL G   E     +  E +  G+L   +     Q  L     L     A +G
Sbjct: 141 GLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVK---EQGCLPEDRALYYLGQALEG 197
Query: 702 LEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLTHISSVAR----GT 756
           LEYLH+     I+H DVK+ N+LL  +   A + DFG +   + D    S +      GT
Sbjct: 198 LEYLHSR---RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGT 254
Query: 757 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
             ++ PE    +    K DV+S   ++L +++G  P
Sbjct: 255 ETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHP 290

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 32/211 (15%)
Query: 599 GKGSFGSVYYGKMKD-GKEVAVK--IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 655
           G+G+FG+V  GK K  G  VA+K  I      +R  Q + ++A+L   HH N+V L  Y 
Sbjct: 32  GQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVL---HHPNIVQLQSYF 88
Query: 656 EE--EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT-----G 708
               E  R  +Y  +    + D LH            R Q+A        +L       G
Sbjct: 89  YTLGERDRRDIYLNVVMEYVPDTLHRCCRN-----YYRRQVAPPPILIKVFLFQLIRSIG 143
Query: 709 C----NPGIIHRDVKSSNILL-DINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVGYL 760
           C    +  + HRD+K  N+L+ + +   K+ DFG +++   +E ++ +I S       Y 
Sbjct: 144 CLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY-----YR 198
Query: 761 DPEY-YGNQQLTEKSDVYSFGVVLLELISGK 790
            PE  +GNQ  T   D++S G +  E++ G+
Sbjct: 199 APELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 92/204 (45%), Gaps = 18/204 (8%)
Query: 595 CKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVP 650
            + +G GSFG V   K K+ G   A+KI+      + +Q    + E  +   ++   LV 
Sbjct: 47  IRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNFPFLVK 106
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    ++     +V EY   G +   L   G  ++ P       QI        EYLH+ 
Sbjct: 107 LEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSE-PHARFYAAQIVLT----FEYLHS- 160
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
               +I+RD+K  N+L+D     KV+DFG +++ +     +     GT  YL PE   ++
Sbjct: 161 --LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC----GTPEYLAPEIILSK 214
Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
              +  D ++ GV++ E+ +G  P
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 93/204 (45%), Gaps = 18/204 (8%)
Query: 595 CKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVP 650
            K +G GSFG V   K K+ G   A+KI+      + +Q    + E  +L  ++   LV 
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    ++     +V EY+  G +   L   G  ++ P       QI        EYLH+ 
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE-PHARFYAAQIVLT----FEYLHS- 159
Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
               +I+RD+K  N+L+D     +V+DFG +++ +     +     GT   L PE   ++
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEALAPEIILSK 213
Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
              +  D ++ GV++ E+ +G  P
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 94/205 (45%), Gaps = 27/205 (13%)
Query: 597 KIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRTQQF----VTEVALLSRIHHRNLVPL 651
           K+G+G++G VY        + VA+K +     H  +      + EV+LL  + HRN++ L
Sbjct: 41  KLGEGTYGEVYKAIDTVTNETVAIKRI--RLEHEEEGVPGTAIREVSLLKELQHRNIIEL 98
Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRL--QIAHDAAKGLEYLHT-G 708
                  H+  L++EY  N      L   +++ P D   R+     +    G+ + H+  
Sbjct: 99  KSVIHHNHRLHLIFEYAEND-----LKKYMDKNP-DVSMRVIKSFLYQLINGVNFCHSRR 152
Query: 709 CNPGIIHRDVKSSNILLDINMRA-----KVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 763
           C    +HRD+K  N+LL ++  +     K+ DFGL+R     +   +     T+ Y  PE
Sbjct: 153 C----LHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TLWYRPPE 207
Query: 764 -YYGNQQLTEKSDVYSFGVVLLELI 787
              G++  +   D++S   +  E++
Sbjct: 208 ILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 51/220 (23%), Positives = 95/220 (43%), Gaps = 15/220 (6%)
Query: 598 IGKGSFGSVYYGKMKDGKEVAV--KIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 655
           +G+G++G V     K   E+    KI          + + E+ +L    H N++ +    
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQ 78
Query: 656 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 715
             +        Y+    ++  LH  ++ + L         +   + ++ LH G N  +IH
Sbjct: 79  RPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLH-GSN--VIH 135
Query: 716 RDVKSSNILLDINMRAKVSDFGLSRQAEE---DLTHISSVARGTVGYLDPEYYGNQQLTE 772
           RD+K SN+L++ N   KV DFGL+R  +E   D +  +    G V ++   +Y   ++  
Sbjct: 136 RDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVML 195
Query: 773 KS-------DVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
            S       DV+S G +L EL   +      D+  +L ++
Sbjct: 196 TSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI 235

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 54/99 (54%), Gaps = 10/99 (10%)
Query: 693 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV 752
           +IA    K LE+LH+  +  +IHRDVK SN+L++   + K  DFG+S    +D+     +
Sbjct: 140 KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVA--KDI 195
Query: 753 ARGTVGYLDPEYYGNQQLTE-----KSDVYSFGVVLLEL 786
             G   Y  PE   N +L +     KSD++S G+  +EL
Sbjct: 196 DAGCKPYXAPERI-NPELNQKGYSVKSDIWSLGITXIEL 233

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 84/186 (45%), Gaps = 20/186 (10%)
Query: 616 EVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHNGTLR 674
           E AVKI+  S    T+    E+ +L R   H N++ L    ++     +V E    G L 
Sbjct: 49  EFAVKIIDKSKRDPTE----EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELL 104
Query: 675 DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNIL-LDINMRA-- 731
           D++   + QK         +     K +EYLH     G++HRD+K SNIL +D +     
Sbjct: 105 DKI---LRQKFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPES 158
Query: 732 -KVSDFGLSRQ--AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
            ++ DFG ++Q  AE  L         T  ++ PE    Q      D++S GV+L   ++
Sbjct: 159 IRICDFGFAKQLRAENGLLXTPCY---TANFVAPEVLERQGYDAACDIWSLGVLLYTXLT 215
Query: 789 GKKPVS 794
           G  P +
Sbjct: 216 GYTPFA 221

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/220 (23%), Positives = 94/220 (42%), Gaps = 15/220 (6%)
Query: 598 IGKGSFGSVYYGKMKDGKEVAV--KIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 655
           +G+G++G V     K   E+    KI          + + E+ +L    H N++ +    
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQ 78
Query: 656 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 715
             +        Y+    ++  LH  ++ + L         +   + ++ LH G N  +IH
Sbjct: 79  RPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLH-GSN--VIH 135
Query: 716 RDVKSSNILLDINMRAKVSDFGLSRQAEE---DLTHISSVARGTVGYLDPEYYGNQQLTE 772
           RD+K SN+L++ N   KV DFGL+R  +E   D +  +    G   Y+   +Y   ++  
Sbjct: 136 RDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRAPEVML 195
Query: 773 KS-------DVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
            S       DV+S G +L EL   +      D+  +L ++
Sbjct: 196 TSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI 235

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 23/211 (10%)
Query: 598 IGKG--SFGSVYYGKMK-DGKEVAVK-IMADSCSHRTQQFVT-EVALLSRIHHRNLVPLI 652
           IGKG     +V   + K  G+ V V+ I  ++CS+    F+  E+ +    +H N+VP  
Sbjct: 17  IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYR 76
Query: 653 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH---DAAKGLEYLHTGC 709
                +++  +V  +M  G+ +D     +    +D +  L IA+      K L+Y+H   
Sbjct: 77  ATFIADNELWVVTSFMAYGSAKDL----ICTHFMDGMNELAIAYILQGVLKALDYIH--- 129
Query: 710 NPGIIHRDVKSSNILLDINMRAKVSDF-----GLSRQAEEDLTH-ISSVARGTVGYLDPE 763
           + G +HR VK+S+IL+ ++ +  +S        +S    + + H     +   + +L PE
Sbjct: 130 HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPE 189
Query: 764 YYGN--QQLTEKSDVYSFGVVLLELISGKKP 792
                 Q    KSD+YS G+   EL +G  P
Sbjct: 190 VLQQNLQGYDAKSDIYSVGITACELANGHVP 220

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 99/218 (45%), Gaps = 29/218 (13%)
Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKD---GKEVAVKIMADSCSHRTQQF-VTEVALLS 641
           E+  AT+    ++G+GSFG V+  +M+D   G + AVK +      R + F   E+   +
Sbjct: 72  EVHWATHQL--RLGRGSFGEVH--RMEDKQTGFQCAVKKV------RLEVFRAEELMACA 121
Query: 642 RIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 701
            +    +VPL G   E     +  E +  G+L   +     Q  L     L     A +G
Sbjct: 122 GLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVK---EQGCLPEDRALYYLGQALEG 178
Query: 702 LEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEED------LTHISSVAR 754
           LEYLH+     I+H DVK+ N+LL  +   A + DFG +   + D      LT       
Sbjct: 179 LEYLHSR---RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLT--GDYIP 233
Query: 755 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           GT  ++ PE    +    K DV+S   ++L +++G  P
Sbjct: 234 GTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHP 271

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 97/212 (45%), Gaps = 31/212 (14%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVK-IMADSCSHRTQ-----QFVTEVALLSRIH--HRNL 648
           +G G FGSVY G ++ D   VA+K +  D  S   +     +   EV LL ++      +
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLT-RLQIAHDAAKG-----L 702
           + L+ + E     +L+ E M              Q   D++T R  +  + A+      L
Sbjct: 76  IRLLDWFERPDSFVLILERMEP-----------VQDLFDFITERGALQEELARSFFWQVL 124
Query: 703 EYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 761
           E +    N G++HRD+K  NIL+D+N    K+ DFG     ++    + +   GT  Y  
Sbjct: 125 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSP 181
Query: 762 PEYYGNQQLTEKS-DVYSFGVVLLELISGKKP 792
           PE+    +   +S  V+S G++L +++ G  P
Sbjct: 182 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 213

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 75/300 (25%), Positives = 127/300 (42%), Gaps = 60/300 (20%)
Query: 597 KIGKGSFGSVYYG--KMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 654
           KIG+G+F SVY    +++ G E  + +     +    +   E+  L+    ++ V  + Y
Sbjct: 28  KIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKY 87
Query: 655 CEEEHQRILV-YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 713
           C  ++  +++   Y+ + +  D L+    Q+  +++  L       K L+ +H     GI
Sbjct: 88  CFRKNDHVVIAMPYLEHESFLDILNSLSFQEVREYMLNL------FKALKRIH---QFGI 138
Query: 714 IHRDVKSSNILLDINMRA-KVSDFGLSRQAE----EDLTHISSVAR-------------- 754
           +HRDVK SN L +  ++   + DFGL++       E L  + S A+              
Sbjct: 139 VHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLS 198
Query: 755 ---------GTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL 802
                    GT G+  PE      NQ  T   D++S GV+ L L+SG+ P     + A  
Sbjct: 199 RRQQVAPRAGTPGFRAPEVLTKCPNQ--TTAIDMWSAGVIFLSLLSGRYPF----YKASD 252
Query: 803 NIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQ-----CVEQRGF--SRPKM 855
           ++   A+ M  +G   +I      G    +SI    EV  Q     C   RG   S PK+
Sbjct: 253 DLTALAQIMTIRGSRETIQAAKTFG----KSILCSKEVPAQDLRKLCERLRGMDSSTPKL 308

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 54/103 (52%), Gaps = 13/103 (12%)
Query: 702 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR-GTVGYL 760
           LE +HT    GI+H D+K +N L+ ++   K+ DFG++ Q + D T +   ++ GTV Y+
Sbjct: 121 LEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 179
Query: 761 DPEYYGNQQLTEKS-----------DVYSFGVVLLELISGKKP 792
            PE   +   + ++           DV+S G +L  +  GK P
Sbjct: 180 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 222

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 54/103 (52%), Gaps = 13/103 (12%)
Query: 702 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR-GTVGYL 760
           LE +HT    GI+H D+K +N L+ ++   K+ DFG++ Q + D T +   ++ GTV Y+
Sbjct: 165 LEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 223
Query: 761 DPEYYGNQQLTEKS-----------DVYSFGVVLLELISGKKP 792
            PE   +   + ++           DV+S G +L  +  GK P
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 54/103 (52%), Gaps = 13/103 (12%)
Query: 702 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR-GTVGYL 760
           LE +HT    GI+H D+K +N L+ ++   K+ DFG++ Q + D T +   ++ GTV Y+
Sbjct: 137 LEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 195
Query: 761 DPEYYGNQQLTEKS-----------DVYSFGVVLLELISGKKP 792
            PE   +   + ++           DV+S G +L  +  GK P
Sbjct: 196 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 54/103 (52%), Gaps = 13/103 (12%)
Query: 702 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR-GTVGYL 760
           LE +HT    GI+H D+K +N L+ ++   K+ DFG++ Q + D T +   ++ GTV Y+
Sbjct: 117 LEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 175
Query: 761 DPEYYGNQQLTEKS-----------DVYSFGVVLLELISGKKP 792
            PE   +   + ++           DV+S G +L  +  GK P
Sbjct: 176 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 218

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 54/103 (52%), Gaps = 13/103 (12%)
Query: 702 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR-GTVGYL 760
           LE +HT    GI+H D+K +N L+ ++   K+ DFG++ Q + D T +   ++ GTV Y+
Sbjct: 118 LEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 176
Query: 761 DPEYYGNQQLTEKS-----------DVYSFGVVLLELISGKKP 792
            PE   +   + ++           DV+S G +L  +  GK P
Sbjct: 177 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 54/103 (52%), Gaps = 13/103 (12%)
Query: 702 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR-GTVGYL 760
           LE +HT    GI+H D+K +N L+ ++   K+ DFG++ Q + D T +   ++ GTV Y+
Sbjct: 165 LEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 223
Query: 761 DPEYYGNQQLTEKS-----------DVYSFGVVLLELISGKKP 792
            PE   +   + ++           DV+S G +L  +  GK P
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 88/205 (42%), Gaps = 17/205 (8%)
Query: 594 FCKKIGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 652
             K IG G+FG     + K   E VAVK + +      +    E+     + H N+V   
Sbjct: 23  LVKDIGAGNFGVARLMRDKQANELVAVKYI-ERGEKIDENVKREIINHRSLRHPNIVRFK 81
Query: 653 GYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 710
                     +V EY   G L +R+   G  ++    +  +  I+     G+ Y H    
Sbjct: 82  EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS-----GVSYAHAM-- 134
Query: 711 PGIIHRDVKSSNILLDIN--MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
             + HRD+K  N LLD +   R K++DFG S+ +   L      A GT  Y+ PE    +
Sbjct: 135 -QVAHRDLKLENTLLDGSPAPRLKIADFGYSKASV--LHSQPKSAVGTPAYIAPEVLLKK 191
Query: 769 QLTEK-SDVYSFGVVLLELISGKKP 792
           +   K +DV+S GV L  ++ G  P
Sbjct: 192 EYDGKVADVWSCGVTLYVMLVGAYP 216

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/230 (22%), Positives = 97/230 (42%), Gaps = 40/230 (17%)
Query: 583 PLPELEEATNNFCKKIGKGSFGSVYYGKM------KDGKEVAVKIMADSCSHRTQ----- 631
           P P+    T+++  ++ K   G    GK+      + G++ A+K++ DS   R +     
Sbjct: 19  PEPKKYAVTDDY--QLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHW 76
Query: 632 ------QFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKP 685
                   V  + +   +HH     LI           + E M  G L  R+    +Q  
Sbjct: 77  QASGGPHIVCILDVYENMHHGKRCLLI-----------IMECMEGGELFSRIQERGDQAF 125
Query: 686 LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQA 742
            +     +I  D    +++LH+     I HRDVK  N+L    + +   K++DFG +++ 
Sbjct: 126 TE-REAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET 181
Query: 743 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
            ++          T  Y+ PE  G ++  +  D++S GV++  L+ G  P
Sbjct: 182 TQNALQTPCY---TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/195 (23%), Positives = 83/195 (42%), Gaps = 32/195 (16%)
Query: 612 KDGKEVAVKIMADSCSHRTQ-----------QFVTEVALLSRIHHRNLVPLIGYCEEEHQ 660
           + G++ A+K++ DS   R +             V  + +   +HH     LI        
Sbjct: 33  RTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLI-------- 84
Query: 661 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKS 720
              + E M  G L  R+    +Q   +     +I  D    +++LH+     I HRDVK 
Sbjct: 85  ---IMECMEGGELFSRIQERGDQAFTE-REAAEIMRDIGTAIQFLHSH---NIAHRDVKP 137
Query: 721 SNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVY 777
            N+L    + +   K++DFG +++  ++          T  Y+ PE  G ++  +  D++
Sbjct: 138 ENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCY---TPYYVAPEVLGPEKYDKSCDMW 194
Query: 778 SFGVVLLELISGKKP 792
           S GV++  L+ G  P
Sbjct: 195 SLGVIMYILLCGFPP 209

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/220 (23%), Positives = 91/220 (41%), Gaps = 15/220 (6%)
Query: 598 IGKGSFGSVYYGKMKDGKEVAV--KIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 655
           +G+G++G V     K   E+    KI          + + E+ +L    H N++ +    
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQ 78
Query: 656 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 715
             +        Y+    ++  LH  ++ + L         +   + ++ LH G N  +IH
Sbjct: 79  RPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLH-GSN--VIH 135
Query: 716 RDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG---------YLDPE-YY 765
           RD+K SN+L++ N   KV DFGL+R  +E     S       G         Y  PE   
Sbjct: 136 RDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRAPEVML 195
Query: 766 GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
            + + +   DV+S G +L EL   +      D+  +L ++
Sbjct: 196 TSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI 235

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 31/212 (14%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVK-IMADSCSHRTQ-----QFVTEVALLSRIH--HRNL 648
           +G G FGSVY G ++ D   VA+K +  D  S   +     +   EV LL ++      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLT-RLQIAHDAAKG-----L 702
           + L+ + E     +L+ E                Q   D++T R  +  + A+      L
Sbjct: 72  IRLLDWFERPDSFVLILE-----------RPEPVQDLFDFITERGALQEELARSFFWQVL 120
Query: 703 EYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 761
           E +    N G++HRD+K  NIL+D+N    K+ DFG     ++    + +   GT  Y  
Sbjct: 121 EAVRHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSP 177
Query: 762 PEYYGNQQLTEKS-DVYSFGVVLLELISGKKP 792
           PE+    +   +S  V+S G++L +++ G  P
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 209

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 31/212 (14%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVK-IMADSCSHRTQ-----QFVTEVALLSRIH--HRNL 648
           +G G FGSVY G ++ D   VA+K +  D  S   +     +   EV LL ++      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLT-RLQIAHDAAKG-----L 702
           + L+ + E     +L+ E                Q   D++T R  +  + A+      L
Sbjct: 104 IRLLDWFERPDSFVLILE-----------RPEPVQDLFDFITERGALQEELARSFFWQVL 152
Query: 703 EYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 761
           E +    N G++HRD+K  NIL+D+N    K+ DFG     ++    + +   GT  Y  
Sbjct: 153 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSP 209
Query: 762 PEYYGNQQLTEKS-DVYSFGVVLLELISGKKP 792
           PE+    +   +S  V+S G++L +++ G  P
Sbjct: 210 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 241

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 31/212 (14%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVK-IMADSCSHRTQ-----QFVTEVALLSRIH--HRNL 648
           +G G FGSVY G ++ D   VA+K +  D  S   +     +   EV LL ++      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLT-RLQIAHDAAKG-----L 702
           + L+ + E     +L+ E                Q   D++T R  +  + A+      L
Sbjct: 77  IRLLDWFERPDSFVLILE-----------RPEPVQDLFDFITERGALQEELARSFFWQVL 125
Query: 703 EYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 761
           E +    N G++HRD+K  NIL+D+N    K+ DFG     ++    + +   GT  Y  
Sbjct: 126 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSP 182
Query: 762 PEYYGNQQLTEKS-DVYSFGVVLLELISGKKP 792
           PE+    +   +S  V+S G++L +++ G  P
Sbjct: 183 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 214

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 31/212 (14%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVK-IMADSCSHRTQ-----QFVTEVALLSRIH--HRNL 648
           +G G FGSVY G ++ D   VA+K +  D  S   +     +   EV LL ++      +
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLT-RLQIAHDAAKG-----L 702
           + L+ + E     +L+ E                Q   D++T R  +  + A+      L
Sbjct: 119 IRLLDWFERPDSFVLILE-----------RPEPVQDLFDFITERGALQEELARSFFWQVL 167
Query: 703 EYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 761
           E +    N G++HRD+K  NIL+D+N    K+ DFG     ++    + +   GT  Y  
Sbjct: 168 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSP 224
Query: 762 PEYYGNQQLTEKS-DVYSFGVVLLELISGKKP 792
           PE+    +   +S  V+S G++L +++ G  P
Sbjct: 225 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 256

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 31/212 (14%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVK-IMADSCSHRTQ-----QFVTEVALLSRIH--HRNL 648
           +G G FGSVY G ++ D   VA+K +  D  S   +     +   EV LL ++      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLT-RLQIAHDAAKG-----L 702
           + L+ + E     +L+ E                Q   D++T R  +  + A+      L
Sbjct: 105 IRLLDWFERPDSFVLILE-----------RPEPVQDLFDFITERGALQEELARSFFWQVL 153
Query: 703 EYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 761
           E +    N G++HRD+K  NIL+D+N    K+ DFG     ++    + +   GT  Y  
Sbjct: 154 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSP 210
Query: 762 PEYYGNQQLTEKS-DVYSFGVVLLELISGKKP 792
           PE+    +   +S  V+S G++L +++ G  P
Sbjct: 211 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 242

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 31/212 (14%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVK-IMADSCSHRTQ-----QFVTEVALLSRIH--HRNL 648
           +G G FGSVY G ++ D   VA+K +  D  S   +     +   EV LL ++      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLT-RLQIAHDAAKG-----L 702
           + L+ + E     +L+ E                Q   D++T R  +  + A+      L
Sbjct: 77  IRLLDWFERPDSFVLILE-----------RPEPVQDLFDFITERGALQEELARSFFWQVL 125
Query: 703 EYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 761
           E +    N G++HRD+K  NIL+D+N    K+ DFG     ++    + +   GT  Y  
Sbjct: 126 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSP 182
Query: 762 PEYYGNQQLTEKS-DVYSFGVVLLELISGKKP 792
           PE+    +   +S  V+S G++L +++ G  P
Sbjct: 183 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 214

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 31/212 (14%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVK-IMADSCSHRTQ-----QFVTEVALLSRIH--HRNL 648
           +G G FGSVY G ++ D   VA+K +  D  S   +     +   EV LL ++      +
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLT-RLQIAHDAAKG-----L 702
           + L+ + E     +L+ E                Q   D++T R  +  + A+      L
Sbjct: 76  IRLLDWFERPDSFVLILE-----------RPEPVQDLFDFITERGALQEELARSFFWQVL 124
Query: 703 EYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 761
           E +    N G++HRD+K  NIL+D+N    K+ DFG     ++    + +   GT  Y  
Sbjct: 125 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSP 181
Query: 762 PEYYGNQQLTEKS-DVYSFGVVLLELISGKKP 792
           PE+    +   +S  V+S G++L +++ G  P
Sbjct: 182 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 213

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 31/212 (14%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVK-IMADSCSHRTQ-----QFVTEVALLSRIH--HRNL 648
           +G G FGSVY G ++ D   VA+K +  D  S   +     +   EV LL ++      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLT-RLQIAHDAAKG-----L 702
           + L+ + E     +L+ E                Q   D++T R  +  + A+      L
Sbjct: 105 IRLLDWFERPDSFVLILE-----------RPEPVQDLFDFITERGALQEELARSFFWQVL 153
Query: 703 EYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 761
           E +    N G++HRD+K  NIL+D+N    K+ DFG     ++    + +   GT  Y  
Sbjct: 154 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSP 210
Query: 762 PEYYGNQQLTEKS-DVYSFGVVLLELISGKKP 792
           PE+    +   +S  V+S G++L +++ G  P
Sbjct: 211 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 242

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 31/212 (14%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVK-IMADSCSHRTQ-----QFVTEVALLSRIH--HRNL 648
           +G G FGSVY G ++ D   VA+K +  D  S   +     +   EV LL ++      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLT-RLQIAHDAAKG-----L 702
           + L+ + E     +L+ E                Q   D++T R  +  + A+      L
Sbjct: 104 IRLLDWFERPDSFVLILE-----------RPEPVQDLFDFITERGALQEELARSFFWQVL 152
Query: 703 EYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 761
           E +    N G++HRD+K  NIL+D+N    K+ DFG     ++    + +   GT  Y  
Sbjct: 153 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSP 209
Query: 762 PEYYGNQQLTEKS-DVYSFGVVLLELISGKKP 792
           PE+    +   +S  V+S G++L +++ G  P
Sbjct: 210 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 241

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 31/212 (14%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVK-IMADSCSHRTQ-----QFVTEVALLSRIH--HRNL 648
           +G G FGSVY G ++ D   VA+K +  D  S   +     +   EV LL ++      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLT-RLQIAHDAAKG-----L 702
           + L+ + E     +L+ E                Q   D++T R  +  + A+      L
Sbjct: 105 IRLLDWFERPDSFVLILE-----------RPEPVQDLFDFITERGALQEELARSFFWQVL 153
Query: 703 EYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 761
           E +    N G++HRD+K  NIL+D+N    K+ DFG     ++    + +   GT  Y  
Sbjct: 154 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSP 210
Query: 762 PEYYGNQQLTEKS-DVYSFGVVLLELISGKKP 792
           PE+    +   +S  V+S G++L +++ G  P
Sbjct: 211 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 242

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 72/171 (42%), Gaps = 28/171 (16%)
Query: 576 EGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVT 635
           +G  + + + +L     +  +K+G G F +V+      GK+     +  S  H T+  + 
Sbjct: 23  KGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD 82
Query: 636 EVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH-------NGTLRDRLHGSVNQKPLDW 688
           E+ LL  +  RN  P       +  R +V + +        NGT    +   +    L W
Sbjct: 83  EIRLLKSV--RNSDP------NDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKW 134
Query: 689 LTR-----------LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN 728
           + +            +I     +GL+YLHT C   IIH D+K  NILL +N
Sbjct: 135 IIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVN 183

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 31/212 (14%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVK-IMADSCSHRTQ-----QFVTEVALLSRIH--HRNL 648
           +G G FGSVY G ++ D   VA+K +  D  S   +     +   EV LL ++      +
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLT-RLQIAHDAAKG-----L 702
           + L+ + E     +L+ E                Q   D++T R  +  + A+      L
Sbjct: 91  IRLLDWFERPDSFVLILE-----------RPEPVQDLFDFITERGALQEELARSFFWQVL 139
Query: 703 EYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 761
           E +    N G++HRD+K  NIL+D+N    K+ DFG     ++    + +   GT  Y  
Sbjct: 140 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSP 196
Query: 762 PEYYGNQQLTEKS-DVYSFGVVLLELISGKKP 792
           PE+    +   +S  V+S G++L +++ G  P
Sbjct: 197 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 228

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 72/171 (42%), Gaps = 28/171 (16%)
Query: 576 EGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVT 635
           +G  + + + +L     +  +K+G G F +V+      GK+     +  S  H T+  + 
Sbjct: 7   KGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD 66
Query: 636 EVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH-------NGTLRDRLHGSVNQKPLDW 688
           E+ LL  +  RN  P       +  R +V + +        NGT    +   +    L W
Sbjct: 67  EIRLLKSV--RNSDP------NDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKW 118
Query: 689 LTR-----------LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN 728
           + +            +I     +GL+YLHT C   IIH D+K  NILL +N
Sbjct: 119 IIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVN 167

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 31/212 (14%)
Query: 598 IGKGSFGSVYYG-KMKDGKEVAVK-IMADSCSHRTQ-----QFVTEVALLSRIH--HRNL 648
           +G G FGSVY G ++ D   VA+K +  D  S   +     +   EV LL ++      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLT-RLQIAHDAAKG-----L 702
           + L+ + E     +L+ E                Q   D++T R  +  + A+      L
Sbjct: 92  IRLLDWFERPDSFVLILE-----------RPEPVQDLFDFITERGALQEELARSFFWQVL 140
Query: 703 EYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 761
           E +    N G++HRD+K  NIL+D+N    K+ DFG     ++    + +   GT  Y  
Sbjct: 141 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSP 197
Query: 762 PEYYGNQQLTEKS-DVYSFGVVLLELISGKKP 792
           PE+    +   +S  V+S G++L +++ G  P
Sbjct: 198 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 229
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	912
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-155
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-127
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-121
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-86
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-73
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-72
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-68
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	6e-66
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	7e-66
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-65
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-63
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	4e-63
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-62
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	5e-61
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-60
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	8e-59
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	7e-58
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-57
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-43
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-42
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	7e-42
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-41
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-41
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-41
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	4e-41
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	5e-41
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	5e-41
2a19_B	284	Interferon-induced, double-stranded RNA-activated	5e-41
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-40
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-40
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-40
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-40
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-39
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-39
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-39
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	3e-39
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-39
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-39
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	8e-39
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	9e-39
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-38
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-38
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-38
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-38
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-38
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	5e-38
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	5e-38
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	5e-38
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	6e-38
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	7e-38
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	8e-38
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	8e-38
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-37
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-37
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-37
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-37
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-37
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-37
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-37
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-37
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-37
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	7e-37
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-36
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-36
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-36
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-36
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-36
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-36
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-36
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	4e-36
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	5e-36
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-35
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-35
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-35
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	4e-35
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	5e-35
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	5e-35
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	6e-35
4aoj_A	329	High affinity nerve growth factor receptor; transf	7e-35
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-34
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-34
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-34
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-34
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-34
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-34
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-34
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-34
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-34
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	3e-34
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-34
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-34
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	4e-34
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	4e-34
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	4e-34
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	4e-34
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	4e-34
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	5e-34
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-33
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-33
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-33
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	6e-33
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-32
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	4e-32
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	4e-32
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	9e-32
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-31
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-31
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	5e-31
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	5e-31
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	7e-31
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-30
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	4e-30
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	4e-30
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	5e-30
3fme_A	290	Dual specificity mitogen-activated protein kinase;	6e-30
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	9e-30
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-29
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-29
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-29
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	4e-29
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	4e-29
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	5e-29
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	5e-29
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	5e-29
3aln_A	327	Dual specificity mitogen-activated protein kinase;	9e-29
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-28
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-28
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-28
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-28
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-28
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	7e-28
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-27
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-27
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-27
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-27
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	5e-27
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	5e-27
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	6e-27
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	6e-27
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	6e-27
3bhy_A	283	Death-associated protein kinase 3; death associate	7e-27
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	8e-27
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	9e-27
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-26
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-26
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-26
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-26
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	6e-26
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	9e-26
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-25
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-25
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	4e-25
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	5e-25
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	6e-25
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	7e-25
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	8e-25
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-24
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-24
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-24
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-24
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-21
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	8e-19
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-17
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-11
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-06
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-24
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	6e-24
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	8e-24
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-23
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	3e-23
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	9e-23
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-22
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-22
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-22
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-22
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-22
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-22
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-22
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	4e-22
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	4e-22
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-21
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-21
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	7e-21
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-20
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	7e-19
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-18
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-18
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-18
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-17
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	6e-17
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	7e-17
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-15
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-14
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-13
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-21
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-21
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-21
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	6e-21
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	6e-21
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	7e-21
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-20
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-20
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-20
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	4e-20
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-19
3niz_A	311	Rhodanese family protein; structural genomics, str	4e-19
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	4e-19
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	4e-19
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	8e-19
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-18
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-18
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-18
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-18
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-18
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	4e-18
3o0g_A	292	Cell division protein kinase 5; kinase activator c	4e-18
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	9e-18
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	9e-18
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-17
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-17
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-17
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-17
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-17
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-17
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-17
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-17
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	4e-17
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	7e-17
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	9e-17
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-16
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-16
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-16
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-16
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-16
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-16
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	4e-16
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	6e-16
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	6e-16
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	8e-16
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-15
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-15
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-15
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-15
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-15
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	4e-15
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	8e-15
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-14
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	8e-14
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-11
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-11
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-11
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-10
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-10
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-10
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	8e-10
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-09
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	8e-15
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-14
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-14
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-14
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-14
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-10
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-13
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	6e-13
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	8e-13
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	8e-13
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-12
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-12
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	8e-12
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	5e-11
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-10
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	6e-10
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-07
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	6e-07
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-06
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-12
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-12
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	4e-12
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	4e-11
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	4e-11
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	6e-11
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-08
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	4e-05
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-04
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-11
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-11
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-11
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-11
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	6e-11
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-10
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-10
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-10
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-10
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-10
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-10
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-10
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	8e-10
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-09
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-04
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-11
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-10
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	6e-10
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	7e-10
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	7e-10
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-09
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-09
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-09
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-06
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-05
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-10
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	6e-10
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-09
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-09
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-09
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	8e-09
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-08
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-07
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-06
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	7e-06
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-10
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-10
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	7e-10
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-07
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-06
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-06
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	5e-06
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-10
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-09
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-09
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-09
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	6e-09
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	6e-09
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	9e-09
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-08
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-08
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-07
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-07
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	7e-06
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-04
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	4e-10
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	5e-08
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-06
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-05
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	3e-05
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	8e-10
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	7e-09
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	8e-09
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-08
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-08
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	6e-08
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-07
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-07
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-06
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-05
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	8e-10
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-08
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	5e-08
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-07
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	6e-07
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-06
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-06
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-05
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-05
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-09
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-08
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-07
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-06
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-06
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-05
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	4e-05
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	5e-05
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-09
1o6v_A	466	Internalin A; bacterial infection, extracellular r	4e-09
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-08
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-08
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-08
1o6v_A	466	Internalin A; bacterial infection, extracellular r	4e-08
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-07
1o6v_A	466	Internalin A; bacterial infection, extracellular r	5e-07
1o6v_A	466	Internalin A; bacterial infection, extracellular r	6e-07
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-06
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-04
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-09
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-09
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-08
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	9e-08
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	6e-07
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	3e-09
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	4e-08
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-06
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-05
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	7e-09
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-07
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-07
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-06
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-06
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	9e-09
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-07
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-07
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	9e-09
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	5e-08
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-07
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	8e-06
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	9e-06
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-05
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-08
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	7e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-06
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-08
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-07
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	4e-04
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-08
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	3e-07
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	5e-06
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-05
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-08
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	9e-07
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	5e-06
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-05
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-05
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	4e-08
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-05
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	3e-05
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	4e-08
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-06
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-06
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	7e-06
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-05
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	8e-05
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	4e-04
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	5e-08
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	6e-08
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-07
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	4e-07
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	5e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	7e-08
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	8e-08
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	8e-08
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-07
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-07
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-06
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	7e-06
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-05
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	6e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-07
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-04
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-05
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-07
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-06
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	4e-06
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	7e-06
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-04
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-07
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	4e-07
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	3e-07
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	7e-07
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-06
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	4e-06
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	4e-07
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	4e-07
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	8e-06
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-04
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	5e-07
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	5e-05
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	7e-07
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	7e-07
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-04
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-04
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-04
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	3e-04
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-06
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	7e-06
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	6e-05
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	6e-04
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-06
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-06
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	3e-06
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-05
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	3e-05
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-04
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	3e-04
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	1e-06
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	6e-05
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-06
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-06
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-06
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-05
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-05
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-04
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	6e-04
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-06
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	4e-06
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-05
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-05
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-06
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-06
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-05
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	8e-05
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-04
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	3e-06
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	9e-05
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	4e-06
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	4e-06
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	5e-06
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-04
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-04
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-04
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	3e-04
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	6e-06
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-05
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-05
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-04
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-05
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	3e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	4e-05
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	5e-05
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	8e-05
3m19_A	251	Variable lymphocyte receptor A diversity region; a	6e-05
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	7e-05
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-04
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	4e-04
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	4e-04
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	8e-05
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	1e-04
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	2e-04
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	3e-04
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	8e-04
3e6j_A	229	Variable lymphocyte receptor diversity region; var	3e-04
3e6j_A	229	Variable lymphocyte receptor diversity region; var	8e-04
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	7e-04

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  458 bits (1180), Expect = e-155
 Identities = 127/319 (39%), Positives = 193/319 (60%), Gaps = 7/319 (2%)

Query: 556 TSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKK--IGKGSFGSVYYGKMKD 613
           +    +  + + A    ++    +Y +PL +LEEATNNF  K  IG G FG VY G ++D
Sbjct: 3   SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62

Query: 614 GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 673
           G +VA+K      S   ++F TE+  LS   H +LV LIG+C+E ++ IL+Y+YM NG L
Sbjct: 63  GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL 122

Query: 674 RDRLHGSVNQK-PLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK 732
           +  L+GS      + W  RL+I   AA+GL YLHT     IIHRDVKS NILLD N   K
Sbjct: 123 KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPK 179

Query: 733 VSDFGLSRQA-EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKK 791
           ++DFG+S++  E D TH+S+V +GT+GY+DPEY+   +LTEKSDVYSFGVVL E++  + 
Sbjct: 180 ITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARS 239

Query: 792 PVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFS 851
            +        +N+  WA      G +  IVDP L   ++ ES+ +  + A++C+      
Sbjct: 240 AIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSED 299

Query: 852 RPKMQEIVLAIQDSIKIEK 870
           RP M +++  ++ ++++++
Sbjct: 300 RPSMGDVLWKLEYALRLQE 318

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  384 bits (989), Expect = e-127
 Identities = 112/282 (39%), Positives = 173/282 (61%), Gaps = 6/282 (2%)

Query: 586 ELEEATNNFCK--KIGKGSFGSVYYGKMKDGKEVAVK-IMADSCSHRTQQFVTEVALLSR 642
           EL+ A++NF     +G+G FG VY G++ DG  VAVK +  +       QF TEV ++S 
Sbjct: 24  ELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISM 83

Query: 643 IHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKP-LDWLTRLQIAHDAAKG 701
             HRNL+ L G+C    +R+LVY YM NG++   L      +P LDW  R +IA  +A+G
Sbjct: 84  AVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARG 143

Query: 702 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 761
           L YLH  C+P IIHRDVK++NILLD    A V DFGL++  +   TH+++  RGT+G++ 
Sbjct: 144 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 203

Query: 762 PEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE--LNIVHWARSMIKKGDVIS 819
           PEY    + +EK+DV+ +GV+LLELI+G++   +     +  + ++ W + ++K+  + +
Sbjct: 204 PEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEA 263

Query: 820 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 861
           +VD  L GN K E + ++ +VA+ C +     RPKM E+V  
Sbjct: 264 LVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRM 305

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  370 bits (952), Expect = e-121
 Identities = 102/292 (34%), Positives = 153/292 (52%), Gaps = 26/292 (8%)

Query: 586 ELEEATNNF--------CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQ----F 633
           EL+  TNNF          K+G+G FG VY G + +   VAVK +A      T++    F
Sbjct: 19  ELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQF 77

Query: 634 VTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ 693
             E+ ++++  H NLV L+G+  +     LVY YM NG+L DRL       PL W  R +
Sbjct: 78  DQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCK 137

Query: 694 IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSV 752
           IA  AA G+ +LH       IHRD+KS+NILLD    AK+SDFGL+R + +   T ++S 
Sbjct: 138 IAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSR 194

Query: 753 ARGTVGYLDPEYY-GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG-AELNIVHWARS 810
             GT  Y+ PE   G  ++T KSD+YSFGVVLLE+I+G   V   D       ++     
Sbjct: 195 IVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAV---DEHREPQLLLDIKEE 249

Query: 811 MIK-KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 861
           +   +  +   +D  +  +    S+  +  VA QC+ ++   RP ++++   
Sbjct: 250 IEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  278 bits (713), Expect = 2e-86
 Identities = 74/308 (24%), Positives = 118/308 (38%), Gaps = 31/308 (10%)

Query: 582 IPLPELEEATNNFC--KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVAL 639
           +    L   +      +   +G FG V+  ++   + VAVKI       ++ Q   EV  
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQ-DKQSWQNEYEVYS 71

Query: 640 LSRIHHRNLVPLIGYCEE----EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA 695
           L  + H N++  IG  +     +    L+  +   G+L D L        + W     IA
Sbjct: 72  LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA----NVVSWNELCHIA 127

Query: 696 HDAAKGLEYLHT-------GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 748
              A+GL YLH        G  P I HRD+KS N+LL  N+ A ++DFGL+ + E   + 
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187

Query: 749 ISSVAR-GTVGYLDPEY-----YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL 802
             +  + GT  Y+ PE         +    + D+Y+ G+VL EL S             L
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247

Query: 803 NIVHWARSMIKKGDVISIV-----DPVLIGNV-KIESIWRIAEVAIQCVEQRGFSRPKMQ 856
                        D+  +V      PVL     K   +  + E   +C +    +R    
Sbjct: 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAG 307

Query: 857 EIVLAIQD 864
            +   I  
Sbjct: 308 CVGERITQ 315

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  242 bits (621), Expect = 2e-73
 Identities = 86/213 (40%), Positives = 123/213 (57%), Gaps = 10/213 (4%)

Query: 582 IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH--RTQQFVTEVAL 639
           IP  +L        +KIG GSFG+V+  +   G +VAVKI+ +   H  R  +F+ EVA+
Sbjct: 34  IPWCDLN-----IKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAI 87

Query: 640 LSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA 699
           + R+ H N+V  +G   +     +V EY+  G+L   LH S  ++ LD   RL +A+D A
Sbjct: 88  MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVA 147

Query: 700 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 759
           KG+ YLH   NP I+HR++KS N+L+D     KV DFGLSR          S A GT  +
Sbjct: 148 KGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA-GTPEW 205

Query: 760 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           + PE   ++   EKSDVYSFGV+L EL + ++P
Sbjct: 206 MAPEVLRDEPSNEKSDVYSFGVILWELATLQQP 238

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  240 bits (614), Expect = 2e-72
 Identities = 84/328 (25%), Positives = 144/328 (43%), Gaps = 39/328 (11%)

Query: 580 YFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVAL 639
           + I   E+E       + +G+G+FG V   K +  K+VA+K +        + F+ E+  
Sbjct: 3   HMIDYKEIE-----VEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESE--RKAFIVELRQ 54

Query: 640 LSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA 699
           LSR++H N+V L G C       LV EY   G+L + LHG+           +      +
Sbjct: 55  LSRVNHPNIVKLYGACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS 112

Query: 700 KGLEYLHTGCNPGIIHRDVKSSNILLDINMR-AKVSDFGLSRQAEEDLTHISSVARGTVG 758
           +G+ YLH+     +IHRD+K  N+LL       K+ DFG +   +  +T+     +G+  
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTN----NKGSAA 168

Query: 759 YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG--- 815
           ++ PE +     +EK DV+S+G++L E+I+ +KP   ++ G     + WA   +  G   
Sbjct: 169 WMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKP--FDEIGGPAFRIMWA---VHNGTRP 223

Query: 816 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQK 875
            +I  +               I  +  +C  +    RP M+EIV  +   ++   G D+ 
Sbjct: 224 PLIKNLPK------------PIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271

Query: 876 F----SSSSSKGQSSRKTLLTSFLEIES 899
                  S   G+  R      F E   
Sbjct: 272 LQYPCQHSLPPGEDGRVEPYVDFAEFYR 299

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  229 bits (585), Expect = 1e-68
 Identities = 75/240 (31%), Positives = 120/240 (50%), Gaps = 29/240 (12%)

Query: 568 ARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC 626
           A GG    +     +   E+E     + K+IGKG FG V+ G++  D   VA+K +    
Sbjct: 2   AMGGSEFPKSRLPTLADNEIE-----YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGD 56

Query: 627 SH-------RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG 679
           S        + Q+F  EV ++S ++H N+V L G         +V E++  G L  RL  
Sbjct: 57  SEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLD 114

Query: 680 SVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-----INMRAKVS 734
                P+ W  +L++  D A G+EY+    NP I+HRD++S NI L        + AKV+
Sbjct: 115 --KAHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171

Query: 735 DFGLSRQAEEDLTHISSVARGTVGYLDPE--YYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           DFGLS+Q+   ++       G   ++ PE      +  TEK+D YSF ++L  +++G+ P
Sbjct: 172 DFGLSQQSVHSVSG----LLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP 227

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  220 bits (564), Expect = 6e-66
 Identities = 48/218 (22%), Positives = 97/218 (44%), Gaps = 21/218 (9%)

Query: 582 IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH--RTQQFVTEVAL 639
           I   +L      F  K+ +   G ++ G+ + G ++ VK++        +++ F  E   
Sbjct: 7   IDFKQLN-----FLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPR 60

Query: 640 LSRIHHRNLVPLIGYCEEEHQRIL--VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHD 697
           L    H N++P++G C+         +  +M  G+L + LH       +D    ++ A D
Sbjct: 61  LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLH-EGTNFVVDQSQAVKFALD 119

Query: 698 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTV 757
            A+G+ +LHT   P I    + S ++++D +M A++S   +    +      S       
Sbjct: 120 MARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAP 172

Query: 758 GYLDPEYYGNQQL---TEKSDVYSFGVVLLELISGKKP 792
            ++ PE    +        +D++SF V+L EL++ + P
Sbjct: 173 AWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVP 210

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  220 bits (564), Expect = 7e-66
 Identities = 75/223 (33%), Positives = 103/223 (46%), Gaps = 25/223 (11%)

Query: 582 IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIM----ADSCSHRTQQFVTEV 637
           I   EL        + IG G FG VY      G EVAVK       +  S   +    E 
Sbjct: 4   IDFAELT-----LEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEA 57

Query: 638 ALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHD 697
            L + + H N++ L G C +E    LV E+   G L   L G    K +     +  A  
Sbjct: 58  KLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG----KRIPPDILVNWAVQ 113

Query: 698 AAKGLEYLHTGCNPGIIHRDVKSSNILLD--------INMRAKVSDFGLSRQAEEDLTHI 749
            A+G+ YLH      IIHRD+KSSNIL+          N   K++DFGL+R  E   T  
Sbjct: 114 IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR--EWHRTTK 171

Query: 750 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
            S A G   ++ PE       ++ SDV+S+GV+L EL++G+ P
Sbjct: 172 MSAA-GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  222 bits (567), Expect = 1e-65
 Identities = 72/339 (21%), Positives = 128/339 (37%), Gaps = 48/339 (14%)

Query: 582 IPLPELEEATNNFC--KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTE--V 637
               E     +N    + IG+G +G+VY G + D + VAVK+ +       Q F+ E  +
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFS---FANRQNFINEKNI 58

Query: 638 ALLSRIHHRNLVPLIGYCEE-----EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRL 692
             +  + H N+   I   E        + +LV EY  NG+L   L         DW++  
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS----LHTSDWVSSC 114

Query: 693 QIAHDAAKGLEYLHT------GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR------ 740
           ++AH   +GL YLHT         P I HRD+ S N+L+  +    +SDFGLS       
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174

Query: 741 -QAEEDLTHISSVARGTVGYLDPEY-------YGNQQLTEKSDVYSFGVVLLELISGKKP 792
                +  + +    GT+ Y+ PE           +   ++ D+Y+ G++  E+      
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234

Query: 793 VSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV--KIESIWR--------IAEVAI 842
           +   +   E  +  +   +        +   V       K    W+        + E   
Sbjct: 235 LFPGESVPEYQMA-FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293

Query: 843 QCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQKFSSSSS 881
            C +Q   +R   Q     + + + I +       ++  
Sbjct: 294 DCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAHH 332

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  214 bits (547), Expect = 3e-63
 Identities = 68/217 (31%), Positives = 113/217 (52%), Gaps = 19/217 (8%)

Query: 582 IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH--RTQQFVTEVAL 639
           IP  ++        ++IG GSFG+VY GK     +VAVK++  +     + Q F  EV +
Sbjct: 21  IPDGQIT-----VGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGV 73

Query: 640 LSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA 699
           L +  H N++  +GY       I V ++    +L   LH   ++   +    + IA   A
Sbjct: 74  LRKTRHVNILLFMGYSTAPQLAI-VTQWCEGSSLYHHLH--ASETKFEMKKLIDIARQTA 130

Query: 700 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR-QAEEDLTHISSVARGTVG 758
           +G++YLH      IIHRD+KS+NI L  +   K+ DFGL+  ++    +H      G++ 
Sbjct: 131 RGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 187

Query: 759 YLDPE---YYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           ++ PE      +   + +SDVY+FG+VL EL++G+ P
Sbjct: 188 WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  215 bits (549), Expect = 4e-63
 Identities = 60/226 (26%), Positives = 96/226 (42%), Gaps = 28/226 (12%)

Query: 582 IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIM--ADSCSHRTQQFVTEVAL 639
           IP  +LE       + IGKG FG VY+G+     EVA++++        + + F  EV  
Sbjct: 30  IPFEQLE-----IGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMA 82

Query: 640 LSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA 699
             +  H N+V  +G C       ++       TL   +     +  LD     QIA +  
Sbjct: 83  YRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIV 140

Query: 700 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR----QAEEDLTHISSVARG 755
           KG+ YLH     GI+H+D+KS N+  D N +  ++DFGL                 +  G
Sbjct: 141 KGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNG 196

Query: 756 TVGYLDPEYYGNQQL---------TEKSDVYSFGVVLLELISGKKP 792
            + +L PE                ++ SDV++ G +  EL + + P
Sbjct: 197 WLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  209 bits (533), Expect = 5e-61
 Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 19/213 (8%)

Query: 594 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 652
             + +GKG FG       ++ G+ + +K +        + F+ EV ++  + H N++  I
Sbjct: 14  HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFI 73

Query: 653 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 712
           G   ++ +   + EY+  GTLR  +          W  R+  A D A G+ YLH   +  
Sbjct: 74  GVLYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLH---SMN 128

Query: 713 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR-------------GTVGY 759
           IIHRD+ S N L+  N    V+DFGL+R   ++ T    +               G   +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188

Query: 760 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           + PE    +   EK DV+SFG+VL E+I     
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA 221

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  208 bits (530), Expect = 3e-60
 Identities = 77/324 (23%), Positives = 130/324 (40%), Gaps = 44/324 (13%)

Query: 584 LPELEEATNN----FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVAL 639
           LP L + T        K+IGKG +G V+ GK + G++VAVK+   +    +    TE+  
Sbjct: 27  LPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE-EASWFRETEIYQ 84

Query: 640 LSRIHHRNLVPLIGYCEEEHQRI----LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA 695
              + H N++  I    +         L+ +Y  NG+L D L        LD  + L++A
Sbjct: 85  TVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLK----STTLDAKSMLKLA 140

Query: 696 HDAAKGLEYLHT-----GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 750
           + +  GL +LHT        P I HRD+KS NIL+  N    ++D GL+ +   D   + 
Sbjct: 141 YSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVD 200

Query: 751 SVARGTVG---YLDPE------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 801
                 VG   Y+ PE         + Q    +D+YSFG++L E+              E
Sbjct: 201 IPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVS----GGIVE 256

Query: 802 LNIVHWARSMIKKGDVISIVDPVLIGNV--KIESIWR-------IAEVAIQCVEQRGFSR 852
              + +   +        + + V I  +     + W        + ++  +C      SR
Sbjct: 257 EYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASR 316

Query: 853 PKMQEIVLAIQDSIKIEKGGDQKF 876
                +   +    K+ +  D K 
Sbjct: 317 LTALRVKKTLA---KMSESQDIKL 337

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  201 bits (513), Expect = 7e-58
 Identities = 78/318 (24%), Positives = 136/318 (42%), Gaps = 40/318 (12%)

Query: 584 LPELEEATN----NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVAL 639
           LP L + T        + IGKG FG V+ GK + G+EVAVKI   S   R+     E+  
Sbjct: 32  LPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIF-SSREERSWFREAEIYQ 89

Query: 640 LSRIHHRNLVPLIGYCEEEHQRI----LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA 695
              + H N++  I    +++       LV +Y  +G+L D L+    +  +     +++A
Sbjct: 90  TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLA 145

Query: 696 HDAAKGLEYLH-----TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR---QAEEDLT 747
              A GL +LH     T   P I HRD+KS NIL+  N    ++D GL+     A + + 
Sbjct: 146 LSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTID 205

Query: 748 HISSVARGTVGYLDPE------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 801
              +   GT  Y+ PE         + +  +++D+Y+ G+V  E+        + +   +
Sbjct: 206 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE-DYQ 264

Query: 802 LNIVHWARSMIKKGDVISIVD------PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKM 855
           L       S     ++  +V        +       E++  +A++  +C    G +R   
Sbjct: 265 LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA 324

Query: 856 QEIV-----LAIQDSIKI 868
             I      L+ Q+ IK+
Sbjct: 325 LRIKKTLSQLSQQEGIKM 342

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  199 bits (507), Expect = 1e-57
 Identities = 61/224 (27%), Positives = 99/224 (44%), Gaps = 28/224 (12%)

Query: 594 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFV--TEVALLSRIHHRNLVPL 651
             + +GKG +G V+ G  + G+ VAVKI +   S   + +   TE+     + H N++  
Sbjct: 12  LLECVGKGRYGEVWRGSWQ-GENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGF 67

Query: 652 IGYC----EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
           I           Q  L+  Y   G+L D L        LD ++ L+I    A GL +LH 
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHI 123

Query: 708 -----GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR---QAEEDLTHISSVARGTVGY 759
                   P I HRD+KS NIL+  N +  ++D GL+    Q+   L   ++   GT  Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183

Query: 760 LDPE------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 797
           + PE              ++ D+++FG+VL E+        + +
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE 227

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  158 bits (401), Expect = 2e-43
 Identities = 66/207 (31%), Positives = 101/207 (48%), Gaps = 20/207 (9%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 652
            +IG+GSF +VY G   +   EVA   + D    ++  Q+F  E  +L  + H N+V   
Sbjct: 32  IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91

Query: 653 GY----CEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
                  + +   +LV E M +GTL+  L     +  K L    R QI     KGL++LH
Sbjct: 92  DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCR-QIL----KGLQFLH 146

Query: 707 TGCNPGIIHRDVKSSNILLD-INMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 765
           T   P IIHRD+K  NI +       K+ D GL+       +   +V  GT  ++ PE Y
Sbjct: 147 T-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--SFAKAV-IGTPEFMAPEMY 202

Query: 766 GNQQLTEKSDVYSFGVVLLELISGKKP 792
             ++  E  DVY+FG+ +LE+ + + P
Sbjct: 203 -EEKYDESVDVYAFGMCMLEMATSEYP 228

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  158 bits (403), Expect = 1e-42
 Identities = 64/207 (30%), Positives = 101/207 (48%), Gaps = 17/207 (8%)

Query: 594 FCKKIGKGSFGSVYYGKMKDGK-EVAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNLVPL 651
             ++IG+G+FG V+ G+++     VAVK   ++     +  F+ E  +L +  H N+V L
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177

Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 711
           IG C ++    +V E +  G     L        L   T LQ+  DAA G+EYL    + 
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLE---SK 232

Query: 712 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYL-----DPEYYG 766
             IHRD+ + N L+      K+SDFG+SR+  +        A G +  +      PE   
Sbjct: 233 CCIHRDLAARNCLVTEKNVLKISDFGMSREEADG----VYAASGGLRQVPVKWTAPEALN 288

Query: 767 NQQLTEKSDVYSFGVVLLELIS-GKKP 792
             + + +SDV+SFG++L E  S G  P
Sbjct: 289 YGRYSSESDVWSFGILLWETFSLGASP 315

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  153 bits (389), Expect = 7e-42
 Identities = 64/200 (32%), Positives = 107/200 (53%), Gaps = 7/200 (3%)

Query: 594 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 653
             K++G G FG V  GK K   +VAVK++ +       +F  E   + ++ H  LV   G
Sbjct: 12  LLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE-DEFFQEAQTMMKLSHPKLVKFYG 70

Query: 654 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 713
            C +E+   +V EY+ NG L + L    + K L+    L++ +D  +G+ +L    +   
Sbjct: 71  VCSKEYPIYIVTEYISNGCLLNYLRS--HGKGLEPSQLLEMCYDVCEGMAFLE---SHQF 125

Query: 714 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 773
           IHRD+ + N L+D ++  KVSDFG++R   +D    S   +  V +  PE +   + + K
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSK 185

Query: 774 SDVYSFGVVLLELIS-GKKP 792
           SDV++FG+++ E+ S GK P
Sbjct: 186 SDVWAFGILMWEVFSLGKMP 205

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  152 bits (387), Expect = 1e-41
 Identities = 66/200 (33%), Positives = 104/200 (52%), Gaps = 7/200 (3%)

Query: 594 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 653
           F ++IG G FG V+ G   +  +VA+K + +      + F+ E  ++ ++ H  LV L G
Sbjct: 12  FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYG 70

Query: 654 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 713
            C E+    LV E+M +G L D L         + L  L +  D  +G+ YL       +
Sbjct: 71  VCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETL--LGMCLDVCEGMAYL---EEACV 125

Query: 714 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 773
           IHRD+ + N L+  N   KVSDFG++R   +D    S+  +  V +  PE +   + + K
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 185

Query: 774 SDVYSFGVVLLELIS-GKKP 792
           SDV+SFGV++ E+ S GK P
Sbjct: 186 SDVWSFGVLMWEVFSEGKIP 205

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  157 bits (399), Expect = 2e-41
 Identities = 65/200 (32%), Positives = 101/200 (50%), Gaps = 7/200 (3%)

Query: 594 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 653
              K+G+G FG V+ G       VA+K +        + F+ E  ++ ++ H  LV L  
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYA 246

Query: 654 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 713
              EE   I V EYM  G+L D L G    K L     + +A   A G+ Y+        
Sbjct: 247 VVSEEPIYI-VTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVE---RMNY 301

Query: 714 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 773
           +HRD++++NIL+  N+  KV+DFGL+R  E++       A+  + +  PE     + T K
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361

Query: 774 SDVYSFGVVLLELIS-GKKP 792
           SDV+SFG++L EL + G+ P
Sbjct: 362 SDVWSFGILLTELTTKGRVP 381

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  158 bits (401), Expect = 2e-41
 Identities = 65/201 (32%), Positives = 101/201 (50%), Gaps = 7/201 (3%)

Query: 594 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 652
              K+G G +G VY G  K     VAVK + +      ++F+ E A++  I H NLV L+
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLL 282

Query: 653 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 712
           G C  E    ++ E+M  G L D L    N++ +  +  L +A   +  +EYL       
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISSAMEYLE---KKN 338

Query: 713 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 772
            IHR++ + N L+  N   KV+DFGLSR    D     + A+  + +  PE     + + 
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 398

Query: 773 KSDVYSFGVVLLELIS-GKKP 792
           KSDV++FGV+L E+ + G  P
Sbjct: 399 KSDVWAFGVLLWEIATYGMSP 419

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  151 bits (384), Expect = 4e-41
 Identities = 63/200 (31%), Positives = 104/200 (52%), Gaps = 7/200 (3%)

Query: 594 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 653
           F K++G G FG V YGK +   +VA+K++ +       +F+ E  ++  + H  LV L G
Sbjct: 28  FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYG 86

Query: 654 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 713
            C ++    ++ EYM NG L + L     +        L++  D  + +EYL    +   
Sbjct: 87  VCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLE---SKQF 141

Query: 714 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 773
           +HRD+ + N L++     KVSDFGLSR   +D    S  ++  V +  PE     + + K
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 201

Query: 774 SDVYSFGVVLLELIS-GKKP 792
           SD+++FGV++ E+ S GK P
Sbjct: 202 SDIWAFGVLMWEIYSLGKMP 221

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  158 bits (400), Expect = 5e-41
 Identities = 65/200 (32%), Positives = 101/200 (50%), Gaps = 7/200 (3%)

Query: 594 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 653
              K+G+G FG V+ G       VA+K +        + F+ E  ++ ++ H  LV L  
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYA 329

Query: 654 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 713
              EE   I V EYM  G+L D L G    K L     + +A   A G+ Y+        
Sbjct: 330 VVSEEPIYI-VTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVE---RMNY 384

Query: 714 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 773
           +HRD++++NIL+  N+  KV+DFGL+R  E++       A+  + +  PE     + T K
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 444

Query: 774 SDVYSFGVVLLELIS-GKKP 792
           SDV+SFG++L EL + G+ P
Sbjct: 445 SDVWSFGILLTELTTKGRVP 464

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  151 bits (383), Expect = 5e-41
 Identities = 61/200 (30%), Positives = 102/200 (51%), Gaps = 7/200 (3%)

Query: 594 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 653
             +++G G FG V+ G      +VAVK +          F+ E  L+ ++ H+ LV L  
Sbjct: 17  LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYA 75

Query: 654 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 713
              +E   I + EYM NG+L D L    +   L     L +A   A+G+ ++        
Sbjct: 76  VVTQEPIYI-ITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIE---ERNY 130

Query: 714 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 773
           IHRD++++NIL+   +  K++DFGL+R  E++       A+  + +  PE       T K
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 190

Query: 774 SDVYSFGVVLLELIS-GKKP 792
           SDV+SFG++L E+++ G+ P
Sbjct: 191 SDVWSFGILLTEIVTHGRIP 210

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  151 bits (383), Expect = 5e-41
 Identities = 56/214 (26%), Positives = 96/214 (44%), Gaps = 27/214 (12%)

Query: 596 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 654
           + IG G FG V+  K + DGK   +K +     +  ++   EV  L+++ H N+V   G 
Sbjct: 17  ELIGSGGFGQVFKAKHRIDGKTYVIKRV----KYNNEKAEREVKALAKLDHVNIVHYNGC 72

Query: 655 CEEEHQRI----------------LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDA 698
            +                      +  E+   GTL   +      + LD +  L++    
Sbjct: 73  WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQI 131

Query: 699 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG 758
            KG++Y+H   +  +I+RD+K SNI L    + K+ DFGL    + D     S   GT+ 
Sbjct: 132 TKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK--GTLR 186

Query: 759 YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           Y+ PE   +Q   ++ D+Y+ G++L EL+     
Sbjct: 187 YMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  150 bits (381), Expect = 1e-40
 Identities = 66/201 (32%), Positives = 101/201 (50%), Gaps = 7/201 (3%)

Query: 594 FCKKIGKGSFGSVYYGKMKDGK-EVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 652
              K+G G +G VY G  K     VAVK + +      ++F+ E A++  I H NLV L+
Sbjct: 17  MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLL 75

Query: 653 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 712
           G C  E    ++ E+M  G L D L    N++ +  +  L +A   +  +EYL       
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLE---KKN 131

Query: 713 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 772
            IHRD+ + N L+  N   KV+DFGLSR    D     + A+  + +  PE     + + 
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191

Query: 773 KSDVYSFGVVLLELIS-GKKP 792
           KSDV++FGV+L E+ + G  P
Sbjct: 192 KSDVWAFGVLLWEIATYGMSP 212

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  154 bits (392), Expect = 1e-40
 Identities = 57/200 (28%), Positives = 98/200 (49%), Gaps = 7/200 (3%)

Query: 594 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 653
             KK+G G FG V+        +VAVK M        + F+ E  ++  + H  LV L  
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLVKLHA 250

Query: 654 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 713
              +E   I + E+M  G+L D L              +  +   A+G+ ++        
Sbjct: 251 VVTKEPIYI-ITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIE---QRNY 305

Query: 714 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 773
           IHRD++++NIL+  ++  K++DFGL+R  E++       A+  + +  PE       T K
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 365

Query: 774 SDVYSFGVVLLELIS-GKKP 792
           SDV+SFG++L+E+++ G+ P
Sbjct: 366 SDVWSFGILLMEIVTYGRIP 385

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  151 bits (383), Expect = 2e-40
 Identities = 53/226 (23%), Positives = 109/226 (48%), Gaps = 19/226 (8%)

Query: 575 DEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHR 629
           ++ +   +   E +       K +G G+FG+VY G      E     VA+K + ++ S +
Sbjct: 5   NQALLRILKETEFK-----KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK 59

Query: 630 TQQ-FVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDW 688
             +  + E  +++ + + ++  L+G C       L+ + M  G L D +    ++  +  
Sbjct: 60  ANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVRE--HKDNIGS 116

Query: 689 LTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLT 747
              L      AKG+ YL    +  ++HRD+ + N+L+      K++DFGL++    E+  
Sbjct: 117 QYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173

Query: 748 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
           + +   +  + ++  E   ++  T +SDV+S+GV + EL++ G KP
Sbjct: 174 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  154 bits (391), Expect = 2e-40
 Identities = 66/201 (32%), Positives = 108/201 (53%), Gaps = 13/201 (6%)

Query: 594 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 653
             + IGKG FG V  G  + G +VAVK + +  +   Q F+ E ++++++ H NLV L+G
Sbjct: 197 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLG 253

Query: 654 YCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 712
              EE   + +V EYM  G+L D L     +  L     L+ + D  + +EYL       
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE---GNN 309

Query: 713 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 772
            +HRD+ + N+L+  +  AKVSDFGL++    + +      +  V +  PE    ++ + 
Sbjct: 310 FVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFST 365

Query: 773 KSDVYSFGVVLLELIS-GKKP 792
           KSDV+SFG++L E+ S G+ P
Sbjct: 366 KSDVWSFGILLWEIYSFGRVP 386

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  147 bits (373), Expect = 1e-39
 Identities = 58/203 (28%), Positives = 104/203 (51%), Gaps = 13/203 (6%)

Query: 597 KIGKGSFGSVYYGKMKDGKE---VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNLVPLI 652
           ++G G+FGSV  G  +  K+   VA+K++         +  + E  ++ ++ +  +V LI
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76

Query: 653 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 712
           G C+ E   +LV E    G L   L G   ++ +      ++ H  + G++YL       
Sbjct: 77  GVCQAE-ALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYL---EEKN 130

Query: 713 IIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPEYYGNQQL 770
            +HRD+ + N+LL     AK+SDFGLS+   A++      S  +  + +  PE    ++ 
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 190

Query: 771 TEKSDVYSFGVVLLELIS-GKKP 792
           + +SDV+S+GV + E +S G+KP
Sbjct: 191 SSRSDVWSYGVTMWEALSYGQKP 213

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  146 bits (371), Expect = 3e-39
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 12/203 (5%)

Query: 596 KKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNLVP 650
           + IG+G FG V+ G     +     VA+K   +  S   ++ F+ E   + +  H ++V 
Sbjct: 21  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80

Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 710
           LIG   E    I + E    G LR  L     +  LD  + +  A+  +  L YL    +
Sbjct: 81  LIGVITENPVWI-IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLE---S 134

Query: 711 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 770
              +HRD+ + N+L+  N   K+ DFGLSR  E+   + +S  +  + ++ PE    ++ 
Sbjct: 135 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 194

Query: 771 TEKSDVYSFGVVLLELIS-GKKP 792
           T  SDV+ FGV + E++  G KP
Sbjct: 195 TSASDVWMFGVCMWEILMHGVKP 217

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  147 bits (372), Expect = 3e-39
 Identities = 53/217 (24%), Positives = 98/217 (45%), Gaps = 28/217 (12%)

Query: 596 KKIGKGSFGSVYYGKMK-DGKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVPLIG 653
           + +G+G FG V+  K K D    A+K +   +     ++ + EV  L+++ H  +V    
Sbjct: 11  QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 70

Query: 654 YCEEEH---------QRILVY---EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 701
              E++          ++ +Y   +      L+D ++G    +  +    L I    A+ 
Sbjct: 71  AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEA 130

Query: 702 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR------- 754
           +E+LH   + G++HRD+K SNI   ++   KV DFGL    ++D    + +         
Sbjct: 131 VEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187

Query: 755 ----GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELI 787
               GT  Y+ PE       + K D++S G++L EL+
Sbjct: 188 TGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  147 bits (374), Expect = 3e-39
 Identities = 60/209 (28%), Positives = 108/209 (51%), Gaps = 17/209 (8%)

Query: 594 FCKKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNL 648
             K IG G  G V YG+++   +    VA+K +    + R ++ F++E +++ +  H N+
Sbjct: 53  IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI 112

Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           + L G        ++V EYM NG+L   L    +      +  + +      G+ YL   
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYLSD- 169

Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPE--Y 764
              G +HRD+ + N+L+D N+  KVSDFGLSR  + + D  + ++  +  + +  PE   
Sbjct: 170 --LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA 227

Query: 765 YGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
           +     +  SDV+SFGVV+ E+++ G++P
Sbjct: 228 FR--TFSSASDVWSFGVVMWEVLAYGERP 254

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  147 bits (373), Expect = 3e-39
 Identities = 52/214 (24%), Positives = 87/214 (40%), Gaps = 20/214 (9%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 654
           +K+G+G F  V   + + DG   A+K +        ++   E  +    +H N++ L+ Y
Sbjct: 35  QKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAY 94

Query: 655 CEEEHQR----ILVYEYMHNGTLRDRL-HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 709
           C  E        L+  +   GTL + +         L     L +     +GLE +H   
Sbjct: 95  CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH--- 151

Query: 710 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--------GTVGYLD 761
             G  HRD+K +NILL    +  + D G   QA   +                 T+ Y  
Sbjct: 152 AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRA 211

Query: 762 PE---YYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           PE      +  + E++DV+S G VL  ++ G+ P
Sbjct: 212 PELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  146 bits (370), Expect = 3e-39
 Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 12/213 (5%)

Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRTQQ-FVTEVALL 640
            +        + +G+G FG VY G   + K     VAVK     C+   ++ F++E  ++
Sbjct: 8   GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIM 67

Query: 641 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 700
             + H ++V LIG  EEE   I + E    G L   L    N+  L  LT +  +    K
Sbjct: 68  KNLDHPHIVKLIGIIEEEPTWI-IMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICK 124

Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYL 760
            + YL    +   +HRD+   NIL+      K+ DFGLSR  E++  + +SV R  + ++
Sbjct: 125 AMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM 181

Query: 761 DPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
            PE    ++ T  SDV+ F V + E++S GK+P
Sbjct: 182 SPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  145 bits (368), Expect = 8e-39
 Identities = 65/219 (29%), Positives = 103/219 (47%), Gaps = 15/219 (6%)

Query: 584 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRTQQ-FVTEVA 638
           +        +F + IG+G FG VY+G + D        AVK +           F+TE  
Sbjct: 19  VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI 78

Query: 639 LLSRIHHRNLVPLIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHD 697
           ++    H N++ L+G C   E   ++V  YM +G LR+ +              +     
Sbjct: 79  IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQ 136

Query: 698 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED---LTHISSVAR 754
            AKG++YL    +   +HRD+ + N +LD     KV+DFGL+R   +      H  + A+
Sbjct: 137 VAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 193

Query: 755 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
             V ++  E    Q+ T KSDV+SFGV+L EL++ G  P
Sbjct: 194 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  145 bits (367), Expect = 9e-39
 Identities = 66/228 (28%), Positives = 98/228 (42%), Gaps = 21/228 (9%)

Query: 575 DEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYG--KMKDGKE--VAVKIM-ADSCSHR 629
            + +   I   +L        +K+G GSFG V  G      GK   VAVK +  D  S  
Sbjct: 8   LQSLTCLIGEKDLR-----LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQP 62

Query: 630 TQQ--FVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD 687
                F+ EV  +  + HRNL+ L G       ++ V E    G+L DRL        L 
Sbjct: 63  EAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLG 121

Query: 688 WLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEED 745
            L   + A   A+G+ YL    +   IHRD+ + N+LL      K+ DFGL R     +D
Sbjct: 122 TL--SRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD 176

Query: 746 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
              +    +    +  PE    +  +  SD + FGV L E+ + G++P
Sbjct: 177 HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  152 bits (386), Expect = 1e-38
 Identities = 70/296 (23%), Positives = 126/296 (42%), Gaps = 24/296 (8%)

Query: 515 GTSIGVLAILLVLFLC--------SLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYS 566
             +I      L+   C        S I+  +   + +     + A++ +   +    + S
Sbjct: 303 SLTIAENMADLIDGYCRLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVS 362

Query: 567 IARG-GHFMDEGVAYFIPLP---ELEEATNNFCKKIGKGSFGSVYYGKMKDGKE----VA 618
                   +DE   Y +P     E++       + IG+G FG V+ G     +     VA
Sbjct: 363 ETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVA 422

Query: 619 VKIMADSCSHRTQQ-FVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL 677
           +K   +  S   ++ F+ E   + +  H ++V LIG   E     ++ E    G LR  L
Sbjct: 423 IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFL 481

Query: 678 HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 737
                +  LD  + +  A+  +  L YL    +   +HRD+ + N+L+  N   K+ DFG
Sbjct: 482 QV--RKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFG 536

Query: 738 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
           LSR  E+   + +S  +  + ++ PE    ++ T  SDV+ FGV + E++  G KP
Sbjct: 537 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  143 bits (364), Expect = 2e-38
 Identities = 67/201 (33%), Positives = 108/201 (53%), Gaps = 13/201 (6%)

Query: 594 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 653
             + IGKG FG V  G  + G +VAVK + +  +   Q F+ E ++++++ H NLV L+G
Sbjct: 25  LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLG 81

Query: 654 YCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 712
              EE   + +V EYM  G+L D L     +  L     L+ + D  + +EYL       
Sbjct: 82  VIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE---GNN 137

Query: 713 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 772
            +HRD+ + N+L+  +  AKVSDFGL+++A           +  V +  PE    ++ + 
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDTGKLPVKWTAPEALREKKFST 193

Query: 773 KSDVYSFGVVLLELIS-GKKP 792
           KSDV+SFG++L E+ S G+ P
Sbjct: 194 KSDVWSFGILLWEIYSFGRVP 214

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  143 bits (364), Expect = 2e-38
 Identities = 61/205 (29%), Positives = 105/205 (51%), Gaps = 15/205 (7%)

Query: 596 KKIGKGSFGSVYYGKMKDGK---EVAVKIM-ADSCSHRTQQ-FVTEVALLSRIHHRNLVP 650
           K++G G+FG+V  G  +  K    VAVKI+  ++     +   + E  ++ ++ +  +V 
Sbjct: 23  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82

Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 710
           +IG CE E   + V E    G L   L      + +     +++ H  + G++YL     
Sbjct: 83  MIGICEAESWML-VMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLE---E 135

Query: 711 PGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPEYYGNQ 768
              +HRD+ + N+LL     AK+SDFGLS+  +A+E+     +  +  V +  PE     
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 195

Query: 769 QLTEKSDVYSFGVVLLELIS-GKKP 792
           + + KSDV+SFGV++ E  S G+KP
Sbjct: 196 KFSSKSDVWSFGVLMWEAFSYGQKP 220

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  143 bits (363), Expect = 3e-38
 Identities = 68/212 (32%), Positives = 108/212 (50%), Gaps = 14/212 (6%)

Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMK-----DGKEVAVKIMADSCSHRTQQFVTEVALL 640
           + EE    F +++GKG+FGSV   +        G+ VAVK +  S     + F  E+ +L
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65

Query: 641 SRIHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDA 698
             + H N+V   G C    +R   L+ EY+  G+LRD L    +++ +D +  LQ     
Sbjct: 66  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQI 123

Query: 699 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGT 756
            KG+EYL T      IHRD+ + NIL++   R K+ DFGL++    +++   +       
Sbjct: 124 CKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESP 180

Query: 757 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
           + +  PE     + +  SDV+SFGVVL EL +
Sbjct: 181 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  144 bits (366), Expect = 3e-38
 Identities = 53/226 (23%), Positives = 109/226 (48%), Gaps = 19/226 (8%)

Query: 575 DEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHR 629
           ++ +   +   E +       K +G G+FG+VY G      E     VA+K + ++ S +
Sbjct: 5   NQALLRILKETEFK-----KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK 59

Query: 630 TQQ-FVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDW 688
             +  + E  +++ + + ++  L+G C       L+ + M  G L D +    ++  +  
Sbjct: 60  ANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVRE--HKDNIGS 116

Query: 689 LTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLT 747
              L      AKG+ YL    +  ++HRD+ + N+L+      K++DFGL++    E+  
Sbjct: 117 QYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173

Query: 748 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
           + +   +  + ++  E   ++  T +SDV+S+GV + EL++ G KP
Sbjct: 174 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  144 bits (365), Expect = 5e-38
 Identities = 63/208 (30%), Positives = 107/208 (51%), Gaps = 14/208 (6%)

Query: 594 FCKKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRN 647
             K IG G FG VY G +K         VA+K +    + + +  F+ E  ++ +  H N
Sbjct: 48  RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107

Query: 648 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
           ++ L G   +    +++ EYM NG L   L           L  + +    A G++YL  
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLA- 164

Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPEYY 765
             N   +HRD+ + NIL++ N+  KVSDFGLSR  + + + T+ +S  +  + +  PE  
Sbjct: 165 --NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 222

Query: 766 GNQQLTEKSDVYSFGVVLLELIS-GKKP 792
             ++ T  SDV+SFG+V+ E+++ G++P
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMTYGERP 250

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  144 bits (366), Expect = 5e-38
 Identities = 62/207 (29%), Positives = 99/207 (47%), Gaps = 22/207 (10%)

Query: 596 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRT----QQFVTEVALLSRIHHRNLVP 650
           +KIG+GSFG     K   DG++  +K +  + S  +    ++   EVA+L+ + H N+V 
Sbjct: 30  QKIGEGSFGKAILVKSTEDGRQYVIKEI--NISRMSSKEREESRREVAVLANMKHPNIVQ 87

Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQ-----KPLDWLTRLQIAHDAAKGLEYL 705
                EE     +V +Y   G L  R++          + LDW    QI       L+++
Sbjct: 88  YRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFV--QICL----ALKHV 141

Query: 706 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 765
           H   +  I+HRD+KS NI L  +   ++ DFG++R     +    +   GT  YL PE  
Sbjct: 142 H---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEIC 197

Query: 766 GNQQLTEKSDVYSFGVVLLELISGKKP 792
            N+    KSD+++ G VL EL + K  
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLKHA 224

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  142 bits (361), Expect = 5e-38
 Identities = 54/229 (23%), Positives = 101/229 (44%), Gaps = 32/229 (13%)

Query: 584 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGK--------EVAVKIMADSCSHRTQQFVT 635
             ++      F + +G+G+F  ++ G  ++          EV +K++  +  + ++ F  
Sbjct: 2   FHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFE 61

Query: 636 EVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA 695
             +++S++ H++LV   G C    + ILV E++  G+L   L  + N   + W   L++A
Sbjct: 62  AASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWK--LEVA 119

Query: 696 HDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI--------NMRAKVSDFGLSRQAEEDLT 747
              A  + +L       +IH +V + NILL              K+SD G+S        
Sbjct: 120 KQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK-- 174

Query: 748 HISSVARGTVGYLDPE---YYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
               + +  + ++ PE      N  L   +D +SFG  L E+ S G KP
Sbjct: 175 ---DILQERIPWVPPECIENPKN--LNLATDKWSFGTTLWEICSGGDKP 218

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  143 bits (362), Expect = 6e-38
 Identities = 55/220 (25%), Positives = 104/220 (47%), Gaps = 16/220 (7%)

Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMK-----DGKEVAVKIMADSCSHRTQQ-FVTEVAL 639
             E+      + +G+G FG V   +        G++VAVK +              E+ +
Sbjct: 17  HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEI 76

Query: 640 LSRIHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHD 697
           L  ++H N+V   G C E+      L+ E++ +G+L++ L    N+  ++   +L+ A  
Sbjct: 77  LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK--NKNKINLKQQLKYAVQ 134

Query: 698 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARG 755
             KG++YL    +   +HRD+ + N+L++   + K+ DFGL++  + +++   +      
Sbjct: 135 ICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDS 191

Query: 756 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVS 794
            V +  PE     +    SDV+SFGV L EL++      S
Sbjct: 192 PVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSS 231

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  149 bits (378), Expect = 7e-38
 Identities = 57/204 (27%), Positives = 104/204 (50%), Gaps = 13/204 (6%)

Query: 596 KKIGKGSFGSVYYGKMKDGKE---VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNLVPL 651
            ++G G+FGSV  G  +  K+   VA+K++         +  + E  ++ ++ +  +V L
Sbjct: 342 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 401

Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 711
           IG C+ E   +LV E    G L   L G   ++ +      ++ H  + G++YL      
Sbjct: 402 IGVCQAE-ALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYL---EEK 455

Query: 712 GIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPEYYGNQQ 769
             +HR++ + N+LL     AK+SDFGLS+   A++      S  +  + +  PE    ++
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 515

Query: 770 LTEKSDVYSFGVVLLELIS-GKKP 792
            + +SDV+S+GV + E +S G+KP
Sbjct: 516 FSSRSDVWSYGVTMWEALSYGQKP 539

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  143 bits (363), Expect = 8e-38
 Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 15/217 (6%)

Query: 586 ELEEATNNFCKKIGKGSFGSVYYG-----KMKDGKEVAVKIMADSCSHRTQQFVTEVALL 640
             EE    +  ++GKG+FGSV            G  VAVK +  S   + + F  E+ +L
Sbjct: 19  IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQIL 78

Query: 641 SRIHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDA 698
             +H   +V   G      ++   LV EY+ +G LRD L    ++  LD    L  +   
Sbjct: 79  KALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR--HRARLDASRLLLYSSQI 136

Query: 699 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGT 756
            KG+EYL +      +HRD+ + NIL++     K++DFGL++    ++D   +    +  
Sbjct: 137 CKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP 193

Query: 757 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
           + +  PE   +   + +SDV+SFGVVL EL +   K 
Sbjct: 194 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS 230

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  143 bits (362), Expect = 8e-38
 Identities = 57/235 (24%), Positives = 100/235 (42%), Gaps = 32/235 (13%)

Query: 596 KKIGKGSFGSVYYGKMK-DGKEVAVKI--MADSCSHRT-QQFVTEVALLSRIHHRNLVPL 651
           KKIG+G F  VY      DG  VA+K   + D    +     + E+ LL +++H N++  
Sbjct: 38  KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97

Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKP-------LDWLTRLQIAHDAAKGLEY 704
                E+++  +V E    G L   +     QK          +    Q+       LE+
Sbjct: 98  YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFV--QLCS----ALEH 151

Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLD 761
           +H   +  ++HRD+K +N+ +      K+ D GL R      +  ++ A   VG   Y+ 
Sbjct: 152 MH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRF----FSSKTTAAHSLVGTPYYMS 204

Query: 762 PEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 816
           PE         KSD++S G +L E+ + + P     F  +   ++     I++ D
Sbjct: 205 PERIHENGYNFKSDIWSLGCLLYEMAALQSP-----FYGDKMNLYSLCKKIEQCD 254

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  143 bits (362), Expect = 1e-37
 Identities = 68/212 (32%), Positives = 108/212 (50%), Gaps = 14/212 (6%)

Query: 586 ELEEATNNFCKKIGKGSFGSVYYG-----KMKDGKEVAVKIMADSCSHRTQQFVTEVALL 640
           + EE    F +++GKG+FGSV        +   G+ VAVK +  S     + F  E+ +L
Sbjct: 37  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 96

Query: 641 SRIHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDA 698
             + H N+V   G C    +R   L+ EY+  G+LRD L    +++ +D +  LQ     
Sbjct: 97  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQI 154

Query: 699 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGT 756
            KG+EYL T      IHRD+ + NIL++   R K+ DFGL++    +++   +       
Sbjct: 155 CKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESP 211

Query: 757 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 788
           + +  PE     + +  SDV+SFGVVL EL +
Sbjct: 212 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 243

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  144 bits (365), Expect = 1e-37
 Identities = 67/219 (30%), Positives = 105/219 (47%), Gaps = 15/219 (6%)

Query: 584 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRT-QQFVTEVA 638
           +        +F + IG+G FG VY+G + D        AVK +          QF+TE  
Sbjct: 83  VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI 142

Query: 639 LLSRIHHRNLVPLIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHD 697
           ++    H N++ L+G C   E   ++V  YM +G LR+ +              +     
Sbjct: 143 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQ 200

Query: 698 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR---QAEEDLTHISSVAR 754
            AKG+++L    +   +HRD+ + N +LD     KV+DFGL+R     E D  H  + A+
Sbjct: 201 VAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 257

Query: 755 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
             V ++  E    Q+ T KSDV+SFGV+L EL++ G  P
Sbjct: 258 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  141 bits (358), Expect = 1e-37
 Identities = 62/205 (30%), Positives = 93/205 (45%), Gaps = 9/205 (4%)

Query: 596 KKIGKGSFGSVYYGKMK-DGKEVAVK-IMADSCSHRT-QQFVTEVALLSRIHHRNLVPLI 652
             IG GS+G     + K DGK +  K +   S +    Q  V+EV LL  + H N+V   
Sbjct: 12  YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71

Query: 653 GYCEEEHQRIL--VYEYMHNGTLRDRL-HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 709
               +     L  V EY   G L   +  G+  ++ LD    L++       L+  H   
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131

Query: 710 NPG--IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 767
           + G  ++HRD+K +N+ LD     K+ DFGL+R    D +   +   GT  Y+ PE    
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQMNR 190

Query: 768 QQLTEKSDVYSFGVVLLELISGKKP 792
               EKSD++S G +L EL +   P
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPP 215

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  142 bits (361), Expect = 1e-37
 Identities = 54/205 (26%), Positives = 102/205 (49%), Gaps = 14/205 (6%)

Query: 596 KKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNLV 649
           K +G G FG+V+ G      E     V +K++ D    ++ Q     +  +  + H ++V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78

Query: 650 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 709
            L+G C     ++ V +Y+  G+L D +    ++  L     L      AKG+ YL    
Sbjct: 79  RLLGLCPGSSLQL-VTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMYYLE--- 132

Query: 710 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE-EDLTHISSVARGTVGYLDPEYYGNQ 768
             G++HR++ + N+LL    + +V+DFG++     +D   + S A+  + ++  E     
Sbjct: 133 EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG 192

Query: 769 QLTEKSDVYSFGVVLLELIS-GKKP 792
           + T +SDV+S+GV + EL++ G +P
Sbjct: 193 KYTHQSDVWSYGVTVWELMTFGAEP 217

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  144 bits (364), Expect = 1e-37
 Identities = 59/207 (28%), Positives = 109/207 (52%), Gaps = 13/207 (6%)

Query: 594 FCKKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNL 648
             K +G G FG V  G++K   +    VA+K +    + + ++ F+ E +++ +  H N+
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI 108

Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           + L G   +    ++V EYM NG+L   L    +      +  + +    A G++YL   
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSD- 165

Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPEYYG 766
              G +HRD+ + NIL++ N+  KVSDFGL R  + + +  + +   +  + +  PE   
Sbjct: 166 --MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223

Query: 767 NQQLTEKSDVYSFGVVLLELIS-GKKP 792
            ++ T  SDV+S+G+VL E++S G++P
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERP 250

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  142 bits (359), Expect = 1e-37
 Identities = 58/231 (25%), Positives = 96/231 (41%), Gaps = 48/231 (20%)

Query: 594 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 652
               +G+G+FG V   +   D +  A+K +      +    ++EV LL+ ++H+ +V   
Sbjct: 10  EIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVVRYY 68

Query: 653 G-YCEEEHQRI------------LVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHD 697
             + E  +               +  EY  NGTL D +       Q+   W    QI   
Sbjct: 69  AAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL-- 126

Query: 698 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--- 754
             + L Y+H   + GIIHRD+K  NI +D +   K+ DFGL++     L  +   ++   
Sbjct: 127 --EALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181

Query: 755 ----------GTVGYLDPE------YYGNQQLTEKSDVYSFGVVLLELISG 789
                     GT  Y+  E      +Y      EK D+YS G++  E+I  
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYN-----EKIDMYSLGIIFFEMIYP 227

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  142 bits (359), Expect = 2e-37
 Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 15/207 (7%)

Query: 596 KKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRT-QQFVTEVALLSRIHHRNLVP 650
           + IGKG FG VY+G+  D  +     A+K ++     +  + F+ E  L+  ++H N++ 
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86

Query: 651 LIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 709
           LIG     E    ++  YM +G L   +     Q+       +      A+G+EYL    
Sbjct: 87  LIGIMLPPEGLPHVLLPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLA--- 141

Query: 710 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT---VGYLDPEYYG 766
               +HRD+ + N +LD +   KV+DFGL+R   +   +     R     V +   E   
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQ 201

Query: 767 NQQLTEKSDVYSFGVVLLELIS-GKKP 792
             + T KSDV+SFGV+L EL++ G  P
Sbjct: 202 TYRFTTKSDVWSFGVLLWELLTRGAPP 228

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  141 bits (358), Expect = 2e-37
 Identities = 62/203 (30%), Positives = 103/203 (50%), Gaps = 14/203 (6%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVT----EVALLSRIHHRNLVP 650
            K+G G   +VY  +      +VA+K +        ++ +     EV   S++ H+N+V 
Sbjct: 17  DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPR-EKEETLKRFEREVHNSSQLSHQNIVS 75

Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 710
           +I   EE+    LV EY+   TL + +    +  PL   T +   +    G+++ H   +
Sbjct: 76  MIDVDEEDDCYYLVMEYIEGPTLSEYIE---SHGPLSVDTAINFTNQILDGIKHAH---D 129

Query: 711 PGIIHRDVKSSNILLDINMRAKVSDFGLSR-QAEEDLTHISSVARGTVGYLDPEYYGNQQ 769
             I+HRD+K  NIL+D N   K+ DFG+++  +E  LT  + V  GTV Y  PE    + 
Sbjct: 130 MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVL-GTVQYFSPEQAKGEA 188

Query: 770 LTEKSDVYSFGVVLLELISGKKP 792
             E +D+YS G+VL E++ G+ P
Sbjct: 189 TDECTDIYSIGIVLYEMLVGEPP 211

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  144 bits (366), Expect = 2e-37
 Identities = 53/209 (25%), Positives = 89/209 (42%), Gaps = 22/209 (10%)

Query: 596 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGY 654
             +G G+ G++ Y  M D ++VAVK +   C     +   EV LL     H N++     
Sbjct: 30  DVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADR---EVQLLRESDEHPNVIRYFCT 86

Query: 655 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 714
            ++   + +  E     TL++ +           L  + +      GL +LH   +  I+
Sbjct: 87  EKDRQFQYIAIELC-AATLQEYVEQ--KDFAHLGLEPITLLQQTTSGLAHLH---SLNIV 140

Query: 715 HRDVKSSNILL-----DINMRAKVSDFGLSRQAEED---LTHISSVARGTVGYLDPEYY- 765
           HRD+K  NIL+        ++A +SDFGL ++        +  S V  GT G++ PE   
Sbjct: 141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP-GTEGWIAPEMLS 199

Query: 766 --GNQQLTEKSDVYSFGVVLLELISGKKP 792
               +  T   D++S G V   +IS    
Sbjct: 200 EDCKENPTYTVDIFSAGCVFYYVISEGSH 228

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  141 bits (357), Expect = 7e-37
 Identities = 56/251 (22%), Positives = 97/251 (38%), Gaps = 46/251 (18%)

Query: 596 KKIGKGSFGSVYYGKMKDGKEVAVKIM-----------------ADSCSHRTQQFVTEVA 638
           + + +G F  +   + KD K  A+K                     S   +   F  E+ 
Sbjct: 37  RTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQ 95

Query: 639 LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQ--- 693
           +++ I +   +   G      +  ++YEYM N ++         +++    ++       
Sbjct: 96  IITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKC 155

Query: 694 IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 753
           I         Y+H      I HRDVK SNIL+D N R K+SDFG S    +     S   
Sbjct: 156 IIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS--- 210

Query: 754 RGTVGYLDPE-------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVH 806
           RGT  ++ PE       Y G      K D++S G+ L  +     P     F  ++++V 
Sbjct: 211 RGTYEFMPPEFFSNESSYNG-----AKVDIWSLGICLYVMFYNVVP-----FSLKISLVE 260

Query: 807 WARSMIKKGDV 817
              + I+  ++
Sbjct: 261 -LFNNIRTKNI 270

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  139 bits (353), Expect = 1e-36
 Identities = 57/220 (25%), Positives = 94/220 (42%), Gaps = 18/220 (8%)

Query: 586 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHRTQQ-FVTEVAL 639
              +      + +G+G FG V         +     VAVK +      + +  +  E+ +
Sbjct: 27  VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDI 86

Query: 640 LSRIHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHD 697
           L  ++H +++   G CE+       LV EY+  G+LRD L     +  +     L  A  
Sbjct: 87  LRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP----RHSIGLAQLLLFAQQ 142

Query: 698 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARG 755
             +G+ YLH       IHRD+ + N+LLD +   K+ DFGL++      +   +      
Sbjct: 143 ICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 199

Query: 756 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVS 794
            V +  PE     +    SDV+SFGV L EL++      S
Sbjct: 200 PVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQS 239

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  140 bits (354), Expect = 1e-36
 Identities = 67/237 (28%), Positives = 105/237 (44%), Gaps = 19/237 (8%)

Query: 572 HFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGK------EVAVKIMADS 625
           +      +    L E+        + +G G+FG VY G++          +VAVK + + 
Sbjct: 12  YCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV 71

Query: 626 CSHRTQQ-FVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGT----LRDRLHGS 680
           CS + +  F+ E  ++S+ +H+N+V  IG   +   R ++ E M  G     LR+     
Sbjct: 72  CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRP 131

Query: 681 VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFG 737
                L  L  L +A D A G +YL        IHRD+ + N LL        AK+ DFG
Sbjct: 132 SQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFG 188

Query: 738 LSRQ-AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
           ++R             A   V ++ PE +     T K+D +SFGV+L E+ S G  P
Sbjct: 189 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  139 bits (353), Expect = 2e-36
 Identities = 58/215 (26%), Positives = 103/215 (47%), Gaps = 19/215 (8%)

Query: 594 FCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQ-FVTEVALLSRIHHR 646
             +++G+GSFG VY G  K   +      VA+K + ++ S R +  F+ E +++   +  
Sbjct: 29  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88

Query: 647 NLVPLIGYCEEEHQRILVYEYMHNGT----LRDRLHGSVNQKPLDWLTR---LQIAHDAA 699
           ++V L+G   +    +++ E M  G     LR       N   L   +    +Q+A + A
Sbjct: 89  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148

Query: 700 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVG 758
            G+ YL+       +HRD+ + N ++  +   K+ DFG++R   E D           V 
Sbjct: 149 DGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205

Query: 759 YLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
           ++ PE   +   T  SDV+SFGVVL E+ +  ++P
Sbjct: 206 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  138 bits (349), Expect = 2e-36
 Identities = 60/201 (29%), Positives = 91/201 (45%), Gaps = 13/201 (6%)

Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHR---TQQFVTEVALLSRIHHRNLVPL 651
           + +GKG FG+VY  + K     +A+K++  +   +     Q   EV + S + H N++ L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74

Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 711
            GY  +  +  L+ EY   GT+   L         D         + A  L Y H   + 
Sbjct: 75  YGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCH---SK 128

Query: 712 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 771
            +IHRD+K  N+LL      K++DFG S  A            GT+ YL PE    +   
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC---GTLDYLPPEMIEGRMHD 185

Query: 772 EKSDVYSFGVVLLELISGKKP 792
           EK D++S GV+  E + GK P
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPP 206

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  139 bits (353), Expect = 2e-36
 Identities = 69/218 (31%), Positives = 104/218 (47%), Gaps = 24/218 (11%)

Query: 594 FCKKIGKGSFGSVYYGKMKDGKE---VAVKIMADSCSHRTQQ-FVTEVALLSRI-HHRNL 648
           F   IG+G+FG V   ++K        A+K M +  S    + F  E+ +L ++ HH N+
Sbjct: 29  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88

Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGS-------------VNQKPLDWLTRLQIA 695
           + L+G CE      L  EY  +G L D L  S                  L     L  A
Sbjct: 89  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148

Query: 696 HDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARG 755
            D A+G++YL        IHRD+ + NIL+  N  AK++DFGLSR   +++    ++ R 
Sbjct: 149 ADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRL 203

Query: 756 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
            V ++  E       T  SDV+S+GV+L E++S G  P
Sbjct: 204 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  138 bits (351), Expect = 2e-36
 Identities = 65/213 (30%), Positives = 103/213 (48%), Gaps = 19/213 (8%)

Query: 596 KKIGKGSFGSVYYGKMKDGKE----VAVKIM-ADSCSHRTQQ-FVTEVALLSRIHHRNLV 649
           K +G+G FGSV  G +K        VAVK M  D+ S R  + F++E A +    H N++
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99

Query: 650 PLIGYCEEEHQRI-----LVYEYMHNGTLRDRLHGSVNQKPLDWLTR---LQIAHDAAKG 701
            L+G C E   +      ++  +M  G L   L  S  +     +     L+   D A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159

Query: 702 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYL 760
           +EYL        +HRD+ + N +L  +M   V+DFGLS++    D      +A+  V ++
Sbjct: 160 MEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 216

Query: 761 DPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
             E   ++  T KSDV++FGV + E+ + G  P
Sbjct: 217 AIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  140 bits (355), Expect = 2e-36
 Identities = 71/279 (25%), Positives = 116/279 (41%), Gaps = 19/279 (6%)

Query: 530 CSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEE 589
              I   +         S  ++   + S   ++T  +     +      +    L E+  
Sbjct: 11  DYDIPTTENLYFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPR 70

Query: 590 ATNNFCKKIGKGSFGSVYYGKMKDGK------EVAVKIMADSCSHRTQQ-FVTEVALLSR 642
                 + +G G+FG VY G++          +VAVK + + CS + +  F+ E  ++S+
Sbjct: 71  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130

Query: 643 IHHRNLVPLIGYCEEEHQRILVYEYMHNGT----LRDRLHGSVNQKPLDWLTRLQIAHDA 698
            +H+N+V  IG   +   R ++ E M  G     LR+          L  L  L +A D 
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190

Query: 699 AKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQ-AEEDLTHISSVAR 754
           A G +YL        IHRD+ + N LL        AK+ DFG++R             A 
Sbjct: 191 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAM 247

Query: 755 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
             V ++ PE +     T K+D +SFGV+L E+ S G  P
Sbjct: 248 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  138 bits (350), Expect = 4e-36
 Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 20/214 (9%)

Query: 596 KKIGKGSFGSVYYGKMKDGKE----VAVKIM-ADSCSHR-TQQFVTEVALLSRIHHRNLV 649
           + +GKG FGSV   ++K        VAVK++ AD  +    ++F+ E A +    H ++ 
Sbjct: 29  RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88

Query: 650 PLIGYCEEEHQRI------LVYEYMHNGTLRDRLHGS---VNQKPLDWLTRLQIAHDAAK 700
            L+G       +       ++  +M +G L   L  S    N   L   T ++   D A 
Sbjct: 89  KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148

Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGY 759
           G+EYL +      IHRD+ + N +L  +M   V+DFGLSR+    D       ++  V +
Sbjct: 149 GMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKW 205

Query: 760 LDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
           L  E   +   T  SDV++FGV + E+++ G+ P
Sbjct: 206 LALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  137 bits (348), Expect = 5e-36
 Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 14/203 (6%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVT----EVALLSRIHHRNLVP 650
           + +G+G  G VY  +     + VA+K+M+++ S     F T    E     R+   ++VP
Sbjct: 40  RLVGRGGMGDVYEAEDTVRERIVALKLMSETLS-SDPVFRTRMQREARTAGRLQEPHVVP 98

Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 710
           +  + E + Q  +    ++   L   L     Q PL     + I       L+  H    
Sbjct: 99  IHDFGEIDGQLYVDMRLINGVDLAAMLR---RQGPLAPPRAVAIVRQIGSALDAAHAA-- 153

Query: 711 PGIIHRDVKSSNILLDINMRAKVSDFGLSR-QAEEDLTHISSVARGTVGYLDPEYYGNQQ 769
            G  HRDVK  NIL+  +  A + DFG++    +E LT + +   GT+ Y+ PE +    
Sbjct: 154 -GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYMAPERFSESH 211

Query: 770 LTEKSDVYSFGVVLLELISGKKP 792
            T ++D+Y+   VL E ++G  P
Sbjct: 212 ATYRADIYALTCVLYECLTGSPP 234

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  137 bits (347), Expect = 1e-35
 Identities = 51/220 (23%), Positives = 91/220 (41%), Gaps = 24/220 (10%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIG 653
           + + +G F  VY  + +  G+E A+K +  +   + +  + EV  + ++  H N+V    
Sbjct: 34  RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93

Query: 654 YCEEEHQR-------ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
                 +         L+   +  G L + L    ++ PL   T L+I +   + ++++H
Sbjct: 94  AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH 153

Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA-----------RG 755
               P IIHRD+K  N+LL      K+ DFG +        +  S               
Sbjct: 154 R-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212

Query: 756 TVGYLDPE---YYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           T  Y  PE    Y N  + EK D+++ G +L  L   + P
Sbjct: 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  135 bits (343), Expect = 2e-35
 Identities = 58/243 (23%), Positives = 103/243 (42%), Gaps = 33/243 (13%)

Query: 596 KKIGKGSFGSVYYGKMKDGKEVAVKIMA-DSCSHRT-QQFVTEVALLSRIHHRNL--VPL 651
           K+IG G    V+    +  +  A+K +  +   ++T   +  E+A L+++   +   + L
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93

Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 711
             Y   +    +V E   N  L   L     +K +D   R     +  + +  +H     
Sbjct: 94  YDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIH---QH 146

Query: 712 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI---SSVARGTVGYLDPE----- 763
           GI+H D+K +N L+  +   K+ DFG++ Q + D T +   S V  GTV Y+ PE     
Sbjct: 147 GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQV--GTVNYMPPEAIKDM 203

Query: 764 ------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 817
                      +++ KSDV+S G +L  +  GK P     F   +N +    ++I     
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP-----FQQIINQISKLHAIIDPNHE 258

Query: 818 ISI 820
           I  
Sbjct: 259 IEF 261

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  134 bits (340), Expect = 3e-35
 Identities = 54/202 (26%), Positives = 86/202 (42%), Gaps = 15/202 (7%)

Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPL 651
           + +GKG FG+VY  + K     +A+K++  S         Q   E+ + S + H N++ +
Sbjct: 20  RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79

Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD-WLTRLQIAHDAAKGLEYLHTGCN 710
             Y  +  +  L+ E+   G L   L         D   +      + A  L Y H    
Sbjct: 80  YNYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSA-TFMEELADALHYCH---E 132

Query: 711 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 770
             +IHRD+K  N+L+      K++DFG S  A            GT+ YL PE    +  
Sbjct: 133 RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC---GTLDYLPPEMIEGKTH 189

Query: 771 TEKSDVYSFGVVLLELISGKKP 792
            EK D++  GV+  E + G  P
Sbjct: 190 DEKVDLWCAGVLCYEFLVGMPP 211

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  134 bits (339), Expect = 4e-35
 Identities = 65/208 (31%), Positives = 97/208 (46%), Gaps = 24/208 (11%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPL 651
             +GKGSF  VY  + +  G EVA+K++       +   Q+   EV +  ++ H +++ L
Sbjct: 17  NLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILEL 76

Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD-WLTR---LQIAHDAAKGLEYLHT 707
             Y E+ +   LV E  HNG +   L      KP      R    QI      G+ YLH 
Sbjct: 77  YNYFEDSNYVYLVLEMCHNGEMNRYLK--NRVKPFSENEARHFMHQII----TGMLYLH- 129

Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDPEY 764
             + GI+HRD+  SN+LL  NM  K++DFGL+ Q +              GT  Y+ PE 
Sbjct: 130 --SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP----HEKHYTLCGTPNYISPEI 183

Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKP 792
                   +SDV+S G +   L+ G+ P
Sbjct: 184 ATRSAHGLESDVWSLGCMFYTLLIGRPP 211

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  137 bits (348), Expect = 5e-35
 Identities = 59/241 (24%), Positives = 98/241 (40%), Gaps = 41/241 (17%)

Query: 596 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGY 654
           K +G GS G+V +     G+ VAVK M             E+ LL+    H N++     
Sbjct: 21  KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALM---EIKLLTESDDHPNVIRYYCS 77

Query: 655 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK-------GLEYLHT 707
              +    +  E   N  L+D +    ++   D   +LQ  ++          G+ +LH 
Sbjct: 78  ETTDRFLYIALELC-NLNLQDLV---ESKNVSDENLKLQKEYNPISLLRQIASGVAHLH- 132

Query: 708 GCNPGIIHRDVKSSNILLDI-------------NMRAKVSDFGLSRQAEEDLTHISSVAR 754
             +  IIHRD+K  NIL+               N+R  +SDFGL ++ +   +   +   
Sbjct: 133 --SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190

Query: 755 ---GTVGYLDPE-------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNI 804
              GT G+  PE           ++LT   D++S G V   ++S  K    + +  E NI
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNI 250

Query: 805 V 805
           +
Sbjct: 251 I 251

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  134 bits (339), Expect = 5e-35
 Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 18/206 (8%)

Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 654
             +GKG++G VY G+       +A+K + +  S  +Q    E+AL   + H+N+V  +G 
Sbjct: 28  VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87

Query: 655 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD-----WLTRLQIAHDAAKGLEYLHTGC 709
             E     +  E +  G+L   L         +     + T+ QI      GL+YLH   
Sbjct: 88  FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK-QILE----GLKYLH--- 139

Query: 710 NPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE--YYG 766
           +  I+HRD+K  N+L++  +   K+SDFG S++         +   GT+ Y+ PE    G
Sbjct: 140 DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF-TGTLQYMAPEIIDKG 198

Query: 767 NQQLTEKSDVYSFGVVLLELISGKKP 792
            +   + +D++S G  ++E+ +GK P
Sbjct: 199 PRGYGKAADIWSLGCTIIEMATGKPP 224

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  135 bits (342), Expect = 6e-35
 Identities = 54/205 (26%), Positives = 90/205 (43%), Gaps = 21/205 (10%)

Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 654
            ++G+GSFG V+  K K  G + AVK +             E+   + +    +VPL G 
Sbjct: 64  PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVPLYGA 118

Query: 655 CEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 712
             E     +  E +  G+L   +   G + +    +    Q      +GLEYLH      
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG-QAL----EGLEYLH---TRR 170

Query: 713 IIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDPEYYGN 767
           I+H DVK+ N+LL  +  RA + DFG +   + D    S +      GT  ++ PE    
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230

Query: 768 QQLTEKSDVYSFGVVLLELISGKKP 792
           +    K D++S   ++L +++G  P
Sbjct: 231 KPCDAKVDIWSSCCMMLHMLNGCHP 255

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  135 bits (341), Expect = 7e-35
 Identities = 66/231 (28%), Positives = 107/231 (46%), Gaps = 27/231 (11%)

Query: 584 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQFVTEV 637
           +  ++        ++G+G+FG V+  +  +         VAVK + ++     Q F  E 
Sbjct: 35  VHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREA 94

Query: 638 ALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHG----------SVNQKP 685
            LL+ + H+++V   G C E    ++V+EYM +G L    R HG           V   P
Sbjct: 95  ELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGP 154

Query: 686 LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEE 744
           L     L +A   A G+ YL        +HRD+ + N L+   +  K+ DFG+SR     
Sbjct: 155 LGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST 211

Query: 745 DLTHISSVARGTVGYLDPE--YYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
           D   +       + ++ PE   Y   + T +SDV+SFGVVL E+ + GK+P
Sbjct: 212 DYYRVGGRTMLPIRWMPPESILYR--KFTTESDVWSFGVVLWEIFTYGKQP 260

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  133 bits (337), Expect = 1e-34
 Identities = 65/222 (29%), Positives = 104/222 (46%), Gaps = 28/222 (12%)

Query: 594 FCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQFVTEVALLSRIHHRN 647
             +++G+G+FG V+  +  +         VAVK + D      + F  E  LL+ + H +
Sbjct: 19  LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78

Query: 648 LVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHG-----------SVNQKPLDWLTRLQI 694
           +V   G C +    I+V+EYM +G L    R HG              +  L     L I
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138

Query: 695 AHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVA 753
           A   A G+ YL    +   +HRD+ + N L+  N+  K+ DFG+SR     D   +    
Sbjct: 139 ASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 195

Query: 754 RGTVGYLDPE--YYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
              + ++ PE   Y   + T +SDV+SFGV+L E+ + GK+P
Sbjct: 196 MLPIRWMPPESIMYR--KFTTESDVWSFGVILWEIFTYGKQP 235

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  133 bits (337), Expect = 1e-34
 Identities = 57/233 (24%), Positives = 108/233 (46%), Gaps = 29/233 (12%)

Query: 584 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQ-FVTE 636
           L E+  +   F +++G+  FG VY G +           VA+K + D      ++ F  E
Sbjct: 3   LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHE 62

Query: 637 VALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHG-----------SVNQ 683
             L +R+ H N+V L+G   ++    +++ Y  +G L +   +                +
Sbjct: 63  AMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 122

Query: 684 KPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-A 742
             L+    + +    A G+EYL +     ++H+D+ + N+L+   +  K+SD GL R+  
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVY 179

Query: 743 EEDLTHISSVARGTVGYLDPE--YYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
             D   +   +   + ++ PE   YG  + +  SD++S+GVVL E+ S G +P
Sbjct: 180 AADYYKLLGNSLLPIRWMAPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQP 230

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  134 bits (340), Expect = 1e-34
 Identities = 59/243 (24%), Positives = 104/243 (42%), Gaps = 33/243 (13%)

Query: 596 KKIGKGSFGSVYYGKMKDGKEVAVKIMA-DSCSHRT-QQFVTEVALLSRI--HHRNLVPL 651
           K+IG G    V+    +  +  A+K +  +   ++T   +  E+A L+++  H   ++ L
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 711
             Y   +    +V E   N  L   L     +K +D   R     +  + +  +H     
Sbjct: 75  YDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIH---QH 127

Query: 712 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI---SSVARGTVGYLDPE----- 763
           GI+H D+K +N L+  +   K+ DFG++ Q + D T +   S V  GTV Y+ PE     
Sbjct: 128 GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQV--GTVNYMPPEAIKDM 184

Query: 764 ------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 817
                      +++ KSDV+S G +L  +  GK P     F   +N +    ++I     
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP-----FQQIINQISKLHAIIDPNHE 239

Query: 818 ISI 820
           I  
Sbjct: 240 IEF 242

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  133 bits (338), Expect = 1e-34
 Identities = 63/209 (30%), Positives = 104/209 (49%), Gaps = 20/209 (9%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVT----EVALLSRIHHRNLVP 650
           + +G G    V+  + ++D ++VAVK++    + R   F      E    + ++H  +V 
Sbjct: 18  EILGFGGMSEVHLARDLRDHRDVAVKVLRADLA-RDPSFYLRFRREAQNAAALNHPAIVA 76

Query: 651 LIGYCEEEHQRI----LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           +    E E        +V EY+   TLRD +H    + P+     +++  DA + L + H
Sbjct: 77  VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSH 133

Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR---QAEEDLTHISSVARGTVGYLDPE 763
                GIIHRDVK +NI++      KV DFG++R    +   +T  ++V  GT  YL PE
Sbjct: 134 ---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI-GTAQYLSPE 189

Query: 764 YYGNQQLTEKSDVYSFGVVLLELISGKKP 792
                 +  +SDVYS G VL E+++G+ P
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  133 bits (337), Expect = 1e-34
 Identities = 57/216 (26%), Positives = 95/216 (43%), Gaps = 21/216 (9%)

Query: 593 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVP 650
                +G+G+  +V+ G+ K  G   A+K+    S        + E  +L +++H+N+V 
Sbjct: 12  LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71

Query: 651 LIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    EE   R  +L+ E+   G+L   L    N   L     L +  D   G+ +L   
Sbjct: 72  LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR-- 129

Query: 709 CNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
              GI+HR++K  NI+     D     K++DFG +R+ E+D   +S    GT  YL P+ 
Sbjct: 130 -ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--GTEEYLHPDM 186

Query: 765 Y--------GNQQLTEKSDVYSFGVVLLELISGKKP 792
           Y          ++     D++S GV      +G  P
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  133 bits (337), Expect = 2e-34
 Identities = 65/224 (29%), Positives = 103/224 (45%), Gaps = 28/224 (12%)

Query: 594 FCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQ-FVTEVALLSRI-HH 645
           F K +G G+FG V         +      VAVK++  S     ++  ++E+ +LS + +H
Sbjct: 27  FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86

Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL---------------HGSVNQKPLDWLT 690
            N+V L+G C      +++ EY   G L + L                   ++  LD   
Sbjct: 87  MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146

Query: 691 RLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHI 749
            L  ++  AKG+ +L    +   IHRD+ + NILL      K+ DFGL+R    +    +
Sbjct: 147 LLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203

Query: 750 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
              AR  V ++ PE   N   T +SDV+S+G+ L EL S G  P
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  133 bits (336), Expect = 2e-34
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 19/205 (9%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPL 651
           + +GKG F   +        +  A KI+  S     H+ ++   E+++   + H+++V  
Sbjct: 21  RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80

Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD-WLTR---LQIAHDAAKGLEYLHT 707
            G+ E+     +V E     +L +       +K L     R    QI      G +YLH 
Sbjct: 81  HGFFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIV----LGCQYLH- 132

Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 767
                +IHRD+K  N+ L+ ++  K+ DFGL+ + E D      V  GT  Y+ PE    
Sbjct: 133 --RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-GERKKVLCGTPNYIAPEVLSK 189

Query: 768 QQLTEKSDVYSFGVVLLELISGKKP 792
           +  + + DV+S G ++  L+ GK P
Sbjct: 190 KGHSFEVDVWSIGCIMYTLLVGKPP 214

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  133 bits (338), Expect = 2e-34
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 19/205 (9%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPL 651
           + +GKG F   +        +  A KI+  S     H+ ++   E+++   + H+++V  
Sbjct: 47  RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106

Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD-WLTR---LQIAHDAAKGLEYLHT 707
            G+ E+     +V E     +L +       +K L     R    QI      G +YLH 
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIV----LGCQYLH- 158

Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 767
                +IHRD+K  N+ L+ ++  K+ DFGL+ + E D      V  GT  Y+ PE    
Sbjct: 159 --RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-GERKKVLCGTPNYIAPEVLSK 215

Query: 768 QQLTEKSDVYSFGVVLLELISGKKP 792
           +  + + DV+S G ++  L+ GK P
Sbjct: 216 KGHSFEVDVWSIGCIMYTLLVGKPP 240

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  134 bits (340), Expect = 2e-34
 Identities = 71/285 (24%), Positives = 126/285 (44%), Gaps = 38/285 (13%)

Query: 539 RRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNN--FCK 596
           R+   + +S    +S     + +    S A                P+ E   +     K
Sbjct: 28  RQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGK 87

Query: 597 KIGKGSFGSVYYG--------KMKDGKEVAVKIMADSCSHRTQQ-FVTEVALLSRI-HHR 646
            +G+G FG V           K K+   VAVK++ D  + +     V+E+ ++  I  H+
Sbjct: 88  PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 147

Query: 647 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRL-------------HGSVNQKPLDWLTRLQ 693
           N++ L+G C ++    ++ EY   G LR+ L                V ++ + +   + 
Sbjct: 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207

Query: 694 IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 753
             +  A+G+EYL    +   IHRD+ + N+L+  N   K++DFGL+R    D+ +I    
Sbjct: 208 CTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLAR----DINNIDYYK 260

Query: 754 RGTVGYL-----DPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
           + T G L      PE   ++  T +SDV+SFGV++ E+ + G  P
Sbjct: 261 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  132 bits (334), Expect = 3e-34
 Identities = 56/201 (27%), Positives = 103/201 (51%), Gaps = 15/201 (7%)

Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 654
           +KIG+G+ G+VY       G+EVA++ M      + +  + E+ ++    + N+V  +  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 655 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGCNP 711
                +  +V EY+  G+L D +  +        +   QIA    +  + LE+LH+    
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTETC-------MDEGQIAAVCRECLQALEFLHSN--- 135

Query: 712 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 771
            +IHRD+KS NILL ++   K++DFG   Q   + +  S++  GT  ++ PE    +   
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYG 194

Query: 772 EKSDVYSFGVVLLELISGKKP 792
            K D++S G++ +E+I G+ P
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPP 215

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  133 bits (337), Expect = 3e-34
 Identities = 62/228 (27%), Positives = 111/228 (48%), Gaps = 36/228 (15%)

Query: 594 FCKKIGKGSFGSVYYGKMKDGKE--------VAVKIMADSCSHRTQQ-FVTEVALLSRI- 643
             K +G+G+FG V   +     +        VAVK++ D  + +     V+E+ ++  I 
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98

Query: 644 HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL-------------HGSVNQKPLDWLT 690
            H+N++ L+G C ++    ++ EY   G LR+ L                V ++ + +  
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158

Query: 691 RLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 750
            +   +  A+G+EYL    +   IHRD+ + N+L+  N   K++DFGL+R    D+ +I 
Sbjct: 159 LVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLAR----DINNID 211

Query: 751 SVARGTVGYL-----DPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
              + T G L      PE   ++  T +SDV+SFGV++ E+ + G  P
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  134 bits (340), Expect = 3e-34
 Identities = 57/243 (23%), Positives = 102/243 (41%), Gaps = 33/243 (13%)

Query: 596 KKIGKGSFGSVYYGKMKDGKEVAVKIMA-DSCSHRT-QQFVTEVALLSRIHHRNL--VPL 651
           K+IG G    V+    +  +  A+K +  +   ++T   +  E+A L+++   +   + L
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 711
             Y   +    +V E   N  L   L     +K +D   R     +  + +  +H     
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIH---QH 174

Query: 712 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI---SSVARGTVGYLDPE----- 763
           GI+H D+K +N L+  +   K+ DFG++ Q + D T +   S V  G V Y+ PE     
Sbjct: 175 GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQV--GAVNYMPPEAIKDM 231

Query: 764 ------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 817
                      +++ KSDV+S G +L  +  GK P     F   +N +    ++I     
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP-----FQQIINQISKLHAIIDPNHE 286

Query: 818 ISI 820
           I  
Sbjct: 287 IEF 289

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  132 bits (334), Expect = 4e-34
 Identities = 60/233 (25%), Positives = 107/233 (45%), Gaps = 41/233 (17%)

Query: 594 FCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQ-FVTEVALLSRIHHR 646
             K +G+G FG V        K       VAVK++ ++ S    +  ++E  +L +++H 
Sbjct: 27  LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86

Query: 647 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRL---------------------HGSVNQKP 685
           +++ L G C ++   +L+ EY   G+LR  L                         +++ 
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146

Query: 686 LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 745
           L     +  A   ++G++YL       ++HRD+ + NIL+    + K+SDFGLSR    D
Sbjct: 147 LTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSR----D 199

Query: 746 LTHISSVARGTVGYL-----DPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
           +    S  + + G +       E   +   T +SDV+SFGV+L E+++ G  P
Sbjct: 200 VYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  139 bits (350), Expect = 4e-34
 Identities = 67/252 (26%), Positives = 110/252 (43%), Gaps = 21/252 (8%)

Query: 594 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVT-EVALLSRIHHRNLVPL 651
             +++G G FG V     +D G++VA+K      S + ++    E+ ++ +++H N+V  
Sbjct: 18  MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSA 77

Query: 652 IGYCEEE------HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 705
               +           +L  EY   G LR  L+   N   L       +  D +  L YL
Sbjct: 78  REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL 137

Query: 706 HTGCNPGIIHRDVKSSNILLDIN---MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDP 762
           H      IIHRD+K  NI+L      +  K+ D G +++ ++       V  GT+ YL P
Sbjct: 138 H---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV--GTLQYLAP 192

Query: 763 EYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 822
           E    ++ T   D +SFG +  E I+G +P     F      V W   + +K +   +V 
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECITGFRP-----FLPNWQPVQWHGKVREKSNEHIVVY 247

Query: 823 PVLIGNVKIESI 834
             L G VK  S+
Sbjct: 248 DDLTGAVKFSSV 259

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  133 bits (336), Expect = 4e-34
 Identities = 70/278 (25%), Positives = 118/278 (42%), Gaps = 39/278 (14%)

Query: 545 QKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFG 604
           Q  YE    +   T  S+  Y       ++D     +    E       F K +G G+FG
Sbjct: 6   QFRYESQLQMVQVTGSSDNEY------FYVDFREYEYDLKWEFPRENLEFGKVLGSGAFG 59

Query: 605 SVYYGKMKDGKE------VAVKIMADSCSHRTQQ-FVTEVALLSRI-HHRNLVPLIGYCE 656
            V         +      VAVK++ +      ++  ++E+ +++++  H N+V L+G C 
Sbjct: 60  KVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119

Query: 657 EEHQRILVYEYMHNGTLRDRL-----------------HGSVNQKPLDWLTR---LQIAH 696
                 L++EY   G L + L                      ++ L+ LT    L  A+
Sbjct: 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAY 179

Query: 697 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARG 755
             AKG+E+L        +HRD+ + N+L+      K+ DFGL+R    +    +   AR 
Sbjct: 180 QVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARL 236

Query: 756 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
            V ++ PE       T KSDV+S+G++L E+ S G  P
Sbjct: 237 PVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  132 bits (334), Expect = 4e-34
 Identities = 63/227 (27%), Positives = 101/227 (44%), Gaps = 35/227 (15%)

Query: 594 FCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQ-FVTEVALLSRI-HH 645
             K +G+G+FG V         +      VAVK++ +  +H   +  ++E+ +L  I HH
Sbjct: 31  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90

Query: 646 RNLVPLIGYC-EEEHQRILVYEYMHNGTLRDRL-------------HGSVNQKPLDWLTR 691
            N+V L+G C +     +++ E+   G L   L                + +  L     
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150

Query: 692 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 751
           +  +   AKG+E+L    +   IHRD+ + NILL      K+ DFGL+R    D+     
Sbjct: 151 ICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLAR----DIYKDPD 203

Query: 752 VARGTVGYL-----DPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
             R     L      PE   ++  T +SDV+SFGV+L E+ S G  P
Sbjct: 204 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  132 bits (333), Expect = 4e-34
 Identities = 50/201 (24%), Positives = 76/201 (37%), Gaps = 13/201 (6%)

Query: 596 KKIGKGSFGSVYYGKMK-DGKEVAVKI--MADSCSHRTQQFVTEVALLSRI-HHRNLVPL 651
            ++G GS+G V+  + K DG+  AVK             + + EV    ++  H   V L
Sbjct: 63  SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRL 122

Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 711
               EE     L  E     +L+           L          D    L +LH   + 
Sbjct: 123 EQAWEEGGILYLQTELC-GPSLQQHC--EAWGASLPEAQVWGYLRDTLLALAHLH---SQ 176

Query: 712 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 771
           G++H DVK +NI L    R K+ DFGL  +             G   Y+ PE        
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE--GDPRYMAPELL-QGSYG 233

Query: 772 EKSDVYSFGVVLLELISGKKP 792
             +DV+S G+ +LE+    + 
Sbjct: 234 TAADVFSLGLTILEVACNMEL 254

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  134 bits (338), Expect = 5e-34
 Identities = 57/216 (26%), Positives = 95/216 (43%), Gaps = 21/216 (9%)

Query: 593 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVP 650
                +G+G+  +V+ G+ K  G   A+K+    S        + E  +L +++H+N+V 
Sbjct: 12  LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71

Query: 651 LIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    EE   R  +L+ E+   G+L   L    N   L     L +  D   G+ +L   
Sbjct: 72  LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR-- 129

Query: 709 CNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
              GI+HR++K  NI+     D     K++DFG +R+ E+D   +S    GT  YL P+ 
Sbjct: 130 -ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--GTEEYLHPDM 186

Query: 765 Y--------GNQQLTEKSDVYSFGVVLLELISGKKP 792
           Y          ++     D++S GV      +G  P
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  131 bits (332), Expect = 1e-33
 Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 24/220 (10%)

Query: 594 FCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQ-FVTEVALLSRI-HH 645
           F K +G G+FG V         +      VAVK++  +     ++  ++E+ ++S +  H
Sbjct: 50  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109

Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGSVNQ---------KPLDWLTRLQI 694
            N+V L+G C      +++ EY   G L +  R    V +                 L  
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169

Query: 695 AHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVA 753
           +   A+G+ +L    +   IHRDV + N+LL     AK+ DFGL+R    +    +   A
Sbjct: 170 SSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 226

Query: 754 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
           R  V ++ PE   +   T +SDV+S+G++L E+ S G  P
Sbjct: 227 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  131 bits (331), Expect = 2e-33
 Identities = 68/246 (27%), Positives = 101/246 (41%), Gaps = 67/246 (27%)

Query: 594 FCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQ-FVTEVALLSRIHHR 646
           + + IG+G+FG V+  +            VAVK++ +  S   Q  F  E AL++   + 
Sbjct: 51  YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110

Query: 647 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRL---------------------HGSVNQKP 685
           N+V L+G C       L++EYM  G L + L                       S    P
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170

Query: 686 LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 745
           L    +L IA   A G+ YL        +HRD+ + N L+  NM  K++DFGLSR     
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227

Query: 746 LTHISSVARGTVGYLDPEYY---GNQQL---------------TEKSDVYSFGVVLLELI 787
                            +YY   GN  +               T +SDV+++GVVL E+ 
Sbjct: 228 -----------------DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270

Query: 788 S-GKKP 792
           S G +P
Sbjct: 271 SYGLQP 276

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  130 bits (328), Expect = 3e-33
 Identities = 61/201 (30%), Positives = 99/201 (49%), Gaps = 15/201 (7%)

Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 654
            KIG+GS G V   + K  G++VAVK+M      R +    EV ++    H N+V +   
Sbjct: 51  VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110

Query: 655 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGCNP 711
                +  ++ E++  G L D +           L   QIA       + L YLH     
Sbjct: 111 YLVGEELWVLMEFLQGGALTDIVSQVR-------LNEEQIATVCEAVLQALAYLH---AQ 160

Query: 712 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 771
           G+IHRD+KS +ILL ++ R K+SDFG   Q  +D+    S+  GT  ++ PE        
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRSLYA 219

Query: 772 EKSDVYSFGVVLLELISGKKP 792
            + D++S G++++E++ G+ P
Sbjct: 220 TEVDIWSLGIMVIEMVDGEPP 240

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  130 bits (329), Expect = 6e-33
 Identities = 62/226 (27%), Positives = 109/226 (48%), Gaps = 36/226 (15%)

Query: 596 KKIGKGSFGSVYYGKMKDGK--------EVAVKIMADSCSHRTQQ-FVTEVALLSRI-HH 645
           K +G+G+FG V   +             +VAVK++    + +     ++E+ ++  I  H
Sbjct: 75  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134

Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL-------------HGSVNQKPLDWLTRL 692
           +N++ L+G C ++    ++ EY   G LR+ L                  ++ L     +
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194

Query: 693 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV 752
             A+  A+G+EYL    +   IHRD+ + N+L+  +   K++DFGL+R    D+ HI   
Sbjct: 195 SCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYY 247

Query: 753 ARGTVGYL-----DPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
            + T G L      PE   ++  T +SDV+SFGV+L E+ + G  P
Sbjct: 248 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  129 bits (326), Expect = 1e-32
 Identities = 40/263 (15%), Positives = 82/263 (31%), Gaps = 28/263 (10%)

Query: 552 DSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFC--KKIGKGSFGSVYYG 609
             L +      ++Y            +    P  E +  +        +G+G+F  VY  
Sbjct: 28  FKLLSGLSKPVSSYP---NTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEA 84

Query: 610 KMKD------GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 663
              D       ++  +K+   +           +  L        +        ++  +L
Sbjct: 85  TQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVL 144

Query: 664 VYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSS 721
           V E    GTL + +  + +  +K +     +  A      +E +H      IIH D+K  
Sbjct: 145 VGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPD 201

Query: 722 NILL-----------DINMRAKVSDFGLSRQAEEDLTHISSVAR-GTVGYLDPEYYGNQQ 769
           N +L           D++    + D G S   +         A+  T G+   E   N+ 
Sbjct: 202 NFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP 261

Query: 770 LTEKSDVYSFGVVLLELISGKKP 792
              + D +     +  ++ G   
Sbjct: 262 WNYQIDYFGVAATVYCMLFGTYM 284

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  126 bits (318), Expect = 4e-32
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 22/205 (10%)

Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVPLIG 653
           +KIGKGSFG V+ G      K VA+KI+  +      +    E+ +LS+     +    G
Sbjct: 28  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87

Query: 654 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGCN 710
              ++ +  ++ EY+  G+  D L           L   QIA    +  KGL+YLH   +
Sbjct: 88  SYLKDTKLWIIMEYLGGGSALDLLEPGP-------LDETQIATILREILKGLDYLH---S 137

Query: 711 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLDPEYYGN 767
              IHRD+K++N+LL  +   K++DFG++ Q    LT         VG   ++ PE    
Sbjct: 138 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQ----LTDTQIKRNTFVGTPFWMAPEVIKQ 193

Query: 768 QQLTEKSDVYSFGVVLLELISGKKP 792
                K+D++S G+  +EL  G+ P
Sbjct: 194 SAYDSKADIWSLGITAIELARGEPP 218

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  126 bits (318), Expect = 4e-32
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 25/214 (11%)

Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVPLIG 653
           + IG G+   V         ++VA+K +  + C     + + E+  +S+ HH N+V    
Sbjct: 21  EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYT 80

Query: 654 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDW--LTRLQIA---HDAAKGLEYLHTG 708
               + +  LV + +  G++ D +   V +       L    IA    +  +GLEYLH  
Sbjct: 81  SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH-- 138

Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT-VG---YLDPE- 763
              G IHRDVK+ NILL  +   +++DFG+S           +  R T VG   ++ PE 
Sbjct: 139 -KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEV 197

Query: 764 -----YYGNQQLTEKSDVYSFGVVLLELISGKKP 792
                 Y       K+D++SFG+  +EL +G  P
Sbjct: 198 MEQVRGYD-----FKADIWSFGITAIELATGAAP 226

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  131 bits (331), Expect = 9e-32
 Identities = 43/204 (21%), Positives = 77/204 (37%), Gaps = 23/204 (11%)

Query: 597 KIGKGSFGSVYYGK--MKDGKEVAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNLVPLIG 653
            I  G  G +Y       +G+ V +K +  S     Q   + E   L+ + H ++V +  
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 654 YCEEEHQRI-----LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           + E   +       +V EY+   +L+           L     +    +    L YLH  
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLH-- 199

Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
            + G+++ D+K  NI+L    + K+ D G   +    +     +  GT G+  PE     
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR----INSFGYLY-GTPGFQAPEIVRTG 252

Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
             T  +D+Y+ G  L  L      
Sbjct: 253 P-TVATDIYTVGRTLAALTLDLPT 275

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  124 bits (314), Expect = 1e-31
 Identities = 51/206 (24%), Positives = 98/206 (47%), Gaps = 18/206 (8%)

Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 654
            ++G G+FG VY  K K+ G   A K++        + ++ E+ +L+   H  +V L+G 
Sbjct: 25  GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA 84

Query: 655 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGCNP 711
              + +  ++ E+   G +   +           LT  QI        + L +LH+    
Sbjct: 85  YYHDGKLWIMIEFCPGGAVDAIMLELDRG-----LTEPQIQVVCRQMLEALNFLHSK--- 136

Query: 712 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 771
            IIHRD+K+ N+L+ +    +++DFG+S +  + L    S   GT  ++ PE    + + 
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMCETMK 195

Query: 772 E-----KSDVYSFGVVLLELISGKKP 792
           +     K+D++S G+ L+E+   + P
Sbjct: 196 DTPYDYKADIWSLGITLIEMAQIEPP 221

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  125 bits (315), Expect = 3e-31
 Identities = 24/232 (10%), Positives = 59/232 (25%), Gaps = 42/232 (18%)

Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVKIM---ADSCSHRTQQFVTEVALLSRIHHRNLVPL 651
           + +  G    V+  +  +  ++ A+K+    A++     ++        +R+   +    
Sbjct: 68  EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEA 127

Query: 652 IGYC--------------------------EEEHQRILVYEYMH--NGTLRDRLH-GSVN 682
                                               +L+          L   L    V 
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVF 187

Query: 683 QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 742
           +     L    +     +    L +    G++H      N+ +  + R  + D     + 
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKV 244

Query: 743 EEDLTHISSVARGTVGYLDPEYYG--NQQLTEKSDVYSFGVVLLELISGKKP 792
                  S      V Y   E+        T   + +  G+ +  +     P
Sbjct: 245 GTRGPASS----VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  123 bits (311), Expect = 5e-31
 Identities = 60/201 (29%), Positives = 103/201 (51%), Gaps = 15/201 (7%)

Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 654
           +K+G+GS+GSVY    K+ G+ VA+K +        Q+ + E++++ +    ++V   G 
Sbjct: 35  EKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESDLQEIIKEISIMQQCDSPHVVKYYGS 92

Query: 655 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGCNP 711
             +     +V EY   G++ D +   +  K L      +IA       KGLEYLH     
Sbjct: 93  YFKNTDLWIVMEYCGAGSVSDIIR--LRNKTLT---EDEIATILQSTLKGLEYLHFM--- 144

Query: 712 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 771
             IHRD+K+ NILL+    AK++DFG++ Q  + +   ++V  GT  ++ PE        
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYN 203

Query: 772 EKSDVYSFGVVLLELISGKKP 792
             +D++S G+  +E+  GK P
Sbjct: 204 CVADIWSLGITAIEMAEGKPP 224

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  122 bits (308), Expect = 5e-31
 Identities = 43/222 (19%), Positives = 79/222 (35%), Gaps = 33/222 (14%)

Query: 596 KKIGKGSFGSVYYGKMK-DGKEVAVKI--MADSCSHRTQQFVTEVALLSRI-HHRNLVPL 651
           +KIG G FGSV+    + DG   A+K      + S   Q  + EV   + +  H ++V  
Sbjct: 17  EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 76

Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRL-HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 710
                E+   ++  EY + G+L D +                 +     +GL Y+H   +
Sbjct: 77  FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---S 133

Query: 711 PGIIHRDVKSSNILLDIN-------------------MRAKVSDFGLSRQAEEDLTHISS 751
             ++H D+K SNI +                      +  K+ D G   +          
Sbjct: 134 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE-- 191

Query: 752 VARGTVGYLDPE-YYGNQQLTEKSDVYSFGVVLLELISGKKP 792
              G   +L  E    N     K+D+++  + ++     +  
Sbjct: 192 ---GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  124 bits (313), Expect = 7e-31
 Identities = 52/220 (23%), Positives = 91/220 (41%), Gaps = 33/220 (15%)

Query: 594 FCKKIGKG--SFGSVYYGKMKD-GKEVAVKIMA-DSCSHRTQQFV-TEVALLSRIHHRNL 648
               IGKG     +V   + K  G+ V V+ +  ++CS+    F+  E+ +    +H N+
Sbjct: 29  LLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNI 88

Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYL 705
           VP       +++  +V  +M  G+ +D +           +  L IA       K L+Y+
Sbjct: 89  VPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDG----MNELAIAYILQGVLKALDYI 144

Query: 706 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR------GTVGY 759
           H   + G +HR VK+S+IL+ ++ +  +S    +            V          + +
Sbjct: 145 H---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPW 201

Query: 760 LDPE-------YYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           L PE        Y       KSD+YS G+   EL +G  P
Sbjct: 202 LSPEVLQQNLQGYD-----AKSDIYSVGITACELANGHVP 236

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  123 bits (310), Expect = 1e-30
 Identities = 56/232 (24%), Positives = 104/232 (44%), Gaps = 23/232 (9%)

Query: 575 DEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKD---GKEVAVKIM-ADSCSHRT 630
            +     +   + E+       ++G G+ G V+  K+     G  +A K++  +      
Sbjct: 23  QKQKVGELKDDDFEK-----ISELGAGNGGVVF--KVSHKPSGLVMARKLIHLEIKPAIR 75

Query: 631 QQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLT 690
            Q + E+ +L   +   +V   G    + +  +  E+M  G+L D++     + P   L 
Sbjct: 76  NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILG 134

Query: 691 RLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL--TH 748
           +  ++    KGL YL       I+HRDVK SNIL++     K+ DFG+S Q  + +  + 
Sbjct: 135 K--VSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 190

Query: 749 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA 800
           +     GT  Y+ PE       + +SD++S G+ L+E+  G+ P+   D   
Sbjct: 191 V-----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 237

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  122 bits (307), Expect = 4e-30
 Identities = 41/272 (15%), Positives = 88/272 (32%), Gaps = 61/272 (22%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVKIM------ADSCSHRTQQFVTEVALLSRIHH--- 645
             +G+    +       + G+   V +         +   + ++ V  + LL  I +   
Sbjct: 79  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138

Query: 646 -----RNLVPLIGYCEEEHQRI----------------LVYEYMH--NGTLRDRL-HGSV 681
                R + P     + + +++                 +Y  M     T  + L   S 
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198

Query: 682 NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 741
             K L    RLQ+     + L  LH   + G++H  ++  +I+LD      ++ F    +
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255

Query: 742 AEEDLTHISSVARGTVGYLDPEY-----------YGNQQLTEKSDVYSFGVVLLELISGK 790
               +      +  + G+  PE                 +T   D ++ G+V+  +    
Sbjct: 256 DGARVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310

Query: 791 KP--------VSVEDFGAELNIVHWARSMIKK 814
            P         S   F +  NI    R++++ 
Sbjct: 311 LPITKDAALGGSEWIFRSCKNIPQPVRALLEG 342

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  124 bits (313), Expect = 4e-30
 Identities = 64/209 (30%), Positives = 98/209 (46%), Gaps = 20/209 (9%)

Query: 593 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNL 648
              + +GKGSFG V   K K  G+E AVK+++          +  + EV LL ++ H N+
Sbjct: 29  KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88

Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           + L  + E++    LV E    G L D +      ++     + R Q+      G+ Y+H
Sbjct: 89  MKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIR-QV----LSGITYMH 143

Query: 707 TGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 763
                 I+HRD+K  N+LL     +   ++ DFGLS   E        +  GT  Y+ PE
Sbjct: 144 ---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI--GTAYYIAPE 198

Query: 764 YYGNQQLTEKSDVYSFGVVLLELISGKKP 792
              +    EK DV+S GV+L  L+SG  P
Sbjct: 199 VL-HGTYDEKCDVWSTGVILYILLSGCPP 226

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  120 bits (304), Expect = 5e-30
 Identities = 58/216 (26%), Positives = 96/216 (44%), Gaps = 31/216 (14%)

Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIG 653
           + +G G++G VY G+    G+  A+K+M D      ++   E+ +L +  HHRN+    G
Sbjct: 30  ELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEINMLKKYSHHRNIATYYG 88

Query: 654 ------YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEY 704
                     + Q  LV E+   G++ D +  +        L    IA    +  +GL +
Sbjct: 89  AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT----LKEEWIAYICREILRGLSH 144

Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLD 761
           LH      +IHRD+K  N+LL  N   K+ DFG+S Q    L          +G   ++ 
Sbjct: 145 LH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ----LDRTVGRRNTFIGTPYWMA 197

Query: 762 PEYYGNQQLTE-----KSDVYSFGVVLLELISGKKP 792
           PE     +  +     KSD++S G+  +E+  G  P
Sbjct: 198 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  119 bits (301), Expect = 6e-30
 Identities = 59/214 (27%), Positives = 101/214 (47%), Gaps = 31/214 (14%)

Query: 596 KKIGKGSFGSVYYGKMKD---GKEVAVKIM-ADSCSHRTQQFVTEVA-LLSRIHHRNLVP 650
            ++G+G++G V   KM+    G+ +AVK + A   S   ++ + ++   +  +     V 
Sbjct: 13  MELGRGAYGVVE--KMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVT 70

Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQK----PLDWLTRLQIAHDAAKGLEYLH 706
             G    E    +  E M + +L D+ +  V  K    P D L +  IA    K LE+LH
Sbjct: 71  FYGALFREGDVWICMELM-DTSL-DKFYKQVIDKGQTIPEDILGK--IAVSIVKALEHLH 126

Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDP 762
           +     +IHRDVK SN+L++   + K+ DFG+S         +  VA+    G   Y+ P
Sbjct: 127 S--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYL------VDDVAKDIDAGCKPYMAP 178

Query: 763 E----YYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           E        +  + KSD++S G+ ++EL   + P
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  123 bits (310), Expect = 9e-30
 Identities = 62/207 (29%), Positives = 99/207 (47%), Gaps = 19/207 (9%)

Query: 594 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVP 650
             KK+G G++G V   + K    E A+KI+  +   +    + + EVA+L  + H N++ 
Sbjct: 41  RVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMK 100

Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L  + E++    LV E    G L D +      N+     + + Q+      G+ YLH  
Sbjct: 101 LYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIK-QV----LSGVTYLH-- 153

Query: 709 CNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 765
               I+HRD+K  N+LL   + +   K+ DFGLS   E        +  GT  Y+ PE  
Sbjct: 154 -KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL--GTAYYIAPEVL 210

Query: 766 GNQQLTEKSDVYSFGVVLLELISGKKP 792
             ++  EK DV+S GV+L  L++G  P
Sbjct: 211 -RKKYDEKCDVWSIGVILFILLAGYPP 236

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  119 bits (300), Expect = 2e-29
 Identities = 60/249 (24%), Positives = 90/249 (36%), Gaps = 53/249 (21%)

Query: 594 FCKKIGKGSFGSVYYGKMKD-GKEVAVKI-----MADSCSHRTQQFVTEVALLSRIHHRN 647
               IG+GS+G V            A+KI     +        ++  TEV L+ ++HH N
Sbjct: 30  LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPN 89

Query: 648 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH----------- 696
           +  L    E+E    LV E  H G L D+L+  ++         +               
Sbjct: 90  IARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149

Query: 697 -------------------DAAK-------GLEYLHTGCNPGIIHRDVKSSNILL--DIN 728
                                +         L YLH   N GI HRD+K  N L   + +
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKS 206

Query: 729 MRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDPE--YYGNQQLTEKSDVYSFGVVL 783
              K+ DFGLS++  +             GT  ++ PE     N+    K D +S GV+L
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266

Query: 784 LELISGKKP 792
             L+ G  P
Sbjct: 267 HLLLMGAVP 275

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  118 bits (298), Expect = 2e-29
 Identities = 61/206 (29%), Positives = 101/206 (49%), Gaps = 17/206 (8%)

Query: 593 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 651
            F + +G G+F  V+  K +  GK  A+K +  S + R      E+A+L +I H N+V L
Sbjct: 12  IFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTL 71

Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 709
               E      LV + +  G L DR+   G   +K    + + Q+       ++YLH   
Sbjct: 72  EDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQ-QV----LSAVKYLH--- 123

Query: 710 NPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 766
             GI+HRD+K  N+L    + N +  ++DFGLS+  +  +  +S+   GT GY+ PE   
Sbjct: 124 ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MSTAC-GTPGYVAPEVLA 180

Query: 767 NQQLTEKSDVYSFGVVLLELISGKKP 792
            +  ++  D +S GV+   L+ G  P
Sbjct: 181 QKPYSKAVDCWSIGVITYILLCGYPP 206

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  120 bits (302), Expect = 4e-29
 Identities = 59/238 (24%), Positives = 99/238 (41%), Gaps = 34/238 (14%)

Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVKIMA--------DSCSHRTQQFVTEVALLSRIHHR 646
           K +G G+ G V     +   K+VA++I++           +       TE+ +L +++H 
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 200

Query: 647 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEY 704
            ++ +  + + E    +V E M  G L D++  +  + +         Q+       ++Y
Sbjct: 201 CIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY-QMLL----AVQY 254

Query: 705 LHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 761
           LH     GIIHRD+K  N+LL   + +   K++DFG S+   E     +    GT  YL 
Sbjct: 255 LH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC--GTPTYLA 309

Query: 762 PE---YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 816
           PE     G        D +S GV+L   +SG  P S       L      +  I  G 
Sbjct: 310 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL------KDQITSGK 361

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  120 bits (301), Expect = 4e-29
 Identities = 28/236 (11%), Positives = 66/236 (27%), Gaps = 42/236 (17%)

Query: 596 KKIGKGSFGSVYYGKMK-DGKEVAVKIM------ADSCSHRTQQFVTEVALLSRIHHRNL 648
             +G+    +      +  G+   V +         +   + ++ V  + LL  I ++  
Sbjct: 84  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143

Query: 649 ------------------VPLIGYCEEEHQRILVYEY--------MHNGTLRDRLHGSV- 681
                                +     + + + V            +  T  + L     
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203

Query: 682 NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 741
             K L    RLQ+     + L  LH   + G++H  ++  +I+LD      ++ F    +
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260

Query: 742 AEEDLTHISSVARGTVGYLDPE-----YYGNQQLTEKSDVYSFGVVLLELISGKKP 792
                                       +    +T   D ++ G+ +  +     P
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  121 bits (305), Expect = 5e-29
 Identities = 59/218 (27%), Positives = 98/218 (44%), Gaps = 30/218 (13%)

Query: 594 FCKKIGKGSFGSVYYGKMK-DGKEVAVKI-------------MADSCSHRTQQFVTEVAL 639
             +K+G G++G V   K K    E A+K+                +     ++   E++L
Sbjct: 40  KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISL 99

Query: 640 LSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHD 697
           L  + H N++ L    E++    LV E+   G L +++      ++     + + QI   
Sbjct: 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMK-QI--- 155

Query: 698 AAKGLEYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVAR 754
              G+ YLH      I+HRD+K  NILL   +  +  K+ DFGLS    +D      +  
Sbjct: 156 -LSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL-- 209

Query: 755 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           GT  Y+ PE    ++  EK DV+S GV++  L+ G  P
Sbjct: 210 GTAYYIAPEVL-KKKYNEKCDVWSCGVIMYILLCGYPP 246

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  118 bits (297), Expect = 5e-29
 Identities = 68/207 (32%), Positives = 100/207 (48%), Gaps = 24/207 (11%)

Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVKIM---ADSCSHRTQQFVTEVALLSRIHHRNLVPL 651
           ++IG GSFG+VY+ +     + VA+K M       + + Q  + EV  L ++ H N +  
Sbjct: 60  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119

Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTG 708
            G    EH   LV EY   G+  D L   V++KPL     ++IA   H A +GL YLH+ 
Sbjct: 120 RGCYLREHTAWLVMEYC-LGSASDLLE--VHKKPLQ---EVEIAAVTHGALQGLAYLHSH 173

Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
               +IHRDVK+ NILL      K+ DFG +       + +     GT  ++ PE     
Sbjct: 174 ---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVILAM 225

Query: 769 QLTE---KSDVYSFGVVLLELISGKKP 792
              +   K DV+S G+  +EL   K P
Sbjct: 226 DEGQYDGKVDVWSLGITCIELAERKPP 252

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  116 bits (294), Expect = 5e-29
 Identities = 59/216 (27%), Positives = 96/216 (44%), Gaps = 29/216 (13%)

Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVKIM---------ADSCSHRTQQFVTEVALLSRI-H 644
           + +G+G    V     K   KE AVKI+         A+      +  + EV +L ++  
Sbjct: 23  EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82

Query: 645 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGL 702
           H N++ L    E      LV++ M  G L D L    ++++K    + R  +     + +
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMR-ALL----EVI 137

Query: 703 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDP 762
             LH      I+HRD+K  NILLD +M  K++DFG S Q +           GT  YL P
Sbjct: 138 CALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC--GTPSYLAP 192

Query: 763 E------YYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           E         +    ++ D++S GV++  L++G  P
Sbjct: 193 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  117 bits (294), Expect = 9e-29
 Identities = 60/214 (28%), Positives = 95/214 (44%), Gaps = 30/214 (14%)

Query: 596 KKIGKGSFGSVYYGKMKD---GKEVAVKIM-ADSCSHRTQQFVTEVA-LLSRIHHRNLVP 650
            +IG+G++GSV   KM     G+ +AVK + +       +Q + ++  ++       +V 
Sbjct: 28  GEIGRGAYGSVN--KMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQ 85

Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQK----PLDWLTRLQIAHDAAKGLEYLH 706
             G    E    +  E M + +         +      P + L +  I     K L +L 
Sbjct: 86  FYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGK--ITLATVKALNHLK 142

Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDP 762
              N  IIHRD+K SNILLD +   K+ DFG+S Q       + S+A+    G   Y+ P
Sbjct: 143 E--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL------VDSIAKTRDAGCRPYMAP 194

Query: 763 E----YYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           E        Q    +SDV+S G+ L EL +G+ P
Sbjct: 195 ERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  115 bits (290), Expect = 1e-28
 Identities = 48/210 (22%), Positives = 81/210 (38%), Gaps = 25/210 (11%)

Query: 593 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 651
                IG+GS+G V     K      A K +         +F  E+ ++  + H N++ L
Sbjct: 12  TLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRL 71

Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 709
               E+     LV E    G L +R+       +     + +  +       + Y H   
Sbjct: 72  YETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMK-DV----LSAVAYCH--- 123

Query: 710 NPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE--- 763
              + HRD+K  N L      +   K+ DFGL+ + +      + V  GT  Y+ P+   
Sbjct: 124 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV--GTPYYVSPQVLE 181

Query: 764 -YYGNQQLTEKSDVYSFGVVLLELISGKKP 792
             YG      + D +S GV++  L+ G  P
Sbjct: 182 GLYG-----PECDEWSAGVMMYVLLCGYPP 206

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  116 bits (292), Expect = 2e-28
 Identities = 60/238 (25%), Positives = 99/238 (41%), Gaps = 36/238 (15%)

Query: 571 GHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKD---GKEVAVKIM-ADSC 626
           G+    G  Y   + +LE        ++G G+ G V+  KM+    G  +AVK M     
Sbjct: 11  GYLTIGGQRYQAEINDLEN-----LGEMGSGTCGQVW--KMRFRKTGHVIAVKQMRRSGN 63

Query: 627 SHRTQQFVTEVA-LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGSVNQ 683
               ++ + ++  +L       +V   G         +  E M     +   R+ G + +
Sbjct: 64  KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPE 123

Query: 684 KPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 743
           + L      ++     K L YL      G+IHRDVK SNILLD   + K+ DFG+S +  
Sbjct: 124 RILG-----KMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRL- 175

Query: 744 EDLTHISSVAR----GTVGYLDPE-----YYGNQQLTEKSDVYSFGVVLLELISGKKP 792
                +   A+    G   Y+ PE              ++DV+S G+ L+EL +G+ P
Sbjct: 176 -----VDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  119 bits (300), Expect = 2e-28
 Identities = 63/208 (30%), Positives = 98/208 (47%), Gaps = 19/208 (9%)

Query: 593 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLV 649
           N    +GKGSFG V   K +   +E AVK++  +   +  T   + EV LL ++ H N++
Sbjct: 25  NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84

Query: 650 PLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
            L    E+     +V E    G L D +      ++     + + Q+      G+ Y+H 
Sbjct: 85  KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK-QV----FSGITYMH- 138

Query: 708 GCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
                I+HRD+K  NILL   + +   K+ DFGLS   +++      +  GT  Y+ PE 
Sbjct: 139 --KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIAPEV 194

Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKP 792
                  EK DV+S GV+L  L+SG  P
Sbjct: 195 L-RGTYDEKCDVWSAGVILYILLSGTPP 221

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  115 bits (289), Expect = 2e-28
 Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 24/212 (11%)

Query: 593 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVP 650
            F +K+G G+FG V+  + +  G E  +K +  D      +Q   E+ +L  + H N++ 
Sbjct: 25  IFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIK 84

Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK-------GLE 703
           +    E+ H   +V E    G L +R+  +  +     L+        A+        L 
Sbjct: 85  IFEVFEDYHNMYIVMETCEGGELLERIVSAQARG--KALSE----GYVAELMKQMMNALA 138

Query: 704 YLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYL 760
           Y H   +  ++H+D+K  NIL      +   K+ DFGL+   + D    ++   GT  Y+
Sbjct: 139 YFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA--GTALYM 193

Query: 761 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
            PE +  + +T K D++S GVV+  L++G  P
Sbjct: 194 APEVF-KRDVTFKCDIWSAGVVMYFLLTGCLP 224

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  114 bits (287), Expect = 3e-28
 Identities = 64/212 (30%), Positives = 99/212 (46%), Gaps = 27/212 (12%)

Query: 593 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLV 649
           N    +GKGSFG V   K +   +E AVK++  +   +  T   + EV LL ++ H N++
Sbjct: 25  NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84

Query: 650 PLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
            L    E+     +V E    G L D +      ++     + + Q+      G+ Y+H 
Sbjct: 85  KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK-QV----FSGITYMH- 138

Query: 708 GCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE- 763
                I+HRD+K  NILL   + +   K+ DFGLS   +++      +  GT  Y+ PE 
Sbjct: 139 --KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIAPEV 194

Query: 764 ---YYGNQQLTEKSDVYSFGVVLLELISGKKP 792
               Y      EK DV+S GV+L  L+SG  P
Sbjct: 195 LRGTYD-----EKCDVWSAGVILYILLSGTPP 221

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  115 bits (289), Expect = 7e-28
 Identities = 53/217 (24%), Positives = 86/217 (39%), Gaps = 30/217 (13%)

Query: 594 FCKKIGKGSFGSVYYGKMKD-GKEVAVKI-----MADSCSHRTQQFVTEVALLSRIHHRN 647
            C+ IGKG F  V     ++ G++ AVKI        S    T+    E ++   + H +
Sbjct: 28  LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87

Query: 648 LVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAK----- 700
           +V L+     +    +V+E+M    L   +              +       A+      
Sbjct: 88  IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFV----YSE----AVASHYMRQI 139

Query: 701 --GLEYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARG 755
              L Y H   +  IIHRDVK   +LL   + +   K+  FG++ Q  E          G
Sbjct: 140 LEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-G 195

Query: 756 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           T  ++ PE    +   +  DV+  GV+L  L+SG  P
Sbjct: 196 TPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  113 bits (285), Expect = 1e-27
 Identities = 59/228 (25%), Positives = 100/228 (43%), Gaps = 19/228 (8%)

Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIG 653
           K +G+GSF        K   +  AVKI++      TQ+   E+  L     H N+V L  
Sbjct: 17  KPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHE 73

Query: 654 YCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 711
              ++    LV E ++ G L +R+      ++    ++ R ++       + ++H   + 
Sbjct: 74  VFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMR-KL----VSAVSHMH---DV 125

Query: 712 GIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
           G++HRD+K  N+L    + N+  K+ DFG +R    D   + +    T+ Y  PE     
Sbjct: 126 GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPELLNQN 184

Query: 769 QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 816
              E  D++S GV+L  ++SG+ P    D              IKKGD
Sbjct: 185 GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD 232

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  112 bits (283), Expect = 1e-27
 Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 18/208 (8%)

Query: 593 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMA-DSCSHRTQQFV-TEVALLSRIHHRNLV 649
           +  +++GKG+F  V     K  G E A KI+     S R  Q +  E  +  ++ H N+V
Sbjct: 9   DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 68

Query: 650 PLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
            L    +EE    LV++ +  G L + +      ++       + QI     + + Y H 
Sbjct: 69  RLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ-QI----LESIAYCH- 122

Query: 708 GCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
             + GI+HR++K  N+LL         K++DFGL+ +  +          GT GYL PE 
Sbjct: 123 --SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA--GTPGYLSPEV 178

Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKP 792
                 ++  D+++ GV+L  L+ G  P
Sbjct: 179 LKKDPYSKPVDIWACGVILYILLVGYPP 206

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  113 bits (285), Expect = 3e-27
 Identities = 60/215 (27%), Positives = 95/215 (44%), Gaps = 28/215 (13%)

Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVKIMA--------DSCSHRTQQFVTEVALLSRIH-H 645
             IG+G    V     +  G E AVKIM         +      +    E  +L ++  H
Sbjct: 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH 159

Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLE 703
            +++ LI   E      LV++ M  G L D L    ++++K    + R  +     + + 
Sbjct: 160 PHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMR-SLL----EAVS 214

Query: 704 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 763
           +LH      I+HRD+K  NILLD NM+ ++SDFG S   E           GT GYL PE
Sbjct: 215 FLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELC--GTPGYLAPE 269

Query: 764 ------YYGNQQLTEKSDVYSFGVVLLELISGKKP 792
                    +    ++ D+++ GV+L  L++G  P
Sbjct: 270 ILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  114 bits (286), Expect = 3e-27
 Identities = 48/206 (23%), Positives = 98/206 (47%), Gaps = 16/206 (7%)

Query: 593 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 651
           +  +++G G+FG V+    K  G+    K +             E+++++++HH  L+ L
Sbjct: 54  DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINL 113

Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH---DAAKGLEYLHTG 708
               E++++ +L+ E++  G L DR+     +     ++  ++ +    A +GL+++H  
Sbjct: 114 HDAFEDKYEMVLILEFLSGGELFDRI---AAED--YKMSEAEVINYMRQACEGLKHMH-- 166

Query: 709 CNPGIIHRDVKSSNILL--DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 766
               I+H D+K  NI+         K+ DFGL+ +   D   I  V   T  +  PE   
Sbjct: 167 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVKVTTATAEFAAPEIVD 223

Query: 767 NQQLTEKSDVYSFGVVLLELISGKKP 792
            + +   +D+++ GV+   L+SG  P
Sbjct: 224 REPVGFYTDMWAIGVLGYVLLSGLSP 249

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  111 bits (279), Expect = 5e-27
 Identities = 58/234 (24%), Positives = 100/234 (42%), Gaps = 50/234 (21%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVKIM--------ADSCSHRTQQFVT----------- 635
            +IGKGS+G V       D    A+K++        A        +              
Sbjct: 19  DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78

Query: 636 -------EVALLSRIHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPL 686
                  E+A+L ++ H N+V L+   ++ ++    +V+E ++ G + +        KPL
Sbjct: 79  PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV----PTLKPL 134

Query: 687 DWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 746
                     D  KG+EYLH      IIHRD+K SN+L+  +   K++DFG+S + +   
Sbjct: 135 SEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191

Query: 747 THISSVARGTVGYLDPE--------YYGNQQLTEKSDVYSFGVVLLELISGKKP 792
             +S+   GT  ++ PE        + G     +  DV++ GV L   + G+ P
Sbjct: 192 ALLSNTV-GTPAFMAPESLSETRKIFSG-----KALDVWAMGVTLYCFVFGQCP 239

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  111 bits (281), Expect = 5e-27
 Identities = 56/213 (26%), Positives = 94/213 (44%), Gaps = 23/213 (10%)

Query: 593 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIM------ADSCSHRTQQFVTEVALLSRIHH 645
           +  +++G G F  V   + K  G E A K +      A       ++   EV++L ++ H
Sbjct: 15  DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLH 74

Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLE 703
            N++ L    E     +L+ E +  G L D L    S++++      + QI      G+ 
Sbjct: 75  HNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK-QI----LDGVN 129

Query: 704 YLHTGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 759
           YLH      I H D+K  NI+L          K+ DFGL+ + E+          GT  +
Sbjct: 130 YLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG--VEFKNIFGTPEF 184

Query: 760 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           + PE    + L  ++D++S GV+   L+SG  P
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  111 bits (280), Expect = 6e-27
 Identities = 60/238 (25%), Positives = 99/238 (41%), Gaps = 34/238 (14%)

Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVKIMA--------DSCSHRTQQFVTEVALLSRIHHR 646
           K +G G+ G V     +   K+VA+KI++           +       TE+ +L +++H 
Sbjct: 16  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75

Query: 647 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEY 704
            ++ +  + + E    +V E M  G L D++  +  + +         Q+       ++Y
Sbjct: 76  CIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY-QML----LAVQY 129

Query: 705 LHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 761
           LH     GIIHRD+K  N+LL   + +   K++DFG S+   E     +    GT  YL 
Sbjct: 130 LH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC--GTPTYLA 184

Query: 762 PE---YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 816
           PE     G        D +S GV+L   +SG  P S       L      +  I  G 
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL------KDQITSGK 236

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  115 bits (290), Expect = 6e-27
 Identities = 54/265 (20%), Positives = 106/265 (40%), Gaps = 21/265 (7%)

Query: 539 RRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATN-----N 593
                 +K     D               +   +++ +    + P P   +  +     +
Sbjct: 101 LIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYD 160

Query: 594 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 652
             +++G G+FG V+    +  G   A K +        +    E+  +S + H  LV L 
Sbjct: 161 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLH 220

Query: 653 GYCEEEHQRILVYEYMHNGTLRDRL---HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 709
              E++++ +++YE+M  G L +++   H  +++       R Q+     KGL ++H   
Sbjct: 221 DAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR-QV----CKGLCHMH--- 272

Query: 710 NPGIIHRDVKSSNILLDINMRA--KVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 767
               +H D+K  NI+         K+ DFGL+   +        V  GT  +  PE    
Sbjct: 273 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--QSVKVTTGTAEFAAPEVAEG 330

Query: 768 QQLTEKSDVYSFGVVLLELISGKKP 792
           + +   +D++S GV+   L+SG  P
Sbjct: 331 KPVGYYTDMWSVGVLSYILLSGLSP 355

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  111 bits (279), Expect = 6e-27
 Identities = 58/215 (26%), Positives = 93/215 (43%), Gaps = 26/215 (12%)

Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIG 653
             +G+G+   V         +E AVKI+     H   +   EV +L +   HRN++ LI 
Sbjct: 19  DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIE 78

Query: 654 YCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 711
           + EEE +  LV+E M  G++   +H     N+     + +  +    A  L++LH   N 
Sbjct: 79  FFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQ-DV----ASALDFLH---NK 130

Query: 712 GIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVAR------GTVGYLDP 762
           GI HRD+K  NIL    +     K+ DF L    + +               G+  Y+ P
Sbjct: 131 GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAP 190

Query: 763 E-----YYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           E             ++ D++S GV+L  L+SG  P
Sbjct: 191 EVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  110 bits (277), Expect = 7e-27
 Identities = 58/213 (27%), Positives = 93/213 (43%), Gaps = 23/213 (10%)

Query: 593 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMA------DSCSHRTQQFVTEVALLSRIHH 645
              +++G G F  V   + K  GKE A K +              ++   EV +L  I H
Sbjct: 8   EMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH 67

Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLE 703
            N++ L    E +   +L+ E +  G L D L    S+ +       + QI      G+ 
Sbjct: 68  PNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLK-QI----LDGVH 122

Query: 704 YLHTGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 759
           YLH   +  I H D+K  NI+L      N R K+ DFG++ + E    +      GT  +
Sbjct: 123 YLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG--NEFKNIFGTPEF 177

Query: 760 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           + PE    + L  ++D++S GV+   L+SG  P
Sbjct: 178 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  113 bits (286), Expect = 8e-27
 Identities = 51/207 (24%), Positives = 90/207 (43%), Gaps = 17/207 (8%)

Query: 594 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIM--ADSCSHRTQQFVTEVALLSRIHHRNLVP 650
             +++GKG+F  V        G+E A  I+      +   Q+   E  +   + H N+V 
Sbjct: 15  LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVR 74

Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L     EE    L+++ +  G L + +      ++       + QI     + + + H  
Sbjct: 75  LHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQ-QI----LEAVLHCH-- 127

Query: 709 CNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 765
              G++HR++K  N+LL         K++DFGL+ + E +       A GT GYL PE  
Sbjct: 128 -QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYLSPEVL 185

Query: 766 GNQQLTEKSDVYSFGVVLLELISGKKP 792
                 +  D+++ GV+L  L+ G  P
Sbjct: 186 RKDPYGKPVDLWACGVILYILLVGYPP 212

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  111 bits (279), Expect = 9e-27
 Identities = 50/267 (18%), Positives = 90/267 (33%), Gaps = 73/267 (27%)

Query: 596 KKIGKGSFGSVYYGKMK-DG-----KEVA--------------VKIMA------------ 623
           + +G+G FG V+  K K D      K +               VK +A            
Sbjct: 12  QCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 71

Query: 624 ---------------------------DSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 656
                                       S          ++  +     +N V  +    
Sbjct: 72  AWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSS 131

Query: 657 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHR 716
            +    +  +      L+D ++   + +  +    L I    A+ +E+LH   + G++HR
Sbjct: 132 PKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH---SKGLMHR 188

Query: 717 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR-----------GTVGYLDPEYY 765
           D+K SNI   ++   KV DFGL    ++D    + +             GT  Y+ PE  
Sbjct: 189 DLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQI 248

Query: 766 GNQQLTEKSDVYSFGVVLLELISGKKP 792
                + K D++S G++L EL+     
Sbjct: 249 HGNNYSHKVDIFSLGLILFELLYSFST 275

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  111 bits (279), Expect = 1e-26
 Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 23/213 (10%)

Query: 593 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMA------DSCSHRTQQFVTEVALLSRIHH 645
           +  +++G G F  V   + K  G + A K +              +    EV++L  I H
Sbjct: 14  DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 73

Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLE 703
            N++ L    E +   IL+ E +  G L D L    S+ ++      + QI      G+ 
Sbjct: 74  PNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK-QI----LNGVY 128

Query: 704 YLHTGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 759
           YLH   +  I H D+K  NI+L        R K+ DFGL+ + +      +    GT  +
Sbjct: 129 YLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--GTPEF 183

Query: 760 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           + PE    + L  ++D++S GV+   L+SG  P
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  111 bits (280), Expect = 1e-26
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 18/207 (8%)

Query: 594 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIMA-DSCSHRTQQFV-TEVALLSRIHHRNLVP 650
             +++GKG+F  V     K  G E A KI+     S R  Q +  E  +  ++ H N+V 
Sbjct: 33  VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 92

Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           L    +EE    LV++ +  G L + +      ++       + QI     + + Y H  
Sbjct: 93  LHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ-QI----LESIAYCH-- 145

Query: 709 CNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 765
            + GI+HR++K  N+LL         K++DFGL+ +  +          GT GYL PE  
Sbjct: 146 -SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA--GTPGYLSPEVL 202

Query: 766 GNQQLTEKSDVYSFGVVLLELISGKKP 792
                ++  D+++ GV+L  L+ G  P
Sbjct: 203 KKDPYSKPVDIWACGVILYILLVGYPP 229

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  110 bits (277), Expect = 3e-26
 Identities = 56/213 (26%), Positives = 94/213 (44%), Gaps = 23/213 (10%)

Query: 593 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIM------ADSCSHRTQQFVTEVALLSRIHH 645
           +  +++G G F  V   + K  G E A K +      A       ++   EV++L ++ H
Sbjct: 15  DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLH 74

Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLE 703
            N++ L    E     +L+ E +  G L D L    S++++      + QI      G+ 
Sbjct: 75  PNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK-QI----LDGVN 129

Query: 704 YLHTGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 759
           YLH      I H D+K  NI+L          K+ DFGL+ + E+          GT  +
Sbjct: 130 YLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG--VEFKNIFGTPEF 184

Query: 760 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           + PE    + L  ++D++S GV+   L+SG  P
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  109 bits (274), Expect = 3e-26
 Identities = 43/207 (20%), Positives = 92/207 (44%), Gaps = 19/207 (9%)

Query: 593 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFV-TEVALLSRIHHRNLVP 650
              + +G+G FG V+        K    K +        Q  V  E+++L+   HRN++ 
Sbjct: 8   MIAEDLGRGEFGIVHRCVETSSKKTYMAKFV--KVKGTDQVLVKKEISILNIARHRNILH 65

Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRL---HGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
           L    E   + ++++E++    + +R+      +N++ +      Q+     + L++LH 
Sbjct: 66  LHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVH-QV----CEALQFLH- 119

Query: 708 GCNPGIIHRDVKSSNILL--DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 765
             +  I H D++  NI+     +   K+ +FG +RQ +        +      Y  PE +
Sbjct: 120 --SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--DNFRLLFTAPEYYAPEVH 175

Query: 766 GNQQLTEKSDVYSFGVVLLELISGKKP 792
            +  ++  +D++S G ++  L+SG  P
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINP 202

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  108 bits (271), Expect = 6e-26
 Identities = 60/222 (27%), Positives = 94/222 (42%), Gaps = 45/222 (20%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVKIMA----DSCSHRTQQFVTEVALLSRIHHRNLVP 650
             +G+GS+G V      +     AVKI+         +       E+ LL R+ H+N++ 
Sbjct: 11  DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70

Query: 651 L--IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK-------G 701
           L  + Y EE+ +  +V EY   G     +  SV +K      R  +   A         G
Sbjct: 71  LVDVLYNEEKQKMYMVMEYCVCGM--QEMLDSVPEK------RFPV-CQAHGYFCQLIDG 121

Query: 702 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS----RQAEEDLTHISSVARGTV 757
           LEYLH   + GI+H+D+K  N+LL      K+S  G++      A +D    S    G+ 
Sbjct: 122 LEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ---GSP 175

Query: 758 GYLDPE-------YYGNQQLTEKSDVYSFGVVLLELISGKKP 792
            +  PE       + G      K D++S GV L  + +G  P
Sbjct: 176 AFQPPEIANGLDTFSG-----FKVDIWSAGVTLYNITTGLYP 212

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  108 bits (271), Expect = 9e-26
 Identities = 57/257 (22%), Positives = 100/257 (38%), Gaps = 52/257 (20%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVKIM--------ADSCSHRTQQFVTEVALLSRIHHR 646
             +G G+FG V+     +  KEV VK +              +  +   E+A+LSR+ H 
Sbjct: 30  SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89

Query: 647 NLVPLIGYCEEEHQRILVYEYMHNGT-LRDRL--HGSVNQKPLDWLTRL---QIAHDAAK 700
           N++ ++   E +    LV E   +G  L   +  H  +++     L      Q+      
Sbjct: 90  NIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEP----LASYIFRQLVS---- 141

Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYL 760
            + YL       IIHRD+K  NI++  +   K+ DFG +   E     +     GT+ Y 
Sbjct: 142 AVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG--KLFYTFCGTIEYC 196

Query: 761 DPE------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF----GAELNIVHW--- 807
            PE      Y G      + +++S GV L  L+  + P    +      A ++  +    
Sbjct: 197 APEVLMGNPYRG-----PELEMWSLGVTLYTLVFEENP--FCELEETVEAAIHPPYLVSK 249

Query: 808 -ARSMIKKGDVISIVDP 823
              S++     +    P
Sbjct: 250 ELMSLVSG---LLQPVP 263

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  106 bits (267), Expect = 1e-25
 Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 40/216 (18%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVPLIG 653
           + +G+G++G V         + VAVKI+         +    E+ +   ++H N+V   G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72

Query: 654 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK-------GLEYLH 706
           +  E + + L  EY   G L DR+        +          DA +       G+ YLH
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRI---EPDIGMP-------EPDAQRFFHQLMAGVVYLH 122

Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS----RQAEEDLTHISSVARGTVGYLDP 762
                GI HRD+K  N+LLD     K+SDFGL+        E L +      GT+ Y+ P
Sbjct: 123 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC---GTLPYVAP 176

Query: 763 E------YYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           E      ++      E  DV+S G+VL  +++G+ P
Sbjct: 177 ELLKRREFHA-----EPVDVWSCGIVLTAMLAGELP 207

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  107 bits (269), Expect = 2e-25
 Identities = 54/222 (24%), Positives = 89/222 (40%), Gaps = 36/222 (16%)

Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQ----QFVTEVALLSRI-HHRNLV 649
           K++G+G F  V     K  G+E A K +      R Q    + + E+A+L        ++
Sbjct: 35  KELGRGKFAVVRQCISKSTGQEYAAKFL--KKRRRGQDCRAEILHEIAVLELAKSCPRVI 92

Query: 650 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK-------GL 702
            L    E   + IL+ EY   G +          +  + ++     +D  +       G+
Sbjct: 93  NLHEVYENTSEIILILEYAAGGEIFSL----CLPELAEMVSE----NDVIRLIKQILEGV 144

Query: 703 EYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 759
            YLH      I+H D+K  NILL         K+ DFG+SR+             GT  Y
Sbjct: 145 YYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA--CELREIMGTPEY 199

Query: 760 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 801
           L PE      +T  +D+++ G++   L++   P     F  E
Sbjct: 200 LAPEILNYDPITTATDMWNIGIIAYMLLTHTSP-----FVGE 236

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  106 bits (267), Expect = 4e-25
 Identities = 67/208 (32%), Positives = 98/208 (47%), Gaps = 26/208 (12%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLI 652
           K IGKG+F  V   + +  G+EVA+KI+  +       Q+   EV ++  ++H N+V L 
Sbjct: 21  KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 80

Query: 653 GYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 710
              E E    L+ EY   G + D L  HG + +K      R QI       ++Y H    
Sbjct: 81  EVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR-QIVS----AVQYCH---Q 132

Query: 711 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE------Y 764
             I+HRD+K+ N+LLD +M  K++DFG S +             G   Y  PE      Y
Sbjct: 133 KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG--GKLDAFCGAPPYAAPELFQGKKY 190

Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKP 792
            G      + DV+S GV+L  L+SG  P
Sbjct: 191 DG-----PEVDVWSLGVILYTLVSGSLP 213

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  107 bits (268), Expect = 5e-25
 Identities = 63/264 (23%), Positives = 114/264 (43%), Gaps = 37/264 (14%)

Query: 539 RRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKI 598
           R  + ++++   A  +     P +     A+ G        Y +   E           +
Sbjct: 51  RMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSF---YTVSKTE----------IL 97

Query: 599 GKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE 657
           G G FG V+  +    G ++A KI+        ++   E+++++++ H NL+ L    E 
Sbjct: 98  GGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFES 157

Query: 658 EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH---DAAKGLEYLHTGCNPGII 714
           ++  +LV EY+  G L DR+   +++     LT L          +G+ ++H      I+
Sbjct: 158 KNDIVLVMEYVDGGELFDRI---IDES--YNLTELDTILFMKQICEGIRHMH---QMYIL 209

Query: 715 HRDVKSSNILL------DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
           H D+K  NIL        I    K+ DFGL+R+ +        V  GT  +L PE     
Sbjct: 210 HLDLKPENILCVNRDAKQI----KIIDFGLARRYKPR--EKLKVNFGTPEFLAPEVVNYD 263

Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
            ++  +D++S GV+   L+SG  P
Sbjct: 264 FVSFPTDMWSVGVIAYMLLSGLSP 287

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  105 bits (265), Expect = 6e-25
 Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 40/216 (18%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVPLIG 653
           + +G+G++G V         + VAVKI+         +    E+ +   ++H N+V   G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72

Query: 654 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK-------GLEYLH 706
           +  E + + L  EY   G L DR+        +          DA +       G+ YLH
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRI---EPDIGMP-------EPDAQRFFHQLMAGVVYLH 122

Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS----RQAEEDLTHISSVARGTVGYLDP 762
                GI HRD+K  N+LLD     K+SDFGL+        E L +      GT+ Y+ P
Sbjct: 123 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC---GTLPYVAP 176

Query: 763 E------YYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           E      ++      E  DV+S G+VL  +++G+ P
Sbjct: 177 ELLKRREFHA-----EPVDVWSCGIVLTAMLAGELP 207

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  105 bits (265), Expect = 7e-25
 Identities = 49/209 (23%), Positives = 93/209 (44%), Gaps = 27/209 (12%)

Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIG 653
           + +G G  G V     +  G++ A+K++ DS   R      EV    +     ++V ++ 
Sbjct: 35  QVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ-----EVDHHWQASGGPHIVCILD 89

Query: 654 YCEEEHQRI----LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ---IAHDAAKGLEYLH 706
             E  H       ++ E M  G L  R+     ++     T  +   I  D    +++LH
Sbjct: 90  VYENMHHGKRCLLIIMECMEGGELFSRIQ----ERGDQAFTEREAAEIMRDIGTAIQFLH 145

Query: 707 TGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 763
              +  I HRDVK  N+L    + +   K++DFG +++  ++   + +    T  Y+ PE
Sbjct: 146 ---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPC-YTPYYVAPE 199

Query: 764 YYGNQQLTEKSDVYSFGVVLLELISGKKP 792
             G ++  +  D++S GV++  L+ G  P
Sbjct: 200 VLGPEKYDKSCDMWSLGVIMYILLCGFPP 228

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  105 bits (265), Expect = 8e-25
 Identities = 53/209 (25%), Positives = 88/209 (42%), Gaps = 23/209 (11%)

Query: 593 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADS-CSHRTQQFVTEVALLSR-IHHRNLV 649
              + IG GS+        K    E AVKI+  S           E+ +L R   H N++
Sbjct: 25  EVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE-----EIEILLRYGQHPNII 79

Query: 650 PLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
            L    ++     +V E M  G L D++      +++    +    I     K +EYLH 
Sbjct: 80  TLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLF-TI----TKTVEYLH- 133

Query: 708 GCNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 763
               G++HRD+K SNIL           ++ DFG ++Q   +   + +    T  ++ PE
Sbjct: 134 --AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTANFVAPE 190

Query: 764 YYGNQQLTEKSDVYSFGVVLLELISGKKP 792
               Q      D++S GV+L  +++G  P
Sbjct: 191 VLERQGYDAACDIWSLGVLLYTMLTGYTP 219

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  105 bits (263), Expect = 1e-24
 Identities = 57/219 (26%), Positives = 94/219 (42%), Gaps = 41/219 (18%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVKIMA-----DSCSHRTQQFVT-EVALLSRIHHR-- 646
             +G G FGSVY G  + D   VA+K +      D         V  EV LL ++     
Sbjct: 49  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108

Query: 647 NLVPLIGYCEEEHQRILVYEYMHN-GTLRDRL--HGSVNQKPLDWLTRL---QIAHDAAK 700
            ++ L+ + E     +L+ E       L D +   G++ ++    L R    Q+      
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEE----LARSFFWQVLE---- 160

Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLTHISSVARGTVGY 759
            + + H   N G++HRD+K  NIL+D+N    K+ DFG     ++ +        GT  Y
Sbjct: 161 AVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD---GTRVY 214

Query: 760 LDPE------YYGNQQLTEKSDVYSFGVVLLELISGKKP 792
             PE      Y+G       + V+S G++L +++ G  P
Sbjct: 215 SPPEWIRYHRYHG-----RSAAVWSLGILLYDMVCGDIP 248

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  105 bits (264), Expect = 1e-24
 Identities = 60/237 (25%), Positives = 99/237 (41%), Gaps = 38/237 (16%)

Query: 594 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 652
              ++G+G+   VY  K K   K  A+K++  +     +   TE+ +L R+ H N++ L 
Sbjct: 57  VESELGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLK 114

Query: 653 GYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAK-------GLE 703
              E   +  LV E +  G L DR+   G  +++            DAA         + 
Sbjct: 115 EIFETPTEISLVLELVTGGELFDRIVEKGYYSER------------DAADAVKQILEAVA 162

Query: 704 YLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYL 760
           YLH     GI+HRD+K  N+L      +   K++DFGLS+  E  +   +    GT GY 
Sbjct: 163 YLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC--GTPGYC 217

Query: 761 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 817
            PE         + D++S G++   L+ G +P   E     +         I   + 
Sbjct: 218 APEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMF------RRILNCEY 268

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  103 bits (259), Expect = 2e-24
 Identities = 60/209 (28%), Positives = 92/209 (44%), Gaps = 27/209 (12%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPL 651
             +G G+FG V  G+    G +VAVKI+            +   E+  L    H +++ L
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76

Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 709
                      +V EY+  G L D +  HG V +     L + QI       ++Y H   
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQ-QILS----AVDYCH--- 128

Query: 710 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE------ 763
              ++HRD+K  N+LLD +M AK++DFGLS    +        + G+  Y  PE      
Sbjct: 129 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFLRTSCGSPNYAAPEVISGRL 186

Query: 764 YYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           Y G      + D++S GV+L  L+ G  P
Sbjct: 187 YAG-----PEVDIWSCGVILYALLCGTLP 210

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  104 bits (261), Expect = 2e-24
 Identities = 34/119 (28%), Positives = 58/119 (48%), Gaps = 6/119 (5%)

Query: 372 NDRGDPCVPVPWEWVTCSTTT-PPRITKIALSGKNLKGE--IPPELKNMEALTELWL-DG 427
               D C    W  V C T T   R+  + LSG NL     IP  L N+  L  L++   
Sbjct: 28  LPTTDCC-NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGI 86

Query: 428 NFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 485
           N L GP+P  +++L  L  +++ +  ++G++P ++  +  L  L    N+  G +PP++
Sbjct: 87  NNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSI 145

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 96.1 bits (240), Expect = 1e-21
 Identities = 28/106 (26%), Positives = 46/106 (43%), Gaps = 1/106 (0%)

Query: 396 ITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTG 455
           +  + LS   L+G+      + +   ++ L  N L   L  +    +L  + L NN + G
Sbjct: 199 LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYG 258

Query: 456 SLPSYMGSLPNLQELHIENNSFVGEIPPAL-LTGKVIFKYDNNPKL 500
           +LP  +  L  L  L++  N+  GEIP    L    +  Y NN  L
Sbjct: 259 TLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCL 304

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 87.2 bits (217), Expect = 8e-19
 Identities = 27/91 (29%), Positives = 40/91 (43%), Gaps = 3/91 (3%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEAL-TELWLDGNFLTGPLP-DMSRLIDLRIVHLENN 451
           P +  I   G  + G IP    +   L T + +  N LTG +P   + L +L  V L  N
Sbjct: 149 PNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRN 207

Query: 452 ELTGSLPSYMGSLPNLQELHIENNSFVGEIP 482
            L G      GS  N Q++H+  NS   ++ 
Sbjct: 208 MLEGDASVLFGSDKNTQKIHLAKNSLAFDLG 238

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 83.7 bits (208), Expect = 1e-17
 Identities = 24/93 (25%), Positives = 41/93 (44%), Gaps = 7/93 (7%)

Query: 397 TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD----MSRLIDLRIVHLENNE 452
             +  S   L G +PP + ++  L  +  DGN ++G +PD     S+L     + +  N 
Sbjct: 128 VTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKL--FTSMTISRNR 185

Query: 453 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 485
           LTG +P    +L NL  + +  N   G+     
Sbjct: 186 LTGKIPPTFANL-NLAFVDLSRNMLEGDASVLF 217

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 66.0 bits (162), Expect = 1e-11
 Identities = 22/88 (25%), Positives = 39/88 (44%), Gaps = 3/88 (3%)

Query: 396 ITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELT 454
             KI L+  +L  ++  ++   + L  L L  N + G LP  +++L  L  +++  N L 
Sbjct: 223 TQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC 281

Query: 455 GSLPSYMGSLPNLQELHIENNSFVGEIP 482
           G +P   G+L         NN  +   P
Sbjct: 282 GEIPQ-GGNLQRFDVSAYANNKCLCGSP 308

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 50.2 bits (121), Expect = 1e-06
 Identities = 17/69 (24%), Positives = 27/69 (39%), Gaps = 2/69 (2%)

Query: 393 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLE-NN 451
              +  + L    + G +P  L  ++ L  L +  N L G +P    L    +     N 
Sbjct: 243 SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNK 302

Query: 452 ELTGS-LPS 459
            L GS LP+
Sbjct: 303 CLCGSPLPA 311

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  102 bits (257), Expect = 3e-24
 Identities = 23/214 (10%), Positives = 58/214 (27%), Gaps = 40/214 (18%)

Query: 597 KIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSH---RTQQFVTEVALLSRIHHRNLVPLI 652
             G       +        ++VA+  +           Q+ ++    LSRI    +  ++
Sbjct: 38  FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97

Query: 653 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 712
                    ++V E++  G+L++             +  ++     A   +  H     G
Sbjct: 98  DVVHTRAGGLVVAEWIRGGSLQEVADT-----SPSPVGAIRAMQSLAAAADAAHRA---G 149

Query: 713 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 772
           +       S + + I+    ++                         +            
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYP---------------------ATMPDA-------NP 181

Query: 773 KSDVYSFGVVLLELISGKKPVSVEDFGAELNIVH 806
           + D+   G  L  L+  + P+      + L    
Sbjct: 182 QDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE 215

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  102 bits (257), Expect = 6e-24
 Identities = 59/258 (22%), Positives = 106/258 (41%), Gaps = 52/258 (20%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVKIMA-----DSCSHRTQQFVT-EVALLSRIH---- 644
             +GKG FG+V+ G  + D  +VA+K++                   EVALL ++     
Sbjct: 37  PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96

Query: 645 HRNLVPLIGYCEEEHQRILVYEYMHNGT-LRDRL--HGSVNQKPLDWLTRL---QIAHDA 698
           H  ++ L+ + E +   +LV E       L D +   G + +      +R    Q+    
Sbjct: 97  HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEG----PSRCFFGQVVA-- 150

Query: 699 AKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEEDLTHISSVARGTV 757
              +++ H   + G++HRD+K  NIL+D+    AK+ DFG      ++         GT 
Sbjct: 151 --AIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD---GTR 202

Query: 758 GYLDPE------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED--FGAELNIVHW-- 807
            Y  PE      Y+        + V+S G++L +++ G  P   +     AEL+      
Sbjct: 203 VYSPPEWISRHQYHA-----LPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHVS 257

Query: 808 --ARSMIKKGDVISIVDP 823
               ++I++        P
Sbjct: 258 PDCCALIRR---CLAPKP 272

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  102 bits (256), Expect = 8e-24
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 37/218 (16%)

Query: 593 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNL 648
            F K +G+GSF +V   +     +E A+KI+      +  +      E  ++SR+ H   
Sbjct: 33  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92

Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI-AHDAAK------- 700
           V L    +++ +      Y  NG L            L ++ ++        +       
Sbjct: 93  VKLYFTFQDDEKLYFGLSYAKNGEL------------LKYIRKIGSFDETCTRFYTAEIV 140

Query: 701 -GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----- 754
             LEYLH     GIIHRD+K  NILL+ +M  +++DFG ++    +    S  AR     
Sbjct: 141 SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE----SKQARANSFV 193

Query: 755 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           GT  Y+ PE    +   + SD+++ G ++ +L++G  P
Sbjct: 194 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  103 bits (258), Expect = 2e-23
 Identities = 50/209 (23%), Positives = 88/209 (42%), Gaps = 26/209 (12%)

Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIG 653
           + +G G  G V     K   ++ A+K++ D    R      EV L  R     ++V ++ 
Sbjct: 68  QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-----EVELHWRASQCPHIVRIVD 122

Query: 654 YCEEEHQRI----LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ---IAHDAAKGLEYLH 706
             E  +       +V E +  G L  R+      +     T  +   I     + ++YLH
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGELFSRIQ----DRGDQAFTEREASEIMKSIGEAIQYLH 178

Query: 707 TGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 763
              +  I HRDVK  N+L      N   K++DFG +++     +  +     T  Y+ PE
Sbjct: 179 ---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC--YTPYYVAPE 233

Query: 764 YYGNQQLTEKSDVYSFGVVLLELISGKKP 792
             G ++  +  D++S GV++  L+ G  P
Sbjct: 234 VLGPEKYDKSCDMWSLGVIMYILLCGYPP 262

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  102 bits (255), Expect = 3e-23
 Identities = 63/211 (29%), Positives = 101/211 (47%), Gaps = 31/211 (14%)

Query: 595 CKKIGKGSFGSVYYGKMKDGKEVAVK-IMADSC-SHRTQQFVTEVALLSRIHHRNLVPLI 652
           CK IG GSFG V+  K+ +  EVA+K ++ D    +R      E+ ++  + H N+V L 
Sbjct: 45  CKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR------ELQIMRIVKHPNVVDLK 98

Query: 653 ------GYCEEEHQRILVYEYMHNGTLRD--RLHGSVNQKPLDWLTRL---QIAHDAAKG 701
                 G  ++E    LV EY+   T+    R +  + Q     L +L   Q+     + 
Sbjct: 99  AFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQL----LRS 153

Query: 702 LEYLHTGCNPGIIHRDVKSSNILLDINMRA-KVSDFGLSRQAEEDLTHISSVARGTVGYL 760
           L Y+H+    GI HRD+K  N+LLD      K+ DFG ++       ++S +   +  Y 
Sbjct: 154 LAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYIC--SRYYR 208

Query: 761 DPE-YYGNQQLTEKSDVYSFGVVLLELISGK 790
            PE  +G    T   D++S G V+ EL+ G+
Sbjct: 209 APELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  100 bits (252), Expect = 9e-23
 Identities = 61/212 (28%), Positives = 89/212 (41%), Gaps = 18/212 (8%)

Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQ--QFVTEVALLSRIHHRNL 648
              K IG+G+F  V   KMK   +V A+KIM       R +   F  E  +L     R +
Sbjct: 64  EILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWI 123

Query: 649 VPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
             L  +  ++   + LV EY   G L   L     + P +   R  +A +    ++ +H 
Sbjct: 124 TQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEM-ARFYLA-EIVMAIDSVH- 179

Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 767
               G +HRD+K  NILLD     +++DFG   +   D T  S VA GT  YL PE    
Sbjct: 180 --RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQA 237

Query: 768 QQLTEKSDVY-------SFGVVLLELISGKKP 792
                 +  Y       + GV   E+  G+ P
Sbjct: 238 VGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  100 bits (251), Expect = 1e-22
 Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 17/208 (8%)

Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQQF--VTEVALLSRIHHRNL 648
              + IGKGSFG V   +  D K++ A+K M    C  R +      E+ ++  + H  L
Sbjct: 18  EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFL 77

Query: 649 VPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
           V L  Y  ++ + + +V + +  G LR  L    N    +   +L I  +    L+YL  
Sbjct: 78  VNLW-YSFQDEEDMFMVVDLLLGGDLRYHL--QQNVHFKEETVKLFIC-ELVMALDYLQ- 132

Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 767
             N  IIHRD+K  NILLD +    ++DF ++     +    +++A GT  Y+ PE + +
Sbjct: 133 --NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI-TTMA-GTKPYMAPEMFSS 188

Query: 768 QQLTEKS---DVYSFGVVLLELISGKKP 792
           ++    S   D +S GV   EL+ G++P
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  102 bits (256), Expect = 1e-22
 Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 12/210 (5%)

Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQQFVT--EVALLSRIHHRNL 648
              + +GKG FG V   +++   ++ A K +       R  + +   E  +L +++ R +
Sbjct: 187 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFV 246

Query: 649 VPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
           V L  Y  E    + LV   M+ G L+  ++        +       A     GLE LH 
Sbjct: 247 VSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLEDLH- 303

Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 767
                I++RD+K  NILLD +   ++SD GL+    E  T    V  GTVGY+ PE   N
Sbjct: 304 --RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV--GTVGYMAPEVVKN 359

Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVSVED 797
           ++ T   D ++ G +L E+I+G+ P     
Sbjct: 360 ERYTFSPDWWALGCLLYEMIAGQSPFQQRK 389

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 99.4 bits (248), Expect = 1e-22
 Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 27/208 (12%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 654
           K IG G+FG     +     + VAVK + +  +   +    E+     + H N+V     
Sbjct: 26  KDIGSGNFGVARLMRDKLTKELVAVKYI-ERGAAIDENVQREIINHRSLRHPNIVRFKEV 84

Query: 655 CEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 712
                   ++ EY   G L +R+   G  ++    +  + Q+      G+ Y H   +  
Sbjct: 85  ILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQ-QLLS----GVSYCH---SMQ 136

Query: 713 IIHRDVKSSNILLDIN--MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE------Y 764
           I HRD+K  N LLD +   R K+ DFG S+ +       S+V  GT  Y+ PE      Y
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV--GTPAYIAPEVLLRQEY 194

Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKP 792
            G     + +DV+S GV L  ++ G  P
Sbjct: 195 DG-----KIADVWSCGVTLYVMLVGAYP 217

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 99.3 bits (248), Expect = 2e-22
 Identities = 61/239 (25%), Positives = 106/239 (44%), Gaps = 29/239 (12%)

Query: 570 GGHFMDEGVAYFIPLPELEEATN-NFCKKIGKGSFGSVYYGKMKD-GKEVAVK-IMAD-S 625
            G  M    A        +E       +  G+G+FG+V  GK K  G  VA+K ++ D  
Sbjct: 2   PGSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR 61

Query: 626 CSHRTQQFVTEVALLSRIHHRNLVPLIGY----CEEEHQRI---LVYEYMHNGTLRD--R 676
             +R  Q    +  L+ +HH N+V L  Y     E + + I   +V EY+   TL    R
Sbjct: 62  FRNRELQ---IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCR 117

Query: 677 LHGSVNQKPLDWLTRL---QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-INMRAK 732
            +      P   L ++   Q+     + +  LH      + HRD+K  N+L++  +   K
Sbjct: 118 NYYRRQVAPPPILIKVFLFQLI----RSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLK 172

Query: 733 VSDFGLSRQAEEDLTHISSVARGTVGYLDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 790
           + DFG +++      +++ +   +  Y  PE  +GNQ  T   D++S G +  E++ G+
Sbjct: 173 LCDFGSAKKLSPSEPNVAYIC--SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 98.9 bits (247), Expect = 2e-22
 Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 28/209 (13%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPL 651
           + +G+GSFG V      K  ++VA+K ++      S    +   E++ L  + H +++ L
Sbjct: 15  ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74

Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 709
                     ++V EY   G L D +     + +       + QI       +EY H   
Sbjct: 75  YDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQ-QIIC----AIEYCH--- 125

Query: 710 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE------ 763
              I+HRD+K  N+LLD N+  K++DFGLS    +   +    + G+  Y  PE      
Sbjct: 126 RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG--NFLKTSCGSPNYAAPEVINGKL 183

Query: 764 YYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           Y G      + DV+S G+VL  ++ G+ P
Sbjct: 184 YAG-----PEVDVWSCGIVLYVMLVGRLP 207

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  101 bits (252), Expect = 2e-22
 Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 11/206 (5%)

Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQQFVT--EVALLSRIHHRNL 648
              + +G+G FG V+  +MK   ++ A K +       R        E  +L+++H R +
Sbjct: 188 LDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFI 247

Query: 649 VPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI-AHDAAKGLEYLH 706
           V L  Y  E    + LV   M+ G +R  ++      P     R          GLE+LH
Sbjct: 248 VSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306

Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 766
                 II+RD+K  N+LLD +   ++SD GL+ + +   T     A GT G++ PE   
Sbjct: 307 ---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPELLL 362

Query: 767 NQQLTEKSDVYSFGVVLLELISGKKP 792
            ++     D ++ GV L E+I+ + P
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIAARGP 388

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  100 bits (250), Expect = 3e-22
 Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 29/210 (13%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPL 651
             +G G+FG V  GK    G +VAVKI+            +   E+  L    H +++ L
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81

Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 709
                      +V EY+  G L D +  +G +++K    L + QI      G++Y H   
Sbjct: 82  YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQ-QILS----GVDYCH--- 133

Query: 710 NPGIIHRDVKSSNILLDINMRAKVSDFGLSR-QAEEDLTHISSVARGTVGYLDPE----- 763
              ++HRD+K  N+LLD +M AK++DFGLS   ++ +    S    G+  Y  PE     
Sbjct: 134 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPEVISGR 190

Query: 764 -YYGNQQLTEKSDVYSFGVVLLELISGKKP 792
            Y G      + D++S GV+L  L+ G  P
Sbjct: 191 LYAG-----PEVDIWSSGVILYALLCGTLP 215

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 99.4 bits (248), Expect = 4e-22
 Identities = 63/212 (29%), Positives = 101/212 (47%), Gaps = 32/212 (15%)

Query: 595 CKKIGKGSFGSVYYGKMKD-GKEVAVK-IMADSC-SHRTQQFVTEVALLSRIHHRNLVPL 651
            K IG GSFG VY  K+ D G+ VA+K ++ D    +R      E+ ++ ++ H N+V L
Sbjct: 59  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNIVRL 112

Query: 652 IGYCEEEHQRI------LVYEYMHNGTLRD--RLHGSVNQKPLDWLTRL---QIAHDAAK 700
             +     ++       LV +Y+   T+    R +    Q       +L   Q+     +
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLF----R 167

Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDINMRA-KVSDFGLSRQAEEDLTHISSVARGTVGY 759
            L Y+H+    GI HRD+K  N+LLD +    K+ DFG ++Q      ++S +   +  Y
Sbjct: 168 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRYY 222

Query: 760 LDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 790
             PE  +G    T   DV+S G VL EL+ G+
Sbjct: 223 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =   99 bits (250), Expect = 1e-21
 Identities = 41/107 (38%), Positives = 57/107 (53%), Gaps = 6/107 (5%)

Query: 380 PVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MS 438
            +P    + S     ++  + L    L+GEIP EL  ++ L  L LD N LTG +P  +S
Sbjct: 433 TIPSSLGSLS-----KLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLS 487

Query: 439 RLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 485
              +L  + L NN LTG +P ++G L NL  L + NNSF G IP  L
Sbjct: 488 NCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAEL 534

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 98.1 bits (245), Expect = 5e-21
 Identities = 39/150 (26%), Positives = 64/150 (42%), Gaps = 14/150 (9%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNE 452
             +  + L   +L GEIP  L N   L  + L  N LTG +P  + RL +L I+ L NN 
Sbjct: 466 KTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNS 525

Query: 453 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL-----------LTGKVIFKYDNNPKLH 501
            +G++P+ +G   +L  L +  N F G IP A+           + GK      N+    
Sbjct: 526 FSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKK 585

Query: 502 K--ESRRRMRFKLILGTSIGVLAILLVLFL 529
           +   +   + F+ I    +  L+      +
Sbjct: 586 ECHGAGNLLEFQGIRSEQLNRLSTRNPCNI 615

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 97.3 bits (243), Expect = 7e-21
 Identities = 26/119 (21%), Positives = 50/119 (42%), Gaps = 5/119 (4%)

Query: 380 PVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSR 439
                WV         +  +A+SG  + G++   +     L  L +  N  +  +P +  
Sbjct: 166 ANVVGWVLSDGCG--ELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPFLGD 221

Query: 440 LIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG-KVIFKYDNN 497
              L+ + +  N+L+G     + +   L+ L+I +N FVG IPP  L   + +   +N 
Sbjct: 222 CSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENK 280

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 96.9 bits (242), Expect = 1e-20
 Identities = 30/96 (31%), Positives = 45/96 (46%), Gaps = 1/96 (1%)

Query: 391 TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLE 449
                + ++ L      G+IPP L N   L  L L  N+L+G +P  +  L  LR + L 
Sbjct: 391 NPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLW 450

Query: 450 NNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 485
            N L G +P  +  +  L+ L ++ N   GEIP  L
Sbjct: 451 LNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGL 486

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 91.1 bits (227), Expect = 7e-19
 Identities = 30/95 (31%), Positives = 49/95 (51%), Gaps = 3/95 (3%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENN 451
             +T + LSG +  G +PP   +   L  L L  N  +G LP   + ++  L+++ L  N
Sbjct: 294 DTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFN 353

Query: 452 ELTGSLPSYMGSL-PNLQELHIENNSFVGEIPPAL 485
           E +G LP  + +L  +L  L + +N+F G I P L
Sbjct: 354 EFSGELPESLTNLSASLLTLDLSSNNFSGPILPNL 388

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 90.4 bits (225), Expect = 1e-18
 Identities = 35/96 (36%), Positives = 49/96 (51%), Gaps = 3/96 (3%)

Query: 393 PPRITKIALSGKNLKGEIPPELKN--MEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLE 449
              +  + LS  N  G I P L       L EL+L  N  TG +P  +S   +L  +HL 
Sbjct: 367 SASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLS 426

Query: 450 NNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 485
            N L+G++PS +GSL  L++L +  N   GEIP  L
Sbjct: 427 FNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQEL 462

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 88.4 bits (220), Expect = 4e-18
 Identities = 26/120 (21%), Positives = 49/120 (40%), Gaps = 11/120 (9%)

Query: 372 NDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLK---GEIPPELKNMEALTELWLDGN 428
           +   +PC    ++ VTC      ++T I LS K L      +   L ++  L  L+L  +
Sbjct: 34  SSNKNPCT---FDGVTCRDD---KVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNS 87

Query: 429 FLTGPLPDMSRLIDLRIVHLENNELTGSLPSYM--GSLPNLQELHIENNSFVGEIPPALL 486
            + G +        L  + L  N L+G + +    GS   L+ L++ +N+       +  
Sbjct: 88  HINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGG 147

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 88.0 bits (219), Expect = 5e-18
 Identities = 28/95 (29%), Positives = 44/95 (46%), Gaps = 4/95 (4%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENN 451
             +  + +S     G IPP    +++L  L L  N  TG +PD        L  + L  N
Sbjct: 247 TELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGN 304

Query: 452 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALL 486
              G++P + GS   L+ L + +N+F GE+P   L
Sbjct: 305 HFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTL 339

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 86.9 bits (216), Expect = 1e-17
 Identities = 28/95 (29%), Positives = 43/95 (45%), Gaps = 3/95 (3%)

Query: 394 PRITKIALSGKNLKGEIPPELK-NMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENN 451
             +  ++L+     GEIP  L    + LT L L GN   G +P        L  + L +N
Sbjct: 269 KSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSN 328

Query: 452 ELTGSLP-SYMGSLPNLQELHIENNSFVGEIPPAL 485
             +G LP   +  +  L+ L +  N F GE+P +L
Sbjct: 329 NFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESL 363

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 84.6 bits (210), Expect = 6e-17
 Identities = 33/97 (34%), Positives = 50/97 (51%), Gaps = 5/97 (5%)

Query: 394 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPD-MSRL-IDLRIVHLEN 450
             +  +ALS  N  GE+P + L  M  L  L L  N  +G LP+ ++ L   L  + L +
Sbjct: 318 SLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSS 377

Query: 451 NELTGSLPSYMG--SLPNLQELHIENNSFVGEIPPAL 485
           N  +G +   +       LQEL+++NN F G+IPP L
Sbjct: 378 NNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTL 414

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 84.6 bits (210), Expect = 7e-17
 Identities = 31/133 (23%), Positives = 56/133 (42%), Gaps = 26/133 (19%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNE 452
                  ++ +   G   P   N  ++  L +  N L+G +P  +  +  L I++L +N+
Sbjct: 608 STRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHND 667

Query: 453 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL---------------LTGKV----IFK 493
           ++GS+P  +G L  L  L + +N   G IP A+               L+G +     F+
Sbjct: 668 ISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFE 727

Query: 494 ------YDNNPKL 500
                 + NNP L
Sbjct: 728 TFPPAKFLNNPGL 740

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 80.3 bits (199), Expect = 1e-15
 Identities = 20/101 (19%), Positives = 37/101 (36%), Gaps = 7/101 (6%)

Query: 394 PRITKIALSGKNLKGEIPP--ELKNMEALTELWLDGNFLTG--PLPDMSRLIDLRIVHLE 449
             +T + LS  +L G +     L +   L  L +  N L     +    +L  L ++ L 
Sbjct: 100 ASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLS 159

Query: 450 NNELTGSLPS---YMGSLPNLQELHIENNSFVGEIPPALLT 487
            N ++G+             L+ L I  N   G++  +   
Sbjct: 160 ANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCV 200

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 76.1 bits (188), Expect = 3e-14
 Identities = 17/88 (19%), Positives = 33/88 (37%), Gaps = 1/88 (1%)

Query: 399 IALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSL 457
            A +    +G    +L  +       +      G           +  + +  N L+G +
Sbjct: 589 GAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYI 648

Query: 458 PSYMGSLPNLQELHIENNSFVGEIPPAL 485
           P  +GS+P L  L++ +N   G IP  +
Sbjct: 649 PKEIGSMPYLFILNLGHNDISGSIPDEV 676

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 72.6 bits (179), Expect = 3e-13
 Identities = 15/89 (16%), Positives = 30/89 (33%), Gaps = 3/89 (3%)

Query: 400 ALSGKNLKGEIPPELKNMEALTELWLDGNF--LTGPLP-DMSRLIDLRIVHLENNELTGS 456
            ++   + G+    +KN     E    GN     G     ++RL      ++ +    G 
Sbjct: 564 KIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGH 623

Query: 457 LPSYMGSLPNLQELHIENNSFVGEIPPAL 485
                 +  ++  L +  N   G IP  +
Sbjct: 624 TSPTFDNNGSMMFLDMSYNMLSGYIPKEI 652

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 97.1 bits (242), Expect = 2e-21
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 16/210 (7%)

Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIM--ADSCSHR-TQQFVTEVALLSRIHHRNL 648
              K IG+G+FG V   K+K+  +V A+KI+   +      T  F  E  +L     + +
Sbjct: 77  EILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWI 136

Query: 649 VPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
             L  Y  ++   + LV +Y   G L   L    ++ P +   R  +A +    ++ +H 
Sbjct: 137 TTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEM-ARFYLA-EMVIAIDSVH- 192

Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 767
                 +HRD+K  NIL+D+N   +++DFG   +  ED T  SSVA GT  Y+ PE    
Sbjct: 193 --QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 250

Query: 768 QQLTEKS-----DVYSFGVVLLELISGKKP 792
            +  +       D +S GV + E++ G+ P
Sbjct: 251 MEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 95.4 bits (238), Expect = 3e-21
 Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 29/208 (13%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 652
             +G G++GSV      + G++VA+K ++         ++   E+ LL  + H N++ L+
Sbjct: 30  THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 89

Query: 653 -----GYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRL---QIAHDAAKGLE 703
                           LV  +M      D L   +  K  +   +    Q+     KGL+
Sbjct: 90  DVFTPASSLRNFYDFYLVMPFMQT----D-LQKIMGLKFSEEKIQYLVYQML----KGLK 140

Query: 704 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 763
           Y+H+    G++HRD+K  N+ ++ +   K+ DFGL+R A+ ++T    V   T  Y  PE
Sbjct: 141 YIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG--YVV--TRWYRAPE 193

Query: 764 -YYGNQQLTEKSDVYSFGVVLLELISGK 790
                    +  D++S G ++ E+++GK
Sbjct: 194 VILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 96.8 bits (241), Expect = 3e-21
 Identities = 64/268 (23%), Positives = 109/268 (40%), Gaps = 37/268 (13%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 652
           K IG G+ G V         + VA+K ++    ++T  ++   E+ L+  ++H+N++ L+
Sbjct: 68  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 127

Query: 653 ------GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
                    EE     LV E M      + L   V Q  LD      + +    G+++LH
Sbjct: 128 NVFTPQKTLEEFQDVYLVMELMDA----N-LC-QVIQMELDHERMSYLLYQMLCGIKHLH 181

Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 766
           +    GIIHRD+K SNI++  +   K+ DFGL+R A         V   T  Y  PE   
Sbjct: 182 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVIL 236

Query: 767 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 826
                E  D++S G ++ E++  K      D+  + N                +++   +
Sbjct: 237 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK---------------VIE--QL 279

Query: 827 GNVKIESIWRIAEVAIQCVEQRGFSRPK 854
           G    E + ++       VE R      
Sbjct: 280 GTPCPEFMKKLQPTVRNYVENRPKYAGL 307

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 94.8 bits (236), Expect = 6e-21
 Identities = 65/268 (24%), Positives = 110/268 (41%), Gaps = 37/268 (13%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 652
           K IG G+ G V         + VA+K ++    ++T  ++   E+ L+  ++H+N++ L+
Sbjct: 31  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 90

Query: 653 -----GYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
                    EE Q + +V E M      + L   V Q  LD      + +    G+++LH
Sbjct: 91  NVFTPQKSLEEFQDVYIVMELMDA----N-LC-QVIQMELDHERMSYLLYQMLCGIKHLH 144

Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 766
           +    GIIHRD+K SNI++  +   K+ DFGL+R A         V   T  Y  PE   
Sbjct: 145 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVIL 199

Query: 767 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 826
                E  D++S G ++ E+I G       D   + N                +++   +
Sbjct: 200 GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK---------------VIE--QL 242

Query: 827 GNVKIESIWRIAEVAIQCVEQRGFSRPK 854
           G    E + ++       VE R      
Sbjct: 243 GTPCPEFMKKLQPTVRTYVENRPKYAGY 270

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 97.6 bits (243), Expect = 6e-21
 Identities = 57/211 (27%), Positives = 99/211 (46%), Gaps = 23/211 (10%)

Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQQF--VTEVALLSRIH---H 645
           +  + IG+G FG VY  +  D  ++ A+K +       +  +   + E  +LS +     
Sbjct: 192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 251

Query: 646 RNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGL 702
             +V +  Y      ++  + + M+ G L   L  HG  ++       R   A +   GL
Sbjct: 252 PFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA----DMRFYAA-EIILGL 305

Query: 703 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDP 762
           E++H   N  +++RD+K +NILLD +   ++SD GL+    +   H +SV  GT GY+ P
Sbjct: 306 EHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH-ASV--GTHGYMAP 359

Query: 763 EYYGNQQLTEKS-DVYSFGVVLLELISGKKP 792
           E        + S D +S G +L +L+ G  P
Sbjct: 360 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 94.7 bits (236), Expect = 7e-21
 Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 34/211 (16%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 652
             +G G++GSV      K G  VAVK ++         ++   E+ LL  + H N++ L+
Sbjct: 35  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 94

Query: 653 -----GYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
                    EE   + LV   M  G   D L+  V  + L       + +   +GL+Y+H
Sbjct: 95  DVFTPARSLEEFNDVYLVTHLM--GA--D-LNNIVKCQKLTDDHVQFLIYQILRGLKYIH 149

Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY- 765
           +     IIHRD+K SN+ ++ +   K+ DFGL+R   +++T          GY+   +Y 
Sbjct: 150 SA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT----------GYVATRWYR 196

Query: 766 ------GNQQLTEKSDVYSFGVVLLELISGK 790
                       +  D++S G ++ EL++G+
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 93.9 bits (234), Expect = 1e-20
 Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 22/205 (10%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 652
           + +G G++G+V      + G +VA+K +          ++   E+ LL  + H N++ L+
Sbjct: 31  QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 90

Query: 653 -----GYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
                    ++     LV  +M      D L   +  + L       + +   KGL Y+H
Sbjct: 91  DVFTPDETLDDFTDFYLVMPFMGT----D-LGKLMKHEKLGEDRIQFLVYQMLKGLRYIH 145

Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY-Y 765
                GIIHRD+K  N+ ++ +   K+ DFGL+RQA+ ++T    V   T  Y  PE   
Sbjct: 146 AA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTG--YVV--TRWYRAPEVIL 198

Query: 766 GNQQLTEKSDVYSFGVVLLELISGK 790
              + T+  D++S G ++ E+I+GK
Sbjct: 199 NWMRYTQTVDIWSVGCIMAEMITGK 223

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 94.4 bits (235), Expect = 1e-20
 Identities = 54/216 (25%), Positives = 94/216 (43%), Gaps = 31/216 (14%)

Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRTQQ---FVTEVALLSRIHHRNL 648
              K IG+G+FG V   + K  ++V A+K+++     +      F  E  +++  +   +
Sbjct: 72  EVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWV 131

Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK-------- 700
           V L    +++    +V EYM  G L            ++ ++   +    A+        
Sbjct: 132 VQLFYAFQDDRYLYMVMEYMPGGDL------------VNLMSNYDVPEKWARFYTAEVVL 179

Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYL 760
            L+ +H   + G IHRDVK  N+LLD +   K++DFG   +  ++       A GT  Y+
Sbjct: 180 ALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYI 236

Query: 761 DPE---YYGNQQLTEKS-DVYSFGVVLLELISGKKP 792
            PE     G      +  D +S GV L E++ G  P
Sbjct: 237 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 92.8 bits (231), Expect = 2e-20
 Identities = 55/215 (25%), Positives = 89/215 (41%), Gaps = 31/215 (14%)

Query: 596 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVT-----------EVALLSRIH 644
           + I  GS+G+V  G   +G  VA+K + ++ S      +            E+ LL+  H
Sbjct: 28  RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87

Query: 645 HRNLVPL----IGYCEEEHQRI-LVYEYMHNGTLRDRLHG--SVNQKPLDWLTRLQ-IAH 696
           H N++ L    + + E    ++ LV E M      D L       +  +     +Q   +
Sbjct: 88  HPNILGLRDIFVHFEEPAMHKLYLVTELMRT----D-LAQVIHDQRIVIS-PQHIQYFMY 141

Query: 697 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT 756
               GL  LH     G++HRD+   NILL  N    + DF L+R+   D      V    
Sbjct: 142 HILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVT--H 196

Query: 757 VGYLDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 790
             Y  PE     +  T+  D++S G V+ E+ + K
Sbjct: 197 RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 93.3 bits (232), Expect = 4e-20
 Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 12/210 (5%)

Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHR--TQQFVTEVALLSRIHHRNL 648
            + K +GKG+FG V   K K      A+KI+  +    +      +TE  +L    H  L
Sbjct: 151 EYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFL 210

Query: 649 VPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
             L  Y  + H R+  V EY + G L    H S  +   +   R   A +    L+YLH+
Sbjct: 211 TALK-YSFQTHDRLCFVMEYANGGELF--FHLSRERVFSEDRARFYGA-EIVSALDYLHS 266

Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 767
                +++RD+K  N++LD +   K++DFGL ++  +D   + +   GT  YL PE   +
Sbjct: 267 --EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLAPEVLED 323

Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVSVED 797
                  D +  GVV+ E++ G+ P   +D
Sbjct: 324 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 353

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 89.6 bits (223), Expect = 2e-19
 Identities = 50/206 (24%), Positives = 97/206 (47%), Gaps = 26/206 (12%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPL-- 651
           +K+G+G +  V+    + + ++V VKI+      + ++   E+ +L  +    N++ L  
Sbjct: 42  RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR---EIKILENLRGGPNIITLAD 98

Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTG 708
           I          LV+E+++N   +         +    LT   I    ++  K L+Y H+ 
Sbjct: 99  IVKDPVSRTPALVFEHVNNTDFK---------QLYQTLTDYDIRFYMYEILKALDYCHSM 149

Query: 709 CNPGIIHRDVKSSNILLDINMRA-KVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 767
              GI+HRDVK  N+++D   R  ++ D+GL+        +   VA  +  +  PE   +
Sbjct: 150 ---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA--SRYFKGPELLVD 204

Query: 768 QQLTEKS-DVYSFGVVLLELISGKKP 792
            Q+ + S D++S G +L  +I  K+P
Sbjct: 205 YQMYDYSLDMWSLGCMLASMIFRKEP 230

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 88.4 bits (220), Expect = 4e-19
 Identities = 59/213 (27%), Positives = 100/213 (46%), Gaps = 40/213 (18%)

Query: 596 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQF-----VT---EVALLSRIHHRN 647
           +K+G+G++G VY  K   G+ VA+K +      R          T   E++LL  +HH N
Sbjct: 27  EKVGEGTYGVVYKAKDSQGRIVALKRI------RLDAEDEGIPSTAIREISLLKELHHPN 80

Query: 648 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR------LQIAHDAAKG 701
           +V LI     E    LV+E+M      D L   +++               Q+     +G
Sbjct: 81  IVSLIDVIHSERCLTLVFEFMEK----D-LKKVLDENKTGLQDSQIKIYLYQLL----RG 131

Query: 702 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVG 758
           + + H      I+HRD+K  N+L++ +   K++DFGL+R         TH   V   T+ 
Sbjct: 132 VAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHE--VV--TLW 184

Query: 759 YLDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 790
           Y  P+   G+++ +   D++S G +  E+I+GK
Sbjct: 185 YRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 88.4 bits (220), Expect = 4e-19
 Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 27/208 (12%)

Query: 597 KIGKGSFGSVYYGKMKD-GKEVAVKIM-------ADSCSHRTQQFVTEVALLSRIHHRNL 648
           K+G G++ +VY G  K  G  VA+K +         S + R      E++L+  + H N+
Sbjct: 12  KLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR------EISLMKELKHENI 65

Query: 649 VPLIGYCEEEHQRILVYEYMHN--GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           V L      E++  LV+E+M N      D        + L+            +GL + H
Sbjct: 66  VRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH 125

Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVGYLDPE 763
                 I+HRD+K  N+L++   + K+ DFGL+R         +    V   T+ Y  P+
Sbjct: 126 EN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSE--VV--TLWYRAPD 178

Query: 764 Y-YGNQQLTEKSDVYSFGVVLLELISGK 790
              G++  +   D++S G +L E+I+GK
Sbjct: 179 VLMGSRTYSTSIDIWSCGCILAEMITGK 206

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 88.1 bits (219), Expect = 4e-19
 Identities = 47/211 (22%), Positives = 80/211 (37%), Gaps = 47/211 (22%)

Query: 594 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPL 651
             + +G G  G V     K   ++ A+K++ D    R      EV L  R     ++V +
Sbjct: 22  TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-----EVELHWRASQCPHIVRI 76

Query: 652 IGYCEEEHQRI----LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ---IAHDAAKGLEY 704
           +   E  +       +V E +  G L  R+      +     T  +   I     + ++Y
Sbjct: 77  VDVYENLYAGRKCLLIVMECLDGGELFSRIQ----DRGDQAFTEREASEIMKSIGEAIQY 132

Query: 705 LHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 761
           LH   +  I HRDVK  N+L      N   K++DFG +++                    
Sbjct: 133 LH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE------------------TT 171

Query: 762 PEYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
            E Y      +  D++S GV++  L+ G  P
Sbjct: 172 GEKYD-----KSCDMWSLGVIMYILLCGYPP 197

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 88.4 bits (219), Expect = 8e-19
 Identities = 60/270 (22%), Positives = 105/270 (38%), Gaps = 71/270 (26%)

Query: 594 FCKKIGKGSFGSVYYG------KMKDGKEVAVKIMADSCSHR-TQQFVTEVALLSRI-HH 645
             K +G+G+FG V         K    + VAVK++ +  +H   +  ++E+ +L  I HH
Sbjct: 26  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 85

Query: 646 RNLVPLIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQ--------------------- 683
            N+V L+G C +     +++ E+   G L   L    N+                     
Sbjct: 86  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAI 145

Query: 684 -----KPLDWLTRLQIAHDAA----KGLEYLHTGCNPGIIHRDVKSSNILLDI------- 727
                + LD +T  Q +  +     K L  +     P  +++D  +   L+         
Sbjct: 146 PVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKG 205

Query: 728 -----------------------NMRAKVSDFGLSRQAEEDLTHI-SSVARGTVGYLDPE 763
                                      K+ DFGL+R   +D  ++    AR  + ++ PE
Sbjct: 206 MEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 265

Query: 764 YYGNQQLTEKSDVYSFGVVLLELIS-GKKP 792
              ++  T +SDV+SFGV+L E+ S G  P
Sbjct: 266 TIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 86.8 bits (216), Expect = 1e-18
 Identities = 59/208 (28%), Positives = 91/208 (43%), Gaps = 29/208 (13%)

Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVKIM--------ADSCSHRTQQFVTEVALLSRIHHR 646
            KIG+GS+G V+  + +D G+ VA+K              + R      E+ +L ++ H 
Sbjct: 9   GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR------EIRMLKQLKHP 62

Query: 647 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           NLV L+     + +  LV+EY  + T+   L     Q+ +       I     + + + H
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDH-TVLHEL--DRYQRGVPEHLVKSITWQTLQAVNFCH 119

Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVGYLDPE 763
                  IHRDVK  NIL+  +   K+ DFG +R      +       VA  T  Y  PE
Sbjct: 120 KH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDD--EVA--TRWYRSPE 172

Query: 764 Y-YGNQQLTEKSDVYSFGVVLLELISGK 790
              G+ Q     DV++ G V  EL+SG 
Sbjct: 173 LLVGDTQYGPPVDVWAIGCVFAELLSGV 200

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 87.9 bits (218), Expect = 2e-18
 Identities = 50/243 (20%), Positives = 91/243 (37%), Gaps = 62/243 (25%)

Query: 595 CKKIGKGSFGSVYYGKMKD-GKEVAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPL- 651
            K +G GSFG V      + GK  A+K ++ D       +   E+ ++  + H N++ L 
Sbjct: 12  GKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP--RYKNR---ELDIMKVLDHVNIIKLV 66

Query: 652 -IGYCEEEHQRI------------------------------------LVYEYMHNGTLR 674
              Y   + +                                      ++ EY+   TL 
Sbjct: 67  DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV-PDTLH 125

Query: 675 D--RLHGSVNQKPLDWLTRL---QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM 729
              +      +     L  +   Q+     + + ++H+    GI HRD+K  N+L++   
Sbjct: 126 KVLKSFIRSGRSIPMNLISIYIYQLF----RAVGFIHSL---GICHRDIKPQNLLVNSKD 178

Query: 730 -RAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYGNQQLTEKSDVYSFGVVLLELI 787
              K+ DFG +++       ++ +   +  Y  PE   G  + T   D++S G V  ELI
Sbjct: 179 NTLKLCDFGSAKKLIPSEPSVAYIC--SRFYRAPELMLGATEYTPSIDLWSIGCVFGELI 236

Query: 788 SGK 790
            GK
Sbjct: 237 LGK 239

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 85.3 bits (212), Expect = 3e-18
 Identities = 51/212 (24%), Positives = 97/212 (45%), Gaps = 40/212 (18%)

Query: 597 KIGKGSFGSVYYGKMKDGKEVAVKIM--------ADSCSHRTQQFVTEVALLSRIHHRNL 648
           KIG+G++G VY  +   G+  A+K +          S + R      E+++L  + H N+
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR------EISILKELKHSNI 62

Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR------LQIAHDAAKGL 702
           V L      + + +LV+E++      D L   ++       +       LQ+      G+
Sbjct: 63  VKLYDVIHTKKRLVLVFEHLDQ----D-LKKLLDVCEGGLESVTAKSFLLQLL----NGI 113

Query: 703 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVGY 759
            Y H      ++HRD+K  N+L++     K++DFGL+R         TH   +   T+ Y
Sbjct: 114 AYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE--IV--TLWY 166

Query: 760 LDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 790
             P+   G+++ +   D++S G +  E+++G 
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 86.1 bits (214), Expect = 3e-18
 Identities = 58/208 (27%), Positives = 98/208 (47%), Gaps = 29/208 (13%)

Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVKIM--------ADSCSHRTQQFVTEVALLSRIHHR 646
             +G+GS+G V   + KD G+ VA+K              + R      E+ LL ++ H 
Sbjct: 31  GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR------EIKLLKQLRHE 84

Query: 647 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           NLV L+  C+++ +  LV+E++ + T+ D L   +    LD+    +       G+ + H
Sbjct: 85  NLVNLLEVCKKKKRWYLVFEFVDH-TILDDL--ELFPNGLDYQVVQKYLFQIINGIGFCH 141

Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVGYLDPE 763
           +     IIHRD+K  NIL+  +   K+ DFG +R      E       VA  T  Y  PE
Sbjct: 142 SH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE--VA--TRWYRAPE 194

Query: 764 Y-YGNQQLTEKSDVYSFGVVLLELISGK 790
              G+ +  +  DV++ G ++ E+  G+
Sbjct: 195 LLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 85.8 bits (213), Expect = 3e-18
 Identities = 51/216 (23%), Positives = 95/216 (43%), Gaps = 31/216 (14%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI-- 652
           K +G G  G V+        K VA+K +  +     +  + E+ ++ R+ H N+V +   
Sbjct: 17  KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEI 76

Query: 653 ------------GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 700
                       G   E +   +V EYM   T  D L   + Q PL         +   +
Sbjct: 77  LGPSGSQLTDDVGSLTELNSVYIVQEYM--ET--D-LANVLEQGPLLEEHARLFMYQLLR 131

Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLD-INMRAKVSDFGLSRQAEEDLTHISS----VARG 755
           GL+Y+H+     ++HRD+K +N+ ++  ++  K+ DFGL+R  +   +H       +   
Sbjct: 132 GLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV-- 186

Query: 756 TVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGK 790
           T  Y  P    +    T+  D+++ G +  E+++GK
Sbjct: 187 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 84.9 bits (211), Expect = 4e-18
 Identities = 52/215 (24%), Positives = 96/215 (44%), Gaps = 41/215 (19%)

Query: 597 KIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQF-----VT---EVALLSRIHHRN 647
           KIG+G++G+V+  K ++  + VA+K +      R          +   E+ LL  + H+N
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRV------RLDDDDEGVPSSALREICLLKELKHKN 62

Query: 648 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR------LQIAHDAAKG 701
           +V L      + +  LV+E+       D L    +    D           Q+     KG
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFCDQ----D-LKKYFDSCNGDLDPEIVKSFLFQLL----KG 113

Query: 702 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVG 758
           L + H+     ++HRD+K  N+L++ N   K+++FGL+R         +    V   T+ 
Sbjct: 114 LGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA--EVV--TLW 166

Query: 759 YLDPEY-YGNQQLTEKSDVYSFGVVLLELISGKKP 792
           Y  P+  +G +  +   D++S G +  EL +  +P
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 85.0 bits (211), Expect = 9e-18
 Identities = 50/217 (23%), Positives = 90/217 (41%), Gaps = 35/217 (16%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLI- 652
             +G+G++G V        G+ VA+K I          + + E+ +L    H N++ +  
Sbjct: 17  SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFN 76

Query: 653 ----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD-----WLTRLQIAHDAAKGLE 703
                  E  ++  ++ E M   T  D LH  ++ + L      +    Q      + ++
Sbjct: 77  IQRPDSFENFNEVYIIQELM--QT--D-LHRVISTQMLSDDHIQYFIY-QTL----RAVK 126

Query: 704 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTV---GYL 760
            LH      +IHRD+K SN+L++ N   KV DFGL+R  +E     S           ++
Sbjct: 127 VLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFV 183

Query: 761 DPEYY-------GNQQLTEKSDVYSFGVVLLELISGK 790
              +Y        + + +   DV+S G +L EL   +
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 85.5 bits (212), Expect = 9e-18
 Identities = 63/227 (27%), Positives = 106/227 (46%), Gaps = 45/227 (19%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIH-HRNLVPL 651
           KK+GKG++G V+     + G+ VAVK + D+  + T  Q+   E+ +L+ +  H N+V L
Sbjct: 15  KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNL 74

Query: 652 --IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD-----WLTRLQIAHDAAKGLEY 704
             +   + +    LV++YM   T  D LH  +    L+     ++   Q+     K ++Y
Sbjct: 75  LNVLRADNDRDVYLVFDYM--ET--D-LHAVIRANILEPVHKQYVVY-QLI----KVIKY 124

Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
           LH+G   G++HRD+K SNILL+     KV+DFGLSR         +++        +   
Sbjct: 125 LHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFD 181

Query: 765 YGNQQLTE---------------------KSDVYSFGVVLLELISGK 790
                LT+                       D++S G +L E++ GK
Sbjct: 182 DDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 85.0 bits (211), Expect = 1e-17
 Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 28/210 (13%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVK-IMA-DSCSH--RTQQFVTEVALLSRIHHRNLVP 650
             IG+G++G V       +   VA+K I   +  ++  RT   + E+ +L R  H N++ 
Sbjct: 33  SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT---LREIKILLRFRHENIIG 89

Query: 651 LI-----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 705
           +         E+     +V + M   T  D L+  +  + L         +   +GL+Y+
Sbjct: 90  INDIIRAPTIEQMKDVYIVQDLM--ET--D-LYKLLKTQHLSNDHICYFLYQILRGLKYI 144

Query: 706 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS----VARGTVGYLD 761
           H+     ++HRD+K SN+LL+     K+ DFGL+R A+ D  H       VA  T  Y  
Sbjct: 145 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA--TRWYRA 199

Query: 762 PEYYGN-QQLTEKSDVYSFGVVLLELISGK 790
           PE   N +  T+  D++S G +L E++S +
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 83.6 bits (207), Expect = 1e-17
 Identities = 54/212 (25%), Positives = 86/212 (40%), Gaps = 27/212 (12%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVP-LIG 653
           +KIG GSFG +Y G  +  G+EVA+K+      H   Q   E  +   +     +P +  
Sbjct: 15  RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRW 72

Query: 654 YCEEEHQRILVYEYMHNG----TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 709
              E    ++V E +  G     L +      + K     T L +A      +EY+H   
Sbjct: 73  CGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLK-----TVLLLADQMISRIEYIH--- 122

Query: 710 NPGIIHRDVKSSNILLDINMRAK---VSDFGLSRQ--AEEDLTHISSVA----RGTVGYL 760
           +   IHRDVK  N L+ +  +     + DFGL+++        HI         GT  Y 
Sbjct: 123 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182

Query: 761 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
               +   + + + D+ S G VL+    G  P
Sbjct: 183 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 84.2 bits (209), Expect = 1e-17
 Identities = 59/225 (26%), Positives = 97/225 (43%), Gaps = 43/225 (19%)

Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQQF--VTEVALLSRIHHRNL 648
           ++ K +GKG+FG V   + K      A+KI+  +    + +    VTE  +L    H  L
Sbjct: 8   DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67

Query: 649 VPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH----DAAK--- 700
             L  Y  + H R+  V EY + G L                  L        + A+   
Sbjct: 68  TALK-YAFQTHDRLCFVMEYANGGEL---------------FFHLSRERVFTEERARFYG 111

Query: 701 -----GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR- 754
                 LEYLH   +  +++RD+K  N++LD +   K++DFGL +   E ++   +  + 
Sbjct: 112 AEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISD-GATMKT 164

Query: 755 --GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 797
             GT  YL PE   +       D +  GVV+ E++ G+ P   +D
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 84.8 bits (210), Expect = 2e-17
 Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 26/213 (12%)

Query: 597 KIGKGSFGSVYYGKMKD---GKEVAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 652
           K+G+G++G VY  K KD    K+ A+K I     S        E+ALL  + H N++ L 
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA---CREIALLRELKHPNVISLQ 84

Query: 653 GYCEEEHQRI--LVYEYMHN--GTLRDRLHGSVNQKPLDWLTRLQI---AHDAAKGLEYL 705
                   R   L+++Y  +    +      S   K    L R  +    +    G+ YL
Sbjct: 85  KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144

Query: 706 HTGCNPGIIHRDVKSSNILLDI----NMRAKVSDFGLSRQ---AEEDLTHISSVARGTVG 758
           H      ++HRD+K +NIL+        R K++D G +R      + L  +  V   T  
Sbjct: 145 HAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFW 200

Query: 759 YLDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 790
           Y  PE   G +  T+  D+++ G +  EL++ +
Sbjct: 201 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 83.7 bits (208), Expect = 2e-17
 Identities = 56/216 (25%), Positives = 98/216 (45%), Gaps = 38/216 (17%)

Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRTQQF---VTEVALLSRIHHRNL 648
              + +G GSFG V+  + +      A+K++      R +Q      E  +LS + H  +
Sbjct: 9   QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFI 68

Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH----DAAK---- 700
           + + G  ++  Q  ++ +Y+  G L                + L+ +       AK    
Sbjct: 69  IRMWGTFQDAQQIFMIMDYIEGGEL---------------FSLLRKSQRFPNPVAKFYAA 113

Query: 701 ----GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT 756
                LEYLH   +  II+RD+K  NILLD N   K++DFG ++    D+T+      GT
Sbjct: 114 EVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKY-VPDVTY---TLCGT 166

Query: 757 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
             Y+ PE    +   +  D +SFG+++ E+++G  P
Sbjct: 167 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 83.8 bits (208), Expect = 2e-17
 Identities = 55/226 (24%), Positives = 97/226 (42%), Gaps = 55/226 (24%)

Query: 597 KIGKGSFGSVYYGKMKD-GKEVAVK------------IMADSCSHRTQQFVTEVALLSRI 643
           KIG+G+FG V+  + +  G++VA+K            I A          + E+ +L  +
Sbjct: 24  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITA----------LREIKILQLL 73

Query: 644 HHRNLVPLIGYCEEEHQRI--------LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA 695
            H N+V LI  C  +            LV+++  +    D L G ++   +   T  +I 
Sbjct: 74  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH----D-LAGLLSNVLVK-FTLSEIK 127

Query: 696 HDAA---KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR-------QAEED 745
                   GL Y+H      I+HRD+K++N+L+  +   K++DFGL+R            
Sbjct: 128 RVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184

Query: 746 LTHISSVARGTVGYLDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 790
            T+   V   T+ Y  PE   G +      D++  G ++ E+ +  
Sbjct: 185 YTNR--VV--TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 83.9 bits (208), Expect = 2e-17
 Identities = 51/216 (23%), Positives = 91/216 (42%), Gaps = 38/216 (17%)

Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRTQQF---VTEVALLSRIHHRNL 648
           +  K +G GSFG V   K K+     A+KI+      + +Q    + E  +L  ++   L
Sbjct: 44  DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFL 103

Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH----DAAK---- 700
           V L    ++     +V EY+  G +                + L+         A+    
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVAGGEM---------------FSHLRRIGRFSEPHARFYAA 148

Query: 701 ----GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT 756
                 EYLH   +  +I+RD+K  N+L+D     +V+DFG +++  +  T       GT
Sbjct: 149 QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTW---TLCGT 201

Query: 757 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
              L PE   ++   +  D ++ GV++ E+ +G  P
Sbjct: 202 PEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 83.0 bits (206), Expect = 3e-17
 Identities = 62/224 (27%), Positives = 104/224 (46%), Gaps = 39/224 (17%)

Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEV----AVKIM--ADSCSHRTQQFVTEVALLSRIHHR 646
              K +G+GSFG V+  K   G +     A+K++  A        +   E  +L  ++H 
Sbjct: 27  ELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHP 86

Query: 647 NLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH----DAAK- 700
            +V L  Y  +   ++ L+ +++  G L                TRL        +  K 
Sbjct: 87  FIVKLH-YAFQTEGKLYLILDFLRGGDL---------------FTRLSKEVMFTEEDVKF 130

Query: 701 -------GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 753
                   L++LH   + GII+RD+K  NILLD     K++DFGLS+++ +      S  
Sbjct: 131 YLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC 187

Query: 754 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 797
            GTV Y+ PE    +  T+ +D +SFGV++ E+++G  P   +D
Sbjct: 188 -GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD 230

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 83.0 bits (206), Expect = 4e-17
 Identities = 58/214 (27%), Positives = 93/214 (43%), Gaps = 38/214 (17%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVK-IMADSCSHRTQQF-VT---EVALLSRIHHRNLV 649
             +G+G F +VY  +     + VA+K I     S        T   E+ LL  + H N++
Sbjct: 16  DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75

Query: 650 PLIGYCEEEHQRILVYEYMHN---GTLRDRLHGSVNQKPLD------WLTRLQIAHDAAK 700
            L+     +    LV+++M       ++D      N   L       ++  L       +
Sbjct: 76  GLLDAFGHKSNISLVFDFMETDLEVIIKD------NSLVLTPSHIKAYM--LMTL----Q 123

Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTV 757
           GLEYLH      I+HRD+K +N+LLD N   K++DFGL++         TH   V   T 
Sbjct: 124 GLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ--VV--TR 176

Query: 758 GYLDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 790
            Y  PE  +G +      D+++ G +L EL+   
Sbjct: 177 WYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 83.3 bits (206), Expect = 7e-17
 Identities = 52/243 (21%), Positives = 87/243 (35%), Gaps = 55/243 (22%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 652
             IG+GS+G VY        K VA+K +          ++ + E+ +L+R+    ++ L 
Sbjct: 32  HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLY 91

Query: 653 GYCEEEHQRI-----LVYEYMHNGTLRDRLHGSV--NQKPLDWLTRL-------QIAHDA 698
                +         +V E     +  D L             LT          +    
Sbjct: 92  DLIIPDDLLKFDELYIVLEIA--DS--D-LKKLFKTPIF----LTEEHIKTILYNLL--- 139

Query: 699 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTV 757
             G  ++H     GIIHRD+K +N LL+ +   KV DFGL+R    +  T+I +      
Sbjct: 140 -LGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENE 195

Query: 758 GYLDPEYYGNQQLTE--------------------KS-DVYSFGVVLLELISGKKPVSVE 796
                     +QLT                     KS D++S G +  EL++  +    +
Sbjct: 196 EPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND 255

Query: 797 DFG 799
              
Sbjct: 256 PTN 258

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 81.4 bits (202), Expect = 9e-17
 Identities = 52/228 (22%), Positives = 97/228 (42%), Gaps = 45/228 (19%)

Query: 593 NFCKKIGKGSFGSVY---YGKMKDGKEV-AVKIMA-DSCSHRTQQFV---TEVALLSRIH 644
              + +GKG +G V+        +  ++ A+K++         +       E  +L  + 
Sbjct: 20  ELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK 79

Query: 645 HRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH----DAA 699
           H  +V LI Y  +   ++ L+ EY+  G L                 +L+       D A
Sbjct: 80  HPFIVDLI-YAFQTGGKLYLILEYLSGGEL---------------FMQLEREGIFMEDTA 123

Query: 700 K--------GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA--EEDLTHI 749
                     L +LH     GII+RD+K  NI+L+     K++DFGL +++  +  +TH 
Sbjct: 124 CFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTH- 179

Query: 750 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 797
            +   GT+ Y+ PE           D +S G ++ ++++G  P + E+
Sbjct: 180 -TFC-GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN 225

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 81.5 bits (202), Expect = 1e-16
 Identities = 54/219 (24%), Positives = 95/219 (43%), Gaps = 42/219 (19%)

Query: 592 NNFCK--KIGKGSFGSVYYGK-MKDGKEVAVKIM-------ADSCSHRTQQFVTEVALLS 641
             + K  K+G+G++ +VY GK       VA+K +       A   + R      EV+LL 
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR------EVSLLK 55

Query: 642 RIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR------LQIA 695
            + H N+V L      E    LV+EY+     +D L   ++                Q+ 
Sbjct: 56  DLKHANIVTLHDIIHTEKSLTLVFEYLD----KD-LKQYLDDCGNIINMHNVKLFLFQLL 110

Query: 696 HDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSV 752
               +GL Y H      ++HRD+K  N+L++     K++DFGL+R      +   +   V
Sbjct: 111 ----RGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNE--V 161

Query: 753 ARGTVGYLDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 790
              T+ Y  P+   G+   + + D++  G +  E+ +G+
Sbjct: 162 V--TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 82.9 bits (205), Expect = 1e-16
 Identities = 44/197 (22%), Positives = 80/197 (40%), Gaps = 33/197 (16%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 652
             IG GS+G V       + + VA+K +          ++ + E+A+L+R++H ++V ++
Sbjct: 59  HLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVL 118

Query: 653 -----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH------DAAKG 701
                   E+  +  +V E        D        K       L   H      +   G
Sbjct: 119 DIVIPKDVEKFDELYVVLEIAD----SD-FK-----KLFRTPVYLTELHIKTLLYNLLVG 168

Query: 702 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARG------ 755
           ++Y+H+    GI+HRD+K +N L++ +   KV DFGL+R  +      S +         
Sbjct: 169 VKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225

Query: 756 TVGYLDPEYYGNQQLTE 772
            +          +QLT 
Sbjct: 226 NLVTFPHTKNLKRQLTG 242

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 80.9 bits (200), Expect = 1e-16
 Identities = 38/157 (24%), Positives = 63/157 (40%), Gaps = 23/157 (14%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVP-LIG 653
           KKIG G+FG +  GK +   + VA+K+          Q   E     ++   + +P +  
Sbjct: 15  KKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGIPQVYY 72

Query: 654 YCEEEHQRILVYEYMHNG----TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 709
           +        +V E +  G     L D    + + K     T L IA      +EY+H   
Sbjct: 73  FGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLK-----TVLMIAIQLISRMEYVH--- 122

Query: 710 NPGIIHRDVKSSNILLDINMRAKVS-----DFGLSRQ 741
           +  +I+RDVK  N L+              DF L+++
Sbjct: 123 SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 81.5 bits (202), Expect = 2e-16
 Identities = 61/226 (26%), Positives = 93/226 (41%), Gaps = 44/226 (19%)

Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQQFVTEV---ALLSRIHHRN 647
           +F K IGKGSFG V   + K  +   AVK++   +   + ++         LL  + H  
Sbjct: 41  HFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPF 100

Query: 648 LVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH----DAAK-- 700
           LV L  +  +   ++  V +Y++ G L                  LQ         A+  
Sbjct: 101 LVGLH-FSFQTADKLYFVLDYINGGEL---------------FYHLQRERCFLEPRARFY 144

Query: 701 ------GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR 754
                  L YLH   +  I++RD+K  NILLD      ++DFGL +   E++ H +S   
Sbjct: 145 AAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEH-NSTTS 197

Query: 755 ---GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 797
              GT  YL PE    Q      D +  G VL E++ G  P    +
Sbjct: 198 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 243

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 80.1 bits (198), Expect = 2e-16
 Identities = 43/214 (20%), Positives = 84/214 (39%), Gaps = 29/214 (13%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVP-LIG 653
           ++IG+GSFG ++ G  + + ++VA+K           Q   E      +     +P +  
Sbjct: 16  RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYY 73

Query: 654 YCEEEHQRILVYEYMHNG----TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 709
           + +E    +LV + +  G     L D      + K     T    A      ++ +H   
Sbjct: 74  FGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVK-----TVAMAAKQMLARVQSIH--- 123

Query: 710 NPGIIHRDVKSSNILLDINMRAK-----VSDFGLSRQAEEDLT--HISSVA----RGTVG 758
              +++RD+K  N L+            V DFG+ +   + +T  HI         GT  
Sbjct: 124 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 183

Query: 759 YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           Y+    +  ++ + + D+ + G V +  + G  P
Sbjct: 184 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 80.4 bits (199), Expect = 2e-16
 Identities = 49/212 (23%), Positives = 89/212 (41%), Gaps = 35/212 (16%)

Query: 597 KIGKGSFGSVYYGKMKD-GKEVAVKIM--------ADSCSHRTQQFVTEVALLSRIHHRN 647
           K+G+G++G VY        + VA+K +            + R      EV+LL  + HRN
Sbjct: 41  KLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR------EVSLLKELQHRN 94

Query: 648 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
           ++ L       H+  L++EY  N  L+  +        +         +    G+ + H+
Sbjct: 95  IIELKSVIHHNHRLHLIFEYAEN-DLKKYMD---KNPDVSMRVIKSFLYQLINGVNFCHS 150

Query: 708 GCNPGIIHRDVKSSNILLDINMRA-----KVSDFGLSRQ---AEEDLTHISSVARGTVGY 759
                 +HRD+K  N+LL ++  +     K+ DFGL+R         TH   +   T+ Y
Sbjct: 151 ---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHE--II--TLWY 203

Query: 760 LDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 790
             PE   G++  +   D++S   +  E++   
Sbjct: 204 RPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 80.1 bits (198), Expect = 4e-16
 Identities = 52/220 (23%), Positives = 95/220 (43%), Gaps = 37/220 (16%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH---------- 644
           +K+G G F +V+  K M +   VA+KI+     +  +    E+ LL R++          
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-EAAEDEIKLLQRVNDADNTKEDSM 83

Query: 645 -HRNLVPLIGY-----CEEEHQRILVYEYMHNGTLRDRLHGSVNQK-PLDWLTRLQIAHD 697
              +++ L+ +         H  ++V+E +    L   +    ++  PL    + QI+  
Sbjct: 84  GANHILKLLDHFNHKGPNGVHV-VMVFEVLGE-NLLALIKKYEHRGIPLI-YVK-QISKQ 139

Query: 698 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRA------KVSDFGLSRQAEEDLT-HIS 750
              GL+Y+H  C   IIH D+K  N+L++I          K++D G +   +E  T  I 
Sbjct: 140 LLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 197

Query: 751 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGK 790
           +       Y  PE          +D++S   ++ ELI+G 
Sbjct: 198 TRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 80.4 bits (198), Expect = 6e-16
 Identities = 53/212 (25%), Positives = 93/212 (43%), Gaps = 27/212 (12%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVP-LIG 653
           +KIG GSFG +Y G  ++  +EVA+K+      H   Q + E  +   +     +P +  
Sbjct: 13  RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRW 70

Query: 654 YCEEEHQRILVYEYMHNG----TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 709
           +  E    +LV + +  G     L +     ++ K     T L +A      +E++H   
Sbjct: 71  FGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLK-----TVLMLADQMINRVEFVH--- 120

Query: 710 NPGIIHRDVKSSNILLDINMRAK---VSDFGLSRQAEEDLT--HISSVA----RGTVGYL 760
           +   +HRD+K  N L+ +  RA    + DFGL+++  +  T  HI         GT  Y 
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180

Query: 761 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
               +   + + + D+ S G VL+  + G  P
Sbjct: 181 SVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 79.3 bits (196), Expect = 6e-16
 Identities = 60/232 (25%), Positives = 101/232 (43%), Gaps = 49/232 (21%)

Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEV----AVKIMA-DSCSHRTQQFV---TEVALLSRI- 643
              K +G G++G V+  +   G +     A+K++   +   + +      TE  +L  I 
Sbjct: 57  ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR 116

Query: 644 HHRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH----DA 698
               LV L  Y  +   ++ L+ +Y++ G L                T L          
Sbjct: 117 QSPFLVTLH-YAFQTETKLHLILDYINGGEL---------------FTHLSQRERFTEHE 160

Query: 699 AK--------GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 750
            +         LE+LH     GII+RD+K  NILLD N    ++DFGLS+   E +   +
Sbjct: 161 VQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSK---EFVADET 214

Query: 751 SVAR---GTVGYLDPE-YYGNQQLTEKS-DVYSFGVVLLELISGKKPVSVED 797
             A    GT+ Y+ P+   G     +K+ D +S GV++ EL++G  P +V+ 
Sbjct: 215 ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG 266

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 78.4 bits (194), Expect = 8e-16
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 29/212 (13%)

Query: 597 KIGKGSFGSVYYGK-MKDGKEVAVK-IMADSCSHRTQQF-VT---EVALLSRIH---HRN 647
           +IG G++G+VY  +    G  VA+K +   +         ++   EVALL R+    H N
Sbjct: 16  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75

Query: 648 LVPLI-----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI---AHDAA 699
           +V L+        + E +  LV+E++     +D L   +++ P   L    I        
Sbjct: 76  VVRLMDVCATSRTDREIKVTLVFEHVD----QD-LRTYLDKAPPPGLPAETIKDLMRQFL 130

Query: 700 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 759
           +GL++LH      I+HRD+K  NIL+      K++DFGL+R     +     V   T+ Y
Sbjct: 131 RGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV--TLWY 185

Query: 760 LDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 790
             PE    +   T   D++S G +  E+   K
Sbjct: 186 RAPEVLLQSTYATP-VDMWSVGCIFAEMFRRK 216

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 78.4 bits (194), Expect = 1e-15
 Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 26/212 (12%)

Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEV-AVK------IMADSCSHRTQQFVTEVALLSRI-H 644
           +  + IG+GS+  V   ++K    + A+K      +  D      Q   TE  +  +  +
Sbjct: 12  DLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQ---TEKHVFEQASN 68

Query: 645 HRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLD-WLTRLQIAHDAAKGL 702
           H  LV L   C +   R+  V EY++ G L   +     Q+ L     R   A + +  L
Sbjct: 69  HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ---RQRKLPEEHARFYSA-EISLAL 123

Query: 703 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ--AEEDLTHISSVARGTVGYL 760
            YLH     GII+RD+K  N+LLD     K++D+G+ ++     D T       GT  Y+
Sbjct: 124 NYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC---GTPNYI 177

Query: 761 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
            PE    +      D ++ GV++ E+++G+ P
Sbjct: 178 APEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 80.5 bits (198), Expect = 1e-15
 Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 14/211 (6%)

Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQQFVTEV---ALLSRIHHRN 647
           NF   +GKGSFG V   + K   E+ AVKI+  D          T V    L        
Sbjct: 344 NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPF 403

Query: 648 LVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           L  L   C +   R+  V EY++ G L    H     +  +       A + A GL +L 
Sbjct: 404 LTQLH-SCFQTMDRLYFVMEYVNGGDLM--YHIQQVGRFKEPHAVFYAA-EIAIGLFFLQ 459

Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 766
              + GII+RD+K  N++LD     K++DFG+ ++   D     +   GT  Y+ PE   
Sbjct: 460 ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDYIAPEIIA 515

Query: 767 NQQLTEKSDVYSFGVVLLELISGKKPVSVED 797
            Q   +  D ++FGV+L E+++G+ P   ED
Sbjct: 516 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 546

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 78.9 bits (195), Expect = 1e-15
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 26/212 (12%)

Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEV-AVK------IMADSCSHRTQQFVTEVALLSRI-H 644
           +  + IG+GS+  V   ++K    + A++      +  D      Q   TE  +  +  +
Sbjct: 55  DLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQ---TEKHVFEQASN 111

Query: 645 HRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLD-WLTRLQIAHDAAKGL 702
           H  LV L   C +   R+  V EY++ G L   +     Q+ L     R   A + +  L
Sbjct: 112 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ---RQRKLPEEHARFYSA-EISLAL 166

Query: 703 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ--AEEDLTHISSVARGTVGYL 760
            YLH     GII+RD+K  N+LLD     K++D+G+ ++     D T       GT  Y+
Sbjct: 167 NYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC---GTPNYI 220

Query: 761 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
            PE    +      D ++ GV++ E+++G+ P
Sbjct: 221 APEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 78.0 bits (193), Expect = 1e-15
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 24/216 (11%)

Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEV-AVK------IMADSCSHRTQQFVTEVALLSRI-H 644
            F + +GKGSFG V   ++K+  ++ AVK      I+ D     T    TE  +LS   +
Sbjct: 26  EFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTM---TEKRILSLARN 82

Query: 645 HRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 703
           H  L  L   C +   R+  V E+++ G L    H   +++  +   R   A +    L 
Sbjct: 83  HPFLTQLF-CCFQTPDRLFFVMEFVNGGDLM--FHIQKSRRFDEARARFYAA-EIISALM 138

Query: 704 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ--AEEDLTHISSVARGTVGYLD 761
           +LH     GII+RD+K  N+LLD     K++DFG+ ++       T  ++   GT  Y+ 
Sbjct: 139 FLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTT--ATFC-GTPDYIA 192

Query: 762 PEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 797
           PE           D ++ GV+L E++ G  P   E+
Sbjct: 193 PEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN 228

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 77.3 bits (191), Expect = 3e-15
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 20/214 (9%)

Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQQFVTEV---ALLSRIHHRN 647
              K +GKGSFG V+  + K   +  A+K +  D          T V    L     H  
Sbjct: 20  ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPF 79

Query: 648 LVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           L  +     +  + +  V EY++ G L   +      K          A +   GL++LH
Sbjct: 80  LTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAA-EIILGLQFLH 135

Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDPE 763
              + GI++RD+K  NILLD +   K++DFG+ +   E++    +      GT  Y+ PE
Sbjct: 136 ---SKGIVYRDLKLDNILLDKDGHIKIADFGMCK---ENMLG-DAKTNTFCGTPDYIAPE 188

Query: 764 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 797
               Q+     D +SFGV+L E++ G+ P   +D
Sbjct: 189 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 222

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 76.9 bits (190), Expect = 4e-15
 Identities = 63/217 (29%), Positives = 99/217 (45%), Gaps = 26/217 (11%)

Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEV-AVK------IMADSCSHRTQQFVTEVALLSRI-H 644
           NF   +GKGSFG V   + K   E+ AVK      ++ D     T     E  +L+    
Sbjct: 23  NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTM---VEKRVLALPGK 79

Query: 645 HRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 703
              L  L   C +   R+  V EY++ G L   +   V +           A + A GL 
Sbjct: 80  PPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQ-QVGRFKEPH-AVFYAA-EIAIGLF 135

Query: 704 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYL 760
           +L    + GII+RD+K  N++LD     K++DFG+ +   E++       +   GT  Y+
Sbjct: 136 FLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWD-GVTTKTFCGTPDYI 188

Query: 761 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 797
            PE    Q   +  D ++FGV+L E+++G+ P   ED
Sbjct: 189 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 225

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 77.8 bits (192), Expect = 8e-15
 Identities = 20/136 (14%), Positives = 41/136 (30%), Gaps = 12/136 (8%)

Query: 372 NDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLT 431
           N   +  +      V+ ++    R+T ++L G    G +P  +  +  L  L L  +   
Sbjct: 61  NFNKELDMWGAQPGVSLNSNG--RVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEK 118

Query: 432 GP-----LPDMSRLIDLRIVHLENNELTGSLPSYMG--SLPNLQELHIENNSFVGEIPPA 484
                     +S  +              +   Y       +L +  I ++     I  +
Sbjct: 119 VNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKS 178

Query: 485 ---LLTGKVIFKYDNN 497
               L    I +  NN
Sbjct: 179 SRITLKDTQIGQLSNN 194

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 77.0 bits (190), Expect = 1e-14
 Identities = 24/95 (25%), Positives = 37/95 (38%), Gaps = 2/95 (2%)

Query: 396 ITKIALSGKNLK-GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELT 454
           I  I +   NLK   +   L+ M+ L  L    N L G LP     I L  ++L  N++T
Sbjct: 307 IQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQIT 366

Query: 455 GSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGK 489
               ++ G    ++ L   +N     IP       
Sbjct: 367 EIPANFCGFTEQVENLSFAHNKL-KYIPNIFDAKS 400

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 74.3 bits (183), Expect = 8e-14
 Identities = 16/98 (16%), Positives = 36/98 (36%), Gaps = 10/98 (10%)

Query: 395 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGP---------LPDMSRLIDLRI 445
            +T + +       ++P  LK +  +  + +  N              L D      ++I
Sbjct: 250 DLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQI 309

Query: 446 VHLENNEL-TGSLPSYMGSLPNLQELHIENNSFVGEIP 482
           +++  N L T  + + +  +  L  L    N   G++P
Sbjct: 310 IYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP 347

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 66.6 bits (163), Expect = 2e-11
 Identities = 16/126 (12%), Positives = 38/126 (30%), Gaps = 22/126 (17%)

Query: 397 TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP--------------------D 436
           T+I     N+   +   +  +  L + ++  +                            
Sbjct: 186 TQIGQLSNNI-TFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLK 244

Query: 437 MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDN 496
              L DL  V + N      LP+++ +LP +Q +++  N  +          + +     
Sbjct: 245 WDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGIS-GEQLKDDWQALADAPV 303

Query: 497 NPKLHK 502
             K+  
Sbjct: 304 GEKIQI 309

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 65.8 bits (161), Expect = 4e-11
 Identities = 15/110 (13%), Positives = 36/110 (32%), Gaps = 19/110 (17%)

Query: 395 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELT 454
            + K  ++    +  I    +     T++    N +T     + RL  LR  ++ N+   
Sbjct: 160 DLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITFVSKAVMRLTKLRQFYMGNSPFV 219

Query: 455 G-------------------SLPSYMGSLPNLQELHIENNSFVGEIPPAL 485
                               +      +L +L ++ + N   + ++P  L
Sbjct: 220 AENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFL 269

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 65.8 bits (161), Expect = 4e-11
 Identities = 18/103 (17%), Positives = 33/103 (32%), Gaps = 12/103 (11%)

Query: 394 PRITKIALSGKNLKGEIPPELK--NMEALTELWLDGNFLTGPLPD----MSRLIDLRIVH 447
             +T I L    L   +  + +   +  L  + L  N  +   P      S L    I +
Sbjct: 488 YLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRN 545

Query: 448 ---LENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT 487
               + N      P  +   P+L +L I +N     +   +  
Sbjct: 546 QRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKITP 587

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 63.5 bits (155), Expect = 2e-10
 Identities = 21/98 (21%), Positives = 32/98 (32%), Gaps = 10/98 (10%)

Query: 397 TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG--------PLPDMSRLIDLRIVHL 448
           + I LS   +             L+ + L GN LT            +      L  + L
Sbjct: 436 SSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDL 495

Query: 449 ENNELTGSLPS-YMGSLPNLQELHIENNSFVGEIPPAL 485
             N+LT         +LP L  + +  NSF  + P   
Sbjct: 496 RFNKLTKLSDDFRATTLPYLVGIDLSYNSF-SKFPTQP 532

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 63.5 bits (155), Expect = 2e-10
 Identities = 20/116 (17%), Positives = 42/116 (36%), Gaps = 19/116 (16%)

Query: 390 TTTPPRI-------TKIALSGKNLKGEIPP--ELKNMEALTELWLDGNFLTG-------P 433
           T  P            ++ +   LK  IP   + K++  ++ +    N +         P
Sbjct: 366 TEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDP 424

Query: 434 LP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 488
           L     + I++  ++L NN+++        +   L  +++  N    EIP   L  
Sbjct: 425 LDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNML-TEIPKNSLKD 479

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 62.4 bits (152), Expect = 4e-10
 Identities = 11/89 (12%), Positives = 31/89 (34%), Gaps = 4/89 (4%)

Query: 401 LSGKNLKGEIPPELK--NMEALTELWLDGNFLTGPLPDMSRL-IDLRIVHLENNELTGSL 457
               + +          +   L +  ++ +     +   SR+ +    +   +N +T  +
Sbjct: 140 KMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT-FV 198

Query: 458 PSYMGSLPNLQELHIENNSFVGEIPPALL 486
              +  L  L++ ++ N+ FV E      
Sbjct: 199 SKAVMRLTKLRQFYMGNSPFVAENICEAW 227

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 61.6 bits (150), Expect = 8e-10
 Identities = 11/95 (11%), Positives = 32/95 (33%), Gaps = 10/95 (10%)

Query: 401 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELT----- 454
                       +  N++ LT++ +        LP  +  L +++++++  N        
Sbjct: 232 SEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQL 291

Query: 455 ---GSLPSYMGSLPNLQELHIENNSF-VGEIPPAL 485
                  +       +Q ++I  N+     +  +L
Sbjct: 292 KDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSL 326

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 60.8 bits (148), Expect = 1e-09
 Identities = 20/118 (16%), Positives = 39/118 (33%), Gaps = 15/118 (12%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTEL------WLDGNFLTGPLPD-MSRLIDLRIV 446
           P +  I LS  +     P +  N   L            GN      P+ ++    L  +
Sbjct: 513 PYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQL 571

Query: 447 HLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT----GKVIFKYDNNPKL 500
            + +N++   +       PN+  L I++N  +      +      G  +  YD    +
Sbjct: 572 QIGSNDIR-KVNE--KITPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQDI 626

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 75.9 bits (187), Expect = 8e-15
 Identities = 40/231 (17%), Positives = 80/231 (34%), Gaps = 45/231 (19%)

Query: 596 KKIGKGSFGSVYYGK---------MKDGKEVAVKI-MADSCSHRTQQF------VTEVAL 639
               + + G +Y                ++ ++K+   D      Q F        +V  
Sbjct: 48  SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNK 107

Query: 640 LSRIHHRNL--VPLIGYC--EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA 695
             +++   L  +P        ++  R LV   +  G           +  L   + LQ+A
Sbjct: 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVA 165

Query: 696 HDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKV--SDFGLSRQAEEDLTHI---- 749
                 LE+LH       +H +V + NI +D   +++V  + +G + +      H+    
Sbjct: 166 CRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVE 222

Query: 750 --SSVARGTVGYLDPEY------YGNQQLTEKSDVYSFGVVLLELISGKKP 792
              S   G +     E+       G    + +SD+ S G  +L+ + G  P
Sbjct: 223 GSRSPHEGDL-----EFISMDLHKGCGP-SRRSDLQSLGYCMLKWLYGFLP 267

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 75.5 bits (186), Expect = 1e-14
 Identities = 53/254 (20%), Positives = 92/254 (36%), Gaps = 60/254 (23%)

Query: 582 IPLPELEEATNNFC------KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFV 634
           +P PE +   +         KKIG G FG +Y        ++ A  ++            
Sbjct: 23  MPFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVE-YQENGPLF 81

Query: 635 TEVALLSRIHHRNL--------------VPLIGYC-----EEEHQRILVYEYMHNGT-LR 674
           +E+    R+  ++               +PL         +    R +V E +  G  L+
Sbjct: 82  SELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQ 139

Query: 675 D--RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK 732
                +G+  +      T LQ+       LEY+H       +H D+K++N+LL      +
Sbjct: 140 KISGQNGTFKKS-----TVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQ 191

Query: 733 V--SDFGLSRQAEEDLTHISSVAR------GTVGYLDPEY------YGNQQLTEKSDVYS 778
           V  +D+GLS +   +  H            GT+     E+       G    + +SDV  
Sbjct: 192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTI-----EFTSLDAHKGVAL-SRRSDVEI 245

Query: 779 FGVVLLELISGKKP 792
            G  +L  + GK P
Sbjct: 246 LGYCMLRWLCGKLP 259

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 74.2 bits (183), Expect = 2e-14
 Identities = 58/218 (26%), Positives = 100/218 (45%), Gaps = 43/218 (19%)

Query: 597 KIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRTQQF-----VT---EVALL---S 641
           +IG+G++G V+  K +D K     VA+K +      R Q       ++   EVA+L    
Sbjct: 18  EIGEGAYGKVF--KARDLKNGGRFVALKRV------RVQTGEEGMPLSTIREVAVLRHLE 69

Query: 642 RIHHRNLVPLI-----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI-- 694
              H N+V L         + E +  LV+E++     +D L   +++ P   +    I  
Sbjct: 70  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD----QD-LTTYLDKVPEPGVPTETIKD 124

Query: 695 -AHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 753
                 +GL++LH+     ++HRD+K  NIL+  + + K++DFGL+R     +   S V 
Sbjct: 125 MMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV 181

Query: 754 RGTVGYLDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 790
             T+ Y  PE    +   T   D++S G +  E+   K
Sbjct: 182 --TLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRK 216

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 72.1 bits (177), Expect = 2e-13
 Identities = 48/253 (18%), Positives = 84/253 (33%), Gaps = 57/253 (22%)

Query: 583 PLPELEEATNNFC------KKIGKGSFGSVYYGKMKDGKEVAVKI--MADSCSHRTQQFV 634
                E  T+           IG+G FG +Y   M   + V      +            
Sbjct: 22  QFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLF 81

Query: 635 TEVALLSRIHHRNL--------------VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGS 680
           TE+    R                    VP         +    Y +M    + DR    
Sbjct: 82  TELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFM----IMDRFGSD 137

Query: 681 VNQKPLDWLTR-------LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKV 733
           + QK  +   +       LQ++      LEY+H       +H D+K+SN+LL+     +V
Sbjct: 138 L-QKIYEANAKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQV 193

Query: 734 --SDFGLSRQAEEDLTHISSVAR------GTVGYLDPEY------YGNQQLTEKSDVYSF 779
              D+GL+ +   +  H +  A       GT+     E+       G    + + D+   
Sbjct: 194 YLVDYGLAYRYCPEGVHKAYAADPKRCHDGTI-----EFTSIDAHNGVAP-SRRGDLEIL 247

Query: 780 GVVLLELISGKKP 792
           G  +++ ++G  P
Sbjct: 248 GYCMIQWLTGHLP 260

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 70.9 bits (174), Expect = 6e-13
 Identities = 56/213 (26%), Positives = 91/213 (42%), Gaps = 37/213 (17%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR------NL 648
           K IGKGSFG V      K  + VA+K++ +      Q    E+ +L  +  +      N+
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAE-EIRILEHLRKQDKDNTMNV 161

Query: 649 VPLIGY-------CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ-IAHDAAK 700
           + ++         C       + +E +    L + +  +   +    L  ++  AH   +
Sbjct: 162 IHMLENFTFRNHIC-------MTFELLSM-NLYELIKKN-KFQGFS-LPLVRKFAHSILQ 211

Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDINMRA--KVSDFGLSRQAEEDL-THISSVARGTV 757
            L+ LH      IIH D+K  NILL    R+  KV DFG S    + + T+I S  R   
Sbjct: 212 CLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQS--R--- 263

Query: 758 GYLDPEYYGNQQLTEKSDVYSFGVVLLELISGK 790
            Y  PE     +     D++S G +L EL++G 
Sbjct: 264 FYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 71.2 bits (175), Expect = 8e-13
 Identities = 19/96 (19%), Positives = 36/96 (37%), Gaps = 1/96 (1%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNE 452
           P +  + LS   ++       +++  L+ L L GN +        S L  L+ +      
Sbjct: 52  PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETN 111

Query: 453 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 488
           L       +G L  L+EL++ +N       P   + 
Sbjct: 112 LASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 71.2 bits (175), Expect = 8e-13
 Identities = 17/87 (19%), Positives = 32/87 (36%), Gaps = 2/87 (2%)

Query: 401 LSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLP 458
           ++G + +    P+    +  LT L L    L    P   + L  L+++++ +N       
Sbjct: 452 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDT 511

Query: 459 SYMGSLPNLQELHIENNSFVGEIPPAL 485
                L +LQ L    N  +      L
Sbjct: 512 FPYKCLNSLQVLDYSLNHIMTSKKQEL 538

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 70.8 bits (174), Expect = 1e-12
 Identities = 17/94 (18%), Positives = 36/94 (38%), Gaps = 2/94 (2%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNE 452
             ++ + L+G  ++         + +L +L      L          L  L+ +++ +N 
Sbjct: 76  SHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNL 135

Query: 453 LTG-SLPSYMGSLPNLQELHIENNSFVGEIPPAL 485
           +    LP Y  +L NL+ L + +N         L
Sbjct: 136 IQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDL 169

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 70.4 bits (173), Expect = 1e-12
 Identities = 16/97 (16%), Positives = 31/97 (31%), Gaps = 3/97 (3%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENN 451
             +  + LS   +   +      +E L  L    + L           L +L  + + + 
Sbjct: 373 TSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 431

Query: 452 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 488
               +       L +L+ L +  NSF     P + T 
Sbjct: 432 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 468

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 68.1 bits (167), Expect = 8e-12
 Identities = 17/91 (18%), Positives = 32/91 (35%), Gaps = 2/91 (2%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNE 452
             +T + LS   L+   P    ++ +L  L +  N            L  L+++    N 
Sbjct: 470 RNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNH 529

Query: 453 LTGSLPSYMGSLP-NLQELHIENNSFVGEIP 482
           +  S    +   P +L  L++  N F     
Sbjct: 530 IMTSKKQELQHFPSSLAFLNLTQNDFACTCE 560

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 65.0 bits (159), Expect = 5e-11
 Identities = 16/82 (19%), Positives = 25/82 (30%), Gaps = 1/82 (1%)

Query: 405 NLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLP-SYMGS 463
           + KG          +L  L L  N +     +   L  L  +  +++ L      S   S
Sbjct: 360 SFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS 419

Query: 464 LPNLQELHIENNSFVGEIPPAL 485
           L NL  L I +           
Sbjct: 420 LRNLIYLDISHTHTRVAFNGIF 441

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 64.3 bits (157), Expect = 1e-10
 Identities = 17/86 (19%), Positives = 26/86 (30%), Gaps = 4/86 (4%)

Query: 401 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPS 459
               N   +IP  L    +   L L  N L            +L+++ L   E+      
Sbjct: 14  CMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG 70

Query: 460 YMGSLPNLQELHIENNSFVGEIPPAL 485
              SL +L  L +  N        A 
Sbjct: 71  AYQSLSHLSTLILTGNPIQSLALGAF 96

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 62.0 bits (151), Expect = 6e-10
 Identities = 19/98 (19%), Positives = 37/98 (37%), Gaps = 6/98 (6%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDM-SRLIDLRIVHLENN 451
             + K+     NL       + +++ L EL +  N +    LP+  S L +L  + L +N
Sbjct: 100 SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 159

Query: 452 ELTGSLPSYMGSLPNLQ----ELHIENNSFVGEIPPAL 485
           ++     + +  L  +      L +  N      P A 
Sbjct: 160 KIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF 197

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 53.1 bits (128), Expect = 3e-07
 Identities = 12/96 (12%), Positives = 30/96 (31%), Gaps = 4/96 (4%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLI--DLRIVHLENN 451
             +  + +S  N         K + +L  L    N +        +     L  ++L  N
Sbjct: 494 SSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN 553

Query: 452 ELTGSLPS--YMGSLPNLQELHIENNSFVGEIPPAL 485
           +   +     ++  + + ++L +E        P   
Sbjct: 554 DFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDK 589

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 52.0 bits (125), Expect = 6e-07
 Identities = 16/94 (17%), Positives = 33/94 (35%), Gaps = 5/94 (5%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALT----ELWLDGNFLTGPLPDMSRLIDLRIVHLE 449
             +  + LS   ++     +L+ +  +      L L  N +    P   + I L  + L 
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLR 208

Query: 450 NNELTGSLPSY-MGSLPNLQELHIENNSFVGEIP 482
           NN  + ++    +  L  L+   +    F  E  
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGN 242

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 50.8 bits (122), Expect = 2e-06
 Identities = 15/114 (13%), Positives = 30/114 (26%), Gaps = 11/114 (9%)

Query: 395 RITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTG----PLPDMSRLIDLRIVHLE 449
           R+ K+ L        +    ++ +  L    L              D S L  L  + +E
Sbjct: 201 RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIE 260

Query: 450 NNELT------GSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNN 497
              L         +      L N+    + + +       +   G    +  N 
Sbjct: 261 EFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNC 314

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 69.6 bits (170), Expect = 2e-12
 Identities = 54/258 (20%), Positives = 91/258 (35%), Gaps = 73/258 (28%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH--------HR 646
           +K+G G F +V+    ++  K VA+K++  S  H T+  + E+ LL  +           
Sbjct: 43  RKLGWGHFSTVWLSWDIQGKKFVAMKVVK-SAEHYTETALDEIRLLKSVRNSDPNDPNRE 101

Query: 647 NLVPLIGY-----CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 701
            +V L+           H   +V+E + +  L   +  S N + L      +I     +G
Sbjct: 102 MVVQLLDDFKISGVNGTHI-CMVFEVLGH-HLLKWIIKS-NYQGLPLPCVKKIIQQVLQG 158

Query: 702 LEYLHTGCNPGIIHRDVKSSNILLDIN--------------------------------- 728
           L+YLHT C   IIH D+K  NILL +N                                 
Sbjct: 159 LDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216

Query: 729 ----------------MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 772
                           ++ K++D G +    +  T        T  Y   E         
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ----TRQYRSLEVLIGSGYNT 272

Query: 773 KSDVYSFGVVLLELISGK 790
            +D++S   +  EL +G 
Sbjct: 273 PADIWSTACMAFELATGD 290

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 68.4 bits (166), Expect = 2e-12
 Identities = 33/193 (17%), Positives = 57/193 (29%), Gaps = 54/193 (27%)

Query: 595 CKKIGKGSFGSVYYGKMKDGKEVAVKIMA--------DSCSHRTQQFVTEVALLSRIH-- 644
           C+KIG+G FG V+     D   VA+KI+A         S     ++ + E+ +   +   
Sbjct: 25  CEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLL 83

Query: 645 -------HRNLVPLIGYC------------------------------EEEHQRILVYEY 667
                      + L                                   ++ Q  +V E+
Sbjct: 84  SGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEF 143

Query: 668 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 727
              G   +++      K     T   I H     L       +    HRD+   N+LL  
Sbjct: 144 EFGGIDLEQMR----TKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVLLKK 197

Query: 728 NMRAKVSDFGLSR 740
               K+      +
Sbjct: 198 TSLKKLHYTLNGK 210

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 67.3 bits (165), Expect = 4e-12
 Identities = 27/95 (28%), Positives = 41/95 (43%), Gaps = 4/95 (4%)

Query: 392 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLEN 450
           T P    + L    L  + P +   +  L  + +D   L   LPD M +   L  + L  
Sbjct: 79  TQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLAR 136

Query: 451 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 485
           N L  +LP+ + SL  L+EL I     + E+P  L
Sbjct: 137 NPLR-ALPASIASLNRLRELSIRACPELTELPEPL 170

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 64.6 bits (158), Expect = 4e-11
 Identities = 21/95 (22%), Positives = 41/95 (43%), Gaps = 12/95 (12%)

Query: 401 LSGKNLKGEIPPELKNMEA---------LTELWLDGNFLTGPLPD-MSRLIDLRIVHLEN 450
           +       E+P  L + +A         L  L L+   +   LP  ++ L +L+ + + N
Sbjct: 157 IRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRN 215

Query: 451 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 485
           + L+ +L   +  LP L+EL +   + +   PP  
Sbjct: 216 SPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIF 249

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 64.2 bits (157), Expect = 4e-11
 Identities = 19/106 (17%), Positives = 39/106 (36%), Gaps = 3/106 (2%)

Query: 397 TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGS 456
             + L    ++  +P  + N++ L  L +  + L+   P +  L  L  + L       +
Sbjct: 186 QSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRN 244

Query: 457 LPSYMGSLPNLQELHIENNSFVGEIPPAL--LTGKVIFKYDNNPKL 500
            P   G    L+ L +++ S +  +P  +  LT            L
Sbjct: 245 YPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNL 290

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 63.8 bits (156), Expect = 6e-11
 Identities = 20/89 (22%), Positives = 29/89 (32%), Gaps = 4/89 (4%)

Query: 401 LSGKNLKGEIPPELKNMEALTELWL-DGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLP 458
           L G       PP       L  L L D + L   LP  + RL  L  + L        LP
Sbjct: 236 LRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT-LPLDIHRLTQLEKLDLRGCVNLSRLP 294

Query: 459 SYMGSLPNLQELHIENNSFVGEIPPALLT 487
           S +  LP    + +  +    ++      
Sbjct: 295 SLIAQLPANCIILVPPH-LQAQLDQHRPV 322

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 56.9 bits (138), Expect = 1e-08
 Identities = 26/100 (26%), Positives = 40/100 (40%), Gaps = 15/100 (15%)

Query: 397 TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHL-ENNELT 454
             + +    L  E+P  ++    L  L L  N L   LP  ++ L  LR + +    ELT
Sbjct: 107 QHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELT 164

Query: 455 GSLPSYMGS---------LPNLQELHIENNSFVGEIPPAL 485
             LP  + S         L NLQ L +E       +P ++
Sbjct: 165 -ELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASI 202

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 45.7 bits (109), Expect = 4e-05
 Identities = 13/69 (18%), Positives = 27/69 (39%), Gaps = 4/69 (5%)

Query: 401 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENN---ELTGS 456
           L   +    +P ++  +  L +L L G      LP  +++L    I+ +  +   +L   
Sbjct: 260 LKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQH 319

Query: 457 LPSYMGSLP 465
            P    + P
Sbjct: 320 RPVARPAEP 328

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 44.2 bits (105), Expect = 1e-04
 Identities = 11/107 (10%), Positives = 23/107 (21%), Gaps = 24/107 (22%)

Query: 401 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRL-------------------- 440
             G          L   +       +         + +                      
Sbjct: 19  FQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDA 78

Query: 441 --IDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 485
                  + L +  L    P     L +LQ + I+    + E+P  +
Sbjct: 79  TQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTM 123

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 67.7 bits (166), Expect = 1e-11
 Identities = 17/98 (17%), Positives = 34/98 (34%), Gaps = 6/98 (6%)

Query: 394 PRITKIALSGKNLKGEIPPELK---NMEALTELWLDGNFLTGPLPDM---SRLIDLRIVH 447
            R+  + L+   L   +  +L       ++  L L  + L+          +  +L ++ 
Sbjct: 195 GRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLD 254

Query: 448 LENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 485
           L  N L          LP L+   +E N+       +L
Sbjct: 255 LSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSL 292

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 67.3 bits (165), Expect = 1e-11
 Identities = 18/111 (16%), Positives = 33/111 (29%), Gaps = 9/111 (8%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM---SRLIDLRIVHLEN 450
             +  + LS   L          +E L EL L  N +     +         L+ + L +
Sbjct: 121 KNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS 180

Query: 451 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLH 501
           N++    P    ++  L  L + N      +   L           N  + 
Sbjct: 181 NQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKL------CLELANTSIR 225

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 66.2 bits (162), Expect = 3e-11
 Identities = 22/93 (23%), Positives = 33/93 (35%), Gaps = 1/93 (1%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNE 452
           P +  + L    L             LTEL L  N +     +   +  +L  + L +N 
Sbjct: 73  PMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNG 132

Query: 453 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 485
           L+ +       L NLQEL + NN         L
Sbjct: 133 LSSTKLGTQVQLENLQELLLSNNKIQALKSEEL 165

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 66.2 bits (162), Expect = 3e-11
 Identities = 23/94 (24%), Positives = 41/94 (43%), Gaps = 1/94 (1%)

Query: 393 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 451
           P  IT + L+   L+            LT L +  N ++   P++  +L  L++++L++N
Sbjct: 24  PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83

Query: 452 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 485
           EL+           NL ELH+ +NS         
Sbjct: 84  ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPF 117

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 65.4 bits (160), Expect = 6e-11
 Identities = 15/93 (16%), Positives = 31/93 (33%), Gaps = 1/93 (1%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNE 452
            ++T + +    +    P   + +  L  L L  N L+       +   +L  +HL +N 
Sbjct: 49  SQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNS 108

Query: 453 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 485
           +     +      NL  L + +N          
Sbjct: 109 IQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQ 141

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 63.9 bits (156), Expect = 1e-10
 Identities = 18/89 (20%), Positives = 31/89 (34%), Gaps = 1/89 (1%)

Query: 401 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPS 459
           L      G     LK +  L  L L+ N       ++   L +L+I+ L  N L     S
Sbjct: 519 LWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPAS 578

Query: 460 YMGSLPNLQELHIENNSFVGEIPPALLTG 488
              +  +L+ L+++ N             
Sbjct: 579 VFNNQVSLKSLNLQKNLITSVEKKVFGPA 607

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 63.9 bits (156), Expect = 2e-10
 Identities = 27/139 (19%), Positives = 44/139 (31%), Gaps = 4/139 (2%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG---PLPDMSRLIDLRIVHLEN 450
             I +I LS              + +L  L L    L            L +L I+ L N
Sbjct: 430 ENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSN 489

Query: 451 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRF 510
           N +       +  L  L+ L +++N+    +      G  I+       LH  +     F
Sbjct: 490 NNIANINDDMLEGLEKLEILDLQHNNLA-RLWKHANPGGPIYFLKGLSHLHILNLESNGF 548

Query: 511 KLILGTSIGVLAILLVLFL 529
             I       L  L ++ L
Sbjct: 549 DEIPVEVFKDLFELKIIDL 567

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 63.5 bits (155), Expect = 2e-10
 Identities = 16/96 (16%), Positives = 37/96 (38%), Gaps = 3/96 (3%)

Query: 393 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 451
              +T++ L   +++          + L  L L  N L+        +L +L+ + L NN
Sbjct: 96  CTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNN 155

Query: 452 ELTGSLPS--YMGSLPNLQELHIENNSFVGEIPPAL 485
           ++         + +  +L++L + +N      P   
Sbjct: 156 KIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCF 191

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 63.5 bits (155), Expect = 2e-10
 Identities = 19/99 (19%), Positives = 36/99 (36%), Gaps = 6/99 (6%)

Query: 393 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM----SRLIDLRIVHL 448
              + K+ LS   +K   P     +  L  L+L+   L   L +          +R + L
Sbjct: 170 NSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSL 229

Query: 449 ENNELTGSLPSYMGSL--PNLQELHIENNSFVGEIPPAL 485
            N++L+ +  +    L   NL  L +  N+       + 
Sbjct: 230 SNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSF 268

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 63.1 bits (154), Expect = 3e-10
 Identities = 16/103 (15%), Positives = 33/103 (32%), Gaps = 4/103 (3%)

Query: 387 TCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM--SRLIDLR 444
           T  +     +  + L+   +          +  L  L L  N +   L       L ++ 
Sbjct: 374 TFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIF 433

Query: 445 IVHLENNELTGSLPSYMGSLPNLQELHIENNSF--VGEIPPAL 485
            ++L  N+      +    +P+LQ L +   +   V   P   
Sbjct: 434 EIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPF 476

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 63.1 bits (154), Expect = 3e-10
 Identities = 22/101 (21%), Positives = 36/101 (35%), Gaps = 9/101 (8%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLT---------GPLPDMSRLIDLR 444
             +T + LS  N+       L+ +E L  L L  N L          GP+  +  L  L 
Sbjct: 480 RNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLH 539

Query: 445 IVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 485
           I++LE+N            L  L+ + +  N+         
Sbjct: 540 ILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVF 580

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 62.3 bits (152), Expect = 5e-10
 Identities = 15/100 (15%), Positives = 32/100 (32%), Gaps = 5/100 (5%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMS-----RLIDLRIVHL 448
             +  + +   ++ G        +  L  L L  +F +                L I++L
Sbjct: 329 KCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNL 388

Query: 449 ENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 488
             N+++         L +L+ L +  N    E+      G
Sbjct: 389 TKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRG 428

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 61.6 bits (150), Expect = 8e-10
 Identities = 19/90 (21%), Positives = 35/90 (38%), Gaps = 7/90 (7%)

Query: 401 LSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLP 458
            S   L  ++P +L  N   +T L L  N L      + +R   L  + +  N ++   P
Sbjct: 11  CSHLKLT-QVPDDLPTN---ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEP 66

Query: 459 SYMGSLPNLQELHIENNSFVGEIPPALLTG 488
                LP L+ L++++N     +       
Sbjct: 67  ELCQKLPMLKVLNLQHNELSQ-LSDKTFAF 95

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 59.6 bits (145), Expect = 3e-09
 Identities = 26/146 (17%), Positives = 49/146 (33%), Gaps = 15/146 (10%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD----------MSRLIDL 443
           P++    L   N++      L  +  +  L L  +F    +               L  L
Sbjct: 272 PQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCL 331

Query: 444 RIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKE 503
             +++E+N++ G   +    L NL+ L + N+                F    +  LH  
Sbjct: 332 EHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNE-----TFVSLAHSPLHIL 386

Query: 504 SRRRMRFKLILGTSIGVLAILLVLFL 529
           +  + +   I   +   L  L VL L
Sbjct: 387 NLTKNKISKIESDAFSWLGHLEVLDL 412

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 42.7 bits (101), Expect = 5e-04
 Identities = 18/110 (16%), Positives = 31/110 (28%), Gaps = 5/110 (4%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLENN 451
             +  I L   NL         N  +L  L L  N +T     +      +L  + +  N
Sbjct: 560 FELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFN 619

Query: 452 ELTGSLPSYMGSLPNLQELHIENNSFVGEIP---PALLTGKVIFKYDNNP 498
               +  S    +  + E H              P    G  +  +D + 
Sbjct: 620 PFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPHYHGFPVRLFDTSS 669

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 67.6 bits (165), Expect = 1e-11
 Identities = 10/81 (12%), Positives = 29/81 (35%), Gaps = 4/81 (4%)

Query: 405 NLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSL 464
           N    I   ++ +  L  ++   +  T         +D    + +  +   +      +L
Sbjct: 435 NRITFISKAIQRLTKLQIIYFANSPFTYDNI----AVDWEDANSDYAKQYENEELSWSNL 490

Query: 465 PNLQELHIENNSFVGEIPPAL 485
            +L ++ + N   + ++P  L
Sbjct: 491 KDLTDVELYNCPNMTQLPDFL 511

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 64.1 bits (156), Expect = 1e-10
 Identities = 17/103 (16%), Positives = 31/103 (30%), Gaps = 13/103 (12%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGP---------LPDM-SRLIDL 443
             +T + L       ++P  L ++  L  L +  N              L D       +
Sbjct: 491 KDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKI 550

Query: 444 RIVHLENNELTGSLPSY-MGSLPNLQELHIENNSFVGEIPPAL 485
           +I ++  N L     S  +  +  L  L   +N        A 
Sbjct: 551 QIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKV--RHLEAF 591

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 62.2 bits (151), Expect = 6e-10
 Identities = 21/110 (19%), Positives = 41/110 (37%), Gaps = 12/110 (10%)

Query: 401 LSGKNLKGEIPPELK--NMEALTELWLDGNFLTGPLPD----MSRLIDLRIVH---LENN 451
           L    L   +  + +   +  L+ + +  N  +   P      S+L    I H    E N
Sbjct: 735 LRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGN 792

Query: 452 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLH 501
            +    P+ + + P+L +L I +N    ++   L     I    +NP + 
Sbjct: 793 RILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLTPQLYILDIADNPNIS 841

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 62.2 bits (151), Expect = 7e-10
 Identities = 22/100 (22%), Positives = 35/100 (35%), Gaps = 14/100 (14%)

Query: 395 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD---MSRLIDLRIVHLENN 451
            +T I    +N         KN   LT + L  N LT  L D    + L  L  + +  N
Sbjct: 708 LMTSIP---ENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYN 763

Query: 452 ELTGSLPSYMGSLPNLQELHIE------NNSFVGEIPPAL 485
             + S P+   +   L+   I        N  + + P  +
Sbjct: 764 CFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGI 802

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 61.8 bits (150), Expect = 7e-10
 Identities = 13/108 (12%), Positives = 32/108 (29%), Gaps = 4/108 (3%)

Query: 372 NDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLT 431
           N   +  +      V        R+T ++L+G   KG +P  +  +  L  L    +  T
Sbjct: 303 NFNKELDMWGDQPGVDLDNNG--RVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSET 360

Query: 432 GPLPDMSRL-IDLRIVHLENNELTGSLPS-YMGSLPNLQELHIENNSF 477
                     +   +     + +       ++     L    +  ++ 
Sbjct: 361 VSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAI 408

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 61.0 bits (148), Expect = 1e-09
 Identities = 19/104 (18%), Positives = 36/104 (34%), Gaps = 10/104 (9%)

Query: 394 PRITKIALSGKNLKGEIPP--ELKNMEALTELWLDGNFLTGPLPDMS------RLIDLRI 445
            ++  +  S   LK  IP     K++  +  +    N +     ++S      + I+   
Sbjct: 619 DQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINAST 677

Query: 446 VHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGK 489
           V L  NE+         +   +  + + NN     IP   L  K
Sbjct: 678 VTLSYNEIQKFPTELFATGSPISTIILSNNLM-TSIPENSLKPK 720

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 60.3 bits (146), Expect = 2e-09
 Identities = 20/99 (20%), Positives = 35/99 (35%), Gaps = 7/99 (7%)

Query: 394 PRITKIALSGKNLKGEIPPE--LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENN 451
           P+I    +   NL+ E P    L+ M  L  L    N +   L      + L  + L+ N
Sbjct: 548 PKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVRH-LEAFGTNVKLTDLKLDYN 605

Query: 452 ELTGSLPSYMGS-LPNLQELHIENNSFVGEIPPALLTGK 489
           ++   +P    +    ++ L   +N     IP       
Sbjct: 606 QIE-EIPEDFCAFTDQVEGLGFSHNKL-KYIPNIFNAKS 642

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 59.5 bits (144), Expect = 3e-09
 Identities = 20/118 (16%), Positives = 41/118 (34%), Gaps = 15/118 (12%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTEL------WLDGNFLTGPLPD-MSRLIDLRIV 446
           P ++ + +S        P +  N   L           +GN +    P  ++    L  +
Sbjct: 753 PYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQL 811

Query: 447 HLENNELTGSLPSYMGSLPNLQELHIENNSF----VGEIPPALLTGKVIFKYDNNPKL 500
            + +N++   +   +   P L  L I +N      V  + P +  G  +  YD    +
Sbjct: 812 QIGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDI 866

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 50.6 bits (121), Expect = 2e-06
 Identities = 11/94 (11%), Positives = 29/94 (30%), Gaps = 8/94 (8%)

Query: 401 LSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTG---- 455
                ++       L   + L    L  + +    P+M  +     + L++ ++      
Sbjct: 378 ERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINR-NPEMKPIKKDSRISLKDTQIGNLTNR 436

Query: 456 --SLPSYMGSLPNLQELHIENNSFVGEIPPALLT 487
              +   +  L  LQ ++  N+ F  +       
Sbjct: 437 ITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWE 470

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 46.8 bits (111), Expect = 3e-05
 Identities = 24/148 (16%), Positives = 43/148 (29%), Gaps = 8/148 (5%)

Query: 398 KIALSGKNLK-----GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 452
             AL GKN +             N     EL + G+     L +  R+  L    L    
Sbjct: 278 WEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGL---SLAGFG 334

Query: 453 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKL 512
             G +P  +G L  L+ L    +S                  +      +   ++M    
Sbjct: 335 AKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDY 394

Query: 513 ILGTSIGVLAILLVLFLCSLIVLRKLRR 540
               ++  L    +     +  ++K  R
Sbjct: 395 DQRLNLSDLLQDAINRNPEMKPIKKDSR 422

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 64.3 bits (157), Expect = 1e-10
 Identities = 14/97 (14%), Positives = 24/97 (24%), Gaps = 3/97 (3%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG--PLPDMSRLIDLRIVHLENN 451
             +  + LS       +      +E L  L    + L           L  L  + +   
Sbjct: 376 NSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYT 434

Query: 452 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 488
                       L +L  L +  NSF       +   
Sbjct: 435 NTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFAN 471

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 62.0 bits (151), Expect = 6e-10
 Identities = 19/97 (19%), Positives = 38/97 (39%), Gaps = 3/97 (3%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNE 452
             ++ + L+G  ++   P     + +L  L      L         +LI L+ +++ +N 
Sbjct: 80  HHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNF 139

Query: 453 LTG-SLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 488
           +    LP+Y  +L NL  + +  N     I    L  
Sbjct: 140 IHSCKLPAYFSNLTNLVHVDLSYNYIQT-ITVNDLQF 175

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 60.8 bits (148), Expect = 1e-09
 Identities = 18/88 (20%), Positives = 30/88 (34%), Gaps = 3/88 (3%)

Query: 401 LSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLP 458
           ++G + K         N   LT L L    L      +   L  L+++++ +N L     
Sbjct: 455 MAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDS 514

Query: 459 SYMGSLPNLQELHIENNSFVGEIPPALL 486
           S+   L +L  L    N         L 
Sbjct: 515 SHYNQLYSLSTLDCSFNRIET-SKGILQ 541

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 59.3 bits (144), Expect = 4e-09
 Identities = 15/89 (16%), Positives = 29/89 (32%), Gaps = 5/89 (5%)

Query: 401 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPS 459
              + L  ++P ++    +   + L  N L        S   +L+ + L   E+      
Sbjct: 18  CMDQKLS-KVPDDI--PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDK 74

Query: 460 YMGSLPNLQELHIENNSFVGEIPPALLTG 488
               L +L  L +  N       P   +G
Sbjct: 75  AWHGLHHLSNLILTGNPIQS-FSPGSFSG 102

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 58.9 bits (143), Expect = 5e-09
 Identities = 19/96 (19%), Positives = 35/96 (36%), Gaps = 1/96 (1%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNE 452
             +  + LS   ++         +  L+ L L GN +    P   S L  L  +     +
Sbjct: 56  SELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETK 115

Query: 453 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 488
           L       +G L  L++L++ +N       PA  + 
Sbjct: 116 LASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSN 151

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 58.1 bits (141), Expect = 8e-09
 Identities = 18/94 (19%), Positives = 24/94 (25%), Gaps = 1/94 (1%)

Query: 393 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 451
           P     I LS   LK        N   L  L L    +          L  L  + L  N
Sbjct: 31  PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGN 90

Query: 452 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 485
            +    P     L +L+ L              +
Sbjct: 91  PIQSFSPGSFSGLTSLENLVAVETKLASLESFPI 124

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 56.6 bits (137), Expect = 2e-08
 Identities = 16/86 (18%), Positives = 28/86 (32%), Gaps = 1/86 (1%)

Query: 393 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 451
              +T + LS   L+         +  L  L +  N L        ++L  L  +    N
Sbjct: 472 TTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFN 531

Query: 452 ELTGSLPSYMGSLPNLQELHIENNSF 477
            +  S         +L   ++ NNS 
Sbjct: 532 RIETSKGILQHFPKSLAFFNLTNNSV 557

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 54.3 bits (131), Expect = 1e-07
 Identities = 18/101 (17%), Positives = 30/101 (29%), Gaps = 7/101 (6%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPD-MSRLIDLRIVHLENN 451
             +  +      L       +  +  L +L +  NF+    LP   S L +L  V L  N
Sbjct: 104 TSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYN 163

Query: 452 ELTGSLPSYMGSLPNL----QELHIENNSFVGEIPPALLTG 488
            +     + +  L         L +  N     I      G
Sbjct: 164 YIQTITVNDLQFLRENPQVNLSLDMSLNPI-DFIQDQAFQG 203

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 51.2 bits (123), Expect = 1e-06
 Identities = 18/98 (18%), Positives = 34/98 (34%), Gaps = 6/98 (6%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD---MSRLIDLRIVHLEN 450
           P +  + L+    KG I  +   + +L+ L L  N L+              LR + L  
Sbjct: 328 PFLKSLTLT--MNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSF 385

Query: 451 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 488
           N     + +    L  LQ L  ++++       +    
Sbjct: 386 NGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLS 422

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 48.9 bits (117), Expect = 7e-06
 Identities = 13/77 (16%), Positives = 30/77 (38%), Gaps = 4/77 (5%)

Query: 401 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 460
           L+  N   +   +   +  ++ + L G  +   L D+ +    + + +   +L    P+ 
Sbjct: 268 LTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY-LEDVPKHFKWQSLSIIRCQLK-QFPT- 324

Query: 461 MGSLPNLQELHIENNSF 477
              LP L+ L +  N  
Sbjct: 325 -LDLPFLKSLTLTMNKG 340

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 62.8 bits (153), Expect = 2e-10
 Identities = 65/247 (26%), Positives = 101/247 (40%), Gaps = 25/247 (10%)

Query: 555 RTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGK-MKD 613
            +S K     Y+      + D+   Y +   E           IGKGSFG V       +
Sbjct: 23  MSSHKKERKVYN----DGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVE 78

Query: 614 GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR------NLVPLIGYCEEEHQRILVYEY 667
            + VA+KI+ +  +    Q   EV LL  ++         +V L  +    +   LV+E 
Sbjct: 79  QEWVAIKIIKNKKAFL-NQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEM 137

Query: 668 MHNGTLRDRLHGSVNQKPLDWLTRLQ-IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD 726
           +    L D L  + N + +  L   +  A      L +L T     IIH D+K  NILL 
Sbjct: 138 LSY-NLYDLLRNT-NFRGVS-LNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLC 193

Query: 727 INMRA--KVSDFGLSRQAEEDL-THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVL 783
              R+  K+ DFG S Q  + +  +I S  R    Y  PE           D++S G +L
Sbjct: 194 NPKRSAIKIVDFGSSCQLGQRIYQYIQS--R---FYRSPEVLLGMPYDLAIDMWSLGCIL 248

Query: 784 LELISGK 790
           +E+ +G+
Sbjct: 249 VEMHTGE 255

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 62.9 bits (153), Expect = 2e-10
 Identities = 22/154 (14%), Positives = 46/154 (29%), Gaps = 6/154 (3%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 453
             +  + L    +  ++  ++     L  L L  N L    P+      +  + L NN+L
Sbjct: 169 DTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKL 226

Query: 454 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKY---DNNPKLHKESRRRMRF 510
              +   +    NL+   +  N F         +     +        KL  ++      
Sbjct: 227 V-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTV 285

Query: 511 KLILGTSIGVLAILLVLFLCSLIVLRKLRRKISN 544
             +          L   F   LI L++    + +
Sbjct: 286 PTLGHYGAYCCEDLPAPFADRLIALKRKEHALLS 319

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 61.4 bits (149), Expect = 7e-10
 Identities = 24/95 (25%), Positives = 37/95 (38%), Gaps = 7/95 (7%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 453
             + ++ LSG  L      +L     L  L L  N L     D+  L  LR + L NN +
Sbjct: 34  WNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE-TLDLESLSTLRTLDLNNNYV 92

Query: 454 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 488
              L       P+++ LH  NN+    +  +   G
Sbjct: 93  Q-ELL----VGPSIETLHAANNNI-SRVSCSRGQG 121

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 54.1 bits (130), Expect = 2e-07
 Identities = 20/91 (21%), Positives = 37/91 (40%), Gaps = 4/91 (4%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNE 452
            R     ++  +LK  +    ++   + EL L GN L+       +    L +++L +N 
Sbjct: 10  NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69

Query: 453 LTGSLPSYMGSLPNLQELHIENNSFVGEIPP 483
           L       + SL  L+ L + NN    E+  
Sbjct: 70  LY-ETLD-LESLSTLRTLDLNNNYV-QELLV 97

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 50.6 bits (121), Expect = 2e-06
 Identities = 16/76 (21%), Positives = 30/76 (39%), Gaps = 3/76 (3%)

Query: 413 ELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 472
           EL    ++  L    N ++  +   SR    + ++L NN++T       G    +Q L +
Sbjct: 94  ELLVGPSIETLHAANNNISR-VSC-SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDL 151

Query: 473 ENNSFVGEIPPALLTG 488
           + N     +  A L  
Sbjct: 152 KLNEID-TVNFAELAA 166

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 49.8 bits (119), Expect = 3e-06
 Identities = 11/87 (12%), Positives = 29/87 (33%), Gaps = 5/87 (5%)

Query: 401 LSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDM-SRLIDLRIVHLENNELTGSLP 458
           L+   +      +      +  L L  N +      ++ +    L  ++L+ N +   + 
Sbjct: 127 LANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVK 185

Query: 459 SYMGSLPNLQELHIENNSFVGEIPPAL 485
             +     L+ L + +N     + P  
Sbjct: 186 GQV-VFAKLKTLDLSSNKLA-FMGPEF 210

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 49.1 bits (117), Expect = 5e-06
 Identities = 10/69 (14%), Positives = 24/69 (34%), Gaps = 2/69 (2%)

Query: 416 NMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 474
           N        +  + L   L  +     +++ + L  N L+    + +     L+ L++ +
Sbjct: 8   NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67

Query: 475 NSFVGEIPP 483
           N    E   
Sbjct: 68  NVLY-ETLD 75

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 63.1 bits (154), Expect = 2e-10
 Identities = 18/94 (19%), Positives = 29/94 (30%)

Query: 395 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELT 454
            +  I L                  L EL L    L+     +  L  L+ + L  N+  
Sbjct: 255 SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFE 314

Query: 455 GSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 488
                   + P+L  L I+ N+   E+    L  
Sbjct: 315 NLCQISASNFPSLTHLSIKGNTKRLELGTGCLEN 348

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 60.8 bits (148), Expect = 1e-09
 Identities = 19/99 (19%), Positives = 38/99 (38%), Gaps = 4/99 (4%)

Query: 394 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTG-PLPDMS--RLIDLRIVHLE 449
           P +T +++ G   + E+    L+N+E L EL L  + +      ++    L  L+ ++L 
Sbjct: 325 PSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLS 384

Query: 450 NNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 488
            NE            P L+ L +       +   +    
Sbjct: 385 YNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQN 423

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 60.4 bits (147), Expect = 2e-09
 Identities = 19/91 (20%), Positives = 30/91 (32%), Gaps = 2/91 (2%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLENN 451
             +  + LS            K    L  L L    L           L  L++++L ++
Sbjct: 376 SHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHS 435

Query: 452 ELTGSLPSYMGSLPNLQELHIENNSFVGEIP 482
            L  S       LP LQ L+++ N F     
Sbjct: 436 LLDISSEQLFDGLPALQHLNLQGNHFPKGNI 466

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 60.4 bits (147), Expect = 2e-09
 Identities = 16/97 (16%), Positives = 23/97 (23%), Gaps = 2/97 (2%)

Query: 393 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 451
           P     +  S   L          +  LT L L    +     D       L  + L  N
Sbjct: 32  PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTAN 91

Query: 452 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 488
            L     + +     L+ L          I    L  
Sbjct: 92  PLIFMAETALSGPKALKHLFFIQTGISS-IDFIPLHN 127

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 58.5 bits (142), Expect = 6e-09
 Identities = 14/96 (14%), Positives = 32/96 (33%), Gaps = 2/96 (2%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNE 452
            R+  + L+   L       L   +AL  L+     ++            L  ++L +N 
Sbjct: 81  HRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNH 140

Query: 453 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 488
           ++            L+ L  +NN+    +    ++ 
Sbjct: 141 ISSIKLPKGFPTEKLKVLDFQNNAIH-YLSKEDMSS 175

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 58.5 bits (142), Expect = 6e-09
 Identities = 15/84 (17%), Positives = 35/84 (41%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 453
            R+  + LS  +L         +++ +  + L  N LT    +    +    ++L +N +
Sbjct: 476 GRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASNHI 535

Query: 454 TGSLPSYMGSLPNLQELHIENNSF 477
           +  LPS +  L   + +++  N  
Sbjct: 536 SIILPSLLPILSQQRTINLRQNPL 559

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 58.1 bits (141), Expect = 9e-09
 Identities = 13/93 (13%), Positives = 29/93 (31%), Gaps = 1/93 (1%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNE 452
             +T + L+   +        ++   L  L L  N L        S    L+ +      
Sbjct: 57  INLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTG 116

Query: 453 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 485
           ++      + +   L+ L++ +N       P  
Sbjct: 117 ISSIDFIPLHNQKTLESLYLGSNHISSIKLPKG 149

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 57.7 bits (140), Expect = 1e-08
 Identities = 20/89 (22%), Positives = 29/89 (32%), Gaps = 5/89 (5%)

Query: 401 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPS 459
                L  EIP  L    +   L    N L        SRLI+L  + L   ++      
Sbjct: 19  CENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHED 75

Query: 460 YMGSLPNLQELHIENNSFVGEIPPALLTG 488
              S   L  L +  N  +  +    L+G
Sbjct: 76  TFQSQHRLDTLVLTANPLIF-MAETALSG 103

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 56.6 bits (137), Expect = 3e-08
 Identities = 17/99 (17%), Positives = 31/99 (31%), Gaps = 4/99 (4%)

Query: 393 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 451
           P  +  +      +       L N + L  L+L  N ++            L+++  +NN
Sbjct: 104 PKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNN 163

Query: 452 ELTGSLPSYMGSLPNLQ--ELHIENNSFVGEIPPALLTG 488
            +       M SL       L++  N     I P     
Sbjct: 164 AIHYLSKEDMSSLQQATNLSLNLNGNDI-AGIEPGAFDS 201

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 54.6 bits (132), Expect = 1e-07
 Identities = 18/97 (18%), Positives = 30/97 (30%), Gaps = 4/97 (4%)

Query: 393 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLID----LRIVHL 448
              +  + LS   L          + AL  L L GN         +  +     L I+ L
Sbjct: 424 LHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVL 483

Query: 449 ENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 485
              +L+        SL  +  + + +N        AL
Sbjct: 484 SFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEAL 520

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 53.1 bits (128), Expect = 4e-07
 Identities = 20/99 (20%), Positives = 39/99 (39%), Gaps = 5/99 (5%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENN 451
             + K+ LS    +        N  +LT L + GN     L    +  L +LR + L ++
Sbjct: 301 STLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHD 360

Query: 452 ELTGSLPSYM--GSLPNLQELHIENNSFVGEIPPALLTG 488
           ++  S    +   +L +LQ L++  N  +  +       
Sbjct: 361 DIETSDCCNLQLRNLSHLQSLNLSYNEPLS-LKTEAFKE 398

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 48.9 bits (117), Expect = 7e-06
 Identities = 15/97 (15%), Positives = 30/97 (30%), Gaps = 6/97 (6%)

Query: 394 PRITKIALSGKNLKGEIPPELKN--MEALTELWLDGNFLTGPLPDM---SRLIDLRIVHL 448
                +   G      I   LKN  +++L     +        P +      + +  ++L
Sbjct: 202 AVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINL 261

Query: 449 ENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 485
           + +       +       LQEL +       E+P  L
Sbjct: 262 QKHYFFNISSNTFHCFSGLQELDLTATHL-SELPSGL 297

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 43.1 bits (102), Expect = 4e-04
 Identities = 13/99 (13%), Positives = 32/99 (32%), Gaps = 7/99 (7%)

Query: 395 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM---SRLIDLRIVHLENN 451
               + L+G ++   I P   +      L   G      +      S +  L +   E+ 
Sbjct: 180 TNLSLNLNGNDIA-GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDM 238

Query: 452 ELTGSLPSYMGSLP--NLQELHIENNSFVGEIPPALLTG 488
           +     P+    L   +++ ++++ + F   I       
Sbjct: 239 DDEDISPAVFEGLCEMSVESINLQKHYFFN-ISSNTFHC 276

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 61.2 bits (149), Expect = 4e-10
 Identities = 17/99 (17%), Positives = 35/99 (35%), Gaps = 7/99 (7%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMS---RLIDLRIVHLEN 450
             +  + LS   +   +      +E L  L    + L   + + S    L +L  + + +
Sbjct: 78  TSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQ-MSEFSVFLSLRNLIYLDISH 135

Query: 451 NELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 488
                   + +   L +L+ L +  NSF     P + T 
Sbjct: 136 THTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 173

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 54.6 bits (132), Expect = 5e-08
 Identities = 18/95 (18%), Positives = 37/95 (38%), Gaps = 7/95 (7%)

Query: 393 PPRITKIALSGKNLKGEIPP-ELKNMEALTELWLDGNFLTG---PLPDMSRLIDLRIVHL 448
           P   T++ L    L+  +P      +  LT+L L  N L+              L+ + L
Sbjct: 27  PSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDL 85

Query: 449 ENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPP 483
             N +  ++ S    L  L+ L  ++++   ++  
Sbjct: 86  SFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSE 118

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 49.6 bits (119), Expect = 2e-06
 Identities = 13/100 (13%), Positives = 31/100 (31%), Gaps = 8/100 (8%)

Query: 394 PRITKIALSGKNLKGEIPPE--LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLE 449
            ++  +     NLK ++       ++  L  L +          +   + L  L ++ + 
Sbjct: 101 EQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRV-AFNGIFNGLSSLEVLKMA 158

Query: 450 NNELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 488
            N    +    +   L NL  L +       ++ P     
Sbjct: 159 GNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNS 197

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 46.5 bits (111), Expect = 2e-05
 Identities = 14/80 (17%), Positives = 25/80 (31%), Gaps = 4/80 (5%)

Query: 411 PPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYM--GSLPNLQ 468
                   +L  L L  N +     +   L  L  +  +++ L   +  +    SL NL 
Sbjct: 71  SQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLI 129

Query: 469 ELHIENNSFVGEIPPALLTG 488
            L I +          +  G
Sbjct: 130 YLDISHTHTR-VAFNGIFNG 148

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 45.8 bits (109), Expect = 3e-05
 Identities = 18/88 (20%), Positives = 35/88 (39%), Gaps = 6/88 (6%)

Query: 394 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLEN 450
             +T + LS   L+ ++ P    ++ +L  L +  N     L       L  L+++    
Sbjct: 175 RNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFS-LDTFPYKCLNSLQVLDYSL 232

Query: 451 NELTGSLPSYMGSLP-NLQELHIENNSF 477
           N +  S    +   P +L  L++  N F
Sbjct: 233 NHIMTSKKQELQHFPSSLAFLNLTQNDF 260

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 60.6 bits (148), Expect = 8e-10
 Identities = 20/91 (21%), Positives = 36/91 (39%), Gaps = 11/91 (12%)

Query: 395 RITKI-ALSG-KNLKG--------EIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLR 444
           +IT +  L+    L               +K++  L  L +  N ++  +  ++ L  L 
Sbjct: 232 KITDLSPLANLSQLTWLEIGTNQISDINAVKDLTKLKMLNVGSNQISD-ISVLNNLSQLN 290

Query: 445 IVHLENNELTGSLPSYMGSLPNLQELHIENN 475
            + L NN+L       +G L NL  L +  N
Sbjct: 291 SLFLNNNQLGNEDMEVIGGLTNLTTLFLSQN 321

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 57.6 bits (140), Expect = 7e-09
 Identities = 16/83 (19%), Positives = 31/83 (37%), Gaps = 5/83 (6%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNE 452
            ++  + +    +       L N+  L  L+L+ N L     ++   L +L  + L  N 
Sbjct: 265 TKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNH 322

Query: 453 LTGSLPSYMGSLPNLQELHIENN 475
           +T   P  + SL  +      N 
Sbjct: 323 ITDIRP--LASLSKMDSADFANQ 343

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 57.6 bits (140), Expect = 8e-09
 Identities = 18/92 (19%), Positives = 42/92 (45%), Gaps = 5/92 (5%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 453
            R+  + +    +   + P L N+  LT L +  N ++  +  +  L  L+++++ +N++
Sbjct: 221 TRLNSLKIGNNKITD-LSP-LANLSQLTWLEIGTNQISD-INAVKDLTKLKMLNVGSNQI 277

Query: 454 TGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 485
           +    S + +L  L  L + NN    E    +
Sbjct: 278 SD--ISVLNNLSQLNSLFLNNNQLGNEDMEVI 307

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 56.4 bits (137), Expect = 2e-08
 Identities = 17/92 (18%), Positives = 38/92 (41%), Gaps = 15/92 (16%)

Query: 395 RITKI-ALSG-KNLK---------GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDL 443
           ++  +  ++   +L           +I P L ++ +L       N +T  +  ++ +  L
Sbjct: 166 KVKDVTPIANLTDLYSLSLNYNQIEDISP-LASLTSLHYFTAYVNQITD-ITPVANMTRL 223

Query: 444 RIVHLENNELTGSLPSYMGSLPNLQELHIENN 475
             + + NN++T   P  + +L  L  L I  N
Sbjct: 224 NSLKIGNNKITDLSP--LANLSQLTWLEIGTN 253

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 56.0 bits (136), Expect = 2e-08
 Identities = 23/90 (25%), Positives = 48/90 (53%), Gaps = 6/90 (6%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 453
             ITK+ ++G+ +       ++ +  L  L L+GN +T  +  +S L+ L  +++  N++
Sbjct: 44  ESITKLVVAGEKVAS--IQGIEYLTNLEYLNLNGNQITD-ISPLSNLVKLTNLYIGTNKI 100

Query: 454 TGSLPSYMGSLPNLQELHIENNSFVGEIPP 483
           T    S + +L NL+EL++  ++    I P
Sbjct: 101 TD--ISALQNLTNLRELYLNEDNISD-ISP 127

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 54.5 bits (132), Expect = 6e-08
 Identities = 14/82 (17%), Positives = 37/82 (45%), Gaps = 4/82 (4%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 453
            ++T + +    +       L+N+  L EL+L+ + ++  +  ++ L  +  ++L  N  
Sbjct: 88  VKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISD-ISPLANLTKMYSLNLGANHN 144

Query: 454 TGSLPSYMGSLPNLQELHIENN 475
             S  S + ++  L  L +  +
Sbjct: 145 L-SDLSPLSNMTGLNYLTVTES 165

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 53.7 bits (130), Expect = 1e-07
 Identities = 21/94 (22%), Positives = 39/94 (41%), Gaps = 4/94 (4%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 453
             + ++ L+  N+   I P L N+  +  L L  N     L  +S +  L  + +  +++
Sbjct: 110 TNLRELYLNEDNISD-ISP-LANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKV 167

Query: 454 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT 487
               P  + +L +L  L +  N      P A LT
Sbjct: 168 KDVTP--IANLTDLYSLSLNYNQIEDISPLASLT 199

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 53.3 bits (129), Expect = 2e-07
 Identities = 18/76 (23%), Positives = 31/76 (40%), Gaps = 3/76 (3%)

Query: 412 PELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 471
             + N+  L  L L+ N +   +  ++ L  L       N++T   P  + ++  L  L 
Sbjct: 171 TPIANLTDLYSLSLNYNQIED-ISPLASLTSLHYFTAYVNQITDITP--VANMTRLNSLK 227

Query: 472 IENNSFVGEIPPALLT 487
           I NN      P A L+
Sbjct: 228 IGNNKITDLSPLANLS 243

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 49.5 bits (119), Expect = 3e-06
 Identities = 13/80 (16%), Positives = 29/80 (36%), Gaps = 4/80 (5%)

Query: 408 GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNL 467
            +I P   ++       L    +T  +     L  +  + +   ++  S+   +  L NL
Sbjct: 13  NQIFP-DADLAEGIRAVLQKASVTDVVT-QEELESITKLVVAGEKVA-SIQG-IEYLTNL 68

Query: 468 QELHIENNSFVGEIPPALLT 487
           + L++  N      P + L 
Sbjct: 69  EYLNLNGNQITDISPLSNLV 88

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 46.4 bits (111), Expect = 3e-05
 Identities = 11/61 (18%), Positives = 24/61 (39%), Gaps = 1/61 (1%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 453
            ++  + L+   L  E    +  +  LT L+L  N +T  +  ++ L  +      N  +
Sbjct: 287 SQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD-IRPLASLSKMDSADFANQVI 345

Query: 454 T 454
            
Sbjct: 346 K 346

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 61.3 bits (149), Expect = 8e-10
 Identities = 18/105 (17%), Positives = 36/105 (34%), Gaps = 5/105 (4%)

Query: 387 TCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMS---RLIDL 443
           + S      +  + LS   +   +      +E L  L    + L   + + S    L +L
Sbjct: 366 SQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQ-MSEFSVFLSLRNL 423

Query: 444 RIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 488
             + + +     +       L +L+ L +  NSF     P + T 
Sbjct: 424 IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 468

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 56.3 bits (136), Expect = 4e-08
 Identities = 19/99 (19%), Positives = 41/99 (41%), Gaps = 7/99 (7%)

Query: 394 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLEN 450
             ++ + L+G  ++  +       + +L +L      L   L +  +  L  L+ +++ +
Sbjct: 76  SHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLAS-LENFPIGHLKTLKELNVAH 133

Query: 451 NELT-GSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 488
           N +    LP Y  +L NL+ L + +N     I    L  
Sbjct: 134 NLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRV 171

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 55.5 bits (134), Expect = 5e-08
 Identities = 18/87 (20%), Positives = 41/87 (47%), Gaps = 4/87 (4%)

Query: 394 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 451
             +  + ++G + +    P+    +  LT L L    L    P   + L  L+++++ +N
Sbjct: 445 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASN 504

Query: 452 ELTGSLPSYM-GSLPNLQELHIENNSF 477
           +L  S+P  +   L +LQ++ +  N +
Sbjct: 505 QLK-SVPDGIFDRLTSLQKIWLHTNPW 530

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 53.6 bits (129), Expect = 2e-07
 Identities = 17/89 (19%), Positives = 28/89 (31%), Gaps = 5/89 (5%)

Query: 401 LSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENNELTGSLPS 459
               N   +IP  L    +   L L  N L            +L+++ L   E+      
Sbjct: 14  CMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG 70

Query: 460 YMGSLPNLQELHIENNSFVGEIPPALLTG 488
              SL +L  L +  N     +     +G
Sbjct: 71  AYQSLSHLSTLILTGNPIQ-SLALGAFSG 98

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 52.0 bits (125), Expect = 6e-07
 Identities = 16/99 (16%), Positives = 30/99 (30%), Gaps = 6/99 (6%)

Query: 393 PPRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDMS--RLIDLRIVHLE 449
           P     + LS   L+  +      +   L  L L    +   + D +   L  L  + L 
Sbjct: 27  PFSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQT-IEDGAYQSLSHLSTLILT 84

Query: 450 NNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 488
            N +          L +LQ+L     +    +    +  
Sbjct: 85  GNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGH 122

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 50.5 bits (121), Expect = 2e-06
 Identities = 19/101 (18%), Positives = 37/101 (36%), Gaps = 7/101 (6%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLT-GPLPD-MSRLIDLRIVHLENN 451
             + K+     NL       + +++ L EL +  N +    LP+  S L +L  + L +N
Sbjct: 100 SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 159

Query: 452 ELTGSLPSYMGSLPNLQ----ELHIENNSFVGEIPPALLTG 488
           ++     + +  L  +      L +  N     I P     
Sbjct: 160 KIQSIYCTDLRVLHQMPLLNLSLDLSLNPM-NFIQPGAFKE 199

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 49.3 bits (118), Expect = 4e-06
 Identities = 20/97 (20%), Positives = 37/97 (38%), Gaps = 3/97 (3%)

Query: 394 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 451
           P +  + LS   ++  I     +++  L+ L L GN +        S L  L+ +     
Sbjct: 52  PELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVET 110

Query: 452 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 488
            L       +G L  L+EL++ +N       P   + 
Sbjct: 111 NLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 47.8 bits (114), Expect = 1e-05
 Identities = 16/95 (16%), Positives = 37/95 (38%), Gaps = 7/95 (7%)

Query: 393 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMS--RLIDLRIVHLE 449
              + ++  +  N  G    E+ ++ +L  L L  N L+       S      L+ + L 
Sbjct: 324 LKSLKRLTFTS-NKGGNAFSEV-DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLS 381

Query: 450 NNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPA 484
            N +  ++ S    L  L+ L  ++++   ++   
Sbjct: 382 FNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEF 414

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 46.6 bits (111), Expect = 3e-05
 Identities = 21/99 (21%), Positives = 33/99 (33%), Gaps = 6/99 (6%)

Query: 394 PRITKIALSGKNL--KGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENN 451
           P +  + LS   L  KG          +L  L L  N +     +   L  L  +  +++
Sbjct: 347 PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHS 406

Query: 452 ELTGSLP--SYMGSLPNLQELHIENNSFVGEIPPALLTG 488
            L   +   S   SL NL  L I +          +  G
Sbjct: 407 NLK-QMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNG 443

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 60.8 bits (148), Expect = 1e-09
 Identities = 28/93 (30%), Positives = 47/93 (50%), Gaps = 8/93 (8%)

Query: 393 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 452
           PP +  + +S   L+ ++P EL+N   L  + +D N L   LPD+     L  +   NN+
Sbjct: 130 PPLLEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLKK-LPDL--PPSLEFIAAGNNQ 184

Query: 453 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 485
           L   LP  + +LP L  ++ +NNS   ++P   
Sbjct: 185 LE-ELPE-LQNLPFLTAIYADNNSLK-KLPDLP 214

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 56.2 bits (136), Expect = 3e-08
 Identities = 29/99 (29%), Positives = 40/99 (40%), Gaps = 10/99 (10%)

Query: 390 TTTPPRI---TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIV 446
              P        I      L  E  PEL+N+  LT ++ D N L   LPD+     L  +
Sbjct: 208 KKLPDLPLSLESIVAGNNIL--EELPELQNLPFLTTIYADNNLLKT-LPDL--PPSLEAL 262

Query: 447 HLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 485
           ++ +N LT  LP    SL  L       +    E+PP L
Sbjct: 263 NVRDNYLT-DLPELPQSLTFLDVSENIFSGLS-ELPPNL 299

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 54.2 bits (131), Expect = 1e-07
 Identities = 22/96 (22%), Positives = 36/96 (37%), Gaps = 12/96 (12%)

Query: 390 TTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLE 449
           +  PP +  +  S   ++  +     +   L EL +  N L   LP +     L  +   
Sbjct: 293 SELPPNLYYLNASSNEIR-SLCDLPPS---LEELNVSNNKLIE-LPAL--PPRLERLIAS 345

Query: 450 NNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 485
            N L   +P       NL++LH+E N    E P   
Sbjct: 346 FNHLA-EVPE---LPQNLKQLHVEYNPLR-EFPDIP 376

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 50.4 bits (121), Expect = 2e-06
 Identities = 26/110 (23%), Positives = 42/110 (38%), Gaps = 25/110 (22%)

Query: 392 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENN 451
            PP + ++ +S   L  E+P        L  L    N L   +P++    +L+ +H+E N
Sbjct: 315 LPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLAE-VPEL--PQNLKQLHVEYN 367

Query: 452 ELTGSLPSYMGSL----------------PNLQELHIENNSFVGEIPPAL 485
            L    P    S+                 NL++LH+E N    E P   
Sbjct: 368 PLR-EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPDIP 415

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 50.0 bits (120), Expect = 3e-06
 Identities = 26/99 (26%), Positives = 39/99 (39%), Gaps = 20/99 (20%)

Query: 401 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP---------DMSRLID-----LRIV 446
               NL  E+P E +N+++ TE +   +      P          +SRL D        +
Sbjct: 18  RHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHEL 76

Query: 447 HLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 485
            L N  L+ SLP      P+L+ L    NS   E+P   
Sbjct: 77  ELNNLGLS-SLPE---LPPHLESLVASCNSLT-ELPELP 110

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 47.3 bits (113), Expect = 2e-05
 Identities = 21/105 (20%), Positives = 33/105 (31%), Gaps = 18/105 (17%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEA-------------LTELWLDGNFLTGPLPDMSRL 440
              T+   +    +   PP                      EL L+   L+  LP+    
Sbjct: 34  KSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLPE--LP 90

Query: 441 IDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 485
             L  +    N LT  LP    SL +L   +    +   ++PP L
Sbjct: 91  PHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKAL-SDLPPLL 133

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 46.1 bits (110), Expect = 4e-05
 Identities = 16/88 (18%), Positives = 32/88 (36%), Gaps = 9/88 (10%)

Query: 390 TTTPPRITKI-ALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVH 447
              P     +  L   +   E+P   +N   L +L ++ N L    PD    + DLR   
Sbjct: 370 REFPDIPESVEDLRMNSHLAEVPELPQN---LKQLHVETNPLRE-FPDIPESVEDLR--- 422

Query: 448 LENNELTGSLPSYMGSLPNLQELHIENN 475
           + +  +         +   L++   E++
Sbjct: 423 MNSERVVDPYEFAHETTDKLEDDVFEHH 450

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 45.8 bits (109), Expect = 5e-05
 Identities = 26/129 (20%), Positives = 49/129 (37%), Gaps = 28/129 (21%)

Query: 392 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRI----- 445
            PPR+ ++  S  +L  E+P   +N   L +L ++ N L    PD    + DLR+     
Sbjct: 335 LPPRLERLIASFNHLA-EVPELPQN---LKQLHVEYNPLRE-FPDIPESVEDLRMNSHLA 389

Query: 446 -----------VHLENNELTGSLPSYMGSLPNLQELHIENNSFVG--EIPPALLTGKVIF 492
                      +H+E N L    P       ++++L + +   V   E            
Sbjct: 390 EVPELPQNLKQLHVETNPLR-EFPD---IPESVEDLRMNSERVVDPYEFAHETTDKLEDD 445

Query: 493 KYDNNPKLH 501
            ++++   H
Sbjct: 446 VFEHHHHHH 454

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 60.4 bits (147), Expect = 1e-09
 Identities = 15/104 (14%), Positives = 42/104 (40%), Gaps = 6/104 (5%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 453
             +T + L   N+    P  + ++  L  L+   N ++  +  ++ L ++  +   +N++
Sbjct: 309 KNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD-VSSLANLTNINWLSAGHNQI 365

Query: 454 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNN 497
           +   P  + +L  + +L + + ++    P        I     N
Sbjct: 366 SDLTP--LANLTRITQLGLNDQAWTN-APVNYKANVSIPNTVKN 406

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 59.2 bits (144), Expect = 4e-09
 Identities = 22/89 (24%), Positives = 39/89 (43%), Gaps = 5/89 (5%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 453
             + +++L+G  LK      L ++  LT+L L  N ++  L  +S L  L  + L  N++
Sbjct: 221 TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN-LAPLSGLTKLTELKLGANQI 277

Query: 454 TGSLPSYMGSLPNLQELHIENNSFVGEIP 482
           +   P  +  L  L  L +  N      P
Sbjct: 278 SNISP--LAGLTALTNLELNENQLEDISP 304

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 57.7 bits (140), Expect = 1e-08
 Identities = 24/94 (25%), Positives = 41/94 (43%), Gaps = 5/94 (5%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 453
             +T + L+   +    P  L  +  LTEL L  N ++  +  ++ L  L  + L  N+L
Sbjct: 243 TNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN-ISPLAGLTALTNLELNENQL 299

Query: 454 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT 487
                S + +L NL  L +  N+     P + LT
Sbjct: 300 ED--ISPISNLKNLTYLTLYFNNISDISPVSSLT 331

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 56.9 bits (138), Expect = 2e-08
 Identities = 24/82 (29%), Positives = 38/82 (46%), Gaps = 5/82 (6%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 453
            ++T++ L    +    P  L  + ALT L L+ N L   +  +S L +L  + L  N +
Sbjct: 265 TKLTELKLGANQISNISP--LAGLTALTNLELNENQLED-ISPISNLKNLTYLTLYFNNI 321

Query: 454 TGSLPSYMGSLPNLQELHIENN 475
           +   P  + SL  LQ L   NN
Sbjct: 322 SDISP--VSSLTKLQRLFFYNN 341

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 56.5 bits (137), Expect = 3e-08
 Identities = 20/94 (21%), Positives = 37/94 (39%), Gaps = 5/94 (5%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 453
             + ++ +S   +       L  +  L  L    N ++  +  +  L +L  + L  N+L
Sbjct: 177 TTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISD-ITPLGILTNLDELSLNGNQL 233

Query: 454 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT 487
                  + SL NL +L + NN      P + LT
Sbjct: 234 KD--IGTLASLTNLTDLDLANNQISNLAPLSGLT 265

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 55.7 bits (135), Expect = 4e-08
 Identities = 20/94 (21%), Positives = 39/94 (41%), Gaps = 5/94 (5%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 453
            ++T +      +K      ++ +  LT++    N LT  +  +  L  L  + + NN++
Sbjct: 46  DQVTTLQADRLGIK--SIDGVEYLNNLTQINFSNNQLTD-ITPLKNLTKLVDILMNNNQI 102

Query: 454 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT 487
                + + +L NL  L + NN      P   LT
Sbjct: 103 AD--ITPLANLTNLTGLTLFNNQITDIDPLKNLT 134

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 53.0 bits (128), Expect = 3e-07
 Identities = 21/89 (23%), Positives = 37/89 (41%), Gaps = 5/89 (5%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 453
             +  +  +   +    P  L  +  L EL L+GN L   +  ++ L +L  + L NN++
Sbjct: 199 TNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-IGTLASLTNLTDLDLANNQI 255

Query: 454 TGSLPSYMGSLPNLQELHIENNSFVGEIP 482
           +   P  +  L  L EL +  N      P
Sbjct: 256 SNLAP--LSGLTKLTELKLGANQISNISP 282

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 52.3 bits (126), Expect = 5e-07
 Identities = 21/92 (22%), Positives = 39/92 (42%), Gaps = 5/92 (5%)

Query: 396 ITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTG 455
             K  L   N+   +     +++ +T L  D   +   +  +  L +L  ++  NN+LT 
Sbjct: 26  KMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-IDGVEYLNNLTQINFSNNQLTD 82

Query: 456 SLPSYMGSLPNLQELHIENNSFVGEIPPALLT 487
             P  + +L  L ++ + NN      P A LT
Sbjct: 83  ITP--LKNLTKLVDILMNNNQIADITPLANLT 112

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 51.9 bits (125), Expect = 6e-07
 Identities = 26/102 (25%), Positives = 48/102 (47%), Gaps = 5/102 (4%)

Query: 396 ITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTG 455
           +T+I  S   L   I P LKN+  L ++ ++ N +   +  ++ L +L  + L NN++T 
Sbjct: 70  LTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIAD-ITPLANLTNLTGLTLFNNQITD 126

Query: 456 SLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNN 497
             P  + +L NL  L + +N+       + LT      + N 
Sbjct: 127 IDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQ 166

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 51.1 bits (123), Expect = 1e-06
 Identities = 19/94 (20%), Positives = 37/94 (39%), Gaps = 6/94 (6%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 453
             + ++ LS   +       L  + +L +L          L  ++ L  L  + + +N++
Sbjct: 134 TNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQVTD--LKPLANLTTLERLDISSNKV 189

Query: 454 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT 487
           +    S +  L NL+ L   NN      P  +LT
Sbjct: 190 SD--ISVLAKLTNLESLIATNNQISDITPLGILT 221

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 43.8 bits (104), Expect = 2e-04
 Identities = 14/107 (13%), Positives = 31/107 (28%), Gaps = 10/107 (9%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 453
             I  ++     +    P  L N+  +T+L L+    T    +    + +          
Sbjct: 353 TNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGA 410

Query: 454 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKL 500
               P+ +    +  E  I  N           T +V + +     +
Sbjct: 411 L-IAPATISDGGSYTEPDITWNL-------PSYTNEVSYTFSQPVTI 449

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 59.2 bits (144), Expect = 2e-09
 Identities = 23/112 (20%), Positives = 46/112 (41%), Gaps = 9/112 (8%)

Query: 392 TPPRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHL 448
            PP +T++ L G  +  ++    LK +  L +L L  N ++  + +  ++    LR +HL
Sbjct: 190 LPPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISA-VDNGSLANTPHLRELHL 247

Query: 449 ENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKL 500
            NN+L   +P  +     +Q +++ NN+    I                   
Sbjct: 248 NNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYN--TKKASY 295

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 59.2 bits (144), Expect = 2e-09
 Identities = 25/98 (25%), Positives = 41/98 (41%), Gaps = 7/98 (7%)

Query: 393 PPRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLEN 450
           PP    + L    +  EI     KN++ L  L L  N ++   P   + L+ L  ++L  
Sbjct: 51  PPDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 109

Query: 451 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 488
           N+L   LP        LQEL +  N    ++  ++  G
Sbjct: 110 NQLK-ELPE--KMPKTLQELRVHENEIT-KVRKSVFNG 143

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 55.8 bits (135), Expect = 2e-08
 Identities = 17/101 (16%), Positives = 41/101 (40%), Gaps = 9/101 (8%)

Query: 392 TPPRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLT-GPLPDM--SRLIDLRIVH 447
            P  + ++ +    +  ++       +  +  + L  N L    + +     +  L  + 
Sbjct: 119 MPKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIR 177

Query: 448 LENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 488
           + +  +T ++P   G  P+L ELH++ N    ++  A L G
Sbjct: 178 IADTNIT-TIPQ--GLPPSLTELHLDGNKI-TKVDAASLKG 214

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 54.2 bits (131), Expect = 9e-08
 Identities = 12/91 (13%), Positives = 33/91 (36%), Gaps = 10/91 (10%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLT-------GPLPDMSRLIDLRIV 446
           P + ++ L+   L  ++P  L + + +  ++L  N ++        P    ++      V
Sbjct: 240 PHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGV 298

Query: 447 HLENNELT-GSLPSYM-GSLPNLQELHIENN 475
            L +N +    +       +     + + N 
Sbjct: 299 SLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 51.5 bits (124), Expect = 6e-07
 Identities = 21/103 (20%), Positives = 40/103 (38%), Gaps = 9/103 (8%)

Query: 394 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 452
             + K+ LS  ++   +    L N   L EL L+ N L      ++    +++V+L NN 
Sbjct: 216 NNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNN 274

Query: 453 LTG------SLPSYMGSLPNLQELHIENNSF-VGEIPPALLTG 488
           ++         P Y     +   + + +N     EI P+    
Sbjct: 275 ISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRC 317

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 58.5 bits (142), Expect = 3e-09
 Identities = 22/98 (22%), Positives = 42/98 (42%), Gaps = 7/98 (7%)

Query: 393 PPRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLEN 450
            P  T + L   ++  E+  +  K ++ L  L L  N ++       S L  L+ +++  
Sbjct: 53  SPDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISK 111

Query: 451 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 488
           N L   +P       +L EL I +N    ++P  + +G
Sbjct: 112 NHLV-EIPP--NLPSSLVELRIHDNRIR-KVPKGVFSG 145

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 55.0 bits (133), Expect = 4e-08
 Identities = 14/91 (15%), Positives = 32/91 (35%), Gaps = 10/91 (10%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLT-------GPLPDMSRLIDLRIV 446
           P + ++ L    L   +P  L +++ L  ++L  N +T        P+    +      +
Sbjct: 241 PTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGI 299

Query: 447 HLENNELT-GSLPSYM-GSLPNLQELHIENN 475
            L NN +    +       + +   +   N 
Sbjct: 300 SLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 50.0 bits (120), Expect = 2e-06
 Identities = 28/87 (32%), Positives = 42/87 (48%), Gaps = 7/87 (8%)

Query: 401 LSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENNELTGSLPS 459
           +S   L   IP +L   E L EL LD N +    L D+ R   L  + L +N++   + +
Sbjct: 179 ISEAKLT-GIPKDL--PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIR-MIEN 234

Query: 460 YM-GSLPNLQELHIENNSFVGEIPPAL 485
                LP L+ELH++NN     +P  L
Sbjct: 235 GSLSFLPTLRELHLDNNKLS-RVPAGL 260

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 46.9 bits (112), Expect = 1e-05
 Identities = 16/98 (16%), Positives = 34/98 (34%), Gaps = 7/98 (7%)

Query: 394 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 452
             +  + L   N   +I  +    +  L +L++  N L   +P       L  + + +N 
Sbjct: 78  QHLYALVLVN-NKISKIHEKAFSPLRKLQKLYISKNHLVE-IPPNL-PSSLVELRIHDNR 134

Query: 453 LTGSLPSYM-GSLPNLQELHIENNSF-VGEIPPALLTG 488
           +   +P  +   L N+  + +  N        P    G
Sbjct: 135 IR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDG 171

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 57.3 bits (139), Expect = 7e-09
 Identities = 15/88 (17%), Positives = 29/88 (32%), Gaps = 3/88 (3%)

Query: 401 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 460
           L    +  ++  ++     L  L L  N L    P+      +  + L NN+L   +   
Sbjct: 176 LQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKA 232

Query: 461 MGSLPNLQELHIENNSFVGEIPPALLTG 488
           +    NL+   +  N F         + 
Sbjct: 233 LRFSQNLEHFDLRGNGFHCGTLRDFFSK 260

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 53.1 bits (128), Expect = 2e-07
 Identities = 15/93 (16%), Positives = 35/93 (37%), Gaps = 8/93 (8%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENN 451
           P I  +  +  N+   +       +    ++L  N +T  L D        ++ + L+ N
Sbjct: 99  PSIETLHAANNNIS-RVSCS--RGQGKKNIYLANNKITM-LRDLDEGCRSRVQYLDLKLN 154

Query: 452 ELTG-SLPSYMGSLPNLQELHIENNSFVGEIPP 483
           E+   +      S   L+ L+++ N    ++  
Sbjct: 155 EIDTVNFAELAASSDTLEHLNLQYNFIY-DVKG 186

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 52.7 bits (127), Expect = 2e-07
 Identities = 21/91 (23%), Positives = 39/91 (42%), Gaps = 4/91 (4%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENNE 452
            R     ++  +LK  +    ++   + EL L GN L+     D++    L +++L +N 
Sbjct: 10  NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69

Query: 453 LTGSLPSYMGSLPNLQELHIENNSFVGEIPP 483
           L       + SL  L+ L + NN    E+  
Sbjct: 70  LY-ETLD-LESLSTLRTLDLNNNYV-QELLV 97

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 49.2 bits (118), Expect = 3e-06
 Identities = 16/77 (20%), Positives = 30/77 (38%), Gaps = 3/77 (3%)

Query: 413 ELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 472
           EL    ++  L    N ++  +   SR    + ++L NN++T       G    +Q L +
Sbjct: 94  ELLVGPSIETLHAANNNISR-VSC-SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDL 151

Query: 473 ENNSFVGEIPPALLTGK 489
           + N     +  A L   
Sbjct: 152 KLNEID-TVNFAELAAS 167

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 49.2 bits (118), Expect = 3e-06
 Identities = 11/75 (14%), Positives = 26/75 (34%), Gaps = 2/75 (2%)

Query: 410 IPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPSYMGSLPNLQ 468
           I    +N        +  + L   L  +     +++ + L  N L+    + +     L+
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 469 ELHIENNSFVGEIPP 483
            L++ +N    E   
Sbjct: 62  LLNLSSNVLY-ETLD 75

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 55.4 bits (134), Expect = 9e-09
 Identities = 14/71 (19%), Positives = 35/71 (49%), Gaps = 1/71 (1%)

Query: 414 LKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 472
           +  +  L  L + G  +T   +P++S L  L ++ + ++    S+ + + +LP +  + +
Sbjct: 84  ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDL 143

Query: 473 ENNSFVGEIPP 483
             N  + +I P
Sbjct: 144 SYNGAITDIMP 154

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 51.9 bits (125), Expect = 1e-07
 Identities = 15/90 (16%), Positives = 38/90 (42%), Gaps = 3/90 (3%)

Query: 396 ITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTG 455
           +T I L+  N+  ++   ++    + +L ++    T     +S L +L  + +   ++T 
Sbjct: 46  LTYITLANINVT-DLTG-IEYAHNIKDLTINNIHATN-YNPISGLSNLERLRIMGKDVTS 102

Query: 456 SLPSYMGSLPNLQELHIENNSFVGEIPPAL 485
                +  L +L  L I +++    I   +
Sbjct: 103 DKIPNLSGLTSLTLLDISHSAHDDSILTKI 132

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 51.1 bits (123), Expect = 2e-07
 Identities = 10/82 (12%), Positives = 32/82 (39%), Gaps = 2/82 (2%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 453
             +T + +S       I  ++  +  +  + L  N     +  +  L +L+ ++++ + +
Sbjct: 112 TSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGV 171

Query: 454 TGSLPSYMGSLPNLQELHIENN 475
                  +   P L +L+  + 
Sbjct: 172 HDY--RGIEDFPKLNQLYAFSQ 191

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 58.2 bits (141), Expect = 9e-09
 Identities = 21/86 (24%), Positives = 35/86 (40%), Gaps = 5/86 (5%)

Query: 393 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 452
           P  +  + +S  NL       L     L EL++  N L   LPD S    L ++ +  N+
Sbjct: 430 PQTLEVLDVSNNNLD-SFSLFLPR---LQELYISRNKLKT-LPDASLFPVLLVMKISRNQ 484

Query: 453 LTGSLPSYMGSLPNLQELHIENNSFV 478
           L          L +LQ++ +  N + 
Sbjct: 485 LKSVPDGIFDRLTSLQKIWLHTNPWD 510

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 55.5 bits (134), Expect = 5e-08
 Identities = 22/154 (14%), Positives = 47/154 (30%), Gaps = 4/154 (2%)

Query: 394 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENN 451
             +  + +       EI       + +L EL +    L       +  + D+  + L  +
Sbjct: 123 TNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLS 182

Query: 452 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFK 511
           E    L  +   L +++ L + + +       + L    +                  F 
Sbjct: 183 ESAFLLEIFADILSSVRYLELRDTNL-ARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFN 241

Query: 512 LILGTSIGVLAILLVLFL-CSLIVLRKLRRKISN 544
            +L     +L +  V F  C+L  L       S+
Sbjct: 242 ELLKLLRYILELSEVEFDDCTLNGLGDFNPSESD 275

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 52.8 bits (127), Expect = 4e-07
 Identities = 21/100 (21%), Positives = 37/100 (37%), Gaps = 7/100 (7%)

Query: 393 PPRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLE 449
              +  + LS   +   I    L+    L  L L  + +   +       L  L  + L 
Sbjct: 25  TAAMKSLDLSFNKIT-YIGHGDLRACANLQVLILKSSRINT-IEGDAFYSLGSLEHLDLS 82

Query: 450 NNELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 488
           +N L+ SL S   G L +L+ L++  N +      +L   
Sbjct: 83  DNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPN 121

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 48.6 bits (116), Expect = 8e-06
 Identities = 11/98 (11%), Positives = 29/98 (29%), Gaps = 4/98 (4%)

Query: 394 PRITKIALSGKNLKG-EIPPELKNMEALTELWLDGNFLTGPLP--DMSRLIDLRIVHLEN 450
             +  + L G   +   +     N+  L  L +        +   D + L  L  + ++ 
Sbjct: 98  SSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKA 157

Query: 451 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 488
             L       + S+ ++  L +  +     +       
Sbjct: 158 LSLRNYQSQSLKSIRDIHHLTLHLSES-AFLLEIFADI 194

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 48.2 bits (115), Expect = 9e-06
 Identities = 16/101 (15%), Positives = 35/101 (34%), Gaps = 6/101 (5%)

Query: 387 TCSTTTPPRITKIALSGKNLK--GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLR 444
           +      P +  + LS  +L+   +    L  ++ LT L +  N              +R
Sbjct: 354 SACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMR 413

Query: 445 IVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 485
            ++L +  +   + +       L+ L + NN+        L
Sbjct: 414 FLNLSSTGIR-VVKT--CIPQTLEVLDVSNNNL-DSFSLFL 450

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 47.0 bits (112), Expect = 2e-05
 Identities = 20/100 (20%), Positives = 39/100 (39%), Gaps = 11/100 (11%)

Query: 394 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDMSRLID----LRIVHL 448
            ++ +I +    +   +P    +++++L  L L  N +       S        L+ + L
Sbjct: 310 EKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVL 368

Query: 449 ENNELTGSLPSYMG---SLPNLQELHIENNSFVGEIPPAL 485
             N L  S+        +L NL  L I  N+F   +P + 
Sbjct: 369 SQNHLR-SMQKTGEILLTLKNLTSLDISRNTF-HPMPDSC 406

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 56.7 bits (137), Expect = 1e-08
 Identities = 34/111 (30%), Positives = 43/111 (38%), Gaps = 11/111 (9%)

Query: 386 VTCS----TTTPPRI----TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM 437
           V C     T  PP +    T + LS   L       L     LT+L LD   LT  L   
Sbjct: 15  VNCDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQVD 73

Query: 438 SRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 488
             L  L  + L +N+L  SLP    +LP L  L +  N     +P   L G
Sbjct: 74  GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRG 122

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 44.7 bits (106), Expect = 7e-05
 Identities = 27/86 (31%), Positives = 41/86 (47%), Gaps = 7/86 (8%)

Query: 394 PRITKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLEN 450
           P +T + +S   L   +P    + +  L EL+L GN L   LP   ++    L  + L N
Sbjct: 100 PALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKT-LPPGLLTPTPKLEKLSLAN 157

Query: 451 NELTGSLPSYM-GSLPNLQELHIENN 475
           N LT  LP+ +   L NL  L ++ N
Sbjct: 158 NNLT-ELPAGLLNGLENLDTLLLQEN 182

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 58.3 bits (140), Expect = 1e-08
 Identities = 113/703 (16%), Positives = 199/703 (28%), Gaps = 202/703 (28%)

Query: 56  DLPIDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLWSTVTVLDASR 115
           D      +Y Y  I            F+            F    D        V D  +
Sbjct: 8   DFETGEHQYQYKDILS---------VFE----------DAFVDNFDCK-----DVQDMPK 43

Query: 116 -VYAKE---MIIRAPSDSIDVCICCAVTGSPFI-STLELRPLNLSMYATDFEDNFFLKVA 170
            + +KE    II +            V+G+  +  TL  +     M         F++  
Sbjct: 44  SILSKEEIDHIIMSKDA---------VSGTLRLFWTLLSKQEE--MVQK------FVEEV 86

Query: 171 ARVNFGALTKDALRY-PDDPYD--RIWDSDLDRRPNFVVGAASGTV-RINTTKNIETRTR 226
            R+N+  L    ++     P    R++    DR  N     A   V R+     +     
Sbjct: 87  LRINYKFLM-SPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALL 145

Query: 227 EYPPVKVMQTAVVGTEG----VL------SYRLNLEDFPANARAFAYF--------AEIQ 268
           E  P K +   + G  G     +      SY++           F  F        +   
Sbjct: 146 ELRPAKNV--LIDGVLGSGKTWVALDVCLSYKV-QCKMD-----FKIFWLNLKNCNSPET 197

Query: 269 DLGPSETRKFKLEQPYFADYSNAVVNIAENANG-----SYTLYEPSYMNVTLNFVL---- 319
            L   +   ++++  +    S+   NI    +         L    Y N  L  VL    
Sbjct: 198 VLEMLQKLLYQIDPNW-TSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLL--VLLNVQ 254

Query: 320 ------SFSF-----VKTRDSTLGPLLNAIEISKYQKIAAKTEWQDVMVLEALRSISDES 368
                 +F+      + TR   +    + +  +    I+             L    DE 
Sbjct: 255 NAKAWNAFNLSCKILLTTRFKQV---TDFLSAATTTHISL------DHHSMTLTP--DEV 303

Query: 369 ERTNDRGDPCVPVPWEWVTCSTTT-PPRITKI---ALSGKNLKGEIPPELKNMEALTELW 424
           +           +  +++ C     P  +       LS       I   +++  A  + W
Sbjct: 304 KS----------LLLKYLDCRPQDLPREVLTTNPRRLSI------IAESIRDGLATWDNW 347

Query: 425 LDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI-ENNSFVGEIPP 483
              N        ++ +I+  +  LE  E                 L +   ++    IP 
Sbjct: 348 KHVNC-----DKLTTIIESSLNVLEPAEYR----------KMFDRLSVFPPSA---HIPT 389

Query: 484 ALLTGKVIFKYDNNP--------KLHKES---RRRMRFKLILGTSIGVLAILLVLFLCSL 532
            LL    +  +D           KLHK S   ++          +I + +I L L    L
Sbjct: 390 ILL---SLIWFDVIKSDVMVVVNKLHKYSLVEKQPKES------TISIPSIYLEL-KVKL 439

Query: 533 IVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATN 592
                L R I +  +  K         P    Y  +  GH +           E  E   
Sbjct: 440 ENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNI--------EHPERMT 491

Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 652
            F           V+     D + +  KI  DS +      +     L ++  +   P I
Sbjct: 492 LFRM---------VFL----DFRFLEQKIRHDSTAWNASGSILN--TLQQL--KFYKPYI 534

Query: 653 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA 695
              + +++R LV   +    L       +  K  D    L+IA
Sbjct: 535 CDNDPKYER-LVNAILDF--LPKIEENLICSKYTDL---LRIA 571

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 49.9 bits (118), Expect = 4e-06
 Identities = 50/319 (15%), Positives = 88/319 (27%), Gaps = 101/319 (31%)

Query: 621 IMADSCSHRTQQFVTEVA------LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLR 674
            +        Q+FV EV       L+S I      P +            Y        R
Sbjct: 70  TLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRM--------YIEQ-----R 116

Query: 675 DRLHGSVNQKPLDWLTRLQIAHDAAKGLE--------YLH--TGCNPGIIHRDVKSS--- 721
           DRL+          ++RLQ      + L          +    G   G      K+    
Sbjct: 117 DRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGS--G------KTWVAL 168

Query: 722 NILLDINMRAKVSD------FGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSD 775
           ++ L   ++ K+               E  L  +  +       +DP +      T +SD
Sbjct: 169 DVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLY----QIDPNW------TSRSD 218

Query: 776 VYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS--IVDPVLIGNVKIES 833
                       S    + +    AEL      R +  K       ++      NV+   
Sbjct: 219 -----------HSSNIKLRIHSIQAELR-----RLLKSKPYENCLLVLL-----NVQNAK 257

Query: 834 IWRIAEVAIQCVEQRGFSRPKMQEIVL----AIQDSIKIEKGGD---QKFSSSSSKGQSS 886
            W      + C         K+  ++      + D +             S + +  +  
Sbjct: 258 AWN--AFNLSC---------KI--LLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEV- 303

Query: 887 RKTLLTSFLEIESPDLSNE 905
            K+LL  +L+    DL  E
Sbjct: 304 -KSLLLKYLDCRPQDLPRE 321

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 57.1 bits (137), Expect = 2e-08
 Identities = 22/84 (26%), Positives = 37/84 (44%), Gaps = 5/84 (5%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 453
             +T + LS   L+  +PP L  +  L  L    N L   +  ++ L  L+ + L NN L
Sbjct: 463 LLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VDGVANLPRLQELLLCNNRL 520

Query: 454 TGSLPS--YMGSLPNLQELHIENN 475
                +   + S P L  L+++ N
Sbjct: 521 Q-QSAAIQPLVSCPRLVLLNLQGN 543

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 53.6 bits (128), Expect = 2e-07
 Identities = 22/87 (25%), Positives = 40/87 (45%), Gaps = 4/87 (4%)

Query: 389 STTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHL 448
                  +  + L+ K+L   +   L+ +  +T L L  N L    P ++ L  L ++  
Sbjct: 436 LKMEYADVRVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQA 493

Query: 449 ENNELTGSLPSYMGSLPNLQELHIENN 475
            +N L  ++   + +LP LQEL + NN
Sbjct: 494 SDNALE-NVDG-VANLPRLQELLLCNN 518

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 42.8 bits (100), Expect = 4e-04
 Identities = 13/65 (20%), Positives = 24/65 (36%), Gaps = 7/65 (10%)

Query: 412 PELKNMEALTELWLDGNFLTGP--LPDMSRLIDLRIVHLENNELTGSLPSY----MGSLP 465
             + N+  L EL L  N L     +  +     L +++L+ N L              LP
Sbjct: 502 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEMLP 560

Query: 466 NLQEL 470
           ++  +
Sbjct: 561 SVSSI 565

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 56.7 bits (137), Expect = 2e-08
 Identities = 17/97 (17%), Positives = 36/97 (37%), Gaps = 5/97 (5%)

Query: 394 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 452
           P + ++ L        I     + +  L  L L    +   +P+++ L+ L  + +  N 
Sbjct: 171 PSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MPNLTPLVGLEELEMSGNH 229

Query: 453 LTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 488
               +       L +L++L + N+  V  I      G
Sbjct: 230 FP-EIRPGSFHGLSSLKKLWVMNSQ-VSLIERNAFDG 264

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 52.8 bits (127), Expect = 3e-07
 Identities = 23/98 (23%), Positives = 39/98 (39%), Gaps = 5/98 (5%)

Query: 394 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 451
             +  + L   +++ +I       + +L  L L  N+LT         L  LR + L NN
Sbjct: 99  HHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNN 157

Query: 452 ELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 488
            +  S+PSY    +P+L  L +     +  I      G
Sbjct: 158 PIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEG 194

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 49.0 bits (117), Expect = 5e-06
 Identities = 21/91 (23%), Positives = 43/91 (47%), Gaps = 11/91 (12%)

Query: 394 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLT----GPLPDMSRLIDLRIVHL 448
             + ++ +SG +   EI P     + +L +LW+  + ++         ++ L     ++L
Sbjct: 218 VGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASL---VELNL 273

Query: 449 ENNELTGSLPSYM-GSLPNLQELHIENNSFV 478
            +N L+ SLP  +   L  L ELH+ +N + 
Sbjct: 274 AHNNLS-SLPHDLFTPLRYLVELHLHHNPWN 303

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 47.4 bits (113), Expect = 1e-05
 Identities = 19/79 (24%), Positives = 35/79 (44%), Gaps = 4/79 (5%)

Query: 412 PELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPSYM-GSLPNLQE 469
           P L  +  L EL + GN      P     L  L+ + + N++++  +       L +L E
Sbjct: 212 PNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVE 270

Query: 470 LHIENNSFVGEIPPALLTG 488
           L++ +N+    +P  L T 
Sbjct: 271 LNLAHNNLS-SLPHDLFTP 288

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 56.3 bits (136), Expect = 2e-08
 Identities = 19/97 (19%), Positives = 36/97 (37%), Gaps = 5/97 (5%)

Query: 394 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 452
           P + ++ L        I     + +  L  L L    L   +P+++ LI L  + L  N 
Sbjct: 160 PSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IPNLTPLIKLDELDLSGNH 218

Query: 453 LTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 488
           L+ ++       L +LQ+L +  +     I       
Sbjct: 219 LS-AIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDN 253

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 51.3 bits (123), Expect = 9e-07
 Identities = 24/99 (24%), Positives = 41/99 (41%), Gaps = 7/99 (7%)

Query: 394 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLEN 450
             +  + LS  +++  I       +  L  L L  N LT  +P+     L  L+ + L N
Sbjct: 88  RHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLTT-IPNGAFVYLSKLKELWLRN 145

Query: 451 NELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 488
           N +  S+PSY    +P+L+ L +     +  I      G
Sbjct: 146 NPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEG 183

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 49.0 bits (117), Expect = 5e-06
 Identities = 21/88 (23%), Positives = 43/88 (48%), Gaps = 5/88 (5%)

Query: 394 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 451
            ++ ++ LSG +L   I P   + +  L +LW+  + +     +    L  L  ++L +N
Sbjct: 207 IKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHN 265

Query: 452 ELTGSLPSYM-GSLPNLQELHIENNSFV 478
            LT  LP  +   L +L+ +H+ +N + 
Sbjct: 266 NLT-LLPHDLFTPLHHLERIHLHHNPWN 292

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 47.4 bits (113), Expect = 2e-05
 Identities = 24/94 (25%), Positives = 38/94 (40%), Gaps = 9/94 (9%)

Query: 394 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHL-E 449
             +  + L    L   IP      +  L ELWL  N +   +P    +R+  LR + L E
Sbjct: 112 ANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIES-IPSYAFNRIPSLRRLDLGE 169

Query: 450 NNELTGSLPSYM-GSLPNLQELHIENNSFVGEIP 482
              L+  +       L NL+ L++   +   EIP
Sbjct: 170 LKRLS-YISEGAFEGLSNLRYLNLAMCNLR-EIP 201

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 47.1 bits (112), Expect = 2e-05
 Identities = 19/82 (23%), Positives = 35/82 (42%), Gaps = 10/82 (12%)

Query: 412 PELKNMEALTELWLDGNFLT----GPLPDMSRLIDLRIVHLENNELTGSLPSYM-GSLPN 466
           P L  +  L EL L GN L+    G    +  L  L    +  +++   +      +L +
Sbjct: 201 PNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKL---WMIQSQIQ-VIERNAFDNLQS 256

Query: 467 LQELHIENNSFVGEIPPALLTG 488
           L E+++ +N+    +P  L T 
Sbjct: 257 LVEINLAHNNLT-LLPHDLFTP 277

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 55.5 bits (134), Expect = 4e-08
 Identities = 25/115 (21%), Positives = 39/115 (33%), Gaps = 10/115 (8%)

Query: 393 PPRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLEN 450
              +  + LS   +   I    L+    L  L L  N +     D  S L  L  + L  
Sbjct: 51  TEAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSY 109

Query: 451 NELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPA----LLTGKVIFKYDNNPKL 500
           N L+ +L S     L +L  L++  N +   +        LT   I +  N    
Sbjct: 110 NYLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTF 162

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 47.4 bits (113), Expect = 1e-05
 Identities = 11/65 (16%), Positives = 27/65 (41%), Gaps = 2/65 (3%)

Query: 414 LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELHI 472
           L        + +    L   +  ++++  L  +    N+L  S+P  +   L +LQ++ +
Sbjct: 250 LIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWL 308

Query: 473 ENNSF 477
             N +
Sbjct: 309 HTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 46.3 bits (110), Expect = 3e-05
 Identities = 23/99 (23%), Positives = 36/99 (36%), Gaps = 6/99 (6%)

Query: 394 PRITKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLT--GPLPDMSRLIDLRIVHLEN 450
             +  + LS   L   +     K + +LT L L GN     G     S L  L+I+ + N
Sbjct: 100 GSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGN 158

Query: 451 NELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 488
            +    +       L  L+EL I+ +       P  L  
Sbjct: 159 MDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKS 196

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 55.8 bits (135), Expect = 4e-08
 Identities = 19/110 (17%), Positives = 44/110 (40%), Gaps = 8/110 (7%)

Query: 389 STTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHL 448
           S      +T +     ++  ++   ++ +  LT+L    N +T    D+S+  +L  +  
Sbjct: 37  SEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNNITT--LDLSQNTNLTYLAC 92

Query: 449 ENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNP 498
           ++N+LT +L   +  L  L  L+ + N    ++  +            N 
Sbjct: 93  DSNKLT-NLD--VTPLTKLTYLNCDTNKL-TKLDVSQNPLLTYLNCARNT 138

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 50.1 bits (120), Expect = 3e-06
 Identities = 24/107 (22%), Positives = 39/107 (36%), Gaps = 9/107 (8%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 453
             + ++     N+  ++   L     LT L    N LT    D++ L  L       N L
Sbjct: 191 KLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLTE--IDVTPLTQLTYFDCSVNPL 245

Query: 454 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKL 500
           T  L   + +L  L  LH      + EI     T  + F+ +   K+
Sbjct: 246 T-ELD--VSTLSKLTTLHCIQTDLL-EIDLTHNTQLIYFQAEGCRKI 288

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 49.7 bits (119), Expect = 3e-06
 Identities = 15/82 (18%), Positives = 30/82 (36%), Gaps = 7/82 (8%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 453
            ++T++             ++     LT L    N +T    D+S+   L  ++ + N +
Sbjct: 148 TQLTELDCHLNKKIT--KLDVTPQTQLTTLDCSFNKITE--LDVSQNKLLNRLNCDTNNI 203

Query: 454 TGSLPSYMGSLPNLQELHIENN 475
           T  L   +     L  L   +N
Sbjct: 204 T-KLD--LNQNIQLTFLDCSSN 222

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 48.5 bits (116), Expect = 7e-06
 Identities = 16/75 (21%), Positives = 28/75 (37%), Gaps = 5/75 (6%)

Query: 401 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 460
              +  +     ++ +   L  L      +T  L D+S+   L  ++L N ELT  L   
Sbjct: 280 FQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-EL-DLSQNPKLVYLYLNNTELT-ELD-- 334

Query: 461 MGSLPNLQELHIENN 475
           +     L+ L   N 
Sbjct: 335 VSHNTKLKSLSCVNA 349

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 46.2 bits (110), Expect = 3e-05
 Identities = 19/94 (20%), Positives = 34/94 (36%), Gaps = 8/94 (8%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 453
            ++  +      +  E+   L     L  L+L+   LT  L D+S    L+ +   N  +
Sbjct: 297 TQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELTE-L-DVSHNTKLKSLSCVNAHI 351

Query: 454 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT 487
                S +G +P L          +  +P   LT
Sbjct: 352 Q-DFSS-VGKIPALNNNFEAEGQTI-TMPKETLT 382

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 45.1 bits (107), Expect = 8e-05
 Identities = 19/97 (19%), Positives = 37/97 (38%), Gaps = 8/97 (8%)

Query: 391 TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLEN 450
           +T  ++T +     +L  EI   L +   L     +G      L D++    L ++  + 
Sbjct: 251 STLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRKIKEL-DVTHNTQLYLLDCQA 306

Query: 451 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT 487
             +T  L   +   P L  L++ N     E+  +  T
Sbjct: 307 AGIT-ELD--LSQNPKLVYLYLNNTELT-ELDVSHNT 339

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 42.8 bits (101), Expect = 4e-04
 Identities = 16/84 (19%), Positives = 26/84 (30%), Gaps = 7/84 (8%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 453
            ++T +      L  ++   +     LT L    N LT    D+S    L  +    N+ 
Sbjct: 106 TKLTYLNCDTNKLT-KLD--VSQNPLLTYLNCARNTLT--EIDVSHNTQLTELDCHLNKK 160

Query: 454 TGSLPSYMGSLPNLQELHIENNSF 477
              L   +     L  L    N  
Sbjct: 161 ITKLD--VTPQTQLTTLDCSFNKI 182

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 55.5 bits (134), Expect = 5e-08
 Identities = 20/99 (20%), Positives = 37/99 (37%), Gaps = 8/99 (8%)

Query: 394 PRITKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLEN 450
             +TK+ +S   +   +   + +++  L  L +  N L   +     S L  L  + LE 
Sbjct: 104 SNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLVY-ISHRAFSGLNSLEQLTLEK 161

Query: 451 NELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 488
             LT S+P+     L  L  L + + +    I       
Sbjct: 162 CNLT-SIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKR 198

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 55.1 bits (133), Expect = 6e-08
 Identities = 22/100 (22%), Positives = 40/100 (40%), Gaps = 8/100 (8%)

Query: 393 PPRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLE 449
           P     + L    +K  +  +   +   L EL L+ N ++  +     + L +LR + L 
Sbjct: 31  PTETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENIVSA-VEPGAFNNLFNLRTLGLR 88

Query: 450 NNELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 488
           +N L   +P  +   L NL +L I  N  V  +   +   
Sbjct: 89  SNRLK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQD 126

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 54.7 bits (132), Expect = 1e-07
 Identities = 18/97 (18%), Positives = 35/97 (36%), Gaps = 4/97 (4%)

Query: 394 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 451
             + ++ L   NL   IP E L ++  L  L L    +         RL  L+++ + + 
Sbjct: 152 NSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHW 210

Query: 452 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 488
               ++        NL  L I + +    +P   +  
Sbjct: 211 PYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRH 246

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 52.8 bits (127), Expect = 4e-07
 Identities = 20/91 (21%), Positives = 39/91 (42%), Gaps = 11/91 (12%)

Query: 394 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLT----GPLPDMSRLIDLRIVHL 448
             +  + LS   +   I    L  +  L E+ L G  L          ++ L   R++++
Sbjct: 248 VYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYL---RVLNV 303

Query: 449 ENNELTGSLPSYM-GSLPNLQELHIENNSFV 478
             N+LT +L   +  S+ NL+ L +++N   
Sbjct: 304 SGNQLT-TLEESVFHSVGNLETLILDSNPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 45.9 bits (109), Expect = 5e-05
 Identities = 18/98 (18%), Positives = 41/98 (41%), Gaps = 6/98 (6%)

Query: 394 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 451
             +T ++++  NL   +P   ++++  L  L L  N ++     M   L+ L+ + L   
Sbjct: 224 LNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGG 282

Query: 452 ELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 488
           +L   +  Y    L  L+ L++  N     +  ++   
Sbjct: 283 QLA-VVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHS 318

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 52.1 bits (125), Expect = 7e-08
 Identities = 22/85 (25%), Positives = 36/85 (42%), Gaps = 2/85 (2%)

Query: 392 TPPRITKIALSG-KNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLEN 450
           TP  + ++ L   K+  G+I         L  L L    L   + ++ +L  L+ + L  
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS-VSNLPKLPKLKKLELSE 80

Query: 451 NELTGSLPSYMGSLPNLQELHIENN 475
           N + G L      LPNL  L++  N
Sbjct: 81  NRIFGGLDMLAEKLPNLTHLNLSGN 105

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 54.9 bits (132), Expect = 8e-08
 Identities = 15/84 (17%), Positives = 36/84 (42%), Gaps = 4/84 (4%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 453
            R+ ++ +S   L   +    + +  L  L L  N L     +  +   L  ++L++N +
Sbjct: 278 QRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLHVERNQPQFDRLENLYLDHNSI 336

Query: 454 TGSLPSYMGSLPNLQELHIENNSF 477
             +L   + +   L+ L + +N +
Sbjct: 337 V-TLK--LSTHHTLKNLTLSHNDW 357

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 54.9 bits (132), Expect = 8e-08
 Identities = 22/99 (22%), Positives = 42/99 (42%), Gaps = 8/99 (8%)

Query: 394 PRITKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLEN 450
             I K+ +    ++  +PP + +N+  LT L L+ N L+  LP         L  + + N
Sbjct: 99  HTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSS-LPRGIFHNTPKLTTLSMSN 156

Query: 451 NELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 488
           N L   +      +  +LQ L + +N     +  +L+  
Sbjct: 157 NNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIPS 193

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 54.2 bits (130), Expect = 2e-07
 Identities = 14/100 (14%), Positives = 37/100 (37%), Gaps = 6/100 (6%)

Query: 392 TPPRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLE 449
           T      +      ++ ++P   L +   +  L L+   +        +    ++ +++ 
Sbjct: 49  TLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMG 107

Query: 450 NNELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 488
            N +   LP ++  ++P L  L +E N     +P  +   
Sbjct: 108 FNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHN 145

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 53.4 bits (128), Expect = 3e-07
 Identities = 21/99 (21%), Positives = 41/99 (41%), Gaps = 8/99 (8%)

Query: 394 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLEN 450
            ++  + L+   ++ EI          + +L++  N +   LP      +  L ++ LE 
Sbjct: 75  RQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLER 132

Query: 451 NELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 488
           N+L+ SLP  +  + P L  L + NN+    I       
Sbjct: 133 NDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQA 169

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 50.3 bits (120), Expect = 2e-06
 Identities = 21/94 (22%), Positives = 35/94 (37%), Gaps = 7/94 (7%)

Query: 393 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 452
           P  + ++  S  ++   +   +     LT L L  N LT     +     L  V L  NE
Sbjct: 210 PIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTAWLLNYPGLVEVDLSYNE 265

Query: 453 LTGSLPSYM-GSLPNLQELHIENNSFVGEIPPAL 485
           L   +  +    +  L+ L+I NN  V  +    
Sbjct: 266 LE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYG 297

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 48.8 bits (116), Expect = 7e-06
 Identities = 20/87 (22%), Positives = 35/87 (40%), Gaps = 8/87 (9%)

Query: 394 PRITKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLEN 450
           P +T + L   +L   +P  +  N   LT L +  N L   + D        L+ + L +
Sbjct: 123 PLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSS 180

Query: 451 NELTGSLPSYMGSLPNLQELHIENNSF 477
           N LT  +      +P+L   ++  N  
Sbjct: 181 NRLT-HVDL--SLIPSLFHANVSYNLL 204

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 47.6 bits (113), Expect = 2e-05
 Identities = 19/98 (19%), Positives = 35/98 (35%), Gaps = 10/98 (10%)

Query: 391 TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLEN 450
           +  P +    +S   L       L    A+ EL    N +   +      ++L I+ L++
Sbjct: 189 SLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINV-VRGPV-NVELTILKLQH 241

Query: 451 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 488
           N LT      + + P L E+ +  N    +I       
Sbjct: 242 NNLT-DTAW-LLNYPGLVEVDLSYNELE-KIMYHPFVK 276

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 45.7 bits (108), Expect = 6e-05
 Identities = 10/80 (12%), Positives = 31/80 (38%), Gaps = 6/80 (7%)

Query: 412 PELKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENNELTGSLPSYM-GSLPNLQ 468
            E   +     +    + +   LP   +     + +++L + ++   + +Y       +Q
Sbjct: 45  FEDITLNNQKIVTFKNSTMRK-LPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQ 102

Query: 469 ELHIENNSFVGEIPPALLTG 488
           +L++  N+    +PP +   
Sbjct: 103 KLYMGFNAIR-YLPPHVFQN 121

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 51.2 bits (123), Expect = 1e-07
 Identities = 20/85 (23%), Positives = 39/85 (45%), Gaps = 2/85 (2%)

Query: 392 TPPRITKIALSG-KNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLEN 450
           TP  + ++ L   ++ +G++       E L  L      LT  + ++ +L  L+ + L +
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTS-IANLPKLNKLKKLELSD 73

Query: 451 NELTGSLPSYMGSLPNLQELHIENN 475
           N ++G L       PNL  L++  N
Sbjct: 74  NRVSGGLEVLAEKCPNLTHLNLSGN 98

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 40.4 bits (95), Expect = 5e-04
 Identities = 22/83 (26%), Positives = 37/83 (44%), Gaps = 7/83 (8%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGP--LPDMSRLIDLRIVHLENN 451
            ++ K+ LS   + G +    +    LT L L GN +     +  + +L +L+ + L N 
Sbjct: 64  NKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

Query: 452 ELTGSLPSY----MGSLPNLQEL 470
           E+T +L  Y       LP L  L
Sbjct: 124 EVT-NLNDYRENVFKLLPQLTYL 145

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 53.6 bits (128), Expect = 1e-07
 Identities = 22/115 (19%), Positives = 39/115 (33%), Gaps = 13/115 (11%)

Query: 376 DPCVPVPWEWVTCS----TTTPPRI------TKIALSGKNLKGEIPPE-LKNMEALTELW 424
           D C P     + C+      +   +      T++ +  +     +    L+ +  L  L 
Sbjct: 3   DACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLT 62

Query: 425 LDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFV 478
           +  + L    PD       L  ++L  N L  SL        +LQEL +  N   
Sbjct: 63  IVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 46.7 bits (110), Expect = 2e-05
 Identities = 18/95 (18%), Positives = 33/95 (34%), Gaps = 7/95 (7%)

Query: 409 EIPPELKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENNELTGSLPSYMGS-LP 465
           +    L   E LTEL+++       L    +  L +LR + +  + L   +        P
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80

Query: 466 NLQELHIENNSFVGEIPPALLTGK--VIFKYDNNP 498
            L  L++  N+    +    + G          NP
Sbjct: 81  RLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNP 114

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 53.1 bits (128), Expect = 2e-07
 Identities = 13/99 (13%), Positives = 37/99 (37%), Gaps = 8/99 (8%)

Query: 394 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDMS--RLIDLRIVHLEN 450
                +      ++ ++P   L +   +  L L+   +   +   +      ++ +++  
Sbjct: 45  NNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGF 102

Query: 451 NELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 488
           N +   LP ++  ++P L  L +E N     +P  +   
Sbjct: 103 NAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHN 139

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 50.4 bits (121), Expect = 2e-06
 Identities = 21/93 (22%), Positives = 36/93 (38%), Gaps = 5/93 (5%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENNE 452
             +T + L   NL       L N   L E+ L  N L         ++  L  +++ NN 
Sbjct: 226 VELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNR 283

Query: 453 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 485
           L  +L  Y   +P L+ L + +N  +  +    
Sbjct: 284 LV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQ 314

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 49.3 bits (118), Expect = 4e-06
 Identities = 20/87 (22%), Positives = 35/87 (40%), Gaps = 8/87 (9%)

Query: 394 PRITKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLEN 450
           P +T + L   +L   +P  +  N   LT L +  N L   + D        L+ + L +
Sbjct: 117 PLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSS 174

Query: 451 NELTGSLPSYMGSLPNLQELHIENNSF 477
           N LT  +      +P+L   ++  N  
Sbjct: 175 NRLT-HVDL--SLIPSLFHANVSYNLL 198

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 48.1 bits (115), Expect = 7e-06
 Identities = 19/98 (19%), Positives = 35/98 (35%), Gaps = 10/98 (10%)

Query: 391 TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLEN 450
           +  P +    +S   L       L    A+ EL    N +   +      ++L I+ L++
Sbjct: 183 SLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINV-VRGPV-NVELTILKLQH 235

Query: 451 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 488
           N LT      + + P L E+ +  N    +I       
Sbjct: 236 NNLT-DTAW-LLNYPGLVEVDLSYNELE-KIMYHPFVK 270

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 43.1 bits (102), Expect = 3e-04
 Identities = 19/95 (20%), Positives = 37/95 (38%), Gaps = 5/95 (5%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 453
           P +  + LS  +L   +       + L  L+LD N +   L  +S    L+ + L +N+ 
Sbjct: 295 PTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK-LSTHHTLKNLTLSHNDW 351

Query: 454 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 488
             +  S      N+    +++     +I   L  G
Sbjct: 352 DCN--SLRALFRNVARPAVDDADQHCKIDYQLEHG 384

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 52.9 bits (127), Expect = 2e-07
 Identities = 22/88 (25%), Positives = 35/88 (39%), Gaps = 8/88 (9%)

Query: 393 PPRITKIALSGKNLKGEIPPE--LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHL 448
           P     + LS  NL   +  E     +  L  L L  N L   +       + +LR + L
Sbjct: 38  PSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNF-ISSEAFVPVPNLRYLDL 95

Query: 449 ENNELTGSLPSYM-GSLPNLQELHIENN 475
            +N L  +L  ++   L  L+ L + NN
Sbjct: 96  SSNHLH-TLDEFLFSDLQALEVLLLYNN 122

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 52.2 bits (125), Expect = 4e-07
 Identities = 35/174 (20%), Positives = 60/174 (34%), Gaps = 25/174 (14%)

Query: 394 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLEN 450
             +  + LS  +L   I  E    +  L  L L  N L   L +   S L  L ++ L N
Sbjct: 64  TNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLHT-LDEFLFSDLQALEVLLLYN 121

Query: 451 NELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMR 509
           N +   +       +  LQ+L++  N      P  L+        +  PKL        +
Sbjct: 122 NHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKD-----GNKLPKLMLLDLSSNK 174

Query: 510 FKLILGTSIGVLAILLVLFL----------CSLIVLRK--LRRKISNQKSYEKA 551
            K +  T +  L   +   L          C L  L      R++S+   +++ 
Sbjct: 175 LKKLPLTDLQKLPAWVKNGLYLHNNPLECDCKLYQLFSHWQYRQLSSVMDFQED 228

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 51.9 bits (125), Expect = 3e-07
 Identities = 25/99 (25%), Positives = 40/99 (40%), Gaps = 8/99 (8%)

Query: 394 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLEN 450
            R+  + L    L+ E+ P   + + AL  L+L  N L   LPD     L +L  + L  
Sbjct: 105 GRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQA-LPDDTFRDLGNLTHLFLHG 162

Query: 451 NELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 488
           N ++ S+P      L +L  L +  N     + P     
Sbjct: 163 NRIS-SVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRD 199

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 50.8 bits (122), Expect = 7e-07
 Identities = 21/84 (25%), Positives = 31/84 (36%), Gaps = 7/84 (8%)

Query: 409 EIPPE-LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLENNELTGSLPSYM-GSL 464
            + P     +  L  L LD   L   L       L  L+ ++L++N L  +LP      L
Sbjct: 95  SVDPATFHGLGRLHTLHLDRCGLQE-LGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDL 152

Query: 465 PNLQELHIENNSFVGEIPPALLTG 488
            NL  L +  N     +P     G
Sbjct: 153 GNLTHLFLHGNRIS-SVPERAFRG 175

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 50.4 bits (121), Expect = 1e-06
 Identities = 20/104 (19%), Positives = 41/104 (39%), Gaps = 9/104 (8%)

Query: 387 TCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMSRLIDLRI 445
            C           +   + L+  +P  +    A   ++L GN ++  P        +L I
Sbjct: 7   VCYNEPK---VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTI 60

Query: 446 VHLENNELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 488
           + L +N L   + +     L  L++L + +N+ +  + PA   G
Sbjct: 61  LWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHG 103

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 48.5 bits (116), Expect = 4e-06
 Identities = 21/89 (23%), Positives = 39/89 (43%), Gaps = 7/89 (7%)

Query: 394 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLEN 450
             +T + L G  +   +P    + + +L  L L  N +   +       L  L  ++L  
Sbjct: 153 GNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAH-VHPHAFRDLGRLMTLYLFA 210

Query: 451 NELTGSLPSY-MGSLPNLQELHIENNSFV 478
           N L+ +LP+  +  L  LQ L + +N +V
Sbjct: 211 NNLS-ALPTEALAPLRALQYLRLNDNPWV 238

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 53.0 bits (127), Expect = 4e-07
 Identities = 26/96 (27%), Positives = 38/96 (39%), Gaps = 12/96 (12%)

Query: 390 TTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLE 449
              P  + K+ + G  L   +P        L EL +  N L   LP +    +L  +   
Sbjct: 117 PALPSGLCKLWIFGNQLT-SLPVLPPG---LQELSVSDNQLAS-LPAL--PSELCKLWAY 169

Query: 450 NNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 485
           NN+LT SLP        LQEL + +N     +P   
Sbjct: 170 NNQLT-SLPM---LPSGLQELSVSDNQLA-SLPTLP 200

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 52.6 bits (126), Expect = 4e-07
 Identities = 22/89 (24%), Positives = 32/89 (35%), Gaps = 8/89 (8%)

Query: 397 TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGS 456
             + +    L   +P  L     +T L +  N LT  LP      +LR + +  N+LT S
Sbjct: 43  AVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLTS-LPA--LPPELRTLEVSGNQLT-S 95

Query: 457 LPSYMGSLPNLQELHIENNSFVGEIPPAL 485
           LP     L  L             +P  L
Sbjct: 96  LPVLPPGLLELSIFSNPLTHLP-ALPSGL 123

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 48.7 bits (116), Expect = 8e-06
 Identities = 26/95 (27%), Positives = 38/95 (40%), Gaps = 12/95 (12%)

Query: 391 TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLEN 450
           T P  + K+      L   +P        L EL + GN LT  LP +    +L+ + +  
Sbjct: 198 TLPSELYKLWAYNNRLT-SLPALPSG---LKELIVSGNRLTS-LPVL--PSELKELMVSG 250

Query: 451 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 485
           N LT SLP        L  L +  N     +P +L
Sbjct: 251 NRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESL 280

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 44.9 bits (106), Expect = 1e-04
 Identities = 26/110 (23%), Positives = 41/110 (37%), Gaps = 26/110 (23%)

Query: 393 PPRITKIALSGKNLKGEIPPELKNM-----------------EALTELWLDGNFLTGPLP 435
           PP +  + +SG  L   +P     +                   L +LW+ GN LT  LP
Sbjct: 80  PPELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLTS-LP 137

Query: 436 DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 485
                  L+ + + +N+L  SLP+       L +L   NN     +P   
Sbjct: 138 V--LPPGLQELSVSDNQLA-SLPA---LPSELCKLWAYNNQLT-SLPMLP 180

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 50.8 bits (122), Expect = 5e-07
 Identities = 28/108 (25%), Positives = 40/108 (37%), Gaps = 22/108 (20%)

Query: 387 TCSTTT---------------PPRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFL 430
           TCS                  P  IT+I L    +K  IPP      + L  + L  N +
Sbjct: 10  TCSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQI 68

Query: 431 TGPLPDM--SRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELHIENN 475
           +  L       L  L  + L  N++T  LP  +   L +LQ L +  N
Sbjct: 69  SE-LAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNAN 114

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 44.6 bits (106), Expect = 5e-05
 Identities = 20/84 (23%), Positives = 36/84 (42%), Gaps = 5/84 (5%)

Query: 397 TKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENNEL 453
             + L G  +  E+P  L + + +L  L L+ N +   L       L +L ++ L +N+L
Sbjct: 83  NSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINC-LRVDAFQDLHNLNLLSLYDNKL 140

Query: 454 TGSLPSYMGSLPNLQELHIENNSF 477
                     L  +Q +H+  N F
Sbjct: 141 QTIAKGTFSPLRAIQTMHLAQNPF 164

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 51.2 bits (123), Expect = 7e-07
 Identities = 47/236 (19%), Positives = 87/236 (36%), Gaps = 65/236 (27%)

Query: 596 KKIGKGSFGSVY--YGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR------N 647
             +G+G+FG V       +   +VA+KI+ +   +R    + E+ +L +I  +       
Sbjct: 25  GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARL-EINVLKKIKEKDKENKFL 83

Query: 648 LVPLIGY-------CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ-IAHDAA 699
            V +  +       C       + +E +      + L  + N +P   L  ++ +A+   
Sbjct: 84  CVLMSDWFNFHGHMC-------IAFELLGK-NTFEFLKEN-NFQPYP-LPHVRHMAYQLC 133

Query: 700 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRA-------------------KVSDFGLSR 740
             L +LH      + H D+K  NIL   +                      +V+DFG + 
Sbjct: 134 HALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSAT 190

Query: 741 QAEEDL-THISSVARGTVGYLDPE-----YYGNQQLTEKSDVYSFGVVLLELISGK 790
              E   T +++  R    Y  PE      +      +  DV+S G +L E   G 
Sbjct: 191 FDHEHHTTIVAT--R---HYRPPEVILELGWA-----QPCDVWSIGCILFEYYRGF 236

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 50.8 bits (122), Expect = 7e-07
 Identities = 20/82 (24%), Positives = 41/82 (50%), Gaps = 5/82 (6%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 453
            ++  ++L    +  +I   L ++  L  L+L  N +T  +  +SRL  L  + LE+N++
Sbjct: 112 KKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITD-ITVLSRLTKLDTLSLEDNQI 168

Query: 454 TGSLPSYMGSLPNLQELHIENN 475
           +  +   +  L  LQ L++  N
Sbjct: 169 S-DIVP-LAGLTKLQNLYLSKN 188

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 43.5 bits (103), Expect = 2e-04
 Identities = 17/62 (27%), Positives = 33/62 (53%), Gaps = 3/62 (4%)

Query: 414 LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 473
           LK+++ L  L L+ N ++  +  +  L  L  ++L NN++T    + +  L  L  L +E
Sbjct: 108 LKDLKKLKSLSLEHNGISD-INGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLE 164

Query: 474 NN 475
           +N
Sbjct: 165 DN 166

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 43.1 bits (102), Expect = 2e-04
 Identities = 21/82 (25%), Positives = 45/82 (54%), Gaps = 5/82 (6%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 453
             I +I  +  ++K  +   ++ +  +T+L+L+GN LT  +  ++ L +L  + L+ N++
Sbjct: 46  NSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLTD-IKPLANLKNLGWLFLDENKV 102

Query: 454 TGSLPSYMGSLPNLQELHIENN 475
              L S +  L  L+ L +E+N
Sbjct: 103 K-DLSS-LKDLKKLKSLSLEHN 122

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 43.1 bits (102), Expect = 2e-04
 Identities = 16/85 (18%), Positives = 37/85 (43%), Gaps = 3/85 (3%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 453
            ++  ++L    +  +I P L  +  L  L+L  N ++  L  ++ L +L ++ L + E 
Sbjct: 156 TKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHISD-LRALAGLKNLDVLELFSQEC 212

Query: 454 TGSLPSYMGSLPNLQELHIENNSFV 478
                ++  +L     +   + S V
Sbjct: 213 LNKPINHQSNLVVPNTVKNTDGSLV 237

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 43.1 bits (102), Expect = 3e-04
 Identities = 27/82 (32%), Positives = 46/82 (56%), Gaps = 5/82 (6%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 453
           P +TK+ L+G  L  +I P L N++ L  L+LD N +   L  +  L  L+ + LE+N +
Sbjct: 68  PNVTKLFLNGNKLT-DIKP-LANLKNLGWLFLDENKVKD-LSSLKDLKKLKSLSLEHNGI 124

Query: 454 TGSLPSYMGSLPNLQELHIENN 475
           +  +   +  LP L+ L++ NN
Sbjct: 125 S-DING-LVHLPQLESLYLGNN 144

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 51.4 bits (123), Expect = 1e-06
 Identities = 15/87 (17%), Positives = 33/87 (37%), Gaps = 6/87 (6%)

Query: 393 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMS--RLIDLRIVHLEN 450
             + T + +S   +      ++ ++  L  L +  N +   L         +L  + L +
Sbjct: 20  SQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQY-LDISVFKFNQELEYLDLSH 78

Query: 451 NELTGSLPSYMGSLPNLQELHIENNSF 477
           N+L   +        NL+ L +  N+F
Sbjct: 79  NKLV-KISC--HPTVNLKHLDLSFNAF 102

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 48.7 bits (116), Expect = 7e-06
 Identities = 15/100 (15%), Positives = 31/100 (31%), Gaps = 6/100 (6%)

Query: 393 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLID----LRIVHL 448
                 +  S   L   +     ++  L  L L  N L   L  ++ +      L+ + +
Sbjct: 323 ISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKE-LSKIAEMTTQMKSLQQLDI 381

Query: 449 ENNELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLT 487
             N ++            +L  L++ +N     I   L  
Sbjct: 382 SQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPP 421

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 45.6 bits (108), Expect = 6e-05
 Identities = 17/86 (19%), Positives = 37/86 (43%), Gaps = 4/86 (4%)

Query: 393 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 452
              +  + +S   L   I   L     +  L L  N +      + +L  L+ +++ +N+
Sbjct: 398 TKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIKSIPKQVVKLEALQELNVASNQ 455

Query: 453 LTGSLPSYM-GSLPNLQELHIENNSF 477
           L  S+P  +   L +LQ++ +  N +
Sbjct: 456 LK-SVPDGIFDRLTSLQKIWLHTNPW 480

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 42.2 bits (99), Expect = 6e-04
 Identities = 27/142 (19%), Positives = 45/142 (31%), Gaps = 10/142 (7%)

Query: 420 LTELWLDGNFLTGPLPDM---SRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNS 476
           L  L L  N     LP       +  L+ + L    L  S    +  L   + L +   +
Sbjct: 92  LKHLDLSFNAFDA-LPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGET 150

Query: 477 FVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILLVLFLCSLIVLR 536
           +  +  P  L      +  N   LH        F  IL  S+  +A L +  +  ++   
Sbjct: 151 YGEKEDPEGL------QDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDN 204

Query: 537 KLRRKISNQKSYEKADSLRTST 558
           K    +S     +    L   T
Sbjct: 205 KCSYFLSILAKLQTNPKLSNLT 226

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 50.5 bits (121), Expect = 1e-06
 Identities = 21/106 (19%), Positives = 46/106 (43%), Gaps = 6/106 (5%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 453
             +  +++    +  ++ P L N+  LT L  D N ++  +  ++ L +L  VHL+NN++
Sbjct: 151 TNLQYLSIGNAQVS-DLTP-LANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNNQI 207

Query: 454 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPK 499
           +  +   + +  NL  + + N +     P       V+      P 
Sbjct: 208 S-DVSP-LANTSNLFIVTLTNQTIT-NQPVFYNNNLVVPNVVKGPS 250

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 50.5 bits (121), Expect = 1e-06
 Identities = 23/105 (21%), Positives = 44/105 (41%), Gaps = 5/105 (4%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 453
             +  + L    +   I P L  +  L  L +    ++  L  ++ L  L  +  ++N++
Sbjct: 129 SNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVSD-LTPLANLSKLTTLKADDNKI 185

Query: 454 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNP 498
           +  +   + SLPNL E+H++NN      P A  +   I    N  
Sbjct: 186 S-DISP-LASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTNQT 228

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 48.9 bits (117), Expect = 3e-06
 Identities = 18/82 (21%), Positives = 39/82 (47%), Gaps = 5/82 (6%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 453
             I  + L+      ++ P L  +  L  L+LD N +T  +  ++ L +L+ + + N ++
Sbjct: 107 QSIKTLDLTS-TQITDVTP-LAGLSNLQVLYLDLNQITN-ISPLAGLTNLQYLSIGNAQV 163

Query: 454 TGSLPSYMGSLPNLQELHIENN 475
           +  L   + +L  L  L  ++N
Sbjct: 164 S-DLTP-LANLSKLTTLKADDN 183

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 46.2 bits (110), Expect = 2e-05
 Identities = 17/90 (18%), Positives = 39/90 (43%), Gaps = 6/90 (6%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 453
             IT ++  G  +   I   ++ +  L  L L  N +T  L  +  L  +  + L  N L
Sbjct: 41  DGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQITD-LAPLKNLTKITELELSGNPL 97

Query: 454 TGSLPSYMGSLPNLQELHIENNSFVGEIPP 483
             ++ + +  L +++ L + +   + ++ P
Sbjct: 98  K-NVSA-IAGLQSIKTLDLTSTQ-ITDVTP 124

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 45.8 bits (109), Expect = 3e-05
 Identities = 23/90 (25%), Positives = 45/90 (50%), Gaps = 6/90 (6%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 453
             +  + L    +  ++ P LKN+  +TEL L GN L   +  ++ L  ++ + L + ++
Sbjct: 63  NNLIGLELKDNQIT-DLAP-LKNLTKITELELSGNPLKN-VSAIAGLQSIKTLDLTSTQI 119

Query: 454 TGSLPSYMGSLPNLQELHIENNSFVGEIPP 483
           T    + +  L NLQ L+++ N  +  I P
Sbjct: 120 TD--VTPLAGLSNLQVLYLDLNQ-ITNISP 146

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 43.1 bits (102), Expect = 2e-04
 Identities = 18/82 (21%), Positives = 37/82 (45%), Gaps = 5/82 (6%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 453
               KIA    N+   +     +++ +T L   G  +T  +  +  L +L  + L++N++
Sbjct: 19  ANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT-IEGVQYLNNLIGLELKDNQI 75

Query: 454 TGSLPSYMGSLPNLQELHIENN 475
           T  L   + +L  + EL +  N
Sbjct: 76  T-DLAP-LKNLTKITELELSGN 95

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 42.8 bits (101), Expect = 3e-04
 Identities = 21/103 (20%), Positives = 43/103 (41%), Gaps = 6/103 (5%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 453
            ++T +      +  +I P L ++  L E+ L  N ++  +  ++   +L IV L N  +
Sbjct: 173 SKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQISD-VSPLANTSNLFIVTLTNQTI 229

Query: 454 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDN 496
           T + P +     NL   ++        I PA ++    +   N
Sbjct: 230 T-NQPVFY--NNNLVVPNVVKGPSGAPIAPATISDNGTYASPN 269

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 49.7 bits (119), Expect = 1e-06
 Identities = 18/106 (16%), Positives = 37/106 (34%), Gaps = 16/106 (15%)

Query: 383 WEWVTCS----TTTPPRI----TKIALSGKNLKGEIPPE--LKNMEALTELWLDGNFLTG 432
              V CS       P  I     ++ L+       +      K +  L ++    N +T 
Sbjct: 13  GTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITD 71

Query: 433 PLPDM--SRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELHIENN 475
            + +        +  + L +N L  ++   M   L +L+ L + +N
Sbjct: 72  -IEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSN 115

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 44.3 bits (105), Expect = 6e-05
 Identities = 22/86 (25%), Positives = 43/86 (50%), Gaps = 9/86 (10%)

Query: 397 TKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELT 454
            +I L+   L+  +  ++ K +E+L  L L  N +T    D    L  +R++ L +N++T
Sbjct: 84  NEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT 142

Query: 455 GSLPSYMG---SLPNLQELHIENNSF 477
            ++    G   +L +L  L++  N F
Sbjct: 143 -TVAP--GAFDTLHSLSTLNLLANPF 165

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 51.7 bits (124), Expect = 1e-06
 Identities = 17/90 (18%), Positives = 33/90 (36%), Gaps = 7/90 (7%)

Query: 401 LSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENNELTGSLPS 459
               NL  ++P  L        L L  N++          L  L+++ L +     ++  
Sbjct: 11  YRFCNLT-QVPQVLNT---TERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDK 66

Query: 460 YM-GSLPNLQELHIENNSFVGEIPPALLTG 488
               +LPNL+ L + ++     + P    G
Sbjct: 67  EAFRNLPNLRILDLGSSKIY-FLHPDAFQG 95

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 51.3 bits (123), Expect = 1e-06
 Identities = 27/112 (24%), Positives = 44/112 (39%), Gaps = 9/112 (8%)

Query: 393 PPRITKIALSGKNLKGEIPPEL-----KNMEALTELWLDGNFLTGPLPDM-SRLIDLRIV 446
            P + ++ L    L+     EL     + +  L  L+L+ N+L    P + S L  LR +
Sbjct: 450 NPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGL 509

Query: 447 HLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNP 498
            L +N LT  L        NL+ L I  N  +    P +     +    +N 
Sbjct: 510 SLNSNRLT-VLSHND-LPANLEILDISRNQLL-APNPDVFVSLSVLDITHNK 558

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 49.8 bits (119), Expect = 4e-06
 Identities = 18/100 (18%), Positives = 35/100 (35%), Gaps = 7/100 (7%)

Query: 394 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPD---MSRLIDLRIVHLE 449
           P +  + L    +   + P+  + +  L EL L    L+  +        L  L  + L 
Sbjct: 73  PNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLS 131

Query: 450 NNELTG-SLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 488
            N++    L    G L +L+ +   +N     +    L  
Sbjct: 132 KNQIRSLYLHPSFGKLNSLKSIDFSSNQIF-LVCEHELEP 170

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 47.1 bits (112), Expect = 3e-05
 Identities = 16/85 (18%), Positives = 34/85 (40%), Gaps = 5/85 (5%)

Query: 396 ITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNEL 453
           +  + LS   +   +     + ++ L  L L  N +     +    L +L++++L  N L
Sbjct: 268 VRHLDLSHGFVF-SLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLL 326

Query: 454 TGSLPSYM-GSLPNLQELHIENNSF 477
              L S     LP +  + ++ N  
Sbjct: 327 G-ELYSSNFYGLPKVAYIDLQKNHI 350

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 46.3 bits (110), Expect = 4e-05
 Identities = 18/103 (17%), Positives = 34/103 (33%), Gaps = 10/103 (9%)

Query: 394 PRITKIALSGKNLKGEIPPE--LKNMEALTELWLDGNFLTG------PLPDMSRLIDLRI 445
           P +  + L+          +       +L +L+L  N L               L  L++
Sbjct: 426 PHLQILILNQNRFS-SCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQV 484

Query: 446 VHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 488
           ++L +N L    P     L  L+ L + +N     +    L  
Sbjct: 485 LYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHNDLPA 526

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 44.8 bits (106), Expect = 1e-04
 Identities = 22/146 (15%), Positives = 44/146 (30%), Gaps = 10/146 (6%)

Query: 401 LSGKNLKGEIPPE--LKNMEALTELWLDGNFLT--GPLPDMSRLIDLRIVHLENNELTGS 456
           L    L   +  +   +N++ALT L L  N +      P   +L  L+ +   +N++   
Sbjct: 104 LYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLV 163

Query: 457 LPSYMGSL--PNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLIL 514
               +  L    L    +  NS    +          F+   N  L         + + +
Sbjct: 164 CEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFR---NMVLEILDVSGNGWTVDI 220

Query: 515 -GTSIGVLAILLVLFLCSLIVLRKLR 539
            G     ++      L     +    
Sbjct: 221 TGNFSNAISKSQAFSLILAHHIMGAG 246

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 42.5 bits (100), Expect = 6e-04
 Identities = 16/86 (18%), Positives = 31/86 (36%), Gaps = 3/86 (3%)

Query: 394 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENN 451
             +  + L+   +  +I  E    ++ L  L L  N L      +   L  +  + L+ N
Sbjct: 290 KDLKVLNLAYNKIN-KIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKN 348

Query: 452 ELTGSLPSYMGSLPNLQELHIENNSF 477
            +          L  LQ L + +N+ 
Sbjct: 349 HIAIIQDQTFKFLEKLQTLDLRDNAL 374

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 50.7 bits (121), Expect = 1e-06
 Identities = 18/92 (19%), Positives = 30/92 (32%), Gaps = 5/92 (5%)

Query: 389 STTTPPRITKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPDMSRLIDLRIVH 447
                 ++  + LS  +L+             L  L L    L      +     L ++ 
Sbjct: 223 LAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPA--KLSVLD 280

Query: 448 LENNELTGSLPSYMGSLPNLQELHIENNSFVG 479
           L  N L    PS    LP +  L ++ N F+ 
Sbjct: 281 LSYNRLD-RNPS-PDELPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 48.7 bits (116), Expect = 4e-06
 Identities = 15/99 (15%), Positives = 32/99 (32%), Gaps = 8/99 (8%)

Query: 393 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP--------DMSRLIDLR 444
            P +  ++++  +       +++   AL+ L L  N   G               L  L 
Sbjct: 148 KPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLA 207

Query: 445 IVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPP 483
           + +      +G   +   +   LQ L + +NS       
Sbjct: 208 LRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGA 246

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 46.0 bits (109), Expect = 3e-05
 Identities = 21/114 (18%), Positives = 39/114 (34%), Gaps = 4/114 (3%)

Query: 376 DPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP 435
           +PC           +   P  +           E+    +++E L    +D     G   
Sbjct: 4   EPCELDEESCSCNFSDPKPDWSSAFNCLGAADVELYGGGRSLEYL-LKRVDTEADLGQFT 62

Query: 436 DMSRLIDLRIVHLENNELTGSLPSYM---GSLPNLQELHIENNSFVGEIPPALL 486
           D+ + + L+ + +    +   +         +  LQEL +EN    G  PP LL
Sbjct: 63  DIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLL 116

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 46.0 bits (109), Expect = 3e-05
 Identities = 16/96 (16%), Positives = 30/96 (31%), Gaps = 7/96 (7%)

Query: 394 PRITKIALSGKNLKGEIPPELKN--MEALTELWLDGNFLTGPLPDMSRLID-----LRIV 446
             + ++ L    + G  PP L       L  L L           ++ L       L+++
Sbjct: 95  SGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVL 154

Query: 447 HLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIP 482
            +            +   P L  L + +N  +GE  
Sbjct: 155 SIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG 190

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 50.0 bits (120), Expect = 2e-06
 Identities = 52/241 (21%), Positives = 91/241 (37%), Gaps = 71/241 (29%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-----HHRNLV 649
           +K+G G+FG V   + + + K  AVK++ +   +  +    E  +L +I     ++ N+V
Sbjct: 41  RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYT-RSAKIEADILKKIQNDDINNNNIV 99

Query: 650 PLIGY-------CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ-IAHDAAKG 701
              G        C       L++E +   +L + +  + N      +  ++    +  K 
Sbjct: 100 KYHGKFMYYDHMC-------LIFEPLGP-SLYEIITRN-NYNGFH-IEDIKLYCIEILKA 149

Query: 702 LEYLHTGCNPGIIHRDVKSSNILLDINMRA-------------------------KVSDF 736
           L YL       + H D+K  NILLD                              K+ DF
Sbjct: 150 LNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDF 206

Query: 737 GLSRQAEEDL-THISSVARGTVGYLDPE------YYGNQQLTEKSDVYSFGVVLLELISG 789
           G +    +   + I++  R    Y  PE      +         SD++SFG VL EL +G
Sbjct: 207 GCATFKSDYHGSIINT--R---QYRAPEVILNLGW------DVSSDMWSFGCVLAELYTG 255

Query: 790 K 790
            
Sbjct: 256 S 256

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 50.1 bits (120), Expect = 2e-06
 Identities = 20/115 (17%), Positives = 38/115 (33%), Gaps = 17/115 (14%)

Query: 376 DPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PL 434
           DP          CS              + L  ++P    +   +  + L  N +     
Sbjct: 2   DPGTS------ECSVIG----YNAICINRGLH-QVPELPAH---VNYVDLSLNSIAELNE 47

Query: 435 PDMSRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 488
              SRL DL+ + +E       + +     L +L  L ++ N F+ ++      G
Sbjct: 48  TSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNG 101

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 47.0 bits (112), Expect = 2e-05
 Identities = 20/86 (23%), Positives = 36/86 (41%), Gaps = 7/86 (8%)

Query: 394 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDMS--RLIDLRIVHLEN 450
             + ++ L+   +  +I       +  L +L L  NFL   +       L  L ++ L  
Sbjct: 299 TDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGS-IDSRMFENLDKLEVLDLSY 356

Query: 451 NELTGSLPSYM-GSLPNLQELHIENN 475
           N +  +L       LPNL+EL ++ N
Sbjct: 357 NHIR-ALGDQSFLGLPNLKELALDTN 381

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 45.1 bits (107), Expect = 8e-05
 Identities = 24/85 (28%), Positives = 42/85 (49%), Gaps = 7/85 (8%)

Query: 397 TKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPDMS--RLIDLRIVHLENNEL 453
            K+ LS   L   I   + +N++ L  L L  N +   L D S   L +L+ + L+ N+L
Sbjct: 326 LKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIRA-LGDQSFLGLPNLKELALDTNQL 383

Query: 454 TGSLPSYM-GSLPNLQELHIENNSF 477
             S+P  +   L +LQ++ +  N +
Sbjct: 384 K-SVPDGIFDRLTSLQKIWLHTNPW 407

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 44.0 bits (104), Expect = 2e-04
 Identities = 14/87 (16%), Positives = 27/87 (31%), Gaps = 6/87 (6%)

Query: 394 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTG-PLPDMS--RLIDLRIVHLE 449
             +  + L       ++       +  L  L L    L G  L       L  L ++ L 
Sbjct: 79  SSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLR 137

Query: 450 NNELTGSLPSYM-GSLPNLQELHIENN 475
           +N +    P+    ++     L +  N
Sbjct: 138 DNNIKKIQPASFFLNMRRFHVLDLTFN 164

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 48.5 bits (116), Expect = 3e-06
 Identities = 22/100 (22%), Positives = 39/100 (39%), Gaps = 6/100 (6%)

Query: 394 PRITKIALSGKNLKGEIPPEL-KNMEALTELWLDGN-FLTGPLPDM-SRLIDLRIVHLEN 450
           P I++I +S      ++      N+  +T + +     LT   PD    L  L+ + + N
Sbjct: 55  PNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFN 114

Query: 451 NELTGSLP--SYMGSLPNLQELHIENNSFVGEIPPALLTG 488
             L    P  + + S      L I +N ++  IP     G
Sbjct: 115 TGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQG 153

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 44.2 bits (105), Expect = 9e-05
 Identities = 19/108 (17%), Positives = 37/108 (34%), Gaps = 19/108 (17%)

Query: 387 TCSTTTPPRITKIALSGKNLKG--EIPPELKNMEALTELWLDGNFLTGPLPDM--SRLID 442
            C            ++ K+++    +PP          L L    L   +P    S L +
Sbjct: 9   ECHQEE-----DFRVTCKDIQRIPSLPPST------QTLKLIETHLRT-IPSHAFSNLPN 56

Query: 443 LRIVHL-ENNELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 488
           +  +++  +  L   L S+   +L  +  + I N   +  I P  L  
Sbjct: 57  ISRIYVSIDVTLQ-QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKE 103

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 49.6 bits (118), Expect = 4e-06
 Identities = 23/104 (22%), Positives = 34/104 (32%), Gaps = 16/104 (15%)

Query: 390 TTTPPRI---TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIV 446
           T  P        I      L   +P    +   L  L +  N LT  LP++     L  +
Sbjct: 133 TMLPELPALLEYINADNNQLT-MLPELPTS---LEVLSVRNNQLTF-LPEL--PESLEAL 185

Query: 447 HLENNELTGSLPSYMGSLPNLQE----LHIENNSFVGEIPPALL 486
            +  N L  SLP+      + +E         N     IP  +L
Sbjct: 186 DVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENIL 227

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 49.6 bits (118), Expect = 4e-06
 Identities = 21/101 (20%), Positives = 40/101 (39%), Gaps = 16/101 (15%)

Query: 390 TTTPPRI-----TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLR 444
            +          +++ L+  NL   +P  L     +T L +  N L   LP++     L 
Sbjct: 50  VSLLKECLINQFSELQLNRLNLS-SLPDNLPP--QITVLEITQNALI-SLPEL--PASLE 103

Query: 445 IVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 485
            +   +N L+ +LP       +L+ L ++NN     +P   
Sbjct: 104 YLDACDNRLS-TLPE---LPASLKHLDVDNNQLT-MLPELP 139

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 49.3 bits (117), Expect = 5e-06
 Identities = 21/82 (25%), Positives = 41/82 (50%), Gaps = 5/82 (6%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 453
            ++  ++L    +  +I   L ++  L  L+L  N +T  +  +SRL  L  + LE+N++
Sbjct: 109 KKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITD-ITVLSRLTKLDTLSLEDNQI 165

Query: 454 TGSLPSYMGSLPNLQELHIENN 475
           +  +    G L  LQ L++  N
Sbjct: 166 S-DIVPLAG-LTKLQNLYLSKN 185

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 44.7 bits (105), Expect = 1e-04
 Identities = 19/82 (23%), Positives = 40/82 (48%), Gaps = 5/82 (6%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 453
             +  + L    +K ++   LK+++ L  L L+ N ++  +  +  L  L  ++L NN++
Sbjct: 87  KNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGISD-INGLVHLPQLESLYLGNNKI 143

Query: 454 TGSLPSYMGSLPNLQELHIENN 475
           T    + +  L  L  L +E+N
Sbjct: 144 TD--ITVLSRLTKLDTLSLEDN 163

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 44.7 bits (105), Expect = 1e-04
 Identities = 13/82 (15%), Positives = 35/82 (42%), Gaps = 5/82 (6%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 453
               K  L  K++   +      + ++ ++  + + +   +  +  L ++  + L  N+L
Sbjct: 21  AETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQGIQYLPNVTKLFLNGNKL 77

Query: 454 TGSLPSYMGSLPNLQELHIENN 475
           T  +   + +L NL  L ++ N
Sbjct: 78  T-DI-KPLTNLKNLGWLFLDEN 97

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 43.9 bits (103), Expect = 2e-04
 Identities = 17/92 (18%), Positives = 39/92 (42%), Gaps = 5/92 (5%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 453
           P++  + L    +  +I   L  +  L  L L+ N ++  +  ++ L  L+ ++L  N +
Sbjct: 131 PQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQISD-IVPLAGLTKLQNLYLSKNHI 187

Query: 454 TGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 485
           +  L   +  L NL  L + +   + +     
Sbjct: 188 S-DL-RALAGLKNLDVLELFSQECLNKPINHQ 217

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 43.6 bits (102), Expect = 3e-04
 Identities = 27/82 (32%), Positives = 47/82 (57%), Gaps = 5/82 (6%)

Query: 394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 453
           P +TK+ L+G  L  +I P L N++ L  L+LD N +   L  +  L  L+ + LE+N +
Sbjct: 65  PNVTKLFLNGNKLT-DIKP-LTNLKNLGWLFLDENKIKD-LSSLKDLKKLKSLSLEHNGI 121

Query: 454 TGSLPSYMGSLPNLQELHIENN 475
           +  + + +  LP L+ L++ NN
Sbjct: 122 S-DI-NGLVHLPQLESLYLGNN 141

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 48.4 bits (116), Expect = 6e-06
 Identities = 49/236 (20%), Positives = 90/236 (38%), Gaps = 65/236 (27%)

Query: 596 KKIGKGSFGSVY--YGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR------N 647
             +G+G+FG V         G+ VAVKI+ +   +  +   +E+ +L  ++         
Sbjct: 20  DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYC-EAARSEIQVLEHLNTTDPNSTFR 78

Query: 648 LVPLIGY-------CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ-IAHDAA 699
            V ++ +       C       +V+E +   +  D +  +    P   L  ++ +A+   
Sbjct: 79  CVQMLEWFEHHGHIC-------IVFELLGL-STYDFIKEN-GFLPFR-LDHIRKMAYQIC 128

Query: 700 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRA-------------------KVSDFGLSR 740
           K + +LH   +  + H D+K  NIL   +                      KV DFG + 
Sbjct: 129 KSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSAT 185

Query: 741 QAEEDL-THISSVARGTVGYLDPE-----YYGNQQLTEKSDVYSFGVVLLELISGK 790
             +E   T +S+  R    Y  PE      +      +  DV+S G +L+E   G 
Sbjct: 186 YDDEHHSTLVST--R---HYRAPEVILALGWS-----QPCDVWSIGCILIEYYLGF 231

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 46.5 bits (111), Expect = 2e-05
 Identities = 24/83 (28%), Positives = 40/83 (48%), Gaps = 7/83 (8%)

Query: 397 TKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENNEL 453
             + L+   L+  +P  + K ++ L  LW+  N L   LP     +L++L  + L+ N+L
Sbjct: 64  RLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQL 121

Query: 454 TGSLPSYM-GSLPNLQELHIENN 475
             SLP  +  SL  L  L +  N
Sbjct: 122 K-SLPPRVFDSLTKLTYLSLGYN 143

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 46.1 bits (110), Expect = 2e-05
 Identities = 29/102 (28%), Positives = 44/102 (43%), Gaps = 15/102 (14%)

Query: 386 VTCS----TTTPPRI----TKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPD 436
           V CS    T  P  I     K+ L    L   +P +    +  L  L+L+ N L   LP 
Sbjct: 21  VDCSSKKLTAIPSNIPADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQT-LPA 78

Query: 437 M--SRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELHIENN 475
                L +L  + + +N+L  +LP  +   L NL EL ++ N
Sbjct: 79  GIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRN 119

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 43.0 bits (102), Expect = 2e-04
 Identities = 27/108 (25%), Positives = 46/108 (42%), Gaps = 19/108 (17%)

Query: 387 TCSTTTPPRITKIALSGKNLK---GEIPPELKNMEALTELWLDGNFLTGPLPDM--SRLI 441
           +C+         +  S K L      IP +        +L L  N L+  LP     RL 
Sbjct: 13  SCNNNK----NSVDCSSKKLTAIPSNIPADT------KKLDLQSNKLSS-LPSKAFHRLT 61

Query: 442 DLRIVHLENNELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 488
            LR+++L +N+L  +LP+ +   L NL+ L + +N     +P  +   
Sbjct: 62  KLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQ 107

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 46.5 bits (111), Expect = 2e-05
 Identities = 18/100 (18%), Positives = 39/100 (39%), Gaps = 9/100 (9%)

Query: 394 PRITKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLEN 450
             ++ + L+G  ++  +       + +L +L      L   L +     L  L+ +++ +
Sbjct: 76  SHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLAS-LENFPIGHLKTLKELNVAH 133

Query: 451 NELTGSLPS--YMGSLPNLQELHIENNSFVGEIPPALLTG 488
           N +  S     Y  +L NL+ L + +N     I    L  
Sbjct: 134 NLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRV 171

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 45.7 bits (109), Expect = 3e-05
 Identities = 22/119 (18%), Positives = 33/119 (27%), Gaps = 28/119 (23%)

Query: 376 DPCVPVPWEWVTCSTTT---------------PPRITKIALSGKNLKGEIPPE-LKNMEA 419
           +PCV            T               P     + LS   L+  +      +   
Sbjct: 1   EPCV------EVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLR-HLGSYSFFSFPE 53

Query: 420 LTELWLDGNFLTGPLPDM--SRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELHIENN 475
           L  L L    +   + D     L  L  + L  N +  SL       L +LQ+L     
Sbjct: 54  LQVLDLSRCEIQT-IEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVET 110

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 44.3 bits (105), Expect = 4e-05
 Identities = 17/83 (20%), Positives = 31/83 (37%), Gaps = 2/83 (2%)

Query: 393 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 452
             R  ++ L G  +   I      ++    +    N +   L     L  L+ + + NN 
Sbjct: 18  AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDGFPLLRRLKTLLVNNNR 75

Query: 453 LTGSLPSYMGSLPNLQELHIENN 475
           +         +LP+L EL + NN
Sbjct: 76  ICRIGEGLDQALPDLTELILTNN 98

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 44.2 bits (105), Expect = 5e-05
 Identities = 17/56 (30%), Positives = 29/56 (51%), Gaps = 2/56 (3%)

Query: 421 TELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELHIENN 475
           TEL+LDGN  T    ++S    L ++ L NN ++ +L +    ++  L  L +  N
Sbjct: 34  TELYLDGNQFTLVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYN 88

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 43.8 bits (104), Expect = 8e-05
 Identities = 27/101 (26%), Positives = 41/101 (40%), Gaps = 14/101 (13%)

Query: 386 VTCS----TTTPPRI----TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD- 436
           V CS       P  I    T++ L G      +P EL N + LT + L  N ++  L + 
Sbjct: 15  VRCSNKGLKVLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQ 72

Query: 437 -MSRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELHIENN 475
             S +  L  + L  N L   +P      L +L+ L +  N
Sbjct: 73  SFSNMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGN 112

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 44.7 bits (106), Expect = 6e-05
 Identities = 29/103 (28%), Positives = 39/103 (37%), Gaps = 17/103 (16%)

Query: 386 VTCS----TTTPPRI----TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD- 436
           V C      + P  I     K+ L    L        + +  LT L LD N L   L   
Sbjct: 19  VDCQGKSLDSVPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAG 77

Query: 437 -MSRLIDLRIVHLENNELTGSLPSYMG---SLPNLQELHIENN 475
               L +L  + L NN+L  SLP   G    L  L +L++  N
Sbjct: 78  VFDDLTELGTLGLANNQLA-SLPL--GVFDHLTQLDKLYLGGN 117

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 45.6 bits (108), Expect = 7e-05
 Identities = 19/88 (21%), Positives = 37/88 (42%), Gaps = 8/88 (9%)

Query: 393 PPRITKIALSGKNLKGEIPP-ELKNMEALTELWLDGNFLTGPLPDMS--RLIDLRIVHLE 449
           PPR   ++LS  ++  E+   ++  +  L  L L  N +   L         DL  + + 
Sbjct: 51  PPRTKALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRIRS-LDFHVFLFNQDLEYLDVS 108

Query: 450 NNELTGSLPSYMGSLPNLQELHIENNSF 477
           +N L  ++      + +L+ L +  N F
Sbjct: 109 HNRLQ-NISC--CPMASLRHLDLSFNDF 133

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 44.1 bits (104), Expect = 2e-04
 Identities = 15/77 (19%), Positives = 24/77 (31%), Gaps = 2/77 (2%)

Query: 401 LSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENNELTGSLPS 459
           LS  +          +  + T L    N  T       S L  L+ + L+ N L  +   
Sbjct: 336 LSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFK 394

Query: 460 YMGSLPNLQELHIENNS 476
                 N+  L   + S
Sbjct: 395 VALMTKNMSSLETLDVS 411

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 42.9 bits (101), Expect = 4e-04
 Identities = 22/91 (24%), Positives = 39/91 (42%), Gaps = 11/91 (12%)

Query: 401 LSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENNELTGSLPS 459
            S +NL   +P +L        L L  N ++   +PD+S L +LR++ L +N +  SL  
Sbjct: 38  YSNRNLT-HVPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDF 93

Query: 460 YMG---SLPNLQELHIENNSFVGEIPPALLT 487
                    +L+ L + +N     I    + 
Sbjct: 94  --HVFLFNQDLEYLDVSHNRLQ-NISCCPMA 121

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 42.9 bits (101), Expect = 4e-04
 Identities = 20/91 (21%), Positives = 39/91 (42%), Gaps = 4/91 (4%)

Query: 388 CSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVH 447
            +      I  + LS   L G +   L     +  L L  N +     D++ L  L+ ++
Sbjct: 422 RTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIMSIPKDVTHLQALQELN 479

Query: 448 LENNELTGSLP-SYMGSLPNLQELHIENNSF 477
           + +N+L  S+P      L +LQ + + +N +
Sbjct: 480 VASNQLK-SVPDGVFDRLTSLQYIWLHDNPW 509

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 44.8 bits (106), Expect = 8e-05
 Identities = 20/99 (20%), Positives = 37/99 (37%), Gaps = 5/99 (5%)

Query: 394 PRITKIALSGKNLKGEIPPE-LKNMEALTELWL-DGNFLTGPLPDM-SRLIDLRIVHLEN 450
             + KI +S  ++   I  +   N+  L E+ +   N L    P+    L +L+ + + N
Sbjct: 54  GDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISN 113

Query: 451 NELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 488
             +   LP            L I++N  +  I      G
Sbjct: 114 TGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVG 151

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 32/103 (31%), Positives = 48/103 (46%), Gaps = 17/103 (16%)

Query: 386 VTCS----TTTPPRI----TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD- 436
           V C     T+ P  I    T + L   +LK         + +LT+L+L GN L   LP+ 
Sbjct: 12  VECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQS-LPNG 70

Query: 437 -MSRLIDLRIVHLENNELTGSLPSYMG---SLPNLQELHIENN 475
             ++L  L  ++L  N+L  SLP+  G    L  L+EL +  N
Sbjct: 71  VFNKLTSLTYLNLSTNQLQ-SLPN--GVFDKLTQLKELALNTN 110

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 43.5 bits (103), Expect = 2e-04
 Identities = 16/100 (16%), Positives = 38/100 (38%), Gaps = 13/100 (13%)

Query: 386 VTCS----TTTPPRI----TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM 437
           +T S       P        K  L  K++  +   +   + ++ ++  + + +   +  +
Sbjct: 3   ITVSTPIKQIFPDDAFAETIKANLKKKSVT-DAVTQ-NELNSIDQIIANNSDIKS-VQGI 59

Query: 438 SRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSF 477
             L ++R + L  N+L   + +    L NL  L +  N  
Sbjct: 60  QYLPNVRYLALGGNKLH-DISAL-KELTNLTYLILTGNQL 97

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 42.7 bits (101), Expect = 3e-04
 Identities = 24/83 (28%), Positives = 37/83 (44%), Gaps = 7/83 (8%)

Query: 396 ITKIALSGKNLKGEIP-PELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELT 454
           I +I  +  ++K       L N   +  L L GN L   +  +  L +L  + L  N+L 
Sbjct: 43  IDQIIANNSDIKSVQGIQYLPN---VRYLALGGNKLH-DISALKELTNLTYLILTGNQLQ 98

Query: 455 GSLPS-YMGSLPNLQELHIENNS 476
            SLP+     L NL+EL +  N 
Sbjct: 99  -SLPNGVFDKLTNLKELVLVENQ 120

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 41.2 bits (97), Expect = 8e-04
 Identities = 24/61 (39%), Positives = 31/61 (50%), Gaps = 9/61 (14%)

Query: 420 LTELWLDGNFLTGPLPD--MSRLIDLRIVHLENNELTGSLPSYMG---SLPNLQELHIEN 474
           L EL L  N L   LPD    +L +L  ++L +N+L  SLP   G    L NL EL +  
Sbjct: 111 LKELVLVENQLQS-LPDGVFDKLTNLTYLNLAHNQLQ-SLPK--GVFDKLTNLTELDLSY 166

Query: 475 N 475
           N
Sbjct: 167 N 167

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 42.4 bits (100), Expect = 3e-04
 Identities = 28/103 (27%), Positives = 40/103 (38%), Gaps = 17/103 (16%)

Query: 386 VTCS----TTTPPRI----TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD- 436
           V C      + P  I      + L    +    P    ++  L EL+L  N L   LP  
Sbjct: 24  VDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA-LPVG 82

Query: 437 -MSRLIDLRIVHLENNELTGSLPSYMG---SLPNLQELHIENN 475
               L  L ++ L  N+LT  LPS       L +L+EL +  N
Sbjct: 83  VFDSLTQLTVLDLGTNQLT-VLPS--AVFDRLVHLKELFMCCN 122

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 40.8 bits (96), Expect = 8e-04
 Identities = 21/58 (36%), Positives = 30/58 (51%), Gaps = 4/58 (6%)

Query: 420 LTELWLDGNFLTGPLPD--MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 475
           LT L L  N LT  LP     RL+ L+ + +  N+LT  LP  +  L +L  L ++ N
Sbjct: 90  LTVLDLGTNQLTV-LPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQN 145

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 40.8 bits (96), Expect = 7e-04
 Identities = 26/102 (25%), Positives = 50/102 (49%), Gaps = 15/102 (14%)

Query: 395 RITKIA-LSG-KNLK---------GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDL 443
            I KI+ LSG +NL+          +I       + L ELW+  N +   L  + +L++L
Sbjct: 59  NIEKISSLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIAS-LSGIEKLVNL 117

Query: 444 RIVHLENNELT--GSLPSYMGSLPNLQELHIENNSFVGEIPP 483
           R++++ NN++T  G +   + +L  L++L +  N    +   
Sbjct: 118 RVLYMSNNKITNWGEI-DKLAALDKLEDLLLAGNPLYNDYKE 158

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

No hit with probability above 80.00

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	912
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-66
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	4e-64
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-63
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-63
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	4e-63
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	4e-62
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-60
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	5e-59
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-58
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	4e-58
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	6e-58
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	7e-58
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	8e-58
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-57
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	8e-57
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-56
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-56
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	4e-56
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-55
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-55
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	4e-55
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-54
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-54
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-53
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	9e-53
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-52
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-52
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	7e-51
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-50
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	6e-50
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-49
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	9e-49
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-48
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-47
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	6e-47
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	6e-46
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-45
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	3e-45
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-45
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-44
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-44
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-44
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	8e-44
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-42
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-42
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-42
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-41
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-41
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-41
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	4e-41
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	4e-40
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	4e-40
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	6e-40
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-39
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	8e-39
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	5e-38
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-36
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	5e-35
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	5e-35
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-31
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	4e-31
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	7e-31
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-21
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-12
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	7e-09
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-05
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-04
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	0.001
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	0.002
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-10
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	4e-10
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	4e-09
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	5e-09
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	5e-08
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	4e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	5e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.004
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	3e-07
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	2e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.003
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-05
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	4e-04
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	4e-04
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	8e-04
d1j7la_	263	d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phos	0.003
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.004

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  221 bits (565), Expect = 1e-66
 Identities = 78/276 (28%), Positives = 137/276 (49%), Gaps = 25/276 (9%)

Query: 594 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPL 651
             ++IG GSFG+VY GK     +VAVK++  +     + Q F  EV +L +  H N++  
Sbjct: 12  VGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69

Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 711
           +GY        +V ++    +L   LH    +   + +  + IA   A+G++YLH     
Sbjct: 70  MGYSTAPQ-LAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLH---AK 123

Query: 712 GIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYLDPEYYGNQQ- 769
            IIHRD+KS+NI L  ++  K+ DFGL+   +    +H      G++ ++ PE    Q  
Sbjct: 124 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183

Query: 770 --LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 827
              + +SDVY+FG+VL EL++G+ P S       +N       M+ +G     + P L  
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLPYS------NINNRDQIIFMVGRG----YLSPDL-S 232

Query: 828 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 863
            V+      +  +  +C++++   RP   +I+ +I+
Sbjct: 233 KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (547), Expect = 4e-64
 Identities = 67/271 (24%), Positives = 122/271 (45%), Gaps = 21/271 (7%)

Query: 594 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 653
             +++G G FG V+ G      +VAVK +    S     F+ E  L+ ++ H+ LV L  
Sbjct: 17  LVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75

Query: 654 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 713
              +E    ++ EYM NG+L D L    +   L     L +A   A+G+ ++        
Sbjct: 76  VVTQEP-IYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIE---ERNY 130

Query: 714 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 773
           IHRD++++NIL+   +  K++DFGL+R  E++       A+  + +  PE       T K
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 190

Query: 774 SDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 833
           SDV+SFG++L E+++  +         E+         +++G  +   D           
Sbjct: 191 SDVWSFGILLTEIVTHGRIPYPGMTNPEV------IQNLERGYRMVRPDNCP-------- 236

Query: 834 IWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 864
              + ++   C ++R   RP    +   ++D
Sbjct: 237 -EELYQLMRLCWKERPEDRPTFDYLRSVLED 266

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (542), Expect = 1e-63
 Identities = 72/272 (26%), Positives = 124/272 (45%), Gaps = 21/272 (7%)

Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 652
            F ++IG G FG V+ G   +  +VA+K + +      + F+ E  ++ ++ H  LV L 
Sbjct: 8   TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLY 66

Query: 653 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 712
           G C E+    LV+E+M +G L D  +    +      T L +  D  +G+ YL       
Sbjct: 67  GVCLEQAPICLVFEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEGMAYL---EEAC 121

Query: 713 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 772
           +IHRD+ + N L+  N   KVSDFG++R   +D    S+  +  V +  PE +   + + 
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 181

Query: 773 KSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE 832
           KSDV+SFGV++ E+ S  K        +E+         I  G    +  P L       
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYENRSNSEV------VEDISTG--FRLYKPRLAST---- 229

Query: 833 SIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 864
               + ++   C ++R   RP    ++  + +
Sbjct: 230 ---HVYQIMNHCWKERPEDRPAFSRLLRQLAE 258

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (545), Expect = 2e-63
 Identities = 74/301 (24%), Positives = 132/301 (43%), Gaps = 34/301 (11%)

Query: 596 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 655
           + IGKG FG V+ GK + G+EVAVKI   S   R+     E+     + H N++  I   
Sbjct: 9   ESIGKGRFGEVWRGKWR-GEEVAVKIF-SSREERSWFREAEIYQTVMLRHENILGFIAAD 66

Query: 656 EEEH----QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC-- 709
            +++    Q  LV +Y  +G+L D L+    +  +     +++A   A GL +LH     
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHMEIVG 122

Query: 710 ---NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDPE 763
               P I HRD+KS NIL+  N    ++D GL+ + +     I        GT  Y+ PE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182

Query: 764 YY------GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG----AELNIVHWARSMIK 813
                    + +  +++D+Y+ G+V  E+        + +       +L     +   ++
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242

Query: 814 KGDVISIVDPVLIGNVK-IESIWRIAEVAIQCVEQRGFSRPKMQEIV-----LAIQDSIK 867
           K      + P +    +  E++  +A++  +C    G +R     I      L+ Q+ IK
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIK 302

Query: 868 I 868
           +
Sbjct: 303 M 303

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (538), Expect = 4e-63
 Identities = 72/272 (26%), Positives = 125/272 (45%), Gaps = 21/272 (7%)

Query: 593 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 652
            F K++G G FG V YGK +   +VA+K++ +  S    +F+ E  ++  + H  LV L 
Sbjct: 7   TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLY 65

Query: 653 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 712
           G C ++    ++ EYM NG L + L     +        L++  D  + +EYL    +  
Sbjct: 66  GVCTKQRPIFIITEYMANGCLLNYLR--EMRHRFQTQQLLEMCKDVCEAMEYLE---SKQ 120

Query: 713 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 772
            +HRD+ + N L++     KVSDFGLSR   +D    S  ++  V +  PE     + + 
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180

Query: 773 KSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE 832
           KSD+++FGV++ E+ S  K        +E          I +G  + +  P L       
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMPYERFTNSET------AEHIAQG--LRLYRPHLASE---- 228

Query: 833 SIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 864
              ++  +   C  ++   RP  + ++  I D
Sbjct: 229 ---KVYTIMYSCWHEKADERPTFKILLSNILD 257

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (538), Expect = 4e-62
 Identities = 55/215 (25%), Positives = 98/215 (45%), Gaps = 12/215 (5%)

Query: 587 LEEATNNF--CKKIGKGSFGSVYYGKMK-DGKEVAVKIM-ADSCSHRTQQFVTEVALLSR 642
           +E   ++F    ++G G+ G V+    K  G  +A K++  +       Q + E+ +L  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 643 IHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGL 702
            +   +V   G    + +  +  E+M  G+L   L        +      +++    KGL
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGL 117

Query: 703 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDP 762
            YL       I+HRDVK SNIL++     K+ DFG+S Q  + + +      GT  Y+ P
Sbjct: 118 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---SFVGTRSYMSP 172

Query: 763 EYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 797
           E       + +SD++S G+ L+E+  G+ P+   D
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (519), Expect = 3e-60
 Identities = 73/272 (26%), Positives = 124/272 (45%), Gaps = 27/272 (9%)

Query: 594 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 653
             + IGKG FG V  G  + G +VAVK + +  +   Q F+ E ++++++ H NLV L+G
Sbjct: 11  LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLG 67

Query: 654 YCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 712
              EE   + +V EYM  G+L D L     +  L     L+ + D  + +EYL       
Sbjct: 68  VIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE---GNN 123

Query: 713 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 772
            +HRD+ + N+L+  +  AKVSDFGL+++A           +  V +  PE    ++ + 
Sbjct: 124 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT----GKLPVKWTAPEALREKKFST 179

Query: 773 KSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE 832
           KSDV+SFG++L E+ S  +         ++         ++KG  +   D          
Sbjct: 180 KSDVWSFGILLWEIYSFGRVPYPRIPLKDV------VPRVEKGYKMDAPDGCP------- 226

Query: 833 SIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 864
               + EV   C       RP   ++   ++ 
Sbjct: 227 --PAVYEVMKNCWHLDAAMRPSFLQLREQLEH 256

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (512), Expect = 5e-59
 Identities = 69/274 (25%), Positives = 120/274 (43%), Gaps = 21/274 (7%)

Query: 594 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 653
              K+G+G FG V+ G       VA+K +    +   + F+ E  ++ ++ H  LV L  
Sbjct: 21  LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYA 79

Query: 654 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 713
              EE    +V EYM  G+L D L G    K L     + +A   A G+ Y+        
Sbjct: 80  VVSEEP-IYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVE---RMNY 134

Query: 714 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 773
           +HRD++++NIL+  N+  KV+DFGL+R  E++       A+  + +  PE     + T K
Sbjct: 135 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 194

Query: 774 SDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 833
           SDV+SFG++L EL +  +         E+         +++G  +               
Sbjct: 195 SDVWSFGILLTELTTKGRVPYPGMVNREV------LDQVERGYRMPCPPECPE------- 241

Query: 834 IWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 867
              + ++  QC  +    RP  + +   ++D   
Sbjct: 242 --SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  200 bits (510), Expect = 1e-58
 Identities = 77/311 (24%), Positives = 123/311 (39%), Gaps = 49/311 (15%)

Query: 584 LPELEEATNNF--CKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSHRTQ-QFV 634
           L  LE   NN    + IG+G+FG V+  +            VAVK++ +  S   Q  F 
Sbjct: 5   LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64

Query: 635 TEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG--------------- 679
            E AL++   + N+V L+G C       L++EYM  G L + L                 
Sbjct: 65  REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124

Query: 680 ------SVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKV 733
                 S    PL    +L IA   A G+ YL        +HRD+ + N L+  NM  K+
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKI 181

Query: 734 SDFGLSRQ-AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
           +DFGLSR     D           + ++ PE     + T +SDV+++GVVL E+ S    
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241

Query: 793 VSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSR 852
                   E+         ++ G++++  +   +          +  +   C  +    R
Sbjct: 242 PYYGMAHEEV------IYYVRDGNILACPENCPL---------ELYNLMRLCWSKLPADR 286

Query: 853 PKMQEIVLAIQ 863
           P    I   +Q
Sbjct: 287 PSFCSIHRILQ 297

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (504), Expect = 4e-58
 Identities = 67/276 (24%), Positives = 124/276 (44%), Gaps = 29/276 (10%)

Query: 596 KKIGKGSFGSVYYGKMKD---GKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVP 650
           K++G G+FG+V  G  +     K VAVKI+ +  +      + + E  ++ ++ +  +V 
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 710
           +IG CE E   +LV E    G L   L      + +     +++ H  + G++YL     
Sbjct: 73  MIGICEAES-WMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLE---E 125

Query: 711 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS--VARGTVGYLDPEYYGNQ 768
              +HRD+ + N+LL     AK+SDFGLS+    D  +  +    +  V +  PE     
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185

Query: 769 QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 828
           + + KSDV+SFGV++ E  S  +       G+E+       +M++KG+ +          
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV------TAMLEKGERMGCPAGCP--- 236

Query: 829 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 864
                   + ++   C      +RP    + L +++
Sbjct: 237 ------REMYDLMNLCWTYDVENRPGFAAVELRLRN 266

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (503), Expect = 6e-58
 Identities = 75/274 (27%), Positives = 116/274 (42%), Gaps = 30/274 (10%)

Query: 594 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVP 650
           F  +IG+GSF +VY G   +   EVA   + D    ++  Q+F  E  +L  + H N+V 
Sbjct: 13  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72

Query: 651 LIGYCEE----EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
                E     +   +LV E M +GTL+  L      K +             KGL++LH
Sbjct: 73  FYDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLH 129

Query: 707 TGCNPGIIHRDVKSSNILL-DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 765
           T   P IIHRD+K  NI +       K+ D GL+               GT  ++ PE Y
Sbjct: 130 T-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPEMY 185

Query: 766 GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 825
             ++  E  DVY+FG+ +LE+ + + P S      E          +  G   +  D V 
Sbjct: 186 -EEKYDESVDVYAFGMCMLEMATSEYPYS------ECQNAAQIYRRVTSGVKPASFDKVA 238

Query: 826 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 859
           I  VK        E+   C+ Q    R  +++++
Sbjct: 239 IPEVK--------EIIEGCIRQNKDERYSIKDLL 264

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  198 bits (503), Expect = 7e-58
 Identities = 73/276 (26%), Positives = 118/276 (42%), Gaps = 21/276 (7%)

Query: 593 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 651
               K+G G +G VY G  K     VAVK + +  +   ++F+ E A++  I H NLV L
Sbjct: 20  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQL 78

Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 711
           +G C  E    ++ E+M  G L D L    N++ +  +  L +A   +  +EYL      
Sbjct: 79  LGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLE---KK 134

Query: 712 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 771
             IHRD+ + N L+  N   KV+DFGLSR    D     + A+  + +  PE     + +
Sbjct: 135 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 194

Query: 772 EKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 831
            KSDV++FGV+L E+ +                       I    V  +++         
Sbjct: 195 IKSDVWAFGVLLWEIATYGMSP---------------YPGIDLSQVYELLEKDYRMERPE 239

Query: 832 ESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 867
               ++ E+   C +     RP   EI  A +   +
Sbjct: 240 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (503), Expect = 8e-58
 Identities = 63/288 (21%), Positives = 123/288 (42%), Gaps = 30/288 (10%)

Query: 586 ELEEATNNFC---KKIGKGSFGSVYYGKMK---DGKEVAVKIM-ADSCSHRTQQFVTEVA 638
           +L    +N      ++G G+FGSV  G  +      +VA+K++   +    T++ + E  
Sbjct: 2   KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61

Query: 639 LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDA 698
           ++ ++ +  +V LIG C+     +LV E    G L   L G   ++ +      ++ H  
Sbjct: 62  IMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQV 118

Query: 699 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED--LTHISSVARGT 756
           + G++YL        +HRD+ + N+LL     AK+SDFGLS+    D       S  +  
Sbjct: 119 SMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175

Query: 757 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 816
           + +  PE    ++ + +SDV+S+GV + E +S  +    +  G E+       + I++G 
Sbjct: 176 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV------MAFIEQGK 229

Query: 817 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 864
            +                  +  +   C   +   RP    +   ++ 
Sbjct: 230 RMECPPECP---------PELYALMSDCWIYKWEDRPDFLTVEQRMRA 268

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  196 bits (500), Expect = 3e-57
 Identities = 72/303 (23%), Positives = 136/303 (44%), Gaps = 42/303 (13%)

Query: 586 ELEEATNNFC-----------KKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRT 630
           +  EA   F            + IG G FG V  G +K   +    VA+K +    + + 
Sbjct: 11  DPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQ 70

Query: 631 -QQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWL 689
            + F++E +++ +  H N++ L G   +    +++ E+M NG+L   L    N      +
Sbjct: 71  RRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ--NDGQFTVI 128

Query: 690 TRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 749
             + +    A G++YL    +   +HRD+ + NIL++ N+  KVSDFGLSR  E+D +  
Sbjct: 129 QLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP 185

Query: 750 SSVA----RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNI 804
           +  +    +  + +  PE    ++ T  SDV+S+G+V+ E++S G++P         +N 
Sbjct: 186 TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINA 245

Query: 805 VHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 864
           +     +    D  S                 + ++ + C ++    RPK  +IV  +  
Sbjct: 246 IEQDYRLPPPMDCPS----------------ALHQLMLDCWQKDRNHRPKFGQIVNTLDK 289

Query: 865 SIK 867
            I+
Sbjct: 290 MIR 292

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (495), Expect = 8e-57
 Identities = 68/275 (24%), Positives = 110/275 (40%), Gaps = 25/275 (9%)

Query: 593 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLV 649
                IG GS+G     + K DGK +  K +          Q  V+EV LL  + H N+V
Sbjct: 7   EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV 66

Query: 650 PLIGYCEEEHQRIL--VYEYMHNGTLRDRLH-GSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
                  +     L  V EY   G L   +  G+  ++ LD    L++       L+  H
Sbjct: 67  RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 126

Query: 707 --TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
             +     ++HRD+K +N+ LD     K+ DFGL+R    D +   +   GT  Y+ PE 
Sbjct: 127 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAF-VGTPYYMSPEQ 185

Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 824
                  EKSD++S G +L EL +   P +                 I++G    I    
Sbjct: 186 MNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG-------KIREGKFRRIPYRY 238

Query: 825 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 859
                       + E+  + +  + + RP ++EI+
Sbjct: 239 SD---------ELNEIITRMLNLKDYHRPSVEEIL 264

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  195 bits (496), Expect = 1e-56
 Identities = 68/271 (25%), Positives = 113/271 (41%), Gaps = 33/271 (12%)

Query: 596 KKIGKGSFGSVYYGKMK-DGKEVAVKIM---ADSCSHRTQQFVTEVALLSRIHHRNLVPL 651
           ++IG GSFG+VY+ +   + + VA+K M       + + Q  + EV  L ++ H N +  
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80

Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 711
            G    EH   LV EY              ++KPL  +    + H A +GL YLH   + 
Sbjct: 81  RGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLH---SH 134

Query: 712 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY---GNQ 768
            +IHRDVK+ NILL      K+ DFG +       + +     GT  ++ PE        
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVILAMDEG 189

Query: 769 QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 828
           Q   K DV+S G+  +EL   K P+   +  + L         I + +  ++        
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-------HIAQNESPALQSGHWSEY 242

Query: 829 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 859
            +             C+++    RP  + ++
Sbjct: 243 FR--------NFVDSCLQKIPQDRPTSEVLL 265

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (496), Expect = 1e-56
 Identities = 75/286 (26%), Positives = 121/286 (42%), Gaps = 29/286 (10%)

Query: 588 EEATNNFCKKIGKGSFGSVYYGKMKDGK----EVAVKIM-ADSCSHRTQQFVTEVALLSR 642
                +F + IG+G FG VY+G + D        AVK +   +      QF+TE  ++  
Sbjct: 25  SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD 84

Query: 643 IHHRNLVPLIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 701
             H N++ L+G C   E   ++V  YM +G LR+                +      AKG
Sbjct: 85  FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKG 142

Query: 702 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA---EEDLTHISSVARGTVG 758
           +       +   +HRD+ + N +LD     KV+DFGL+R     E D  H  + A+  V 
Sbjct: 143 M---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 199

Query: 759 YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 818
           ++  E    Q+ T KSDV+SFGV+L EL++   P        ++N        + +G  +
Sbjct: 200 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITV-YLLQGRRL 253

Query: 819 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 864
              +              + EV ++C   +   RP   E+V  I  
Sbjct: 254 LQPE---------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 290

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (492), Expect = 4e-56
 Identities = 58/269 (21%), Positives = 114/269 (42%), Gaps = 26/269 (9%)

Query: 596 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 654
            ++G G+FG VY  + K+     A K++        + ++ E+ +L+   H N+V L+  
Sbjct: 18  GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77

Query: 655 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 714
              E+   ++ E+   G +   +     ++PL       +       L YLH   +  II
Sbjct: 78  FYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLH---DNKII 132

Query: 715 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY-----YGNQQ 769
           HRD+K+ NIL  ++   K++DFG+S +    +    S   GT  ++ PE        ++ 
Sbjct: 133 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF-IGTPYWMAPEVVMCETSKDRP 191

Query: 770 LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 829
              K+DV+S G+ L+E+   + P    +    L         I K +  ++  P    + 
Sbjct: 192 YDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL-------KIAKSEPPTLAQPSRWSS- 243

Query: 830 KIESIWRIAEVAIQCVEQRGFSRPKMQEI 858
                    +   +C+E+   +R    ++
Sbjct: 244 ------NFKDFLKKCLEKNVDARWTTSQL 266

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 3e-55
 Identities = 67/268 (25%), Positives = 109/268 (40%), Gaps = 30/268 (11%)

Query: 596 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQ---QFVTEVALLSRIHHRNLVPL 651
           + +GKG FG+VY  + K     +A+K++  +   +     Q   EV + S + H N++ L
Sbjct: 12  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71

Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 711
            GY  +  +  L+ EY   GT+   L         D         + A  L Y H   + 
Sbjct: 72  YGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCH---SK 125

Query: 712 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 771
            +IHRD+K  N+LL      K++DFG S  A            GT+ YL PE    +   
Sbjct: 126 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL---CGTLDYLPPEMIEGRMHD 182

Query: 772 EKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 831
           EK D++S GV+  E + GK P     F A      + R    +      V          
Sbjct: 183 EKVDLWSLGVLCYEFLVGKPP-----FEANTYQETYKRISRVEFTFPDFVTEGAR----- 232

Query: 832 ESIWRIAEVAIQCVEQRGFSRPKMQEIV 859
                  ++  + ++     RP ++E++
Sbjct: 233 -------DLISRLLKHNPSQRPMLREVL 253

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 3e-55
 Identities = 75/280 (26%), Positives = 129/280 (46%), Gaps = 28/280 (10%)

Query: 596 KKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNLV 649
           K IG G FG VY G +K         VA+K +    + + +  F+ E  ++ +  H N++
Sbjct: 13  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 72

Query: 650 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 709
            L G   +    +++ EYM NG L   L           L  + +    A G++YL    
Sbjct: 73  RLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLA--- 127

Query: 710 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED--LTHISSVARGTVGYLDPEYYGN 767
           N   +HRD+ + NIL++ N+  KVSDFGLSR  E+D   T+ +S  +  + +  PE    
Sbjct: 128 NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY 187

Query: 768 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 827
           ++ T  SDV+SFG+V+ E+++  +    E                   +V+  ++     
Sbjct: 188 RKFTSASDVWSFGIVMWEVMTYGERPYWEL---------------SNHEVMKAINDGFRL 232

Query: 828 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 867
              ++    I ++ +QC +Q    RPK  +IV  +   I+
Sbjct: 233 PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 4e-55
 Identities = 74/298 (24%), Positives = 124/298 (41%), Gaps = 41/298 (13%)

Query: 594 FCKKIGKGSFGSVYYGKMK------DGKEVAVKIM-ADSCSHRTQQFVTEVALLSRI-HH 645
           F K +G G+FG V                VAVK++   +     +  ++E+ +LS + +H
Sbjct: 27  FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86

Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG---------------SVNQKPLDWLT 690
            N+V L+G C      +++ EY   G L + L                   ++  LD   
Sbjct: 87  MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146

Query: 691 RLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH-I 749
            L  ++  AKG+ +L    +   IHRD+ + NILL      K+ DFGL+R  + D  + +
Sbjct: 147 LLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203

Query: 750 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR 809
              AR  V ++ PE   N   T +SDV+S+G+ L EL S             + +     
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS-----PYPGMPVDSKFY 258

Query: 810 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 867
            MIK+G  +   +              + ++   C +     RP  ++IV  I+  I 
Sbjct: 259 KMIKEGFRMLSPEHAP---------AEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 2e-54
 Identities = 54/198 (27%), Positives = 102/198 (51%), Gaps = 9/198 (4%)

Query: 596 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 654
           +KIG+G+ G+VY       G+EVA++ M      + +  + E+ ++    + N+V  +  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 655 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 714
                +  +V EY+  G+L D +     +  +D      +  +  + LE+LH   +  +I
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLH---SNQVI 138

Query: 715 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 774
           HRD+KS NILL ++   K++DFG   Q   + +  S++  GT  ++ PE    +    K 
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 197

Query: 775 DVYSFGVVLLELISGKKP 792
           D++S G++ +E+I G+ P
Sbjct: 198 DIWSLGIMAIEMIEGEPP 215

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 3e-54
 Identities = 77/296 (26%), Positives = 128/296 (43%), Gaps = 38/296 (12%)

Query: 593 NFCKKIGKGSFGSVYYGKMKDG---KEVAVKIMADSCSHR-TQQFVTEVALLSRI-HHRN 647
            F   IG+G+FG V   ++K      + A+K M +  S    + F  E+ +L ++ HH N
Sbjct: 13  KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 72

Query: 648 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG-------------SVNQKPLDWLTRLQI 694
           ++ L+G CE      L  EY  +G L D L               +     L     L  
Sbjct: 73  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 132

Query: 695 AHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR 754
           A D A+G++YL        IHRD+ + NIL+  N  AK++DFGLSR  E  +    ++ R
Sbjct: 133 AADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--TMGR 187

Query: 755 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK 814
             V ++  E       T  SDV+S+GV+L E++S           AEL         + +
Sbjct: 188 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL------YEKLPQ 241

Query: 815 GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 870
           G  +                  + ++  QC  ++ + RP   +I++++   ++  K
Sbjct: 242 GYRLEKPLNCD---------DEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 2e-53
 Identities = 64/295 (21%), Positives = 113/295 (38%), Gaps = 46/295 (15%)

Query: 594 FCKKIGKGSFGSVYYGKMKD------GKEVAVKIM-ADSCSHRTQQFVTEVALLSRI-HH 645
           F K +G G+FG V               +VAVK++   + S   +  ++E+ +++++  H
Sbjct: 41  FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 100

Query: 646 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG--------------------SVNQKP 685
            N+V L+G C       L++EY   G L + L                        +   
Sbjct: 101 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160

Query: 686 LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 745
           L +   L  A+  AKG+E+L        +HRD+ + N+L+      K+ DFGL+R    D
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217

Query: 746 LTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNI 804
             + +   AR  V ++ PE       T KSDV+S+G++L E+ S                
Sbjct: 218 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN------------ 265

Query: 805 VHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 859
                 +    +   ++      +    +   I  +   C       RP    + 
Sbjct: 266 --PYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT 318

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (465), Expect = 9e-53
 Identities = 68/281 (24%), Positives = 112/281 (39%), Gaps = 29/281 (10%)

Query: 594 FCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSCSHRTQ---QFVTEVALLSRIHHR 646
             +K+G GSFG V  G+          VAVK +      + +    F+ EV  +  + HR
Sbjct: 12  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 71

Query: 647 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
           NL+ L G       ++ V E    G+L DRL    +Q      T  + A   A+G+ YL 
Sbjct: 72  NLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLE 128

Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH--ISSVARGTVGYLDPEY 764
              +   IHRD+ + N+LL      K+ DFGL R   ++  H  +    +    +  PE 
Sbjct: 129 ---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 185

Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 824
              +  +  SD + FGV L E+ +  +          LN       + K+G+ +   +  
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEMFTYGQE-----PWIGLNGSQILHKIDKEGERLPRPEDC 240

Query: 825 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 865
                       I  V +QC   +   RP    +   + ++
Sbjct: 241 ---------PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (464), Expect = 1e-52
 Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 12/211 (5%)

Query: 584 LPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIM-ADSCSHRTQQFVTEVALLS 641
           +P +E+      + +G+G++G V     +   + VAVKI+         +    E+ +  
Sbjct: 1   VPFVEDWD--LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINK 58

Query: 642 RIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 701
            ++H N+V   G+  E + + L  EY   G L DR+        +      +  H    G
Sbjct: 59  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAG 115

Query: 702 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED-LTHISSVARGTVGYL 760
           + YLH     GI HRD+K  N+LLD     K+SDFGL+     +    + +   GT+ Y+
Sbjct: 116 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 172

Query: 761 DPEYYGNQQL-TEKSDVYSFGVVLLELISGK 790
            PE    ++   E  DV+S G+VL  +++G+
Sbjct: 173 APELLKRREFHAEPVDVWSCGIVLTAMLAGE 203

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (462), Expect = 3e-52
 Identities = 63/282 (22%), Positives = 117/282 (41%), Gaps = 26/282 (9%)

Query: 594 FCKKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRT-QQFVTEVALLSRIHHRNL 648
             + IG+G FG V+ G     +     VA+K   +  S    ++F+ E   + +  H ++
Sbjct: 11  LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70

Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           V LIG   E     ++ E    G LR      V +  LD  + +  A+  +  L YL   
Sbjct: 71  VKLIGVITENP-VWIIMELCTLGELRS--FLQVRKYSLDLASLILYAYQLSTALAYLE-- 125

Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
            +   +HRD+ + N+L+  N   K+ DFGLSR  E+   + +S  +  + ++ PE    +
Sbjct: 126 -SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 184

Query: 769 QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 828
           + T  SDV+ FGV + E++             ++         I+ G+ + +        
Sbjct: 185 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV------IGRIENGERLPMPPNCPP-- 236

Query: 829 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 870
                   +  +  +C       RP+  E+   +   ++ EK
Sbjct: 237 -------TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 271

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (454), Expect = 7e-51
 Identities = 65/289 (22%), Positives = 123/289 (42%), Gaps = 33/289 (11%)

Query: 594 FCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSHR-TQQFVTEVALLSRIHHR 646
             +++G+GSFG VY G  K          VA+K + ++ S R   +F+ E +++   +  
Sbjct: 24  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 83

Query: 647 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLH-------GSVNQKPLDWLTRLQIAHDAA 699
           ++V L+G   +    +++ E M  G L+  L         +    P      +Q+A + A
Sbjct: 84  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143

Query: 700 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTVG 758
            G+ YL        +HRD+ + N ++  +   K+ DFG++R   E D           V 
Sbjct: 144 DGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 200

Query: 759 YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 818
           ++ PE   +   T  SDV+SFGVVL E+ +  +         ++         + +G ++
Sbjct: 201 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV------LRFVMEGGLL 254

Query: 819 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 867
              D              + E+   C +     RP   EI+ +I++ ++
Sbjct: 255 DKPDNCP---------DMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  178 bits (453), Expect = 3e-50
 Identities = 45/200 (22%), Positives = 92/200 (46%), Gaps = 10/200 (5%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 654
           +++G G+FG V+       G+    K +             E+++++++HH  L+ L   
Sbjct: 35  EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 94

Query: 655 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 714
            E++++ +L+ E++  G L DR+        +     +     A +GL+++H      I+
Sbjct: 95  FEDKYEMVLILEFLSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMH---EHSIV 149

Query: 715 HRDVKSSNILLDI--NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 772
           H D+K  NI+ +       K+ DFGL+ +   D     +    T  +  PE    + +  
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAEFAAPEIVDREPVGF 207

Query: 773 KSDVYSFGVVLLELISGKKP 792
            +D+++ GV+   L+SG  P
Sbjct: 208 YTDMWAIGVLGYVLLSGLSP 227

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  177 bits (451), Expect = 6e-50
 Identities = 46/200 (23%), Positives = 90/200 (45%), Gaps = 10/200 (5%)

Query: 596 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 654
           +++G G+FG V+    +  G   A K +        +    E+  +S + H  LV L   
Sbjct: 32  EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 91

Query: 655 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 714
            E++++ +++YE+M  G L +++        +     ++      KGL ++H       +
Sbjct: 92  FEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYV 146

Query: 715 HRDVKSSNILL--DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 772
           H D+K  NI+     +   K+ DFGL+   +   +   +   GT  +  PE    + +  
Sbjct: 147 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAEGKPVGY 204

Query: 773 KSDVYSFGVVLLELISGKKP 792
            +D++S GV+   L+SG  P
Sbjct: 205 YTDMWSVGVLSYILLSGLSP 224

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (443), Expect = 2e-49
 Identities = 60/271 (22%), Positives = 127/271 (46%), Gaps = 28/271 (10%)

Query: 596 KKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHRT-QQFVTEVALLSRIHHRNLV 649
           K +G G+FG+VY G      E     VA+K + ++ S +  ++ + E  +++ + + ++ 
Sbjct: 15  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74

Query: 650 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 709
            L+G C     + L+ + M  G L D +    ++  +     L      AKG+ YL    
Sbjct: 75  RLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL---E 128

Query: 710 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYLDPEYYGNQ 768
           +  ++HRD+ + N+L+      K++DFGL++    E+  + +   +  + ++  E   ++
Sbjct: 129 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 188

Query: 769 QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 828
             T +SDV+S+GV + EL++           +E+       S+++KG+ +       I  
Sbjct: 189 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI------SSILEKGERLPQPPICTI-- 240

Query: 829 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 859
                   +  + ++C      SRPK +E++
Sbjct: 241 -------DVYMIMVKCWMIDADSRPKFRELI 264

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (438), Expect = 9e-49
 Identities = 70/297 (23%), Positives = 125/297 (42%), Gaps = 40/297 (13%)

Query: 594 FCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSHRTQQ-FVTEVALLSRI-HH 645
             K +G+G+FG V              + VAVK++ +  +H   +  ++E+ +L  I HH
Sbjct: 17  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 76

Query: 646 RNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHG-------------SVNQKPLDWLTR 691
            N+V L+G C +    + ++ E+   G L   L                + +  L     
Sbjct: 77  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136

Query: 692 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-S 750
           +  +   AKG+E+L    +   IHRD+ + NILL      K+ DFGL+R   +D  ++  
Sbjct: 137 ICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193

Query: 751 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS 810
             AR  + ++ PE   ++  T +SDV+SFGV+L E+ S             + I      
Sbjct: 194 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDEEFCR 248

Query: 811 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 867
            +K+G  +   D              + +  + C       RP   E+V  + + ++
Sbjct: 249 RLKEGTRMRAPDYTTP---------EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 1e-48
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 11/204 (5%)

Query: 594 FCKKIGKGSFGSVYYGK-MKDGKEVAVKIM---ADSCSHRTQQFVTEVALLSRIHHRNLV 649
           F K +G+GSF +V   + +   +E A+KI+        ++      E  ++SR+ H   V
Sbjct: 12  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 71

Query: 650 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 709
            L    +++ +      Y  NG L   +         D         +    LEYLH   
Sbjct: 72  KLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLH--- 125

Query: 710 NPGIIHRDVKSSNILLDINMRAKVSDFGLSR-QAEEDLTHISSVARGTVGYLDPEYYGNQ 768
             GIIHRD+K  NILL+ +M  +++DFG ++  + E     ++   GT  Y+ PE    +
Sbjct: 126 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185

Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
              + SD+++ G ++ +L++G  P
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPP 209

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 2e-47
 Identities = 64/294 (21%), Positives = 123/294 (41%), Gaps = 42/294 (14%)

Query: 594 FCKKIGKGSFGSVYYGKMK--------DGKEVAVKIM-ADSCSHRTQQFVTEVALLSRI- 643
             K +G+G+FG V   +             +VAVK++ +D+        ++E+ ++  I 
Sbjct: 17  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76

Query: 644 HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLH-------------GSVNQKPLDWLT 690
            H+N++ L+G C ++    ++ EY   G LR+ L                  ++ L    
Sbjct: 77  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136

Query: 691 RLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 750
            +  A+  A+G+EYL    +   IHRD+ + N+L+  +   K++DFGL+R       +  
Sbjct: 137 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193

Query: 751 S-VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR 809
           +   R  V ++ PE   ++  T +SDV+SFGV+L E+ +                V    
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY------PGVPVEELF 247

Query: 810 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 863
            ++K+G  +                  +  +   C       RP  +++V  + 
Sbjct: 248 KLLKEGHRMDKPSNCT---------NELYMMMRDCWHAVPSQRPTFKQLVEDLD 292

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 6e-47
 Identities = 61/322 (18%), Positives = 136/322 (42%), Gaps = 36/322 (11%)

Query: 596 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 654
           + +G+G FG V+        K    K +    + +      E+++L+   HRN++ L   
Sbjct: 11  EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIARHRNILHLHES 69

Query: 655 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 714
            E   + ++++E++    + +R++   +   L+    +   H   + L++LH   +  I 
Sbjct: 70  FESMEELVMIFEFISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLH---SHNIG 124

Query: 715 HRDVKSSNILLDI--NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 772
           H D++  NI+     +   K+ +FG +RQ +               Y  PE + +  ++ 
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL--FTAPEYYAPEVHQHDVVST 182

Query: 773 KSDVYSFGVVLLELISGKKPVSVEDFGAEL-NIVHWARSMIKKG------DVISIVDPVL 825
            +D++S G ++  L+SG  P   E     + NI++   +  ++       + +  VD +L
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLL 242

Query: 826 IGNVK--------------IESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG 871
           +   K               + I R++   I+ ++ R +    +++ +  +  + +I  G
Sbjct: 243 VKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKKDLNMVVSAARISCG 302

Query: 872 GDQKFSSSSSKGQSSRKTLLTS 893
           G    +  S KG S  K  + S
Sbjct: 303 G----AIRSQKGVSVAKVKVAS 320

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  164 bits (415), Expect = 6e-46
 Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 16/207 (7%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPL 651
           + +G G    V+  + ++  ++VAVK++    +       +F  E    + ++H  +V +
Sbjct: 13  EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 72

Query: 652 IGYCEEEHQRI----LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
               E E        +V EY+   TLRD +H    + P+     +++  DA + L +   
Sbjct: 73  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFS-- 127

Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGYLDPEYY 765
               GIIHRDVK +NI++      KV DFG++R   +    ++  A   GT  YL PE  
Sbjct: 128 -HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186

Query: 766 GNQQLTEKSDVYSFGVVLLELISGKKP 792
               +  +SDVYS G VL E+++G+ P
Sbjct: 187 RGDSVDARSDVYSLGCVLYEVLTGEPP 213

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  162 bits (412), Expect = 2e-45
 Identities = 59/214 (27%), Positives = 92/214 (42%), Gaps = 25/214 (11%)

Query: 596 KKIGKGSFGSVYYGKMK-DGKEVAVKIM---------ADSCSHRTQQFVTEVALLSRIH- 644
           + +G+G    V     K   KE AVKI+         A+      +  + EV +L ++  
Sbjct: 9   EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68

Query: 645 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 704
           H N++ L    E      LV++ M  G L D L     +  L      +I     + +  
Sbjct: 69  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRALLEVICA 125

Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
           LH      I+HRD+K  NILLD +M  K++DFG S Q +           GT  YL PE 
Sbjct: 126 LH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EKLREVCGTPSYLAPEI 180

Query: 765 Y------GNQQLTEKSDVYSFGVVLLELISGKKP 792
                   +    ++ D++S GV++  L++G  P
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 214

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  162 bits (412), Expect = 3e-45
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 13/205 (6%)

Query: 593 NFCKKIGKGSFGSVYYGK-MKDGKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVP 650
           +F   +G G+F  V   +  +  K VA+K +A  +   +      E+A+L +I H N+V 
Sbjct: 12  DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVA 71

Query: 651 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 710
           L    E      L+ + +  G L DR+     +         ++       ++YLH    
Sbjct: 72  LDDIYESGGHLYLIMQLVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHDLG- 127

Query: 711 PGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 767
             I+HRD+K  N+L    D + +  +SDFGLS+  +      ++   GT GY+ PE    
Sbjct: 128 --IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC--GTPGYVAPEVLAQ 183

Query: 768 QQLTEKSDVYSFGVVLLELISGKKP 792
           +  ++  D +S GV+   L+ G  P
Sbjct: 184 KPYSKAVDCWSIGVIAYILLCGYPP 208

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  164 bits (417), Expect = 3e-45
 Identities = 56/230 (24%), Positives = 92/230 (40%), Gaps = 19/230 (8%)

Query: 592 NNF--CKKIGKGSFGSVYYGKMKD-GKEVAVKIM------ADSCSHRTQQFVTEVALLSR 642
           N+F   + IG+G FG VY  +  D GK  A+K +                    ++L+S 
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 643 IHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGL 702
                +V +        +   + + M+ G L   L                 A +   GL
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGL 120

Query: 703 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDP 762
           E++H   N  +++RD+K +NILLD +   ++SD GL+    +   H S    GT GY+ P
Sbjct: 121 EHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAP 174

Query: 763 EYY-GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM 811
           E           +D +S G +L +L+ G  P        +  I     +M
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 224

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (408), Expect = 2e-44
 Identities = 56/227 (24%), Positives = 98/227 (43%), Gaps = 12/227 (5%)

Query: 594 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHR---TQQFVTEVALLSR-IHHRNL 648
             K +GKGSFG V+  + K   +  A+K +           +  + E  +LS    H  L
Sbjct: 6   LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 65

Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
             +    + +     V EY++ G L   +    +    D       A +   GL++L   
Sbjct: 66  THMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFL--- 119

Query: 709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 768
            + GI++RD+K  NILLD +   K++DFG+ ++        ++   GT  Y+ PE    Q
Sbjct: 120 HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILLGQ 178

Query: 769 QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 815
           +     D +SFGV+L E++ G+ P   +D     + +        + 
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW 225

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  161 bits (407), Expect = 2e-44
 Identities = 54/201 (26%), Positives = 97/201 (48%), Gaps = 14/201 (6%)

Query: 596 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQ---FVTEVALLSRIHHRNLVPL 651
           + +G GSFG V+  + + +G+  A+K++      R +Q      E  +LS + H  ++ +
Sbjct: 10  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69

Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 711
            G  ++  Q  ++ +Y+  G L   L      +          A +    LEYLH   + 
Sbjct: 70  WGTFQDAQQIFMIMDYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLH---SK 123

Query: 712 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 771
            II+RD+K  NILLD N   K++DFG ++   +    +     GT  Y+ PE    +   
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTL----CGTPDYIAPEVVSTKPYN 179

Query: 772 EKSDVYSFGVVLLELISGKKP 792
           +  D +SFG+++ E+++G  P
Sbjct: 180 KSIDWWSFGILIYEMLAGYTP 200

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  159 bits (403), Expect = 4e-44
 Identities = 61/283 (21%), Positives = 97/283 (34%), Gaps = 28/283 (9%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 654
           +KIG GSFG +Y G  +  G+EVA+K+      H   Q   E  +   +     +P I +
Sbjct: 13  RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRW 70

Query: 655 C-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 713
           C  E    ++V E +               +     T L +A      +EY+H   +   
Sbjct: 71  CGAEGDYNVMVMELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIH---SKNF 124

Query: 714 IHRDVKSSNIL---LDINMRAKVSDFGLSRQAEEDLTHI------SSVARGTVGYLDPEY 764
           IHRDVK  N L           + DFGL+++  +  TH       +    GT  Y     
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184

Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 824
           +   + + + D+ S G VL+    G  P        +                +S    V
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK-----MSTPIEV 239

Query: 825 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 867
           L      E     A     C   R   +P    +    ++   
Sbjct: 240 LCKGYPSE----FATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  158 bits (400), Expect = 8e-44
 Identities = 42/199 (21%), Positives = 89/199 (44%), Gaps = 8/199 (4%)

Query: 596 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLIG 653
           +KIG+G++G VY  +   G+  A+K +             + E+++L  + H N+V L  
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67

Query: 654 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 713
               + + +LV+E++     +        +  L+ +T          G+ Y H   +  +
Sbjct: 68  VIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCH---DRRV 121

Query: 714 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 773
           +HRD+K  N+L++     K++DFGL+R     +   +               G+++ +  
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTT 181

Query: 774 SDVYSFGVVLLELISGKKP 792
            D++S G +  E+++G   
Sbjct: 182 IDIWSVGCIFAEMVNGTPL 200

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 1e-42
 Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 18/214 (8%)

Query: 588 EEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR 646
           +E +    K IG GSFG VY  K+ D G+ VA+K +        +    E+ ++ ++ H 
Sbjct: 18  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHC 73

Query: 647 NLVPLIGYCEEEHQR------ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 700
           N+V L  +     ++       LV +Y+     R   H S  ++ L  +      +   +
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133

Query: 701 GLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLTHISSVARGTVGY 759
            L Y+H   + GI HRD+K  N+LLD +    K+ DFG ++Q      ++S +      Y
Sbjct: 134 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR--YY 188

Query: 760 LDP-EYYGNQQLTEKSDVYSFGVVLLELISGKKP 792
             P   +G    T   DV+S G VL EL+ G+  
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 222

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  155 bits (392), Expect = 1e-42
 Identities = 42/284 (14%), Positives = 91/284 (32%), Gaps = 28/284 (9%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 654
           ++IG+GSFG ++ G  + + ++VA+K           Q   E      +     +P + Y
Sbjct: 11  RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYY 68

Query: 655 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 714
             +E    ++   +   +L D L   +  +     T    A      ++ +H      ++
Sbjct: 69  FGQEGLHNVLVIDLLGPSLEDLLD--LCGRKFSVKTVAMAAKQMLARVQSIH---EKSLV 123

Query: 715 HRDVKSSNILLD-----INMRAKVSDFGLSRQAEEDLTHI------SSVARGTVGYLDPE 763
           +RD+K  N L+            V DFG+ +   + +T             GT  Y+   
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183

Query: 764 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 823
            +  ++ + + D+ + G V +  + G  P                    +   +      
Sbjct: 184 THLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL-----R 238

Query: 824 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 867
            L      E      +           + P    +       ++
Sbjct: 239 ELCAGFPEE----FYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (389), Expect = 3e-42
 Identities = 43/200 (21%), Positives = 88/200 (44%), Gaps = 8/200 (4%)

Query: 596 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 652
           +KIG+G++G VY  + K  G+ VA+K +             + E++LL  ++H N+V L+
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67

Query: 653 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 712
                E++  LV+E++H    +           +             +GL +     +  
Sbjct: 68  DVIHTENKLYLVFEFLHQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFC---HSHR 122

Query: 713 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 772
           ++HRD+K  N+L++     K++DFGL+R     +   +               G +  + 
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 182

Query: 773 KSDVYSFGVVLLELISGKKP 792
             D++S G +  E+++ +  
Sbjct: 183 AVDIWSLGCIFAEMVTRRAL 202

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 1e-41
 Identities = 49/231 (21%), Positives = 90/231 (38%), Gaps = 15/231 (6%)

Query: 596 KKIGKGSFGSVYYGKMK--DGKEVAVKIM-----ADSCSHRTQQFVTEVALLSRIHHRNL 648
            +IG+G++G V+  +     G+ VA+K +      +     T + V  +  L    H N+
Sbjct: 13  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72

Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLR---DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 705
           V L   C            +    +          V +  +   T   +     +GL++L
Sbjct: 73  VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132

Query: 706 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 765
           H   +  ++HRD+K  NIL+  + + K++DFGL+R     +   S V   T+ Y  PE  
Sbjct: 133 H---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV--VTLWYRAPEVL 187

Query: 766 GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 816
                    D++S G +  E+   K          +L  +     +  + D
Sbjct: 188 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 1e-41
 Identities = 51/204 (25%), Positives = 88/204 (43%), Gaps = 14/204 (6%)

Query: 596 KKIGKGSFGSVYYGKMK-DGKEVAVKIM-----ADSCSHRTQQFVTEVALLSRIHHRNLV 649
             +G+G F +VY  + K   + VA+K +     +++     +  + E+ LL  + H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 650 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 709
            L+     +    LV+++M             N   L             +GLEYLH   
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLH--- 117

Query: 710 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY-GNQ 768
              I+HRD+K +N+LLD N   K++DFGL++         +     T  Y  PE   G +
Sbjct: 118 QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGAR 176

Query: 769 QLTEKSDVYSFGVVLLELISGKKP 792
                 D+++ G +L EL+     
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPF 200

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (386), Expect = 2e-41
 Identities = 52/231 (22%), Positives = 94/231 (40%), Gaps = 23/231 (9%)

Query: 596 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIG 653
           + +G G  G V     K   ++ A+K++ D       +   EV L  R     ++V ++ 
Sbjct: 18  QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVD 72

Query: 654 YCE----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 709
             E         ++V E +  G L  R+      +        +I     + ++YLH   
Sbjct: 73  VYENLYAGRKCLLIVMECLDGGELFSRIQ-DRGDQAFTEREASEIMKSIGEAIQYLH--- 128

Query: 710 NPGIIHRDVKSSNILLD---INMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 766
           +  I HRDVK  N+L      N   K++DFG +++     +  +     T  Y+ PE  G
Sbjct: 129 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP--CYTPYYVAPEVLG 186

Query: 767 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 817
            ++  +  D++S GV++  L+ G  P         L I    ++ I+ G  
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNH---GLAISPGMKTRIRMGQY 234

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 4e-41
 Identities = 54/232 (23%), Positives = 103/232 (44%), Gaps = 8/232 (3%)

Query: 596 KKIGKGSFGSVYYGKMK-DGKEVAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 653
             IG+G++G V       +   VA+K +         Q+ + E+ +L R  H N++ +  
Sbjct: 14  SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73

Query: 654 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 713
                    +   Y+    +   L+  +  + L         +   +GL+Y+H   +  +
Sbjct: 74  IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANV 130

Query: 714 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGYLDPEYYGNQQL- 770
           +HRD+K SN+LL+     K+ DFGL+R A+ D  H   +     T  Y  PE   N +  
Sbjct: 131 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 190

Query: 771 TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 822
           T+  D++S G +L E++S +     + +  +LN +        + D+  I++
Sbjct: 191 TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (373), Expect = 4e-40
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 9/200 (4%)

Query: 596 KKIGKGSFGSVYYGKMK-DGKEVAVKIM--ADSCSHRTQQFVTEVALLSRIHHRNLVPLI 652
           +KIG+G++G+V+  K +   + VA+K +   D         + E+ LL  + H+N+V L 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 653 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 712
                + +  LV+E+      +           LD            KGL + H   +  
Sbjct: 68  DVLHSDKKLTLVFEFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCH---SRN 121

Query: 713 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 772
           ++HRD+K  N+L++ N   K+++FGL+R     +   S+             +G +  + 
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181

Query: 773 KSDVYSFGVVLLELISGKKP 792
             D++S G +  EL +  +P
Sbjct: 182 SIDMWSAGCIFAELANAGRP 201

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (373), Expect = 4e-40
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 19/208 (9%)

Query: 596 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRT------QQFVTEVALLSRIHHRNL 648
           +++G G F  V   + K  G + A K +    +  +      +    EV++L  I H N+
Sbjct: 16  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 75

Query: 649 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 708
           + L    E +   IL+ E +  G L D L     ++ L      +       G+ YLH  
Sbjct: 76  ITLHEVYENKTDVILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLH-- 130

Query: 709 CNPGIIHRDVKSSNILLD----INMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 764
            +  I H D+K  NI+L        R K+ DFGL+ + +      +    GT  ++ PE 
Sbjct: 131 -SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--GTPEFVAPEI 187

Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKP 792
              + L  ++D++S GV+   L+SG  P
Sbjct: 188 VNYEPLGLEADMWSIGVITYILLSGASP 215

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 6e-40
 Identities = 54/216 (25%), Positives = 91/216 (42%), Gaps = 11/216 (5%)

Query: 594 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH---RTQQFVTEVALLSRIHHRNLV 649
           + K +GKG+FG V   + K  G+  A+KI+              VTE  +L    H  L 
Sbjct: 9   YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 68

Query: 650 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 709
            L    +   +   V EY + G L   L            T  +     A+ +  L    
Sbjct: 69  ALKYAFQTHDRLCFVMEYANGGELFFHLSRE------RVFTEERARFYGAEIVSALEYLH 122

Query: 710 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQ 769
           +  +++RD+K  N++LD +   K++DFGL ++   D   + +   GT  YL PE   +  
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDND 181

Query: 770 LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
                D +  GVV+ E++ G+ P   +D      ++
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 2e-39
 Identities = 49/223 (21%), Positives = 87/223 (39%), Gaps = 24/223 (10%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVKIM------ADSCSHRTQQFVTEVALLSRIH--HR 646
             +G G FGSVY G  + D   VA+K +               +   EV LL ++     
Sbjct: 10  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69

Query: 647 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
            ++ L+ + E     +L+ E                +  L             + + +  
Sbjct: 70  GVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAVRHC- 126

Query: 707 TGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 765
              N G++HRD+K  NIL+D+N    K+ DFG     ++ +        GT  Y  PE+ 
Sbjct: 127 --HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT---DFDGTRVYSPPEWI 181

Query: 766 -GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHW 807
             ++     + V+S G++L +++ G  P     F  +  I+  
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIP-----FEHDEEIIRG 219

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  145 bits (367), Expect = 8e-39
 Identities = 51/218 (23%), Positives = 90/218 (41%), Gaps = 14/218 (6%)

Query: 596 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQ---FVTEVALLSRIHHRNLVPL 651
           K +G GSFG V   K K  G   A+KI+      + +Q    + E  +L  ++   LV L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106

Query: 652 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 711
               ++     +V EY+  G +   L                 A       EYLH   + 
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLH---SL 160

Query: 712 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 771
            +I+RD+K  N+L+D     +V+DFG +++ +     +     GT   L PE   ++   
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL----CGTPEALAPEIILSKGYN 216

Query: 772 EKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR 809
           +  D ++ GV++ E+ +G  P   +        +   +
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK 254

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 5e-38
 Identities = 50/225 (22%), Positives = 97/225 (43%), Gaps = 21/225 (9%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVKIM--ADSCSHRTQQFVTEVALLSRIHHRNLVPLI 652
            KIG+G+FG V+  +  K G++VA+K +   +         + E+ +L  + H N+V LI
Sbjct: 16  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75

Query: 653 GYCEE--------EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 704
             C          +    LV+++  +       +       L   T  +I       L  
Sbjct: 76  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN------VLVKFTLSEIKRVMQMLLNG 129

Query: 705 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVGYLD 761
           L+      I+HRD+K++N+L+  +   K++DFGL+R    A+    +  +    T+ Y  
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189

Query: 762 PEYY-GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 805
           PE   G +      D++  G ++ E+ +    +       +L ++
Sbjct: 190 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 234

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 2e-36
 Identities = 46/201 (22%), Positives = 88/201 (43%), Gaps = 10/201 (4%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 652
           + +G G++G+V      + G +VA+K +          ++   E+ LL  + H N++ L+
Sbjct: 24  QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 83

Query: 653 GYCEEEHQRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 711
                +       ++           G +   + L       + +   KGL Y+H     
Sbjct: 84  DVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH---AA 140

Query: 712 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 771
           GIIHRD+K  N+ ++ +   K+ DFGL+RQA+ ++T                     + T
Sbjct: 141 GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT---GYVVTRWYRAPEVILNWMRYT 197

Query: 772 EKSDVYSFGVVLLELISGKKP 792
           +  D++S G ++ E+I+GK  
Sbjct: 198 QTVDIWSVGCIMAEMITGKTL 218

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  134 bits (337), Expect = 5e-35
 Identities = 45/205 (21%), Positives = 92/205 (44%), Gaps = 20/205 (9%)

Query: 594 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPL 651
             +K+G+G +  V+      + ++V VKI+      + ++   E+ +L  +    N++ L
Sbjct: 39  LVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITL 95

Query: 652 IGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 709
               ++   R   LV+E+++N   +         + L         ++  K L+Y H   
Sbjct: 96  ADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCH--- 146

Query: 710 NPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY-GN 767
           + GI+HRDVK  N+++D  + + ++ D+GL+        +   V   +  +  PE     
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV--ASRYFKGPELLVDY 204

Query: 768 QQLTEKSDVYSFGVVLLELISGKKP 792
           Q      D++S G +L  +I  K+P
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEP 229

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 5e-35
 Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 17/208 (8%)

Query: 596 KKIGKGSFGSVYYGK----MKDGKEVAVKIM----ADSCSHRTQQFVTEVALLSRI-HHR 646
           K +G G++G V+  +       GK  A+K++        +  T+   TE  +L  I    
Sbjct: 30  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89

Query: 647 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
            LV L    + E +  L+ +Y++ G L   L         +  T  ++     + +  L 
Sbjct: 90  FLVTLHYAFQTETKLHLILDYINGGELFTHLSQR------ERFTEHEVQIYVGEIVLALE 143

Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE--Y 764
                GII+RD+K  NILLD N    ++DFGLS++   D T  +    GT+ Y+ P+   
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 203

Query: 765 YGNQQLTEKSDVYSFGVVLLELISGKKP 792
            G+    +  D +S GV++ EL++G  P
Sbjct: 204 GGDSGHDKAVDWWSLGVLMYELLTGASP 231

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 2e-31
 Identities = 44/205 (21%), Positives = 87/205 (42%), Gaps = 18/205 (8%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 652
             +G G++GSV      K G  VAVK ++         ++   E+ LL  + H N++ L+
Sbjct: 24  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83

Query: 653 GYCEE-----EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 707
                     E   + +  ++    L + +      + L       + +   +GL+Y+H 
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIH- 138

Query: 708 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 767
             +  IIHRD+K SN+ ++ +   K+ DFGL+R  +     ++                 
Sbjct: 139 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---DEMTGYVATRWYRAPEIMLNW 193

Query: 768 QQLTEKSDVYSFGVVLLELISGKKP 792
               +  D++S G ++ EL++G+  
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTL 218

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 4e-31
 Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 20/217 (9%)

Query: 596 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 652
           K IG G+ G V         + VA+K ++    ++T  ++   E+ L+  ++H+N++ L+
Sbjct: 23  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82

Query: 653 GYC------EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 706
                    EE     LV E M     +        Q  LD      + +    G+++LH
Sbjct: 83  NVFTPQKTLEEFQDVYLVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHLH 136

Query: 707 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 766
           +      IHRD+K SNI++  +   K+ DFGL+R A         V   T  Y  PE   
Sbjct: 137 SAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV--VTRYYRAPEVIL 191

Query: 767 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN 803
                E  D++S G ++ E++  K      D+  + N
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 228

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  122 bits (307), Expect = 7e-31
 Identities = 50/238 (21%), Positives = 94/238 (39%), Gaps = 27/238 (11%)

Query: 596 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 654
           +K+G G F +V+  K M +   VA+KI+       T+    E+ LL R++  +       
Sbjct: 19  RKLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 77

Query: 655 CEEEHQRILVY-------------EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 701
                 ++L +              +   G     L      + +  +   QI+     G
Sbjct: 78  GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137

Query: 702 LEYLHTGCNPGIIHRDVKSSNILLDIN------MRAKVSDFGLSRQAEEDLTHISSVARG 755
           L+Y+H     GIIH D+K  N+L++I       ++ K++D G +   +E  T+       
Sbjct: 138 LDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS----IQ 191

Query: 756 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK 813
           T  Y  PE          +D++S   ++ ELI+G      ++  +          +I+
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 91.4 bits (226), Expect = 1e-21
 Identities = 24/163 (14%), Positives = 49/163 (30%), Gaps = 28/163 (17%)

Query: 596 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS----------HRTQQFVTEVALLSRIHH 645
           K +G+G   +V+    +   E  VK      +          +    F       +R   
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 646 RNLVPLIGYCEEEH----QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 701
           R L  L G    +        ++ E +                 +      ++     + 
Sbjct: 66  RALQKLQGLAVPKVYAWEGNAVLMELIDAK----------ELYRVRVENPDEVLDMILEE 115

Query: 702 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 744
           +   +   + GI+H D+   N+L+       + DF  S +  E
Sbjct: 116 VAKFY---HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGE 154

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 67.3 bits (163), Expect = 2e-12
 Identities = 12/93 (12%), Positives = 37/93 (39%), Gaps = 5/93 (5%)

Query: 383 WEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLID 442
                   +    +T + L   N+    P  + ++  L  L+   N ++     ++ L +
Sbjct: 296 QLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDV-SSLANLTN 352

Query: 443 LRIVHLENNELTGSLPSYMGSLPNLQELHIENN 475
           +  +   +N+++   P  + +L  + +L + + 
Sbjct: 353 INWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 56.5 bits (135), Expect = 7e-09
 Identities = 21/72 (29%), Positives = 35/72 (48%), Gaps = 3/72 (4%)

Query: 416 NMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 475
           N++ LT L L  N ++   P +S L  L+ +   NN+++    S + +L N+  L   +N
Sbjct: 305 NLKNLTYLTLYFNNISDISP-VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHN 361

Query: 476 SFVGEIPPALLT 487
                 P A LT
Sbjct: 362 QISDLTPLANLT 373

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 45.8 bits (107), Expect = 2e-05
 Identities = 17/78 (21%), Positives = 35/78 (44%), Gaps = 5/78 (6%)

Query: 398 KIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSL 457
           K  L   N+   +     +++ +T L  D   +   +  +  L +L  ++  NN+LT   
Sbjct: 26  KTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-IDGVEYLNNLTQINFSNNQLTDIT 82

Query: 458 PSYMGSLPNLQELHIENN 475
           P  + +L  L ++ + NN
Sbjct: 83  P--LKNLTKLVDILMNNN 98

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 42.7 bits (99), Expect = 2e-04
 Identities = 12/73 (16%), Positives = 26/73 (35%), Gaps = 3/73 (4%)

Query: 415 KNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 474
             +    +  L    +T  +   + L  +  +  +   +  S+   +  L NL +++  N
Sbjct: 19  TALAEKMKTVLGKTNVTDTVSQ-TDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSN 75

Query: 475 NSFVGEIPPALLT 487
           N      P   LT
Sbjct: 76  NQLTDITPLKNLT 88

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.4 bits (93), Expect = 0.001
 Identities = 28/125 (22%), Positives = 49/125 (39%), Gaps = 23/125 (18%)

Query: 393 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 452
              + +++L+G  LK      L ++  LT+L L  N ++  L  +S L  L  + L  N+
Sbjct: 218 LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN-LAPLSGLTKLTELKLGANQ 274

Query: 453 LTGSLP--------------------SYMGSLPNLQELHIENNSFVGEIPPALLTGKVIF 492
           ++   P                    S + +L NL  L +  N+     P + LT     
Sbjct: 275 ISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVSSLTKLQRL 334

Query: 493 KYDNN 497
            + NN
Sbjct: 335 FFANN 339

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 39.2 bits (90), Expect = 0.002
 Identities = 16/67 (23%), Positives = 25/67 (37%), Gaps = 3/67 (4%)

Query: 416 NMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 475
            +  L  L    N ++   P      +L  + L  N+L       + SL NL +L + NN
Sbjct: 195 KLTNLESLIATNNQISDITPLGIL-TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANN 251

Query: 476 SFVGEIP 482
                 P
Sbjct: 252 QISNLAP 258

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 61.3 bits (147), Expect = 1e-10
 Identities = 18/84 (21%), Positives = 29/84 (34%), Gaps = 2/84 (2%)

Query: 378 CVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM 437
                  +          +  + L    + G +P  L  ++ L  L +  N L G +P  
Sbjct: 228 LAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG 287

Query: 438 SRLIDLRIVHLENN-ELTGS-LPS 459
             L    +    NN  L GS LP+
Sbjct: 288 GNLQRFDVSAYANNKCLCGSPLPA 311

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 59.8 bits (143), Expect = 4e-10
 Identities = 34/141 (24%), Positives = 64/141 (45%), Gaps = 9/141 (6%)

Query: 353 QDVMVLEALR-SISDESERT--NDRGDPCVPVPWEWVTCS-TTTPPRITKIALSGKNLKG 408
           QD   L  ++  + + +  +      D C    W  V C   T   R+  + LSG NL  
Sbjct: 6   QDKQALLQIKKDLGNPTTLSSWLPTTDCC-NRTWLGVLCDTDTQTYRVNNLDLSGLNLPK 64

Query: 409 --EIPPELKNMEALTELWLDG--NFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSL 464
              IP  L N+  L  L++ G  N +    P +++L  L  +++ +  ++G++P ++  +
Sbjct: 65  PYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQI 124

Query: 465 PNLQELHIENNSFVGEIPPAL 485
             L  L    N+  G +PP++
Sbjct: 125 KTLVTLDFSYNALSGTLPPSI 145

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 57.1 bits (136), Expect = 4e-09
 Identities = 19/55 (34%), Positives = 26/55 (47%), Gaps = 1/55 (1%)

Query: 447 HLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPP-ALLTGKVIFKYDNNPKL 500
            L NN + G+LP  +  L  L  L++  N+  GEIP    L    +  Y NN  L
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCL 304

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 56.7 bits (135), Expect = 5e-09
 Identities = 16/60 (26%), Positives = 26/60 (43%), Gaps = 2/60 (3%)

Query: 424 WLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIP 482
            L  N + G LP  +++L  L  +++  N L G +P   G+L         NN  +   P
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSP 308

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 53.5 bits (127), Expect = 5e-08
 Identities = 23/112 (20%), Positives = 40/112 (35%), Gaps = 11/112 (9%)

Query: 387 TCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRI 445
            C          +  S   L+ ++P +L        L L  N +T     D   L +L  
Sbjct: 9   QCHLRV------VQCSDLGLE-KVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHT 59

Query: 446 VHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNN 497
           + L NN+++   P     L  L+ L++  N    E+P  +       +   N
Sbjct: 60  LILINNKISKISPGAFAPLVKLERLYLSKNQL-KELPEKMPKTLQELRVHEN 110

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 40.8 bits (94), Expect = 4e-04
 Identities = 22/124 (17%), Positives = 41/124 (33%), Gaps = 31/124 (25%)

Query: 392 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNF---------------------- 429
            PP +T++ L G  +       LK +  L +L L  N                       
Sbjct: 169 LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNN 228

Query: 430 --LTGPLPDMSRLIDLRIVHLENNELTG------SLPSYMGSLPNLQELHIENNSF-VGE 480
             L      ++    +++V+L NN ++         P Y     +   + + +N     E
Sbjct: 229 NKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWE 288

Query: 481 IPPA 484
           I P+
Sbjct: 289 IQPS 292

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 51.7 bits (122), Expect = 2e-07
 Identities = 19/84 (22%), Positives = 36/84 (42%), Gaps = 8/84 (9%)

Query: 385 WVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLR 444
            +      PP + ++ +S   L  E+P        L  L    N L   +P++ +  +L+
Sbjct: 275 EIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLAE-VPELPQ--NLK 327

Query: 445 IVHLENNELTGSLPSYMGSLPNLQ 468
            +H+E N L    P    S+ +L+
Sbjct: 328 QLHVEYNPLR-EFPDIPESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 47.1 bits (110), Expect = 5e-06
 Identities = 22/116 (18%), Positives = 37/116 (31%), Gaps = 9/116 (7%)

Query: 372 NDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLT 431
           +    P      +      +    +            EI        +L EL +  N L 
Sbjct: 238 DLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI 297

Query: 432 GPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSF--VGEIPPAL 485
             LP +     L  +    N L   +P       NL++LH+E N      +IP ++
Sbjct: 298 E-LPAL--PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESV 346

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 38.3 bits (87), Expect = 0.004
 Identities = 15/53 (28%), Positives = 26/53 (49%), Gaps = 4/53 (7%)

Query: 393 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRI 445
           PPR+ ++  S  +L  E+P   +N   L +L ++ N L         + DLR+
Sbjct: 303 PPRLERLIASFNHLA-EVPELPQN---LKQLHVEYNPLREFPDIPESVEDLRM 351

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 47.8 bits (113), Expect = 3e-07
 Identities = 23/103 (22%), Positives = 38/103 (36%), Gaps = 25/103 (24%)

Query: 401 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDL----------------- 443
           L+ K+L   +   L+ +  +T L L  N L    P ++ L  L                 
Sbjct: 5   LAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGVA 62

Query: 444 -----RIVHLENNELTG-SLPSYMGSLPNLQELHIENNSFVGE 480
                + + L NN L   +    + S P L  L+++ NS   E
Sbjct: 63  NLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 47.7 bits (112), Expect = 2e-06
 Identities = 18/64 (28%), Positives = 33/64 (51%), Gaps = 3/64 (4%)

Query: 411 PPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQEL 470
              L N+  LT L  D N ++  +  ++ L +L  VHL+NN+++   P  + +  NL  +
Sbjct: 166 LTPLANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIV 222

Query: 471 HIEN 474
            + N
Sbjct: 223 TLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.7 bits (86), Expect = 0.003
 Identities = 15/53 (28%), Positives = 28/53 (52%), Gaps = 2/53 (3%)

Query: 435 PDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT 487
             ++ L  L  +  ++N+++   P  + SLPNL E+H++NN      P A  +
Sbjct: 167 TPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSPLANTS 217

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.4 bits (105), Expect = 2e-05
 Identities = 15/75 (20%), Positives = 30/75 (40%), Gaps = 6/75 (8%)

Query: 420 LTELWLDGNFLT-GPLPDM-SRLIDLRIVHLENNELTG----SLPSYMGSLPNLQELHIE 473
           +  L +    L+     ++   L   ++V L++  LT      + S +   P L EL++ 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 474 NNSFVGEIPPALLTG 488
           +N         +L G
Sbjct: 64  SNELGDVGVHCVLQG 78

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.4 bits (93), Expect = 4e-04
 Identities = 15/94 (15%), Positives = 29/94 (30%), Gaps = 4/94 (4%)

Query: 408 GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNL 467
            +I           +  L    +T  +   + L  +  +   N+++       +  LPN+
Sbjct: 15  KQIFS-DDAFAETIKDNLKKKSVTDAVT-QNELNSIDQIIANNSDIKSVQG--IQYLPNV 70

Query: 468 QELHIENNSFVGEIPPALLTGKVIFKYDNNPKLH 501
            +L +  N      P A L        D N    
Sbjct: 71  TKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKD 104

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.4 bits (90), Expect = 4e-04
 Identities = 23/127 (18%), Positives = 39/127 (30%), Gaps = 19/127 (14%)

Query: 376 DPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP 435
           D C P     + C+                   +    L   E LTEL+++       L 
Sbjct: 3   DACCPHGSSGLRCT-------------RDGAL-DSLHHLPGAENLTELYIENQQHLQHLE 48

Query: 436 D--MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG--KVI 491
              +  L +LR + +  + L    P      P L  L++  N+    +    + G     
Sbjct: 49  LRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQE 107

Query: 492 FKYDNNP 498
                NP
Sbjct: 108 LVLSGNP 114

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.1 bits (92), Expect = 8e-04
 Identities = 16/75 (21%), Positives = 29/75 (38%), Gaps = 2/75 (2%)

Query: 413 ELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 472
           E+  + +  E+  D   LT   PD+ +  D  I+HL  N L     + +     L +L++
Sbjct: 5   EVSKVASHLEVNCDKRNLTALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNL 62

Query: 473 ENNSFVGEIPPALLT 487
           +            L 
Sbjct: 63  DRAELTKLQVDGTLP 77

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

 Score = 38.4 bits (88), Expect = 0.003
 Identities = 17/135 (12%), Positives = 45/135 (33%), Gaps = 10/135 (7%)

Query: 585 PELEEATNNF-CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI 643
           PEL++    + C K  +G   +  Y  + + + + +K+        T     E  ++  +
Sbjct: 7   PELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWL 66

Query: 644 HHRNLVP-LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGL 702
             +  VP ++ +   +    L+          +           D  +  +I    A+ +
Sbjct: 67  EGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEE--------YEDEQSPEKIIELYAECI 118

Query: 703 EYLHTGCNPGIIHRD 717
              H+       + +
Sbjct: 119 RLFHSIDISDCPYTN 133

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 38.3 bits (87), Expect = 0.004
 Identities = 17/112 (15%), Positives = 33/112 (29%), Gaps = 29/112 (25%)

Query: 401 LSGKNLK---------GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENN 451
           + GK+LK           +   L   +++ E+ L GN +                     
Sbjct: 5   IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIG-------------------T 45

Query: 452 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFK-YDNNPKLHK 502
           E    L   + S  +L+     +              +++ +     PKLH 
Sbjct: 46  EAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHT 97

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	912
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.9
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.86
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.58
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.54
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.5
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.43
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.39
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.36
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.3
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.25
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.23
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.23
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.21
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.17
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.14
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.06
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	98.94
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	98.93
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	98.9
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	98.86
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.82
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	98.81
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	98.81
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	98.73
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	98.71
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	98.67
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	98.65
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	98.62
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	98.54
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.53
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	98.47
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	98.38
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	98.27
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.16
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	97.91
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.81
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.74
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	97.66
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	97.65
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	97.59
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	97.24
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	97.12
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	97.04
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.04
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	97.02
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	96.21
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	94.17
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	90.96
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	87.5

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=0  Score=365.67  Aligned_cols=259  Identities=26%  Similarity=0.452  Sum_probs=209.3

Q ss_pred             HHHHHCCCCCCCCEEEEEEEECC-C---CEEEEEECCCCCC-HHHHHHHHHHHHHHHCCCCCCCCEEEEEECCCEEEEEE
Q ss_conf             98640503846608999999659-9---7999998147651-45677999999998337898523546984177289999
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMKD-G---KEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY  665 (912)
Q Consensus       591 ~~~~~~~LG~G~fG~Vy~~~~~~-g---~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  665 (912)
                      .+++.+.||+|+||+||+|+++. +   ..||||.+..... ...+.|.+|++++++++|||||+++|++...+..++||
T Consensus        27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~  106 (299)
T d1jpaa_          27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIIT  106 (299)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             HCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf             42785698027882999999957997889999999784459899999999999998579988861899996288779999


Q ss_pred             EECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCCEEEEECCCCCCCCCC
Q ss_conf             93689999888514789998898989999999999988988149998064399999821258994999420675335556
Q 002529          666 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED  745 (912)
Q Consensus       666 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLHs~~~~~ivH~DIkp~NILl~~~~~ikL~DFGla~~~~~~  745 (912)
                      ||+++|+|.+++..  ....+++..++.++.|++.||+|||+   ++++||||||+|||++.++.+||+|||+++.....
T Consensus       107 Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  181 (299)
T d1jpaa_         107 EFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  181 (299)
T ss_dssp             ECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EECCCCCCEEEECC--CCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCEEEECCCCCEEECCCCCCEECCCC
T ss_conf             72279853002104--56799999999999999998898852---79835761504489889991998884431575677


Q ss_pred             CCC----CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCC
Q ss_conf             652----0014567775448774489977922578999999999992-99999865732202289999864304981001
Q 002529          746 LTH----ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISI  820 (912)
Q Consensus       746 ~~~----~~~~~~gt~~y~APE~l~~~~~s~~sDVwSlGvil~ellt-G~~P~~~~~~~~~~~~~~~~~~~i~~~~~~~~  820 (912)
                      ...    ......|++.|+|||++.+..++.++|||||||++|||+| |+.||......   .+...+    ..+..   
T Consensus       182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~---~~~~~i----~~~~~---  251 (299)
T d1jpaa_         182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ---DVINAI----EQDYR---  251 (299)
T ss_dssp             --------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHH----HTTCC---
T ss_pred             CCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHH---HHHHHH----HCCCC---
T ss_conf             77653650256668830038788836997861214453578999986799999999999---999999----73788---


Q ss_pred             CCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHCC
Q ss_conf             17534688898899999999986235799999999999999863121002
Q 002529          821 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK  870 (912)
Q Consensus       821 ~d~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~eIl~~L~~~~~~~~  870 (912)
                            ...+.+.+..+.+++.+||+.+|++||+|.||++.|++++..+.
T Consensus       252 ------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p~  295 (299)
T d1jpaa_         252 ------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPN  295 (299)
T ss_dssp             ------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred             ------CCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCCHH
T ss_conf             ------99974226999999999758797689299999999999841862

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=0  Score=374.09  Aligned_cols=262  Identities=28%  Similarity=0.403  Sum_probs=214.8

Q ss_pred             HHHHHHHHHHCCCCCCCCEEEEEEEEC-CCCEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCEEEEEECCCEEEEE
Q ss_conf             799999864050384660899999965-9979999981476514567799999999833789852354698417728999
Q 002529          586 ELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV  664 (912)
Q Consensus       586 el~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  664 (912)
                      |+....+++.++||+|+||.||+|.++ +++.||||+++... ...++|.+|++++++++|||||++++++.+.+..++|
T Consensus        13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (287)
T d1opja_          13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII   91 (287)
T ss_dssp             BCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             EECHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCC-CHHHHHHHHHHHHHHCCCCCEECCCCCEEECCEEEEE
T ss_conf             745799398659820888089999999999699999977761-0399999999999867999882677527457854787


Q ss_pred             EEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCCEEEEECCCCCCCCC
Q ss_conf             99368999988851478999889898999999999998898814999806439999982125899499942067533555
Q 002529          665 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE  744 (912)
Q Consensus       665 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLHs~~~~~ivH~DIkp~NILl~~~~~ikL~DFGla~~~~~  744 (912)
                      |||+++|+|.+++... ....+++..++.++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+|+....
T Consensus        92 ~E~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~  167 (287)
T d1opja_          92 TEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  167 (287)
T ss_dssp             EECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred             EECCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCEEEECCCCCEEECCCCCEEECCC
T ss_conf             6314676067775303-55415799999999999997888987---8930576045768998999289832445465378


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf             66520014567775448774489977922578999999999992999998657322022899998643049810011753
Q 002529          745 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV  824 (912)
Q Consensus       745 ~~~~~~~~~~gt~~y~APE~l~~~~~s~~sDVwSlGvil~elltG~~P~~~~~~~~~~~~~~~~~~~i~~~~~~~~~d~~  824 (912)
                      ..........|++.|+|||++.+..++.++||||||+++|||++|..|+......  ..+.+.    +..+..       
T Consensus       168 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~--~~~~~~----i~~~~~-------  234 (287)
T d1opja_         168 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYEL----LEKDYR-------  234 (287)
T ss_dssp             SSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHHH----HHTTCC-------
T ss_pred             CCCEEECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHH----HHCCCC-------
T ss_conf             8722103556654666927872799981043021789999998679988774259--999999----855888-------


Q ss_pred             CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf             4688898899999999986235799999999999999863121
Q 002529          825 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK  867 (912)
Q Consensus       825 l~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~eIl~~L~~~~~  867 (912)
                        ...+...+..+.+++.+||+.+|++||||.||++.|+.+..
T Consensus       235 --~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         235 --MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             --CCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf             --88874330999999999757797689399999999999987

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=368.72  Aligned_cols=255  Identities=27%  Similarity=0.438  Sum_probs=209.6

Q ss_pred             HHHHCCCCCCCCEEEEEEEECCCCEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCEEEEEECCCEEEEEEEECCCC
Q ss_conf             86405038466089999996599799999814765145677999999998337898523546984177289999936899
Q 002529          592 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG  671 (912)
Q Consensus       592 ~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g  671 (912)
                      +++.+.||+|+||.||+|++++++.||||+++... ...+.|.+|++++++++||||++++|++...+..++||||+++|
T Consensus         7 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g   85 (263)
T d1sm2a_           7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHG   85 (263)
T ss_dssp             EEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred             CEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEEEEEECCCC
T ss_conf             58888982088829999998899999999987886-76899999999999668997565352431599337999836999


Q ss_pred             CHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCC
Q ss_conf             99888514789998898989999999999988988149998064399999821258994999420675335556652001
Q 002529          672 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS  751 (912)
Q Consensus       672 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLHs~~~~~ivH~DIkp~NILl~~~~~ikL~DFGla~~~~~~~~~~~~  751 (912)
                      +|.+++...  ...+++..++.++.|+|.||+|||+   ++|+||||||+|||++.++.+||+|||+++...........
T Consensus        86 ~L~~~l~~~--~~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~  160 (263)
T d1sm2a_          86 CLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST  160 (263)
T ss_dssp             BHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred             CHHHHHHCC--CCCCCHHHHHHHHHHHHHHHHHHHC---CCEEECCCCHHHEEECCCCCEEECCCCHHEECCCCCCEEEC
T ss_conf             189975201--3478899999999999998776531---64310443153266668877686553210023688733504


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCH
Q ss_conf             45677754487744899779225789999999999929999986573220228999986430498100117534688898
Q 002529          752 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI  831 (912)
Q Consensus       752 ~~~gt~~y~APE~l~~~~~s~~sDVwSlGvil~elltG~~P~~~~~~~~~~~~~~~~~~~i~~~~~~~~~d~~l~~~~~~  831 (912)
                      ...|++.|+|||++.+..++.++||||||+++|||+|+..|+.....  ...+.+.+..    +..  ...       +.
T Consensus       161 ~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~--~~~~~~~i~~----~~~--~~~-------p~  225 (263)
T d1sm2a_         161 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--NSEVVEDIST----GFR--LYK-------PR  225 (263)
T ss_dssp             ----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC--HHHHHHHHHH----TCC--CCC-------CT
T ss_pred             CEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCCC--HHHHHHHHHH----CCC--CCC-------CC
T ss_conf             30017666785786079998403321059999999878988877899--9999999980----688--899-------54


Q ss_pred             HHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf             899999999986235799999999999999863121
Q 002529          832 ESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK  867 (912)
Q Consensus       832 ~~~~~l~~li~~Cl~~~P~~RPs~~eIl~~L~~~~~  867 (912)
                      .....+.+++.+||+.+|++||+|+||++.|+++..
T Consensus       226 ~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         226 LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf             367999999999765797689199999999999985

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=359.11  Aligned_cols=248  Identities=24%  Similarity=0.373  Sum_probs=205.0

Q ss_pred             HHHHHCCCCCCCCEEEEEEEEC-CCCEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCEEEEEECCCEEEEEEEECC
Q ss_conf             9864050384660899999965-997999998147651456779999999983378985235469841772899999368
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH  669 (912)
Q Consensus       591 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~  669 (912)
                      .|++.+.||+|+||+||+|+.. +|+.||+|++........+.+.+|++++++++||||+++++++...+..++||||++
T Consensus        21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~  100 (293)
T d1yhwa1          21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA  100 (293)
T ss_dssp             TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             CCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEECC
T ss_conf             53887898128582999999989998999999843017279999999999986799988058577988999899997037


Q ss_pred             CCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCC
Q ss_conf             99998885147899988989899999999999889881499980643999998212589949994206753355566520
Q 002529          670 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI  749 (912)
Q Consensus       670 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLHs~~~~~ivH~DIkp~NILl~~~~~ikL~DFGla~~~~~~~~~~  749 (912)
                      +|+|.+++..    ..+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+|+........ 
T Consensus       101 gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~-  172 (293)
T d1yhwa1         101 GGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-  172 (293)
T ss_dssp             TCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC-
T ss_pred             CCCHHHHHHC----CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHEEECCCCCEEECCCHHHEEECCCCCC-
T ss_conf             9808988641----599999999999999999999998---79722677688868878996864251564132136664-


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCCC
Q ss_conf             01456777544877448997792257899999999999299999865732202289999864304981001175346888
Q 002529          750 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV  829 (912)
Q Consensus       750 ~~~~~gt~~y~APE~l~~~~~s~~sDVwSlGvil~elltG~~P~~~~~~~~~~~~~~~~~~~i~~~~~~~~~d~~l~~~~  829 (912)
                      .....||+.|+|||++.+..++.++||||+||++|||++|+.||...+....      .......+.. ..       ..
T Consensus       173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~------~~~~~~~~~~-~~-------~~  238 (293)
T d1yhwa1         173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATNGTP-EL-------QN  238 (293)
T ss_dssp             BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHHCSC-CC-------SS
T ss_pred             CCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCCHHHH------HHHHHHCCCC-CC-------CC
T ss_conf             4444447773682664479988012031372999998048899899799999------9999857999-88-------88


Q ss_pred             CHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             9889999999998623579999999999999
Q 002529          830 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       830 ~~~~~~~l~~li~~Cl~~~P~~RPs~~eIl~  860 (912)
                      +......+.+++.+||+.+|++||++.|+++
T Consensus       239 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             5537999999999986699668909999964

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=363.96  Aligned_cols=261  Identities=29%  Similarity=0.498  Sum_probs=206.4

Q ss_pred             HHHHHHHCCCCCCCCEEEEEEEECCCCEEEEEECCCC--CCHHHHHHHHHHHHHHHCCCCCCCCEEEEEECCCEEEEEEE
Q ss_conf             9998640503846608999999659979999981476--51456779999999983378985235469841772899999
Q 002529          589 EATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE  666 (912)
Q Consensus       589 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E  666 (912)
                      ...+++.+.||+|+||.||+|+++  ..||||+++..  .....+.|.+|+.++++++||||+++++++.. +..++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             CCCEEEEEEEEECCCCEEEEEEEC--CEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CEEEEEEE
T ss_conf             451899889830788589999999--989999997346998999999999999984799878645679715-58999996


Q ss_pred             ECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCCEEEEECCCCCCCCCCC
Q ss_conf             36899998885147899988989899999999999889881499980643999998212589949994206753355566
Q 002529          667 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL  746 (912)
Q Consensus       667 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLHs~~~~~ivH~DIkp~NILl~~~~~ikL~DFGla~~~~~~~  746 (912)
                      |+++|+|.+++...  ...+++..++.++.|+++||+|||+   ++|+||||||+|||++.++.+||+|||+|+......
T Consensus        84 y~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~  158 (276)
T d1uwha_          84 WCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS  158 (276)
T ss_dssp             CCCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred             CCCCCCHHHHHHHC--CCCCCHHHHHHHHHHHHHHHHHHHC---CCEECCCCCHHHEEECCCCCEEECCCCCEEECCCCC
T ss_conf             58998889998523--5789999999999999999888750---999516147899798189978875002213335567


Q ss_pred             -CCCCCCCCCCCCCCCCCCCCCC---CCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf             -5200145677754487744899---779225789999999999929999986573220228999986430498100117
Q 002529          747 -THISSVARGTVGYLDPEYYGNQ---QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD  822 (912)
Q Consensus       747 -~~~~~~~~gt~~y~APE~l~~~---~~s~~sDVwSlGvil~elltG~~P~~~~~~~~~~~~~~~~~~~i~~~~~~~~~d  822 (912)
                       ........||+.|+|||++.+.   .++.++|||||||++|||+||+.||.......  .+...+..........    
T Consensus       159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~--~~~~~~~~~~~~p~~~----  232 (276)
T d1uwha_         159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIFMVGRGYLSPDLS----  232 (276)
T ss_dssp             -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--HHHHHHHHTSCCCCGG----
T ss_pred             CCCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHCCCCCCCCH----
T ss_conf             7631256655743179999950568999953151635999999997889989989699--9999996588898600----


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf             5346888988999999999862357999999999999998631210
Q 002529          823 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI  868 (912)
Q Consensus       823 ~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~eIl~~L~~~~~~  868 (912)
                           ..+.+.+..+.+++.+||+.+|++||||.||++.|+.+...
T Consensus       233 -----~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~  273 (276)
T d1uwha_         233 -----KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS  273 (276)
T ss_dssp             -----GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             -----HCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf             -----03655549999999997588976892999999999999970

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=369.60  Aligned_cols=261  Identities=25%  Similarity=0.415  Sum_probs=210.5

Q ss_pred             HHHHHHHHHHCCCCCCCCEEEEEEEECCCCEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCEEEEEECCCEEEEEE
Q ss_conf             79999986405038466089999996599799999814765145677999999998337898523546984177289999
Q 002529          586 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY  665 (912)
Q Consensus       586 el~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  665 (912)
                      |+....+++.+.||+|+||.||+|.+++++.||||+++... ...+.|.+|++++++++|||||+++|++.+ +..++||
T Consensus         9 ei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~   86 (272)
T d1qpca_           9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT   86 (272)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             ECCHHHEEEEEEEECCCCCEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEECC-CCEEEEE
T ss_conf             03889938867981079828999999999999999986476-888999999999986799988578731045-9769999


Q ss_pred             EECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCCEEEEECCCCCCCCCC
Q ss_conf             93689999888514789998898989999999999988988149998064399999821258994999420675335556
Q 002529          666 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED  745 (912)
Q Consensus       666 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLHs~~~~~ivH~DIkp~NILl~~~~~ikL~DFGla~~~~~~  745 (912)
                      ||+++|+|.+++... ....+++..++.++.||++||+|||+   ++|+||||||+|||+++++.+||+|||+|+.....
T Consensus        87 Ey~~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~  162 (272)
T d1qpca_          87 EYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (272)
T ss_dssp             ECCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             EECCCCCHHHHHHHC-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHEEEECCCCEEECCCCCEEECCCC
T ss_conf             957898288887514-78988788999999999999999974---89546756422515620244042341014773588


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf             65200145677754487744899779225789999999999929999986573220228999986430498100117534
Q 002529          746 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL  825 (912)
Q Consensus       746 ~~~~~~~~~gt~~y~APE~l~~~~~s~~sDVwSlGvil~elltG~~P~~~~~~~~~~~~~~~~~~~i~~~~~~~~~d~~l  825 (912)
                      .........|++.|+|||++....++.++|||||||++|||+||..|+.....  .....+.    +..+..     +. 
T Consensus       163 ~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~--~~~~~~~----i~~~~~-----~~-  230 (272)
T d1qpca_         163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--NPEVIQN----LERGYR-----MV-  230 (272)
T ss_dssp             CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHH----HHTTCC-----CC-
T ss_pred             CCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCC--HHHHHHH----HHHCCC-----CC-
T ss_conf             64420356774444582898379998245645257999999968988888889--9999999----970688-----88-


Q ss_pred             CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf             688898899999999986235799999999999999863121
Q 002529          826 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK  867 (912)
Q Consensus       826 ~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~eIl~~L~~~~~  867 (912)
                         .+...+..+.+++.+||+.+|++||||.||++.|++.-.
T Consensus       231 ---~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         231 ---RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---CCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf             ---965571999999999758897689399999998611321

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=363.92  Aligned_cols=261  Identities=27%  Similarity=0.422  Sum_probs=209.2

Q ss_pred             HHHHHHHHHHCCCCCCCCEEEEEEEECC-C-----CEEEEEECCCCC-CHHHHHHHHHHHHHHHC-CCCCCCCEEEEEEC
Q ss_conf             7999998640503846608999999659-9-----799999814765-14567799999999833-78985235469841
Q 002529          586 ELEEATNNFCKKIGKGSFGSVYYGKMKD-G-----KEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEE  657 (912)
Q Consensus       586 el~~~~~~~~~~LG~G~fG~Vy~~~~~~-g-----~~vAvK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~  657 (912)
                      |+....+++.++||+|+||+||+|++.. +     ..||+|.+.... ......+.+|+.++.++ +|||||++++++..
T Consensus        33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~  112 (325)
T d1rjba_          33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL  112 (325)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE
T ss_conf             57789939701983078819999998578855420499999966335878999999999999971589968687788862


Q ss_pred             CCEEEEEEEECCCCCHHHHHCCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECC
Q ss_conf             7728999993689999888514789--------------------99889898999999999998898814999806439
Q 002529          658 EHQRILVYEYMHNGTLRDRLHGSVN--------------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRD  717 (912)
Q Consensus       658 ~~~~~lV~E~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~qia~aL~yLHs~~~~~ivH~D  717 (912)
                      .+..++||||+++|+|.++++....                    ...+++..++.++.|++.||+|||+   ++|+|||
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRD  189 (325)
T d1rjba_         113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRD  189 (325)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETT
T ss_pred             CCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECC
T ss_conf             9958999972799959999986257775102210000122200125778999999999999999999973---9905052


Q ss_pred             CCCCCCCCCCCCCEEEEECCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCC
Q ss_conf             9999821258994999420675335556652-0014567775448774489977922578999999999992-9999986
Q 002529          718 VKSSNILLDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSV  795 (912)
Q Consensus       718 Ikp~NILl~~~~~ikL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~~sDVwSlGvil~ellt-G~~P~~~  795 (912)
                      |||+|||++.++.+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||+| |+.||..
T Consensus       190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~  269 (325)
T d1rjba_         190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG  269 (325)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             CCHHCCCCCCCCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCCCCCCC
T ss_conf             70321443459828985142222045778615623435787657838872799996330300039999998389999999


Q ss_pred             CCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHH
Q ss_conf             573220228999986430498100117534688898899999999986235799999999999999863
Q 002529          796 EDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD  864 (912)
Q Consensus       796 ~~~~~~~~~~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~eIl~~L~~  864 (912)
                      .+...  .+...    +..+..         ...+......+.+++.+||+.+|++|||++||++.|.-
T Consensus       270 ~~~~~--~~~~~----~~~~~~---------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~  323 (325)
T d1rjba_         270 IPVDA--NFYKL----IQNGFK---------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC  323 (325)
T ss_dssp             CCCSH--HHHHH----HHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCHHH--HHHHH----HHCCCC---------CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf             89899--99999----856998---------99887678999999999758896689399999999748

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=356.87  Aligned_cols=250  Identities=22%  Similarity=0.355  Sum_probs=204.5

Q ss_pred             HHHHHCCCCCCCCEEEEEEEEC-CCCEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCEEEEEECCCEEEEEEEECC
Q ss_conf             9864050384660899999965-997999998147651456779999999983378985235469841772899999368
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH  669 (912)
Q Consensus       591 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~  669 (912)
                      .|++.+.||+|+||.||+|+.+ +++.||+|++........+.+.+|++++++++|||||++++++.+.+..++||||++
T Consensus        13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~   92 (288)
T d2jfla1          13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   92 (288)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             CEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEECCC
T ss_conf             75984799307781999999999993999999872899999999999999986799998849889800995899996279


Q ss_pred             CCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCC
Q ss_conf             99998885147899988989899999999999889881499980643999998212589949994206753355566520
Q 002529          670 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI  749 (912)
Q Consensus       670 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLHs~~~~~ivH~DIkp~NILl~~~~~ikL~DFGla~~~~~~~~~~  749 (912)
                      +|+|.+++...  ...+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+|........ .
T Consensus        93 ~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~-~  166 (288)
T d2jfla1          93 GGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-R  166 (288)
T ss_dssp             TEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH-H
T ss_pred             CCCHHHHHHHC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEEEEECCHHHEEECCCCCEEEEECHHHHCCCCCCC-C
T ss_conf             98188999862--8999999999999999999999998---8988714070031487899989971612303577864-1


Q ss_pred             CCCCCCCCCCCCCCCCC-----CCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf             01456777544877448-----9977922578999999999992999998657322022899998643049810011753
Q 002529          750 SSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV  824 (912)
Q Consensus       750 ~~~~~gt~~y~APE~l~-----~~~~s~~sDVwSlGvil~elltG~~P~~~~~~~~~~~~~~~~~~~i~~~~~~~~~d~~  824 (912)
                      .....||+.|+|||++.     ...++.++||||+||++|||++|+.||......+..  ..    .. .+.....    
T Consensus       167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~--~~----i~-~~~~~~~----  235 (288)
T d2jfla1         167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL--LK----IA-KSEPPTL----  235 (288)
T ss_dssp             HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH--HH----HH-HSCCCCC----
T ss_pred             CCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH--HH----HH-CCCCCCC----
T ss_conf             0010256264799998320257888880665787899999982088999998999999--99----97-0799877----


Q ss_pred             CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             468889889999999998623579999999999999
Q 002529          825 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       825 l~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~eIl~  860 (912)
                         ..+......+.+++.+||+.+|++|||+.|+++
T Consensus       236 ---~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         236 ---AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             ---SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             ---765669999999999976699668919999962

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=357.02  Aligned_cols=252  Identities=28%  Similarity=0.467  Sum_probs=210.0

Q ss_pred             HHHHCCCCCCCCEEEEEEEECCCCEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCEEEEEECCCEEEEEEEECCCC
Q ss_conf             86405038466089999996599799999814765145677999999998337898523546984177289999936899
Q 002529          592 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG  671 (912)
Q Consensus       592 ~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g  671 (912)
                      +++.++||+|+||+||+|++++++.||||+++... ...++|.+|+.++++++||||++++|++.+++..++||||+++|
T Consensus         6 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g   84 (258)
T d1k2pa_           6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANG   84 (258)
T ss_dssp             CCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTE
T ss_pred             CEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEECCCCC
T ss_conf             79968982078839999998899899999987475-77899999999999668986015889985078169999704899


Q ss_pred             CHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCC
Q ss_conf             99888514789998898989999999999988988149998064399999821258994999420675335556652001
Q 002529          672 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS  751 (912)
Q Consensus       672 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLHs~~~~~ivH~DIkp~NILl~~~~~ikL~DFGla~~~~~~~~~~~~  751 (912)
                      +|.+++...  ...+++..++.++.|+++||+|||+   ++|+||||||+|||++.++.+||+|||+++...........
T Consensus        85 ~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~  159 (258)
T d1k2pa_          85 CLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV  159 (258)
T ss_dssp             EHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCC
T ss_pred             CHHHHHHCC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCEEEEECCCCCEEECCCHHHEECCCCCCEEEC
T ss_conf             388864102--4677689999999999999998754---68434665413588769984798861442023578722524


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCCCC
Q ss_conf             4567775448774489977922578999999999992-999998657322022899998643049810011753468889
Q 002529          752 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK  830 (912)
Q Consensus       752 ~~~gt~~y~APE~l~~~~~s~~sDVwSlGvil~ellt-G~~P~~~~~~~~~~~~~~~~~~~i~~~~~~~~~d~~l~~~~~  830 (912)
                      ...|++.|+|||++....++.++||||||+++|||+| |+.||......+   +.    ..+..+..  ...       +
T Consensus       160 ~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~---~~----~~i~~~~~--~~~-------p  223 (258)
T d1k2pa_         160 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---TA----EHIAQGLR--LYR-------P  223 (258)
T ss_dssp             CSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH---HH----HHHHTTCC--CCC-------C
T ss_pred             CCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCCHHH---HH----HHHHHCCC--CCC-------C
T ss_conf             65788775780786379988521033643246739755999988999999---99----99980797--899-------6


Q ss_pred             HHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf             88999999999862357999999999999998631
Q 002529          831 IESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS  865 (912)
Q Consensus       831 ~~~~~~l~~li~~Cl~~~P~~RPs~~eIl~~L~~~  865 (912)
                      ......+.+++.+||+.+|++|||++||++.|.++
T Consensus       224 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         224 HLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCC
T ss_conf             54659999999997668976893999999874188

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=355.42  Aligned_cols=249  Identities=24%  Similarity=0.375  Sum_probs=202.1

Q ss_pred             HHHHCCCCCCCCEEEEEEEEC-CCCEEEEEECCCCC-CHHHHHHHHHHHHHHHCCCCCCCCEEEEEECCCEEEEEEEECC
Q ss_conf             864050384660899999965-99799999814765-1456779999999983378985235469841772899999368
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH  669 (912)
Q Consensus       592 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~  669 (912)
                      |++.+.||+|+||+||+|+++ +++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++||||++
T Consensus         7 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~   86 (271)
T d1nvra_           7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS   86 (271)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             EEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEEEECCC
T ss_conf             08998972174809999999999979999998456641279999999999985799888469654046743679886458


Q ss_pred             CCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCCEEEEECCCCCCCCCCC-CC
Q ss_conf             99998885147899988989899999999999889881499980643999998212589949994206753355566-52
Q 002529          670 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-TH  748 (912)
Q Consensus       670 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLHs~~~~~ivH~DIkp~NILl~~~~~ikL~DFGla~~~~~~~-~~  748 (912)
                      +|+|.+++.   ....+++..+..++.|++.||+|||+   ++|+||||||+|||+++++.+||+|||+|+...... ..
T Consensus        87 gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~  160 (271)
T d1nvra_          87 GGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  160 (271)
T ss_dssp             TEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             CCCHHHHHH---CCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHEEECCCCCEEECCCHHHEEECCCCCCC
T ss_conf             980899975---37999999999999999999999997---598357546899788789987983231422404688653


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCC-CCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf             0014567775448774489977-922578999999999992999998657322022899998643049810011753468
Q 002529          749 ISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG  827 (912)
Q Consensus       749 ~~~~~~gt~~y~APE~l~~~~~-s~~sDVwSlGvil~elltG~~P~~~~~~~~~~~~~~~~~~~i~~~~~~~~~d~~l~~  827 (912)
                      ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||........ ....+.    .......        
T Consensus       161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~-~~~~~~----~~~~~~~--------  227 (271)
T d1nvra_         161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWK----EKKTYLN--------  227 (271)
T ss_dssp             CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH-HHHHHH----TTCTTST--------
T ss_pred             CCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHH----CCCCCCC--------
T ss_conf             111325574742872861899999710161737999999829978888985999-999986----3888788--------


Q ss_pred             CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             889889999999998623579999999999999
Q 002529          828 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       828 ~~~~~~~~~l~~li~~Cl~~~P~~RPs~~eIl~  860 (912)
                       ........+.+++.+||+.+|++|||++|+++
T Consensus       228 -~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         228 -PWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             -TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             -64469999999999976799668909999961

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=0  Score=355.17  Aligned_cols=251  Identities=21%  Similarity=0.335  Sum_probs=206.0

Q ss_pred             HHHHHCCCCCCCCEEEEEEEEC-CCCEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCEEEEEECCCEEEEEEEECC
Q ss_conf             9864050384660899999965-997999998147651456779999999983378985235469841772899999368
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH  669 (912)
Q Consensus       591 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~  669 (912)
                      .|++.+.||+|+||.||+|+.+ +|+.||+|++........+.+.+|+.++++++|||||++++++.+.+..++||||++
T Consensus        27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~  106 (350)
T d1koaa2          27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS  106 (350)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred             CEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEECCC
T ss_conf             75898898407681999999889998999999845243169999999999986799799929999998999999998579


Q ss_pred             CCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCC--CCCEEEEECCCCCCCCCCCC
Q ss_conf             9999888514789998898989999999999988988149998064399999821258--99499942067533555665
Q 002529          670 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI--NMRAKVSDFGLSRQAEEDLT  747 (912)
Q Consensus       670 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLHs~~~~~ivH~DIkp~NILl~~--~~~ikL~DFGla~~~~~~~~  747 (912)
                      +|+|.+++...  ...+++..+..++.||+.||+|||+   ++++||||||+|||++.  ++.+||+|||+++.......
T Consensus       107 gg~L~~~l~~~--~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~  181 (350)
T d1koaa2         107 GGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS  181 (350)
T ss_dssp             SCBHHHHHTCT--TSCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC
T ss_pred             CCCHHHHHHHH--CCCCCHHHHHHHHHHHHHHHHHHHH---CCCEEEEECHHHEEECCCCCCEEEEEECCHHEECCCCCC
T ss_conf             98899999762--3789999999999999999999975---697600015467364168898699954521044256543


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf             20014567775448774489977922578999999999992999998657322022899998643049810011753468
Q 002529          748 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG  827 (912)
Q Consensus       748 ~~~~~~~gt~~y~APE~l~~~~~s~~sDVwSlGvil~elltG~~P~~~~~~~~~~~~~~~~~~~i~~~~~~~~~d~~l~~  827 (912)
                        .....||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+..+..   .   . +......  .+.... 
T Consensus       182 --~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~---~---~-i~~~~~~--~~~~~~-  249 (350)
T d1koaa2         182 --VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL---R---N-VKSCDWN--MDDSAF-  249 (350)
T ss_dssp             --EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H---H-HHHTCCC--SCCGGG-
T ss_pred             --CCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH---H---H-HHHCCCC--CCCCCC-
T ss_conf             --20006862421889975899872676554659999998598998997999999---9---9-9847889--894223-


Q ss_pred             CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf             8898899999999986235799999999999999
Q 002529          828 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       828 ~~~~~~~~~l~~li~~Cl~~~P~~RPs~~eIl~~  861 (912)
                         ......+.+++.+||+.+|++|||++|+++.
T Consensus       250 ---~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         250 ---SGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             ---GGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             ---CCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             ---5899999999999756896679089998629

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=353.11  Aligned_cols=255  Identities=25%  Similarity=0.431  Sum_probs=206.0

Q ss_pred             HHC-CCCCCCCEEEEEEEEC---CCCEEEEEECCCCCC-HHHHHHHHHHHHHHHCCCCCCCCEEEEEECCCEEEEEEEEC
Q ss_conf             405-0384660899999965---997999998147651-45677999999998337898523546984177289999936
Q 002529          594 FCK-KIGKGSFGSVYYGKMK---DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM  668 (912)
Q Consensus       594 ~~~-~LG~G~fG~Vy~~~~~---~g~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~  668 (912)
                      +.+ +||+|+||.||+|.++   ++..||||+++.... ...+.|.+|++++++++|||||+++|++.. +..++||||+
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~   90 (285)
T d1u59a_          12 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMA   90 (285)
T ss_dssp             EEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred             ECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-CEEEEEEEEC
T ss_conf             878487306080999999960897689999998820397899999999999986799888068656036-8079999807


Q ss_pred             CCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCCEEEEECCCCCCCCCCCC-
Q ss_conf             8999988851478999889898999999999998898814999806439999982125899499942067533555665-
Q 002529          669 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT-  747 (912)
Q Consensus       669 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLHs~~~~~ivH~DIkp~NILl~~~~~ikL~DFGla~~~~~~~~-  747 (912)
                      ++|+|.+++..  ....+++..++.++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+++....... 
T Consensus        91 ~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~  165 (285)
T d1u59a_          91 GGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY  165 (285)
T ss_dssp             TTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE
T ss_pred             CCCCHHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEECCCCCEEECCCHHHHCCCCCCCC
T ss_conf             89968997521--25699999999999999998789986---88105767646604546885420331342115543432


Q ss_pred             -CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf             -20014567775448774489977922578999999999992-9999986573220228999986430498100117534
Q 002529          748 -HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL  825 (912)
Q Consensus       748 -~~~~~~~gt~~y~APE~l~~~~~s~~sDVwSlGvil~ellt-G~~P~~~~~~~~~~~~~~~~~~~i~~~~~~~~~d~~l  825 (912)
                       .......|++.|+|||++....++.++|||||||++|||+| |+.||......+   +.    ..+..+....      
T Consensus       166 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~---~~----~~i~~~~~~~------  232 (285)
T d1u59a_         166 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VM----AFIEQGKRME------  232 (285)
T ss_dssp             ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HH----HHHHTTCCCC------
T ss_pred             CCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCHHH---HH----HHHHCCCCCC------
T ss_conf             1135621137433586887279999541232201789999938999999979999---99----9998189999------


Q ss_pred             CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHCC
Q ss_conf             688898899999999986235799999999999999863121002
Q 002529          826 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK  870 (912)
Q Consensus       826 ~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~eIl~~L~~~~~~~~  870 (912)
                         .+...+..+.+++.+||+.+|++||+|.+|++.|+.+.....
T Consensus       233 ---~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~  274 (285)
T d1u59a_         233 ---CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA  274 (285)
T ss_dssp             ---CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             ---CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHHH
T ss_conf             ---997678999999999757797689099999999999999854

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=361.70  Aligned_cols=269  Identities=22%  Similarity=0.326  Sum_probs=206.1

Q ss_pred             HHHHHHHCCCCCCCCEEEEEEEEC-CCCEEEEEECCCCC-CHHHHHHHHHHHHHHHCCCCCCCCEEEEEECCCEEEEEEE
Q ss_conf             999864050384660899999965-99799999814765-1456779999999983378985235469841772899999
Q 002529          589 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE  666 (912)
Q Consensus       589 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E  666 (912)
                      ...|++.+.||+|+||+||+|+.. +++.||+|+++... ......+.+|+.++++++|||||++++++.+....++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEE
T ss_conf             56888978971277809999999899969999998754097899999999999986799999949999998999999997


Q ss_pred             ECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCCEEEEECCCCCCCCCCC
Q ss_conf             36899998885147899988989899999999999889881499980643999998212589949994206753355566
Q 002529          667 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL  746 (912)
Q Consensus       667 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLHs~~~~~ivH~DIkp~NILl~~~~~ikL~DFGla~~~~~~~  746 (912)
                      |+++|+|.+++.+   ...+++..+..++.|++.||+|||+  ..+|+||||||+|||++.++.+||+|||+|+......
T Consensus        85 y~~gg~L~~~l~~---~~~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~  159 (322)
T d1s9ja_          85 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  159 (322)
T ss_dssp             CCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT
T ss_pred             CCCCCCHHHHHHH---CCCCCHHHHHHHHHHHHHHHHHHHH--HCCEECCCCCHHHEEECCCCCEEEEECCCCCCCCCCC
T ss_conf             6799868998742---4999999999999999999999998--5999714457799468789989995487762567886


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHH-HHHHHHHHCC--------C--
Q ss_conf             5200145677754487744899779225789999999999929999986573220228-9999864304--------9--
Q 002529          747 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNI-VHWARSMIKK--------G--  815 (912)
Q Consensus       747 ~~~~~~~~gt~~y~APE~l~~~~~s~~sDVwSlGvil~elltG~~P~~~~~~~~~~~~-~~~~~~~i~~--------~--  815 (912)
                         .....||+.|+|||++.+..++.++||||+||++|||++|+.||...+....... ..........        .  
T Consensus       160 ---~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (322)
T d1s9ja_         160 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP  236 (322)
T ss_dssp             ---C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred             ---CCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCCC
T ss_conf             ---21113771411946875899894888998999999999888998998878999999887517754577421233322


Q ss_pred             ------------CCCCCCCCCCC---CCCC-HHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHHHH
Q ss_conf             ------------81001175346---8889-889999999998623579999999999999--98631
Q 002529          816 ------------DVISIVDPVLI---GNVK-IESIWRIAEVAIQCVEQRGFSRPKMQEIVL--AIQDS  865 (912)
Q Consensus       816 ------------~~~~~~d~~l~---~~~~-~~~~~~l~~li~~Cl~~~P~~RPs~~eIl~--~L~~~  865 (912)
                                  ...+..+....   ...+ ......+.+++.+||+.+|++|||++|+++  .+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~  304 (322)
T d1s9ja_         237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  304 (322)
T ss_dssp             ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred             CCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHCHHHCCC
T ss_conf             11112223541347788766502687667644489999999999868994679089999609864769

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=360.17  Aligned_cols=260  Identities=28%  Similarity=0.438  Sum_probs=209.0

Q ss_pred             HHHHHCCCCCCCCEEEEEEEECCC-----CEEEEEECCCCCC-HHHHHHHHHHHHHHHCCCCCCCCEEEEEECCCEEEEE
Q ss_conf             986405038466089999996599-----7999998147651-4567799999999833789852354698417728999
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMKDG-----KEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV  664 (912)
Q Consensus       591 ~~~~~~~LG~G~fG~Vy~~~~~~g-----~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  664 (912)
                      .+++.+.||+|+||.||+|.++..     ..||||++..... .....|.+|++++++++|||||+++|++.+....++|
T Consensus         8 ~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v   87 (283)
T d1mqba_           8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMII   87 (283)
T ss_dssp             TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred             HEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEEE
T ss_conf             96861598117790999999968998787999999988445968999999999999856898783236778338803899


Q ss_pred             EEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCCEEEEECCCCCCCCC
Q ss_conf             99368999988851478999889898999999999998898814999806439999982125899499942067533555
Q 002529          665 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE  744 (912)
Q Consensus       665 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLHs~~~~~ivH~DIkp~NILl~~~~~ikL~DFGla~~~~~  744 (912)
                      +||+.+|++.+.+..  ....+++..++.++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+++....
T Consensus        88 ~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  162 (283)
T d1mqba_          88 TEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  162 (283)
T ss_dssp             EECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             EEECCCCCCHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHCCC---CCCCCCCCCCCEEEECCCCEEEECCCCHHHCCCC
T ss_conf             972135740222102--34542089999999999985412121---2342576564427888998499845510300357


Q ss_pred             CCC--CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf             665--200145677754487744899779225789999999999929999986573220228999986430498100117
Q 002529          745 DLT--HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD  822 (912)
Q Consensus       745 ~~~--~~~~~~~gt~~y~APE~l~~~~~s~~sDVwSlGvil~elltG~~P~~~~~~~~~~~~~~~~~~~i~~~~~~~~~d  822 (912)
                      ...  .......||+.|+|||++....++.++||||||+++|||+++..|+......  ..+.+.+    ..+.      
T Consensus       163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~--~~~~~~i----~~~~------  230 (283)
T d1mqba_         163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEVMKAI----NDGF------  230 (283)
T ss_dssp             -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHH----HTTC------
T ss_pred             CCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCH--HHHHHHH----HCCC------
T ss_conf             876526742677773434888870499997355634489899999679886556899--9999998----6357------


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHCC
Q ss_conf             534688898899999999986235799999999999999863121002
Q 002529          823 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK  870 (912)
Q Consensus       823 ~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~eIl~~L~~~~~~~~  870 (912)
                         ....+.+.+..+.+++.+||+.+|++||+|.||++.|++++...+
T Consensus       231 ---~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p~  275 (283)
T d1mqba_         231 ---RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD  275 (283)
T ss_dssp             ---CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred             ---CCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCCC
T ss_conf             ---899850457999999999776797689399999999999866956

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=0  Score=353.21  Aligned_cols=250  Identities=22%  Similarity=0.346  Sum_probs=206.0

Q ss_pred             HHHHHCCCCCCCCEEEEEEEEC-CCCEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCEEEEEECCCEEEEEEEECC
Q ss_conf             9864050384660899999965-997999998147651456779999999983378985235469841772899999368
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH  669 (912)
Q Consensus       591 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~  669 (912)
                      .|++.+.||+|+||.||+|+.. +++.||+|+++.........+.+|++++++++||||+++++++.+++..++||||++
T Consensus        30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~  109 (352)
T d1koba_          30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS  109 (352)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             CEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEECCC
T ss_conf             35998999317782999999989997999999887264679999999999986799798919999998999999998289


Q ss_pred             CCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCC--CCCCEEEEECCCCCCCCCCCC
Q ss_conf             999988851478999889898999999999998898814999806439999982125--899499942067533555665
Q 002529          670 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD--INMRAKVSDFGLSRQAEEDLT  747 (912)
Q Consensus       670 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLHs~~~~~ivH~DIkp~NILl~--~~~~ikL~DFGla~~~~~~~~  747 (912)
                      +|+|.+.+..  ....+++..++.++.||+.||+|||+   ++|+||||||+|||++  .++.+||+|||+|........
T Consensus       110 gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~  184 (352)
T d1koba_         110 GGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI  184 (352)
T ss_dssp             CCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred             CCHHHHHHHH--CCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCCCCCCCCCCCCCCCEEEEEECCCCEECCCCCC
T ss_conf             9808888986--38998999999999999999999997---792651314455311346788489952563034378872


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf             20014567775448774489977922578999999999992999998657322022899998643049810011753468
Q 002529          748 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG  827 (912)
Q Consensus       748 ~~~~~~~gt~~y~APE~l~~~~~s~~sDVwSlGvil~elltG~~P~~~~~~~~~~~~~~~~~~~i~~~~~~~~~d~~l~~  827 (912)
                        .....|++.|+|||++.+..++.++||||+||++|||++|+.||.+.+..+..   .    .+..+...  ..+... 
T Consensus       185 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~---~----~i~~~~~~--~~~~~~-  252 (352)
T d1koba_         185 --VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL---Q----NVKRCDWE--FDEDAF-  252 (352)
T ss_dssp             --EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH---H----HHHHCCCC--CCSSTT-
T ss_pred             --EEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHH---H----HHHHCCCC--CCCCCC-
T ss_conf             --01004764534899974799897633389899999999688998997999999---9----99847889--893002-


Q ss_pred             CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             889889999999998623579999999999999
Q 002529          828 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       828 ~~~~~~~~~l~~li~~Cl~~~P~~RPs~~eIl~  860 (912)
                         ......+.+++.+||+.+|.+|||+.|+++
T Consensus       253 ---~~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         253 ---SSVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             ---TTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             ---CCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             ---479999999999975699668918999960

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=354.47  Aligned_cols=244  Identities=26%  Similarity=0.424  Sum_probs=203.0

Q ss_pred             HHHHHCCCCCCCCEEEEEEEEC-CCCEEEEEECCCCC---CHHHHHHHHHHHHHHHCCCCCCCCEEEEEECCCEEEEEEE
Q ss_conf             9864050384660899999965-99799999814765---1456779999999983378985235469841772899999
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE  666 (912)
Q Consensus       591 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E  666 (912)
                      .|++.+.||+|+||.||+|+.+ +++.||+|++....   ....+.+.+|+++++.++||||+++++++.+++..++|||
T Consensus         7 dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmE   86 (263)
T d2j4za1           7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE   86 (263)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             HEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEE
T ss_conf             76998898517785899999989994999999816885676899999999999985688888859999998999899985


Q ss_pred             ECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCCEEEEECCCCCCCCCCC
Q ss_conf             36899998885147899988989899999999999889881499980643999998212589949994206753355566
Q 002529          667 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL  746 (912)
Q Consensus       667 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLHs~~~~~ivH~DIkp~NILl~~~~~ikL~DFGla~~~~~~~  746 (912)
                      |+++|+|.+++..   ...+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+|.......
T Consensus        87 y~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~  160 (263)
T d2j4za1          87 YAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR  160 (263)
T ss_dssp             CCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred             ECCCCCHHHHHHH---CCCCCHHHHHHHHHHHHHHHHHHHH---CCEEEEEECCCCCEECCCCCEEECCCCEEEECCCCC
T ss_conf             0479858988750---4899999999999999999999998---894652202344146689987115556335448885


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf             52001456777544877448997792257899999999999299999865732202289999864304981001175346
Q 002529          747 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI  826 (912)
Q Consensus       747 ~~~~~~~~gt~~y~APE~l~~~~~s~~sDVwSlGvil~elltG~~P~~~~~~~~~~~~~~~~~~~i~~~~~~~~~d~~l~  826 (912)
                         .....||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+.   .    ..+..+..      .+ 
T Consensus       161 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~---~----~~i~~~~~------~~-  223 (263)
T d2j4za1         161 ---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET---Y----KRISRVEF------TF-  223 (263)
T ss_dssp             ---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH---H----HHHHTTCC------CC-
T ss_pred             ---CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHH---H----HHHHCCCC------CC-
T ss_conf             ---2355788763499997589989314404675999998329999888999999---9----99971899------99-


Q ss_pred             CCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             8889889999999998623579999999999999
Q 002529          827 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       827 ~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~eIl~  860 (912)
                         +......+.+++.+||+.+|++|||++|+++
T Consensus       224 ---p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         224 ---PDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             ---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             ---8668999999999976479768909999971

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=352.84  Aligned_cols=248  Identities=27%  Similarity=0.465  Sum_probs=202.0

Q ss_pred             CCCCCCCCEEEEEEEECC---CCEEEEEECCCCC--CHHHHHHHHHHHHHHHCCCCCCCCEEEEEECCCEEEEEEEECCC
Q ss_conf             503846608999999659---9799999814765--14567799999999833789852354698417728999993689
Q 002529          596 KKIGKGSFGSVYYGKMKD---GKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN  670 (912)
Q Consensus       596 ~~LG~G~fG~Vy~~~~~~---g~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~  670 (912)
                      ++||+|+||.||+|.++.   ++.||||+++...  ....+.|.+|++++++++|||||+++|+|.. +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC-CCEEEEEECCCC
T ss_conf             7834587829999998169738599999988010898999999999999986799898527777505-977999974788


Q ss_pred             CCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCC--
Q ss_conf             999888514789998898989999999999988988149998064399999821258994999420675335556652--
Q 002529          671 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH--  748 (912)
Q Consensus       671 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLHs~~~~~ivH~DIkp~NILl~~~~~ikL~DFGla~~~~~~~~~--  748 (912)
                      |+|.++++.   ...+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++........  
T Consensus        92 g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~  165 (277)
T d1xbba_          92 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  165 (277)
T ss_dssp             EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred             CCHHHHHHH---CCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCCCCCC
T ss_conf             968999752---2578999999999999999766874---7955677761131023567512341345331343234432


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf             0014567775448774489977922578999999999992-999998657322022899998643049810011753468
Q 002529          749 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG  827 (912)
Q Consensus       749 ~~~~~~gt~~y~APE~l~~~~~s~~sDVwSlGvil~ellt-G~~P~~~~~~~~~~~~~~~~~~~i~~~~~~~~~d~~l~~  827 (912)
                      ......||+.|+|||++.+..++.++||||||+++|||++ |+.||......+   +.    ..+..+...         
T Consensus       166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~---~~----~~i~~~~~~---------  229 (277)
T d1xbba_         166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VT----AMLEKGERM---------  229 (277)
T ss_dssp             C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HH----HHHHTTCCC---------
T ss_pred             CCCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCHHH---HH----HHHHCCCCC---------
T ss_conf             24456778420391665379998434430340313289658999999989999---99----999828999---------


Q ss_pred             CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf             889889999999998623579999999999999986312
Q 002529          828 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI  866 (912)
Q Consensus       828 ~~~~~~~~~l~~li~~Cl~~~P~~RPs~~eIl~~L~~~~  866 (912)
                      ..+...+..+.+++.+||+.+|++||++++|++.|+...
T Consensus       230 ~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~  268 (277)
T d1xbba_         230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  268 (277)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCHH
T ss_conf             998656799999999975889768909899999852887

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=356.57  Aligned_cols=260  Identities=26%  Similarity=0.403  Sum_probs=211.2

Q ss_pred             HHHHHHHHCCCCCCCCEEEEEEEECCCCEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCEEEEEECCCEEEEEEEE
Q ss_conf             99998640503846608999999659979999981476514567799999999833789852354698417728999993
Q 002529          588 EEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY  667 (912)
Q Consensus       588 ~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~  667 (912)
                      ....+++.+.||+|+||.||+|++++++.||||+++.. ....+.|.+|+.++++++|||||+++|++.+ +..++||||
T Consensus        15 ~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey   92 (285)
T d1fmka3          15 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY   92 (285)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             CHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CCEEEEEEE
T ss_conf             77997984699307980999999999999999998804-4888999999999986666788689999823-975999994


Q ss_pred             CCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCCEEEEECCCCCCCCCCCC
Q ss_conf             68999988851478999889898999999999998898814999806439999982125899499942067533555665
Q 002529          668 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT  747 (912)
Q Consensus       668 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLHs~~~~~ivH~DIkp~NILl~~~~~ikL~DFGla~~~~~~~~  747 (912)
                      +++|+|.+++... ....++|.+++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......
T Consensus        93 ~~~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~  168 (285)
T d1fmka3          93 MSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  168 (285)
T ss_dssp             CTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred             CCCCCHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHH---HHEECCCCCCEEEEECCCCCEEECCCCHHHHCCCCCC
T ss_conf             4799435420000-35530599999999999999998754---1143353123079998999299844255542568873


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf             20014567775448774489977922578999999999992999998657322022899998643049810011753468
Q 002529          748 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG  827 (912)
Q Consensus       748 ~~~~~~~gt~~y~APE~l~~~~~s~~sDVwSlGvil~elltG~~P~~~~~~~~~~~~~~~~~~~i~~~~~~~~~d~~l~~  827 (912)
                      .......|++.|+|||++....++.++||||||+++|||++|..|+......  ..+...+..    +..     +    
T Consensus       169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~--~~~~~~i~~----~~~-----~----  233 (285)
T d1fmka3         169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQVER----GYR-----M----  233 (285)
T ss_dssp             -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHHT----TCC-----C----
T ss_pred             EEECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCCCCH--HHHHHHHHH----CCC-----C----
T ss_conf             3524545566545808983799891774132358999998689999988889--999999982----689-----9----


Q ss_pred             CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf             88988999999999862357999999999999998631210
Q 002529          828 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI  868 (912)
Q Consensus       828 ~~~~~~~~~l~~li~~Cl~~~P~~RPs~~eIl~~L~~~~~~  868 (912)
                      ..+......+.+++.+||+.+|++||+|.+|+++|++....
T Consensus       234 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~  274 (285)
T d1fmka3         234 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  274 (285)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCC
T ss_conf             99832379999999997566975891999999987666238

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=348.60  Aligned_cols=244  Identities=29%  Similarity=0.437  Sum_probs=194.6

Q ss_pred             HHHCCCCCCCCEEEEEEEEC-CCCEEEEEECCCC--CCHHHHHHHHHHHHHHHCCCCCCCCEEEEEEC----CCEEEEEE
Q ss_conf             64050384660899999965-9979999981476--51456779999999983378985235469841----77289999
Q 002529          593 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE----EHQRILVY  665 (912)
Q Consensus       593 ~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~----~~~~~lV~  665 (912)
                      ++.++||+|+||+||+|.+. +++.||+|++...  .....+.+.+|++++++++||||+++++++..    ....++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEEEE
T ss_conf             85169700828499999999999599999985122798999999999999985799985069999840334588899999


Q ss_pred             EECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCC--EEECCCCCCCCCCC-CCCCEEEEECCCCCCC
Q ss_conf             93689999888514789998898989999999999988988149998--06439999982125-8994999420675335
Q 002529          666 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG--IIHRDVKSSNILLD-INMRAKVSDFGLSRQA  742 (912)
Q Consensus       666 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLHs~~~~~--ivH~DIkp~NILl~-~~~~ikL~DFGla~~~  742 (912)
                      ||+++|+|.+++..   ...+++..+..++.|++.||+|||+   ++  |+||||||+|||++ +++.+||+|||+++..
T Consensus        92 E~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~  165 (270)
T d1t4ha_          92 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  165 (270)
T ss_dssp             ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             ECCCCCCHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCCCEEECCCCHHHCEEECCCCCEEEEECCCCEEC
T ss_conf             57898948999751---3554699999999999999999997---89979968767435116679998898005765423


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf             55665200145677754487744899779225789999999999929999986573220228999986430498100117
Q 002529          743 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD  822 (912)
Q Consensus       743 ~~~~~~~~~~~~gt~~y~APE~l~~~~~s~~sDVwSlGvil~elltG~~P~~~~~~~~~~~~~~~~~~~i~~~~~~~~~d  822 (912)
                      ....   .....||+.|+|||++.+ .++.++||||+||++|||++|+.||.......  .+.+    .+..+.....++
T Consensus       166 ~~~~---~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~--~~~~----~i~~~~~~~~~~  235 (270)
T d1t4ha_         166 RASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIYR----RVTSGVKPASFD  235 (270)
T ss_dssp             CTTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHHH----HHTTTCCCGGGG
T ss_pred             CCCC---CCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHH--HHHH----HHHCCCCCCCCC
T ss_conf             6876---677553813008988478-99986711007999999987889998765599--9999----997389986567


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             53468889889999999998623579999999999999
Q 002529          823 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       823 ~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~eIl~  860 (912)
                      .    ..+    ..+.+++.+||+.+|++|||++|+++
T Consensus       236 ~----~~~----~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         236 K----VAI----PEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             G----CCC----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             C----CCC----HHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             5----578----99999999976379758929999967

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=355.38  Aligned_cols=253  Identities=26%  Similarity=0.383  Sum_probs=203.3

Q ss_pred             HHHHHCCCCCCCCEEEEEEEEC-CCCEEEEEECCCCC--CHHHHHHHHHHHHHHHCCCCCCCCEEEEEEC--CCEEEEEE
Q ss_conf             9864050384660899999965-99799999814765--1456779999999983378985235469841--77289999
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQRILVY  665 (912)
Q Consensus       591 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~lV~  665 (912)
                      .|++.+.||+|+||.||+|+.+ +|+.||+|++....  ....+.+.+|++++++++||||+++++++.+  .+..++||
T Consensus         5 dy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivm   84 (269)
T d2java1           5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM   84 (269)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEE
T ss_pred             HCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEE
T ss_conf             37996798308891999999999997999999874657979999999999999977899982489999917899899999


Q ss_pred             EECCCCCHHHHHCCCC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCEEECCCCCCCCCCCCCCCEEEEECCCCCCC
Q ss_conf             9368999988851478-9998898989999999999988988149--998064399999821258994999420675335
Q 002529          666 EYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGC--NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA  742 (912)
Q Consensus       666 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLHs~~--~~~ivH~DIkp~NILl~~~~~ikL~DFGla~~~  742 (912)
                      ||+++|+|.+++.... ....+++..++.++.|++.||+|||+..  ..+|+||||||+|||++.++.+||+|||+++..
T Consensus        85 Ey~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~  164 (269)
T d2java1          85 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL  164 (269)
T ss_dssp             ECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC
T ss_pred             ECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCCEEEC
T ss_conf             56899938999985154578999999999999999999999971677887885867654257478885798001000322


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf             55665200145677754487744899779225789999999999929999986573220228999986430498100117
Q 002529          743 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD  822 (912)
Q Consensus       743 ~~~~~~~~~~~~gt~~y~APE~l~~~~~s~~sDVwSlGvil~elltG~~P~~~~~~~~~~~~~~~~~~~i~~~~~~~~~d  822 (912)
                      ...... .....||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+   +    ...+..+....   
T Consensus       165 ~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~---~----~~~i~~~~~~~---  233 (269)
T d2java1         165 NHDTSF-AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---L----AGKIREGKFRR---  233 (269)
T ss_dssp             ------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---H----HHHHHHTCCCC---
T ss_pred             CCCCCC-CCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHH---H----HHHHHCCCCCC---
T ss_conf             457775-566778823279999839999938988752789999801889989989999---9----99997189988---


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             53468889889999999998623579999999999999
Q 002529          823 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       823 ~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~eIl~  860 (912)
                        +...++    ..+.+++.+||+.+|++||++.|+++
T Consensus       234 --~~~~~s----~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         234 --IPYRYS----DELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             --CCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --CCCCCC----HHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf             --974359----99999999976799557918999972

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=349.81  Aligned_cols=246  Identities=28%  Similarity=0.395  Sum_probs=200.2

Q ss_pred             HHHHHHHCCCCCCCCEEEEEEEEC-CCCEEEEEECCCCCC---HHHHHHHHHHHHHHHCCCCCCCCEEEEEECCCEEEEE
Q ss_conf             999864050384660899999965-997999998147651---4567799999999833789852354698417728999
Q 002529          589 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV  664 (912)
Q Consensus       589 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  664 (912)
                      +..|+..+.||+|+||.||+|+.. +++.||||++.....   ...+.+.+|++++++++|||||++++++.+++..++|
T Consensus        14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   93 (309)
T d1u5ra_          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV   93 (309)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEE
T ss_conf             78567627970188809999999899939999998444435889999999999999977899982389999989988999


Q ss_pred             EEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCCEEEEECCCCCCCCC
Q ss_conf             99368999988851478999889898999999999998898814999806439999982125899499942067533555
Q 002529          665 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE  744 (912)
Q Consensus       665 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLHs~~~~~ivH~DIkp~NILl~~~~~ikL~DFGla~~~~~  744 (912)
                      |||+++|+|..++.   ....+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++.....
T Consensus        94 ~E~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~  167 (309)
T d1u5ra_          94 MEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (309)
T ss_dssp             EECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             EEECCCCCHHHHHH---HCCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCCCEEEECCCCCEEEEECCCCCCCCC
T ss_conf             98069994578997---37999999999999999999999986---8976667884217987999789844365334677


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCC---CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCC
Q ss_conf             66520014567775448774489---977922578999999999992999998657322022899998643049810011
Q 002529          745 DLTHISSVARGTVGYLDPEYYGN---QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV  821 (912)
Q Consensus       745 ~~~~~~~~~~gt~~y~APE~l~~---~~~s~~sDVwSlGvil~elltG~~P~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  821 (912)
                      .     ....||+.|+|||++.+   ..++.++||||+||++|||++|+.||......+.      ...... +......
T Consensus       168 ~-----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~------~~~i~~-~~~~~~~  235 (309)
T d1u5ra_         168 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQ-NESPALQ  235 (309)
T ss_dssp             B-----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHH-SCCCCCS
T ss_pred             C-----CCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHH------HHHHHH-CCCCCCC
T ss_conf             8-----731347663688998346788867214545589999999878899999799999------999982-8999888


Q ss_pred             CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             753468889889999999998623579999999999999
Q 002529          822 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       822 d~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~eIl~  860 (912)
                      .    ..+    ...+.+++.+||+.+|++|||+.|+++
T Consensus       236 ~----~~~----s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         236 S----GHW----SEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             C----TTS----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             C----CCC----CHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf             7----888----999999999977379657918999971

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=348.50  Aligned_cols=251  Identities=25%  Similarity=0.356  Sum_probs=204.1

Q ss_pred             HHHHHHHCCCCCCCCEEEEEEEEC-CCCEEEEEECCCCCC-HHHHHHHHHHHHHHHCCCCCCCCEEEEEECCCEEEEEEE
Q ss_conf             999864050384660899999965-997999998147651-456779999999983378985235469841772899999
Q 002529          589 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE  666 (912)
Q Consensus       589 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E  666 (912)
                      ...|++.+.||+|+||+||+|+.+ +++.||+|++..... .....+.+|++++++++||||+++++++.+.+..++|||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEE
T ss_conf             66669988994065839999999999989999998157731289999999999986799899919899998998889885


Q ss_pred             ECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCC---CCCCEEEEECCCCCCCC
Q ss_conf             368999988851478999889898999999999998898814999806439999982125---89949994206753355
Q 002529          667 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD---INMRAKVSDFGLSRQAE  743 (912)
Q Consensus       667 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLHs~~~~~ivH~DIkp~NILl~---~~~~ikL~DFGla~~~~  743 (912)
                      |+++|+|.+++..   ...+++..+..++.|++.||+|||+   ++|+||||||+|||+.   +++.+||+|||+++...
T Consensus        88 ~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~  161 (307)
T d1a06a_          88 LVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED  161 (307)
T ss_dssp             CCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred             CCCCCCHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---CEEEEEEECCCCEEECCCCCCCEEEEECCCEEEECC
T ss_conf             2689848886530---3678878999999999999875241---305568704630011046888249983154358725


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf             56652001456777544877448997792257899999999999299999865732202289999864304981001175
Q 002529          744 EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP  823 (912)
Q Consensus       744 ~~~~~~~~~~~gt~~y~APE~l~~~~~s~~sDVwSlGvil~elltG~~P~~~~~~~~~~~~~~~~~~~i~~~~~~~~~d~  823 (912)
                      ....  .....||+.|+|||++.+..++.++||||+||++|||++|+.||......+   ....    +..+...  ...
T Consensus       162 ~~~~--~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~~~----i~~~~~~--~~~  230 (307)
T d1a06a_         162 PGSV--LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK---LFEQ----ILKAEYE--FDS  230 (307)
T ss_dssp             -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHH----HHTTCCC--CCT
T ss_pred             CCCE--EEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH---HHHH----HHCCCCC--CCC
T ss_conf             8970--440032842259188737999807873451599999985979999989999---9999----8616877--787


Q ss_pred             CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             3468889889999999998623579999999999999
Q 002529          824 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       824 ~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~eIl~  860 (912)
                      ...    .+....+.+++.+||+.+|++|||++|+++
T Consensus       231 ~~~----~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         231 PYW----DDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             TTT----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCC----CCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             666----678999999999976089757918999862

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=345.12  Aligned_cols=245  Identities=24%  Similarity=0.360  Sum_probs=202.8

Q ss_pred             HHHHCCCCCCCCEEEEEEEEC-CCCEEEEEECCCCC---CHHHHHHHHHHHHHHHCCCCCCCCEEEEEECCCEEEEEEEE
Q ss_conf             864050384660899999965-99799999814765---14567799999999833789852354698417728999993
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY  667 (912)
Q Consensus       592 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~  667 (912)
                      |++.+.||+|+||.||+|+.+ +++.||+|++++..   ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         7 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey   86 (337)
T d1o6la_           7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY   86 (337)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCEEC
T ss_conf             28988983176849999999899989999998156544979999999999999867999887787640356421110003


Q ss_pred             CCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCCEEEEECCCCCCCCCCCC
Q ss_conf             68999988851478999889898999999999998898814999806439999982125899499942067533555665
Q 002529          668 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT  747 (912)
Q Consensus       668 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLHs~~~~~ivH~DIkp~NILl~~~~~ikL~DFGla~~~~~~~~  747 (912)
                      +++|+|.+++..   ...+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+|+.......
T Consensus        87 ~~gg~L~~~~~~---~~~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~  160 (337)
T d1o6la_          87 ANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             CTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred             CCCCCHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHEEECCCCCEEEEECCCCCCCCCCCC
T ss_conf             579860555532---5677599999999999652113431---5962246477784765899888820565200356786


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf             20014567775448774489977922578999999999992999998657322022899998643049810011753468
Q 002529          748 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG  827 (912)
Q Consensus       748 ~~~~~~~gt~~y~APE~l~~~~~s~~sDVwSlGvil~elltG~~P~~~~~~~~~~~~~~~~~~~i~~~~~~~~~d~~l~~  827 (912)
                      . .....||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+..       ..+..+.+      .+..
T Consensus       161 ~-~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-------~~i~~~~~------~~p~  226 (337)
T d1o6la_         161 T-MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF-------ELILMEEI------RFPR  226 (337)
T ss_dssp             C-BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHCCC------CCCT
T ss_pred             C-CCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCCHHHHH-------HHHHCCCC------CCCC
T ss_conf             2-05510088996666504898883331022306788998789999996999999-------99852899------8986


Q ss_pred             CCCHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHH
Q ss_conf             889889999999998623579999999-----999999
Q 002529          828 NVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVL  860 (912)
Q Consensus       828 ~~~~~~~~~l~~li~~Cl~~~P~~RPs-----~~eIl~  860 (912)
                      ..+    ..+.+++.+||+.+|++|++     ++|+++
T Consensus       227 ~~s----~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         227 TLS----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             TSC----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CCC----HHHHHHHHHHCCCCCHHHCCCCCCCHHHHHC
T ss_conf             689----9999999866638934422565234999972

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=350.22  Aligned_cols=261  Identities=25%  Similarity=0.402  Sum_probs=212.3

Q ss_pred             HHHHHHHHCCCCCCCCEEEEEEEECC----CCEEEEEECCCCCC-HHHHHHHHHHHHHHHCCCCCCCCEEEEEECCCEEE
Q ss_conf             99998640503846608999999659----97999998147651-45677999999998337898523546984177289
Q 002529          588 EEATNNFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI  662 (912)
Q Consensus       588 ~~~~~~~~~~LG~G~fG~Vy~~~~~~----g~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  662 (912)
                      ....|++.+.||+|+||.||+|.+..    +..||+|.++.... ...+.+.+|++++++++||||+++++++.+ +..+
T Consensus         5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~   83 (273)
T d1mp8a_           5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVW   83 (273)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCE
T ss_pred             CHHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CEEE
T ss_conf             889969877993078829999999369964499999993656687999999999999986899998569889953-7479


Q ss_pred             EEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCCEEEEECCCCCCC
Q ss_conf             99993689999888514789998898989999999999988988149998064399999821258994999420675335
Q 002529          663 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA  742 (912)
Q Consensus       663 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLHs~~~~~ivH~DIkp~NILl~~~~~ikL~DFGla~~~  742 (912)
                      +||||+++|+|.+++..  ....+++..++.++.|+++||+|||+   ++++||||||+||+++.++.+||+|||+++..
T Consensus        84 iv~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~  158 (273)
T d1mp8a_          84 IIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  158 (273)
T ss_dssp             EEEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             EEEEECCCCCHHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHCC---CCEECCCCCHHHEEECCCCCEEECCCHHHEEC
T ss_conf             99984069807765422--47899999999999999877523022---67441410265532067896787650342133


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCC
Q ss_conf             5566520014567775448774489977922578999999999992-999998657322022899998643049810011
Q 002529          743 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV  821 (912)
Q Consensus       743 ~~~~~~~~~~~~gt~~y~APE~l~~~~~s~~sDVwSlGvil~ellt-G~~P~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  821 (912)
                      ............||+.|+|||++....++.++|||||||++|||++ |..||......+   +...    +..+....  
T Consensus       159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~~~~----i~~~~~~~--  229 (273)
T d1mp8a_         159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGR----IENGERLP--  229 (273)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHH----HHTTCCCC--
T ss_pred             CCCCCEECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHH---HHHH----HHCCCCCC--
T ss_conf             67762330540058310326675169988745244424789999826999988899999---9999----98189998--


Q ss_pred             CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHCC
Q ss_conf             7534688898899999999986235799999999999999863121002
Q 002529          822 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK  870 (912)
Q Consensus       822 d~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~eIl~~L~~~~~~~~  870 (912)
                             .+...+..+.+++.+||+.+|++|||+.||++.|+.++..++
T Consensus       230 -------~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~k  271 (273)
T d1mp8a_         230 -------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK  271 (273)
T ss_dssp             -------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             -------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHHH
T ss_conf             -------987779999999999768797689299999999999977861

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=351.31  Aligned_cols=247  Identities=23%  Similarity=0.347  Sum_probs=204.0

Q ss_pred             HHHHHCCCCCCCCEEEEEEEEC-CCCEEEEEECCCCC---CHHHHHHHHHHHHHHHCCCCCCCCEEEEEECCCEEEEEEE
Q ss_conf             9864050384660899999965-99799999814765---1456779999999983378985235469841772899999
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE  666 (912)
Q Consensus       591 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E  666 (912)
                      .|++.+.||+|+||.||+|+.+ +++.||||++....   ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         9 dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmE   88 (288)
T d1uu3a_           9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS   88 (288)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEEC
T ss_pred             CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEE
T ss_conf             77898898508790999999989997999999865775577789999999999987688886179999998998899997


Q ss_pred             ECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCCEEEEECCCCCCCCCCC
Q ss_conf             36899998885147899988989899999999999889881499980643999998212589949994206753355566
Q 002529          667 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL  746 (912)
Q Consensus       667 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLHs~~~~~ivH~DIkp~NILl~~~~~ikL~DFGla~~~~~~~  746 (912)
                      |+++|+|.+++..   .+.+++..+..++.|++.||+|||+   ++|+||||||+|||+++++.+||+|||+|+......
T Consensus        89 y~~gg~L~~~~~~---~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~  162 (288)
T d1uu3a_          89 YAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  162 (288)
T ss_dssp             CCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             CCCCCCHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHCC---CCEECCCCCCCCCCCCCCCEEEECCCCCCEECCCCC
T ss_conf             0489877776531---5999999999999999999976216---508847677412366888538860321024225677


Q ss_pred             -CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf             -5200145677754487744899779225789999999999929999986573220228999986430498100117534
Q 002529          747 -THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL  825 (912)
Q Consensus       747 -~~~~~~~~gt~~y~APE~l~~~~~s~~sDVwSlGvil~elltG~~P~~~~~~~~~~~~~~~~~~~i~~~~~~~~~d~~l  825 (912)
                       ........||+.|+|||++.+..++.++||||+||++|||++|+.||...+....   .    ..+..+..      .+
T Consensus       163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~---~----~~i~~~~~------~~  229 (288)
T d1uu3a_         163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI---F----QKIIKLEY------DF  229 (288)
T ss_dssp             -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H----HHHHTTCC------CC
T ss_pred             CCCCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCHHHH---H----HHHHCCCC------CC
T ss_conf             64333555677552584400268989666230456999998038899899599999---9----99971899------99


Q ss_pred             CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             68889889999999998623579999999999999
Q 002529          826 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       826 ~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~eIl~  860 (912)
                          +......+.+++.+||+.+|++|||++|++.
T Consensus       230 ----p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         230 ----PEKFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             ----CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             ----CCCCCHHHHHHHHHHCCCCHHHCCCHHHHCC
T ss_conf             ----8547999999999985579768919789737

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=350.21  Aligned_cols=259  Identities=27%  Similarity=0.446  Sum_probs=209.2

Q ss_pred             HHHHHHCCCCCCCCEEEEEEEEC------CCCEEEEEECCCCCCH-HHHHHHHHHHHHHHCCCCCCCCEEEEEECCCEEE
Q ss_conf             99864050384660899999965------9979999981476514-5677999999998337898523546984177289
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI  662 (912)
Q Consensus       590 ~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  662 (912)
                      ..+++.+.||+|+||+||+|+++      +++.||||+++..... ..+.|.+|++++++++||||+++++++......+
T Consensus        13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~   92 (301)
T d1lufa_          13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC   92 (301)
T ss_dssp             GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCCCCEE
T ss_conf             89388679820788399999988876577882999999882108579999999999999668997655246660598038


Q ss_pred             EEEEECCCCCHHHHHCCCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCC
Q ss_conf             9999368999988851478---------------------9998898989999999999988988149998064399999
Q 002529          663 LVYEYMHNGTLRDRLHGSV---------------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSS  721 (912)
Q Consensus       663 lV~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qia~aL~yLHs~~~~~ivH~DIkp~  721 (912)
                      +++|++++|+|.+++....                     ....+++..++.++.|++.||+|||+   ++++||||||+
T Consensus        93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivHrDlKp~  169 (301)
T d1lufa_          93 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATR  169 (301)
T ss_dssp             EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGG
T ss_pred             EEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCC---CCEEEEEECCC
T ss_conf             999815899299999852755421000011100121034678898999999999999998554135---78685488401


Q ss_pred             CCCCCCCCCEEEEECCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCC-CCCCCCCCC
Q ss_conf             821258994999420675335556-652001456777544877448997792257899999999999299-999865732
Q 002529          722 NILLDINMRAKVSDFGLSRQAEED-LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGK-KPVSVEDFG  799 (912)
Q Consensus       722 NILl~~~~~ikL~DFGla~~~~~~-~~~~~~~~~gt~~y~APE~l~~~~~s~~sDVwSlGvil~elltG~-~P~~~~~~~  799 (912)
                      |||++.++.+||+|||+|+..... .........|++.|+|||++.+..++.++|||||||++|||++|. .||...+..
T Consensus       170 NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~  249 (301)
T d1lufa_         170 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE  249 (301)
T ss_dssp             GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred             CEEECCCCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHCCCCCCCCCCCHH
T ss_conf             16898999289833144211367764111577776767679899726889805630252362999980689999998999


Q ss_pred             CHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf             20228999986430498100117534688898899999999986235799999999999999863121
Q 002529          800 AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK  867 (912)
Q Consensus       800 ~~~~~~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~eIl~~L~~~~~  867 (912)
                         .+..    .+..+.....         +...+..+.+++.+||+.+|++||||.||++.|+++..
T Consensus       250 ---e~~~----~v~~~~~~~~---------p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~  301 (301)
T d1lufa_         250 ---EVIY----YVRDGNILAC---------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  301 (301)
T ss_dssp             ---HHHH----HHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             ---HHHH----HHHCCCCCCC---------CCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCC
T ss_conf             ---9999----9973997888---------73252999999999748896579399999999998429

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=342.24  Aligned_cols=256  Identities=29%  Similarity=0.455  Sum_probs=205.2

Q ss_pred             HHHCCCCCCCCEEEEEEEECCC----CEEEEEECCCC-CCHHHHHHHHHHHHHHHCCCCCCCCEEEEEEC-CCEEEEEEE
Q ss_conf             6405038466089999996599----79999981476-51456779999999983378985235469841-772899999
Q 002529          593 NFCKKIGKGSFGSVYYGKMKDG----KEVAVKIMADS-CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE-EHQRILVYE  666 (912)
Q Consensus       593 ~~~~~LG~G~fG~Vy~~~~~~g----~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~~lV~E  666 (912)
                      +|.++||+|+||+||+|++..+    ..||||+++.. .....+.|.+|++++++++||||++++|++.. ++..++|||
T Consensus        30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E  109 (311)
T d1r0pa_          30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP  109 (311)
T ss_dssp             EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred             CCCEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEE
T ss_conf             26669813688099999997799879999999988436978999999999999867899986786789806994389998


Q ss_pred             ECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCCEEEEECCCCCCCCCCC
Q ss_conf             36899998885147899988989899999999999889881499980643999998212589949994206753355566
Q 002529          667 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL  746 (912)
Q Consensus       667 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLHs~~~~~ivH~DIkp~NILl~~~~~ikL~DFGla~~~~~~~  746 (912)
                      |+++|+|.++++..  ...+++..++.++.|++.||.|||+   ++|+||||||+|||+++++.+||+|||+++......
T Consensus       110 ~~~~g~l~~~~~~~--~~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~  184 (311)
T d1r0pa_         110 YMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  184 (311)
T ss_dssp             CCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred             EEECCCHHHHHCCC--CCCCHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCHHHEEECCCCCEEEECCCCHHHCCCCC
T ss_conf             74067414421013--4540489999999998876520033---676257766875767799988991065232255665


Q ss_pred             CC---CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf             52---001456777544877448997792257899999999999299999865732202289999864304981001175
Q 002529          747 TH---ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP  823 (912)
Q Consensus       747 ~~---~~~~~~gt~~y~APE~l~~~~~s~~sDVwSlGvil~elltG~~P~~~~~~~~~~~~~~~~~~~i~~~~~~~~~d~  823 (912)
                      ..   ......|++.|+|||.+....++.++||||||+++|||++|+.||......  ..+..++.    .+...  .. 
T Consensus       185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~~~~~~i~----~g~~~--~~-  255 (311)
T d1r0pa_         185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVYLL----QGRRL--LQ-  255 (311)
T ss_dssp             CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHH----TTCCC--CC-
T ss_pred             CCCCEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCH--HHHHHHHH----CCCCC--CC-
T ss_conf             55310025655564556768874379997457466199999999789999888999--99999998----08988--99-


Q ss_pred             CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf             346888988999999999862357999999999999998631210
Q 002529          824 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI  868 (912)
Q Consensus       824 ~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~eIl~~L~~~~~~  868 (912)
                            +......+.+++.+||+.+|++||+|.||++.|+++...
T Consensus       256 ------p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         256 ------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             ------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             ------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf             ------644759999999997688976893999999999999975

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=345.19  Aligned_cols=256  Identities=23%  Similarity=0.390  Sum_probs=206.2

Q ss_pred             HHHHHCCCCCCCCEEEEEEEEC-CCC----EEEEEECCCCC-CHHHHHHHHHHHHHHHCCCCCCCCEEEEEECCCEEEEE
Q ss_conf             9864050384660899999965-997----99999814765-14567799999999833789852354698417728999
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMK-DGK----EVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV  664 (912)
Q Consensus       591 ~~~~~~~LG~G~fG~Vy~~~~~-~g~----~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  664 (912)
                      .|++.++||+|+||+||+|.+. +|+    .||+|+++... ....+.|.+|++++++++|||||+++|+|.++ ..+++
T Consensus        10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v   88 (317)
T d1xkka_          10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLI   88 (317)
T ss_dssp             TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEE
T ss_pred             HCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC-CEEEE
T ss_conf             99783198208992999999958998898999999965134979999999999999867998881589999619-83699


Q ss_pred             EEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCCEEEEECCCCCCCCC
Q ss_conf             99368999988851478999889898999999999998898814999806439999982125899499942067533555
Q 002529          665 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE  744 (912)
Q Consensus       665 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLHs~~~~~ivH~DIkp~NILl~~~~~ikL~DFGla~~~~~  744 (912)
                      +|++.+|+|.+.+..  ....+++..++.++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+++....
T Consensus        89 ~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~  163 (317)
T d1xkka_          89 TQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  163 (317)
T ss_dssp             EECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred             EEECCCCCCCCCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCHHHCCEECCCCCEEEECCCCCEECCC
T ss_conf             984268740101113--34579999999999999999999987---6950476212031167998758602552223354


Q ss_pred             CCCC-CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf             6652-0014567775448774489977922578999999999992-9999986573220228999986430498100117
Q 002529          745 DLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD  822 (912)
Q Consensus       745 ~~~~-~~~~~~gt~~y~APE~l~~~~~s~~sDVwSlGvil~ellt-G~~P~~~~~~~~~~~~~~~~~~~i~~~~~~~~~d  822 (912)
                      .... ......||+.|+|||++.+..++.++|||||||++|||+| |..||......+....   +    ..+..     
T Consensus       164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~---i----~~~~~-----  231 (317)
T d1xkka_         164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---L----EKGER-----  231 (317)
T ss_dssp             TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHH---H----HHTCC-----
T ss_pred             CCCCCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH---H----HCCCC-----
T ss_conf             44532236510586446708874699983565440799999999779999999998999999---9----75998-----


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf             5346888988999999999862357999999999999998631210
Q 002529          823 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI  868 (912)
Q Consensus       823 ~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~eIl~~L~~~~~~  868 (912)
                          ...+......+.+++.+||+.+|++||++.||++.|+.+...
T Consensus       232 ----~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~  273 (317)
T d1xkka_         232 ----LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  273 (317)
T ss_dssp             ----CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             ----CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf             ----999855689999999984789934691999999999998758

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=0  Score=342.44  Aligned_cols=243  Identities=22%  Similarity=0.353  Sum_probs=201.7

Q ss_pred             HHHHCCCCCCCCEEEEEEEEC-CCCEEEEEECCCCC---CHHHHHHHHHHHHHHHCCCCCCCCEEEEEECCCEEEEEEEE
Q ss_conf             864050384660899999965-99799999814765---14567799999999833789852354698417728999993
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY  667 (912)
Q Consensus       592 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~  667 (912)
                      |++.+.||+|+||+||+|+.+ +|+.||+|+++...   ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~   85 (316)
T d1fota_           6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY   85 (316)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred             EEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEEEEEE
T ss_conf             08888972076808999999899979999998457754889999999999999863696753303568528800567650


Q ss_pred             CCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCCEEEEECCCCCCCCCCCC
Q ss_conf             68999988851478999889898999999999998898814999806439999982125899499942067533555665
Q 002529          668 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT  747 (912)
Q Consensus       668 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLHs~~~~~ivH~DIkp~NILl~~~~~ikL~DFGla~~~~~~~~  747 (912)
                      ++||+|...+..   ...+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+|+...... 
T Consensus        86 ~~gg~l~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~-  158 (316)
T d1fota_          86 IEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-  158 (316)
T ss_dssp             CCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB-
T ss_pred             CCCCCCCCCCCC---CCCCCCCHHHHHHHHHHHHHHHHCC---CCEECCCCCCHHEEECCCCCEEEECCCCCEEECCCC-
T ss_conf             378632234322---2211100799999999876554124---767705568105038689988983175216712456-


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf             20014567775448774489977922578999999999992999998657322022899998643049810011753468
Q 002529          748 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG  827 (912)
Q Consensus       748 ~~~~~~~gt~~y~APE~l~~~~~s~~sDVwSlGvil~elltG~~P~~~~~~~~~~~~~~~~~~~i~~~~~~~~~d~~l~~  827 (912)
                         ....||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+..      . .+..+..          
T Consensus       159 ---~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~------~-~i~~~~~----------  218 (316)
T d1fota_         159 ---YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY------E-KILNAEL----------  218 (316)
T ss_dssp             ---CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------H-HHHHCCC----------
T ss_pred             ---CCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCHHHHH------H-HHHCCCC----------
T ss_conf             ---4345763435999983899980430465333689997598999996999999------9-9970898----------


Q ss_pred             CCCHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHHH
Q ss_conf             88988999999999862357999999-----99999999
Q 002529          828 NVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA  861 (912)
Q Consensus       828 ~~~~~~~~~l~~li~~Cl~~~P~~RP-----s~~eIl~~  861 (912)
                      ..+......+.+++.+||+.+|.+|+     +++|+++.
T Consensus       219 ~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         219 RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             CCCCCCCHHHHHHHHHHHHHCHHHCCCCCHHHHHHHHCC
T ss_conf             899778999999999995449976664310219999819

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=340.78  Aligned_cols=250  Identities=23%  Similarity=0.304  Sum_probs=202.5

Q ss_pred             HHHHHHCCCCCCCCEEEEEEEEC-CCCEEEEEECCCCCC------HHHHHHHHHHHHHHHCCCCCCCCEEEEEECCCEEE
Q ss_conf             99864050384660899999965-997999998147651------45677999999998337898523546984177289
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI  662 (912)
Q Consensus       590 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~------~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  662 (912)
                      ..|++.+.||+|+||+||+|+.+ +|+.||+|++.....      ...+.+.+|++++++++|||||++++++.+.+..+
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEE
T ss_conf             67798279811789599999999999899999987566321340689999999999998679989993889999799899


Q ss_pred             EEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCC----CEEEEECCC
Q ss_conf             9999368999988851478999889898999999999998898814999806439999982125899----499942067
Q 002529          663 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM----RAKVSDFGL  738 (912)
Q Consensus       663 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLHs~~~~~ivH~DIkp~NILl~~~~----~ikL~DFGl  738 (912)
                      +||||+++|+|.+++..   ...+++..++.++.|++.||+|||+   .+|+||||||+|||++.++    .+||+|||+
T Consensus        90 iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~  163 (293)
T d1jksa_          90 LILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL  163 (293)
T ss_dssp             EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEECCCCCCCCCHHCC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCCCCCEEEEECCCCCCCCEEECCHHH
T ss_conf             99986778643100103---5642155789999999999876662---54221133301279825898666469643344


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCCCCC
Q ss_conf             53355566520014567775448774489977922578999999999992999998657322022899998643049810
Q 002529          739 SRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI  818 (912)
Q Consensus       739 a~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~~sDVwSlGvil~elltG~~P~~~~~~~~~~~~~~~~~~~i~~~~~~  818 (912)
                      +........  .....|++.|+|||++.+..++.++||||+||++|||++|+.||.+.+..+..   .    .+......
T Consensus       164 a~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~---~----~i~~~~~~  234 (293)
T d1jksa_         164 AHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL---A----NVSAVNYE  234 (293)
T ss_dssp             CEECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H----HHHTTCCC
T ss_pred             HHHCCCCCC--CCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHH---H----HHHHCCCC
T ss_conf             210577763--12247777430999981899997665221409999997088998899999999---9----99816888


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             011753468889889999999998623579999999999999
Q 002529          819 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       819 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~eIl~  860 (912)
                        ..+.....    ....+.+++.+||+.+|++|||++|+++
T Consensus       235 --~~~~~~~~----~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         235 --FEDEYFSN----TSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             --CCHHHHTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             --CCCHHCCC----CCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             --87010478----8999999999986389668919999961

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=342.39  Aligned_cols=260  Identities=30%  Similarity=0.490  Sum_probs=208.2

Q ss_pred             HHHHHHCCCCCCCCEEEEEEEEC-CCC--EEEEEECCCCC-CHHHHHHHHHHHHHHHC-CCCCCCCEEEEEECCCEEEEE
Q ss_conf             99864050384660899999965-997--99999814765-14567799999999833-789852354698417728999
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMK-DGK--EVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILV  664 (912)
Q Consensus       590 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~--~vAvK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV  664 (912)
                      ..+++.++||+|+||.||+|.++ ++.  .||||++.... ....+.+.+|++++.++ +||||++++|++...+..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
T ss_conf             99688779820788289999998999699999999782338579999999999998622899883678888418736999


Q ss_pred             EEECCCCCHHHHHCCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCCE
Q ss_conf             9936899998885147-------------899988989899999999999889881499980643999998212589949
Q 002529          665 YEYMHNGTLRDRLHGS-------------VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRA  731 (912)
Q Consensus       665 ~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qia~aL~yLHs~~~~~ivH~DIkp~NILl~~~~~i  731 (912)
                      |||+++|+|.++++..             .....+++..++.++.|||.||.|||+   ++++||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred             EEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEEECCCCCE
T ss_conf             98028986999986403555551231012345789999999999999999876630---895455505204898688763


Q ss_pred             EEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCC-CCCCCCCCCHHHHHHHHHH
Q ss_conf             994206753355566520014567775448774489977922578999999999992999-9986573220228999986
Q 002529          732 KVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKK-PVSVEDFGAELNIVHWARS  810 (912)
Q Consensus       732 kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~~sDVwSlGvil~elltG~~-P~~~~~~~~~~~~~~~~~~  810 (912)
                      ||+|||+++........  ....|+..|+|||.+....++.++||||||+++|||++|.. ||...+.   ..+..    
T Consensus       167 kl~DfG~a~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~---~~~~~----  237 (309)
T d1fvra_         167 KIADFGLSRGQEVYVKK--TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELYE----  237 (309)
T ss_dssp             EECCTTCEESSCEECCC------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHH----
T ss_pred             EECCCCCCCCCCCCCCC--CCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCCCCH---HHHHH----
T ss_conf             87434432244422345--5301377555538752699996221531388999998368999999999---99999----


Q ss_pred             HHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHCC
Q ss_conf             430498100117534688898899999999986235799999999999999863121002
Q 002529          811 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK  870 (912)
Q Consensus       811 ~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~eIl~~L~~~~~~~~  870 (912)
                      .+..+..     +    ..+......+.+++.+||+.+|++||+|.||++.|+++.....
T Consensus       238 ~i~~~~~-----~----~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~  288 (309)
T d1fvra_         238 KLPQGYR-----L----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  288 (309)
T ss_dssp             HGGGTCC-----C----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred             HHHHCCC-----C----CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCCC
T ss_conf             9982688-----8----8876678999999999767896689499999999999986186

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=341.96  Aligned_cols=265  Identities=28%  Similarity=0.427  Sum_probs=212.6

Q ss_pred             HHHHHHHHHHCCCCCCCCEEEEEEEEC------CCCEEEEEECCCCCC-HHHHHHHHHHHHHHHC-CCCCCCCEEEEEEC
Q ss_conf             799999864050384660899999965------997999998147651-4567799999999833-78985235469841
Q 002529          586 ELEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEE  657 (912)
Q Consensus       586 el~~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~  657 (912)
                      ++....+++.++||+|+||.||+|++.      .++.||||+++.... .....+.+|+.++..+ +|||||++++++..
T Consensus        19 ~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~   98 (311)
T d1t46a_          19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI   98 (311)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CCCHHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEE
T ss_conf             37789969854982068829999998066447788699999987424877999999999998762699988789989831


Q ss_pred             CCEEEEEEEECCCCCHHHHHCCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCC
Q ss_conf             772899999368999988851478---------------99988989899999999999889881499980643999998
Q 002529          658 EHQRILVYEYMHNGTLRDRLHGSV---------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN  722 (912)
Q Consensus       658 ~~~~~lV~E~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~qia~aL~yLHs~~~~~ivH~DIkp~N  722 (912)
                      ....++||||+++|+|.++++...               ....+++..++.++.||+.||+|||+   ++++||||||+|
T Consensus        99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~N  175 (311)
T d1t46a_          99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARN  175 (311)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGG
T ss_pred             CCEEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCCCCCC
T ss_conf             99789999737998799999853566544444533222334588999999999999999998875---792666241021


Q ss_pred             CCCCCCCCEEEEECCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCCCC
Q ss_conf             2125899499942067533555665-20014567775448774489977922578999999999992-999998657322
Q 002529          723 ILLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGA  800 (912)
Q Consensus       723 ILl~~~~~ikL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~~sDVwSlGvil~ellt-G~~P~~~~~~~~  800 (912)
                      ||++.++.+|++|||+++....... .......|++.|+|||++....++.++||||||+++|||+| |.+|+......+
T Consensus       176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~  255 (311)
T d1t46a_         176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS  255 (311)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred             CCCCCCCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHH
T ss_conf             00002575210234010233678861586201359687677886179999740010258999999858998877899899


Q ss_pred             HHHHHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf             02289999864304981001175346888988999999999862357999999999999998631210
Q 002529          801 ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI  868 (912)
Q Consensus       801 ~~~~~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~eIl~~L~~~~~~  868 (912)
                      .  +...+..    +.         ....+......+.+++.+||+.+|++||+|.||+++|++.+..
T Consensus       256 ~--~~~~i~~----~~---------~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~  308 (311)
T d1t46a_         256 K--FYKMIKE----GF---------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (311)
T ss_dssp             H--HHHHHHH----TC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             H--HHHHHHC----CC---------CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCC
T ss_conf             9--9999866----89---------8898543659999999997577965792999999999876534

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=343.60  Aligned_cols=265  Identities=26%  Similarity=0.412  Sum_probs=207.6

Q ss_pred             HHHHHHHHHHCCCCCCCCEEEEEEEEC------CCCEEEEEECCCCCC-HHHHHHHHHHHHHHHC-CCCCCCCEEEEEEC
Q ss_conf             799999864050384660899999965------997999998147651-4567799999999833-78985235469841
Q 002529          586 ELEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEE  657 (912)
Q Consensus       586 el~~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~  657 (912)
                      |+....|++.++||+|+||.||+|.+.      +++.||+|+++.... ...+.+.+|...+.++ +|+||+.+++++..
T Consensus         9 ei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~   88 (299)
T d1ywna1           9 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK   88 (299)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCEEEEEEEEECC
T ss_conf             61679979844984167839999998677755578399999986001717899999999998861499849974115404


Q ss_pred             C-CEEEEEEEECCCCCHHHHHCCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCC
Q ss_conf             7-72899999368999988851478-------------999889898999999999998898814999806439999982
Q 002529          658 E-HQRILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNI  723 (912)
Q Consensus       658 ~-~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~yLHs~~~~~ivH~DIkp~NI  723 (912)
                      . ...++||||+++|+|.++++...             ....+++..++.++.|++.||+|||+   ++|+||||||+||
T Consensus        89 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NI  165 (299)
T d1ywna1          89 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNI  165 (299)
T ss_dssp             TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGE
T ss_pred             CCCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCCE
T ss_conf             7975799998458992999998536666653222023321468999999999999999998873---7971786773106


Q ss_pred             CCCCCCCEEEEECCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCC-CCCCCCCCCCH
Q ss_conf             125899499942067533555665-2001456777544877448997792257899999999999299-99986573220
Q 002529          724 LLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGK-KPVSVEDFGAE  801 (912)
Q Consensus       724 Ll~~~~~ikL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~~sDVwSlGvil~elltG~-~P~~~~~~~~~  801 (912)
                      |+++++.+||+|||+|+....... .......||+.|+|||++.+..++.++|||||||++|||+++. .||....... 
T Consensus       166 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~-  244 (299)
T d1ywna1         166 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-  244 (299)
T ss_dssp             EECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH-
T ss_pred             EECCCCCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCHHH-
T ss_conf             5779982898457520011356652224751667210203686468899663221367899999868899998999899-


Q ss_pred             HHHHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf             2289999864304981001175346888988999999999862357999999999999998631210
Q 002529          802 LNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI  868 (912)
Q Consensus       802 ~~~~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~eIl~~L~~~~~~  868 (912)
                       .+..    .+..+....         .+......+.+++.+||+.+|++|||+.||++.|+++++.
T Consensus       245 -~~~~----~~~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~  297 (299)
T d1ywna1         245 -EFCR----RLKEGTRMR---------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  297 (299)
T ss_dssp             -HHHH----HHHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -HHHH----HHHCCCCCC---------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf             -9999----996389888---------8865789999999997677966791999999999799867

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=0  Score=340.03  Aligned_cols=246  Identities=22%  Similarity=0.276  Sum_probs=195.2

Q ss_pred             HHHHCCCCCCCCEEEEEEEEC-CCCEEEEEECCCCCC---HHHHHHHH---HHHHHHHCCCCCCCCEEEEEECCCEEEEE
Q ss_conf             864050384660899999965-997999998147651---45677999---99999833789852354698417728999
Q 002529          592 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVT---EVALLSRIHHRNLVPLIGYCEEEHQRILV  664 (912)
Q Consensus       592 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~---E~~il~~l~HpnIv~l~~~~~~~~~~~lV  664 (912)
                      |++.+.||+|+||.||+|+.. +|+.||+|++.....   .....+.+   |+.+++.++||||+++++++...+..++|
T Consensus         6 y~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~iv   85 (364)
T d1omwa3           6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI   85 (364)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred             CEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEEEE
T ss_conf             85101884288909999999999979999998458754266799999999999998508998588999999989988999


Q ss_pred             EEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCCEEEEECCCCCCCCC
Q ss_conf             99368999988851478999889898999999999998898814999806439999982125899499942067533555
Q 002529          665 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE  744 (912)
Q Consensus       665 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLHs~~~~~ivH~DIkp~NILl~~~~~ikL~DFGla~~~~~  744 (912)
                      |||+++|+|.+++..   ...+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+|+....
T Consensus        86 mE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~  159 (364)
T d1omwa3          86 LDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK  159 (364)
T ss_dssp             ECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred             EEECCCCCHHHHHHH---CCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCEEECCCEEEECCCCCEEEEEECEEEECCC
T ss_conf             991489838999873---2553278999999999999999997---7962204442216785889679822010233378


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf             66520014567775448774489-97792257899999999999299999865732202289999864304981001175
Q 002529          745 DLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP  823 (912)
Q Consensus       745 ~~~~~~~~~~gt~~y~APE~l~~-~~~s~~sDVwSlGvil~elltG~~P~~~~~~~~~~~~~~~~~~~i~~~~~~~~~d~  823 (912)
                      ..   .....||+.|+|||++.. ..++.++||||+||++|||++|+.||......+...+..    ......      .
T Consensus       160 ~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~----~~~~~~------~  226 (364)
T d1omwa3         160 KK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR----MTLTMA------V  226 (364)
T ss_dssp             SC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHH----HSSSCC------C
T ss_pred             CC---CCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH----HCCCCC------C
T ss_conf             86---4331134554216876038999844104677899999985999888899899999998----604688------8


Q ss_pred             CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHH
Q ss_conf             3468889889999999998623579999999-----999999
Q 002529          824 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVL  860 (912)
Q Consensus       824 ~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPs-----~~eIl~  860 (912)
                      ......+    ..+.+++.+||+.+|++||+     ++|+++
T Consensus       227 ~~~~~~s----~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         227 ELPDSFS----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             CCCSSSC----HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             CCCCCCC----HHHHHHHHHHCCCCHHHHCCCCCCCHHHHHC
T ss_conf             7887789----9999999998566988808874357999974

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=350.06  Aligned_cols=252  Identities=30%  Similarity=0.483  Sum_probs=205.9

Q ss_pred             HHHHHCCCCCCCCEEEEEEEECCCCEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCEEEEEEC-CCEEEEEEEECC
Q ss_conf             9864050384660899999965997999998147651456779999999983378985235469841-772899999368
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE-EHQRILVYEYMH  669 (912)
Q Consensus       591 ~~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~~lV~E~~~  669 (912)
                      .+++.+.||+|+||.||+|+++ ++.||||+++..  ...+.+.+|++++++++||||++++|++.+ .+..++||||++
T Consensus         8 ~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~   84 (262)
T d1byga_           8 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA   84 (262)
T ss_dssp             GEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred             HEEEEEEEECCCCEEEEEEEEC-CEEEEEEEECCH--HHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEECCC
T ss_conf             9488579820798089999999-909999998857--7799999999999867898985498788723892899996369


Q ss_pred             CCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCC
Q ss_conf             99998885147899988989899999999999889881499980643999998212589949994206753355566520
Q 002529          670 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI  749 (912)
Q Consensus       670 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLHs~~~~~ivH~DIkp~NILl~~~~~ikL~DFGla~~~~~~~~~~  749 (912)
                      +|+|.+++... ....+++..++.++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++......   
T Consensus        85 ~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~---  157 (262)
T d1byga_          85 KGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---  157 (262)
T ss_dssp             TEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred             CCCHHHHHHHC-CCCCCCHHHHHHHHHHHHHHCCCCCC---CCEECCCCCHHHHEECCCCCEEECCCCCCEECCCCC---
T ss_conf             99899998745-78888999999999999852321133---765536665676014689977632456003447877---


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCC
Q ss_conf             014567775448774489977922578999999999992-9999986573220228999986430498100117534688
Q 002529          750 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN  828 (912)
Q Consensus       750 ~~~~~gt~~y~APE~l~~~~~s~~sDVwSlGvil~ellt-G~~P~~~~~~~~~~~~~~~~~~~i~~~~~~~~~d~~l~~~  828 (912)
                       ....++..|+|||++.+..++.++||||||+++|||+| |+.||......   .+..++    ..+...         .
T Consensus       158 -~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~---~~~~~i----~~~~~~---------~  220 (262)
T d1byga_         158 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRV----EKGYKM---------D  220 (262)
T ss_dssp             -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHHH----TTTCCC---------C
T ss_pred             -CCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HHHHHH----HCCCCC---------C
T ss_conf             -65566646778178727988858877757999999997899999999999---999999----808999---------9


Q ss_pred             CCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHC
Q ss_conf             89889999999998623579999999999999986312100
Q 002529          829 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE  869 (912)
Q Consensus       829 ~~~~~~~~l~~li~~Cl~~~P~~RPs~~eIl~~L~~~~~~~  869 (912)
                      .+......+.+++.+||+.+|++||||.|+++.|++++.-|
T Consensus       221 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~~  261 (262)
T d1byga_         221 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE  261 (262)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCC
T ss_conf             97657999999999975669768939999999999998677

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=341.25  Aligned_cols=263  Identities=25%  Similarity=0.443  Sum_probs=212.4

Q ss_pred             HHHHHHHHHCCCCCCCCEEEEEEEECC--------CCEEEEEECCCCCC-HHHHHHHHHHHHHHHC-CCCCCCCEEEEEE
Q ss_conf             999998640503846608999999659--------97999998147651-4567799999999833-7898523546984
Q 002529          587 LEEATNNFCKKIGKGSFGSVYYGKMKD--------GKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCE  656 (912)
Q Consensus       587 l~~~~~~~~~~LG~G~fG~Vy~~~~~~--------g~~vAvK~l~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~~~~~  656 (912)
                      +....|++.+.||+|+||.||+|+...        +..||||+++.... .....+.+|...+.++ +|||||+++++|.
T Consensus        10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~   89 (299)
T d1fgka_          10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT   89 (299)
T ss_dssp             CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CCHHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEECCCCCC
T ss_conf             25899697009851678289999985787555667549999998811286889999999999998139996973465220


Q ss_pred             CCCEEEEEEEECCCCCHHHHHCCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCC
Q ss_conf             1772899999368999988851478-------------999889898999999999998898814999806439999982
Q 002529          657 EEHQRILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNI  723 (912)
Q Consensus       657 ~~~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~yLHs~~~~~ivH~DIkp~NI  723 (912)
                      +++..++||||+++|+|.+++....             ....+++..++.++.|++.||+|||+   .+++||||||+||
T Consensus        90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~Ni  166 (299)
T d1fgka_          90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNV  166 (299)
T ss_dssp             SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGE
T ss_pred             CCCEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEEEEECCCCE
T ss_conf             1886899997369990999998606776432223345743467999999999999999987663---7978630221022


Q ss_pred             CCCCCCCEEEEECCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCCCCH
Q ss_conf             125899499942067533555665-20014567775448774489977922578999999999992-9999986573220
Q 002529          724 LLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAE  801 (912)
Q Consensus       724 Ll~~~~~ikL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~~sDVwSlGvil~ellt-G~~P~~~~~~~~~  801 (912)
                      |++.++.+||+|||+++....... .......|++.|+|||.+.+..++.++||||||+++|||++ |..||......  
T Consensus       167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~--  244 (299)
T d1fgka_         167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--  244 (299)
T ss_dssp             EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--
T ss_pred             EECCCCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCHH--
T ss_conf             454789767622111011355555431466788846632667517988825554775888887401798989999999--


Q ss_pred             HHHHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf             2289999864304981001175346888988999999999862357999999999999998631210
Q 002529          802 LNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI  868 (912)
Q Consensus       802 ~~~~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~eIl~~L~~~~~~  868 (912)
                       .+.+    .+..+....         .+......+.+++.+||+.+|++|||+.||++.|++++..
T Consensus       245 -~~~~----~i~~~~~~~---------~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~  297 (299)
T d1fgka_         245 -ELFK----LLKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL  297 (299)
T ss_dssp             -HHHH----HHHTTCCCC---------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -HHHH----HHHCCCCCC---------CCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf             -9999----997288889---------8743529999999997667976793999999999888604

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=0  Score=339.12  Aligned_cols=243  Identities=23%  Similarity=0.294  Sum_probs=201.5

Q ss_pred             HHHHHCCCCCCCCEEEEEEEEC-CCCEEEEEECCCCC---CHHHHHHHHHHHHHHHCCCCCCCCEEEEEECCCEEEEEEE
Q ss_conf             9864050384660899999965-99799999814765---1456779999999983378985235469841772899999
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE  666 (912)
Q Consensus       591 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E  666 (912)
                      .|++.+.||+|+||.||+|+.+ +|+.||+|++....   ....+.+.+|+++++.++||||+++++++......++|+|
T Consensus        42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e  121 (350)
T d1rdqe_          42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME  121 (350)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCCC
T ss_conf             70898896117680899999989998999999826774588999999999999997487727403444432222232222


Q ss_pred             ECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCCEEEEECCCCCCCCCCC
Q ss_conf             36899998885147899988989899999999999889881499980643999998212589949994206753355566
Q 002529          667 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL  746 (912)
Q Consensus       667 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLHs~~~~~ivH~DIkp~NILl~~~~~ikL~DFGla~~~~~~~  746 (912)
                      ++.+|+|.+++..   ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+|+......
T Consensus       122 ~~~~g~l~~~l~~---~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~  195 (350)
T d1rdqe_         122 YVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT  195 (350)
T ss_dssp             CCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB
T ss_pred             CCCCCCHHHHHHH---CCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHCCCCCCCCEEEEECEEEEECCCCC
T ss_conf             3346622666751---5898999999999999998999985---998617679999360778978861010333225666


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf             52001456777544877448997792257899999999999299999865732202289999864304981001175346
Q 002529          747 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI  826 (912)
Q Consensus       747 ~~~~~~~~gt~~y~APE~l~~~~~s~~sDVwSlGvil~elltG~~P~~~~~~~~~~~~~~~~~~~i~~~~~~~~~d~~l~  826 (912)
                          ....||+.|+|||++.+..++.++||||+||++|||++|+.||...+...   ...    .+..+..      .. 
T Consensus       196 ----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~----~i~~~~~------~~-  257 (350)
T d1rdqe_         196 ----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ---IYE----KIVSGKV------RF-  257 (350)
T ss_dssp             ----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH----HHHHCCC------CC-
T ss_pred             ----CCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHH---HHH----HHHCCCC------CC-
T ss_conf             ----43367635678899717998853311450078999975889989959999---999----9861798------89-


Q ss_pred             CCCCHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHH
Q ss_conf             888988999999999862357999999-----9999999
Q 002529          827 GNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL  860 (912)
Q Consensus       827 ~~~~~~~~~~l~~li~~Cl~~~P~~RP-----s~~eIl~  860 (912)
                         +......+.+++.+||+.+|.+|+     +++|+++
T Consensus       258 ---p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         258 ---PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             ---CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ---CCCCCHHHHHHHHHHHHHCHHHCCCCCCCCHHHHHC
T ss_conf             ---766899999999998340998606553454999971

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=343.04  Aligned_cols=267  Identities=25%  Similarity=0.373  Sum_probs=201.6

Q ss_pred             HHHHCCCCCCCCEEEEEEEECCCCEEEEEECCCCCCHHHHHHHH--HHHHHHHCCCCCCCCEEEEEECCC----EEEEEE
Q ss_conf             86405038466089999996599799999814765145677999--999998337898523546984177----289999
Q 002529          592 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVT--EVALLSRIHHRNLVPLIGYCEEEH----QRILVY  665 (912)
Q Consensus       592 ~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~--E~~il~~l~HpnIv~l~~~~~~~~----~~~lV~  665 (912)
                      +.+.++||+|+||.||+|+++ |+.||||+++...   .+.+.+  |+..+..++||||+++++++...+    ..++||
T Consensus         5 ~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           5 IVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             EEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             EEEEEEEEECCCEEEEEEEEC-CEEEEEEEECCCC---HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEEEE
T ss_conf             999889820788199999999-9899999987200---467999999999962799868326889983798604899999


Q ss_pred             EECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CCCEEECCCCCCCCCCCCCCCEEEEECCCCC
Q ss_conf             93689999888514789998898989999999999988988149-----9980643999998212589949994206753
Q 002529          666 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC-----NPGIIHRDVKSSNILLDINMRAKVSDFGLSR  740 (912)
Q Consensus       666 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLHs~~-----~~~ivH~DIkp~NILl~~~~~ikL~DFGla~  740 (912)
                      ||+++|+|.+++++    ..++|..++.++.|+|.||+|||+..     +++|+||||||+|||++.++.+||+|||+++
T Consensus        81 Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~  156 (303)
T d1vjya_          81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             ECCCCCCHHHHHHC----CCCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEECCCCC
T ss_conf             64669898999865----89998999999999999999988766520468986615317313578688776887638662


Q ss_pred             CCCCCCCC---CCCCCCCCCCCCCCCCCCCCC------CCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHH--------H
Q ss_conf             35556652---001456777544877448997------792257899999999999299999865732202--------2
Q 002529          741 QAEEDLTH---ISSVARGTVGYLDPEYYGNQQ------LTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL--------N  803 (912)
Q Consensus       741 ~~~~~~~~---~~~~~~gt~~y~APE~l~~~~------~s~~sDVwSlGvil~elltG~~P~~~~~~~~~~--------~  803 (912)
                      ........   ......||+.|+|||++....      ++.++|||||||++|||+||..|+.........        .
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~  236 (303)
T d1vjya_         157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             CCCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCCC
T ss_conf             34677762001355250354767822105654546777675012201599999996289988766311241012255643


Q ss_pred             HHHHHHHHHCCCCCCCCCCCCCCCCC-CHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHCC
Q ss_conf             89999864304981001175346888-98899999999986235799999999999999863121002
Q 002529          804 IVHWARSMIKKGDVISIVDPVLIGNV-KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK  870 (912)
Q Consensus       804 ~~~~~~~~i~~~~~~~~~d~~l~~~~-~~~~~~~l~~li~~Cl~~~P~~RPs~~eIl~~L~~~~~~~~  870 (912)
                      ...........+.    .+|.+.... +.+.+..+.+++.+||+.+|++|||+.||++.|+++...+.
T Consensus       237 ~~~~~~~~~~~~~----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~  300 (303)
T d1vjya_         237 SVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG  300 (303)
T ss_dssp             CHHHHHHHHTTSC----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             HHHHHHHHHHCCC----CCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHCC
T ss_conf             0999999875024----688877655776899999999999760698589599999999998888659

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=338.93  Aligned_cols=263  Identities=24%  Similarity=0.424  Sum_probs=210.2

Q ss_pred             HHHHHHHHHHCCCCCCCCEEEEEEEEC------CCCEEEEEECCCCCC-HHHHHHHHHHHHHHHCCCCCCCCEEEEEECC
Q ss_conf             799999864050384660899999965------997999998147651-4567799999999833789852354698417
Q 002529          586 ELEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEE  658 (912)
Q Consensus       586 el~~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  658 (912)
                      |+....+++.+.||+|+||.||+|.++      +++.||||+++.... .....|.+|++++++++||||+++++++...
T Consensus        16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~   95 (308)
T d1p4oa_          16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG   95 (308)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred             EECHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC
T ss_conf             42689918835982078818999998786447789689999987012868999999999999976999884125478428


Q ss_pred             CEEEEEEEECCCCCHHHHHCCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCCE
Q ss_conf             72899999368999988851478-------99988989899999999999889881499980643999998212589949
Q 002529          659 HQRILVYEYMHNGTLRDRLHGSV-------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRA  731 (912)
Q Consensus       659 ~~~~lV~E~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~qia~aL~yLHs~~~~~ivH~DIkp~NILl~~~~~i  731 (912)
                      ...++||||+++|+|.+++....       ....+++..+.+++.|+|+||+|||+   ++|+||||||+|||++.++.+
T Consensus        96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~  172 (308)
T d1p4oa_          96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTV  172 (308)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCE
T ss_pred             CCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECEECCCCEEECCCCEE
T ss_conf             81067776048998899987503321134446887999999999999999998764---796543286775403599649


Q ss_pred             EEEECCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCC-CCCCCCCCCCHHHHHHHHH
Q ss_conf             9942067533555665-2001456777544877448997792257899999999999299-9998657322022899998
Q 002529          732 KVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGK-KPVSVEDFGAELNIVHWAR  809 (912)
Q Consensus       732 kL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~~sDVwSlGvil~elltG~-~P~~~~~~~~~~~~~~~~~  809 (912)
                      ||+|||+++....... .......|++.|+|||.+.+..++.++||||||+++|||+||. .||......+   ...   
T Consensus       173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~---~~~---  246 (308)
T d1p4oa_         173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ---VLR---  246 (308)
T ss_dssp             EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH---HHH---
T ss_pred             EEEECCCCEECCCCCCEEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHH---HHH---
T ss_conf             99424542023577630313402316323788887369988333444378999999968999999989999---999---


Q ss_pred             HHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf             6430498100117534688898899999999986235799999999999999863121
Q 002529          810 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK  867 (912)
Q Consensus       810 ~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~eIl~~L~~~~~  867 (912)
                       .+..+.....         +...+..+.+++.+||+.+|++||+|.||++.|++.++
T Consensus       247 -~i~~~~~~~~---------p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         247 -FVMEGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             -HHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             -HHHHCCCCCC---------CCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCC
T ss_conf             -9980888888---------63353999999999757796589399999999787617

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=332.62  Aligned_cols=249  Identities=19%  Similarity=0.292  Sum_probs=201.6

Q ss_pred             HHHHHCCCCCCCCEEEEEEEEC-CCCEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCEEEEEECCCEEEEEEEECC
Q ss_conf             9864050384660899999965-997999998147651456779999999983378985235469841772899999368
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH  669 (912)
Q Consensus       591 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~  669 (912)
                      .|++.+.||+|+||+||+|..+ +++.||+|+++... .....+.+|+++|+.++||||+++++++.+.+..++||||++
T Consensus         6 rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~   84 (321)
T d1tkia_           6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS   84 (321)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred             CEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEECCC
T ss_conf             0588789831778399999998999699999975786-659999999999985799798909899988998899995389


Q ss_pred             CCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCC--CCCEEEEECCCCCCCCCCCC
Q ss_conf             9999888514789998898989999999999988988149998064399999821258--99499942067533555665
Q 002529          670 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI--NMRAKVSDFGLSRQAEEDLT  747 (912)
Q Consensus       670 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLHs~~~~~ivH~DIkp~NILl~~--~~~ikL~DFGla~~~~~~~~  747 (912)
                      +|+|.+++...  ...+++..+..++.||+.||+|||+   ++|+||||||+|||++.  ...+||+|||++........
T Consensus        85 gg~L~~~i~~~--~~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~  159 (321)
T d1tkia_          85 GLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN  159 (321)
T ss_dssp             CCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred             CCCHHHHHHHC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCCEEECCCCCEEEEECCCCHHHCCCCCCC
T ss_conf             98088998753--8999999999999999999999987---699751355444344378851899764411100346775


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf             20014567775448774489977922578999999999992999998657322022899998643049810011753468
Q 002529          748 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG  827 (912)
Q Consensus       748 ~~~~~~~gt~~y~APE~l~~~~~s~~sDVwSlGvil~elltG~~P~~~~~~~~~~~~~~~~~~~i~~~~~~~~~d~~l~~  827 (912)
                        .....+++.|+|||...+..++.++||||+||++|+|++|+.||......+..   .    .+..+...  ++.....
T Consensus       160 --~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~---~----~i~~~~~~--~~~~~~~  228 (321)
T d1tkia_         160 --FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII---E----NIMNAEYT--FDEEAFK  228 (321)
T ss_dssp             --EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---H----HHHHTCCC--CCHHHHT
T ss_pred             --CCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCCHHHHH---H----HHHHCCCC--CCHHHCC
T ss_conf             --32122332223402104877784011302799999998289999998999999---9----99838999--8802236


Q ss_pred             CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             889889999999998623579999999999999
Q 002529          828 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       828 ~~~~~~~~~l~~li~~Cl~~~P~~RPs~~eIl~  860 (912)
                      ..    ...+.+++.+||+.+|++||++.|+++
T Consensus       229 ~~----s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         229 EI----SIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             TS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CC----CHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             78----999999999986699668909999963

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=0  Score=333.37  Aligned_cols=258  Identities=24%  Similarity=0.370  Sum_probs=207.0

Q ss_pred             HHHHHHCCCCCCCCEEEEEEEEC-CCCEEEEEECCCCCC---HHHHHHHHHHHHHHHCCCCCCCCEEEEEECCC----EE
Q ss_conf             99864050384660899999965-997999998147651---45677999999998337898523546984177----28
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH----QR  661 (912)
Q Consensus       590 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~----~~  661 (912)
                      .+|++.+.||+|+||.||+|+.. +++.||+|+++....   ...+.+.+|+++++.++||||+++++++....    ..
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~   86 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   86 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             CEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCEE
T ss_conf             20698689960899299999999999899999985566469899999999999998569998873114354326887669


Q ss_pred             EEEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCCEEEEECCCCCC
Q ss_conf             99999368999988851478999889898999999999998898814999806439999982125899499942067533
Q 002529          662 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ  741 (912)
Q Consensus       662 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLHs~~~~~ivH~DIkp~NILl~~~~~ikL~DFGla~~  741 (912)
                      ++||||+++|+|.+++..   ...+++..++.++.|++.||+|||+   ++++||||||+|||++.++..+++|||.+..
T Consensus        87 ~lvmE~~~g~~L~~~~~~---~~~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~  160 (277)
T d1o6ya_          87 YIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARA  160 (277)
T ss_dssp             EEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred             EEEEECCCCCEEHHHHCC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCCCCCCCCCCCEEEHHHHHHH
T ss_conf             999977889871011203---5899999999999999999999985---7952763467556657543201003444322


Q ss_pred             CCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCC
Q ss_conf             55566--5200145677754487744899779225789999999999929999986573220228999986430498100
Q 002529          742 AEEDL--THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS  819 (912)
Q Consensus       742 ~~~~~--~~~~~~~~gt~~y~APE~l~~~~~s~~sDVwSlGvil~elltG~~P~~~~~~~~~~~~~~~~~~~i~~~~~~~  819 (912)
                      .....  ........||+.|+|||++.+..++.++||||+||++|||+||+.||......+      .....+..+....
T Consensus       161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~~~~~~~~~~  234 (277)
T d1o6ya_         161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQHVREDPIPP  234 (277)
T ss_dssp             CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHCCCCCG
T ss_pred             HCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCCHHH------HHHHHHHCCCCCC
T ss_conf             1235443333464257624369999839999966320265289999976979989969999------9999984699997


Q ss_pred             CCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCC-CHHHHHHHHHHHH
Q ss_conf             1175346888988999999999862357999999-9999999986312
Q 002529          820 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP-KMQEIVLAIQDSI  866 (912)
Q Consensus       820 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RP-s~~eIl~~L~~~~  866 (912)
                      .   ......    ...+.+++.+||+.+|++|| +++++.+.|.++.
T Consensus       235 ~---~~~~~~----s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         235 S---ARHEGL----SADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             G---GTSSSC----CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             C---HHCCCC----CHHHHHHHHHHCCCCHHHCHHHHHHHHHHHHHHH
T ss_conf             1---003478----9999999999866797677739999999999975

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=334.08  Aligned_cols=259  Identities=20%  Similarity=0.217  Sum_probs=197.6

Q ss_pred             HCCCCCCCCEEEEEEEEC-CCCEEEEEECCCCCCH-----HHHHHHHHHHHHHHCCCCCCCCEEEEEECCCEEEEEEEEC
Q ss_conf             050384660899999965-9979999981476514-----5677999999998337898523546984177289999936
Q 002529          595 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH-----RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM  668 (912)
Q Consensus       595 ~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~-----~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~  668 (912)
                      .++||+|+||+||+|+.+ +++.||||+++.....     ..+.+.+|++++++++||||+++++++..++..++||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             CEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHHHH
T ss_conf             63851272829999999999969999998420212456799999999999998679999868985422587402204553


Q ss_pred             CCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCC
Q ss_conf             89999888514789998898989999999999988988149998064399999821258994999420675335556652
Q 002529          669 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH  748 (912)
Q Consensus       669 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLHs~~~~~ivH~DIkp~NILl~~~~~ikL~DFGla~~~~~~~~~  748 (912)
                      .++++.....   ....+++..+..++.|++.||+|||+   ++++||||||+|||++.++.+||+|||+++........
T Consensus        83 ~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~  156 (299)
T d1ua2a_          83 ETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA  156 (299)
T ss_dssp             SEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred             CCHHHHHHHH---CCCCCCHHHHHHHHHHHHHHHHHHHC---CCEECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCC
T ss_conf             4507765541---26677899999999999999988631---63550357762588537784114657610005787554


Q ss_pred             CCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCC---CC
Q ss_conf             0014567775448774489-9779225789999999999929999986573220228999986430498100117---53
Q 002529          749 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD---PV  824 (912)
Q Consensus       749 ~~~~~~gt~~y~APE~l~~-~~~s~~sDVwSlGvil~elltG~~P~~~~~~~~~~~~~~~~~~~i~~~~~~~~~d---~~  824 (912)
                       .....||+.|+|||++.. ..++.++||||+||++|||++|+.||......+....+.................   ..
T Consensus       157 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~  235 (299)
T d1ua2a_         157 -YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV  235 (299)
T ss_dssp             -CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred             -CCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCHHCCCHHH
T ss_conf             -3302047333639997267788805643630428999985969999999999999999851899725452100021344


Q ss_pred             C---CCCCCH-----HHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             4---688898-----89999999998623579999999999999
Q 002529          825 L---IGNVKI-----ESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       825 l---~~~~~~-----~~~~~l~~li~~Cl~~~P~~RPs~~eIl~  860 (912)
                      .   ....+.     .....+.+++.+||+.+|++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             HHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             30347898867856568999999999976389456908999967

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=341.63  Aligned_cols=255  Identities=28%  Similarity=0.412  Sum_probs=204.7

Q ss_pred             HHHHHHCCCCCCCCEEEEEEEECC--C--CEEEEEECCCC---CCHHHHHHHHHHHHHHHCCCCCCCCEEEEEECCCEEE
Q ss_conf             998640503846608999999659--9--79999981476---5145677999999998337898523546984177289
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMKD--G--KEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI  662 (912)
Q Consensus       590 ~~~~~~~~LG~G~fG~Vy~~~~~~--g--~~vAvK~l~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  662 (912)
                      ..+++.+.||+|+||.||+|++..  +  ..||||++...   .....+.|.+|++++++++||||++++|++.+ ...+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-CCHH
T ss_conf             891997898038883999999988999079999999983555798999999999999986899998789877740-1001


Q ss_pred             EEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCCEEEEECCCCCCC
Q ss_conf             99993689999888514789998898989999999999988988149998064399999821258994999420675335
Q 002529          663 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA  742 (912)
Q Consensus       663 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLHs~~~~~ivH~DIkp~NILl~~~~~ikL~DFGla~~~  742 (912)
                      +||||+++|++.+.+...  ...+++..++.++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+++..
T Consensus        87 lv~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~  161 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRAL  161 (273)
T ss_dssp             EEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEEECCCCHHHHHHCC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEEEEEECHHHHCCCCCCCEEECCCHHHHHC
T ss_conf             146542386125444212--6899999999999999999987521---78752056688815655654332561155530


Q ss_pred             CCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHHHCCCCCCC
Q ss_conf             556652--0014567775448774489977922578999999999992-9999986573220228999986430498100
Q 002529          743 EEDLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVIS  819 (912)
Q Consensus       743 ~~~~~~--~~~~~~gt~~y~APE~l~~~~~s~~sDVwSlGvil~ellt-G~~P~~~~~~~~~~~~~~~~~~~i~~~~~~~  819 (912)
                      ......  ......|+..|+|||++.+..++.++||||||+++|||+| |+.||...+..+   ...+   ..+.+... 
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~---~~~~---i~~~~~~~-  234 (273)
T d1u46a_         162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---ILHK---IDKEGERL-  234 (273)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHH---HHTSCCCC-
T ss_pred             CCCCCCCEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHHH---HHHCCCCC-
T ss_conf             3588752654763257310799998379999421566148999999968999999969999---9999---98479999-


Q ss_pred             CCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf             1175346888988999999999862357999999999999998631
Q 002529          820 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS  865 (912)
Q Consensus       820 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~eIl~~L~~~  865 (912)
                              ..+...+..+.+++.+||+.+|++||||.||++.|++.
T Consensus       235 --------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         235 --------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHC
T ss_conf             --------98544539999999997688966792999999999964

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=338.48  Aligned_cols=246  Identities=24%  Similarity=0.364  Sum_probs=199.4

Q ss_pred             HHHHHCCCCCCCCEEEEEEEEC-CCCEEEEEECCCCC---CHHHHHHHHHHHHHH-HCCCCCCCCEEEEEECCCEEEEEE
Q ss_conf             9864050384660899999965-99799999814765---145677999999998-337898523546984177289999
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLS-RIHHRNLVPLIGYCEEEHQRILVY  665 (912)
Q Consensus       591 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~il~-~l~HpnIv~l~~~~~~~~~~~lV~  665 (912)
                      .|++.++||+|+||+||+|+.+ +++.||+|+++...   ....+.+..|..++. .++||||+++++++.+++..++||
T Consensus         3 dy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivm   82 (320)
T d1xjda_           3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM   82 (320)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEEE
T ss_conf             71886589408782899999999998999999805553384899999999999998479996878988970498316777


Q ss_pred             EECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCCEEEEECCCCCCCCCC
Q ss_conf             93689999888514789998898989999999999988988149998064399999821258994999420675335556
Q 002529          666 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED  745 (912)
Q Consensus       666 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLHs~~~~~ivH~DIkp~NILl~~~~~ikL~DFGla~~~~~~  745 (912)
                      ||+++|+|.+++..   ...+++..+..++.||+.||+|||+   ++++||||||+|||++.++.+||+|||+++.....
T Consensus        83 Ey~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~  156 (320)
T d1xjda_          83 EYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG  156 (320)
T ss_dssp             ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EECCCCCHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCCCCCCEEECCCCCEECCCCCHHHHCCCC
T ss_conf             50379808998640---4789999999999999999999986---89340347654044448996301555302323566


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf             65200145677754487744899779225789999999999929999986573220228999986430498100117534
Q 002529          746 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL  825 (912)
Q Consensus       746 ~~~~~~~~~gt~~y~APE~l~~~~~s~~sDVwSlGvil~elltG~~P~~~~~~~~~~~~~~~~~~~i~~~~~~~~~d~~l  825 (912)
                      ... .....||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+.....       ..+..+..      ..
T Consensus       157 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~-------~~i~~~~~------~~  222 (320)
T d1xjda_         157 DAK-TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF-------HSIRMDNP------FY  222 (320)
T ss_dssp             TCC-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHCCC------CC
T ss_pred             CCC-CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH-------HHHHCCCC------CC
T ss_conf             533-45457877768999982799883232011227898987388999998999999-------99971899------89


Q ss_pred             CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHH-HHHH
Q ss_conf             6888988999999999862357999999999-9999
Q 002529          826 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQ-EIVL  860 (912)
Q Consensus       826 ~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~-eIl~  860 (912)
                          +......+.+++.+||+.+|++||++. |+++
T Consensus       223 ----p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         223 ----PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             ----CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             ----CCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHH
T ss_conf             ----75679999999999654489878388999980

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=332.51  Aligned_cols=250  Identities=22%  Similarity=0.297  Sum_probs=195.4

Q ss_pred             HHHHH-CCCCCCCCEEEEEEEEC-CCCEEEEEECCCCCCHHHHHHHHHHHHHHHC-CCCCCCCEEEEEEC----CCEEEE
Q ss_conf             98640-50384660899999965-9979999981476514567799999999833-78985235469841----772899
Q 002529          591 TNNFC-KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEE----EHQRIL  663 (912)
Q Consensus       591 ~~~~~-~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~----~~~~~l  663 (912)
                      .|++. +.||+|+||.||+|+.. +++.||||+++.     ...+.+|++++.++ +||||+++++++.+    ....++
T Consensus        12 ~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~i   86 (335)
T d2ozaa1          12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI   86 (335)
T ss_dssp             TEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred             CEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECC-----CHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCEEEE
T ss_conf             879810796545486999999889998999999897-----477999999999866999978298999503468978999


Q ss_pred             EEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCC---CCCEEEEECCCCC
Q ss_conf             9993689999888514789998898989999999999988988149998064399999821258---9949994206753
Q 002529          664 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSR  740 (912)
Q Consensus       664 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLHs~~~~~ivH~DIkp~NILl~~---~~~ikL~DFGla~  740 (912)
                      |||||+||+|.+++... ....+++..+..++.|++.||+|||+   .+|+||||||+|||++.   ++.+||+|||+++
T Consensus        87 vmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~  162 (335)
T d2ozaa1          87 VMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  162 (335)
T ss_dssp             EEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EEECCCCCCHHHHHHHC-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEE
T ss_conf             99778998499999862-78775799999999999999999997---698644410022011355556631135455123


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCC
Q ss_conf             35556652001456777544877448997792257899999999999299999865732202289999864304981001
Q 002529          741 QAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI  820 (912)
Q Consensus       741 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~~sDVwSlGvil~elltG~~P~~~~~~~~~~~~~~~~~~~i~~~~~~~~  820 (912)
                      .......  .....|++.|+|||++.+..++.++||||+||++|+|++|+.||.........   ......+..+..   
T Consensus       163 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~---~~~~~~i~~~~~---  234 (335)
T d2ozaa1         163 ETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---PGMKTRIRMGQY---  234 (335)
T ss_dssp             ECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCSS---
T ss_pred             ECCCCCC--CCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHH---HHHHHHHHCCCC---
T ss_conf             3368886--43226775637927774898888888876451677886588998898877889---999999853888---


Q ss_pred             CCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             1753468889889999999998623579999999999999
Q 002529          821 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       821 ~d~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~eIl~  860 (912)
                         .+...........+.+++.+||+.+|++||++.|+++
T Consensus       235 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         235 ---EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             ---SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ---CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             ---8898543469999999999975699657909999970

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=0  Score=329.13  Aligned_cols=249  Identities=25%  Similarity=0.298  Sum_probs=200.5

Q ss_pred             HHHHHCCCCCCCCEEEEEEEEC-CCCEEEEEECCCCCC---------HHHHHHHHHHHHHHHCC-CCCCCCEEEEEECCC
Q ss_conf             9864050384660899999965-997999998147651---------45677999999998337-898523546984177
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---------HRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEH  659 (912)
Q Consensus       591 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~---------~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~  659 (912)
                      .|++.+.||+|+||+||+|+.. +++.||||++.....         ...+.+.+|+.++++++ ||||+++++++.+++
T Consensus         4 ~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~   83 (277)
T d1phka_           4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT   83 (277)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             CCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCC
T ss_conf             38885288417684999999999998999999962446411478889999999999999998507997479976214676


Q ss_pred             EEEEEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCCEEEEECCCC
Q ss_conf             28999993689999888514789998898989999999999988988149998064399999821258994999420675
Q 002529          660 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS  739 (912)
Q Consensus       660 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLHs~~~~~ivH~DIkp~NILl~~~~~ikL~DFGla  739 (912)
                      ..++||||+++|+|.+++..   ...+++..+..++.||+.||+|||+   ++++||||||+|||++.++.+||+|||++
T Consensus        84 ~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a  157 (277)
T d1phka_          84 FFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS  157 (277)
T ss_dssp             EEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             CEEEEEECCCCCHHHHHHHH---CCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCEEEECCCCCEEECCCHHE
T ss_conf             05999976898668999986---5999999999999999999999987---59943234625489868998387124031


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCC------CCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHC
Q ss_conf             335556652001456777544877448------99779225789999999999929999986573220228999986430
Q 002529          740 RQAEEDLTHISSVARGTVGYLDPEYYG------NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK  813 (912)
Q Consensus       740 ~~~~~~~~~~~~~~~gt~~y~APE~l~------~~~~s~~sDVwSlGvil~elltG~~P~~~~~~~~~~~~~~~~~~~i~  813 (912)
                      +.......  .....||+.|+|||++.      ...++.++||||+||++|||++|+.||......+.       ...+.
T Consensus       158 ~~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~-------~~~i~  228 (277)
T d1phka_         158 CQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM-------LRMIM  228 (277)
T ss_dssp             EECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHH
T ss_pred             EECCCCCC--EEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCCHHHH-------HHHHH
T ss_conf             67268872--1345246788898886053445678899233185656023103228889889999999-------99998


Q ss_pred             CCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             49810011753468889889999999998623579999999999999
Q 002529          814 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       814 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~eIl~  860 (912)
                      .+... .     ...........+.+++.+||+.+|++||++.|+++
T Consensus       229 ~~~~~-~-----~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         229 SGNYQ-F-----GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             HTCCC-C-----CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HCCCC-C-----CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             18988-8-----98543468999999999976589668919999973

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=325.38  Aligned_cols=265  Identities=20%  Similarity=0.268  Sum_probs=198.2

Q ss_pred             HHHHHCCCCCCCCEEEEEEEEC-CCCEEEEEECCCCCC--HHHHHHHHHHHHHHHCCCCCCCCEEEEEECCCEEEEEEEE
Q ss_conf             9864050384660899999965-997999998147651--4567799999999833789852354698417728999993
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY  667 (912)
Q Consensus       591 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~  667 (912)
                      .|++.+.||+|+||+||+|... +++.||+|+++....  ...+.+.+|++++++++||||+++++++.+....++||||
T Consensus         3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~   82 (298)
T d1gz8a_           3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   82 (298)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             CCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEEE
T ss_conf             97765177237680999999999997999999802225758999999999999867998388744533224320378862


Q ss_pred             CCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCCEEEEECCCCCCCCCCCC
Q ss_conf             68999988851478999889898999999999998898814999806439999982125899499942067533555665
Q 002529          668 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT  747 (912)
Q Consensus       668 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLHs~~~~~ivH~DIkp~NILl~~~~~ikL~DFGla~~~~~~~~  747 (912)
                      +.+ ++.+.+... ....+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+|+.......
T Consensus        83 ~~~-~~~~~~~~~-~~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~  157 (298)
T d1gz8a_          83 LHQ-DLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  157 (298)
T ss_dssp             CSE-EHHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred             CCC-CHHHHHHHH-CCCCCCHHHHHHHHHHHHHHHHHHHC---CCEECCCCCCHHEEECCCCCCEECCCCCCEECCCCCC
T ss_conf             377-445554420-25688889999999999999998652---8899213571140113467621035786134368864


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCC-CCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCC-CCCC
Q ss_conf             2001456777544877448997-7922578999999999992999998657322022899998643049810011-7534
Q 002529          748 HISSVARGTVGYLDPEYYGNQQ-LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV-DPVL  825 (912)
Q Consensus       748 ~~~~~~~gt~~y~APE~l~~~~-~s~~sDVwSlGvil~elltG~~P~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-d~~l  825 (912)
                      . .....|++.|+|||.+.... ++.++|+||+||++|+|++|+.||...+..+.............+....... .+..
T Consensus       158 ~-~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  236 (298)
T d1gz8a_         158 T-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY  236 (298)
T ss_dssp             C-TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             C-CEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCCCCCCCC
T ss_conf             1-001036521541122136657774221033331342796687998988999999999983289833314442224212


Q ss_pred             CC------CCC-----HHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf             68------889-----8899999999986235799999999999999
Q 002529          826 IG------NVK-----IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       826 ~~------~~~-----~~~~~~l~~li~~Cl~~~P~~RPs~~eIl~~  861 (912)
                      ..      ..+     ......+.+++.+||+.+|++|||+.|+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             43454322220444166789999999999763995579189999678

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=0  Score=323.58  Aligned_cols=263  Identities=18%  Similarity=0.250  Sum_probs=201.2

Q ss_pred             HHHHHCCCCCCCCEEEEEEEECCCCEEEEEECCCCCC--HHHHHHHHHHHHHHHCCCCCCCCEEEEEECCCEEEEEEEEC
Q ss_conf             9864050384660899999965997999998147651--45677999999998337898523546984177289999936
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM  668 (912)
Q Consensus       591 ~~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~  668 (912)
                      +|++.++||+|+||+||+|++++++.||||+++....  ...+.+.+|+.++++++||||+++++.+...+..++++|++
T Consensus         3 ~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~   82 (286)
T d1ob3a_           3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL   82 (286)
T ss_dssp             SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred             CCEECCEEECCCCCEEEEEEECCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEEEEEE
T ss_conf             96343187227781899999689999999998123268589999999999998679986876601204677315899740


Q ss_pred             CCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCC
Q ss_conf             89999888514789998898989999999999988988149998064399999821258994999420675335556652
Q 002529          669 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH  748 (912)
Q Consensus       669 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLHs~~~~~ivH~DIkp~NILl~~~~~ikL~DFGla~~~~~~~~~  748 (912)
                      .++.+.....   ....+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||.+.........
T Consensus        83 ~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~  156 (286)
T d1ob3a_          83 DQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK  156 (286)
T ss_dssp             SEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             HHHHHHHHHH---HCCCCCHHHHHHHHHHHHHHHHHHCC---CCEEECCCCCCEEEECCCCCEEECCCCCCEECCCCCCC
T ss_conf             0456789986---04775144568999999999998605---74882678775056868997873236643011467654


Q ss_pred             CCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCC------
Q ss_conf             0014567775448774489-977922578999999999992999998657322022899998643049810011------
Q 002529          749 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV------  821 (912)
Q Consensus       749 ~~~~~~gt~~y~APE~l~~-~~~s~~sDVwSlGvil~elltG~~P~~~~~~~~~~~~~~~~~~~i~~~~~~~~~------  821 (912)
                       .....|++.|+|||.+.. ..++.++||||+||++|||++|+.||......+...-.................      
T Consensus       157 -~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T d1ob3a_         157 -YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD  235 (286)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             -CCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHCCCHHHHHHCC
T ss_conf             -1010243110137887178888841002111758999977979989889899999999863899711042123332214


Q ss_pred             ------CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             ------753468889889999999998623579999999999999
Q 002529          822 ------DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       822 ------d~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~eIl~  860 (912)
                            .+.............+.+++.+||+.+|++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             333335676466651258999999999986689668909999856

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=321.93  Aligned_cols=264  Identities=20%  Similarity=0.247  Sum_probs=195.5

Q ss_pred             HHHHHHCCCCCCCCEEEEEEEEC-C-CCEEEEEECCCCCC--HHHHHHHHHHHHHHHC---CCCCCCCEEEEEEC-----
Q ss_conf             99864050384660899999965-9-97999998147651--4567799999999833---78985235469841-----
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMK-D-GKEVAVKIMADSCS--HRTQQFVTEVALLSRI---HHRNLVPLIGYCEE-----  657 (912)
Q Consensus       590 ~~~~~~~~LG~G~fG~Vy~~~~~-~-g~~vAvK~l~~~~~--~~~~~~~~E~~il~~l---~HpnIv~l~~~~~~-----  657 (912)
                      ..|++.++||+|+||+||+|+.. + ++.||+|+++....  .....+.+|+.+++.+   +||||+++++++..     
T Consensus         7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~   86 (305)
T d1blxa_           7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   86 (305)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred             CCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCC
T ss_conf             89798889921558699999998889989999998023245167999999999999874258988023663221466666


Q ss_pred             CCEEEEEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCCEEEEECC
Q ss_conf             77289999936899998885147899988989899999999999889881499980643999998212589949994206
Q 002529          658 EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG  737 (912)
Q Consensus       658 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLHs~~~~~ivH~DIkp~NILl~~~~~ikL~DFG  737 (912)
                      ....++++|+++++.+......  ....+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||
T Consensus        87 ~~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~dfg  161 (305)
T d1blxa_          87 ETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFG  161 (305)
T ss_dssp             EEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             CCEEEEEEEECCCCCHHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCCCCCEEEECCCCCEEECCHH
T ss_conf             7469999974058714444430--37899989999999999999999975---889835798627898589975421000


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCCCC
Q ss_conf             75335556652001456777544877448997792257899999999999299999865732202289999864304981
Q 002529          738 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV  817 (912)
Q Consensus       738 la~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~~sDVwSlGvil~elltG~~P~~~~~~~~~~~~~~~~~~~i~~~~~  817 (912)
                      ++.......  ......||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+.................
T Consensus       162 ~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  239 (305)
T d1blxa_         162 LARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW  239 (305)
T ss_dssp             SCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred             HHHHHCCCC--CCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHCC
T ss_conf             101100234--577765485114831001798881110003289999998787998998989999999984079961105


Q ss_pred             CCC------CC----CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             001------17----53468889889999999998623579999999999999
Q 002529          818 ISI------VD----PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       818 ~~~------~d----~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~eIl~  860 (912)
                      ...      ..    ..............+.+++.+||+.+|++|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             32111103330223456454404458999999999987489667918999966

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=319.21  Aligned_cols=267  Identities=24%  Similarity=0.244  Sum_probs=193.8

Q ss_pred             HHHHHCCCCCCCCEEEEEEEEC-CCCEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCEEEEEEC------CCEEEE
Q ss_conf             9864050384660899999965-997999998147651456779999999983378985235469841------772899
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE------EHQRIL  663 (912)
Q Consensus       591 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~------~~~~~l  663 (912)
                      +|+..++||+|+||+||+|+.. +++.||||++....    ....+|++++++++||||+++++++..      ....++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCC----HHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEEE
T ss_conf             7675169821768399999999999799999988160----689999999986689898738789974476577318999


Q ss_pred             EEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCC-CEEEEECCCCCCC
Q ss_conf             999368999988851478999889898999999999998898814999806439999982125899-4999420675335
Q 002529          664 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQA  742 (912)
Q Consensus       664 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLHs~~~~~ivH~DIkp~NILl~~~~-~ikL~DFGla~~~  742 (912)
                      ||||++++.+....+.......+++..+..++.|++.||+|||+   ++|+||||||+|||++.++ .+||+|||++...
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEECCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCEEEEECCCCCEEEECCCCHHHC
T ss_conf             98416886078888631036899999999999999999999986---687645788603787358971167336605440


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHH---------HHHHH
Q ss_conf             5566520014567775448774489-9779225789999999999929999986573220228999---------98643
Q 002529          743 EEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHW---------ARSMI  812 (912)
Q Consensus       743 ~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~~sDVwSlGvil~elltG~~P~~~~~~~~~~~~~~~---------~~~~i  812 (912)
                      .....  .....|+..|+|||.+.+ ..++.++||||+||++|||++|+.||......+....+..         .....
T Consensus       174 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~  251 (350)
T d1q5ka_         174 VRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN  251 (350)
T ss_dssp             CTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred             CCCCC--CCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHHHHHHHHHHHHCCCHHHHHHHHC
T ss_conf             47765--3200255555682776404688821000246527785502879989879999999999974898177654306


Q ss_pred             ---CCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH--HHHHH
Q ss_conf             ---0498100117534688898899999999986235799999999999999--86312
Q 002529          813 ---KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDSI  866 (912)
Q Consensus       813 ---~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~eIl~~--L~~~~  866 (912)
                         ........................+.+++.+||+.+|++|||+.|+++.  ++++.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  310 (350)
T d1q5ka_         252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  310 (350)
T ss_dssp             C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             CCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf             21011035544567444431568999999999997658955792999996698452466

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=313.72  Aligned_cols=263  Identities=21%  Similarity=0.284  Sum_probs=196.4

Q ss_pred             HHHHHCCCCCCCCEEEEEEEEC-CCCEEEEEECCCCC-CHHHHHHHHHHHHHHHCCCCCCCCEEEEEECCC----EEEEE
Q ss_conf             9864050384660899999965-99799999814765-145677999999998337898523546984177----28999
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH----QRILV  664 (912)
Q Consensus       591 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~----~~~lV  664 (912)
                      +|++.+.||+|+||+||+|..+ +++.||||++.... ....+.+++|+++|++++||||+++++++....    ..+++
T Consensus         9 rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l   88 (345)
T d1pmea_           9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYL   88 (345)
T ss_dssp             TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred             CEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEE
T ss_conf             85997899406480999999999994999999803109589999999999999768989885888995056455414999


Q ss_pred             EEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCCEEEEECCCCCCCCC
Q ss_conf             99368999988851478999889898999999999998898814999806439999982125899499942067533555
Q 002529          665 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE  744 (912)
Q Consensus       665 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLHs~~~~~ivH~DIkp~NILl~~~~~ikL~DFGla~~~~~  744 (912)
                      ++++.+|+|.+++..    ..+++..++.++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||++.....
T Consensus        89 ~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~  161 (345)
T d1pmea_          89 VTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP  161 (345)
T ss_dssp             EEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred             EEEECCCCHHHHHHC----CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCEEEECCCCCEEECCCCCEEECCC
T ss_conf             996259865664405----899999999999999999999997---8986777876437887999778754570565047


Q ss_pred             CCC--CCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCC-
Q ss_conf             665--20014567775448774489-97792257899999999999299999865732202289999864304981001-
Q 002529          745 DLT--HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI-  820 (912)
Q Consensus       745 ~~~--~~~~~~~gt~~y~APE~l~~-~~~s~~sDVwSlGvil~elltG~~P~~~~~~~~~~~~~~~~~~~i~~~~~~~~-  820 (912)
                      ...  .......|++.|+|||++.. ..++.++||||+||++|||++|+.||......+.................... 
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (345)
T d1pmea_         162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII  241 (345)
T ss_dssp             GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCC
T ss_pred             CCCCCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHH
T ss_conf             77641010110265200038786047888741010046701337766979978888899999876520699756642343


Q ss_pred             ---------CCCCCCCCCC-----HHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf             ---------1753468889-----8899999999986235799999999999999
Q 002529          821 ---------VDPVLIGNVK-----IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       821 ---------~d~~l~~~~~-----~~~~~~l~~li~~Cl~~~P~~RPs~~eIl~~  861 (912)
                               ..+.. ...+     ......+.+++.+||+.||++||+++|+++.
T Consensus       242 ~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         242 NLKARNYLLSLPHK-NKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             CHHHHHHHHTSCCC-CCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHHCCCCCCCCC-CCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             32222024467755-7787778378999999999999764895679089998619

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=315.44  Aligned_cols=265  Identities=19%  Similarity=0.236  Sum_probs=198.1

Q ss_pred             HHHHHHCCCCCCCCEEEEEEEEC-CCCEEEEEECCCCC--CHHHHHHHHHHHHHHHCCCCCCCCEEEEEEC--------C
Q ss_conf             99864050384660899999965-99799999814765--1456779999999983378985235469841--------7
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--------E  658 (912)
Q Consensus       590 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--------~  658 (912)
                      .+|++.++||+|+||+||+|+.. +|+.||||++....  ....+.+.+|+++++.++||||+++++++..        .
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCCC
T ss_conf             79889999722748299999998999799999984222463789999999999998359996606765402465444457


Q ss_pred             CEEEEEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCCEEEEECCC
Q ss_conf             72899999368999988851478999889898999999999998898814999806439999982125899499942067
Q 002529          659 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL  738 (912)
Q Consensus       659 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLHs~~~~~ivH~DIkp~NILl~~~~~ikL~DFGl  738 (912)
                      ...++|||++.++.+.....   ....++...+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+
T Consensus        90 ~~~~iv~e~~~~~~~~~~~~---~~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~dfg~  163 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGL  163 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHTC---TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             CEEEEEEECCCCCCCCHHHH---CCCCCCCHHHHHHHHHHHHHHHHHCC---CCEEECCCCCHHEEECCCCCEEEEECCE
T ss_conf             63899985357874101222---03443308999999999999988522---9988567672220366899687631350


Q ss_pred             CCCCCCCCC---CCCCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCC
Q ss_conf             533555665---200145677754487744899-7792257899999999999299999865732202289999864304
Q 002529          739 SRQAEEDLT---HISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK  814 (912)
Q Consensus       739 a~~~~~~~~---~~~~~~~gt~~y~APE~l~~~-~~s~~sDVwSlGvil~elltG~~P~~~~~~~~~~~~~~~~~~~i~~  814 (912)
                      +........   .......||+.|+|||++.+. .++.++||||+||++|||++|+.||.....................
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  243 (318)
T d3blha1         164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  243 (318)
T ss_dssp             CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             EEECCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCHHHHHHHHHHHCCCCCH
T ss_conf             02235544432113566024978742899707999891787006786466174487998998999999999984189982


Q ss_pred             CCCCCCCCCCCC--------CCCCHH-------HHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             981001175346--------888988-------9999999998623579999999999999
Q 002529          815 GDVISIVDPVLI--------GNVKIE-------SIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       815 ~~~~~~~d~~l~--------~~~~~~-------~~~~l~~li~~Cl~~~P~~RPs~~eIl~  860 (912)
                      ............        ......       ....+.+++.+||+.+|++|||++|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             5534432034443320133445550334044459989999999987389658909999974

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=324.00  Aligned_cols=239  Identities=25%  Similarity=0.398  Sum_probs=193.3

Q ss_pred             HHHHHHCCCCCCCCEEEEEEEEC-CCCEEEEEECCCCCC------HHHHHHHHHHHHHHHCC--CCCCCCEEEEEECCCE
Q ss_conf             99864050384660899999965-997999998147651------45677999999998337--8985235469841772
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS------HRTQQFVTEVALLSRIH--HRNLVPLIGYCEEEHQ  660 (912)
Q Consensus       590 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~------~~~~~~~~E~~il~~l~--HpnIv~l~~~~~~~~~  660 (912)
                      ..|++.+.||+|+||.||+|+.. +++.||+|++.....      .....+.+|+.++++++  ||||+++++++...+.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCE
T ss_conf             83799679840878399999999999799999985688443345567999999999999743589881279999830996


Q ss_pred             EEEEEEECCC-CCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCC-CCCEEEEECCC
Q ss_conf             8999993689-999888514789998898989999999999988988149998064399999821258-99499942067
Q 002529          661 RILVYEYMHN-GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGL  738 (912)
Q Consensus       661 ~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLHs~~~~~ivH~DIkp~NILl~~-~~~ikL~DFGl  738 (912)
                      .++|||++.+ +++.+++..   ...+++..+..++.|++.||+|||+   ++|+||||||+|||++. ++.+||+|||+
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG~  157 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGS  157 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEEEEEECCCCCHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCCEEEECCCCEEEECCCCC
T ss_conf             89999833686228999861---5899999999999999999999987---79755667611147744788489775465


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCCCC
Q ss_conf             53355566520014567775448774489977-92257899999999999299999865732202289999864304981
Q 002529          739 SRQAEEDLTHISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV  817 (912)
Q Consensus       739 a~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-s~~sDVwSlGvil~elltG~~P~~~~~~~~~~~~~~~~~~~i~~~~~  817 (912)
                      |+......   .....||+.|+|||++.+..+ +.++||||+||++|||++|+.||....     .+       . .+..
T Consensus       158 a~~~~~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~i-------~-~~~~  221 (273)
T d1xwsa_         158 GALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EI-------I-RGQV  221 (273)
T ss_dssp             CEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HH-------H-HCCC
T ss_pred             CEECCCCC---CCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCCH-----HH-------H-HCCC
T ss_conf             35324445---5665658774799998489978865332554034536756889988736-----77-------6-1544


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             0011753468889889999999998623579999999999999
Q 002529          818 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       818 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~eIl~  860 (912)
                            ......+    ..+.+++.+||+.+|++|||++|+++
T Consensus       222 ------~~~~~~s----~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         222 ------FFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             ------CCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ------CCCCCCC----HHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             ------7787799----99999999976089758939999853

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=313.09  Aligned_cols=265  Identities=22%  Similarity=0.300  Sum_probs=199.9

Q ss_pred             HHHHHHCCCCCCCCEEEEEEEEC-CCCEEEEEECCCCC--CHHHHHHHHHHHHHHHCCCCCCCCEEEEEECCC------E
Q ss_conf             99864050384660899999965-99799999814765--145677999999998337898523546984177------2
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------Q  660 (912)
Q Consensus       590 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~------~  660 (912)
                      .+|++.++||+|+||+||+|..+ +++.||||+++...  ....+.+.+|+++|+.++|||||++++++...+      .
T Consensus        18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~   97 (346)
T d1cm8a_          18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD   97 (346)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCCE
T ss_conf             71899889801778199999999999899999985222596999999999999986689875479998635765555415


Q ss_pred             EEEEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCCEEEEECCCCC
Q ss_conf             89999936899998885147899988989899999999999889881499980643999998212589949994206753
Q 002529          661 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR  740 (912)
Q Consensus       661 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLHs~~~~~ivH~DIkp~NILl~~~~~ikL~DFGla~  740 (912)
                      .++||||+ +++|....+    ...+++..++.++.|++.||+|||+   ++|+||||||+|||++.++.+|++|||+|+
T Consensus        98 ~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~  169 (346)
T d1cm8a_          98 FYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR  169 (346)
T ss_dssp             CEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEECC-CCCHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCHHHCCCCCCCCCCCCCCEE
T ss_conf             99998405-521899987----4022699999999999999999873---787645668511112100122113431022


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHH-----CC
Q ss_conf             355566520014567775448774489-977922578999999999992999998657322022899998643-----04
Q 002529          741 QAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI-----KK  814 (912)
Q Consensus       741 ~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~~sDVwSlGvil~elltG~~P~~~~~~~~~~~~~~~~~~~i-----~~  814 (912)
                      ......    ....|++.|+|||++.+ ..++.++||||+||++|||++|+.||...+...............     ..
T Consensus       170 ~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (346)
T d1cm8a_         170 QADSEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR  245 (346)
T ss_dssp             ECCSSC----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred             CCCCCC----CCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCHHHHHH
T ss_conf             068763----1024553335889981787899650103003899999978699888976899999985037884888865


Q ss_pred             CC----------CCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH--HHHHHH
Q ss_conf             98----------100117534688898899999999986235799999999999999--863121
Q 002529          815 GD----------VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDSIK  867 (912)
Q Consensus       815 ~~----------~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~eIl~~--L~~~~~  867 (912)
                      ..          ........+. .........+.+++.+||+.+|++|||+.|+++.  ++++..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~  309 (346)
T d1cm8a_         246 LQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD  309 (346)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred             HCCHHHHHHHCCCCCCCCCCHH-HHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCC
T ss_conf             3000344331157866655667-755689999999999977299557929999963962375877

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=0  Score=309.45  Aligned_cols=262  Identities=16%  Similarity=0.198  Sum_probs=208.7

Q ss_pred             HHHHHCCCCCCCCEEEEEEEEC-CCCEEEEEECCCCCCHHHHHHHHHHHHHHHCC-CCCCCCEEEEEECCCEEEEEEEEC
Q ss_conf             9864050384660899999965-99799999814765145677999999998337-898523546984177289999936
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYM  668 (912)
Q Consensus       591 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lV~E~~  668 (912)
                      .|++.++||+|+||.||+|++. +++.||+|++...  .....+.+|++.+..++ |+|++.+++++......++|||++
T Consensus         6 ~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~   83 (293)
T d1csna_           6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL   83 (293)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred             CEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCC--CCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEEEC
T ss_conf             069979984178829999999889979999997502--582999999999999648999877999960188117999964


Q ss_pred             CCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCC-----CCCEEEEECCCCCCCC
Q ss_conf             89999888514789998898989999999999988988149998064399999821258-----9949994206753355
Q 002529          669 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-----NMRAKVSDFGLSRQAE  743 (912)
Q Consensus       669 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLHs~~~~~ivH~DIkp~NILl~~-----~~~ikL~DFGla~~~~  743 (912)
                       +++|.+.+...  ...++...+..++.|++.||+|||+   ++|+||||||+|||++.     ++.+||+|||+|+...
T Consensus        84 -~~~l~~~~~~~--~~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~  157 (293)
T d1csna_          84 -GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  157 (293)
T ss_dssp             -CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             -CCCHHHHHHHH--CCCHHHHHHHHHHHHHHHHHHHHHH---CCCEECCCCCCCEEECCCCCCCCCCEEECCCCEEEECC
T ss_conf             -88879999752--0311068999999999999999997---79662667713152347543447956872366057714


Q ss_pred             CCCCC------CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCCCC
Q ss_conf             56652------001456777544877448997792257899999999999299999865732202289999864304981
Q 002529          744 EDLTH------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV  817 (912)
Q Consensus       744 ~~~~~------~~~~~~gt~~y~APE~l~~~~~s~~sDVwSlGvil~elltG~~P~~~~~~~~~~~~~~~~~~~i~~~~~  817 (912)
                      .....      ......||+.|+|||++.+..++.++||||+|+++|||++|+.||..............+.........
T Consensus       158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (293)
T d1csna_         158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL  237 (293)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred             CCCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCCCCCCH
T ss_conf             67665411102467627751026798964888886999898319999998698767885302199999999705679995


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHC
Q ss_conf             0011753468889889999999998623579999999999999986312100
Q 002529          818 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE  869 (912)
Q Consensus       818 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~eIl~~L~~~~~~~  869 (912)
                      .+     +....+    ..+.+++..|+..+|++||+++.+.+.|+++....
T Consensus       238 ~~-----l~~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~  280 (293)
T d1csna_         238 RE-----LCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL  280 (293)
T ss_dssp             HH-----HTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             HH-----HCCCCC----HHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHC
T ss_conf             89-----657998----99999999984399300859999999999999975

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=310.08  Aligned_cols=261  Identities=22%  Similarity=0.291  Sum_probs=200.5

Q ss_pred             HHHHHCCCCCCCCEEEEEEEEC-CCCEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCC-CEEEEEECCCEEEEEEEEC
Q ss_conf             9864050384660899999965-9979999981476514567799999999833789852-3546984177289999936
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLV-PLIGYCEEEHQRILVYEYM  668 (912)
Q Consensus       591 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv-~l~~~~~~~~~~~lV~E~~  668 (912)
                      +|++.+.||+|+||.||+|++. +++.||||++....  ....+..|+++++.++|++++ .+.++.......++|||++
T Consensus         8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~   85 (299)
T d1ckia_           8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL   85 (299)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             EEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHC--CCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEEEEC
T ss_conf             8999689850788099999998899899999972100--58889999999997038996017999995198778999873


Q ss_pred             CCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCC---CCCCEEEEECCCCCCCCCC
Q ss_conf             8999988851478999889898999999999998898814999806439999982125---8994999420675335556
Q 002529          669 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD---INMRAKVSDFGLSRQAEED  745 (912)
Q Consensus       669 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLHs~~~~~ivH~DIkp~NILl~---~~~~ikL~DFGla~~~~~~  745 (912)
                       +++|.+.+..  ....+++..+..++.|++.||+|||+   ++|+||||||+|||++   .+..++|+|||+|+.....
T Consensus        86 -~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~  159 (299)
T d1ckia_          86 -GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  159 (299)
T ss_dssp             -CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred             -CCCHHHHHHH--CCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCCCHHHCCCCCCCCCCEEEEECCCCCEECCCC
T ss_conf             -8713332443--06887689999999999999999997---99442667876606433577761565046751342554


Q ss_pred             CCC------CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHH-HHHHHHHHHCCCCCC
Q ss_conf             652------0014567775448774489977922578999999999992999998657322022-899998643049810
Q 002529          746 LTH------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN-IVHWARSMIKKGDVI  818 (912)
Q Consensus       746 ~~~------~~~~~~gt~~y~APE~l~~~~~s~~sDVwSlGvil~elltG~~P~~~~~~~~~~~-~~~~~~~~i~~~~~~  818 (912)
                      ...      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......... ...+...... ... 
T Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~-~~~-  237 (299)
T d1ckia_         160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-TPI-  237 (299)
T ss_dssp             TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH-SCH-
T ss_pred             CCCCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCC-CCH-
T ss_conf             455410001357767873532999991899898321886177899998498766553057799999985235678-983-


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHC
Q ss_conf             011753468889889999999998623579999999999999986312100
Q 002529          819 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE  869 (912)
Q Consensus       819 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~eIl~~L~~~~~~~  869 (912)
                          +.+....+    ..+.+++.+|++.+|++||++.++.+.|++.....
T Consensus       238 ----~~~~~~~p----~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~  280 (299)
T d1ckia_         238 ----EVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  280 (299)
T ss_dssp             ----HHHTTTSC----HHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             ----HHHCCCCC----HHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHC
T ss_conf             ----57534788----99999999984399557919999999999999976

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=313.29  Aligned_cols=251  Identities=26%  Similarity=0.358  Sum_probs=200.9

Q ss_pred             HHHHHCCCCCCCCEEEEEEEEC----CCCEEEEEECCCCC----CHHHHHHHHHHHHHHHCCC-CCCCCEEEEEECCCEE
Q ss_conf             9864050384660899999965----99799999814765----1456779999999983378-9852354698417728
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC----SHRTQQFVTEVALLSRIHH-RNLVPLIGYCEEEHQR  661 (912)
Q Consensus       591 ~~~~~~~LG~G~fG~Vy~~~~~----~g~~vAvK~l~~~~----~~~~~~~~~E~~il~~l~H-pnIv~l~~~~~~~~~~  661 (912)
                      .|++.++||+|+||+||+|+..    +|+.||+|+++...    ....+.+.+|++++++++| |||+++++++.+....
T Consensus        25 ~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~  104 (322)
T d1vzoa_          25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKL  104 (322)
T ss_dssp             GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEE
T ss_pred             CEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCE
T ss_conf             25999898328783999999876588794899999836772101689999999999998646798399962000248730


Q ss_pred             EEEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCCEEEEECCCCCC
Q ss_conf             99999368999988851478999889898999999999998898814999806439999982125899499942067533
Q 002529          662 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ  741 (912)
Q Consensus       662 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLHs~~~~~ivH~DIkp~NILl~~~~~ikL~DFGla~~  741 (912)
                      ++++||+.+|+|.+++..   ...+.......++.|++.||+|||+   ++++||||||+|||++.++.+||+|||+++.
T Consensus       105 ~~v~e~~~~~~L~~~i~~---~~~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~  178 (322)
T d1vzoa_         105 HLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKE  178 (322)
T ss_dssp             EEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             EEEEECCCCCHHHHHHHH---CCCCCHHHHHHHHHHHHHHHHHHHC---CCEEECCCCCCCEEECCCCCEEEEECCCHHH
T ss_conf             012312341179999873---0454378888889999999988514---9989654773201246999888741320222


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCC--CCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCC
Q ss_conf             555665200145677754487744899--779225789999999999929999986573220228999986430498100
Q 002529          742 AEEDLTHISSVARGTVGYLDPEYYGNQ--QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS  819 (912)
Q Consensus       742 ~~~~~~~~~~~~~gt~~y~APE~l~~~--~~s~~sDVwSlGvil~elltG~~P~~~~~~~~~~~~~~~~~~~i~~~~~~~  819 (912)
                      .............|++.|+|||.+.+.  .++.++||||+||++|||++|+.||......+.....  ....... .   
T Consensus       179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i--~~~~~~~-~---  252 (322)
T d1vzoa_         179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI--SRRILKS-E---  252 (322)
T ss_dssp             CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH--HHHHHHC-C---
T ss_pred             HCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH--HHHCCCC-C---
T ss_conf             034444322122233333106876057768871325177779999997689998888777799999--9833568-9---


Q ss_pred             CCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHH
Q ss_conf             11753468889889999999998623579999999-----999999
Q 002529          820 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVL  860 (912)
Q Consensus       820 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPs-----~~eIl~  860 (912)
                         +    ..+.+....+.+++.+||+.+|++||+     ++|+++
T Consensus       253 ---~----~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         253 ---P----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             ---C----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             ---C----CCCCCCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHC
T ss_conf             ---9----88654799999999997445898819997450999974

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=0  Score=303.63  Aligned_cols=257  Identities=19%  Similarity=0.272  Sum_probs=193.3

Q ss_pred             HHHHHHCCCCCCCCEEEEEEEEC-CCCEEEEEECCCCCCHHHHHHHHHHHHHHHCC-CCCCCCEEEEEEC--CCEEEEEE
Q ss_conf             99864050384660899999965-99799999814765145677999999998337-8985235469841--77289999
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEE--EHQRILVY  665 (912)
Q Consensus       590 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~--~~~~~lV~  665 (912)
                      ..|++.++||+|+||+||+|+.. +++.||+|+++..   ..+.+.+|+++|+.++ ||||+++++++..  ....++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEEEEE
T ss_conf             6718978983174819999998899979999998889---9999999999998515799876799999816877126888


Q ss_pred             EECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCC-CEEEEECCCCCCCCC
Q ss_conf             9368999988851478999889898999999999998898814999806439999982125899-499942067533555
Q 002529          666 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEE  744 (912)
Q Consensus       666 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLHs~~~~~ivH~DIkp~NILl~~~~-~ikL~DFGla~~~~~  744 (912)
                      ||+.+++|.+..      +.+++..+..++.||+.||+|||+   ++|+||||||+|||++.++ .+||+|||+|.....
T Consensus       112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred             EECCCCCHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCCEEECCCCCEEEECCCCCCEECCC
T ss_conf             631798589974------689999999999999999988764---33443456441237748998366415654266468


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHH--HHH---------HHHHHHH
Q ss_conf             665200145677754487744899-7792257899999999999299999865732202--289---------9998643
Q 002529          745 DLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL--NIV---------HWARSMI  812 (912)
Q Consensus       745 ~~~~~~~~~~gt~~y~APE~l~~~-~~s~~sDVwSlGvil~elltG~~P~~~~~~~~~~--~~~---------~~~~~~i  812 (912)
                      ...  .....+|+.|+|||.+.+. .++.++|+||+||+++||++|+.||.........  .+.         .+.....
T Consensus       183 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  260 (328)
T d3bqca1         183 GQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN  260 (328)
T ss_dssp             TCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred             CCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCHHHHHHHHCC
T ss_conf             874--443224864247610268888884523233545558760488999887601899999999878841555554225


Q ss_pred             CCC--CCCCCCCCC--------CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             049--810011753--------468889889999999998623579999999999999
Q 002529          813 KKG--DVISIVDPV--------LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       813 ~~~--~~~~~~d~~--------l~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~eIl~  860 (912)
                      ...  .........        ............+.+++.+||+.+|++|||++|+++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             4447430000033343311211552112448999999999986699568908999964

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=302.13  Aligned_cols=260  Identities=22%  Similarity=0.274  Sum_probs=197.3

Q ss_pred             HHHHHCCCCCCCCEEEEEEEEC-CCCEEEEEECCCCC--CHHHHHHHHHHHHHHHCCCCCCCCEEEEEEC------CCEE
Q ss_conf             9864050384660899999965-99799999814765--1456779999999983378985235469841------7728
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE------EHQR  661 (912)
Q Consensus       591 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~------~~~~  661 (912)
                      .|++.++||+|+||+||+|++. +|+.||||++....  ......+.+|+.++++++||||+++++++..      ....
T Consensus        18 ~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~   97 (355)
T d2b1pa1          18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV   97 (355)
T ss_dssp             TEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred             CEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCCCEE
T ss_conf             75998896217585999999999998999999882336979999999999999864898764899897025643457626


Q ss_pred             EEEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCCEEEEECCCCCC
Q ss_conf             99999368999988851478999889898999999999998898814999806439999982125899499942067533
Q 002529          662 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ  741 (912)
Q Consensus       662 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLHs~~~~~ivH~DIkp~NILl~~~~~ikL~DFGla~~  741 (912)
                      ++||||+.++ +.+.+.     ..+++..++.++.|++.||+|||+   .||+||||||+|||++.++.++++|||+++.
T Consensus        98 ~iv~Ey~~~~-l~~~~~-----~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~~~  168 (355)
T d2b1pa1          98 YLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART  168 (355)
T ss_dssp             EEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             EEEEECCCHH-HHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCCCCCCCCCCEEEECHHHHHC
T ss_conf             9998414467-787650-----389999999999999999988652---2112456776321136544313201023211


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHH-HHH------------
Q ss_conf             5556652001456777544877448997792257899999999999299999865732202289-999------------
Q 002529          742 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV-HWA------------  808 (912)
Q Consensus       742 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~~sDVwSlGvil~elltG~~P~~~~~~~~~~~~~-~~~------------  808 (912)
                      ......  .....||+.|+|||++.+..++.++||||+||+++||++|+.||.+.+........ +..            
T Consensus       169 ~~~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~  246 (355)
T d2b1pa1         169 AGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ  246 (355)
T ss_dssp             --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred             CCCCCC--CCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHH
T ss_conf             466655--332214655558133147777877433356625789865989988897788999999720589879998765


Q ss_pred             ---HHHHCCC------CCCCCCCCCCCCCC---CHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf             ---8643049------81001175346888---98899999999986235799999999999999
Q 002529          809 ---RSMIKKG------DVISIVDPVLIGNV---KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA  861 (912)
Q Consensus       809 ---~~~i~~~------~~~~~~d~~l~~~~---~~~~~~~l~~li~~Cl~~~P~~RPs~~eIl~~  861 (912)
                         .......      ..............   .......+.+++.+|++.+|++|||++|+++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             66777764175435666421264333543210133379999999999876994579089999669

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=304.04  Aligned_cols=263  Identities=21%  Similarity=0.252  Sum_probs=200.4

Q ss_pred             HHHHHCCCCCCCCEEEEEEEEC-CCCEEEEEECCCCC--CHHHHHHHHHHHHHHHCCCCCCCCEEEEEECCCEEEEEEEE
Q ss_conf             9864050384660899999965-99799999814765--14567799999999833789852354698417728999993
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY  667 (912)
Q Consensus       591 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~  667 (912)
                      .|++.++||+|+||+||+|+.. +++.||||+++...  ......+.+|+.+++.++||||+++++++......++|+|+
T Consensus         3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~   82 (292)
T d1unla_           3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_dssp             SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEEE
T ss_conf             97862697128681999999999996999999803217868999999999999856757888213544444311588630


Q ss_pred             CCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCCEEEEECCCCCCCCCCCC
Q ss_conf             68999988851478999889898999999999998898814999806439999982125899499942067533555665
Q 002529          668 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT  747 (912)
Q Consensus       668 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLHs~~~~~ivH~DIkp~NILl~~~~~ikL~DFGla~~~~~~~~  747 (912)
                      +.+++|...+.   ..+.+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||.++.......
T Consensus        83 ~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~  156 (292)
T d1unla_          83 CDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR  156 (292)
T ss_dssp             CSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred             CCCCCCCCCCC---CCCCCCHHHHHHHHHHHHHHHHHHHC---CCEEEECCCCCCCCCCCCCCEEEEECCHHHCCCCCCC
T ss_conf             23322211212---35654036789999999999877433---9986001467612113378266520460110468875


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCC-CCCHHHHHHHHHHHHHHHHCCCCCCCCCCC-CHHHHHHHHHHHHCCCCCCC---CCC
Q ss_conf             2001456777544877448997-792257899999999999299999865732-20228999986430498100---117
Q 002529          748 HISSVARGTVGYLDPEYYGNQQ-LTEKSDVYSFGVVLLELISGKKPVSVEDFG-AELNIVHWARSMIKKGDVIS---IVD  822 (912)
Q Consensus       748 ~~~~~~~gt~~y~APE~l~~~~-~s~~sDVwSlGvil~elltG~~P~~~~~~~-~~~~~~~~~~~~i~~~~~~~---~~d  822 (912)
                      . .....++..|+|||++.... ++.++||||+||++|||++|+.||...... +...................   ..+
T Consensus       157 ~-~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (292)
T d1unla_         157 C-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD  235 (292)
T ss_dssp             C-CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred             C-CEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHHHCCC
T ss_conf             1-001034431014667506988880444026541889985189999889999999999986118997355134432221


Q ss_pred             C---------CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             5---------3468889889999999998623579999999999999
Q 002529          823 P---------VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL  860 (912)
Q Consensus       823 ~---------~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~eIl~  860 (912)
                      .         .-...........+.+++.+||+.+|.+|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             CCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             13344454431043306568999999999986499668909999964

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=304.02  Aligned_cols=264  Identities=19%  Similarity=0.278  Sum_probs=196.6

Q ss_pred             HHHHHCCCCCCCCEEEEEEEEC-CCCEEEEEECCCCC--CHHHHHHHHHHHHHHHCCCCCCCCEEEEEECC-----CEEE
Q ss_conf             9864050384660899999965-99799999814765--14567799999999833789852354698417-----7289
Q 002529          591 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE-----HQRI  662 (912)
Q Consensus       591 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~~~~  662 (912)
                      +|++.++||+|+||+||+|+.. +++.||||+++...  ....+.+.+|+++++.++||||+++++++...     ...+
T Consensus        19 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~   98 (348)
T d2gfsa1          19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV   98 (348)
T ss_dssp             TEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCC
T ss_pred             CEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCCEE
T ss_conf             71888898317883999999999997999999882002868999999999999866898742599999634645668649


Q ss_pred             EEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCCEEEEECCCCCCC
Q ss_conf             99993689999888514789998898989999999999988988149998064399999821258994999420675335
Q 002529          663 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA  742 (912)
Q Consensus       663 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLHs~~~~~ivH~DIkp~NILl~~~~~ikL~DFGla~~~  742 (912)
                      ++++++.+|+|.+++.    ...+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+|++|||++...
T Consensus        99 ~i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~  171 (348)
T d2gfsa1          99 YLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT  171 (348)
T ss_dssp             EEEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred             EEEEEECCCCHHHHCC----CCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCC
T ss_conf             9999625886232002----2453099999999999999999973---88765166776334554322001321000125


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCC-----CC
Q ss_conf             55665200145677754487744899-7792257899999999999299999865732202289999864304-----98
Q 002529          743 EEDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK-----GD  816 (912)
Q Consensus       743 ~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~~sDVwSlGvil~elltG~~P~~~~~~~~~~~~~~~~~~~i~~-----~~  816 (912)
                      ...    .....|++.|+|||...+. .++.++||||+||++|+|++|+.||.+.+.......+.........     ..
T Consensus       172 ~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~  247 (348)
T d2gfsa1         172 DDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS  247 (348)
T ss_dssp             TGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCC
T ss_pred             CCC----CCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHCC
T ss_conf             754----4443454355583553377567855124320589999976889978898899999999730799757732001


Q ss_pred             ---CCCCCCCC-CCCCCC-----HHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHHHH
Q ss_conf             ---10011753-468889-----889999999998623579999999999999--98631
Q 002529          817 ---VISIVDPV-LIGNVK-----IESIWRIAEVAIQCVEQRGFSRPKMQEIVL--AIQDS  865 (912)
Q Consensus       817 ---~~~~~d~~-l~~~~~-----~~~~~~l~~li~~Cl~~~P~~RPs~~eIl~--~L~~~  865 (912)
                         ........ ......     ......+.+++.+||+.+|++|||++|+++  .+++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~  307 (348)
T d2gfsa1         248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  307 (348)
T ss_dssp             CHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             CHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf             024454443035578755566267899999999999775883459389998559954879

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.9e-44  Score=280.53  Aligned_cols=296  Identities=20%  Similarity=0.260  Sum_probs=204.8

Q ss_pred             HHHHHHCCCCCCCCEEEEEEEEC-CCCEEEEEECCCCCCHHHHHHHHHHHHHHHCC-----------CCCCCCEEEEEEC
Q ss_conf             99864050384660899999965-99799999814765145677999999998337-----------8985235469841
Q 002529          590 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-----------HRNLVPLIGYCEE  657 (912)
Q Consensus       590 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-----------HpnIv~l~~~~~~  657 (912)
                      .+|++.++||+|+||+||+|+.. +|+.||||+++... ...+.+.+|+++++.++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCC-CCHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEEEE
T ss_conf             85799899750778189999999999799999983431-33689999999999840145555542276764789987631


Q ss_pred             --CCEEEEEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCC------
Q ss_conf             --772899999368999988851478999889898999999999998898814999806439999982125899------
Q 002529          658 --EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM------  729 (912)
Q Consensus       658 --~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLHs~~~~~ivH~DIkp~NILl~~~~------  729 (912)
                        ....+++++++..+..............+++..+..++.|++.||+|||+  ..+|+||||||+|||++.++      
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~  169 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLI  169 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred             CCCCCEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH--HCCCCCCCCCHHHEEEECCCCCCCCC
T ss_conf             2565202343200035420000012234678689999999999999888764--05864656770570563057656443


Q ss_pred             CEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHH----HHH
Q ss_conf             4999420675335556652001456777544877448997792257899999999999299999865732202----289
Q 002529          730 RAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL----NIV  805 (912)
Q Consensus       730 ~ikL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~~sDVwSlGvil~elltG~~P~~~~~~~~~~----~~~  805 (912)
                      .++++|||.+.......    ....|++.|+|||++....++.++|+||+||++++|++|+.||.........    .+.
T Consensus       170 ~~kl~dfg~s~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~  245 (362)
T d1q8ya_         170 QIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA  245 (362)
T ss_dssp             EEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred             EEEEEECCCCCCCCCCC----CCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHH
T ss_conf             05675314421234454----22366521057132146677764320123789999987889989875543210268999


Q ss_pred             HHHHHH-------HCCC-CCCCCCC---------C----------CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHH
Q ss_conf             999864-------3049-8100117---------5----------34688898899999999986235799999999999
Q 002529          806 HWARSM-------IKKG-DVISIVD---------P----------VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEI  858 (912)
Q Consensus       806 ~~~~~~-------i~~~-~~~~~~d---------~----------~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~eI  858 (912)
                      ..+...       .... ......+         .          .............+.+++.+|++.||.+|||++|+
T Consensus       246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~  325 (362)
T d1q8ya_         246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL  325 (362)
T ss_dssp             HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred             HHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHH
T ss_conf             99998379987886245322000132012202432357764442100015674358999999999877994579089999


Q ss_pred             HHH--HHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCEEC
Q ss_conf             999--863121002899865568988888421212320101
Q 002529          859 VLA--IQDSIKIEKGGDQKFSSSSSKGQSSRKTLLTSFLEI  897 (912)
Q Consensus       859 l~~--L~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~  897 (912)
                      ++.  +++....++-..+.-...+     +.+.+...+.|+
T Consensus       326 L~Hp~f~~~~~~~~~~~p~~~~~~-----~~~~~~~~~~~~  361 (362)
T d1q8ya_         326 VNHPWLKDTLGMEEIRVPDRELYG-----SGSDIPGWFEEV  361 (362)
T ss_dssp             HTCGGGTTCTTCTTCCCTTSCTTC-----BSTTSTTSSSCC
T ss_pred             HCCCCCCCCCCCCCCCCCCCCCCC-----CCCCCCCHHHHC
T ss_conf             669340789874447799866678-----889998435440

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.90  E-value=3e-24  Score=160.83  Aligned_cols=169  Identities=15%  Similarity=0.150  Sum_probs=118.1

Q ss_pred             HHCCCCCCCCEEEEEEEECCCCEEEEEECCCCCC------------------HHHHHHHHHHHHHHHCCCCCCCCEEEEE
Q ss_conf             4050384660899999965997999998147651------------------4567799999999833789852354698
Q 002529          594 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS------------------HRTQQFVTEVALLSRIHHRNLVPLIGYC  655 (912)
Q Consensus       594 ~~~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~------------------~~~~~~~~E~~il~~l~HpnIv~l~~~~  655 (912)
                      ++++||+|+||.||+|...+|+.||||+++....                  .......+|...+.++.|.+++..+++.
T Consensus         4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~   83 (191)
T d1zara2           4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE   83 (191)
T ss_dssp             EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred             HCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEC
T ss_conf             27780248565999999799999999998604434666556563000888999999778999999981699914499862


Q ss_pred             ECCCEEEEEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCCEEEEE
Q ss_conf             41772899999368999988851478999889898999999999998898814999806439999982125899499942
Q 002529          656 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSD  735 (912)
Q Consensus       656 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLHs~~~~~ivH~DIkp~NILl~~~~~ikL~D  735 (912)
                      .    .+++||+++++.+.+          ++......++.|++.+|+|||+   .+++||||||+|||+++ ..++|+|
T Consensus        84 ~----~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~-~~~~liD  145 (191)
T d1zara2          84 G----NAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSE-EGIWIID  145 (191)
T ss_dssp             T----TEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEET-TEEEECC
T ss_pred             C----CEEEEEEECCCCCCC----------HHHHHHHHHHHHHHHHHHHHHH---CCEEECCCCHHHEEEEC-CCEEEEE
T ss_conf             8----889999504565420----------0157899999999999999826---88898368903611428-9899987


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf             0675335556652001456777544877448997792257899999999
Q 002529          736 FGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLL  784 (912)
Q Consensus       736 FGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~~sDVwSlGvil~  784 (912)
                      ||+|....++....-  .......+ .+.+ ...|+.++|+||..--++
T Consensus       146 FG~a~~~~~~~~~~~--l~rd~~~~-~~~f-~r~y~~~~d~~s~~~~~~  190 (191)
T d1zara2         146 FPQSVEVGEEGWREI--LERDVRNI-ITYF-SRTYRTEKDINSAIDRIL  190 (191)
T ss_dssp             CTTCEETTSTTHHHH--HHHHHHHH-HHHH-HHHHCCCCCHHHHHHHHH
T ss_pred             CCCCCCCCCCCCHHH--HHHHHHHH-HHHH-CCCCCCCCCHHHHHHHHH
T ss_conf             788430899870999--98779999-9997-578998446899999874

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.86  E-value=1.3e-21  Score=144.98  Aligned_cols=152  Identities=26%  Similarity=0.482  Sum_probs=128.0

Q ss_pred             CCCCCHHHHHHHHHHHCCC-CCCCCCC-CCCCCCCCCCEEEEECCC-CCCEEEEECCCCCCCC--CCCCCCCCCCCCCEE
Q ss_conf             6970049999999831398-8899999-998867899618985899-9947999917997741--299221363346246
Q 002529          349 KTEWQDVMVLEALRSISDE-SERTNDR-GDPCVPVPWEWVTCSTTT-PPRITKIALSGKNLKG--EIPPELKNMEALTEL  423 (912)
Q Consensus       349 ~t~~~d~~~l~~l~~~~~~-~~~~~w~-~dpC~~~~w~~~~c~~~~-~~~l~~L~Ls~n~l~g--~ip~~i~~l~~L~~L  423 (912)
                      .+.++|..||.++|+.+.. +...+|. +..||.+.|.||.|+... ..||+.|+|+++++.|  .+|++|++|++|++|
T Consensus         2 ~c~~~e~~aLl~~k~~~~~~~~l~sW~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L   81 (313)
T d1ogqa_           2 LCNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFL   81 (313)
T ss_dssp             CSCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEE
T ss_pred             CCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCEEEEEEECCCCCCCCCCCCCHHHHCCCCCCCC
T ss_conf             98989999999999977999867788999999889488969748999479889989899888888798478467533520


Q ss_pred             CCCC-CCCCCCCC-CCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCC--CCEEEEECCCCC
Q ss_conf             2446-55789998-8677543425421363324888876787554530034014687899854467--951221049988
Q 002529          424 WLDG-NFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT--GKVIFKYDNNPK  499 (912)
Q Consensus       424 ~Ls~-N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~iP~~~~~--~~~~~~~~~n~~  499 (912)
                      +|++ |+++|.+| +|++|++|+.|+|++|++.+..|..+..+..|+.+++++|.+.+.+|..+..  .+..+.+++|..
T Consensus        82 ~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l  161 (313)
T d1ogqa_          82 YIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRI  161 (313)
T ss_dssp             EEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCC
T ss_pred             CCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHCCCCCCCEEECCCCCC
T ss_conf             20265433300243114542001102035643443322222011100111122455556851220674000000235533


Q ss_pred             C
Q ss_conf             7
Q 002529          500 L  500 (912)
Q Consensus       500 ~  500 (912)
                      .
T Consensus       162 ~  162 (313)
T d1ogqa_         162 S  162 (313)
T ss_dssp             E
T ss_pred             C
T ss_conf             5

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.58  E-value=2.5e-15  Score=106.88  Aligned_cols=123  Identities=19%  Similarity=0.209  Sum_probs=101.6

Q ss_pred             CCCEEEEECC--------CCCCEEEEECCCCCCCCCCC-CCCCCCCCCCEECCCCCCCCCCCC-CCCCCCCCCEEECCCC
Q ss_conf             9961898589--------99947999917997741299-221363346246244655789998-8677543425421363
Q 002529          382 PWEWVTCSTT--------TPPRITKIALSGKNLKGEIP-PELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENN  451 (912)
Q Consensus       382 ~w~~~~c~~~--------~~~~l~~L~Ls~n~l~g~ip-~~i~~l~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N  451 (912)
                      .|..|.|+..        -+..++.|+|++|.|++.++ ..+..+++|+.|+|++|.+.+.++ .+..+++|+.|+|++|
T Consensus         9 ~~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N   88 (192)
T d1w8aa_           9 EGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN   88 (192)
T ss_dssp             ETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred             CCCEEEEECCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCEEEECCC
T ss_conf             69999970899670298989787889848987755302002578762721301363221212122211222210100355


Q ss_pred             CCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCC---CCEEEEECCCCCCCCCCC
Q ss_conf             324888876787554530034014687899854467---951221049988765422
Q 002529          452 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT---GKVIFKYDNNPKLHKESR  505 (912)
Q Consensus       452 ~l~g~iP~~l~~l~~L~~L~l~~N~l~g~iP~~~~~---~~~~~~~~~n~~~c~~~~  505 (912)
                      +|+...|+.|.++++|+.|+|++|+|+ .||+..+.   .+..+.+.+|++.|.+.-
T Consensus        89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~-~i~~~~f~~l~~L~~l~L~~N~~~~~~~~  144 (192)
T d1w8aa_          89 KIKEISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASNPFNCNCHL  144 (192)
T ss_dssp             CCCEECSSSSTTCTTCCEEECCSSCCC-EECTTSSTTCTTCCEEECTTCCBCCSGGG
T ss_pred             CCCCCCHHHHHCCCCCCCCCCCCCCCC-CCCHHHHCCCCCCCCCCCCCCCCCCCCCH
T ss_conf             344349799807974655245774535-35977856875334200036443435302

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.54  E-value=6.7e-16  Score=110.37  Aligned_cols=110  Identities=25%  Similarity=0.305  Sum_probs=98.7

Q ss_pred             CEEEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCC
Q ss_conf             47999917997741299221363346246244655789998867754342542136332488887678755453003401
Q 002529          395 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN  474 (912)
Q Consensus       395 ~l~~L~Ls~n~l~g~ip~~i~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~  474 (912)
                      ....++++++.+.|.+|..+..++.|+.|++++|.+++.+|.++.+++|+.|+|++|+++|.+|++++++++|+.|+|++
T Consensus       198 ~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~  277 (313)
T d1ogqa_         198 NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSF  277 (313)
T ss_dssp             CCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCS
T ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEECCCCCHHHHCCCCCCEEECCC
T ss_conf             22233333343322222222222221112222222222222222455444444765706660876884799999897958


Q ss_pred             CCCCCCCCCCC-CCCCEEEEECCCCCCCCCC
Q ss_conf             46878998544-6795122104998876542
Q 002529          475 NSFVGEIPPAL-LTGKVIFKYDNNPKLHKES  504 (912)
Q Consensus       475 N~l~g~iP~~~-~~~~~~~~~~~n~~~c~~~  504 (912)
                      |+|+|.||... ...+..+.+.+|+.+|+.+
T Consensus       278 N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~p  308 (313)
T d1ogqa_         278 NNLCGEIPQGGNLQRFDVSAYANNKCLCGSP  308 (313)
T ss_dssp             SEEEEECCCSTTGGGSCGGGTCSSSEEESTT
T ss_pred             CCCCCCCCCCCCCCCCCHHHHCCCCCCCCCC
T ss_conf             8351668986667998978868895001989

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.50  E-value=9.3e-14  Score=97.39  Aligned_cols=112  Identities=28%  Similarity=0.328  Sum_probs=99.6

Q ss_pred             CCCCEEEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCC-CCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEE
Q ss_conf             999479999179977412992213633462462446557899988-6775434254213633248888767875545300
Q 002529          392 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQEL  470 (912)
Q Consensus       392 ~~~~l~~L~Ls~n~l~g~ip~~i~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L  470 (912)
                      ..++++.|+++++.+.+..+..+..+.+++.|++++|.++...+. +..++.|+.|++++|++++..|..+..+++|+.|
T Consensus        98 ~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L  177 (266)
T d1p9ag_          98 TLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL  177 (266)
T ss_dssp             TCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEE
T ss_pred             CCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCCEE
T ss_conf             22222222222231101100112222111122124342102212333221110000000156522372001342124234


Q ss_pred             CCCCCCCCCCCCCCCCC--CCEEEEECCCCCCCCCC
Q ss_conf             34014687899854467--95122104998876542
Q 002529          471 HIENNSFVGEIPPALLT--GKVIFKYDNNPKLHKES  504 (912)
Q Consensus       471 ~l~~N~l~g~iP~~~~~--~~~~~~~~~n~~~c~~~  504 (912)
                      +|++|+|+ .||.+++.  .+..+.+.+||+.|+|.
T Consensus       178 ~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC~  212 (266)
T d1p9ag_         178 LLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCE  212 (266)
T ss_dssp             ECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred             ECCCCCCC-CCCHHHCCCCCCCEEEECCCCCCCCCC
T ss_conf             30139785-568667778889999836999878864

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.43  E-value=1.1e-13  Score=96.98  Aligned_cols=112  Identities=19%  Similarity=0.232  Sum_probs=96.7

Q ss_pred             CCCEEEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCC-CCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEC
Q ss_conf             9947999917997741299221363346246244655789998-867754342542136332488887678755453003
Q 002529          393 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH  471 (912)
Q Consensus       393 ~~~l~~L~Ls~n~l~g~ip~~i~~l~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~  471 (912)
                      ...+..+++++|.+++..+..+..+++|+.|+|++|++++..+ .+.++++|+.|++++|++++..|..+..+++|+.|+
T Consensus       128 ~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~  207 (284)
T d1ozna_         128 LAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLY  207 (284)
T ss_dssp             CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred             HCCCCHHHHCCCCCCCCCHHHHCCCCCHHHCCCCCCCCCCCCHHHHCCCCCCCHHHHHHCCCCCCCHHHHHHHHHCCCCC
T ss_conf             00121102001431445805740434050223141765662566654656341314211434662816766532000233


Q ss_pred             CCCCCCCCCCCCCCCC--CCEEEEECCCCCCCCCC
Q ss_conf             4014687899854467--95122104998876542
Q 002529          472 IENNSFVGEIPPALLT--GKVIFKYDNNPKLHKES  504 (912)
Q Consensus       472 l~~N~l~g~iP~~~~~--~~~~~~~~~n~~~c~~~  504 (912)
                      +++|++.+..|..+..  .+..+.+++||+.|.+.
T Consensus       208 l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~  242 (284)
T d1ozna_         208 LFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR  242 (284)
T ss_dssp             CCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred             CCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCC
T ss_conf             33352210000023554656889811998878756

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.39  E-value=5.6e-13  Score=92.69  Aligned_cols=106  Identities=18%  Similarity=0.180  Sum_probs=89.6

Q ss_pred             EEECCCCCCCCCCCCCCCCCCCCCEECCCCC-CCCCCCC-CCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCC
Q ss_conf             9991799774129922136334624624465-5789998-8677543425421363324888876787554530034014
Q 002529          398 KIALSGKNLKGEIPPELKNMEALTELWLDGN-FLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN  475 (912)
Q Consensus       398 ~L~Ls~n~l~g~ip~~i~~l~~L~~L~Ls~N-~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N  475 (912)
                      .++++++++. .+|..+..+++|+.|+|++| .|+...+ .|.++++|+.|+|++|+|+..-|..+..+++|+.|+|++|
T Consensus        12 ~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N   90 (156)
T d2ifga3          12 GLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN   90 (156)
T ss_dssp             CEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred             EEEECCCCCC-CCCCCCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEECCCC
T ss_conf             6985289976-586002576565743168986644369212256666672162021247742011124554333322678


Q ss_pred             CCCCCCCCCCCC--CCEEEEECCCCCCCCCCC
Q ss_conf             687899854467--951221049988765422
Q 002529          476 SFVGEIPPALLT--GKVIFKYDNNPKLHKESR  505 (912)
Q Consensus       476 ~l~g~iP~~~~~--~~~~~~~~~n~~~c~~~~  505 (912)
                      +++ .+|...+.  .+..+.+++||+.|++.-
T Consensus        91 ~l~-~l~~~~~~~~~l~~L~L~~Np~~C~C~~  121 (156)
T d2ifga3          91 ALE-SLSWKTVQGLSLQELVLSGNPLHCSCAL  121 (156)
T ss_dssp             CCS-CCCSTTTCSCCCCEEECCSSCCCCCGGG
T ss_pred             CCC-CCCHHHHCCCCCCCCCCCCCCCCCCCHH
T ss_conf             785-1574563353212433579863388117

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.36  E-value=1.3e-12  Score=90.47  Aligned_cols=108  Identities=23%  Similarity=0.290  Sum_probs=95.8

Q ss_pred             CCCEEEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCC-CCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEC
Q ss_conf             9947999917997741299221363346246244655789998-867754342542136332488887678755453003
Q 002529          393 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH  471 (912)
Q Consensus       393 ~~~l~~L~Ls~n~l~g~ip~~i~~l~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~  471 (912)
                      .++++.|++++|...+..+..+..++.++.|++++|.+++..+ .+.++++|+.|+|++|+|+ .+|+++.++++|+.|+
T Consensus       170 ~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~  248 (305)
T d1xkua_         170 PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVY  248 (305)
T ss_dssp             CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEE
T ss_pred             CCCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCC-CCCCCCCCCCCCCEEE
T ss_conf             776678989788677888267641341330154455332223454334433224302554002-4631103346789898


Q ss_pred             CCCCCCCCCCCCCCCC---------CCEEEEECCCCCCCC
Q ss_conf             4014687899854467---------951221049988765
Q 002529          472 IENNSFVGEIPPALLT---------GKVIFKYDNNPKLHK  502 (912)
Q Consensus       472 l~~N~l~g~iP~~~~~---------~~~~~~~~~n~~~c~  502 (912)
                      +++|+++ .|+...+.         .+..+.+++||+.+.
T Consensus       249 Ls~N~i~-~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~  287 (305)
T d1xkua_         249 LHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYW  287 (305)
T ss_dssp             CCSSCCC-CCCTTSSSCSSCCTTSCCCSEEECCSSSSCGG
T ss_pred             CCCCCCC-CCCHHHCCCCCHHCCCCCCCEEECCCCCCCCC
T ss_conf             9898657-63810026721002158889788989957667

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.30  E-value=3.3e-12  Score=88.00  Aligned_cols=99  Identities=25%  Similarity=0.359  Sum_probs=78.1

Q ss_pred             EEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCC
Q ss_conf             99917997741299221363346246244655789998867754342542136332488887678755453003401468
Q 002529          398 KIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSF  477 (912)
Q Consensus       398 ~L~Ls~n~l~g~ip~~i~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l  477 (912)
                      .|+|++|+++ .++ .+..|++|++|+|++|+|+..++.++.+++|+.|++++|+++ .+|+ ++.+++|+.|++++|++
T Consensus         2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~~lp~~~~~l~~L~~L~l~~N~i~-~l~~-~~~l~~L~~L~l~~N~i   77 (124)
T d1dcea3           2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRL   77 (124)
T ss_dssp             EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCC-CCGG-GTTCSSCCEEECCSSCC
T ss_pred             EEECCCCCCC-CCC-CCCCCCCCCEEECCCCCCCCCHHHHHHHHCCCCCCCCCCCCC-CCCC-CCCCCCCCEEECCCCCC
T ss_conf             8986899898-871-010589889897978716865215655431354532432112-3574-12335557688889865


Q ss_pred             CCCCCC--CCCC--CCEEEEECCCCCCC
Q ss_conf             789985--4467--95122104998876
Q 002529          478 VGEIPP--ALLT--GKVIFKYDNNPKLH  501 (912)
Q Consensus       478 ~g~iP~--~~~~--~~~~~~~~~n~~~c  501 (912)
                      + .+|.  .+..  .+..+.+.+|+...
T Consensus        78 ~-~~~~~~~l~~~~~L~~L~l~~N~i~~  104 (124)
T d1dcea3          78 Q-QSAAIQPLVSCPRLVLLNLQGNSLCQ  104 (124)
T ss_dssp             C-SSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred             C-CCCCCHHHCCCCCCCEEECCCCCCCC
T ss_conf             8-88882565379999999897996886

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.25  E-value=9.3e-12  Score=85.29  Aligned_cols=102  Identities=22%  Similarity=0.224  Sum_probs=85.3

Q ss_pred             CCCCCCCCCEEEEECC----------CCCCEEEEECCCCC-CCCCCCCCCCCCCCCCEECCCCCCCCCCCC-CCCCCCCC
Q ss_conf             9886789961898589----------99947999917997-741299221363346246244655789998-86775434
Q 002529          376 DPCVPVPWEWVTCSTT----------TPPRITKIALSGKN-LKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDL  443 (912)
Q Consensus       376 dpC~~~~w~~~~c~~~----------~~~~l~~L~Ls~n~-l~g~ip~~i~~l~~L~~L~Ls~N~l~g~~p-~~~~l~~L  443 (912)
                      +.|.+..++.+.|+..          ..++++.|++++|+ |+..-+..|.+|++|+.|+|++|+|+.+.| .|..+++|
T Consensus         3 ~~C~c~~~~~l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L   82 (156)
T d2ifga3           3 DACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL   82 (156)
T ss_dssp             SSSCCSSSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCC
T ss_pred             CCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCC
T ss_conf             97886999969852899765860025765657431689866443692122566666721620212477420111245543


Q ss_pred             CEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCC
Q ss_conf             25421363324888876787554530034014687
Q 002529          444 RIVHLENNELTGSLPSYMGSLPNLQELHIENNSFV  478 (912)
Q Consensus       444 ~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~  478 (912)
                      +.|+|++|+|+ .+|..+.....|+.|+|++|.+.
T Consensus        83 ~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~  116 (156)
T d2ifga3          83 SRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH  116 (156)
T ss_dssp             CEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred             CCEECCCCCCC-CCCHHHHCCCCCCCCCCCCCCCC
T ss_conf             33322678785-15745633532124335798633

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.23  E-value=6e-12  Score=86.43  Aligned_cols=104  Identities=22%  Similarity=0.266  Sum_probs=87.2

Q ss_pred             CCCEEEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCC-CCCCCCCCEEC
Q ss_conf             99479999179977412992213633462462446557899988677543425421363324888876-78755453003
Q 002529          393 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY-MGSLPNLQELH  471 (912)
Q Consensus       393 ~~~l~~L~Ls~n~l~g~ip~~i~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~-l~~l~~L~~L~  471 (912)
                      +.++..|+|++|+++ .++..+..+++|+.|+|++|+|+.. +.+..+++|+.|++++|+++ .+|.. +..+++|+.|+
T Consensus        17 ~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l-~~~~~l~~L~~L~ls~N~i~-~l~~~~~~~l~~L~~L~   93 (162)
T d1a9na_          17 AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDLTELI   93 (162)
T ss_dssp             TTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCC-EECSCHHHHCTTCCEEE
T ss_pred             CCCCCEEECCCCCCC-CCCCCCCCCCCCCEEECCCCCCCCC-CCCCCCCCHHHHHCCCCCCC-CCCCCCCCCCCCCCCCE
T ss_conf             574848978899788-6576200414599898979978764-77445761306431021345-77763223345344342


Q ss_pred             CCCCCCCCCCCC--CC--CCCCEEEEECCCCCC
Q ss_conf             401468789985--44--679512210499887
Q 002529          472 IENNSFVGEIPP--AL--LTGKVIFKYDNNPKL  500 (912)
Q Consensus       472 l~~N~l~g~iP~--~~--~~~~~~~~~~~n~~~  500 (912)
                      +++|+++ .+++  .+  +..+..+.+.+||..
T Consensus        94 L~~N~i~-~~~~l~~l~~l~~L~~L~l~~N~i~  125 (162)
T d1a9na_          94 LTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT  125 (162)
T ss_dssp             CCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred             ECCCCCC-CCCCCCCCCCCCCCCHHHCCCCCCC
T ss_conf             0300016-6542110013653206640799634

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.23  E-value=6.5e-12  Score=86.24  Aligned_cols=105  Identities=29%  Similarity=0.383  Sum_probs=73.6

Q ss_pred             EECCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCC--CCCCCCCCCEEECCCCCCCCCCCCCCCCCC
Q ss_conf             858999947999917997741299221363346246244655789998--867754342542136332488887678755
Q 002529          388 CSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP--DMSRLIDLRIVHLENNELTGSLPSYMGSLP  465 (912)
Q Consensus       388 c~~~~~~~l~~L~Ls~n~l~g~ip~~i~~l~~L~~L~Ls~N~l~g~~p--~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~  465 (912)
                      |+|..    +.+++++++|+ .+|..|.  +.++.|+|++|+|++.++  .|.++++|+.|+|++|++.+..+..+..++
T Consensus         6 C~C~~----~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~   78 (192)
T d1w8aa_           6 CHCEG----TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGAS   78 (192)
T ss_dssp             SEEET----TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCT
T ss_pred             CEECC----CEEEEECCCCC-CCCCCCC--CCCCEEEECCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCC
T ss_conf             89769----99997089967-0298989--78788984898775530200257876272130136322121212221122


Q ss_pred             CCCEECCCCCCCCCCCCCCCCC---CCEEEEECCCCCC
Q ss_conf             4530034014687899854467---9512210499887
Q 002529          466 NLQELHIENNSFVGEIPPALLT---GKVIFKYDNNPKL  500 (912)
Q Consensus       466 ~L~~L~l~~N~l~g~iP~~~~~---~~~~~~~~~n~~~  500 (912)
                      +|+.|+|++|+++ .+|+..+.   .+..+.+++|...
T Consensus        79 ~L~~L~Ls~N~l~-~l~~~~F~~l~~L~~L~L~~N~l~  115 (192)
T d1w8aa_          79 HIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQIS  115 (192)
T ss_dssp             TCCEEECCSCCCC-EECSSSSTTCTTCCEEECCSSCCC
T ss_pred             CCCEEEECCCCCC-CCCHHHHHCCCCCCCCCCCCCCCC
T ss_conf             2210100355344-349799807974655245774535

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.21  E-value=1.5e-11  Score=84.09  Aligned_cols=85  Identities=24%  Similarity=0.251  Sum_probs=71.6

Q ss_pred             CCCEEEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCC-CCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEC
Q ss_conf             99479999179977412992213633462462446557899988-67754342542136332488887678755453003
Q 002529          393 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH  471 (912)
Q Consensus       393 ~~~l~~L~Ls~n~l~g~ip~~i~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~  471 (912)
                      ..++..|++++|.+....+..+..++.|+.|++++|+|++.+++ +..+++|+.|+|++|+|+ .||+++..+++|+.|+
T Consensus       123 l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~  201 (266)
T d1p9ag_         123 LGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAF  201 (266)
T ss_dssp             CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEE
T ss_pred             CCCCCCCCCCCCCCCEECCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCC-CCCHHHCCCCCCCEEE
T ss_conf             211112212434210221233322111000000015652237200134212423430139785-5686677788899998


Q ss_pred             CCCCCCC
Q ss_conf             4014687
Q 002529          472 IENNSFV  478 (912)
Q Consensus       472 l~~N~l~  478 (912)
                      |++|.+.
T Consensus       202 L~~Np~~  208 (266)
T d1p9ag_         202 LHGNPWL  208 (266)
T ss_dssp             CCSCCBC
T ss_pred             ECCCCCC
T ss_conf             3699987

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.17  E-value=2.2e-11  Score=83.04  Aligned_cols=86  Identities=27%  Similarity=0.332  Sum_probs=77.3

Q ss_pred             CCCEEEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCC--CCCCCCCCCCEE
Q ss_conf             994799991799774129922136334624624465578999886775434254213633248888--767875545300
Q 002529          393 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLP--SYMGSLPNLQEL  470 (912)
Q Consensus       393 ~~~l~~L~Ls~n~l~g~ip~~i~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP--~~l~~l~~L~~L  470 (912)
                      ...++.|++++|.++ .+|+.++.+++|+.|++++|+++.. |.+..+++|+.|++++|+++ .+|  ..++.+++|+.|
T Consensus        19 l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~~~~~l~~L~~L~l~~N~i~-~~~~~~~l~~~~~L~~L   95 (124)
T d1dcea3          19 LLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-DGVANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLL   95 (124)
T ss_dssp             GTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-GGGTTCSSCCEEECCSSCCC-SSSTTGGGGGCTTCCEE
T ss_pred             CCCCCEEECCCCCCC-CCHHHHHHHHCCCCCCCCCCCCCCC-CCCCCCCCCCEEECCCCCCC-CCCCCHHHCCCCCCCEE
T ss_conf             898898979787168-6521565543135453243211235-74123355576888898658-88882565379999999


Q ss_pred             CCCCCCCCCCCC
Q ss_conf             340146878998
Q 002529          471 HIENNSFVGEIP  482 (912)
Q Consensus       471 ~l~~N~l~g~iP  482 (912)
                      ++++|+++ .++
T Consensus        96 ~l~~N~i~-~~~  106 (124)
T d1dcea3          96 NLQGNSLC-QEE  106 (124)
T ss_dssp             ECTTSGGG-GSS
T ss_pred             ECCCCCCC-CCC
T ss_conf             89799688-682

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.14  E-value=7.4e-11  Score=79.83  Aligned_cols=95  Identities=22%  Similarity=0.249  Sum_probs=70.1

Q ss_pred             CCCEEEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCC-------CCCCCC
Q ss_conf             9947999917997741299221363346246244655789998867754342542136332488887-------678755
Q 002529          393 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPS-------YMGSLP  465 (912)
Q Consensus       393 ~~~l~~L~Ls~n~l~g~ip~~i~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~-------~l~~l~  465 (912)
                      ...+..|++++|.+.+..+..+..+++|+.|+|++|+|+..++.+..+++|+.|+|++|+|+ .|+.       ....+.
T Consensus       194 ~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~lp~~l~~l~~L~~L~Ls~N~i~-~i~~~~f~~~~~~~~~~  272 (305)
T d1xkua_         194 LNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKA  272 (305)
T ss_dssp             CTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTCSSCCEEECCSSCCC-CCCTTSSSCSSCCTTSC
T ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCC-CCCHHHCCCCCHHCCCC
T ss_conf             34133015445533222345433443322430255400246311033467898989898657-63810026721002158


Q ss_pred             CCCEECCCCCCCC-CCCCCCCCCC
Q ss_conf             4530034014687-8998544679
Q 002529          466 NLQELHIENNSFV-GEIPPALLTG  488 (912)
Q Consensus       466 ~L~~L~l~~N~l~-g~iP~~~~~~  488 (912)
                      +|+.|+|++|.++ ..+++..+.+
T Consensus       273 ~L~~L~L~~N~~~~~~~~~~~f~~  296 (305)
T d1xkua_         273 SYSGVSLFSNPVQYWEIQPSTFRC  296 (305)
T ss_dssp             CCSEEECCSSSSCGGGSCGGGGTT
T ss_pred             CCCEEECCCCCCCCCCCCHHHHCC
T ss_conf             889788989957667689768300

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.06  E-value=3.3e-10  Score=75.91  Aligned_cols=87  Identities=22%  Similarity=0.302  Sum_probs=56.3

Q ss_pred             CCEEEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCC-CCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECC
Q ss_conf             947999917997741299221363346246244655789998-8677543425421363324888876787554530034
Q 002529          394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI  472 (912)
Q Consensus       394 ~~l~~L~Ls~n~l~g~ip~~i~~l~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l  472 (912)
                      ..++.|+|++|++.+..+..+..+++|+.|++++|++++..| .|..+++|+.|++++|++++..|..++.+++|+.|++
T Consensus       153 ~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l  232 (284)
T d1ozna_         153 GNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRL  232 (284)
T ss_dssp             TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEEC
T ss_pred             CCHHHCCCCCCCCCCCCHHHHCCCCCCCHHHHHHCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCEEEE
T ss_conf             40502231417656625666546563413142114346628167665320002333335221000002355465688981


Q ss_pred             CCCCCCCC
Q ss_conf             01468789
Q 002529          473 ENNSFVGE  480 (912)
Q Consensus       473 ~~N~l~g~  480 (912)
                      ++|.+.+.
T Consensus       233 ~~N~l~C~  240 (284)
T d1ozna_         233 NDNPWVCD  240 (284)
T ss_dssp             CSSCEECS
T ss_pred             CCCCCCCC
T ss_conf             19988787

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.94  E-value=9.3e-10  Score=73.20  Aligned_cols=99  Identities=22%  Similarity=0.277  Sum_probs=48.9

Q ss_pred             CCEEEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCC
Q ss_conf             94799991799774129922136334624624465578999886775434254213633248888767875545300340
Q 002529          394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE  473 (912)
Q Consensus       394 ~~l~~L~Ls~n~l~g~ip~~i~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~  473 (912)
                      ..+..+.+..|.+.+  ...+..++.++.|+|++|++++.. .+..+++|+.|+|++|+++ .+| .++++++|+.|+++
T Consensus       285 ~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~-~l~~l~~L~~L~L~~n~l~-~l~-~l~~l~~L~~L~l~  359 (384)
T d2omza2         285 TALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDIS-PVSSLTKLQRLFFANNKVS-DVS-SLANLTNINWLSAG  359 (384)
T ss_dssp             TTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCG-GGGGCTTCCEEECCSSCCC-CCG-GGGGCTTCCEEECC
T ss_pred             CCCCCCCCCCCCCCC--CCCCCHHCCCCEEECCCCCCCCCC-CCCCCCCCCEEECCCCCCC-CCH-HHCCCCCCCEEECC
T ss_conf             522223323233333--221000024676777788778984-5366898898989899899-974-67089999989897


Q ss_pred             CCCCCCCCCCCCCCCCEEEEECCC
Q ss_conf             146878998544679512210499
Q 002529          474 NNSFVGEIPPALLTGKVIFKYDNN  497 (912)
Q Consensus       474 ~N~l~g~iP~~~~~~~~~~~~~~n  497 (912)
                      +|++++-.|-.-+..+..+.+++|
T Consensus       360 ~N~l~~l~~l~~l~~L~~L~L~~N  383 (384)
T d2omza2         360 HNQISDLTPLANLTRITQLGLNDQ  383 (384)
T ss_dssp             SSCCCBCGGGTTCTTCSEEECCCE
T ss_pred             CCCCCCCHHHCCCCCCCEEECCCC
T ss_conf             995899800003999999639789

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.93  E-value=4.1e-10  Score=75.35  Aligned_cols=79  Identities=15%  Similarity=0.371  Sum_probs=66.5

Q ss_pred             CCCEEEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECC
Q ss_conf             99479999179977412992213633462462446557899988677543425421363324888876787554530034
Q 002529          393 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI  472 (912)
Q Consensus       393 ~~~l~~L~Ls~n~l~g~ip~~i~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l  472 (912)
                      .+.+..|+|++|++++ ++ .+..+++|+.|+|++|+|++ ++.+.++++|+.|+|++|++++..|  +.++++|+.|++
T Consensus       306 ~~~l~~L~ls~n~l~~-l~-~l~~l~~L~~L~L~~n~l~~-l~~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L  380 (384)
T d2omza2         306 LKNLTYLTLYFNNISD-IS-PVSSLTKLQRLFFANNKVSD-VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGL  380 (384)
T ss_dssp             CTTCSEEECCSSCCSC-CG-GGGGCTTCCEEECCSSCCCC-CGGGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEEC
T ss_pred             HCCCCEEECCCCCCCC-CC-CCCCCCCCCEEECCCCCCCC-CHHHCCCCCCCEEECCCCCCCCCHH--HCCCCCCCEEEC
T ss_conf             0246767777887789-84-53668988989898998999-7467089999989897995899800--003999999639


Q ss_pred             CCCC
Q ss_conf             0146
Q 002529          473 ENNS  476 (912)
Q Consensus       473 ~~N~  476 (912)
                      ++|.
T Consensus       381 ~~Na  384 (384)
T d2omza2         381 NDQA  384 (384)
T ss_dssp             CCEE
T ss_pred             CCCC
T ss_conf             7895

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.90  E-value=2.9e-10  Score=76.27  Aligned_cols=86  Identities=22%  Similarity=0.242  Sum_probs=65.6

Q ss_pred             CCEEEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCC-CCCCCCCCEEECCCCCCCCCCCC--CCCCCCCCCEE
Q ss_conf             9479999179977412992213633462462446557899988-67754342542136332488887--67875545300
Q 002529          394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPS--YMGSLPNLQEL  470 (912)
Q Consensus       394 ~~l~~L~Ls~n~l~g~ip~~i~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g~iP~--~l~~l~~L~~L  470 (912)
                      ..|+.|+|++|.++ .++ .+..|++|+.|+|++|+++...+. +..+++|+.|+|++|+++ .+++  .+..+++|+.|
T Consensus        41 ~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~-~~~~l~~l~~l~~L~~L  117 (162)
T d1a9na_          41 DQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYL  117 (162)
T ss_dssp             TCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEE
T ss_pred             CCCCEEECCCCCCC-CCC-CCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCEECCCCCC-CCCCCCCCCCCCCCCHH
T ss_conf             45998989799787-647-7445761306431021345777632233453443420300016-65421100136532066


Q ss_pred             CCCCCCCCCCCCC
Q ss_conf             3401468789985
Q 002529          471 HIENNSFVGEIPP  483 (912)
Q Consensus       471 ~l~~N~l~g~iP~  483 (912)
                      ++++|.++ .+|.
T Consensus       118 ~l~~N~i~-~~~~  129 (162)
T d1a9na_         118 CILRNPVT-NKKH  129 (162)
T ss_dssp             ECCSSGGG-GSTT
T ss_pred             HCCCCCCC-CCCC
T ss_conf             40799634-5610

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.86  E-value=4.3e-09  Score=69.17  Aligned_cols=83  Identities=27%  Similarity=0.462  Sum_probs=39.4

Q ss_pred             CCEEEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCC
Q ss_conf             94799991799774129922136334624624465578999886775434254213633248888767875545300340
Q 002529          394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE  473 (912)
Q Consensus       394 ~~l~~L~Ls~n~l~g~ip~~i~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~  473 (912)
                      +.++.|+++++.+.. + ..+..+++|+.|++++|++.. ++.+..+++|+.|++.+|+++ .++. ++++++|+.|+++
T Consensus       106 ~~L~~L~l~~~~~~~-~-~~~~~l~~L~~L~l~~n~l~~-~~~l~~~~~L~~L~l~~n~l~-~l~~-l~~l~~L~~L~ls  180 (199)
T d2omxa2         106 TNLTGLTLFNNQITD-I-DPLKNLTNLNRLELSSNTISD-ISALSGLTSLQQLNFSSNQVT-DLKP-LANLTTLERLDIS  180 (199)
T ss_dssp             TTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCCC-CGGGTTCTTCSEEECCSSCCC-CCGG-GTTCTTCCEEECC
T ss_pred             CCCCCCCCCCCCCCC-C-CCCCHHHHHHHHHHHHHHHCC-CCCCCCCCCCCCCCCCCCCCC-CCCC-CCCCCCCCEEECC
T ss_conf             232221112222223-2-100012236776431111002-343332111111223455556-7701-1679989999787


Q ss_pred             CCCCCCCCC
Q ss_conf             146878998
Q 002529          474 NNSFVGEIP  482 (912)
Q Consensus       474 ~N~l~g~iP  482 (912)
                      +|+++ .+|
T Consensus       181 ~N~i~-~i~  188 (199)
T d2omxa2         181 SNKVS-DIS  188 (199)
T ss_dssp             SSCCC-CCG
T ss_pred             CCCCC-CCC
T ss_conf             99799-881

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.82  E-value=5.5e-08  Score=62.49  Aligned_cols=134  Identities=13%  Similarity=0.086  Sum_probs=95.1

Q ss_pred             CCCCCEEEEEEEECCCCEEEEEECCCCCCHHHHHHHHHHHHHHHCC-CCCCCCEEEEEECCCEEEEEEEECCCCCHHHHH
Q ss_conf             8466089999996599799999814765145677999999998337-898523546984177289999936899998885
Q 002529          599 GKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL  677 (912)
Q Consensus       599 G~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l  677 (912)
                      +.+..+.||+.... ++.+.+|+...........+.+|...+..+. +--+.+++.+....+..++||++++|.++.+..
T Consensus        23 ~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~  101 (263)
T d1j7la_          23 EGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEY  101 (263)
T ss_dssp             CCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHT
T ss_pred             CCCCCCCEEEEEEC-CCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCEEEEEEECCCCCCCCCC
T ss_conf             89987718999908-98699998488765325569999999998760699872899975089649999860433435433


Q ss_pred             CCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC------------------------------------------------
Q ss_conf             14789998898989999999999988988149------------------------------------------------
Q 002529          678 HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC------------------------------------------------  709 (912)
Q Consensus       678 ~~~~~~~~l~~~~~~~i~~qia~aL~yLHs~~------------------------------------------------  709 (912)
                      ...     .   ....++.++++.++.||+..                                                
T Consensus       102 ~~~-----~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (263)
T d1j7la_         102 EDE-----Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDF  173 (263)
T ss_dssp             TTC-----S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHH
T ss_pred             CCC-----C---CHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHH
T ss_conf             440-----2---69999998999999985568421435764465655577899877655554303323200579999999


Q ss_pred             --------CCCEEECCCCCCCCCCCCCCCEEEEECCCCCC
Q ss_conf             --------99806439999982125899499942067533
Q 002529          710 --------NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ  741 (912)
Q Consensus       710 --------~~~ivH~DIkp~NILl~~~~~ikL~DFGla~~  741 (912)
                              ...++|+|+.+.|||++++....|.||+.+..
T Consensus       174 l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         174 LKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             HHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCCC
T ss_conf             9844986781789860047642364996599960231441

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=98.81  E-value=3.2e-11  Score=82.01  Aligned_cols=104  Identities=25%  Similarity=0.223  Sum_probs=83.8

Q ss_pred             CCCCEEEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEC
Q ss_conf             99947999917997741299221363346246244655789998867754342542136332488887678755453003
Q 002529          392 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH  471 (912)
Q Consensus       392 ~~~~l~~L~Ls~n~l~g~ip~~i~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~  471 (912)
                      ...+|+.|+|++|+++ .++ .+..|++|+.|+|++|.++...+-...++.|+.|++++|+++ .++ .+..+++|+.|+
T Consensus        46 ~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~~i~~~~~~~~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~  121 (198)
T d1m9la_          46 TLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIA-SLS-GIEKLVNLRVLY  121 (198)
T ss_dssp             HTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEECSCSSHHHHHHHCCEEECSEEECC-CHH-HHHHHHHSSEEE
T ss_pred             CCCCCCEEECCCCCCC-CCC-CCCCCCCCCCHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCC-CCCCCCCCCCCC
T ss_conf             2604615199446899-864-424782535734135343210000332212333333332222-222-222222341112


Q ss_pred             CCCCCCCCCCCC--CCC--CCCEEEEECCCCCC
Q ss_conf             401468789985--446--79512210499887
Q 002529          472 IENNSFVGEIPP--ALL--TGKVIFKYDNNPKL  500 (912)
Q Consensus       472 l~~N~l~g~iP~--~~~--~~~~~~~~~~n~~~  500 (912)
                      +++|+++ .++.  .+.  ..+..+.+.+||..
T Consensus       122 L~~N~i~-~~~~~~~l~~l~~L~~L~L~~N~l~  153 (198)
T d1m9la_         122 MSNNKIT-NWGEIDKLAALDKLEDLLLAGNPLY  153 (198)
T ss_dssp             ESEEECC-CHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred             CCCCHHC-CCCCCCCCCCCCCCCEEECCCCCCC
T ss_conf             3410212-5542212367776302342798434

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.81  E-value=7.7e-09  Score=67.64  Aligned_cols=62  Identities=29%  Similarity=0.474  Sum_probs=21.4

Q ss_pred             CCCCCCCCEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCC
Q ss_conf             13633462462446557899988677543425421363324888876787554530034014687
Q 002529          414 LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFV  478 (912)
Q Consensus       414 i~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~  478 (912)
                      +..++.|+.+++++|.+++. +.+..+++|+.+++++|+++ .+++ +.++++|+.|++++|+++
T Consensus       130 l~~l~~l~~l~~~~n~l~~~-~~~~~l~~L~~l~l~~n~l~-~i~~-l~~l~~L~~L~Ls~N~i~  191 (210)
T d1h6ta2         130 LVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHIS  191 (210)
T ss_dssp             GGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCC-CCGG-GTTCTTCCEEECCSSCCC
T ss_pred             CCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCC-CCCC-CCCCCCCCEEECCCCCCC
T ss_conf             01111122211222333454-31000133210013464302-5645-367898999989799899

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.73  E-value=1.5e-08  Score=65.83  Aligned_cols=78  Identities=26%  Similarity=0.464  Sum_probs=28.4

Q ss_pred             EEEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCC
Q ss_conf             79999179977412992213633462462446557899988677543425421363324888876787554530034014
Q 002529          396 ITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN  475 (912)
Q Consensus       396 l~~L~Ls~n~l~g~ip~~i~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N  475 (912)
                      ++.|+++++.+. .++ .+..+++|+.|+|++|++++.. .++.+++|+.|++++|+++ .+| .+..+++|+.|++++|
T Consensus        48 L~~L~l~~~~i~-~l~-~l~~l~~L~~L~L~~n~i~~l~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~~  122 (210)
T d1h6ta2          48 IDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIK-PLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHN  122 (210)
T ss_dssp             CCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEECTTS
T ss_pred             CCEEECCCCCCC-CCH-HHHHCCCCCEEECCCCCCCCCC-CCCCCCCCCCCCCCCCCCC-CCC-CCCCCCCCCCCCCCCC
T ss_conf             458978279888-744-4764899898769896025860-1135862120143333321-222-1212221112234565


Q ss_pred             CCC
Q ss_conf             687
Q 002529          476 SFV  478 (912)
Q Consensus       476 ~l~  478 (912)
                      .+.
T Consensus       123 ~~~  125 (210)
T d1h6ta2         123 GIS  125 (210)
T ss_dssp             CCC
T ss_pred             CCC
T ss_conf             322

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.71  E-value=7.1e-09  Score=67.85  Aligned_cols=75  Identities=21%  Similarity=0.395  Sum_probs=34.1

Q ss_pred             CCEEEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCC
Q ss_conf             94799991799774129922136334624624465578999886775434254213633248888767875545300340
Q 002529          394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE  473 (912)
Q Consensus       394 ~~l~~L~Ls~n~l~g~ip~~i~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~  473 (912)
                      ++++.|++++|.+.+ ++ .+.++++|+.|+|++|++++ ++.++.+++|+.|+|++|+++ .+|. +.++++|+.|+++
T Consensus       151 ~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~Ls~n~l~~-l~~l~~l~~L~~L~Ls~N~lt-~i~~-l~~l~~L~~L~ls  225 (227)
T d1h6ua2         151 TNLQYLSIGNAQVSD-LT-PLANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNNQIS-DVSP-LANTSNLFIVTLT  225 (227)
T ss_dssp             TTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC-CGGGGGCTTCCEEECTTSCCC-BCGG-GTTCTTCCEEEEE
T ss_pred             CCCCCCCCCCCCCCC-CH-HHCCCCCCEECCCCCCCCCC-CHHHCCCCCCCEEECCCCCCC-CCCC-CCCCCCCCEEEEE
T ss_conf             111002333333331-00-10564633564458884177-853447999998979599689-9802-0369998989712

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.67  E-value=3.5e-08  Score=63.65  Aligned_cols=76  Identities=24%  Similarity=0.211  Sum_probs=27.8

Q ss_pred             CEEEEECCCCCCCCCCCCCCCCCCCCCEE-CCCCCCCCCCCCC-CCCCCCCCEEECCCCCCCCCCCC-CCCCCCCCCEEC
Q ss_conf             47999917997741299221363346246-2446557899988-67754342542136332488887-678755453003
Q 002529          395 RITKIALSGKNLKGEIPPELKNMEALTEL-WLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPS-YMGSLPNLQELH  471 (912)
Q Consensus       395 ~l~~L~Ls~n~l~g~ip~~i~~l~~L~~L-~Ls~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g~iP~-~l~~l~~L~~L~  471 (912)
                      .+..|++++|+++ .++....+.+++..+ ++++|+++...+. +.++++|+.|+|++|+++ .+|. .+.++++|+.++
T Consensus       154 ~l~~L~l~~n~l~-~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~l~~L~~l~  231 (242)
T d1xwdc1         154 ESVILWLNKNGIQ-EIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARS  231 (242)
T ss_dssp             SCEEEECCSSCCC-EECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCC-CCCSSSCTTCCEEESSS
T ss_pred             CCEEEECCCCCCC-CCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHCCCCCCCEEECCCCCCC-CCCHHHHCCCCCCCCCC
T ss_conf             1001220012333-322222220111012123543246424788668999998989799289-45977973771341476


Q ss_pred             C
Q ss_conf             4
Q 002529          472 I  472 (912)
Q Consensus       472 l  472 (912)
                      +
T Consensus       232 ~  232 (242)
T d1xwdc1         232 T  232 (242)
T ss_dssp             E
T ss_pred             C
T ss_conf             7

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.65  E-value=4.9e-08  Score=62.77  Aligned_cols=79  Identities=24%  Similarity=0.403  Sum_probs=37.2

Q ss_pred             CEEEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCC
Q ss_conf             47999917997741299221363346246244655789998867754342542136332488887678755453003401
Q 002529          395 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN  474 (912)
Q Consensus       395 ~l~~L~Ls~n~l~g~ip~~i~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~  474 (912)
                      +++.|+++++++. .++ .+..|++|+.|+|++|++++..| ++++++|+.|++++|.+. .+|. +..++.|+.|++++
T Consensus        41 ~l~~L~l~~~~i~-~l~-~l~~l~nL~~L~Ls~N~l~~~~~-l~~l~~L~~L~l~~n~~~-~~~~-l~~l~~L~~L~l~~  115 (199)
T d2omxa2          41 QVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDITP-LKNLTKLVDILMNNNQIA-DITP-LANLTNLTGLTLFN  115 (199)
T ss_dssp             TCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCC-CCGG-GTTCTTCSEEECCS
T ss_pred             CCCEEECCCCCCC-CCC-CCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCC-CCCC-CCCCCCCCCCCCCC
T ss_conf             8789989999997-752-02137886757545655667640-167752231111222222-2211-11122322211122


Q ss_pred             CCCC
Q ss_conf             4687
Q 002529          475 NSFV  478 (912)
Q Consensus       475 N~l~  478 (912)
                      |.+.
T Consensus       116 ~~~~  119 (199)
T d2omxa2         116 NQIT  119 (199)
T ss_dssp             SCCC
T ss_pred             CCCC
T ss_conf             2222

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.62  E-value=3.2e-08  Score=63.92  Aligned_cols=97  Identities=20%  Similarity=0.352  Sum_probs=75.6

Q ss_pred             CCCEEEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECC
Q ss_conf             99479999179977412992213633462462446557899988677543425421363324888876787554530034
Q 002529          393 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI  472 (912)
Q Consensus       393 ~~~l~~L~Ls~n~l~g~ip~~i~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l  472 (912)
                      .+.+..+.++++.+...  ..+..+++|+.|++++|.++... .++++++|+.|+|++|+++ .+|. ++.+++|+.|++
T Consensus       128 ~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~~-~l~~l~~L~~L~Ls~n~l~-~l~~-l~~l~~L~~L~L  202 (227)
T d1h6ua2         128 LSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLT-PLANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHL  202 (227)
T ss_dssp             CTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCC-CCGG-GGGCTTCCEEEC
T ss_pred             CCCHHHHHCHHHHHCHH--HHHCCCCCCCCCCCCCCCCCCCH-HHCCCCCCEECCCCCCCCC-CCHH-HCCCCCCCEEEC
T ss_conf             23012220000000000--00010211100233333333100-1056463356445888417-7853-447999998979


Q ss_pred             CCCCCCCCCCC-CCCCCCEEEEEC
Q ss_conf             01468789985-446795122104
Q 002529          473 ENNSFVGEIPP-ALLTGKVIFKYD  495 (912)
Q Consensus       473 ~~N~l~g~iP~-~~~~~~~~~~~~  495 (912)
                      ++|+++ .+|+ .-+..+..++++
T Consensus       203 s~N~lt-~i~~l~~l~~L~~L~ls  225 (227)
T d1h6ua2         203 KNNQIS-DVSPLANTSNLFIVTLT  225 (227)
T ss_dssp             TTSCCC-BCGGGTTCTTCCEEEEE
T ss_pred             CCCCCC-CCCCCCCCCCCCEEEEE
T ss_conf             599689-98020369998989712

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=98.54  E-value=1.9e-07  Score=59.19  Aligned_cols=78  Identities=26%  Similarity=0.345  Sum_probs=53.0

Q ss_pred             CCEEEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCC
Q ss_conf             94799991799774129922136334624624465578999886775434254213633248888767875545300340
Q 002529          394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE  473 (912)
Q Consensus       394 ~~l~~L~Ls~n~l~g~ip~~i~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~  473 (912)
                      ......++..+.+.+ ++   ..+++|+.|+|++|+|+.. |.  .+++|+.|+|++|+|+ .+|..   +.+|+.|+++
T Consensus       264 ~~~~~~~~~~~~~~~-~~---~~~~~L~~L~Ls~N~l~~l-p~--~~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~  332 (353)
T d1jl5a_         264 PNLYYLNASSNEIRS-LC---DLPPSLEELNVSNNKLIEL-PA--LPPRLERLIASFNHLA-EVPEL---PQNLKQLHVE  332 (353)
T ss_dssp             TTCCEEECCSSCCSE-EC---CCCTTCCEEECCSSCCSCC-CC--CCTTCCEEECCSSCCS-CCCCC---CTTCCEEECC
T ss_pred             CHHCCCCCCCCCCCC-CC---CCCCCCCEEECCCCCCCCC-CC--CCCCCCEEECCCCCCC-CCCCC---CCCCCEEECC
T ss_conf             000123333575323-45---6689889897979916835-66--5487998989999687-54532---2888989876


Q ss_pred             CCCCCCCCCC
Q ss_conf             1468789985
Q 002529          474 NNSFVGEIPP  483 (912)
Q Consensus       474 ~N~l~g~iP~  483 (912)
                      +|+++ .+|.
T Consensus       333 ~N~L~-~lp~  341 (353)
T d1jl5a_         333 YNPLR-EFPD  341 (353)
T ss_dssp             SSCCS-SCCC
T ss_pred             CCCCC-CCCC
T ss_conf             99189-7776

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.53  E-value=2.4e-07  Score=58.62  Aligned_cols=131  Identities=17%  Similarity=0.089  Sum_probs=87.0

Q ss_pred             CCCCCCC-EEEEEEEECCCCEEEEEECCCCCCHHHHHHHHHHHHHHHCC--CCCCCCEEEEEECCCEEEEEEEECCCCCH
Q ss_conf             0384660-89999996599799999814765145677999999998337--89852354698417728999993689999
Q 002529          597 KIGKGSF-GSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH--HRNLVPLIGYCEEEHQRILVYEYMHNGTL  673 (912)
Q Consensus       597 ~LG~G~f-G~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~il~~l~--HpnIv~l~~~~~~~~~~~lV~E~~~~gsL  673 (912)
                      .+..|.. +.||+....++..+++|.....   ....+..|...++.+.  .-.+.+++.+..+.+..++||++++|.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             ECCCCCCCCEEEEEEECCCCEEEEEECCCC---CHHHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEEECCCC
T ss_conf             767865477589999389878999958966---77689999999999986599988613222456615999874413554


Q ss_pred             HHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---------------------------------------------
Q ss_conf             88851478999889898999999999998898814---------------------------------------------
Q 002529          674 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG---------------------------------------------  708 (912)
Q Consensus       674 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLHs~---------------------------------------------  708 (912)
                      .+..        ...   ...+.++++.|+-||+.                                             
T Consensus        94 ~~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (255)
T d1nd4a_          94 LSSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF  162 (255)
T ss_dssp             TTSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred             CCCC--------CCH---HHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHH
T ss_conf             3221--------268---99999999999987368854488755412468899999987541101134011213799999


Q ss_pred             ----------CCCCEEECCCCCCCCCCCCCCCEEEEECCCCCC
Q ss_conf             ----------999806439999982125899499942067533
Q 002529          709 ----------CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ  741 (912)
Q Consensus       709 ----------~~~~ivH~DIkp~NILl~~~~~ikL~DFGla~~  741 (912)
                                ....++|+|+.+.|||++++..+.|+||+.+..
T Consensus       163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHCCCCCCCEEEECCCCCCCEEEECCCEEEEEECHHCCC
T ss_conf             9998718765795678678887635773796589998533265

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=98.47  E-value=1.1e-09  Score=72.66  Aligned_cols=86  Identities=21%  Similarity=0.284  Sum_probs=50.4

Q ss_pred             CCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCC--
Q ss_conf             299221363346246244655789998867754342542136332488887678755453003401468789985446--
Q 002529          409 EIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALL--  486 (912)
Q Consensus       409 ~ip~~i~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~iP~~~~--  486 (912)
                      .++.++..|++|+.|+|++|+|+.. +.+..+++|+.|+|++|+++ .+|.....+++|+.|++++|+++ .++. +.  
T Consensus        39 ~l~~sl~~L~~L~~L~Ls~n~I~~i-~~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~-~l~~-~~~l  114 (198)
T d1m9la_          39 KMDATLSTLKACKHLALSTNNIEKI-SSLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLSG-IEKL  114 (198)
T ss_dssp             CCHHHHHHTTTCCEEECSEEEESCC-CCHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC-CHHH-HHHH
T ss_pred             HHHHHHHCCCCCCEEECCCCCCCCC-CCCCCCCCCCCHHHCCCCCC-CCCCCCCCCCCCCCCCCCCCCCC-CCCC-CCCC
T ss_conf             0246776260461519944689986-44247825357341353432-10000332212333333332222-2222-2222


Q ss_pred             CCCEEEEECCCC
Q ss_conf             795122104998
Q 002529          487 TGKVIFKYDNNP  498 (912)
Q Consensus       487 ~~~~~~~~~~n~  498 (912)
                      ..+..+.+++|.
T Consensus       115 ~~L~~L~L~~N~  126 (198)
T d1m9la_         115 VNLRVLYMSNNK  126 (198)
T ss_dssp             HHSSEEEESEEE
T ss_pred             CCCCCCCCCCCH
T ss_conf             234111234102

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=98.38  E-value=6.3e-07  Score=56.06  Aligned_cols=59  Identities=27%  Similarity=0.475  Sum_probs=29.8

Q ss_pred             CCEEEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCC
Q ss_conf             9479999179977412992213633462462446557899988677543425421363324888876
Q 002529          394 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY  460 (912)
Q Consensus       394 ~~l~~L~Ls~n~l~g~ip~~i~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~  460 (912)
                      ++|++|+|++|.|+ .+|..   +++|+.|+|++|+|+. +|+.  +.+|+.|+|++|+++ .+|+.
T Consensus       284 ~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~~-l~~~--~~~L~~L~L~~N~L~-~lp~~  342 (353)
T d1jl5a_         284 PSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLAE-VPEL--PQNLKQLHVEYNPLR-EFPDI  342 (353)
T ss_dssp             TTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCSC-CCCC--CTTCCEEECCSSCCS-SCCCC
T ss_pred             CCCCEEECCCCCCC-CCCCC---CCCCCEEECCCCCCCC-CCCC--CCCCCEEECCCCCCC-CCCCC
T ss_conf             98898979799168-35665---4879989899996875-4532--288898987699189-77765

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.27  E-value=2.5e-06  Score=52.47  Aligned_cols=97  Identities=15%  Similarity=0.123  Sum_probs=45.9

Q ss_pred             CCEEEEECCCCCCCCCCCCCCCCCC-CCCEECCCCCCCCCCCCCCCCCCCC-CEEECCCCCCCCCCCC-CCCCCCCCCEE
Q ss_conf             9479999179977412992213633-4624624465578999886775434-2542136332488887-67875545300
Q 002529          394 PRITKIALSGKNLKGEIPPELKNME-ALTELWLDGNFLTGPLPDMSRLIDL-RIVHLENNELTGSLPS-YMGSLPNLQEL  470 (912)
Q Consensus       394 ~~l~~L~Ls~n~l~g~ip~~i~~l~-~L~~L~Ls~N~l~g~~p~~~~l~~L-~~L~L~~N~l~g~iP~-~l~~l~~L~~L  470 (912)
                      ..+..+...++.+...-+..+..++ .++.|++++|+++...+......++ +.+++++|+++ .+|. .+..+++|+.|
T Consensus       128 ~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l~-~l~~~~f~~l~~L~~L  206 (242)
T d1xwdc1         128 QKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVIL  206 (242)
T ss_dssp             SCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTCC-CCCTTTTTTSCCCSEE
T ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCHHHHCCCCCCCCCCC-CCCHHHHCCCCCCCEE
T ss_conf             112222222121112222222222331001220012333322222220111012123543246-4247886689999989


Q ss_pred             CCCCCCCCCCCCCCCCCCCEEE
Q ss_conf             3401468789985446795122
Q 002529          471 HIENNSFVGEIPPALLTGKVIF  492 (912)
Q Consensus       471 ~l~~N~l~g~iP~~~~~~~~~~  492 (912)
                      ++++|+++ .+|...+..+..+
T Consensus       207 ~Ls~N~l~-~l~~~~~~~l~~L  227 (242)
T d1xwdc1         207 DISRTRIH-SLPSYGLENLKKL  227 (242)
T ss_dssp             ECTTSCCC-CCCSSSCTTCCEE
T ss_pred             ECCCCCCC-CCCHHHHCCCCCC
T ss_conf             89799289-4597797377134

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.16  E-value=6.5e-06  Score=49.94  Aligned_cols=76  Identities=16%  Similarity=0.183  Sum_probs=49.7

Q ss_pred             HCCCCCCCCEEEEEEEECC-CCEEEEEECCCCC-------CHHHHHHHHHHHHHHHCC-C--CCCCCEEEEEECCCEEEE
Q ss_conf             0503846608999999659-9799999814765-------145677999999998337-8--985235469841772899
Q 002529          595 CKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSC-------SHRTQQFVTEVALLSRIH-H--RNLVPLIGYCEEEHQRIL  663 (912)
Q Consensus       595 ~~~LG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~-------~~~~~~~~~E~~il~~l~-H--pnIv~l~~~~~~~~~~~l  663 (912)
                      .+.||.|....||+....+ ++.+++|.-.+..       .........|.+.++.+. +  ..+.+++.+.  ....++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred             EEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEEC--CCCCEE
T ss_conf             998079852768999957998489996177130346777888778999999999986505798855289985--988779


Q ss_pred             EEEECCCCC
Q ss_conf             999368999
Q 002529          664 VYEYMHNGT  672 (912)
Q Consensus       664 V~E~~~~gs  672 (912)
                      |||++++..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEECCCCCC
T ss_conf             871357765

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.91  E-value=6.5e-07  Score=55.98  Aligned_cols=73  Identities=25%  Similarity=0.214  Sum_probs=45.9

Q ss_pred             CCCCCCCCCCCCCEECCCCCCCCCCCC--C-CCCCCCCCEEECCCCCCCCCCCC-CCCCCCCCCEECCCCCCCCCCCC
Q ss_conf             299221363346246244655789998--8-67754342542136332488887-67875545300340146878998
Q 002529          409 EIPPELKNMEALTELWLDGNFLTGPLP--D-MSRLIDLRIVHLENNELTGSLPS-YMGSLPNLQELHIENNSFVGEIP  482 (912)
Q Consensus       409 ~ip~~i~~l~~L~~L~Ls~N~l~g~~p--~-~~~l~~L~~L~L~~N~l~g~iP~-~l~~l~~L~~L~l~~N~l~g~iP  482 (912)
                      .++.....+++|+.|+|++|+|+...+  . +..+++|+.|+|++|+++ .+++ ......+|+.|++++|.++....
T Consensus        56 ~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~~~  132 (162)
T d1koha1          56 TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSDTFR  132 (162)
T ss_dssp             HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSSSSS
T ss_pred             HHHHHHHHCCCCCEEECCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCC-CCHHHHHHHCCCCCEEECCCCCCCCCCC
T ss_conf             6078897487878863777666677315889865885610004357213-4234422203310426648997676766

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.81  E-value=0.00015  Score=41.67  Aligned_cols=138  Identities=12%  Similarity=0.125  Sum_probs=77.9

Q ss_pred             CCCEEEEEEEECCCCEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCC--CCEEE-----EEECCCEEEEEEEECCCCCH
Q ss_conf             660899999965997999998147651456779999999983378985--23546-----98417728999993689999
Q 002529          601 GSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNL--VPLIG-----YCEEEHQRILVYEYMHNGTL  673 (912)
Q Consensus       601 G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnI--v~l~~-----~~~~~~~~~lV~E~~~~gsL  673 (912)
                      +.-..||+++.++|+.+++|+.++. ....+++..|...+..|....+  +..+.     .....+..+.++++++|..+
T Consensus        33 s~EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~  111 (325)
T d1zyla1          33 SYENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF  111 (325)
T ss_dssp             CSSSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred             CCCCEEEEEECCCCCEEEEEEECCC-CCCHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCCCCC
T ss_conf             6120269998389997999984787-788999999999999998559987875206898056653479999865277688


Q ss_pred             ------------------HHHHCCCC--CCCCCCHH----------------------HHHHHHHHHHHHHHHH-HHCCC
Q ss_conf             ------------------88851478--99988989----------------------8999999999998898-81499
Q 002529          674 ------------------RDRLHGSV--NQKPLDWL----------------------TRLQIAHDAAKGLEYL-HTGCN  710 (912)
Q Consensus       674 ------------------~~~l~~~~--~~~~l~~~----------------------~~~~i~~qia~aL~yL-Hs~~~  710 (912)
                                        ........  .....++.                      .....+.++...+.-+ .....
T Consensus       112 ~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p  191 (325)
T d1zyla1         112 EADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT  191 (325)
T ss_dssp             CSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCC
T ss_conf             99999999998999999886303578655677897887665689998747699889899999999999999984545687


Q ss_pred             CCEEECCCCCCCCCCCCCCCEEEEECCCCCC
Q ss_conf             9806439999982125899499942067533
Q 002529          711 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQ  741 (912)
Q Consensus       711 ~~ivH~DIkp~NILl~~~~~ikL~DFGla~~  741 (912)
                      .+++|+|+.+.|||++++  ..+.||+-+..
T Consensus       192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         192 VLRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             CEEECCCCCCCCEEEECC--CEEEECHHCCC
T ss_conf             120247888042878389--35886520146

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.74  E-value=0.00013  Score=42.09  Aligned_cols=73  Identities=14%  Similarity=0.246  Sum_probs=49.7

Q ss_pred             HCCCCCCCCEEEEEEEECC--------CCEEEEEECCCCCCHHHHHHHHHHHHHHHCC-CCCCCCEEEEEECCCEEEEEE
Q ss_conf             0503846608999999659--------9799999814765145677999999998337-898523546984177289999
Q 002529          595 CKKIGKGSFGSVYYGKMKD--------GKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVY  665 (912)
Q Consensus       595 ~~~LG~G~fG~Vy~~~~~~--------g~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lV~  665 (912)
                      .+.|+.|-.-.+|++...+        .+.|.+++.... .. .....+|..+++.+. +.-..++++++.+    .+|+
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ET-ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CC-HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECCCC-CH-HHHHHHHHHHHHHHHHCCCCCEEEEECCC----CEEE
T ss_conf             999178533434899968877544578981799965996-11-65899999999999757999808998189----5699


Q ss_pred             EECCCCCH
Q ss_conf             93689999
Q 002529          666 EYMHNGTL  673 (912)
Q Consensus       666 E~~~~gsL  673 (912)
                      ||++|..+
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEECCCCC
T ss_conf             97345548

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.66  E-value=4.6e-06  Score=50.84  Aligned_cols=78  Identities=23%  Similarity=0.318  Sum_probs=35.6

Q ss_pred             CCEEEEECCCCCCCCC--CCCCCCCCCCCCEECCCCCCCCCCCC-CCCCCCCCCEEECCCCCCCCCCCCC-------CCC
Q ss_conf             9479999179977412--99221363346246244655789998-8677543425421363324888876-------787
Q 002529          394 PRITKIALSGKNLKGE--IPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSY-------MGS  463 (912)
Q Consensus       394 ~~l~~L~Ls~n~l~g~--ip~~i~~l~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~-------l~~  463 (912)
                      +.|+.|+|++|+|+..  ++..+..+++|+.|+|++|.++...+ .......|+.|++++|.++......       +..
T Consensus        65 ~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~  144 (162)
T d1koha1          65 PELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRER  144 (162)
T ss_dssp             TTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTT
T ss_pred             CCCCEEECCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHCCCCCEEECCCCCCCCCCCCCHHHHHHHHHH
T ss_conf             78788637776666773158898658856100043572134234422203310426648997676766615699999998


Q ss_pred             CCCCCEEC
Q ss_conf             55453003
Q 002529          464 LPNLQELH  471 (912)
Q Consensus       464 l~~L~~L~  471 (912)
                      +|+|+.||
T Consensus       145 ~P~L~~LD  152 (162)
T d1koha1         145 FPKLLRLD  152 (162)
T ss_dssp             STTCCEET
T ss_pred             CCCCCEEC
T ss_conf             89978799

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.65  E-value=6.5e-07  Score=56.00  Aligned_cols=60  Identities=20%  Similarity=0.193  Sum_probs=24.4

Q ss_pred             CEEEEECCCCCCCCCC-CCCCCCCCCCCEECCCCCCCCCC----CC-CCCCCCCCCEEECCCCCCC
Q ss_conf             4799991799774129-92213633462462446557899----98-8677543425421363324
Q 002529          395 RITKIALSGKNLKGEI-PPELKNMEALTELWLDGNFLTGP----LP-DMSRLIDLRIVHLENNELT  454 (912)
Q Consensus       395 ~l~~L~Ls~n~l~g~i-p~~i~~l~~L~~L~Ls~N~l~g~----~p-~~~~l~~L~~L~L~~N~l~  454 (912)
                      +|+.||++.+++++.. ..-+..+++++.|+|++|.++..    +. .+..+++|+.|+|++|+++
T Consensus         3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~   68 (460)
T d1z7xw1           3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELG   68 (460)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCH
T ss_pred             CCCEEEEECCCCCHHHHHHHHHHCCCCCEEEECCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCC
T ss_conf             877798208958868999999767799999828999988999999999853999888979598597

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.59  E-value=9.4e-07  Score=55.02  Aligned_cols=85  Identities=31%  Similarity=0.392  Sum_probs=62.9

Q ss_pred             CCEEEEECCCCCCCC----CCCCCCCCCCCCCEECCCCCCCCCC----CC-CCC-CCCCCCEEECCCCCCCCC----CCC
Q ss_conf             947999917997741----2992213633462462446557899----98-867-754342542136332488----887
Q 002529          394 PRITKIALSGKNLKG----EIPPELKNMEALTELWLDGNFLTGP----LP-DMS-RLIDLRIVHLENNELTGS----LPS  459 (912)
Q Consensus       394 ~~l~~L~Ls~n~l~g----~ip~~i~~l~~L~~L~Ls~N~l~g~----~p-~~~-~l~~L~~L~L~~N~l~g~----iP~  459 (912)
                      .+++.|+|++|+++-    .+...+..+++|+.|+|++|.|+..    +. .+. ...+|+.|+|++|+++..    ++.
T Consensus        27 ~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~  106 (460)
T d1z7xw1          27 QQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSS  106 (460)
T ss_dssp             TTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHH
T ss_pred             CCCCEEEECCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHCCCCCCCEEECCCCCCCCCCCCCCCC
T ss_conf             79999982899998899999999985399988897959859728999999998437887788778887754322101211


Q ss_pred             CCCCCCCCCEECCCCCCCC
Q ss_conf             6787554530034014687
Q 002529          460 YMGSLPNLQELHIENNSFV  478 (912)
Q Consensus       460 ~l~~l~~L~~L~l~~N~l~  478 (912)
                      .+..+++|+.|++++|.+.
T Consensus       107 ~l~~~~~L~~L~L~~N~i~  125 (460)
T d1z7xw1         107 TLRTLPTLQELHLSDNLLG  125 (460)
T ss_dssp             HTTSCTTCCEEECCSSBCH
T ss_pred             HHHCCCCCCCCCCCCCCCH
T ss_conf             0000343200244433202

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.24  E-value=6.8e-05  Score=43.79  Aligned_cols=82  Identities=22%  Similarity=0.301  Sum_probs=36.9

Q ss_pred             CCEEEEECCCC--CCCCC-CCCCCCCCCCCCEECCCCC-CCCCCCC-CCCCCCCCCEEECCC-CCCCCCCCCCCCCCCCC
Q ss_conf             94799991799--77412-9922136334624624465-5789998-867754342542136-33248888767875545
Q 002529          394 PRITKIALSGK--NLKGE-IPPELKNMEALTELWLDGN-FLTGPLP-DMSRLIDLRIVHLEN-NELTGSLPSYMGSLPNL  467 (912)
Q Consensus       394 ~~l~~L~Ls~n--~l~g~-ip~~i~~l~~L~~L~Ls~N-~l~g~~p-~~~~l~~L~~L~L~~-N~l~g~iP~~l~~l~~L  467 (912)
                      +.++.|++++.  +++.. +..-..++++|+.|+|++| .+++... .+.++++|+.|+|++ +++++.....++++++|
T Consensus       148 ~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L  227 (284)
T d2astb2         148 ETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTL  227 (284)
T ss_dssp             TTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTC
T ss_pred             CCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCEEECCCCCCCCHHHHHHHHCCCCC
T ss_conf             11101221355424444434342323222123553223477830333321357687798999997873789997269998


Q ss_pred             CEECCCCC
Q ss_conf             30034014
Q 002529          468 QELHIENN  475 (912)
Q Consensus       468 ~~L~l~~N  475 (912)
                      +.|+++++
T Consensus       228 ~~L~l~~~  235 (284)
T d2astb2         228 KTLQVFGI  235 (284)
T ss_dssp             CEEECTTS
T ss_pred             CEEEEECC
T ss_conf             98964488

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.12  E-value=6.1e-05  Score=44.05  Aligned_cols=85  Identities=21%  Similarity=0.280  Sum_probs=40.3

Q ss_pred             CCEEEEECCCC-CCCCC-CCCCCCCC-CCCCEECCCCC--CCCCC-CCC-CCCCCCCCEEECCCC-CCCCCCCCCCCCCC
Q ss_conf             94799991799-77412-99221363-34624624465--57899-988-677543425421363-32488887678755
Q 002529          394 PRITKIALSGK-NLKGE-IPPELKNM-EALTELWLDGN--FLTGP-LPD-MSRLIDLRIVHLENN-ELTGSLPSYMGSLP  465 (912)
Q Consensus       394 ~~l~~L~Ls~n-~l~g~-ip~~i~~l-~~L~~L~Ls~N--~l~g~-~p~-~~~l~~L~~L~L~~N-~l~g~iP~~l~~l~  465 (912)
                      ++|+.|+++++ +++.. +...+..+ +.|+.|+|++.  .++.. +.. ..++++|+.|++++| .+++..+..+++++
T Consensus       121 ~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~  200 (284)
T d2astb2         121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLN  200 (284)
T ss_dssp             TTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCT
T ss_pred             HHCCCCCCCCCCCCCCCCCHHHHCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHCCCC
T ss_conf             74356522453323332200010001111101221355424444434342323222123553223477830333321357


Q ss_pred             CCCEECCCCC-CCC
Q ss_conf             4530034014-687
Q 002529          466 NLQELHIENN-SFV  478 (912)
Q Consensus       466 ~L~~L~l~~N-~l~  478 (912)
                      +|+.|+++++ .++
T Consensus       201 ~L~~L~L~~C~~i~  214 (284)
T d2astb2         201 YLQHLSLSRCYDII  214 (284)
T ss_dssp             TCCEEECTTCTTCC
T ss_pred             CCCEEECCCCCCCC
T ss_conf             68779899999787

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=97.04  E-value=1.9e-05  Score=47.19  Aligned_cols=64  Identities=22%  Similarity=0.311  Sum_probs=25.0

Q ss_pred             CCCCCCCEECCCCCCCCCC-----C-CCCCCCCCCCEEECCCCCCCCC----CCCCCCCCCCCCEECCCCCCCC
Q ss_conf             3633462462446557899-----9-8867754342542136332488----8876787554530034014687
Q 002529          415 KNMEALTELWLDGNFLTGP-----L-PDMSRLIDLRIVHLENNELTGS----LPSYMGSLPNLQELHIENNSFV  478 (912)
Q Consensus       415 ~~l~~L~~L~Ls~N~l~g~-----~-p~~~~l~~L~~L~L~~N~l~g~----iP~~l~~l~~L~~L~l~~N~l~  478 (912)
                      ..+..|+.|+|++|+++..     + ..+..+++|+.|+|++|.++..    +...+..+++|+.|+|++|.++
T Consensus       183 ~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~  256 (344)
T d2ca6a1         183 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS  256 (344)
T ss_dssp             HHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCC
T ss_pred             HHHHHHCCCCCCCCCCCCCCCCCCHHHHHCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHCCCCC
T ss_conf             23332133543332222222320024332110121122233332222222234443323221111030047567

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.04  E-value=0.0052  Score=32.39  Aligned_cols=143  Identities=13%  Similarity=0.107  Sum_probs=74.7

Q ss_pred             CCCCCCCCEEEEEEEECCCCEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCC--CCCEEE------EEECCCEEEEEEEE
Q ss_conf             5038466089999996599799999814765145677999999998337898--523546------98417728999993
Q 002529          596 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRN--LVPLIG------YCEEEHQRILVYEY  667 (912)
Q Consensus       596 ~~LG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~il~~l~Hpn--Iv~l~~------~~~~~~~~~lV~E~  667 (912)
                      +.|..|.-.+.|+....+|+ +++|+.....  ..+.+..|.+++..+...+  +...+.      +.........++.+
T Consensus        24 ~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~  100 (316)
T d2ppqa1          24 KGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF  100 (316)
T ss_dssp             EEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred             ECCCCCCCCCEEEEEECCCC-EEEEECCCCC--CHHHHHHHHHHHHHHHHCCCCCCCCCEECCCCCCEEEECCCCEEEEE
T ss_conf             23788852673899978972-8999807899--98899999999875430255545564104897621341255024531


Q ss_pred             CCCCCHH--------------HHHCC----CCCCC--CCC------------------HHHHHHHHHHHHHHHHHHH-HC
Q ss_conf             6899998--------------88514----78999--889------------------8989999999999988988-14
Q 002529          668 MHNGTLR--------------DRLHG----SVNQK--PLD------------------WLTRLQIAHDAAKGLEYLH-TG  708 (912)
Q Consensus       668 ~~~gsL~--------------~~l~~----~~~~~--~l~------------------~~~~~~i~~qia~aL~yLH-s~  708 (912)
                      ..+....              ..++.    .....  ...                  .......+..+...+...+ ..
T Consensus       101 ~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  180 (316)
T d2ppqa1         101 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD  180 (316)
T ss_dssp             CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred             CCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHCCHHHHHHHHHHHHHHHCCCCCC
T ss_conf             14655333204678888899876454443202453101110120024567777653114127999999987642048554


Q ss_pred             CCCCEEECCCCCCCCCCCCCCCEEEEECCCCCC
Q ss_conf             999806439999982125899499942067533
Q 002529          709 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ  741 (912)
Q Consensus       709 ~~~~ivH~DIkp~NILl~~~~~ikL~DFGla~~  741 (912)
                      ...+++|+|+.+.|++++.+...-+.||+.+..
T Consensus       181 L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         181 LPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             SCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             CCCCCCCCCCCHHHHHCCCCCCEEEECCCCCCC
T ss_conf             545033378636564020454126742221236

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=97.02  E-value=2.6e-05  Score=46.28  Aligned_cols=15  Identities=27%  Similarity=0.260  Sum_probs=5.3

Q ss_pred             CCCCCCEEECCCCCC
Q ss_conf             754342542136332
Q 002529          439 RLIDLRIVHLENNEL  453 (912)
Q Consensus       439 ~l~~L~~L~L~~N~l  453 (912)
                      ..+.|+.|+|++|.+
T Consensus       241 ~~~~L~~L~Ls~n~i  255 (344)
T d2ca6a1         241 SWPNLRELGLNDCLL  255 (344)
T ss_dssp             GCTTCCEEECTTCCC
T ss_pred             CCCCCHHHHHHCCCC
T ss_conf             322111103004756

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=96.21  E-value=0.00019  Score=41.08  Aligned_cols=88  Identities=14%  Similarity=0.156  Sum_probs=62.8

Q ss_pred             CCEEEEECCCC-CCCCC----CCCCCCCCCCCCEECCCCCCCCCCC--C---CCCCCCCCCEEECCCCCCCCC----CCC
Q ss_conf             94799991799-77412----9922136334624624465578999--8---867754342542136332488----887
Q 002529          394 PRITKIALSGK-NLKGE----IPPELKNMEALTELWLDGNFLTGPL--P---DMSRLIDLRIVHLENNELTGS----LPS  459 (912)
Q Consensus       394 ~~l~~L~Ls~n-~l~g~----ip~~i~~l~~L~~L~Ls~N~l~g~~--p---~~~~l~~L~~L~L~~N~l~g~----iP~  459 (912)
                      +.|+.|+|+++ .+...    +-..+...+.|+.|+|++|.+...-  .   .+...+.|+.|+|++|.++..    +-.
T Consensus        15 ~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~   94 (167)
T d1pgva_          15 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR   94 (167)
T ss_dssp             SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred             CCCCEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCCEEEEHHHCCHHHHHHHHH
T ss_conf             99819782799998989999999997637764540120156215679887531000234330033010214599999999


Q ss_pred             CCCCCCCCCEECCCCCCCCCCCC
Q ss_conf             67875545300340146878998
Q 002529          460 YMGSLPNLQELHIENNSFVGEIP  482 (912)
Q Consensus       460 ~l~~l~~L~~L~l~~N~l~g~iP  482 (912)
                      .+...+.|+.|++++|.+. .+-
T Consensus        95 aL~~n~sL~~L~l~~n~~~-~~g  116 (167)
T d1pgva_          95 STLVTQSIVEFKADNQRQS-VLG  116 (167)
T ss_dssp             HTTTTCCCSEEECCCCSSC-CCC
T ss_pred             HHHHCCCCCEEECCCCCCC-CCC
T ss_conf             9984893898778877688-865

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=94.17  E-value=0.0016  Score=35.54  Aligned_cols=61  Identities=18%  Similarity=0.210  Sum_probs=32.7

Q ss_pred             CCEEEEECCCCCCCCCCC----CCCCCCCCCCEECCCCCCCCCCCC-----CCCCCCCCCEEECCCCCCC
Q ss_conf             947999917997741299----221363346246244655789998-----8677543425421363324
Q 002529          394 PRITKIALSGKNLKGEIP----PELKNMEALTELWLDGNFLTGPLP-----DMSRLIDLRIVHLENNELT  454 (912)
Q Consensus       394 ~~l~~L~Ls~n~l~g~ip----~~i~~l~~L~~L~Ls~N~l~g~~p-----~~~~l~~L~~L~L~~N~l~  454 (912)
                      ..|+.|+|++|.+...-.    ..+...+.|+.|+|++|.++..--     .+..-+.|+.|+|++|++.
T Consensus        44 ~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~  113 (167)
T d1pgva_          44 KHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQS  113 (167)
T ss_dssp             SCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSC
T ss_pred             CCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCCEEEEHHHCCHHHHHHHHHHHHHCCCCCEEECCCCCCC
T ss_conf             7645401201562156798875310002343300330102145999999999984893898778877688

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=90.96  E-value=0.0072  Score=31.55  Aligned_cols=85  Identities=21%  Similarity=0.292  Sum_probs=49.7

Q ss_pred             CCEEEEECCC-CCCCCC----CCCCCCCCCCCCEECCCCCCCCCCCC-----CCCCCCCCCEEECCCCCCCCC----CCC
Q ss_conf             9479999179-977412----99221363346246244655789998-----867754342542136332488----887
Q 002529          394 PRITKIALSG-KNLKGE----IPPELKNMEALTELWLDGNFLTGPLP-----DMSRLIDLRIVHLENNELTGS----LPS  459 (912)
Q Consensus       394 ~~l~~L~Ls~-n~l~g~----ip~~i~~l~~L~~L~Ls~N~l~g~~p-----~~~~l~~L~~L~L~~N~l~g~----iP~  459 (912)
                      +.|+.|+|++ +.++..    +-..+...+.|+.|+|++|.++...-     .+...+.|+.|++++|.++..    +-.
T Consensus        17 ~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~   96 (166)
T d1io0a_          17 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE   96 (166)
T ss_dssp             TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred             CCCCEEECCCCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCHHHHHCCCCCCCHHHHHHHH
T ss_conf             99868876899998989999999888419825743015896117789999987752122101210254322014788999


Q ss_pred             CCCCCCCCCEECC--CCCCCC
Q ss_conf             6787554530034--014687
Q 002529          460 YMGSLPNLQELHI--ENNSFV  478 (912)
Q Consensus       460 ~l~~l~~L~~L~l--~~N~l~  478 (912)
                      .+...++|+.++|  ++|.+.
T Consensus        97 ~l~~~~~L~~l~L~l~~n~i~  117 (166)
T d1io0a_          97 ALQSNTSLIELRIDNQSQPLG  117 (166)
T ss_dssp             GGGGCSSCCEEECCCCSSCCC
T ss_pred             HHHHCCCCCEEEECCCCCCCC
T ss_conf             998486524773216778676

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=87.50  E-value=0.01  Score=30.63  Aligned_cols=83  Identities=14%  Similarity=0.245  Sum_probs=40.3

Q ss_pred             CCEEEEECCCCCCCCCC----CCCCCCCCCCCEECCCCCCCCCCC-----CCCCCCCCCCEEEC--CCCCCCC----CCC
Q ss_conf             94799991799774129----922136334624624465578999-----88677543425421--3633248----888
Q 002529          394 PRITKIALSGKNLKGEI----PPELKNMEALTELWLDGNFLTGPL-----PDMSRLIDLRIVHL--ENNELTG----SLP  458 (912)
Q Consensus       394 ~~l~~L~Ls~n~l~g~i----p~~i~~l~~L~~L~Ls~N~l~g~~-----p~~~~l~~L~~L~L--~~N~l~g----~iP  458 (912)
                      +.|+.|+|++|.+....    ...+...+.++.|++++|.++...     ..+...+.|+.++|  ++|.+..    .+.
T Consensus        46 ~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La  125 (166)
T d1io0a_          46 TYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIA  125 (166)
T ss_dssp             CSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHH
T ss_pred             CCCCEEECCCCCCCHHHHHHHHHHHHHCCCCHHHHHCCCCCCCHHHHHHHHHHHHCCCCCEEEECCCCCCCCHHHHHHHH
T ss_conf             82574301589611778999998775212210121025432201478899999848652477321677867679999999


Q ss_pred             CCCCCCCCCCEECCCCCC
Q ss_conf             767875545300340146
Q 002529          459 SYMGSLPNLQELHIENNS  476 (912)
Q Consensus       459 ~~l~~l~~L~~L~l~~N~  476 (912)
                      +.+...+.|+.|+++.+.
T Consensus       126 ~~L~~n~~L~~L~l~~~~  143 (166)
T d1io0a_         126 NMLEKNTTLLKFGYHFTQ  143 (166)
T ss_dssp             HHHHHCSSCCEEECCCSS
T ss_pred             HHHHHCCCCCEEECCCCC
T ss_conf             999849984788581898